PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Li, L; Kumar, U; You, J; Zhou, YF; Weiss, SA; Engel, J; Bragin, A				Li, Lin; Kumar, Udaya; You, Jing; Zhou, Yufeng; Weiss, Shennan A.; Engel, Jerome; Bragin, Anatol			Spatial and temporal profile of high-frequency oscillations in posttraumatic epileptogenesis	NEUROBIOLOGY OF DISEASE			English	Article						Ripple; Fast ripple; Extrahippocampal HFO; Posttraumatic epilepsy; Epileptogenesis	TRAUMATIC BRAIN-INJURY; HUMAN EPILEPTIC BRAIN; FAST RIPPLES; 80-500 HZ; MODEL; ONSET; NETWORK; HIPPOCAMPAL; GENERATION; FEATURES	We studied the role of temporal and spatial changes in high-frequency oscillation (HFO, 80-500 Hz) generation in epileptogenesis following traumatic brain injury (TBI). Experiments were conducted on adult male Sprague Dawley rats. For the TBI group, fluid percussion injury (FPI) on the left sensorimotor area was performed to induce posttraumatic epileptogenesis. For the sham control group, only the craniotomy was performed. After TBI, 8 bipolar micro-electrodes were implanted bilaterally in the prefrontal cortex, perilesional area and homotopic contralateral site, striatum, and hippocampus. Long-term video/local field potential (LFP) recordings were performed for up to 21 weeks to identify and characterize seizures and capture HFOs. The electrode tip locations and the volume of post TBI brain lesions were further estimated by ex-vivo MRI scans. HFOs were detected during slow-wave sleep and categorized as ripple (80-200 Hz) and fast ripple (FR, 250-500 Hz) events. HFO rates and the HFO peak frequencies were compared in the 8 recording locations and across 8-weeks following TBI. Data from 48 rats (8 sham controls and 40 TBI rats) were analyzed. Within the TBI group, 22 rats (55%) developed recurrent spontaneous seizures (E+ group), at an average of 62.2 (+17.1) days, while 18 rats (45%) did not (E- group). We observed that the HFOs in the E+ group had a higher mean peak frequency than the Egroup and the sham group (P < 0.05). Furthermore, the FR rate of the E+ group showed a significant increase compared to the E-group (P < 0.01) and sham control group (P < 0.01), specifically in the perilesional area, homotopic contralateral site, bilateral hippocampus, and to a lesser degree bilateral striatum. When compared across time, the increased FR rate in the E+ group occurred immediately after the insult and remained stable across the duration of the experiment. In addition, lesion size was not statistically different in the E+ and Egroup and was not correlated with HFO rates. Our results suggest that TBI results in the formation of a widespread epileptogenic network. FR rates serve as a biomarker of network formation and predict the future development of epilepsy, however FR are not a temporally specific biomarker of TBI sequelae responsible for epileptogenesis. These results suggest that in patients, future risk of post-TBI epilepsy can be predicted early using FR.	[Li, Lin; Kumar, Udaya; Engel, Jerome; Bragin, Anatol] Univ Calif Los Angeles, Dept Neurol, 710 Westwood Plz, Los Angeles, CA 90095 USA; [Li, Lin; You, Jing; Zhou, Yufeng] Univ North Texas, Dept Biomed Engn, 3940 N Elm, Denton, TX 76207 USA; [Weiss, Shennan A.] State Univ New York Downstate, Dept Neurol, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Weiss, Shennan A.] New York City Hlth Hosp Kings Cty, Dept Neurol, Brooklyn, NY 11203 USA; [Engel, Jerome; Bragin, Anatol] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Engel, Jerome] Univ Calif Los Angeles, Dept Neurobiol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Engel, Jerome] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, David Geffen Sch Med, Los Angeles, CA 90095 USA		Bragin, A (corresponding author), Univ Calif Los Angeles, Dept Neurol, 710 Westwood Plz, Los Angeles, CA 90095 USA.; Li, L (corresponding author), Univ North Texas, Dept Biomed Engn, 3940 N Elm, Denton, TX 76207 USA.	lin.li@unt.edu; abragin@mednet.ucla.edu		LI, LIN/0000-0002-9996-9377; Bragin, Anatol/0000-0003-1207-8481	National Institutes of Health, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS065877, R56-NS065877, R01-NS033310, U54NS100064]; University of North Texas Faculty Research Award [1600733]	This study was supported by National Institutes of Health, USA R01NS065877 and R56-NS065877 (A.B), R01-NS033310 (J.E), U54NS100064 (J.E), and University of North Texas Faculty Research Award 1600733 (L.L).	Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bernardo D, 2020, CLIN NEUROPHYSIOL, V131, P1433, DOI 10.1016/j.clinph.2020.03.025; Bertoglio D, 2019, NEUROBIOL DIS, V127, P45, DOI 10.1016/j.nbd.2019.02.012; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; Bragin A, 2004, EPILEPSIA, V45, P1017, DOI 10.1111/j.0013-9580.2004.17004.x; Bragin A, 2003, EPILEPSIA, V44, P1233, DOI 10.1046/j.1528-1157.2003.18503.x; Bragin A, 2002, ANN NEUROL, V52, P407, DOI 10.1002/ana.10291; Bragin A, 2002, J NEUROSCI, V22, P2012, DOI 10.1523/JNEUROSCI.22-05-02012.2002; Bragin A, 2000, EPILEPSIA, V41, pS144, DOI 10.1111/j.1528-1157.2000.tb01573.x; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Chauviere L, 2012, ANN NEUROL, V71, P805, DOI 10.1002/ana.23549; Courrieu P, 2011, BEHAV RES METHODS, V43, P310, DOI 10.3758/s13428-011-0071-2; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Fedele T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13064-1; Ferrari-Marinho T, 2016, EPILEPSY RES, V127, P200, DOI 10.1016/j.eplepsyres.2016.09.009; Frauscher B, 2017, EPILEPSIA, V58, P1316, DOI 10.1111/epi.13829; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Giza CC, 2002, J NEUROTRAUM, V19, P387, DOI 10.1089/08977150252932352; Grosmark AD, 2012, NEURON, V75, P1001, DOI 10.1016/j.neuron.2012.08.015; Jacobs J, 2008, EPILEPSIA, V49, P1893, DOI 10.1111/j.1528-1167.2008.01656.x; Jenkinson M., 2005, 11 ANN M ORG HUM BRA; Jiruska P, 2010, BRAIN, V133, P1380, DOI 10.1093/brain/awq070; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; KEMP B, 1992, ELECTROEN CLIN NEURO, V82, P391, DOI 10.1016/0013-4694(92)90009-7; Kendirli MT, 2014, EPILEPSIA, V55, P1969, DOI 10.1111/epi.12854; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Li L, 2021, EPILEPSIA, V62, P1231, DOI 10.1111/epi.16863; Li L, 2018, EPILEPSIA, V59, pE51, DOI 10.1111/epi.14041; Li L, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.5.050801; Manninen E, 2020, J NEUROTRAUM, V37, P2580, DOI 10.1089/neu.2019.6796; Modur PN, 2011, EPILEPSIA, V52, P1792, DOI 10.1111/j.1528-1167.2011.03165.x; Otarula KAG, 2018, BRAIN, V141, P731, DOI 10.1093/brain/awx383; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perucca P, 2014, BRAIN, V137, P183, DOI 10.1093/brain/awt299; Pitkanen A, 2016, LANCET NEUROL, V15, P843, DOI 10.1016/S1474-4422(16)00112-5; Pitkanen A, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022822; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Pizzo F, 2016, BRAIN TOPOGR, V29, P358, DOI 10.1007/s10548-016-0481-7; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Rehulka P, 2019, CLIN NEUROPHYSIOL, V130, P1151, DOI 10.1016/j.clinph.2019.03.026; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Sheybani L, 2018, J NEUROSCI, V38, P3776, DOI 10.1523/JNEUROSCI.2193-17.2018; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Staba RJ, 2002, J NEUROPHYSIOL, V88, P1743, DOI 10.1152/jn.2002.88.4.1743; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; Waldman ZJ, 2018, CLIN NEUROPHYSIOL, V129, P308, DOI 10.1016/j.clinph.2017.10.004; Worrell GA, 2004, BRAIN, V127, P1496, DOI 10.1093/brain/awh149; Wu JY, 2010, NEUROLOGY, V75, P1686, DOI 10.1212/WNL.0b013e3181fc27d0; Yung Y.-F., 1996, ADV STRUCTURAL EQUAT, P195; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zijlmans M, 2012, ANN NEUROL, V71, P169, DOI 10.1002/ana.22548	54	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	DEC	2021	161								105544	10.1016/j.nbd.2021.105544			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WY4MD	WOS:000719251600005	34742877	gold			2022-02-06	
J	Li, X; Julin, P; Li, TQ				Li, Xia; Julin, Per; Li, Tie-Qiang			Limbic Perfusion Is Reduced in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)	TOMOGRAPHY			English	Article						chronic fatigue syndrome; regional cerebral blood flow; pseudo-continuous arterial spin labeling; sustained attention; magnetic resonance imaging; limbic system	CEREBRAL-BLOOD-FLOW; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; COGNITIVE FATIGUE; HOSPITAL ANXIETY; SEVERITY SCALE; FRONTAL-CORTEX; BOLUS TRACKING; ASL PERFUSION; REPRODUCIBILITY	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an illness characterized by a diverse range of debilitating symptoms including autonomic, immunologic, and cognitive dysfunction. Although neurological and cognitive aberrations have been consistently reported, relatively little is known regarding the regional cerebral blood flow (rCBF) in ME/CFS. In this study, we studied a cohort of 31 ME/CSF patients (average age: 42.8 +/- 13.5 years) and 48 healthy controls (average age: 42.9 +/- 12.0 years) using the pseudo-continuous arterial spin labeling (PCASL) technique on a whole-body clinical 3T MRI scanner. Besides routine clinical MRI, the protocol included a session of over 8 min-long rCBF measurement. The differences in the rCBF between the ME/CSF patients and healthy controls were statistically assessed with voxel-wise and AAL ROI-based two-sample t-tests. Linear regression analysis was also performed on the rCBF data by using the symptom severity score as the main regressor. In comparison with the healthy controls, the patient group showed significant hypoperfusion (uncorrected voxel wise p <= 0.001, FWE p <= 0.01) in several brain regions of the limbic system, including the anterior cingulate cortex, putamen, pallidum, and anterior ventral insular area. For the ME/CFS patients, the overall symptom severity score at rest was significantly associated with a reduced rCBF in the anterior cingulate cortex. The results of this study show that brain blood flow abnormalities in the limbic system may contribute to ME/CFS pathogenesis.	[Li, Xia; Li, Tie-Qiang] China Jiliang Univ, Inst Informat Engn, 258 Xueyuan St, Hangzhou 310018, Peoples R China; [Julin, Per] Karolinska Inst, Dept Neurobiol Care Sci & Soc, S-17177 Stockholm, Sweden; [Li, Tie-Qiang] Karolinska Inst, Dept Clin Sci Intervent & Technol, S-17177 Stockholm, Sweden; [Li, Tie-Qiang] Karolinska Univ Hosp, Dept Med Radiat & Nucl Med, C2-76, S-14186 Stockholm, Sweden		Li, TQ (corresponding author), China Jiliang Univ, Inst Informat Engn, 258 Xueyuan St, Hangzhou 310018, Peoples R China.; Li, TQ (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, S-17177 Stockholm, Sweden.; Li, TQ (corresponding author), Karolinska Univ Hosp, Dept Med Radiat & Nucl Med, C2-76, S-14186 Stockholm, Sweden.	sdlixia@126.com; per.julin@ki.se; Tie-qiang.li@ki.se					Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990; Barnden LR, 2015, NMR BIOMED, V28, P404, DOI 10.1002/nbm.3261; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Blomberg J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00229; Boissoneault J, 2016, MAGN RESON IMAGING, V34, P603, DOI 10.1016/j.mri.2015.12.008; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Bynke Annie, 2020, Brain Behav Immun Health, V7, P100107, DOI 10.1016/j.bbih.2020.100107; Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Carruthers B.M., 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [10.1300/J092v11n01_02, DOI 10.1300/J092V11N01_02]; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Donahue MJ, 2006, NMR BIOMED, V19, P1043, DOI 10.1002/nbm.1075; Finsterer J, 2014, AM J HOSP PALLIAT ME, V31, P562, DOI 10.1177/1049909113494748; Floyd TF, 2003, J MAGN RESON IMAGING, V18, P649, DOI 10.1002/jmri.10416; Gherardi RK, 2019, AUTOIMMUN REV, V18, P691, DOI 10.1016/j.autrev.2019.05.006; Hanken K, 2015, MULT SCLER J, V21, P376, DOI 10.1177/1352458514549567; Hewlett S, 2011, ARTHRIT CARE RES, V63, pS263, DOI 10.1002/acr.20579; Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Jahng GH, 2005, RADIOLOGY, V234, P909, DOI 10.1148/radiol.2343031499; Jonsjo MA, 2017, FATIGUE, V5, P33, DOI 10.1080/21641846.2017.1287546; Kim J, 2006, NEUROIMAGE, V31, P376, DOI 10.1016/j.neuroimage.2005.11.035; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kohrle J, 2009, BEST PRACT RES CL EN, V23, P815, DOI 10.1016/j.beem.2009.08.002; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Li TQ, 2000, NEUROIMAGE, V12, P442, DOI 10.1006/nimg.2000.0634; Li TQ, 2000, MAGN RESON IMAGING, V18, P503, DOI 10.1016/S0730-725X(00)00137-5; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Luh WM, 2013, MAGN RESON MED, V69, P402, DOI 10.1002/mrm.24266; Maksoud R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232475; Mizuno K, 2015, NEUROIMAGE-CLIN, V9, P355, DOI 10.1016/j.nicl.2015.09.001; Moller M.C, 2017, FRONT NEUROL PRESS, V8, P21183; Moller MC, 2014, J CLIN EXP NEUROPSYC, V36, P716, DOI 10.1080/13803395.2014.933779; Mueller C, 2020, BRAIN IMAGING BEHAV, V14, P562, DOI 10.1007/s11682-018-0029-4; Nakagawa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21386; Nakatomi Y, 2014, J NUCL MED, V55, P945, DOI 10.2967/jnumed.113.131045; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Pellicano C, 2010, ARCH NEUROL-CHICAGO, V67, P447, DOI 10.1001/archneurol.2010.48; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Roelcke U, 1997, NEUROLOGY, V48, P1566, DOI 10.1212/WNL.48.6.1566; Shan ZY, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02506-6; Staud R, 2018, FATIGUE, V6, P63, DOI 10.1080/21641846.2018.1453919; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; van Der Schaaf ME, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0515-9; Wang JJ, 2003, MAGN RESON MED, V49, P796, DOI 10.1002/mrm.10437; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Ye FQ, 2000, MAGNET RESON MED, V44, P450, DOI 10.1002/1522-2594(200009)44:3<450::AID-MRM16>3.3.CO;2-S; Zeineh MM, 2015, RADIOLOGY, V274, P517, DOI 10.1148/radiol.14141079; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	55	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2379-1381	2379-139X		TOMOGRAPHY	Tomography	DEC	2021	7	4					675	687		10.3390/tomography7040056			13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	YA5UV	WOS:000738398800001	34842817	gold, Green Published			2022-02-06	
J	Lorente, L; Martin, MM; Ruiz, C; Abreu-Gonzalez, P; Ramos-Gomez, L; Argueso, M; Sole-Violan, J; Caceres, JJ; Jimenez, A				Lorente, Leonardo; Martin, Maria M.; Ruiz, Candelaria; Abreu-Gonzalez, Pedro; Ramos-Gomez, Luis; Argueso, Monica; Sole-Violan, Jordi; Caceres, Juan J.; Jimenez, Alejandro			Serum melatonin levels in predicting mortality in patients with severe traumatic brain injury	ANAESTHESIA CRITICAL CARE & PAIN MEDICINE			English	Article						Melatonin; Traumatic brain injury; Patients; Mortality; Prognosis	HEAD-INJURY; SECRETION	Purpose: A secondary brain injury could appear after traumatic brain injury (TBI) due to neuroinflammation, oxidation and apoptosis. Higher levels of serum melatonin have been found on admission for TBI in non-surviving than in surviving patients. Thus, the objective of this study was to know serum melatonin levels during the first week of TBI in surviving and non-surviving patients, and to know if serum melatonin levels during the first week of TBI can be used to predict mortality. Methods: Patients with an isolated and severe TBI were included; that is, if they scored < 10 points in non-cranial aspects of Injury Severity Score and < 9 points in the Glasgow Coma Scale. We measured serum melatonin concentrations at days 1, 4 and 8 of TBI. Thirty-day mortality was the end-point study. Results: Lower serum melatonin levels were found in the surviving patients (n = 90) than in the non survivors (n = 34) on days 1 (p < 0.001), 4 (p < 0.001), and 8 (p = 0.02) of TBI. Serum melatonin concentrations on days 1, 4, and 8 of TBI had an area under curve (95% Confidence Interval) for the prediction of 30-day mortality of 0.85 (0.77-0.91; p < 0.001), 0.82 (0.74-0.89; p < 0.001) and 0.71 (0.61-0.79; p = 0.06) respectively. Conclusions: The new findings of this study were the presence of higher levels of serum melatonin on days 1, 4 and 8 of TBI in non-survivors than in survivors, and the ability to predict 30-day mortality for serum melatonin levels measured at these time points. However, more research is necessary to confirm our results. (C) 2021 Societe francaise d'anesthesie et de reanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Ofra s n,Laguna, Santa Cruz de La Palma 38320, CA, Spain; [Martin, Maria M.; Ruiz, Candelaria] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Crta Rosario s n, Santa Cruz de La Palma 38010, CA, Spain; [Abreu-Gonzalez, Pedro] Univ Laguna, Fac Med, Dept Physiol, Ofra s n,Laguna, Santa Cruz de La Palma 38320, CA, Spain; [Ramos-Gomez, Luis] Hosp Gen Palma, Intens Care Unit, Buenavista Arriba s n, I-38713 Palermo, Italy; [Argueso, Monica] Univ Valencia, Hosp Clin, Intens Care Unit, Avda. Blasco Ibanez n 17-19, Valencia 46004, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, CIBERES, Intens Care Unit, Barranco Ballena s n, Palencia 35010, Spain; [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Plaza Dr,Pasteur s n, Palencia, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Ofra s n, Santa Cruz de La Palma 38320, CA, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Ofra s n,Laguna, Santa Cruz de La Palma 38320, CA, Spain.	lorentemartin@msn.com	; Sole-Violan, Jordi/H-4760-2015	Abreu-Gonzalez, Pedro/0000-0002-7553-1784; Sole-Violan, Jordi/0000-0002-0483-4470; Jimenez-Sosa, Alejandro/0000-0001-8732-2616	Instituto de Salud Carlos III (Madrid, Spain)Instituto de Salud Carlos III [PI-18-00500]; Fondo Europeo de Desarrollo Regional (FEDER)European Commission	This study was supported by a grant from Instituto de Salud Carlos III (PI-18-00500) (Madrid, Spain) and co-financed with Fondo Europeo de Desarrollo Regional (FEDER) . Fundings did not influence in the study design, the collection, analysis, and interpretation of data, the manuscript writing, and the decision to submit it for publication.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barlow KM, 2019, J NEUROTRAUM, V36, P523, DOI 10.1089/neu.2018.5752; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Dehghan F, 2018, INFLAMMOPHARMACOLOGY, V26, P1017, DOI 10.1007/s10787-017-0417-1; Ermolenko K S, 2013, Klin Med (Mosk), V91, P52; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Kemp S, 2004, BRAIN INJURY, V18, P911, DOI 10.1080/02699050410001671892; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lorente L, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0922-2; Marseglia L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051053; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Obayashi K, 2015, J EPIDEMIOL, V25, P38, DOI 10.2188/jea.JE20140035; Osier N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051539; Paparrigopoulos T, 2006, BRAIN INJURY, V20, P873, DOI 10.1080/02699050600832114; Paul T, 2007, CHRONOBIOL INT, V24, P45, DOI 10.1080/07420520601142569; Rehman SU, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070760; Reiter RJ, 2014, BRAIN STRUCT FUNCT, V219, P1873, DOI 10.1007/s00429-014-0719-7; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Seifman MA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00237; Shahrokhi N, 2018, IRAN J BASIC MED SCI, V21, P301, DOI 10.22038/ijbms.2018.25928.6377; TEASDALE G, 1974, LANCET, V2, P81; TOUITOU Y, 1985, ACTA ENDOCRINOL-COP, V108, P135, DOI 10.1530/acta.0.1080135; Wada K, 2013, ANN EPIDEMIOL, V23, P60, DOI 10.1016/j.annepidem.2012.11.003; Wang JM, 2019, FREE RADICAL BIO MED, V131, P345, DOI 10.1016/j.freeradbiomed.2018.12.014; Wetterberg Lennart, 1992, Journal of Psychiatry and Neuroscience, V17, P215	26	0	0	1	1	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	2352-5568			ANAESTH CRIT CARE PA	Anaesth. Crit. Care Pain Med.	DEC	2021	40	6							100966	10.1016/j.accpm.2021.100966			5	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	WZ2GC	WOS:000719789000001	34718184				2022-02-06	
J	Lorenz, LS; Doonan, M				Lorenz, Laura S.; Doonan, Michael			Value and Cost Savings From Access to Multi-disciplinary Rehabilitation Services After Severe Acquired Brain Injury	FRONTIERS IN PUBLIC HEALTH			English	Article						health policy; cost-effectiveness; shared decision-making; societal model of health; lifetime savings; traumatic brain injury; stroke; post-acute rehabilitation	RESIDENTIAL COMMUNITY REINTEGRATION; TRAUMATIC BRAIN; LIFE; CARE; EPIDEMIOLOGY; BENEFITS; OUTCOMES; SYSTEMS; IMPACT	Acquired brain injury (ABI) is a major global public health problem and source of disability. A major contributor to disability after severe ABI is limited access to multidisciplinary rehabilitation, despite evidence of sustained functional gains, improved quality of life, increased return-to-work, and reduced need for long-term care. A societal model of value in rehabilitation matches patient and family expectations of outcomes and system expectations of value for money. A policy analysis of seven studies (2009-2019) exploring outcomes and cost-savings from access to multi-disciplinary rehabilitation identified average lifetime savings of $1.50M per person, with costs recouped within 18 months.Recommendations: Increase access to multi-disciplinary rehabilitation following severe ABI; strengthen prevention focus; increase access to case management; support return-to-work; and systematically collect outcome and cost data.	[Lorenz, Laura S.; Doonan, Michael] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA		Lorenz, LS (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA.	llorenz@brandeis.edu					Agha L., 2017, CAUSES CONSEQUENCES; Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; [Anonymous], 2015, C TRAUM BRAIN INJ US; [Anonymous], 2012, HEALTH AFFAIR, DOI [10.1377/hblog20120921.023379, DOI 10.1377/HBLOG20120921.023379]; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Centers for Disease Control Prevention, 2021, MOD SEV TBI; Collie A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006900; Cooney MT, 2016, CLIN MED, V16, P109, DOI 10.7861/clinmedicine.16-2-109; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Doonan M., 2013, AM FEDERALISM PRACTI; Eurostat Organisation for Economic Co-operation and Development, 2012, EUR OECD METH MAN PU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Geurtsen GJ, 2012, ARCH PHYS MED REHAB, V93, P908, DOI 10.1016/j.apmr.2011.12.008; Griesbach GS, 2015, J NEUROTRAUM, V32, P704, DOI 10.1089/neu.2014.3754; Hammond FM, 2010, EUR J PHYS REHAB MED, V46, P545; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; KATZ DI, 2006, COGNITIVE REHABILITA; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewis FD., 2017, SCI RES PUBLIS, V7, P254, DOI [10.4236/ojs.2017.72020, DOI 10.4236/OJS.2017.72020]; Lin JA, 2016, JAMA SURG, V151, P678, DOI 10.1001/jamasurg.2016.0040; Lorenz L.., 2019, POLICY ANAL ACCESS P; Malec JF, 2016, J NEUROTRAUM, V33, P1371, DOI 10.1089/neu.2015.4080; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Marzorati C, 2017, J MULTIDISCIP HEALTH, V10, P101, DOI 10.2147/JMDH.S122383; Meixner C, 2021, J HEAD TRAUMA REHAB, V36, P72, DOI 10.1097/HTR.0000000000000590; Mori K., 2020, 1 OPINION; National Association of State Head Injury Administrators, 2005, GUID STAT GOV BRAIN; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Oddy M, 2013, BRAIN INJURY, V27, P1500, DOI 10.3109/02699052.2013.830332; Radford K, 2018, HEALTH TECHNOL ASSES, V22, P1, DOI 10.3310/hta22330; Reid I., 2011, POTENTIAL EC IMPACT; Relyea-Chew A, 2009, ARCH PHYS MED REHAB, V90, P413, DOI 10.1016/j.apmr.2008.07.031; Ribbers GM, 2007, J HEAD TRAUMA REHAB, V22, P234, DOI 10.1097/01.HTR.0000281839.07968.32; Schneider ALC, 2021, NEUROLOGY, V97, pE124, DOI 10.1212/WNL.0000000000012148; Stange KC, 2009, ANN FAM MED, V7, P100, DOI 10.1370/afm.971; Taylor RR, 2004, AM J OCCUP THER, V58, P73, DOI 10.5014/ajot.58.1.73; Texas Legislature, INS COD CHAPT 1352 B; Transport AccidentCommission., 2019, 2017 2018 ANN REP; Trexler LE, 2016, ARCH PHYS MED REHAB, V97, P204, DOI 10.1016/j.apmr.2015.09.016; Trexler LE., 2014, RESOURCE FACILITATIO; Turner-Stokes L, 2007, BRAIN INJURY, V21, P1015, DOI 10.1080/02699050701591445; Turner-Stokes L, 2019, J HEAD TRAUMA REHAB, V34, P205, DOI 10.1097/HTR.0000000000000473; Turner-Stokes L, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012112; Turner-Stokes L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub3; University of Missouri-Columbia, 2006, 2005 MISS TBI EARL R; van Heugten CM, 2011, J REHABIL MED, V43, P647, DOI 10.2340/16501977-0818; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; World Health Organisation, 2017, REH HLTH SYST; Worthington AD, 2006, BRAIN INJURY, V20, P947, DOI 10.1080/02699050600888314; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	51	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-2565		FRONT PUBLIC HEALTH	Front. Public Health	DEC 1	2021	9								753447	10.3389/fpubh.2021.753447			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	XO4SO	WOS:000730177200001	34926379	Green Published, gold			2022-02-06	
J	Lu, Y; Zhou, XS; Cheng, JC; Ma, Q				Lu, Yin; Zhou, Xianshan; Cheng, Jincheng; Ma, Qing			Early Intensified Rehabilitation Training with Hyperbaric Oxygen Therapy Improves Functional Disorders and Prognosis of Patients with Traumatic Brain Injury	ADVANCES IN WOUND CARE			English	Article						traumatic brain injury; hyperbaric oxygen therapy; comprehensive rehabilitation; function assessment; multicenter research	RECOVERY; OUTCOMES; TRIAL	Objective: Traumatic brain injury (TBI) is a global public health problem. Hyperbaric oxygen (HBO) therapy may be beneficial for TBI because it improves cerebral blood flow into tissues exhibiting low blood flow. This was done to observe the clinical therapeutic effect of different intensities of rehabilitation training and HBO therapy in early stages of TBI. Approach: In this multicenter, randomized, stratified case-controlled prospective clinical trial, we selected 158 patients with moderate-severe TBI and assigned them into (1) a control group receiving routine once-daily (1/d) rehabilitation training without HBO, (2) study group A receiving routine 1/d rehabilitation training with HBO, (3) study group B receiving twice-daily (2/d) intensified rehabilitation training with HBO, and (4) study group C receiving 2/d intensified rehabilitation training without HBO, all for 3 months. The cognitive ability, activities of daily life (ADL), and movement ability were assessed before and after training with the Fugl-Meyer Assessment (FMA), Functional Independence Measure (FIM), Modified Barthel Index (MBI), and Mini-Mental State Examination (MMSE). Results: FIM, FMA, MBI, and MMSE scores were improved significantly after 1-, 2-, and 3-month rehabilitation training in all TBI patients (p < 0.01), and this improvement was especially remarkable in patients who received 2/d intensified rehabilitation training with HBO (p < 0.01). Innovation: With extensive and intensive research on TBI rehabilitation, it was proved that TBI rehabilitation intervention should be initiated as early as possible. Conclusion: Early intensified rehabilitation training in combination with HBO is more beneficial to the recovery of cognitive, ADL, and movement abilities of TBI patients.	[Lu, Yin; Ma, Qing] Zhejiang Shuren Univ, Coll Biol & Environm Engn, Hangzhou 310015, Peoples R China; [Zhou, Xianshan] Traumat Rehabil Ctr Hangzhou Sanat, Hangzhou, Peoples R China; [Cheng, Jincheng] Dept Neurol, Bengbu, Peoples R China; [Cheng, Jincheng] Dept Surg, Bengbu, Peoples R China		Lu, Y (corresponding author), Zhejiang Shuren Univ, Coll Biol & Environm Engn, Hangzhou 310015, Peoples R China.	luyin_zjsru@aliyun.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31600257]; Public welfare project of Zhejiang provincial Science and Technology Department [2016C32022]	The authors of this study express their gratitude to the National Natural Science Foundation of China (31600257) and the Public welfare project of Zhejiang provincial Science and Technology Department (2016C32022) for the financial support for this study.	Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Barrett KF, 2004, UNDERSEA HYPERBAR M, V31, P395; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Cakmak T, 2015, UNDERSEA HYPERBAR M, V42, P9; Camporesi EM, 2014, UNDERSEA HYPERBAR M, V41, P253; Chin LMK, 2015, J HEAD TRAUMA REHAB, V30, P382, DOI 10.1097/HTR.0000000000000062; Cifu DX, 2014, ANN NEUROL, V75, P277, DOI 10.1002/ana.24067; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Godman CA, 2010, CELL STRESS CHAPERON, V15, P431, DOI 10.1007/s12192-009-0159-0; Harch PG., 2009, TXB HYPERBARIC MED; Hellweg S, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/768456; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Innes KE, 2011, J ALTERN COMPLEM MED, V17, P453, DOI 10.1089/acm.2010.0401; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Lippert-Gruner M, 2011, PHYSIOL RES, V60, P367, DOI 10.33549/physiolres.931816; Lund VE, 2005, UNDERSEA HYPERBAR M, V32, P111; Mauritz W, 2011, EUR J TRAUMA EMERG S, V37, P387, DOI 10.1007/s00068-010-0053-6; Norup A, 2017, CLIN NEUROPSYCHOL, V31, P20, DOI 10.1080/13854046.2017.1291857; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ovalle Fernando Jr, 2014, Inj Epidemiol, V1, P15; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sahni T, 2012, BRIT J NEUROSURG, V26, P202, DOI 10.3109/02688697.2011.626879; Schwandt M, 2012, J HEAD TRAUMA REHAB, V27, P99, DOI 10.1097/HTR.0b013e31820e6858; Swain RA, 2012, BRAIN SCI, V2, P709, DOI 10.3390/brainsci2040709; Turner-Stokes L, 2016, COCHRANE DB SYST REV, V33, P434; Walker WC, 2014, NEUROREHAB NEURAL RE, V28, P420, DOI 10.1177/1545968313516869; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wolf EG, 2012, UNDERSEA HYPERBAR M, V39, P1075; Zhang GX, 2016, NEUROCHEM RES, V41, P2948, DOI 10.1007/s11064-016-2013-y; Zhu XL, 2001, BRIT J NEUROSURG, V15, P464, DOI 10.1080/02688690120097688	36	0	0	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2162-1918	2162-1934		ADV WOUND CARE	Adv. Wound Care	DEC 1	2021	10	12					663	670		10.1089/wound.2018.0876			8	Dermatology	Science Citation Index Expanded (SCI-EXPANDED)	Dermatology	US6EF	WOS:000697519400001	34546088	Green Published, hybrid			2022-02-06	
J	Major, B; Symons, GF; Sinclair, B; O'Brien, WT; Costello, D; Wright, DK; Clough, M; Mutimer, S; Sun, MJ; Yamakawa, GR; Brady, RD; O'Sullivan, MJ; Mychasiuk, R; McDonald, SJ; O'Brien, TJ; Law, M; Kolbe, S; Shultz, SR				Major, Brendan; Symons, Georgia F.; Sinclair, Ben; O'Brien, William T.; Costello, Daniel; Wright, David K.; Clough, Meaghan; Mutimer, Steven; Sun, Mujun; Yamakawa, Glenn R.; Brady, Rhys D.; O'Sullivan, Michael J.; Mychasiuk, Richelle; McDonald, Stuart J.; O'Brien, Terence J.; Law, Meng; Kolbe, Scott; Shultz, Sandy R.			White and Gray Matter Abnormalities in Australian Footballers With a History of Sports-Related Concussion: An MRI Study	CEREBRAL CORTEX			English	Article						biomarker; cavum septum pellucidum; diffusion weighted imaging; mild traumatic brain injury; neuroimaging	TRAUMATIC BRAIN-INJURY; SEPTUM PELLUCIDUM; DIFFUSION; PLAYERS; SEGMENTATION; DEGENERATION; DYSFUNCTION; VOLUMES; DETECTS	Sports-related concussion (SRC) is a form of mild traumatic brain injury that has been linked to long-term neurological abnormalities. Australian rules football is a collision sport with wide national participation and is growing in popularity worldwide. However, the chronic neurological consequences of SRC in Australian footballers remain poorly understood. This study investigated the presence of brain abnormalities in Australian footballers with a history of sports-related concussion (HoC) using multimodal MRI. Male Australian footballers with HoC (n=26), as well as noncollision sport athletes with no HoC (n=27), were recruited to the study. None of the footballers had sustained a concussion in the preceding 6 months, and all players were asymptomatic. Data were acquired using a 3T MRI scanner. White matter integrity was assessed using diffusion tensor imaging. Cortical thickness, subcortical volumes, and cavum septum pellucidum (CSP) were analyzed using structural MRI. Australian footballers had evidence of widespread microstructural white matter damage and cortical thinning. No significant differences were found regarding subcortical volumes or CSP. These novel findings provide evidence of persisting white and gray matter abnormalities in Australian footballers with HoC, and raise concerns related to the long-term neurological health of these athletes.	[Major, Brendan; Symons, Georgia F.; Sinclair, Ben; O'Brien, William T.; Wright, David K.; Clough, Meaghan; Mutimer, Steven; Sun, Mujun; Yamakawa, Glenn R.; Brady, Rhys D.; Mychasiuk, Richelle; McDonald, Stuart J.; O'Brien, Terence J.; Law, Meng; Kolbe, Scott; Shultz, Sandy R.] Monash Univ, Dept Neurosci, 6th Floor,Alfred Ctr,99 Commercial Rd, Melbourne, Vic 3004, Australia; [Sinclair, Ben; O'Brien, Terence J.; Shultz, Sandy R.] Alfred Hlth, Dept Neurol, Melbourne, Vic 3004, Australia; [Costello, Daniel; Brady, Rhys D.; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Dept Med, Parkville, Vic 3050, Australia; [O'Sullivan, Michael J.] Univ Queensland, Dept Fac Med, UQ Ctr Clin Res, Brisbane, Qld 4072, Australia; [O'Sullivan, Michael J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic 3086, Australia; [Law, Meng] Alfred Hlth, Dept Radiol, Melbourne, Vic 3004, Australia; [Law, Meng] Monash Univ, Dept Elect & Comp Syst Engn, Melbourne, Vic 3800, Australia		Shultz, SR (corresponding author), Monash Univ, Dept Neurosci, 6th Floor,Alfred Ctr,99 Commercial Rd, Melbourne, Vic 3004, Australia.	sandy.shultz@monash.edu	O'Brien, Terence/L-8102-2013	McDonald, Stuart/0000-0001-5190-3179; O'Brien, Terence/0000-0002-7198-8621	Australian National Health and Research CouncilAustralian Research Council	Australian National Health and Research Council (to S.R.C., R.M., and S.J.M.).	Alosco ML, 2020, BRAIN IMAGING BEHAV, V14, P1419, DOI 10.1007/s11682-019-00060-4; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Beaton EA, 2010, PSYCHIAT RES-NEUROIM, V181, P108, DOI 10.1016/j.pscychresns.2009.10.009; Bernick C, 2020, NEUROLOGY, V94, pE232, DOI 10.1212/WNL.0000000000008817; Born CM, 2004, EUR ARCH PSY CLIN N, V254, P295, DOI 10.1007/s00406-004-0496-z; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Clough M, 2018, J NEUROTRAUM, V35, P730, DOI 10.1089/neu.2017.5204; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Costello DM, 2018, J CLIN NEUROSCI, V56, P88, DOI 10.1016/j.jocn.2018.07.003; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Gorgoraptis N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1993; Gur RE, 2013, AM J NEURORADIOL, V34, P2021, DOI 10.3174/ajnr.A3525; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Hwang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078590; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Lancaster MA, 2018, HUM BRAIN MAPP, V39, P4276, DOI 10.1002/hbm.24245; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Major BP, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.549624; Manning KY, 2020, NEUROLOGY, V95, pE402, DOI 10.1212/WNL.0000000000009821; McDonald SJ, 2021, BIOMARK RES, V9, DOI 10.1186/s40364-020-00256-7; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McNeel C, 2020, J SCI MED SPORT, V23, P125, DOI 10.1016/j.jsams.2019.10.010; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Mills BD, 2020, NEUROIMAGE, V217, DOI 10.1016/j.neuroimage.2020.116864; Ng TSC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt239; O'Brien WT, 2021, J NEUROTRAUM, V38, P1350, DOI 10.1089/neu.2020.7479; Patel JB, 2020, AM J NEURORADIOL, V41, P92, DOI 10.3174/ajnr.A6346; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Symons GF, 2020, J NEUROTRAUM, V37, P792, DOI 10.1089/neu.2019.6884; Symons GF, 2020, J CONCUSSION, V4, DOI 10.1177/2059700220975609; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wojtowicz M, 2018, NEUROIMAGE-CLIN, V18, P377, DOI 10.1016/j.nicl.2018.01.005; Wright DK, 2021, CEREB CORTEX, V31, P4411, DOI 10.1093/cercor/bhab095; Wright DK, 2021, J NEUROTRAUM, V38, P983, DOI 10.1089/neu.2019.6886; Zhang J, 2019, J NEUROL NEUROSUR PS, V90, P98, DOI 10.1136/jnnp-2017-317691	53	0	0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	DEC	2021	31	12					5331	5338		10.1093/cercor/bhab161			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XT1PK	WOS:000733367300004	34148076				2022-02-06	
J	Mansouri, A; Ledwidge, P; Sayood, K; Molfese, DL				Mansouri, Amirsalar; Ledwidge, Patrick; Sayood, Khalid; Molfese, Dennis L.			A Routine Electroencephalography Monitoring System for Automated Sports-Related Concussion Detection	NEUROTRAUMA REPORTS			English	Article						EEG; EEG monitoring; electrode networks; non-patient-specific; sports-related concussion; SVM	FOOTBALL PLAYERS; RECOVERY-TIME; HEAD-INJURY; HIGH-SCHOOL; BRAIN; EEG; EPIDEMIOLOGY; STATEMENT; DIAGNOSIS; NETWORKS	AbstractCases of concussions in the United States keep increasing and are now up to 2 million to 3 million incidents per year. Although concussions are recoverable and usually not life-threatening, the degree and rate of recovery may vary depending on age, severity of the injury, and past concussion history. A subsequent concussion before full recovery may lead to more-severe brain damage and poorer outcomes. Electroencephalography (EEG) recordings can identify brain dysfunctionality and abnormalities, such as after a concussion. Routine EEG monitoring can be a convenient method for reducing unreported injuries and preventing long-term damage, especially among groups with a greater risk of experiencing a concussion, such as athletes participating in contact sports. Because of the relative availability of EEG compared to other brain-imaging techniques (e.g., functional magnetic resonance imaging), the use of EEG monitoring is growing for various neurological disorders. In this longitudinal study, EEG was analyzed from 4 football athletes before their athletic season and also within 7 days of concussion. Compared to a control group of 4 additional athletes, a concussion was detected with up to 99.5% accuracy using EEG recordings in the Theta-Alpha band. Classifiers that use data from only a subset of the EEG electrodes providing reliable detection are also proposed. The most effective classifiers used EEG recordings from the Central scalp region in the Beta band and over the Temporal scalp region using the Theta-Alpha band. This proof-of-concept study and preliminary findings suggest that EEG monitoring may be used to identify a sports-related concussion occurrence with a high level of accuracy and thus reduce the chance of unreported concussion.	[Mansouri, Amirsalar; Sayood, Khalid] Univ Nebraska, Dept Elect & Comp Engineer, Nebraska Hall E419, Lincoln, NE 68588 USA; [Ledwidge, Patrick] Univ Nebraska, Ctr Brain Biol, Lincoln, NE USA; [Molfese, Dennis L.] Baldwin Wallace Univ, Dept Psychol, Berea, OH 44017 USA		Mansouri, A (corresponding author), Univ Nebraska, Dept Elect & Comp Engineer, Nebraska Hall E419, Lincoln, NE 68588 USA.	amansouri@huskers.unl.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD073202, R01EB007684]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [HD062072]	This study was supported partially by grants from the National Institutes of Health (R01 HD073202,R01EB007684) and the National Institute of Mental Health (HD062072).	Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Betzel RF, 2014, NEUROIMAGE, V102, P345, DOI 10.1016/j.neuroimage.2014.07.067; Bloomfield P, 2004, FOURIER ANAL TIME SE; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Cao C, 2008, IEEE T NEUR SYS REH, V16, P327, DOI 10.1109/TNSRE.2008.918422; Centers for Disease Control and Prevention, 2020, HEADS BRAIN INJ BAS; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Committee on Sports-Related Concussions in Youth; Board on Children., 2014, CONS REP HEAD IMP MU; Conley AC, 2019, J NEUROTRAUM, V36, P1, DOI 10.1089/neu.2018.5761; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hudac CM, 2018, INT J PSYCHOPHYSIOL, V132, P135, DOI 10.1016/j.ijpsycho.2017.09.020; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Ledwidge PS, 2019, CLIN J SPORT MED, V29, P292, DOI 10.1097/JSM.0000000000000512; Ledwidge PS, 2016, J NEUROTRAUM, V33, P2081, DOI 10.1089/neu.2015.4251; Lee RR, 2014, PROG NEUROL SURG, V28, P94, DOI 10.1159/000358768; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Mansouri A, 2019, ALGORITHMS, V12, DOI 10.3390/a12090176; Mansouri A, 2017, INT CONF ELECTRO INF, P416, DOI 10.1109/EIT.2017.8053397; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Michels L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010298; Munia TTK, 2016, IEEE ENG MED BIO, P41, DOI 10.1109/EMBC.2016.7590635; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Pal S, 2018, US PHARM, V43, P24; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Teel EF, 2014, CLIN NEUROPHYSIOL, V125, P703, DOI 10.1016/j.clinph.2013.08.027; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Wickramaratne SD, 2020, IEEE ICC; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	46	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	DEC 1	2021	2	1					626	638		10.1089/neur.2021.0047			13	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	XS5VH	WOS:000732975800001	35018364	gold, Green Published			2022-02-06	
J	Max, JE; Judd, N; Bigler, ED; Wilde, EA; Patterson, JE; Edwards, TM; Calahorra, A; De La Garza, BG; Vaida, F				Max, Jeffrey E.; Judd, Nicholas; Bigler, Erin D.; Wilde, Elisabeth A.; Patterson, Jo Ellen; Edwards, Todd M.; Calahorra, Ainara; De La Garza, Bianca G.; Vaida, Florin			Three-Month Psychiatric Outcome of Pediatric Mild Traumatic Brain Injury: A Controlled Study	JOURNAL OF NEUROTRAUMA			English	Article						mild traumatic brain injury; pediatrics; prospective longitudinal controlled study; psychiatric disorders	POST-CONCUSSIVE SYMPTOMS; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; K-SADS; CHILDREN; DISORDERS; ADOLESCENTS; RELIABILITY; PREDICTORS; TERM	The objective was to clarify occurrence, phenomenology, and risk factors for novel psychiatric disorder (NPD) in the first 3 months after mild traumatic brain injury (mTBI) and orthopedic injury (OI). Children aged 8-15 years with mTBI (n = 220) and with OI but no TBI (n = 110) from consecutive admissions to an emergency department were followed prospectively at baseline and 3 months post-injury with semi-structured psychiatric interviews to document the number of NPDs that developed in each participant. Pre-injury child variables (adaptive, cognitive, and academic function, and psychiatric disorder), pre-injury family variables (socioeconomic status, family psychiatric history, and family function), and injury severity were assessed and analyzed as potential confounders and predictors of NPD. NPD occurred at a significantly higher frequency in children with mTBI versus OI in analyses unadjusted (mean ratio [MR] 3.647, 95% confidence interval [CI95] (1.264, 15.405), p = 0.014) and adjusted (MR = 3.724, CI95 (1.264, 15.945), p = 0.015) for potential confounders. In multi-predictor analyses, the factors besides mTBI that were significantly associated with higher NPD frequency after adjustment for each other were pre-injury lifetime psychiatric disorder [MR = 2.284, CI95 (1.026, 5.305), p = 0.043]; high versus low family psychiatric history [MR = 2.748, CI95 (1.201, 6.839), p = 0.016], and worse socio-economic status [MR = 0.618 per additional unit, CI95 (0.383, 0.973), p = 0.037]. These findings demonstrate that mild injury to the brain compared with an OI had a significantly greater deleterious effect on psychiatric outcome in the first 3 months post-injury. This effect was present even after accounting for specific child and family variables, which were themselves independently related to the adverse psychiatric outcome.	[Max, Jeffrey E.; Calahorra, Ainara; De La Garza, Bianca G.] Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth, Dept Psychiat, San Diego, CA 92121 USA; [Vaida, Florin] Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth, Div Biostat, San Diego, CA 92121 USA; [Max, Jeffrey E.] Rady Childrens Hosp, San Diego, CA USA; [Judd, Nicholas] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Bigler, Erin D.] Univ Utah, Sch Med, Dept Psychiat, Provo, UT USA; [Bigler, Erin D.; Wilde, Elisabeth A.] Univ Utah, Sch Med, Dept Neurol, Provo, UT USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol & Neurosci, Provo, UT USA; [Patterson, Jo Ellen; Edwards, Todd M.] Univ San Diego, Marital & Family Therapy Program, San Diego, CA USA		Max, JE (corresponding author), Univ Calif San Diego, Dept Psychiat, 5755 Oberlin Dr,Suite 301, San Diego, CA 92121 USA.	jmax@health.ucsd.edu			National Institute of Child Health and Development Grant [HD088438]	This research was supported by a National Institute of Child Health and Development Grant HD088438 (Dr. Max: Principal Investigator; Drs. Wilde and Vaida).	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; American Psychiatric Association, DIAGNOSTIC STAT MANU, V4th edn; Andreasen N.C., 1994, PSYCHAT EPIDEMIOLOGY, P349; Arif H, 2021, J NEUROTRAUM, V38, P1515, DOI 10.1089/neu.2020.7238; Association for the Advancement of Automotive Medicine, ABBREVIATED INJURY S; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Brunkhorst-Kanaan N, 2021, NEUROSCI BIOBEHAV R, V125, P582, DOI 10.1016/j.neubiorev.2021.02.002; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Last CG, 1996, J AM ACAD CHILD PSY, V35, P1502, DOI 10.1097/00004583-199611000-00019; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; Max Jeffrey E, 1800, J Neuropsychiatry Clin Neurosci, V34, P60, DOI 10.1176/appi.neuropsych.20050104; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P112, DOI 10.1176/appi.neuropsych.13080190; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P272, DOI 10.1176/appi.neuropsych.12040078; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P187, DOI 10.1176/appi.neuropsych.12010011; Mayer AR, 2020, J NEUROTRAUM, V37, P1504, DOI 10.1089/neu.2019.6805; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; MILLER IW, 1994, FAM PROCESS, V33, P53, DOI 10.1111/j.1545-5300.1994.00053.x; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Ornstein TJ, 2014, J INT NEUROPSYCH SOC, V20, P971, DOI 10.1017/S1355617714000903; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Reiss F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213700; RUTTER M, 1990, J CHILD PSYCHOL PSYC, V31, P39, DOI 10.1111/j.1469-7610.1990.tb02273.x; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Wassenberg R, 2004, BRAIN INJURY, V18, P377, DOI 10.1080/02699050310001617325; Wechsler D., 2011, WECHSLER ABBREVIATED; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 1997, J CLIN EXP NEUROPSYC, V19, P825, DOI 10.1080/01688639708403763	50	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2021	38	23					3341	3351		10.1089/neu.2021.0324			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XJ2CB	WOS:000726601700015	34714155				2022-02-06	
J	McGeown, JP; Hume, PA; Kara, S; King, D; Theadom, A				McGeown, Joshua P.; Hume, Patria A.; Kara, Stephen; King, Doug; Theadom, Alice			Preliminary Evidence for the Clinical Utility of Tactile Somatosensory Assessments of Sport-Related mTBI	SPORTS MEDICINE-OPEN			English	Article						Somatosensory; mTBI; Modelling; Prediction; Diagnosis; Recovery; Brain Gauge	TRAUMATIC BRAIN-INJURY; FUNCTIONAL CONNECTIVITY; NEUROSENSORY ASSESSMENTS; CONCUSSION; ABNORMALITIES; NETWORK; CLASSIFICATION; INDIVIDUALS; RELIABILITY; FOOTBALL	Objectives To evaluate the clinical utility of tactile somatosensory assessments to assist clinicians in diagnosing sport-related mild traumatic brain injury (SR-mTBI), classifying recovery trajectory based on performance at initial clinical assessment, and determining if neurophysiological recovery coincided with clinical recovery. Research Design Prospective cohort study with normative controls. Methods At admission (n = 79) and discharge (n = 45/79), SR-mTBI patients completed the SCAT-5 symptom scale, along with the following three components from the Cortical Metrics Brain Gauge somatosensory assessment (BG-SA): temporal order judgement (TOJ), TOJ with confounding condition (TOJc), and duration discrimination (DUR). To assist SR-mTBI diagnosis on admission, BG-SA performance was used in logistic regression to discriminate cases belonging to the SR-mTBI sample or a healthy reference sample (pooled BG-SA data for healthy participants in previous studies). Decision trees evaluated how accurately BG-SA performance classified SR-mTBI recovery trajectories. Results BG-SA TOJ, TOJc, and DUR poorly discriminated between cases belonging to the SR-mTBI sample or a healthy reference sample (0.54-0.70 AUC, 47.46-64.71 PPV, 48.48-61.11 NPV). The BG-SA evaluated did not accurately classify SR-mTBI recovery trajectories (> 14-day resolution 48%, <= 14-day resolution 54%, lost to referral/follow-up 45%). Mann-Whitney U tests revealed differences in BG-SA TOJc performance between SR-mTBI participants and the healthy reference sample at initial clinical assessment and at clinical recovery (p < 0.05). Conclusions BG-SA TOJ, TOJc, and DUR appear to have limited clinical utility to assist clinicians with diagnosing SR-mTBI or predicting recovery trajectories under ecologically valid conditions. Neurophysiological abnormalities persisted beyond clinical recovery given abnormal BG-SA TOJc performance observed when SR-mTBI patients achieved clinical recovery.	[McGeown, Joshua P.; Hume, Patria A.; King, Doug] Auckland Univ Technol, Sports Performance Res Inst New Zealand SPRINZ, Fac Hlth & Environm Sci, Private Bag 92006, Auckland 1142, New Zealand; [McGeown, Joshua P.; Hume, Patria A.; King, Doug; Theadom, Alice] Auckland Univ Technol, Traumat Brain Injury Network, Auckland, New Zealand; [Kara, Stephen] Axis Sports Med Clin, Auckland, New Zealand; [King, Doug] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia		McGeown, JP (corresponding author), Auckland Univ Technol, Sports Performance Res Inst New Zealand SPRINZ, Fac Hlth & Environm Sci, Private Bag 92006, Auckland 1142, New Zealand.; McGeown, JP (corresponding author), Auckland Univ Technol, Traumat Brain Injury Network, Auckland, New Zealand.	josh.mcgeown@aut.ac.nz		McGeown, Joshua/0000-0003-0225-4488	AUT Vice Chancellor's PhD Scholarship; Rutherford Discovery Fellowship	Usual academic and physician salaries were utilised in conducting this study. Joshua McGeown acknowledges the AUT Vice Chancellor's PhD Scholarship funding for his stipend. Alice Theadom was supported by a Rutherford Discovery Fellowship, administered by the Royal Society of New Zealand.	Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Favorov OV, 2019, MIL MED, V184, P228, DOI 10.1093/milmed/usy411; Fernandez LM, 2020, ROYAL SOC OPEN SCI, V7, P1; Guay S, 2018, NEUROPSYCHOLOGIA, V108, P42, DOI 10.1016/j.neuropsychologia.2017.11.022; Hastie T, 2009, ELEMENTS STAT LEARNI; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Holden JK, 2012, J NEUROSCI METH, V204, P215, DOI 10.1016/j.jneumeth.2011.11.007; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Jones CB, 2016, J NEUROPHYSIOL, V115, P2681, DOI 10.1152/jn.00630.2015; Kara S, 2020, CLIN J SPORT MED, V30, P96, DOI 10.1097/JSM.0000000000000811; Kenzie ES, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00203; King D., 2018, J PHYS RES, V2, P1; King D, 2019, J NEUROL SCI, V399, P61, DOI 10.1016/j.jns.2019.01.049; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGeown JP, 2020, SPORTS MED, V50, P1191, DOI 10.1007/s40279-019-01240-4; McGrath S, 2020, BIOMETRICAL J, V62, P69, DOI 10.1002/bimj.201900036; Meehan SK, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00005; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Mohamadpour M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00007; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Nguyen RH, 2013, BRAIN RES, V1498, P50, DOI 10.1016/j.brainres.2012.12.043; Pearce AJ, 2020, SOMATOSENS MOT RES, V37, P14, DOI 10.1080/08990220.2019.1699045; Pearce AJ, 2019, NEUROSCIENCE, V408, P272, DOI 10.1016/j.neuroscience.2019.04.019; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Purves D., 2012, NEUROSCIENCE, V5, P189; Puts NAJ, 2017, J NEUROPHYSIOL, V118, P2568, DOI 10.1152/jn.00087.2017; Radoi A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212541; RATCLIFF R, 1979, PSYCHOL BULL, V86, P446, DOI 10.1037/0033-2909.86.3.446; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Seeger TA, 2017, BRAIN STIMUL, V10, P305, DOI 10.1016/j.brs.2016.11.011; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Teel EF, 2017, J ATHL TRAINING, V52, P288, DOI 10.4085/1062-6050-52.1.12; Theadom A, 2014, J SCI MED SPORT, V17, P591, DOI 10.1016/j.jsams.2014.02.001; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Tommerdahl M, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-19; Tommerdahl M, 2016, MIL MED, V181, P45, DOI 10.7205/MILMED-D-15-00172; Wang K, 2016, FRONT BIOSCI-LANDMRK, V21, P890; Whelan R, 2008, PSYCHOL REC, V58, P475, DOI 10.1007/BF03395630; Xiao H, 2015, NEURAL REGEN RES, V10, P2062, DOI 10.4103/1673-5374.172328	63	0	0	5	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2199-1170	2198-9761		SPORTS MED-OPEN	Sports Med.-Open	DEC	2021	7	1							56	10.1186/s40798-021-00340-8			14	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TZ6MX	WOS:000684586000002	34370132	Green Published, gold			2022-02-06	
J	Mikolic, A; Groeniger, JO; Zeldovich, M; Wilson, L; van Lennep, JR; van Klaveren, D; Polinder, S				Mikolic, Ana; Groeniger, Joost Oude; Zeldovich, Marina; Wilson, Lindsay; van Lennep, Jeanine Roeters; van Klaveren, David; Polinder, Suzanne		Collaborative European NeuroTrauma	Explaining Outcome Differences between Men and Women following Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						care pathways; mediation; outcomes; sex differences; sociodemographic factors; traumatic brain injury	POST-CONCUSSION SYMPTOMS; QUALITY-OF-LIFE; SEX-DIFFERENCES; GENDER-DIFFERENCES; CENTER-TBI; CARE; MASCULINITY; PREVALENCE; SCALE; WORK	Men and women differ in outcomes following mild traumatic brain injury (TBI). In the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study, we previously found that women had worse 6-month functional outcome (Glasgow Outcome Score Extended [GOSE]), health-related quality of life (HRQoL), and mental health following mild TBI. The aim of this study was to investigate whether those differences were mediated by psychiatric history, gender-related sociodemographic variables, or by care pathways. We analyzed sex/gender differences in 6-month GOSE, generic and TBI-specific HRQoL, and post-concussion and mental health symptoms using three sets of mediators: psychiatric history, sociodemographic variables (living alone, living with children, education and employment status/job category), and care-pathways (referral to study hospital and discharge destination after emergency department); while controlling for a substantial number of potential confounders (pre-injury health and injury-related characteristics). We included 1842 men and 1022 women (16+) with a Glasgow Coma Score 13-15, among whom 83% had GOSE available and about 60% other 6-month outcomes. We used natural effects models to decompose the total effect of sex/gender on the outcomes into indirect effects that passed through the specified mediators and the remaining direct effects. In our study population, women had worse outcomes and these were only partly explained by psychiatric history, and not considerably explained by sociodemographic variables nor by care pathways. Factors other than differences in specified variables seem to underlie observed differences between men and women in outcomes after mild TBI. Future studies should explore more aspects of gender roles and identity and biological factors underpinning sex and gender differences in TBI outcomes.	[Mikolic, Ana; Groeniger, Joost Oude; Polinder, Suzanne] Erasmus MC, Dept Publ Hlth, Univ Med Ctr, Rotterdam, Netherlands; [van Lennep, Jeanine Roeters] Erasmus MC, Dept Internal Med, Univ Med Ctr, Rotterdam, Netherlands; [Groeniger, Joost Oude; van Klaveren, David] Erasmus Univ, Dept Publ Adm & Sociol, Rotterdam, Netherlands; [Zeldovich, Marina] Georg August Univ, Inst Med Psychol & Med Sociol, Gottingen, Germany; [Wilson, Lindsay] Univ Stirling, Div Psychol, Stirling, Scotland; [van Klaveren, David] Tufts Med Ctr, Predict Analyt & Comparat Effectiveness Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA		Mikolic, A (corresponding author), Erasmus MC, Dept Publ Hlth, Univ Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.mikolic@erasmusmc.nl	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193; Zeiler, Frederick/0000-0003-1737-0510; Radoi, Andreea/0000-0002-0677-3544; Dark, Paul/0000-0003-3309-0164	Netherlands Organization for Health Research and Development (ZonMw)Netherlands Organization for Health Research and Development; European Union 7th Framework Programme [602150]; Integra LifeSciences Corporation (USA); Neurotrauma Sciences (USA); OneMind (USA); Hannelore Kohl Stiftung (Germany)	This study was supported by The Netherlands Organization for Health Research and Development (ZonMw). The authors A. Mikolic, S. Polinder, L. Wilson and M. Zeldovich were supported by the European Union 7th Framework Programme (EC grant 602150). Additional support was obtained from the Hannelore Kohl Stiftung (Germany), OneMind (USA), Integra LifeSciences Corporation (USA), and Neurotrauma Sciences (USA).	Addis ME, 2003, AM PSYCHOL, V58, P5, DOI 10.1037/0003-066X.58.1.5; Bale TL, 2015, NAT NEUROSCI, V18, P1413, DOI 10.1038/nn.4112; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bonow RH, 2019, NEUROCRIT CARE, V30, P157, DOI 10.1007/s12028-018-0590-0; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Chang VC, 2014, OCCUP ENVIRON MED, V71, P695, DOI 10.1136/oemed-2014-102097; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; D'Souza A, 2020, NEUROPSYCHOL REHABIL, DOI 10.1080/09602011.2020.1822882; De Smedt J., 2021, SEMANTIC WEB EUROPEA; Devillard S., 2018, STILL LOOKING ROOM T; Dolan A, 2011, SOCIOL HEALTH ILL, V33, P586, DOI 10.1111/j.1467-9566.2010.01300.x; European Comission., REP EQ WOM MEN EU; Eurostat , 2018, LIF WOM MEN EUR STAT; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fausto-Sterling A., 2012, SEX GENDER BIOL SOCI; Fowler RA, 2007, CAN MED ASSOC J, V177, P1513, DOI 10.1503/cmaj.071112; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gulland A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5320; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Haag HL, 2016, ARCH PHYS MED REHAB, V97, pS64, DOI 10.1016/j.apmr.2014.12.018; Hartung CM, 2019, PSYCHOL BULL, V145, P390, DOI 10.1037/bul0000183; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kivits J, 2013, REV EPIDEMIOL SANTE, V61, pS189, DOI 10.1016/j.respe.2013.06.001; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kunzmann K, 2021, J NEUROTRAUM, V38, P455, DOI 10.1089/neu.2019.6858; Lahana E, 2010, INT J PUBLIC HEALTH, V55, P391, DOI 10.1007/s00038-010-0171-2; Larsson E, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0693-4; Levin HS, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.3046; Lumley T., 2006, MITOOLS PACKAGE; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mackenzie CR, 2014, SOC SCI MED, V117, P96, DOI 10.1016/j.socscimed.2014.07.043; Malmusi D, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23189; McManus S., 2021, ADULT PSYCHIAT MORB; Mikolic A, 2021, J NEUROTRAUM, V38, P235, DOI 10.1089/neu.2020.7228; Mollayeva T, 2021, DISABIL REHABIL, V43, P1872, DOI 10.1080/09638288.2019.1683235; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; O'Donnell ML, 2010, J TRAUMA, V69, P627, DOI 10.1097/TA.0b013e3181bc0923; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Poritz JMP, 2019, REHABIL PSYCHOL, V64, P65, DOI 10.1037/rep0000234; Prause W, 2005, HUM PSYCHOPHARM CLIN, V20, P359, DOI 10.1002/hup.699; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Riecher-Rossler A, 2017, LANCET PSYCHIAT, V4, P8, DOI 10.1016/S2215-0366(16)30348-0; Robinson K., 2017, WOMEN WORKPLACE 2017; Russell AL, 2018, ENDOCRINOLOGY, V159, P2363, DOI 10.1210/en.2018-00203; Salinas PC, 2017, NEURON, V96, P721, DOI 10.1016/j.neuron.2017.10.002; Sanchez-Lopez MP, 2012, WOMEN HEALTH, V52, P182, DOI 10.1080/03630242.2011.652352; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schopp LH, 2006, BRAIN INJURY, V20, P1155, DOI 10.1080/02699050600983735; Seidler ZE, 2016, CLIN PSYCHOL REV, V49, P106, DOI 10.1016/j.cpr.2016.09.002; Slewa-Younan S, 2008, BRAIN INJURY, V22, P183, DOI 10.1080/02699050801888808; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Steen J, 2017, AM J EPIDEMIOL, V186, P184, DOI 10.1093/aje/kwx051; Steen J, 2017, J STAT SOFTW, V76, DOI 10.18637/jss.v076.i11; Stergiou-Kita M, 2016, ARCH PHYS MED REHAB, V97, pS40, DOI 10.1016/j.apmr.2015.04.008; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Todorov A, 2021, INTENS CARE MED, V47, P577, DOI 10.1007/s00134-021-06393-3; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; van Buuren S, 2011, J STAT SOFTW, V45, P1; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Volovici V, 2019, J CRIT CARE, V49, P158, DOI 10.1016/j.jcrc.2018.11.002; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yue JK, 2019, NEUROL RES, V41, P609, DOI 10.1080/01616412.2019.1602312	75	0	0	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2021	38	23					3315	3331		10.1089/neu.2021.0116			17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XJ2CB	WOS:000726601700013	34617454	hybrid			2022-02-06	
J	Mizu, D; Matsuoka, Y; Huh, JY; Onishi, M; Ariyoshi, K				Mizu, Daisuke; Matsuoka, Yoshinori; Huh, Ji-Young; Onishi, Masafumi; Ariyoshi, Koichi			Head CT findings and deterioration risk in children with head injuries and Glasgow Coma Scales of 15	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Child; Glasgow coma scale; Minor head injury; Subarachnoid hemorrhage; Skull fracture	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; MANAGEMENT	Objective: Head injuries are an important problem in pediatric emergency care. The majority of head injuries are mild. Even when abnormalities are noted on computed tomography (CT), most patients have good outcomes. We aimed to evaluate the clinical course of pediatric patients who had head injuries and Glasgow Coma Scale (GCS) scores of 15, in whom abnormal findings were noted on head CT, to determine the impact of radiographic features on the need for hospitalization and clinical progression. Methods: We retrospectively examined patients under 15 years of age with isolated mild head injuries, GCS scores of 15, and abnormal CT findings, and visited the emergency department between September 2011 and March 2019. Results: Ninety-nine patients were included in the study. The median age was 2 years (0-15 years), and 61 (62%) patients were male. Eighty-six (87%) patients were hospitalized, and the median hospital stay was 1 day (1-10 days). Sixty-eight (69%) patients underwent repeat CT, and 12 (18%) patients showed signs of radiographic progression. These 12 patients had subdural or epidural hematomas, and surgical intervention was required for two patients (2%). In patients with isolated skull fracture or subarachnoid hemorrhage alone, no deterioration was noted radiographically or clinically. Conclusion: Pediatric head injuries with GCS scores of 15 may rarely require surgical intervention, even when CT shows abnormalities. In particular, patients diagnosed with isolated skull fracture or subarachnoid hemorrhage on Cl' may not require routine hospitalization. A validation study is needed to confirm the findings of this study. (C) 2021 The Author(s). Published by Elsevier Inc.	[Mizu, Daisuke; Matsuoka, Yoshinori; Huh, Ji-Young; Onishi, Masafumi; Ariyoshi, Koichi] Kobe City Med Ctr Gen Hosp, Dept Emergency Med, Chuo Ku, 2-1-1 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan		Mizu, D (corresponding author), Kobe City Med Ctr Gen Hosp, Dept Emergency Med, Chuo Ku, 2-1-1 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	water@kcho.jp					Boran BO, 2006, PEDIATR NEUROSURG, V42, P203, DOI 10.1159/000092355; Bressan S, 2018, ANN EMERG MED, V71, P714, DOI 10.1016/j.annemergmed.2017.10.014; Dawson EC, 2012, PEDIATR NEUROSURG, V48, P221, DOI 10.1159/000346697; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Harty E, 2010, EMERG MED J, V27, P750, DOI 10.1136/emj.2009.077644; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Holsti M, 2005, PEDIATR EMERG CARE, V21, P639, DOI 10.1097/01.pec.0000181426.25342.a9; Jacquet C, 2018, NEUROPEDIATRICS, V49, P385, DOI 10.1055/s-0038-1668138; Johnson MA, 2020, PEDIATR EMERG CARE, V36, pE610, DOI 10.1097/PEC.0000000000001701; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lefort R, 2017, PEDIATR EMERG CARE, V33, P161, DOI 10.1097/PEC.0000000000000863; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mannix R, 2013, ANN EMERG MED, V62, P327, DOI 10.1016/j.annemergmed.2013.02.027; Noje C, 2019, PEDIATR CRIT CARE ME, V20, P1061, DOI 10.1097/PCC.0000000000002033; Ore CLD, 2018, J NEUROSURG-PEDIATR, V22, P559, DOI 10.3171/2018.5.PEDS18140; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x	23	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	DEC	2021	50						399	403		10.1016/j.ajem.2021.08.060			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	WE1SM	WOS:000705407400071	34481258	hybrid			2022-02-06	
J	Morrison, HR; Miutz, LN; Emery, CA; Smirl, JD				Morrison, Heidi R.; Miutz, Lauren N.; Emery, Carolyn A.; Smirl, Jonathan D.			A Standardized Buffalo Concussion Treadmill Test After Sport-Related Concussion in Youth: Do Matter?	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injuries; adolescents; athletes; actigraphy	PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; EXERCISE; ACCELEROMETER; CALIBRATION; VALIDATION; CHILDREN; RETURN	Context: Current guidelines for recovery after sport-relat-ed concussion (SRC) recommend 24 to 48 hours of rest, followed by a gradual return to activity with heart rate (HR) maintained below the symptom threshold. In addition, moni-toring physical activity (PA) after SRC using ActiGraph accelerometers can provide further objective insight into the amounts of activity associated with recovery trajectories. Cutpoint algorithms for these devices allow minute-by-minute PA to be classified into intensity domains; however, research -ers have shown that different algorithms used to evaluate the same healthy participant dataset can produce various classi-fications. Objective: To identify the more physiologically appropriate cutpoint algorithm (Evenson or Romanzini) to analyze ActiGraph data among concussed adolescents in comparison with their HR responses on the Buffalo Concussion Treadmill Test (BCTT). Design: Prospective cohort study. Setting: University sport concussion clinic. Patients or Other Participants: Eleven high school stu-dents (5 boys, 6 girls; median [range] age = 16 years [15-17 years], height = 177.8 cm [157.5-198.1 cm], mass = 67 kg [52- 98 kg], body mass index = 22 [17-31]) involved in high-risk sports who sustained a physician-diagnosed SRC. Main Outcome Measure(s): Evenson and Romanzini algo-rithm PA intensity domains via ActiGraph data and HR during the BCTT. Results: We observed differences in PA time classified as moderate (P = .003) and vigorous (P = .004) intensities between algorithms but no difference in PA time classified as light intensity (P = .48). The Evenson algorithm classified most of the time as moderate-intensity PA (mean = 57.03%, range = 0.00%- 94.12%), whereas the Romanzini algorithm classified virtually all PA as vigorous intensity (mean = 88.25%, range = 2.94%- 97.06%]). Physical activity based on HR (stages 1-7 = 20%- 39% HR reserve [HRR], stages 8-13 = 40%-59% HRR, stages >14 = 60%-85% HRR) indicated the BCTT primarily involved light to moderate intensity and, therefore, was better represent-ed by the Evenson algorithm. Conclusions: The Evenson algorithm better characterized the HR response during a standardized exercise test in concussed individuals and, thus, should be used to analyze ActiGraph PA data in pediatric populations with concussion.	[Morrison, Heidi R.; Miutz, Lauren N.; Emery, Carolyn A.; Smirl, Jonathan D.] Univ Calgary, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Emery, Carolyn A.; Smirl, Jonathan D.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Emery, Carolyn A.; Smirl, Jonathan D.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Emery, Carolyn A.] Univ Calgary, Dept Psychol & Neurosci, Calgary, AB, Canada; [Emery, Carolyn A.] Univ Calgary, Dept Paediat, Calgary, AB, Canada; [Emery, Carolyn A.] Univ Calgary, Community Hlth Sci, Calgary, AB, Canada; [Smirl, Jonathan D.] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada		Smirl, JD (corresponding author), Univ Calgary, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.				International Olympic Committee; National Football League Scientific Advisory Board; Vi-Riddell Paediatric Research Program	The Sport Injury Prevention Research Centre is one of the International Research Centres for Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee. Funding for this study was provided by the National Football League Scientific Advisory Board and Vi-Riddell Paediatric Research Program (C.A.E.) . We thank the participating school boards, schools, teachers, coaches, and students for their time and support in completing this research project.	ASTRAND PO, 1954, J APPL PHYSIOL, V7, P218, DOI 10.1152/jappl.1954.7.2.218; Banda JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150534; Boddy LM, 2018, J SPORT SCI, V36, P1340, DOI 10.1080/02640414.2017.1377842; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Canadian Society for Exercise Physiology, 2013, CSEP PHYS ACT TRAIN; De Vries SI, 2009, MED SCI SPORT EXER, V41, P818, DOI 10.1249/MSS.0b013e31818e5819; Duncan MJ, 2020, ACTA PAEDIATR, V109, P1825, DOI 10.1111/apa.15189; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Guinhouya BC, 2013, PUBLIC HEALTH, V127, P301, DOI 10.1016/j.puhe.2013.01.020; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Lishchynsky JT, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00588; Mann T, 2013, SPORTS MED, V43, P613, DOI 10.1007/s40279-013-0045-x; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Mattocks C, 2007, INT J PEDIATR OBES, V2, P218, DOI 10.1080/17477160701408809; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Migueles JH, 2017, SPORTS MED, V47, P1821, DOI 10.1007/s40279-017-0716-0; Norton K, 2010, J SCI MED SPORT, V13, P496, DOI 10.1016/j.jsams.2009.09.008; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Reilly JJ, 2003, OBES RES, V11, P1155, DOI 10.1038/oby.2003.158; Romanzini M, 2014, EUR J SPORT SCI, V14, P91, DOI 10.1080/17461391.2012.732614; Sirard J.R., 2005, J PHYS ACTIVITY HLTH, V2, P345, DOI [https://doi.org/10.1123/jpah.2.3.345, DOI 10.1123/JPAH.2.3.345, 10. 1123/jpah.2.3.345]; Smith MP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187706; Treuth MS, 2004, MED SCI SPORT EXER, V36, P1259, DOI 10.1249/01.MSS.0000074670.03001.98	26	0	0	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	DEC	2021	56	12					1300	1305		10.4085/527-20			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	XR2GR	WOS:000732055000006	33481016	gold			2022-02-06	
J	Motah, M; Ndoumbe, A; Massi, DG; Bekolo, FF; Inemb, GB; Moumi, M; Esene, I; Chunteng, NT; Boukar, YE; Eyenga, VC				Motah, Mathieu; Ndoumbe, Aurelien; Massi, Daniel Gams; Bekolo, Fabien Fouda; Inemb, Gabriel Batamag; Moumi, Mireille; Esene, Ignatius; Chunteng, Nana Theophil; Boukar, Yannick Ekani; Eyenga, Victor -Claude			Traumatic intracranial haemorrhage in Cameroon: Clinical features, treatment options and outcome	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						Traumatic brain injury; Intracranial haemorrhage; Subdural hematoma; Epidural hematoma; Douala; Cameroon	MANAGEMENT; HEMATOMA; INJURIES	Traumatic intracranial haemorrhage (t-ICH) is major medical and surgical emergency. Road traffic accident related traumatic brain injury remains the main aetiology. Brain CT scan has contributed to early diagnosis and rapid management. The aim of this study was to describe clinical features, treatment options and outcome of t-ICH in a referral hospital in Cameroon. We retrospectively studied the medical records of patients admitted for t-ICH at the Douala General Hospital from January 1st, 2009 to December 31st, 2018. Data collected included: demographic, diagnostic, treatment, and outcome in the hospital. The traumatic brain injury severity was defined based on the Glasgow coma scale (GCS). Data analysis was performed using EPI Info 3.5.4. Logistic regression was done to identify predictive factors of mortality. The level of significance was set at p < 0.05. Among the 2368 files reviewed, we found 413 (17.4%) cases of t-ICH including 219 complete files. The most affected age group was 27 to 36 years. Male patients represented 83.6%. Road traffic accident was the commonest cause (74.9%). Initial loss of consciousness was found in 69.41% of patients. 17.8% of patients presented with severe traumatic brain injury. The commonest lesion were subdural and epidural hematomas. Surgical treatment was performed in 56.6% of cases. In-hospital mortality rate was 17.35%, and age >= 63 years and Glasgow <= 8 were the predictive factors of death. Traumatic intracranial haemorrhage provide significant mortality in this study. Road traffic accident is the leading cause, more affecting young adults. Older age and severe traumatic brain injury are predictors of in-hospital mortality. Multicentre studies are need to provide accurate data on traumatic intracranial haemorrhage in Cameroon.	[Motah, Mathieu; Ndoumbe, Aurelien; Bekolo, Fabien Fouda; Inemb, Gabriel Batamag] Univ Douala, Fac Med & Pharmaceut Sci, Dept Surg, Douala, Cameroon; [Massi, Daniel Gams] Univ Buea, Dept Internal Med & Pediat, Fac Hlth Sci, Buea, Cameroon; [Motah, Mathieu; Moumi, Mireille] Douala Gen Hosp, Neurosurg Unit, Douala, Cameroon; [Esene, Ignatius] Univ Bamenda, Fac Hlth Sci, Neurosurgery Div, Bamenda, Cameroon; [Chunteng, Nana Theophil; Boukar, Yannick Ekani] Univ Buea, Fac Hlth Sci, Dept Surg, Buea, Cameroon; [Eyenga, Victor -Claude] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon		Motah, M (corresponding author), Univ Douala, Fac Med & Pharmaceut Sci, Dept Surg, Douala, Cameroon.; Motah, M (corresponding author), Douala Gen Hosp, Neurosurg Unit, Douala, Cameroon.	motmath@yahoo.fr; moumimireille@yahoo.fr; ignatiusesene@yahoo.co.uk; nana2theo@yahoo.fr; dreyenga@yahoo.fr					Abdelmalik PA, 2019, TRANSFUSION, V59, P1529, DOI 10.1111/trf.15171; Albers CE, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/453978; Alliez J.R., 2008, HEMATOMES INTRACRANI, P17, DOI [10.1016/S0246- 0378(08)45269-7, DOI 10.1016/S0246-0378(08)45269-7]; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen FM, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01669-5; Djientcheu V, 2016, J NEUROL SCI, V371, P100, DOI 10.1016/j.jns.2016.10.016; Djientcheu VD, 2005, AFR J NEUROL SCI, V24, P33; Guilah S., 2012, J AFR MAG MED, V1, P4; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jang SH, 2019, AM J PHYS MED REHAB, V98, P1067, DOI 10.1097/PHM.0000000000001243; Kiwango G, 2013, AFR J EMERG MED, V3, pS6, DOI 10.1016/j.afjem.2013.08.012; Krueger EM, 2019, CUREUS, V11, DOI 10.7759/cureus.5982; Ma Cheng, 2019, Chin Neurosurg J, V5, P24, DOI 10.1186/s41016-019-0173-8; Motah M., 2011, HLTH SG DIS, V3; Moustafa F, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0515-0; Ndoumbe A., 2018, OPEN J MODERN NEUROS, V08, P119, DOI [10.4236/ojmn.2018.81010, DOI 10.4236/OJMN.2018.81010]; Nishijima DK, 2018, J NEUROTRAUM, V35, P750, DOI 10.1089/neu.2017.5232; Pang CH, 2015, J NEUROSURG, V123, P65, DOI 10.3171/2014.12.JNS141189; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Powers AY, 2020, J NEUROSURG, V132, P552, DOI 10.3171/2018.11.JNS182199; Rush B, 2016, WORLD NEUROSURG, V88, P25, DOI 10.1016/j.wneu.2015.12.034; Sawanyawisuth K., CLIN FACTORS PREDICT, V5; Shibahashi K, 2020, J NEUROSURG, V133, P504, DOI 10.3171/2019.4.JNS182660; Subaiya S, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-17; Wang Justin Z, 2019, CMAJ Open, V7, pE511, DOI 10.9778/cmajo.20180188; Waseem N., 2020, EAS J MED SURG, V2, P205, DOI [10.36349/easjms.2020.v02i11.002, DOI 10.36349/EASJMS.2020.V02I11.002]; Wu E, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.587587; Wu XJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205729	29	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2214-7519		INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	DEC	2021	26								101346	10.1016/j.inat.2021.101346			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WJ8DQ	WOS:000709269600015		gold			2022-02-06	
J	Motanis, H; Khorasani, LN; Giza, CC; Harris, NG				Motanis, Helen; Khorasani, Laila N.; Giza, Christopher C.; Harris, Neil G.			Peering into the Brain through the Retrosplenial Cortex to Assess Cognitive Function of the Injured Brain	NEUROTRAUMA REPORTS			English	Article						cognitive impairments; hippocampal marker; network activity; neural deficits; sensory-cognitive network; traumatic brain injury	DEFAULT-MODE NETWORK; MEDIAL PREFRONTAL CORTEX; TRAUMATIC AXONAL INJURY; NEURONAL CELL-DEATH; ANTERIOR CINGULATE; STRUCTURAL CONNECTIVITY; ALZHEIMERS-DISEASE; RECOGNITION MEMORY; PATH-INTEGRATION; HEAD-DIRECTION	The retrosplenial cortex (RSC) is a posterior cortical area that has been drawing increasing interest in recent years, with a growing number of studies studying its contribution to cognitive and sensory functions. From an anatomical perspective, it has been established that the RSC is extensively and often reciprocally connected with the hippocampus, neocortex, and many midbrain regions. Functionally, the RSC is an important hub of the default-mode network. This endowment, with vast anatomical and functional connections, positions the RSC to play an important role in episodic memory, spatial and contextual learning, sensory-cognitive activities, and multi-modal sensory information processing and integration. Additionally, RSC dysfunction has been reported in cases of cognitive decline, particularly in Alzheimer's disease and stroke. We review the literature to examine whether the RSC can act as a cortical marker of persistent cognitive dysfunction after traumatic brain injury (TBI). Because the RSC is easily accessible at the brain's surface using in vivo techniques, we argue that studying RSC network activity post-TBI can shed light into the mechanisms of less-accessible brain regions, such as the hippocampus. There is a fundamental gap in the TBI field about the microscale alterations occurring post-trauma, and by studying the RSC's neuronal activity at the cellular level we will be able to design better therapeutic tools. Understanding how neuronal activity and interactions produce normal and abnormal activity in the injured brain is crucial to understanding cognitive dysfunction. By using this approach, we expect to gain valuable insights to better understand brain disorders like TBI.	[Motanis, Helen; Khorasani, Laila N.; Giza, Christopher C.; Harris, Neil G.] Univ Calif Los Angeles, Geffen Med Sch, Dept Neurosurg, UCLA Brain Injury Res Ctr, Los Angeles, CA USA; [Harris, Neil G.] Univ Calif Los Angeles, Intellectual Dev & Disabil Res Ctr, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Dept Pediat, UCLA Mattel Childrens Hosp, Los Angeles, CA USA		Harris, NG (corresponding author), Univ Calif Los Angeles, Dept Neurosurg, Wasserman Bldg,300 Stein Plaza,Room 551, Los Angeles, CA 90095 USA.	ngharris@ucla.edu			NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1NS091222]; UCLA Brain Injury Research Center	This work was supported by NIH NINDS RO1NS091222 and the UCLA Brain Injury Research Center.	Aggleton JP, 2016, BRAIN, V139, P1877, DOI 10.1093/brain/aww083; Aggleton JP, 2012, HIPPOCAMPUS, V22, P1883, DOI 10.1002/hipo.22024; Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Aggleton JP, 2010, NEUROPSYCHOLOGIA, V48, P2328, DOI 10.1016/j.neuropsychologia.2009.09.030; Akamatsu Y, 2020, NEUROTHERAPEUTICS, V17, P446, DOI 10.1007/s13311-020-00840-7; Alexander AS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz2322; Alexander AS, 2015, NAT NEUROSCI, V18, P1143, DOI 10.1038/nn.4058; Allegra M, 2020, NEURON, V108, DOI 10.1016/j.neuron.2020.09.032; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Arulsamy A, 2018, BEHAV BRAIN RES, V348, P127, DOI 10.1016/j.bbr.2018.04.009; Ash JA, 2016, P NATL ACAD SCI USA, V113, P12286, DOI 10.1073/pnas.1525309113; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Auger SD, 2017, NEUROPSYCHOLOGIA, V104, P102, DOI 10.1016/j.neuropsychologia.2017.08.012; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Barriere DAP, 2019, PAIN, V160, P2241, DOI 10.1097/j.pain.0000000000001610; Barthas F, 2017, TRENDS NEUROSCI, V40, P181, DOI 10.1016/j.tins.2016.11.006; Baxendale S, 2019, PRACT NEUROL, V19, P476, DOI 10.1136/practneurol-2018-002113; de Landeta AB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60937-z; Bhowmick S, 2019, J MOL MED, V97, P1627, DOI 10.1007/s00109-019-01851-4; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Blakey SM, 2018, J PAIN, V19, P797, DOI 10.1016/j.jpain.2018.02.012; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Broussard JI, 2020, J NEUROTRAUM, V37, P227, DOI 10.1089/neu.2019.6766; Buckley MJ, 2016, CEREB CORTEX, V26, P2905, DOI 10.1093/cercor/bhw054; Buckwalter JA, 2008, EXP BRAIN RES, V186, P47, DOI 10.1007/s00221-007-1203-x; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; Carbonell WS, 1999, ANN NY ACAD SCI, V890, P287, DOI 10.1111/j.1749-6632.1999.tb08005.x; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; Chen P, 2020, CHIN J TRAUMATOL, V23, P202, DOI 10.1016/j.cjtee.2020.05.006; Cho JW, 2001, BEHAV NEUROSCI, V115, P3, DOI 10.1037//0735-7044.115.1.3; Chrastil ER, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0346-16.2017; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Clark BJ, 2018, BEHAV NEUROSCI, V132, P416, DOI 10.1037/bne0000260; Cogan AM, 2020, PM&R, V12, P301, DOI 10.1002/pmrj.12237; Cooper BG, 2001, J NEUROSCI, V21, P3986, DOI 10.1523/JNEUROSCI.21-11-03986.2001; Cooper BG, 1999, NEUROREPORT, V10, P625, DOI 10.1097/00001756-199902250-00033; Corcoran KA, 2011, J NEUROSCI, V31, P11655, DOI 10.1523/JNEUROSCI.2107-11.2011; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Crafa D, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00232; Cross L, 2013, LEARN MEMORY, V20, P41, DOI 10.1101/lm.028266.112; Czajkowski R, 2014, P NATL ACAD SCI USA, V111, P8661, DOI 10.1073/pnas.1313222111; Daugherty J, 2019, MMWR-MORBID MORTAL W, V68, P1050, DOI 10.15585/mmwr.mm6846a2; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Dias R, 2000, EUR J NEUROSCI, V12, P4457, DOI 10.1046/j.0953-816X.2000.01323.x; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; DiLeonardi AM, 2012, J NEUROPATH EXP NEUR, V71, P959, DOI 10.1097/NEN.0b013e31826f5876; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Dillen KNH, 2016, NEUROBIOL AGING, V44, P114, DOI 10.1016/j.neurobiolaging.2016.04.010; Dougan L, 2011, P NATL ACAD SCI USA, V108, P9759, DOI [10.1073/pnas.1200506109, 10.1073/pnas.1101934108]; DUSOIR H, 1990, BRAIN, V113, P1695, DOI 10.1093/brain/113.6.1695; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Elduayen C, 2014, BEHAV BRAIN RES, V272, P303, DOI 10.1016/j.bbr.2014.07.009; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Fischer LF, 2020, ELIFE, V9, DOI 10.7554/eLife.51458; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Floresco SB, 2008, BEHAV BRAIN RES, V190, P85, DOI 10.1016/j.bbr.2008.02.008; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Foster BL, 2013, J NEUROSCI, V33, P10439, DOI 10.1523/JNEUROSCI.0513-13.2013; Fournier DI, 2020, BEHAV NEUROSCI, V134, P198, DOI 10.1037/bne0000365; Fournier DI, 2019, BEHAV BRAIN RES, V369, DOI 10.1016/j.bbr.2019.111920; Gainotti G, 1998, NEUROCASE, V4, P519; Gilbert N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197419; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Grant DA, 2018, J NEUROTRAUM, V35, P94, DOI 10.1089/neu.2017.5042; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Gurkoff GG, 2013, J NEUROTRAUM, V30, P292, DOI 10.1089/neu.2012.2463; Haberman RP, 2017, NEUROTHERAPEUTICS, V14, P662, DOI 10.1007/s13311-017-0541-z; Haddon JE, 2006, J NEUROSCI, V26, P2933, DOI 10.1523/JNEUROSCI.3243-05.2006; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hannesson DK, 2004, J NEUROSCI, V24, P4596, DOI 10.1523/JNEUROSCI.5517-03.2004; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Hayashi T, 2020, NEUROSCI RES, V154, P52, DOI 10.1016/j.neures.2019.05.005; Helpern JA, 2004, MAGNET RESON MED, V51, P794, DOI 10.1002/mrm.20038; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hindley EL, 2014, BEHAV BRAIN RES, V263, P98, DOI 10.1016/j.bbr.2014.01.028; Hogeveen J, 2018, BIOL PSYCHIAT, V84, P287, DOI 10.1016/j.biopsych.2018.01.015; Honan CA, 2015, BRAIN LANG, V150, P69, DOI 10.1016/j.bandl.2015.08.007; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Iaria G, 2007, EUR J NEUROSCI, V25, P890, DOI 10.1111/j.1460-9568.2007.05371.x; Ino T, 2007, CORTEX, V43, P248, DOI 10.1016/S0010-9452(08)70479-9; Itoh T, 2013, BRAIN STRUCT FUNCT, V218, P209, DOI 10.1007/s00429-012-0394-5; Jacobs PY, 2017, NAT NEUROSCI, V20, P173, DOI 10.1038/nn.4465; Ji XR, 2017, BRAIN RES, V1659, P88, DOI 10.1016/j.brainres.2016.12.031; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones BF, 2005, NEUROSCIENCE, V133, P193, DOI 10.1016/j.neuroscience.2005.01.063; Kaboodvand N, 2018, HUM BRAIN MAPP, V39, P2020, DOI 10.1002/hbm.23983; Kang WH, 2015, J NEUROTRAUM, V32, P1011, DOI 10.1089/neu.2014.3667; Kawakami R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01014; Kim DH, 2020, PHYSIOL BEHAV, V222, DOI 10.1016/j.physbeh.2020.112891; Kim JH, 2007, J CLIN NEUROL, V3, P62, DOI 10.3988/jcn.2007.3.1.62; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Kim WS, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0489-9; Kleffelgaard I, 2019, CLIN REHABIL, V33, P74, DOI 10.1177/0269215518791274; Koch PF, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0495-19.2020; Koike Bruna Del Vechio, 2017, J Neurosci, V37, P8003, DOI 10.1523/JNEUROSCI.0026-17.2017; Kononenko NL, 2012, HIPPOCAMPUS, V22, P881, DOI 10.1002/hipo.20949; Krishna G, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801055; Kucyi A, 2014, J NEUROSCI, V34, P3969, DOI 10.1523/JNEUROSCI.5055-13.2014; Kulkarni P, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00034; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Lemke S, 2013, JAMA OPHTHALMOL, V131, P1602, DOI 10.1001/jamaophthalmol.2013.5028; Li PL, 2018, NEUROSCI LETT, V674, P24, DOI 10.1016/j.neulet.2018.03.016; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Lippa SM, 2018, J HEAD TRAUMA REHAB, V33, P101, DOI 10.1097/HTR.0000000000000353; Liu J, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.587053; Livingstone SA, 2007, BEHAV BRAIN RES, V185, P21, DOI 10.1016/j.bbr.2007.07.015; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lukoyanov NV, 2005, BEHAV BRAIN RES, V158, P175, DOI 10.1016/j.bbr.2004.08.023; Lynch CJ, 2013, BIOL PSYCHIAT, V74, P212, DOI 10.1016/j.biopsych.2012.12.013; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; Makino H, 2015, NAT NEUROSCI, V18, P1116, DOI 10.1038/nn.4061; Mao D, 2020, CURR BIOL, V30, P1680, DOI 10.1016/j.cub.2020.02.070; Marion CM, 2019, EXP NEUROL, V321, DOI 10.1016/j.expneurol.2019.113040; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; McGuire JL, 2019, NEUROBIOL DIS, V132, DOI 10.1016/j.nbd.2019.104611; Meng GH, 2019, ELIFE, V8, DOI 10.7554/eLife.40805; Merezhinskaya N, 2019, OPTOMETRY VISION SCI, V96, P542, DOI 10.1097/OPX.0000000000001407; Milczarek MM, 2018, CURR BIOL, V28, P1975, DOI 10.1016/j.cub.2018.05.002; Miller AMP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00586; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Miyashita T, 2007, EUR J NEUROSCI, V26, P1193, DOI 10.1111/j.1460-9568.2007.05745.x; Mohamed AZ, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102136; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Munyon C, 2014, BRAIN RES, V1582, P220, DOI 10.1016/j.brainres.2014.07.036; Nasseef MT, 2021, BRAIN IMAGING BEHAV, V15, P2406, DOI 10.1007/s11682-020-00438-9; Nelson AJD, 2014, LEARN MEMORY, V21, P90, DOI 10.1101/lm.032136.113; Nestor PJ, 2003, EUR J NEUROSCI, V18, P2663, DOI 10.1046/j.1460-9568.2003.02999.x; Ng CW, 2007, J NEUROSCI, V27, P12123, DOI 10.1523/JNEUROSCI.2745-07.2007; Nitzan N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15787-8; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Ondek K, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.600171; Page HJI, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00191; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Parent M, 2019, J NEUROTRAUM, V36, P601, DOI 10.1089/neu.2018.5741; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Paterno R, 2016, J NEUROTRAUM, V33, P1645, DOI 10.1089/neu.2015.4107; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Pinar C, 2020, BEHAV BRAIN RES, V387, DOI 10.1016/j.bbr.2020.112585; Pottker B, 2017, BRAIN STRUCT FUNCT, V222, P4005, DOI 10.1007/s00429-017-1452-9; Pothuizen HHJ, 2009, EUR J NEUROSCI, V30, P877, DOI 10.1111/j.1460-9568.2009.06881.x; Pothuizen HHJ, 2008, EUR J NEUROSCI, V28, P2486, DOI 10.1111/j.1460-9568.2008.06550.x; Powell A, 2020, CEREB CORTEX, V30, P4424, DOI 10.1093/cercor/bhaa030; Powell AL, 2017, BEHAV BRAIN RES, V335, P88, DOI 10.1016/j.bbr.2017.08.010; Powell AL, 2017, EUR J NEUROSCI, V45, P1451, DOI 10.1111/ejn.13577; Pradat-Diehl P, 1999, REV NEUROL, V155, P375; Rabinowitz AR, 2019, J INT NEUROPSYCH SOC, V25, P998, DOI 10.1017/S1355617718000346; Radford K, 2018, HEALTH TECHNOL ASSES, V22, P1, DOI 10.3310/hta22330; Raichle ME, 2015, ANNU REV NEUROSCI, V38, P433, DOI 10.1146/annurev-neuro-071013-014030; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Regen W, 2016, J PSYCHIATR NEUROSCI, V41, P295, DOI 10.1503/jpn.140290; Reid JM, 2014, CEREB CORTEX, V24, P2108, DOI 10.1093/cercor/bht061; RINK A, 1995, AM J PATHOL, V147, P1575; Robinson S, 2014, J NEUROSCI, V34, P10982, DOI 10.1523/JNEUROSCI.1349-14.2014; Robinson S, 2011, BEHAV NEUROSCI, V125, P578, DOI 10.1037/a0024262; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rowland DC, 2013, J NEUROSCI, V33, P14889, DOI 10.1523/JNEUROSCI.1046-13.2013; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Sato N, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81943-9; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Shandra O, 2019, J NEUROSCI, V39, P1944, DOI 10.1523/JNEUROSCI.1067-18.2018; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sherrill KR, 2013, J NEUROSCI, V33, P19304, DOI 10.1523/JNEUROSCI.1825-13.2013; Shibata H, 2004, NEUROSCI RES, V49, P1, DOI 10.1016/j.neures.2004.01.005; Shibata H, 2008, J COMP NEUROL, V506, P30, DOI 10.1002/cne.21523; Shin SS, 2018, BRAIN STIMUL, V11, P1306, DOI 10.1016/j.brs.2018.07.050; Shumskaya E, 2017, EXP BRAIN RES, V235, P799, DOI 10.1007/s00221-016-4841-z; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Skelton RW, 2006, BRAIN INJURY, V20, P189, DOI 10.1080/02699050500456410; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Sporns O., 2010, NETWORKS BRAIN; SRIPANIDKULCHAI K, 1986, J COMP NEUROL, V254, P143, DOI 10.1002/cne.902540202; Stephens JA, 2017, J NEUROTRAUM, V34, P3117, DOI 10.1089/neu.2017.5081; Sugar Jorgen, 2011, Front Neuroinform, V5, P7, DOI 10.3389/fninf.2011.00007; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Swanson LW, 2010, P NATL ACAD SCI USA, V107, P20610, DOI 10.1073/pnas.1015128107; Sydnor VJ, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2020.102190; Tan RH, 2013, DEMENT GERIATR COGN, V35, P177, DOI 10.1159/000346392; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Taxidis J, 2020, NEURON, V108, DOI 10.1016/j.neuron.2020.08.028; Tayim FM, 2016, J CLIN EXP NEUROPSYC, V38, P1005, DOI 10.1080/13803395.2016.1182968; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Tsuda S, 2016, NEUROREPORT, V27, P724, DOI 10.1097/WNR.0000000000000598; Tu WY, 2021, CEREB CORTEX, V31, P312, DOI 10.1093/cercor/bhaa227; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; Ustinova KI, 2015, PHYSIOTHER THEOR PR, V31, P1, DOI 10.3109/09593985.2014.945674; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vakil E, 2019, NEUROPSYCHOL REV, V29, P270, DOI 10.1007/s11065-019-09413-8; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; van Groen T, 2003, J COMP NEUROL, V463, P249, DOI 10.1002/cne.10757; VANGROEN T, 1992, J COMP NEUROL, V315, P200, DOI 10.1002/cne.903150207; VANGROEN T, 1990, J COMP NEUROL, V300, P593, DOI 10.1002/cne.903000412; Vann SD, 2005, BEHAV NEUROSCI, V119, P1682, DOI 10.1037/0735-7044.119.6.1682; Vann SD, 2004, BEHAV BRAIN RES, V155, P97, DOI 10.1016/j.bbr.2004.04.005; Vann SD, 2003, BEHAV BRAIN RES, V140, P107, DOI 10.1016/S0166-4328(02)00274-7; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Verley DR, 2018, J NEUROTRAUM, V35, P2448, DOI 10.1089/neu.2017.5536; Wammes JD, 2017, BRAIN COGNITION, V111, P112, DOI 10.1016/j.bandc.2016.11.004; Wang JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146535; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Wang QX, 2012, J NEUROSCI, V32, P4386, DOI 10.1523/JNEUROSCI.6063-11.2012; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Wang WJ, 2018, BRAIN INJURY, V32, P1858, DOI 10.1080/02699052.2018.1537513; Wesierska M, 2009, NEUROBIOL LEARN MEM, V91, P41, DOI 10.1016/j.nlm.2008.09.005; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Wiggs CL, 1999, NEUROPSYCHOLOGIA, V37, P103; Wilber AA, 2015, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00146; Williamson DR, 2016, SYST REV, V5, DOI 10.1186/s13643-016-0374-6; Wilson NM, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00005; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; WYSS JM, 1992, HIPPOCAMPUS, V2, P1; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yamawaki N, 2016, J NEUROSCI, V36, P9365, DOI 10.1523/JNEUROSCI.1099-16.2016; Yan H, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6353845; Yang YX, 2019, NEUROCHEM RES, V44, P811, DOI 10.1007/s11064-018-02714-z; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Zhang QQ, 2021, ACUPUNCT MED, V39, P200, DOI 10.1177/0964528420921190; Zhou LYY, 2016, BEHAV BRAIN RES, V296, P373, DOI 10.1016/j.bbr.2015.08.022; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zingg B, 2014, CELL, V156, P1096, DOI 10.1016/j.cell.2014.02.023	254	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	DEC 1	2021	2	1					564	580		10.1089/neur.2021.0044			17	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	XJ0TX	WOS:000726512900002	34901949	gold, Green Published			2022-02-06	
J	Narducci, DM; Moran, B; Coris, E; Tsalatsanis, A; Graulich, I; Del Rossi, G				Narducci, Dusty Marie; Moran, Byron; Coris, Eric; Tsalatsanis, Athanasios; Graulich, Ian; Del Rossi, Gianluca			Predicting Concussion Recovery with PHQ-9 and GAD-7	SOUTHERN MEDICAL JOURNAL			English	Article						concussion; head injury; mood; recovery	TRAUMATIC BRAIN-INJURY; PERSISTENT SYMPTOMS; FOOTBALL PLAYERS; ANXIETY; EPIDEMIOLOGY; RISK	Objective To determine whether scores obtained from Patient Health Questionnaire-9 (PHQ-9) or the General Anxiety Disorder-7 (GAD-7) instruments administered following a concussion can be used to predict recovery time. Method Retrospective cohort study in a university-based specialty concussion center of 502 concussed participants. Participants completed a PHQ-9 and GAD-7 during their initial visit and subsequent visits during the recovery period (ie, at 14, 28, 56, and 84 days). Results The median recovery time from a concussion was 21 days from the initial clinical evaluation; however, individuals with a PHQ-9 score <= 6 (n = 262) had a median recovery time of 17 (95% confidence interval [CI] 15-19) days, whereas those with PHQ-9 scores >6 (n = 240) had a median recovery time of 33 (95% CI 28-37) days and a hazard ratio of 0.525 (95% CI 0.438-0.629, P < 0.0001). For individuals with a GAD-7 score <= 4 (n = 259), the median recovery was 19 (95% CI 17-21), days whereas for those with a GAD-7 score > 4 (n = 243), the median recovery was 32 (95% CI 28-36) days with a hazard ratio of 0.554 (95% CI 0.462-0.664, P < 0.00). Conclusions Scores obtained from PHQ-9 and GAD-7 screening tools appear to be predictive of an individual's recovery and may help identify those subjects who may benefit from early psychological interventions.	Univ S Florida, Dept Family Med, Morsani Coll Med, Coll Med Off Res, Tampa, FL 33612 USA; Univ S Florida, Dept Orthoped, Tampa, FL 33612 USA; Creighton Univ, Dept Phys Therapy, Phoenix, AZ USA		Narducci, DM (corresponding author), Univ S Florida, 13330 USF Laurel Dr, Tampa, FL 33612 USA.	dustynarducci@usf.edu					Anand Sharma, 2015, British Journal of Medicine and Medical Research, V10; Barker-Collo S, 2018, BRAIN INJURY, V32, P1651, DOI 10.1080/02699052.2018.1540797; Boulton AJ, 2019, J HEAD TRAUMA REHAB, V34, P353, DOI 10.1097/HTR.0000000000000529; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Cornett K, 2019, ARCH CLIN NEUROPSYCH, V34, P1020, DOI 10.1093/arclin/acz034.155; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hammer E, 2021, SPORTS HEALTH, V13, P31, DOI 10.1177/1941738120938010; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kumar S., 2018, ARCH PHYS MED REHAB, V99; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lanois C, 2019, NEUROLOGY, V93, pS12, DOI 10.1212/01.wnl.0000580944.99412.91; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Putukian M., 2017, BR J SPORTS MED, V51, pA28; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Roberts AL, 2021, J NEUROTRAUM, V38, P189, DOI 10.1089/neu.2020.7070; Tarkenton T, 2017, ARCH CLIN NEUROPSYCH, V32, P729, DOI 10.1093/arclin/acx076.156; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Wilmoth K, 2021, ARCH CLIN NEUROPSYCH, V36, P430, DOI 10.1093/arclin/acz061; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	38	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0038-4348	1541-8243		SOUTH MED J	South.Med.J.	DEC	2021	114	12					760	765		10.14423/SMJ.0000000000001336			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	WX2ML	WOS:000718436500005	34853851				2022-02-06	
J	Niu, F; Zhang, B; Feng, J; Mao, X; Xu, XJ; Dong, JQ; Liu, BY				Niu, Fei; Zhang, Bin; Feng, Jie; Mao, Xiang; Xu, Xiao-Jian; Dong, Jin-Qian; Liu, Bai-Yun			Protein profiling identified mitochondrial dysfunction and synaptic abnormalities after dexamethasone intervention in rats with traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article							CORTICOSTEROID INSUFFICIENCY; HIPPOCAMPAL-NEURONS; MONOAMINE-OXIDASE; RECEPTOR; NEUROPROTECTION; HYDROCORTISONE; LOCALIZATION; STRESS; MEMORY	Dexamethasone has been widely used after various neurosurgical procedures due to its anti-inflammatory property and the abilities to restore vascular permeability, inhibit free radicals, and reduce cerebrospinal fluid production. According to the latest guidelines for the treatment of traumatic brain injury in the United States, high-dose glucocorticoids cause neurological damage. To investigate the reason why high-dose glucocorticoids after traumatic brain injury exhibit harmful effect, rat controlled cortical impact models of traumatic brain injury were established. At 1 hour and 2 days after surgery, rat models were intraperitoneally administered dexamethasone 10 mg/kg. The results revealed that 31 proteins were significantly upregulated and 12 proteins were significantly downregulated in rat models of traumatic brain injury after dexamethasone treatment. The Ingenuity Pathway Analysis results showed that differentially expressed proteins were enriched in the mitochondrial dysfunction pathway and synaptogenesis signaling pathway. Western blot analysis and immunohistochemistry results showed that Ndufv2, Maob and Gria3 expression and positive cell count in the dexamethasone-treated group were significantly greater than those in the model group. These findings suggest that dexamethasone may promote a compensatory increase in complex I subunits (Ndufs2 and Ndufv2), increase the expression of mitochondrial enzyme Maob, and upregulate synaptic-transmission-related protein Gria3. These changes may be caused by nerve injury after traumatic brain injury treatment by dexamethasone. The study was approved by Institutional Ethics Committee of Beijing Neurosurgical Institute (approval No. 201802001) on June 6, 2018.	[Niu, Fei; Xu, Xiao-Jian; Liu, Bai-Yun] Capital Med Univ, Beijing Neurosurg Inst, Dept Neurotrauma, Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China; [Zhang, Bin; Dong, Jin-Qian; Liu, Bai-Yun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Feng, Jie] Capital Med Univ, Key Lab Cent Nervous Syst Injury Res, Beijing Inst Brain Disorders, Ctr Brain Tumor,Beijing Neurosurg Inst, Beijing, Peoples R China; [Mao, Xiang] Anhui Med Univ, Dept Neurosurg, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; [Liu, Bai-Yun] Beijing Inst Brain Disorders, Ctr Nerve Injury & Repair, Beijing, Peoples R China; [Liu, Bai-Yun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Neurotrauma, Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.; Liu, BY (corresponding author), Beijing Inst Brain Disorders, Ctr Nerve Injury & Repair, Beijing, Peoples R China.; Liu, BY (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.	liubaiyun@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771327]; Platform Construction of Basic Research and Clinical Translation of Nervous System Injury, China [PXM2020_026280_000002]; Scientific Research and Cultivation Fund of Beijing Neurosurgical Institute of China [2020002]	This study was supported by the National Natural Science Foundation of China, No. 81771327 (to BYL), the Platform Construction of Basic Research and Clinical Translation of Nervous System Injury, China, No. PXM2020_026280_000002 (to BYL); and the Scientific Research and Cultivation Fund of Beijing Neurosurgical Institute of China, No. 2020002 (to FN).	Balan IS, 2013, J NEUROTRAUM, V30, P367, DOI 10.1089/neu.2012.2339; Chen X, 2013, CRIT CARE, V17, DOI 10.1186/cc13067; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Czekajlo Michael S, 2005, Crit Care, V9, pE21; de Kloet ER, 2018, FRONT NEUROENDOCRIN, V49, P124, DOI 10.1016/j.yfrne.2018.02.003; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Dunham-Snary KJ, 2019, CIRC RES, V124, P1727, DOI 10.1161/CIRCRESAHA.118.314284; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Ganor Y, 2003, J IMMUNOL, V170, P4362, DOI 10.4049/jimmunol.170.8.4362; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Ikeda M, 2015, J ENDOCRINOL, V226, pM13, DOI 10.1530/JOE-15-0078; Issaq HJ, 2008, BIOTECHNIQUES, V44, P697, DOI 10.2144/000112823; Jo S, 2014, NAT MED, V20, P886, DOI 10.1038/nm.3639; JOHNSTON JP, 1968, BIOCHEM PHARMACOL, V17, P1285, DOI 10.1016/0006-2952(68)90066-X; Kasahara E, 2015, REDOX REP, V20, DOI 10.1179/1351000214Y.0000000107; Kiray M, 2006, PHYSIOL RES, V55, P205; Koufali MM, 2003, MOL CELL ENDOCRINOL, V209, P51, DOI 10.1016/j.mce.2003.07.003; Levite M, 2014, J NEURAL TRANSM, V121, P1029, DOI 10.1007/s00702-014-1193-3; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; Miyamoto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044055; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nagatsu T, 2004, NEUROTOXICOLOGY, V25, P11, DOI 10.1016/S0161-813X(03)00085-8; Nishioka K, 2010, PARKINSONISM RELAT D, V16, P686, DOI 10.1016/j.parkreldis.2010.09.007; O'Rourke T, 2020, NEUROSCI BIOBEHAV R, V108, P341, DOI 10.1016/j.neubiorev.2019.10.004; Odashima M, 2006, WORLD J GASTROENTERO, V12, P568, DOI 10.3748/wjg.v12.i4.568; Qin DY, 2020, ZHONGGUO ZUZHI GONGC, V24, P2011; ratton SL, 2007, STEROIDS J NEUROTRAU, V24, pS91; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005; Spychala MS, 2017, J NEUROSCI RES, V95, P462, DOI 10.1002/jnr.23962; Tang VM, 2013, HORM METAB RES, V45, P709, DOI 10.1055/s-0033-1345119; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Warris LT, 2016, J CLIN ONCOL, V34, P2287, DOI 10.1200/JCO.2015.66.0761; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Zhang B, 2020, NEUROSCIENCE, V424, P1, DOI 10.1016/j.neuroscience.2019.10.026; Zhang B, 2019, BRAIN RES, V1725, DOI 10.1016/j.brainres.2019.146469; Zhang B, 2020, J NEUROTRAUM, V37, P262, DOI 10.1089/neu.2019.6556; Zhou C, 2020, NEURAL REGEN RES, V15, P2318, DOI 10.4103/1673-5374.285001; Zhou ZD, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080911; Zhu H, 2013, BRAIN RES, V1541, P69, DOI 10.1016/j.brainres.2013.10.002; Ziegler C, 2018, J NEURAL TRANSM, V125, P1581, DOI 10.1007/s00702-018-1929-6	46	0	0	8	17	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	DEC	2021	16	12					2438	2445		10.4103/1673-5374.313047			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	RW0TG	WOS:000646236800028	33907032	gold, Green Published			2022-02-06	
J	Nyancho, D; Atem, FD; Venkatachalam, AM; Barnes, A; Hill, M; Traylor, JI; Stutzman, SE; Bedros, N; Aiyagari, V; Aoun, SG				Nyancho, Daniel; Atem, Folefac D.; Venkatachalam, Aardhra M.; Barnes, Arianna; Hill, Michelle; Traylor, Jeffrey, I; Stutzman, Sonja E.; Bedros, Nicole; Aiyagari, Venkatesh; Aoun, Salah G.			Anisocoria Correlates With Injury Severity and Outcomes After Blunt Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE NURSING			English	Article						anisocoria; automated pupillometry; Glasgow Coma Scale; modified Rankin score; outcomes; pupillometry; traumatic brain injury	DELAYED CEREBRAL-ISCHEMIA; NEUROLOGICAL PUPIL INDEX; AUTOMATED PUPILLOMETRY; INTENSIVE-CARE; RELIABILITY	BACKGROUND: Automated infrared pupillometry (AIP) has been shown to be helpful in the setting of aneurysmal subarachnoid hemorrhage and stroke as an indicator of imminent irreversible brain injury. We postulated that the early detection of pupillary dysfunction after light stimulation using AIP may be useful in patients with traumatic brain injury (TBI). METHODS: We performed a retrospective review of the Establishing Normative Data for Pupillometer Assessment in Neuroscience Intensive Care database, a prospectively populated multicenter registry of patients who had AIP measurements taken during their intensive care unit admission. The primary eligibility criterion was a diagnosis of blunt TBI. Ordinal logistic modeling was used to explore the association between anisocoria and daily Glasgow Coma Scale scores and discharge modified Rankin Scale scores from the intensive care unit and from the hospital. RESULTS: Among 118 subjects in the who met inclusion, there were 6187 pupillometer readings. Of these, anisocoria in ambient light was present in 12.8%, and that after light stimulation was present in 9.8%. Anisocoria after light stimulation was associated with worse injury severity (odds ratio [OR], 0.26 [95% confidence interval (CI), 0.14-0.46]), lower discharge Glasgow Coma Scale scores (OR, 0.28 [95% CI, 0.17-0.45]), and lower discharge modified Rankin Scale scores (OR, 0.28 [95% CI, 0.17-0.47]). Anisocoria in ambient light showed a similar but weaker association. CONCLUSION: Anisocoria correlates with injury severity and with patient outcomes after blunt TBI. Anisocoria after light stimulation seems to be a stronger predictor than does anisocoria in ambient light. These findings represent continued efforts to understand pupillary changes in the setting of TBI.	[Aoun, Salah G.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosurg, Dallas, TX 75390 USA; [Nyancho, Daniel; Atem, Folefac D.; Aiyagari, Venkatesh] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Venkatachalam, Aardhra M.; Stutzman, Sonja E.] Univ Texas Southwestern Med Ctr Dallas, ODonnell Brain Inst, Dallas, TX 75390 USA; [Barnes, Arianna] Providence St Joseph Hlth, Surg Intens Care Unit, Mission Viejo, CA USA; [Hill, Michelle] OhioHlth Riverside Methodist Hosp, Columbus, OH USA; [Traylor, Jeffrey, I] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA; [Bedros, Nicole] Baylor Univ, Med Ctr, Dept Surg, Div Trauma, Dallas, TX USA; [Aiyagari, Venkatesh] Univ Texas Southwestern Med Ctr Dallas, Dept Neurocrit Care, Dallas, TX 75390 USA		Aoun, SG (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurosurg, Dallas, TX 75390 USA.	Salah.aoun@utsouthwestern.edu		Nyancho, Daniel/0000-0002-7753-5244	NeurOptics; University of Texas Southwestern Department of Neurosurgery; University of Texas Southwestern Department of Nursing	This study was partially funded by NeurOptics, the University of Texas Southwestern Department of Neurosurgery, and the University of Texas Southwestern Department of Nursing.	Abdelmalik PA, 2019, TRANSFUSION, V59, P1529, DOI 10.1111/trf.15171; Anderson M, 2018, J NEUROSCI NURS, V50, P30, DOI 10.1097/JNN.0000000000000333; Aoun SG, 2020, J NEUROSURG, V132, P27, DOI 10.3171/2018.9.JNS181928; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chen JW, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-548; Chesnut RM, 2018, J NEUROTRAUM, V35, P54, DOI 10.1089/neu.2016.4472; Cortes MX, 2021, J NEUROSCI NURS, V53, P145, DOI 10.1097/JNN.0000000000000584; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; Dance S, 2020, J NEUROSCI NURS, V52, P128, DOI 10.1097/JNN.0000000000000501; El Ahmadieh TY, 2021, WORLD NEUROSURG, V145, pE163, DOI 10.1016/j.wneu.2020.09.152; Jahns FP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2436-3; Jeffery RCH, 2019, AUST J GEN PRACT, V48, P39, DOI 10.31128/AJGP-07-18-4641; Jellinger KA, 2013, DEJONGS NEUROLOGIC E, V7th; Kerr RG, 2016, AM J CRIT CARE, V25, P213, DOI 10.4037/ajcc2016554; Koyanagi M, 2018, J NEUROSURG, V128, P717, DOI 10.3171/2016.10.JNS162227; LAM BL, 1987, AM J OPHTHALMOL, V104, P69, DOI 10.1016/0002-9394(87)90296-0; Loewenfeld I. E., 1993, PUPIL ANATOMY PHYSL; Lussier BL, 2019, J NEUROSCI NURS, V51, P335, DOI 10.1097/JNN.0000000000000478; Marshall M, 2019, J NEUROSCI NURS, V51, P84, DOI 10.1097/JNN.0000000000000416; Mease L, 2018, MIL MED, V183, pE291, DOI 10.1093/milmed/usy011; Miroz JP, 2020, CHEST, V157, P1167, DOI 10.1016/j.chest.2019.11.037; Olson DM, 2017, J NEUROSCI NURS, V49, P251, DOI 10.1097/JNN.0000000000000296; Olson DM, 2016, NEUROCRIT CARE, V24, P251, DOI 10.1007/s12028-015-0182-1; Ortega-Perez S, 2018, J NEUROSCI NURS, V50, P220, DOI 10.1097/JNN.0000000000000384; Papangelou A, 2018, MIL MED, V183, pE113, DOI 10.1093/milmed/usx018; Regasa LE, 2019, J HEAD TRAUMA REHAB, V34, P21, DOI 10.1097/HTR.0000000000000417; Riker RR, 2020, NEUROCRIT CARE, V32, P152, DOI 10.1007/s12028-019-00717-4; Spector R.H., 1990, CLIN METHODS HIST PH, V58, P201; Tamura T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228224; Truong JQ, 2016, MIL MED, V181, P1382, DOI 10.7205/MILMED-D-15-00587; Truong JQ, 2016, BRAIN INJURY, V30, P1372, DOI 10.1080/02699052.2016.1192220; Vedantam A, 2018, J NEUROSURG, V129, P234, DOI 10.3171/2017.3.JNS162720; Weerakoon SM, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.104693; Zafar SF, 2014, J CRIT CARE, V29, P599, DOI 10.1016/j.jcrc.2014.01.012; Zhao WD, 2016, J CLIN NEUROSCI, V33, P79, DOI 10.1016/j.jocn.2016.01.039	37	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	DEC	2021	53	6					251	255		10.1097/JNN.0000000000000613			5	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	WS8RY	WOS:000715446000008	34620803				2022-02-06	
J	O'Halloran, P; Goggins, L; Peirce, N				O'Halloran, Patrick; Goggins, Luke; Peirce, Nicholas			Observable player behaviours and playing performance following helmet strikes in elite cricket	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article						concussion; diagnosis; performance	CONSENSUS STATEMENT; CONCUSSION; VIDEO; MANAGEMENT	Objectives Investigate the observable player behaviours and features of both concussive (HS-C) and non-concussive (HS-NC) helmet strikes and describe their impact on playing performance. Methods Elite male cricketers sustaining helmet strikes between the 2016 and 2018 seasons were identified by the England and Wales Cricket Board. Medical records identified players sustaining a concussion and those in whom concussion was excluded. Retrospective cohort analysis was performed on batting and bowling performance data available for these players in the 2 years prior to and 3 months post helmet strike. Video analysis of available incidents was conducted to describe the characteristics of the helmet strike and subsequent observable player behaviours. The HS-C and HS-NC cohorts were compared. Results Data were available for 194 helmet strikes. 56 (29%) resulted in concussion. No significant differences were seen in playing performance in the 3 months post concussive helmet strike. However, a significant decline in batting performance was seen in this period in the HS-NC group (p<0.001). Video features signifying motor incoordination were most useful in identifying concussion post helmet strike, however, typical features suggesting transient loss of consciousness were not seen. Features such as a longer duration pause prior to the batsman resuming play and the level of concern shown by other players were also useful features. Conclusion HS-NC may be more significant for player performance than previously thought. Guidance for using video replay to identify concussion in cricket may need to be modified when compared with other field sports.	[O'Halloran, Patrick] Marker Diagnost UK Ltd, Birmingham, W Midlands, England; [O'Halloran, Patrick] Royal Orthopaed Hosp NHS Fdn Trust, Musculoskeletal Med, Birmingham, W Midlands, England; [Goggins, Luke] Univ Bath, Dept Hlth, Bath, Avon, England; [Peirce, Nicholas] England & Wales Cricket Board, Sci & Med, Loughborough, Leics, England; [Peirce, Nicholas] Nat Ctr Sports Med, Loughborough, Leics, England		O'Halloran, P (corresponding author), Marker Diagnost UK Ltd, Birmingham, W Midlands, England.; O'Halloran, P (corresponding author), Royal Orthopaed Hosp NHS Fdn Trust, Musculoskeletal Med, Birmingham, W Midlands, England.	patrickohalloran@doctors.org.uk		O'Halloran, Patrick/0000-0002-1185-3485; Goggins, Luke/0000-0001-5540-3729	Drake FoundationSmithsonian InstitutionSmithsonian National Museum of Natural History	Dr PO'H has received funding from The Drake Foundation.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Davis G, 2016, J SCI MED SPORT, V19, P898, DOI 10.1016/j.jsams.2016.02.005; Davis GE, 2018, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-319-99319-5_1; Di Virgilio TG, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00294; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; Fuller GW, 2017, J SCI MED SPORT, V20, P246, DOI 10.1016/j.jsams.2016.07.008; Hill T, 2019, SPORTS HEALTH, V11, P180, DOI 10.1177/1941738118811315; International Cricket Council, 2018, CONC MAN GUID; Jones ME, 2018, J SCI MED SPORT, V21, P558, DOI 10.1016/j.jsams.2017.10.013; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kramer E., 2015, FIFA FOOTBALL EMERGE, V2nd; Liao S, 2016, MED SCI SPORT EXER, V48, P1239, DOI 10.1249/MSS.0000000000000896; LoBue C, 2020, CURR OPIN PSYCHIATR, V33, P130, DOI 10.1097/YCO.0000000000000580; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Navarro SM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740847; Orchard JW, 2016, BRIT J SPORT MED, V50, P1245, DOI 10.1136/bjsports-2016-096125; Ramkumar PN, 2019, AM J SPORT MED, V47, P2287, DOI 10.1177/0363546519859542; Sabesan VJ, 2018, OPEN ACCESS J SPORTS, V9, P253, DOI 10.2147/OAJSM.S157433; Saw AE., 2020, J CONCUSSION, V4, DOI [10.1177/2059700220947197, DOI 10.1177/2059700220947197]; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130	27	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.	DEC	2021	7	4							e001128	10.1136/bmjsem-2021-001128			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	XM1TV	WOS:000728619000001	34950503	Green Published, gold			2022-02-06	
J	Palzur, E; Edelman, D; Sakas, R; Soustiel, JF				Palzur, Eilam; Edelman, Doron; Sakas, Reem; Soustiel, Jean Francois			Etifoxine Restores Mitochondrial Oxidative Phosphorylation and Improves Cognitive Recovery Following Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						mitochondria; traumatic brain injury; mitochondrial permeability transition pore; translocator protein; etifoxine	CEREBRAL-BLOOD-FLOW; PERMEABILITY TRANSITION PORE; PERIPHERAL BENZODIAZEPINE-RECEPTOR; SEVERE HEAD-INJURY; CYCLOSPORINE-A; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; TRANSLOCATOR PROTEIN; CLINICAL-TRIALS; MOUSE MODEL	The opening of the mitochondrial permeability transition pore (mPTP) has emerged as a pivotal event following traumatic brain injury (TBI). Evidence showing the impact of the translocator protein (TSPO) over mPTP activity has prompted several studies exploring the effect of TSPO ligands, including etifoxine, on the outcome of traumatic brain injury (TBI). Mitochondrial respiration was assessed by respirometry in isolated rat brain mitochondria (RBM) by measurements of oxidative phosphorylation capacity (OXPHOS). The addition of calcium to RBM was used to induce mitochondrial injury and resulted in significant OXPHOS reduction that could be reversed by preincubation of RBM with etifoxine. Sensorimotor and cognitive functions were assessed following controlled cortical impact and compared in vehicle and etifoxine-treated animals. There was no difference between the vehicle and etifoxine groups for sensorimotor functions as assessed by rotarod. In contrast, etifoxine resulted in a significant improvement of cognitive functions expressed by faster recovery in Morris water maze testing. The present findings show a significant neuroprotective effect of etifoxine in TBI through restoration of oxidative phosphorylation capacity associated with improved behavioral and cognitive outcomes. Since etifoxine is a registered drug used in common clinical practice, implementation in a phase II study may represent a reasonable step forward.	[Palzur, Eilam; Sakas, Reem; Soustiel, Jean Francois] Galilee Med Ctr, Eliachar Res Lab, IL-2210001 Nahariyya, Israel; [Edelman, Doron; Soustiel, Jean Francois] Galilee Med Ctr, Dept Neurosurg, IL-2210001 Nahariyya, Israel; [Soustiel, Jean Francois] Bar Ilan Univ, Azrieli Fac Med, IL-1311502 Zafed, Israel		Soustiel, JF (corresponding author), Galilee Med Ctr, Eliachar Res Lab, IL-2210001 Nahariyya, Israel.; Soustiel, JF (corresponding author), Galilee Med Ctr, Dept Neurosurg, IL-2210001 Nahariyya, Israel.; Soustiel, JF (corresponding author), Bar Ilan Univ, Azrieli Fac Med, IL-1311502 Zafed, Israel.	eilam.palzur@gmail.com		Palzur, Eilam/0000-0003-2032-2974			Aouad M, 2009, PAIN, V147, P54, DOI 10.1016/j.pain.2009.08.001; Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Chieregato A, 2007, INTENS CARE MED, V33, P856, DOI 10.1007/s00134-007-0604-4; Cleary J, 2007, BIOORG MED CHEM LETT, V17, P1667, DOI 10.1016/j.bmcl.2006.12.102; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Daugherty DJ, 2013, EMBO MOL MED, V5, P891, DOI 10.1002/emmm.201202124; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Girard C, 2008, P NATL ACAD SCI USA, V105, P20505, DOI 10.1073/pnas.0811201106; Girard P, 2009, CLIN EXP PHARMACOL P, V36, P655, DOI 10.1111/j.1440-1681.2008.05127.x; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Johnson KM, 2005, CHEM BIOL, V12, P485, DOI 10.1016/j.chembiol.2005.02.012; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; KINNALLY KW, 1993, P NATL ACAD SCI USA, V90, P1374, DOI 10.1073/pnas.90.4.1374; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Li HD, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0921-7; Li MS, 2017, FASEB J, V31, P3278, DOI 10.1096/fj.201601377RR; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Nakamoto Y, 1996, BRAIN RES, V717, P91, DOI 10.1016/0006-8993(96)00033-9; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; QUINLAN PT, 1983, BIOCHEM J, V214, P395, DOI 10.1042/bj2140395; REILLY PL, 1975, LANCET, V2, P375; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Shehadeh M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112639; Shiotani T, 2000, BRAIN RES, V859, P255, DOI 10.1016/S0006-8993(00)01971-5; Sileikyte J, 2014, J BIOL CHEM, V289, P13769, DOI 10.1074/jbc.M114.549634; Soustiel JF, 2008, NEUROPATH APPL NEURO, V34, P412, DOI 10.1111/j.1365-2990.2007.00906.x; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; Soustiel JF, 2011, PHARM RES-DORDR, V28, P2945, DOI 10.1007/s11095-011-0463-0; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Soustiel JF, 2008, EXP NEUROL, V214, P201, DOI 10.1016/j.expneurol.2008.08.008; Springer JE, 2018, NEURAL REGEN RES, V13, P1338, DOI 10.4103/1673-5374.235218; Stein DJ, 2015, ADV THER, V32, P57, DOI 10.1007/s12325-015-0176-6; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sumbalova Z, 2010, CELL MOL NEUROBIOL, V30, P751, DOI 10.1007/s10571-010-9501-4; Szabo C, 2005, CRIT CARE MED, V33, pS530, DOI 10.1097/01.CCM.0000187002.88999.CF; Veech RL, 2012, IUBMB LIFE, V64, P203, DOI 10.1002/iub.590; Veiga S, 2005, J NEUROSCI RES, V80, P129, DOI 10.1002/jnr.20430; Verleye M, 2005, PHARMACOL BIOCHEM BE, V82, P712, DOI 10.1016/j.pbb.2005.11.013; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vlodavsky E, 2017, J CEREBR BLOOD F MET, V37, P166, DOI 10.1177/0271678X15621068	56	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	DEC	2021	22	23							12881	10.3390/ijms222312881			14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	XV5KL	WOS:000734981000001	34884686	Green Published			2022-02-06	
J	Park, JT; DeLozier, SJ; Chugani, HT				Park, Jun T.; DeLozier, Sarah J.; Chugani, Harry T.			Epilepsy Due to Mild TBI in Children: An Experience at a Tertiary Referral Center	JOURNAL OF CLINICAL MEDICINE			English	Article						mild TBI; posttraumatic epilepsy (PTE); intractable epilepsy; pediatric epilepsy; TBI in children; seizures; accidental trauma; non-accidental trauma; mechanism of mild TBI; Post-impact seizures; seizure semiology	TRAUMATIC BRAIN-INJURY; EARLY POSTTRAUMATIC SEIZURES; CONCUSSIVE CONVULSIONS; UNPROVOKED SEIZURES; HEAD-INJURY; RISK; PREDICTION; SPORT	Rationale: Posttraumatic epilepsy (PTE) is a common cause of morbidity in children after a traumatic brain injury (TBI), occurring in 10-20% of children following severe TBI. PTE is diagnosed after two or more unprovoked seizures occurring 1-week post TBI. More often, studies have focused on children with epilepsy due to severe TBI. We aim to understand the utility of head computed tomography (HCT), EEG, and the risk of developing drug-resistant epilepsy in children after mild TBI. Method: We retrospectively studied 321 children with TBI at a tertiary pediatric referral center during a 10-year period. Mild TBI was defined as loss of consciousness (LOC) or amnesia < 30 min, moderate TBI as LOC or amnesia between 30 min and 1 day, and severe TBI as LOC or amnesia > 1 day, subdural hemorrhage, or contusion. Multiple clinical variables were reviewed, including past and present antiepileptic drug(s), seizure control, and mode of injury. First and subsequent post-TBI EEGs/prolonged video-EEGs were obtained acutely, subacutely, and/or chronically (range, day 1-3 years, median 1 month). Descriptive analyses were conducted using medians and ranges for continuous data. Categorical data were reported using frequencies and percentages, while comparisons between groups were made using Fisher's exact test for small sample sizes. Results: Forty-seven children were diagnosed with posttraumatic epilepsy: eight children (17%) due to mild TBI, 39 children (83%) due to severe TBI. For the eight children with mild TBI whom all had an accidental trauma (non-inflicted), the median follow-up time was 25 months (range 1.5 months-84 months). The median age was 10 years (range 4-18 years), and the median age at the time of injury was seven years (range: 23 months-13 years). No relevant previous medical history was present for six patients (80%), and two patients' (20%) relevant previous medical histories were unknown. Seven patients (88%) had no history of seizures, and patient #6 (12%) had unknown seizure history. Six patients (75%) had normal routine EEG(s). Patient #6 (13%) had an abnormal VEEG 3 months after the initial normal routine EEG, while patient #1 (13%) had an initial prolonged EEG 8 months after TBI. Compared to the 39 patients with severe TBI, 31 (79%) of whom had abnormal EEGs (routine and/or prolonged with video), mild TBI patients were more likely to have normal EEGs, p = 0.005. Head CT scans were obtained acutely for seven patients (90%), all of which were normal. One patient only had brain magnetic resonance imaging (MRI) 8 months after the injury. Compared to the 39 patients with severe TBI, all of whom had abnormal HCTs, mild TBI patients were less likely to have abnormal HCTs, p < 0.0001. In patients with mild TBI, no patient had both abnormal EEG/VEEG and HCT, and no one was on more than one Antiepileptic drug (AED), p < 0.005. Six patients (75%) had MRIs, of which five (63%) were normal. Two patients (#1, 7) did not have MRIs, while one patient's (#4) MRI was unavailable. Five patients (63%) had a seizure <24 h post TBI, while the rest had seizures after the first week of injury. Conclusion: Children with epilepsy due to mild TBI, loss of consciousness, or amnesia < 30 min are more likely to have normal HCT and EEG and to be on 0-1 AED. Limitations of our study include the small sample size and retrospective design. The current findings add to the paucity of data in children who suffer from epilepsy due to mild TBI.	[Park, Jun T.] UH Rainbow Babies & Childrens Hosp, Epilepsy Ctr, Cleveland, OH 44106 USA; [Park, Jun T.] Case Western Reserve Univ, Sch Med, Dept Pediat & Neurol, Cleveland, OH 44106 USA; [Park, Jun T.; DeLozier, Sarah J.] UH Cleveland Med Ctr, Cleveland, OH 44106 USA; [Chugani, Harry T.] NYU Sch Med, Comprehens Epilepsy Ctr, NYU Langone Hlth, New York, NY 10016 USA		Park, JT (corresponding author), UH Rainbow Babies & Childrens Hosp, Epilepsy Ctr, Cleveland, OH 44106 USA.; Park, JT (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pediat & Neurol, Cleveland, OH 44106 USA.; Park, JT (corresponding author), UH Cleveland Med Ctr, Cleveland, OH 44106 USA.	jun.park@uhhospitals.org; Sarah.Delozier@UHhospitals.org; Harry.Chugani@nyulangone.org	Park, Jun/C-1894-2018	Park, Jun/0000-0002-9325-0038			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS68; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Appleton RE, 2002, J NEUROL NEUROSUR PS, V72, P669, DOI 10.1136/jnnp.72.5.669; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Bennett KS, 2017, PEDIATR CRIT CARE ME, V18, P54, DOI 10.1097/PCC.0000000000000948; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Gilad R, 2013, J NEUROTRAUM, V30, P469, DOI 10.1089/neu.2012.2625; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Huguenard AL, 2016, J NEUROSURG-PEDIATR, V17, P476, DOI 10.3171/2015.7.PEDS14723; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; JENNETT B, 1975, EPILEPSIA, V16, P251, DOI 10.1111/j.1528-1157.1975.tb06055.x; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keret A, 2017, J NEUROSURG-PEDIATR, V20, P64, DOI 10.3171/2017.2.PEDS16585; Kim JA, 2018, ANN NEUROL, V83, P858, DOI 10.1002/ana.25211; Luders H, 1998, EPILEPSIA, V39, P1006, DOI 10.1111/j.1528-1157.1998.tb01452.x; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Ong LC, 1996, J PAEDIATR CHILD H, V32, P173, DOI 10.1111/j.1440-1754.1996.tb00917.x; Park JT, 2017, EPILEPTIC DISORD, V19, P24, DOI 10.1684/epd.2017.0900; Park JT, 2015, PEDIATR NEUROL, V52, P174, DOI 10.1016/j.pediatrneurol.2014.09.013; Ratan SK, 1999, PEDIATR NEUROSURG, V30, P127, DOI 10.1159/000028779; Tai PC, 2004, CAN J NEUROL SCI, V31, P394, DOI 10.1017/S0317167100003516; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Terespolsky P S, 1972, Forensic Sci, V1, P147, DOI 10.1016/0300-9432(72)90039-8; Vaca GFB, 2018, EPILEPTIC DISORD, V20, P179, DOI 10.1684/epd.2018.0970; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; WALTON J N, 1963, Med Leg J, V31, P15	35	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	DEC	2021	10	23							5695	10.3390/jcm10235695			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XV2BH	WOS:000734753500001	34884396	Green Published, gold			2022-02-06	
J	Patel, PD; Kelly, KA; Chen, HD; Greeno, A; Shannon, CN; Naftel, RP				Patel, Pious D.; Kelly, Katherine A.; Chen, Heidi; Greeno, Amber; Shannon, Chevis N.; Naftel, Robert P.			Measuring the effects of institutional pediatric traumatic brain injury volume on outcomes for rural-dwelling children	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						neurological surgery; traumatic brain injury; institutional volume; rural; urban; trauma	HEALTH; GUIDELINES; MANAGEMENT	OBJECTIVE Rural-dwelling children may suffer worse pediatric traumatic brain injury (TBI) outcomes due to distance from and accessibility to high-volume trauma centers. This study aimed to compare the impacts of institutional TBI volume and sociodemographics on outcomes between rural- and urban-dwelling children. METHODS This retrospective study identified patients 0-19 years of age with ICD-9 codes for TBI in the 2012-2015 National Inpatient Sample database. Patients were characterized as rural- or urban-dwelling using United States Census classification. Logistic and linear (in log scale) regressions were performed to measure the effects of institutional characteristics, patient sociodemographics, and mechanism/severity of injury on occurrence of medical complications, mortality, length of stay (LOS), and costs. Separate models were built for rural- and urban-dwelling patients. RESULTS A total of 19,736 patients were identified (median age 11 years, interquartile range [IQR] 2-16 years, 66% male, 55% Caucasian). Overall, rural-dwelling patients had higher All Patient Refined Diagnosis Related Groups injury severity (median 2 [IQR 1-3] vs 1 [IQR 1-2], p < 0.001) and more intracranial monitoring (6% vs 4%, p < 0.001). Univariate analysis showed that overall, rural-dwelling patients suffered increased medical complications (6% vs 4%, p < 0.001), mortality (6% vs 4%, p < 0.001), and LOS (median 2 days [IQR 1-4 days ] vs 2 days [IQR 1-3 days], p < 0.001), but multivariate analysis showed rural-dwelling status was not associated with these outcomes after adjusting for injury severity, mechanism, and hospital characteristics. Institutional TBI volume was not associated with medical complications, disposition, or mortality for either population but was associated with LOS for urban-dwelling patients (nonlinear beta, p = 0.008) and cost for both rural-dwelling (nonlinear beta, p < 0.001) and urban-dwelling (nonlinear beta, p < 0.001) patients. CONCLUSIONS Overall, rural-dwelling pediatric patients with TBI have worsened injury severity, mortality, and inhospital complications, but these disparities disappear after adjusting for injury severity and mechanism. Institutional TBI volume does not impact clinical outcomes for rural- or urban-dwelling children after adjusting for these covariates. Addressing the root causes of the increased injury severity at hospital arrival may be a useful path to improve TBI outcomes for rural-dwelling children. https://thejns.org/doi/abs/10.3171/2021.7.PEDS21159	[Patel, Pious D.; Kelly, Katherine A.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Patel, Pious D.; Kelly, Katherine A.; Greeno, Amber; Shannon, Chevis N.] Vanderbilt Monroe Carell Jr Childrens Hosp, Surg Outcomes Ctr Kids, Nashville, TN USA; [Chen, Heidi] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Shannon, Chevis N.; Naftel, Robert P.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN USA		Patel, PD (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	pious.d.patel@vanderbilt.edu					Ammar Ahmed, 1800, Asian J Neurosurg, V13, P955, DOI 10.4103/1793-5482.238015; [Anonymous], DEF RUR POP; Averill R, 2003, ALL PATIENT REFINED; Azzopardi PS, 2019, LANCET, V393, P1101, DOI 10.1016/S0140-6736(18)32427-9; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Caminiti C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-14; Carey MR, 2005, J GEN INTERN MED, V20, P108, DOI 10.1111/j.1525-1497.2005.40269.x; Ellis MJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00840; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Healthcare Cost and Utilization Project (HCUP), OVERVIEW NATIONWIDE; Kassebaum N, 2017, JAMA PEDIATR, V171, P573, DOI 10.1001/jamapediatrics.2017.0250; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Matrix of E-code groupings, 2018, CTR DIS CONTR PREV; Meena Ugan Singh, 2018, Asian J Neurosurg, V13, P636, DOI 10.4103/1793-5482.238011; NEWGARD CD, 2017, JAMA SURG; NIS description of data elements, HEALTHC COST UT PROJ; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Shojania KG, 2002, JAMA-J AM MED ASSOC, V288, P508, DOI 10.1001/jama.288.4.508; Spleen AM, 2014, J RURAL HEALTH, V30, P79, DOI 10.1111/jrh.12032; Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5; Tang OY, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19486; van Essen TA, 2019, ACTA NEUROCHIR, V161, P435, DOI 10.1007/s00701-018-3761-z; Yue JK, 2020, J NEUROSCI RURAL PRA, V11, P23, DOI 10.1055/s-0039-3402581; Yue JK, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10030135	24	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2021	28	6					638	646		10.3171/2021.7.PEDS21159			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	XN9ER	WOS:000729800900003	34598145				2022-02-06	
J	Pedragosa, J; Mercurio, D; Oggioni, M; Marquez-Kisinousky, L; de Simoni, MG; Planas, AM				Pedragosa, Jordi; Mercurio, Domenico; Oggioni, Marco; Marquez-Kisinousky, Leonardo; de Simoni, Maria-Grazia; Planas, Anna M.			Mannose-binding lectin promotes blood-brain barrier breakdown and exacerbates axonal damage after traumatic brain injury in mice	EXPERIMENTAL NEUROLOGY			English	Article						Lectin pathway; Complement; Brain injury; Trauma; Neutrophils	LONG PENTRAXIN PTX3; ALPHA-II-SPECTRIN; 1 CR-1; COMPLEMENT; RECEPTOR; INFLAMMATION; EXPRESSION; ACCUMULATION; DEGENERATION; DYSFUNCTION	Leukocyte infiltration and blood-brain barrier breakdown contribute to secondary brain damage after traumatic brain injury (TBI). TBI induces neuroimmune responses triggering pathogenic complement activation through different pathways, including the lectin pathway. We investigated mechanisms underlying mannose-binding lectin (MBL)-mediated brain damage focusing on neutrophil infiltration and blood-brain barrier breakdown in a TBI mouse model. Wild type mice and MBL-/- null mice were subjected to controlled cortical impact. We studied neutrophil infiltration and regional localization by confocal microscopy 1, 4 and 15 days post-trauma, and investigated neutrophil extracellular trap (NET) formation. By immunofluorescence and/or Western blotting in various brain regions we studied the presence of fibrin(ogen), pentraxin-3, albumin and immunoglobulin G. Finally, we studied neurofilament proteins, synaptophysin, and alpha II-spectrin, and assessed white matter content in the injured tissue. TBI triggered an acute wave of neutrophil infiltration at day 1 followed by a more discrete persistence of neutrophils in the injured tissue at least until day 15. We detected the presence of NETs and pentraxin-3 in the injured tissue, as well as accumulation of fibrin(ogen), increased blood-brain barrier permeability, and neurofilament, synaptophysin and white matter loss, and calpain-mediated alpha II spectrin breakdown. MBL- /- mice showed reduced number of Ly6G+ neutrophils 4 days after TBI, lower accumulation of pentraxin-3 and fibrin(ogen) in the injured tissue, reduced global plasma protein extravasation, and better preservation of axonal and white matter integrity. These results show that MBL participates in secondary neutrophil accumulation and blood-brain barrier breakdown, and promotes axonal and white matter damage after TBI in mice.	[Pedragosa, Jordi; Marquez-Kisinousky, Leonardo; Planas, Anna M.] CSIC, Inst Biomed Res Barcelona IIBB, Dept Neurosci & Expt Therapeut, Barcelona, Spain; [Pedragosa, Jordi; Marquez-Kisinousky, Leonardo; Planas, Anna M.] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain; [Mercurio, Domenico; Oggioni, Marco; de Simoni, Maria-Grazia] Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, I-20156 Milan, Italy		Planas, AM (corresponding author), IDIBAPS, IIBB CSIC, Dept Neurosci & Expt Therapeut, RossellO 161,Planta 6, Barcelona 08036, Spain.	anna.planas@iibb.csic.es			ERA-NET-NEURON, JTC 2016: LEAP from Ministerio de Economia, Industria y Competitividad Spain [NEURON9-FP-044, PCIN-2017-035]; ERA-NET-NEURON, JTC 2016: LEAP from Italian Ministry of Health (Ministero della Salute), Italy [NEURON9-FP-044]	This work was supported by ERA-NET-NEURON, JTC 2016: LEAP, NEURON9-FP-044 from the following national funding institutions: Ministerio de Economia, Industria y Competitividad (PCIN-2017-035) Spain, and the Italian Ministry of Health (Ministero della Salute) , Italy.	Abou-Abbass H, 2016, ELECTROPHORESIS, V37, P1549, DOI 10.1002/elps.201500585; Alam A, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02005-x; Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Ciechanowska A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010045; Ciencewicki JM, 2016, AM J PHYSIOL-LUNG C, V311, pL280, DOI 10.1152/ajplung.00205.2015; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Daigo K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00378; De Blasio D, 2019, J CEREBR BLOOD F MET, V39, DOI 10.1177/0271678X18758881; De Blasio D, 2017, J CEREBR BLOOD F MET, V37, P938, DOI 10.1177/0271678X16647397; de Bont CM, 2019, CELL MOL IMMUNOL, V16, P19, DOI 10.1038/s41423-018-0024-0; de la Rosa X, 2014, STROKE, V45, P1453, DOI 10.1161/STROKEAHA.113.004111; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Erreni M, 2017, IMMUNOL REV, V280, P112, DOI 10.1111/imr.12570; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Ghiran I, 2000, J EXP MED, V192, P1797, DOI 10.1084/jem.192.12.1797; Gout E, 2011, J IMMUNOL, V186, P5815, DOI 10.4049/jimmunol.1100180; Gudi V, 2017, J NEUROPATH EXP NEUR, V76, P109, DOI 10.1093/jnen/nlw114; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; Hu Y, 2021, J NEUROTRAUM, V38, P399, DOI 10.1089/neu.2020.7271; Inforzato A, 2013, SEMIN IMMUNOL, V25, P79, DOI 10.1016/j.smim.2013.05.002; Jacquet M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00453; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jenkins DR, 2018, J NEUROTRAUM, V35, P2259, DOI 10.1089/neu.2017.5291; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; Justicia C, 2003, J CEREBR BLOOD F MET, V23, P1430, DOI 10.1097/01.WCB.0000090680.07515.C8; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Klickstein LB, 1997, IMMUNITY, V7, P345, DOI 10.1016/S1074-7613(00)80356-8; Kobeissy FH, 2015, MOL NEUROBIOL, V52, P696, DOI 10.1007/s12035-014-8898-z; Krarup A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000623; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Kumar A, 1997, BLOOD, V89, P4555, DOI 10.1182/blood.V89.12.4555; Kumar MA, 2019, J NEUROTRAUM, V36, P222, DOI 10.1089/neu.2018.5696; Leung LL, 2016, EBIOMEDICINE, V5, P20, DOI 10.1016/j.ebiom.2016.03.015; Liang Y, 2019, BRAIN RES BULL, V153, P289, DOI 10.1016/j.brainresbull.2019.09.004; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Liu H, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.627110; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Mages B, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00161; Manfredi AA, 2008, CURR OPIN IMMUNOL, V20, P538, DOI 10.1016/j.coi.2008.05.004; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Mercurio D, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-01041-1; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Napoleone E, 2002, ARTERIOSCL THROM VAS, V22, P782, DOI 10.1161/01.ATV.0000012282.39306.64; Nasr IW, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112957; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Neubert E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06263-5; O'Hanlon GM, 2003, BRAIN, V126, P2497, DOI 10.1093/brain/awg254; Oggioni M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89032-7; Patel PK, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2020.151972; Perez-de-Puig I, 2015, ACTA NEUROPATHOL, V129, P239, DOI 10.1007/s00401-014-1381-0; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Prineas JW, 2012, ANN NEUROL, V72, P18, DOI 10.1002/ana.23634; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Razvina O, 2015, EXP MOL PATHOL, V98, P33, DOI 10.1016/j.yexmp.2014.11.009; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; Sabouri E, 2020, WORLD NEUROSURG, V140, P142, DOI 10.1016/j.wneu.2020.04.185; Sahyouni Ronald, 2017, J Concussion, V1, DOI 10.1177/2059700216684518; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Vaibhav K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax8847; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072505; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272; Yuan AD, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a018309; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041	76	0	0	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2021	346								113865	10.1016/j.expneurol.2021.113865			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WB6PA	WOS:000703691300003	34547288	hybrid			2022-02-06	
J	Garcia, GP; Perez, GM; Otero-Pagan, A; Abutarboush, R; Kawoos, U; De Gasperi, R; Sosa, MGA; Pryor, D; Hof, PR; Cook, DG; Gandy, S; Ahlers, ST; Elder, GA				Perez Garcia, Georgina; Perez, Gissel M.; Otero-Pagan, Alena; Abutarboush, Rania; Kawoos, Usmah; De Gasperi, Rita; Gama Sosa, Miguel A.; Pryor, Dylan; Hof, Patrick R.; Cook, David G.; Gandy, Sam; Ahlers, Stephen T.; Elder, Gregory A.			Transcranial Laser Therapy Does Not Improve Cognitive and Post-Traumatic Stress Disorder-Related Behavioral Traits in Rats Exposed to Repetitive Low-Level Blast Injury	NEUROTRAUMA REPORTS			English	Article						blast; post-traumatic stress disorder; rat; transcranial laser therapy; traumatic brain injury	TRAUMATIC BRAIN-INJURY; LIGHT THERAPY; MODEL; PHOTOBIOMODULATION	Many military veterans who experienced blast-related traumatic brain injuries (TBIs) in the conflicts in Iraq and Afghanistan suffer from chronic cognitive and mental health problems, including post-traumatic stress disorder (PTSD). Transcranial laser therapy (TLT) uses low-power lasers emitting light in the far- to near-infrared ranges. Beneficial effects of TLT have been reported in neurological and mental-health-related disorders in humans and animal models, including TBI. Rats exposed to repetitive low-level blast develop chronic cognitive and PTSD-related behavioral traits. We tested whether TLT treatment could reverse these traits. Rats received a 74.5-kPa blast or sham exposures delivered one per day for 3 consecutive days. Beginning at 34 weeks after blast exposure, the following groups of rats were treated with active or sham TLT: 1) Sham-exposed rats (n = 12) were treated with sham TLT; 2) blast-exposed rats (n = 13) were treated with sham TLT; and 3) blast-exposed rats (n = 14) were treated with active TLT. Rats received 5 min of TLT five times per week for 6 weeks (wavelength, 808 nm; power of irradiance, 240 mW). At the end of treatment, rats were tested in tasks found previously to be most informative (novel object recognition, novel object localization, contextual/cued fear conditioning, elevated zero maze, and light/dark emergence). TLT did not improve blast-related effects in any of these tests, and blast-exposed rats were worse after TLT in some anxiety-related measures. Based on these findings, TLT does not appear to be a promising treatment for the chronic cognitive and mental health problems that follow blast injury.	[Perez Garcia, Georgina; Perez, Gissel M.; Otero-Pagan, Alena; De Gasperi, Rita; Pryor, Dylan; Gandy, Sam] James J Peters Dept Vet Affairs Med Ctr, Res & Dev Serv, Bronx, NY USA; [Gama Sosa, Miguel A.] James J Peters Dept Vet Affairs Med Ctr, Gen Med Res Serv, Bronx, NY USA; [Elder, Gregory A.] James J Peters Dept Vet Affairs Med Ctr, Neurol Serv, Bronx, NY USA; [Perez Garcia, Georgina; Gandy, Sam; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [De Gasperi, Rita; Gama Sosa, Miguel A.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Nash Family Dept Neurosci, New York, NY 10029 USA; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Care, New York, NY 10029 USA; [Hof, Patrick R.; Gandy, Sam] Icahn Sch Med Mt Sinai, Mt Sinai Alzheimers Dis Res Ctr, New York, NY 10029 USA; [Hof, Patrick R.; Gandy, Sam; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA; [Gandy, Sam] Icahn Sch Med Mt Sinai, Barbara & Maurice A Deane Ctr Wellness & Cognit H, New York, NY 10029 USA; [Gandy, Sam] Icahn Sch Med Mt Sinai, Mt Sinai NFL Neurol Care Ctr, New York, NY 10029 USA; [Abutarboush, Rania; Kawoos, Usmah; Ahlers, Stephen T.] Naval Med Res Ctr, Dept Neurotrauma, Silver Spring, MD USA; [Abutarboush, Rania; Kawoos, Usmah] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA; [Cook, David G.] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Cook, David G.] Univ Washington, Dept Med, Seattle, WA USA		Garcia, GP (corresponding author), James J Peters VA Med Ctr, Res & Dev 3F-26, 130 West Kingsbridge Rd, Bronx, NY 10468 USA.	Georgina.perez-garcia@mssm.edu			Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research, and Development Service awardsUS Department of Veterans Affairs [1I01RX000996, 1I01RX002660, 1I21RX003019, 1I01RX000684, 1I01RX002333]; Department of Veterans Affairs Office of Research and Development Medical Research ServiceUS Department of Veterans Affairs [1I01BX004067, 1I01BX002311]; Department of DefenseUnited States Department of Defense [0000B999.0000.000.A1503]; Alzheimer's Drug Discovery Foundation; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG005138, P30 AG066514]	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research, and Development Service awards 1I01RX000996 (to G.E.), 1I01RX002660 (to G.E.), 1I21RX003019 (to G.E.), 1I01RX000684 (to S.G.), and 1I01RX002333 (to S.G.); the Department of Veterans Affairs Office of Research and Development Medical Research Service (1I01BX004067, to G.E.; 1I01BX002311, to D.C.); Department of Defense work unit number 0000B999.0000.000.A1503 (to S.T.A.); the Alzheimer's Drug Discovery Foundation (to S.G.); and by NIA P50 AG005138 (to S.G., P.R.H.) and P30 AG066514 (to S.G., P.R.H.).	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; de la Torre JC, 2017, J PHOTOCH PHOTOBIO B, V168, P149, DOI 10.1016/j.jphotobiol.2017.02.008; Dickstein DL, 2021, MOL PSYCHIATR, V26, P5940, DOI 10.1038/s41380-020-0674-z; Elder GA, 2019, NEUROSCI LETT, V707, DOI 10.1016/j.neulet.2019.134294; Elder GA, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0591-8; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Engel C., 2019, NEUROLOGICAL EFFECTS; Esenaliev RO, 2018, J NEUROTRAUM, V35, P1510, DOI 10.1089/neu.2017.5249; Eshaghi E, 2019, LASER SURG MED, V51, P634, DOI 10.1002/lsm.23082; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Henderson Theodore A, 2015, Adv Mind Body Med, V29, P27; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lapchak PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127580; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; Li Y, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01389-5; Li Y, 2021, MOL PSYCHIATR, V26, P6666, DOI 10.1038/s41380-021-01088-z; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; McCarthy TJ, 2010, PHOTOMED LASER SURG, V28, P663, DOI 10.1089/pho.2009.2581; Meynaghizadeh-Zargar R, 2020, LASER MED SCI, V35, P573, DOI 10.1007/s10103-019-02851-z; Mohammed HS, 2016, LASER MED SCI, V31, P1651, DOI 10.1007/s10103-016-2033-5; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Naeser MA, 2016, PHOTOMED LASER SURG, V34, P610, DOI 10.1089/pho.2015.4037; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Oron A, 2012, J NEUROTRAUM, V29, P401, DOI 10.1089/neu.2011.2062; Perez Garcia G., 2021, J NEUROTRAUM, V38, P2030; Perez Garcia G, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01128-3; Perez-Garcia G, 2019, NEUROPHARMACOLOGY, V145, P220, DOI 10.1016/j.neuropharm.2018.09.023; Perez-Garcia G, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0357-17.2018; Perez-Garcia G, 2018, BEHAV BRAIN RES, V340, P117, DOI 10.1016/j.bbr.2016.09.061; Perez-Garcia G, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00176; Rojas JC, 2012, J ALZHEIMERS DIS, V32, P741, DOI 10.3233/JAD-2012-120817; Salehpour F, 2019, PHOTOBIOMOD PHOTOMED, V37, P581, DOI 10.1089/photob.2019.4676; Salehpour F, 2018, MOL NEUROBIOL, V55, P6601, DOI 10.1007/s12035-017-0852-4; Salehpour F, 2017, REV NEUROSCIENCE, V28, P441, DOI 10.1515/revneuro-2016-0087; Salehpour F, 2016, LASER SURG MED, V48, P695, DOI 10.1002/lsm.22542; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thunshelle C, 2016, PHOTOMED LASER SURG, V34, P587, DOI 10.1089/pho.2015.4051; Tschiffely AE, 2020, J NEUROTRAUM, V37, P1091, DOI 10.1089/neu.2019.6512; Vargas E, 2017, LASER MED SCI, V32, P1153, DOI 10.1007/s10103-017-2221-y; Wang ZY, 2020, J NEUROTRAUM, V37, P1221, DOI 10.1089/neu.2019.6742; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xuan WJ, 2016, J BIOPHOTONICS, V9, P1263, DOI 10.1002/jbio.201500336; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069	51	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	DEC 1	2021	2	1					548	563		10.1089/neur.2021.0005			16	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	XJ0TX	WOS:000726512900001	34901948	gold, Green Published			2022-02-06	
J	Picon, EL; Perez, DL; Burke, MJ; Debert, CT; Iverson, GL; Panenka, WJ; Silverberg, ND				Picon, Edwina L.; Perez, David L.; Burke, Matthew J.; Debert, Chantel T.; Iverson, Grant L.; Panenka, William J.; Silverberg, Noah D.			Unexpected symptoms after concussion: Potential links to functional neurological and somatic symptom disorders	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article						Concussion; Exaggeration; Functional neurological disorder; Somatic symptom disorder; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; SCALE; SOMATIZATION; RECOVERY; MODEL; PAIN	Objective: Reporting of unexpected symptoms after concussion might, in some people, reflect a Functional Neurological Disorder (FND), Somatic Symptom Disorder (SSD), or exaggeration (feigning). This study aimed to determine whether reporting unexpected symptoms after concussion was associated with risk factors for FND/SSD, exaggeration, or both. Method: Adults with persistent symptoms following concussion (N = 77; 61% women) rated the presence and severity of unexpected neurological symptoms (from the Screening for Somatoform Symptoms scale, e.g., paralysis) and somatic symptoms (from the Patient Health Questionnaire-15, e.g., stomach pain) that did not overlap with post-concussion symptom scale items. The independent variables were risk factors for exaggeration (neuropsychological performance validity test failure and personal injury litigation) and predisposing and perpetuating factors for developing FND and/or SSD (e.g., fear avoidance behavior). Results: When adjusting for all covariates, fear avoidance behavior was most strongly related to unexpected neurological symptoms (B = 0.11, 95% confidence interval = 0.05-0.18, p < .001), while current anxiety scores were most strongly related to unexpected somatic symptoms (B = 0.34, 95% confidence interval = 0.15-0.52, p < .001). Performance validity test failure and litigation were not significant predictors in either model. Conclusion: Unexpected neurological and other somatic symptoms after concussion should not be dismissed as exaggeration. Psychological factors thought to perpetuate FND and SSD (e.g., fear avoidance behavior) may contribute to unexpected symptoms following concussion. More research is needed at the intersection of FND, SSD, and persistent post-concussive symptoms.	[Picon, Edwina L.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Perez, David L.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Perez, David L.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA; [Burke, Matthew J.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Psychiat, Neuropsychiat Program, Toronto, ON, Canada; [Burke, Matthew J.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Div Neurol, Toronto, ON, Canada; [Burke, Matthew J.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Div Cognit Neurol, Boston, MA 02115 USA; [Debert, Chantel T.] Univ Calgary, Alberta Childrens Hosp Res Inst, Hotchkiss Brain Inst, Phys Med & Rehabil,Dept Clin Neurosci,Cumming Sch, Calgary, AB, Canada; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Boston, MA USA; [Iverson, Grant L.] MassGen Hosp Children Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Home Base, Boston, MA USA; [Panenka, William J.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Panenka, William J.] BC Mental Hlth & Subst Use Res Inst, Vancouver, BC, Canada; [Panenka, William J.] BC Neuropsychiat Program, Vancouver, BC, Canada; [Silverberg, Noah D.] Univ British Columbia, Dept Psychol, Rehabil Res Program, Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada		Silverberg, ND (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	epicon@psych.ubc.ca; dlperez@partners.org; matthew.burke@sunnybrook.ca; Chantel.Debert@albertahealthservices.ca; giverson@mgh.harvard.edu; will.panenka@ubc.ca; noah.silverberg@ubc.ca		Perez, David/0000-0003-2721-583X	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research	This work was supported by Canadian Institutes of Health Research (CIHR). N.D.S. also received salary support from the Michael Smith Foundation for Health Research. These funders played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Avbersek A, 2010, J NEUROL NEUROSUR PS, V81, P719, DOI 10.1136/jnnp.2009.197996; Burton C, 2020, BMC MED, V18, DOI 10.1186/s12916-020-1505-4; Cassetta BD, 2021, REHABIL PSYCHOL, V66, P160, DOI 10.1037/rep0000372; Chaput G, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/2825856; Daum C, 2014, J NEUROL NEUROSUR PS, V85, P180, DOI 10.1136/jnnp-2012-304607; Deary V, 2007, CLIN PSYCHOL REV, V27, P781, DOI 10.1016/j.cpr.2007.07.002; Espay AJ, 2018, JAMA NEUROL, V75, P1132, DOI 10.1001/jamaneurol.2018.1264; Green K, 2021, J NEUROPSYCH CLIN N, V33, P109, DOI 10.1176/appi.neuropsych.20060159; Greenberg J, 2020, PSYCHOSOMATICS, V61, P49, DOI 10.1016/j.psym.2019.09.004; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Henningsen P, 2018, DIALOGUES CLIN NEURO, V20, P23; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kontos K.E. Anthony, 2020, MENT HEAL ATHL, DOI [10.1007/978-3-030-44754-0, DOI 10.1007/978-3-030-44754-0]; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Lange RT, 2013, J CLIN EXP NEUROPSYC, V35, P192, DOI 10.1080/13803395.2012.761677; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Lee JEC, 2015, PSYCHOSOM MED, V77, P1006, DOI 10.1097/PSY.0000000000000250; Lippa SM, 2016, J CLIN EXP NEUROPSYC, V38, P721, DOI 10.1080/13803395.2016.1161732; Marshall CM, 2019, PHYSICIAN SPORTSMED, V47, P158, DOI 10.1080/00913847.2018.1542258; Martin PK, 2020, CLIN NEUROPSYCHOL, V34, P88, DOI 10.1080/13854046.2019.1637027; McWhirter L, 2020, LANCET PSYCHIAT, V7, P191, DOI 10.1016/S2215-0366(19)30405-5; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Ord AS, 2021, NEUROPSYCHOLOGY, V35, P241, DOI 10.1037/neu0000722; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Parees I, 2012, BRAIN, V135, P117, DOI 10.1093/brain/awr292; Phillips W, 2021, BMJ NEUROL OPEN, V3, DOI 10.1136/bmjno-2020-000100; Popkirov S, 2018, SEIZURE-EUR J EPILEP, V58, P127, DOI 10.1016/j.seizure.2018.04.009; Popov N, 2022, CAN J NEUROL SCI, V49, P109, DOI 10.1017/cjn.2021.53; Rief W, 2003, PSYCHOSOMATICS, V44, P492, DOI 10.1176/appi.psy.44.6.492; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Snell DL, 2020, J NEUROTRAUM, V37, P1566, DOI 10.1089/neu.2019.6729; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stone J, 2009, J PSYCHOSOM RES, V66, P383, DOI 10.1016/j.jpsychores.2008.07.010; Stubbs JL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00043; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Teodoro T, 2018, J NEUROL NEUROSUR PS, V89, P1308, DOI 10.1136/jnnp-2017-317823; Terpstra AR, 2021, REHABIL PSYCHOL, V66, P470, DOI 10.1037/rep0000390; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Voigt K, 2010, J PSYCHOSOM RES, V68, P403, DOI 10.1016/j.jpsychores.2010.01.015; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wertli MM, 2014, SPINE J, V14, P816, DOI 10.1016/j.spinee.2013.09.036; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Windle K, 2021, APPL NEUROPSYCH-ADUL, V28, P512, DOI 10.1080/23279095.2019.1660880	49	0	0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	DEC	2021	151								110661	10.1016/j.jpsychores.2021.110661			5	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	XR0YF	WOS:000731965000001	34739941				2022-02-06	
J	Pizzi, M; Borella, E; Piras, F				Pizzi, Marcella; Borella, Erika; Piras, Federica			Performance-Based Everyday Problem-Solving in Patients With TBI	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Everyday problems test; Performance-based test; Traumatic brain injury; Problem-solving; Functional independence; Outcome measures	TRAUMATIC BRAIN-INJURY; ADULT LIFE-SPAN; OLDER-ADULTS; ECOLOGICAL VALIDITY; NEUROPSYCHOLOGICAL ASSESSMENT; COGNITIVE IMPAIRMENT; VIRTUAL-REALITY; EDUCATION; ATTENTION; SPEED	Objective: The present study examined whether the everyday problems test (EPT), a performance-based measure of everyday problem-solving, can be considered a useful test in assessing functional independence in patients with traumatic brain injury (TBI). The relationship between EPT, cognitive abilities (i.e., selective attention, set switching, and working memory) and self-rated measures of everyday functioning and disability in these patients was also assessed. Method: In this case-control study 25 postcomatose outpatientswith TBI (ageM = 35.9, SD= 14.21) from a neurorehabilitation unit and 25 matched controls were enrolled. Participants were administered the EPT along with neuropsychological tests of selective attention, set switching and working memory, and self-rated measures of everyday functioning and disability. Results: Patients with TBI were less accurate and slower than controls in the EPT; the two groups were accurately classified based on EPT completion time (likelihood ratio test chi(2) = 28.67, R-2 = 0.72, p <.001). In the patient group education and selective attention explained a large portion of variance in EPT accuracy (R-2 = 0.53, p = .001), while only selective attention explained a significant portion of variance in EPT time (R-2 = 0.24, p < .01). Self-rated measures of everyday functioning and disability did not significantly contribute to EPT performance variance. Conclusion: Including performance-based measures as the EPT in a multifactorial approach to assessment can be useful for unraveling cognitive factors contributing to TBI's impact on everyday functioning. Since attentional processes seem to play a significant role in determining EPT performance, rehabilitation of functional independence should target this ability first.	[Pizzi, Marcella] IRCCS Santa Lucia Fdn, Speech Therapy Sch, Rome, Italy; [Borella, Erika] Univ Padua, Dept Gen Psychol, Padua, Italy; [Piras, Federica] IRCCS Santa Lucia Fdn, Neuropsychiat Lab, Rome, Italy		Pizzi, M (corresponding author), IRCCS Santa Lucia Fdn, Via Ardeatina 306, I-00142 Rome, Italy.	marcellapizzi2@gmail.com					Allaire JC, 2002, PSYCHOL AGING, V17, P101, DOI [10.1037//0882-7974.17.1.101, 10.1037/0882-7974.17.1.101]; [Anonymous], 1987, Ital J Neurol Sci, VSuppl 8, P1; Batterham PJ, 2011, PSYCHOL AGING, V26, P339, DOI 10.1037/a0021845; Bianchi A, 2008, NEUROL SCI, V29, P209, DOI 10.1007/s10072-008-0970-x; Borella E, 2020, PSYCHOL RES-PSYCH FO, V84, P1622, DOI 10.1007/s00426-019-01173-7; Borella E, 2017, INT PSYCHOGERIATR, V29, P2059, DOI 10.1017/S1041610217000680; Burton CL, 2006, CLIN NEUROPSYCHOL, V20, P432, DOI 10.1080/13854040590967063; Capitani E, 1997, J CLIN EXP NEUROPSYC, V19, P795, DOI 10.1080/01688639708403761; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Chen X, 2017, GERONTOLOGY, V63, P372, DOI 10.1159/000459622; Cohen J, 1988, J AM STAT ASSOC, V2, DOI [10.1016/B978-0-12-179060-8.50012-8, DOI 10.1016/B978-0-12-179060-8.50012-8, 10.2307/2529115, DOI 10.2307/2529115]; Cristofori I, 2017, EXECUTIVE FUNCTIONS IN HEALTH AND DISEASE, P421, DOI 10.1016/B978-0-12-803676-1.00018-0; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; DIEHL M, 1995, PSYCHOL AGING, V10, P478, DOI 10.1037/0882-7974.10.3.478; Dymowski AR, 2015, J CLIN EXP NEUROPSYC, V37, P1024, DOI 10.1080/13803395.2015.1074663; Edwards J, 2014, APPL NEUROPSYCH-ADUL, V21, P220, DOI 10.1080/09084282.2013.796554; Elliott CS, 2014, COGN NEUROPSYCHIATRY, V19, P485, DOI 10.1080/13546805.2014.922062; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Finucane ML, 2005, PSYCHOL AGING, V20, P71, DOI 10.1037/0882-7974.20.1.71; FULLERTON KJ, 1986, LANCET, V1, P430; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Hagen C., 1972, LEVELS COGNITIVE FUN; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Law LLF, 2012, AGE AGEING, V41, P9, DOI 10.1093/ageing/afr104; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; Marcotte T. D., 2010, NEUROPSYCHOLOGY EVER; Margrett J. A., 2010, AGING AM, V1, P79; MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205; Marsiske M., 2006, HDB PSYCHOL AGING, P315, DOI [10.1016/B978-012101264-9/50017-3, DOI 10.1016/B978-012101264-9/50017-3]; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mienaltowski A., 2015, ENCY ADULTHOOD AGING, P1, DOI [10.1002/9781118521373.wbeaa145, DOI 10.1002/9781118521373.WBEAA145]; Mienaltowski A, 2011, ANN NY ACAD SCI, V1235, P75, DOI 10.1111/j.1749-6632.2011.06207.x; Moore DJ, 2007, J PSYCHIATR RES, V41, P97, DOI 10.1016/j.jpsychires.2005.10.008; Negut A, 2016, CLIN NEUROPSYCHOL, V30, P165, DOI 10.1080/13854046.2016.1144793; Nouri F. M., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Ritchie SJ, 2013, PSYCHOL AGING, V28, P515, DOI 10.1037/a0030820; Schmitter-Edgecombe M, 2014, CLIN NEUROPSYCHOL, V28, P726, DOI 10.1080/13854046.2014.911964; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Shah SA, 2017, NEUROIMAGE-CLIN, V14, P233, DOI 10.1016/j.nicl.2017.01.010; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Stierwalt Julie A. G., 2002, Seminars in Speech and Language, V23, P129, DOI 10.1055/s-2002-24989; Suchy Y, 2017, EXECUTIVE FUNCTIONS IN HEALTH AND DISEASE, P197, DOI 10.1016/B978-0-12-803676-1.00009-X; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Tucker-Drob EA, 2009, DEV PSYCHOL, V45, P431, DOI 10.1037/a0014012; Wallace CJ, 2000, SCHIZOPHRENIA BULL, V26, P631, DOI 10.1093/oxfordjournals.schbul.a033483; Willis S., 1993, MANUAL EVERYDAY PROB	57	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2021	36	8					1393	1403		10.1093/arclin/acab015			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	YH7IH	WOS:000743336400001	33834212				2022-02-06	
J	Pradhan, GN; Ottestad, W; Meland, A; Kasin, JI; Hoiseth, LO; Cevette, MJ; Stepanek, J				Pradhan, Gaurav N.; Ottestad, William; Meland, Anders; Kasin, Jan Ivar; Hoiseth, Lars Oivind; Cevette, Michael J.; Stepanek, Jan			Oculometric Feature Changes During Acute Hypoxia in a Simulated High-Altitude Airdrop Scenario	AEROSPACE MEDICINE AND HUMAN PERFORMANCE			English	Article						oculometric; acute hypoxia; cognitive performance; high-altitude high opening	SACCADIC EYE-MOVEMENTS; COGNITIVE PERFORMANCE; CONCUSSION	BACKGROUND: Severe acute hypoxia results in a rapid deterioration of cognitive functioning and thus poses a risk for human operations in high altitude environments. This study aimed at investigating the effects of oxygen system failure during a high-altitude high-opening (HAHO) parachute jump scenario from 30,000 ft (9144 m) on human physiology and cognitive performance using a noncontact eye-tracking task. METHODS: Nine healthy male volunteers (ages 27-48) were recruited from the Norwegian Special Operations Commandos. Eye-tracking data were collected to derive information on cognitive performance in the context of rapid dynamic changes in pressure altitude while performing a modified King-Devick test. The baseline data was collected at 8000 ft (2438 m) while breathing 100% oxygen during decompression. For every test, the corresponding arterial blood gas analysis was performed. RESULTS: The study subjects endured severe hypoxia, which resulted in significant prolongations of fixation time (range: 284.1-245.6 ms) until 23,397 ft (131 m) and fixation size (range: 34.6-32.4 mm) until 25,389 ft (7739 m) as compared to the baseline (217.6 +/- 17.8 ms and 27.2 +/- 4.5 mm, respectively). The increase in the saccadic movement and decrease in the saccadic velocity was observed until 28,998 ft and 27,360 ft (8839 and 8339 m), respectively. DISCUSSION: This is the first study to investigate cognitive performance from measured oculometric variables during severe hypobaric hypoxia in a simulated high-altitude airdrop mission scenario. The measurement of altered oculometric variables under hypoxic conditions represents a potential avenue to study altered cognitive performance using noncontact sensors that can derive information and serve to provide the individual with a warning from impending incapacitation.	[Pradhan, Gaurav N.; Ottestad, William; Meland, Anders; Kasin, Jan Ivar; Hoiseth, Lars Oivind; Cevette, Michael J.; Stepanek, Jan] Mayo Clin, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA		Pradhan, GN (corresponding author), Mayo Clin, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	pradhan.gaurav@mayo.edu			Norwegian Defence Medical Services, Institute of Aviation Medicine, Oslo, Norway	We give special thanks to the Norwegian Special Operations Commando for facilitating the study and to the operators who participated. We are grateful for the support granted by the Norwegian Defence Medical Services, Institute of Aviation Medicine, Oslo, Norway.	Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Cymerman A, 2003, OCULOMOTOR PUPILLARY; Di Stasi LL, 2014, J VISUAL-JAPAN, V14, P113; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Holmqvist K., 2011, EYE TRACKING COMPREH; Kapoula Z, 2014, AGE, V36, P535, DOI 10.1007/s11357-013-9582-3; Kulp MT, 1996, OPTOMETRY VISION SCI, V73, P283, DOI 10.1097/00006324-199604000-00011; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; Marshall SP, 2007, AVIAT SPACE ENVIR MD, V78, pB165; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; Merz TM, 2013, EUR J APPL PHYSIOL, V113, P2025, DOI 10.1007/s00421-013-2635-6; MILLER GA, 1956, IRE T INFORM THEOR, V2, P129, DOI 10.1109/TIT.1956.1056815; Moser A, 1998, J NEUROL, V245, P542, DOI 10.1007/s004150050240; Ottestad W, 2018, AEROSP MED HUM PERF, V89, P1045, DOI 10.3357/AMHP.5173.2018; Ottestad W, 2017, J APPL PHYSIOL, V123, P1443, DOI 10.1152/japplphysiol.00169.2017; Pradhan GN, 2019, J HEALTHC INFORM RES, V3, P371, DOI 10.1007/s41666-019-00045-4; Pradhan GN, 2018, J HEALTHC INFORM RES, V2, P132, DOI 10.1007/s41666-017-0011-8; Rayner K., 1985, REMEDIAL SPEC ED, V6, P53, DOI 10.1177/074193258500600609; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; Stepanek J, 2014, AVIAT SPACE ENVIR MD, V85, P700, DOI 10.3357/ASEM.3645.2014; Stepanek J, 2013, AVIAT SPACE ENVIR MD, V84, P1017, DOI 10.3357/ASEM.3616.2013; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Thomas ML, 2007, AVIAT SPACE ENVIR MD, V78, pB144; Thropp JE, 2018, INT J AVIAT AERONAUT, V5; Turner CE, 2015, PHYSIOL BEHAV, V142, P104, DOI 10.1016/j.physbeh.2015.02.006; van der Post J, 2002, J PSYCHOPHARMACOL, V16, P337, DOI 10.1177/026988110201600408; Wesnes K, 2002, LANCET NEUROL, V1, P473, DOI 10.1016/S1474-4422(02)00236-3; Wilson MH, 2008, HIGH ALT MED BIOL, V9, P319, DOI 10.1089/ham.2008.1026	30	0	0	0	0	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579 USA	2375-6314	2375-6322		AEROSP MED HUM PERF	Aerosp. Med.Hum. Perform.	DEC	2021	92	12					928	936		10.3357/AMHP.5930.2021			9	Biophysics; Public, Environmental & Occupational Health; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Public, Environmental & Occupational Health; Research & Experimental Medicine	YG4TQ	WOS:000742483500002	34986930				2022-02-06	
J	Ramey, WL; Reyes, AA; Avila, MJ; Hurlbert, RJ; Chapman, JR; Dumont, TM				Ramey, Wyatt L.; Reyes, Angelica Alvarez; Avila, Mauricio J.; Hurlbert, R. John; Chapman, Jens R.; Dumont, Travis M.			The Central Cord Score: A Novel Classification and Scoring System Specific to Acute Traumatic Central Cord Syndrome	WORLD NEUROSURGERY			English	Article						Central cord syndrome; Classification systems; Neurotrauma; Spinal cord injury; Spine decompression	SPINAL-CORD; SURGICAL DECOMPRESSION; NEUROLOGICAL RECOVERY; SIGNAL INTENSITY; INJURY; MANAGEMENT; INTERVENTION; COMPRESSION; OUTCOMES	BACKGROUND: Acute traumatic central cord syndrome (ATCCS) is the most common form of spinal cord injury in the United States. Treatment remains controversial, which is a consequence of ATCCS having an inherently different natural history from conventional spinal cord injury, thus requiring a separate classification system. We devised a novel Central Cord Score (CCscore), which both guides treatment and tracks improvement over time with symp-toms specific to ATCCS. METHODS: Medical records of patients with a diagnosis of ATCCS were retrospectively reviewed at a single insti-tution. The CCscore was devised based on signs, symp-toms, and imaging findings we believed to be critical in assessing severity of ATCCS. Numeric values were assigned for distal upper extremity motor strength, upper extremity sensation, ambulatory status, magnetic reso-nance imaging cord signal, and urinary retention. RESULTS: We identified 51 patients with follow-up data; there were 17 cases of mild injury (CCscore 1-5), 23 mod-erate cases (CCscore 6-10), and 11 severe cases (CCscore 11-15). Patients treated surgically had significantly greater improvement in upper extremity motor scores and total CCscore only up to 3 months. In terms of timing of surgery, patients treated <24 hours after injury had significantly improved upper extremity motor scores and overall CCscores at last follow-up of double dagger 3 months. CONCLUSIONS: Based on these data and their align-ment with past literature, the CCscore is able to objectively and specifically categorize the severity and outcome of ATCCS, which represents a step forward in the quest to determine the ultimate efficacy and timing of surgery for ATCCS.	[Ramey, Wyatt L.; Reyes, Angelica Alvarez; Avila, Mauricio J.; Hurlbert, R. John; Dumont, Travis M.] Banner Univ, Dept Neurosurg, Med Ctr Tucson, Tucson, AZ 85719 USA; [Chapman, Jens R.] Swedish Neurosci Inst, Dept Neurosurg, Seattle, WA USA		Ramey, WL (corresponding author), Banner Univ, Dept Neurosurg, Med Ctr Tucson, Tucson, AZ 85719 USA.	Wyatt.ramey@gmail.com	; Avila, Mauricio J/G-9359-2013	Alvarez, Angelica/0000-0002-6708-1365; Avila, Mauricio J/0000-0001-5855-2033			Aarabi B, 2011, J NEUROSURG-SPINE, V14, P122, DOI 10.3171/2010.9.SPINE09922; BOSE B, 1984, NEUROSURGERY, V15, P367, DOI 10.1227/00006123-198409000-00012; Brodell DW, 2015, SPINE J, V15, P435, DOI 10.1016/j.spinee.2014.09.015; Burns AS, 2001, SPINE, V26, pS137, DOI 10.1097/00007632-200112151-00023; Collignon FD, 2002, J NEUROSURG, V96, P29, DOI 10.3171/spi.2002.96.1.0029; Divi SN, 2019, GLOB SPINE J, V9, p89S, DOI 10.1177/2192568219830943; Dvorak MF, 2005, SPINE, V30, P2303, DOI 10.1097/01.brs.0000182304.35949.11; Fehlings MG, 2001, SPINE, V26, pS101, DOI 10.1097/00007632-200112151-00017; Fehlings MG, 2017, GLOB SPINE J, V7, p195S, DOI 10.1177/2192568217706367; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Fehlings MG, 2010, SPINE, V35, pS166, DOI 10.1097/BRS.0b013e3181f386f6; Godzik Jakub, 2019, J Spine Surg, V5, P466, DOI 10.21037/jss.2019.09.26; Guest J, 2002, J NEUROSURG, V97, P25, DOI 10.3171/spi.2002.97.1.0025; GUHA A, 1987, PARAPLEGIA, V25, P324, DOI 10.1038/sc.1987.61; Hohl JB, 2010, SPINE, V35, pE238, DOI 10.1097/BRS.0b013e3181c15887; Ishida Y, 2002, SPINE, V27, P1652, DOI 10.1097/00007632-200208010-00011; Jug M, 2015, J NEUROTRAUM, V32, P1385, DOI 10.1089/neu.2014.3767; Lee BA, 2016, J SPINAL CORD MED, V39, P67, DOI 10.1179/2045772314Y.0000000280; Lenehan B, 2010, SPINE, V35, pS180, DOI 10.1097/BRS.0b013e3181f32a44; Miranda P, 2008, J NEUROSURG SCI, V52, P107; Newey ML, 2000, J BONE JOINT SURG BR, V82B, P851, DOI 10.1302/0301-620X.82B6.9866; Pollard ME, 2003, SPINE, V28, P33, DOI 10.1097/00007632-200301010-00009; Pouw MH, 2010, SPINAL CORD, V48, P652, DOI 10.1038/sc.2009.155; Samuel AM, 2015, SPINE, V40, P349, DOI 10.1097/BRS.0000000000000756; SCHNEIDER RC, 1954, J NEUROSURG, V11, P546, DOI 10.3171/jns.1954.11.6.0546; SCHNEIDER RC, 1958, J NEUROL NEUROSUR PS, V21, P216, DOI 10.1136/jnnp.21.3.216; Schroeder GD, 2016, J NEUROSURG-SPINE, V24, P792, DOI 10.3171/2015.9.SPINE15661; SHROSBREE RD, 1977, PARAPLEGIA, V14, P251, DOI 10.1038/sc.1976.42; Song J, 2006, SURG NEUROL, V65, P117, DOI 10.1016/j.surneu.2005.06.045; Stevens EA, 2010, SPINE J, V10, P874, DOI 10.1016/j.spinee.2010.07.388; Tow AMPE, 1998, SPINAL CORD, V36, P156, DOI 10.1038/sj.sc.3100618; Yelamarthy PKK, 2019, EUR SPINE J, V28, P2390, DOI 10.1007/s00586-019-06085-z	32	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2021	156						E235	E242		10.1016/j.wneu.2021.09.037			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	XG8VJ	WOS:000725025500042	34536617				2022-02-06	
J	Reif, S; Lauer, EA; Adams, RS; Brucker, DL; Ritter, GA; Mitra, M				Reif, Sharon; Lauer, Eric A.; Adams, Rachel Sayko; Brucker, Debra L.; Ritter, Grant A.; Mitra, Monika			Examining differences in prescription opioid use behaviors among US adults with and without disabilities	PREVENTIVE MEDICINE			English	Article						Disabilities; Prescription opioids; Pain; Surveillance; National surveys	TRAUMATIC BRAIN-INJURY; CHRONIC PAIN; LIFETIME HISTORY; UNITED-STATES; ACCESS; ABUSE; HOSPITALIZATIONS	We aimed to identify differences in prescription opioid-related behaviors between adults with and without disabilities in the U.S. We analyzed data from the 2015-2017 National Survey on Drug Use and Health (128,740 individuals; weighted N of 244,831,740) to examine disability-based differences in (1) reasons and sources of last prescription opioid misuse and, in multivariate models overall and stratified by disability, the likelihood of (2) prescription opioid use, and if used, (3) misuse and prescription opioid use disorder (OUD), overall and stratified by disability. Adults with disabilities were 11% more likely than adults without disabilities to report any pastyear prescription opioid use, adjusted for sociodemographic, health, and behavioral health characteristics. However, among adults with any prescription opioid use, which is more common among people with disabilities, likelihood of prescription OUD did not vary by disability status. Pain relief as the reason for last misuse was associated with 18% increased likelihood of prescription OUD, if any use. To reduce risk of opioid misuse among people with disabilities, accessible and inclusive chronic pain management services are essential. Further, the substance use treatment field should provide accessible and inclusive services, and be aware of the need for pain management by many people with disabilities, which may include the use of prescription opioids. These findings highlight essential opportunities for public health and policies to improve access, accommodations, and quality of health and behavioral health care for people with disabilities, and to encourage a holistic perspective of people with disabilities and their needs.	[Reif, Sharon; Adams, Rachel Sayko] Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St, Waltham, MA 02453 USA; [Lauer, Eric A.; Brucker, Debra L.] Univ New Hampshire, Inst Disabil, 10 West Edge Dr,Suite 101, Durham, NH 03824 USA; [Adams, Rachel Sayko] Vet Hlth Adm, Rocky Mt Mental Illness Res Educ & Clin Ctr, Aurora, CO 80045 USA; [Ritter, Grant A.] Brandeis Univ, Heller Sch Social Policy & Management, Schneider Inst Hlth Policy & Res, 415 South St, Waltham, MA 02453 USA; [Mitra, Monika] Brandeis Univ, Heller Sch Social Policy & Management, Lurie Inst Disabil Policy, 415 South St, Waltham, MA 02453 USA		Reif, S (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St, Waltham, MA 02453 USA.	reif@brandeis.edu			U.S. Department of Health and Human Services, Administration for Community Living's National Institute for Disability, Independent Living, and Rehabilitation Research (NIDILRR) [90RTGE00010100, 90DPGE0007]	This work was supported by the U.S. Department of Health and Human Services, Administration for Community Living's National Institute for Disability, Independent Living, and Rehabilitation Research (NIDILRR) grants 90RTGE00010100 and 90DPGE0007. The contents of this paper do not necessarily represent the policy of NIDILRR, ACL, HHS, or VHA, and you should not assume endorsement by the Federal Government.	Adams RS, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6451; American Society of Addiction Medicine, 2015, NAT PRACT GUID US ME; Bellows T., 1995, THESIS U PENNSYLVANI; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Brennan F, 2019, AM J PUBLIC HEALTH, V109, P61, DOI 10.2105/AJPH.2018.304743; Centers for Disease Control and Prevention, 2020, UND EP DRUG OV; Centers for Disease Control and Prevention National Center on Birth Defects and Developmental Disabilities Division of Human Development and Disability, 2021, DIS HLTH DAT SYST DH; Cicero TJ, 2017, DRUG ALCOHOL DEPEN, V173, pS4, DOI 10.1016/j.drugalcdep.2016.03.014; Corrigan JD, 2019, ADDICT BEHAV, V90, P143, DOI 10.1016/j.addbeh.2018.10.030; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Ehde DM, 2003, CLIN J PAIN, V19, P3, DOI 10.1097/00002508-200301000-00002; Han B, 2017, ANN INTERN MED, V167, P293, DOI 10.7326/M17-0865; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Henningfield JE, 2019, PREV MED, V128, DOI 10.1016/j.ypmed.2019.105852; Hong Y, 2019, ARCH PHYS MED REHAB, V100, P86, DOI 10.1016/j.apmr.2018.06.034; Jensen MP, 2011, ARCH PHYS MED REHAB, V92, P146, DOI 10.1016/j.apmr.2010.09.021; Katz N, 2010, PHARMACOEPIDEM DR S, V19, P115, DOI 10.1002/pds.1878; Kennedy J, 2014, J PAIN, V15, P979, DOI 10.1016/j.jpain.2014.05.009; Krahn G, 2006, J SUBST ABUSE TREAT, V31, P375, DOI 10.1016/j.jsat.2006.05.011; Kuo YF, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.15638; Lauer EA, 2019, DISABIL HEALTH J, V12, P519, DOI 10.1016/j.dhjo.2018.12.001; Liaw V, 2020, PUBLIC HEALTH REP, V135, P114, DOI 10.1177/0033354919892638; LOTTMAN TJ, 1993, J ALCOHOL DRUG EDUC, V39, P41; McKee MM, 2019, AM J PREV MED, V56, P586, DOI 10.1016/j.amepre.2018.10.026; Morden NE, 2014, MED CARE, V52, P852, DOI 10.1097/MLR.0000000000000183; Office of the Assistant Secretary for Planning and Evaluation, 2015, HHS IMPL GUID DAT CO; Peters JL, 2018, J AM BOARD FAM MED, V31, P881, DOI 10.3122/jabfm.2018.06.180152; Ruf G., 1999, NADD NEWSLETTER, V2; SAMHSA Center for Behavioral Health Statistics and Quality, 2016, IMP DSMIV DSM 5 CHAN; Song ZR, 2017, HEALTH AFFAIR, V36, P2054, DOI 10.1377/hlthaff.2017.0689; Substance Abuse and Mental Health Services Administration, 2019, SUBST US DIS TREATM; Substance Abuse and Mental Health Services Administration, 2020, NSDUH 2017 DAT COLL; Substance Abuse and Mental Health Services Administration, 2017, NSDUH2017DS0001 SAMH; Substance Abuse Mental Health Services Administration (Ed.), 2010, REL KEY MEAS NAT SUR; U.S. Department of Health and Human Services, 2017, HHS GOV OP PRESCR DR; Volkow ND, 2019, JAMA PSYCHIAT, V76, P208, DOI 10.1001/jamapsychiatry.2018.3126; Volkow ND, 2016, NEW ENGL J MED, V374, P1253, DOI 10.1056/NEJMra1507771; Yi HG, 2018, J HEAD TRAUMA REHAB, V33, pE24, DOI 10.1097/HTR.0000000000000352	38	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0091-7435	1096-0260		PREV MED	Prev. Med.	DEC	2021	153								106754	10.1016/j.ypmed.2021.106754			8	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine	WB4VT	WOS:000703571900020	34348132	Bronze			2022-02-06	
J	Robac, A; Neveu, P; Hugede, A; Garrido, E; Nicol, L; Delarue, Q; Guerout, N				Robac, Amandine; Neveu, Pauline; Hugede, Alizee; Garrido, Elisabeth; Nicol, Lionel; Delarue, Quentin; Guerout, Nicolas			Repetitive Trans Spinal Magnetic Stimulation Improves Functional Recovery and Tissue Repair in Contusive and Penetrating Spinal Cord Injury Models in Rats	BIOMEDICINES			English	Article						rehabilitation; spinal cord injury; glial scar; magnetic stimulation; cystic cavities and functional recovery	FIBROTIC SCAR; MICROGLIA; DEPLETION; STROKE; BRAIN	Spinal cord injury (SCI) is an incurable condition in which the brain is disconnected partially or completely from the periphery. Mainly, SCIs are traumatic and are due to traffic, domestic or sport accidents. To date, SCIs are incurable and, most of the time, leave the patients with a permanent loss of sensitive and motor functions. Therefore, for several decades, researchers have tried to develop treatments to cure SCI. Among them, recently, our lab has demonstrated that, in mice, repetitive trans-spinal magnetic stimulation (rTSMS) can, after SCI, modulate the lesion scar and can induce functional locomotor recovery non-invasively. These results are promising; however, before we can translate them to humans, it is important to reproduce them in a more clinically relevant model. Indeed, SCIs do not lead to the same cellular events in mice and humans. In particular, SCIs in humans induce the formation of cystic cavities. That is why we propose here to validate the effects of rTSMS in a rat animal model in which SCI leads to the formation of cystic cavities after penetrating and contusive SCI. To do so, several techniques, including immunohistochemical, behavioral and MRI, were performed. Our results demonstrate that rTSMS, in both SCI models, modulates the lesion scar by decreasing the formation of cystic cavities and by improving axonal survival. Moreover, rTSMS, in both models, enhances functional locomotor recovery. Altogether, our study describes that rTSMS exerts positive effects after SCI in rats. This study is a further step towards the use of this treatment in humans.	[Robac, Amandine; Neveu, Pauline; Hugede, Alizee; Garrido, Elisabeth; Delarue, Quentin; Guerout, Nicolas] UNIROUEN, Normandy Univ, Inst Res & Innovat Biomed IRIB, EA3830 GRHV, F-76000 Rouen, France; [Garrido, Elisabeth] Rouen Univ Hosp, Dept Neurosurg, 1 Rue Germont, F-76000 Rouen, France; [Nicol, Lionel] UNIROUEN, Normandy Univ, Inserm U1096, Inst Res & Innovat Biomed IRIB, F-76000 Rouen, France		Guerout, N (corresponding author), UNIROUEN, Normandy Univ, Inst Res & Innovat Biomed IRIB, EA3830 GRHV, F-76000 Rouen, France.	lionel.nicol@univ-rouen.fr; quentin.delarue@univ-rouen.fr		NICOL, Lionel/0000-0002-7820-4148; Guerout, Nicolas/0000-0003-0237-4981	ADIR association [ADIR-2019-03]; IRME association, fonds de dotation Neuroglia; Fondation de l'Avenir [AP-RM-20-028]	This research was supported by ADIR association (ADIR-2019-03), IRME association, fonds de dotation Neuroglia (REGENrTSMS) and Fondation de l'Avenir (AP-RM-20-028).	Algahtany M, 2021, WORLD NEUROSURG, V149, pE116, DOI 10.1016/j.wneu.2021.02.066; Bellver-Landete V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08446-0; Brifault C, 2015, STROKE, V46, P520, DOI 10.1161/STROKEAHA.114.006864; Brockie S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22189706; Chalfouh C, 2020, NEUROTHERAPEUTICS, V17, P2069, DOI 10.1007/s13311-020-00915-5; Chedly J, 2017, BIOMATERIALS, V138, P91, DOI 10.1016/j.biomaterials.2017.05.024; Courtine G, 2019, NAT MED, V25, P898, DOI 10.1038/s41591-019-0475-6; Delarue Q, 2021, J NEUROSCI RES, V99, P1835, DOI 10.1002/jnr.24836; Delarue Q, 2021, NEURAL REGEN RES, V16, P2429, DOI 10.4103/1673-5374.313033; Delarue Q, 2020, J NEUROTRAUM, V37, P507, DOI 10.1089/neu.2019.6481; Dias DO, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25585-5; Evans TA, 2014, EXP NEUROL, V254, P109, DOI 10.1016/j.expneurol.2014.01.013; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Gregoire CA, 2015, GLIA, V63, P1469, DOI 10.1002/glia.22851; Guerout N, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10081886; Hejrati N, 2021, CURR OPIN PHARMACOL, V60, P331, DOI 10.1016/j.coph.2021.08.009; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hussein RK, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00208; Kobashi S, 2020, MOL THER, V28, P254, DOI 10.1016/j.ymthe.2019.09.004; Li Y, 2020, NATURE, V587, P613, DOI 10.1038/s41586-020-2795-6; Li Y, 2020, THERANOSTICS, V10, P11376, DOI 10.7150/thno.49199; Luo Y, 2022, BIOACT MATER, V7, P98, DOI 10.1016/j.bioactmat.2021.05.039; Nakhjavan-Shahraki B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18754-4; Olah M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19737-2; Sabelstrom H, 2014, EXP NEUROL, V260, P44, DOI 10.1016/j.expneurol.2013.01.026; Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576; Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013; Vinhas A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155441; Watzlawick R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002468; Zhang YF, 2021, CELL BIOSCI, V11, DOI 10.1186/s13578-021-00679-1; Zhu Y, 2015, NEUROBIOL DIS, V74, P114, DOI 10.1016/j.nbd.2014.10.024	31	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9059		BIOMEDICINES	Biomedicines	DEC	2021	9	12							1827	10.3390/biomedicines9121827			17	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine; Pharmacology & Pharmacy	XX3AJ	WOS:000736172800001	34944643	Green Submitted, gold, Green Published			2022-02-06	
J	Robba, C; Iannuzzi, F; Taccone, FS				Robba, Chiara; Iannuzzi, Francesca; Taccone, Fabio S.			Tier-three therapies for refractory intracranial hypertension in adult head trauma	MINERVA ANESTESIOLOGICA			English	Article						Brain injuries; traumatic; Barbiturates; Decompressive craniectomy; Hypothermia	BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; THERAPEUTIC HYPOTHERMIA; CONSENSUS CONFERENCE; MANAGEMENT; PRESSURE; CARE; MULTICENTER	Refractory intracranial hypertension after traumatic brain injury (TBI) is defined as recurrent increase of intracranial pressure above 20-22 mmHg for sustained period of time (10-15 min), despite conventional therapies, such as osmotic therapy, cerebral spinal fluid drainage and mild hyperventilation. As such, more aggressive treatments should be taken into consideration. in particular, therapeutic hypothermia, barbiturates administration and decompressive craniectomy are considered as tier-three or "salvage" interventions, as they have shown to be able to control refractory hypertension; however, they are also associated with an increased risk of significant side effects. Therefore, the aim of this review was to describe the evidence supporting the use of these tier-three therapies in the management of refractory intracranial hypertension in tBi patients	[Robba, Chiara; Iannuzzi, Francesca] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Robba, Chiara] IRCCS Osped Policlin San Martino, Genoa, Italy; [Taccone, Fabio S.] Univ Brussels, Erasme Hosp, Dept Intens Care Med, Brussels, Belgium		Robba, C (corresponding author), Univ Genoa, IRCCS Osped Policlin San Martino, Dept Surg Sci & Integrated Diagnost, Largo Rosanna Benzi 10, I-16132 Genoa, Italy.	kiarobba@gmail.com					Andrews PJD, 2018, HEALTH TECHNOL ASSES, V22, P1, DOI 10.3310/hta22450; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bogossian EG, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.580859; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons, 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2007.9991; Brandi G, 2019, CRIT CARE, V23, DOI 10.1186/s13054-018-2304-6; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut R, 2020, INTENS CARE MED, V46, P919, DOI 10.1007/s00134-019-05900-x; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Hifumi T, 2016, J NEUROTRAUM, V33, P1047, DOI 10.1089/neu.2015.4033; Hirst TC, 2020, J NEUROTRAUM, V37, P2057, DOI 10.1089/neu.2019.6923; Huijben JA, 2020, INTENS CARE MED, V46, P995, DOI 10.1007/s00134-020-05965-z; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Imberti R, 2002, J NEUROSURG, V96, P97, DOI 10.3171/jns.2002.96.1.0097; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matz PG, 2003, NEUROSURGERY, V14, P99; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Robba C, 2020, INTENS CARE MED, V46, P2397, DOI 10.1007/s00134-020-06283-0; Robba C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2529-z; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Sahuquillo J, 2006, Cochrane Database Syst Rev, pCD003983; Smith M, 2017, ANESTH ANALG, V125, P1999, DOI 10.1213/ANE.0000000000002399; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Taccone FS, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2825-7; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Urwin SC, 2004, DRUG SAFETY, V27, P107, DOI 10.2165/00002018-200427020-00003; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; WINER JW, 1991, NEUROSURGERY, V29, P739, DOI 10.1227/00006123-199111000-00016; Zeiler FA, 2017, J INTENSIVE CARE MED, V32, P130, DOI 10.1177/0885066615593939	43	0	0	1	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	DEC	2021	87	12					1359	1366		10.23736/s0375-9393.21.15827-4			8	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	XN5KB	WOS:000729542600012	34337922				2022-02-06	
J	Salottolo, K; Panchal, R; Dhakal, L; Madayag, R; Banton, K; Tanner, A; Rosenberg, WS; Bar-Or, D				Salottolo, Kristin; Panchal, Ripul; Dhakal, Laxmi; Madayag, Robert; Banton, Kaysie; Tanner, Allen, II; Rosenberg, William S.; Bar-Or, David			Recalibrating the Glasgow Coma Score as an Age-Adjusted Risk Metric for Neurosurgical Intervention	JOURNAL OF SURGICAL RESEARCH			English	Article						Glasgow coma scale; Age; Neurosurgical intervention; Risk metric	TRAUMATIC BRAIN-INJURY; SCALE SCORE; COMPUTED-TOMOGRAPHY; UNDERTRIAGE; PREDICTION; MANAGEMENT; MORTALITY; RULE	Background: The Glasgow Coma Scale (GCS) score is the most frequently used neurologic assessment in traumatic brain injury (TBI). The risk for neurosurgical intervention based on GCS is heavily modified by age. The objective is to create a recalibrated Glasgow Coma Scale (GCS) score that accounts for an interaction by age and determine the predictive performance of the recalibrated GCS (rGCS) compared to the standard GCS for predicting neu-rosurgical intervention. Methods: This retrospective cohort study utilized the National Trauma Data Bank and in-cluded all patients admitted from 2010-2015 with TBI (ICD9 diagnosis code 850-854.19). The study population was divided into 2 subsets: a model development dataset (75% of patients) and a model validation dataset (remaining 25%). In the development dataset, logistic regression models were used to calculate conditional probabilities of having a neurosurgical intervention for each combination of age and GCS score, to develop a point-based risk score termed the rGCS. Model performance was examined in the validation dataset using area under the receiver operating characteristic (AUROC) curves and calibration plots. Results: There were 472,824 patients with TBI. The rGCS ranged from 1-15, where rGCS 15 denotes the baseline risk for neurosurgical intervention (4.4%) and rGCS 1 represents the greatest risk (62.6%). In the validation dataset there was a statistically significant improvement in predictive performance for neurosurgical intervention for the rGCS compared to the standard GCS (AUROC: 0.71 versus 0.67, difference, -0.04, P <0.001), overall and by trauma level designation. The rGCS was better calibrated than the standard GCS score. Conclusions: The relationship between GCS score and neurosurgical intervention is signifi-cantly modified by age. A revision to the GCS that incorporates age, the rGCS, provides risk of neurosurgical intervention that has better predictive performance than the standard ED GCS score. (c) 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)	[Salottolo, Kristin; Bar-Or, David] Med City Plano, Trauma Res Dept, Plano, TX USA; [Salottolo, Kristin; Bar-Or, David] Wesley Med Ctr, Trauma Res Dept, Wichita, KS USA; [Salottolo, Kristin; Bar-Or, David] St Anthony Hosp, Trauma Res Dept, Lakewood, CO USA; [Salottolo, Kristin; Bar-Or, David] Swedish Med Ctr, Trauma Res Dept, 501 Hampden Ave,Room 4-454, Englewood, CO 80113 USA; [Salottolo, Kristin; Bar-Or, David] Trauma Res Dept, Penrose St Francis Hlth Serv, Colorado Springs, CO USA; [Salottolo, Kristin; Bar-Or, David] Res Med Ctr, Trauma Res Dept, Kansas City, MO USA; [Panchal, Ripul] Med City Plano, Dept Neurosurg, Plano, TX USA; [Dhakal, Laxmi] Wesley Med Ctr, Dept Neurosurg, Wichita, KS USA; [Banton, Kaysie] Swedish Med Ctr, Dept Neurosurg, Englewood, CO USA; [Rosenberg, William S.] Res Med Ctr, Dept Neurosurg, Kansas City, MO USA; [Madayag, Robert] St Anthony Hosp, Trauma Serv Dept, Lakewood, CO USA; [Tanner, Allen, II] Trauma Serv Dept, Penrose St Francis Hlth Serv, Colorado Springs, CO USA		Bar-Or, D (corresponding author), Swedish Med Ctr, Trauma Res Dept, 501 Hampden Ave,Room 4-454, Englewood, CO 80113 USA.	davidbme49@gmail.com		Panchal, Ripul/0000-0002-0717-8288	Swedish Medical Center; St. Anthony Hospital; Medical City Plano; Penrose-St. Francis Medical Center; Wesley Medical Center; Research Medical Center Kansas City	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Internal (hospital) funding provided by Swedish Medical Center, St. Anthony Hospital, Medical City Plano, Penrose-St. Francis Medical Center; Wesley Medical Center, and Research Medical Center Kansas City.	Adams SD, 2015, CURR OPIN CRIT CARE, V21, P520, DOI 10.1097/MCC.0000000000000246; Alali AS, 2019, J NEUROSURG, V131, P612, DOI 10.3171/2018.4.JNS173166; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Caterino JM, 2011, ACAD EMERG MED, V18, P1014, DOI 10.1111/j.1553-2712.2011.01164.x; Caterino JM, 2010, AM J EMERG MED, V28, P151, DOI 10.1016/j.ajem.2008.10.027; Chang DC, 2008, ARCH SURG-CHICAGO, V143, P776, DOI 10.1001/archsurg.143.8.776; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gu T, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00085; Hall Chad, 2019, Proc (Bayl Univ Med Cent), V32, P181, DOI 10.1080/08998280.2018.1550468; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Khan M, 2017, J SURG RES, V216, P109, DOI 10.1016/j.jss.2017.04.026; Kodadek LM, 2015, J SURG RES, V199, P220, DOI 10.1016/j.jss.2015.05.017; Kozar RA, 2015, J TRAUMA ACUTE CARE, V78, P1197, DOI [10.1097/TA.0000000000000656, 10.1097/TA.0000000000000652]; Llompart-Pou JA, 2019, MED INTENSIVA, V43, P44, DOI 10.1016/j.medin.2018.02.009; Llompart-Pou Juan Antonio, 2017, World J Crit Care Med, V6, P99, DOI 10.5492/wjccm.v6.i2.99; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Muballe KD, 2019, J NEUROSURG, V131, P1648, DOI 10.3171/2018.4.JNS172185; Orlando A, 2019, J NEUROSURG, V130, P1626, DOI 10.3171/2018.1.JNS171906; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Peters ME, 2016, INT PSYCHOGERIATR, V28, P1931, DOI 10.1017/S1041610216001666; Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111378; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Salottolo K, 2021, TRAUMA SURG ACUTE CA, P6; Salottolo K, 2016, INJURY, V47, P70, DOI 10.1016/j.injury.2015.10.002; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Shih FY, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0069-2; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, NURS TIMES, V110, P12; Teoh LSG, 2000, INTENS CARE MED, V26, P157, DOI 10.1007/s001340050039; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611	43	0	0	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2021	268						696	704		10.1016/j.jss.2021.08.002			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	WA4PM	WOS:000702868600037	34487962	hybrid			2022-02-06	
J	Sandry, J; Dobryakova, E				Sandry, Joshua; Dobryakova, Ekaterina			Global hippocampal and selective thalamic nuclei atrophy differentiate chronic TBI from Non-TBI	CORTEX			English	Article						Chronic brain injury; Trauma; Head injury; Subcortical gray matter; Hippocampus; Thalamus; Subfields; Nuclei; Neurodegeneration; Atrophy	TRAUMATIC BRAIN-INJURY; GRAY-MATTER VOLUME; ALZHEIMERS-DISEASE; FUNCTIONAL CONNECTIVITY; WHITE-MATTER; NEURODEGENERATIVE DISEASES; SUBCORTICAL ATROPHY; CHOLINERGIC NEURONS; RELATIVE IMPORTANCE; OXIDATIVE STRESS	Traumatic brain injury (TBI) may increase susceptibility to neurodegenerative diseases later in life. One neurobiological parallel between chronic TBI and neurodegeneration may be accelerated aging and the nature of atrophy across subcortical gray matter structures. The main aim of the present investigation is to evaluate and rank the degree that subcortical gray matter atrophy differentiates chronic moderate-severe TBI from non-TBI participants by evaluating morphometric differences between groups. Forty individuals with moderate-severe chronic TBI (9.23 yrs from injury) and 33 healthy controls (HC) underwent high resolution 3D T1-weighted structural magnetic resonance imaging. Whole brain volume was classified into white matter, cortical and subcortical gray matter structures with hippocampi and thalami further segmented into subfields and nuclei, respectively. Extensive atrophy was observed across nearly all brain regions for chronic TBI participants. A series of multivariate logistic regression models identified subcortical gray matter structures of the hippocampus and thalamus as the most sensitive to differentiating chronic TBI from non-TBI participants (McFadden R-2 = .36, p < .001). Further analyses revealed the pattern of hippocampal atrophy to be global, occurring across nearly all subfields. The pattern of thalamic atrophy appeared to be much more selective and nonuniform, with largest between-group differences evident for nuclei bordering the ventricles. Subcortical gray matter was negatively correlated with time since injury (r = -.31, p = .054), while white matter and cortical gray matter were not. Cognitive ability was lower in the chronic TBI group (Cohen's d = .97, p = .003) and correlated with subcortical structures including the pallidum (r(2) = .23, p = .038), thalamus (r(2) = .36, p = .007) and ventral diencephalon (r(2) = .23, p = .036). These data may support an accelerated aging hypothesis in chronic moderate-severe TBI that coincides with a similar neuropathological profile found in neurodegenerative diseases. (C) 2021 Elsevier Ltd. All rights reserved.	[Sandry, Joshua] Montclair State Univ, Dept Psychol, Montclair, NJ 07043 USA; [Dobryakova, Ekaterina] Kessler Fdn, Ctr Traumat Brain Injury Res, E Hanover, NJ USA; [Dobryakova, Ekaterina] Rutgers New Jersey Med Sch Newark, Dept Phys Med & Rehabil, Newark, NJ USA		Sandry, J (corresponding author), Montclair State Univ, Dept Psychol, Montclair, NJ 07043 USA.	sandryj@montclair.edu		Dobryakova, Ekaterina/0000-0002-6005-2115	New Jersey Commission on Brain Injury Research [CBIR201RG027, CBIR17PIL022]; New Jersey Health Foundation [PC103-17]; Consortium of Multiple Sclerosis Centers; Kessler Foundation	This study was funded in part by an Individual Research and Pilot Grants from the New Jersey Commission on Brain Injury Research CBIR201RG027 (JS) & CBIR17PIL022 (ED); New Jersey Health Foundation PC103-17 (ED); Pilot Research Grant from the Consortium of Multiple Sclerosis Centers (JS) & Kessler Foundation.	Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Alves PN, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0611-3; Azen R, 2009, J EDUC BEHAV STAT, V34, P319, DOI 10.3102/1076998609332754; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Bagnato S, 2020, NEURAL REGEN RES, V15, P1247, DOI 10.4103/1673-5374.272574; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Barrett MJ, 2019, J NEUROL NEUROSUR PS, V90, P1251, DOI 10.1136/jnnp-2019-320450; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Belchev Z., 2021, J HEAD TRAUMA REHAB; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bergsland N, 2016, MULT SCLER J, V22, P1327, DOI 10.1177/1352458515616204; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; BRAAK H, 1991, ACTA NEUROPATHOL, V81, P261, DOI 10.1007/BF00305867; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Brown EM, 2020, NEUROIMAGE, V210, DOI 10.1016/j.neuroimage.2020.116563; Budescu DV, 2004, ORGAN RES METHODS, V7, P341, DOI 10.1177/1094428104267049; BUDESCU DV, 1993, PSYCHOL BULL, V114, P542, DOI 10.1037/0033-2909.114.3.542; Cash DM, 2013, NEUROLOGY, V81, P1425, DOI 10.1212/WNL.0b013e3182a841c6; Christidi F, 2019, NEUROBIOL AGING, V84, P178, DOI 10.1016/j.neurobiolaging.2019.07.019; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Cunningham SI, 2017, HUM BRAIN MAPP, V38, P938, DOI 10.1002/hbm.23429; DAVIES P, 1976, LANCET, V2, P1403; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Dennis EL, 2022, HUM BRAIN MAPP, V43, P149, DOI 10.1002/hbm.25046; Dima D., 2020, BIORXIV, DOI [DOI 10.1101/2020.05.05.079475, 10.1101/2020.05.05.079475v1.abstract]; Drijkoningen D, 2017, J NEUROTRAUM, V34, P1022, DOI 10.1089/neu.2016.4500; Eckerstrom C, 2008, J NEUROL SCI, V272, P48, DOI 10.1016/j.jns.2008.04.024; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Eshaghi A, 2018, BRAIN, V141, P1665, DOI 10.1093/brain/awy088; Esopenko C, 2015, J NEUROTRAUM, V32, P209, DOI 10.1089/neu.2014.3506; Iglesias JE, 2015, NEUROIMAGE, V115, P117, DOI 10.1016/j.neuroimage.2015.04.042; Evans TE, 2018, NEUROIMAGE, V178, P129, DOI 10.1016/j.neuroimage.2018.05.041; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Fernandez-Cabello S, 2020, BRAIN, V143, P993, DOI 10.1093/brain/awaa012; Firth J, 2018, NEUROIMAGE, V166, P230, DOI 10.1016/j.neuroimage.2017.11.007; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fjell AM, 2013, NEUROBIOL AGING, V34, P2239, DOI 10.1016/j.neurobiolaging.2013.04.006; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; Fu HJ, 2018, NAT NEUROSCI, V21, P1350, DOI 10.1038/s41593-018-0221-2; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Goh SYM, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00019; Gooijers J, 2016, NEUROREHAB NEURAL RE, V30, P603, DOI 10.1177/1545968315613448; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Grauwmeijer E, 2018, J NEUROTRAUM, V35, P1543, DOI 10.1089/neu.2017.5404; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Griesbach GS, 2018, J NEUROTRAUM, V35, P17, DOI 10.1089/neu.2017.5103; Grodd W, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67770-4; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Harris TC, 2019, ANN BIOMED ENG, V47, P1941, DOI 10.1007/s10439-018-02148-2; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Henneman WJP, 2009, NEUROLOGY, V72, P999, DOI 10.1212/01.wnl.0000344568.09360.31; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; Hwang K, 2017, J NEUROSCI, V37, P5594, DOI 10.1523/JNEUROSCI.0067-17.2017; Iglesias JE, 2018, NEUROIMAGE, V183, P314, DOI 10.1016/j.neuroimage.2018.08.012; Insausti R, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00084; Jancke L, 2015, HUM BRAIN MAPP, V36, P150, DOI 10.1002/hbm.22619; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Kempuraj D, 2020, NEUROSCIENTIST, V26, P134, DOI 10.1177/1073858419848293; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kim GW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67873-y; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; King D. J., 2020, FLORIDA NOUROSCIENCE, V14, P1234; Konstantinou N, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00029; Kuhn S, 2014, MOL PSYCHIATR, V19, P265, DOI 10.1038/mp.2013.120; Last N, 2017, J ALZHEIMERS DIS, V56, P275, DOI 10.3233/JAD-160899; Ledig C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188152; Ledig C, 2015, MED IMAGE ANAL, V21, P40, DOI 10.1016/j.media.2014.12.003; Lenka A, 2018, J NEURAL TRANSM, V125, P1361, DOI 10.1007/s00702-018-1891-3; Leung KK, 2013, NEUROLOGY, V80, P648, DOI 10.1212/WNL.0b013e318281ccd3; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513; Lutkenhoff ES, 2020, NEUROLOGY, V95, pE2398, DOI 10.1212/WNL.0000000000010825; Lutkenhoff ES, 2013, NEUROIMAGE-CLIN, V3, P396, DOI 10.1016/j.nicl.2013.09.010; Mak E, 2015, NEUROBIOL AGING, V36, P1743, DOI 10.1016/j.neurobiolaging.2014.12.038; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Narvacan K, 2017, HUM BRAIN MAPP, V38, P3771, DOI 10.1002/hbm.23604; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Niemann C, 2014, NEUROSCIENCE, V281, P147, DOI 10.1016/j.neuroscience.2014.09.033; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Parker TD, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2018.101632; Pepeu G, 2017, BRAIN RES, V1670, P173, DOI 10.1016/j.brainres.2017.06.023; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; Pintzka CWS, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00238; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Risacher SL, 2009, CURR ALZHEIMER RES, V6, P347, DOI 10.2174/156720509788929273; Ruet A, 2018, J NEUROTRAUM, V35, P1552, DOI 10.1089/neu.2017.5242; Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sanchis-Segura C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69361-9; Sandry J, 2021, MULT SCLER RELAT DIS, V51, DOI 10.1016/j.msard.2021.102950; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Sayre LM, 2001, CURR MED CHEM, V8, P721, DOI 10.2174/0929867013372922; Scahill RI, 2002, P NATL ACAD SCI USA, V99, P4703, DOI 10.1073/pnas.052587399; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sele S, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00363; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Steiner L, 2020, NEUROIMAGE, V223, DOI 10.1016/j.neuroimage.2020.117361; Stepan-Buksakowska I, 2014, ALZ DIS ASSOC DIS, V28, P65, DOI 10.1097/WAD.0b013e318299d3d6; Svingos AM, 2019, J CLIN EXP NEUROPSYC, V41, P775, DOI 10.1080/13803395.2019.1620695; Tamnes CK, 2018, DEV COGN NEUROS-NETH, V30, P212, DOI 10.1016/j.dcn.2018.03.009; Tomaiuolo F, 2021, J NEUROTRAUM, V38, P283, DOI 10.1089/neu.2020.7203; Tomaiuolo F, 2012, BRAIN RES BULL, V87, P373, DOI 10.1016/j.brainresbull.2012.01.008; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Vinke EJ, 2018, NEUROBIOL AGING, V71, P32, DOI 10.1016/j.neurobiolaging.2018.07.001; Voss MW, 2019, TRENDS COGN SCI, V23, P318, DOI 10.1016/j.tics.2019.01.006; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wei K, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1457; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; West GL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187779; Whelan CD, 2016, NEUROIMAGE, V128, P125, DOI 10.1016/j.neuroimage.2015.12.039; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Wilkinson ST, 2017, BIOL PSYCHIAT-COGN N, V2, P327, DOI 10.1016/j.bpsc.2017.01.011; Wilson H, 2019, J NEUROL SCI, V398, P31, DOI 10.1016/j.jns.2019.01.020; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Xiao H, 2015, NEURAL REGEN RES, V10, P2062, DOI 10.4103/1673-5374.172328; Xu R, 2020, QUANT IMAG MED SURG, V10, P220, DOI 10.21037/qims.2019.10.17; XUEREB JH, 1991, BRAIN, V114, P1363; Yi HA, 2016, J NEUROL NEUROSUR PS, V87, P425, DOI 10.1136/jnnp-2014-309105; Yuan R, 2016, BRAIN STRUCT FUNCT, V221, P1971, DOI 10.1007/s00429-015-1018-7; Zarei M, 2010, NEUROIMAGE, V49, P1, DOI 10.1016/j.neuroimage.2009.09.001; Zheng FL, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00320; Zheng FL, 2019, J MAGN RESON IMAGING, V49, P152, DOI 10.1002/jmri.26037; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	151	0	0	1	1	ELSEVIER MASSON, CORP OFF	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	DEC	2021	145						37	56		10.1016/j.cortex.2021.08.011			20	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	XB8HA	WOS:000721562900004	34689031				2022-02-06	
J	Sarmiento, K; Waltzman, D; Wright, D				Sarmiento, Kelly; Waltzman, Dana; Wright, David			Do healthcare providers assess for risk factors and talk to patients about return to driving after a mild traumatic brain injury (mTBI)? Findings from the 2020 DocStyles Survey	INJURY PREVENTION			English	Article							FITNESS-TO-DRIVE; QUALITY-OF-LIFE; ACUTE CONCUSSION; SYMPTOMS; CESSATION; CRASH	Background There is a dearth of information and guidance for healthcare providers on how to manage a patient's return to driving following a mild traumatic brain injury (mTBI). Methods Using the 2020 DocStyles survey, 958 healthcare providers were surveyed about their diagnosis and management practices related to driving after an mTBI. Results Approximately half (52.0%) of respondents reported routinely (more than 75% of the time) talking with patients with mTBI about how to safely return to driving after their injury. When asked about how many days they recommend their patients with mTBI wait before returning to driving after their injury: 1.0% recommended 1 day or less; 11.7% recommended 2-3 days; 24.5% recommended 4-7 days and 45.9% recommended more than 7 days. Many respondents did not consistently screen patients with mTBI for risk factors that may affect their driving ability or provide them with written instructions on how to safely return to driving (59.7% and 62.6%, respectively). Approximately 16.8% of respondents reported they do not usually make a recommendation regarding how long patients should wait after their injury to return to driving. Conclusions Many healthcare providers in this study reported that they do not consistently screen nor educate patients with mTBI about driving after their injury. In order to develop interventions, future studies are needed to assess factors that influence healthcare providers behaviours on this topic.	[Sarmiento, Kelly; Waltzman, Dana] Natl Ctr Injury Prevent & Control, Div Injury Prevent, Atlanta, GA USA; [Wright, David] Emory Univ, Sch Med, Atlanta, GA 30322 USA		Sarmiento, K (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30329 USA.	KSarmiento@cdc.gov					Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Badaczewski A, 2017, PATIENT EDUC COUNS, V100, P1345, DOI 10.1016/j.pec.2017.02.022; Baker A, 2015, ACCIDENT ANAL PREV, V79, P50, DOI 10.1016/j.aap.2015.03.014; Baker A, 2015, AUST OCCUP THER J, V62, P50, DOI 10.1111/1440-1630.12172; Brown AM, 2018, INJURY PREV, V24, P390, DOI 10.1136/injuryprev-2018-042865; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Cyr AA, 2009, J CLIN EXP NEUROPSYC, V31, P472, DOI 10.1080/13803390802255627; DeCarlo DK, 2003, OPTOMETRY VISION SCI, V80, P207, DOI 10.1097/00006324-200303000-00010; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Fonda SJ, 2001, J GERONTOL B-PSYCHOL, V56, pS343, DOI 10.1093/geronb/56.6.S343; Fraade-Blanar LA, 2018, J AM GERIATR SOC, V66, P1075, DOI 10.1111/jgs.15378; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Huisingh C, 2017, INVEST OPHTH VIS SCI, V58, P2959, DOI 10.1167/iovs.17-21482; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Koval RR, 2020, ANN EMERG MED, V75, P483, DOI 10.1016/j.annemergmed.2019.08.419; Lane AD, 2017, J EMERG MED, V52, P690, DOI 10.1016/j.jemermed.2016.12.017; Liu SY, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy023; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Mantua J, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx062; Marottoli RA, 2000, J GERONTOL B-PSYCHOL, V55, pS334, DOI 10.1093/geronb/55.6.S334; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Preece MHW, 2016, BRAIN INJURY, V30, P1096, DOI 10.3109/02699052.2016.1165868; Preece MHW, 2013, BRAIN INJURY, V27, P83, DOI 10.3109/02699052.2012.722260; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Ragland DR, 2005, J GERONTOL A-BIOL, V60, P399, DOI 10.1093/gerona/60.3.399; Sarmiento K, 2018, BRAIN INJURY, V32, P889, DOI 10.1080/02699052.2018.1466197; Schmidt JD, 2018, J NEUROTRAUM, V35, P2418, DOI 10.1089/neu.2018.5707; Schmidt JD, 2019, BRAIN INJURY, V33, P1652, DOI 10.1080/02699052.2019.1664765; Schmidt JD, 2017, J NEUROTRAUM, V34, P1571, DOI 10.1089/neu.2016.4668; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Shepherd D, 2020, QUAL LIFE RES, V29, P665, DOI 10.1007/s11136-019-02346-y; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Stuart Emily A, 2016, Pediatr Qual Saf, V1, pe006, DOI 10.1097/pq9.0000000000000006; Wammes JD, 2017, BRAIN COGNITION, V111, P112, DOI 10.1016/j.bandc.2016.11.004; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	42	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	DEC	2021	27	6					560	566		10.1136/injuryprev-2020-044034			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	XK9AG	WOS:000727748300009	33452014				2022-02-06	
J	Sayore, CM; Bechri, H; Oudrhiri, MY; El Ouahabi, A				Sayore, C. M.; Bechri, H.; Oudrhiri, M. Y.; El Ouahabi, A.			Acute traumatic posterior fossa subdural hematoma: A case report	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						Subdural; Hematoma; Posterior fossa; Cerebellopontine angle		Background: Acute traumatic posterior fossa subdural hematomas are rare lesions in adult. Data on its physiopathology are limited. Timely surgical evacuation is the mainstay of treatment, particularly in selected cases with large volume hematomas compressing the posterior fossa neural elements. The outcome is generally poor and the overall mortality rate is high. The outcome depends on the clinical status of the patient and the timing of surgery. Results: We report a case of a 22-years old patient admitted after a severe traumatic brain injury, with a Glasgow coma scale (GCS) of 12. The CT scan showed a right acute subdural hematoma of the cerebellar hemisphere, extending to right the cerebellar pontine angle (CPA) with compression of the posterior fossa neural elements. The patient had surgery within four hours from the trauma with a good recovery. Conclusion: Despite the high rate of mortality related to posterior fossa subdural hematomas, our case report and literature analysis highlight the importance of early surgical management in ensuring a better clinical outcome.	[Sayore, C. M.; Bechri, H.; Oudrhiri, M. Y.; El Ouahabi, A.] Hop Specialites, Dept Neurosurg, Rabat, Morocco		Sayore, CM (corresponding author), 27 RUE Abdelkrim Diouri,Et1,Apt 2, Rabat 10050, Morocco.	saymilena@yahoo.fr					Aji Yunus Kuntawi, 2018, Asian J Neurosurg, V13, P453, DOI 10.4103/ajns.AJNS_282_16; ARSENI C, 1972, PSYCHIAT NEUROL NEUR, V75, P113; Bhardwaj S, 2019, J NEUROSCI RURAL PRA, V10, P675, DOI 10.1055/s-0039-1696610; BORZONE M, 1995, ACTA NEUROCHIR, V135, P32, DOI 10.1007/BF02307411; CIEMBRONIEWICZ JE, 1965, J NEUROSURG, V22, P465, DOI 10.3171/jns.1965.22.5.0465; CLITHEROW N R, 1969, Journal of Neurosurgery, V30, P744, DOI 10.3171/jns.1969.30.6.0744; d'Avella D, 2003, ACTA NEUROCHIR, V145, P1037, DOI 10.1007/s00701-003-0150-y; ESTRIDGE MN, 1961, J NEUROSURG, V18, P248, DOI 10.3171/jns.1961.18.2.0248; Finger G, 2018, WORLD NEUROSURG, V119, P146, DOI 10.1016/j.wneu.2018.07.220; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Gulsen S, 2009, J KOREAN NEUROSURG S, V46, P277, DOI 10.3340/jkns.2009.46.3.277; Hecimovic I, 1999, SURG NEUROL, V51, P247, DOI 10.1016/S0090-3019(97)00473-4; Karasawa H, 1997, J NEUROSURG, V86, P629, DOI 10.3171/jns.1997.86.4.0629; Liu K, 1997, Zhonghua Wai Ke Za Zhi, V35, P166; de Amorim RLO, 2014, ACTA NEUROCHIR, V156, P199, DOI 10.1007/s00701-013-1850-6; RAFTOPOULOS C, 1990, CLIN NEUROL NEUROSUR, V92, P57, DOI 10.1016/0303-8467(90)90008-S; Shibahashi K, 2018, WORLD NEUROSURG, V119, pE513, DOI 10.1016/j.wneu.2018.07.191; Stendel R, 2002, ACTA NEUROCHIR, V144, P497, DOI 10.1007/s007010200072; Takeuchi S, 2012, J TRAUMA ACUTE CARE, V72, P480, DOI 10.1097/TA.0b013e31823c89b3; YOUNG HA, 1982, J TRAUMA, V22, P914, DOI 10.1097/00005373-198211000-00006	20	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2214-7519		INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	DEC	2021	26								101313	10.1016/j.inat.2021.101313			4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WA4DI	WOS:000702837000005		gold			2022-02-06	
J	Schellenberg, M; Owattanapanich, N; Grigorian, A; Lam, L; Nahmias, J; Inaba, K				Schellenberg, Morgan; Owattanapanich, Natthida; Grigorian, Areg; Lam, Lydia; Nahmias, Jeffry; Inaba, Kenji			Surviving Nonsurvivable Injuries: Patients Who Elude the 'Lethal' Abbreviated Injury Scale (AIS) Score of Six	JOURNAL OF SURGICAL RESEARCH			English	Article						Abbreviated Injury Scale; mortality; major trauma; severe injury; traumatic brain injury		Background: The Abbreviated Injury Scale (AIS) score is used widely to quantify injury severity by body region. The maximal AIS score is 6, which defines a nonsurvivable injury. This study was undertaken to define mortality after AIS-6 injuries in order to determine if they are uniformly lethal and, if not, if differences between survivors and nonsurvivors exist which may aid in prognostication or refinement of the current AIS system. Methods: All patients in the National Trauma Data Bank (2007-2017) with >= 1 AIS-6 injury were included. Exclusions were age <16 years, AIS-6 coding in the face/extremities (i.e., coding errors, as there are no AIS-6 injuries in these regions), and missing data. In-hospital mortality defined study groups, i.e., survivors vs. nonsurvivors. Univariable analysis compared clinical/injury data and outcomes. Multivariable analysis examined independent factors associated with mortality. Results: 19,247 patients met inclusion/exclusion criteria. Of these, 25% (n=4,886) survived to hospital discharge and 75% (n=14,361) died. The most common discharge destination among survivors was home (n=2,187,45%) Nonsurvivors had significantly worse GCS in the field (3 vs. 14, p<0.001) and ED (3 vs. 15, p<0.001). Median AIS was higher among nonsurvivors in the Head (5 vs. 3, p<0.001), Abdomen (3 vs. 2, P<0.001), and External regions (1 vs. 1, p<0.001). Median time to death was 0.65h, with maximum time to death 8.76h. Multivariable analysis revealed External AIS-6 injuries were associated with greatest odds of mortality (OR 34.002, p<0.001) followed by Head AIS-6 (OR 10.501, p<0.001). Conclusion: AIS-6 injuries are not uniformly fatal, with 25% of such patients surviving to hospital discharge. Therefore, AIS-6 injuries may not be as catastrophic as previously considered. External and Head AIS-6, i.e. extensive burns and severe traumatic brain injuries, were associated with greatest odds of mortality. When death occurs after AIS-6 injury, it occurs rapidly, with all mortalities in this series occurring <9h after arrival. We suggest that the AIS-6 verbiage be revised to remove 'nonsurvivable'. (C) 2021 Elsevier Inc. All rights reserved.	[Schellenberg, Morgan; Owattanapanich, Natthida; Grigorian, Areg; Lam, Lydia; Inaba, Kenji] Univ Southern Calif, LAC USC Med Ctr, Div Acute Care Surg, 2051 Marengo St,Inpatient Tower,C5L100, Los Angeles, CA 90033 USA; [Nahmias, Jeffry] Univ Calif Irvine, Dept Surg, Orange, CA 92668 USA		Schellenberg, M (corresponding author), Univ Southern Calif, LAC USC Med Ctr, Div Acute Care Surg, 2051 Marengo St,Inpatient Tower,C5L100, Los Angeles, CA 90033 USA.	morgan.schellenberg@med.usc.edu					American College of Surgeons, 2017, NATL TRAUMA DATA BAN; American College of Surgeons Committee on Trauma (ACS COT), 2014, RESOURCES OPTIMAL CA; [Anonymous], 1971, JAMA, V215, P277; Antonopoulos CN., 2017, INT ENCY PUBLIC HLTH, P258; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Hsu SY, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16245033; Jochems D, 2018, INJURY, V49, P1661, DOI 10.1016/j.injury.2018.05.012; Peng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134821; Schellenberg M, 2019, J TRAUMA ACUTE CARE, V87, P865, DOI 10.1097/TA.0000000000002393	9	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2021	268						616	622		10.1016/j.jss.2021.06.087			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	WA4PM	WOS:000702868600027	34469860				2022-02-06	
J	Schmidt, AT; Lindsey, HM; Dennis, E; Wilde, EA; Bieknian, BD; Chu, ZD; Hanten, GR; Fornion, DL; Spruiell, MS; Hunter, JV; Levin, HS				Schmidt, Adam T.; Lindsey, Hannah M.; Dennis, Emily; Wilde, Elisabeth A.; Bieknian, Brian D.; Chu, Zili D.; Hanten, Gerri R.; Fornion, Dana L.; Spruiell, Matthew S.; Hunter, Jill, V; Levin, Harvey S.			Diffusion Tensor Imaging Correlates of Resilience Following Adolescent Traumatic Brain Injury	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article						traumatic brain injury; diffusion tensor imaging; resilience-promoting factors; neuroimaging; resilience	WHITE-MATTER MICROSTRUCTURE; EXECUTIVE DYSFUNCTION; EMOTION RECOGNITION; SOCIAL NEUROSCIENCE; FAMILY ENVIRONMENT; BEHAVIOR PROBLEMS; CORPUS-CALLOSUM; CHILDREN; CHILDHOOD; OUTCOMES	Background: Traumatic brain injury (TBI) is associated with considerable mortality and morbidity in adolescents, but positive outcomes are possible. Resilience is the concept that some individuals flourish despite significant adversity. Objective: To determine if there is a relationship between resilience-promoting factors that are known to promote resilience and white matter (WM) microstructure 1 year after complicated mild TBI or moderate or severe TBI that is sustained by adolescents. Method: We examined the relationship between performance on a self-report measure of resilience-promoting factors and WM integrity assessed by diffusion tensor imaging in a group of adolescents who had sustained either a TBI (n = 38) or an orthopedic injury (OI) (n = 23). Results: Immediately following injury, the individuals with TBI and the OI controls had comparable levels of resilience-promoting factors; however, at 1 year post injury, the TBI group endorsed fewer resilience-promoting factors and exhibited WM disruption compared with the OI controls. The individuals with TBI who had more resilience-promoting factors at 1 year post injury exhibited increased WM integrity, but the OI controls did not. Findings were particularly strong for the following structures: anterior corona radiata, anterior limb of the internal capsule, and genu of the corpus callosum-structures that are implicated in social cognition and are frequently disrupted after TBI. Relationships were notable for caregiver and community-level resilience-promoting factors. Conclusion: The current findings are some of the first to indicate neurobiological evidence of previously noted buffering effects of resilience-promoting factors in individuals with TBI.	[Schmidt, Adam T.] Texas Tech Univ Campus, Dept Psychol Sci, Campus Box 42051, Lubbock, TX 79409 USA; [Lindsey, Hannah M.; Dennis, Emily; Wilde, Elisabeth A.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Bieknian, Brian D.; Chu, Zili D.; Hanten, Gerri R.; Spruiell, Matthew S.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Hunter, Jill, V] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Fornion, Dana L.] Colorado Dept Human Serv, Court Serv Div, Off Behav Hlth, Denver, CO USA; [Hunter, Jill, V] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA		Schmidt, AT (corresponding author), Texas Tech Univ Campus, Dept Psychol Sci, Campus Box 42051, Lubbock, TX 79409 USA.	adam.t.schmidt@ttu.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS21899]	Supported in part by a grant (R01-NS21899) from the National Institute of Neurological Disorders and Stroke to G.R.H. and H.S.L.	Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Armstrong M.I., 2005, J CHILD FAM STUD, V14, P269, DOI [10.1007/s10826-005-5054-4, DOI 10.1007/S10826-005-5054-4]; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avci G, 2013, J PUBLIC MENT HEALTH, V12, P165, DOI 10.1108/JPMH-02-2013-0005; Batista S, 2017, NEUROLOGY, V89, P38, DOI 10.1212/WNL.0000000000004060; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burt KB, 2016, J CHILD PSYCHOL PSYC, V57, P1287, DOI 10.1111/jcpp.12552; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Cheng YW, 2010, NEUROIMAGE, V50, P873, DOI 10.1016/j.neuroimage.2010.01.011; Cicchetti D, 2009, NEW DIR CHILD ADOLES, V124, P47, DOI 10.1002/cd.242; Clausen F, 2012, J NEUROTRAUM, V29, P766, DOI 10.1089/neu.2011.1754; Cohen J., 2013, STAT POWER ANAL BEHA; Dennis EL, 2018, NEUROSCIENTIST, V24, P652, DOI 10.1177/1073858418759489; Elliott TR, 2015, REHABIL PSYCHOL, V60, P263, DOI 10.1037/rep0000050; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Galinowski A, 2015, PSYCHOL MED, V45, P2285, DOI 10.1017/S0033291715000239; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Grieve SM, 2007, AM J NEURORADIOL, V28, P226; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Jahanshad N, 2013, NEUROIMAGE, V81, P455, DOI 10.1016/j.neuroimage.2013.04.061; Johnson NF, 2013, AGE, V35, P2045, DOI 10.1007/s11357-012-9493-8; Kalisch R, 2015, BEHAV BRAIN SCI, V38, DOI 10.1017/S0140525X15000023; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Kreber LA, 2016, BRAIN RES, V1640, P152, DOI 10.1016/j.brainres.2016.01.016; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Martino J, 2010, CORTEX, V46, P691, DOI 10.1016/j.cortex.2009.07.015; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Masten AS, 1999, DEV PSYCHOPATHOL, V11, P143, DOI 10.1017/S0954579499001996; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McDonald S, 2018, SOC NEUROSCI-UK, V13, P471, DOI 10.1080/17470919.2017.1356370; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Mike A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082422; Pineda RG, 2014, J PEDIATR-US, V164, P52, DOI 10.1016/j.jpeds.2013.08.047; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; Radoeva PD, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-38; Raikes AC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00468; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2018, PSYCHOL MED, V48, P679, DOI 10.1017/S0033291717002057; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Schmidt A., 2014, PRINCIPLES PRACTICE, P737; Schmidt AT, 2013, BRAIN INJURY, V27, P1528, DOI 10.3109/02699052.2013.828851; Schmidt AT, 2012, INT J DEV NEUROSCI, V30, P225, DOI 10.1016/j.ijdevneu.2011.11.003; Schmidt AT, 2010, BRAIN INJURY, V24, P1550, DOI 10.3109/02699052.2010.523047; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Schmidt AT, 2010, NEUROCASE, V16, P74, DOI 10.1080/13554790903329133; Schmidt AT., 2013, J JUV JUSTICE, V2, P69; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Srinivas R, 2010, CHILD NERV SYST, V26, P647, DOI 10.1007/s00381-009-1038-9; Steinberg L, 2004, ANN NY ACAD SCI, V1021, P51, DOI 10.1196/annals.1308.005; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2010, DEV PSYCHOBIOL, V52, P216, DOI 10.1002/dev.20445; TEASDALE G, 1974, LANCET, V2, P81; Terry DP, 2019, J INT NEUROPSYCH SOC, V25, P950, DOI 10.1017/S1355617719000754; Tonks J, 2011, BRAIN INJURY, V25, P870, DOI 10.3109/02699052.2011.581641; Tukey JW, 1977, EXPLORATORY DATA ANA, V2, P131; Tustison NJ, 2014, NEUROIMAGE, V99, P166, DOI 10.1016/j.neuroimage.2014.05.044; Ungar M, 2004, FAM PROCESS, V43, P23, DOI 10.1111/j.1545-5300.2004.04301004.x; Ungar M, 2008, BRIT J SOC WORK, V38, P218, DOI 10.1093/bjsw/bc1343; Ungar M, 2011, J MIX METHOD RES, V5, P126, DOI 10.1177/1558689811400607; van der Werff SJA, 2013, HUM PSYCHOPHARM CLIN, V28, P529, DOI 10.1002/hup.2336; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Waugh CE, 2008, SOC COGN AFFECT NEUR, V3, P322, DOI 10.1093/scan/nsn024; Wechsler D., 2011, WECHSLER ABBREVIATED; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yin B, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00028	84	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1543-3633	1543-3641		COGN BEHAV NEUROL	Cogn. Behav. Neurol.	DEC	2021	34	4					259	274		10.1097/WNN.0000000000000283			16	Behavioral Sciences; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	XF9NQ	WOS:000724391300002	34851864	Bronze			2022-02-06	
J	Selvaraj, P; Tanaka, M; Wen, J; Zhang, YM				Selvaraj, Prabhuanand; Tanaka, Mikiei; Wen, Jie; Zhang, Yumin			The Novel Monoacylglycerol Lipase Inhibitor MJN110 Suppresses Neuroinflammation, Normalizes Synaptic Composition and Improves Behavioral Performance in the Repetitive Traumatic Brain Injury Mouse Model	CELLS			English	Article						monoacylglycerol lipase inhibitor; 2-arachidonyl glycerol; glutamate receptors; GABA receptors; microglia; neuronal cell death; hippocampus; repetitive mTBI	AMPA RECEPTORS; NMDA RECEPTOR; FUNCTIONAL RECOVERY; EXPRESSION; SUBUNIT; GABA; NEURODEGENERATION; BARRIER; NEURONS; MEMORY	Modulation of the endocannabinoid system has emerged as an effective approach for the treatment of many neurodegenerative and neuropsychological diseases. However, the underlying mechanisms are still uncertain. Using a repetitive mild traumatic brain injury (mTBI) mouse model, we found that there was an impairment in locomotor function and working memory within two weeks post-injury, and that treatment with MJN110, a novel inhibitor of the principal 2-arachidononyl glycerol (2-AG) hydrolytic enzyme monoacylglycerol lipase dose-dependently ameliorated those behavioral changes. Spatial learning and memory deficits examined by Morris water maze between three and four weeks post-TBI were also reversed in the drug treated animals. Administration of MJN110 selectively elevated the levels of 2-AG and reduced the production of arachidonic acid (AA) and prostaglandin E-2 (PGE(2)) in the TBI mouse brain. The increased production of proinflammatory cytokines, accumulation of astrocytes and microglia in the TBI mouse ipsilateral cerebral cortex and hippocampus were significantly reduced by MJN110 treatment. Neuronal cell death was also attenuated in the drug treated animals. MJN110 treatment normalized the expression of the NMDA receptor subunits NR2A and NR2B, the AMPA receptor subunits GluR1 and GluR2, and the GABA(A) receptor subunits alpha 1, beta 2,3 and gamma 2, which were all reduced at 1, 2 and 4 weeks post-injury. The reduced inflammatory response and restored glutamate and GABA receptor expression likely contribute to the improved motor function, learning and memory in the MJN110 treated animals. The therapeutic effects of MJN110 were partially mediated by activation of CB1 and CB2 cannabinoid receptors and were eliminated when it was co-administered with DO34, a novel inhibitor of the 2-AG biosynthetic enzymes. Our results suggest that augmentation of the endogenous levels of 2-AG can be therapeutically useful in the treatment of TBI by suppressing neuroinflammation and maintaining the balance between excitatory and inhibitory neurotransmission.	[Selvaraj, Prabhuanand; Tanaka, Mikiei; Wen, Jie; Zhang, Yumin] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Selvaraj, Prabhuanand; Zhang, Yumin] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Zhang, YM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.; Zhang, YM (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	prabanan@gmail.com; mikiei.tanaka.ctr@usuhs.edu; jie.wen.ctr@usuhs.edu; yumin.zhang@usuhs.edu					Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carvajal FJ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2701526; Cavener VS, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00479; Choi SH, 2018, STROKE, V49, P718, DOI 10.1161/STROKEAHA.117.019664; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; Cui ZZ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01036; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Fan XL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00160; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fucich EA, 2020, J NEUROPHYSIOL, V123, P707, DOI 10.1152/jn.00570.2019; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gardoni F, 2006, EUR J NEUROSCI, V24, P2694, DOI 10.1111/j.1460-9568.2006.05140.x; Gascon S, 2008, MOL PSYCHIATR, V13, P99, DOI 10.1038/sj.mp.4002017; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hill MN, 2013, BIOL MOOD ANXIETY DI, V3, DOI 10.1186/2045-5380-3-19; Hobbs JG, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15617; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; Hwang J, 2010, LIFE SCI, V86, P615, DOI 10.1016/j.lfs.2009.06.003; Hynd MR, 2004, J NEUROCHEM, V90, P913, DOI 10.1111/j.1471-4159.2004.02548.x; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Ignatowska-Jankowska Bogna, 2015, J Pharmacol Exp Ther, V353, P424, DOI 10.1124/jpet.114.222315; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Lewis DA, 2008, AM J PSYCHIAT, V165, P1585, DOI 10.1176/appi.ajp.2008.08030395; Lindberg Megan A, 2020, Fed Pract, V37, P410, DOI 10.12788/fp.0044; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Lopez-Picon F, 2016, J NUCL MED, V57, P1442, DOI 10.2967/jnumed.115.167403; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Mayeux J, 2017, J NEUROTRAUM, V34, P436, DOI 10.1089/neu.2016.4452; Mechoulam R, 2002, Sci STKE, V2002, pre5, DOI 10.1126/stke.2002.129.re5; Niphakis MJ, 2013, ACS CHEM NEUROSCI, V4, P1322, DOI 10.1021/cn400116z; Noga JT, 1997, SYNAPSE, V27, P168, DOI 10.1002/(SICI)1098-2396(199711)27:3<168::AID-SYN2>3.3.CO;2-#; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; O'Brien LD, 2021, CANNABIS CANNABINOID, DOI 10.1089/can.2020.0175; Ogasawara D, 2016, P NATL ACAD SCI USA, V113, P26, DOI 10.1073/pnas.1522364112; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pertwee RG, 2014, P NUTR SOC, V73, P96, DOI 10.1017/S0029665113003649; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Nguyen QA, 2018, NEURON, V98, P718, DOI 10.1016/j.neuron.2018.03.046; Rakhade SN, 2008, J NEUROSCI, V28, P7979, DOI 10.1523/JNEUROSCI.1734-08.2008; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schurman LD, 2019, J NEUROSCI, V39, P5949, DOI 10.1523/JNEUROSCI.1353-18.2019; Schurman LD, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00069; Selvaraj P, 2019, J NEUROTRAUM, V36, P1655, DOI 10.1089/neu.2018.6226; Serrano A, 2018, NEUROPSYCHOPHARMACOL, V43, P1840, DOI 10.1038/s41386-018-0055-3; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Sigel E, 2011, P NATL ACAD SCI USA, V108, P18150, DOI 10.1073/pnas.1113444108; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sokolov BP, 1998, J NEUROCHEM, V71, P2454; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; Sperk G, 2004, ADV EXP MED BIOL, V548, P92; Sze CI, 2001, J NEUROL SCI, V182, P151, DOI 10.1016/S0022-510X(00)00467-6; Tanaka K, 2009, NEUROSCI LETT, V462, P235, DOI 10.1016/j.neulet.2009.07.024; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Ueda N, 2011, BIOFACTORS, V37, P1, DOI 10.1002/biof.131; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Viader A, 2016, ELIFE, V5, DOI 10.7554/eLife.12345; Walker Chandler L, 2013, Front Biol (Beijing), V8, DOI 10.1007/s11515-013-1255-1; Wilkerson JL, 2016, BRIT J PHARMACOL, V173, P1678, DOI 10.1111/bph.13469; Wilkerson JL, 2017, J PHARMACOL EXP THER, V363, P394, DOI 10.1124/jpet.117.243808; Wu C, 2015, METAB BRAIN DIS, V30, P367, DOI 10.1007/s11011-014-9560-1; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942; Zhang C, 2014, BRAIN RES, V1555, P1, DOI 10.1016/j.brainres.2014.01.051; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216; Zhang ZJ, 2002, SCHIZOPHR RES, V55, P1, DOI 10.1016/S0920-9964(01)00188-8	88	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	DEC	2021	10	12							3454	10.3390/cells10123454			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	XX4QQ	WOS:000736282700001	34943962	Green Published			2022-02-06	
J	Shen, JB; Shi, JX; Cooper, J; Chen, C; Taylor, HG; Xiang, H				Shen, Jiabin; Shi, Junxin; Cooper, Jennifer; Chen, Cheng; Taylor, H. Gerry; Xiang, Henry			A Population-Based Study of the Incidence, Medical Care, and Medical Expenditures for Pediatric Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Children; Traumatic brain injury; Expenditure; MEPS; Burden	HEALTH EQUITY; DISPARITIES; ADJUSTMENT; MODERATE; CHILDREN; PARENTS; COSTS; NEEDS; RACE	Background: Traumatic brain injury (TBI) is one of the leading causes of pediatric trauma morbidity and mortality around the world. However, limited research exists regarding disparities in the incidence of TBI and medical care seeking behaviors and medical expenditures for TBI, particularly using population-based and nationally-representative data. Materials and Methods: The present study used the Medical Expenditure Panel Survey (MEPS) Panels 9-19 (2004-2015) to provide nationally-representative estimates for the civilian, non institutionalized U.S. population. We examined differences in TBI incidence and associated medical care seeking behaviors and expenditures in relation to individual and family sociodemographic characteristics. Results: From a total of 50,563 children in the MEPS Panels 9-19, we identified 449 children with TBI. For 82% of these children, medical treatment was sought. The estimated annual total expenditure associated with pediatric TBIs nationally was approximately $667 million, with mean expenditures per TBI being $1,532 and family out of pocket expenditures accounting for 8.3% of total expenditures. Race/ethnicity was the only significant factor associated with both medical care seeking behavior and total expenditures. Conclusions: The present study is among the first to compare pediatric TBI-related medical expenditures among different sociodemographic groups in the U.S. Our findings can inform future intervention research and policy-making from the perspectives of both epidemiological and behavioral sciences. (c) 2021 Elsevier Inc. All rights reserved.	[Shen, Jiabin] Univ Massachusetts, Dept Psychol, Lowell, MA 01854 USA; [Shi, Junxin; Chen, Cheng; Xiang, Henry] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Injury Res & Prevent, 700 Childrens Dr, Columbus, OH USA; [Cooper, Jennifer; Taylor, H. Gerry] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Biobehav Hlth, Columbus, OH USA; [Cooper, Jennifer; Taylor, H. Gerry; Xiang, Henry] Ohio State Univ, Coll Med, Columbus, OH 43210 USA		Shen, JB (corresponding author), Univ Massachusetts, Dept Psychol, Lowell, MA 01854 USA.	Jiabin_Shen@uml.edu		Xiang, Henry/0000-0001-8112-319X; Shen, Jiabin/0000-0001-6625-5215; Cooper, Jennifer/0000-0001-7590-7166	Health Resources and Services AdministrationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [R40MC30759]; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K99HD093814, R00HD093814]	This work has been supported by the Health Resources and Services Administration (R40MC30759; 2017-2018) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (K99HD093814; R00HD093814). Thanks to Tyler Busch and Tim Horn for assistance in editing the manuscript.	Adler NE, 2008, ANNU REV PUBL HEALTH, V29, P235, DOI 10.1146/annurev.publhealth.29.020907.090852; Alghnam S, 2016, J TRAUMA ACUTE CARE, V80, P258, DOI 10.1097/TA.0000000000000910; Arnett JJ, 1997, ACCIDENT ANAL PREV, V29, P57, DOI 10.1016/S0001-4575(97)87007-8; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Braveman P, 2014, PUBLIC HEALTH REP, V129, P5, DOI 10.1177/00333549141291S203; Brener I, 2004, J HEAD TRAUMA REHAB, V19, P405, DOI 10.1097/00001199-200409000-00005; Brown FL, 2013, BRAIN INJURY, V27, P1570, DOI 10.3109/02699052.2013.841996; Cheng TL, 2015, PEDIATRICS, V135, pE225, DOI 10.1542/peds.2014-3109; Copeland LA, 1996, J SCHOOL HEALTH, V66, P254, DOI 10.1111/j.1746-1561.1996.tb06281.x; Cusimano MD, 2017, SAGE OPEN MED, V5, DOI [10.1177/2050312117694794, 10.1177/2050312117699799]; Faul M, 2010, TRAUMATIC BRAIN INJU; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Greene K, 2000, J ADOLESCENCE, V23, P439, DOI 10.1006/jado.2000.0330; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Harre N, 2000, J SAFETY RES, V31, P185, DOI 10.1016/S0022-4375(00)00035-9; Hill PL, 2012, J EARLY ADOLESCENCE, V32, P489, DOI 10.1177/0272431611400304; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Igra V., 1996, ISSUES CLIN CHILD PS, P35, DOI 10.1007/978-1-4899-0203-0_3; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Mantwill S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145455; McMahon MA, 2001, J HEAD TRAUMA REHAB, V16, P587, DOI 10.1097/00001199-200112000-00006; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Relyea-Chew A, 2009, ARCH PHYS MED REHAB, V90, P413, DOI 10.1016/j.apmr.2008.07.031; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; Romer D, 2010, DEV PSYCHOBIOL, V52, P263, DOI 10.1002/dev.20442; Roscigno CI, 2015, DISABIL REHABIL, V37, P523, DOI 10.3109/09638288.2014.933896; Slovic P., 1976, DECISION MAKING CHAN, P7, DOI [10.1007/978-94-010-1276-8_2, DOI 10.1007/978-94-010-1276-8_2]; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2010, DEV PSYCHOBIOL, V52, P216, DOI 10.1002/dev.20445; VanVoorhis CRW, 2007, TUTOR QUANT METHODS, V3, P43, DOI 10.20982/tqmp.03.2.p043; Wasserman J, 2019, AM J PUBLIC HEALTH, V109, pS64, DOI [10.2105/ajph.2018.304922, 10.2105/AJPH.2018.304922]; Woolf SH, 2017, HEALTH AFFAIR, V36, P984, DOI 10.1377/hlthaff.2017.0197	36	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2021	268						87	96		10.1016/j.jss.2021.06.025			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	UY8PK	WOS:000701779100010	34298211				2022-02-06	
J	Simpson, GK; Anderson, MI; Daher, M; Jones, KF; Morey, P				Simpson, Grahame K.; Anderson, Malcolm, I; Daher, Maysaa; Jones, Kate F.; Morey, Peter			Testing a Model of Resilience in Family Members of Relatives with Traumatic Brain Injury vs Spinal Cord Injury: Multigroup Analysis	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; traumatic; Caregivers; Emotional adjustment; Rehabilitation; Resilience; psychological; Spinal cord injuries	QUALITY-OF-LIFE; CAREGIVER BURDEN; PSYCHOLOGICAL ADJUSTMENT; PERCEIVED BURDEN; INDIVIDUALS; DISTRESS; HEALTH; REHABILITATION; IMPACT; SATISFACTION	Objective: To test a model comprising explanatory (neurologic impairment, coping, personality) and mediating (resilience, self-efficacy, hope, social support) variables on psychological adjustment and burden among family caregivers of individuals with traumatic brain injury (TBI) vs spinal cord injury (SCI). Design: Structural equation modeling with multigroup analysis. Setting: Six rehabilitation centers across New South Wales and Queensland, Australia. Participants: A total of 181 family members (N=181; 131 TBI, 50 SCI). Interventions: Not applicable. Main Outcome Measures: Connor-Davidson Resilience Scale, Eysenck Personality Questionnaire, Ways of Coping Questionnaire, General SelfEfficacy Scale, Herth Hope Scale, Medical Outcome Study Social Support Survey; and 4 measures of psychological adjustment including: Caregiver Burden Scale, Medical Outcomes Survey Short Form-36 (SF-36), General Health Questionnaire-28, and Positive and Negative Affect Scale. Results: The model for the aggregated sample demonstrated a very good model fit (x2=47.42, df=39, r=0.167, normed fit index=.962, incremental fit index=.993, Tucker-Lewis index=.985, comparative fit index=.993, root-mean-squared error of approximation=.035). Multi-group analysis found significant commonalities in the pattern of relationships among variables across the 2 groups. In the only differences found, neuroticism was significantly more influential on burden in family members supporting individuals with TBI than family members of individuals with SCI. Furthermore, problem-focused coping was statistically more influential on positive affect in family members of individuals with TBI when compared with family members of individuals with SCI. Conclusions: The study found significant similarities in the patterns of resilience and psychological adjustment among family caregivers of individuals with TBI and SCI. Archives of Physical Medicine and Rehabilitation 2021;102:2325-34 (c) 2021 The American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.	[Simpson, Grahame K.; Daher, Maysaa] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Locked Bag 7103, Sydney, NSW 1871, Australia; [Simpson, Grahame K.] Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Anderson, Malcolm, I; Morey, Peter] Avondale Univ, Sch Nursing & Hlth, Sydney, NSW, Australia; [Daher, Maysaa] NSW Hlth, Agcy Clin Innovat, Brain Injury Rehabil Directorate, Sydney, NSW, Australia; [Jones, Kate F.] Univ Notre Dame, Inst Eth & Soc, Sydney, NSW, Australia		Simpson, GK (corresponding author), Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Locked Bag 7103, Sydney, NSW 1871, Australia.	grahame.simpson@health.nsw.gov.au			Avondale University [170-00-7857]	Supported by Avondale University (grant no. 170-00-7857).	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Akaike H., 1973, 2 INT S INFORM THEOR, P267610, DOI 10.1007/978-1-4612-0919-5_38; Alfano D P, 1994, Appl Neuropsychol, V1, P57, DOI 10.1207/s15324826an0101&2_10; Anderson M, 2020, NEUROPSYCHOL REHABIL, V30, P3; Anderson MI, 2015, ANNU REV NURS RES-SE, V33, P219, DOI 10.1891/0739-6686.33.219; Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Blais MC, 2007, BRAIN INJURY, V21, P357, DOI 10.1080/02699050701311075; Boschen KA, 2005, REHABIL PSYCHOL, V50, P397, DOI 10.1037/0090-5550.50.4.397; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Charlifue SB, 2016, SPINAL CORD, V54, P732, DOI 10.1038/sc.2016.25; Chronister J, 2016, REHABIL COUNS BULL, V59, P235, DOI 10.1177/0034355215601072; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Elliott TR, 2008, BEHAV RES THER, V46, P1220, DOI 10.1016/j.brat.2008.08.004; Elliott TR, 2014, J CONSULT CLIN PSYCH, V82, P1072, DOI 10.1037/a0037593; Elmstahl S, 1996, ARCH PHYS MED REHAB, V77, P177, DOI 10.1016/S0003-9993(96)90164-1; Eysenck HJ., 1991, MANUAL EYSENCK PERSO; Folkman S., 1988, MANUAL WAYS COPING Q; Godwin EE, 2015, FAM RELAT, V64, P347, DOI 10.1111/fare.12122; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; HERTH K, 1992, J ADV NURS, V17, P1251, DOI 10.1111/j.1365-2648.1992.tb01843.x; Ho R., 2014, HDB UNIVARIATE MULTI, V2nd ed.; HOOKER K, 1994, GERONTOLOGIST, V34, P386, DOI 10.1093/geront/34.3.386; Jazayeri SB, 2015, EUR SPINE J, V24, P905, DOI 10.1007/s00586-014-3424-6; JORESKOG KG, 1989, LISREL 8 GUIDE PROGR; KESTER BL, 1988, REHABIL COUNS BULL, V32, P4; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kline RB., 2011, PRINCIPLES PRACTICE, V3; Kolakowsky-Hayner SA, 1999, NEUROREHABILITATION, V13, P27; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kyriazos T.A., 2018, PSYCH, V09, DOI [DOI 10.4236/PSYCH.2018.98126, 10.4236/psych.2018.98126]; Lightsey OR, 2006, COUNS PSYCHOL, V34, P96, DOI 10.1177/0011000005282369; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Manskow US, 2017, NEUROREHABILITATION, V40, P211, DOI 10.3233/NRE-161406; Middleton JW, 2014, ARCH PHYS MED REHAB, V95, P1312, DOI 10.1016/j.apmr.2014.03.017; Mullen, 2008, ELECT J BUSINESS RES, V6, P53, DOI DOI 10.21427/D7CF7R; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Nogales-Gonzalez C, 2015, AGING MENT HEALTH, V19, P1022, DOI 10.1080/13607863.2014.995593; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pedhazur, 1997, MULTIPLE REGRESSION; Pelletier P M, 1994, Appl Neuropsychol, V1, P38, DOI 10.1207/s15324826an0101&2_8; PETERS L C, 1992, Brain Injury, V6, P461, DOI 10.3109/02699059209008141; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Robinson PL, 2019, BRAIN IMPAIR, V20, P58, DOI 10.1017/BrImp.2019.2; Rodakowski J, 2013, CLIN REHABIL, V27, P565, DOI 10.1177/0269215512464503; Sander AM, 2013, BRAIN IMPAIR, V14, P113, DOI 10.1017/BrImp.2013.12; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Secinti E, 2017, SPINAL CORD, V55, P782, DOI 10.1038/sc.2017.6; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Simpson G, 2013, CLIN REHABIL, V27, P367, DOI 10.1177/0269215512457961; Simpson GK, 2020, NEUROREHABILITATION, V46, P3, DOI 10.3233/NRE-192945; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Trujillo M, 2016, REHABIL PSYCHOL, V61, P389, DOI 10.1037/rep0000108; van der Lee J, 2014, AGEING RES REV, V15, P76, DOI 10.1016/j.arr.2014.03.003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watson D., 1994, PANAS X MANUAL POSIT, DOI DOI 10.17077/48VT-M4T2; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9	62	0	0	2	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2021	102	12					2325	2334		10.1016/j.apmr.2021.06.016			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	XJ1SP	WOS:000726577100006	34358498				2022-02-06	
J	Singh, G; Storey, KB				Singh, Gurjit; Storey, Kenneth B.			MicroRNA Cues from Nature: A Roadmap to Decipher and Combat Challenges in Human Health and Disease?	CELLS			English	Article						hibernation; anoxia and hypoxia tolerance; freeze tolerance; Oxymirs; mitoMirs; CryomiRs; cancer; ageing; mitochondrial dysfunction; hypothermia	HIBERNATING GROUND-SQUIRREL; TRAUMATIC BRAIN-INJURY; SKELETAL-MUSCLE; DIFFERENTIAL EXPRESSION; NONSHIVERING THERMOGENESIS; OXIDATIVE STRESS; BROWN FAT; ROLES; TORPOR; CYCLE	MicroRNAs are small non-coding RNA (18-24 nt long) that fine-tune gene expression at the post-transcriptional level. With the advent of "multi-omics" analysis and sequencing approaches, they have now been implicated in every facet of basic molecular networks, including metabolism, homeostasis, and cell survival to aid cellular machinery in adapting to changing environmental cues. Many animals must endure harsh environmental conditions in nature, including cold/freezing temperatures, oxygen limitation (anoxia/hypoxia), and food or water scarcity, often requiring them to revamp their metabolic organization, frequently on a seasonal or life stage basis. MicroRNAs are important regulatory molecules in such processes, just as they are now well-known to be involved in many human responses to stress or disease. The present review outlines the role of miRNAs in natural animal models of environmental stress and adaptation including torpor/hibernation, anoxia/hypoxia tolerance, and freeze tolerance. We also discuss putative medical applications of advances in miRNA biology including organ preservation for transplant, inflammation, ageing, metabolic disorders (e.g., obesity), mitochondrial dysfunction (mitoMirs) as well as specialized miRNA subgroups respective to low temperature (CryomiRs) and low oxygen (OxymiRs). The review also covers differential regulation of conserved and novel miRNAs involved at cell, tissue, and stress specific levels across multiple species and their roles in survival. Ultimately, the species-specific comparison and conserved miRNA responses seen in evolutionarily disparate animal species can help us to understand the complex miRNA network involved in regulating and reorganizing metabolism to achieve diverse outcomes, not just in nature, but in human health and disease.	[Singh, Gurjit; Storey, Kenneth B.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada		Storey, KB (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	gurjitsingh@cmail.carleton.ca; kenstorey@cunet.carleton.ca		Singh, Gurjit/0000-0001-5830-518X; Storey, Kenneth/0000-0002-7363-1853			Abbasi J, 2018, JAMA-J AM MED ASSOC, V319, P2263, DOI 10.1001/jama.2018.7234; Abdellatif M, 2010, CIRC RES, V106, P16, DOI 10.1161/CIRCRESAHA.109.212183; Adams BD, 2014, CURR BIOL, V24, pR762, DOI 10.1016/j.cub.2014.06.043; Al-attar R, 2020, EXP GERONTOL, V134, DOI 10.1016/j.exger.2020.110889; Arranz E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/865638; Aulston B, 2019, J ALZHEIMERS DIS, V72, P575, DOI 10.3233/JAD-190656; Ballinger MA, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.162586; Bansal S, 2016, J COMP PHYSIOL B, V186, P229, DOI 10.1007/s00360-015-0951-3; Barre-Sinoussi F, 2015, FUTUR SCI OA, V1, DOI [10.4155/fso.15.63, 10.4155/FSO.15.63]; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beg MS, 2017, INVEST NEW DRUG, V35, P180, DOI 10.1007/s10637-016-0407-y; BENSON D W, 1959, Anesth Analg, V38, P423; Beyar R, 2011, RAMBAM MAIMONIDES ME, V2, DOI 10.5041/RMMJ.10049; Biggar KK, 2018, GENE, V677, P332, DOI 10.1016/j.gene.2018.08.014; Biggar KK, 2018, J MOL CELL BIOL, V10, P93, DOI 10.1093/jmcb/mjx053; Biggar KK, 2017, J THERM BIOL, V68, P139, DOI 10.1016/j.jtherbio.2016.09.008; Biggar KK, 2015, J EXP BIOL, V218, P1281, DOI 10.1242/jeb.104828; Biggar KK, 2014, GENE, V544, P67, DOI 10.1016/j.gene.2014.04.048; Biggar KK, 2012, CELL CYCLE, V11, P1705, DOI 10.4161/cc.19790; Biggar KK, 2011, J MOL CELL BIOL, V3, P167, DOI 10.1093/jmcb/mjq045; Biggar KK, 2009, CRYOBIOLOGY, V59, P317, DOI 10.1016/j.cryobiol.2009.08.009; Borralho PM, 2015, ADV EXP MED BIOL, V887, P31, DOI 10.1007/978-3-319-22380-3_3; Bozinovic F, 2004, J COMP PHYSIOL B, V174, P293, DOI 10.1007/s00360-004-0414-8; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Brodhun M, 2001, ACTA NEUROPATHOL, V101, P424; Buffenstein R, 2022, BIOL REV, V97, P115, DOI 10.1111/brv.12791; Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016; Camandola S, 2017, EMBO J, V36, P1474, DOI 10.15252/embj.201695810; Chae SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243873; Chan Shih-Peng, 2006, RNA Biol, V3, P97; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Chondronikola M., 2017, ADIPOSE TISSUE BIOL, P201, DOI [10.1007/978-3-319-52031-5_6, DOI 10.1007/978-3-319-52031-5_6]; Cohen P, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju006; da Costa JP, 2016, AGEING RES REV, V29, P90, DOI 10.1016/j.arr.2016.06.005; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; de Jong JMA, 2015, AM J PHYSIOL-ENDOC M, V308, pE1085, DOI 10.1152/ajpendo.00023.2015; Demetrius L, 2006, ANN NY ACAD SCI, V1067, P66, DOI 10.1196/annals.1354.010; Donzelli S, 2012, CELL DEATH DIFFER, V19, P1038, DOI 10.1038/cdd.2011.190; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; English SG, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.190579; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Feng XN, 2016, INT J ONCOL, V49, P2600, DOI 10.3892/ijo.2016.3751; Fhu CW, 2020, MOLECULES, V25, DOI 10.3390/molecules25173935; Forman HJ, 2021, NAT REV DRUG DISCOV, V20, P689, DOI 10.1038/s41573-021-00233-1; Frigault JJ, 2018, J THERM BIOL, V75, P38, DOI 10.1016/j.jtherbio.2018.05.008; Giroud S, 2021, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.623665; Giwa S, 2017, NAT BIOTECHNOL, V35, P530, DOI 10.1038/nbt.3889; Golden RJ, 2017, NATURE, V542, P197, DOI 10.1038/nature21025; Goodwin Matthew L, 2014, Front Nutr, V1, P27, DOI 10.3389/fnut.2014.00027; Graves Paul, 2012, Genomics Proteomics & Bioinformatics, V10, P239, DOI 10.1016/j.gpb.2012.06.004; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Gurtner A, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0319-x; Ha Tai-You, 2011, Immune Netw, V11, P135, DOI [10.4110/in.2011.11.1.11, 10.4110/in.2011.11.3.135]; Hadj-Moussa Hanane, 1800, Methods Mol Biol, V2257, P311, DOI 10.1007/978-1-0716-1170-8_16; Hadj-Moussa H, 2021, J CELL PHYSIOL, V236, P5080, DOI 10.1002/jcp.30216; Hadj-Moussa H, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.204594; Hadj-Moussa H, 2019, FEBS J, V286, P1094, DOI 10.1111/febs.14683; Hadj-Moussa H, 2018, BBA-GENE REGUL MECH, V1861, P586, DOI 10.1016/j.bbagrm.2018.04.007; Hadj-Moussa H, 2018, CELL MOL LIFE SCI, V75, P3635, DOI 10.1007/s00018-018-2821-0; Hadj-Moussa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep24627; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765; Heid J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16829-w; Hoey C, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1920-5; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Humphries B, 2015, ONCOTARGET, V6, P6472, DOI 10.18632/oncotarget.3052; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Izzo C, 2021, LIFE-BASEL, V11, DOI 10.3390/life11010060; Javadov S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051177; Jing L, 2018, ACTA PHARMACOL SIN, V39, P845, DOI 10.1038/aps.2017.182; Jing XM, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1089-9; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kashyap D, 2020, LIFE SCI, V246, DOI 10.1016/j.lfs.2020.117417; Kollias HD, 2006, MOL CELL BIOL, V26, P6248, DOI 10.1128/MCB.00384-06; Kornfeld Samantha F., 2012, Genomics Proteomics & Bioinformatics, V10, P295, DOI 10.1016/j.gpb.2012.09.001; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lang-Ouellette D, 2014, MOL CELL BIOCHEM, V394, P291, DOI 10.1007/s11010-014-2105-4; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Lee YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047787; Li CY, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00160; Li GR, 2010, INVEST OPHTH VIS SCI, V51, P2976, DOI 10.1167/iovs.09-4874; Li HP, 2019, MOL THER-NUCL ACIDS, V17, P424, DOI 10.1016/j.omtn.2019.06.013; Li N, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0551-0; Li ZQ, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0305-8; Liu FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128432; Liu YW, 2015, QUANT IMAG MED SURG, V5, P708, DOI 10.3978/j.issn.2223-4292.2015.06.01; Logan SM, 2021, GENOMICS, V113, P769, DOI 10.1016/j.ygeno.2021.01.017; Logan SM, 2020, NEURAL REGEN RES, V15, P2027, DOI 10.4103/1673-5374.282242; Logan SM, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.215905; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lupo MA, 2020, DIAGN CYTOPATHOL, V48, P1254, DOI 10.1002/dc.24564; Luu BE, 2020, J CELL PHYSIOL, V235, P3984, DOI 10.1002/jcp.29294; Luu BE, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201800092; Machado IF, 2020, CELL MOL LIFE SCI, V77, P1947, DOI 10.1007/s00018-019-03375-z; Majid S, 2010, CANCER-AM CANCER SOC, V116, P5637, DOI 10.1002/cncr.25488; Manikandan J, 2008, BIOINFORMATION, V2, P330, DOI 10.6026/97320630002330; McMahon G, 2011, J AM SOC NEPHROL, V22, P408, DOI 10.1681/ASN.2010040351; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Moon JM, 2013, J CEREBR BLOOD F MET, V33, P1976, DOI 10.1038/jcbfm.2013.157; Ayala MAM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65381-7; Morin MD, 2017, CRYOLETTERS, V38, P269; Morin P, 2009, INT J DEV BIOL, V53, P433, DOI 10.1387/ijdb.082643pm; Niikura T, 2004, MOL NEUROBIOL, V30, P327, DOI 10.1385/MN:30:3:327; Nikolov N.M., 2003, SURV ANESTHESIOL, V47, P219, DOI [10.1097/01.sa.0000087691.31092.12, DOI 10.1097/01.SA.0000087691.31092.12]; Olivieri Fabiola, 2013, Frontiers in Genetics, V4, P121, DOI 10.3389/fgene.2013.00121; Omran F, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00156; Opazo JC, 1999, COMP BIOCHEM PHYS A, V123, P393, DOI 10.1016/S1095-6433(99)00081-1; Ouyang YB, 2013, CURR DRUG TARGETS, V14, P90, DOI 10.2174/138945013804806424; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Quiles JM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90583-y; Reese SA, 2004, J EXP BIOL, V207, P2889, DOI 10.1242/jeb.01124; Rippo MR, 2014, EXP GERONTOL, V56, P154, DOI 10.1016/j.exger.2014.03.002; Rosa R, 2010, PROG OCEANOGR, V86, P72, DOI 10.1016/j.pocean.2010.04.004; Rose RW, 1999, PHYSIOL BIOCHEM ZOOL, V72, P699, DOI 10.1086/316709; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Rubinsky B., 1994, American Journal of Physiology, V266, pR1771; Ruiz JR, 2018, PROG CARDIOVASC DIS, V61, P232, DOI 10.1016/j.pcad.2018.07.002; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Segal M, 2020, EXPERT OPIN DRUG DIS, V15, P987, DOI 10.1080/17460441.2020.1765770; Seyfried Thomas N, 2005, Nutr Metab (Lond), V2, P30, DOI 10.1186/1743-7075-2-30; Shen MY, 2021, DIABET METAB SYND OB, V14, P2335, DOI 10.2147/DMSO.S306026; Shinde S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/206382; Shu J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13470-5; Siasos G, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.06.21; Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002; Singh G, 2020, MOL CELL BIOCHEM, V473, P203, DOI 10.1007/s11010-020-03820-9; Smith-Vikos T, 2012, J CELL SCI, V125, P7, DOI 10.1242/jcs.099200; Spitschak A, 2017, MOL CANCER, V16, DOI 10.1186/s12943-016-0563-x; Sreekumar PG, 2016, INVEST OPHTH VIS SCI, V57, P1238, DOI 10.1167/iovs.15-17053; Statello L, 2021, NAT REV MOL CELL BIO, V22, P96, DOI 10.1038/s41580-020-00315-9; Storey KB, 2007, COMP BIOCHEM PHYS A, V147, P263, DOI 10.1016/j.cbpa.2006.03.019; Storey KB, 2017, PHYSIOL REV, V97, P623, DOI 10.1152/physrev.00016.2016; Storey KB, 2015, GENOM PROTEOM BIOINF, V13, P77, DOI 10.1016/j.gpb.2015.06.001; Storey KB, 2013, COMPR PHYSIOL, V3, P1283, DOI 10.1002/cphy.c130007; Storey KB, 2010, ADV CLIN CHEM, V52, P77, DOI 10.1016/S0065-2423(10)52003-1; Syed-Abdul MM, 2020, HEPATOLOGY, V72, P103, DOI 10.1002/hep.31000; Szereszewski KE, 2019, CELL BIOCHEM FUNCT, V37, P494, DOI 10.1002/cbf.3422; Tan SY, 2019, SINGAP MED J, V60, P162, DOI 10.11622/smedj.2019032; Teixeira AF, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00605; Tong NT, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00137; Torres-Berrio A, 2020, MOL PSYCHIATR, V25, P951, DOI 10.1038/s41380-019-0421-5; Trist BG, 2019, AGING CELL, V18, DOI 10.1111/acel.13031; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Turbill C, 2011, P ROY SOC B-BIOL SCI, V278, P3355, DOI 10.1098/rspb.2011.0190; Umehara T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71931-w; Wang XX, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4042509; Wegert J, 2015, CANCER CELL, V27, P298, DOI 10.1016/j.ccell.2015.01.002; Wei WY, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00187; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; Wijenayake S, 2021, PROTEIN J, V40, P87, DOI 10.1007/s10930-020-09944-7; Willyard C, 2018, NATURE, V560, P156, DOI 10.1038/d41586-018-05890-8; Wu C.W., 2017, AGING EXPLORING COMP, P617, DOI [10.1201/b21905, DOI 10.1201/B21905]; Wu CW, 2016, PHYSIOL GENOMICS, V48, P388, DOI 10.1152/physiolgenomics.00005.2016; Wu Cheng-Wei, 2014, Genomics Proteomics & Bioinformatics, V12, P284, DOI 10.1016/j.gpb.2014.08.003; Wu CW, 2012, J EXP BIOL, V215, P1720, DOI 10.1242/jeb.066225; Xu LJ, 2015, EXP NEUROL, V264, P1, DOI 10.1016/j.expneurol.2014.11.007; Yan KW, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1734-7; Yao T, 2019, J CELL PHYSIOL, V234, P871, DOI 10.1002/jcp.26908; Yen K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32616-7; Yuan LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135064; Zhang J, 2013, GENE, V513, P147, DOI 10.1016/j.gene.2012.10.049; Zhang S, 2020, ONCOTARGETS THER, V13, P5495, DOI 10.2147/OTT.S249168; Zhang YJ, 2014, J PROTEOMICS, V105, P266, DOI 10.1016/j.jprot.2014.01.006; Zhang YP, 2015, INT J CLIN EXP PATHO, V8, P15677; Zhang ZP, 2020, J CELL BIOCHEM, V121, P3825, DOI 10.1002/jcb.29539; Zhang ZJ, 2001, MOL BRAIN RES, V95, P75, DOI 10.1016/S0169-328X(01)00247-9	171	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	DEC	2021	10	12							3374	10.3390/cells10123374			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	XW4NK	WOS:000735597900001	34943882	Green Published			2022-02-06	
J	Singh, LN; Kao, SH; Wallace, DC				Singh, Larry N.; Kao, Shih-Han; Wallace, Douglas C.			Unlocking the Complexity of Mitochondrial DNA: A Key to Understanding Neurodegenerative Disease Caused by Injury	CELLS			English	Article						mitochondria; traumatic brain injury; ischaemic stroke; evolution; genomics; genetics	TRAUMATIC BRAIN-INJURY; BASE EXCISION-REPAIR; APOLIPOPROTEIN-E; APOE GENOTYPE; ALZHEIMERS-DISEASE; COPY NUMBER; NUCLEAR; GENOME; DAMAGE; HETEROPLASMY	Neurodegenerative disorders that are triggered by injury typically have variable and unpredictable outcomes due to the complex and multifactorial cascade of events following the injury and during recovery. Hence, several factors beyond the initial injury likely contribute to the disease progression and pathology, and among these are genetic factors. Genetics is a recognized factor in determining the outcome of common neurodegenerative diseases. The role of mitochondrial genetics and function in traditional neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, is well-established. Much less is known about mitochondrial genetics, however, regarding neurodegenerative diseases that result from injuries such as traumatic brain injury and ischaemic stroke. We discuss the potential role of mitochondrial DNA genetics in the progression and outcome of injury-related neurodegenerative diseases. We present a guide for understanding mitochondrial genetic variation, along with the nuances of quantifying mitochondrial DNA variation. Evidence supporting a role for mitochondrial DNA as a risk factor for neurodegenerative disease is also reviewed and examined. Further research into the impact of mitochondrial DNA on neurodegenerative disease resulting from injury will likely offer key insights into the genetic factors that determine the outcome of these diseases together with potential targets for treatment.	[Singh, Larry N.; Wallace, Douglas C.] Childrens Hosp Philadelphia, Div Human Genet, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA; [Kao, Shih-Han] Childrens Hosp Philadelphia, Resuscitat Sci Ctr, Philadelphia, PA 19104 USA; [Wallace, Douglas C.] Univ Penn, Dept Pediat, Div Human Genet, Perelman Sch Med, Philadelphia, PA 19104 USA		Singh, LN (corresponding author), Childrens Hosp Philadelphia, Div Human Genet, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.	singhln@chop.edu; kaos@chop.edu; wallaced1@chop.edu					Akbari M, 2019, AGEING RES REV, V54, DOI 10.1016/j.arr.2019.100940; Akbari M, 2015, DNA REPAIR, V32, P172, DOI 10.1016/j.dnarep.2015.04.029; Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641; Allen JF, 2015, P NATL ACAD SCI USA, V112, P10231, DOI 10.1073/pnas.1500012112; Arancio O, 2017, ALZHEIMERS DEMENT, V13, P178, DOI 10.1016/j.jalz.2016.12.006; Archibald JM, 2015, CURR BIOL, V25, pR911, DOI 10.1016/j.cub.2015.07.055; Area-Gomez E, 2019, J CLIN INVEST, V129, P34, DOI 10.1172/JCI120848; Babbar M, 2020, MECH AGEING DEV, V186, DOI 10.1016/j.mad.2020.111207; Bar-Yaacov D, 2013, GENOME RES, V23, P1789, DOI 10.1101/gr.161265.113; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bulstrode H, 2014, ANN NEUROL, V75, P186, DOI 10.1002/ana.24116; Cadonic C, 2016, MOL NEUROBIOL, V53, P6078, DOI 10.1007/s12035-015-9515-5; Calabrese C, 2014, BIOINFORMATICS, V30, P3115, DOI 10.1093/bioinformatics/btu483; Campbell BCV, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0118-8; Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6; Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022; Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463; Chalkia D, 2017, JAMA PSYCHIAT, V74, P1161, DOI 10.1001/jamapsychiatry.2017.2604; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Chen HK, 2012, J BIOL CHEM, V287, P5253, DOI 10.1074/jbc.M111.276162; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1; Choudhury AR, 2017, SEMIN CANCER BIOL, V47, P125, DOI 10.1016/j.semcancer.2017.05.001; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Compagnoni GM, 2020, MOL NEUROBIOL, V57, P2959, DOI 10.1007/s12035-020-01926-1; Conley YP, 2014, J NEUROTRAUM, V31, P34, DOI 10.1089/neu.2013.2855; Coppede F, 2015, MUTAT RES-FUND MOL M, V776, P84, DOI 10.1016/j.mrfmmm.2014.11.010; Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144; D'Souza AR, 2018, ESSAYS BIOCHEM, V62, P309, DOI 10.1042/EBC20170102; Dayama G, 2014, NUCLEIC ACIDS RES, V42, P12640, DOI 10.1093/nar/gku1038; DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014; Ekblom R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-467; Falk MJ, 2012, DISCOV MED, V14, P389; Fan L, 2020, NAT ECOL EVOL, V4, P1213, DOI 10.1038/s41559-020-1239-x; Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Fries GR, 2020, NEUROSCI BIOBEHAV R, V112, P107, DOI 10.1016/j.neubiorev.2020.01.035; Fukunaga H, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126634; Ga L, 2018, NAT NEUROSCI, V21, P1300, DOI 10.1038/s41593-018-0237-7; Govindaraju DR, 2020, TRENDS GENET, V36, P395, DOI 10.1016/j.tig.2020.02.004; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hazkani-Covo E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000237; Hrelia P, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8363245; Johnston IG, 2016, CELL SYST, V2, P101, DOI 10.1016/j.cels.2016.01.013; Jonkhout N, 2017, RNA, V23, P1754, DOI 10.1261/rna.063503.117; Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439; Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770; Khermesh K, 2016, RNA, V22, P290, DOI 10.1261/rna.054627.115; Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175; Kopinski PK, 2021, NAT REV CANCER, V21, P431, DOI 10.1038/s41568-021-00358-w; Lareau CA, 2021, NAT BIOTECHNOL, V39, P451, DOI 10.1038/s41587-020-0645-6; Lien LM, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006157; Lin KL, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.636295; LoBue C, 2020, ARCH CLIN NEUROPSYCH, V35, P123, DOI 10.1093/arclin/acz074; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Maas Stefan, 2006, RNA Biol, V3, P1; MacDonald JA, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0513-4; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Marom S, 2019, ISCIENCE, V12, P141, DOI 10.1016/j.isci.2018.12.032; Mayne K, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.572090; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Modesti L, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10061317; Moreira S, 2016, NUCLEIC ACIDS RES, V44, P4907, DOI 10.1093/nar/gkw188; Mourier T, 2001, MOL BIOL EVOL, V18, P1833, DOI 10.1093/oxfordjournals.molbev.a003971; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nakamura T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-35; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Nei M, 2010, ANNU REV GENOM HUM G, V11, P265, DOI 10.1146/annurev-genom-082908-150129; Nicoll JAR, 1996, ANN NY ACAD SCI, V777, P271, DOI 10.1111/j.1749-6632.1996.tb34431.x; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Parikh S, 2017, GENET MED, V19, DOI 10.1038/gim.2017.107; Picard M, 2021, MITOCHONDRION, V60, P1, DOI 10.1016/j.mito.2021.06.010; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Rackham O, 2011, RNA, V17, P2085, DOI 10.1261/rna.029405.111; Rorbach J, 2012, BIOCHEM J, V444, P357, DOI 10.1042/BJ20112208; Russo E, 2018, BRAIN CIRC, V4, P95, DOI 10.4103/bc.bc_20_18; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Schumacker PT, 2014, AM J PHYSIOL-LUNG C, V306, pL962, DOI 10.1152/ajplung.00073.2014; SenGupta T, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109668; Sia E.A., 2020, HUMAN MITOCHONDRIAL, P173; Simon R, 2019, TRANSL STROKE RES, V10, P664, DOI 10.1007/s12975-018-0680-5; Singh KK, 2017, SEMIN CANCER BIOL, V47, P101, DOI 10.1016/j.semcancer.2017.05.003; Singh Larry N, 1800, PLoS Comput Biol, V17, pe1009594, DOI 10.1371/journal.pcbi.1009594; Singh LN, 2018, INVEST OPHTH VIS SCI, V59, P4598, DOI 10.1167/iovs.18-25085; Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043; Srinivasainagendra V, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0420-6; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Testai FD, 2010, ARCH NEUROL-CHICAGO, V67, P19, DOI 10.1001/archneurol.2009.309; Tetsuka S, 2021, METAB BRAIN DIS, V36, P2181, DOI 10.1007/s11011-021-00772-x; Tria FDK, 2021, GENOME BIOL EVOL, V13, DOI 10.1093/gbe/evab055; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Tsai MH, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081885; Tsuji J, 2012, NUCLEIC ACIDS RES, V40, P9073, DOI 10.1093/nar/gks424; Umbria M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59631-x; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Walker MA, 2020, NEW ENGL J MED, V383, P1556, DOI 10.1056/NEJMoa2001265; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067; Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x; Wang SS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23645-4; Weerts MJA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20623-7; Wei RP, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.018776; Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW64, DOI 10.1093/nar/gkw247; Weissman L, 2007, NUCLEIC ACIDS RES, V35, P5545, DOI 10.1093/nar/gkm605; Wenger AM, 2019, NAT BIOTECHNOL, V37, P1155, DOI 10.1038/s41587-019-0217-9; Wu Z, 2021, TRENDS BIOCHEM SCI, V46, P812, DOI 10.1016/j.tibs.2021.05.004; Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271; Yue P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206003; Zeiler FA, 2021, J NEUROTRAUM, V38, P1107, DOI 10.1089/neu.2017.5583; Zhang RY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49279-7	118	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	DEC	2021	10	12							3460	10.3390/cells10123460			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	YF8IE	WOS:000742044100001	34943968	Green Published			2022-02-06	
J	Siwicka-Gieroba, D; Dabrowski, W				Siwicka-Gieroba, Dorota; Dabrowski, Wojciech			Credibility of the Neutrophil-to-Lymphocyte Count Ratio in Severe Traumatic Brain Injury	LIFE-BASEL			English	Article						TBI; brain injury; neutrophils; lymphocytes; NLR; mortality	NEUTROPHIL/LYMPHOCYTE RATIO; MATRIX METALLOPROTEINASES; EXTRACELLULAR TRAPS; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; CEREBRAL EDEMA; MESSENGER-RNA; BLOOD-FLOW; TNF-ALPHA; DAMAGE	Traumatic brain injury (TBI) is one of the leading causes of morbidity and mortality worldwide. The consequences of a TBI generate the activation and accumulation of inflammatory cells. The peak number of neutrophils entering into an injured brain is observed after 24 h; however, cells infiltrate within 5 min of closed brain injury. Neutrophils release toxic molecules including free radicals, proinflammatory cytokines, and proteases that advance secondary damage. Regulatory T cells impair T cell infiltration into the central nervous system and elevate reactive astrogliosis and interferon-gamma gene expression, probably inducing the process of healing. Therefore, the neutrophil-to-lymphocyte ratio (NLR) may be a low-cost, objective, and available predictor of inflammation as well as a marker of secondary injury associated with neutrophil activation. Recent studies have documented that an NLR value on admission might be effective for predicting outcome and mortality in severe brain injury patients.	[Siwicka-Gieroba, Dorota; Dabrowski, Wojciech] Med Univ Lublin, Dept Anaesthesiol & Intens Care, PL-20059 Lublin, Poland		Siwicka-Gieroba, D (corresponding author), Med Univ Lublin, Dept Anaesthesiol & Intens Care, PL-20059 Lublin, Poland.	dsiw@wp.pl; w.dabrowski5@yahoo.com		Dabrowski, Wojciech/0000-0003-0449-2375			Adrover JM, 2016, TRENDS IMMUNOL, V37, P334, DOI 10.1016/j.it.2016.03.005; Alexiou GA, 2020, BIOMARK MED, V14, P1085, DOI 10.2217/bmm-2020-0150; Ali T, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00096; Allport JR, 1997, J EXP MED, V186, P517, DOI 10.1084/jem.186.4.517; Aly M, 2021, J NEUROINTERV SURG, V13, P609, DOI 10.1136/neurintsurg-2020-016342; Bagheri H, 2020, CELL ONCOL, V43, P353, DOI 10.1007/s13402-020-00501-z; Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Banks WA, 2016, BRAIN BEHAV IMMUN, V52, P81, DOI 10.1016/j.bbi.2015.10.002; Battaglini D, 2021, CURR NEUROPHARMACOL, V19, P1661, DOI 10.2174/1570159X19666210225145957; Bilgi K, 2021, WORLD NEUROSURG, V146, pE590, DOI 10.1016/j.wneu.2020.10.134; Bilgin YM, 2016, CURR OPIN HEMATOL, V23, P67, DOI 10.1097/MOH.0000000000000200; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; Brooks SD, 2014, J NEUROINTERV SURG, V6, P578, DOI 10.1136/neurintsurg-2013-010780; Campbell IK, 2016, J IMMUNOL, V197, P4392, DOI 10.4049/jimmunol.1600121; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Chen WQ, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000320; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Corbett JM, 2020, J NEUROSURG, V132, P545, DOI 10.3171/2018.10.JNS182293; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Dabrowski W, 2021, CURR NEUROPHARMACOL, V19, P1164, DOI 10.2174/1570159X18666201119155535; Daglas M, 2019, CELL REP, V29, P1178, DOI 10.1016/j.celrep.2019.09.046; Dantzer R, 2018, PHYSIOL REV, V98, P477, DOI 10.1152/physrev.00039.2016; Dinet V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01178; Dolmans RGF, 2020, WORLD NEUROSURG, V136, pE60, DOI 10.1016/j.wneu.2019.10.086; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Emerich DF, 2002, EXP NEUROL, V173, P168, DOI 10.1006/exnr.2001.7835; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; Ferro D, 2021, STROKE, V52, P859, DOI 10.1161/STROKEAHA.120.032130; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Fortin CF, 2009, FASEB J, V23, P194, DOI 10.1096/fj.08-110213; Fukuzuka K, 2000, AM J PHYSIOL-REG I, V278, pR1005, DOI 10.1152/ajpregu.2000.278.4.R1005; Furze RC, 2008, IMMUNOLOGY, V125, P281, DOI 10.1111/j.1365-2567.2008.02950.x; Ge SJ, 2008, J NEUROCHEM, V104, P1219, DOI 10.1111/j.1471-4159.2007.05056.x; Giede-Jeppe A, 2020, J NEUROSURG, V132, P400, DOI 10.3171/2018.9.JNS181975; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Gusdon AM, 2017, STROKE, V48, P2589, DOI 10.1161/STROKEAHA.117.018120; HALLENBECK JM, 1986, STROKE, V17, P246, DOI 10.1161/01.STR.17.2.246; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hillhouse EE, 2013, J AUTOIMMUN, V40, P58, DOI 10.1016/j.jaut.2012.07.010; Hirahara T, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5903-y; Hoenderdos K, 2016, THORAX, V71, P1030, DOI 10.1136/thoraxjnl-2015-207604; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Huang YL, 2017, ANN CLIN BIOCHEM, V54, P696, DOI 10.1177/0004563216686623; Huang ZW, 2020, AM J EMERG MED, V38, P641, DOI 10.1016/j.ajem.2019.10.023; Huner EA, 2018, J CHILD NEUROL, V33, P164, DOI 10.1177/0883073817748109; JENNETT B, 1975, LANCET, V1, P480; Joachim RA, 2007, J MOL MED-JMM, V85, P1369, DOI 10.1007/s00109-007-0236-8; Johnson EA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-41; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kang LJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16191-y; Kara SP, 2021, NEUROL SCI, DOI 10.1007/s10072-021-05507-5; Kaur T, 2020, BIOMATER SCI-UK, V8, P3212, DOI 10.1039/d0bm00355g; Keeling KL, 2000, J NEUROIMMUNOL, V105, P20, DOI 10.1016/S0165-5728(00)00183-1; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kimball R, 2020, CLIN NEUROL NEUROSUR, V193, DOI 10.1016/j.clineuro.2020.105772; Kjeldsen L, 1996, FEBS LETT, V380, P246, DOI 10.1016/0014-5793(96)00030-0; Klopf J, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9091236; Kochanek PM, 2017, CHILD NERV SYST, V33, P1693, DOI 10.1007/s00381-017-3474-2; Koiwa M, 2016, J NIPPON MED SCH, V83, P118, DOI 10.1272/jnms.83.118; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kostulas N, 1998, STROKE, V29, P462, DOI 10.1161/01.STR.29.2.462; Kostulas N, 1999, STROKE, V30, P2174, DOI 10.1161/01.STR.30.10.2174; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kuwar R, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1471-y; Kwiecien JM, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100372; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Lee WL, 2001, AM J RESP CRIT CARE, V164, P896, DOI 10.1164/ajrccm.164.5.2103040; Levochkina M, 2021, J CLIN MED, V10, DOI 10.3390/jcm10194365; Liu CL, 2021, INT J MED SCI, V18, P1639, DOI 10.7150/ijms.54913; Mairesse J, 2019, GLIA, V67, P345, DOI 10.1002/glia.23546; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Matlung HL, 2017, IMMUNOL REV, V276, P145, DOI 10.1111/imr.12527; Mencl S, 2014, J NEUROIMMUNOL, V274, P125, DOI 10.1016/j.jneuroim.2014.07.010; Meng HL, 2019, P NATL ACAD SCI USA, V116, P5558, DOI 10.1073/pnas.1814394116; Mitroulis I, 2015, PHARMACOL THERAPEUT, V147, P123, DOI 10.1016/j.pharmthera.2014.11.008; Mrakovcic-Sutic I, 2010, SCAND J IMMUNOL, V72, P57, DOI 10.1111/j.1365-3083.2010.02407.x; Mrass P, 2006, IMMUNOL REV, V213, P195, DOI 10.1111/j.1600-065X.2006.00433.x; Mukherjee S, 2021, J NEUROSURG-PEDIATR, V27, P335, DOI 10.3171/2020.7.PEDS19627; Newell-Rogers MK, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207448; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Nishihara T, 2011, EXP NEUROL, V229, P507, DOI 10.1016/j.expneurol.2011.04.006; O'Byrne PM, 2016, LANCET RESP MED, V4, P797, DOI 10.1016/S2213-2600(16)30227-2; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; Palmer C, 2004, PEDIATR RES, V55, P549, DOI 10.1203/01.PDR.0000113546.03897.FC; Petrone AB, 2017, NEUROREHABILITATION, V40, P501, DOI 10.3233/NRE-171437; Pikija S, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1359-2; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Ren HL, 2018, STROKE, V49, P184, DOI 10.1161/STROKEAHA.117.018904; Rosell A, 2008, STROKE, V39, P1121, DOI 10.1161/STROKEAHA.107.500868; Semple BD, 2015, NEUROBIOL DIS, V74, P263, DOI 10.1016/j.nbd.2014.12.003; Shan YL, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1638-6; Sharma S, 2020, CLIN DRUG INVEST, V40, P327, DOI 10.1007/s40261-020-00896-5; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Sieper J, 2019, NAT REV RHEUMATOL, V15, P747, DOI 10.1038/s41584-019-0294-7; Siwicka-Gieroba D, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091453; Skundric DS, 2005, J NEUROSCI RES, V79, P680, DOI 10.1002/jnr.20377; Steffen BJ, 1996, AM J PATHOL, V148, P1819; Suzuki Y, 2002, BRAIN RES, V945, P242, DOI 10.1016/S0006-8993(02)02806-8; Switonska M, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110771; Szot P, 2017, NEUROSCIENCE, V355, P9, DOI 10.1016/j.neuroscience.2017.04.028; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Tan S, 2017, CLIN SCI, V131, P1499, DOI 10.1042/CS20170984; Taylor RA, 2017, J CLIN INVEST, V127, P280, DOI 10.1172/JCI88647; Teixido J, 2018, INT J BIOCHEM CELL B, V95, P121, DOI 10.1016/j.biocel.2017.12.018; Teng TS, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/9671604; Tobin RP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0143-5; Vaibhav K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax8847; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Wang JY, 2020, WORLD NEUROSURG, V138, pE317, DOI 10.1016/j.wneu.2020.02.112; Wang JM, 2019, FREE RADICAL BIO MED, V131, P345, DOI 10.1016/j.freeradbiomed.2018.12.014; Wang RR, 2021, BLOOD, V138, P91, DOI 10.1182/blood.2020008913; Wang ZG, 2016, MOL NEUROBIOL, V53, P7298, DOI 10.1007/s12035-015-9583-6; Williams AM, 2020, J TRAUMA ACUTE CARE, V89, P388, DOI 10.1097/TA.0000000000002698; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wo J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.580304; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Wu HT, 2010, J NEUROSURG, V113, P591, DOI 10.3171/2009.9.JNS09859; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367; Zhang HB, 2020, CHIN J INTEGR MED, V26, P510, DOI 10.1007/s11655-020-3183-7; Zhang XY, 2014, ARTERIOSCL THROM VAS, V34, P587, DOI 10.1161/ATVBAHA.113.302868; Zhao JL, 2019, WORLD NEUROSURG, V124, pE411, DOI 10.1016/j.wneu.2018.12.107; Zhao XR, 2014, TRANSL STROKE RES, V5, P554, DOI 10.1007/s12975-014-0341-2; Zhao YL, 2021, BMC GERIATR, V21, DOI 10.1186/s12877-021-02284-w; Zheng JJ, 2020, J CELL PHYSIOL, V235, P2792, DOI 10.1002/jcp.29183; Zhu KX, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.621477	133	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-1729		LIFE-BASEL	Life-Basel	DEC	2021	11	12							1352	10.3390/life11121352			16	Biology; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Microbiology	XZ5RP	WOS:000737709200001	34947883	Green Published			2022-02-06	
J	St John, AE; Wang, X; Ringgold, K; Lim, EB; Chien, DA; Statz, ML; Stern, SA; White, NJ				St John, Alexander E.; Wang, Xu; Ringgold, Kristyn; Lim, Esther B.; Chien, Diana; Statz, Matthew L.; Stern, Susan A.; White, Nathan J.			A Multifunctional, Low-Volume Resuscitation Cocktail Improves Vital Organ Blood Flow and Hemostasis in a Pig Model of Polytrauma with Traumatic Brain Injury	JOURNAL OF CLINICAL MEDICINE			English	Article						multifunctional resuscitation fluid; damage control resuscitation; fibrinogen; hemostasis; perfusion	TRANEXAMIC ACID; FIBRINOGEN CONCENTRATE; DILUTIONAL COAGULOPATHY; LIMITED RESUSCITATION; HEMORRHAGIC-SHOCK; SURVIVAL; DEATH; FIBRINOLYSIS; ASSOCIATION; COAGULATION	The resuscitation of polytrauma with hemorrhagic shock and traumatic brain injury (TBI) is a balance between permissive hypotension and maintaining vital organ perfusion. There is no current optimal solution. This study tested whether a multifunctional resuscitation cocktail supporting hemostasis and perfusion could mitigate blood loss while improving vital organ blood flow during prolonged limited resuscitation. Anesthetized Yorkshire swine were subjected to fluid percussion TBI, femur fracture, catheter hemorrhage, and aortic tear. Fluid resuscitation was started when lactate concentration reached 3-4 mmol/L. Animals were randomized to one of five groups. All groups received hydroxyethyl starch solution and vasopressin. Low- and high-dose fibrinogen (FBG) groups additionally received 100 and 200 mg/kg FBG, respectively. A third group received TXA and low-dose FBG. Two control groups received albumin, with one also including TXA. Animals were monitored for up to 6 h. Blood loss was decreased and vital organ blood flow was improved with low- and high-dose fibrinogen compared to albumin controls, but survival was not improved. There was no additional benefit of high- vs. low-dose FBG on blood loss or survival. TXA alone decreased blood loss but had no effect on survival, and combining TXA with FBG provided no additional benefit. Pooled analysis of all groups containing fibrinogen vs. albumin controls found improved survival, decreased blood loss, and improved vital organ blood flow with fibrinogen delivery. In conclusion, a low-volume resuscitation cocktail consisting of hydroxyethyl starch, vasopressin, and fibrinogen concentrate improved outcomes compare to controls during limited resuscitation of polytrauma.	[St John, Alexander E.; Wang, Xu; Ringgold, Kristyn; Lim, Esther B.; Chien, Diana; Statz, Matthew L.; Stern, Susan A.; White, Nathan J.] Univ Washington, Dept Emergency Med, Sch Med, Seattle, WA 98195 USA		White, NJ (corresponding author), Univ Washington, Dept Emergency Med, Sch Med, Seattle, WA 98195 USA.	aestjohn@uw.edu; xuwang58@uw.edu; kringgo@uw.edu; esther.br.lim@gmail.com; chiend7@uw.edu; matt.statz@gmail.com; sstern@uw.edu; whiten4@uw.edu			United States Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-USSOCOM-BAA 15-1]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [KL2 TR002317]; National Heart Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1K08HL146840-01A1]; Emergency Medicine Foundation [2015-17]; United States Department of DefenseUnited States Department of Defense [W81XWH-17-1-0651]	This research was funded by the United States Army Medical Research and Materiel Command (W81XWH-USSOCOM-BAA 15-1), the National Institutes of Health (KL2 TR002317), the National Heart Lung and Blood Institute (1K08HL146840-01A1), and the Emergency Medicine Foundation (Research Training Grant 2015-17). The APC was funded by the United States Department of Defense (W81XWH-17-1-0651).	BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cho SD, 2009, SHOCK, V31, P87, DOI 10.1097/SHK.0b013e3181777ffb; Dickson JM, 2018, MIL MED, V183, pE460, DOI 10.1093/milmed/usy001; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Fries D, 2005, BRIT J ANAESTH, V95, P172, DOI 10.1093/bja/aei160; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; Godier A, 2017, J CLIN PATHOL, V70, P154, DOI 10.1136/jclinpath-2016-203854; Grottke O, 2010, CRIT CARE, V14, DOI 10.1186/cc8960; Hayakawa M, 2011, SURGERY, V149, P221, DOI 10.1016/j.surg.2010.06.010; HIIPPALA ST, 1995, ANESTH ANALG, V81, P360, DOI 10.1097/00000539-199508000-00026; Innerhofer P, 2017, LANCET HAEMATOL, V4, pE258, DOI 10.1016/S2352-3026(17)30077-7; Ives C, 2012, J AM COLL SURGEONS, V215, P496, DOI 10.1016/j.jamcollsurg.2012.06.005; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Krishnamoorthy V, 2017, NEUROCRIT CARE, V26, P379, DOI 10.1007/s12028-016-0335-x; Krishnamoorthy Vijay, 2015, Int J Crit Illn Inj Sci, V5, P103, DOI 10.4103/2229-5151.158409; LaMantia MA, 2013, WEST J EMERG MED, V14, P453, DOI 10.5811/westjem.2013.5.13411; Martini J, 2014, TRANSFUSION, V54, P149, DOI 10.1111/trf.12241; Military Health System, TACT COMB CAS CAR GU; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Rourke C, 2012, J THROMB HAEMOST, V10, P1342, DOI 10.1111/j.1538-7836.2012.04752.x; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sheppard FR, 2018, J TRAUMA ACUTE CARE, V85, pS33, DOI 10.1097/TA.0000000000001772; STERN SA, 1993, ANN EMERG MED, V22, P155, DOI 10.1016/S0196-0644(05)80195-7; STERN SA, 1995, ACAD EMERG MED, V2, P89, DOI 10.1111/j.1553-2712.1995.tb03167.x; TAKADA A, 1986, THROMB RES, V42, P39, DOI 10.1016/0049-3848(86)90194-5; Villalba N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001474; Wafaisade A, 2013, J TRAUMA ACUTE CARE, V74, P387, DOI 10.1097/TA.0b013e31827e2410; White NJ, 2015, J THROMB HAEMOST, V13, P978, DOI 10.1111/jth.12919; White NJ, 2014, SHOCK, V42, P456, DOI 10.1097/SHK.0000000000000238; Zink BJ, 2006, J NEUROSURG, V105, P884, DOI 10.3171/jns.2006.105.6.884	35	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	DEC	2021	10	23							5484	10.3390/jcm10235484			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XV9AK	WOS:000735225300001	34884185	Green Published, gold			2022-02-06	
J	Stuart, MJ; Mehigan, B; Colbran, RE; Withers, TK; Ng, W				Stuart, M. J.; Mehigan, B.; Colbran, R. E.; Withers, T. K.; Ng, W.			Orthogonal external ventricular drain (EVD) trajectory from burr holes sited by junior neurosurgical staff is superior to freehand placement: An in-silico model	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Hydrocephalus; Traumatic brain injury; External ventricular drain; Ventriculostomy	CATHETER PLACEMENT; COMPLICATION RATES; ACCURACY; INSERTION; SAFETY; EFFICACY	External ventricular drain (EVD) or ventriculostomy placement is one of the most common neurosurgical procedures performed worldwide and is associated with complications including haemorrhage, malposition and infection. Several authors have attempted to define an ideal trajectory for placement, and scalp mounted guidance devices have been devised to exploit the theoretical ideal orthogonal trajectory from the scalp to the lateral ventricles. However, uptake has been limited due to lack of demonstrated superiority to freehand placement. Previous modelling studies have failed to include a true-to-life sample of patients undergoing EVD insertion and excluded cases with midline shift or non-hydrocephalus indications. Further, none have attempted to model the orthogonal insertion of EVD via actual burr holes placed by junior neurosurgical staff. In our report of 58 cases of frontal EVD insertion in a low-volume Australian neurosurgical unit freehand EVD insertion resulted in acceptable placement in the ipsilateral frontal horn in 62% of cases, any ventricle in 22%, and in eloquent or non-eloquent brain in 16% of cases. The modelled orthogonal trajectory from the same burr holes, using post-procedural computed tomography scans and the S8 Stealth Station (Medtronic), resulted in superior placement; 80% in the ipsilateral frontal horn and 20% contralateral (p = 0.007). There were no significant malpositions associated with the modelled trajectories. In our series, 18% of freehand catheters required multiple placement attempts. In conclusion, our data suggests that an orthogonal trajectory may result in improved EVD positioning compared to freehand placement. (c) 2021 Elsevier Ltd. All rights reserved.	[Stuart, M. J.] Townsville Univ Hosp, Dept Neurosurg, Townsville, Qld 4811, Australia; [Stuart, M. J.; Mehigan, B.] James Cook Univ, Sch Med & Dent, Townsville, Qld 4811, Australia; [Colbran, R. E.] Univ Queensland, Fac Med, Brisbane, Qld 4006, Australia; [Withers, T. K.; Ng, W.] Gold Coast Univ Hosp, Dept Neurosurg, Brisbane, Qld 4215, Australia; [Withers, T. K.; Ng, W.] Griffith Univ, Sch Med, Brisbane, Qld 4215, Australia		Stuart, MJ (corresponding author), Townsville Univ Hosp, Dept Neurosurg, 100 Angus Smith Dr, Douglas, Qld 4814, Australia.	Michael.stuart@my.jcu.edu.au		Ng, Wayne/0000-0002-9438-8055			Abdoh MG, 2012, ACTA NEUROCHIR, V154, P153, DOI 10.1007/s00701-011-1136-9; AlAzri A, 2017, ACTA NEUROCHIR, V159, P1399, DOI 10.1007/s00701-017-3201-5; Ann JM, 2016, J KOREAN NEUROSURG S, V59, P322, DOI 10.3340/jkns.2016.59.3.322; Bender M, 2019, J NEUROL SURG PART A, V80, P116, DOI 10.1055/s-0038-1676576; Brand C, 2019, J NEUROL SURG PART A, V80, P277, DOI 10.1055/s-0039-1685195; Brenke C, 2020, NEUROCHIRURGIE, V66, P435, DOI 10.1016/j.neuchi.2020.09.009; Ellens NR, 2019, NEUROSURGERY, V84, P235, DOI 10.1093/neuros/nyy090; Enriquez-Marulanda A, 2018, NEUROCRIT CARE, V29, P435, DOI 10.1007/s12028-018-0556-2; Foreman PM, 2015, CLIN NEUROL NEUROSUR, V128, P94, DOI 10.1016/j.clineuro.2014.09.026; Huyette DR, 2008, J NEUROSURG, V108, P88, DOI 10.3171/JNS/2008/108/01/0088; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Kirkman MA, 2017, J NEUROSURG, V126, P304, DOI 10.3171/2016.1.JNS152263; Lee Ji Hoon, 2010, Journal of Cerebrovascular and Endovascular Neurosurgery, V12, P82; Lee Keng Siang, 2020, Asian J Neurosurg, V15, P45, DOI 10.4103/ajns.AJNS_292_19; Lind CRP, 2008, J CLIN NEUROSCI, V15, P886, DOI 10.1016/j.jocn.2007.05.013; Maniker AH, 2006, NEUROSURGERY, V59, P419, DOI 10.1227/01.NEU.0000222817.99752.E6; Mizrahi CJ, 2020, J CLIN NEUROSCI, V81, P27, DOI 10.1016/j.jocn.2020.09.003; Muirhead WR, 2012, BRIT J NEUROSURG, V26, P710, DOI 10.3109/02688697.2012.671973; Muller A, 2018, NEUROCRIT CARE, V29, P23, DOI 10.1007/s12028-017-0492-6; O'Leary ST, 2000, J NEUROSURG, V92, P801, DOI 10.3171/jns.2000.92.5.0801; O'Neill BR, 2008, SURG NEUROL, V70, P268, DOI 10.1016/j.surneu.2007.05.007; Park J, 2016, J NEUROSURG, V124, P1429, DOI 10.3171/2015.5.JNS15226; Park YG, 2011, J KOREAN NEUROSURG S, V50, P317, DOI 10.3340/jkns.2011.50.4.317; Patil V, 2013, ACTA NEUROCHIR, V155, P1773, DOI 10.1007/s00701-013-1769-y; Rehman T, 2013, WORLD NEUROSURG, V80, P173, DOI 10.1016/j.wneu.2012.12.012; Saladino A, 2009, NEUROCRIT CARE, V10, P248, DOI 10.1007/s12028-008-9154-z; Toma AK, 2009, NEUROSURGERY, V65, P1197, DOI 10.1227/01.NEU.0000356973.39913.0B; Yuen J, 2018, ANN ROY COLL SURG, V100, P221, DOI 10.1308/rcsann.2017.0221	28	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2021	94						65	69		10.1016/j.jocn.2021.09.041			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YJ1IT	WOS:000744292000009	34863464				2022-02-06	
J	Tabio, L; Walker, R; Crane, PK; Gibbons, LE; Kumar, RG; Power, MC; Kelley, AS; Larson, EB; Dams-O'Connor, K				Tabio, Laura; Walker, Rod L.; Crane, Paul K.; Gibbons, Laura E.; Kumar, Raj G.; Power, Melinda C.; Kelley, Amy S.; Larson, Eric B.; Dams-O'Connor, Kristen			Association of Lifetime TBI and Military Employment with Late Life ADL Functioning: A Population-Based Prospective Cohort Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Activities of daily living; Brain injuries; traumatic; Military personnel; Prospective cohort studies; Rehabilitation	TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; US VETERANS; DISABILITY; IMPACT; MORTALITY; MODERATE; OUTCOMES; SERVICE; 1ST	Objective: To determine associations of traumatic brain injury (TBI) and military employment with activities of daily living (ADL) in late life. Design: Population-based prospective cohort study with biennial follow-up and censoring at the time of dementia diagnosis. Setting: Community-based integrated health care delivery system. Participants: Participants (N=4953) were men (n=2066) and women (n=2887) aged >= 65 years who were dementia free. Interventions: Not applicable. Main Outcome Measures: ADL difficulties at baseline and accumulation during follow-up. Results: TBI with loss of consciousness (LOC) before the age of 40 years was associated with slightly higher ADL difficulty at baseline for women (rate ratio [RR], 1.44; 95% confidence interval [CI], 1.08-1.93; P=.01). For men, TBI with LOC at any age was associated with greater ADL difficulty at baseline (age <40y: RR, 1.58; 95% CI, 1.20-2.08; P=.001; age >= 40y: RR, 2.14; 95% CI, 1.24-3.68; P=.006). TBI with LOC was not associated with the rate of accumulation of ADL difficulties over time in men or women. There was no evidence of an association between military employment and either outcome, nor of an interaction between military employment and TBI with LOC. Findings were consistent across a variety of sensitivity analyses. Conclusions: Further investigation into factors underlying greater late life functional impairment among survivors of TBI is warranted. (C) 2021 Published by Elsevier Inc. on behalf of The American Congress of Rehabilitation Medicine.	[Tabio, Laura; Kumar, Raj G.; Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, One Gustave L Levy Pl,Box 1163, New York, NY 10029 USA; [Walker, Rod L.; Larson, Eric B.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Crane, Paul K.; Gibbons, Laura E.] Univ Washington, Dept Med, Seattle, WA USA; [Power, Melinda C.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Epidemiol, Washington, DC USA; [Kelley, Amy S.] Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA		Tabio, L (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, One Gustave L Levy Pl,Box 1163, New York, NY 10029 USA.	laura.tabio@mountsinai.org			US Department of Defense Peer Reviewed Alzheimer's Research Program [W81XWH-17-1-0330]; US National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01 AG006781, U19 AG066567, P50 AG05136, K24AG062785]	Supported by the US Department of Defense Peer Reviewed Alzheimer's Research Program (PRARP; grant no. W81XWH-17-1-0330) and the US National Institute on Aging (grant nos. U01 AG006781, U19 AG066567, P50 AG05136, K24AG062785).	Agha Z, 2000, ARCH INTERN MED, V160, P3252, DOI 10.1001/archinte.160.21.3252; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Bedard K, 2006, AM ECON REV, V96, P176, DOI 10.1257/000282806776157731; Boehmer TKC, 2004, ARCH INTERN MED, V164, P1908, DOI 10.1001/archinte.164.17.1908; Brasure M, 2012, MULTIDISCIPLINARY PO; Braveman P, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/00333549141291S206; Centers for Disease Control and Prevention,, LIF EXP; Chosy EJ, 2020, J ALZHEIMERS DIS, V73, P317, DOI 10.3233/JAD-190053; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2017, JAMA NEUROL, V74, P763, DOI 10.1001/jamaneurol.2017.0176; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Department of Veterans Affairs, AM WOM VET MIL HIST; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Eibner Christine, 2016, Rand Health Q, V5, P13; Fitzgerald KG, 2006, RES AGING, V28, P56, DOI 10.1177/0164027505281574; Freedman VA, 2008, SOC SCI MED, V66, P1588, DOI 10.1016/j.socscimed.2007.11.037; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hartigan I, 2007, INT J OLDER PEOPLE N, V2, P204, DOI 10.1111/j.1748-3743.2007.00074.x; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kansagara D., 2013, COMPLICATIONS MILD T; KATZ S, 1976, INT J HEALTH SERV, V6, P493, DOI 10.2190/UURL-2RYU-WRYD-EY3K; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kazis LE, 2006, J AMBUL CARE MANAG, V29, P310, DOI 10.1097/00004479-200610000-00007; Kolakowsky-Hayner SA, 2012, BRAIN INJURY, V26, P1328, DOI 10.3109/02699052.2012.706353; Kornblith ES, 2020, J HEAD TRAUMA REHAB, V35, pE320, DOI 10.1097/HTR.0000000000000552; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Millan-Calenti JC, 2010, ARCH GERONTOL GERIAT, V50, P306, DOI 10.1016/j.archger.2009.04.017; National Academies of Sciences Engineering Medicine, 2019, DEM MIL SERV CHAR MI; Patten E, WOMEN US MILITARY GR; Pietrzak RH, 2014, AM J GERIAT PSYCHIAT, V22, P551, DOI 10.1016/j.jagp.2012.11.018; Ponsford J, 2021, ARCH PHYS MED REHAB, V102, P371, DOI 10.1016/j.apmr.2020.09.387; Pruchno R, 2016, GERONTOLOGIST, V56, P1, DOI 10.1093/geront/gnv671; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Rozanova J, 2015, AM J GERIAT PSYCHIAT, V23, P744, DOI 10.1016/j.jagp.2014.09.006; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Sternke LM, 2011, WOMEN HEALTH ISS, V21, pS160, DOI 10.1016/j.whi.2011.04.020; Sugarman MA, 2019, ALZHEIMERS DEMENT, V15, P686, DOI 10.1016/j.jalz.2018.12.015; Traumatic Brain Injury Center of Excellence,, DOD TBI WORLDW NUMB; United States Census Bureau,, VET DAY 2019 NOV 11; Villa VM, 2002, MIL MED, V167, P783, DOI 10.1093/milmed/167.9.783; von Strauss E, 2003, J CLIN EPIDEMIOL, V56, P669, DOI 10.1016/S0895-4356(03)00089-1; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Wang L, 2002, J AM GERIATR SOC, V50, P1525, DOI 10.1046/j.1532-5415.2002.50408.x; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Wilmoth JM, 2010, J GERONTOL B-PSYCHOL, V65, P744, DOI 10.1093/geronb/gbq072; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wolinsky FD, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-43	59	0	0	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2021	102	12					2316	+		10.1016/j.apmr.2021.06.018			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	XJ1SP	WOS:000726577100005	34283993				2022-02-06	
J	Tavares, GA; Louveau, A				Tavares, Gabriel A.; Louveau, Antoine			Meningeal Lymphatics: An Immune Gateway for the Central Nervous System	CELLS			English	Article						meningeal lymphatics; immune cells; neurological disorders; brain pathologies	TRAUMATIC BRAIN-INJURY; T-CELL TRAFFICKING; DENDRITIC CELLS; MULTIPLE-SCLEROSIS; MIGRATION; CNS; ENCEPHALOMYELITIS; LYMPHOCYTES; RECEPTORS; VESSELS	The recent (re)discovery of the meningeal lymphatic system has opened new theories as to how immune cells traffic and interact with the central nervous system (CNS). While evidence is accumulating on the contribution of the meningeal lymphatic system in both homeostatic and disease conditions, a lot remains unknown about the mechanisms that allow for interaction between the meningeal lymphatic system and immune cells. In this review, we synthesize the knowledge about the lymphatic immune interaction in the CNS and highlight the important questions that remain to be answered.	[Tavares, Gabriel A.; Louveau, Antoine] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; [Louveau, Antoine] Case Western Reserve Univ, Cleveland Clin, Coll Med, Dept Mol Med, Cleveland, OH 44195 USA		Louveau, A (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA.; Louveau, A (corresponding author), Case Western Reserve Univ, Cleveland Clin, Coll Med, Dept Mol Med, Cleveland, OH 44195 USA.	TAVAREG@ccf.org; louveaa@ccf.org					Absinta M, 2017, ELIFE, V6, DOI 10.7554/eLife.29738; Ahn JH, 2019, NATURE, V572, P62, DOI 10.1038/s41586-019-1419-5; de Lima KA, 2020, NAT IMMUNOL, V21, P1421, DOI 10.1038/s41590-020-0776-4; Antila S, 2017, J EXP MED, V214, P3645, DOI 10.1084/jem.20170391; Arasa J, 2021, J EXP MED, V218, DOI 10.1084/jem.20201413; Arokiasamy S, 2017, SCI REP-UK, V7, DOI 10.1038/srep44189; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Bai RJ, 2017, NEUROCHEM RES, V42, P2892, DOI 10.1007/s11064-017-2310-0; Balint L, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03043; Bolte AC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18113-4; Bower NI, 2017, NAT NEUROSCI, V20, P774, DOI 10.1038/nn.4558; Brioschi S, 2021, SCIENCE, V373, P408, DOI 10.1126/science.abf9277; Brombacher TM, 2017, J IMMUNOL, V198, P2681, DOI 10.4049/jimmunol.1601546; Castranova D, 2021, CIRC RES, V128, P42, DOI 10.1161/CIRCRESAHA.120.317372; Chen JM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16851-z; Choi C, 2004, BRAIN RES REV, V44, P65, DOI 10.1016/j.brainresrev.2003.08.007; Clarkson BD, 2017, SCI REP-UK, V7, DOI 10.1038/srep42856; Coisne C, 2011, ANTIOXID REDOX SIGN, V15, P1285, DOI 10.1089/ars.2011.3929; Croese T, 2021, NAT IMMUNOL, V22, P1083, DOI 10.1038/s41590-021-00994-2; Cugurra A, 2021, SCIENCE, V373, P409, DOI 10.1126/science.abf7844; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Da Mesquita S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe4601; Da Mesquita S, 2021, NATURE, V593, P255, DOI 10.1038/s41586-021-03489-0; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; Daglas M, 2019, CELL REP, V29, P1178, DOI 10.1016/j.celrep.2019.09.046; Ding XB, 2021, NAT MED, V27, P411, DOI 10.1038/s41591-020-01198-1; Ellwardt E, 2016, TRENDS IMMUNOL, V37, P154, DOI 10.1016/j.it.2015.12.008; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626; Hampton HR, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01168; Harp CRP, 2019, P NATL ACAD SCI USA, V116, P24221, DOI 10.1073/pnas.1909098116; Hsu M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08163-0; Hu XT, 2020, CELL RES, V30, P229, DOI 10.1038/s41422-020-0287-8; Hunter MC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00520; Izen RM, 2018, DEV DYNAM, V247, P741, DOI 10.1002/dvdy.24624; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johnson LA, 2017, NAT IMMUNOL, V18, P762, DOI 10.1038/ni.3750; Johnson LA, 2013, J CELL SCI, V126, P5259, DOI 10.1242/jcs.135343; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kivisakk P, 2002, CLIN EXP IMMUNOL, V129, P510, DOI 10.1046/j.1365-2249.2002.01947.x; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Louveau A, 2018, NAT NEUROSCI, V21, P1380, DOI 10.1038/s41593-018-0227-9; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Ma QL, 2019, J EXP MED, V216, P2492, DOI 10.1084/jem.20190351; Ma QL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01484-6; Mohammad MG, 2014, J CLIN INVEST, V124, P1228, DOI 10.1172/JCI71544; Pasciuto E, 2020, CELL, V182, P625, DOI 10.1016/j.cell.2020.06.026; Patel TK, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0312-x; Pinheiro MAL, 2016, BBA-MOL BASIS DIS, V1862, P461, DOI 10.1016/j.bbadis.2015.10.018; Raghunandan A, 2021, ELIFE, V10, DOI 10.7554/eLife.65958; Rathinasamy A, 2010, J IMMUNOL, V185, P4072, DOI 10.4049/jimmunol.1000568; Rigby DA, 2015, J LEUKOCYTE BIOL, V98, P897, DOI 10.1189/jlb.1HI0415-149R; Sandrone S, 2019, NAT MED, V25, P538, DOI 10.1038/s41591-019-0417-3; Schafflick D, 2021, NAT NEUROSCI, V24, P1225, DOI 10.1038/s41593-021-00880-y; Schlager C, 2016, NATURE, V530, P349, DOI 10.1038/nature16939; Semyachkina-Glushkovskaya O, 2020, ADV EXP MED BIOL, V1232, P63, DOI 10.1007/978-3-030-34461-0_9; Sen MK, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.572186; SKUNDRIC DS, 1994, LAB INVEST, V71, P671; Song E, 2020, NATURE, V577, P689, DOI 10.1038/s41586-019-1912-x; Suarez I, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10040799; Teijeira A, 2017, CELL REP, V18, P857, DOI 10.1016/j.celrep.2016.12.078; Thomas JL, 2020, M S-MED SCI, V36, P709, DOI 10.1051/medsci/2020141; TSUCHIDA M, 1994, IMMUNOLOGY, V81, P420; Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4; Wang LM, 2019, BRAIN PATHOL, V29, P176, DOI 10.1111/bpa.12656; Wen YR, 2018, NEURAL REGEN RES, V13, P709, DOI 10.4103/1673-5374.230299; Wojciechowski S, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.559810; Wood DD, 1996, ANN NEUROL, V40, P18, DOI 10.1002/ana.410400106; Yanev P, 2020, J CEREBR BLOOD F MET, V40, P263, DOI 10.1177/0271678X18822921; Yankova G, 2021, REV NEUROSCIENCE, V32, P693, DOI 10.1515/revneuro-2020-0106; Zhang X, 2017, BRAIN RES, V1670, P96, DOI 10.1016/j.brainres.2017.06.019; Zou WY, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0147-y	74	0	0	3	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	DEC	2021	10	12							3385	10.3390/cells10123385			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	XX0FN	WOS:000735983300001	34943894	Green Published			2022-02-06	
J	Teixeira, TL; Peluso, L; Banco, P; Njimi, H; Abi-Khalil, L; Pillajo, MC; Schuind, S; Creteur, J; Bouzat, P; Taccone, FS				Teixeira, Thomas Luz; Peluso, Lorenzo; Banco, Pierluigi; Njimi, Hassane; Abi-Khalil, Layal; Pillajo, Melanie Chanchay; Schuind, Sophie; Creteur, Jacques; Bouzat, Pierre; Taccone, Fabio Silvio			Early Pupillometry Assessment in Traumatic Brain Injury Patients: A Retrospective Study	BRAIN SCIENCES			English	Article						pupillometry; traumatic brain injury; outcome; prediction	GLASGOW COMA SCALE; AUTOMATED PUPILLOMETRY; INTRACRANIAL-PRESSURE; RELIABILITY; MANAGEMENT; SCORE	Background: The aim of this study was to evaluate whether the early assessment of neurological pupil index (NPi) values derived from automated pupillometry could predict neurological outcome after traumatic brain injury (TBI). Methods: Retrospective observational study including adult (>18 years) TBI patients admitted from January 2018 to December 2020, with available NPi on admission. Abnormal NPi was considered if <3. Unfavorable neurological outcome (UO) at hospital discharge was considered for a Glasgow Outcome Scale of 1-3. Results: 100 patients were included over the study period (median age 48 (34-69) years and median GCS on admission 11 (6-15)); 49 (49%) patients had UO. On admission, 20 (20%) patients had an abnormal NPi (NPi < 3); median worst (i.e., from both eyes) NPi was 4.2 (3.2-4.5). Median worst and mean NPi on admission were significantly lower in the UO group than others (3.9 (1.7-4.4) vs. 4.4 (3.7-4.6); p = 0.005-4.0 (2.6-4.5) vs. 4.5 (3.9-4.7); p = 0.002, respectively). The ROC curve for the worst and mean NPi showed a moderate accuracy to predict UO (AUC 0.66 (0.56-0.77); p = 0.005 and 0.68 (0.57-0.78); p = 0.002). However, in a generalized linear model, the prognostic role of NPi on admission was limited. Conclusions: Low NPi on admission has limited prognostic value in TBI.	[Teixeira, Thomas Luz; Peluso, Lorenzo; Njimi, Hassane; Abi-Khalil, Layal; Pillajo, Melanie Chanchay; Creteur, Jacques; Taccone, Fabio Silvio] Univ Libre Bruxelles ULB, Dept Intens Care, Hop Erasme, B-1050 Brussels, Belgium; [Peluso, Lorenzo; Bouzat, Pierre] Univ Grenobles, Dept Anesthesiol & Intens Care, F-38400 Grenobles, France; [Schuind, Sophie] Univ Libre Bruxelles ULB, Dept Neurosurg, Hop Erasme, B-1070 Brussels, Belgium; [Bouzat, Pierre] Univ Grenoble Alpes, Grenoble Inst Neurosci, F-38700 Grenoble, France		Taccone, FS (corresponding author), Univ Libre Bruxelles ULB, Dept Intens Care, Hop Erasme, B-1050 Brussels, Belgium.	thomas.luz.teixeira@ulb.be; lorenzo.peluso@erasme.ulb.ac.be; pbanco@chu-grenoble.fr; hassane.njimi@ulb.be; layal.abi-khalil@ulb.be; melanie.chanchay.pillajo@ulb.be; sophie.schuind@erasme.ulb.ac.be; jcreteur@ulb.ac.be; PBouzat@chu-grenoble.fr; fabio.taccone@ulb.be		Peluso, Lorenzo/0000-0001-6885-5353			Bower MM, 2021, J INTENSIVE CARE MED, V36, P383, DOI 10.1177/0885066619881124; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chen JW, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-548; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; El Ahmadieh TY, 2021, WORLD NEUROSURG, V145, pE163, DOI 10.1016/j.wneu.2020.09.152; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Jahns FP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2436-3; JENNETT B, 1975, LANCET, V1, P480; Larson MD, 2015, ANESTH ANALG, V120, P1242, DOI 10.1213/ANE.0000000000000314; Litvan I, 2000, NEUROLOGY, V54, P530, DOI 10.1212/WNL.54.2.530; Mader MMD, 2021, NEUROSURG REV, V44, P2697, DOI 10.1007/s10143-020-01456-3; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Miroz JP, 2020, CHEST, V157, P1167, DOI 10.1016/j.chest.2019.11.037; Morelli P, 2019, MINERVA ANESTESIOL, V85, P995, DOI 10.23736/S0375-9393.19.13437-2; Oddo M, 2018, INTENS CARE MED, V44, P2102, DOI 10.1007/s00134-018-5448-6; Park JG, 2015, J KOREAN NEUROSURG S, V58, P363, DOI 10.3340/jkns.2015.58.4.363; Phillips SS, 2019, NEUROCRIT CARE, V31, P142, DOI 10.1007/s12028-018-0645-2; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Sharshar T, 2014, INTENS CARE MED, V40, P484, DOI 10.1007/s00134-014-3214-y; Singer KE, 2021, J SURG RES, V262, P27, DOI 10.1016/j.jss.2020.12.042; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2013, CRIT CARE, V17, DOI 10.1186/cc11513; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Zuercher P, 2016, J NEUROTRAUM, V33, P1768, DOI 10.1089/neu.2015.4266	28	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	DEC	2021	11	12							1657	10.3390/brainsci11121657			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH3NQ	WOS:000743077500001	34942959	Green Published, Green Submitted			2022-02-06	
J	Terai, H; Gwedela, MNV; Kawakami, K; Aizawa, H				Terai, Haruhi; Gwedela, Mayeso Naomi Victoria; Kawakami, Koichi; Aizawa, Hidenori			Electrophysiological and pharmacological characterization of spreading depolarization in the adult zebrafish tectum	JOURNAL OF NEUROPHYSIOLOGY			English	Article						glutamate; migraine; spreading depolarization; stroke; zebrafish	C-FOS; DEPRESSION; BRAIN; EXPRESSION; MUTATIONS; MIGRAINE; SYSTEM	Spreading depolarization (SD) is a slowly propagating wave of neuronal and glial depolarization. A growing number of studies show that SD and SD-like phenomena play a role in neurological disorders such as migraine, stroke, and traumatic brain injury. Despite the clinical importance of SD, its underlying molecular and cellular mechanisms remain elusive, possibly because of insufficient animal model allowing genetic manipulation. Such a model would also allow high-throughput screening for SD-suppressing drug development. To address this, we developed a novel experimental system to study SD using zebrafish. Electrophysiological recordings in the immobilized adult zebrafish revealed that increasing extracellular potassium concentration elicited SD with a large and long-lasting negative shift of direct current (DC) potential in the optic tectum. It also reduced the oscillatory activity in the extracellular field potential and increased the expression of the immediate early gene c-fos. Pharmacological blocking of the N-methyl-D-aspartate (NMDA) glutamate receptor attenuated the propagation of SD, suggesting that glutamatergic neurotransmission mediated tectal SD in zebrafish. Our analyses revealed that the zebrafish tectum and rodent cortex had similar SD kinetics. The current study provides electrophysiological and pharmacological evidence that zebrafish SD and mammal SD are comparable. This zebrafish SD model is suitable for genetic manipulation and cost-effective high-throughput screening. It could pave the way to novel diagnostic and therapeutic methods applicable to SD-associated neurological disorders. NEW & NOTEWORTHY Previous studies have implicated spreading depolarization (SD) in stroke and migraine. Here, we demonstrate SD, for the first time, in the adult zebrafish tectum showing waveform kinetics, c-fos expression, and attenuation by Nmethyl-D-aspartate glutamate receptor blocker as observed in the rodent cortex. Since the zebrafish is an animal model amenable to genetic manipulation and chemical screening, this result could pave the way to novel diagnostic and therapeutic methods applicable to SD-associated neurological disorders.	[Terai, Haruhi; Gwedela, Mayeso Naomi Victoria; Aizawa, Hidenori] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurobiol, Hiroshima, Japan; [Kawakami, Koichi] SOKENDAI Grad Univ Adv Studies, Natl Inst Genet & Dept Genet, Lab Mol & Dev Biol, Shizuoka, Japan		Aizawa, H (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurobiol, Hiroshima, Japan.	haizawa@hiroshima-u.ac.jp		Aizawa, Hidenori/0000-0002-2896-1298	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP19H05723, 21H02581, 21H05628, 21H00203, 21H02463]	This research was supported by KAKENHI Grant Nos. JP19H05723, 21H02581, 21H05628, and 21H00203 (to H.A.) and 21H02463 (to K.K.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) .	Aizawa H, 2020, GLIA, V68, P2631, DOI 10.1002/glia.23874; Attili S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103751; Ayata C, 2000, NEUROSCIENCE, V95, P639; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P1172, DOI 10.1097/01.WCB.0000137057.92786.F3; Ayata C, 2013, CEPHALALGIA, V33, P604, DOI 10.1177/0333102412470216; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Bhogal R., 2010, THESIS WINDSOR U WIN, P8212; BOONE K, 1994, PHYSIOL MEAS, V15, pA189, DOI 10.1088/0967-3334/15/2A/024; Bradley DP, 2002, J PHYSIOL-LONDON, V544, P39, DOI 10.1113/jphysiol.2002.025353; Demarest ST, 2018, NAT REV NEUROL, V14, P736, DOI 10.1038/s41582-018-0099-3; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Ezquer M, 2003, EXP NEUROL, V183, P523, DOI 10.1016/S0014-4886(03)00247-4; Folgueira M, 2020, FRONT NEURAL CIRCUIT, V14, DOI 10.3389/fncir.2020.00008; Gebhardt C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13484-9; Sosthenes MCK, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01020; Kudo C, 2013, NEUROPHARMACOLOGY, V67, P32, DOI 10.1016/j.neuropharm.2012.10.018; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Maeyama K, 2000, ZOOL SCI, V17, P959, DOI 10.2108/zsj.17.959; MARRANNES R, 1988, BRAIN RES, V457, P226, DOI 10.1016/0006-8993(88)90690-7; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Mullard A, 2019, NAT REV DRUG DISCOV, V18, P811, DOI 10.1038/d41573-019-00165-x; Muto A, 2013, CURR BIOL, V23, P307, DOI 10.1016/j.cub.2012.12.040; Nordgreen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092116; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; PAPE LG, 1972, BRAIN RES, V38, P71, DOI 10.1016/0006-8993(72)90590-2; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Pietrobon D, 2014, NAT REV NEUROSCI, V15, P379, DOI 10.1038/nrn3770; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sieger D, 2012, DEV CELL, V22, P1138, DOI 10.1016/j.devcel.2012.04.012; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Spong KE, 2016, J EXP BIOL, V219, P626, DOI 10.1242/jeb.132456	31	0	0	1	1	AMER PHYSIOLOGICAL SOC	Rockville	6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	DEC	2021	126	6					1934	1942		10.1152/jn.00343.2021			9	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	XL9UI	WOS:000728483900007	34731067				2022-02-06	
J	Tomczyk, CP; Anderson, M; Petit, KM; Savage, JL; Covassin, T				Tomczyk, Christopher P.; Anderson, Morgan; Petit, Kyle M.; Savage, Jennifer L.; Covassin, Tracey			Vestibular/Ocular Motor Screening Assessment Outcomes After Sport-Related Concussion in High School and Collegiate Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						multifaceted assessment; total scores; change scores; age	AGE; RECOVERY; SYMPTOMS; YOUTH; VOMS; RELIABILITY; PERFORMANCE; MATURATION; BALANCE; TIME	Context: Vestibular and ocular motor assessment is an emerging clinical assessment for patients with sport-related concussion (SRC). The increased use of these assessments by clinicians calls for the examination of outcomes that may affect clinical practice. Objective: To compare vestibular and ocular motor impairments in high school and collegiate athletes within 72 hours of SRC and examine the distribution of impairments in these populations based on pre-established clinical cutoff scores. Design: Cross-sectional study. Setting: High school and collegiate athletics. Patients or Other Participants: Data were collected from 110 athletes (high school: n = 47, age = 15.40 +/- 1.35 years; college: n = 63, age = 19.46 +/- 1.28 years) within 72 hours of sustaining an SRC. Main Outcome Measure(s): Total and change scores were calculated for the Vestibular/Ocular Motor Screening (VOMS) tool, along with average near point of convergence (NPC) distance. Separate Mann-Whitney U tests were used to compare group differences, and chi(2) analyses were used to examine the proportion of athletes with scores greater than clinical cutoff scores for all VOMS outputs. The alpha level was set a priori at .05. Results: No differences were found between high school and collegiate athletes for VOMS total and change scores and NPC distance. A larger proportion of the sample had scores greater than the cutoff for all total scores (P < .001) and change scores in horizontal vestibulo-ocular reflex (59.01%; P < .001), vertical vestibulo-ocular reflex (60.91%; P < .001), and visual motion sensitivity (60.91%; P < .001). However, a larger proportion demonstrated smooth pursuit change scores (85.45%; P < .001) and NPC distances (73.64%; P = .01) that were less than the cutoff scores. Conclusions: During the acute phase of SRC, high school and collegiate athletes presented with similar vestibular and ocular motor impairments as measured using the VOMS, but vestibular tasks appeared to cause greater symptom provocation. Lastly, VOMS change scores may offer more clinical utility compared with total scores in assessing specific impairments after SRC.	[Tomczyk, Christopher P.; Anderson, Morgan; Covassin, Tracey] Michigan State Univ, Dept Kinesiol, 308 W Circle Dr,Room 134, E Lansing, MI 48824 USA; [Petit, Kyle M.] Univ Mary, Sch Hlth Sci, Bismarck, ND USA; [Savage, Jennifer L.] Jacksonville State Univ, Dept Kinesiol, Jacksonville, AL 36265 USA		Tomczyk, CP (corresponding author), Michigan State Univ, Dept Kinesiol, 308 W Circle Dr,Room 134, E Lansing, MI 48824 USA.	tomczykc@msu.edu					Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Broglio SP, 2019, SPORTS MED, V49, P1977, DOI 10.1007/s40279-019-01155-0; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; D'Amico NR, 2021, CLIN J SPORT MED, V31, pE240, DOI 10.1097/JSM.0000000000000776; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Furman Joseph M, 2012, Continuum (Minneap Minn), V18, P1102, DOI 10.1212/01.CON.0000421621.18407.96; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Pritcher MR, 2008, OTOL NEUROTOL, V29, P982, DOI 10.1097/MAO.0b013e31818457fb; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Womble MN, 2021, CLIN J SPORT MED, V31, pE193, DOI 10.1097/JSM.0000000000000761	28	0	0	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	DEC	2021	56	12					1285	1291		10.4085/1062-6050-0588.20			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	XR2GR	WOS:000732055000004	34911074	gold			2022-02-06	
J	Tracy, BM; Silverman, ME; Cordero-Caballero, C; Durr, EA; Gelbard, RB				Tracy, Brett M.; Silverman, Michael E.; Cordero-Caballero, Carlos; Durr, Emily A.; Gelbard, Rondi B.			Dual Neurostimulant Therapy May Optimize Acute Neurorecovery for Severe Traumatic Brain Injuries	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	16th Annual Academic Surgical Congress (ASC)	FEB 02-04, 2021	ELECTR NETWORK			Neurostimulants; Methylphenidate; Amantadine; Traumatic brain injury; Consciousness; Neurorecovery	DIFFUSE AXONAL INJURY; DOUBLE-BLIND; ATTENTION DEFICITS; METHYLPHENIDATE; AMANTADINE; REHABILITATION; EFFICACY; MODERATE	Background: Neurostimulants (NS) can be used to treat patients with a traumatic brain injury (TBI) with altered levels of consciousness. We sought to determine if amantadine alone (monotherapy) versus amantadine + methylphenidate (dual therapy) would correlate with better neurorecovery (NR) among acutely hospitalized patients with a severe TBI. Methods: We performed a retrospective review of adult patients admitted to our level I trauma center from 2016-2019 with a severe TBI. NR was calculated by dividing the difference between admission and discharge Glasgow Coma Scale (GCS) scores by 12. Resulting ratios were used to divide the cohort into two groups: excellent NR (1) and non-excellent NR (<1). Results: A total of 76 patients comprised the cohort; 19.7% (n = 15) had excellent NR. The excellent NR group had a larger proportion of patients receiving dual therapy compared to the non-excellent group (86.7% versus 59%, P = 0.04). In monotherapy (n = 27), amantadine was initiated 13 (8-20) d following injury and treatment lasted 7 (2-16) d. In dual therapy (n = 49), amantadine was initiated 12 (6-19) d following injury and continued for 9 (4-25.5) d. Methylphenidate was initiated 15 (7-20.5) d following injury and continued for 5 (2-13.5) d. After adjusting for confounders, dual versus monotherapy predicted excellent NR (OR 5.4, 95% CI 1.2 - 38.9, P = 0.03). Conclusions: During the acute hospitalization for a severe TBI, dual NS therapy compared to monotherapy is associated with an increased likelihood of excellent NR. Larger prospective trials are warranted to validate these findings. (C) 2021 Elsevier Inc. All rights reserved.	[Tracy, Brett M.; Cordero-Caballero, Carlos] Ohio State Univ, Wexner Med Ctr, Div Trauma, Crit Care,Burn, 395 W 12th Ave, Columbus, OH 43210 USA; [Silverman, Michael E.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Silverman, Michael E.; Durr, Emily A.] Grady Mem Hosp, Div Acute Care Surg, Atlanta, GA USA; [Gelbard, Rondi B.] Univ Alabama Birmingham, Div Acute Care Surg, Birmingham, AL USA		Tracy, BM (corresponding author), Ohio State Univ, Wexner Med Ctr, Div Trauma, Crit Care,Burn, 395 W 12th Ave, Columbus, OH 43210 USA.	brett.tracy@osumc.edu					Al-Sarraj S, 2016, DIAGNOSTIC HISTOPATH, V22, P318, DOI [10.1016/j.mpdhp.2016.08.005, DOI 10.1016/J.MPDHP.2016.08.005]; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Davanzo JR, 2018, CONTROVERSIES SEVERE, P179; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Glorioso C, 2011, PROG NEUROBIOL, V93, P165, DOI 10.1016/j.pneurobio.2010.11.006; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Herrold Amy A, 2014, ScientificWorldJournal, V2014, P964578, DOI 10.1155/2014/964578; Husson I, 2004, NEUROSCIENCE, V125, P163, DOI 10.1016/j.neuroscience.2004.01.010; Kovacs EJ, 2005, EXP GERONTOL, V40, P549, DOI 10.1016/j.exger.2005.04.009; Kuczenski R, 2002, J NEUROSCI, V22, P7264; Li CMF, 2019, J TRAUMA ACUTE CARE, V86, P1033, DOI 10.1097/TA.0000000000002233; Mandrekar JN, 2010, J THORAC ONCOL, V5, P1315, DOI 10.1097/JTO.0b013e3181ec173d; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moein H, 2006, CLIN NEUROL NEUROSUR, V108, P539, DOI 10.1016/j.clineuro.2005.09.003; Morrison A, 2019, J NEUROTRAUM, V36, P293, DOI 10.1089/neu.2017.5575; Oommen JK, 2019, P & T, V44, P676; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Rabinowitz AR, 2020, J HEAD TRAUMA REHAB, V35, P76, DOI 10.1097/HTR.0000000000000537; Reynolds JC, 2013, RESUSCITATION, V84, P818, DOI 10.1016/j.resuscitation.2012.11.014; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Tramontana MG, 2014, BRAIN INJURY, V28, P1461, DOI 10.3109/02699052.2014.930179; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632	25	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2021	268						546	551		10.1016/j.jss.2021.07.037			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	WA4PM	WOS:000702868600020	34464892				2022-02-06	
J	Tse, R; Ioelu, L; Chen, M; McCarthy, S; Glenn, C; Kesha, K; Morrow, P; Stables, S				Tse, Rexson; Ioelu, Leilani; Chen, Matthew; McCarthy, Sinead; Glenn, Charley; Kesha, Kilak; Morrow, Paul; Stables, Simon			A 5-Year Retrospective Study on Infant Homicide Presenting as Cot Death Are We Missing Infant Homicides?	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						Postmortem; SIDS; SUDI; cot death; homicide; infant	CHILD-ABUSE; TRAUMA; TIME; BONE	Being found dead in cot or bed is the most common presentation encountered with infant deaths. These deaths are often associated with unsafe sleep environment. The postmortem examination in such cases is often negative, and along with family objections, cultural, and other factors, may lead to a coroner considering not authorizing a postmortem examination. However, not identifying a homicide is a potential risk if a postmortem examination is not performed. This 5-year retrospective study investigated the proportion of infant homicide death initially presenting as cot death. Of a total of 103 cases of infants initially presenting as being found dead in cot or bed, 3 (approximately 3%) were classified as homicides after postmortem examination. During the study period, a total of 9 infant homicides were reported, translating to 33% (3 of 9) of infant homicides presented as cot deaths. Postmortem radiology was a valuable adjunct, but was unable to recognize 2 of the homicide cases with traumatic head injuries (with subdural hemorrhage and brain injury only). We strongly advocate that all infant deaths presenting as cot death require a full postmortem examination.	[Tse, Rexson; Glenn, Charley; Kesha, Kilak; Morrow, Paul; Stables, Simon] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand; [Tse, Rexson; Ioelu, Leilani; Chen, Matthew; McCarthy, Sinead; Glenn, Charley; Kesha, Kilak; Morrow, Paul; Stables, Simon] Northern Forens Pathol Serv New Zealand, Auckland, New Zealand		Tse, R (corresponding author), Auckland City Hosp, Dept Forens Pathol, LabPLUS, Auckland 1148, New Zealand.	rexsont@adhb.govt.nz	Tse, Rexson/Y-1939-2019	Tse, Rexson/0000-0002-1388-9537			Ampanozi G, 2020, INT J LEGAL MED, V134, P321, DOI 10.1007/s00414-019-02140-y; [Anonymous], 2016, SUDDEN UNEXPECTED DE; Berger N, 2015, FORENSIC SCI MED PAT, V11, P40, DOI 10.1007/s12024-014-9642-8; Cattaneo C, 2006, FORENSIC SCI INT, V164, P131, DOI 10.1016/j.forsciint.2005.12.016; EMERY JL, 1985, ARCH DIS CHILD, V60, P505, DOI 10.1136/adc.60.6.505; EMERY JL, 1989, BRIT MED J, V299, P1240, DOI 10.1136/bmj.299.6710.1240; Femia G, 2021, FORENSIC SCI MED PAT, V17, P10, DOI 10.1007/s12024-020-00343-z; Garland J, 2021, AM J FOREN MED PATH, V42, P170, DOI 10.1097/PAF.0000000000000632; Goldstein RD, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2298; Green MA, 1999, BRIT MED J, V319, P697, DOI 10.1136/bmj.319.7211.697; Herath JC, 2021, FORENSIC SCI MED PAT, V17, P175, DOI 10.1007/s12024-020-00279-4; HILTON JMN, 1989, BRIT MED J, V299, P178, DOI 10.1136/bmj.299.6692.178-b; Karibe H, 2016, NEUROL MED-CHIR, V56, P264, DOI 10.2176/nmc.ra.2015-0308; Khokhlov VD, 2015, LEGAL MED-TOKYO, V17, P17, DOI 10.1016/j.legalmed.2014.09.005; Levene S, 2004, ARCH DIS CHILD, V89, P443, DOI 10.1136/adc.2003.036202; Limerick S, 1999, BRIT MED J, V319, P698; McCarthy S., 2019, PATHOLOGY, V51, pS116; MCCLAIN PW, 1993, PEDIATRICS, V91, P338; McGraw EP, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781517; Milroy Christopher M, 2017, Acad Forensic Pathol, V7, P163, DOI 10.23907/2017.018; NEWLANDS M, 1991, CHILD ABUSE NEGLECT, V15, P275, DOI 10.1016/0145-2134(91)90071-K; Norberti N, 2019, VIRCHOWS ARCH, V475, P139, DOI 10.1007/s00428-019-02562-4; O'Donnell C, 2008, CLIN RADIOL, V63, P1189, DOI 10.1016/j.crad.2008.05.008; Pinneri Kathryn, 2017, Acad Forensic Pathol, V7, P171, DOI 10.23907/2017.019; Pollack HA, 2006, PAEDIATR PERINAT EP, V20, P2, DOI 10.1111/j.1365-3016.2006.00693.x; TAYLOR EM, 1982, ARCH DIS CHILD, V57, P668, DOI 10.1136/adc.57.9.668; Tse R, 2021, FORENSIC SCI MED PAT, V17, P373, DOI 10.1007/s12024-020-00303-7; Tse R, 2018, AM J FOREN MED PATH, V39, P123, DOI 10.1097/PAF.0000000000000364; Vester MEM, 2020, INT J LEGAL MED, V134, P1457, DOI 10.1007/s00414-019-02219-6; WILLINGER M, 1991, Pediatric Pathology, V11, P677	30	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	DEC	2021	42	4					324	327		10.1097/PAF.0000000000000693			4	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	WZ6EA	WOS:000720056700006	34054016				2022-02-06	
J	Turcato, G; Zaboli, A; Pfeifer, N; Maccagnani, A; Tenci, A; Giudiceandrea, A; Zannoni, M; Ricci, G; Bonora, A; Brigo, F				Turcato, Gianni; Zaboli, Arian; Pfeifer, Norbert; Maccagnani, Antonio; Tenci, Andrea; Giudiceandrea, Alberto; Zannoni, Massimo; Ricci, Giorgio; Bonora, Antonio; Brigo, Francesco			Decision tree analysis to predict the risk of intracranial haemorrhage after mild traumatic brain injury in patients taking DOACs	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						DOACs; Mild traumatic brain injury; Direct oral anticoagulants; Oral anticoagulant terapy; Intracranial haemorrhage; Decision tree	HEAD-INJURY; ADULTS	Background: Although the preliminary evidence seems to confirm a lower incidence of post-traumatic bleeding in patients treated with direct oral anticoagulants (DOACs) compared to those on vitamin K antagonists (VKAs), the recommended management of mild traumatic brain injury (MTBI) in patients on DOACs is the same as those on the older VKAs, risking excessive use of CT in the emergency department (ED). Aim: To determine which easily identifiable clinical risk factors at the first medical evaluation in the ED may indicate an increased risk of post-traumatic intracranial haemorrhage (ICH) in patients on DOACs with MTBI. Methods: Patients on DOAC5 who were evaluated in the ED for an MTBI from 2016 to 2020 at four centres in Northern Italy were considered. A decision tree analysis using the chi-square automatic interaction detection (CHAID) method was conducted to assess the risk of post-traumatic ICH after an MTBI. Known pre- and post-traumatic clinical risk factors that are easily identifiable at the first medical evaluation in the ED were used as input predictor variables. Results: Among the 1196 patients on DOAC5 in this study, post-traumatic ICH was present in 65% (75/1196). Decision tree analysis using the CHAID method found post-traumatic TLOC, post-traumatic amnesia, major trauma dynamic, previous neurosurgery and evidence of trauma above the clavicles to be the strongest predictors associated with the presence of post-traumatic ICH in patients on DOAC5. The absence of a concussion seems to indicate subgroups at very low risk of requiring neurosurgery. Conclusions: The machine-based CHAID model identified distinct prognostic groups of patients with distinct outcomes based on clinical factors. Decision trees can be useful as guides for patient selection and risk stratification. (C) 2021 Published by Elsevier Inc.	[Turcato, Gianni; Zaboli, Arian; Pfeifer, Norbert; Giudiceandrea, Alberto] Hosp Merano SABES ASDAA, Emergency Dept, Merano Meran, Italy; [Maccagnani, Antonio; Bonora, Antonio] Policlin Univ Verona, Azienda Osped Univ Integrata, Dept Emergency Med, Verona, Italy; [Tenci, Andrea] Girolamo Fracastoro Hosp San Bonifacio, Azienda Osped Scaligera, Dept Emergency Med, Verona, Italy; [Zannoni, Massimo; Ricci, Giorgio] Hosp Civile Maggiore, Azienda Osped Univ Integrata, Dept Emergency Med, Verona, Italy; [Brigo, Francesco] Hosp Merano SABES ASDAA, Dept Neurol, Merano, Italy; [Turcato, Gianni] Franz Tappeiner Hosp, Azienda Sanit Alto Adige, Dept Emergency Med, Merano, Italy		Turcato, G (corresponding author), Hosp Merano, Emergency Dept, Via Rossini 5, I-39012 Merano, Italy.	gianni.turcato@yahoo.it		Zaboli, Arian/0000-0002-4204-8884			Acanfora D, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01048; ASSR, 2007, TRATT TRAUM CRAN SEV; Bonaca MP, 2020, NEW ENGL J MED, V382, P1994, DOI 10.1056/NEJMoa2000052; Chan YH, 2016, J AM COLL CARDIOL, V68, P1389, DOI 10.1016/j.jacc.2016.06.062; Chen A, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.017559; Cipriano A, 2021, INTERN EMERG MED, V16, P1061, DOI 10.1007/s11739-020-02576-w; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Foks KA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3527; Fuller G, 2020, EMERG MED J, V37, P666, DOI 10.1136/emermed-2019-209307; Fuller GW, 2019, ANN EMERG MED, V73, P66, DOI 10.1016/j.annemergmed.2018.07.020; Gavin O, 2021, J THROMB THROMBOLYS, V51, P475, DOI 10.1007/s11239-020-02194-5; National Institute for Health and Care Excellence, 2019, HEAD INJ ASS EARL MA; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Shirali GA, 2018, J PUBLIC HEALTH RES, V7, P74, DOI 10.4081/jphr.2018.1361; Song Yan-Yan, 2015, Shanghai Arch Psychiatry, V27, P130, DOI 10.11919/j.issn.1002-0829.215044; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Sussman ES, 2018, HAND CLINIC, V158, P21, DOI 10.1016/B978-0-444-63954-7.00003-3; Svensson S, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0673-8; Turcato G, 2021, AM J EMERG MED, V43, P180, DOI [10.1016/j.ajem.2020.02.046, DOI 10.1016/j.ajem.2020.02.046]; Turcato G, 2019, J EMERG MED, V57, P817, DOI 10.1016/j.jemermed.2019.09.007; Uccella L, 2016, WORLD NEUROSURG, V93, P100, DOI 10.1016/j.wneu.2016.05.061	22	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	DEC	2021	50						388	393		10.1016/j.ajem.2021.08.048			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	WE1SM	WOS:000705407400069	34478944				2022-02-06	
J	Ueno, D; Yasukazu, S; Takahashi, J; Miyamoto, S; Inoue, T				Ueno, Daisuke; Yasukazu, Shiino; Takahashi, Jiro; Miyamoto, Satomi; Inoue, Takahiro			A fatal case of traumatic brain injury with severe coagulopathy due to Rhabdophis tigrinus (yamakagashi) bites: a case report	INTERNATIONAL JOURNAL OF EMERGENCY MEDICINE			English	Article						Recombinant thrombomodulin; Disseminated with a fibrinolytic phenotype; Antivenom	HUMAN SOLUBLE THROMBOMODULIN	Background Yamakagashi venom is a prothrombin activator, leading to disseminated intravascular coagulation. We report a fatal case of severe coagulopathy from head trauma assumed to be caused by a yamakagashi bite. Case presentation An 80-year-old man fell and developed systemic tonic-clonic convulsions. Head computed tomography revealed brain contusion and acute subdural hematoma. Physical examination revealed two bite marks with persistent bleeding on the right lower leg. The patient stated that he had been bitten by some creature 3 days prior, but the bite was left untreated. Laboratory tests showed fibrinogen levels below the detection limit. Although eighteen units of fresh frozen plasma were administered for coagulopathy, fibrinogen levels did not improve. He died about 18 h after a head injury. Conclusion In this case of a yamakagashi bite with active bleeding due to trauma, early administration of yamakagashi antivenom should be considered to control coagulopathy.	[Ueno, Daisuke; Yasukazu, Shiino; Takahashi, Jiro; Miyamoto, Satomi; Inoue, Takahiro] Kawasaki Med Sch, Dept Acute Med, 577 Matsushima, Kurashiki, Okayama 7010192, Japan		Ueno, D (corresponding author), Kawasaki Med Sch, Dept Acute Med, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	daisuke0111@hotmail.co.jp					Asai Y, 2020, J PHARM HEALTH CARE, V6, DOI 10.1186/s40780-020-00183-7; Hifumi T, 2015, ACUTE MED SURG, V2, P123, DOI 10.1002/ams2.69; Hifumi T, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0081-8; Hifumi T, 2014, J INTENSIVE CARE, V2, DOI 10.1186/s40560-014-0044-5; Komori Koji, 2006, Journal of Toxicological Sciences, V31, P157, DOI 10.2131/jts.31.157; Morokuma K, 2011, JPN J INFECT DIS, V64, P397; Ogawa H., 1986, J JPN SURG ASS, V47, P250; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; Yamakawa K, 2015, J THROMB HAEMOST, V13, P508, DOI 10.1111/jth.12841	9	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1865-1372	1865-1380		INT J EMERG MED	Int. J. Emergency Medicine	DEC	2021	14	1							77	10.1186/s12245-021-00402-4			4	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	XS5JU	WOS:000732945900004	34930106	gold, Green Submitted			2022-02-06	
J	Um, JH; Jo, DI; Kim, SH				Um, Jung H.; Jo, Dong, I; Kim, Soon H.			p Traumi correlati al golf: uno studio di 5 anni del pronto soccorso di un singolo ospedale regionale	MEDICINA DELLO SPORT			English	Article						Golf; Wounds and injuries; Emergency service; hospital; Lacerations; Fractures; bone	INJURIES	BACKGROUND: Visits to the Emergency Department (ED) due to golf-related trauma have recently increased in Korea; however, no studies in Korea have investigated this. Moreover, studies on golf-related trauma are limited internationally as well. Thus, this study aimed to determine the characteristics of golf-related trauma in Korea to contribute to a safer golf culture. METHODS: We collated baseline data concerning the cause, location, and degree of injury in 56 patients who visited our ED with golf-related trauma injuries between January 2015 and December 2019 and compared accident-related medical expenses. RESULTS: The most common injuries involved being hit with a golf ball, golf cart, or golf club. The head was the most frequently injured area, with concussion being the most common symptom (17%, N.=9), followed by blurred vision and hemi-facial paresthesia. Lacerations and fractures comprised 21% (N.=12) and 7% (N.=6) of all injuries, respectively. The average medical expenditure was $ 260.13. CONCLUSIONS: Golfers need to maintain a sufficient safety distance and tee-off interval, and the golf cart should be safely driven to help prevent golf-related trauma.	[Um, Jung H.; Jo, Dong, I; Kim, Soon H.] Konkuk Univ, Konkuk Univ Sch Med, Chungju Hosp, Dept Plast & Reconstruct Surg, 82 Gugwon Daero, Chungju 27376, South Korea		Kim, SH (corresponding author), Konkuk Univ, Konkuk Univ Sch Med, Chungju Hosp, Dept Plast & Reconstruct Surg, 82 Gugwon Daero, Chungju 27376, South Korea.	plastics7@kku.ac.kr					[Anonymous], 2019, KOREA GOLF J; [Anonymous], 2017, 2017 KOREAN GOLF IND; [Anonymous], 2018, GOLF MONTHLY; [Anonymous], 2016, 10 WORST WAYS GOLF C; Bruttini F, 2019, MED SPORT, V72, P474, DOI 10.23736/S0025-7826.19.03565-8; Government of Korea, 2020, CURR STAT GOLF COURS; Han YH, 2018, JOONG ANG; Jayasundera T, 2003, CLIN EXP OPHTHALMOL, V31, P110, DOI 10.1046/j.1442-9071.2003.00615.x; Jung HK, 2019, MAEIL BUSINESS NEWSP; Jung JS, 2020, ARCH PLAST SURG-APS, V47, P223, DOI 10.5999/aps.2020.00430; Lyman Stephen, 2005, Med Sport Sci, V49, P9, DOI 10.1159/000085340; Park SJ, 2014, EYE, V28, P312, DOI 10.1038/eye.2013.283; Rahimi SY, 2005, J NEUROSURG, V102, P163, DOI 10.3171/jns.2005.102.2.0163; Shanley E, 2011, J ATHL TRAINING, V46, P648; Simpson B, 2019, BRAIN INJURY, V33, P1476, DOI 10.1080/02699052.2019.1642516; Sweetman T., 2020, ROUGH TIMES AHEAD GR; The United States Golf Association, 2020, EQ RUL 2020 V2; Turvey TA, 2012, ORAL MAXIL SURG CLIN, V24, P525, DOI 10.1016/j.coms.2012.08.003; Walsh BA, 2017, AM J EMERG MED, V35, P1666, DOI 10.1016/j.ajem.2017.05.035; Weitgasser U, 2004, J TRAUMA, V56, P648, DOI 10.1097/01.TA.0000062970.91139.05	20	0	0	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0025-7826	1827-1863		MED SPORT	Med. Sport	DEC	2021	74	4					682	693		10.23736/S0025-7826.21.03919-3			12	Medicine, General & Internal; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Sport Sciences	YN1SR	WOS:000747045600010					2022-02-06	
J	Underwood, L; Kiffer, T; Sran, H; Jay, K; Villien, A; Kabaliuk, N; Jermy, M				Underwood, L.; Kiffer, T.; Sran, H.; Jay, K.; Villien, A.; Kabaliuk, N.; Jermy, M.			Simultaneous assessment of thermal comfort and aerodynamic drag of cycling helmets as a function of ventilation hole configuration	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Cycling aerodynamics; helmet design; thermal comfort; head angle; ventilation holes	QUANTIFICATION; EFFICIENCY	Although the main aim of cycling helmets is to protect cyclists from injury, the ideal cycling helmet minimizes aerodynamic drag and also allows rapid heat loss from the head to prevent overheating. This study takes the methods developed by Underwood et al., in which an aero helmet with reconfigurable ventilation holes was mounted on a heated mannequin head in a wind tunnel at 16.7 m/s (60 km/h) at a single angle and applies them to a range of angles representative of realistic riding positions. Thermal measurements were area weighted to provide a heat map of temperature variations over the head at different angles. Four helmet hole configurations were chosen for this study: no holes open, all holes open, front holes open and middle holes open. The results showed that the head angle had a stronger effect on drag than hole configuration. As expected, having all holes open had the greatest heat loss at any angle, but the lowest drag was found when the middle holes were open at head angles of 0 degrees and 20 degrees (at 0 degrees the neck is vertical) and all holes closed at head angles of 40 degrees and 60 degrees. The results indicate that a good venting geometry, combined with an efficient aerodynamic shape could provide an optimized helmet.	[Underwood, L.; Sran, H.] Ara Inst Canterbury, Dept Engn, Christchurch, New Zealand; [Kiffer, T.] ISAE ENSMA, Chasseneuil, France; [Jay, K.; Villien, A.] Ecole Air, Salon De Provence, France; [Kabaliuk, N.; Jermy, M.] Univ Canterbury, Dept Mech Engn, Christchurch 8140, New Zealand		Jermy, M (corresponding author), Univ Canterbury, Dept Mech Engn, Christchurch 8140, New Zealand.	mark.jermy@canterbury.ac.nz					Alam F., 2005, P ICME ICME05 TH 32, P28; Alam F, 2010, PROCEDIA ENGINEER, V2, P2413, DOI 10.1016/j.proeng.2010.04.008; Beaumont F, 2018, J BIOMECH, V67, P1, DOI 10.1016/j.jbiomech.2017.10.042; Bruhwiler PA, 2003, MEAS SCI TECHNOL, V14, P217, DOI 10.1088/0957-0233/14/2/309; Cooper KR, 1999, WIND ENGINEERING INTO THE 21ST CENTURY, VOLS 1-3, P1627; De Bruyne G, 2012, INT J IND ERGONOM, V42, P278, DOI 10.1016/j.ergon.2012.02.003; FANGER PO, 1973, BRIT J IND MED, V30, P313; Fitzgerald S., 2018, P INT SPORT ENG ASS, V2, P272, DOI [10.3390/proceedings2060272, DOI 10.3390/PROCEEDINGS2060272]; Martinez N, 2016, INT J IND ERGONOM, V53, P157, DOI 10.1016/j.ergon.2015.11.012; Pang TY, 2013, INT J IND ERGONOM, V43, P161, DOI 10.1016/j.ergon.2012.12.003; Underwood L, 2015, SPORTS ENG, V18, P241, DOI 10.1007/s12283-015-0181-7; Underwood L, 2018, P I MECH ENG P-J SPO, V232, P15, DOI 10.1177/1754337117707876; Van Brecht A, 2008, APPL ERGON, V39, P332, DOI 10.1016/j.apergo.2007.08.003	13	0	0	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	DEC	2021	235	4			SI		277	285		10.1177/1754337119852538			9	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Sport Sciences	WD2BM	WOS:000704752800001					2022-02-06	
J	Uzdavines, A; Gonzalez, RD; Price, A; Broadway, D; Smith, TL; Rodrigues, M; Woods, K; Zimmerman, MB; Jorge, R; Dindo, L				Uzdavines, Alex; Gonzalez, Raquel D.; Price, Alexandra; Broadway, Dakota; Smith, Tracey L.; Rodrigues, Merlyn; Woods, Ken; Zimmerman, M. Bridget; Jorge, Ricardo; Dindo, Lilian			Acceptance and Commitment Training for Veterans with polytrauma: A randomized controlled trial protocol	CONTEMPORARY CLINICAL TRIALS			English	Article						Acceptance commitment therapy; Polytrauma; Mild traumatic brain injury; Veterans; Randomized controlled trial; Brief intervention	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH-CARE; CHRONIC PAIN; PSYCHOTHERAPY UTILIZATION; COMMUNITY REINTEGRATION; 3RD WAVE; AFGHANISTAN; IRAQ; BARRIERS	Background: Mild traumatic brain injury (mTBI) is a signature wound of Veterans of operations in Iraq and Afghanistan (i.e., OIF/OEF/OND). Most Veterans with mTBI also experience stress-based psychopathology (e.g., depression, posttraumatic stress disorder) and chronic pain. This combination - referred to as polytrauma - results in detrimental long-term effects on social, occupational, and community reintegration. This study will compare the efficacy of a one-day Acceptance and Commitment Training plus Education, Resources, and Support (ACT+ERS) workshop to a one-day active control group (ERS) on symptoms of distress and social, occupational, and community reintegration. We will also examine mediators and moderators of treatment response. Methods: This is an ongoing randomized clinical trial. 212 OIF/OEF/OND Veterans with polytrauma are being recruited. Veterans are randomly assigned to a one-day ACT+ERS or a one-day ERS workshop with two individualized booster sessions approximately two-and four-weeks post-workshop. Veterans complete assessments prior to the workshop and again at six weeks, three months, and six months post-workshop. Of note, workshops were converted to a virtual format due to the COVID-19 pandemic. Results: The primary outcomes are symptoms of distress and reintegration; secondary outcomes are post-traumatic stress disorder symptoms and pain interference. Secondary analyses will assess whether changes in avoidance at three months mediate changes in distress and reintegration at six months. Conclusion: Facilitating the psychological adjustment and reintegration of Veterans with polytrauma is critical. The results of this study will provide important information about the impact of a brief intervention for Veterans with these concerns.	[Uzdavines, Alex; Gonzalez, Raquel D.; Broadway, Dakota; Woods, Ken] Michael E DeBakey VA Med Ctr, South Cent Mental Illness Res Educ & Clin Ctr, Houston, TX USA; [Uzdavines, Alex; Smith, Tracey L.; Jorge, Ricardo] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Price, Alexandra; Rodrigues, Merlyn; Dindo, Lilian] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Price, Alexandra; Rodrigues, Merlyn; Jorge, Ricardo; Dindo, Lilian] Michael E DeBakey VA Med Ctr, Houston VA HSR & Ctr Innovat Qual Effectiveness &, Houston, TX USA; [Zimmerman, M. Bridget] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA		Dindo, L (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	lilian.dindo@bcm.edu			Veterans Affairs Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [1 I01 RX003117-01A1]; Houston VA HSR&D Center for Innovations in Quality, Effectiveness and Safety [CIN13-413]	This work was made possible by grant number 1 I01 RX003117-01A1 from the Veterans Affairs Rehabilitation Research and Development Service awarded to Lilian N. Dindo and was partially supported by the use and resources of the Houston VA HSR&D Center for Innovations in Quality, Effectiveness and Safety (CIN13-413) . The funding agency did not play a role in study design; in the collection, analysis, and inter-pretation of data; in the writing of the report. The opinions expressed reflect those of the authors and not necessarily those of the Department of Veterans Affairs, the US government, or Baylor College of Medicine.	Arcury TA, 2005, HEALTH SERV RES, V40, P135, DOI 10.1111/j.1475-6773.2005.00346.x; Blais RK, 2013, J TRAUMA STRESS, V26, P77, DOI 10.1002/jts.21772; Blevins D, 2011, PROF PSYCHOL-RES PR, V42, P32, DOI 10.1037/a0022321; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Bricker JB, 2021, TRANSL BEHAV MED, V11, P1527, DOI 10.1093/tbm/ibab012; CARLSON CR, 1993, J CONSULT CLIN PSYCH, V61, P1059, DOI 10.1037/0022-006X.61.6.1059; Chapoutot M, 2021, J SLEEP RES, V30, DOI 10.1111/jsr.13199; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Coleman BC, 2020, TRANSL BEHAV MED, V10, P827, DOI 10.1093/tbm/ibaa074; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Department of Veterans Affairs, 2012, AN VA HLTH CAR UT OP; Dimidjian S, 2016, BEHAV THER, V47, P886, DOI 10.1016/j.beth.2016.07.002; Dindo L., 2020, INNOVATIONS ACCEPTAN, P296; Dindo L, 2020, CONTEMP CLIN TRIALS, V90, DOI 10.1016/j.cct.2020.105954; Dindo L, 2017, NEUROTHERAPEUTICS, V14, P546, DOI 10.1007/s13311-017-0521-3; Dindo L, 2015, CURR OPIN PSYCHOL, V2, P38, DOI 10.1016/j.copsyc.2015.01.018; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Elbogen EB, 2013, PSYCHIAT SERV, V64, P134, DOI 10.1176/appi.ps.004792011; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Flaxman PE, 2010, BEHAV RES THER, V48, P816, DOI 10.1016/j.brat.2010.05.004; Garcia HA, 2014, MIL MED, V179, P273, DOI 10.7205/MILMED-D-13-00076; Gentry MT, 2019, J TELEMED TELECARE, V25, P327, DOI 10.1177/1357633X18775855; Goetter EM, 2015, J TRAUMA STRESS, V28, P401, DOI 10.1002/jts.22038; Gorman LA, 2011, PSYCHIAT SERV, V62, P28, DOI 10.1176/ps.62.1.pss6201_0028; Graham CD, 2016, CLIN PSYCHOL REV, V46, P46, DOI 10.1016/j.cpr.2016.04.009; Hall BJ, 2019, EUR J PSYCHOTRAUMATO, V10, DOI 10.1080/20008198.2019.1571378; Hayes SC, 2013, BEHAV THER, V44, P180, DOI 10.1016/j.beth.2009.08.002; Herbert MS, 2017, J PAIN, V18, P200, DOI 10.1016/j.jpain.2016.10.014; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jaycox, 2008, INVISIBLE WOUNDS WAR; Jerath R, 2006, MED HYPOTHESES, V67, P566, DOI 10.1016/j.mehy.2006.02.042; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Mittal D, 2013, PSYCHIATR REHABIL J, V36, P86, DOI 10.1037/h0094976; Moos R. H., 1993, HDB STRESS THEORETIC; Mott JM, 2015, J RURAL HEALTH, V31, P235, DOI 10.1111/jrh.12099; Mott JM, 2014, PSYCHIAT SERV, V65, P106, DOI 10.1176/appi.ps.201300056; Ost LG, 2008, BEHAV RES THER, V46, P296, DOI 10.1016/j.brat.2007.12.005; Pain Management Collaboratory Coordinating Center, PHEN OUTC WORKGR PAI; PEKARIK G, 1986, PSYCHOTHER, V23, P532, DOI 10.1037/h0085653; Pettersson A, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-017-0674-5; Phillips KM, 2016, J REHABIL RES DEV, V53, P413, DOI 10.1682/JRRD.2014.05.0126; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Polomano RC, 2016, PAIN MED, V17, P1505, DOI 10.1093/pm/pnw105; Powers MB, 2009, PSYCHOTHER PSYCHOSOM, V78, P73, DOI 10.1159/000190790; Preacher KJ, 2010, PSYCHOL METHODS, V15, P209, DOI 10.1037/a0020141; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Reay RE, 2020, AUSTRALAS PSYCHIATRY, V28, P514, DOI 10.1177/1039856220943032; Ruiz F. J., 2012, INT J PSYCHOL, DOI DOI 10.1016/J.BETH.2011.07.004; Ruiz FJ., 2010, INT J PSYCHOL PSYCHO, V10, P125, DOI DOI 10.1080/028457199439937; Ruiz MA, 2011, J AFFECT DISORDERS, V128, P277, DOI 10.1016/j.jad.2010.07.010; Sayer NA, 2011, J TRAUMA STRESS, V24, P660, DOI 10.1002/jts.20706; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Shin C, 2019, PSYCHIAT INVEST, V16, P300, DOI 10.30773/pi.2019.02.01; Spelman JF, 2012, J GEN INTERN MED, V27, P1200, DOI 10.1007/s11606-012-2061-1; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stecker T, 2013, PSYCHIAT SERV, V64, P280, DOI 10.1176/appi.ps.001372012; Tanielian T, 2016, PSYCHIAT SERV, V67, P718, DOI 10.1176/appi.ps.201500237; True G, 2015, QUAL HEALTH RES, V25, P1443, DOI 10.1177/1049732314562894; US Department of Defense, 2010, VA DOD CLIN PRACT GU, P1; Walser RD, 2015, BEHAV RES THER, V74, P25, DOI 10.1016/j.brat.2015.08.012; Walser RD, 2013, BEHAV RES THER, V51, P555, DOI 10.1016/j.brat.2013.05.009; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Whiting D, 2020, NEUROPSYCHOL REHABIL, V30, P1348, DOI 10.1080/09602011.2019.1583582; Wilson K.G., 2014, ACT MATRIX NEW APPRO; Wilson KG, 2010, PSYCHOL REC, V60, P249, DOI 10.1007/BF03395706; Zinzow HM, 2012, CLIN PSYCHOL REV, V32, P741, DOI 10.1016/j.cpr.2012.09.002	74	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	DEC	2021	111								106601	10.1016/j.cct.2021.106601			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	WX0EX	WOS:000718279200011	34687944				2022-02-06	
J	van der Veen, SM; Thomas, JS				van der Veen, Susanne M.; Thomas, James S.			A Pilot Study Quantifying Center of Mass Trajectory during Dynamic Balance Tasks Using an HTC Vive Tracker Fixed to the Pelvis	SENSORS			English	Article						center of mass; balance; berg balance scale; virtual reality	ASSESSING FALL RISK; WEARABLE DEVICE; SCALE; VALIDATION; STROKE; RELIABILITY; COMMUNITY; REHABILITATION; ASSOCIATION; EFFICACY	Fall rates are increasing among the aging population and even higher falls rates have been reported in populations with neurological impairments. The Berg Balance Scale is often used to assess balance in older adults and has been validated for use in people with stroke, traumatic brain injury, and Parkinson's disease. While the Berg Balance Scale (BBS) has been found to be predictive of the length of rehabilitation stay following stroke, a recent review concluded the BBS lacked predictive validity for fall risk. Conversely, sophisticated measures assessing center of mass (COM) displacement have shown to be predictive of falls risk. However, calculating COM displacement is difficult to measure outside a laboratory. Accordingly, we sought to validate COM displacement measurements derived from an HTC Vive tracker secured to the pelvis by comparing it to COM derived from 'gold' standard laboratory-based full-body motion capture. Results showed that RMS between the COM calculated from HTC Vive tracker and full body motion capture agree with an average error rate of 2.1 +/- 2.6 cm. Therefore, we conclude measurement of COM displacement using an HTC Vive tracker placed on the pelvis is reasonably representative of laboratory-based measurement of COM displacement.	[van der Veen, Susanne M.; Thomas, James S.] Virginia Commonwealth Univ, Dept Phys Therapy, Richmond, VA 23298 USA		van der Veen, SM (corresponding author), Virginia Commonwealth Univ, Dept Phys Therapy, Richmond, VA 23298 USA.	smvanderveen@vcu.edu					BERG K, 1995, SCAND J REHABIL MED, V27, P27; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Florence CS, 2018, J AM GERIATR SOC, V66, P693, DOI 10.1111/jgs.15304; FORSTER A, 1995, BRIT MED J, V311, P83, DOI 10.1136/bmj.311.6997.83; Ganea R, 2011, MED ENG PHYS, V33, P1086, DOI 10.1016/j.medengphy.2011.04.015; Giansanti D, 2008, PHYSIOL MEAS, V29, pN11, DOI 10.1088/0967-3334/29/3/N01; Giansanti D, 2008, MED ENG PHYS, V30, P367, DOI 10.1016/j.medengphy.2007.04.006; Giansanti D, 2006, PHYSIOL MEAS, V27, P1081, DOI 10.1088/0967-3334/27/11/003; Gietzelt M, 2009, INFORM HEALTH SOC CA, V34, P181, DOI 10.3109/17538150903356275; Godi M, 2013, PHYS THER, V93, P158, DOI 10.2522/ptj.20120171; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Howcroft J, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-91; Hurvitz EA, 2000, ARCH PHYS MED REHAB, V81, P587, DOI 10.1053/mr.2000.6293; Hyndman D, 2002, ARCH PHYS MED REHAB, V83, P165, DOI 10.1053/apmr.2002.28030; KOLLER WC, 1989, CLIN NEUROPHARMACOL, V12, P98; Liang HW, 2021, IEEE T NEUR SYS REH, V29, P85, DOI 10.1109/TNSRE.2020.3034876; Liu Y, 2011, IEEE ENG MED BIO, P1499, DOI 10.1109/IEMBS.2011.6090342; Liu Y, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2151193; Mapelli A, 2014, GAIT POSTURE, V39, P460, DOI 10.1016/j.gaitpost.2013.08.025; Marschollek M, 2011, METHOD INFORM MED, V50, P420, DOI 10.3414/ME10-01-0040; Muir SW, 2008, PHYS THER, V88, P449, DOI 10.2522/ptj.20070251; O'Sullivan M, 2009, AGE AGEING, V38, P308, DOI 10.1093/ageing/afp009; Park SH, 2018, AGING CLIN EXP RES, V30, P1, DOI 10.1007/s40520-017-0749-0; Qutubuddin AA, 2005, ARCH PHYS MED REHAB, V86, P789, DOI 10.1016/j.apmr.2004.11.005; Redmond SJ, 2010, IEEE ENG MED BIO, P2234, DOI 10.1109/IEMBS.2010.5627384; Rispens SM, 2015, NEUROREHAB NEURAL RE, V29, P54, DOI 10.1177/1545968314532031; Shany T, 2012, Z GERONTOL GERIATR, V45, P694, DOI 10.1007/s00391-012-0407-2; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Stefan AM, 2019, BEHAV RES METHODS, V51, P1042, DOI 10.3758/s13428-018-01189-8; Stevenson TJ, 1996, ARCH PHYS MED REHAB, V77, P656, DOI 10.1016/S0003-9993(96)90004-0; Stevenson TJ, 2001, AUST J PHYSIOTHER, V47, P29, DOI 10.1016/S0004-9514(14)60296-8; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239; van der Veen SM, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19173632; Whitney S., 2003, CONCURRENT VALIDITY; Yardley L, 2005, AGE AGEING, V34, P614, DOI 10.1093/ageing/afi196	36	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	DEC	2021	21	23							8034	10.3390/s21238034			9	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Chemistry; Engineering; Instruments & Instrumentation	XU9TS	WOS:000734598500001	34884036	Green Published			2022-02-06	
J	Vivash, L; Bertram, KL; Malpas, CB; Marotta, C; Harding, IH; Kolbe, S; Fielding, J; Clough, M; Lewis, SJG; Tisch, S; Evans, AH; O'Sullivan, JD; Kimber, T; Darby, D; Churilov, L; Law, M; Hovens, CM; Velakoulis, D; O'Brien, TJ				Vivash, Lucy; Bertram, Kelly L.; Malpas, Charles B.; Marotta, Cassandra; Harding, Ian H.; Kolbe, Scott; Fielding, Joanne; Clough, Meaghan; Lewis, Simon J. G.; Tisch, Stephen; Evans, Andrew H.; O'Sullivan, John D.; Kimber, Thomas; Darby, David; Churilov, Leonid; Law, Meng; Hovens, Christopher M.; Velakoulis, Dennis; O'Brien, Terence J.			Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial	BMJ OPEN			English	Article						clinical trials; neurology; Parkinson's disease	PROTEIN PHOSPHATASE 2A; TRAUMATIC BRAIN-INJURY; HYPERPHOSPHORYLATED TAU; ALZHEIMERS-DISEASE; ACQUIRED EPILEPSY; PATHOLOGY; ACTIVATOR; OUTCOMES	Introduction Progressive supranuclear palsy (PSP) is a neurodegenerative disorder for which there are currently no disease-modifying therapies. The neuropathology of PSP is associated with the accumulation of hyperphosphorylated tau in the brain. We have previously shown that protein phosphatase 2 activity in the brain is upregulated by sodium selenate, which enhances dephosphorylation. Therefore, the objective of this study is to evaluate the efficacy and safety of sodium selenate as a disease-modifying therapy for PSP. Methods and analysis This will be a multi-site, phase 2b, double-blind, placebo-controlled trial of sodium selenate. 70 patients will be recruited at six Australian academic hospitals and research institutes. Following the confirmation of eligibility at screening, participants will be randomised (1:1) to receive 52 weeks of active treatment (sodium selenate; 15 mg three times a day) or matching placebo. Regular safety and efficacy visits will be completed throughout the study period. The primary study outcome is change in an MRI volume composite (frontal lobe+midbrain-3rd ventricle) over the treatment period. Analysis will be with a general linear model (GLM) with the MRI composite at 52 weeks as the dependent variable, treatment group as an independent variable and baseline MRI composite as a covariate. Secondary outcomes are change in PSP rating scale, clinical global impression of change (clinician) and change in midbrain mean diffusivity. These outcomes will also be analysed with a GLM as above, with the corresponding baseline measure entered as a covariate. Secondary safety and tolerability outcomes are frequency of serious adverse events, frequency of down-titration occurrences and frequency of study discontinuation. Additional, as yet unplanned, exploratory outcomes will include analyses of other imaging, cognitive and biospecimen measures. Ethics and dissemination The study was approved by the Alfred Health Ethics Committee (594/20). Each participant or their legally authorised representative and their study partner will provide written informed consent at trial commencement. The results of the study will be presented at national and international conferences and published in peer-reviewed journals.	[Vivash, Lucy; Bertram, Kelly L.; Malpas, Charles B.; Marotta, Cassandra; Harding, Ian H.; Kolbe, Scott; Fielding, Joanne; Clough, Meaghan; Darby, David; Law, Meng; O'Brien, Terence J.] Monash Univ, Dept Neurosci, Melbourne, Vic, Australia; [Vivash, Lucy; Bertram, Kelly L.; Malpas, Charles B.; Marotta, Cassandra; O'Brien, Terence J.] Alfred Hlth, Dept Neurol, Melbourne, Vic, Australia; [Vivash, Lucy; Evans, Andrew H.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia; [Vivash, Lucy; Churilov, Leonid; O'Brien, Terence J.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Malpas, Charles B.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Lewis, Simon J. G.] Univ Sydney, Brain & Mind Ctr, ForeFront Parkinsons Dis Res Clin, Sydney, NSW, Australia; [Tisch, Stephen] St Vincents Hosp Sydney, Dept Neurol, Darlinghurst, NSW, Australia; [O'Sullivan, John D.] Univ Queensland, Ctr Clin Res, Brisbane, Qld, Australia; [O'Sullivan, John D.] Royal Brisbane & Womens Hosp, Dept Neurol, Brisbane, Qld, Australia; [Kimber, Thomas] Royal Adelaide Hosp, Dept Neurol, Adelaide, SA, Australia; [Darby, David] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Darby, David] Box Hill Hosp, Eastern Cognit Disorders Clin, Melbourne, Vic, Australia; [Law, Meng] Alfred Hosp, Dept Radiol, Melbourne, Vic, Australia; [Hovens, Christopher M.] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic, Australia; [Velakoulis, Dennis] Royal Melbourne Hosp, Dept Neuropsychiat, Parkville, Vic, Australia; [Velakoulis, Dennis] Univ Melbourne, Melbourne Neuropsychiat Ctr, Parkville, Vic, Australia		Vivash, L (corresponding author), Monash Univ, Dept Neurosci, Melbourne, Vic, Australia.; Vivash, L (corresponding author), Alfred Hlth, Dept Neurol, Melbourne, Vic, Australia.; Vivash, L (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia.; Vivash, L (corresponding author), Univ Melbourne, Dept Med, Melbourne, Vic, Australia.	lucy.vivash@monash.edu	O'Brien, Terence/L-8102-2013	Malpas, Charles/0000-0003-0534-3718; Vivash, Lucy/0000-0002-1182-0907	Australian National Health and Medical Research Council (NHMRC) Medical Research Future FundNational Health and Medical Research Council of Australia [GNT1200254]; NHMRC Investigator GrantNational Health and Medical Research Council of Australia [APP1176426]; NHMRC Leadership FellowshipNational Health and Medical Research Council of Australia [1195830]	This work is supported by the Australian National Health and Medical Research Council (NHMRC) Medical Research Future Fund grant number GNT1200254. TJOB is supported by an NHMRC Investigator Grant (APP1176426). SJGL is supported by NHMRC Leadership Fellowship (#1195830).	Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Bensimon G, 2009, BRAIN, V132, P156, DOI 10.1093/brain/awn291; Benton A., 1976, MULTILINGUAL APHASIA; Brady RD, 2016, J MUSCULOSKEL NEURON, V16, P369; Burgess P.W., 1997, HAYLING BRIXTON TEST; Cardoso BR, 2019, NEUROTHERAPEUTICS, V16, P192, DOI 10.1007/s13311-018-0662-z; Chare L, 2014, J NEUROL NEUROSUR PS, V85, P866, DOI 10.1136/jnnp-2013-306948; Corcoran NM, 2010, BRIT J CANCER, V103, P462, DOI 10.1038/sj.bjc.6605798; Corcoran NM, 2010, J CLIN NEUROSCI, V17, P1025, DOI 10.1016/j.jocn.2010.04.020; Corcoran NM, 2004, J UROLOGY, V171, P907, DOI 10.1097/01.ju.0000092859.16817.8e; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; Golbe LI, 2007, BRAIN, V130, P1552, DOI 10.1093/brain/awm032; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; Guy W, 1976, ECDEU ASSESSMENT MAN, P218; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hoglinger GU, 2021, LANCET NEUROL, V20, P182, DOI 10.1016/S1474-4422(20)30489-0; Hoglinger GU, 2017, MOVEMENT DISORD, V32, P842, DOI 10.1002/mds.26973; Hoglinger GU, 2017, MOVEMENT DISORD, V32, P853, DOI 10.1002/mds.26987; Hovens, IN PRESS, DOI [10.1136/bmjopen-2020-040100, DOI 10.1136/BMJOPEN-2020-040100]; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Jones NC, 2012, NEUROBIOL DIS, V45, P897, DOI 10.1016/j.nbd.2011.12.005; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; Malpas CB, 2016, J ALZHEIMERS DIS, V54, P223, DOI 10.3233/JAD-160544; O'Sullivan SS, 2008, BRAIN, V131, P1362, DOI 10.1093/brain/awn065; Roth RM, 2005, ARCH CLIN NEUROPSYCH, V20, P906; Schrag A, 1999, LANCET, V354, P1771, DOI 10.1016/S0140-6736(99)04137-9; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Takao H, 2012, EUR J RADIOL, V81, P2801, DOI 10.1016/j.ejrad.2011.10.011; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Vivash L, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040100; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Williams DR, 2009, LANCET NEUROL, V8, P270, DOI 10.1016/S1474-4422(09)70042-0; Zheng P, 2014, MOL NEUROBIOL, V49, P1532, DOI 10.1007/s12035-013-8601-9	40	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	DEC	2021	11	12							e055019	10.1136/bmjopen-2021-055019			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XR0DW	WOS:000731910700012	34916328	gold, Green Published			2022-02-06	
J	Walia, B; Kmush, BL; Ehrlich, J; Mackowski, M; Sanders, S				Walia, Bhavneet; Kmush, Brittany L.; Ehrlich, Justin; Mackowski, Madeline; Sanders, Shane			Age at League Entry and Early All-Cause Mortality among National Football League Players	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						NFL player health; sports; American football; mortality; league health and safety policy; cumulative head impact; Cox proportional hazard regression; risk factors; retired athletes	HEAD IMPACT EXPOSURE; HIGH-SCHOOL FOOTBALL; CONCUSSION; INJURY; ASSOCIATION; LAWS; NFL; NBA	Background: A growing body of research suggests that American football players are exposed to higher cumulative head impact risk as competition level rises. Related literature finds that head impacts absorbed by youth, adolescent, and emerging adult players are associated with elevated risk of long-term health problems (e.g., neurodegenerative disease onset). Most National Football League (NFL) players enter the League as emerging adults (18-24 years old), a period of continued cognitive and overall physical development. However, no prior research has studied the effect of age-at-entry on long-term NFL player health. Hypothesis/Purpose: This study assesses whether early NFL player age-at-entry is associated with increased risk of early all-cause mortality, controlling for player position, BMI, year-of-entry, birth year, and NFL Draft round (expected ability upon League entry). Study Design: This retrospective cohort study included 9049 players who entered the NFL from 1970-2017 and subsequently played at least one game. The variables whether deceased, age-at-death, age-at-entry, and controls were collected from Pro Football Reference website, a leading data site for American football that has been used extensively in the literature. Data collection began on 13 July 2017, and follow-up ended on 1 July 2018. Statistical analysis was performed from 10 March 2020 to 3 August 2020. Data was validated by checking a large sub-sample of data points against alternative sources such as NFL.com and NFLsavant.com. Methods: Cox proportional hazards regression models were used to examine variation in death hazard by NFL player age-at-entry, conditional upon a full set of controls. Results: Conditional on controls, Cox regression results indicate that a one-year increase in age-at-entry was significantly associated with a 14% decreased hazard-of-death (H.R., 0.86; 95% CI, 0.74-0.98). Among relatively young entering players, the increased hazard appears to be concentrated in the first quartile of players by age at League entry (20.2 to 22.3 years). Players not in this quartile exhibited a decreased hazard-of-death (H.R., 0.74; 95% CI, 0.57-0.97) compared with players who entered at a relatively young (first quartile) age. Conclusion: An earlier age-at-entry is associated with an increased hazard-of-death among NFL players. Currently, the NFL regulates age-at-entry only indirectly by requiring players to be 3 years removed from high school before becoming NFL Draft-eligible. Implementing a minimum age at entry for NFL players of 22 years and 4 months at beginning of season is expected to result in reduced mortality. What is known about this subject? There are no prior studies on the effects of NFL player age-at-entry on early mortality risk. What this study adds to existing knowledge: This study determines whether entering the NFL at an age of physical and physiological development is related to early mortality risk.	[Walia, Bhavneet; Kmush, Brittany L.; Mackowski, Madeline] Syracuse Univ, Dept Publ Hlth, Syracuse, NY 13244 USA; [Ehrlich, Justin; Sanders, Shane] Syracuse Univ, Dept Sport Management, Syracuse, NY 13244 USA		Sanders, S (corresponding author), Syracuse Univ, Dept Sport Management, Syracuse, NY 13244 USA.	bwalia@syr.edu; blkmush@syr.edu; mahilton@syr.edu; jaehrlic@syr.edu; sdsander@syr.edu					Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2019, SEMIN PEDIATR NEUROL, V30, P107, DOI 10.1016/j.spen.2019.03.016; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; AMA, 2020, SCIENCEDAILY; [Anonymous], 2015, STATACORP STATA STAT; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Baugh C.M., 2016, CONCUSSION, V1, P1, DOI [DOI 10.2217/CNC.15.6, 10.2217/cnc.15.6]; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Camerer CF, 1999, J ECON BEHAV ORGAN, V39, P59, DOI 10.1016/S0167-2681(99)00026-8; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Edelman M., 10 YEARS AGO TODAY; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Kerr ZY, 2019, ENVIRON HEALTH PERSP, V127, DOI [10.1289/EHP4163, 10.1289/ehp4163]; Kmush BL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.4442; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; NCAA, WHAT SPORT HAS MOST; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Silveri MM, 2012, HARVARD REV PSYCHIAT, V20, P189, DOI 10.3109/10673229.2012.714642; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; STAW BM, 1995, ADMIN SCI QUART, V40, P474, DOI 10.2307/2393794; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Venkataramani AS, 2018, JAMA-J AM MED ASSOC, V319, P800, DOI 10.1001/jama.2018.0140; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056	30	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	DEC	2021	18	24							13356	10.3390/ijerph182413356			12	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	YA2XS	WOS:000738203000001	34948966	Green Published			2022-02-06	
J	Wang, BY; Zeldovich, M; Rauen, K; Wu, YJ; Covic, A; Muller, I; Haagsma, JA; Polinder, S; Menon, D; Asendorf, T; Andelic, N; von Steinbuechel, N				Wang, Biyao; Zeldovich, Marina; Rauen, Katrin; Wu, Yi-Jhen; Covic, Amra; Muller, Isabelle; Haagsma, Juanita A.; Polinder, Suzanne; Menon, David; Asendorf, Thomas; Andelic, Nada; von Steinbuechel, Nicole			Longitudinal Analyses of the Reciprocity of Depression and Anxiety after Traumatic Brain Injury and Its Clinical Implications	JOURNAL OF CLINICAL MEDICINE			English	Article						major depression; generalized anxiety disorder; traumatic brain injury; longitudinal; reciprocal relationship	PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; MOOD DISORDERS; RISK-FACTORS; CENTER-TBI; 1ST YEAR; MODERATE; MODEL; OUTCOMES; SCALE	Depression and anxiety are common following traumatic brain injury (TBI). Understanding their prevalence and interplay within the first year after TBI with differing severities may improve patients' outcomes after TBI. Individuals with a clinical diagnosis of TBI recruited for the large European collaborative longitudinal study CENTER-TBI were screened for patient-reported major depression (MD) and generalized anxiety disorder (GAD) at three, six, and twelve months post-injury (N = 1683). Data were analyzed using autoregressive cross-lagged models. Sociodemographic, premorbid and injury-related factors were examined as risk factors. 14.1-15.5% of TBI patients reported moderate to severe MD at three to twelve months after TBI, 7.9-9.5% reported GAD. Depression and anxiety after TBI presented high within-domain persistency and cross-domain concurrent associations. MD at three months post-TBI had a significant impact on GAD at six months post-TBI, while both acted bidirectionally at six to twelve months post-TBI. Being more severely disabled, having experienced major extracranial injuries, an intensive care unit stay, and being female were risk factors for more severe MD and GAD. Major trauma and the level of consciousness after TBI were additionally associated with more severe MD, whereas being younger was related to more severe GAD. Individuals after TBI should be screened and treated for MD and GAD early on, as both psychiatric disturbances are highly persistent and bi-directional in their impact. More severely disabled patients are particularly vulnerable, and thus warrant timely screening and intensive follow-up treatment.	[Wang, Biyao; Zeldovich, Marina; Wu, Yi-Jhen; Covic, Amra; Muller, Isabelle; von Steinbuechel, Nicole] Univ Med Ctr Goettingen, Inst Med Psychol & Med Sociol, Waldweg 37A, D-37073 Gottingen, Germany; [Wang, Biyao] UCL, Div Psychol & Language Sci, London WC1H 0AP, England; [Rauen, Katrin] Univ Zurich, Psychiat Hosp Zurich, Dept Geriatr Psychiat, Minervastr 145, CH-8032 Zurich, Switzerland; [Rauen, Katrin] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Stroke & Dementia Res ISD, Feodor Lynen Str 17, D-81377 Munich, Germany; [Haagsma, Juanita A.; Polinder, Suzanne] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Haagsma, Juanita A.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Emergency Med, NL-3000 CA Rotterdam, Netherlands; [Menon, David] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Box 157, Cambridge CB2 0QQ, England; [Asendorf, Thomas] Univ Med Ctr Goettingen, Dept Med Stat, D-37073 Gottingen, Germany; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway; [Andelic, Nada] Univ Oslo, Inst Hlth & Soc, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, N-0373 Oslo, Norway		Wang, BY (corresponding author), Univ Med Ctr Goettingen, Inst Med Psychol & Med Sociol, Waldweg 37A, D-37073 Gottingen, Germany.; Wang, BY (corresponding author), UCL, Div Psychol & Language Sci, London WC1H 0AP, England.	marina.zeldovich@med.uni-goettingen.de; katrin.rauen@uzh.ch; amra.covic@med.uni-goettingen.de; dkm13@cam.ac.uk; thomas.asendorf@med.uni-goettingen.de; NADAND@ous-hf.no		Zeldovich, Marina/0000-0003-0172-9904; Rauen, Katrin/0000-0003-4555-6697; Asendorf, Thomas/0000-0003-1317-2138			Allen Mike., 2017, SAGE ENCY COMMUNICAT, V4, DOI [10.4135/9781483381411, DOI 10.4135/9781483381411]; Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Alway Y, 2016, DEPRESS ANXIETY, V33, P19, DOI 10.1002/da.22396; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Barker-Collo S, 2018, BRAIN INJURY, V32, P1651, DOI 10.1080/02699052.2018.1540797; Beauducel A, 2006, STRUCT EQU MODELING, V13, P186, DOI 10.1207/s15328007sem1302_2; Bollen K.A., 2005, ENCY BIOSTATISTICS, DOI [10.1002/0470011815.b2a13089, DOI 10.1002/0470011815.B2A13089]; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Carroll EL, 2020, J HEAD TRAUMA REHAB, V35, pE513, DOI 10.1097/HTR.0000000000000575; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Curran PJ, 2001, DECADE BEHAV, P107, DOI 10.1037/10409-004; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Demakis GJ, 2010, APPL NEUROPSYCHOL, V17, P183, DOI 10.1080/09084282.2010.499752; First M., 2015, STRUCTURED CLIN INTE, P1; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Godwin EE, 2015, FAM RELAT, V64, P347, DOI 10.1111/fare.12122; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hanel G, 2009, J PSYCHOSOM RES, V67, P189, DOI 10.1016/j.jpsychores.2009.04.013; Hirschfeld Robert M. A., 2001, Prim Care Companion J Clin Psychiatry, V3, P244; Hoffman AN, 2019, BEHAV PHARMACOL, V30, P115, DOI 10.1097/FBP.0000000000000461; Huda MF, 2004, NEUROL INDIA, V52, P450; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; Masten AS, 2010, DEV PSYCHOPATHOL, V22, P491, DOI 10.1017/S0954579410000222; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Moreno-Lopez L, 2016, BRAIN INJURY, V30, P1319, DOI 10.1080/02699052.2016.1186839; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Osborn AJ, 2017, J AFFECT DISORDERS, V213, P214, DOI 10.1016/j.jad.2016.09.045; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Osman A, 2012, J CLIN PSYCHOL, V68, P1322, DOI 10.1002/jclp.21908; Perrin PB, 2017, AM J PHYS MED REHAB, V96, P374, DOI 10.1097/PHM.0000000000000644; R Core Team, 2021, R LANG ENV STAT COMP; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rauen K, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01391-3; Ren DX, 2017, J HEAD TRAUMA REHAB, V32, pE29, DOI 10.1097/HTR.0000000000000294; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Selig J.P., 2012, AUTOREGRESSIVE CROSS; Sewalt CA, 2020, BRIT J SURG, V107, P373, DOI 10.1002/bjs.11304; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Spitz G, 2017, J NEUROTRAUM, V34, P807, DOI 10.1089/neu.2016.4527; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Teymoori A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030873; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2020, INT STAT CLASS DIS R, V11th; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	71	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	DEC	2021	10	23							5597	10.3390/jcm10235597			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XV5QR	WOS:000734997200001	34884299	Green Published			2022-02-06	
J	Wang, TY; Hu, YJ; Wang, DN; Liu, J; Sun, JH; Wei, CX; Dai, H; Li, Y				Wang, Tianyao; Hu, Yujie; Wang, Danni; Liu, Jun; Sun, Jiahua; Wei, Chunxiao; Dai, Hui; Li, Yao			Arcuate Fasciculus Subsegment Impairments Distinctly Associated with Memory and Language Deficits in Acute Mild Traumatic Brain Injury Patients	JOURNAL OF NEUROTRAUMA			English	Article						arcuate fasciculus; automated fiber quantification; diffusion tensor imaging; language; mild traumatic brain injury; verbal memory	FUNCTIONAL CONNECTIVITY; TRACTOGRAPHY; PATHWAYS; APHASIA; ANATOMY; NETWORK; DAMAGE	In acute mild traumatic brain injury (mTBI), the injury-related axonal swelling leads to white matter fiber bundle impairments, closely related to the memory and language deficits commonly shown in the patients. The arcuate fasciculus (AF) plays a central role in verbal learning and language function but could be functionally heterogeneous along the fiber tract. In this study, 25 patients with acute mTBI (<48 h after trauma) and 33 age- and sex-matched healthy controls (HCs) were included. Impaired verbal memory and language functions were shown in the patient group compared with the HCs. Combined diffusion tensor imaging (DTI) and functional magnetic resonance imaging (fMRI) were applied to investigate the altered diffusion measure profiles of the AF tracts and the associated functional features. The fractional anisotropy (FA) in the right AF temporal subsegment of the mTBI group was negatively associated with the patient verbal memory function, whereas a positive correlation was found in the HC group. On the other hand, the correlation between the FA in the right AF frontal subsegment and the language function in HCs diminished in the patient group. Moreover, the functional connectivity between the inferior frontal gyrus and the middle occipital gyrus decreased, and its correlation with language function in HCs was absent in the patients with mTBI. Our work provides new insights into the understanding of the structural and functional heterogeneity of the AF tracts as well as the distinct associations of its subsegment impairments with verbal memory and language function deficits in patients with acute mTBI.	[Wang, Tianyao; Wei, Chunxiao] Fudan Univ, Dept Radiol, Shanghai Peoples Hosp 5, Shanghai, Peoples R China; [Sun, Jiahua] Fudan Univ, Dept Neurosurg, Shanghai Peoples Hosp 5, Shanghai, Peoples R China; [Hu, Yujie; Wang, Danni; Li, Yao] Shanghai Jiao Tong Univ, Sch Biomed Engn, 1954 Huashan Rd, Shanghai 200030, Peoples R China; [Liu, Jun] Shanghai Jiao Tong Univ, Tongren Hosp, Dept Radiol, Sch Med, Shanghai, Peoples R China; [Dai, Hui] Soochow Univ, Dept Radiol, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China; [Dai, Hui] Soochow Univ, Inst Med Imaging, Suzhou, Jiangsu, Peoples R China; [Dai, Hui] Suzhou Key Lab Intelligent Med & Equipment, Suzhou, Jiangsu, Peoples R China		Li, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, 1954 Huashan Rd, Shanghai 200030, Peoples R China.; Dai, H (corresponding author), Soochow Univ, Dept Radiol, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China.	huizi198208@126.com; yaoli@sjtu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81871083, 81971573]; Shanghai Jiao Tong University Scientific and Technological Innovation Funds [2019QYA12]; Key Program of Multidisciplinary Cross Research Foundation of Shanghai Jiao Tong University [YG2021ZD28]; Suzhou Gusu Medical Youth Talent [GSWS2020019]; Project of Invigorating Health Care through Science, Technology and Education, Jiangsu Provincial Medical Youth Talent [QNRC2016709]	This work was supported by the National Natural Science Foundation of China [Grant Nos. 81871083 and 81971573]; Shanghai Jiao Tong University Scientific and Technological Innovation Funds [2019QYA12]; Key Program of Multidisciplinary Cross Research Foundation of Shanghai Jiao Tong University [YG2021ZD28]; the Suzhou Gusu Medical Youth Talent (GSWS2020019) and the Project of Invigorating Health Care through Science, Technology and Education, Jiangsu Provincial Medical Youth Talent (QNRC2016709).	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernal B, 2009, BRAIN, V132, P2309, DOI 10.1093/brain/awp206; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; Bonhage CE, 2014, J COGNITIVE NEUROSCI, V26, P1654, DOI 10.1162/jocn_a_00566; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M., 2013, DIFFUSION MRI, P511; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Catani M, 2011, BIOL PSYCHIAT, V70, P1143, DOI 10.1016/j.biopsych.2011.06.013; Cui Y, 2015, EUR RADIOL, V25, P3238, DOI 10.1007/s00330-015-3746-8; Dick AS, 2012, BRAIN, V135, P3529, DOI 10.1093/brain/aws222; Fisher JE, 2012, NEUROIMAGE, V59, P2839, DOI 10.1016/j.neuroimage.2011.09.047; Forkel SJ, 2014, BRAIN, V137, P2027, DOI 10.1093/brain/awu113; Frankland SM, 2020, CEREB CORTEX, V30, P3838, DOI 10.1093/cercor/bhaa001; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Fridriksson J, 2013, BRAIN, V136, P3451, DOI 10.1093/brain/awt267; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Hellstrom T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13628-1; Herbet G, 2017, BRAIN STRUCT FUNCT, V222, P1597, DOI 10.1007/s00429-016-1294-x; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Ivanova MV, 2016, CORTEX, V85, P165, DOI 10.1016/j.cortex.2016.04.019; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Liegeois FJ, 2013, BRAIN LANG, V127, P388, DOI 10.1016/j.bandl.2013.05.003; Lindsey HM, 2020, BRAIN IMAGING BEHAV, V14, P1626, DOI 10.1007/s11682-019-00093-9; Lopez-Barroso D, 2013, P NATL ACAD SCI USA, V110, P13168, DOI 10.1073/pnas.1301696110; Lu JM, 2018, NEUROIMAGE-CLIN, V19, P607, DOI 10.1016/j.nicl.2018.05.025; MACK WJ, 1992, J GERONTOL, V47, pP154, DOI 10.1093/geronj/47.3.P154; Majerus S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00357; Massey JS, 2015, NEUROPSYCHOLOGY, V29, P530, DOI 10.1037/neu0000192; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Meyers JE., 1995, REY COMPLEX FIGURE T; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; Pujol J, 2018, NEUROIMAGE-CLIN, V18, P160, DOI 10.1016/j.nicl.2018.01.024; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Schmidt M., 1996, REY AUDITORY VERBAL; Teubner-Rhodes S, 2016, J NEUROSCI, V36, P7210, DOI 10.1523/JNEUROSCI.4342-15.2016; Van Patten R, 2016, J CLIN EXP NEUROPSYC, V38, P12, DOI 10.1080/13803395.2015.1091064; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang ZQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151489; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790	55	0	0	5	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2021	38	23					3279	3287		10.1089/neu.2021.0267			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XJ2CB	WOS:000726601700009	34605664				2022-02-06	
J	Wang, Y; Andrade, P; Pitkaenen, A				Wang, Ying; Andrade, Pedro; Pitkaenen, Asla			Peripheral Infection after Traumatic Brain Injury Augments Excitability in the Perilesional Cortex and Dentate Gyrus	BIOMEDICINES			English	Article						c-Fos; early gene activation; epileptogenesis; lipopolysaccharide; pentylenetetrazole; post-traumatic epilepsy; seizure susceptibility; traumatic brain injury	C-FOS; POSTTRAUMATIC EPILEPSY; SEIZURE SUSCEPTIBILITY; ELECTRICAL-STIMULATION; MICROGLIAL ACTIVATION; MESSENGER-RNA; EPILEPTOGENESIS; INFLAMMATION; IMMUNE; MODEL	Peripheral infections occur in up to 28% of patients with traumatic brain injury (TBI), which is a major etiology for structural epilepsies. We hypothesized that infection occurring after TBI acts as a "second hit" and facilitates post-traumatic epileptogenesis. Adult male Sprague-Dawley rats were subjected to lateral fluid-percussion injury or sham-operation. At 8 weeks post-injury, rats were treated with lipopolysaccharide (LPS, 5 mg/kg) to mimic Gram-negative peripheral infection. T2-weighted magnetic resonance imaging was used to detect the cortical lesion type (small focal inflammatory [TBIFI] vs. large cavity-forming [TBICF]). Spontaneous seizures were detected with video-electroencephalography, and seizure susceptibility was determined by the pentylenetetrazole (PTZ) test. Post-PTZ neuronal activation was assessed using c-Fos immunohistochemistry. LPS treatment increased the percentage of rats with PTZ-induced seizures among animals with TBIFI lesions (p < 0.05). It also increased the cumulative duration of PTZ-induced seizures (p < 0.01), particularly in the TBIFI group (p < 0.05). The number of c-Fos immunopositive cells was higher in the perilesional cortex of injured animals compared with sham-operated animals (p < 0.05), particularly in the TBI-LPS group (p < 0.05). LPS treatment increased the percentage of injured rats with bilateral c-Fos staining in the dentate gyrus (p < 0.05), particularly in the TBIFI group (p < 0.05). Our findings demonstrate that peripheral infection after TBI increases PTZ-induced seizure susceptibility and neuronal activation in the perilesional cortex and bilaterally in the dentate gyrus, particularly in animals with prolonged perilesional T2 enhancement. Our data suggest that treatment of infections and reduction of post-injury neuro-inflammation are important components of the treatment regimen aiming at preventing epileptogenesis after TBI.	[Wang, Ying; Andrade, Pedro; Pitkaenen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland; [Wang, Ying] Dalian Med Univ, Dept Neurol, Affiliated Hosp 1, Dalian 116001, Peoples R China		Pitkaenen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	pedro.andrade@uef.fi; asla.pitkanen@uef.fi		Pitkanen, Asla/0000-0002-8163-5416			Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Auvin S, 2010, EPILEPSIA, V51, P34, DOI 10.1111/j.1528-1167.2010.02606.x; Barros VN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00072; Combrinck MI, 2002, NEUROSCIENCE, V112, P7, DOI 10.1016/S0306-4522(02)00030-1; Dhillon NK, 2018, J SURG RES, V224, P140, DOI 10.1016/j.jss.2017.11.031; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Eun BL, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.348; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Galic MA, 2008, J NEUROSCI, V28, P6904, DOI 10.1523/JNEUROSCI.1901-08.2008; Gass P, 1995, PROG NEUROBIOL, V47, P257, DOI 10.1016/0301-0082(95)00022-4; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Ho YH, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0157-8; Huttunen JK, 2018, J NEUROTRAUM, V35, P2708, DOI 10.1089/neu.2017.5308; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; LEWIS DA, 1986, J COMP NEUROL, V248, P1, DOI 10.1002/cne.902480102; Manninen E, 2020, J NEUROTRAUM, V37, P2580, DOI 10.1089/neu.2019.6796; Mazarati A, 2021, EPILEPSIA, V62, P1472, DOI 10.1111/epi.16909; McGinn Melissa J, 2015, Handb Clin Neurol, V127, P67, DOI 10.1016/B978-0-444-52892-6.00005-2; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Ndode-Ekane XE, 2017, J NEUROTRAUM, V34, P459, DOI 10.1089/neu.2016.4404; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2019, NEUROBIOL DIS, V123, P42, DOI 10.1016/j.nbd.2018.05.007; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Pitkanen A, 2011, NEUROSCI LETT, V497, P163, DOI 10.1016/j.neulet.2011.02.033; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; RAGHUPATHI R, 1995, J CEREBR BLOOD F MET, V15, P467, DOI 10.1038/jcbfm.1995.58; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; Riazi K, 2010, EPILEPSY RES, V89, P34, DOI 10.1016/j.eplepsyres.2009.09.004; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; Saadat S, 2012, ULUS TRAVMA ACIL CER, V18, P219, DOI [10.5505/tjtes.2012.03453, 10.5505/tjtes.2012. 03453]; Sayyah M, 2003, NEUROSCIENCE, V122, P1073, DOI 10.1016/j.neuroscience.2003.08.043; Sharma R, 2019, BRAIN BEHAV IMMUN, V79, P63, DOI 10.1016/j.bbi.2019.04.034; Szyndler J, 2009, EPILEPSY BEHAV, V16, P216, DOI 10.1016/j.yebeh.2009.07.030; Terrone G, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2019.107742; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; van Vliet EA, 2020, NEUROBIOL DIS, V145, DOI 10.1016/j.nbd.2020.105080; Vuokila N, 2020, NEUROSCIENCE, V433, P21, DOI 10.1016/j.neuroscience.2020.02.045; Weisbrod AB, 2012, J TRAUMA ACUTE CARE, V73, P1525, DOI 10.1097/TA.0b013e318270e179; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X	54	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9059		BIOMEDICINES	Biomedicines	DEC	2021	9	12							1946	10.3390/biomedicines9121946			24	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine; Pharmacology & Pharmacy	XX3HE	WOS:000736190500001	34944762	Green Published			2022-02-06	
J	Weiss, J; Rabinowitz, AR; Deshpande, SK; Hasegawa, RB; Small, DS				Weiss, Jordan; Rabinowitz, Amanda R.; Deshpande, Sameer K.; Hasegawa, Raiden B.; Small, Dylan S.			Participation in Collision Sports and Cognitive Aging Among Swedish Twins	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						cognitive aging; cognitive impairment; collision sports; twins	MINI-MENTAL-STATE; RECURRENT CONCUSSION; PROCESSING SPEED; FOOTBALL; IMPAIRMENT; HAZARDS; LIFE; SUBDISTRIBUTION; ASSOCIATION; DEPRESSION	We examined the association between early-life participation in collision sports and later-life cognitive health over a 28-year period in a population-based sample drawn from the longitudinal Swedish Adoption/Twin Study of Aging (1987-2014). Cognitive measures included the Mini-Mental State Examination and performance across multiple cognitive domains (e.g., global cognition, verbal ability, spatial ability, memory, processing speed). Among a sample of 660 adults (mean age at baseline, 62.8 years (range: 50-88); 58.2% female), who contributed 10,944 person-years of follow-up, there were 450 cases of cognitive impairment (crude rate = 41.1/1,000 person-years). Early-life participation in collision sports was not significantly associated with cognitive impairment at baseline or with its onset over a 28-year period in a time-to-event analysis, which accounted for the semi-competing risk of death. Furthermore, growth curve models revealed no association between early-life participation in collision sports and the level of or change in trajectories of cognition across multiple domains overall or in sex-stratified models. We discuss the long-term implications of adolescent participation in collision sports on cognitive health.	[Weiss, Jordan] Univ Calif Berkeley, Dept Demog, 2232 Piedmont Ave, Berkeley, CA 94720 USA; [Rabinowitz, Amanda R.] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Deshpande, Sameer K.] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hasegawa, Raiden B.; Small, Dylan S.] Univ Penn, Wharton Sch, Dept Stat, 265 South 37th St, Philadelphia, PA 19104 USA		Weiss, J (corresponding author), Univ Calif Berkeley, Dept Demog, 2232 Piedmont Ave, Berkeley, CA 94720 USA.; Small, DS (corresponding author), Univ Penn, Wharton Sch, Dept Stat, 265 South 37th St, Philadelphia, PA 19104 USA.	jordanmnw@gmail.com; dsmall@wharton.upenn.edu			National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG04563, AG10175]; MacArthur Foundation Research Network on Successful Aging; Swedish Council for Working Life and Social Research (FAS)Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte) [97:0147:1B, 2009-0795]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [825-2007-7460, 825-2009-6141];  [T32 HD007242];  [T32 AG000246]	The Swedish Adoption/Twin Study of Aging has been supported by the National Institute on Aging (grants AG04563, AG10175), the MacArthur Foundation Research Network on Successful Aging, the Swedish Council for Working Life and Social Research (FAS) (award 97:0147:1B, 2009-0795), and the Swedish Research Council (award 825-2007-7460, 825-2009-6141). J.W. was supported by training grants awarded to the University of Pennsylvania (National Institutes of Health grant T32 HD007242) and University of California, Berkeley (National Institutes of Health grant T32 AG000246).	Alosco ML, 2019, SEMIN PEDIATR NEUROL, V30, P107, DOI 10.1016/j.spen.2019.03.016; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Azuero A, 2016, CANCER-AM CANCER SOC, V122, P1298, DOI 10.1002/cncr.29924; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Barbieri M, 2015, INT J EPIDEMIOL, V44, P1549, DOI 10.1093/ije/dyv105; Bassuk SS, 2000, AM J EPIDEMIOL, V151, P676; Batista MB, 2019, J SPORT SCI, V37, P2253, DOI 10.1080/02640414.2019.1627696; Bohr AD, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119868658; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; Deshpande SK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229978; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Easterlin MC, 2019, JAMA PEDIATR, V173, P681, DOI 10.1001/jamapediatrics.2019.1212; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Finkel D, 2004, AGING NEUROPSYCHOL C, V11, P325, DOI 10.1080/13825580490511152; Finkel D, 2007, PSYCHOL AGING, V22, P558, DOI 10.1037/0882-7974.22.3.558; FOLSTEIN MF, 1991, J GERONTOL, V46, pM132, DOI 10.1093/geronj/46.4.M132; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grambauer N, 2010, STAT MED, V29, P875, DOI 10.1002/sim.3786; Gray B, 2004, COMPREHENSIVE R ARCH CMPRSK PACKAGE; Guo XH, 2019, APPL ECON, V51, P1602, DOI 10.1080/00036846.2018.1527466; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Inter-university Consortium for Political and Social Research, 1962, ICPSR; Jonsson P, 2005, BRIT J SPORT MED, V39, P847, DOI 10.1136/bjsm.2005.018630; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Latouche A, 2013, J CLIN EPIDEMIOL, V66, P648, DOI 10.1016/j.jclinepi.2012.09.017; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lindbergh CA, 2016, NEUROPSYCHOL REV, V26, P129, DOI 10.1007/s11065-016-9321-5; Lindsey HM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01296; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Nguyen VT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4223; Olivier J, 2017, COMMUN STAT-THEOR M, V46, P6774, DOI 10.1080/03610926.2015.1134575; Pate RR, 2000, ARCH PEDIAT ADOL MED, V154, P904, DOI 10.1001/archpedi.154.9.904; Pedersen NL, 1984, SWEDISH ADOPTIONTWIN; R Core Team, 2013, LANGUAGE ENV STAT CO, DOI DOI 11/44679/INDEX.HTM; Rajji TK, 2009, J PSYCHIATR RES, V43, P464, DOI 10.1016/j.jpsychires.2008.06.002; Ransom MR, 2018, ECON EDUC REV, V64, P75, DOI 10.1016/j.econedurev.2018.04.002; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stata Corporation, 2015, STAT STAT SOFTW REL STAT STAT SOFTW REL; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Wlodarczyk JH, 2004, ARCH GERONTOL GERIAT, V39, P25, DOI 10.1016/j.archger.2003.12.004	52	0	0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0002-9262	1476-6256		AM J EPIDEMIOL	Am. J. Epidemiol.	DEC	2021	190	12					2604	2611		10.1093/aje/kwab177			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	YH4LQ	WOS:000743140600014	34142704				2022-02-06	
J	Wong, KR; Sgro, M; Yamakawa, GR; Li, C; McDonald, SJ; Sun, MJ; Shultz, SR; Brady, RD; Mychasiuk, R				Wong, Ker Rui; Sgro, Marissa; Yamakawa, Glenn R.; Li, Crystal; McDonald, Stuart J.; Sun, Mujun; Shultz, Sandy R.; Brady, Rhys D.; Mychasiuk, Richelle			Gut microbiome depletion and repetitive mild traumatic brain injury differentially modify bone development in male and female adolescent rats	BONE REPORTS			English	Article						Antibiotics; Concussion; Femur; Musculoskeletal; Sex differences	MASS; TRANSPORTER; MECHANISMS; EXPRESSION; CHILDHOOD; DENSITY; ALTER; MICE	Dysregulation of the gut microbiome has been shown to disrupt both bone formation and bone resorption in several preclinical and clinical models. However, the role of microbiome in adolescent bone development remains poorly understood. This effect of disrupted bone development may be more pronounced during adolescence, when bone development is vulnerable to environmental stimuli and external insults (e.g., antibiotic treatment and traumatic brain injury), as this is a critical window of development. Therefore, in this study, we sought to investigate the effect of repetitive mild traumatic brain injury (RmTBI) and gut microbiome depletion by antibiotic treatment on femur length and bone density in male and female adolescent Sprague Dawley rats. Rats were randomly assigned to receive standard or antibiotic autoclaved drinking water and to receive sham or RmTBIs injuries. Using micro-computed tomography (mu CT), we found sexually dimorphic changes in adolescent bone development in response to microbiome depletion and RmTBI. Specifically, gut microbiome depletion stunted femur growth in males and altered cross sectional bone area (CSA), bone area fraction, and the bone volume of low and mid density bone in the distal metaphyseal region of the femur. Conversely, RmTBI and antibiotic treatment individually disrupted bone growth, bone area fraction, and bone volume of high-density bone within the distal metaphyseal region of the femur in females, but not when combined. Therefore, findings from this study indicate that gut microbiome and RmTBI may alter bone development in a sex-dependent manner during adolescence.	[Wong, Ker Rui; Sgro, Marissa; Yamakawa, Glenn R.; Li, Crystal; McDonald, Stuart J.; Sun, Mujun; Shultz, Sandy R.; Brady, Rhys D.; Mychasiuk, Richelle] Monash Univ, Cent Clin Sch, Dept Neurosci, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia; [Shultz, Sandy R.; Brady, Rhys D.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [McDonald, Stuart J.] La Trobe Univ, Sch Life Sci, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia		Mychasiuk, R (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia.	Richelle.mychasiuk@monash.edu		Li, Crystal Nuoshi/0000-0002-0999-0229	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	RM, SJM, and SRS are supported by funding from the Australian National Health and Medical Research Council.	Bajwa NM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00115; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bliziotes M, 2006, BONE, V39, P1313, DOI 10.1016/j.bone.2006.06.009; Bonaz B, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00049; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Brady RD, 2016, J MUSCULOSKEL NEURON, V16, P369; Brady RD, 2016, J NEUROTRAUM, V33, P2154, DOI 10.1089/neu.2014.3836; Chen KL, 2016, TRENDS ENDOCRIN MET, V27, P752, DOI 10.1016/j.tem.2016.08.001; Chen YC, 2017, J CLIN ENDOCR METAB, V102, P3635, DOI 10.1210/jc.2017-00513; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cohen J., 1992, CURR DIR PSYCHOL SCI, V1, P98, DOI [DOI 10.2307/20182143, DOI 10.1111/1467-8721.EP10768783]; Cowan CSM, 2020, J CHILD PSYCHOL PSYC, V61, P353, DOI 10.1111/jcpp.13156; Ding K, 2020, AGING DIS, V11, P438, DOI 10.14336/AD.2019.0523; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Gokhale R, 1998, GASTROENTEROLOGY, V114, P902, DOI 10.1016/S0016-5085(98)70309-9; Hernandez CJ, 2016, J BONE MINER RES, V31, P1638, DOI 10.1002/jbmr.2887; Hoban AE, 2016, NEUROSCIENCE, V339, P463, DOI 10.1016/j.neuroscience.2016.10.003; Ibanez L, 2019, JOINT BONE SPINE, V86, P43, DOI 10.1016/j.jbspin.2018.02.008; Imai Y, 2009, ANN NY ACAD SCI, V1173, pE31, DOI 10.1111/j.1749-6632.2009.04954.x; Jin W, 2008, CYTOKINE, V44, P135, DOI 10.1016/j.cyto.2008.07.005; Ke K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246323; Kesavan C, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.42; Li JY, 2016, J CLIN INVEST, V126, P2049, DOI 10.1172/JCI86062; Li LS, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.810; Li Y, 2007, BLOOD, V109, P3839, DOI 10.1182/blood-2006-07-037994; Locatelli V, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/235060; Martin AM, 2020, NEUROGASTROENT MOTIL, V32, DOI 10.1111/nmo.13869; Medina-Gomez C., 2018, J LAB PRECIS MED, V3; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2015, NEUROBIOL DIS, V73, P1, DOI 10.1016/j.nbd.2014.09.003; Olson LE, 2011, CALCIFIED TISSUE INT, V88, P1, DOI 10.1007/s00223-010-9436-2; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Otto E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21144946; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Rauch F, 2012, J MUSCULOSKEL NEURON, V12, P1; Rauch F, 2001, J BONE MINER RES, V16, P597, DOI 10.1359/jbmr.2001.16.4.597; Rizzoli R, 1999, OSTEOPOROSIS INT, V9, P17, DOI 10.1007/PL00004155; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Saltzman JR, 1998, GASTROENTEROL CLIN N, V27, P309, DOI 10.1016/S0889-8553(05)70005-4; Schoenau E, 2001, J CLIN ENDOCR METAB, V86, P613, DOI 10.1210/jc.86.2.613; Schoenau E, 2000, J CLIN ENDOCR METAB, V85, P1095, DOI 10.1210/jc.85.3.1095; Schwarzer M, 2016, SCIENCE, V351, P854, DOI 10.1126/science.aad8588; Simon DW, 2020, BRAIN RES, V1747, DOI 10.1016/j.brainres.2020.147056; Smith E, 2016, IRISH J MED SCI, V185, P473, DOI 10.1007/s11845-016-1399-5; Strandwitz P, 2018, BRAIN RES, V1693, P128, DOI 10.1016/j.brainres.2018.03.015; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Walker E., BIO-PROTOCOL, V11; Walker EC, 2020, ELIFE, V9, DOI 10.7554/eLife.56666; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Williams JA, 2020, BONE REP, V12, DOI 10.1016/j.bonr.2019.100233; Wrigley S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00014; Xu X, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.46; Yan J, 2017, CURR OSTEOPOROS REP, V15, P376, DOI 10.1007/s11914-017-0382-z; Yan J, 2016, P NATL ACAD SCI USA, V113, pE7554, DOI 10.1073/pnas.1607235113; Yu HR, 2014, J REHABIL RES DEV, V51, P1427, DOI 10.1682/JRRD.2014.04.0095; Yu HR, 2014, BRAIN INJURY, V28, P244, DOI 10.3109/02699052.2013.859735; Yuen KCJ, 2020, J CLIN ENDOCR METAB, V105, pE3054, DOI 10.1210/clinem/dgaa398; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	58	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2352-1872			BONE REP	Bone Rep.	DEC	2021	15								101123	10.1016/j.bonr.2021.101123			11	Endocrinology & Metabolism	Emerging Sources Citation Index (ESCI)	Endocrinology & Metabolism	UY7ZF	WOS:000701736700015	34553007	gold, Green Published			2022-02-06	
J	Yang, ST; Hung, HY; Ro, LS; Liao, MF; Amstislavskaya, TG; Tikhonova, MA; Yang, YL; Lu, KT				Yang, Shih-Te; Hung, Hsiu-Yi; Ro, Long-Sun; Liao, Ming-Feng; Amstislavskaya, Tamara G.; Tikhonova, Maria A.; Yang, Yi-Ling; Lu, Kwok-Tung			Chronic Administration of 7,8-DHF Lessens the Depression-like Behavior of Juvenile Mild Traumatic Brain Injury Treated Rats at Their Adult Age	PHARMACEUTICS			English	Article						juvenile; mild traumatic brain injury; depression-like behavior; ventral hippocampus; dorsal hippocampus	MAJOR DEPRESSION; NITRIC-OXIDE; NEURON DEATH; MOUSE MODEL; EDEMA; INHIBITION; PREFERENCE; RECEPTORS; CHILDREN; AMYGDALA	Traumatic brain injury (TBI) is a leading cause of mortality and morbidity among the global youth and commonly results in long-lasting sequelae, including paralysis, epilepsy, and a host of mental disorders such as major depressive disorder. Previous studies were mainly focused on severe TBI as it occurs in adults. This study explored the long-term adverse effect of mild TBI in juvenile animals (mTBI-J). Male Sprague Dawley rats received mTBI-J or sham treatment at six weeks old, then underwent behavioral, biochemical, and histological experiments three weeks later (at nine weeks old). TTC staining, H&E staining, and brain edema measurement were applied to evaluate the mTBI-J induced cerebral damage. The forced swimming test (FST) and sucrose preference test (SPT) were applied for measuring depression-like behavior. The locomotor activity test (LAT) was performed to examine mTBI-J treatment effects on motor function. After the behavioral experiments, the dorsal hippocampus (dHip) and ventral hippocampus (vHip) were dissected out for western blotting to examine the expression of brain-derived neurotrophic factor (BDNF) and tropomyosin receptor kinase B (TrkB). Finally, a TrkB agonist 7,8-DHF was injected intraperitoneally to evaluate its therapeutic effect on the mTBI-J induced behavioral abnormalities at the early adult age. Results showed that a mild brain edema occurred, but no significant neural damage was found in the mTBI-J treated animals. In addition, a significant increase of depression-like behaviors was observed in the mTBI-J treated animals; the FST revealed an increase in immobility, and a decrease in sucrose consumption was found in the mTBI-J treated animals. There were no differences observed in the total distance traveled of the LAT and the fall latency of the rotarod test. The hippocampal BDNF expression, but not the TrkB, were significantly reduced in mTBI-J, and the mTBI-J treatment-induced depression-like behavior was lessened after four weeks of 7,8-DHF administration. Collectively, these results indicate that even a mild juvenile TBI treatment that did not produce motor deficits or significant histological damage could have a long-term adverse effect that could be sustained to adulthood, which raises the depression-like behavior in the adult age. In addition, chronic administration of 7,8-DHF lessens the mTBI-J treatment-induced depression-like behaviors in adult rats. We suggest the potential usage of 7,8-DHF as a therapeutic agent for preventing the long-term adverse effect of mTBI-J.	[Yang, Shih-Te; Hung, Hsiu-Yi; Liao, Ming-Feng; Lu, Kwok-Tung] Natl Taiwan Normal Univ, Dept Life Sci, Taipei 11677, Taiwan; [Ro, Long-Sun; Liao, Ming-Feng] Chang Gung Univ, Dept Neurol, Coll Med, Taipei 33305, Taiwan; [Ro, Long-Sun; Liao, Ming-Feng] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Neurol, Taipei 33305, Taiwan; [Ro, Long-Sun; Liao, Ming-Feng] Chang Gung Univ, Linkou Med Ctr, Coll Med, Dept Neurol, Taipei 33305, Taiwan; [Amstislavskaya, Tamara G.] Novosibirsk State Univ, Inst Med & Psychol, Novosibirsk 630090, Russia; [Tikhonova, Maria A.] Lab Expt Models Neurodegenerat Proc, Sci Res Inst Neurosci & Med, Novosibirsk 630117, Russia; [Yang, Yi-Ling] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi 600355, Taiwan		Lu, KT (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei 11677, Taiwan.; Yang, YL (corresponding author), Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi 600355, Taiwan.	hello9300102a@gmail.com; h82113joe@gmail.com; cgrols@adm.cgmh.org.tw; mingfengliao@hotmail.com; amstislavskayatg@physiol.ru; tikhonovama@physiol.ru; ylyang@mail.ncyu.edu.tw; ktlu@ntnu.edu.tw		Tikhonova, Maria/0000-0002-4265-8981	MOST, TaiwanMinistry of Science and Technology, Taiwan [MOST 108-2320-B-003- 006-MY3, MOST 107-2320-B-415-006]; Russian Science FoundationRussian Science Foundation (RSF) [20-65-46006]	FundingThe study was funded by Ministry of Science and Technology (MOST), Taiwan, MOST 108-2320-B-003- 006-MY3 (KTL); and MOST 107-2320-B-415-006 (YLY). YLY and TGA are also supported by Russian Science Foundation: RSF 20-65-46006.	Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Andrade P, 2019, J NEUROTRAUM, V36, P1890, DOI 10.1089/neu.2018.6107; Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Bayir Aysegul, 2003, Ulus Travma Acil Cerrahi Derg, V9, P154; Blakey SM, 2018, J PAIN, V19, P797, DOI 10.1016/j.jpain.2018.02.012; Bodnar CN, 2018, NEURAL REGEN RES, V13, P1693, DOI 10.4103/1673-5374.238604; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cetin A, 2019, FOLIA MORPHOL, V78, P221, DOI 10.5603/FM.a2018.0085; Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Chen L, 2015, J NEUROPATH EXP NEUR, V74, P557, DOI 10.1097/NEN.0000000000000199; Cheng PX, 2020, J SAFETY RES, V72, P93, DOI 10.1016/j.jsr.2019.12.013; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Chi H.-T, 2007, J EMERG CRIT CARE ME, V18, P61; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; Cho SJ, 2019, BIOMOL THER, V27, P85, DOI 10.4062/biomolther.2018.202; Dong C, 2009, MOL PSYCHIATR, V14, P1105, DOI 10.1038/mp.2009.92; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Gulyaeva NV, 2019, NEUROCHEM RES, V44, P1306, DOI 10.1007/s11064-018-2662-0; Gulyaeva O A, 2019, Stomatologiia (Mosk), V98, P18, DOI 10.17116/stomat20199806118; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; Hoffman AN, 2017, J NEUROTRAUM, V34, P213, DOI 10.1089/neu.2015.4339; Hsu IL, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112457; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Keep RF, 2012, TRANSL STROKE RES, V3, P263, DOI 10.1007/s12975-012-0152-2; Keller J, 2017, MOL PSYCHIATR, V22, P527, DOI 10.1038/mp.2016.120; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Khodorov B I, 2002, Neurosci Behav Physiol, V32, P541, DOI 10.1023/A:1019819925257; Ko MC, 2014, INT J NEUROPSYCHOPH, V17, P1995, DOI 10.1017/S1461145714000868; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Kuehn B, 2019, JAMA-J AM MED ASSOC, V321, P1559, DOI 10.1001/jama.2019.3877; Kuo JR, 2013, J NEUROTRAUM, V30, P1223, DOI 10.1089/neu.2012.2689; Lee AR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00331; Lin BS, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0465-3; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lu KT, 2006, EUR J PHARMACOL, V548, P99, DOI 10.1016/j.ejphar.2006.07.048; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mazwi NL, 2019, J HEAD TRAUMA REHAB, V34, pE10, DOI 10.1097/HTR.0000000000000479; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; Mehta ND, 2018, BRAIN BEHAV IMMUN, V73, P725, DOI 10.1016/j.bbi.2018.07.026; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mete AO, 2021, EUR J PHARMACOL, V907, DOI 10.1016/j.ejphar.2021.174306; Miao Z, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041375; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; PAPP M, 1991, PSYCHOPHARMACOLOGY, V104, P255, DOI 10.1007/BF02244188; Peruzzaro ST, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-018-1383-2; Phillips C, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7260130; Polyakova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141564; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Postolache TT, 2020, J ALZHEIMERS DIS, V74, P1, DOI 10.3233/JAD-191150; Razzoli M, 2011, GENES BRAIN BEHAV, V10, P424, DOI 10.1111/j.1601-183X.2011.00681.x; Reutov V., 2019, BIOPHYSICS, V64, P233, DOI [10.1134/S0006350919020143, DOI 10.1134/S0006350919020143]; Reutov V., 2020, CURR RES BIOPOLYM, V2, P112, DOI [10.29011/crbp-112.000012, DOI 10.29011/CRBP-112.000012]; Reutov V.P.S.E.G, 2021, INT J PSYCHIAT, V6, P33; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Sagarkar S, 2017, NEUROBIOL DIS, V106, P101, DOI 10.1016/j.nbd.2017.06.016; Samosudova N, 2018, BIOPHYSICS, V63, P402, DOI [10.1134/S0006350918030211, DOI 10.1134/S0006350918030211]; Schachar RJ, 2015, J CAN ACAD CHILD ADO, V24, P100; Schafe GE, 2008, LEARN MEMORY, V15, P55, DOI 10.1101/lm.746808; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Silver JM, 2019, TXB TRAUMATIC BRAIN; Silverberg ND, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2076-9; Sorokina E., 2021, NEUROSCI BEHAV PHYSI, V51, P28, DOI [10.1007/s11055-020-01035-5, DOI 10.1007/S11055-020-01035-5]; Sorokina EG, 2007, B EXP BIOL MED+, V143, P442, DOI 10.1007/s10517-007-0151-6; Sorokina Elena G, 2021, Acta Neurochir Suppl, V131, P103, DOI 10.1007/978-3-030-59436-7_22; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Sydnor VJ, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2020.102190; Tang WC, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1457-6; Todkar A, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00090; Tramontana MG, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11010117; Wang WJ, 2018, BRAIN INJURY, V32, P1858, DOI 10.1080/02699052.2018.1537513; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Yankelevitch-Yahav R, 2015, JOVE-J VIS EXP, DOI 10.3791/52587; Yi JH, 2016, BEHAV BRAIN RES, V308, P75, DOI 10.1016/j.bbr.2016.04.019; Yohn CN, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0306-y; Zhang JC, 2016, CURR NEUROPHARMACOL, V14, P721, DOI 10.2174/1570159X14666160119094646; Zhang J, 2017, NEUROCHEM INT, V111, P23, DOI 10.1016/j.neuint.2017.05.020; Zhang MW, 2016, NEUROSCI LETT, V635, P33, DOI 10.1016/j.neulet.2016.10.035; Zhang ZT, 2014, NEUROPSYCHOPHARMACOL, V39, P638, DOI 10.1038/npp.2013.243; Zhao S, 2016, MOL NEUROBIOL, V53, P1884, DOI 10.1007/s12035-015-9128-z; Zhou CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172270	96	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1999-4923		PHARMACEUTICS	Pharmaceutics	DEC	2021	13	12							2169	10.3390/pharmaceutics13122169			16	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	XX8DB	WOS:000736517800001	34959450	Green Published			2022-02-06	
J	Yang, SC; Johnson, DG; Keefe, SH; Bast, BT				Yang, Stephen C.; Johnson, Drake G.; Keefe, Susan H.; Bast, Brian T.			Aquatic Activity-Related Craniofacial Injuries Presenting to United States Emergency Departments, 2010 to 2019	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							FACIAL TRAUMA; SPORTS; PREVENTION; ANXIETY	Purpose: Aquatic activities are some of the most widely enjoyed sports and recreational activities in the United States. This study aimed to analyze the risks and types of craniofacial injuries associated with various aquatic activities. Methods: We retrospectively analyzed aquatic activity-related craniofacial injuries between 2010 and 2019 using the National Electronic Injury Surveillance System database. Aquatic activities included swimming, diving, surfing, water skiing, and water tubing. Risks and types of craniofacial injuries were analyzed according to the types of aquatic activities, age, and sex. Results: Among 48,112 patients with aquatic activity-related injuries, 9,529 (19.8%) had craniofacial injuries. In decreasing order of frequency, the causes of craniofacial injuries were swimming (79.6%), diving (7.5%), surfing (5.9%), water skiing (3.6%), and water tubing (3.5%). The proportion of craniofacial injuries among all injuries was higher in males than in females (22.8 vs 16.3%, P < .001), and decreased with age: 27.7% in 0 to 5 years, 21.5% in 6 to 11 years, 20.5% in 12 to 17 years, and 15.2% in >= 18 years (P < .001). Additionally, the proportion of craniofacial injuries was highest in diving (38.7%), and lowest in swimming (18.1%, P < .001). The male-to-female ratio in the proportion of patients with craniofacial injuries was highest in swimming at 1.42, and close to unity (0.97-1.13) in other activities. The most common type of craniofacial injury was laceration (43.5%), followed by concussion/internal organ injury (38.9%), contusion/abrasion (11.3%), and fracture (3%). Among all craniofacial injuries, the proportion of craniofacial fractures was highest in water tubing (8.5%) and lowest in swimming (2.2%, P < .001). Conclusions: Craniofacial injuries are a frequent cause of morbidity related to aquatic activities. Substantial variability exists in the risk and pattern of craniofacial injuries depending on the type of activity, age, and sex. These findings may aid in instituting educational programs and preventive measures against aquatic activity-related craniofacial injuries. (C) 2021 The American Association of Oral and Maxillofacial Surgeons.	[Yang, Stephen C.; Bast, Brian T.] Univ Calif San Francisco, Dept Oral & Maxillofacial Surg, 533 Parnassus Ave,UB 10, San Francisco, CA 94143 USA; [Yang, Stephen C.; Johnson, Drake G.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Keefe, Susan H.] Univ Calif San Francisco, Sch Dent, San Francisco, CA 94143 USA		Yang, SC (corresponding author), Univ Calif San Francisco, Dept Oral & Maxillofacial Surg, 533 Parnassus Ave,UB 10, San Francisco, CA 94143 USA.	Stephen.Yang@ucsf.edu		Yang, Stephen/0000-0002-2392-1756			Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Brain Injury Research Institute, WHAT IS CONC; Braun TL, 2017, SEMIN PLAST SURG, V31, P118, DOI 10.1055/s-0037-1601380; Day C, 2008, PEDIATRICS, V122, pE388, DOI 10.1542/peds.2008-0024; DeFlorio-Barker S, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-017-0347-9; Finch CF, 2012, BRIT J SPORT MED, V46, P70, DOI 10.1136/bjsports-2011-090329; Glynn SM, 2010, ORAL MAXIL SURG CLIN, V22, P217, DOI 10.1016/j.coms.2010.01.008; Guys NP, 2018, INT J PEDIATR OTORHI, V111, P153, DOI 10.1016/j.ijporl.2018.06.009; Heinsimer KR, 2013, J PHYS ACT HEALTH, V10, P151, DOI 10.1123/jpah.10.2.151; Hill LL, 2020, SHE SURF RISE FEMALE; Howland J, 1996, AM J PUBLIC HEALTH, V86, P93, DOI 10.2105/AJPH.86.1.93; Islam S, 2010, INJURY, V41, P92, DOI 10.1016/j.injury.2009.07.012; Kim HC, 2020, J SPORT SCI MED, V19, P390; Kozminski BU, 2020, J ORTHOP, V19, P184, DOI 10.1016/j.jor.2019.11.042; Marshall SW, 2003, INJURY PREV, V9, P100, DOI 10.1136/ip.9.2.100; Physical Activity Council, 2021, PART REP PHYS ACT CO; Pollard KA, 2013, AM J EMERG MED, V31, P803, DOI 10.1016/j.ajem.2013.01.028; Remnant D, 2020, J SCI MED SPORT, V23, P1049, DOI 10.1016/j.jsams.2020.05.010; Sheu Yahtyng, 2016, Natl Health Stat Report, P1; Tadros A, 2018, INT J INJ CONTROL SA, V25, P347, DOI 10.1080/17457300.2018.1431935; Taylor DM, 2004, J SCI MED SPORT, V7, P429, DOI 10.1016/S1440-2440(04)80260-3; Tebble NJ, 2004, J ADV NURS, V47, P417, DOI 10.1111/j.1365-2648.2004.03123.x; Thacker SB, 2007, J ATHL TRAINING, V42, P171; Trinidad A, 2021, PM&R, V13, P1005, DOI 10.1002/pmrj.12503; United States Consumer Product Safety Commission, NAT EL INJ SURV SYST	25	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	DEC	2021	79	12							2538.e1	10.1016/j.joms.2021.07.018			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	XN9FF	WOS:000729802300028	34453914				2022-02-06	
J	Yount, DL; Jesunathadas, M; Plaisted, TE; York, S; Edwards, ED; Gould, TE; Chatham, LS; Piland, SG				Yount, Darcie L.; Jesunathadas, Mark; Plaisted, Thomas E.; York, Shayne; Edwards, Elizabeth D.; Gould, Trenton E.; Chatham, Lillian S.; Piland, Scott G.			Performance of a novel football helmet technology on head impact kinematics	SPORTS ENGINEERING			English	Article						American football; Helmet; Rotation; Kinematics	ANGULAR ACCELERATION; CONCUSSION; RISK; MOUTHGUARD; SYSTEM	In the effort to reduce concussions in American football, helmet manufacturers are seeking new technologies to reduce peak head impact kinematics. However, the efficacy of these new helmet technologies is unknown. Therefore, the purpose of this study was to evaluate the influence of an intermediary liner on the blunt impact kinematic performance of an American football helmet using a custom test similar to the NOCSAE (ND-081) and NFL linear impactor test methods. Twelve Schutt F7 football helmets with the Radian Diffusion System technology were evaluated under three conditions: with the system (hypothesized to function as a slip plane), without the system, and with a modified system using cloth to cover the hook and loop attachment that, by design, mechanically adheres the system to the comfort liner of the helmet. Helmets were impacted three times at 6 m/s (281 J) at six locations [side, rear boss non-centroidal, rear boss centroidal, rear, front boss, and a random location used for all helmets] using a pneumatic ram. While an effect was found for linear accelerations at the Rear, Rear Boss Center of Gravity, Rear Boss Non-Centroidal, and Random locations, no overall differences between liner conditions were observed for peak resultant linear (p = 0.310) and angular accelerations (p = 0.231), or peak resultant angular velocity (p = 0.127).	[Yount, Darcie L.; Jesunathadas, Mark; York, Shayne; Edwards, Elizabeth D.; Gould, Trenton E.; Piland, Scott G.] Univ Southern Mississippi, Dept Kinesiol & Nutr, Hattiesburg, MS 39406 USA; [Plaisted, Thomas E.] DEVCOM Army Res Lab, Weap & Mat Res Directorate, Aberdeen, MD USA; [Chatham, Lillian S.] Impressio Inc, Res & Dev, Denver, CO USA		Piland, SG (corresponding author), Univ Southern Mississippi, Dept Kinesiol & Nutr, Hattiesburg, MS 39406 USA.	scott.piland@usm.edu	, scott/ABB-2057-2021		University of Southern Mississippi; Combat Capabilities Development Command Army Research Laboratory, Aberdeen Proving Ground, MD [W911NF-18-2-0061]	This research was conducted pursuant to a Cooperative Research Agreement between the University of Southern Mississippi and the Combat Capabilities Development Command Army Research Laboratory, Aberdeen Proving Ground, MD under contract W911NF-18-2-0061. Any opinions, conclusions, or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the sponsoring organizations.	Aare M., 2003, TRAFFIC INJ PREV, DOI [10.1080/15389580390216244, DOI 10.1080/15389580390216244]; [Anonymous], 2019, NFL PLAY SMART PLAY; Arosio B., 2017, TRB 1 INT ROADS SAF; Beusenberg MC., 2000, P INT RES C BIOM IMP; Bland ML, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040019; Bliven E, 2019, ACCIDENT ANAL PREV, V124, P58, DOI 10.1016/j.aap.2018.12.017; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Denavit J., 1955, T ASME J APPL MECH, V22, P215; DiMasi F, 1995, 808 282 DOT HS; Forbes JA, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12288; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Funk JR, 2006, INT BIOM RES P 34 IN, P1; Halldin P, 2001, INT J CRASHWORTHINES, V6, P53, DOI 10.1533/cras.2001.0162; Halldin P, 2003, RTO M; Hansen K, 2013, ACCIDENT ANAL PREV, V59, P109, DOI 10.1016/j.aap.2013.05.019; Hoshizaki TB, 2019, Helmet U.S. patent application, Patent No. [2019/0328072, 20190328072]; Hoshizaki TB, 2017, P I MECH ENG P-J SPO, V231, P83, DOI 10.1177/1754337116633376; Humanetics Innovative Solutions, 2012, HYBR 3 50 PERC MAL, P1; Jesunathadas M, 2020, J BIOMECH, V109, DOI 10.1016/j.jbiomech.2020.109923; King A. I., 2003, IRCOBI C LISB PORT; Mueller FO, 1998, CLIN SPORT MED, V17, P169, DOI 10.1016/S0278-5919(05)70071-5; NOCSAE, 2019, 00217M19A NOCSAE ND; NOCSAE, 2018, STAND PNEUM RAM TEST; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Reid S E, 1974, J Sports Med, V2, P86; Rowson S., ADULT FOOTBALL STAR, P3; Rowson S, 2016, SPORTS MED ARTHROSC, V24, P100, DOI 10.1097/JSA.0000000000000121; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Sances A, 2002, BIOMED SCI INSTRUM, V38, P459; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Siegmund GP, 2014, ANN BIOMED ENG, V42, P1834, DOI 10.1007/s10439-014-1052-2; Takhounts EG, 2009, P 21 INT TECH C ENHA; Vanhoutin L, 2020, Football helmet having exceptional impact performance U.S. application, Patent No. [2020/0345096, 20200345096]; Viano DC., 2018, BRAIN INJURY MED PRI, V2, P124; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Withnall, 2017, NFL LINEAR IMPACTOR; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; York S, 2020, AM SOC BIOM VIRT C, P597; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2017, ANN BIOMED ENG, V45, P2437, DOI 10.1007/s10439-017-1888-3	45	0	0	3	3	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1369-7072	1460-2687		SPORTS ENG	Sports Eng.	DEC	2021	24	1							18	10.1007/s12283-021-00355-0			11	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	UI9VL	WOS:000690944800001					2022-02-06	
J	Yousefvand, S; Hadjzadeh, MAR; Keshavarzi, Z; Dolatshad, H; Vafaee, F; Mahmoudabady, M; Virany, ZG				Yousefvand, Shiba; Hadjzadeh, Mousa-al-Reza; Keshavarzi, Zakieh; Dolatshad, Hamid; Vafaee, Farzaneh; Mahmoudabady, Maryam; Virany, Zahra Gholamzadeh			Effects of prolactin on movement disorders and APOE, GFAP, and PRL receptor gene expression following intracerebral hemorrhage in rats	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						ApoE; GFAP; ICH; PRL receptor; Striatum	TRAUMATIC BRAIN-INJURY; GLIAL ACTIVATION; FEMALE RAT; EXCITOTOXICITY; MARKERS; WEIGHT	Objective(s): Intracerebral hemorrhage (ICH) occurs mostly in the striatum. In ICH, blood prolactin level increases 3-fold. The effects of intracerebroventricular injection (ICV) of prolactin on motor disorders will be investigated. Materials and Methods: This study was performed on 32 male Wistar rats in 4 groups: sham, ICH, and prolactin with 1 mu g/2 mu l (P1) and 2 mu g/2 mu l (P2) doses. Results: The weight of animals on days 1 (P<0.01), 3, and 7 (P<0.05) in the sham and P2 groups increased compared with the ICH group. Neurological Deficit Score (NDS) in ICH and P1 groups decreased, and increased compared with sham and ICH groups (P<0.001), respectively. NDS in the P1 group increased compared with the P2 group on days 1 (P<0.0 5), 3, and 7 (P<0.001). The duration time of rotarod in ICH and P1 groups decreased and increased compared with sham and ICH groups (P<0.001), respectively. The duration time of rotarod in the I'l group on days 3 and 7 increased compared with the P2 group (P<0.001). Travel distance in days 1(P<0.01), 3(P<0.001), and 7(P<0.01) decreased in the ICH group. Prolactin receptor (PRL receptor) expression in ICH, P1, and P2 groups increased compared with sham and ICH groups (P<0.001). Glial fibrillary acidic protein (GFAP) expression (P<0.001) and apolipoprotein E (APOE) (P<0.01) expression in the ICH group increased compared with the sham group. GFAP and APOE expression in the P1 group increased compared with the ICH group (P<0.001). APOE expression in the P1 group increased compared with the P2 group (P<0.001). Conclusion: According to the results, prolactin reduces movement disorders.	[Yousefvand, Shiba; Hadjzadeh, Mousa-al-Reza; Mahmoudabady, Maryam] Mashhad Univ Med Sci, Fac Med, Dept Physiol, Mashhad, Razavi Khorasan, Iran; [Hadjzadeh, Mousa-al-Reza] Mashhad Univ Med Sci, Psychiat & Behav Sci Res Ctr, Div Neurocognit Sci, Mashhad, Razavi Khorasan, Iran; [Hadjzadeh, Mousa-al-Reza; Mahmoudabady, Maryam] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Keshavarzi, Zakieh] North Khorasan Univ Med Sci, Sch Med, Dept Physiol, Bojnurd, Iran; [Dolatshad, Hamid] Univ Oxford, Radcliffe Dept Med, Div Clin Lab Sci, Oxford, England; [Vafaee, Farzaneh] Mashhad Univ Med Sci, Neurosci Res Ctr, Mashhad, Razavi Khorasan, Iran; [Vafaee, Farzaneh] Mashhad Univ Med Sci, Fac Med, Dept Neurosci, Mashhad, Razavi Khorasan, Iran; [Virany, Zahra Gholamzadeh] Islamic Azad Univ, Fac Sci, Dept Biol, Mashhad Branch, Mashhad, Razavi Khorasan, Iran		Hadjzadeh, MAR (corresponding author), Mashhad Univ Med Sci, Fac Med, Dept Physiol, Mashhad, Razavi Khorasan, Iran.; Hadjzadeh, MAR (corresponding author), Mashhad Univ Med Sci, Psychiat & Behav Sci Res Ctr, Div Neurocognit Sci, Mashhad, Razavi Khorasan, Iran.; Hadjzadeh, MAR (corresponding author), Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran.	hajzadehmr@mums.ac.ir			Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Division of Clinical Laboratory Science, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom; Mashhad University of Medical Sciences [981035]; Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran	The authors extend their thanks to the Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran, and Division of Clinical Laboratory Science, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom, for their cooperation and support of this article. The results presented in this paper were part of the postdoctoral thesis of Shiba Yousefvand . This research was supported by a specific grant from Mashhad University of Medical Sciences (Grant no.: 981035) .	Abdi T, 2021, CAN J DIABETES, V45, P220, DOI 10.1016/j.jcjd.2020.08.102; Allard L, 2004, PROTEOMICS, V4, P2242, DOI 10.1002/pmic.200300809; Anagnostou I, 2018, GEN COMP ENDOCR, V265, P106, DOI 10.1016/j.ygcen.2018.01.024; Arnold E, 2014, J NEUROSCI, V34, P1868, DOI 10.1523/JNEUROSCI.2452-13.2014; Augustine RA, 2017, J PHYSIOL-LONDON, V595, P3591, DOI 10.1113/JP273712; Cabrera V, 2013, J NEUROENDOCRINOL, V25, P519, DOI 10.1111/jne.12028; Cai JC, 2018, EXP THER MED, V15, P4131, DOI 10.3892/etm.2018.5938; Council N. R, 2010, GUIDE CARE USE LAB A; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; Cudaback E, 2015, GLIA, V63, P51, DOI 10.1002/glia.22732; Galho AR, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/17/175101; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Grattan DR, 2008, J NEUROENDOCRINOL, V20, P752, DOI 10.1111/j.1365-2826.2008.01736.x; Jonsson AC, 2008, STROKE, V39, P918, DOI 10.1161/STROKEAHA.107.497602; JORGENSEN MB, 1993, EXP NEUROL, V120, P70, DOI 10.1006/exnr.1993.1041; Kim E, 2015, J NEUROSCI, V35, P15113, DOI 10.1523/JNEUROSCI.2890-15.2015; Kirk SE, 2017, J NEUROENDOCRINOL, V29, DOI 10.1111/jne.12477; Klimenko LL, 2016, BIOL TRACE ELEM RES, V172, P93, DOI 10.1007/s12011-015-0586-y; Koch KA, 2004, HORM BEHAV, V46, P498, DOI 10.1016/j.yhbeh.2004.02.012; Krafft PR, 2012, JOVE-J VIS EXP, DOI 10.3791/4289; Levine S, 2018, OBSTET GYNECOL INT, V2018, DOI 10.1155/2018/9253083; Mangoura D, 2000, INT J DEV NEUROSCI, V18, P693, DOI 10.1016/S0736-5748(00)00031-9; Moderscheim TAE, 2007, NEUROSCIENCE, V145, P963, DOI 10.1016/j.neuroscience.2006.12.053; Ochoa-Amaya JE, 2010, NEUROIMMUNOMODULAT, V17, P386, DOI 10.1159/000292063; Ortiz-Perez A, 2019, NEUROSCI LETT, V694, P116, DOI 10.1016/j.neulet.2018.11.052; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rektor I, 2004, EXP BRAIN RES, V158, P289, DOI 10.1007/s00221-004-1901-6; Reyes-Mendoza J, 2016, NEUROSCIENCE, V328, P58, DOI 10.1016/j.neuroscience.2016.04.030; Rivera JC, 2008, EXP EYE RES, V86, P314, DOI 10.1016/j.exer.2007.11.003; Rojas H, 2008, ACTA NEUROCHIR SUPPL, V105, P19; Sansing LH, 2011, JOVE-J VIS EXP, DOI 10.3791/2618; Seghatoleslam M, 2012, IRAN J BASIC MED SCI, V15, P860; Skalny AV, 2017, J TRACE ELEM MED BIO, V43, P142, DOI 10.1016/j.jtemb.2016.12.018; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; Suidan GL, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092161; Tejadilla D, 2010, NEUROSCIENCE, V169, P1178, DOI 10.1016/j.neuroscience.2010.05.074; Tolli A, 2017, J ENDOCRINOL INVEST, V40, P193, DOI 10.1007/s40618-016-0546-1; Vafaee F, 2018, GALEN MED J, V7, DOI 10.22086/gmj.v0i0.1353; Verstraeten S, 2016, STROKE RES THER, V1, P1; Wang XH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113368; Wen ZJ, 2017, NEUROCHEM RES, V42, P2372, DOI 10.1007/s11064-017-2257-1; Yousefvand S, 2020, LIFE SCI, V263, DOI 10.1016/j.lfs.2020.118547; Zhu YG, 2012, GLIA, V60, P559, DOI 10.1002/glia.22289	44	0	0	0	0	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	DEC	2021	24	12					1709	1716					8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	XP3FI	WOS:000730754200012					2022-02-06	
J	Yousefvand, S; Hadjzadeh, MAR; Keshavarzi, Z; Dolatshad, H; Vafaee, F; Mahmoudabady, M; Virany, ZG				Yousefvand, Shiba; Hadjzadeh, Mousa-al-Reza; Keshavarzi, Zakieh; Dolatshad, Hamid; Vafaee, Farzaneh; Mahmoudabady, Maryam; Virany, Zahra Gholamzadeh			Effects of prolactin on movement disorders and APOE, GFAP, and PRL receptor gene expression following intracerebral hemorrhage in rats	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Original; ApoE; GFAP; ICH; PRL receptor; Striatum	TRAUMATIC BRAIN-INJURY; GLIAL ACTIVATION; FEMALE RAT; EXCITOTOXICITY; PROTECTS; MARKERS; WEIGHT; CELLS	Objective(s): Intracerebral hemorrhage (ICH) occurs mostly in the striatum. In ICH, blood prolactin level increases 3-fold. The effects of intracerebroventricular injection (ICV) of prolactin on motor disorders will be investigated. Materials and Methods: This study was performed on 32 male Wistar rats in 4 groups: sham, ICH, and prolactin with 1 mu g/2 mu l (P1) and 2 mu g/2 mu l (P2) doses. Results: The weight of animals on days 1 (P<0.01), 3, and 7 (P<0.05) in the sham and P2 groups increased compared with the ICH group. Neurological Deficit Score (NDS) in ICH and P1 groups decreased, and increased compared with sham and ICH groups (P<0.001), respectively. NDS in the P1 group increased compared with the P2 group on days 1 (P<0.0 5), 3, and 7 (P<0.001). The duration time of rotarod in ICH and P1 groups decreased and increased compared with sham and ICH groups (P<0.001), respectively. The duration time of rotarod in the P1 group on days 3 and 7 increased compared with the P2 group (P<0.001). Travel distance in days 1(P<0.01), 3(P<0.001), and 7(P<0.01) decreased in the ICH group. Prolactin receptor (PRL receptor) expression in ICH, P1, and P2 groups increased compared with sham and ICH groups (P<0.001). Glial fibrillary acidic protein (GFAP) expression (P<0.001) and apolipoprotein E (APOE) (P<0.01) expression in the ICH group increased compared with the sham group. GFAP and APOE expression in the P1 group increased compared with the ICH group (P<0.001). APOE expression in the P1 group increased compared with the P2 group (P<0.001). Conclusion: According to the results, prolactin reduces movement disorders.	[Yousefvand, Shiba; Hadjzadeh, Mousa-al-Reza; Mahmoudabady, Maryam] Mashhad Univ Med Sci, Fac Med, Dept Physiol, Mashhad, Razavi Khorasan, Iran; [Hadjzadeh, Mousa-al-Reza] Mashhad Univ Med Sci, Psychiat & Behav Sci Res Ctr, Div Neurocognit Sci, Mashhad, Razavi Khorasan, Iran; [Hadjzadeh, Mousa-al-Reza; Mahmoudabady, Maryam] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Keshavarzi, Zakieh] North Khorasan Univ Med Sci, Sch Med, Dept Physiol, Bojnurd, Iran; [Dolatshad, Hamid] Univ Oxford, Radcliffe Dept Med, Div Clin Lab Sci, Oxford, England; [Vafaee, Farzaneh] Mashhad Univ Med Sci, Neurosci Res Ctr, Mashhad, Razavi Khorasan, Iran; [Vafaee, Farzaneh] Mashhad Univ Med Sci, Fac Med, Dept Neurosci, Mashhad, Razavi Khorasan, Iran; [Virany, Zahra Gholamzadeh] Islamic Azad Univ, Fac Sci, Dept Biol, Mashhad Branch, Mashhad, Razavi Khorasan, Iran		Hadjzadeh, MAR (corresponding author), Mashhad Univ Med Sci, Fac Med, Dept Physiol, Mashhad, Razavi Khorasan, Iran.; Hadjzadeh, MAR (corresponding author), Mashhad Univ Med Sci, Psychiat & Behav Sci Res Ctr, Div Neurocognit Sci, Mashhad, Razavi Khorasan, Iran.; Hadjzadeh, MAR (corresponding author), Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran.	hajzadehmr@mums.ac.ir			Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Division of Clinical Laboratory Science; Mashhad University of Medical Sciences [981035]	The authors extend their thanks to the Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran, and Division of Clinical Laboratory Science, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom, for their cooperation and support of this article. The results presented in this paper were part of the postdoctoral thesis of Shiba Yousefvand . This research was supported by a specific grant from Mashhad University of Medical Sciences (Grant no.: 981035) .	Abdi T, 2021, CAN J DIABETES, V45, P220, DOI 10.1016/j.jcjd.2020.08.102; Allard L, 2004, PROTEOMICS, V4, P2242, DOI 10.1002/pmic.200300809; Anagnostou I, 2018, GEN COMP ENDOCR, V265, P106, DOI 10.1016/j.ygcen.2018.01.024; Arnold E, 2014, J NEUROSCI, V34, P1868, DOI 10.1523/JNEUROSCI.2452-13.2014; Augustine RA, 2017, J PHYSIOL-LONDON, V595, P3591, DOI 10.1113/JP273712; Cabrera V, 2013, J NEUROENDOCRINOL, V25, P519, DOI 10.1111/jne.12028; Cai JC, 2018, EXP THER MED, V15, P4131, DOI 10.3892/etm.2018.5938; Council N. R, 2010, GUIDE CARE USE LAB A; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; Cudaback E, 2015, GLIA, V63, P51, DOI 10.1002/glia.22732; Galho AR, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/17/175101; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Grattan DR, 2008, J NEUROENDOCRINOL, V20, P752, DOI 10.1111/j.1365-2826.2008.01736.x; Jonsson AC, 2008, STROKE, V39, P918, DOI 10.1161/STROKEAHA.107.497602; JORGENSEN MB, 1993, EXP NEUROL, V120, P70, DOI 10.1006/exnr.1993.1041; Kim E, 2015, J NEUROSCI, V35, P15113, DOI 10.1523/JNEUROSCI.2890-15.2015; Kirk SE, 2017, J NEUROENDOCRINOL, V29, DOI 10.1111/jne.12477; Klimenko LL, 2016, BIOL TRACE ELEM RES, V172, P93, DOI 10.1007/s12011-015-0586-y; Koch KA, 2004, HORM BEHAV, V46, P498, DOI 10.1016/j.yhbeh.2004.02.012; Krafft PR, 2012, JOVE-J VIS EXP, DOI 10.3791/4289; Levine S, 2018, OBSTET GYNECOL INT, V2018, DOI 10.1155/2018/9253083; Mangoura D, 2000, INT J DEV NEUROSCI, V18, P693, DOI 10.1016/S0736-5748(00)00031-9; Moderscheim TAE, 2007, NEUROSCIENCE, V145, P963, DOI 10.1016/j.neuroscience.2006.12.053; Ochoa-Amaya JE, 2010, NEUROIMMUNOMODULAT, V17, P386, DOI 10.1159/000292063; Ortiz-Perez A, 2019, NEUROSCI LETT, V694, P116, DOI 10.1016/j.neulet.2018.11.052; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rektor I, 2004, EXP BRAIN RES, V158, P289, DOI 10.1007/s00221-004-1901-6; Reyes-Mendoza J, 2016, NEUROSCIENCE, V328, P58, DOI 10.1016/j.neuroscience.2016.04.030; Rivera JC, 2008, EXP EYE RES, V86, P314, DOI 10.1016/j.exer.2007.11.003; Rojas H, 2008, ACTA NEUROCHIR SUPPL, V105, P19; Sansing LH, 2011, JOVE-J VIS EXP, DOI 10.3791/2618; Seghatoleslam M, 2012, IRAN J BASIC MED SCI, V15, P860; Skalny AV, 2017, J TRACE ELEM MED BIO, V43, P142, DOI 10.1016/j.jtemb.2016.12.018; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; Suidan GL, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092161; Tejadilla D, 2010, NEUROSCIENCE, V169, P1178, DOI 10.1016/j.neuroscience.2010.05.074; Tolli A, 2017, J ENDOCRINOL INVEST, V40, P193, DOI 10.1007/s40618-016-0546-1; Vafaee F, 2018, GALEN MED J, V7, DOI 10.22086/gmj.v0i0.1353; Verstraeten S, 2016, STROKE RES THER, V1, P1; Wang XH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113368; Wen ZJ, 2017, NEUROCHEM RES, V42, P2372, DOI 10.1007/s11064-017-2257-1; Yousefvand S, 2020, LIFE SCI, V263, DOI 10.1016/j.lfs.2020.118547; Zhu YG, 2012, GLIA, V60, P559, DOI 10.1002/glia.22289	44	0	0	0	0	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	DEC	2021	24	12					1709	1716		10.22038/IJBMS.2021.58176.12927			8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	YJ0IK	WOS:000744222800005					2022-02-06	
J	Yu, H; Liu, XJ; Chen, BX; Vickstrom, CR; Friedman, V; Kelly, TJ; Bai, XW; Zhao, L; Hillard, CJ; Liu, QS				Yu, Hao; Liu, Xiaojie; Chen, Bixuan; Vickstrom, Casey R.; Friedman, Vladislav; Kelly, Thomas J.; Bai, Xiaowen; Zhao, Li; Hillard, Cecilia J.; Liu, Qing-Song			The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson's Disease	CELLS			English	Article						Parkinson's disease; 6-OHDA; GW842166x; dopamine neuron; motor function; I-h; cannabinoid type 2 receptor; substantia nigra pars compacta; neuroprotection	CANNABINOID RECEPTOR AGONIST; LEVODOPA-INDUCED DYSKINESIA; 6-HYDROXYDOPAMINE LESIONS; NEURONAL VULNERABILITY; DOPAMINERGIC-NEURONS; THERAPEUTIC TARGET; CAMP MODULATION; ION CHANNELS; CELL LOSS; L-DOPA	Parkinson's disease (PD) is a chronic neurodegenerative disorder associated with dopamine neuron loss and motor dysfunction. Neuroprotective agents that prevent dopamine neuron death hold great promise for slowing the disease's progression. The activation of cannabinoid (CB) receptors has shown neuroprotective effects in preclinical models of neurodegenerative disease, traumatic brain injury, and stroke, and may provide neuroprotection against PD. Here, we report that the selective CB2 agonist GW842166x exerted protective effects against the 6-hydroxydopamine (6-OHDA)-induced loss of dopamine neurons and its associated motor function deficits in mice, as shown by an improvement in balance beam walking, pole, grip strength, rotarod, and amphetamine-induced rotation tests. The neuroprotective effects of GW842166x were prevented by the CB2 receptor antagonist AM630, suggesting a CB2-dependent mechanism. To investigate potential mechanisms for the neuroprotective effects of GW842166x, we performed electrophysiological recordings from substantia nigra pars compacta (SNc) dopamine neurons in ex vivo midbrain slices prepared from drug-naive mice. We found that the bath application of GW842166x led to a decrease in action potential firing, likely due to a decrease in hyperpolarization-activated currents (I-h) and a shift of the half-activation potential (V-1/2) of I-h to a more hyperpolarized level. Taken together, the CB2 agonist GW842166x may reduce the vulnerability of dopamine neurons to 6-OHDA by decreasing the action potential firing of these neurons and the associated calcium load.	[Yu, Hao; Liu, Xiaojie; Chen, Bixuan; Vickstrom, Casey R.; Friedman, Vladislav; Kelly, Thomas J.; Hillard, Cecilia J.; Liu, Qing-Song] Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Yu, Hao; Zhao, Li] Beijing Sport Univ, Dept Exercise Physiol, Beijing 100084, Peoples R China; [Bai, Xiaowen] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA		Liu, QS (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	xibai@mcw.edu; qsliu@mcw.edu		Hillard, Cecilia/0000-0002-9678-748X; Bai, Xiaowen/0000-0002-9342-4480; Liu, Qing-song/0000-0003-1858-1504; Friedman, Vladislav/0000-0002-5567-2520; Liu, Xiaojie/0000-0001-9843-1674; Kelly, Thomas/0000-0002-8390-0818	Research and Education Initiative Fund, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH121454, R01 DA035217, R01 DA047269, R01 GM112696]	FundingThis work was supported by the Research and Education Initiative Fund, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin (to Q.-S.L. and C.J.H.). This work was also partially supported by the NIH grants R01 MH121454 (to Q.-S.L. and C.J.H.), R01 DA035217 and R01 DA047269 (to Q.-S.L.) and R01 GM112696 (to X.B.).	Basavarajappa BS, 2017, J NEUROCHEM, V142, P624, DOI 10.1111/jnc.14098; Biel Martin, 2009, V191, P111, DOI 10.1007/978-3-540-68964-5_7; Biglan KM, 2017, ANN CLIN TRANSL NEUR, V4, P360, DOI 10.1002/acn3.412; Bjorklund A, 2019, J PARKINSON DIS, V9, P17, DOI 10.3233/JPD-181525; Bonito-Oliva A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00290; Castro B, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2237; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Chung ES, 2012, BRAIN RES, V1451, P110, DOI 10.1016/j.brainres.2012.02.058; Chung YC, 2011, J IMMUNOL, V187, P6508, DOI 10.4049/jimmunol.1102435; Concannon RM, 2015, EXP NEUROL, V269, P133, DOI 10.1016/j.expneurol.2015.04.007; Garcia MC, 2015, NEUROSCI LETT, V587, P1, DOI 10.1016/j.neulet.2014.12.003; Dhopeshwarkar A, 2014, MOL PHARMACOL, V86, P430, DOI 10.1124/mol.114.094649; Duda J, 2016, J NEUROCHEM, V139, P156, DOI 10.1111/jnc.13572; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001; Fox SH, 2002, MOVEMENT DISORD, V17, P1180, DOI 10.1002/mds.10289; Fox SH, 2002, MOVEMENT DISORD, V17, P145, DOI 10.1002/mds.1280; Franz O, 2000, EUR J NEUROSCI, V12, P2685, DOI 10.1046/j.1460-9568.2000.00151.x; Gambardella C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052329; Garcia C, 2011, BRIT J PHARMACOL, V163, P1495, DOI 10.1111/j.1476-5381.2011.01278.x; GERMAN DC, 1992, ANN NY ACAD SCI, V648, P42, DOI 10.1111/j.1749-6632.1992.tb24523.x; Giblin GMP, 2007, J MED CHEM, V50, P2597, DOI 10.1021/jm061195+; Guzman JN, 2018, J CLIN INVEST, V128, P2266, DOI 10.1172/JCI95898; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Han QW, 2020, PROG NEURO-PSYCHOPH, V96, DOI 10.1016/j.pnpbp.2019.109745; Hernandez-Baltazar D, 2017, NEUROLOGIA, V32, P533, DOI 10.1016/j.nrl.2015.06.011; Heuer A, 2012, BEHAV BRAIN RES, V228, P30, DOI 10.1016/j.bbr.2011.11.027; Ibsen MS, 2017, CANNABIS CANNABINOID, V2, P48, DOI 10.1089/can.2016.0037; Jackson-Lewis Vernice, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS183, DOI 10.1016/S1353-8020(11)70057-8; Javed H, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00321; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Konnova EA., 2018, PARKINSONS DIS PATHO, DOI [10.15586/codonpublications.parkinsonsdisease.2018.ch5, DOI 10.15586/CODONPUBLICATIONS.PARKINSONSDISEASE.2018.CH5]; Konta Brigitte, 2008, GMS Health Technol Assess, V4, pDoc05; Ma ZG, 2019, EBIOMEDICINE, V42, P225, DOI 10.1016/j.ebiom.2019.03.040; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; Mazzoni P, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009282; Michel PP, 2016, NEURON, V90, P675, DOI 10.1016/j.neuron.2016.03.038; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Na SJ, 2010, NEUROCHEM RES, V35, P761, DOI 10.1007/s11064-010-0133-3; Navarrete F, 2018, NEUROTHERAPEUTICS, V15, P459, DOI 10.1007/s13311-018-0603-x; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Ostenfeld T, 2011, CLIN J PAIN, V27, P668, DOI 10.1097/AJP.0b013e318219799a; Philippart F, 2016, J NEUROSCI, V36, P7234, DOI 10.1523/JNEUROSCI.0459-16.2016; Price DA, 2009, EUR J NEUROSCI, V29, P2177, DOI 10.1111/j.1460-9568.2009.06764.x; Raza C, 2019, LIFE SCI, V226, P77, DOI 10.1016/j.lfs.2019.03.057; Ross RA, 1999, BRIT J PHARMACOL, V126, P665, DOI 10.1038/sj.bjp.0702351; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Shi J, 2017, ONCOTARGET, V8, P67837, DOI 10.18632/oncotarget.18871; Sieradzan KA, 2001, NEUROLOGY, V57, P2108, DOI 10.1212/WNL.57.11.2108; Song L, 2014, DRUG DES DEV THER, V8, P2173, DOI 10.2147/DDDT.S60944; Surmeier DJ, 2017, NAT REV NEUROSCI, V18, P101, DOI 10.1038/nrn.2016.178; Surmeier DJ, 2013, J BIOL CHEM, V288, P10736, DOI 10.1074/jbc.R112.410530; Ting JT, 2018, JOVE-J VIS EXP, DOI 10.3791/53825; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; VONVOIGTLANDER PF, 1973, NEUROPHARMACOLOGY, V12, P451, DOI 10.1016/0028-3908(73)90061-0; Voon V, 2017, LANCET NEUROL, V16, P238, DOI 10.1016/S1474-4422(17)30004-2; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Walsh S, 2010, BRAIN RES, V1363, P40, DOI 10.1016/j.brainres.2010.09.086; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Zhang HY, 2017, ADDICT BIOL, V22, P752, DOI 10.1111/adb.12367; Zhang HY, 2014, P NATL ACAD SCI USA, V111, pE5007, DOI 10.1073/pnas.1413210111; Zhong P, 2018, ELIFE, V7, DOI 10.7554/eLife.32420	64	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	DEC	2021	10	12							3548	10.3390/cells10123548			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	XX3OR	WOS:000736210000001	34944056	Green Published			2022-02-06	
J	Zanello, M; Roux, A; Gavaret, M; Bartolomei, F; Huberfeld, G; Charlier, P; Georges-Zimmermann, P; Carron, R; Pallud, J				Zanello, Marc; Roux, Alexandre; Gavaret, Martine; Bartolomei, Fabrice; Huberfeld, Gilles; Charlier, Philippe; Georges-Zimmermann, Patrice; Carron, Romain; Pallud, Johan			King Charles VIII of France's Death: From an Unsubstantiated Traumatic Brain Injury to More Realistic Hypotheses	WORLD NEUROSURGERY			English	Article						Brain hemorrhage; Medical history; Neurosyphilis; Retrospective diagnosis; Status epilepticus	STATUS EPILEPTICUS; HEAD TRAUMA; SYPHILIS	On April 7, 1498, Charles VIII, King of France, attended a game of palm in the ditches of the Chateau d'Amboise. The 27-year-old King suddenly collapsed and became comatose. He laid down, almost on his own, on a straw mat that was hastily arranged, and he died 9 hours later. His contemporaries perceived his death as a perfect reminder of fatality: a king could die alone in a miserable gallery. All who looked into this curious death had dwelled on the frontal blow to head that the king had sustained right before his demise and had not considered alternative scenarios. The present study, still with limited available evidence, aimed to reexamine the historical account of his death in light of modern medical knowledge. It is virtually impossible that a minor bump with low kinetic energy could kill a 27-year-old man. Many historical accounts of Charles VIII's life and death, including Italian ambassadors' letters, led us to reconsider the commonly held version and to propose an alternative hypothesis. We have concluded that Charles VIII had experienced an acute consciousness disorder with language impairment that could have been related to an epileptic condition secondary to neurosyphilis. We have discussed whether a more accurate diagnosis for the cause of death could be obtained by a pathological analysis of the King's remains.	[Zanello, Marc; Roux, Alexandre; Pallud, Johan] Hop St Anne, GHU Paris Psychiat & Neurosci, Dept Neurosurg, Paris, France; [Zanello, Marc; Roux, Alexandre; Gavaret, Martine; Pallud, Johan] Univ Paris, Paris, France; [Zanello, Marc; Roux, Alexandre; Pallud, Johan] Inst Psychiat & Neurosci Paris, INSERM UMR 1266, IMA BRAIN, Paris, France; [Gavaret, Martine] St Anne Hosp, GHU Paris Psychiat & Neurosci, Neurophysiol Dept, Paris, France; [Bartolomei, Fabrice] Timone Univ Hosp, AP HM, Epileptol & Cerebral Rythmol, Marseille, France; [Bartolomei, Fabrice; Carron, Romain] Aix Marseille Univ, INSERM, INS, Marseille, France; [Huberfeld, Gilles] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Clin Neurophysiol Dept, Paris, France; [Huberfeld, Gilles] PSL Res Univ, Labex Memolife, CNRS UMR 7241,Neuroglial Interact Cerebral Physio, INSERM,U1050,Coll France,Ctr Interdisciplinary Re, Paris, France; [Charlier, Philippe] Musee Quai Branly Jacques Chirac, Dept Res & Higher Educ, Paris, France; [Charlier, Philippe] Paris Saclay Univ, Lab Anthropol Archaeol Biol, UFR Hlth Sci, Montigny Le Bretonneux, France; [Georges-Zimmermann, Patrice] Timone Univ Hosp, AP HM, INRAR, UMR 5608,CNRS,TRACES, Marseille, France; [Carron, Romain] Timone Univ Hosp, AP HM, DEpt Funct & Stereotact Neurosurg, Marseille, France		Zanello, M (corresponding author), Hop St Anne, GHU Paris Psychiat & Neurosci, Dept Neurosurg, Paris, France.; Zanello, M (corresponding author), Univ Paris, Paris, France.; Zanello, M (corresponding author), Inst Psychiat & Neurosci Paris, INSERM UMR 1266, IMA BRAIN, Paris, France.	zanello.marc@gmail.com			Nuovo-Soldati Foundation for Cancer Research scholarship; Servier Foundation scholarship; Fundapro Foundation scholarship	The present study was supported by the Nuovo-Soldati Foundation for Cancer Research scholarship, Servier Foundation scholarship, and Fundapro Foundation scholarship.	Ances BM, 2004, EPILEPSY RES, V59, P67, DOI 10.1016/j.eplepsyres.2004.03.007; [Anonymous], 1909, Hospital (Lond 1886), V46, P545; Argens J-B de B, 1739, MEMOIRES HIST SECRET; Bagatti D, 2016, WORLD NEUROSURG, V87, DOI 10.1016/j.wneu.2015.10.085; Barberi GF, 1838, GRAND DICT FRANCAIS; Beghi E, 2020, NEUROEPIDEMIOLOGY, V54, P185, DOI 10.1159/000503831; Betjemann JP, 2015, LANCET NEUROL, V14, P615, DOI 10.1016/S1474-4422(15)00042-3; Biraben J-N, 2008, EPILEPSIES, V20, P3; Buchon JAC, 1827, CHRONIQUES JEAN MOLI, V5; Cabanes A, 1910, MORTS MYSTERIEUSES L; CAMPBELL JP, 1989, AM FAM PHYSICIAN, V40, P93; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; de Bourdeille P, 1864, SEIGNEUR BRANTOME 15; de Cherrier C, 1868, HIST CHARLES 8 ROI F; de Commynes P, 1615, MEMOIRES MESSIRE PH; de Lincy AJVLR, 1860, VIE REINE ANNE BRETA; de Marillac G, 1836, VIE CONNETABLE BOURB; Deblauwe J, 2013, QUOI SONT ILS VRAIME; Delaborde H-F, 1888, EXPEDITION CHARLES 8; Diamantis A, 2010, J NEUROL, V257, P691, DOI 10.1007/s00415-009-5433-7; Durer A., BARTSCH, V264; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Farhi D, 2010, CLIN DERMATOL, V28, P533, DOI 10.1016/j.clindermatol.2010.03.011; Gagne J, 2017, TATTI STUD, V20, P127, DOI 10.1086/691389; Gaugain L, 2018, AMBOISE CHATEAU VILL; Georges P, 2003, REV ARCHEOLOGIQUE LO, V28; Guy V, HIST GEN EPILEPSIE S; Hajjaj I, 2010, ACTA NEUROL BELG, V110, P263; Harper KN, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000148; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; JENNETT B, 1975, LANCET, V1, P480; Kuriachan VP, 2015, CURR PROB CARDIOLOGY, V40, P133, DOI 10.1016/j.cpcardiol.2015.01.002; Labande-Mailfert Y, 1975, CHARLES 8 SON MILIEU; Lowenstein DH, 1999, EPILEPSIA, V40, pS3, DOI 10.1111/j.1528-1157.1999.tb00872.x; LUGER A, 1993, SEX TRANSM DIS, V20, P110, DOI 10.1097/00007435-199303000-00010; Markatos K, 2017, WORLD NEUROSURG, V105, P745, DOI 10.1016/j.wneu.2017.06.094; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; Millett David, 2010, Handb Clin Neurol, V95, P387, DOI 10.1016/S0072-9752(08)02126-X; Mitchell PD, 2011, INT J PALEOPATHOL, V1, P81, DOI 10.1016/j.ijpp.2011.04.002; Montelescaut E, 2014, ANN BIOL CLIN-PARIS, V72, P735, DOI 10.1684/abc.2014.1012; Neret J-A, 1947, CHARLES 8 1470 1498; Panteliadis CP, 2017, BRAIN DEV-JPN, V39, P457, DOI 10.1016/j.braindev.2017.02.002; Peeling RW, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.73; Pelissier Leon G., 1896, RECHERCHES ARCH ITAL; Plous S., 1993, PSYCHOL JUDGMENT DEC; Primavera A, 1998, EPILEPSIA, V39, P1367, DOI 10.1111/j.1528-1157.1998.tb01339.x; Ropper AH, 2019, NEW ENGL J MED, V381, P1358, DOI 10.1056/NEJMra1906228; Rothschild BM, 2005, CLIN INFECT DIS, V40, P1454, DOI 10.1086/429626; Santrot J, 2017, REV ARCHEOLOGIQUE LO, V38, P8; Serafini A, 2011, SEIZURE-EUR J EPILEP, V20, P181, DOI 10.1016/j.seizure.2010.10.031; Sillanpaa M, 2008, BRAIN, V131, P938, DOI 10.1093/brain/awn037; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tampa M, 2014, J Med Life, V7, P4; Thuasne L, 1886, MAL FRANCAIS EPOQUE; Wang M-J, 2013, J NEUROCRIT CARE, V6, P40	55	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2021	156						60	67		10.1016/j.wneu.2021.09.056			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WK5EV	WOS:000709749500010	34537407				2022-02-06	
J	Zeng, ZH; Zhang, H; Wu, JW; Wei, LF; Chen, WQ; Wang, SS				Zeng, Zihuan; Zhang, Hao; Wu, Jianwu; Wei, Liangfeng; Chen, Weiqiang; Wang, Shousen			Effects and Mechanism of Mouse Nerve Growth Factor on Diffuse Brain Injury in Rats with Traumatic Brain Injury Combined with Seawater Drowning	JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING			English	Article						Traumatic Brain Injury; Seawater Drowning; Diffuse Axonal Injury; Rat; Nerve Growth Factor	IMPACT	To investigate the effect of mouse nerve growth factor (mNGF) on axonal injury after traumatic brain injury (TBI) combined with seawater drowning (SWD) in rats and the possible mechanism, we assigned 78 SD rats by random into sham group (Group A, n = 14), TBI+ SWD group (Group B, n = 32), and mNGF group (Group C, n = 32). The compound injury model of rats was established by Marmarou method (450 gx1.5 m) and intratracheal pumping seawater (3 ml/kg). Rats in Group C were subject to intraperitoneal injection of mNGF (3 ug/kg) immediately after injury, and Group A as well as Group B were intraperitoneally injected the same amount of normal saline. Modified neurological severity scores(mNSS) was performed on rats at 12 h, 24 h, 72 h as well as 168 h, respectively after injury. HE staining showed that 24 h after injury, the swelling of nerve cells in Group C was relatively milder and the tissue edema was similar to that in Group B. At 72 h and 168 h after injury, the matrix looseness, cell swelling, and nuclear condensation in Group C were improved in comparison with Group B. (2) Compared with group B, mNSS of group C decreased signally at 72 h and 68 h after injury (P < 0.05). (3) IHC staining showed that the protein expressions of beta-APP, NF-L, and AQP4 were decreased in Group C in comparison with Group B at 12 h, 24 h, 72 h and 168 h after injury. (4) Brain water content in Group C was similar to that in Group B (P > 0.05). (5) At 12 h after injury, the expression of TNF-alpha in Group C was signally lower than that in Group B (P < 0.05). Our reseache showed that mNGF might play a neuroprotective role by reducing cerebral edema and inflammatory response after TBI+ SWD injury in rats, thereby restoring part of the injured axons in TBI+ SWD rats.	[Zeng, Zihuan; Zhang, Hao; Wu, Jianwu; Wei, Liangfeng; Wang, Shousen] Fujian Med Univ, Hosp 900, Dept Neurosurg, Fuzong Clin Coll, Fuzhou 350025, Peoples R China; [Chen, Weiqiang] Shantou Univ, Affiliated Hosp 1, Dept Neurosurg, Med Coll, Shantou 515041, Peoples R China		Wang, SS (corresponding author), Fujian Med Univ, Hosp 900, Dept Neurosurg, Fuzong Clin Coll, Fuzhou 350025, Peoples R China.				Major Medical Science and Technology Projects [AHJ14J001]	`This research was financially supported by Major Medical Science and Technology Projects (No. AHJ14J001).	Aloe L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-239; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen JQ, 2016, MED SCI MONITOR, V22, DOI 10.12659/MSM.898190; Chiaretti A, 2005, NEUROL RES, V27, P741, DOI 10.1179/016164105X35611; Chiaretti A, 2008, J TRAUMA, V65, P80, DOI 10.1097/TA.0b013e31805f7036; Chiaretti A, 2017, BRAIN INJURY, V31, P1538, DOI 10.1080/02699052.2017.1376760; Crupi R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040297; Fantacci C, 2013, BRAIN SCI, V3, P1013, DOI 10.3390/brainsci3031013; Gupta S, 2018, TRAFFIC INJ PREV, V19, P66, DOI 10.1080/15389588.2017.1342821; Han Z, 2017, MOL CELL BIOCHEM, V428, P149, DOI 10.1007/s11010-016-2925-5; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hu PJ, 2017, AM J PHYSIOL-LUNG C, V313, pL1, DOI 10.1152/ajplung.00485.2016; Huang LX, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/9497325; Layon AJ, 2009, ANESTHESIOLOGY, V110, P1390, DOI 10.1097/ALN.0b013e3181a4c3b8; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Minnone G, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051028; Pinchi E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20699-1; Rowe RK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1200-y; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Ved R, 2018, J NEUROL, V265, P1241, DOI 10.1007/s00415-018-8855-2; Wang YL, 2019, INT J MED SCI, V16, P675, DOI 10.7150/ijms.32962; Xu Mengmeng, 2017, Adv Exp Med Biol, V969, P81, DOI 10.1007/978-94-024-1057-0_5; [钟旺旺 Zhong Wangwang], 2019, [中华航海医学与高气压医学杂志, Chinese Journal of Nautical Medicine and Hyperbaric Medicine], V26, P267	26	0	0	5	5	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	2157-9083	2157-9091		J BIOMATER TISS ENG	J. Biomater. Tissue Eng.	DEC	2021	11	12					2321	2328		10.1166/jbt.2021.2832			8	Cell & Tissue Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	UH1US	WOS:000689725600002					2022-02-06	
J	Zhu, XH; Huang, LJ; Wu, K; Sun, ZZ; Wang, KK; Ru, JN; Zhuge, QC; Ruan, LH				Zhu, Xiaohong; Huang, Lijie; Wu, Ke; Sun, Zhezhe; Wang, Kankai; Ru, Junnan; Zhuge, Qichuan; Ruan, Linhui			Shikonin regulates autophagy via the AMPK/mTOR pathway and reduces apoptosis of human umbilical cord mesenchymal stem cells to improve survival in tissues surrounding brain contusion	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						shikonin; human umbilical cord mesenchymal stem cells; autophagy; apoptosis; traumatic brain injury	NF-KAPPA-B; ISCHEMIA/REPERFUSION INJURY; ACTIVATION; MECHANISMS; STRESS; DEATH; NUTRIENT; TARGET; AMPK	Shikonin has been reported to regulate autophagy via the AMP-activated protein kinase (AMPK)/mTOR signalling pathway and decrease apoptosis in transplanted human umbilical cord mesenchymal stem cells (HUMSCs). In the present study, HUMSCs were exposed to oxygen glucose deprivation (OGD) in vitro for 12 h, and TUNEL fluorescence staining was used to detect apoptosis. Differences in autophagy and AMPK/mTOR pathway-related protein expression following treatment with shikonin were quantitatively analyzed by western blotting. Green fluorescent protein-labelled stem cells were implanted into traumatic brain injury-model mice and the survival of HUMSCs was observed after 7 days. Shikonin increased the number of cells in brain tissue surrounding the contusion 7 days after transplantation. Furthermore, shikonin treatment decreased apoptosis, increased the expression of autophagy-related proteins, increased phosphorylated AMPK expression and downregulated phosphorylated mTOR expression. In addition, the autophagy inhibitor 3-methyladenine attenuated these effects and aggravated apoptosis. Subsequently, shikonin upregulated autophagy and protected HUMSCs in the area surrounding contused brain tissue. Shikonin may regulate autophagy via the AMPK/mTOR signalling pathway and protect transplanted HUMSCs from apoptosis induced by hypoxia/ischemia.	[Zhu, Xiaohong; Huang, Lijie; Wu, Ke; Sun, Zhezhe; Wang, Kankai; Ru, Junnan; Zhuge, Qichuan; Ruan, Linhui] Wenzhou Med Univ, Dept Neurosurg, Affiliated Hosp 1, 113 Fanhaixi Rd, Wenzhou 325000, Zhejiang, Peoples R China; [Zhu, Xiaohong; Huang, Lijie; Wu, Ke; Sun, Zhezhe; Wang, Kankai; Ru, Junnan; Zhuge, Qichuan; Ruan, Linhui] Wenzhou Med Univ, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Affiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China		Zhuge, QC; Ruan, LH (corresponding author), Wenzhou Med Univ, Dept Neurosurg, Affiliated Hosp 1, 113 Fanhaixi Rd, Wenzhou 325000, Zhejiang, Peoples R China.	zhugeqichuan@vip.163.com; ruanlh522@163.com	Huang, Lijie/AAD-3489-2022		Municipal Science and Technology Bureau of Wenzhou [Y20190568]	This work was partially supported by a grant from the Municipal Science and Technology Bureau of Wenzhou (grant no. Y20190568).	Arataki S, 2005, J NEUROTRAUM, V22, P398, DOI 10.1089/neu.2005.22.398; Bachmann J, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9091935; Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x; Bennett MH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004609.pub3; Bi YH, 2017, CELL PHYSIOL BIOCHEM, V43, P481, DOI 10.1159/000480474; Bolouri H, 2015, BRAIN NEUROTRAUMA MO, P645; Carrico KM, 2009, J NEUROTRAUM, V26, P1369, DOI 10.1089/neu.2008-0870; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Ding H, 2017, AM J PHYSIOL-RENAL, V313, pF561, DOI 10.1152/ajprenal.00036.2017; Fairless R, 2005, INT J BIOCHEM CELL B, V37, P693, DOI 10.1016/j.biocel.2004.10.010; Ferraro E, 2007, ARCH BIOCHEM BIOPHYS, V462, P210, DOI 10.1016/j.abb.2007.02.006; Fillmore N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120257; Gan L, 2015, BIOMED ENVIRON SCI, V28, P148, DOI 10.3967/bes2015.019; Gwon SY, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041133; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawryluk GWJ, 2020, NEUROSURGERY, V87, P427, DOI 10.1093/neuros/nyaa278; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Herberg S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058207; Hu JN, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1210-4; Jiang S, 2018, THERANOSTICS, V8, P4535, DOI 10.7150/thno.25674; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Li F, 2020, WORLD J PEDIATR, V16, P193, DOI 10.1007/s12519-019-00310-x; Li WJ, 2014, MOL CARCINOGEN, V53, P403, DOI 10.1002/mc.21988; Liu B, 2019, BIOCHEM CELL BIOL, V97, P397, DOI 10.1139/bcb-2018-0310; Liu YK, 2019, ARTIF CELL NANOMED B, V47, P626, DOI 10.1080/21691401.2019.1575229; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; McNamara EH, 2020, EXP NEUROL, V333, DOI 10.1016/j.expneurol.2020.113409; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; New J, 2019, AUTOPHAGY, V15, P1682, DOI 10.1080/15548627.2019.1596479; Palikaras K, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1056332; Qiang L, 2013, J BIOL CHEM, V288, P1603, DOI 10.1074/jbc.M112.415224; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Tang Z, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02469-5; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5; Wang FF, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00861; Wang LN, 2014, NEUROCHEM RES, V39, P97, DOI 10.1007/s11064-013-1194-x; Wang ZH, 2010, EUR J PHARMACOL, V643, P211, DOI 10.1016/j.ejphar.2010.06.027; Xia WZ, 2016, MOL MED REP, V13, P2619, DOI 10.3892/mmr.2016.4847; Xiong Y, 2012, ANN NY ACAD SCI, V1270, P51, DOI 10.1111/j.1749-6632.2012.06683.x; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang Q, 2012, STEM CELLS DEV, V21, P1321, DOI 10.1089/scd.2011.0684; Zhang ZX, 2008, CYTOTHERAPY, V10, P134, DOI 10.1080/14653240701883061	55	0	0	3	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	DEC	2021	22	6							1475	10.3892/etm.2021.10910			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	WV1GP	WOS:000716985500001	34765016	Green Published, gold			2022-02-06	
J	Zipfel, J; Engel, J; Hockel, K; Heimberg, E; Schuhmann, MU; Neunhoeffer, F				Zipfel, Julian; Engel, Juliane; Hockel, Konstantin; Heimberg, Ellen; Schuhmann, Martin U.; Neunhoeffer, Felix			Effects of hypertonic saline on intracranial pressure and cerebral autoregulation in pediatric traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; hypertonic saline; cerebral autoregulation; trauma	PERFUSION-PRESSURE; REACTIVITY	OBJECTIVE Hypertonic saline (HTS) is commonly used in children to lower intracranial pressure (ICP) after severe traumatic brain injury (sTBI). While ICP and cerebral perfusion pressure (CPP) correlate moderately to TBI outcome, indices of cerebrovascular autoregulation enhance the correlation of neuromonitoring data to neurological outcome. In this study, the authors sought to investigate the effect of HTS administration on ICP, CPP, and autoregulation in pediatric patients with sTBI. METHODS Twenty-eight pediatric patients with sTBI who were intubated and sedated were included. Blood pressure and ICP were actively managed according to the autoregulation index PRx (pressure relativity index to determine and maintain an optimal CPP [CPPopt]). In cases in which ICP was continuously > 20 mm Hg despite all other measures to decrease it, an infusion of 3% HTS was administered. The monitoring data of the first 6 hours after HTS administration were analyzed. The Glasgow Outcome Scale (GOS) score at the 3-month follow-up was used as the primary outcome measure, and patients were dichotomized into favorable (GOS score 4 or 5) and unfavorable (GOS score 1-3) groups. RESULTS The mean dose of HTS was 40 ml 3% NaCl. No significant difference in ICP and PRx was seen between groups at the HTS administration. ICP was lowered significantly in all children, with the effect lasting as long as 6 hours. The lowering of ICP was significantly greater and longer in children with a favorable outcome (p < 0.001); only this group showed significant improvement of autoregulatory capacity (p = 0.048). A newly established HTS response index clearly separated the outcome groups. CONCLUSIONS HTS significantly lowered ICP in all children after sTBI. This effect was significantly greater and longer-lasting in children with a favorable outcome. Moreover, HTS administration restored disturbed autoregulation only in the favorable outcome group. This highlights the role of a "rescuable" autoregulation regarding outcome, which might be a possible indicator of injury severity. The effect of HTS on autoregulation and other possible mechanisms should be fur-ther investigated. https://thejns.org/doi/abs/10.3171/2021.6.PEDS21143	[Zipfel, Julian; Schuhmann, Martin U.] Univ Tubingen, Dept Neurosurg, Div Pediat Neurosurg, Tubingen, Germany; [Engel, Juliane; Heimberg, Ellen; Neunhoeffer, Felix] Univ Childrens Hosp Tuebingen, Pediat Intens Care Unit, Tubingen, Germany; [Hockel, Konstantin] Isar Klinikum, Dept Spine Surg, Munich, Germany		Zipfel, J (corresponding author), Univ Tubingen, Tubingen, Germany.	julian.zipfel@med.uni-tuebingen.de					AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Appavu B, 2021, NEUROCRIT CARE, V34, P537, DOI 10.1007/s12028-020-01058-3; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2010, STROKE, V41, P1957, DOI 10.1161/STROKEAHA.109.575167; Czosnyka M, 2017, HAND CLINIC, V140, P67, DOI 10.1016/B978-0-444-63600-3.00005-2; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2020, CURR OPIN CRIT CARE, V26, P109, DOI 10.1097/MCC.0000000000000704; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Doering TJ, 1999, AM J PHYS MED REHAB, V78, P33, DOI 10.1097/00002060-199901000-00009; Fenn Norman E 3rd, 2019, J Pediatr Pharmacol Ther, V24, P465, DOI 10.5863/1551-6776-24.6.465; Froese L, 2020, ACTA NEUROCHIR, V162, P2683, DOI 10.1007/s00701-020-04579-0; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Hockel K, 2017, ACTA NEUROCHIR, V159, P2053, DOI 10.1007/s00701-017-3308-8; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lewis PM, 2015, PEDIATR CRIT CARE ME, V16, P739, DOI 10.1097/PCC.0000000000000471; Nagel C, 2016, ACTA NEUROCHIR SUPPL, V122, P239, DOI 10.1007/978-3-319-22533-3_48; Rameshkumar R, 2020, PEDIATR CRIT CARE ME, V21, P1071, DOI 10.1097/PCC.0000000000002557; Schizodimos T, 2020, J ANESTH, V34, P741, DOI 10.1007/s00540-020-02795-7; Washer L, 2021, PEDIATR EMERG CARE, V37, pE791, DOI 10.1097/PEC.0000000000001959; Woods KS, 2021, PEDIATR CRIT CARE ME, V22, P135, DOI 10.1097/PCC.0000000000002618	21	0	0	2	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2021	28	6					631	637		10.3171/2021.6.PEDS21143			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	XN9ER	WOS:000729800900002	34560657				2022-02-06	
J	Cheng, EK; Edelman, PH; Fitzpatrick, BT				Cheng, Edward K.; Edelman, Paul H.; Fitzpatrick, Brian T.			DISTRIBUTING ATTORNEY FEES IN MULTIDISTRICT LITIGATION	JOURNAL OF LEGAL ANALYSIS			English	Article							CLASS-ACTION SETTLEMENTS; RELATIONAL CONTRACTS; MORAL HAZARD; AGENTS; TOURNAMENTS; INFORMATION; INCENTIVES	As consolidated multidistrict litigation has come to dominate the federal civil docket, the problem of how to divide attorney fees among participating firms has become the source of frequent and protracted litigation. For example, in the National Football League (NFL) Concussion Litigation, the judge awarded the plaintiff attorneys over $100 million in fees, but the division of those fees among the twenty-six firms involved sparked two additional years of litigation. We explore solutions to this fee division problem, drawing insights from the economics, game theory, and industrial organization literatures. Ultimately, we propose a novel division method based on peer reports. Participating firms assess the relative contribution of other firms to the litigation, and then optimization or Bayesian techniques arrive at a consensus or compromise fee allocation. Our methods are intuitively easy to understand, enable broad participation, and are resistant to collusion or other strategic behavior, making them likely to be accepted by the firms involved. We thus provide courts with an important mediation tool or decision rule for these fee division disputes.	[Cheng, Edward K.; Edelman, Paul H.; Fitzpatrick, Brian T.] Vanderbilt Univ, Law, 221 Kirkland Hall, Nashville, TN 37235 USA; [Cheng, Edward K.] Hebrew Univ Jerusalem, Jerusalem, Israel; [Cheng, Edward K.] Vanderbilt Law Sch, 131 21st Ave South, Nashville, TN 37203 USA; [Edelman, Paul H.] Vanderbilt Univ, Math, 221 Kirkland Hall, Nashville, TN 37235 USA		Cheng, EK (corresponding author), Vanderbilt Univ, Law, 221 Kirkland Hall, Nashville, TN 37235 USA.; Cheng, EK (corresponding author), Vanderbilt Law Sch, 131 21st Ave South, Nashville, TN 37203 USA.	edward.cheng@vanderbilt.edu					AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; ALCHIAN AA, 1972, AM ECON REV, V62, P777; Amanda Bronstad, 2019, CRITICAL MASS CLASS; [Anonymous], 2021, NFL SETTLEMENT PROGR; BAIMAN S, 1980, J ACCOUNTING RES, V18, P184, DOI 10.2307/2490338; Baldenius T, 2016, J ACCOUNT ECON, V61, P369, DOI 10.1016/j.jacceco.2016.01.002; Becker Charles L., 2016, DREXEL LAW REV, V9, P1; Bronstad Amanda, 2019, STRUCTURAL PROCEDURA; Chamblee Burch Elizabeth, 2019, MASS TORT DEALS BACK; Charles Silver., 2010, VANDERBILT LAW REV, V63, P105; Che YK, 2001, AM ECON REV, V91, P525, DOI 10.1257/aer.91.3.525; CLERMONT KM, 1978, CORNELL LAW REV, V63, P529; COFFEE JC, 1986, COLUMBIA LAW REV, V86, P669, DOI 10.2307/1122577; de Clippel G, 2008, J ECON THEORY, V139, P176, DOI 10.1016/j.jet.2007.06.005; Deb J, 2016, RAND J ECON, V47, P3, DOI 10.1111/1756-2171.12116; Eisenberg T, 2010, J EMPIR LEGAL STUD, V7, P248, DOI 10.1111/j.1740-1461.2010.01178.x; Epstein Richard A, 2002, CIVIL JUSTICE REPORT; Fitzpatrick BT, 2010, J EMPIR LEGAL STUD, V7, P811, DOI 10.1111/j.1740-1461.2010.01196.x; Fitzpatrick BT, 2010, U PENN LAW REV, V158, P2043; Fitzpatrick BT, 2009, VANDERBILT LAW REV, V62, P1623; Fitzpatrick Brian T., 2019, CONSERVATIVE CASE CL; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gershkov A, 2016, J ECON THEORY, V162, P261, DOI 10.1016/j.jet.2015.12.013; Gershkov A, 2015, AM ECON J-MICROECON, V7, P27, DOI 10.1257/mic.20130277; GREEN JR, 1983, J POLIT ECON, V91, P349, DOI 10.1086/261153; Hervi Moulin., 1988, AXIOMS COOPERATIVE D, DOI [10.1017/CCOL0521360552, DOI 10.1017/CCOL0521360552]; HOLMSTROM B, 1982, BELL J ECON, V13, P324, DOI 10.2307/3003457; HOLMSTROM B, 1990, J INST THEOR ECON, V146, P85; ITOH H, 1993, J ECON THEORY, V60, P410, DOI 10.1006/jeth.1993.1050; ITOH H, 1992, J LAW ECON ORGAN, V8, P321; Jack Robertson, 1998, CAKE CUTTING ALGORIT; KANDEL E, 1992, J POLIT ECON, V100, P801, DOI 10.1086/261840; Ken Belson., 2015, NEW YORK TIMES; Klonoff Robert H., 2000, FEDERAL MULTIDISTRIC; Landeo CM, 2015, J ECON BEHAV ORGAN, V119, P496, DOI 10.1016/j.jebo.2015.09.008; LAZEAR EP, 1981, J POLIT ECON, V89, P841, DOI 10.1086/261010; MA CT, 1988, J ECON THEORY, V46, P355, DOI 10.1016/0022-0531(88)90136-6; MACHOSTADLER I, 1993, INT J IND ORGAN, V11, P73, DOI 10.1016/0167-7187(93)90037-D; Mitchell Polinsky A., 2003, AM LAW ECON REV, V5, P165; MOOKHERJEE D, 1984, REV ECON STUD, V51, P433, DOI 10.2307/2297432; Mordechai Avriel., 1976, NONLINEAR PROGRAMMIN; Resnik J, 2017, U PENN LAW REV, V165, P1765; Rubenstein William B, 2011, NEWBERG CLASS ACTION, V5; Rubenstein William B, 2009, CLASS ACTION ATTORNE, V3, P87; Siemsen E, 2007, MANAGE SCI, V53, P1533, DOI 10.1287/mnsc.1070.0714; Stan Development Team, 2020, STAN MOD LANG US GUI; Steven Brams J., 1996, FAIR DIVISION CAKE C; Steven Shavell., 2004, FDN EC ANAL LAW; Tideman TN, 2008, PUBLIC CHOICE, V136, P19, DOI 10.1007/s11127-008-9276-z; VARIAN HR, 1990, J INST THEOR ECON, V146, P153	50	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2161-7201	1946-5319		J LEGAL ANAL	J. Leg. Anal.	NOV 30	2021	13						558	594		10.1093/jla/laab002			37	Law	Social Science Citation Index (SSCI)	Government & Law	YL6IV	WOS:000745993700001		gold			2022-02-06	
J	Della Pepa, GM; Covino, M; Menna, G; Auricchio, AM; Polli, FM; Manno, A; Simeoni, B; Olivi, A; Franceschi, F				Della Pepa, Giuseppe Maria; Covino, Marcello; Menna, Grazia; Auricchio, Anna Maria; Polli, Filippo Maria; Manno, Alberto; Simeoni, Benedetta; Olivi, Alessandro; Franceschi, Francesco			Are oral anticoagulants a risk factor for mild traumatic brain injury progression? A single-center experience focused on of direct oral anticoagulants and vitamin K antagonists	ACTA NEUROCHIRURGICA			English	Article						Mild traumatic brain injury; Oral anticoagulants; Direct oral anticoagulants; Aspirin; VKA	INTRACRANIAL HEMORRHAGE; MORTALITY; WARFARIN; CT	Background Mild traumatic brain injury (TBI) in anticoagulated patients is a common challenge for emergency departments because of lack of appropriate epidemiological data and huge management variability for those under oral anticoagulation therapy. Given the discrepancies between guidelines, the aim of the present study was to quantify the association between oral anticoagulant therapy (either vitamin K antagonist (VKA) or direct oral anticoagulant (DOAC)) and the post-traumatic intracranial hemorrhage worsening compared to admission CT scan. Methods We included all consecutive records of patients admitted to our emergency department for mild TBI as chief complaint and with a positive admission CT scan. After statistical univariate comparison, cause-specific hazard ratio (HR) and 95% confidence interval (CI) were determined with the use of Cox proportional hazard model. Results In the study period, 4667 patients had a CT scan for mild TBI; 439 (9.4%) were found to have intracranial hemorrhage. Among these patients, 299 (68.1%) were prescribed observation and control CT: 46 (15.38%) were on anticoagulant therapy, 23 (50%) on VKA, and 23 (50%) on DOAC. In multivariate analysis, only oral anticoagulation therapy was significantly associated to an increased risk of intracranial hemorrhage progression (HR 2.58; 95% CI 1.411-4.703; p = .002 and HR 1.9; 95% CI 1.004-3.735; p = .0048 for VKA and DOAC, respectively). Surgery was due to isolated subdural hematoma in 87.5% of cases, to subdural hematoma associated with intraparenchymal hemorrhage in 9.38% and to intraparenchymal hemorrhage only in 3.12%; 13 cases (4.35%) deceased in intensive care unit. Conclusions In our series, anticoagulation was associated to a significant increase in intracranial progression, leaving the question open as to what this implies in current clinical practice; subdural hematoma was the major finding associated to evolution and surgery. Against this background, further studies are needed to clarify patients' management and DOAC safety profile compared to VKA in mild TBI.	[Della Pepa, Giuseppe Maria; Menna, Grazia; Auricchio, Anna Maria; Polli, Filippo Maria; Olivi, Alessandro] Catholic Univ, Fdn Policlin Univ Agostino Gemelli IRCCS, Inst Neurosurg, I-00168 Rome 8, Italy; [Covino, Marcello; Manno, Alberto; Simeoni, Benedetta; Franceschi, Francesco] Fdn Policlin Univ A Gemelli, Emergency Dept, IRCCS, Rome, Italy; [Covino, Marcello] Univ Cattolica Sacro Cuore, Rome, Italy		Menna, G (corresponding author), Catholic Univ, Fdn Policlin Univ Agostino Gemelli IRCCS, Inst Neurosurg, I-00168 Rome 8, Italy.	mennagrazia@gmail.com		Menna, Grazia/0000-0003-2594-4967; AURICCHIO, ANNA MARIA/0000-0002-4186-4476			[Anonymous], 2019, 2019 SURV HEAD INJ A; Bittencourt-Villalpando M, 2021, NEUROIMAGE-CLIN, V29, DOI 10.1016/j.nicl.2020.102534; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Fiorelli EM, 2020, J EMERG MED, V59, P843, DOI 10.1016/j.jemermed.2020.07.036; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Hecht JP, 2020, PHARMACOTHERAPY, V40, P604, DOI 10.1002/phar.2435; Hu TT, 2016, BIOL RES NURS, V18, P5, DOI 10.1177/1099800415577634; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Nagesh M, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19527; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Prexl O, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0487-0; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Trevisi G, 2018, WORLD NEUROSURG, V118, pE316, DOI 10.1016/j.wneu.2018.06.185; Turcato G, 2019, J EMERG MED, V57, P817, DOI 10.1016/j.jemermed.2019.09.007; Van Ornam J, 2019, AM J EMERG MED, V37, P1694, DOI 10.1016/j.ajem.2018.12.012; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Won SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199809	23	0	0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JAN	2022	164	1					97	105		10.1007/s00701-021-05066-w		NOV 2021	9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YH5HB	WOS:000723964400001	34850288				2022-02-06	
J	Gan, H; Zhang, L; Chen, H; Xiao, H; Wang, L; Zhai, X; Jiang, N; Liang, P; Zheng, SY; Zhao, J				Gan, Hui; Zhang, Li; Chen, Hui; Xiao, Han; Wang, Lu; Zhai, Xuan; Jiang, Ning; Liang, Ping; Zheng, Shuyue; Zhao, Jing			The pivotal role of the NLRC4 inflammasome in neuroinflammation after intracerebral hemorrhage in rats	EXPERIMENTAL AND MOLECULAR MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; CELL-DEATH; CASE-FATALITY; PROTEIN; ACTIVATION; INHIBITION; MECHANISMS; INTERLEUKIN-1-BETA; REGULATOR; APOPTOSIS	Brain hemorrhage: Reducing inflammation and brain damage Treatments that target the proteins responsible for inflammation might reduce brain damage after a hemorrhage. Sudden bleeding into the brain, known as intracerebral hemorrhage (ICH), is associated with strokes and head injuries. Inflammation exacerbates ICH-induced injury after an incident, and is activated by protein complexes called inflammasomes. Jing Zhao and co-workers at Chongqing Medical University in China induced ICH symptoms in rats by extracting arterial blood and injecting it into the basal ganglia of the brain. When they artificially blocked expression of the inflammasome NLRC4, they saw reductions in neuron death, brain edema and damage to the blood-brain barrier. The team also identified a protein critical for activating NLRC4 and another protein that suppresses NLRC4. These findings could aid the development of treatments to block NLRC4 in the days after an ICH. The NLRC4 inflammasome, a member of the nucleotide-binding and oligomerization domain-like receptor (NLR) family, amplifies inflammation by facilitating the processing of caspase-1, interleukin (IL)-1 beta, and IL-18. We explored whether NLRC4 knockdown alleviated inflammatory injury following intracerebral hemorrhage (ICH). Furthermore, we investigated whether NLRC4 inflammasome activation can be adjusted by the regulator of G protein signaling 2/leucine-rich repeat kinase-2 pathway. Fifty microliters of arterial blood was drawn and injected into the basal ganglion to simulate the ICH model. NLRC4 small interfering RNAs (siRNAs) were utilized to knockdown NLRC4. An LRRK2 inhibitor (GNE7915) was injected into the abdominal cavity. Short hairpin (sh) RNA lentiviruses and lentiviruses containing RGS2 were designed and applied to knockdown and promote RGS2 expression. Neurological functions, brain edema, Western blot, enzyme-linked immunosorbent, hematoxylin and eosin staining, Nissl staining, immunoprecipitation, immunofluorescence assay and Evans blue dye extravasation and autofluorescence assay were evaluated. It was shown that the NLRC4 inflammasome was activated following ICH injury. NLRC4 knockdown extenuated neuronal death, damage to the blood-brain barrier, brain edema and neurological deficiency 3 days after ICH. NLRC4 knockdown reduced myeloperoxidase (MPO) cells as well as tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-1 beta and IL-18 following ICH. GNE7915 reduced pNLRC4 and NLRC4 inflammasome activation. RGS2 suppressed the interaction of LRRK2 and NLRC4 and NLRC4 inflammasome activation by regulating pLRRK2. Our study demonstrated that the NLRC4 inflammasome may aggravate the inflammatory injury induced by ICH and that RGS2/LRRK2 may relieve inflammatory injury by restraining NLRC4 inflammasome activation.	[Gan, Hui; Zhao, Jing] Chongqing Med Univ, Dept Pathophysiol, Chongqing 400010, Peoples R China; [Gan, Hui; Zhai, Xuan; Jiang, Ning; Liang, Ping; Zhao, Jing] Chongqing Med Univ, Inst Neurosci, Chongqing 400010, Peoples R China; [Gan, Hui; Zhang, Li; Chen, Hui; Xiao, Han; Wang, Lu; Zhai, Xuan; Liang, Ping; Zheng, Shuyue] Chongqing Med Univ, Minist Educ, Childrens Hosp, Key Lab Child Dev & Disorders, Chongqing 400010, Peoples R China		Zhao, J (corresponding author), Chongqing Med Univ, Dept Pathophysiol, Chongqing 400010, Peoples R China.; Zhao, J (corresponding author), Chongqing Med Univ, Inst Neurosci, Chongqing 400010, Peoples R China.	zhaojing@cqmu.edu.cn			Chongqing Science and Technology Committee, China [cstc2016shmszx0432]; Natural Science Foundation of Chongqing, ChinaNatural Science Foundation of Chongqing [cstc2015jcyjBX0144]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671158, 81771261]	This work was supported by Chongqing Science and Technology Committee, China (No. cstc2016shmszx0432), Natural Science Foundation of Chongqing, China (cstc2015jcyjBX0144) and the National Natural Science Foundation of China (Nos. 81671158 and 81771261).	Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Babu R, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11366; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Cao J, 2018, NEUROBIOL DIS, V119, P53, DOI 10.1016/j.nbd.2018.07.024; Chen S, 2015, TRANSL STROKE RES, V6, P4, DOI 10.1007/s12975-014-0384-4; Chen YJ, 2015, STROKE, V46, P529, DOI 10.1161/STROKEAHA.114.007265; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Denes A, 2015, P NATL ACAD SCI USA, V112, P4050, DOI 10.1073/pnas.1419090112; DeSantis DA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/751374; Dusonchet J, 2014, HUM MOL GENET, V23, P4887, DOI 10.1093/hmg/ddu202; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Estrada AA, 2012, J MED CHEM, V55, P9416, DOI 10.1021/jm301020q; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Felberg RA, 2002, ANN NEUROL, V51, P517, DOI 10.1002/ana.10160; [甘荟 Gan Hui], 2019, [重庆医科大学学报, Jounral of Chongqing Medical University], V44, P588; Gao Z, 2008, ACTA NEUROCHIR SUPPL, V105, P51; George T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170269; Gerber KJ, 2016, MOL PHARMACOL, V89, P273, DOI 10.1124/mol.115.102210; He Q, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080897; He Q, 2017, INT IMMUNOPHARMACOL, V50, P208, DOI 10.1016/j.intimp.2017.06.029; Heneka MT, 2018, NAT REV NEUROSCI, V19, P610, DOI 10.1038/s41583-018-0055-7; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hohoff C, 2015, AM J MED GENET B, V168, P211, DOI 10.1002/ajmg.b.32299; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Janowski AM, 2016, J CLIN INVEST, V126, P3917, DOI 10.1172/JCI86953; Jiang HH, 2015, AM J RESP CELL MOL, V53, P42, DOI 10.1165/rcmb.2014-0319OC; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kim T, 2017, J CEREBR BLOOD F MET, V37, P1910, DOI 10.1177/0271678X17694186; Kolb R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13007; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Li JQ, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-47; Liao JL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124074; Liu WW, 2017, J EXP MED, V214, P3051, DOI 10.1084/jem.20170014; Liu Y, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00928; Lively S, 2012, TRANSL STROKE RES, V3, pS132, DOI 10.1007/s12975-012-0151-3; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Meng CC, 2019, J MOL NEUROSCI, V69, P411, DOI 10.1007/s12031-019-01370-4; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Qureshi AI, 2003, NEUROSURGERY, V52, P1041, DOI 10.1227/01.NEU.0000057694.96978.BC; Rui Q, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00051; Sasaki Y, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.591713; Song YQ, 2019, MED SCI MONITOR, V25, P1838, DOI 10.12659/MSM.915119; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Voet S, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201810248; Wang BF, 2015, ACTA PHARMACOL SIN, V36, P939, DOI 10.1038/aps.2015.47; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang SH, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00237; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003	55	0	0	4	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1226-3613	2092-6413		EXP MOL MED	Exp. Mol. Med.	NOV	2021	53	11					1807	1818		10.1038/s12276-021-00702-y		NOV 2021	12	Biochemistry & Molecular Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine	XH7LN	WOS:000724047600003	34848837	Green Published, gold			2022-02-06	
J	Howell, DR; Hunt, DL; Aaron, SE; Hamner, JW; Meehan, WP; Tan, CO				Howell, David R.; Hunt, Danielle L.; Aaron, Stacey E.; Hamner, Jason W.; Meehan, William P., III; Tan, Can Ozan			Association of Hemodynamic and Cerebrovascular Responses to Exercise With Symptom Severity in Adolescents and Young Adults With Concussion	NEUROLOGY			English	Article							MIDDLE CEREBRAL-ARTERY; BLOOD-FLOW-VELOCITY; STATEMENT; MEDICINE; SAFETY	Background and Objectives Aerobic exercise has become a useful method to assist with postconcussion management. Exercise can exacerbate concussion symptoms even when symptoms are not apparent at rest. Few studies have examined the reasons for symptom exacerbation during exercise following a concussion. We had 2 primary objectives: (1) to delineate cardiopulmonary and cerebrovascular responses to exercise in adolescents and young adults with a concussion and healthy controls and (2) to determine the association between cerebrovascular responses and symptom burden. Methods We recruited participants with a recent concussion from a sport concussion clinic between September 1, 2018, and February 22, 2020. They were included if their concussion occurred <3 weeks before initial testing and if they were symptomatic at rest. Participants were excluded if they sustained a concussion in the past year (excluding index injury), reported history of neurologic disorders, or were using medications/devices that may alter neurologic function. Participants completed a progressive, symptom-limited, submaximal exercise protocol on a stationary bicycle. We assessed heart rate, blood pressure, fraction of end tidal CO2 (FETCO2), and middle cerebral artery blood flow velocity (CBF) and cerebrovascular function (vasoactivity and autoregulation) at seated rest and during exercise. Results We conducted 107 exercise tests (40 concussed, 37 healthy participants initially; 30 concussed at follow-up). Concussed participants were tested initially (mean 17.6 +/- 2.2 [SD] years of age; 55% female; mean 12.5 +/- 4.7 days postconcussion) and again 8 weeks later (mean 73.3 +/- 9.5 days postconcussion). Control participants (mean 18.3 +/- 2.4 years; 62% female) were tested once. FETCO2 increased throughout the exercise protocol as heart rate increased, reached a plateau, and declined at higher exercise intensities. CO2 explained >25% of the variation in resting CBF (R-2 > 0.25; p < 0.01) in most (73% individuals). Within the concussion group, resting symptom severity and the heart rate at which FETCO2 reached a plateau explained similar to 2/3s of variation in exercise-induced symptom exacerbation (R-2 = 0.65; FETCO2 beta = -1.210 +/- 0.517 [SE], p < 0.05). There was a moderate, statistically significant relationship between cerebrovascular responses to CO2 at rest (cerebral vasoactivity) and cerebrovascular responses to exercise-induced changes in FETCO2 (R-2 = 0.13, p = 0.01). Discussion The arterial CO2 response and symptom exacerbation relationship during postconcussion aerobic exercise may be mediated by increased sensitivity of cerebral vasculature to exercise-related increase in CO2.	[Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO 80045 USA; [Howell, David R.; Hunt, Danielle L.; Meehan, William P., III] Michell Ctr Sports Injury Prevent, Waltham, MA 02453 USA; [Hunt, Danielle L.; Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Aaron, Stacey E.; Hamner, Jason W.; Tan, Can Ozan] Spaulding Rehabil Hosp, Cerebrovasc Res Lab, Charlestown, MA USA; [Hamner, Jason W.; Tan, Can Ozan] Spaulding Rehabil Hosp, Cardiovasc Res Lab, Charlestown, MA USA; [Aaron, Stacey E.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Meehan, William P., III] Harvard Med Sch, Dept Orthoped Surg & Pediat, Boston, MA 02115 USA; [Tan, Can Ozan] Massachusetts Gen Hosp, Div Neuroradiol, Boston, MA 02114 USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA.; Howell, DR (corresponding author), Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO 80045 USA.; Howell, DR (corresponding author), Michell Ctr Sports Injury Prevent, Waltham, MA 02453 USA.	david.howell@cuanschutz.edu		Howell, David/0000-0002-2955-0191	Eunice Kennedy Shriver National Institute of Child Health& Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurologic Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS106444]	Research reported in this work was supported by the Eunice Kennedy Shriver National Institute of Child Health& Human Development (R03HD094560) and the National Institute of Neurologic Disorders and Stroke (R03NS106444).	Aaron SE, 2021, ANN NEUROL, V90, P43, DOI 10.1002/ana.26082; Al-Khazraji BK., PROTOCOL DEPENDENCE; Albalawi T, 2017, J NEUROTRAUM, V34, P2700, DOI 10.1089/neu.2017.5060; American College of Sports Medicine, 2017, ACSMS GUIDELINES EXE; Bollo RJ, 2010, NEUROSURGERY, V67, pE507, DOI 10.1227/01.NEU.0000371976.21043.C8; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Haider MN, 2019, SPORTS HEALTH, V11, P492, DOI 10.1177/1941738119870189; Haider MN, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00395; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hinds A, 2016, J NEUROL NEUROPHYSIO, V7, P388, DOI DOI 10.4172/2155-9562.1000388; Howell DR, 2021, AM J SPORT MED, V49, P1912, DOI 10.1177/03635465211005761; Imhoff S, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13131; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; JORGENSEN LG, 1992, J APPL PHYSIOL, V72, P1123, DOI 10.1152/jappl.1992.72.3.1123; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Mercier LJ, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-1622-x; MORAINE JJ, 1993, EUR J APPL PHYSIOL O, V67, P35, DOI 10.1007/BF00377701; Morissette MP, 2020, MED SCI SPORT EXER, V52, P820, DOI 10.1249/MSS.0000000000002198; Orr R, 2021, CLIN J SPORT MED, V31, P23, DOI 10.1097/JSM.0000000000000683; Ozturk ED, 2018, J PHYSIOL ANTHROPOL, V37, DOI 10.1186/s40101-018-0164-z; Querido JS, 2007, SPORTS MED, V37, P765, DOI 10.2165/00007256-200737090-00002; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Secher NH, 2008, J APPL PHYSIOL, V104, P306, DOI 10.1152/japplphysiol.00853.2007; Siedlecki P, 2018, BRAIN INJURY, V32, P1824, DOI 10.1080/02699052.2018.1506945; Silverberg ND, 2021, ARCH PHYS MED REHAB, V102, P76, DOI 10.1016/j.apmr.2020.08.022; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Wilson Julie C, 2020, J Clin Transl Res, V5, P161	41	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	NOV 30	2021	97	22					E2204	E2212		10.1212/WNL.0000000000012929			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XA9ZG	WOS:000720996500020	34635563				2022-02-06	
J	Tiberini, P; D'Antona, G; Cicchella, A				Tiberini, Paolo; D'Antona, Giuseppe; Cicchella, Antonio			Brain Oxygenation in Post-concussion Combat Sport Athletes	FRONTIERS IN SPORTS AND ACTIVE LIVING			English	Article						brain concussion; mild traumatic brain injuries (mTBI); sway analysis; combat sport athletes; boxing athletes; brain concussion [MeSH]; medio-lateral oscillation; near infrared spectroscopy (NIRS)	COGNITIVE IMPAIRMENT	Purpose: Investigate the feasibility of a non-invasive method to evaluate the physical and cognitive repercussions of long-lasting post-concussion effects in professional combat sports athletes. To help athletes return to professional combat, there is a need for unbiased objective tools and techniques used as a prognostic method of recovery after Sport Related Concussion (SRC).Methods: Six mild Traumatic Brain Injury (mTBI) athletes, age 20 divided by 43 yr (1 female, 5 males) and 7 not concussed (NC) participants (amateur), age 24 divided by 38 yr (3 females, 4 males), were tested Inspired/expired gas concentration, Cerebral changes in oxygenated hemoglobin (Delta[HbO(2)]) and deoxygenated hemoglobin (Delta[HHb]) were measured using near infrared spectroscopy (NIRS) with a 3-step protocol: rest before maximal oxygen uptake (VO(2)max) test, hypercapnia, and recovery after VO(2)max test. The brain oxygenation and respiratory parameters of both sample sets were calculated using a non-parametric test (Mann-Whitney U test). Aerobic fitness outcome was quantified through mean average using the Bruce test. Participants performed Fitt's test using a laptop and analysis of medio-lateral and anterior-posterior range of oscillation was carried out via a force platform Romberg test.Results: mTBI group showed statistically significant differences in saturated hemoglobin Delta[HbO(2)] (p < 0.001) during rest and recovery phase after maximal incremental exercise, in medio-lateral sway eyes open (p = 0.008, NC 25.35 +/- 4.11 mm and mTBI 17.65 +/- 4.79 mm). VO(2)max revealed no significant differences between the two groups: NC 47.47 +/- 4.91 mTBI 49.58 +/- 5.19 ml/kg/min(-1). The 2 groups didn't differ for maximum power output (NC 220 +/- 34, mTBI 255 +/- 50 W). End-tidal fractional concentration of O-2 (FetO(2) NC15.20 +/- 0.41, mTBI 16.09 +/- 0.68) throughout hypercapnia, saturated blood hemoglobin (Delta[HbO(2)]) revealed significant differences with the mTBI group. No differences emerged from Fitt's test.Conclusions: It emerges that NIRS is able to reveal differences in long time outcomes of mTBI. The medio-lateral variations cannot be considered as a marker of long-term damage in athletes specifically trained for balance.	[Tiberini, Paolo] Univ Naples Parthenope, Dept Movement Sci & Well Being, Naples, Italy; [D'Antona, Giuseppe] Univ Pavia, Criams Sport Med Ctr Voghera, Pavia, Italy; [D'Antona, Giuseppe] Univ Pavia, Dept Publ Hlth Expt & Forens Med, Pavia, Italy; [Cicchella, Antonio] Univ Bologna, Dept Qual Life Studies, Bologna, Italy		Tiberini, P (corresponding author), Univ Naples Parthenope, Dept Movement Sci & Well Being, Naples, Italy.	paolo.tiberini001@studenti.uniparthenope.it					Beaulieu C, 2019, J PSYCHOPHYSIOL, V33, P96, DOI 10.1027/0269-8803/a000213; Bhambhani Y, 2007, RESP PHYSIOL NEUROBI, V156, P196, DOI 10.1016/j.resp.2006.08.009; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P573, DOI 10.1111/cpf.12447; Blaszczyk JW, 2016, GAIT POSTURE, V44, P1, DOI 10.1016/j.gaitpost.2015.10.014; Brush CJ, 2018, INT J PSYCHOPHYSIOL, V132, P124, DOI 10.1016/j.ijpsycho.2017.10.006; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Fahr R, 2015, PHYS MED REHAB KUROR, V25, P181, DOI 10.1055/s-0034-1398684; Finkbeiner NWB, 2016, CAN J PSYCHIAT, V61, P270, DOI 10.1177/0706743716644953; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hecimovich M, 2019, PHYSICIAN SPORTSMED, V47, P78, DOI 10.1080/00913847.2018.1525261; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Howell DR, 2019, ARCH PHYS MED REHAB, V100, P613, DOI 10.1016/j.apmr.2018.07.441; Jiang DR, 2020, J CEREBR BLOOD F MET, V40, P1492, DOI 10.1177/0271678X19867154; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kaj B, 2016, CRIT FIND NEURORADIO, V2, P211, DOI [10.1007/978-3-319-27987-9_21, DOI 10.1007/978-3-319-27987-9_21]; Kleinschmidt A, 1996, J CEREBR BLOOD F MET, V16, P817, DOI 10.1097/00004647-199609000-00006; Kontos AP, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P315, DOI 10.1007/0-387-32565-4_14; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MeSH subject heading scope note, 2003, POSTC SYNDR MESH SUB; Mirow S, 2016, UNDERSEA HYPERBAR M, V43, P531; Mueller ST, 2014, J NEUROSCI METH, V222, P250, DOI 10.1016/j.jneumeth.2013.10.024; Neary JP, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00035; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Rupp T, 2008, EUR J APPL PHYSIOL, V102, P153, DOI 10.1007/s00421-007-0568-7; Slessarev M, 2007, J PHYSIOL-LONDON, V581, P1207, DOI 10.1113/jphysiol.2007.129395; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Taylor KM, 2018, AM J SPORT MED, V46, P3262, DOI 10.1177/0363546518798801; Thomas BP, 2017, J CEREBR BLOOD F MET, V37, P1508, DOI 10.1177/0271678X16658662; Wolf M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804899	35	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-9367		FRONT SPORTS ACT LIV	Front. Sports Act. Living	NOV 30	2021	3								725096	10.3389/fspor.2021.725096			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	XO0JW	WOS:000729882700001	34917937	Green Published, gold			2022-02-06	
J	Tobieson, L; Gard, A; Ruscher, K; Marklund, N				Tobieson, Lovisa; Gard, Anna; Ruscher, Karsten; Marklund, Niklas			Intracerebral Proinflammatory Cytokine Increase in Surgically Evacuated Intracerebral Hemorrhage: A Microdialysis Study	NEUROCRITICAL CARE			English	Article; Early Access						Brain injury; Cytokine; Inflammation mediators; Intracranial hemorrhage; Microdialysis; Stroke	INITIAL CONSERVATIVE TREATMENT; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; MICROGLIAL ACTIVATION; MOLECULAR SIGNATURES; EARLY SURGERY; BLOOD-FLOW; INFLAMMATION; POLARIZATION; INTERLEUKIN-6	Background Treatment options for spontaneous intracerebral hemorrhage (ICH) are limited. A possible inflammatory response in the brain tissue surrounding an ICH may exacerbate the initial injury and could be a target for treatment of subsequent secondary brain injury. The study objective was to compare levels of inflammatory mediators in the interstitial fluid of the perihemorrhagic zone (PHZ) and in seemingly normal cortex (SNX) in the acute phase after surgical evacuation of ICH, with the hypothesis being that a difference could be demonstrated between the PHZ and the SNX. Methods In this observational study, ten patients needing surgical evacuation of supratentorial ICH received two cerebral microdialysis catheters: one in the PHZ and one in the SNX that is remote from the ICH. The microdialysate was analyzed for energy metabolites (including lactate pyruvate ratio and glucose) and for inflammatory mediators by using a multiplex immunoassay of 27 cytokines and chemokines at 6-10 h, 20-26 h, and 44-50 h after surgery. Results A metabolic crisis, indicated by altered energy metabolic markers, that persisted throughout the observation period was observed in the PHZ when compared with the SNX. Proinflammatory cytokines interleukin (IL) 8, tumor necrosis factor alpha, IL-2, IL-1 beta, IL-6 and interferon gamma, anti-inflammatory cytokine IL-13, IL-4, and vascular endothelial growth factor A were significantly higher in PHZ compared with SNX and were most prominent at 20-26 h following ICH evacuation. Conclusions Higher levels of both proinflammatory and anti-inflammatory cytokines in the perihemorrhagic brain tissue implies a complex role for inflammatory mediators in the secondary injury cascades following ICH surgery, suggesting a need for targeted pharmacological interventions.	[Tobieson, Lovisa] Linkoping Univ, Dept Neurosurg Linkoping, Linkoping, Sweden; [Tobieson, Lovisa] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden; [Gard, Anna; Ruscher, Karsten; Marklund, Niklas] Lund Univ, Dept Clin Sci Lund, Neurosurg, Lund, Sweden; [Marklund, Niklas] Lund Univ, Skane Univ Hop, Dept Clin Sci Lund, Neurosurg, Lund, Sweden		Tobieson, L (corresponding author), Linkoping Univ, Dept Neurosurg Linkoping, Linkoping, Sweden.; Tobieson, L (corresponding author), Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden.	lovisa.tobieson@regionostergotland.se		Tobieson, Lovisa/0000-0003-2284-846X	Linkoping University; Swedish State Support of Clinical Research [ALFLio-925101]; STROKE-Riksforbundet	Open access funding provided by Linkoping University. This study was supported by grants from the Swedish State Support of Clinical Research (#ALFLio-925101) and STROKE-Riksforbundet.	Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Beez T, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0994-z; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Cavaillon JM, 2001, CELL MOL BIOL, V47, P695; Clausen F, 2019, J NEUROTRAUM, V36, P201, DOI 10.1089/neu.2018.5636; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Dyhrfort P, 2019, J NEUROTRAUM, V36, P2872, DOI 10.1089/neu.2018.6320; Dziedzic T, 2002, STROKE, V33, P2334, DOI 10.1161/01.STR.0000027211.73567.FA; Engelhardt S, 2014, BRIT J PHARMACOL, V171, P1210, DOI 10.1111/bph.12489; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Fahlstrom A, 2019, ACTA NEUROCHIR, V161, P955, DOI 10.1007/s00701-019-03853-0; Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413; Gao Z, 2008, ACTA NEUROCHIR SUPPL, V105, P51; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillman J, 2006, ACTA NEUROCHIR, V148, P319, DOI 10.1007/s00701-005-0670-8; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; Hillman J, 2007, J NEUROSURG, V106, P820, DOI 10.3171/jns.2007.106.5.820; Hutchinson P, 2014, NEUROCRIT CARE, V21, P148, DOI 10.1007/s12028-014-0035-3; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim JS, 1996, STROKE, V27, P1553, DOI 10.1161/01.STR.27.9.1553; Kim-Han JS, 2006, STROKE, V37, P2457, DOI 10.1161/01.STR.0000240674.99945.4e; Lan X, 2018, J CEREB BLOOD FLOW M; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Liu XR, 2016, STROKE, V47, P498, DOI 10.1161/STROKEAHA.115.012079; Lopez-Castejon G, 2011, CELL MOL LIFE SCI, V68, P3095, DOI 10.1007/s00018-010-0609-y; Lu AG, 2006, J CEREBR BLOOD F MET, V26, P230, DOI 10.1038/sj.jcbfm.9600183; Marin-Teva JL, 2011, NEURON GLIA BIOL, V7, P25, DOI 10.1017/S1740925X12000014; Mayne M, 2001, STROKE, V32, P240, DOI 10.1161/01.STR.32.1.240; Mellergard P, 2011, NEUROSURGERY, V68, P12, DOI 10.1227/NEU.0b013e3181ef2a40; Mellergard P, 2010, BRIT J NEUROSURG, V24, P261, DOI 10.3109/02688690903521605; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Mendelow AD, 2005, LANCET, V365, P387; Mracsko E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00388; Nilsson OG, 2006, NEUROSURGERY, V59, P521, DOI 10.1227/01.NEU.0000227521.58701.E5; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; POUNGVARIN N, 1987, NEW ENGL J MED, V316, P1229, DOI 10.1056/NEJM198705143162001; Prasad K, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000200.pub2, 10.1002/14651858.CD002244.pub3]; Qureshi AI, 2010, ARCH NEUROL-CHICAGO, V67, P570, DOI 10.1001/archneurol.2010.61; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Qureshi AI, 1999, NEUROLOGY, V52, P266, DOI 10.1212/WNL.52.2.266; Qureshi AI, 2002, NEUROSURG CLIN N AM, V13, P355, DOI 10.1016/S1042-3680(02)00012-8; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Silva Y, 2005, STROKE, V36, P86, DOI 10.1161/01.STR.0000149615.51204.0b; Sondag L, 2020, ANN NEUROL, V88, P239, DOI 10.1002/ana.25732; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Taylor RA, 2017, J CLIN INVEST, V127, P280, DOI 10.1172/JCI88647; Tobieson L, 2019, NEUROSURGERY, V84, P1269, DOI 10.1093/neuros/nyy179; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Wagner KR, 2006, ACTA NEUROCHIR SUPPL, V96, P177; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wheelock AM, 2013, MOL BIOSYST, V9, P2589, DOI 10.1039/c3mb70194h; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang Z, 2017, MOL NEUROBIOL, V54, P1874, DOI 10.1007/s12035-016-9785-6; Zhao XR, 2009, STROKE, V40, pS92, DOI 10.1161/STROKEAHA.108.533158; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003	65	0	0	3	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01389-9		NOV 2021	12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XF4QY	WOS:000724057800002	34850333	hybrid, Green Published			2022-02-06	
J	Wang, D; Fan, YS; Ma, J; Gao, C; Liu, XH; Zhao, ZL; Wei, HJ; Yang, GL; Huang, JH; Jiang, RC; Zhang, JN				Wang, Dong; Fan, Yueshan; Ma, Jun; Gao, Chuang; Liu, Xuanhui; Zhao, Zilong; Wei, Huijie; Yang, Guili; Huang, Jinhao; Jiang, Rongcai; Zhang, Jianning			Atorvastatin combined with dexamethasone promote hematoma absorption in an optimized rat model of chronic subdural hematoma	AGING-US			English	Article						atorvastatin combined with low-dose dexamethasone treatment; CSDH; optimized CSDH rat model; inflammatory activities; angiogenic processes	TRAUMATIC BRAIN-INJURY; LOW-DOSE DEXAMETHASONE; GROWTH-FACTOR; ANGIOPOIETIN-1; KLF2; ANGIOGENESIS; EXPRESSION; MANAGEMENT; CELLS	Previous studies found that atorvastatin and dexamethasone were effective in promoting the absorption of chronic subdural hematoma. In this study, we aimed to investigate the effect of pharmacotherapy in an optimized rat model of chronic subdural hematoma. Rat model of chronic subdural hematoma via a bEnd.3 cell and Matrigel mix was established and dynamic changes in different drug treatment groups were tested. The hematoma gradually increased, peaked on the fifth day (263.8 +/- 52.85 mu l), and was completely absorbed in two weeks. Notably, Kruppelle-like factor 2 expression was significantly decreased with increasing hematoma volume, and then increased in the repair period. The expression of IL-10 was increased and peaked on 7 days, and then decreased at 14 days. The dynamic trends of IL-6, IL-8, MMP-9, and VEGF were also increased first and then decreased. Both monotherapy and the combined treatment by atorvastatin and dexamethasone could counteract the inflammatory activities, decrease hematoma permeability, and improve hematoma absorption, however, most prominent in combined group. The combined treatment could more effectively increase Kruppelle-like factor 2 and ZO-1 expression, attenuate the expression of NF-kappa b. Most importantly, the combined treatment enhanced the neural functional prognosis and reduced the mortality of chronic subdural hematoma rats. According to our results, the combined treatment could more effectively attenuate inflammatory. And it could also enhance angiogenic activities which could promote the stability of local function and structure of the hematoma cavity, reduce the hematoma volume and improve the outcomes of rats with chronic subdural hematoma than single treatments in the optimized chronic subdural hematoma model.	[Wang, Dong; Fan, Yueshan; Ma, Jun; Gao, Chuang; Liu, Xuanhui; Zhao, Zilong; Wei, Huijie; Yang, Guili; Huang, Jinhao; Jiang, Rongcai; Zhang, Jianning] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin 300052, Peoples R China; [Wang, Dong; Fan, Yueshan; Ma, Jun; Gao, Chuang; Liu, Xuanhui; Zhao, Zilong; Wei, Huijie; Yang, Guili; Huang, Jinhao; Jiang, Rongcai; Zhang, Jianning] Minist Educ & Tianjin City, Key Lab Postneuroinjury Neuro Repair & Regenerat, Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Fan, Yueshan; Liu, Xuanhui] Tianjin Med Univ, Tianjin 300070, Peoples R China		Huang, JH; Jiang, RC; Zhang, JN (corresponding author), Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin 300052, Peoples R China.; Huang, JH; Jiang, RC; Zhang, JN (corresponding author), Minist Educ & Tianjin City, Key Lab Postneuroinjury Neuro Repair & Regenerat, Tianjin Neurol Inst, Tianjin 300052, Peoples R China.	jinhao.huang@tmu.edu.cn; jiang116216@163.com; jnzhang@tmu.edu			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81720108015, 82071389, 81930031]; Natural Science Foundation of TianjinNatural Science Foundation of Tianjin [20JCYBJC00430, 20JCQNJC00460]; Beijing special project [19JCZDJC64600(Z)]; Tianjin special project [19JCZDJC64600(Z)]; Hebei special project [19JCZDJC64600(Z)]	This work was supported by grants from the National Natural Science Foundation of China (grants: 81720108015, 82071389, and 81930031), Natural Science Foundation of Tianjin (grants: 20JCYBJC00430 and 20JCQNJC00460), and Beijing, Tianjin, and Hebei special projects(19JCZDJC64600(Z)).	Allison A, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3866-6; ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Aydin K, 2019, TURK J MED SCI, V49, P738, DOI 10.3906/sag-1708-106; Dran G, 2007, NEUROCHIRURGIE, V53, P477, DOI 10.1016/j.neuchi.2007.09.146; Fan YS, 2021, NEURAL REGEN RES, V16, P523, DOI 10.4103/1673-5374.293152; Fan YS, 2020, DRUG DES DEV THER, V14, P3291, DOI 10.2147/DDDT.S256050; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Gao X, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8564681; Hohenstein A, 2005, J NEUROTRAUM, V22, P518, DOI 10.1089/neu.2005.22.518; Holl DC, 2018, WORLD NEUROSURG, V116, P402, DOI 10.1016/j.wneu.2018.05.037; Hua C, 2016, J NEUROTRAUM, V33, P65, DOI 10.1089/neu.2014.3724; Huang JH, 2019, PHARMACOTHERAPY, V39, P783, DOI 10.1002/phar.2276; Huang JM, 2020, EXPERT REV CLIN PHAR, V13, P451, DOI 10.1080/17512433.2020.1732815; Hutchinson PJ, 2020, NEW ENGL J MED, V383, P2616, DOI 10.1056/NEJMoa2020473; Isaji T, 2020, J NEUROTRAUM, V37, P2493, DOI 10.1089/neu.2020.7042; Jha P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112383; Jiang RC, 2018, JAMA NEUROL, V75, P1338, DOI 10.1001/jamaneurol.2018.2030; Kolias AG, 2014, NAT REV NEUROL, V10, P570, DOI 10.1038/nrneurol.2014.163; Kupriianova E M, 1975, Akush Ginekol (Mosk), P49; Li T, 2014, J NEUROL SCI, V341, P88, DOI 10.1016/j.jns.2014.04.009; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Lingrel JB, 2012, CIRC RES, V110, P1294, DOI 10.1161/CIRCRESAHA.112.267310; Mahabeleshwar GH, 2011, IMMUNITY, V34, P715, DOI 10.1016/j.immuni.2011.04.014; Miah IP, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2945-4; Osuka K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233643; Osuka K, 2017, NEUROSURGERY, V80, P571, DOI 10.1093/neuros/nyw100; Pont LMEB, 2012, EUR J NEUROL, V19, P1397, DOI 10.1111/j.1468-1331.2012.03768.x; Rong HT, 2018, BRAIN RES, V1694, P104, DOI 10.1016/j.brainres.2018.05.015; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Wang B, 2012, J NEUROL SCI, V319, P117, DOI 10.1016/j.jns.2012.04.015; Wang D, 2021, J NEUROSURG, V134, P235, DOI 10.3171/2019.11.JNS192020; Wang D, 2016, J NEUROL SCI, V362, P91, DOI 10.1016/j.jns.2016.01.017; Wang D, 2014, J NEUROL SCI, V336, P237, DOI 10.1016/j.jns.2013.11.005; Wang D, 2010, J NEUROTRAUM, V27, P1489, DOI 10.1089/neu.2009.1057; Weigel R, 2001, ACTA NEUROCHIR, V143, P811, DOI 10.1007/s007010170035; Wu CY, 2013, BIOCHEM BIOPH RES CO, V431, P141, DOI 10.1016/j.bbrc.2013.01.008; Xu X, 2021, BRAIN RES BULL, V172, P108, DOI 10.1016/j.brainresbull.2021.04.024; Zhang ZG, 2002, NEUROSCIENCE, V113, P683, DOI 10.1016/S0306-4522(02)00175-6	39	0	0	5	5	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1945-4589			AGING-US	Aging-US	NOV 30	2021	13	22					24815	24828					14	Cell Biology; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Geriatrics & Gerontology	XH5JN	WOS:000725470600023	34813498	Green Published, gold			2022-02-06	
J	Dasch, B; Lenz, P				Dasch, Burkhard; Lenz, Philipp			The Place of Death of Neurological Patients with Selected Disease Entities: Data from an Observational Study on Places of Death from Germany	FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE			German	Article; Early Access						Place of death; ALS; brain tumour; hypoxic brain damage; SAB; dementia	PALLIATIVE CARE; SCLEROSIS; HOSPICE; TRENDS	Zusammenfassung Ziel der Studie Bislang existieren in Deutschland nur wenige Daten zum Sterbeort von Patienten mit neurologischer Grunderkrankung. Methodik Im Rahmen der bis dato umfangreichsten Sterbeortstudie in Deutschland wurde in vorliegender Untersuchung der Sterbeort von neurologischen Patienten mit ausgewahlten Erkrankungsentitaten (ALS (ALS), bosartige Neubildung des Gehirns (BNG), Hirnmetastase(n) (HM), hypoxischer Hirnschaden nach Reanimation (HHS), nichttraumatische SAB (SAB), Demenz alterer Menschen (>= 65 Jahre) (DEM)) untersucht. Fur die Analyse wurden samtliche Todesbescheinigungen der Stadt Munster des Jahres 2017 ausgewertet. Patienten wurde durch die arztliche Angabe zur Todesursache identifiziert. Ergebnisse Es verstarben 3844 Personen, hiervon neurologische Patienten mit folgenden Erkrankungsentitaten: ALS (6), BNG (29), HM (102), HHS (54), SAB (20), DEM (485). Der Sterbeort war wie folgt verteilt: (ALS, BNG, HM, HHS, SAB, DEM;%): Zuhause 50,0/10,3/13,7/1,9/0,0/12,0; Krankenhaus 33,3/48,3/38,2/90,7/100/23,1; Intensivstation 0,0/6,9/5,9/61,1/65,0/2,7; Palliativstation 33,3/0,0/6,9/0,0/0,0/1,4; Hospiz 16,7/27,6/43,1/0,0/0,0/1,2; Pflegeheim 0,0/13,8/4,9/7,4/0,0/63,7; sonstiger Ort 0,0/0,0/0,0/0,0/0,0/0,0. Schlussfolgerung Der haufigste Sterbeort von neurologischen Patienten mit ausgewahlten Erkrankungsentitaten ist wie folgt: ALS>Zuhause, bosartiger Gehirntumor>Krankenhaus, Hirnmetastase(n)>Hospiz, hypoxischer Hirnschaden nach Reanimation>Krankenhaus, nichttraumatische SAB>Krankenhaus, Demenzpatienten (>= 65 Jahre)>Pflegeheim. Abstract Background So far, there are only few data on places where neurological patients die in Germany. Methods In the context of the most comprehensive study on the place of death in Germany to date, the present investigation examined the place of death of neurological patients with selected disease entities (ALS (ALS), malignant neoplasm of the brain (BNG), brain metastasis(es) (HM), hypoxic brain damage after resuscitation (HHS), non-traumatic SAB (SAB), dementia (>= 65 years) (DEM)). All death certificates issued in the city of Munster of 2017 were evaluated. Patients were identified on the basis of the medical information on the cause of death. Results A total of 3,844 people died, including neurological patients with the following disease entities: ALS (6), BNG (29), HM (102), HHS (54), SAB (20), DEM (485). The distribution of places of death was as follows: (AS, BNG, HM, HHS, SAB, DEM;%): home 50.0/10.3/13.7/1.9/0.0/12.0; hospital 33.3/48.3/38.2/90.7/100/23.1; intensive care unit 0.0/6.9/5.9/61.1/65.0/2.7; palliative care unit 33.3/0.0/6.9/0.0/0.0/1.4; hospice 16.7/27.6/43.1/0.0/0.0/1.2; nursing home 0.0/13.8/4.9/7.4/0.0/63.7; other places 0.0/0.0/0.0/0.0/0.0/0.0. Conclusion The most common place of death of neurological patients with selected disease entities is as follows: ALS>home, malignant brain tumour>hospital, brain metastasis(es)>hospice, hypoxic brain injury after resuscitation>hospital, non-traumatic SAB>hospital, dementia patients (>= 65 years)>nursing home.	[Dasch, Burkhard; Lenz, Philipp] Univ Klinikum Munster, Zentrale Einrichtung Palliat Med, Albert Schweitzer Campus 1,Gebaude W30, D-48149 Munster, Germany		Dasch, B (corresponding author), Univ Klinikum Munster, Zentrale Einrichtung Palliat Med, Albert Schweitzer Campus 1,Gebaude W30, D-48149 Munster, Germany.	burkhard.dasch@ukmuenster.de					Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Cardiac Arrest Registry to Enhance Survival (CARES), 2019, HOSP SURV REP 2018; Dasch B., 2021, DTSCH ARZTBL INT, V118, DOI [10.3238/arztbl.m2021.0124 arztbl.m2021.0124, DOI 10.3238/ARZTBL.M2021.0124ARZTBL.M2021.0124]; Dasch B, 2015, DTSCH ARZTEBL INT, V112, P496, DOI 10.3238/arztebl.2015.0496; Deutsche Alzheimer Gesellschaft e.V. Selbsthilfe Demenz, 2021, HAUF DEM; Deutsche Gesellschaft fur Neurologie, 2021, LEITL DGN VASK ERK S; Deutsche Krebsgesellschaft, 2021, HIRNM HER PAT ARZT; Ditscheid B, 2020, BUNDESGESUNDHEITSBLA, V63, P1502, DOI 10.1007/s00103-020-03240-6; Escarrabill J, 2014, REV PORT PNEUMOL, V20, P188, DOI 10.1016/j.rppneu.2014.03.001; Dominguez-Berjon MF, 2016, AMYOTROPH LAT SCL FR, V17, P62, DOI 10.3109/21678421.2015.1089908; Fischer M., PUBLIC ANN REPORT 20; Gaugler JE, 2009, MED CARE, V47, P191, DOI 10.1097/MLR.0b013e31818457ce; Gil J, 2008, EUR J NEUROL, V15, P1245, DOI 10.1111/j.1468-1331.2008.02307.x; Golla H., 2017, NEUROLOGY INT OPEN, V01, pE117, DOI [10.1055/s-0043-108438, DOI 10.1055/S-0043-108438]; Hess S, 2014, EUR J INTERN MED, V25, P187, DOI 10.1016/j.ejim.2013.11.012; Oliver DJ, 2016, EUR J NEUROL, V23, P30, DOI 10.1111/ene.12889; Ostgathe C, 2010, SUPPORT CARE CANCER, V18, P1157, DOI 10.1007/s00520-009-0735-y; Radbruch L, 2011, Z PALLIATMEDIZIN, V12, P260, DOI 10.1055/s-0031-1276957; Reyniers T, 2015, J AM MED DIR ASSOC, V16, P165, DOI 10.1016/j.jamda.2014.11.003; Rolke R., 2019, KLIN NEUROLOGIE, P1, DOI [10.1007/978-3-662-44768-0_31-1, DOI 10.1007/978-3-662-44768-0_31-1]; Scholten N, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0099-2; Sizoo EM, 2014, SUPPORT CARE CANCER, V22, P847, DOI 10.1007/s00520-013-2088-9; Sleeman KE, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-59; Sleeman KE, 2013, PALLIATIVE MED, V27, P840, DOI 10.1177/0269216313490436; Spataro R, 2010, ACTA NEUROL SCAND, V122, P217, DOI 10.1111/j.1600-0404.2009.01290.x; Statistisches Bundesamt (Destasis), 2021, TOD ANZ GEST KAP ICD; Statistisches Bundesamt (Destasis), 2021, STERB 2016 2021 TAG; Talbott EO, 2016, HAND CLINIC, V138, P225, DOI 10.1016/B978-0-12-802973-2.00013-6; Xu W, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08894-0; Zentrum fur Krebsregisterdaten, 2019, GES EP KREBSR DTSCH	30	0	0	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0720-4299	1439-3522		FORTSCHR NEUROL PSYC	Forschritte Neurol. Psychiatr.												10.1055/a-1669-9177		NOV 2021	9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	XE4QW	WOS:000723375000001	34844276				2022-02-06	
J	Lamontagne, G; Belleville, G; Beaulieu-Bonneau, S; Souesme, G; Savard, J; Sirois, MJ; Giguere, M; Tessier, D; Le Sage, N; Ouellet, MC				Lamontagne, Guillaume; Belleville, Genevieve; Beaulieu-Bonneau, Simon; Souesme, Guillaume; Savard, Josee; Sirois, Marie-Josee; Giguere, Myriam; Tessier, Danielle; Le Sage, Natalie; Ouellet, Marie-Christine			Anxiety Symptoms and Disorders in the First Year After Sustaining Mild Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article; Early Access						anxiety; mild traumatic brain injury (mTBI); long-term outcomes; persistent symptoms	POSTTRAUMATIC-STRESS-DISORDER; MULTIDIMENSIONAL FATIGUE; POSTCONCUSSIVE SYMPTOMS; VALIDATION; DEPRESSION; POPULATION; PREDICTORS; INVENTORY; INSOMNIA; THERAPY	Purpose/Objective: The goals of the present study were (a) to document the prevalence of anxiety-related disorders and anxiety symptoms at 4, 8, and 12 months postinjury in individuals with mild traumatic brain injury (mTBI) while considering preinjury history of anxiety disorders and (b) to verify whether the presence of anxiety in the first months after mTBI was associated with more symptoms present 1 year after the injury. Research Method/Design: One hundred and twenty participants hospitalized after an accident and having sustained mTBI were assessed at 4, 8, and 12 months postaccident with the Mini-International Neuropsychiatric Interview, the Hospital Anxiety and Depression Scale, and questionnaires assessing fatigue, irritability, perceived stress, cognitive difficulties, depression, insomnia, and pain. Results: At 4 months, 23.8% of participants presented with at least one anxiety-related disorder compared with 15.2% at 8 months and 11.2% at 12 months. Overall, 32.5% presented with at least one anxiety disorder over the first 12 months post-mTBI. Participants with a history of anxiety (20.5%) were significantly more anxious after their accident. Individuals who were anxious 4 months after the accident presented with more symptoms in different areas 12 months postinjury compared with nonanxious individuals. Conclusions/Implications: The present results highlight that anxiety should be evaluated and managed carefully as it appears to be a key factor in the persistence of other mTBI-related symptoms. Impact and Implications Anxiety symptoms and disorders are frequent in the first year after mild traumatic brain injury (mTBI) compared with 1-year prevalence rates in the general population. Anxiety seems to exacerbate or prolong mTBI-related symptoms including fatigue, irritability, perceived stress, depressive symptoms, pain, sleep difficulties, and cognitive difficulties. Clinicians should consider monitoring anxiety symptoms more systematically early on after a mTBI to provide preventive or therapeutic interventions.	[Lamontagne, Guillaume; Belleville, Genevieve; Beaulieu-Bonneau, Simon; Savard, Josee; Tessier, Danielle; Ouellet, Marie-Christine] Univ Laval, Fac Sci Sociales, Ecole Psychol, Quebec City, PQ, Canada; [Lamontagne, Guillaume; Beaulieu-Bonneau, Simon; Souesme, Guillaume; Giguere, Myriam; Tessier, Danielle; Ouellet, Marie-Christine] Ctr Interdisciplinaire Rech Readaptat & Integrat, 525 Blvd Hamel, Quebec City, PQ G1M 2S8, Canada; [Savard, Josee; Sirois, Marie-Josee; Le Sage, Natalie] Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ, Canada; [Sirois, Marie-Josee] Univ Laval, Fac Med, Dept Readaptat, Quebec City, PQ, Canada; [Le Sage, Natalie] Univ Laval, Fac Med, Dept Med Familiale & Med Urgence, Quebec City, PQ, Canada		Ouellet, MC (corresponding author), Ctr Interdisciplinaire Rech Readaptat & Integrat, 525 Blvd Hamel, Quebec City, PQ G1M 2S8, Canada.	marie-christine.ouellet@psy.ulaval.ca		Ouellet, Marie-Christine/0000-0003-3477-1893; Beaulieu-Bonneau, Simon/0000-0002-9544-5023; Belleville, Genevieve/0000-0002-4995-3836	Fonds de Recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec [16375]	This study was funded by the Fonds de Recherche du Quebec-Sante (Grant FRQ-S; 16375). We thank all participants who volunteered to take part in the study, Patricia Chabot and Nancy Lemieux, who identified potential participants, Andree-Anne Paradis-Giroux for coordinating the final part of the data collection, Jean Leblond for statistical advice, the graduate students who conducted interviews (Sarah Lavoie-Dugre, Danielle Tessier, Alexandra Champoux-Tremblay, and Stephanie Ropars), and the undergraduate students who collaborated with data entry.	Barker-Collo S, 2018, BRAIN INJURY, V32, P1651, DOI 10.1080/02699052.2018.1540797; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bergersen K, 2017, BRAIN INJURY, V31, P279, DOI 10.1080/02699052.2016.1255779; Blais FC, 1997, ENCEPHALE, V23, P447; Breazeale S, 2021, J TRAUMA NURS, V28, P46, DOI 10.1097/JTN.0000000000000557; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cooper D., 2018, ARCH PHYS MED REHABI, V99, pe156, DOI [10.1016/j.apmr.2018.08.087, DOI 10.1016/J.APMR.2018.08.087]; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Fillion L, 2003, CANCER NURS, V26, P143, DOI 10.1097/00002820-200304000-00008; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Hsieh MY, 2012, BRAIN INJURY, V26, P126, DOI 10.3109/02699052.2011.635365; ILFELD FW, 1976, PSYCHOL REP, V39, P1215, DOI 10.2466/pr0.1976.39.3f.1215; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kang KK, 2021, J AM ACAD ORTHOP SUR, V29, pE322, DOI 10.5435/JAAOS-D-20-00637; Karr JE, 2020, J NEUROTRAUM, V37, P1183, DOI 10.1089/neu.2019.6834; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; King NS, 2019, BRAIN INJURY, V33, P1556, DOI 10.1080/02699052.2019.1655794; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Marshall S., 2018, GUIDELINE CONCUSSION, V3rd; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Moller HJ, 2016, EUR ARCH PSY CLIN N, V266, P725, DOI 10.1007/s00406-016-0684-7; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morin CM, 2003, PSYCHOSOM MED, V65, P259, DOI 10.1097/01.PSY.0000030391.09558.A3; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; O'Donnell S., 2016, PROMOTION SANTE PREV, V36, P307, DOI [10.24095/hpcdp.36.12.02f, DOI 10.24095/HPCDP.36.12.02F]; Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46; Osborn AJ, 2017, J AFFECT DISORDERS, V213, P214, DOI 10.1016/j.jad.2016.09.045; Ouellet MC, 2018, J NEUROTRAUM, V35, P1620, DOI 10.1089/neu.2017.5379; Ouellet MC, 2009, J REHABIL MED, V41, P179, DOI 10.2340/16501977-0306; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; Savard J, 1998, J PERS ASSESS, V71, P349, DOI 10.1207/s15327752jpa7103_5; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Sheehan DV., 2014, MINI INT NEUROPSYCHI; Skandsen T, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00638; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Stergiou-Kita M, 2016, ARCH PHYS MED REHAB, V97, pS40, DOI 10.1016/j.apmr.2015.04.008; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Van Praag DLG, 2019, J NEUROTRAUM, V36, P3220, DOI 10.1089/neu.2018.5759; Vikane E, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00639; Wallace CA, 2000, BRAIN INJURY, V14, P549; Ware J., 2000, SF 36 HLTH SURVEY MA; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	60	0	0	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.												10.1037/rep0000422		NOV 2021	11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	XS7JF	WOS:000733079600001	34843337				2022-02-06	
J	MacDermid, JC; McClure, JA; Richard, L; Faber, KJ; Jaglal, S				MacDermid, Joy C.; McClure, J. Andrew; Richard, Lucie; Faber, Kenneth J.; Jaglal, Susan			Fracture profiles of a 4-year cohort of 266,324 first incident upper extremity fractures from population health data in Ontario	BMC MUSCULOSKELETAL DISORDERS			English	Article						Fractures; Epidemiology; Upper extremity; Distal radius; Proximal humerus; Social deprivation; Comorbidity; Nerve injury; Tendon injury; Sex differences; Scaphoid	OSTEOPOROTIC FRACTURES; EPIDEMIOLOGY; RISK; 10-YEAR; DENSITY	Background Understanding the profiles of different upper extremity fractures, particularly those presenting as a 1st incident can inform prevention and management strategies. The purpose of this population-level study was to describe first incident fractures of the upper extremity in terms of fracture characteristics and demographics. Methods Cases with a first adult upper extremity (UE) fracture from the years 2013 to 2017 were extracted from administrative data in Ontario. Fracture locations (ICD-10 codes) and associated characteristics (open/closed, associated hospitalization within 1-day, associated nerve, or tendon injury) were described by fracture type, age category and sex. Standardized mean differences of at least 10% (clinical significance) and statistical significance (p < 0.01) in ANOVA were used to identify group differences (age/sex). Results We identified 266,324 first incident UE fractures occurring over 4 years. The most commonly affected regions were the hand (93 K), wrist/forearm(80 K), shoulder (48 K) or elbow (35 K). The highest number of specific fractures were: distal radius (DRF, 47.4 K), metacarpal (30.4 K), phalangeal (29.9 K), distal phalangeal (24.4 K), proximal humerus (PHF, 21.7 K), clavicle (15.1 K), radial head (13.9 K), and scaphoid fractures (13.2 K). The most prevalent multiple fractures included: multiple radius and ulna fractures (11.8 K), fractures occurring in multiple regions of the upper extremity (8.7 K), or multiple regions in the forearm (8.4 K). Tendon (0.6% overall; 8.2% in multiple finger fractures) or nerve injuries were rarely reported (0.3% overall, 1.5% in distal humerus). Fractures were reported as being open in 4.7% of cases, most commonly for distal phalanx (23%). A similar proportion of females (51.5%) and males were present in this fracture cohort, but there were highly variant age-sex profiles across fracture subtypes. Fractures most common in 18-40-year-old males included metacarpal and finger fractures. Fractures common in older females were: DRF, PHF and radial head, which exhibited a dramatic increase in the over-50 age group. Conclusions UE fracture profiles vary widely by fracture type. Fracture specific prevention and management should consider fracture profiles that are highly variable according to age and sex.	[MacDermid, Joy C.] Western Univ, Sch Phys Therapy, London, ON, Canada; [MacDermid, Joy C.; McClure, J. Andrew; Richard, Lucie] ICES Western, London, ON, Canada; [MacDermid, Joy C.; Faber, Kenneth J.] Western Univ, Dept Surg, London, ON, Canada; [MacDermid, Joy C.; Faber, Kenneth J.] St Josephs Hlth Ctr, Hand & Upper Limb Ctr, 268 Grosvenor St, London, ON, Canada; [Jaglal, Susan] Univ Toronto, Dept Phys Therapy, Toronto, ON M5G 1V7, Canada		MacDermid, JC (corresponding author), Western Univ, Sch Phys Therapy, London, ON, Canada.; MacDermid, JC (corresponding author), ICES Western, London, ON, Canada.; MacDermid, JC (corresponding author), Western Univ, Dept Surg, London, ON, Canada.; MacDermid, JC (corresponding author), St Josephs Hlth Ctr, Hand & Upper Limb Ctr, 268 Grosvenor St, London, ON, Canada.	Jmacderm@uwo.ca	MacDermid, Joy C/H-7837-2013	MacDermid, Joy C/0000-0001-9311-7379	Canada Research Chair in Musculoskeletal Health Outcomes and Knowledge Translation; Dr. James Roth Chair in Musculoskeletal Measurement and Knowledge Translation; Bone and Joint Institute Catalyst Grant; Team Bone Grant [CIHR FRN: 122070]	Joy MacDermid was supported by a Canada Research Chair in Musculoskeletal Health Outcomes and Knowledge Translation and the Dr. James Roth Chair in Musculoskeletal Measurement and Knowledge Translation. This work was supported by a Bone and Joint Institute Catalyst Grant and a Team Bone Grant (CIHR FRN: 122070).	Ahmed LA, 2009, EUR J EPIDEMIOL, V24, P441, DOI 10.1007/s10654-009-9353-8; Baron JA, 1996, EPIDEMIOLOGY, V7, P612, DOI 10.1097/00001648-199611000-00008; Bonafede Machaon, 2013, J Med Econ, V16, P169, DOI 10.3111/13696998.2012.737391; Calvo E, 2011, J SHOULDER ELB SURG, V20, P795, DOI 10.1016/j.jse.2010.09.008; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Dewan N, 2018, J HAND THER; Hodsman AB, 2008, ARCH INTERN MED, V168, P2261, DOI 10.1001/archinte.168.20.2261; Joyce CW, 2013, INJURY, V44, P1636, DOI 10.1016/j.injury.2013.07.018; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P417, DOI 10.1007/s001980170112; Karl JW, 2015, J ORTHOP TRAUMA, V29, pE242, DOI 10.1097/BOT.0000000000000312; Kennedy CC, 2014, OSTEOPOROSIS INT, V25, P2825, DOI 10.1007/s00198-014-2828-9; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; MacIntyre NJ, 2016, J HAND THER, V29, P136, DOI 10.1016/j.jht.2016.03.003; Ootes Daan, 2012, Hand (N Y), V7, P18, DOI 10.1007/s11552-011-9383-z; Palvanen M, 2006, CLIN ORTHOP RELAT R, P87, DOI 10.1097/01.blo.0000194672.79634.78; Philip SS, 2019, J AGING PHYS ACTIV, V27, P392, DOI 10.1123/japa.2017-0428; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Seeman E, 2008, J BONE MINER METAB, V26, P1, DOI 10.1007/s00774-007-0793-5; Statistics Canada, AG SINGL YEARS AV AG; Tromp AM, 1998, J BONE MINER RES, V13, P1932, DOI 10.1359/jbmr.1998.13.12.1932; Widdifield J., 2014, EPIDEMIOLOGY RHEUMAT; Widdifield J, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-216	22	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2474		BMC MUSCULOSKEL DIS	BMC Musculoskelet. Disord.	NOV 29	2021	22	1							996	10.1186/s12891-021-04849-7			16	Orthopedics; Rheumatology	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rheumatology	XE8UR	WOS:000723658300001	34844604	Green Published, gold			2022-02-06	
J	Mah, K; Gladstone, B; Cameron, D; Reed, N				Mah, Katie; Gladstone, Brenda; Cameron, Deb; Reed, Nick			Thinking Otherwise: Bringing Young People into Pediatric Concussion Clinical and Research Practice	BRAIN IMPAIRMENT			English	Article; Early Access						Young people; concussion; critical social theory; discourse; Foucault	SPORT-RELATED CONCUSSION; QUALITATIVE RESEARCH; SICK-MAN; CHILDREN; HEALTH; DISAPPEARANCE; PERSPECTIVE; CHILDHOOD; DISCOURSE; DRAWINGS	Background: As rates of pediatric concussion have steadily risen, and concerns regarding its consequences have emerged, pediatric concussion has received increased attention in research and clinical spheres. Accordingly, there has been a commitment to determine how best to prevent and manage this injury that so commonly affects young people. Despite this increased attention, and proliferation of research, pediatric concussion as a concept has rarely, if ever, been taken up and questioned. That is, little attention has been directed toward understanding what concussion 'is', or how young people are regarded in relation to it. As a result, pediatric concussion is understood in decidedly narrow terms, constructed as such by a biomedical way of knowing. Aim: We aim to demonstrate how conceptualizing concussion, and young people, 'otherwise', enabled the co-production of a more nuanced and complex understanding of the experience of pediatric concussion from the perspective of young people. Approach: Drawing on an illustrative case example from a critical qualitative arts-based study, we demonstrate how bringing young people into research as 'knowers' enabled us to generate much-needed knowledge about concussion in young people.	[Mah, Katie] Western Univ, Sch Occupat Therapy, London, ON, Canada; [Gladstone, Brenda] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Gladstone, Brenda] Univ Toronto, Ctr Crit Qualitat Hlth Res, Toronto, ON, Canada; [Cameron, Deb; Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Cameron, Deb; Reed, Nick] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada		Mah, K (corresponding author), Western Univ, Sch Occupat Therapy, London, ON, Canada.	kemah@uwo.ca					Allen David, 2005, Nurs Inq, V12, P98, DOI 10.1111/j.1440-1800.2005.00259.x; Armstrong D, 2009, INT J EPIDEMIOL, V38, P642, DOI 10.1093/ije/dyp184; Belsey C., 2003, POSTSTRUCTURALISM VE; Birks M, 2008, J RES NURS, V13, P68, DOI 10.1177/1744987107081254; Boylan AM, 2009, J EARLY CHILD RES, V7, P264, DOI 10.1177/1476718X09336970; Brady G, 2015, SOCIOL HEALTH ILL, V37, P173, DOI 10.1111/1467-9566.12260; Brett BL, 2018, ARCH CLIN NEUROPSYCH, V33, P984, DOI 10.1093/arclin/acy006; Clair R, 2020, APPL NEUROPSYCH-CHIL, V9, P206, DOI 10.1080/21622965.2018.1556102; Clark A, 2005, ADOPT FOSTER, V29, P45, DOI 10.1177/030857590502900106; Coffey A., 1996, MAKING SENSE QUALITA, P26; Covassin T, 2017, SPORT EXERC PERFORM, V6, P220, DOI 10.1037/spy0000105; Eakin J, 1996, HEALTH PROMOT INT, V11, P157, DOI 10.1093/heapro/11.2.157; Eakin JM, 2020, INT J QUAL METH, V19, DOI 10.1177/1609406920949333; Eakin JM, 2016, QUAL INQ, V22, P107, DOI 10.1177/1077800415617207; Einarsdottir J, 2009, EARLY CHILD DEV CARE, V179, P217, DOI 10.1080/03004430802666999; Elden S, 2013, CHILDHOOD, V20, P66, DOI 10.1177/0907568212447243; FOUCAULT M, 1971, SOC SC INFORM, V10, P7, DOI 10.1177/053901847101000201; Foucault M., 2010, ARCHAEOLOGY KNOWLEDG; Foucault M, 1980, POWER KNOWLEDGE; Foucault Michel., 1982, M FOUCAULT STRUCTURA, V2nd ed, P208; Funk LM, 2009, QUAL HEALTH RES, V19, P859, DOI 10.1177/1049732309334105; Gibson B.E., 2016, REHABILITATION POSTC; Gibson BE, 2010, PHYSIOTHER CAN, V62, P98, DOI 10.3138/physio.62.2.98; Gillie BL, 2020, APPL NEUROPSYCH-CHIL, DOI 10.1080/21622965.2020.1799790; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Gladstone B.M., 2015, PARENTAL PSYCHIAT DI, P85, DOI [10.1017/CBO9781107707559.010, DOI 10.1017/CBO9781107707559.010]; Green J., 2018, QUALITATIVE METHODS, V4th ed.; Grover S, 2004, CHILDHOOD, V11, P81, DOI 10.1177/0907568204040186; Guillemin M, 2004, HEALTH-LONDON, V8, P223, DOI 10.1177/1363459304041071; Guillemin M, 2004, QUAL HEALTH RES, V14, P272, DOI 10.1177/1049732303260445; HAHN RA, 1983, ANNU REV ANTHROPOL, V12, P305, DOI 10.1146/annurev.an.12.100183.001513; Hammell K.W., 2006, PERSPECTIVES DISABIL; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Hartman LR, 2015, GLOB QUALIT NURS RES, V2, DOI 10.1177/2333393615614307; Holmes D, 2006, INT J EVID-BASED HEA, V4, P180, DOI 10.1111/j.1479-6988.2006.00041.x; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; James A., 1997, CONSTRUCTING RECONST; James A., 2012, KEY CONCEPTS CHILDHO, DOI [10.4135/9781526435613, DOI 10.4135/9781526435613]; James Allison, 1998, THEORIZING CHILDHOOD; JEWSON ND, 1976, SOCIOLOGY, V10, P225, DOI 10.1177/003803857601000202; Kincheloe J.L., 2011, KEY WORKS CRITICAL P, P285; Kortesluoma RL, 2003, J ADV NURS, V42, P434, DOI 10.1046/j.1365-2648.2003.02643.x; Kroshus E, 2019, SOC SCI MED, V222, P359, DOI 10.1016/j.socscimed.2018.12.037; Kvale S., 1996, INTERVIEWS INTRO QUA, P210; Lincoln Y.S., 2011, SAGE HDB QUALITATIVE, V4th, P97; Literat I, 2013, INT J QUAL METH, V12, P84, DOI 10.1177/160940691301200143; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Lupton Deborah., 2013, RISK; Mah K, 2021, THESIS U TORONTO TOR; Mah K, 2020, DISABIL REHABIL, V42, P2967, DOI 10.1080/09638288.2019.1574916; Mantey DS, 2020, J AFFECT DISORDERS, V263, P684, DOI 10.1016/j.jad.2019.11.047; Mathieu F, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1416-7; McCrea M, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2846; Miles M., 1994, QUALITATIVE DATA ANA; Mills S., 2004, DISCOURSE NEW CRITIC, V2nd; Minney MJ, 2019, BRAIN INJURY, V33, P168, DOI 10.1080/02699052.2018.1540794; Mitchell C., 2011, PICTURING RES DRAWIN, P19; Morrow V, 2008, CHILD GEOGR, V6, P49, DOI 10.1080/14733280701791918; Nixon SA, 2017, PHYS THER, V97, P249, DOI 10.2522/ptj.20160149; Packer M., 2010, SCI QUALITATIVE RES, DOI [10.1017/CBO9780511779947, DOI 10.1017/CBO9780511779947]; Patton MQ., 2002, QUALITATIVE RES EVAL, V3, P207; Phelan SK, 2011, CAN J OCCUP THER, V78, P164, DOI 10.2182/cjot.2011.78.3.4; Punch S, 2020, CHILD GEOGR, V18, P128, DOI 10.1080/14733285.2019.1630716; Qvortrup J., 1985, FAMILY EC MODERN SOC; Ramcharan P, 2001, HEALTH SOC CARE COMM, V9, P358, DOI 10.1046/j.1365-2524.2001.00323.x; Reed N., 2019, LIVING GUIDELINE DIA; Rose G., 2016, VISUAL METHODOLOGIES, V4th ed.; Rosen R, 2020, FAM RELATSH SOC, V9, P7, DOI 10.1332/204674319X15764492732806; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Schmidt JD, 2018, PEDIATR NEUROL, V81, P19, DOI 10.1016/j.pediatrneurol.2017.12.017; Schwandt T.A., 2015, SAGE DICT QUALITATIV; Spyrou S, 2017, CHILDHOOD, V24, P433, DOI 10.1177/0907568217725936; Tay-Lim J, 2013, INT J QUAL METH, V12, P65, DOI 10.1177/160940691301200135; Ulvik OS, 2015, QUAL SOC WORK, V14, P193, DOI 10.1177/1473325014526923; Vanderbeck R. M., 2015, INTERGENERATIONAL SP; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Wyness M, 2013, CHILDHOOD, V20, P429, DOI 10.1177/0907568212459775; Yates S, 2010, THEOR PSYCHOL, V20, P52, DOI 10.1177/0959354309345647; Zemek R, 2013, ACAD EMERG MED, V20, P1041, DOI 10.1111/acem.12220; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	81	0	0	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.											PII S1443964621000280	10.1017/BrImp.2021.28		NOV 2021	14	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	YI4AM	WOS:000743792200001					2022-02-06	
J	Okumura, K; Baum, J; Mateo, R; Shnaydman, I				Okumura, Kenji; Baum, Jeffrey; Mateo, Romeo; Shnaydman, Ilya			Carotid-Subclavian Bypass to Treat Carotid Dissection From Blunt Cerebrovascular Injury Without Traumatic Brain Injury or Cervical Spine Fracture	AMERICAN SURGEON			English	Article; Early Access									[Okumura, Kenji; Baum, Jeffrey; Mateo, Romeo; Shnaydman, Ilya] New York Med Coll, Dept Surg, Westchester Med Ctr, Valhalla, NY USA		Shnaydman, I (corresponding author), Westchester Med Ctr, New York Med Coll, 100 Woods Rd, Valhalla, NY 10595 USA.	Ilya.Shnaydman@wmchealth.org		Okumura, Kenji/0000-0002-7751-2624			Biffl WL, 2009, J TRAUMA, V67, P1150, DOI 10.1097/TA.0b013e3181c1c1d6; Biffl WL, 2002, ANN SURG, V235, P699, DOI 10.1097/00000658-200205000-00012; Franz RW, 2012, J AM COLL SURGEONS, V214, P313, DOI 10.1016/j.jamcollsurg.2011.11.012; Hanna K, 2020, J TRAUMA ACUTE CARE, V89, P74, DOI 10.1097/TA.0000000000002704	4	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.											00031348211058612	10.1177/00031348211058612		NOV 2021	3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XJ2SJ	WOS:000726644300001	34841908				2022-02-06	
J	Sawa, B; Assoumane, I; Ngoko, Y; Sode, HC; Sanoussi, S				Sawa, Brice; Assoumane, Ibrahim; Ngoko, Yvan; Sode, Haboubacar Chaibou; Sanoussi, Samuila			Delays in a traumatic brain injury: A case report	TROPICAL DOCTOR			English	Article; Early Access						scalp; wound; skull fracture; stone; infection		We present a case highlighting bottlenecks on the care chain for a victim of an open traumatic brain injury. Risks of severe complications, infectious in particular, escalate with every hour.	[Sawa, Brice; Assoumane, Ibrahim; Ngoko, Yvan; Sode, Haboubacar Chaibou; Sanoussi, Samuila] Niamey Natl Hosp, Neurosurg Dept, BP 238, Niamey, Niger; [Assoumane, Ibrahim; Sanoussi, Samuila] Abdou Moumouni Univ, Fac Hlth Sci, Niamey, Niger		Sawa, B (corresponding author), Niamey Natl Hosp, Neurosurg Dept, BP 238, Niamey, Niger.	sawabrice@gmail.com					Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Guerra Fernández Lina Maritza, 2019, Rev. colomb. anestesiol., V47, P100, DOI 10.1097/cj9.0000000000000112; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Moscote-Salazar Luis Rafael, 2016, Bull Emerg Trauma, V4, P8; Quenum J-MK., 2013, SOC NEUROCHIRURGIE L, V59, P8, DOI [10.1016/j.neuchi.2013.10.084, DOI 10.1016/J.NEUCHI.2013.10.084]	6	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0049-4755	1758-1133		TROP DOCT	Trop. Dr.											00494755211055539	10.1177/00494755211055539		NOV 2021	4	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Tropical Medicine	XJ7IZ	WOS:000726958000001	34841985				2022-02-06	
J	Suligavi, SS; Saiyad, SN; Doddamani, SS; Mathri, A				Suligavi, Shashidhar S.; Saiyad, Saif N.; Doddamani, Sangappa S.; Mathri, Archana			Early Diagnosis of Hidden Hearing Loss Following Temporal Bone Fractures	INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY			English	Article; Early Access						Otic capsule; Haemotympanum; Hearing loss; Temporal bone fractures	CLASSIFICATION; INJURY	Temporal bone fracture accounts for 30-70% of skull fractures. Temporal bone trauma is associated with severe traumatic brain injury(.) Temporal bone fractures are invariably due to road traffic accidents (RTA). Temporal bone fractures are traditionally classified as transverse, longitudinal or mixed fractures depending on their relationship to the petrous pyramid. Recent studies classify temporal bone fractures as otic capsule sparing (OCS) and otic capsule violating (OCV) types and has more relevance with the prognosis of hearing loss and complications. To study of type and degree of hearing loss following temporal bone fractures according to the old and new classification of temporal bone fractures. The prospective study of 35 cases of head injuries attending emergency department was conducted in the Department of Otorhinolaryngology, SNMC and H.S.K. Hospital & Research centre, Bagalkot during the study period from January 2019 to June 2020. High Resolution Computed Tomography (HRCT) of bilateral temporal bone was done to look for type of temporal bone fractures. Pure tone audiometry (PTA) to assess degree and type of hearing loss. Appropriate statistical analysis at the end of study was done. Most patients were in age group of 21-40 years. Among 35 cases, 30 were longitudinal fractures, 4 were transverse and 1 was mixed.27 cases were OCS and 8 of OCV type.OCV type of fractures are having higher degree of hearing loss. Longitudinal type of temporal bone fractures constitutes majority. Hearing loss was more in OCV type.	[Suligavi, Shashidhar S.; Saiyad, Saif N.; Doddamani, Sangappa S.; Mathri, Archana] S Nijalingappa Med Coll, Dept ENT, Bagalkot, Karnataka, India		Saiyad, SN (corresponding author), S Nijalingappa Med Coll, Dept ENT, Bagalkot, Karnataka, India.	saif8492@gmail.com					Ahluwalia CL., 1983, INDIAN J OTOLARYNGOL, V35, P55, DOI [10.1007/BF02993792, DOI 10.1007/BF02993792]; Amin Z, 2008, Med J Malaysia, V63, P373; BARBER HO, 1969, ANN OTO RHINOL LARYN, V78, P239, DOI 10.1177/000348946907800204; COKER NJ, 1987, OTOLARYNG HEAD NECK, V97, P262, DOI 10.1177/019459988709700303; Dahiya R, 1999, J TRAUMA, V47, P1079, DOI 10.1097/00005373-199912000-00014; Dal Secchi MM, 2012, INT ARCH OTORHINOLAR, V16, P62; Gasparetto Emerson L., 2011, Radiol Bras, V44, pVII, DOI 10.1590/S0100-39842011000200002; GHARPURE P V, 1959, Indian J Med Sci, V13, P232; GURDJIAN ES, 1946, SURG GYNECOL OBSTET, V83, P219; Ishman SL, 2004, LARYNGOSCOPE, V114, P1734, DOI 10.1097/00005537-200410000-00011; Kahn JB, 2000, AM J OTOL, V21, P743; Little SC, 2006, ARCH OTOLARYNGOL, V132, P1300, DOI 10.1001/archotol.132.12.1300; Maradi N., 2017, INT J OTORHINOLARYNG, V3, P390, DOI [10.18203/issn.2454-5929.ijohns20171193, DOI 10.18203/ISSN.2454-5929.IJOHNS20171193]; PODOSHIN L, 1975, ARCH OTOLARYNGOL, V101, P15; Singh G, 2013, INDIAN J OTOLARYNGOL, V65, pS498, DOI 10.1007/s12070-011-0404-6; Tos M, 1971, J Laryngol Otol, V85, P1147, DOI 10.1017/S0022215100074569; Yetiser S, 2008, J TRAUMA, V65, P1314, DOI 10.1097/TA.0b013e3180eead57	17	0	0	0	0	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	2231-3796	0973-7707		INDIAN J OTOLARYNGOL	Indian J. Otolaryngol. Head Neck Surg.												10.1007/s12070-021-02933-x		NOV 2021	5	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	XE0EZ	WOS:000723072200001					2022-02-06	
J	Waqar, M; Chadwick, A; Kersey, J; Horner, D; Kearney, T; Karabatsou, K; Gnanalingham, KK; Pathmanaban, ON				Waqar, Mueez; Chadwick, Annabel; Kersey, James; Horner, Daniel; Kearney, Tara; Karabatsou, Konstantina; Gnanalingham, Kanna K.; Pathmanaban, Omar N.			Venous thromboembolism chemical prophylaxis after endoscopic trans-sphenoidal pituitary surgery	PITUITARY			English	Article; Early Access						Venous thromboembolism; VTE; Hematoma; Haematoma; Transsphenoidal; Pituitary; Heparin; Prophylaxis; Chemoprophylaxis	TRAUMATIC BRAIN-INJURY; MOLECULAR-WEIGHT HEPARIN; CUSHINGS-SYNDROME; SAFETY; CHEMOPROPHYLAXIS; PREVENTION; GUIDELINES; RISK	Purpose There is no compelling outcome data or clear guidance surrounding postoperative venous thromboembolism (VTE) prophylaxis using low molecular weight heparin (chemoprophylaxis) in patients undergoing pituitary surgery. Here we describe our experience of early chemoprophylaxis (post-operative day 1) following trans-sphenoidal pituitary surgery. Methods Single-centre review of a prospective surgical database and VTE records. Adults undergoing first time trans-sphenoidal pituitary surgery were included (2009-2018). VTE was defined as either deep vein thrombosis and/or pulmonary embolism within 3 months of surgery. Postoperative haematomas were those associated with a clinical deterioration together with radiological evidence. Results 651 Patients included with a median age of 55 years (range 16-86 years). Most (99%) patients underwent trans-sphenoidal surgery using a standard endoscopic single nostril or bi-nostril trans-sphenoidal technique. More than three quarters had pituitary adenomas (n = 520, 80%). Postoperative chemoprophylaxis to prevent VTE was administered in 478 patients (73%). Chemoprophylaxis was initiated at a median of 1 day post-procedure (range 1-5 days postoperatively; 92% on postoperative day 1). Tinzaparin was used in 465/478 patients (97%) and enoxaparin was used in 14/478 (3%). There were no cases of VTE, even in 78 ACTH-dependent Cushing's disease patients. Six patients (1%) developed postoperative haematomas. Chemoprophylaxis was not associated with a significantly higher rate of postoperative haematoma formation (Fisher's Exact, p = 0.99) or epistaxis (Fisher's Exact, p > 0.99). Conclusions Chemoprophylaxis after trans-sphenoidal pituitary surgery on post-operative day 1 is a safe strategy to reduce the risk of VTE without significantly increasing the risk of postoperative bleeding events.	[Waqar, Mueez; Chadwick, Annabel; Kersey, James; Karabatsou, Konstantina; Gnanalingham, Kanna K.; Pathmanaban, Omar N.] Salford Royal NHS Fdn Trust, Manchester Ctr Clin Neurosci, Dept Neurosurg, Manchester, Lancs, England; [Waqar, Mueez; Horner, Daniel; Pathmanaban, Omar N.] Univ Manchester, Fac Biol Med & Hlth, Geoffrey Jefferson Brain Res Ctr, Manchester, Lancs, England; [Kersey, James; Horner, Daniel] Salford Royal NHS Fdn Trust, Manchester Ctr Clin Neurosci, Dept Neurocrit Care, Manchester, Lancs, England; [Kearney, Tara] Salford Royal NHS Fdn Trust, Manchester Ctr Clin Neurosci, Dept Endocrinol, Manchester, Lancs, England; [Chadwick, Annabel; Horner, Daniel] Univ Manchester, Geoffrey Jefferson Brain Res Ctr, Sch Med, Manchester, Lancs, England		Pathmanaban, ON (corresponding author), Salford Royal NHS Fdn Trust, Manchester Ctr Clin Neurosci, Dept Neurosurg, Manchester, Lancs, England.; Pathmanaban, ON (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Geoffrey Jefferson Brain Res Ctr, Manchester, Lancs, England.	omar.pathmanaban@manchester.ac.uk		Waqar, Mueez/0000-0002-7848-6237			Afshari A, 2018, EUR J ANAESTH, V35, P77, DOI 10.1097/EJA.0000000000000729; Agam MS, 2019, J NEUROSURG, V130, P1576, DOI 10.3171/2017.12.JNS172318; Alshehri N, 2016, J NEURO-ONCOL, V130, P561, DOI 10.1007/s11060-016-2259-x; Anderson DR, 2019, BLOOD ADV, V3, P3898, DOI 10.1182/bloodadvances.2019000975; Arabi YM, 2019, NEW ENGL J MED, V380, P1305, DOI 10.1056/NEJMoa1816150; Babic B, 2019, J ENDOCR SOC, V3, P304, DOI 10.1210/js.2018-00278; Barbot M, 2015, PITUITARY, V18, P487, DOI 10.1007/s11102-014-0600-y; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Chang R, 2017, J TRAUMA ACUTE CARE, V83, P1088, DOI 10.1097/TA.0000000000001675; Chibbaro S, 2018, WORLD NEUROSURG, V109, pE510, DOI 10.1016/j.wneu.2017.10.012; Dengler BA, 2016, NEUROCRIT CARE, V25, P215, DOI 10.1007/s12028-016-0280-8; Hamilton MG, 2011, NEUROSURGERY, V68, P571, DOI 10.1227/NEU.0b013e3182093145; Jacobs LJ, 2013, SPINE, V38, pE1041, DOI 10.1097/BRS.0b013e31829879cc; Khan NR, 2018, J NEUROSURG, V129, P906, DOI 10.3171/2017.2.JNS162040; Kim DH, 2017, J CRANIOFAC SURG, V28, P959, DOI 10.1097/SCS.0000000000003423; Koutroumpi S, 2013, PITUITARY, V16, P175, DOI 10.1007/s11102-012-0398-4; Manetti L, 2010, EUR J ENDOCRINOL, V163, P783, DOI 10.1530/EJE-10-0583; Galan LAM, 2016, J TRAUMA ACUTE CARE, V81, P567, DOI 10.1097/TA.0000000000001134; Mismetti P, 2000, THROMB HAEMOSTASIS, V83, P14; National Institute of Clinical Excellence (NICE), VEN THROMB 16S RED R; Papakokkinou E, 2020, J CLIN ENDOCR METAB, V105, P2616, DOI 10.1210/clinem/dgaa291; Shalhoub J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1309; Spinazzi EF, 2015, LARYNGOSCOPE, V125, P1563, DOI 10.1002/lary.25161; Strom RG, 2013, SPINE, V38, pE1498, DOI 10.1097/BRS.0b013e3182a4408d; Stuijver DJF, 2011, J CLIN ENDOCR METAB, V96, P3525, DOI 10.1210/jc.2011-1661; Tanweer O, 2013, J NEUROSURG, V119, P1309, DOI 10.3171/2013.7.JNS13313; Wagner J, 2019, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00805; Younus I, 2020, J NEUROSURG, V133, P702, DOI 10.3171/2019.6.JNS191169; Zacharia BE, 2017, NEUROSURGERY, V80, P73, DOI 10.1227/NEU.0000000000001270; Zador Z, 2013, BRIT J NEUROSURG, V27, P718, DOI 10.3109/02688697.2013.798862	30	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1386-341X	1573-7403		PITUITARY	Pituitary												10.1007/s11102-021-01195-8		NOV 2021	8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	XE6LK	WOS:000723496500001	34843070	hybrid			2022-02-06	
J	Zhu, YF; Jin, XQ; Xu, LL; Han, P; Lin, SW; Lu, ZS				Zhu, Yufeng; Jin, Xiaoqing; Xu, Lulu; Han, Pei; Lin, Shengwu; Lu, Zhongsheng			Establishment and validation of prognosis model for patients with cerebral contusion	BMC NEUROLOGY			English	Article						Traumatic brain injury; cerebral contusion; Cerebral edema; Nomogram; Prognosis	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; PROGRESSION; MANAGEMENT; EXPANSION; HEMATOMA	Background And Objective Cerebral Contusion (CC) is one of the most serious injury types in patients with traumatic brain injury (TBI). In this study, the baseline data, imaging features and laboratory examinations of patients with CC were summarized and analyzed to develop and validate a prediction model of nomogram to evaluate the clinical outcomes of patients. Methods A total of 426 patients with cerebral contusion (CC) admitted to the People's Hospital of Qinghai Province and Affiliated Hospital of Qingdao University from January 2018 to January 2021 were included in this study, We randomly divided the cohort into a training cohort (n = 284) and a validation cohort (n = 142) with a ratio of 2:1.At Least absolute shrinkage and selection operator (Lasso) regression were used for screening high-risk factors affecting patient prognosis and development of the predictive model. The identification ability and clinical application value of the prediction model were analyzed through the analysis of receiver operating characteristic curve (ROC), calibration curve, and decision curve analysis (DCA). Results Twelve independent prognostic factors, including age, Glasgow Coma Score (GCS), Basal cistern status, Midline shift (MLS), Third ventricle status, intracranial pressure (ICP) and CT grade of cerebral edema,etc., were selected by Lasso regression analysis and included in the nomogram. The model showed good predictive performance, with a C index of (0.87, 95% CI, 0.026-0.952) in the training cohort and (0.93, 95% CI, 0.032-0.965) in the validation cohort. Clinical decision curve analysis (DCA) also showed that the model brought high clinical benefits to patients. Conclusion This study established a high accuracy of nomogram model to predict the prognosis of patients with CC, its low cost, easy to promote, is especially applicable in the acute environment, at the same time, CSF-glucose/lactate ratio(C-G/L), volume of contusion, and mean CT values of edema zone, which were included for the first time in this study, were independent predictors of poor prognosis in patients with CC. However, this model still has some limitations and deficiencies, which require large sample and multi-center prospective studies to verify and improve our results.	[Zhu, Yufeng; Lin, Shengwu] Qinghai Univ, Dept Grad Sch, Xining 810016, Qinghai, Peoples R China; [Jin, Xiaoqing; Han, Pei; Lu, Zhongsheng] Qinghai Prov Peoples Hosp, Dept Neurosurg, Xining 810007, Qinghai, Peoples R China; [Xu, Lulu] Qingdao Univ, Affiliated Hosp, Dept Geriatr Med, Qingdao 266000, Shandong, Peoples R China		Lu, ZS (corresponding author), Qinghai Prov Peoples Hosp, Dept Neurosurg, Xining 810007, Qinghai, Peoples R China.	LZS13997154047@163.com			scientific research guiding plan project of Qinghai provincial health commission [:2020-wjzdx-30]	This work was supported by funds from the scientific research guiding plan project of Qinghai provincial health commission (NO:2020-wjzdx-30).	Bilotta Federico, 2007, J Neurosurg Anesthesiol, V19, P156, DOI 10.1097/ANA.0b013e3180338e69; Bledsoe BE, 2015, PREHOSP DISASTER MED, V30, P46, DOI 10.1017/S1049023X14001289; Du CN, 2019, WORLD NEUROSURG, V123, pE465, DOI 10.1016/j.wneu.2018.11.189; Chen Hui, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P307; Chou A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061616; Du CN, 2020, CEREBROVASC DIS, V49, P556, DOI 10.1159/000510805; Ertem AG, 2018, CLIN RESPIR J, V12, P580, DOI 10.1111/crj.12565; Finfer S, 2015, INTENS CARE MED, V41, P1037, DOI 10.1007/s00134-015-3757-6; Gregson BA, 2015, HEALTH TECHNOL ASSES, V19, DOI 10.3310/hta19700; Nguyen HS, 2016, NEURORADIOL J, V29, P372, DOI 10.1177/1971400916658795; Hamid HKS, 2021, SURG ONCOL, V37, DOI 10.1016/j.suronc.2021.101556; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Jarrahi A, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100389; Jin XQ, 2019, WORLD NEUROSURG, V124, pE266, DOI 10.1016/j.wneu.2018.12.081; Jin XQ, 2018, WORLD NEUROSURG, V116, pE759, DOI 10.1016/j.wneu.2018.05.086; Kim H, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0186-2; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lietke S, 2020, J NEUROIMAGING, V30, P640, DOI 10.1111/jon.12736; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Lozano A, 2020, J NEUROSURG ANESTH, V32, P162, DOI 10.1097/ANA.0000000000000582; Mangel L, 2002, NEOPLASMA, V49, P237; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nirula R, 2014, J TRAUMA ACUTE CARE, V76, P944, DOI 10.1097/TA.0000000000000194; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Oliveira RAG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00044; Sheng JT, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/5483981; Song QH, 2021, NEUROL SCI, V42, P765, DOI 10.1007/s10072-020-04871-y; Tong WS, 2011, NEURORADIOLOGY, V53, P305, DOI 10.1007/s00234-010-0659-8; Yang MF, 2020, WORLD NEUROSURG, V137, pE470, DOI 10.1016/j.wneu.2020.02.004; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; Zimmerman RD, 2004, AM J NEURORADIOL, V25, P1304	33	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	NOV 29	2021	21	1							463	10.1186/s12883-021-02482-4			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XE8RV	WOS:000723650600001	34844563	gold, Green Published			2022-02-06	
J	Chrisman, SPD; Whelan, BM; Zatzick, DF; Hilt, RJ; Wang, J; Marcynyszyn, LA; Rivara, FP; McCarty, CA				Chrisman, Sara P. D.; Whelan, Bridget M.; Zatzick, Douglas F.; Hilt, Robert J.; Wang, Jin; Marcynyszyn, Lyscha A.; Rivara, Frederick P.; McCarty, Carolyn A.			Prevalence and risk factors for depression, anxiety and suicidal ideation in youth with persistent post-concussive symptoms (PPCS)	BRAIN INJURY			English	Article						Concussion; depression; anxiety; suicide; mental health; sleep; adolescence	PATIENT HEALTH QUESTIONNAIRE-9; SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; PSYCHOMETRIC PROPERTIES; REPRESENTATIVE SAMPLE; POSTTRAUMATIC-STRESS; MAJOR DEPRESSION; ADOLESCENTS; DISORDER	Objectives: To assess the prevalence and risk factors for emotional distress in youth with persistent post-concussive symptoms (PPCS) greater than one month. Methods: We used baseline data from an intervention study for youth with PPCS, utilizing Poisson regression to examine factors associated with exceeding clinical cut-points on measures of depression, anxiety, self-harm and suicidal ideation. Predictors included: age, sex, socioeconomic status, mental health history, duration of concussion symptoms, history of prior concussion, trauma history and sleep quality. Results: The sample included 200 youth with PPCS, (mean 14.7 SD 1.7 years, 82% white, 62% female). Forty percent reported clinically significant depressive symptoms, 25% anxiety, 14% thoughts of self-harm and 8% thoughts of suicide. History of depression was associated with 3-fold higher risk for thoughts of self-harm (95% CI:1.82-6.99) and 6-fold higher risk for suicidal ideation (95% CI:1.74-24.46). Better sleep quality was associated with lower risk for all outcomes. History of prior concussion and duration of PPCS were not significantly associated with any outcomes. Conclusions: Suicidal thoughts are common post-concussion, and history of depression is a strong risk factor. Tailored interventions may be needed to address mental health in this population.	[Chrisman, Sara P. D.; Hilt, Robert J.; Marcynyszyn, Lyscha A.; Rivara, Frederick P.; McCarty, Carolyn A.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371,CW 8-6, Seattle, WA 98145 USA; [Chrisman, Sara P. D.; Whelan, Bridget M.; Rivara, Frederick P.; McCarty, Carolyn A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Zatzick, Douglas F.; Hilt, Robert J.] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Wang, Jin; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA		Chrisman, SPD (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371,CW 8-6, Seattle, WA 98145 USA.	sara.chrisman@seattlechildrens.org		Chrisman, Sara/0000-0001-5373-7223; McCarty, Carolyn/0000-0002-9747-0927	National Institute of Child Health and Human Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD090230]	This work was made possible by a grant from the National Institute of Child Health and Human Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, R01HD090230.	Abdijadid, 2020, STATPEARLS; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Asarnow JR, 2020, SUICIDE LIFE-THREAT, V50, P1189, DOI 10.1111/sltb.12658; Avenevoli S, 2015, J AM ACAD CHILD PSY, V54, P37, DOI 10.1016/j.jaac.2014.10.010; Balis Theodora, 2008, Int J Child Health Hum Dev, V1, P281; Baum KT, 2014, J CHILD PSYCHOL PSYC, V55, P180, DOI 10.1111/jcpp.12125; Beitchman JA, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01434; Bhatta S, 2018, J PEDIATR NURS, V38, P8, DOI 10.1016/j.pedn.2017.10.001; Birmaher B, 1996, J AM ACAD CHILD PSY, V35, P1427, DOI 10.1097/00004583-199611000-00011; Bostwick WB, 2014, AM J PUBLIC HEALTH, V104, P1129, DOI 10.2105/AJPH.2013.301749; Brooks BL, 2019, J NEUROTRAUM, V36, P679, DOI 10.1089/neu.2018.5792; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Burdzovic Andreas Jasmina, 2017, Front Psychol, V8, P887, DOI 10.3389/fpsyg.2017.00887; Byrd-Bredbenner C, 2021, GEN HOSP PSYCHIAT, V69, P61, DOI 10.1016/j.genhosppsych.2021.01.002; Campbell-Sills L, 2021, J HEAD TRAUMA REHAB, V36, pE30, DOI 10.1097/HTR.0000000000000602; Cha CB, 2018, J CHILD PSYCHOL PSYC, V59, P460, DOI 10.1111/jcpp.12831; Cho HB, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8142631; Chong CD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0485-0; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Chung JS, 2019, J CHILD NEUROL, V34, P639, DOI 10.1177/0883073819849741; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Donovan CL, 2000, CLIN PSYCHOL REV, V20, P509, DOI 10.1016/S0272-7358(99)00040-9; Elhai JD, 2013, J TRAUMA STRESS, V26, P10, DOI 10.1002/jts.21755; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Essex MJ, 2006, ARCH GEN PSYCHIAT, V63, P1246, DOI 10.1001/archpsyc.63.11.1246; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Foster CE, 2017, CHILD YOUTH SERV REV, V81, P321, DOI 10.1016/j.childyouth.2017.08.011; Ganguly S, 2013, J ADOLESCENT HEALTH, V52, P546, DOI 10.1016/j.jadohealth.2012.09.012; Garlow SJ, 2008, DEPRESS ANXIETY, V25, P482, DOI 10.1002/da.20321; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Hall-Lande JA, 2007, ADOLESCENCE, V42, P265; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Ho FYY, 2020, J AFFECT DISORDERS, V265, P287, DOI 10.1016/j.jad.2020.01.062; Kann L, 2014, MMWR SURVEILL SUMM, V63, P1; Kessler RC, 2001, BIOL PSYCHIAT, V49, P1002, DOI 10.1016/S0006-3223(01)01129-5; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langer LK, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003652; LeBourgeois MK, 2005, PEDIATRICS, V115, P257, DOI 10.1542/peds.2004-0815H; Lewinsohn PM, 1998, CLIN PSYCHOL REV, V18, P765, DOI 10.1016/S0272-7358(98)00010-5; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Maizels M, 2006, HEADACHE, V46, pS98, DOI 10.1111/j.1526-4610.2006.00561.x; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCarty CA, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3662-3; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Morse AM, 2018, HAND CLINIC, V158, P127, DOI 10.1016/B978-0-444-63954-7.00013-6; Mossman SA, 2017, ANN CLIN PSYCHIATRY, V29, P227; Nestor BA, 2016, J AFFECT DISORDERS, V202, P197, DOI 10.1016/j.jad.2016.05.021; O'Connor SS, 2012, J TRAUMA STRESS, V25, P264, DOI 10.1002/jts.21704; Orchard F, 2020, J CHILD PSYCHOL PSYC, V61, P1126, DOI 10.1111/jcpp.13288; RAO U, 1995, J AM ACAD CHILD PSY, V34, P566, DOI 10.1097/00004583-199505000-00009; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Roberts RE, 2017, SLEEP MED, V30, P82, DOI 10.1016/j.sleep.2016.02.007; Roberts RE, 2014, SLEEP, V37, P239, DOI 10.5665/sleep.3388; Sagarkar S, 2017, NEUROBIOL DIS, V106, P101, DOI 10.1016/j.nbd.2017.06.016; Sarchiapone M, 2014, SLEEP MED, V15, P248, DOI 10.1016/j.sleep.2013.11.780; Simon GE, 2013, PSYCHIAT SERV, V64, P1195, DOI 10.1176/appi.ps.201200587; Siu AL, 2016, ANN INTERN MED, V164, P360, DOI 10.7326/M15-2957; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steinberg Alan M, 2004, Curr Psychiatry Rep, V6, P96, DOI 10.1007/s11920-004-0048-2; Steinberg AM, 2013, J TRAUMA STRESS, V26, P1, DOI 10.1002/jts.21780; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; Tiirikainen K, 2019, PSYCHIAT RES, V272, P30, DOI 10.1016/j.psychres.2018.12.004; Todd R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192125; Tomfohr-Madsen L, 2020, J HEAD TRAUMA REHAB, V35, pE103, DOI 10.1097/HTR.0000000000000504; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Walker J, 2011, PSYCHOSOMATICS, V52, P424, DOI 10.1016/j.psym.2011.02.003; Werner-Seidler A, 2017, CLIN PSYCHOL REV, V51, P30, DOI 10.1016/j.cpr.2016.10.005; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Yang MN, 2019, AM J HEALTH BEHAV, V43, P258, DOI 10.5993/AJHB.43.2.3; Yrondi A, 2017, PRESSE MED, V46, P890, DOI 10.1016/j.lpm.2017.08.013; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	83	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV 10	2021	35	12-13					1637	1644		10.1080/02699052.2021.2008490		NOV 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XP4FK	WOS:000723042900001	34841998	hybrid			2022-02-06	
J	Wang, KK; Pareja, JCM; Mondello, S; Diaz-Arrastia, R; Wellington, C; Kenney, K; Puccio, AM; Hutchison, J; McKinnon, N; Okonkwo, DO; Yang, ZH; Kobeissy, F; Tyndall, JA; Buki, A; Czeiter, E; Zabala, MCP; Gandham, N; Berman, R				Wang, Kevin K.; Pareja, Jennifer C. Munoz; Mondello, Stefania; Diaz-Arrastia, Ramon; Wellington, Cheryl; Kenney, Kimbra; Puccio, Ava M.; Hutchison, Jamie; McKinnon, Nicole; Okonkwo, David O.; Yang, Zhihui; Kobeissy, Firas; Tyndall, J. Adrian; Buki, Andras; Czeiter, Endre; Zabala, Maria C. Pareja; Gandham, Nithya; Berman, Rebecca			Blood-based traumatic brain injury biomarkers - Clinical utilities and regulatory pathways in the United States, Europe and Canada	EXPERT REVIEW OF MOLECULAR DIAGNOSTICS			English	Article						Biomarkers; regulatory pathways; traumatic brain injury; point of care; consortiums	C-TERMINAL HYDROLASE-L1; FIBRILLARY ACIDIC PROTEIN; NEURON-SPECIFIC ENOLASE; SUBJECTIVE COGNITIVE DECLINE; SPECTRIN BREAKDOWN PRODUCTS; SERUM NEUROFILAMENT LIGHT; ALPHA-II-SPECTRIN; S100B PROTEIN; CEREBROSPINAL-FLUID; INTRACRANIAL LESIONS	Introduction Traumatic brain injury (TBI) is a major global health issue, resulting in debilitating consequences to families, communities, and health-care systems. Prior research has found that biomarkers aid in the pathophysiological characterization and diagnosis of TBI. Significantly, the FDA has recently cleared both a bench-top assay and a rapid point-of-care assays of tandem biomarker (UCH-L1/GFAP)-based blood test to aid in the diagnosis mTBI patients. With the global necessity of TBI biomarkers research, several major consortium multicenter observational studies with biosample collection and biomarker analysis have been created in the USA, Europe, and Canada. As each geographical region regulates its data and findings, the International Initiative for Traumatic Brain Injury Research (InTBIR) was formed to facilitate data integration and dissemination across these consortia. Areas Covered This paper covers heavily investigated TBI biomarkers and emerging non-protein markers. Finally, we analyze the regulatory pathways for converting promising TBI biomarkers into approved in-vitro diagnostic tests in the United States, European Union, and Canada. Expert Opinion TBI biomarker research has significantly advanced in the last decade. The recent approval of an iSTAT point of care test to detect mild TBI has paved the way for future biomarker clearance and appropriate clinical use across the globe.	[Wang, Kevin K.; Yang, Zhihui; Kobeissy, Firas; Tyndall, J. Adrian; Gandham, Nithya] Univ Florida, Coll Med, Dept Emergency Med, Program Neurotrauma Neuroprotoem & Biomarker Res, Gainesville, FL USA; [Wang, Kevin K.; Yang, Zhihui; Kobeissy, Firas] Malcom Randall Vet Affairs Med Ctr, Brain Rehabil Res Ctr BRRC, Gainesville, FL USA; [Pareja, Jennifer C. Munoz] Univ Miami, Miller Sch Med, Dept Pediat Crit Care, Miami, FL 33136 USA; [Mondello, Stefania] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wellington, Cheryl] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Kenney, Kimbra] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD USA; [Puccio, Ava M.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Hutchison, Jamie; McKinnon, Nicole] Univ Toronto, Hosp Sick Children, Dept Crit Care Med, Toronto, ON, Canada; [Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA; [Czeiter, Endre] Pecs Univ, Dept Neurosurg, Pecs, Hungary; [Zabala, Maria C. Pareja] Fdn Univ Sanitas, Bogota, Colombia; [Berman, Rebecca] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA		Wang, KK (corresponding author), Univ Florida, Dept Emergency Med, Program Neurotrauma Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA.	kawangwang17@gmail.com	Mondello, Stefania/A-1813-2012; Kobeissy, Firas/E-7042-2017	Mondello, Stefania/0000-0002-8587-3614; Kobeissy, Firas/0000-0002-5008-6944; Wang, Kevin/0000-0002-9343-6473	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1U01 NS086090-01]; DODUnited States Department of Defense [W81XWH-14-2-0176, W81XWH-13-1-04]; European Commission Framework Program 7, FP7-HEALTH2013-INNOVATION-1 grant [602150-2]; U.S. Army Medical Research and Material Command, from the U.S. Department of Veterans Affairs Long-term Impact of Military-related Brain Injury Consortium/Chronic Effects of Neurotrauma Consortium [1I01CX002097-01]; U. S Department of DefenseUnited States Department of Defense [W81XWH-18-PH/TBIRP-LIMBIC]	This study is supported in part by NIH 1U01 NS086090-01 (KKW, RDA), DOD Grant W81XWH-14-2-0176 (KKW, RDA), DOD Grant W81XWH-13-1-04 (KKW, RDA), European Commission Framework Program 7, FP7-HEALTH2013-INNOVATION-1 grant #602150-2; (KKW). This material is also based upon work supported by the U.S. Army Medical Research and Material Command, from the U.S. Department of Veterans Affairs Long-term Impact of Military-related Brain Injury Consortium/Chronic Effects of Neurotrauma Consortium under Award No. 1I01CX002097-01 and the U. S Department of Defense under Award No. W81XWH-18-PH/TBIRP-LIMBIC. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick Md 21702-5014 is the awarding and administering acquisition office.	Abbott DF., DOD BRAIN INJURY GRO; Abbott Diagnostics, 2021, ABB LINK WEV REC FDA; ACRM, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI 10.1097/00001199-199309000-00010; Ahn HJ, 2020, RESUSCITATION, V151, P50, DOI 10.1016/j.resuscitation.2020.03.022; Allouchery G, 2018, CLIN CHEM LAB MED, V56, P1897, DOI 10.1515/cclm-2018-0471; Ankeny DP, 2006, J NEUROCHEM, V99, P1073, DOI 10.1111/j.1471-4159.2006.04147.x; Bailey ZS, 2015, NEUROSCI LETT, V604, P119, DOI 10.1016/j.neulet.2015.07.035; Ballesteros MA, 2018, J NEUROL SCI, V385, P109, DOI 10.1016/j.jns.2017.12.017; Bashir A, 2020, EXP NEUROL, V324, DOI 10.1016/j.expneurol.2019.113116; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Berger RP, 2011, PM&R, V3, pS31, DOI 10.1016/j.pmrj.2011.03.016; Berger RP, 2010, DEV NEUROSCI-BASEL, V32, P396, DOI 10.1159/000316803; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Binder S, 2003, NATL CTR INJURY PREV, P1; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bouvier D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027365; Bouvier D, 2011, CLIN BIOCHEM, V44, P927, DOI 10.1016/j.clinbiochem.2011.05.004; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Camacho-Soto A, 2017, ANN NEUROL, V82, P744, DOI 10.1002/ana.25074; Cavallini A, 2013, J BIOL CHEM, V288, P23331, DOI 10.1074/jbc.M113.463984; Chen J, 2017, NEUROLOGY, V88, P669, DOI 10.1212/WNL.0000000000003615; Clarke GJB, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.643743; Colasanti T, 2010, AUTOIMMUN REV, V9, P807, DOI 10.1016/j.autrev.2010.07.008; Cox AL, 2006, J NEUROIMMUNOL, V174, P180, DOI 10.1016/j.jneuroim.2006.01.007; CSA, 2019, Z316818 CSA; CSA, 2018, REQ DES DEV VAL LAB, P8; Czeiter E, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102785; D'Andrea MR, 2005, MED HYPOTHESES, V64, P458, DOI 10.1016/j.mehy.2004.08.024; Dage JL, 2016, ALZHEIMERS DEMENT, V12, P1226, DOI 10.1016/j.jalz.2016.06.001; Dambinova SA, 2003, CLIN CHEM, V49, P1752, DOI 10.1373/49.10.1752; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI, P1; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Duda I, 2017, ACTA BIOCHIM POL, V64, P647, DOI 10.18388/abp.2017_1619; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Emanuel' A V, 2012, Klin Lab Diagn, P41; Ercole A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0614-3; Food and Drug Administration, 2018, BIOAN METH VAL GUID, P1; Food and Drug Administration, 2018, US DEP HEAL HUM SERV, P1; Fourier A, 2020, EUR J NEUROL, V27, P1164, DOI 10.1111/ene.14247; Gamble Brenda, 2014, Healthc Policy, V10, P67; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Golden Nyoman, 2018, Open Access Maced J Med Sci, V6, P2239, DOI 10.3889/oamjms.2018.432; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goryunova A V, 2007, Neurosci Behav Physiol, V37, P761, DOI 10.1007/s11055-007-0079-3; Government of Canada. Medical test kits for home use, 2016, MED TEST KITS HOM US; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; Guedes VA, 2020, NEUROLOGY, V94, pE2412, DOI 10.1212/WNL.0000000000009577; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Halford J, 2017, J CEREBR BLOOD F MET, V37, P3278, DOI 10.1177/0271678X17724681; Hedegaard CJ, 2009, IMMUNOLOGY, V128, pe451, DOI 10.1111/j.1365-2567.2008.02999.x; Heinzelmann M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00198; Hellewell SC, 2018, CRIT CARE MED, V46, P554, DOI 10.1097/CCM.0000000000002938; Hessena E, 2015, J ALZHEIMERS DIS, V47, P619, DOI 10.3233/JAD-150109; Hicks SD, 2018, J NEUROTRAUM, V35, P64, DOI 10.1089/neu.2017.5111; Higuchi M, 2002, NEUROMOL MED, V2, P131, DOI 10.1385/NMM:2:2:131; Hogan SR, 2018, J PROTEOME RES, V17, P2131, DOI 10.1021/acs.jproteome.8b00068; Holloway K, 2019, CAN MED ASSOC J, V191, pE1067, DOI 10.1503/cmaj.190550; Huie JR, 2019, J NEUROTRAUM, V36, P100, DOI 10.1089/neu.2017.5449; Hutchison JS, 2018, J NEUROTRAUM, V35, P1858, DOI 10.1089/neu.2018.5871; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Jauch, 2012, ISRN EMERGENCY MED, V1, P1, DOI DOI 10.5402/2012/417313; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kahouadji S, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00856; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Lagerstedt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200394; Lancaster E, 2012, NAT REV NEUROL, V8, P380, DOI 10.1038/nrneurol.2012.99; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Lejbman N, 2016, BRAIN INJURY, V30, P1436, DOI 10.1080/02699052.2016.1219054; Lesko MM, 2014, BRAIN INJURY, V28, P987, DOI 10.3109/02699052.2014.890743; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Li H, 2009, CLIN BIOCHEM, V42, P249, DOI 10.1016/j.clinbiochem.2008.09.006; Li XH, 2014, NEUROENDOCRINOL LETT, V35, P58; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Lleo A, 2015, NAT REV NEUROL, V11, P41, DOI 10.1038/nrneurol.2014.232; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Mahler B, 2018, NEUROLOGY, V90, pE779, DOI 10.1212/WNL.0000000000005035; Makarenko S, 2016, J CLIN NEUROSCI, V26, P8, DOI 10.1016/j.jocn.2015.05.065; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Martinez BI, 2019, J BIOL ENG, V13, DOI 10.1186/s13036-019-0145-8; Martinez-Morillo E, 2015, CLIN CHEM LAB MED, V53, P1575, DOI 10.1515/cclm-2014-0908; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mielke MM, 2019, NEUROLOGY, V93, pE252, DOI 10.1212/WNL.0000000000007767; Mondello S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040977; Mondello S, 2018, EXPERT REV PROTEOMIC, V15, P451, DOI 10.1080/14789450.2018.1464914; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Mondello S, 2012, BRAIN INJURY, V26, P1629, DOI 10.3109/02699052.2012.700083; Mondello S, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-85; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Morris MC, 2019, J SURG RES, V244, P63, DOI 10.1016/j.jss.2019.06.023; Muller S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08779-0; Muraoka S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01059; Murillo-Cabezas F, 2010, BRAIN INJURY, V24, P609, DOI 10.3109/02699051003652823; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Obirieze AC, 2020, FRONT NEUROL, V11, P1; Ojo JO, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00405; Okonkwo DO, 2020, J NEUROTRAUM, V37, P2460, DOI 10.1089/neu.2020.7140; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Olivecrona M, 2009, J NEUROL NEUROSUR PS, V80, P1241, DOI 10.1136/jnnp.2008.158196; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Oris C, 2021, J GERONTOL A-BIOL, V76, P1471, DOI 10.1093/gerona/glab055; Oris C, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2018-0037; Papa L, 2019, J NEUROTRAUM, V36, P1343, DOI 10.1089/neu.2018.6072; Papa L, 2017, J NEUROTRAUM, V34, P2132, DOI 10.1089/neu.2016.4806; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2015, NEUROCRIT CARE, V22, P52, DOI 10.1007/s12028-014-0028-2; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Pfortmueller CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152822; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Ponomarenko NA, 2006, IMMUNOL LETT, V103, P45, DOI 10.1016/j.imlet.2005.10.006; Popovich PG, 1996, J NEUROSCI RES, V45, P349, DOI 10.1002/(SICI)1097-4547(19960815)45:4<349::AID-JNR4>3.0.CO;2-9; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Ramezani F, 2018, EMERGENCY, V6; Rodriguez-Rodriguez A, 2016, NEUROL RES, V38, P130, DOI 10.1080/01616412.2016.1144410; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Shahim P, 2020, NEUROLOGY, V95, pE623, DOI 10.1212/WNL.0000000000009985; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shahim P, 2013, EUR J PAEDIATR NEURO, V17, P7, DOI 10.1016/j.ejpn.2012.09.005; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Simic G, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010006; Singh GP, 2018, ANALYST, V143, P3366, DOI 10.1039/c8an00533h; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Sorokina EG, 2010, ZH NEVROL PSIKHIATR, V110, P30; Sport Injury Prevention Research Centre, 2018, SPORT INJ PREV RES C; Stukas S, 2019, LANCET CHILD ADOLESC, V3, P558, DOI 10.1016/S2352-4642(19)30194-4; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; The Centre for Accreditation T. C. F, 2021, ACCR CAN DIAGN; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vijapur SM, 2020, J NEUROTRAUM, V37, P1609, DOI 10.1089/neu.2019.6780; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; WANG K, 2021, ACUTE MED SURG, V8, DOI DOI 10.1002/AMS2.622; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wang KK, 2017, EXPERT OPIN THER TAR, V21, P627, DOI 10.1080/14728222.2017.1321635; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; West J, 2017, ANN CLIN BIOCHEM, V54, P14, DOI 10.1177/0004563216669384; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; Wright DK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51267-w; Wu ZR, 2020, PROG NEUROBIOL, V185, DOI 10.1016/j.pneurobio.2019.101730; Yang J, 2015, CLIN BIOCHEM, V48, P843, DOI 10.1016/j.clinbiochem.2015.05.015; Yang L, 2017, SPRINGER SER ADV MAN, P1, DOI 10.1007/978-3-319-55128-9_1; Yang ZH, 2019, J NEUROTRAUM, V36, P348, DOI 10.1089/neu.2017.5586; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhang Y, 2011, DISCOV MED, V11, P395; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698	190	0	0	2	2	TAYLOR & FRANCIS AS	OSLO	KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY	1473-7159	1744-8352		EXPERT REV MOL DIAGN	Expert Rev. Mol. Diagn.	DEC 2	2021	21	12					1303	1321		10.1080/14737159.2021.2005583		NOV 2021	19	Pathology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pathology	XU6CP	WOS:000723556700001	34783274				2022-02-06	
J	Forssten, MP; Bass, GA; Scheufler, KM; Ismail, AM; Cao, Y; Martin, ND; Sarani, B; Mohseni, S				Forssten, Maximilian Peter; Bass, Gary Alan; Scheufler, Kai-Michael; Ismail, Ahmad Mohammad; Cao, Yang; Martin, Niels Douglas; Sarani, Babak; Mohseni, Shahin			Mortality risk stratification in isolated severe traumatic brain injury using the revised cardiac risk index	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Traumatic brain injury; Revised Cardiac Risk Index; Risk stratification; Mortality	ORGAN DYSFUNCTION; HIP FRACTURE; APACHE-II; EPIDEMIOLOGY; EQUATIONS; COMPLICATIONS; VALIDATION; PREDICTION; OUTCOMES; SURGERY	Purpose Traumatic brain injury (TBI) continues to be a significant cause of mortality and morbidity worldwide. As cardiovascular events are among the most common extracranial causes of death after a severe TBI, the Revised Cardiac Risk Index (RCRI) could potentially aid in the risk stratification of this patient population. This investigation aimed to determine the association between the RCRI and in-hospital deaths among isolated severe TBI patients. Methods All adult patients registered in the TQIP database between 2013 and 2017 who suffered an isolated severe TBI, defined as a head AIS >= 3 with an AIS <= 1 in all other body regions, were included. Patients were excluded if they had a head AIS of 6. The association between different RCRI scores (0, 1, 2, 3, >= 4) and in-hospital mortality was analyzed using a Poisson regression model with robust standard errors while adjusting for potential confounders, with RCRI 0 as the reference. Results 259,399 patients met the study's inclusion criteria. RCRI 2 was associated with a 6% increase in mortality risk [adjusted IRR (95% CI) 1.06 (1.01-1.12), p = 0.027], RCRI 3 was associated with a 17% increased risk of mortality [adjusted IRR (95% CI) 1.17 (1.05-1.31), p = 0.004], and RCRI >= 4 was associated with a 46% increased risk of in-hospital mortality [adjusted IRR(95% CI) 1.46 (1.11-1.90), p = 0.006], compared to RCRI 0. Conclusion An elevated RCRI >= 2 is significantly associated with an increased risk of in-hospital mortality among patients with an isolated severe traumatic brain injury. The simplicity and bedside applicability of the index makes it an attractive choice for risk stratification in this patient population.	[Forssten, Maximilian Peter; Bass, Gary Alan; Ismail, Ahmad Mohammad; Mohseni, Shahin] Orebro Univ, Sch Med Sci, S-70281 Orebro, Sweden; [Forssten, Maximilian Peter; Ismail, Ahmad Mohammad; Mohseni, Shahin] Orebro Univ Hosp, Div Trauma & Emergency Surg, S-70185 Orebro, Sweden; [Bass, Gary Alan; Martin, Niels Douglas] Univ Penn, Div Traumatol Surg Crit Care & Emergency Surg, Philadelphia, PA 19104 USA; [Scheufler, Kai-Michael] Orebro Univ Hosp, Dept Neurosurg, S-70185 Orebro, Sweden; [Scheufler, Kai-Michael] Heinrich Heine Univ Dusseldorf, Med Sch, Dusseldorf, Germany; [Cao, Yang] Orebro Univ, Sch Med Sci, Clin Epidemiol & Biostat, Orebro, Sweden; [Sarani, Babak] George Washington Univ, Sch Med & Hlth Sci, Div Trauma & Acute Care Surg, Washington, DC 20052 USA		Mohseni, S (corresponding author), Orebro Univ, Sch Med Sci, S-70281 Orebro, Sweden.; Mohseni, S (corresponding author), Orebro Univ Hosp, Div Trauma & Emergency Surg, S-70185 Orebro, Sweden.	maximilian.forssten@oru.se; gary.bass@pennmedicine.upenn.edu; kai-michael.scheufler@regionorebrolan.se; amzenik@gmail.com; yang.cao@oru.se; niels.martin@pennmedicine.upenn.edu; bsarani@mfa.gwu.edu; mohsenishahin@yahoo.com	Cao, Yang/C-6185-2008	Cao, Yang/0000-0002-3552-9153; Mohammad Ismail, Ahmad/0000-0003-3436-1026; Forssten, Maximilian Peter/0000-0003-3583-3443; Mohseni, Shahin/0000-0001-7097-487X	Orebro University	Open access funding provided by Orebro University. No financial support or funding was received for the presented work.	Adeleke I, 2020, RISK ASSESSMENT RISK; Ahl R, 2021, EUR J TRAUMA EMERG S, DOI 10.1007/s00068-020-01588-7; Alali AS, 2017, ANN SURG, V266, P952, DOI 10.1097/SLA.0000000000002286; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; [Anonymous], 2006, QUICKSTATS INJURY TR; Astarabadi M, 2020, J TRAUMA ACUTE CARE, V89, P405, DOI 10.1097/TA.0000000000002771; Bass G A, 1800, BJS Open, V5, DOI 10.1093/bjsopen/zrab057; Bertsimas D, 2018, ANN SURG, V268, P574, DOI 10.1097/SLA.0000000000002956; Cao Y, 2021, J PERS MED, V11, DOI 10.3390/jpm11050353; Centers for Disease Control and Prevention, 2021, SURV REP TRAUM BRAIN; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cher EWL, 2019, OSTEOPOROSIS INT, V30, P2477, DOI 10.1007/s00198-019-05139-8; Choi HG, 2018, BONE JOINT J, V100B, P436, DOI 10.1302/0301-620X.100B4.BJJ-2017-0993.R2; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Delanaye P, 2013, NAT REV NEPHROL, V9, P513, DOI 10.1038/nrneph.2013.143; Delanaye P, 2011, CLIN J AM SOC NEPHRO, V6, P906, DOI 10.2215/CJN.10931210; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Duceppe E, 2017, CAN J CARDIOL, V33, P17, DOI 10.1016/j.cjca.2016.09.008; El Hechi MW, 2021, J AM COLL SURGEONS, V232, P912, DOI 10.1016/j.jamcollsurg.2021.02.009; El Hechi MW, 2021, SURGERY, V169, P750, DOI 10.1016/j.surg.2020.06.049; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Flamant M, 2013, AM J KIDNEY DIS, V62, P182, DOI 10.1053/j.ajkd.2013.03.015; Fleisher LA, 2014, J AM COLL CARDIOL, V64, pE77, DOI 10.1016/j.jacc.2014.07.944; Ford MK, 2010, ANN INTERN MED, V152, P26, DOI 10.7326/0003-4819-152-1-201001050-00007; Forssten MP, 2021, TRAUMA SURG ACUTE CA, V6, DOI 10.1136/tsaco-2021-000778; Forssten MP, 2020, EUR J TRAUMA EMERG S, DOI 10.1007/s00068-020-01488-w; Gundel O, 2020, ACTA ORTHOP, V91, P58, DOI 10.1080/17453674.2019.1680485; Gursoy G, 2020, ULUS TRAVMA ACIL CER, V26, P893, DOI 10.14744/tjtes.2020.22654; Hulme RA, 2021, SCAND J SURG, DOI 10.1177/14574969211037588; Ismail A.M., 2021, J TRAUMA ACUTE CARE, DOI [10.1097/TA.0000000000003358, DOI 10.1097/TA.0000000000003358]; Kemp CD, 2008, AM SURGEON, V74, P866; Khalili H, 2020, WORLD J SURG, V44, P1844, DOI 10.1007/s00268-020-05391-8; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krishnamoorthy V, 2021, CHEST, V160, P956, DOI 10.1016/j.chest.2021.01.016; Kureshi N, 2021, J COMMUN HEALTH, V46, P1197, DOI 10.1007/s10900-021-01005-z; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Ley EJ, 2018, J TRAUMA ACUTE CARE, V84, P234, DOI 10.1097/TA.0000000000001747; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mohseni S, 2021, EUR J TRAUMA EMERG S, DOI 10.1007/s00068-021-01647-7; Mohseni S, 2014, J TRAUMA ACUTE CARE, V76, P804, DOI 10.1097/TA.0000000000000139; Nik Amir, 2018, Bull Emerg Trauma, V6, P141, DOI 10.29252/beat-060208; Nyam TTE, 2019, WORLD NEUROSURG, V122, pE740, DOI 10.1016/j.wneu.2018.10.130; Nyam TTE, 2017, NEUROCRIT CARE, V26, P225, DOI 10.1007/s12028-016-0326-y; Peck KA, 2014, J TRAUMA ACUTE CARE, V77, P978, DOI 10.1097/TA.0000000000000356; Popescu C, 2015, J Med Life, V8, P272; R Development Core Team, 2008, R LANGUAGE ENV STAT; Robba C, 2020, CURR OPIN CRIT CARE, V26, P137, DOI 10.1097/MCC.0000000000000707; Stahel PF, 2017, WORLD J EMERG SURG, V12, DOI 10.1186/s13017-017-0125-6; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034	51	0	0	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-021-01841-7		NOV 2021	8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XD8ZN	WOS:000722990200001	34839374	hybrid			2022-02-06	
J	Shojima, H; Hayashi, Y; Tamase, A; Takata, S; Iizuka, H				Shojima, Hirotaka; Hayashi, Yasuhiko; Tamase, Akira; Takata, Sho; Iizuka, Hideaki			Traumatic retroclival epidural hematoma associated with reversible ipsilateral internal carotid artery stenosis	CHILDS NERVOUS SYSTEM			English	Article						Retroclival; Epidural hematoma; Internal carotid artery; Stenosis; Abducens nerve palsy	INJURIES	Introduction Traumatic retroclival epidural hematoma is rare. It is more common in pediatrics than in adults. Although it has been known that these cases are frequently associated with abducens nerve palsy, internal carotid artery stenosis is rarely found with those hematomas. Case report An 8-year-old girl was transferred to our hospital following a traffic accident. She had clear consciousness with right abducens nerve palsy. Computed tomography revealed the left side of both retroclival hematoma without clival fracture and subarachnoid hemorrhage at the Sylvian fissure. She also had a fracture of left femoral neck and ipsilateral lung contusion. Magnetic resonance imaging revealed a retroclival hematoma located in the epidural space and severe stenosis of left internal carotid artery (ICA) from the cavernous to supraclinoid portion without evidence of brain contusion. She was managed conservatively, and her right abducens nerve palsy recovered completely without deterioration of other neurological findings. Neuroradiological findings suggested this ICA stenosis as traumatic dissection. She was discharged home 2 months after the traffic accident. Conclusion Retroclival epidural hematoma without clival fracture associated with ipsilateral ICA stenosis is extremely rare. Although the exact mechanism of the ICA stenosis remains unclear, cerebral vascular events should be considered in the cases with traumatic retroclival hematoma.	[Shojima, Hirotaka; Hayashi, Yasuhiko; Tamase, Akira; Takata, Sho; Iizuka, Hideaki] Kanazawa Med Univ, Dept Neurosurg, 1-1 Daigaku, Kahoku, Ishikawa 9200293, Japan		Hayashi, Y (corresponding author), Kanazawa Med Univ, Dept Neurosurg, 1-1 Daigaku, Kahoku, Ishikawa 9200293, Japan.	yhayashi@kanazawa-med.ac.jp		Hayashi, Yasuhiko/0000-0001-5998-3329			Agrawal D, 2006, CHILD NERV SYST, V22, P670, DOI 10.1007/s00381-006-0059-x; Biffl WL, 1998, ANN SURG, V228, P462, DOI 10.1097/00000658-199810000-00003; Biffl WL, 1999, CURR PROB SURG, V36, P510; Calisaneller T, 2006, CHILD NERV SYST, V22, P726, DOI 10.1007/s00381-005-0036-9; Cirak B, 2004, J PEDIATR SURG, V39, P607, DOI 10.1016/j.jpedsurg.2003.12.011; de Souza RB, 2011, PEDIATR NEUROSURG, V47, P288, DOI 10.1159/000335446; Duyu M, 2020, TURKISH J PEDIATR, V62, P1077, DOI 10.24953/turkjped.2020.06.021; Fiester P, 2021, AM J ROENTGENOL, V216, P1641, DOI 10.2214/AJR.20.22957; Guillaume D, 2006, J NEUROSURG, V105, P321, DOI 10.3171/ped.2006.105.4.321; Nguyen HS, 2016, CHILD NERV SYST, V32, P1749, DOI 10.1007/s00381-016-3098-y; Junewick JJ, 2011, AM J ROENTGENOL, V196, P1003, DOI 10.2214/AJR.10.6051; Koshy J, 2014, CHILD NERV SYST, V30, P835, DOI 10.1007/s00381-014-2369-8; Kwon TH, 2008, NEUROL MED-CHIR, V48, P347, DOI 10.2176/nmc.48.347; McDougall CM, 2011, CAN J NEUROL SCI, V38, P338, DOI 10.1017/S0317167100011550; Meoded A, 2011, AM J NEURORADIOL, V32, P1806, DOI 10.3174/ajnr.A2606; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Paterakis KN, 2005, CLIN NEUROL NEUROSUR, V108, P67, DOI 10.1016/j.clineuro.2004.11.010; Pritchard, 1996, ANN SURG, V228, P462; Ratilal B, 2006, SURG NEUROL, V66, P200, DOI 10.1016/j.surneu.2005.11.030; Resnick DK, 1997, NEUROSURGERY, V40, P1177, DOI 10.1097/00006123-199706000-00012; Tahir Muhammad Zubair, 2011, Surg Neurol Int, V2, P78, DOI 10.4103/2152-7806.82085; UNGER JM, 1990, RADIOLOGY, V175, P175, DOI 10.1148/radiology.175.1.2315477; Uzan M, 1998, NEUROSURGERY, V43, P1314, DOI 10.1097/00006123-199812000-00024	23	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2022	38	2					485	489		10.1007/s00381-021-05276-8		NOV 2021	5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	YN1NI	WOS:000722966400002	34837501				2022-02-06	
J	Cao, R; Li, L; Zhang, W; Lu, J; Wang, Y; Chen, Q; Zhang, WT; Chen, MM; Sheng, L; Cai, KS; Xu, GX				Cao, Rong; Li, Lin; Zhang, Wen; Lu, Jun; Wang, Yu; Chen, Qian; Zhang, Wentong; Chen, Mingming; Sheng, Liang; Cai, Keshu; Xu, Guangxu			Melatonin attenuates repeated mild traumatic brain injury-induced cognitive deficits by inhibiting astrocyte reactivation	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Melatonin; Traumatic brain injury; mPFC; Hippocampus; Astrocyte	CLOSED-HEAD INJURY; POSSIBLE INVOLVEMENT; OXIDATIVE STRESS; ACTIVATION; PATHWAY	Melatonin has been well documented for its neuroprotective role through inhibiting oxidative stress against traumatic brain injury (TBI). However, the specific role of melatonin and the exact effects on cell responses (neurons, astrocytes, and microglia) in different brain regions are unclear. Here, we subjected mice to closed head injury, to establish a repeated mild TBI model and detect neuronal activity and glial responses in cognition-related brain regions after melatonin administration. Melatonin only showed cognitive enhancement if administered during early pathological stages, but not in late (chronic) stages. Additionally, we observed a significant increase in neuronal activity and inhibition of astrocyte reactivation in medial prefrontal cortex and hippocampus, but not in other cognitive deficit related brain regions. Furthermore, by activating astrocytes in these brain regions, we found neuronal activity upregulation and cognitive improvement following melatonin treatment. Therefore, we concluded that melatonin administration during the early stages of TBI is necessary to inhibit astrocyte reactivation and to promote cognitive function. Our results provide evidence for use of melatonin for cognitive improvement after TBIs. (c) 2021 Elsevier Inc. All rights reserved.	[Cao, Rong; Lu, Jun; Cai, Keshu; Xu, Guangxu] Nanjing Med Univ, Dept Rehabil Med, Affiliated Hosp 1, Nanjing 210029, Peoples R China; [Li, Lin] Nanjing Med Univ, Dept Rehabil Med, Affiliated Hosp 2, Nanjing 210003, Peoples R China; [Zhang, Wen; Sheng, Liang] Nanjing Med Univ, Sch Basic Med Sci, Dept Pharmacol, Nanjing 211166, Peoples R China; [Wang, Yu; Xu, Guangxu] Nanjing Med Univ, Sch Rehabil Med, Nanjing 210029, Peoples R China; [Chen, Qian; Cai, Keshu] Nanjing Qixia Dist Hosp, Dept Rehabil Med, Nanjing 210046, Peoples R China; [Zhang, Wentong; Xu, Guangxu] Nanjing Med Univ, Dept Rehabil Med, Jiangsu Shengze Hosp, Suzhou 215228, Peoples R China; [Chen, Mingming] Nanjing Univ Chinese Med, Nanjing Hosp Chinese Med, Chinese Med Modernizat & Big Data Res Ctr, Nanjing 210022, Peoples R China; [Chen, Mingming] Yale Univ, Dept Neurol, Sch Med, New Haven, CT 06536 USA		Cai, KS (corresponding author), Nanjing Med Univ, Dept Rehabil Med, Affiliated Hosp 1, Nanjing 210029, Peoples R China.; Sheng, L; Xu, GX (corresponding author), Nanjing Med Univ, Sch Basic Med Sci, Dept Pharmacol, Nanjing 211166, Peoples R China.; Chen, MM (corresponding author), Nanjing Univ Chinese Med, Nanjing Hosp Chinese Med, Chinese Med Modernizat & Big Data Res Ctr, Nanjing 210022, Peoples R China.	mingming.chen@yale.edu; lgsheng@njmu.edu.cn; caikeshu@sina.com; xuguangxu@njmu.edu.cn			Introduced Project of Suzhou Clinical Medical Expert Team [SZYJTD201725]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81770862]	This study is supported by the Introduced Project of Suzhou Clinical Medical Expert Team (Grant No.: SZYJTD201725) and National Natural Science Foundation of China (Grant No.: 81770862) .	Ates O, 2006, INT J DEV NEUROSCI, V24, P357, DOI 10.1016/j.ijdevneu.2006.08.003; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Barlow K.M., 2021, EFFICACY MELATONIN S, DOI [10.1089/neu.2020.7154, DOI 10.1089/NEU.2020.7154]; Barlow KM, 2019, J NEUROTRAUM, V36, P523, DOI 10.1089/neu.2018.5752; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Ceyzeriat K, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0606-1; Dehghan F, 2018, INFLAMMOPHARMACOLOGY, V26, P1017, DOI 10.1007/s10787-017-0417-1; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Escartin C, 2019, GLIA, V67, P2221, DOI 10.1002/glia.23687; Feng DP, 2019, BIOCHEM BIOPH RES CO, V516, P1053, DOI 10.1016/j.bbrc.2019.06.134; Fenster RJ, 2018, NAT REV NEUROSCI, V19, P535, DOI 10.1038/s41583-018-0039-7; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; Hara M, 2017, NAT MED, V23, P818, DOI 10.1038/nm.4354; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kang WF, 2014, P NATL ACAD SCI USA, V111, pE2987, DOI 10.1073/pnas.1320401111; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kelso ML, 2011, NEUROSCI LETT, V488, P60, DOI 10.1016/j.neulet.2010.11.003; Kerman M, 2005, EXP BRAIN RES, V163, P406, DOI 10.1007/s00221-005-2338-2; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Lamb RG, 1997, J NEUROCHEM, V68, P1904; Li DL, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01799-0; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Lin XJ, 2020, INFLAMMOPHARMACOLOGY, V28, P1553, DOI 10.1007/s10787-020-00750-2; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Paparrigopoulos T, 2006, BRAIN INJURY, V20, P873, DOI 10.1080/02699050600832114; Robel S, 2009, GLIA, V57, P1630, DOI 10.1002/glia.20876; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Samitinjay A, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2019-233197; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Wang JM, 2019, FREE RADICAL BIO MED, V131, P345, DOI 10.1016/j.freeradbiomed.2018.12.014; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Yuruker V, 2015, METAB BRAIN DIS, V30, P223, DOI 10.1007/s11011-014-9623-3; Zhanfeng Niu, 2019, World Neurosurg, V130, pe475, DOI 10.1016/j.wneu.2019.06.122	39	0	0	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	NOV 26	2021	580						20	27		10.1016/j.bbrc.2021.09.025			8	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	WC9TF	WOS:000704591900004	34607259				2022-02-06	
J	Iverson, GL; Deep-Soboslay, A; Hyde, TMM; Kleinman, JE; Erskine, B; Fisher-Hubbard, A; deJong, JL; Castellani, RJ				Iverson, Grant L.; Deep-Soboslay, Amy; Hyde, Thomas M.; Kleinman, Joel E.; Erskine, Brittany; Fisher-Hubbard, Amanda; deJong, Joyce L.; Castellani, Rudolph J.			Suicide in Older Adult Men Is Not Related to a Personal History of Participation in Football	FRONTIERS IN NEUROLOGY			English	Article						suicide; concussion; autopsy; sports; depression	CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL FOOTBALL; LEAGUE PLAYERS; RISK; ASSOCIATION; IDEATION; HOPELESSNESS; DEPRESSION; DISORDERS; MORTALITY	Introduction: It is reasonable to estimate that tens of millions of men in the United States played high school football. There is societal concern that participation in football confers risk for later-in-life mental health problems. The purpose of this study is to examine whether there is an association between a personal history of playing high school football and death by suicide.Methods: The subjects were obtained from the Lieber Institute for Brain Development (LIBD) brain donation program in collaboration with the Office of the Medical Examiner at Western Michigan University Homer Stryker MD School of Medicine. Donor history was documented via medical records, mental health records, and telephone interviews with the next-of-kin.Results: The sample included 198 men aged 50 or older (median = 65.0 years, interquartile range = 57-75). There were 34.8% who participated in contact sports during high school (including football), and 29.8% participated in high school football. Approximately one-third of the sample had suicide as their manner of death (34.8%). There was no statistically significant difference in the proportions of suicide as a manner of death among those men with a personal history of playing football compared to men who did not play football or who did not play sports (p = 0.070, Odds Ratio, OR = 0.537). Those who played football were significantly less likely to have a lifetime history of a suicide attempt (p = 0.012, OR = 0.352). Men with mood disorders (p < 0.001, OR = 10.712), substance use disorders (p < 0.020, OR = 2.075), and those with a history of suicide ideation (p < 0.001, OR = 8.038) or attempts (p < 0.001, OR = 40.634) were more likely to have suicide as a manner of death. Moreover, those men with a family history of suicide were more likely to have prior suicide attempts (p = 0.031, OR = 2.153) and to have completed suicide (p = 0.001, OR = 2.927).Discussion: Suicide was related to well-established risk factors such as a personal history of a mood disorder, substance abuse disorder, prior suicide ideation, suicide attempts, and a family history of suicide attempts. This study adds to a steadily growing body of evidence suggesting that playing high school football is not associated with increased risk for suicidality or suicide during adulthood.	[Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA 02129 USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA 02129 USA; [Iverson, Grant L.] MassGen Hosp, Children Sports Concuss Program, Boston, MA 02114 USA; [Iverson, Grant L.] Home Base, Charlestown, MA 02129 USA; [Deep-Soboslay, Amy; Hyde, Thomas M.; Kleinman, Joel E.] Johns Hopkins Med Campus, Lieber Inst Brain Dev, Baltimore, MD USA; [Hyde, Thomas M.; Kleinman, Joel E.] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Hyde, Thomas M.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Erskine, Brittany; Fisher-Hubbard, Amanda; deJong, Joyce L.] Western Michigan Univ, Dept Pathol, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA; [Castellani, Rudolph J.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA		Iverson, GL (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Iverson, GL (corresponding author), Spaulding Rehabil Hosp, Charlestown, MA 02129 USA.; Iverson, GL (corresponding author), Spaulding Res Inst, Charlestown, MA 02129 USA.; Iverson, GL (corresponding author), MassGen Hosp, Children Sports Concuss Program, Boston, MA 02114 USA.; Iverson, GL (corresponding author), Home Base, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu					Angelakis I, 2019, PSYCHOL MED, V49, P1057, DOI 10.1017/S0033291718003823; Ashrafioun L, 2017, J PSYCHIATR RES, V92, P1, DOI 10.1016/j.jpsychires.2017.03.011; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; BECK AT, 1990, AM J PSYCHIAT, V147, P190; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Blanco C, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.18m12174; Bohr AD, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119868658; Borges G, 2017, PSYCHOL MED, V47, P949, DOI 10.1017/S0033291716002841; Chen LP, 2010, MAYO CLIN PROC, V85, P618, DOI 10.4065/mcp.2009.0583; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.3.CO;2-D; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Conner KR, 2019, SUICIDE LIFE-THREAT, V49, P278, DOI 10.1111/sltb.12422; Deep-Soboslay A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222565; Deshpande SK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229978; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Dong MQ, 2020, PATTERN RECOGN LETT, V132, P21, DOI [10.1016/j.patrec.2018.07.013, 10.1017/S0033291718002301]; Dong M, 2020, EPIDEMIOL PSYCH SCI, V29, DOI 10.1017/S2045796019000593; Ertl A, 2019, MMWR SURVEILL SUMM, V68, P1, DOI 10.15585/mmwr.ss.6809a1; Fassberg MM, 2016, AGING MENT HEALTH, V20, P166, DOI 10.1080/13607863.2015.1083945; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goodwin RD, 2004, PSYCHIAT RES, V126, P159, DOI 10.1016/j.psychres.2004.02.010; Gournellis R, 2018, ACTA PSYCHIAT SCAND, V137, P18, DOI 10.1111/acps.12826; Hanzlick R., 2002, GUIDE MANNER DEATH C, V1st ed; Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004; Hua H, 2019, J AFFECT DISORDERS, V257, P723, DOI 10.1016/j.jad.2019.07.082; Iverson GL., 2021, CLIN J SPORT MED, DOI [10.1097/JSM.0000000000000898, DOI 10.1097/JSM.0000000000000898]; Iverson GL, 2021, CLIN J SPORT MED, V31, P469, DOI 10.1097/JSM.0000000000000890; Iverson GL, 2020, ARCH CLIN NEUROPSYCH, V35, P332, DOI 10.1093/arclin/acz023; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Kanwar A, 2013, DEPRESS ANXIETY, V30, P917, DOI 10.1002/da.22074; Lehman EJ, 2016, AM J SPORT MED, V44, P2486, DOI 10.1177/0363546516645093; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; McAuliffe C, 2002, BEHAV COGN PSYCHOTH, V30, P385, DOI 10.1017/S1352465802004010; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; National Federation of State High School Associations, HIGH SCH ATHL PART S; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; O'Reilly LM, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0850-6; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Plans L, 2019, J AFFECT DISORDERS, V242, P111, DOI 10.1016/j.jad.2018.08.054; Poorolajal J, 2016, J PUBLIC HEALTH-UK, V38, pE282, DOI 10.1093/pubmed/fdv148; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Russell ER, 2020, J NEUROL NEUROSUR PS, V91, P1256, DOI 10.1136/jnnp-2020-323315; Samples H, 2019, AM J EPIDEMIOL, V188, P1245, DOI 10.1093/aje/kwz061; Santos J, 2020, ARCH GERONTOL GERIAT, V87, DOI 10.1016/j.archger.2019.104000; Serafini G, 2016, CURR ALZHEIMER RES, V13, P1083, DOI 10.2174/1567205013666160720112608; Sorensen EH, 2020, J AFFECT DISORDERS, V262, P55, DOI 10.1016/j.jad.2019.10.054; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Van Orden KA, 2005, CURR PSYCHIATRY REV, V1, P187, DOI 10.2174/1573400054065541; Verrocchio MC, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00108; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Wortzel HS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/424280	58	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 26	2021	12								745824	10.3389/fneur.2021.745824			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XM6ZG	WOS:000728971900001	34899570	Green Published, gold			2022-02-06	
J	Lu, YL; Scharfman, HE				Lu, Yi-Ling; Scharfman, Helen E.			New Insights and Methods for Recording and Imaging Spontaneous Spreading Depolarizations and Seizure-Like Events in Mouse Hippocampal Slices	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						spreading depression; intrinsic optical signal; seizures; epilepsy; experimental model; migraine; traumatic brain injury; dentate gyrus	MAGNESIUM-FREE MEDIUM; INTRINSIC OPTICAL SIGNALS; HILAR MOSSY CELLS; EPILEPTIFORM ACTIVITY; RAT HIPPOCAMPAL; CEREBRAL-CORTEX; RECEPTOR ACTIVATION; ENTORHINAL CORTEX; SEX-DIFFERENCES; BRAIN-SLICE	Spreading depolarization (SD) is a sudden, large, and synchronous depolarization of principal cells which also involves interneurons and astrocytes. It is followed by depression of neuronal activity, and it slowly propagates across brain regions like cortex or hippocampus. SD is considered to be mechanistically relevant to migraine, epilepsy, and traumatic brain injury (TBI), but there are many questions about its basic neurophysiology and spread. Research into SD in hippocampus using slices is often used to gain insight and SD is usually triggered by a focal stimulus with or without an altered extracellular buffer. Here, we optimize an in vitro experimental model allowing us to record SD without focal stimulation, which we call spontaneous. This method uses only an altered extracellular buffer containing 0 mM Mg2+ and 5 mM K+ and makes it possible for simultaneous patch and extracellular recording in a submerged chamber plus intrinsic optical imaging in slices of either sex. We also add methods for quantification and show the quantified optical signal is much more complex than imaging alone would suggest. In brief, acute hippocampal slices were prepared with a chamber holding a submerged slice but with flow of artificial cerebrospinal fluid (aCSF) above and below, which we call interface-like. As soon as slices were placed in the chamber, aCSF with 0 Mg2+/5 K+ was used. Most mouse slices developed SD and did so in the first hour of 0 Mg2+/5 K+ aCSF exposure. In addition, prolonged bursts we call seizure-like events (SLEs) occurred, and the interactions between SD and SLEs suggest potentially important relationships. Differences between rats and mice in different chambers are described. Regarding optical imaging, SD originated in CA3 and the pattern of spread to CA1 and the dentate gyrus was similar in some ways to prior studies but also showed interesting differences. In summary, the methods are easy to use, provide new opportunities to study SD, new insights, and are inexpensive. They support previous suggestions that SD is diverse, and also suggest that participation by the dentate gyrus merits greater attention.	[Lu, Yi-Ling; Scharfman, Helen E.] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; [Scharfman, Helen E.] New York Univ Langone Hlth, Dept Child & Adolescent Psychiat, New York, NY 10016 USA; [Scharfman, Helen E.] New York Univ Langone Hlth, Dept Neurosci & Physiol, New York, NY 10016 USA; [Scharfman, Helen E.] New York Univ Langone Hlth, Dept Psychiat, New York, NY 10016 USA		Scharfman, HE (corresponding author), Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA.; Scharfman, HE (corresponding author), New York Univ Langone Hlth, Dept Child & Adolescent Psychiat, New York, NY 10016 USA.; Scharfman, HE (corresponding author), New York Univ Langone Hlth, Dept Neurosci & Physiol, New York, NY 10016 USA.; Scharfman, HE (corresponding author), New York Univ Langone Hlth, Dept Psychiat, New York, NY 10016 USA.	Helen.Scharfman@NKI.rfmh.org			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG-055328, MH-109305, NS-037562, NS-081203]; Pyramid Biosciences; NY State Office of Mental Health	This study was supported by NIH grants AG-055328, MH-109305, NS-037562, NS-081203, Pyramid Biosciences, and the NY State Office of Mental Health. We thank Karim Elayouby for the technical support in immunolabeling experiments. We are grateful to (by alphabetical order) Elissavet Chartampila, Kasey Gerencer, Swati Jain, John LaFrancois, and David Alcantara-Gonzalez, Hannah Bernstein, Justin Botterill, Chiara Criscuolo, Aine Duffy, and Christos Lisgaras for their experimental supports and valuable discussions and feedback on the manuscript.	AITKEN PG, 1995, J NEUROSCI METH, V59, P139, DOI 10.1016/0165-0270(94)00204-T; Anderson TR, 2002, J NEUROPHYSIOL, V88, P2713, DOI 10.1152/jn.00321.2002; ANDERSON WW, 1986, BRAIN RES, V398, P215, DOI 10.1016/0006-8993(86)91274-6; Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Bell MR, 2018, ENDOCRINOLOGY, V159, P2596, DOI 10.1210/en.2018-00220; Billard JM, 1997, NEUROBIOL AGING, V18, P535, DOI 10.1016/S0197-4580(97)00104-8; Borck C, 1999, J NEUROPHYSIOL, V82, P2130, DOI 10.1152/jn.1999.82.5.2130; Botterill JJ, 2017, J COMP NEUROL, V525, P389, DOI 10.1002/cne.24071; Buchheim K, 2002, EXP NEUROL, V175, P76, DOI 10.1006/exnr.2002.7893; Bugay V, 2020, J NEUROTRAUM, V37, P248, DOI 10.1089/neu.2018.6333; Case L, 2013, J NEUROSCI METH, V212, P64, DOI 10.1016/j.jneumeth.2012.09.014; CHURN SB, 1991, EPILEPSY RES, V9, P211, DOI 10.1016/0920-1211(91)90054-J; Croning MDR, 1998, J NEUROSCI METH, V81, P103, DOI 10.1016/S0165-0270(98)00023-5; CZEH G, 1993, BRAIN RES, V632, P195, DOI 10.1016/0006-8993(93)91154-K; D'Arcangelo G, 2001, NEUROBIOL DIS, V8, P993, DOI 10.1006/nbdi.2001.0445; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Duffy AM, 2015, NEUROBIOL AGING, V36, P134, DOI 10.1016/j.neurobiolaging.2014.07.001; Edelstein A., 2014, J BIOL METHODS, V1, pE10, DOI 10.14440/jbm.2014.36; Edelstein Arthur, 1800, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Eickhoff M, 2014, EXP NEUROL, V253, P1, DOI 10.1016/j.expneurol.2013.12.008; Eikermann-Haerter K, 2013, REV NEUROSCIENCE, V24, P353, DOI 10.1515/revneuro-2013-0005; Erdemli G, 1998, J NEUROPHYSIOL, V80, P2378, DOI 10.1152/jn.1998.80.5.2378; Frank R, 2021, BMC NEUROSCI, V22, DOI 10.1186/s12868-021-00637-0; GLOVELI T, 1995, DEV BRAIN RES, V87, P145, DOI 10.1016/0165-3806(95)00069-P; Grube P, 2021, ENEURO, V8, DOI 10.1523/ENEURO.0221-21.2021; HAAS HL, 1979, J NEUROSCI METH, V1, P323, DOI 10.1016/0165-0270(79)90021-9; Hadley A., 2010, COMBINEZP IMAGE STAC; HAGLUND MM, 1984, DEV BRAIN RES, V14, P51, DOI 10.1016/0165-3806(84)90008-7; Hajos N, 2009, J NEUROSCI METH, V183, P107, DOI 10.1016/j.jneumeth.2009.06.005; Hajos N, 2009, EUR J NEUROSCI, V29, P319, DOI 10.1111/j.1460-9568.2008.06577.x; Hamam BN, 2003, J NEUROSCI METH, V123, P61, DOI 10.1016/S0165-0270(02)00341-2; Harte-Hargrove LC, 2013, NEUROSCIENCE, V239, P46, DOI 10.1016/j.neuroscience.2012.12.029; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Heinemann U, 2006, MODELS OF SEIZURES AND EPILEPSY, P35, DOI 10.1016/B978-012088554-1/50006-2; Juzekaeva E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75975-w; Kim YK, 2014, NEUROREHAB NEURAL RE, V28, P576, DOI 10.1177/1545968313520411; KOJIMA H, 1991, JPN J PSYCHIAT NEUR, V45, P279; Kovacs R, 1999, NEUROREPORT, V10, P207, DOI 10.1097/00001756-199902050-00002; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEWIS DV, 1989, EPILEPSY RES, V4, P109, DOI 10.1016/0920-1211(89)90015-6; LEWIS DV, 1990, EPILEPSY RES, V6, P95, DOI 10.1016/0920-1211(90)90083-8; Lian XY, 2004, BRAIN RES, V1012, P177, DOI 10.1016/j.brainres.2004.04.011; Lindquist BE, 2012, NEUROSCIENCE, V223, P365, DOI 10.1016/j.neuroscience.2012.07.053; MACVICAR BA, 1991, J NEUROSCI, V11, P1458; Mane M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043981; Martens-Mantai T, 2014, SYNAPSE, V68, P574, DOI 10.1002/syn.21769; Maslarova A, 2011, STROKE, V42, P2917, DOI 10.1161/STROKEAHA.111.621581; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; Morris G, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00519; NEUMAN RS, 1989, NEUROSCIENCE, V28, P393, DOI 10.1016/0306-4522(89)90186-3; Noseda R, 2013, PAIN, V154, pS44, DOI 10.1016/j.pain.2013.07.021; Obeidat AS, 1998, EUR J NEUROSCI, V10, P3451, DOI 10.1046/j.1460-9568.1998.00358.x; Obeidat AS, 2000, J CEREBR BLOOD F MET, V20, P412, DOI 10.1097/00004647-200002000-00024; Reyes-Garcia SZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25378-9; Rogawski M.A., 2013, JASPERS BASIC MECH E, P930; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Santos E, 2016, J CEREBR BLOOD F MET, V36, P2051, DOI 10.1177/0271678X16671317; SCHARFMAN HE, 1993, HIPPOCAMPUS, V3, P9, DOI 10.1002/hipo.450030103; Scharfman HE, 2003, J NEUROSCI, V23, P11641; SCHARFMAN HE, 1995, J NEUROPHYSIOL, V74, P179, DOI 10.1152/jn.1995.74.1.179; Scharfman HE, 2001, NEUROSCIENCE, V104, P741, DOI 10.1016/S0306-4522(01)00132-4; Scharfman HE, 1997, J NEUROPHYSIOL, V78, P1082, DOI 10.1152/jn.1997.78.2.1082; SCHARFMAN HE, 1993, J NEUROPHYSIOL, V70, P742, DOI 10.1152/jn.1993.70.2.742; Scharfman HE, 2008, HEADACHE, V48, pS77, DOI 10.1111/j.1526-4610.2008.01200.x; Scharfman HE, 2007, PROG BRAIN RES, V163, P627, DOI 10.1016/S0079-6123(07)63034-9; Scharfman HE, 2015, NEUROBIOLOGY OF BRAIN DISORDERS: BIOLOGICAL BASIS OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS, P236, DOI 10.1016/B978-0-12-398270-4.00017-3; Scharfman HE, 2014, NEUROBIOL DIS, V72, P180, DOI 10.1016/j.nbd.2014.07.004; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuchmann S, 2002, J NEUROPHYSIOL, V87, P2929, DOI 10.1152/jn.2002.87.6.2929; SCHWARTZKROIN PA, 1975, BRAIN RES, V85, P423, DOI 10.1016/0006-8993(75)90817-3; Skucas VA, 2013, J NEUROSCI, V33, P2338, DOI 10.1523/JNEUROSCI.3857-12.2013; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; SNOW RW, 1983, J NEUROPHYSIOL, V50, P561, DOI 10.1152/jn.1983.50.3.561; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Ssentongo P, 2017, SCI REP-UK, V7, DOI 10.1038/srep43652; Steffensen AB, 2015, J NEUROSCI, V35, P12172, DOI 10.1523/JNEUROSCI.0400-15.2015; Tamim I, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22464-x; Umorin M., 2002, STACK FOCUSER; Varga DP, 2020, J CEREBR BLOOD F MET, V40, pS67, DOI 10.1177/0271678X19900097; Vetvik KG, 2017, LANCET NEUROL, V16, P76, DOI 10.1016/S1474-4422(16)30293-9; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Wahab A, 2009, EPILEPSY RES, V86, P113, DOI 10.1016/j.eplepsyres.2009.05.008; Witter MP, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00046	87	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	NOV 26	2021	15								761423	10.3389/fncel.2021.761423			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XQ7DQ	WOS:000731705400001	34899190	Green Published, gold			2022-02-06	
J	Streubel-Gallasch, L; Zysk, M; Beretta, C; Erlandsson, A				Streubel-Gallasch, Linn; Zysk, Marlena; Beretta, Chiara; Erlandsson, Anna			Traumatic brain injury in the presence of A beta pathology affects neuronal survival, glial activation and autophagy	SCIENTIFIC REPORTS			English	Article							FIBRILLARY ACIDIC PROTEIN; IN-VITRO MODELS; INTERMEDIATE-FILAMENTS; MITOCHONDRIAL FISSION; REACTIVE ASTROCYTES; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; STEM-CELL; DEMENTIA; DEGRADATION	Traumatic brain injury (TBI) presents a widespread health problem in the elderly population. In addition to the acute injury, epidemiological studies have observed an increased probability and earlier onset of dementias in the elderly following TBI. However, the underlying mechanisms of the connection between TBI and Alzheimer's disease in the aged brain and potential exacerbating factors is still evolving. The aim of this study was to investigate cellular injury-induced processes in the presence of amyloid beta (A beta) pathology. For this purpose, a co-culture system of cortical stem-cell derived astrocytes, neurons and oligodendrocytes were exposed to A beta(42) protofibrils prior to a mechanically induced scratch injury. Cellular responses, including neurodegeneration, glial activation and autophagy was assessed by immunoblotting, immunocytochemistry, ELISA and transmission electron microscopy. Our results demonstrate that the combined burden of A beta exposure and experimental TBI causes a decline in the number of neurons, the differential expression of the key astrocytic markers glial fibrillary acidic protein and S100 calcium-binding protein beta, mitochondrial alterations and prevents the upregulation of autophagy. Our study provides valuable information about the impact of TBI sustained in the presence of A beta deposits and helps to advance the understanding of geriatric TBI on the cellular level.	[Streubel-Gallasch, Linn; Zysk, Marlena; Beretta, Chiara; Erlandsson, Anna] Uppsala Univ, Rudbeck Lab, Dept Publ Hlth & Caring Sci Mol Geriatr, S-75185 Uppsala, Sweden		Erlandsson, A (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Publ Hlth & Caring Sci Mol Geriatr, S-75185 Uppsala, Sweden.	anna.erlandsson@pubcare.uu.se			Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Alzheimer Foundation; Swedish Brain Foundation; Ahlen Foundation; Torsten Soderberg Foundation; Gamla Tjanarinnor Foundation, O and E Edla Johanssons Foundation; Olle Engkvist Byggmastare Foundation, Bertil and Ebon Norlin Foundation; Stohnes Foundation	This study was supported by grants from the Swedish Research Council, the Swedish Alzheimer Foundation, the Swedish Brain Foundation, Ahlen Foundation, Torsten Soderberg Foundation, Gamla Tjanarinnor Foundation, O and E Edla Johanssons Foundation, Olle Engkvist Byggmastare Foundation, Bertil and Ebon Norlin Foundation and Stohnes Foundation. We thank Monika Hodik and Karin Staxang at the BioVis core facility, Uppsala University, for technical assistance with TEM. Figure 1A,A' were created with BioRender.com.	Abolhassani N, 2017, MECH AGEING DEV, V161, P95, DOI 10.1016/j.mad.2016.05.005; ASHFORD TP, 1962, J CELL BIOL, V12, P198, DOI 10.1083/jcb.12.1.198; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278; Beretta C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72355-2; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bordi M, 2016, AUTOPHAGY, V12, P2467, DOI 10.1080/15548627.2016.1239003; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cai Z, 2012, J NEUROSCI RES, V90, P1105, DOI 10.1002/jnr.23011; Chen RH, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0569-y; CLARK SL, 1957, J BIOPHYS BIOCHEM CY, V3, P349, DOI 10.1083/jcb.3.3.349; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Cusimano MD, 2020, NEUROSURG FOCUS, V49, DOI 10.3171/2020.7.FOCUS20520; Daniele S, 2018, BIOCHEM PHARMACOL, V158, P207, DOI 10.1016/j.bcp.2018.10.030; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Ebenezer PJ, 2010, J ALZHEIMERS DIS, V22, P839, DOI 10.3233/JAD-2010-101161; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; Eskelinen EL, 2008, AUTOPHAGY, V4, P257, DOI 10.4161/auto.5179; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Gustafsson G, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1018-z; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Huebschmann NA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.01054; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kapogiannis D, 2011, LANCET NEUROL, V10, P187, DOI 10.1016/S1474-4422(10)70277-5; Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Kerr JS, 2017, TRENDS NEUROSCI, V40, P151, DOI 10.1016/j.tins.2017.01.002; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Lindstrom V, 2017, MOL CELL NEUROSCI, V82, P143, DOI 10.1016/j.mcn.2017.04.009; Loov C, 2015, GLIA, V63, P1997, DOI 10.1002/glia.22873; Loov C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055983; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; Magnusson K, 2013, J ALZHEIMERS DIS, V37, P29, DOI 10.3233/JAD-130029; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Mauvezin C, 2015, AUTOPHAGY, V11, P1437, DOI 10.1080/15548627.2015.1066957; Mauvezin C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8007; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nikitidou E, 2017, J ALZHEIMERS DIS, V60, P305, DOI 10.3233/JAD-170278; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Olsen M, 2018, MOL IMAGING BIOL, V20, P605, DOI 10.1007/s11307-017-1153-z; Omelchenko A, 2020, CURR OPIN BIOMED ENG, V14, P34, DOI 10.1016/j.cobme.2020.05.002; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Plassman Brenda L, 2015, Handb Clin Neurol, V128, P711, DOI 10.1016/B978-0-444-63521-1.00044-3; Plaza-Zabala A, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.620602; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; Rodrigue KM, 2009, NEUROPSYCHOL REV, V19, P436, DOI 10.1007/s11065-009-9118-x; Rostami J, 2017, J NEUROSCI, V37, P11835, DOI 10.1523/JNEUROSCI.0983-17.2017; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Runwal G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46657-z; Schiweck J, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00261; Sehlin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032014; Sehlin D, 2010, J ALZHEIMERS DIS, V21, P1295, DOI 10.3233/JAD-2010-100609; Serrano-Pozo A, 2013, AM J PATHOL, V182, P2332, DOI 10.1016/j.ajpath.2013.02.031; SHAO YP, 1994, GLIA, V11, P147, DOI 10.1002/glia.440110209; Sheng JG, 2000, J NEUROCHEM, V74, P295, DOI 10.1046/j.1471-4159.2000.0740295.x; Sollvander S, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1134-4; Sollvander S, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0098-z; Sorci Guglielmo, 2010, Cardiovasc Psychiatry Neurol, V2010, DOI 10.1155/2010/656481; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Streubel-Gallasch L, 2021, MOL NEUROBIOL, V58, P3119, DOI 10.1007/s12035-021-02327-8; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tan CC, 2014, NEUROBIOL AGING, V35, P941, DOI 10.1016/j.neurobiolaging.2013.11.019; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; VANELDIK LJ, 1994, BBA-MOL CELL RES, V1223, P398, DOI 10.1016/0167-4889(94)90101-5; Waguri S, 2009, METHOD ENZYMOL, V453, P181, DOI 10.1016/S0076-6879(08)04009-3; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wu JF, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070693; Wu YH, 2021, J NEUROTRAUM, V38, P2336, DOI 10.1089/neu.2020.7402; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang Y, 2020, CELL DEATH DIFFER, V27, P858, DOI 10.1038/s41418-019-0480-9; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zeng ZQ, 2020, J CELL PHYSIOL, V235, P1973, DOI 10.1002/jcp.29173; Zhou YX, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00549-2; Zysk M, 2019, J ALZHEIMERS DIS, V72, P161, DOI 10.3233/JAD-190572	116	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	NOV 26	2021	11	1							22982	10.1038/s41598-021-02371-3			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XD8AO	WOS:000722925300054	34837024	gold, Green Published			2022-02-06	
J	Black, AM; Omu, O; Brussoni, M; Emery, CA				Black, Amanda M.; Omu, Onutobor; Brussoni, Mariana; Emery, Carolyn A.			Complexity of concussion management in youth ice hockey: Context matters	TRANSLATIONAL SPORTS MEDICINE			English	Article						behavior; concussion; concussion management; ice hockey; qualitative research	HIGH-SCHOOL; PERCEPTIONS; SYMPTOMS; COACHES; HEALTH; RETURN; TIME	The public's concussion awareness is increasing. However, youth may still participate in sport through concussion symptoms and parents may not take their child with a suspected concussion to a physician for assessment and clearance to return to sport. This study uses qualitative methodology to explore parent and coach experiences with concussion management in youth ice hockey. Potential barriers and facilitators to a coach removing a player from play following a suspected concussion and parents taking their child to see a physician are highlighted. We purposively selected twenty-four hockey parents and coaches in Calgary, Canada, and interviewed them to understand their experience managing youth following a suspected concussion. Using thematic analysis, we highlight barriers and facilitators to coaches appropriately removing a player from participation and parents taking their child to a physician for assessment. Contextual factors including competing priorities, emotional responses, severity of injury, parent and coach beliefs, appropriate communication, and concussion awareness can influence coach and parent concussion management strategies. Coaches, parents, and players play a vital role in facilitating concussion identification and appropriate management. While further education of coaches and parents is indicated, it is important to consider contextual factors that interfere with concussion management behaviors.	[Black, Amanda M.; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Black, Amanda M.; Emery, Carolyn A.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Black, Amanda M.; Emery, Carolyn A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Black, Amanda M.; Emery, Carolyn A.] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Omu, Onutobor] Lifemark Physiotherapy, Calgary, AB, Canada; [Brussoni, Mariana] British Columbia Childrens Hosp Res Inst, Vancouver, BC, Canada; [Brussoni, Mariana] British Columbia Injury Res & Prevent Unit, Vancouver, BC, Canada; [Brussoni, Mariana] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Brussoni, Mariana] Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Emery, Carolyn A.] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB, Canada; [Emery, Carolyn A.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Black, Amanda M.; Emery, Carolyn A.] Sport Injury Res Prevent Ctr, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada		Black, AM (corresponding author), Sport Injury Res Prevent Ctr, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	ablack@ucalgary.ca	Brussoni, Mariana/U-9404-2018	Brussoni, Mariana/0000-0002-1495-816X; Emery, Carolyn Ann/0000-0002-9499-6691	International Olympic Committee; Hockey Canada; Hockey Calgary; Hockey Alberta	The University of Calgary Sport Injury Prevention Research Centre is one of the International Research Centres for Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee. We acknowledge Hockey Canada, Hockey Calgary, Hockey Alberta, and all the coaches and parents involved for their time and support in contributing to this research project. The authors thank all of the research coordinators and research assistants who assisted with this project.	Ahmed OH, 2017, PHYS THER SPORT, V23, P7, DOI 10.1016/j.ptsp.2016.07.003; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bay R. C., 2010, ATHLETIC TRAINING SP, V2, P208, DOI DOI 10.3928/19425864-20100524-03; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Bramley H, 2012, CLIN PEDIATR, V51, P283, DOI 10.1177/0009922811422434; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Calzo, 2015, CONCUSSION UNDER REP, P66; Carey RN, 2019, ANN BEHAV MED, V53, P693, DOI 10.1093/abm/kay078; Caron JG., 2019, PSYCHOL ASPECTS SPOR, P66; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Emery C, 2020, BRIT J SPORT MED, V54, P414, DOI 10.1136/bjsports-2019-101092; Feiss RS, 2020, J CONCUSSION, DOI [10.1177/2059700219900053, DOI 10.1177/2059700219900053]; Findler P, 2015, J PHILOS SPORT, V42, P443, DOI 10.1080/00948705.2015.1079132; Fontana J, 2021, HEALTH COMMUN, DOI 10.1080/10410236.2021.1876326; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2018, HEALTH EDUC BEHAV, V45, P254, DOI 10.1177/1090198117715669; Li H., 2017, CLIN J SPORT MED, P1; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; Michie S, 2004, PSYCHOL HEALTH, V19, P29, DOI 10.1080/0887044031000141199; Morrissey D, 2014, J TRAUMA ACUTE CARE, V77, pS8, DOI 10.1097/TA.0000000000000331; Rieger B, 2018, CUREUS, V10, DOI 10.7759/cureus.2268; Sandel N, 2015, APPL NEUROPSYCH-CHIL, V4, P211, DOI 10.1080/21622965.2013.850692; Sarmiento K, 2017, J SCHOOL HEALTH, V87, P790, DOI 10.1111/josh.12552; Slutzky CB, 2009, PSYCHOL SPORT EXERC, V10, P381, DOI 10.1016/j.psychsport.2008.09.006; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Zullig KJ, 2011, APPL RES QUAL LIFE, V6, P277, DOI 10.1007/s11482-010-9129-z	32	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2573-8488		TRANSL SPORTS MED	Transl. Sports Med.	NOV	2021	4	6					921	930		10.1002/tsm2.296		NOV 2021	10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	XU2YU	WOS:000722185400001					2022-02-06	
J	Chen, H; Zhou, XF; Zhou, DW; Zhou, JX; Yu, RG				Chen, Han; Zhou, Xiao-Fen; Zhou, Da-Wei; Zhou, Jian-Xin; Yu, Rong-Guo			Effect of increased positive end-expiratory pressure on intracranial pressure and cerebral oxygenation: impact of respiratory mechanics and hypovolemia	BMC NEUROSCIENCE			English	Article						Positive end-expiratory pressure; Intracranial pressure; Cerebral oxygenation; Cerebral blood flow; Respiratory mechanics; Hypovolemia	TRAUMATIC BRAIN-INJURY; BLOOD-FLOW; DISTRESS-SYNDROME; PEEP; RESPONSES	Background To evaluate the impact of positive end-expiratory pressure (PEEP) on intracranial pressure (ICP) in animals with different respiratory mechanics, baseline ICP and volume status. Methods A total of 50 male adult Bama miniature pigs were involved in four different protocols (n = 20, 12, 12, and 6, respectively). Under the monitoring of ICP, brain tissue oxygen tension and hemodynamical parameters, PEEP was applied in increments of 5 cm H2O from 5 to 25 cm H2O. Measurements were taken in pigs with normal ICP and normovolemia (Series I), or with intracranial hypertension (via inflating intracranial balloon catheter) and normovolemia (Series II), or with intracranial hypertension and hypovolemia (via exsanguination) (Series III). Pigs randomized to the control group received only hydrochloride instillation while the intervention group received additional chest wall strapping. Common carotid arterial blood flow before and after exsanguination at each PEEP level was measured in pigs with intracranial hypertension and chest wall strapping (Series IV). Results ICP was elevated by increased PEEP in both normal ICP and intracranial hypertension conditions in animals with normal blood volume, while resulted in decreased ICP with PEEP increments in animals with hypovolemia. Increasing PEEP resulted in a decrease in brain tissue oxygen tension in both normovolemic and hypovolemic conditions. The impacts of PEEP on hemodynamical parameters, ICP and brain tissue oxygen tension became more evident with increased chest wall elastance. Compare to normovolemic condition, common carotid arterial blood flow was further lowered when PEEP was raised in the condition of hypovolemia. Conclusions The impacts of PEEP on ICP and cerebral oxygenation are determined by both volume status and respiratory mechanics. Potential conditions that may increase chest wall elastance should also be ruled out to avoid the deleterious effects of PEEP.	[Chen, Han; Zhou, Xiao-Fen; Yu, Rong-Guo] Fujian Med Univ, Fujian Shengli Clin Med Coll, Fuzhou, Peoples R China; [Chen, Han; Zhou, Xiao-Fen; Yu, Rong-Guo] Fujian Prov Hosp, Dept Crit Care Med, Fuzhou, Peoples R China; [Zhou, Da-Wei; Zhou, Jian-Xin] Capital Med Univ, Beijing Tiantan Hosp, Dept Crit Care Med, Beijing, Peoples R China		Yu, RG (corresponding author), Fujian Prov Hosp, Dept Crit Care Med, Fuzhou, Peoples R China.	garyyrg@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701942]; High-level Hospital Foster Grants from Fujian Provincial Hospital [2020HSJJ02]; General Program of Natural Science Foundation of Fujian Provincial [2019J01499]	HC is supported by the National Natural Science Foundation of China (Grant No. 81701942) and the High-level Hospital Foster Grants from Fujian Provincial Hospital (Grant Number: 2020HSJJ02). Xiao-Fen Zhou is supported by General Program of Natural Science Foundation of Fujian Provincial (Grant Number: 2019J01499). The funding bodies have no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	AIDINIS SJ, 1976, ANESTHESIOLOGY, V45, P275, DOI 10.1097/00000542-197609000-00004; Asehnoune K, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1994-0; BURCHIEL KJ, 1981, NEUROSURGERY, V8, P443, DOI 10.1227/00006123-198104000-00007; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang WTW, 2013, NEUROSURG CLIN N AM, V24, P407, DOI 10.1016/j.nec.2013.02.004; CHAPIN JC, 1979, ARCH SURG-CHICAGO, V114, P1193; Chen H, 2019, CRIT CARE MED, V47, P254, DOI 10.1097/CCM.0000000000003558; Chen H, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1191-4; COOPER KR, 1985, J NEUROSURG, V63, P552, DOI 10.3171/jns.1985.63.4.0552; FROST EAM, 1977, J NEUROSURG, V47, P195, DOI 10.3171/jns.1977.47.2.0195; Funk DJ, 2013, CRIT CARE MED, V41, P573, DOI 10.1097/CCM.0b013e31827bfc25; Funk DJ, 2013, CRIT CARE MED, V41, P255, DOI 10.1097/CCM.0b013e3182772ab6; Gattinoni L, 2004, CRIT CARE, V8, P350, DOI 10.1186/cc2854; Huynh T, 2002, J TRAUMA, V53, P488, DOI 10.1097/00005373-200209000-00016; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kurishima C, 2011, ANN THORAC SURG, V91, P1611, DOI 10.1016/j.athoracsur.2010.09.068; Lima Wildberg Alencar, 2011, Rev. bras. ter. intensiva, V23, P291, DOI 10.1590/S0103-507X2011000300006; Ludwig HC, 2000, ANASTH INTENSIV NOTF, V35, P141, DOI 10.1055/s-2000-13008; Magder S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1438-7; Mascia L, 2005, INTENS CARE MED, V31, P373, DOI 10.1007/s00134-004-2491-2; McBryde FD, 2017, ACTA PHYSIOL, V219, P274, DOI 10.1111/apha.12706; McGuire G, 1997, CRIT CARE MED, V25, P1059, DOI 10.1097/00003246-199706000-00025; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; Nemer SN, 2015, J CRIT CARE, V30, P1263, DOI 10.1016/j.jcrc.2015.07.019; SHAPIRO HM, 1978, J TRAUMA, V18, P254, DOI 10.1097/00005373-197804000-00005; Wilson MH, 2016, J CEREBR BLOOD F MET, V36, P1338, DOI 10.1177/0271678X16648711; Zamboni P, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7082856	28	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	NOV 25	2021	22	1							72	10.1186/s12868-021-00674-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XD3KP	WOS:000722610000002	34823465	gold, Green Published			2022-02-06	
J	Dinsmore, M; Hajat, Z; Brenna, CTA; Fisher, J; Venkatraghavan, L				Dinsmore, Michael; Hajat, Zakir; Brenna, Connor T. A.; Fisher, Joseph; Venkatraghavan, Lashmi			Effect of a neck collar on brain turgor: a potential role in preventing concussions?	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article; Early Access						brain concussion	JUGULAR COMPRESSION COLLAR; OPTIC-NERVE SHEATH; WORKING-MEMORY; SEASON; ACTIVATION; ULTRASOUND; PRESSURE; DIAMETER; INJURY	Background Mild internal jugular vein (IJV) compression, aimed at increasing intracranial fluid volume to prevent motion of the brain relative to the skull, has reduced brain injury markers in athletes suffering repeated traumatic brain injuries. However, an increase in intracranial volume with IJV compression has not been well demonstrated. This study used transorbital ultrasound to identify changes in optic nerve sheath diameter (ONSD) as a direct marker of accompanying changes in intracranial volume. Methods Nineteen young, healthy adult volunteers (13 males and 6 females) underwent IJV compression of 20 cm H2O low in the neck, while in upright posture. IJV cross-sectional area at the level of the cricoid cartilage, and the change in right ONSD 3 mm behind the papillary segment of the optic nerve, were measured by ultrasound. Statistical analysis was performed using a paired t-test with Bonferroni correction. Results Mean (SD) cross-sectional area for the right IJV before and after IJV compression was 0.10 (0.05) cm(2) and 0.57 (0.37) cm(2), respectively (p=0.001). ONSD before and after IJV compression was 4.6 (0.5) mm and 4.9 (0.5) mm, respectively (p=0.001). Conclusions These data verify increased cerebral volume following IJV compression, supporting the potential for reduced brain 'slosh' as a mechanism connecting IJV compression to possibly reducing traumatic brain injury following head trauma.	[Dinsmore, Michael; Fisher, Joseph; Venkatraghavan, Lashmi] Toronto Western Hosp, Dept Anaesthesia & Pain Med, Toronto, ON M5T 2S8, Canada; [Hajat, Zakir] Univ Alberta, Dept Anaesthesiol & Pain Med, Edmonton, AB, Canada; [Brenna, Connor T. A.] Univ Toronto, Dept Anaesthesia & Pain Med, Toronto, ON, Canada		Dinsmore, M (corresponding author), Toronto Western Hosp, Dept Anaesthesia & Pain Med, Toronto, ON M5T 2S8, Canada.	michael.dinsmore@uhn.ca	Brenna, Connor/AAH-7334-2019	Brenna, Connor/0000-0002-6126-3897			Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Bonnette S, 2018, EXP BRAIN RES, V236, P2691, DOI 10.1007/s00221-018-5328-x; Diekfuss JA, 2021, J NEUROSCI RES, V99, P423, DOI 10.1002/jnr.24727; Dinsmore M, 2017, ANAESTHESIA, V72, P618, DOI 10.1111/anae.13784; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Dudley J, 2020, BRAIN CONNECT, V10, P292, DOI 10.1089/brain.2019.0729; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Myer GD, 2019, BRIT J SPORT MED, V53, P1539, DOI 10.1136/bjsports-2018-099571; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Padayachy LC, 2016, CHILD NERV SYST, V32, P1779, DOI 10.1007/s00381-016-3068-4; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; TOUNG T, 1984, ANESTHESIOLOGY, V61, P169, DOI 10.1097/00000542-198408000-00010; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Yeoh TY, 2017, CAN J ANESTH, V64, P854, DOI 10.1007/s12630-017-0903-3; Yuan WH, 2018, J NEUROTRAUM, V35, P1248, DOI 10.1089/neu.2017.5262; Yuan WH, 2019, J NEUROTRAUM, V36, P721, DOI 10.1089/neu.2018.5737; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859; Yuan WH, 2017, J NEUROTRAUM, V34, P2432, DOI 10.1089/neu.2016.4834	19	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.												10.1136/bjsports-2021-103961		NOV 2021	4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	XE2LQ	WOS:000723225800001	34824061				2022-02-06	
J	Enciso-Olivera, CO; Ordonez-Rubiano, EG; Casanova-Libreros, R; Rivera, D; Zarate-Ardila, CJ; Rudas, J; Pulido, C; Gomez, F; Martinez, D; Guerrero, N; Hurtado, MA; Aguilera-Bustos, N; Hernandez-Torres, CP; Hernandez, J; Marin-Munoz, JH				Enciso-Olivera, Cesar O.; Ordonez-Rubiano, Edgar G.; Casanova-Libreros, Rosangela; Rivera, Diana; Zarate-Ardila, Carol J.; Rudas, Jorge; Pulido, Cristian; Gomez, Francisco; Martinez, Darwin; Guerrero, Natalia; Hurtado, Mayra A.; Aguilera-Bustos, Natalia; Hernandez-Torres, Clara P.; Hernandez, Jose; Marin-Munoz, Jorge H.			Structural and functional connectivity of the ascending arousal network for prediction of outcome in patients with acute disorders of consciousness	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; WATER DIFFUSION; GRAY-MATTER; TENSOR; SYSTEM; MRI; WHITE; NEUROANATOMY; MULTICENTER	To determine the role of early acquisition of blood oxygen level-dependent (BOLD) signals and diffusion tensor imaging (DTI) for analysis of the connectivity of the ascending arousal network (AAN) in predicting neurological outcomes after acute traumatic brain injury (TBI), cardiopulmonary arrest (CPA), or stroke. A prospective analysis of 50 comatose patients was performed during their ICU stay. Image processing was conducted to assess structural and functional connectivity of the AAN. Outcomes were evaluated after 3 and 6 months. Nineteen patients (38%) had stroke, 18 (36%) CPA, and 13 (26%) TBI. Twenty-three patients were comatose (44%), 11 were in a minimally conscious state (20%), and 16 had unresponsive wakefulness syndrome (32%). Univariate analysis demonstrated that measurements of diffusivity, functional connectivity, and numbers of fibers in the gray matter, white matter, whole brain, midbrain reticular formation, and pontis oralis nucleus may serve as predictive biomarkers of outcome depending on the diagnosis. Multivariate analysis demonstrated a correlation of the predicted value and the real outcome for each separate diagnosis and for all the etiologies together. Findings suggest that the above imaging biomarkers may have a predictive role for the outcome of comatose patients after acute TBI, CPA, or stroke.	[Enciso-Olivera, Cesar O.; Hurtado, Mayra A.] Fdn Univ Ciencias Salud FUCS, Hosp Infantil Univ San Jose, Dept Crit Care, Bogota, Colombia; [Enciso-Olivera, Cesar O.; Hurtado, Mayra A.] Fdn Univ Ciencias Salud FUCS, Hosp Infantil Univ San Jose, Intens Care Unit, Bogota, Colombia; [Ordonez-Rubiano, Edgar G.] Fdn Univ Ciencias Salud FUCS, Hosp San Jose, Dept Neurol Surg, Bogota, Colombia; [Casanova-Libreros, Rosangela; Rivera, Diana; Zarate-Ardila, Carol J.; Aguilera-Bustos, Natalia] Fdn Univ Ciencias Salud FUCS, Hosp San Jose, Hosp Infantil Univ San Jose, Div Clin Res, Bogota, Colombia; [Rudas, Jorge] Univ Nacl Colombia, Dept Biotechnol, Bogota, Colombia; [Pulido, Cristian] Univ Nacl Colombia, Dept Math, Bogota, Colombia; [Gomez, Francisco] Univ Nacl Colombia, Dept Comp Sci, Bogota, Colombia; [Martinez, Darwin] Univ Cent, Dept Comp Sci, Bogota, Colombia; [Guerrero, Natalia; Marin-Munoz, Jorge H.] Fdn Univ Ciencias Salud FUCS, Hosp Infantil Univ San Jose, Dept Radiol, Bogota, Colombia; [Hernandez-Torres, Clara P.] Fdn Univ Ciencias Salud FUCS, Hosp Infantil Univ San Jose, Dept Psychol, Bogota, Colombia; [Hernandez, Jose] Fdn Univ Ciencias Salud FUCS, Hosp Infantil Univ San Jose, Dept Neurol, Bogota, Colombia; [Marin-Munoz, Jorge H.] Imaging Experts & Healthcare Serv ImexHS, Innovat & Res Div, St 92 11-51,202, Bogota, Colombia		Marin-Munoz, JH (corresponding author), Fdn Univ Ciencias Salud FUCS, Hosp Infantil Univ San Jose, Dept Radiol, Bogota, Colombia.; Marin-Munoz, JH (corresponding author), Imaging Experts & Healthcare Serv ImexHS, Innovat & Res Div, St 92 11-51,202, Bogota, Colombia.	jmarin@imexhs.com			Administrative Department of Science, Technology, and Innovation of the government of Colombia (Colciencias)Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias [702-2016]; Ministerio de Ciencia Tecnologia e Innovacion [5007-744-55796]	This article is funded by the Administrative Department of Science, Technology, and Innovation of the government of Colombia (Colciencias) under grant number 702-2016 and Ministerio de Ciencia Tecnologia e Innovacion (No. 5007-744-55796).	Afzali M, 2015, J NEUROSCI METH, V253, P28, DOI 10.1016/j.jneumeth.2015.06.007; Aganj I, 2010, MAGN RESON MED, V64, P554, DOI 10.1002/mrm.22365; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Beare R, 2018, J STAT SOFTW, V86, P1, DOI 10.18637/jss.v086.i08; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Chaudhary N, 2015, EXP NEUROL, V272, P88, DOI 10.1016/j.expneurol.2015.05.011; Chiang MC, 2019, J NEUROSCI, V39, P8225, DOI 10.1523/JNEUROSCI.1162-19.2019; DAVIS D, 1994, MAGNET RESON MED, V31, P454, DOI 10.1002/mrm.1910310416; de la Plata CDM, 2011, J INT NEUROPSYCH SOC, V17, P24, DOI 10.1017/S1355617710001189; Demertzi A, 2014, CORTEX, V52, P35, DOI 10.1016/j.cortex.2013.11.005; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Edlow BL, 2021, NAT REV NEUROL, V17, P135, DOI 10.1038/s41582-020-00428-x; Edlow BL, 2020, NEUROCRIT CARE, V33, P364, DOI 10.1007/s12028-020-01062-7; Edlow BL, 2018, J HEAD TRAUMA REHAB, V33, P424, DOI 10.1097/HTR.0000000000000448; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Fridman EA, 2014, P NATL ACAD SCI USA, V111, P6473, DOI 10.1073/pnas.1320969111; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Garyfallidis E, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00008; Glover GH, 2011, NEUROSURG CLIN N AM, V22, P133, DOI 10.1016/j.nec.2010.11.001; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Hindman J, 2018, ANN NEUROL, V84, P926, DOI 10.1002/ana.25377; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jang SH, 2019, AM J PHYS MED REHAB, V98, P1067, DOI 10.1097/PHM.0000000000001243; Jang SH, 2019, STROKE, V50, P2234, DOI 10.1161/STROKEAHA.118.023710; Jang SH, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0917-z; Kandeepan S, 2020, NEUROIMAGE, V223, DOI 10.1016/j.neuroimage.2020.117367; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Koenig MA, 2014, NEUROCRIT CARE, V20, P348, DOI 10.1007/s12028-014-9953-3; Kondziella D, 2020, EUR J NEUROL, V27, P741, DOI 10.1111/ene.14151; MINTOROVITCH J, 1991, MAGNET RESON MED, V18, P39, DOI 10.1002/mrm.1910180106; Monti MM, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00028; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Nir T, 2020, BRIT J ANAESTH, V125, P529, DOI 10.1016/j.bja.2020.06.058; NITRC, 2020, NITRC NEUR TOOLS RES; Ordonez-Rubiano EG, 2019, J CLIN NEUROSCI, V59, P372, DOI 10.1016/j.jocn.2018.10.074; Ordonez-Rubiano EG, 2017, CUREUS, V9, DOI 10.7759/cureus.1723; Ostrosky-Solis F, 1999, J INT NEUROPSYCH SOC, V5, P413, DOI 10.1017/S1355617799555045; Osuka S, 2012, J NEUROSURG, V117, P363, DOI 10.3171/2012.4.JNS112305; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Parra-Morales AM, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015620; Pujol J, 2021, SLEEP, V44, DOI 10.1093/sleep/zsaa152; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Sekhon MS, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1670-9; Snider SB, 2019, NEUROLOGY, V93, pE1281, DOI 10.1212/WNL.0000000000008163; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Tan XF, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101702; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Thornton JS, 1997, MAGN RESON IMAGING, V15, P433, DOI 10.1016/S0730-725X(96)00378-5; Threlkeld ZD, 2018, CORTEX, V106, P299, DOI 10.1016/j.cortex.2018.05.004; Turner-Stokes L, 2014, CLIN MED, V14, P4, DOI 10.7861/clinmedicine.14-1-4; Velly L, 2018, LANCET NEUROL, V17, P317, DOI 10.1016/S1474-4422(18)30027-9; Wagner F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68683-y; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; Zhang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02950-3	64	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	NOV 25	2021	11	1							22952	10.1038/s41598-021-98506-7			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XD4WB	WOS:000722710200013	34824383	gold, Green Published			2022-02-06	
J	Hsieh, SL; Hsiao, CH; Chiang, WC; Shin, SD; Jamaluddin, SF; Son, DN; Hong, KJ; Jen-Tang, S; Tsai, W; Chien, DK; Chang, WH; Chen, TH				Hsieh, Shang-Lin; Hsiao, Chien-Han; Chiang, Wen-Chu; Shin, Sang Do; Jamaluddin, Sabariah Faizah; Son, Do Ngoc; Hong, Ki Jeong; Jen-Tang, Sun; Tsai, Weide; Chien, Ding-Kuo; Chang, Wen-Han; Chen, Tse-Hao		PATOS Clinical Res Network	Association between the time to definitive care and trauma patient outcomes: every minute in the golden hour matters	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Trauma; Golden hour; Time to definitive care; Pan-Asia trauma outcomes study; PATOS	MODIFIED RANKIN SCALE; QUALITY-OF-LIFE; MORTALITY; SURVIVAL; INJURY; SCORE	Purpose This study examined the association between lapsed time and trauma patients, suggesting that a shorter time to definitive care leads to a better outcome. Methods We used the Pan-Asian Trauma Outcome Study registry to analyze a retrospective cohort of 963 trauma patients who received surgical intervention or transarterial embolization within 2 h of injury in Asian countries between January 2016 and December 2020. Exposure measurement was recorded every 30 min from injury to definitive care. The 30 day mortality rate and functional outcome were studied using the Modified Rankin Scale ratings of 0-3 vs 4-6 for favorable vs poor functional outcomes, respectively. Subgroup analyses of different injury severities and patterns were performed. Results The mean time from injury to definitive care was 1.28 +/- 0.69 h, with cases categorized into the following subgroups: < 30, 30-60, 60-90, and 90-120 min. For all patients, a longer interval was positively associated with the 30 day mortality rate (p = 0.053) and poor functional outcome (p < 0.05). Subgroup analyses showed the same association in the major trauma (n = 321, p < 0.05) and torso injury groups (n = 388, p < 0.01) with the 30 day mortality rate and in the major trauma (p < 0.01), traumatic brain injury (n = 741, p < 0.05), and torso injury (p < 0.05) groups with the poor functional outcome. Conclusion Even within 2 h, a shorter time to definitive care is positively associated with patient survival and functional outcome, especially in the subgroups of major trauma and torso injury.	[Hsieh, Shang-Lin; Tsai, Weide; Chien, Ding-Kuo; Chang, Wen-Han; Chen, Tse-Hao] Mackay Mem Hosp, Dept Emergency Med, Taipei, Taiwan; [Hsiao, Chien-Han] Indiana Univ, Dept Linguist, Bloomington, IN 47401 USA; [Chiang, Wen-Chu] Natl Taiwan Univ Hosp, Dept Emergency Med, Yunlin Branch, Touliu, Yunlin, Taiwan; [Shin, Sang Do] Seoul Natl Univ, Coll Med & Hosp, Dept Emergency Med, Seoul, South Korea; [Jamaluddin, Sabariah Faizah] Univ Teknol MARA, Fac Med, Shah Alam, Malaysia; [Son, Do Ngoc] Bach Mai Hosp, Ctr Emergency Med, Hanoi, Vietnam; [Hong, Ki Jeong] Seoul Natl Univ, Coll Med & Hosp, Dept Emergency Med, Seoul, South Korea; [Jen-Tang, Sun] Far Eastern Mem Hosp, Dept Emergency Med, Taipei, Taiwan		Chen, TH (corresponding author), Mackay Mem Hosp, Dept Emergency Med, Taipei, Taiwan.	99311121@gms.tcu.edu.tw	Chen, Tse-Hao/AAD-3143-2022	Chen, Tse-Hao/0000-0002-6370-7068			Ahmed K, 2019, CUREUS, V11, DOI 10.7759/cureus.3973; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Borges FK, 2020, LANCET, V395, P698, DOI 10.1016/S0140-6736(20)30058-1; Brinck T, 2021, INJURY, V52, P142, DOI 10.1016/j.injury.2020.11.011; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chen CH, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003360; Chen TH, 2021, INJURY, V52, P3528, DOI 10.1016/j.injury.2021.07.003; Cowley R A, 1975, Md State Med J, V24, P37; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; Haslam NR, 2020, BJS OPEN, V4, P963, DOI 10.1002/bjs5.50316; Kohli A, 2016, AM SURGEON, V82, P95; Kong SY, 2018, PREHOSP EMERG CARE, V22, P58, DOI 10.1080/10903127.2017.1347224; Kotwal RS, 2016, JAMA SURG, V151, P15, DOI 10.1001/jamasurg.2015.3104; Marasco S, 2015, INJURY, V46, P61, DOI 10.1016/j.injury.2014.06.014; McIsaac DI, 2017, CAN MED ASSOC J, V189, pE905, DOI 10.1503/cmaj.160576; Newgard CD, 2015, ANN EMERG MED, V66, P30, DOI 10.1016/j.annemergmed.2014.12.004; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; Pincus D, 2017, JAMA-J AM MED ASSOC, V318, P1994, DOI 10.1001/jama.2017.17606; Rangaraju S, 2017, INTERV NEUROL, V6, P36, DOI 10.1159/000452634; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Rogers FB, 2015, INJURY, V46, P525, DOI 10.1016/j.injury.2014.08.043; Shen CY, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18062848; Swanton A, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-00259-w; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI [10.2471/BLT.07.045120, 10.1371/journal.pmed.0040296]	26	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-021-01816-8		NOV 2021	8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XD1NR	WOS:000722479000001	34825274				2022-02-06	
J	Klyce, DW; Perrin, PB; Fisher, LB; Hammond, FM; Juengst, SB; Bergquist, TF; Rabinowitz, AR; Wagner, AK; Bombardier, CH; Niemeier, JP; Gary, KW; Giacino, JT; Zafonte, RD				Klyce, Daniel W.; Perrin, Paul B.; Fisher, Lauren B.; Hammond, Flora M.; Juengst, Shannon B.; Bergquist, Thomas F.; Rabinowitz, Amanda R.; Wagner, Amy K.; Bombardier, Charles H.; Niemeier, Janet P.; Gary, Kelli W.; Giacino, Joseph T.; Zafonte, Ross D.			Identifying group-based patterns of suicidal ideation over the first 10 years after moderate-to-severe TBI	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article; Early Access						cluster analysis; suicidal ideation; suicide; TBI Model Systems; traumatic brain injury	TRAUMATIC BRAIN-INJURY; REHABILITATION; ASSOCIATION; ORIENTATION; DISPARITIES; PREVALENCE; DISABILITY; PREVENTION; MORTALITY; VETERANS	Objective To identify group-based patterns in suicidal ideation (SI) over the first 10 years after traumatic brain injury (TBI). Methods Participants included 9539 individuals in the TBI Model Systems National Database who responded to Patient Health Questionnaire-9 Item 9 assessing SI at 1, 2, 5, and/or 10 years post-injury. A k-means cluster analysis was conducted to determine group-based patterns of SI, and pre-injury variables were compared with ANOVAs and chi-square tests. Results SI and attempts decreased over time. Four group-based patterns emerged: Low, increasing, moderate, and decreasing SI. The low SI group comprised 89% of the sample, had the highest pre-injury employment, fewer mental health vulnerabilities, least severe injuries, and were oldest. The increasing SI group had the most severe TBIs, were youngest, and disproportionately Black or Asian/Pacific Islander. Conclusion These findings reinforce the importance of mental health and suicide risk assessment during chronic recovery from TBI.	[Klyce, Daniel W.; Perrin, Paul B.] Cent Virginia Vet Affairs Hlth Care Syst, Mental Hlth Serv, Richmond, VA USA; [Klyce, Daniel W.] Sheltering Arms Inst, Psychol Serv, Richmond, VA USA; [Klyce, Daniel W.] Virginia Commonwealth Univ Hlth Syst, Dept Phys Med & Rehabil, Richmond, VA USA; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Dept Psychol, Richmond, VA USA; [Fisher, Lauren B.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA; [Fisher, Lauren B.] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Hammond, Flora M.] Rehabil Hosp Indiana, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Juengst, Shannon B.] Inst Rehabil Res, Mem Hermann, Houston, TX USA; [Bergquist, Thomas F.] Mayo Clin Coll Med & Sci, Dept Phys Med & Rehabil, Dept Psychiat & Psychol, Rochester, MN USA; [Rabinowitz, Amanda R.] Moss Rehabil Res Inst, Brain Injury Neuropsychol Lab, Elkins Pk, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Bombardier, Charles H.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Bombardier, Charles H.] Univ Washington, Dept Rehabil Med, Seattle, WA USA; [Niemeier, Janet P.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Gary, Kelli W.] Virginia Commonwealth Univ, Dept Rehabil Counseling, Richmond, VA USA; [Giacino, Joseph T.; Zafonte, Ross D.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Giacino, Joseph T.; Zafonte, Ross D.] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Giacino, Joseph T.; Zafonte, Ross D.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross D.] Brigham & Womens Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Juengst, Shannon B.] Inst Rehabil Res, Mem Hermann, Houston, TX USA		Klyce, DW (corresponding author), Virginia Commonwealth Univ Hlth Syst, 1201 Broad Rock Blvd, Richmond, VA 23249 USA.	daniel.klyce@vcuhealth.org	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DPTB0004, 90DPTB0005, 90DPTB0008, 90DPTB0011, 90DPTB0012, 90DPTB0013, 90DPTB0015, 90DPTB0002]	National Institute on Disability, Independent Living, and Rehabilitation Research, Grant/Award Numbers: 90DPTB0004, 90DPTB0005, 90DPTB0008, 90DPTB0011, 90DPTB0012, 90DPTB0013, 90DPTB0015, 90DPTB0002	Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Awan N, 2021, J HEAD TRAUMA REHAB, V36, pE18, DOI 10.1097/HTR.0000000000000588; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Brenner LA, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000351; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Dreer LE, 2018, CURR OPIN PSYCHOL, V22, P73, DOI 10.1016/j.copsyc.2017.08.030; Enders CK, 2011, REHABIL PSYCHOL, V56, P267, DOI 10.1037/a0025579; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Fisher LB, 2016, BRAIN INJURY, V30, P1311, DOI 10.1080/02699052.2016.1195517; Glenn CR, 2014, AM J PREV MED, V47, pS176, DOI 10.1016/j.amepre.2014.06.004; Guarino, 2017, APPL MULTIVARIATE RE; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kent P, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-113; Kesinger MR, 2016, ARCH PHYS MED REHAB, V97, P1301, DOI 10.1016/j.apmr.2016.02.017; Kleiman EM, 2018, CURR OPIN PSYCHOL, V22, P33, DOI 10.1016/j.copsyc.2017.07.026; Knight E, 2020, BRAIN INJURY, V34, P1010, DOI 10.1080/02699052.2020.1763463; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lamm AG, 2019, J NEUROTRAUM, V36, P2513, DOI 10.1089/neu.2018.6014; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; McIntire KS, 2021, BRAIN INJURY, V35, P151, DOI 10.1080/02699052.2020.1861656; Miller GF, 2021, AM J PREV MED, V61, P501, DOI 10.1016/j.amepre.2021.04.034; Perrin PB, 2019, REHABIL PSYCHOL, V64, P105, DOI 10.1037/rep0000278; Perrin PB, 2014, ARCH PHYS MED REHAB, V95, P2288, DOI 10.1016/j.apmr.2014.07.409; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Rossom RC, 2017, J AFFECT DISORDERS, V215, P77, DOI 10.1016/j.jad.2017.03.037; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Williamson MLC, 2016, J HEAD TRAUMA REHAB, V31, P167, DOI 10.1097/HTR.0000000000000111; Wood RLL, 2010, J INT NEUROPSYCH SOC, V16, P1108, DOI 10.1017/S1355617710001013	37	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9762	1097-4679		J CLIN PSYCHOL	J. Clin. Psychol.												10.1002/jclp.23282		NOV 2021	15	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	XD2PB	WOS:000722550700001	34825373				2022-02-06	
J	Ledoux, AA; Barrowman, N; Bijelic, V; Borghese, MM; Davis, A; Reid, S; Sangha, G; Yeates, KO; Tremblay, MS; McGahern, C; Belanger, K; Barnes, JD; Farion, KJ; DeMatteo, CA; Reed, N; Zemek, R				Ledoux, Andree-Anne; Barrowman, Nick; Bijelic, Vid; Borghese, Michael M.; Davis, Adrienne; Reid, Sarah; Sangha, Gurinder; Yeates, Keith Owen; Tremblay, Mark S.; McGahern, Candice; Belanger, Kevin; Barnes, Joel D.; Farion, Ken J.; DeMatteo, Carol A.; Reed, Nick; Zemek, Roger		PERC PedCARE Concussion Team	Is early activity resumption after paediatric concussion safe and does it reduce symptom burden at 2 weeks post injury? The Pediatric Concussion Assessment of Rest and Exertion (PedCARE) multicentre randomised clinical trial	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article; Early Access							POSTCONCUSSIVE SYMPTOMS; CHILDREN; SPORT; YOUTH	Objective Investigate whether resuming physical activity (PA) at 72 hours post concussion is safe and reduces symptoms at 2 weeks, compared with resting until asymptomatic. Methods Real-life conditions, multicentre, single-blinded randomised clinical trial, conducted in three Canadian paediatric emergency departments (ED). Children/youth aged 10-<18 years with acute concussion were recruited between March 2017 and December 2019, and randomly assigned to a 4-week stepwise return-to-PA protocol at 72 hours post concussion even if symptomatic (experimental group (EG)) or to a return-to-PA once asymptomatic protocol (control group (CG)). The primary outcome was self-reported symptoms at 2 weeks using the Health and Behaviour Inventory. Adherence was measured using accelerometers worn 24 hours/day for 14 days post injury. Adverse events (AE) (worsening of symptoms requiring unscheduled ED or primary care visit) were monitored. Multivariable intention-to-treat (ITT) and per-protocol analyses adjusting for prognostically important covariates were examined. Missing data were imputed for the ITT analysis. Results 456 randomised participants (EG: N=227; mean (SD) age=13.3 (2.1) years; 44.5% women; CG: N=229; mean (SD) age=13.3 (2.2) years; 43.7% women) were analysed. No AE were identified. ITT analysis showed no strong evidence of a group difference at 2 weeks (adjusted mean difference=-1.3 (95% CI:-3.6 to 1.1)). In adherent participants, initiating PA 72 hours post injury significantly reduced symptoms 2 weeks post injury, compared with rest (adjusted mean difference=-4.3 (95% CI:-8.4 to -0.2)). Conclusion Symptoms at 2 weeks did not differ significantly between children/youth randomised to initiate PA 72 hours post injury versus resting until asymptomatic; however, many were non-adherent to the intervention. Among adherent participants, early PA was associated with reduced symptoms at 2 weeks. Resumption of PA is safe and may be associated with milder symptoms at 2 weeks.	[Ledoux, Andree-Anne; Reid, Sarah; Tremblay, Mark S.; McGahern, Candice; Belanger, Kevin; Barnes, Joel D.; Farion, Ken J.; Zemek, Roger] Childrens Hosp Eastern Ontario Res Inst, Ottawa, ON, Canada; [Ledoux, Andree-Anne] Univ Ottawa, Cellular & Mol Med Neurosci, Ottawa, ON, Canada; [Barrowman, Nick; Bijelic, Vid] Childrens Hosp Eastern Ontario Res Inst, Clin Res Unit, Ottawa, ON, Canada; [Barrowman, Nick; Tremblay, Mark S.] Univ Ottawa, Dept Pediat, Ottawa, ON, Canada; [Borghese, Michael M.] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON, Canada; [Davis, Adrienne] Hosp Sick Children, Dept Pediat, Div Pediat Emergency Med, Toronto, ON, Canada; [Davis, Adrienne] Univ Toronto, Toronto, ON, Canada; [Reid, Sarah; Farion, Ken J.; Zemek, Roger] Univ Ottawa, Dept Pediat, Div Emergency Med, Ottawa, ON, Canada; [Sangha, Gurinder] Western Univ, Dept Pediat, Div Emergency Med, London, ON, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [DeMatteo, Carol A.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Ledoux, AA (corresponding author), Childrens Hosp Eastern Ontario, Emergency Reseach Dept, Ottawa, ON K1H 8L1, Canada.	aledoux@cheo.on.ca			OSSU IMPACT Award	This study was supported by OSSU IMPACT Award.	Aubert S, 2018, J PHYS ACT HEALTH, V15, pS251, DOI 10.1123/jpah.2018-0472; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Colley R., 2010, CATALOGUE 82 003 XPE, V21; Colley RC, 2011, J SPORT SCI, V29, P783, DOI 10.1080/02640414.2011.557744; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Coslick AM, 2020, PM&R, V12, P1195, DOI 10.1002/pmrj.12443; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gauvin-Lepage J, 2020, CLIN J SPORT MED, V30, P423, DOI 10.1097/JSM.0000000000000634; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Harrell Frank E Jr, 2020, CRAN; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Leddy JJ, 2021, LANCET CHILD ADOLESC, V5, P792, DOI 10.1016/S2352-4642(21)00267-4; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Ledoux AA, 2019, BRIT J SPORT MED, V53, P195, DOI 10.1136/bjsports-2017-097981; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Micay R, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000404; Peterson A, 2021, INJURY PREV, V27, pi13, DOI 10.1136/injuryprev-2019-043517; Puyau MR, 2004, MED SCI SPORT EXER, V36, P1625, DOI 10.1249/01.MSS.0000139898.30804.60; R Core Team, 2020, R LANG ENV STAT COMP; Reed N., 2019, LIVING GUIDELINE DIA; Reed N, 2018, CAN MED ASSOC J, V190, pS28, DOI 10.1503/cmaj.180450; Roemmich JN, 2006, MED SCI SPORT EXER, V38, P1014, DOI 10.1249/01.mss.0000218123.81079.49; Rubin D.B., 1987, MULTIPLE IMPUTATION; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Willer BS, 2019, ARCH PHYS MED REHAB, V100, P2267, DOI 10.1016/j.apmr.2019.07.003; Wong SL, 2011, J PHYS ACT HEALTH, V8, P587, DOI 10.1123/jpah.8.4.587; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates TM, 2021, J NEUROTRAUM, DOI 10.1089/neu.2020.7470; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	45	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.												10.1136/bjsports-2021-105030		NOV 2021	8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	XF8MT	WOS:000724321200001	34836880				2022-02-06	
J	Moser, RS; Friedman, S; Hensel, GL; Dubnov-Raz, G; Schatz, P				Moser, Rosemarie Scolaro; Friedman, Sarah; Hensel, Gustav Luke; Dubnov-Raz, Gal; Schatz, Philip			A Cross-Cultural Examination of Parental Knowledge of Concussion in Three Countries	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article								The aim of the present study was to examine and compare knowledge regarding concussion among parents of youth soccer players, ages 5-17, from the United States, Israel, and Sicily. Results revealed parents from the United States were more knowledgeable than Israeli and Sicilian parents and were more likely to have a previous history of concussion in their children, themselves, and their social contacts. The success of concussion education, programming, and legislation in the US may account for the greater knowledge of US parents and is reason to advocate for similar resources for youth athletes internationally.	[Moser, Rosemarie Scolaro; Friedman, Sarah] Sports Concuss Ctr New Jersey, 281 Witherspoon St,Suite 230, Princeton, NJ 08540 USA; [Hensel, Gustav Luke] Lehigh Valley Hlth Network Scranton Orthoped, Newfoundland, PA USA; [Dubnov-Raz, Gal] Sheba Med Ctr, Edmond & Lily Safra Childrens Hosp, Tel Hashomer, Israel; [Dubnov-Raz, Gal] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Schatz, Philip] St Joseph Univ, Dept Psychol, Philadelphia, PA USA		Moser, RS (corresponding author), Sports Concuss Ctr New Jersey, 281 Witherspoon St,Suite 230, Princeton, NJ 08540 USA.	rmoser@sportsconcussionNJ.com		Moser, Rosemarie Scolaro/0000-0002-0893-4321; Schatz, Philip/0000-0002-6222-6545			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Brain Injury Alliance of New Jersey, 2017, CONC PAR GUID; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cantu R., 2012, CONCUSSIONS OUR KIDS; Centers for Disease Control and Prevention, 2020, HEADS YOUTH SPORTS; Cohen J, 1988, STAT POWER ANAL BEHA; Concussion in Sport Australia, 2020, INF PAR TEACH; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Feiss RS, 2020, J CONCUSSION, DOI [10.1177/2059700219900053, DOI 10.1177/2059700219900053]; FIFA, 2021, FOOTB LANDSC VIS 202; FIFA, 2021, MAK FOOTB TRUL GLOB; Government of Canada, 2020, CONC SPORT RECR; Israeli Central Bureau of Statistics, 2020, STAT ABSTR ISR 2020; Johnson A., 2015, SOCCER NUMBERS LOOK; Kay MC, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117742370; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; Maraisc I, 2016, SPORT J, P1; Meehan W., 2011, KIDS SPORTS CONCUSSI; Moser R.S., 2012, AHEAD GAME PARENTS G; Moser RS, 2020, DEV NEUROPSYCHOL, V45, P330, DOI 10.1080/87565641.2020.1789644; Moser RS, 2018, ARCH CLIN NEUROPSYCH, V33, P417, DOI 10.1093/arclin/acx070; Parachute, 2020, CONCUSSION; Statista Research Department, 2017, IT NUMB REG YOUTH FO; Union of European Football Associations (UEFA), 2019, UEFA LAUNCH CONC AW; Waltzman Dana, 2018, J Concussion, V2, P1, DOI 10.1177/2059700218769218; Washington State Legislature, 2009, 28A600190 RCW WASH S; Weerdenburg K, 2016, PAED CHILD HEALT-CAN, V21, pE22, DOI 10.1093/pch/21.3.e22	29	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	NOV 17	2021	46	8					588	597		10.1080/87565641.2021.2005600		NOV 2021	10	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	XO8LG	WOS:000724006300001	34844487				2022-02-06	
J	Perkins, J; Shreffler, J; Kamenec, D; Bequer, A; Ziemba, C; O'Brien, D; Shoff, H; Smith, J; Nash, N; Huecker, M				Perkins, Jordan; Shreffler, Jacob; Kamenec, Danielle; Bequer, Alexandra; Ziemba, Corey; O'Brien, Dan; Shoff, Hugh; Smith, Jason; Nash, Nicholas; Huecker, Martin			Short Observation Period and Aggressive Discharge of Patients With Head Injury and Serial CT Scans	AMERICAN SURGEON			English	Article; Early Access							TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; INTRACRANIAL HEMORRHAGE; INFLUENCE MANAGEMENT; LOW-RISK; DETERIORATION	Background: Many patients undergo two head computed tomography (CT) scans after mild traumatic brain injury (TBI). Radiographic progression without clinical deterioration does not usually alter management. Evidence-based guidelines offer potential for limited repeat imaging and safe discharge. This study characterizes patients who had two head CTs in the Emergency Department (ED), determines the change between initial and repeat CTs, and describes timing of repeat scans. Methods: This retrospective series includes all patients with head CTs during the same ED visit at an urban trauma center between May 1st, 2016 and April 30th, 2018. Radiographic interpretation was coded as positive, negative, or equivocal. Results: Of 241 subjects, the number of positive, negative, and equivocal initial CT results were 154, 50, and 37, respectively. On repeat CT, 190 (78.8%) interpretations were congruent with the original scan. Out of the 21.2% of repeat scans that diverged from the original read, 14 (5.8%) showed positive to negative conversion, 1 (.4%) showed positive to equivocal conversion, 2 (.88%) showed negative to positive conversion, 20 (8.3%) showed equivocal to negative conversion, and 14 (5.8%) showed equivocal to positive conversion. Average time between scans was 4.4 hours, and median length of stay was 10.2 hours. Conclusions: In this retrospective review, most repeat CT scans had no new findings. A small percentage converted to positive, rarely altering clinical management. This study demonstrates the need for continued prospective research to update clinical guidelines that could reduce admission and serial CT scanning for mild TBI.	[Perkins, Jordan; Ziemba, Corey] Univ Louisville, Sch Med, 550 South Jackson, Louisville, KY 40202 USA; [Shreffler, Jacob; Kamenec, Danielle; Bequer, Alexandra; O'Brien, Dan; Shoff, Hugh; Huecker, Martin] Univ Louisville, Dept Emergency Med, Louisville, KY 40202 USA; [Smith, Jason; Nash, Nicholas] Univ Louisville, Dept Surg, Louisville, KY 40202 USA		Huecker, M (corresponding author), Univ Louisville, Sch Med, 550 South Jackson, Louisville, KY 40202 USA.	martin.huecker@louisville.edu					Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Chenoweth JA, 2018, JAMA SURG, V153, P570, DOI 10.1001/jamasurg.2017.6159; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Connon FF, 2011, ANN SURG, V254, P1028, DOI 10.1097/SLA.0b013e318219727f; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Khan AD, 2020, TRAUMA SURG ACUTE CA, V5, DOI 10.1136/tsaco-2020-000483; Kreitzer N, 2014, ACAD EMERG MED, V21, P1084, DOI 10.1111/acem.12479; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee Bruce, 2005, NeuroRx, V2, P372; Mann N, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0179-0; Marincowitz C, 2021, EMERG MED J, DOI 10.1136/emermed-2020-210975; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Marincowitz C, 2020, J NEUROTRAUM, V37, P324, DOI 10.1089/neu.2019.6652; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Power SP, 2016, WORLD J RADIOL, V8, P902, DOI 10.4329/wjr.v8.i12.902; Pruitt P, 2017, ACAD EMERG MED, V24, P1377, DOI 10.1111/acem.13306; Pruitt P, 2017, AM J EMERG MED, V35, P255, DOI 10.1016/j.ajem.2016.10.064; REINUS WR, 1994, ANN EMERG MED, V23, P1271, DOI 10.1016/S0196-0644(94)70351-5; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Swap Clifford, 2016, Perm J, V20, P14, DOI 10.7812/TPP/15-095; Uccella L, 2016, WORLD NEUROSURG, V93, P100, DOI 10.1016/j.wneu.2016.05.061; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Yun BJ, 2017, AM J EMERG MED, V35, P1281, DOI 10.1016/j.ajem.2017.03.071	24	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.											00031348211063539	10.1177/00031348211063539		NOV 2021	8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XJ3GI	WOS:000726680600001	34823406				2022-02-06	
J	Romeas, T; Greffou, S; Allard, R; Forget, R; McKerral, M; Faubert, J; Gagnon, I				Romeas, Thomas; Greffou, Selma; Allard, Remy; Forget, Robert; McKerral, Michelle; Faubert, Jocelyn; Gagnon, Isabelle			Dynamic Visual Stimulations Produced in a Controlled Virtual Reality Environment Reveals Long-Lasting Postural Deficits in Children With Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury (mTBI); postural instability; children; virtual reality; balance; sensorimotor control; perception-action coupling	ERROR SCORING SYSTEM; PROCESSING DEFICITS; BALANCE ASSESSMENT; PHYSICAL-THERAPY; CONCUSSION; REHABILITATION; GAIT; STABILITY; SWAY; TIME	Motor control deficits outlasting self-reported symptoms are often reported following mild traumatic brain injury (mTBI). The exact duration and nature of these deficits remains unknown. The current study aimed to compare postural responses to static or dynamic virtual visual inputs and during standard clinical tests of balance in 38 children between 9 and 18 years-of-age, at 2 weeks, 3 and 12 months post-concussion. Body sway amplitude (BSA) and postural instability (vRMS) were measured in a 3D virtual reality (VR) tunnel (i.e., optic flow) moving in the antero-posterior direction in different conditions. Measures derived from standard clinical balance evaluations (BOT-2, Timed tasks) and post-concussion symptoms (PCSS-R) were also assessed. Results were compared to those of 38 healthy non-injured children following a similar testing schedule and matched according to age, gender, and premorbid level of physical activity. Results highlighted greater postural response with BSA and vRMS measures at 3 months post-mTBI, but not at 12 months when compared to controls, whereas no differences were observed in post-concussion symptoms between mTBI and controls at 3 and 12 months. These deficits were specifically identified using measures of postural response in reaction to 3D dynamic visual inputs in the VR paradigm, while items from the BOT-2 and the 3 timed tasks did not reveal deficits at any of the test sessions. PCSS-R scores correlated between sessions and with the most challenging condition of the BOT-2 and as well as with the timed tasks, but not with BSA and vRMS. Scores obtained in the most challenging conditions of clinical balance tests also correlated weakly with BSA and vRMS measures in the dynamic conditions. These preliminary findings suggest that using 3D dynamic visual inputs such as optic flow in a controlled VR environment could help detect subtle postural impairments and inspire the development of clinical tools to guide rehabilitation and return to play recommendations.	[Romeas, Thomas; Greffou, Selma; Allard, Remy; Faubert, Jocelyn] Univ Montreal, Faubert Lab, Ecole Optometrie, Montreal, PQ, Canada; [Romeas, Thomas] Inst Natl Sport Quebec, Montreal, PQ, Canada; [Forget, Robert] Univ Montreal, Fac Med, Sch Rehabil, Montreal, PQ, Canada; [Forget, Robert; McKerral, Michelle] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [McKerral, Michelle] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Fac Med & Hlth Sci, Sch Phys & Occupat Therapy, Montreal, PQ, Canada		Gagnon, I (corresponding author), McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Montreal, PQ, Canada.; Gagnon, I (corresponding author), McGill Univ, Fac Med & Hlth Sci, Sch Phys & Occupat Therapy, Montreal, PQ, Canada.	isabelle.gagnon8@mcgill.ca		/0000-0002-3298-5719			Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Buckley TA, 2020, MED SCI SPORT EXER, V52, P1256, DOI 10.1249/MSS.0000000000002269; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Chermann JF, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000384; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Connaboy C, 2019, AEROSP MED HUM PERF, V90, P77, DOI 10.3357/AMHP.5190.2019; COSTALL AP, 1984, J EXP ANAL BEHAV, V41, P109, DOI 10.1901/jeab.1984.41-109; Damiano DL, 2016, EXP BRAIN RES, V234, P2245, DOI 10.1007/s00221-016-4630-8; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Drijkoningen D, 2015, HUM BRAIN MAPP, V36, P4897, DOI 10.1002/hbm.22958; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Emery CA, 2005, PHYS THER, V85, P502, DOI 10.1093/ptj/85.6.502; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Faubert J, 2004, PROC SPIE, V5291, P491, DOI 10.1117/12.527017; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Gagnon Isabelle, 2006, Phys Occup Ther Pediatr, V26, P23, DOI 10.1300/J006v26n01_04; Gawronska A, 2020, CLIN INTERV AGING, V15, P2397, DOI 10.2147/CIA.S289861; Grants L, 2017, INT J SPORTS PHYS TH, V12, P1011, DOI 10.26603/ijspt20171011; Greffou S, 2012, J AUTISM DEV DISORD, V42, P961, DOI 10.1007/s10803-011-1326-6; Greffou S, 2008, J VISION, V8, DOI 10.1167/8.11.15; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 1996, J ORTHOP SPORT PHYS, V23, P326, DOI 10.2519/jospt.1996.23.5.326; Hanssens JM, 2013, EXP BRAIN RES, V229, P75, DOI 10.1007/s00221-013-3592-3; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Hugentobler JA, 2015, INT J SPORTS PHYS TH, V10, P676; Jahn FS, 2021, PSYCHIAT RES, V300, DOI 10.1016/j.psychres.2021.113928; Keshner Emily A, 2021, Front Virtual Real, V2, DOI 10.3389/frvir.2021.641650; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lachapelle J, 2004, VISION RES, V44, P2835, DOI 10.1016/j.visres.2004.06.007; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; LEE DN, 1974, PERCEPT PSYCHOPHYS, V15, P529, DOI 10.3758/BF03199297; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Minshew NJ, 2004, NEUROLOGY, V63, P2056, DOI 10.1212/01.WNL.0000145771.98657.62; Morel M, 2015, NEUROPHYSIOL CLIN, V45, P315, DOI 10.1016/j.neucli.2015.09.007; Mrazik M, 2000, BRAIN INJURY, V14, P921, DOI 10.1080/026990500445736; Ozdemir AT, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16081161; Paniccia M, 2018, SPORTS HEALTH, V10, P175, DOI 10.1177/1941738117741651; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Piponnier JC, 2016, J NEUROTRAUM, V33, P242, DOI 10.1089/neu.2014.3832; Piponnier JC, 2009, J VISION, V9, DOI 10.1167/9.1.13; Quatman-Yates C, 2014, PHYSICIAN SPORTSMED, V42, P32, DOI 10.3810/psm.2014.09.2073; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Reneker JC, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04527; Reneker JC, 2019, MUSCULOSKEL SCI PRAC, V42, P173, DOI 10.1016/j.msksp.2019.04.004; RUBIN AM, 1995, AM J OTOL, V16, P216; SALLIS JF, 1988, AM J EPIDEMIOL, V127, P933, DOI 10.1093/oxfordjournals.aje.a114896; Santos Fernando V, 2020, J Clin Transl Res, V5, P148; Schmuckler MA, 1997, J EXP PSYCHOL HUMAN, V23, P528, DOI 10.1037/0096-1523.23.2.528; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Sparto PJ, 2006, EXP BRAIN RES, V168, P505, DOI 10.1007/s00221-005-0109-8; Starling Amaal J, 2016, Concussion, V1, pCNC5, DOI 10.2217/cnc.15.5; STOFFREGEN TA, 1987, PERCEPTION, V16, P113, DOI 10.1068/p160113; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Thomas KS., 2014, J NOV PHYSIOTHER, V4, P2, DOI [10.4172/2165-7025.1000206, DOI 10.4172/2165-7025.1000206]; Ustinova KI, 2014, BRAIN INJURY, V28, P486, DOI 10.3109/02699052.2014.888593; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Wilkerson GB, 2018, MED SCI SPORT EXER, V50, P1750, DOI 10.1249/MSS.0000000000001647; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Zanier ER, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00345	79	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 25	2021	12								596615	10.3389/fneur.2021.596615			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XM5VI	WOS:000728894000001	34899549	gold, Green Published			2022-02-06	
J	Wilson, PH; Rogers, JM; Vogel, K; Steenbergen, B; McGuckian, TB; Duckworth, J				Wilson, Peter H.; Rogers, Jeffrey M.; Vogel, Karin; Steenbergen, Bert; McGuckian, Thomas B.; Duckworth, Jonathan			Home-based (virtual) rehabilitation improves motor and cognitive function for stroke patients: a randomized controlled trial of the Elements (EDNA-22) system	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Cognition; Motor activity; Rehabilitation; Stroke; Upper extremity; Virtual rehabilitation	SUPPLEMENTARY PROGRAM GRASP; TRAUMATIC BRAIN-INJURY; UPPER-LIMB; UPPER EXTREMITY; HAND FUNCTION; ARM FUNCTION; REALITY; SURVIVORS; RECOVERY; RELIABILITY	Background: Home-based rehabilitation of arm function is a significant gap in service provision for adult stroke. The EDNA-22 tablet is a portable virtual rehabilitation-based system that provides a viable option for home-based rehabilitation using a suite of tailored movement tasks, and performance monitoring via cloud computing data storage. The study reported here aimed to compare use of the EDNA system with an active control (Graded Repetitive Arm Supplementary Program-GRASP training) group using a parallel RCT design. Methods: Of 19 originally randomized, 17 acute-care patients with upper-extremity dysfunction following unilateral stroke completed training in either the treatment (n = 10) or active control groups (n = 7), each receiving 8-weeks of in-home training involving 30-min sessions scheduled 3-4 times weekly. Performance was assessed across motor, cognitive and functional behaviour in the home. Primary motor measures, collected by a blinded assessor, were the Box and Blocks Task (BBT) and 9-Hole Pegboard Test (9HPT), and for cognition the Montreal Cognitive Assessment (MoCA). Functional behaviour was assessed using the Stroke Impact Scale (SIS) and Neurobehavioural Functioning Inventory (NFI). Results: One participant from each group withdrew for personal reasons. No adverse events were reported. Results showed a significant and large improvement in performance on the BBT for the more-affected hand in the EDNA training group, only (g = 0.90). There was a mild-to-moderate effect of training on the 9HPT for EDNA (g = 0.55) and control (g = 0.42) groups, again for the more affected hand. In relation to cognition, performance on the MoCA improved for the EDNA group (g = 0.70). Finally, the EDNA group showed moderate (but non-significant) improvement in functional behaviour on the SIS (g = 0.57) and NFI (g = 0.49). Conclusion: A short course of home-based training using the EDNA-22 system can yield significant gains in motor and cognitive performance, over and above an active control training that also targets upper-limb function. Intriguingly, these changes in performance were corroborated only tentatively in the reports of caregivers. We suggest that future research consider how the implementation of home-based rehabilitation technology can be optimized. We contend that self-administered digitally-enhanced training needs to become part of the health literacy of all stakeholders who are impacted by stroke and other acquired brain injuries.	[Wilson, Peter H.; McGuckian, Thomas B.] Australian Catholic Univ, Hlth Brain & Mind Res Ctr HBMRC, Melbourne, Vic, Australia; [Wilson, Peter H.; McGuckian, Thomas B.] Australian Catholic Univ, Sch Behav & Hlth Sci, Melbourne, Vic, Australia; [Rogers, Jeffrey M.] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia; [Vogel, Karin] Prince Wales Hosp, Sydney, NSW, Australia; [Steenbergen, Bert] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands; [Duckworth, Jonathan] RMIT, Sch Design, Melbourne, Vic, Australia		Wilson, PH (corresponding author), Australian Catholic Univ, Hlth Brain & Mind Res Ctr HBMRC, Melbourne, Vic, Australia.; Wilson, PH (corresponding author), Australian Catholic Univ, Sch Behav & Hlth Sci, Melbourne, Vic, Australia.	peterh.wilson@acu.edu.au	McGuckian, Thomas Baxter/M-6934-2016; Wilson, Peter/E-2881-2018	McGuckian, Thomas Baxter/0000-0002-5490-0042; Duckworth, Jonathan/0000-0002-8021-3860; Wilson, Peter/0000-0003-3747-0287; Steenbergen, Bert/0000-0001-8863-2624	RMIT through the Design and Creative Practice Enabling Capability Platform; Australian Government, Department of Industry, Innovation and Science, Accelerating Commercialisation grant, an element of the Entrepreneurs' Program	Supported by RMIT through the Design and Creative Practice Enabling Capability Platform and the Australian Government, Department of Industry, Innovation and Science, Accelerating Commercialisation grant, an element of the Entrepreneurs' Program.	Aminov A, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0370-2; Au-Yeung SSY, 2009, DISABIL REHABIL, V31, P394, DOI 10.1080/09638280802061878; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Chen HM, 2009, NEUROREHAB NEURAL RE, V23, P435, DOI 10.1177/1545968308331146; Chen LD, 2016, J ADV NURS, V72, P73, DOI 10.1111/jan.12819; Chen Y, 2019, INT J MED INFORM, V123, P11, DOI 10.1016/j.ijmedinf.2018.12.001; Choi JH, 2014, ANN REHABIL MED-ARM, V38, P485, DOI 10.5535/arm.2014.38.4.485; Chumney D, 2010, J REHABIL RES DEV, V47, P17, DOI 10.1682/JRRD.2009.08.0140; Cohen J., 2013, STAT POWER ANAL BEHA; Crosbie JH, 2012, CLIN REHABIL, V26, P798, DOI 10.1177/0269215511434575; Cameirao MDS, 2011, RESTOR NEUROL NEUROS, V29, P287, DOI 10.3233/RNN-2011-0599; Dong YH, 2010, J NEUROL SCI, V299, P15, DOI 10.1016/j.jns.2010.08.051; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; GRESHAM GE, 1975, NEW ENGL J MED, V293, P954, DOI 10.1056/NEJM197511062931903; Harris JE, 2009, STROKE, V40, P2123, DOI 10.1161/STROKEAHA.108.544585; Jacob-Lloyd HA., 2005, BRIT J OCCUP THER, V68, P253; Kizony R, 2013, 2013 INT C VIRT REH; Kizony R, 2017, DISABIL REHABIL, V39, P1532, DOI 10.1080/09638288.2016.1250827; Knepley KD, 2021, TELEMED E-HEALTH, V27, P239, DOI 10.1089/tmj.2020.0019; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Lang CE, 2009, ARCH PHYS MED REHAB, V90, P1692, DOI 10.1016/j.apmr.2009.04.005; Langhorne P, 2003, J NEUROL NEUROSUR PS, V74, P18; Levac D, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1807-6; Mathiowetz V, 1998, NEUROREHABILITATION, V11, P141, DOI 10.1016/S1053-8135(98)00018-3; McDonald MW, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00135; Mumford N, 2012, BRAIN INJURY, V26, P166, DOI 10.3109/02699052.2011.648706; Mumford N, 2010, BRAIN INJURY, V24, P780, DOI 10.3109/02699051003652807; Mumford N, 2008, 2008 VIRTUAL REHABILITATION, P175, DOI 10.1109/ICVR.2008.4625156; Mumford N, 2009, BRAIN INJURY, V23, P179, DOI 10.1080/02699050802695566; Murdolo Y, 2017, AUST OCCUP THER J, V64, P305, DOI 10.1111/1440-1630.12363; NAKAYAMA H, 1994, ARCH PHYS MED REHAB, V75, P394, DOI 10.1016/0003-9993(94)90161-9; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Penta M, 2001, STROKE, V32, P1627, DOI 10.1161/01.STR.32.7.1627; Piron L, 2009, J REHABIL MED, V41, P1016, DOI 10.2340/16501977-0459; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Rogers JM, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0531-y; Saposnik G, 2010, STROKE, V41, P1477, DOI 10.1161/STROKEAHA.110.584979; Sheehy L, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3438-9; Sin H, 2013, AM J PHYS MED REHAB, V92, P871, DOI 10.1097/PHM.0b013e3182a38e40; Standen PJ, 2017, CLIN REHABIL, V31, P340, DOI 10.1177/0269215516640320; Tchero H, 2018, J MED INTERNET RES, V20, DOI 10.2196/10867; Torrisi M, 2019, INT J REHABIL RES, V42, P344, DOI 10.1097/MRR.0000000000000369; Witmer BG, 2005, PRESENCE-TELEOP VIRT, V14, P298, DOI 10.1162/105474605323384654; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Wu CY, 2019, OCCUP THER INT, DOI 10.1155/2019/2517658; Yin CW, 2014, CLIN REHABIL, V28, P1107, DOI 10.1177/0269215514532851	50	0	0	5	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1743-0003		J NEUROENG REHABIL	J. NeuroEng. Rehabil.	NOV 25	2021	18	1							165	10.1186/s12984-021-00956-7			12	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Neurosciences & Neurology; Rehabilitation	XD3GD	WOS:000722598100001	34823545	gold, Green Published			2022-02-06	
J	Eagle, SR; Kontos, AP; Connaboy, C				Eagle, Shawn R.; Kontos, Anthony P.; Connaboy, Chris			Association of impulsivity, physical development, and mental health to perceptual-motor control after concussion in adolescents	EUROPEAN JOURNAL OF SPORT SCIENCE			English	Article; Early Access						Perceptual-motor control; perception-action coupling; sport-related concussion; adolescence; development	CHILDRENS UNINTENTIONAL INJURY; ANXIETY; RISK; AFFORDANCES; RELIABILITY; ABILITY	Sport-related concussion (SRC) can affect multiple domains including impairment in perceptual-motor control (PMC) in adolescents, potentially increasing subsequent injury risk. Research suggests that impulsivity, physical development, and mental health may be associated with PMC after SRC, but researchers have yet to examine this association. Adolescents (12-18y; n = 48) within 21 days of SRC were compared to 20 healthy adolescents with no concussion history using the Perception-Action Coupling Task (PACT), Barratt Impulsivity Scale (BIS), Pubertal Development Scale (PDS), Generalized Anxiety Disorder-7 (GAD-7) and Personal Health Questionnaire-9 (PHQ-9). All outcomes were entered as predictors in linear regression (LR) models to predict PACT outcomes (accuracy; initiation, movement, and reaction times). Concussed adolescents had lower PACT accuracy (p = 0.016), higher PHQ-9 (p = 0.029), total BIS (p = 0.004), attention impulsivity (p = 0.005), and cognitive instability impulsivity (p = 0.004). All four LRs were statistically significant (R-2 = 0.18-0.38; p < 0.05), and included 1 + impulsivity domains as significant predictors (p < 0.05). Cognitive instability impulsivity appeared in 3/4 models of PACT outcomes. ADD/ADHD history, anxiety, and physical development ratings were also significant predictors of PACT outcomes. This study revealed associations between PMC and medical history, impulsivity, physical development and mental health in adolescents following SRC. Future studies should investigate the temporal relationship among these variables in this at-risk population.	[Eagle, Shawn R.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthoped Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA 15203 USA; [Connaboy, Chris] Univ Pittsburgh, Dept Sports Med & Nutr, Pittsburgh, PA 15203 USA		Eagle, SR (corresponding author), Univ Pittsburgh, 3850 S Water St, Pittsburgh, PA 15203 USA.	seagle@pitt.edu	Connaboy, Christopher/AAH-4514-2020	Connaboy, Christopher/0000-0002-9031-2192	American College of Sports Medicine	This work was supported by American College of Sports Medicine: [Grant Number None].	Bideau B, 2010, IEEE COMPUT GRAPH, V30, P14, DOI 10.1109/MCG.2009.134; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Connaboy C, 2019, AEROSP MED HUM PERF, V90, P77, DOI 10.3357/AMHP.5190.2019; Cordovil R, 2015, NEW IDEAS PSYCHOL, V36, P50, DOI 10.1016/j.newideapsych.2014.10.007; Craig C., 2014, SPORTS TECHNOLOGY, V6, P161, DOI [10.1080/19346182.2013.855224, DOI 10.1080/19346182.2013.855224]; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; de Haan AM, 2018, J EXP CHILD PSYCHOL, V175, P48, DOI 10.1016/j.jecp.2018.05.002; Eagle SR, 2020, J SPORT SCI, V38, P1799, DOI 10.1080/02640414.2020.1756675; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Eagle SR, 2021, CLIN J SPORT MED, V31, P273, DOI 10.1097/JSM.0000000000000731; Ferneyhough E, 2013, COGNITION EMOTION, V27, P166, DOI 10.1080/02699931.2012.689953; Frijda NH, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00518; Fuhrmann D, 2015, TRENDS COGN SCI, V19, P558, DOI 10.1016/j.tics.2015.07.008; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gornall Alice, 2021, Br J Sports Med, V55, P1048, DOI 10.1136/bjsports-2020-103548; Graydon MM, 2012, COGNITION EMOTION, V26, P1301, DOI 10.1080/02699931.2012.667391; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Hare BD, 2020, MOL PSYCHIATR, V25, P2742, DOI 10.1038/s41380-020-0685-9; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Johnson CD, 2019, AEROSP MED HUM PERF, V90, P1000, DOI 10.3357/AMHP.5376.2019; Kriz PK, 2016, J PEDIATR-US, V171, P234, DOI 10.1016/j.jpeds.2015.12.006; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Lee GP, 2011, J ADOLESCENT HEALTH, V48, P164, DOI 10.1016/j.jadohealth.2010.06.002; Liebel SW, 2021, CURR PSYCHIAT REP, V23, DOI 10.1007/s11920-021-01232-0; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Moore RD, 2016, BRAIN IMAGING BEHAV, V10, P1108, DOI 10.1007/s11682-015-9473-6; O'Neal EE, 2018, J EXP PSYCHOL HUMAN, V44, P18, DOI 10.1037/xhp0000378; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Pijpers JR, 2006, ECOL PSYCHOL, V18, P131, DOI 10.1207/s15326969eco1803_1; Romer D, 2010, DEV PSYCHOBIOL, V52, P263, DOI 10.1002/dev.20442; Schmitz KE, 2004, J EARLY ADOLESCENCE, V24, P357, DOI 10.1177/0272431604268531; Schwebel DC, 2004, J PEDIATR PSYCHOL, V29, P93, DOI 10.1093/jpepsy/jsh013; Schwebel DC, 1999, CHILD DEV, V70, P700, DOI 10.1111/1467-8624.00050; Schwebel DC, 2004, AM J ORTHOPSYCHIAT, V74, P584, DOI 10.1037/0002-9432.74.4.584; Schwebel DC, 2004, PERS INDIV DIFFER, V37, P567, DOI 10.1016/j.paid.2003.09.027; Shirtcliff EA, 2009, CHILD DEV, V80, P327, DOI 10.1111/j.1467-8624.2009.01263.x; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Sydnor VJ, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2020.102190; Trofimova A, 2021, J NEUROIMAGING, V31, P277, DOI 10.1111/jon.12834; Watson G, 2011, HUM MOVEMENT SCI, V30, P942, DOI 10.1016/j.humov.2010.08.004; Whelan R, 2012, NAT NEUROSCI, V15, P920, DOI 10.1038/nn.3092	44	0	0	3	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1746-1391	1536-7290		EUR J SPORT SCI	Eur. J. Sport Sci.												10.1080/17461391.2021.2003869		NOV 2021	9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	XD9TN	WOS:000723042300001	34781850				2022-02-06	
J	Guo, YY; Xu, M; Shi, GZ; Zhang, JD				Guo, Yangyang; Xu, Ming; Shi, Guangzhi; Zhang, Jindong			A new strategy of enteral nutrition intervention for ICU patients targeting intestinal flora	MEDICINE			English	Article						enteral nutrition; gut microbiota; intensive care unit; microbial marker	GASTRIC RESIDUAL VOLUME; FEEDING-TUBE PLACEMENT; TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL; INTENSIVE-CARE; GUT MICROBIOME; INTOLERANCE; RISK; CHOLECYSTOKININ; PREVALENCE	Background: Enteral nutrition (EN) therapy is a routine supportive method for patients in the intensive care unit (ICU). However, the incidence of EN intolerance is prevalent, because most ICU patients suffer intestinal mucosal barrier damage and gastrointestinal motility disorder. There is no definite index to predict EN intolerance, and the current treatment methods are not effective in alleviating EN intolerance. Gut microbiota is an important component of the intestinal micro-ecological environment, and alterations in its structure and composition can reflect changes in intestinal function and microenvironment. The purpose of this study is to investigate the effect of EN on the gut microbiota of ICU patients by monitoring the dynamic alterations of gut microbiota and to screen out the microbial markers that can be used to predict the incidence of EN intolerance. Methods: One hundred ICU patients with trauma or in a period of acute stress after surgery will be enrolled, and their fecal samples will be collected at different timepoints for microbial sequencing and analysis. General clinical data (demographic information, surgical data, laboratory parameters, illness severity scores, and therapeutic drugs), nutritional status data (nutritional status assessment and nutrition therapy monitoring data), as well as clinical outcomes, will be recorded. The microbial and clinical data will be combined to analyze the baseline characteristics and dynamic alterations of gut microbiota along with the incidence of EN intolerance. Data related to the gut microbiota will be statistically analyzed by R software, and other data performed by SPSS23.0 software. Conclusions: The effect of EN on gut microbiota and microbial markers predicting the intolerance of EN will lead us to develop a new nutrition intervention strategy for ICU patients. Furthermore, the results of this study will provide a basis for the discovery of potential probiotics used for the prevention and treatment of EN intolerance.	[Guo, Yangyang; Xu, Ming; Shi, Guangzhi] Capital Med Univ, Beijing Tiantan Hosp, Intens Care Unit, Beijing, Peoples R China; [Zhang, Jindong] Peking Univ Third Hosp, Dept Gastroenterol, 49 North Garden Rd, Beijing 100191, Peoples R China		Zhang, JD (corresponding author), Peking Univ Third Hosp, Dept Gastroenterol, 49 North Garden Rd, Beijing 100191, Peoples R China.	zhangjd@bjmu.edu.cn			Beijing Tiantan Hospital Youth Fund [2018YQN-15]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82000510]	This work was supported by the Beijing Tiantan Hospital Youth Fund (2018YQN-15) and the National Natural Science Foundation of China (82000510).	Acosta-Escribano J, 2010, INTENS CARE MED, V36, P1532, DOI 10.1007/s00134-010-1908-3; Agudelo-Ochoa GM, 2020, GUT MICROBES, V12, DOI 10.1080/19490976.2019.1707610; Alberda C, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050539; Artinian V, 2006, CHEST, V129, P960, DOI 10.1378/chest.129.4.960; Barlow GM, 2015, NUTR CLIN PRACT, V30, P787, DOI 10.1177/0884533615609896; Baumler AJ, 2016, NATURE, V535, P85, DOI 10.1038/nature18849; Bochicchio GV, 2006, JPEN-PARENTER ENTER, V30, P503, DOI 10.1177/0148607106030006503; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Deane A, 2007, WORLD J GASTROENTERO, V13, P3909, DOI 10.3748/wjg.v13.i29.3909; Dickson RP, 2016, LANCET RESP MED, V4, P59, DOI 10.1016/S2213-2600(15)00427-0; Doig GS, 2011, INJURY, V42, P50, DOI 10.1016/j.injury.2010.06.008; Gungabissoon U, 2015, JPEN-PARENTER ENTER, V39, P441, DOI 10.1177/0148607114526450; Hang CH, 2004, WORLD J GASTROENTERO, V10, P875; Hernington-Gorse SJ, 2011, BURNS, V37, P277, DOI 10.1016/j.burns.2010.07.011; Hsu CW, 2011, WORLD J GASTROENTERO, V17, P2007, DOI 10.3748/wjg.v17.i15.2007; Inada T, 2004, ANESTH ANALG, V99, P1102, DOI 10.1213/01.ANE.0000130852.53082.D5; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Lankelma JM, 2017, INTENS CARE MED, V43, P59, DOI 10.1007/s00134-016-4613-z; Lavrentieva A, 2014, J BURN CARE RES, V35, P313, DOI 10.1097/BCR.0b013e3182a22403; Lessa FC, 2015, NEW ENGL J MED, V372, P2369, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Bassi GL, 2011, CURR OPIN CRIT CARE, V17, P57, DOI 10.1097/MCC.0b013e3283428b31; Marik PE, 2014, CRIT CARE MED, V42, P962, DOI 10.1097/CCM.0000000000000051; McClave SA, 2005, CRIT CARE MED, V33, P324, DOI 10.1097/01.CCM.0000153413.46627.3A; McDonald D, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00199-16; Montejo JC, 2010, INTENS CARE MED, V36, P1386, DOI 10.1007/s00134-010-1856-y; Nguyen N, 2007, INTENS CARE MED, V33, P2085, DOI 10.1007/s00134-007-0869-7; Nguyen NQ, 2007, CRIT CARE MED, V35, P82, DOI 10.1097/01.CCM.0000250317.10791.6C; Ojima M, 2016, DIGEST DIS SCI, V61, P1628, DOI 10.1007/s10620-015-4011-3; Pettigrew MM, 2019, CLIN INFECT DIS, V69, P604, DOI 10.1093/cid/ciy936; Pinto TF, 2012, BRAIN INJURY, V26, P1113, DOI 10.3109/02699052.2012.666369; Reitmeier S, 2020, CELL HOST MICROBE, V28, P258, DOI 10.1016/j.chom.2020.06.004; Ruppe E, 2018, INTENS CARE MED, V44, P1561, DOI 10.1007/s00134-018-5309-3; Singer P, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2415-8; Singer P, 2019, CLIN NUTR, V38, P48, DOI 10.1016/j.clnu.2018.08.037; Tang WB, 2020, GUT MICROBES, V11, DOI 10.1080/19490976.2020.1711685; Thor Piotr J, 2003, Med Sci Monit, V9, pCR392; Tremaroli V, 2015, CELL METAB, V22, P228, DOI 10.1016/j.cmet.2015.07.009; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Windle EM, 2010, J HUM NUTR DIET, V23, P61, DOI 10.1111/j.1365-277X.2009.01010.x; Wolff NS, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1999-8	40	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	NOV 24	2021	100	47							e27763	10.1097/MD.0000000000027763			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XW3NL	WOS:000735530200028	34964735	Green Published, gold			2022-02-06	
J	Kode, S; Hegde, A; Menon, GR				Kode, Sashanka; Hegde, Ajay; Menon, Girish R.			The Effect of Size of Decompressive Craniectomy on Outcome in Deep Spontaneous Intracerebral Hemorrhage	INDIAN JOURNAL OF NEUROSURGERY			English	Article; Early Access						decompressive craniectomy; spontaneous intracerebral hemorrhage; stroke; mRs; surgical outcome	TRAUMATIC BRAIN-INJURY; MANAGEMENT; SURGERY; MATTER; ICP	Introduction Spontaneous intracerebral hemorrhage (SICH) is one of the most devastating forms of stroke with a mortality of 30 to 40%. We aimed to evaluate the effect of craniotomy size and volume of decompression on surgical outcome, complications, mortality, and morbidity in patients with supratentorial capsuloganglionic bleeds who underwent a decompressive craniectomy (DC) at our institute. Materials and Methods It is a retrospective study done between January 2015 and December 2019. All patients with capsuloganglionic bleeds who had DC and hematoma evacuation were included in the study. Results A total of 55 patients underwent DC for SICH at our hospital during the study period. Mean anteroposterior (AP) diameter of the bone flap was 12.42 cm. The volume of decompression did not influence mortality and morbidity in our study but a larger AP diameter was associated with a higher incidence of hydrocephalus. A smaller craniectomy with an AP diameter of < 12 cm caused a lesser reduction in midline shift (MLS). Persistent postoperative MLS had a significant impact on mortality and its reduction was dependent on the size of craniectomy (p =-0.037) Conclusion DC with a recommended AP diameter of 12 to 13 cm achieves optimal results in terms of reduction in MLS. Larger DC volume carries a higher risk of hydrocephalus and requires close follow-up.	[Kode, Sashanka; Hegde, Ajay; Menon, Girish R.] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Neurosurg, Manipal, Karnataka, India; [Kode, Sashanka] Nizams Inst Neurosci, Dept Neurosurg, Hyderabad, Telangana, India; [Hegde, Ajay] NHS Greater Glasgow & Clyde, Inst Neurol Sci, Glasgow, Lanark, Scotland		Menon, GR (corresponding author), Kasturba Med Coll & Hosp, Dept Neurosurg, Manipal 576104, Karnataka, India.	girish.menon@manipal.edu	Hegde, Ajay/N-3334-2017	Hegde, Ajay/0000-0001-6970-2260			Bor-Seng-Shu E, 2013, NEUROSURG REV, V36, P361, DOI 10.1007/s10143-013-0453-2; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Dennis MS, 2003, CEREBROVASC DIS, V16, P9, DOI 10.1159/000069935; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; Hayes SB, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS12422; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kunze E, 1998, ACT NEUR S, V71, P16; Kurzbuch AR, 2015, NEUROSURG REV, V38, P629, DOI 10.1007/s10143-015-0626-2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Miller K, 2016, WORLD NEUROSURG, V95, P441, DOI 10.1016/j.wneu.2016.08.061; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Nagatani Kimihiro, 2013, Acta Neurochir Suppl, V118, P285, DOI 10.1007/978-3-7091-1434-6_55; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Qureshi Adnan I, 2014, J Vasc Interv Neurol, V7, P34; Tagliaferri F, 2012, ACTA NEUROCHIR, V154, P919, DOI 10.1007/s00701-012-1318-0; Tanrikulu L, 2015, CLIN NEUROL NEUROSUR, V135, P15, DOI 10.1016/j.clineuro.2015.04.019; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yao Z, 2018, WORLD NEUROSURG, V110, P121, DOI 10.1016/j.wneu.2017.10.167	21	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2277-954X	2277-9167		INDIAN J NEUROSURG	Indian J. Neurosurg.												10.1055/s-0041-1730102		NOV 2021	6	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	XC4SF	WOS:000722003700006		gold			2022-02-06	
J	Saalfield, J; Piersol, KL; Esopenko, C; Bates, ME; Weismiller, SA; Brostrand, K; Todaro, SM; Conway, FN; Wilde, EA; Buckman, JF				Saalfield, Jessica; Piersol, Kelsey L.; Esopenko, Carrie; Bates, Marsha E.; Weismiller, Scott A.; Brostrand, Kyle; Todaro, Sabrina M.; Conway, Fiona N.; Wilde, Elisabeth A.; Buckman, Jennifer F.			Digital neuropsychological test performance in a large sample of uninjured collegiate athletes	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Cognitive performance; computerized testing; normative data; sex differences; young adult	TRAUMATIC BRAIN-INJURY; TEST NORMATIVE DATA; PROCESSING SPEED; MODALITIES TEST; TRAIL; AGE; VALIDATION; VALIDITY; ADULTS	Digital neuropsychological test batteries are popular in college athletics; however, well-validated digital tests that are short and portable are needed to expand the feasibility of performing cognitive testing quickly, reliably, and outside standard clinical settings. This study assessed performance on digital versions of Trail Making Test (dTMT) and a modified Symbol Digit Modalities Test (dSDMT) in uninjured collegiate athletes (n = 537; 47% female) using the C3Logix baseline assessment module. Time to complete (dTMT) and the number of correct responses (dSDMT) were computed, transformed into z scores, and compared to age-matched normative data from analogous paper-and-pencil tests. Overall sample performance was compared to normative sample performance using Cohen's d. Sample averages on the dTMT, Part A, and dSDMT were similar to published norms; 97 and 92% of z scores fell within 2 standard deviations of normative means, respectively. The sample averaged faster completion times on dTMT, Part B than published norms, although 98% of z scores were within 2 standard deviations of the normative means. Brief, digitized tests may be useful in populations and testing environments when longer cognitive test batteries are impractical. Future studies should assess the ability of these tests to detect clinically relevant changes following a suspected head injury.	[Saalfield, Jessica; Piersol, Kelsey L.; Bates, Marsha E.; Conway, Fiona N.; Buckman, Jennifer F.] Rutgers State Univ, Dept Kinesiol & Hlth, New Brunswick, NJ 08901 USA; [Esopenko, Carrie] Rutgers Biomed & Hlth Sci, Sch Hlth Profess, Dept Rehabil & Movement Sci, New Brunswick, NJ USA; [Bates, Marsha E.; Weismiller, Scott A.; Todaro, Sabrina M.; Conway, Fiona N.; Buckman, Jennifer F.] Rutgers State Univ, Ctr Alcohol & Subst Use Studies, New Brunswick, NJ USA; [Brostrand, Kyle] Rutgers State Univ, Dept Athlet, New Brunswick, NJ USA; [Wilde, Elisabeth A.] Univ Utah, Sch Med, Dept Neurol, George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT USA; [Saalfield, Jessica] Penn State Univ Schuylkill, Dept Psychol, Schuylkill Haven, PA USA; [Weismiller, Scott A.] Penn State Hlth, Milton S Hersey Med Ctr, Dept Internal Med, Hershey, PA USA; [Brostrand, Kyle] Rutgers Sports Med, Robert Wood Johnson Barnabas Hlth, Piscataway, NJ USA; [Conway, Fiona N.] Univ Texas Austin, Steve Hicks Sch Social Work, Austin, TX 78712 USA		Buckman, JF (corresponding author), Rutgers State Univ, Dept Kinesiol & Hlth, New Brunswick, NJ 08901 USA.	jbuckman@rutgers.edu			NJ Commission on Brain Injury Research [NJCBIR13IRG028]; NIH/NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K02AA025123]; NIH Institutional Research and Academic Career Development Award (IRACDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12GM093854]; School of Health Professions, Rutgers Biomedical Health Sciences	This work was supported in part by the NJ Commission on Brain Injury Research under grant number NJCBIR13IRG028 to J.F.B.; NIH/NIAAA under grant number K02AA025123 to J.F.B.; an NIH Institutional Research and Academic Career Development Award (IRACDA) under grant number K12GM093854 to J.S.; and through intramural funding from the School of Health Professions, Rutgers Biomedical Health Sciences to C.E.	Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Bernstein JPK, 2019, APPL NEUROPSYCH-ADUL, V26, P275, DOI 10.1080/23279095.2017.1416471; Bezdicek O, 2012, ARCH CLIN NEUROPSYCH, V27, P906, DOI 10.1093/arclin/acs084; Borges A, 2017, INT J SPORTS PHYS TH, V12, P381; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; Feldstein SN, 1999, CLIN NEUROPSYCHOL, V13, P303, DOI 10.1076/clin.13.3.303.1744; Fellows RP, 2020, ARCH CLIN NEUROPSYCH, V35, P105, DOI 10.1093/arclin/acz020; Fellows RP, 2017, CLIN NEUROPSYCHOL, V31, P154, DOI 10.1080/13854046.2016.1238510; Ganguli M, 2011, ARCH NEUROL-CHICAGO, V68, P761, DOI 10.1001/archneurol.2011.101; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Higgins JPT, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184; Iverson GL, 2009, J CLIN EXP NEUROPSYC, V31, P594, DOI 10.1080/13803390802372125; Jorm AF, 2004, INTELLIGENCE, V32, P7, DOI 10.1016/j.intell.2003.08.001; Kiely KM, 2014, ARCH CLIN NEUROPSYCH, V29, P767, DOI 10.1093/arclin/acu055; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Makwana B, 2020, APPL NEUROPSYCH-ADUL, V27, P490, DOI 10.1080/23279095.2019.1570927; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merritt VC, 2017, ARCH CLIN NEUROPSYCH, V32, P168, DOI 10.1093/arclin/acw090; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Oliver J, 2015, J EXP NEUROSCI, V9, P67, DOI 10.4137/JEN.S27921; Owens AP, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.579934; Plotek W, 2014, MED SCI MONITOR, V20, P173, DOI 10.12659/MSM.889776; Poreh A., 2012, ARCH ASSESSMENT PSYC, V2, P57; Rao SM, 2017, MULT SCLER J, V23, P1929, DOI 10.1177/1352458516688955; Reitan R., 1995, HALSTEAD REITAN NEUR; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rudick RA, 2014, JOVE-J VIS EXP, DOI 10.3791/51318; SALTHOUSE TA, 1995, NEUROPSYCHOLOGY, V9, P518, DOI 10.1037/0894-4105.9.4.518; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Simon M, 2017, DEV NEUROPSYCHOL, V42, P446, DOI 10.1080/87565641.2017.1383994; Smith, 1973, SYMBOL DIGIT MODALIT; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Then FS, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-23; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tung LC, 2016, DISABIL REHABIL, V38, P1952, DOI 10.3109/09638288.2015.1111438; Woods DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124345; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013	39	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2021.2003365		NOV 2021	7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	XD2JT	WOS:000722536800001	34822256				2022-02-06	
J	Thanjavur, K; Hristopulos, DT; Babul, A; Yi, KM; Virji-Babul, N				Thanjavur, Karun; Hristopulos, Dionissios T.; Babul, Arif; Yi, Kwang Moo; Virji-Babul, Naznin			Deep Learning Recurrent Neural Network for Concussion Classification in Adolescents Using Raw Electroencephalography Signals: Toward a Minimal Number of Sensors	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						concussion; mild traumatic brain injury; resting state EEG; adolescents; machine learning; deep learning; LSTM; concussion classification	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; FEATURE-SELECTION; CONNECTIVITY	Artificial neural networks (ANNs) are showing increasing promise as decision support tools in medicine and particularly in neuroscience and neuroimaging. Recently, there has been increasing work on using neural networks to classify individuals with concussion using electroencephalography (EEG) data. However, to date the need for research grade equipment has limited the applications to clinical environments. We recently developed a deep learning long short-term memory (LSTM) based recurrent neural network to classify concussion using raw, resting state data using 64 EEG channels and achieved high accuracy in classifying concussion. Here, we report on our efforts to develop a clinically practical system using a minimal subset of EEG sensors. EEG data from 23 athletes who had suffered a sport-related concussion and 35 non-concussed, control athletes were used for this study. We tested and ranked each of the original 64 channels based on its contribution toward the concussion classification performed by the original LSTM network. The top scoring channels were used to train and test a network with the same architecture as the previously trained network. We found that with only six of the top scoring channels the classifier identified concussions with an accuracy of 94%. These results show that it is possible to classify concussion using raw, resting state data from a small number of EEG sensors, constituting a first step toward developing portable, easy to use EEG systems that can be used in a clinical setting.	[Thanjavur, Karun; Babul, Arif] Univ Victoria, Dept Phys & Astron, Victoria, BC, Canada; [Hristopulos, Dionissios T.] Tech Univ Crete, Sch Elect & Comp Engn, Khania, Greece; [Yi, Kwang Moo] Univ British Columbia, Dept Comp Sci, Vancouver, BC, Canada; [Virji-Babul, Naznin] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Virji-Babul, Naznin] Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada		Virji-Babul, N (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada.; Virji-Babul, N (corresponding author), Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada.	nvb31@mail.ubc.ca					Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Boshra R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53751-9; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Cao C, 2011, CLIN NEUROPHYSIOL, V122, P1314, DOI 10.1016/j.clinph.2010.12.042; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Churchill NW, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00558; Churchill NW, 2019, NEUROLOGY, V93, pE1980, DOI 10.1212/WNL.0000000000008523; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Conley AC, 2019, J NEUROTRAUM, V36, P1, DOI 10.1089/neu.2018.5761; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Hristopulos DT, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00419; Jacquin A, 2018, COMPUT BIOL MED, V102, P95, DOI 10.1016/j.compbiomed.2018.09.011; Kaplan AY, 2005, SIGNAL PROCESS, V85, P2190, DOI 10.1016/j.sigpro.2005.07.010; Klonowski Wlodzimierz, 2009, Nonlinear Biomed Phys, V3, P2, DOI 10.1186/1753-4631-3-2; Krawczuk J, 2016, ARTIF INTELL MED, V66, P63, DOI 10.1016/j.artmed.2015.11.001; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moctezuma LA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72051-1; Munia TTK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17414-x; Munson NA, 2009, LECT NOTES ARTIF INT, V5782, P144; Murdaugh DL, 2018, J INT NEUROPSYCH SOC, V24, P781, DOI 10.1017/S1355617718000413; Neumann U, 2016, BIODATA MIN, V9, DOI 10.1186/s13040-016-0114-4; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; Safar K, 2021, BRAIN COMMUN, V3, DOI 10.1093/braincomms/fcab044; Sahiner B, 2000, MED PHYS, V27, P1509, DOI 10.1118/1.599017; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schmidt JD, 2018, PEDIATR NEUROL, V81, P19, DOI 10.1016/j.pediatrneurol.2017.12.017; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Smialowski P, 2010, BIOINFORMATICS, V26, P440, DOI 10.1093/bioinformatics/btp621; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Wickramaratne SD, 2020, IEEE ICC; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664	39	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	NOV 24	2021	15								734501	10.3389/fnhum.2021.734501			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	YA4PM	WOS:000738317100001	34899212	gold, Green Published			2022-02-06	
J	Wiseman-Hakes, C; Foster, E; Langer, L; Chandra, T; Bayley, M; Comper, P				Wiseman-Hakes, Catherine; Foster, Evan; Langer, Laura; Chandra, Tharshini; Bayley, Mark; Comper, Paul			Characterizing Sleep and Wakefulness in the Acute Phase of Concussion in the General Population: A Naturalistic Cohort from the Toronto Concussion Study	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						acute concussion; mild TBI; sex; sleep; sleep disturbance; wakefulness	TRAUMATIC BRAIN-INJURY; PAIN; DISORDERS; DISTURBANCES; METABOLISM; COMPLAINTS; CLEARANCE; RISK; NEED	Growing literature links concussion to changes in sleep and wakefulness in humans and in rodent models. Sleep has been linked with synaptic reorganization under other conditions; however, the characterization and role of sleep after acute concussion remains poorly understood. While much research has focused on insomnia among patients with chronic or persistent concussion symptoms, there is limited understanding of sleep and acute concussion, its potential role in recovery, and associated risk factors for the development of chronic sleep disturbance. Studies to date are limited by small sample sizes of primarily athlete or military populations. Additional studies among the general population are critical to inform best practice guidelines.We examined the sleep and daytime wakefulness of 472 adults from a naturalistic general population cohort (mean age, 33.3 years, females = 60.8%) within seven days of diagnosed concussion, using a validated, condition-specific measure, the Sleep and Concussion Questionnaire. Participants identified immediate changes in sleep characterized by hypersomnia and difficulty maintaining daytime wakefulness; 35% considered these changes as moderate to severe and 79% required monitoring or follow-up. Females experienced significantly greater severity of changes in sleep compared with males. Positive correlations between severity of sleep and pain and headache were identified. Differences by sex are an important consideration for early intervention and long-term monitoring. Because sleep was compromised by pain, pain management is also an integral part of early intervention. Our findings suggest that assessment of sleep beginning in the acute stage is a critical component of concussion management in the general population.	[Wiseman-Hakes, Catherine; Foster, Evan; Langer, Laura; Chandra, Tharshini; Bayley, Mark; Comper, Paul] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Wiseman-Hakes, Catherine] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Foster, Evan] Univ Toronto, Translat Res Program, Toronto, ON, Canada; [Bayley, Mark] Univ Toronto, Physiatry, Toronto, ON, Canada; [Comper, Paul] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada		Wiseman-Hakes, C (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Hull Ellis Concuss & Res Clin, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	Wisemc1@mcmaster.ca		Wiseman-Hakes, Catherine/0000-0001-8441-884X; Langer, Laura/0000-0003-4408-355X	Toronto Rehabilitation Institute Foundation	This work was funded by the generous support of the Toronto Rehabilitation Institute Foundation	Alvaro PK, 2013, SLEEP, V36, P1059, DOI 10.5665/sleep.2810; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Chan LG, 2015, J HEAD TRAUMA REHAB, V30, pE67, DOI 10.1097/HTR.0000000000000119; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Dubiel R, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00520; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Edwards KA, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01760-x; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Holland Bloorview Kids Rehabilitation Hospital, 2017, CONC YOU HDB PAR KID; Kalmbach DA, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy147; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Kostyun Regina, 2015, Conn Med, V79, P161; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Leng Y, 2021, NEUROLOGY, V96, pE1792, DOI 10.1212/WNL.0000000000011656; Ludwig R, 2020, PM&R, V12, P500, DOI 10.1002/pmrj.12309; Maerlender A., 2020, SPORTS MED HLTH SCI, V2, P109; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKeon AB, 2019, NEUROREHABILITATION, V45, P163, DOI 10.3233/NRE-192804; Mendelsohn AR, 2013, REJUV RES, V16, P518, DOI 10.1089/rej.2013.1530; Murdaugh DL, 2018, ARCH PHYS MED REHAB, V99, P960, DOI 10.1016/j.apmr.2018.01.005; Paredes I, 2021, NEUROCIRUGIA, V32, P178, DOI [10.1016/j.neucir.2020.09.001, 10.1016/j.neucie.2020.12.001]; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Petit JM, 2015, METAB BRAIN DIS, V30, P263, DOI 10.1007/s11011-014-9629-x; Prolo P., 2007, NEUROIMMUNOLOGY SLEE, P285; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Rogers NL, 2003, FRONT BIOSCI-LANDMRK, V8, pS1056, DOI 10.2741/1174; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Sufrinko AM, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000387; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Suzuki Y, 2017, SLEEP MED, V33, P36, DOI 10.1016/j.sleep.2016.06.033; Tkachenko N, 2016, PEDIATR NEUROL, V57, P46, DOI 10.1016/j.pediatrneurol.2015.12.019; Toccalino D, 2021, BRAIN INJURY, V35, P743, DOI 10.1080/02699052.2021.1906949; VanCauter E, 1996, J PEDIATR-US, V128, pS32, DOI 10.1016/S0022-3476(96)70008-2; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Wiseman-Hakes C, 2019, ASN NEURO, V11, DOI 10.1177/1759091418822405; Wiseman-Hakes C, 2017, BRAIN INJURY, V31, P887; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zhou Y, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8120223	47	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2021.0295		NOV 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XB9II	WOS:000721634000001	34714132				2022-02-06	
J	Ferrel, MN; Iriana, S; Thomason, IR; Ma, CL; Tsarova, K; Wilson, BD; McKellar, SH; Ryan, JJ				Ferrel, Meganne N.; Iriana, Sentia; Thomason, I. Raymond; Ma, Christy L.; Tsarova, Katsiaryna; Wilson, Brent D.; McKellar, Stephen H.; Ryan, John J.			Constrictive pericarditis in the setting of repeated chest trauma in a mixed martial arts fighter	BMC CARDIOVASCULAR DISORDERS			English	Article						Case report; Constrictive; Diastolic heart failure; Hemodynamics; Imaging		Background Constrictive pericarditis (CP) is characterized by scarring and loss of elasticity of the pericardium. This case demonstrates that mixed martial arts (MMA) is a previously unrecognized risk factor for CP, diagnosis of which is supported by cardiac imaging, right and left heart catheterization, and histological findings of dense fibrous tissue without chronic inflammation. Case presentation A 47-year-old Caucasian male former mixed martial arts (MMA) fighter from the Western United States presented to liver clinic for elevated liver injury tests (LIT) and a 35-pound weight loss with associated diarrhea, lower extremity edema, dyspnea on exertion, and worsening fatigue over a period of 6 months. Past medical history includes concussion, right bundle branch block, migraine headache, hypertension, chronic pain related to musculoskeletal injuries and fractures secondary to MMA competition. Involvement in MMA was extensive with an 8-year history of professional MMA competition and 13-year history of MMA fighting with recurrent trauma to the chest wall. The patient also reported a 20-year history of performance enhancing drugs including testosterone. Physical exam was notable for elevated jugular venous pressure, hepatomegaly, and trace peripheral edema. An extensive workup was performed including laboratory studies, abdominal computerized tomography, liver biopsy, echocardiogram, and cardiac magnetic resonance imaging. Finally, right and left heart catheterization-the gold standard-confirmed discordance of the right ventricle-left ventricle, consistent with constrictive physiology. Pericardiectomy was performed with histologic evidence of chronic pericarditis. The patient's hospital course was uncomplicated and he returned to NYHA functional class I. Conclusions CP can be a sequela of recurrent pericarditis or hemorrhagic effusions and may have a delayed presentation. In cases of recurrent trauma, CP may be managed with pericardiectomy with apparent good outcome. Further studies are warranted to analyze the occurrence of CP in MMA so as to better define the risk in such adults.	[Ferrel, Meganne N.] Univ Utah, Sch Med, Salt Lake City, UT 84132 USA; [Iriana, Sentia; Thomason, I. Raymond] Univ Utah, Dept Med, Div Gastroenterol, Salt Lake City, UT 84132 USA; [Ma, Christy L.; Tsarova, Katsiaryna; Wilson, Brent D.; Ryan, John J.] Univ Utah Hlth, Dept Med, Div Cardiovasc Med, 30 North 1900 East,Room 4A100, Salt Lake City, UT 84132 USA; [McKellar, Stephen H.] Univ Utah, Dept Surg, Div Cardiothorac Surg, Salt Lake City, UT 84132 USA		Ryan, JJ (corresponding author), Univ Utah Hlth, Dept Med, Div Cardiovasc Med, 30 North 1900 East,Room 4A100, Salt Lake City, UT 84132 USA.	john.ryan@hsc.utah.edu			Gordon Family	Dr. Ryan and his research team are supported by the Gordon Family.	Anderson Eric M, 2011, J Med Case Rep, V5, P76, DOI 10.1186/1752-1947-5-76; Bledsoe GH, 2006, J SPORT SCI MED, V5, P136; Busch C, 2015, EUR J CARDIO-THORAC, V48, pE110, DOI 10.1093/ejcts/ezv322; GOLDSTEIN S, 1965, AM HEART J, V69, P544, DOI 10.1016/0002-8703(65)90426-6; Grimes JM, 2003, HORM BEHAV, V44, P271, DOI 10.1016/S0018-506X(03)00138-7; Ling LH, 2009, J AM COLL CARDIOL, V53, pA176; Miranda WR, 2017, PROG CARDIOVASC DIS, V59, P369, DOI 10.1016/j.pcad.2016.12.008; Momaya A, 2015, SPORTS MED, V45, P517, DOI 10.1007/s40279-015-0308-9; Nishimura RA, 2001, HEART, V86, P619, DOI 10.1136/heart.86.6.619; OH JK, 1994, J AM COLL CARDIOL, V23, P154, DOI 10.1016/0735-1097(94)90514-2; Ooi A, 2003, EUR J CARDIO-THORAC, V24, P1043, DOI 10.1016/S1010-7940(03)00579-7; Syed FF, 2014, NAT REV CARDIOL, V11, P530, DOI 10.1038/nrcardio.2014.100	12	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2261			BMC CARDIOVASC DISOR	BMC Cardiovasc. Disord.	NOV 22	2021	21	1							561	10.1186/s12872-021-02378-8			6	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XC4EC	WOS:000721967000001	34809565	Green Published, gold			2022-02-06	
J	Frondelli, MJ; Mather, ML; Levison, SW				Frondelli, Michelle J.; Mather, Marie L.; Levison, Steven W.			Oligodendrocyte progenitor proliferation is disinhibited following traumatic brain injury in leukemia inhibitory factor heterozygous mice	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						cell proliferation; cytokines; gliogenesis; neurotrauma; regenerative medicine; RRID:AB_10366688; RRID: AB_10854564; RRID: AB_10926202; RRID:AB_1500674; RRID:AB_1953269; RRID:AB_2099233; RRID:AB_ 2315049; RRID:AB_2340667; RRID:AB_2340696; RRID:AB_2340854; RRID:AB_2492289; RRID:AB_2539705; RRID:AB_2733473; RRID: AB_2734873; RRID:AB_2751913; RRID: AB_329827; RRID:AB_331355; RRID: AB_443209; RRID:AB_570666; RRID:AB_916156; RRID:AB_91789	NEURAL STEM-CELL; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; RECEPTOR-BETA; NEURONS; DEMYELINATION; EXPRESSION; MATURATION; GENERATION; MIGRATION	Traumatic brain injury (TBI) is a significant problem that affects over 800,000 children each year. As cell proliferation is disturbed by injury and required for normal brain development, we investigated how a pediatric closed head injury (CHI) would affect the progenitors of the subventricular zone (SVZ). Additionally, we evaluated the contribution of leukemia inhibitory factor (LIF) using germline LIF heterozygous mice (LIF Het), as LIF is an injury-induced cytokine, known to influence neurogenesis and gliogenesis. CHIs were performed on P20 LIF Het and wild-type (WT) mice. Ki-67 immunostaining and stereology revealed that cell proliferation increased similar to 250% in injured LIF Het mice compared to the 30% increase observed in injured WT mice at 48-hr post-CHI. OLIG2+ cell proliferation increased in the SVZ and white matter of LIF Het injured mice at 48-hr recovery. Using an 8-color flow cytometry panel, the proliferation of three distinct multipotential progenitors and early oligodendrocyte progenitor cell proliferation was significantly increased in LIF Het injured mice compared to WT injured mice. Supporting its cytostatic function, LIF decreased neurosphere progenitor and oligodendrocyte progenitor cell proliferation compared to controls. In highly enriched mouse oligodendrocyte progenitor cell cultures, LIF increased phospho-protein kinase B after 20 min and increased phospho-S6 ribosomal protein at 20 and 40 min of exposure, which are downstream targets of the mammalian target of rapamycin pathway. Altogether, our data provide new insights into the regulatory role of LIF in suppressing neural progenitor cell proliferation and, in particular, oligodendrocyte progenitor cell proliferation after a mild TBI.	[Frondelli, Michelle J.; Mather, Marie L.; Levison, Steven W.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, 205 South Orange Ave, Newark, NJ 07103 USA		Levison, SW (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, 205 South Orange Ave, Newark, NJ 07103 USA.	levisosw@njms.rutgers.edu			New Jersey Commission on Brain Injury Research [CBIR19Felo14, CBIR13IRG0170]	New Jersey Commission on Brain Injury Research, Grant/Award Number: CBIR19Felo14 and CBIR13IRG0170	Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006; Brazel CY, 2003, PROG NEUROBIOL, V69, P49, DOI 10.1016/S0301-0082(03)00002-9; Buono KD, 2015, J NEUROSCI, V35, P8855, DOI 10.1523/JNEUROSCI.2868-12.2015; Buono KD, 2012, DEV NEUROSCI-BASEL, V34, P449, DOI 10.1159/000345155; Butzkueven H, 2006, GLIA, V53, P696, DOI 10.1002/glia.20321; Covey MV, 2010, DEV NEUROSCI-BASEL, V32, P488, DOI 10.1159/000321607; Deverman BE, 2012, J NEUROSCI, V32, P2100, DOI 10.1523/JNEUROSCI.3803-11.2012; Faiz M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-26; Felling RJ, 2006, J NEUROSCI, V26, P4359, DOI 10.1523/JNEUROSCI.1898-05.2006; Felling RJ, 2016, J NEUROSCI RES, V94, P1531, DOI 10.1002/jnr.23929; Frondelli MJ, 2021, NEUROTRAUMA REP, V2, P285, DOI 10.1089/neur.2020.0063; Goodus MT, 2016, J NEUROTRAUM, V33, P1522, DOI 10.1089/neu.2015.4234; Goodus MT, 2015, DEV NEUROSCI-BASEL, V37, P29, DOI 10.1159/000367784; Gresle MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047379; Inamura N, 2011, DEV NEUROSCI-BASEL, V33, P118, DOI 10.1159/000328974; Jinnou H, 2018, CELL STEM CELL, V22, P128, DOI 10.1016/j.stem.2017.11.005; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kerr BJ, 2005, GLIA, V51, P73, DOI 10.1002/glia.20177; Levison S.W., 2021, BIORXIV2021427261; Lin J, 2020, EXP NEUROL, V330, DOI 10.1016/j.expneurol.2020.113324; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Marriott MP, 2008, GLIA, V56, P686, DOI 10.1002/glia.20646; MAYER M, 1994, DEVELOPMENT, V120, P143; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Niimi Y, 2018, PEDIATR RES, V83, P385, DOI 10.1038/pr.2017.261; Ong J, 2005, PEDIATR RES, V58, P600, DOI 10.1203/01.PDR.0000179381.86809.02; Ornelas IM, 2020, GLIA, V68, P1274, DOI 10.1002/glia.23776; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Plane JM, 2004, NEUROBIOL DIS, V16, P585, DOI 10.1016/j.nbd.2004.04.003; Poulton IJ, 2012, J BONE MINER RES, V27, P586, DOI 10.1002/jbmr.1485; Prusac, 2015, NEURAL SURFACE ANTIG, P175; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rittchen S, 2015, BIOMATERIALS, V56, P78, DOI 10.1016/j.biomaterials.2015.03.044; Rowitch DH, 2002, TRENDS NEUROSCI, V25, P417, DOI 10.1016/S0166-2236(02)02201-4; Ryskalin L, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7082696; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Soilu-Hanninen M, 2010, ACTA NEUROL SCAND, V121, P44, DOI 10.1111/j.1600-0404.2009.01179.x; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Turnley AM, 2000, J NEUROCHEM, V74, P889, DOI 10.1046/j.1471-4159.2000.0740889.x; Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009; Vanderlocht J, 2006, J NEUROSCI RES, V83, P763, DOI 10.1002/jnr.20781; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wheeler NA, 2016, EXP NEUROL, V283, P512, DOI 10.1016/j.expneurol.2016.03.019; Wood T.L., 2020, SUBVENTRICULAR ZONE; Wood TL, 2013, ASN NEURO, V5, P63, DOI 10.1042/AN20120092	50	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	FEB	2022	100	2					578	597		10.1002/jnr.24984		NOV 2021	20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YI0XA	WOS:000721044900001	34811802				2022-02-06	
J	Morel, Y; Hegdekar, N; Sarkar, C; Lipinski, MM; Kane, MA; Jones, JW				Morel, Yulemni; Hegdekar, Nivedita; Sarkar, Chinmoy; Lipinski, Marta M.; Kane, Maureen A.; Jones, Jace W.			Structure-specific, accurate quantitation of plasmalogen glycerophosphoethanolamine	ANALYTICA CHIMICA ACTA			English	Article						Plasmalogen; Glycerophosphoethanolamine; Accurate quantitation; Liquid chromatography tandem mass&nbsp; spectrometry; Traumatic brain injury	MASS-SPECTROMETRY; DEFICIENCY; ETHER	Changes in plasmalogen glycerophosphoethanolamine (PE-P) composition (structure and abundance) are a key indicator of altered lipid metabolism. Differential changes in the levels of PE-P have been reported in different disease states, including neurodegenerative diseases. Of particular interest, traumatic brain injury (TBI) has resulted in altered expression of glycerophospholipid profiles, including PE-P. To date, most analytical assays assessing PE-P have focused on general lipidomic workflows to evaluate the relative, semi-quantitative abundance of PE-P during disease progression. This approach provides a broad evaluation of PE-P, yet often lacks specificity and sensitivity for individual PE-P structures which is a necessity for robust quantitative data. The present study highlights the development of a targeted, quantitative method using a HILIC separation and selective reaction monitoring mass spectrometry for the confident identification and accurate quantitation of PE-P. Our innovative method incorporates both the sn-1 alkyl vinyl ether and sn-2 acyl chain as product ion transitions, for specific and sensitive quantitation of 100 PE-P structures. Our method also uniquely allowed for the unambiguous assignment and quantitation of di-unsaturated sn-1 PE-P structures, which to date have not been conclusively quantified. Application of this assay to a TBI mouse model resulted in distinct temporal profiles for plasma PE-P up to 28 days post injury. Plasma PE-P were significantly increased 24 h after induced TBI, followed by a gradual reduction to sham concentrations by day 28. Overall, we established a structure specific, quantitative assay for identification and quantitation of a comprehensive set of PE-P structures with demonstrated relevance to brain injury. (c) 2021 Elsevier B.V. All rights reserved.	[Morel, Yulemni; Kane, Maureen A.; Jones, Jace W.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 N Pine St,Room N721, Baltimore, MD 21201 USA; [Hegdekar, Nivedita; Sarkar, Chinmoy; Lipinski, Marta M.] Univ Maryland, Sch Med, Dept Anesthesiol, Shock Trauma & Anesthesiol Res STAR Ctr, Baltimore, MD 21201 USA; [Lipinski, Marta M.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA		Jones, JW (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 N Pine St,Room N721, Baltimore, MD 21201 USA.	jjones@rx.umaryland.edu			University of Maryland School of Pharmacy Faculty; Federal Drug Administration (FDA) Center of Excellence in Regulatory Science and Innovation (CERSI) Award [3U01FD005946-03S3]; Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS)United States Department of Health & Human Services [U01FD0 05946]; FDA/HHS; Chemistry/Biology Interface (CBI) NIGMS/NIH [T32 GM066706]; University of Maryland School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]	The authors acknowledge the University of Maryland School of Pharmacy Faculty Start-up funds (JWJ) , Federal Drug Administration (FDA) Center of Excellence in Regulatory Science and Innovation (CERSI) Award 3U01FD005946-03S3 (MAK, MML, CS, JWJ) . This publication was supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award U01FD0 05946 totaling $150,000 with 2% percentage and $1000 funded by FDA/HHS and 98% percentage and $49,000 funded by non-government source (s) . The contents are those of the author (s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government. YM was partially supported by the Chemistry/Biology Interface (CBI) NIGMS/NIH T32 GM066706. Additional support was provided by the University of Maryland School of Pharmacy Mass Spectrometry Center (SOP1841-IQB2014) .	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Dean JM, 2018, PROTEIN CELL, V9, P196, DOI 10.1007/s13238-017-0423-5; Domingues MRM, 2008, CHEM PHYS LIPIDS, V156, P1, DOI 10.1016/j.chemphyslip.2008.07.003; Emmerich T, 2017, NEUROMOL MED, V19, P122, DOI 10.1007/s12017-016-8436-4; F.D. Administration, 2018, GUID IND BIOAN METH; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Farooqui AA, 1997, NEUROCHEM RES, V22, P523, DOI 10.1023/A:1027380331807; Farooqui AA, 2001, J MOL NEUROSCI, V16, P263, DOI 10.1385/JMN:16:2-3:263; Fernandes AMAP, 2020, METABOLITES, V10, DOI 10.3390/metabo10060262; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Han XL, 1996, J AM CHEM SOC, V118, P451, DOI 10.1021/ja952326r; Harayama T, 2018, NAT REV MOL CELL BIO, V19, P281, DOI 10.1038/nrm.2017.138; Hogan SR, 2018, J PROTEOME RES, V17, P2131, DOI 10.1021/acs.jproteome.8b00068; Honsho M, 2017, FEBS LETT, V591, P2720, DOI 10.1002/1873-3468.12743; Jones JW, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800297; Koivusalo M, 2001, J LIPID RES, V42, P663; Lange M, 2020, ANAL BIOANAL CHEM, V412, P3573, DOI 10.1007/s00216-020-02576-x; Lessig J, 2009, CURR MED CHEM, V16, P2021; Li Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1764-1; Lopez-Bascon MA, 2020, ANAL BIOANAL CHEM, V412, P489, DOI 10.1007/s00216-019-02261-8; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Ojo JO, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00103; Otoki Y, 2017, J PHARMACEUT BIOMED, V134, P77, DOI 10.1016/j.jpba.2016.11.019; Paul S, 2019, PROG LIPID RES, V74, P186, DOI 10.1016/j.plipres.2019.04.003; Peng B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15960-z; Sarkar C, 2020, AUTOPHAGY, V16, P466, DOI 10.1080/15548627.2019.1628538; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Pham TH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41556-9; WAGNER BA, 1994, BIOCHEMISTRY-US, V33, P4449, DOI 10.1021/bi00181a003; Wang J, 2021, FOOD CHEM, V334, DOI 10.1016/j.foodchem.2020.127558; Wang M, 2017, MASS SPECTROM REV, V36, P693, DOI 10.1002/mas.21492; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u	35	0	0	9	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0003-2670	1873-4324		ANAL CHIM ACTA	Anal. Chim. Acta	NOV 22	2021	1186								339088	10.1016/j.aca.2021.339088			10	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	WQ2QX	WOS:000713666000006	34756256				2022-02-06	
J	Netzley, AH; Hunt, RD; Franco-Arellano, J; Arnold, N; Vazquez, AI; Munoz, KA; Colbath, AC; Bush, TR; Pelled, G				Netzley, Alesa H.; Hunt, Ryan D.; Franco-Arellano, Josue; Arnold, Nicole; Vazquez, Ana I.; Munoz, Kirk A.; Colbath, Aimee C.; Bush, Tamara Reid; Pelled, Galit			Multimodal characterization of Yucatan minipig behavior and physiology through maturation	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; LARGE ANIMAL-MODELS; SUS-SCROFA; SLEEP DISTURBANCES; OPEN-FIELD; SWINE; PIGS; CHILDREN; EMOTIONALITY; CYCLOSPORINE	Brain injuries induced by external forces are particularly challenging to model experimentally. In recent decades, the domestic pig has been gaining popularity as a highly relevant animal model to address the pathophysiological mechanisms and the biomechanics associated with head injuries. Understanding cognitive, motor, and sensory aspects of pig behavior throughout development is crucial for evaluating cognitive and motor deficits after injury. We have developed a comprehensive battery of tests to characterize the behavior and physiological function of the Yucatan minipig throughout maturation. Behavioral testing included assessments of learning and memory, executive functions, circadian rhythms, gait analysis, and level of motor activity. We applied traditional behavioral apparatus and analysis methods, as well as state-of-the-art sensor technologies to report on motion and activity, and artificial intelligent approaches to analyze behavior. We studied pigs from 16 weeks old through sexual maturity at 35 weeks old. The results show multidimensional characterization of minipig behavior, and how it develops and changes with age. This animal model may capitulate the biomechanical consideration and phenotype of head injuries in the developing brain and can drive forward the field of understanding pathophysiological mechanisms and developing new therapies to accelerate recovery in children who have suffered head trauma.	[Netzley, Alesa H.; Hunt, Ryan D.; Franco-Arellano, Josue; Pelled, Galit] Michigan State Univ, Dept Biomed Engn, E Lansing, MI 48824 USA; [Netzley, Alesa H.; Hunt, Ryan D.; Franco-Arellano, Josue; Pelled, Galit] Michigan State Univ, Inst Quantitat Hlth Sci & Engn, Neuroengn Div, E Lansing, MI 48824 USA; [Pelled, Galit] Michigan State Univ, Dept Radiol, E Lansing, MI 48824 USA; [Munoz, Kirk A.] Michigan State Univ, Michigan State Univ Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Colbath, Aimee C.] Michigan State Univ, Coll Vet Med, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Arnold, Nicole; Bush, Tamara Reid] Michigan State Univ, Dept Mech Engn, E Lansing, MI 48824 USA; [Vazquez, Ana I.] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA		Pelled, G (corresponding author), Michigan State Univ, Dept Biomed Engn, E Lansing, MI 48824 USA.; Pelled, G (corresponding author), Michigan State Univ, Inst Quantitat Hlth Sci & Engn, Neuroengn Div, E Lansing, MI 48824 USA.; Pelled, G (corresponding author), Michigan State Univ, Dept Radiol, E Lansing, MI 48824 USA.	pelledga@msu.edu		Netzley, Alesa/0000-0003-0171-3363	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS072171, R01NS098231, UF1NS115817]	G.P. is partially supported by National Institutes of Health grants R01NS072171, R01NS098231 and UF1NS115817.	Antonides A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00043; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Baker EW, 2019, J NEUROTRAUM, V36, P61, DOI 10.1089/neu.2017.5551; Barshikar S, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0792-4; BEILHARZ RG, 1967, ANIM BEHAV, V15, P117, DOI 10.1016/S0003-3472(67)80021-6; Bhatti Z, 2017, BAHRIA U J INF COMMU, V10; Boettcher AN, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00009; BOISSY A, 1990, APPL ANIM BEHAV SCI, V25, P149, DOI 10.1016/0168-1591(90)90077-Q; BREAZILE JE, 1966, AM J VET RES, V27, P1369; BUSTAD LK, 1966, SCIENCE, V152, P1526, DOI 10.1126/science.152.3728.1526; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; CRANER SL, 1991, J COMP NEUROL, V306, P24, DOI 10.1002/cne.903060103; Cywiak C, 2020, BRAIN STIMUL, V13, P1774, DOI 10.1016/j.brs.2020.10.006; Dai JX, 2018, INT J NEUROSCI, V128, P243, DOI 10.1080/00207454.2017.1380008; Davison AN., 1977, BIOCHEMICAL CORRELAT; Dawson HD, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4009-7; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Donald RD, 2011, PHYSIOL BEHAV, V104, P906, DOI 10.1016/j.physbeh.2011.05.031; Douglas WR., 1972, SPACE LIFE SCI, V3, P226; Dupjan S, 2013, J VET BEHAV, V8, P485, DOI 10.1016/j.jveb.2013.05.007; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Fairbairn L, 2011, J LEUKOCYTE BIOL, V89, P855, DOI 10.1189/jlb.1110607; Fang MR, 2005, NEUROSIGNALS, V14, P102, DOI 10.1159/000086292; Finnie JW, 2012, AUST VET J, V90, P301, DOI 10.1111/j.1751-0813.2012.00955.x; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; Gieling E, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-4; Gieling ET, 2011, CURR TOP BEHAV NEURO, V7, P359, DOI 10.1007/7854_2010_112; Gieling ET, 2011, ANIM COGN, V14, P151, DOI 10.1007/s10071-010-0364-3; Glud AN, 2011, ACTA NEUROBIOL EXP, V71, P508; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; Haigh A, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00607; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; HUGHES HC, 1986, LAB ANIM SCI, V36, P348; Hunt RD, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248141; Karlsson M, 2019, J NEUROTRAUM, V36, P14, DOI 10.1089/neu.2018.5706; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kochanek PM, 2017, CHILD NERV SYST, V33, P1693, DOI 10.1007/s00381-017-3474-2; Kornum BR, 2011, NEUROSCI BIOBEHAV R, V35, P437, DOI 10.1016/j.neubiorev.2010.05.004; Kornum BR, 2007, BEHAV BRAIN RES, V181, P210, DOI 10.1016/j.bbr.2007.04.007; Labots M, 2015, JOVE-J VIS EXP, DOI 10.3791/52529; LANDY JJ, 1961, JAMA-J AM MED ASSOC, V178, P1084, DOI 10.1001/jama.1961.73040500001005; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lu HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep14769; Luther M, 2020, SLEEP, V43, DOI 10.1093/sleep/zsaa083; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Margulies SS, 2015, BRAIN PATHOL, V25, P289, DOI 10.1111/bpa.12247; Marino L., 2015, INT J COMP PSYCHOL, V28, P238, DOI 10.46867/ijcp.2015.28.00.04; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; PHILLIPS RW, 1982, DIABETES, V31, P30, DOI 10.2337/diab.31.1.S30; Rutherford KMD, 2012, APPL ANIM BEHAV SCI, V139, P218, DOI 10.1016/j.applanim.2012.04.004; Schlinger HD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00210; SCHNEIDER NR, 1977, TOXICOL APPL PHARM, V39, P531, DOI 10.1016/0041-008X(77)90144-2; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shea-Moore M., 1998, J ANIM SCI, V76, P100; SHIMOKAWA H, 1983, SCIENCE, V221, P560, DOI 10.1126/science.6408736; Shin SS, 2018, BRAIN STIMUL, V11, P1306, DOI 10.1016/j.brs.2018.07.050; Sorby-Adams AJ, 2018, AM J PHYSIOL-REG I, V315, pR165, DOI 10.1152/ajpregu.00163.2017; Spuentrup E, 2005, CIRCULATION, V112, P396, DOI 10.1161/CIRCULATIONAHA.104.529941; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor SR, 2013, J NEUROSURG-PEDIATR, V12, P545, DOI 10.3171/2013.8.PEDS13154; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Tumbleson M.E., 1985, C SWIN BIOM RES U MI; WINFIELD CG, 1981, APPL ANIM ETHOL, V7, P67, DOI 10.1016/0304-3762(81)90052-3; Wofford KL, 2017, EXP NEUROL, V290, P85, DOI 10.1016/j.expneurol.2017.01.004; Wolf E, 2014, TRANSGENIC RES, V23, P27, DOI 10.1007/s11248-013-9755-y; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	73	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	NOV 22	2021	11	1							22688	10.1038/s41598-021-00782-w			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XC8OF	WOS:000722270000032	34811385	Green Submitted, gold, Green Published			2022-02-06	
J	Schafer, KM; Duffy, M; Kennedy, G; Stentz, L; Leon, J; Herrerias, G; Fulcher, S; Joiner, TE				Schafer, Katherine Musacchio; Duffy, Mary; Kennedy, Grace; Stentz, Lauren; Leon, Jagger; Herrerias, Gabriela; Fulcher, Summer; Joiner, Thomas E.			Suicidal ideation, suicide attempts, and suicide death among Veterans and service members: A comprehensive meta-analysis of risk factors	MILITARY PSYCHOLOGY			English	Article; Early Access						Veterans; service members; suicidal ideation; suicide attempts; suicide deaths	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MILITARY PERSONNEL; ACTIVE-DUTY; US MILITARY; HEALTH-CARE; INTERPERSONAL THEORY; CIGARETTE-SMOKING; ARMY; RESILIENCE	Suicide is the tenth leading cause of death in America. Particularly at risk, Veterans are 1.5 times more likely to die by suicide than non-Veterans, and the suicide rate among service members has risen over the last decade. In the present study, we (1) assessed risk factors for suicidal ideation, suicide attempts, and suicide death within and between Veterans and service members, (2) identified the most commonly studied and (3) the strongest risk factors for suicide-related outcomes among Veterans and service members, and (4) compared overall and risk factor-specific meta-analytic prediction of suicide-related outcomes in Veterans and service members, as determined in the present meta-analysis, to that of the general population. Authors harvested longitudinal effects predicting suicidal ideation, suicide attempts, or suicide deaths in Veterans or service members until May 1, 2020. Traumatic Brain Injury, substance/alcohol use disorders, prior Self-Injurious Thoughts and Behavior, PTSD, and depressive symptoms were among the most commonly studied risk factors. Anger/aggression was particularly strong risk factors, providing a source for future study and intervention efforts. When combined, risk factors conferred similar risk for suicide attempts and suicide death among Veterans, service members, and the general population. However, when analyzing p-values, factors conferred significantly more risk of suicidal ideation among Veterans and service members as compared to the general population. That is, p-values for risk factors were lower in an absolute sense but not necessarily to a statistically significant degree.	[Schafer, Katherine Musacchio; Duffy, Mary; Kennedy, Grace; Stentz, Lauren; Leon, Jagger; Herrerias, Gabriela; Fulcher, Summer; Joiner, Thomas E.] Florida State Univ, Dept Psychol, 1107 W Call St, Tallahassee, FL 32308 USA; [Kennedy, Grace] Walter Reed Natl Mil Med Ctr, Dept Psychol, Bethesda, MD USA		Schafer, KM (corresponding author), Florida State Univ, Dept Psychol, 1107 W Call St, Tallahassee, FL 32308 USA.	kmm16n@fsu.edu		Leon, Jagger/0000-0003-0597-187X	National Science Foundation Graduate Research Fellowship ProgramNational Science Foundation (NSF) [NSF [1449440]]; Military Suicide Research Consortium (MSRC); Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-16-2-0003]	This material is based upon work supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. NSF [1449440] and the Military Suicide Research Consortium (MSRC), an effort supported by the Office of the Assistant Secretary of Defense for Health Affairs under Award No. W81XWH-16-2-0003. Any opinions, findings, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the National Science Foundation, Military Suicide Research Consortium, or the U.S. Department of Defense.	Alexander CL, 2014, MIL MED, V179, P1062, DOI 10.7205/MILMED-D-13-00574; Ashrafioun L, 2016, DRUG ALCOHOL DEPEN, V163, P209, DOI 10.1016/j.drugalcdep.2016.04.024; BECK AT, 1975, JAMA-J AM MED ASSOC, V234, P1146, DOI 10.1001/jama.234.11.1146; Belsher BE, 2019, JAMA PSYCHIAT, V76, P642, DOI 10.1001/jamapsychiatry.2019.0174; Bernet AC, 2015, J AM PSYCHIAT NURSES, V21, P212, DOI 10.1177/1078390315592130; Borenstein M., 2009, INTRO META ANAL; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Brignone E, 2017, AM J PREV MED, V52, P557, DOI 10.1016/j.amepre.2016.11.015; Bryan C, 2014, J CLIN PSYCHOL, V70, P874, DOI 10.1002/jclp.22075; Bryan CJ, 2015, DEPRESS ANXIETY, V32, P647, DOI 10.1002/da.22383; Bryan CJ, 2014, J AFFECT DISORDERS, V159, P15, DOI 10.1016/j.jad.2014.02.021; Campbell-Sills L, 2020, J HEAD TRAUMA REHAB, V35, P14, DOI 10.1097/HTR.0000000000000516; Centers for Disease Control and Prevention, 2018, SUIC RIS US MOR MENT; Chapman SLC, 2015, EPIDEMIOL REV, V37, P86, DOI 10.1093/epirev/mxu008; Chu C, 2017, PSYCHOL BULL, V143, P1313, DOI 10.1037/bul0000123; Cigrang JA, 2015, J CLIN PSYCHOL, V71, P828, DOI 10.1002/jclp.22192; Cox KS, 2016, J PSYCHIATR RES, V80, P59, DOI 10.1016/j.jpsychires.2016.05.011; Currier JM, 2018, J AFFECT DISORDERS, V230, P93, DOI 10.1016/j.jad.2018.01.009; Daniel SS, 2009, J CLIN CHILD ADOLESC, V38, P661, DOI 10.1080/15374410903103494; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Department of Defense, 2020, DODSER DEP DEF SUIC; Dobscha SK, 2014, J GEN INTERN MED, V29, pS853, DOI 10.1007/s11606-014-3028-1; Elbogen EB, 2018, PSYCHOL ASSESSMENT, V30, P425, DOI 10.1037/pas0000490; Fralick M, 2019, JAMA NEUROL, V76, P144, DOI 10.1001/jamaneurol.2018.3487; Franklin JC, 2017, PSYCHOL BULL, V143, P187, DOI 10.1037/bul0000084; Goldney R, 1997, COMPR PSYCHIAT, V38, P264, DOI 10.1016/S0010-440X(97)90058-4; Goodin CA, 2019, PSYCHOL SERV, V16, P286, DOI 10.1037/ser0000201; Goodwin RD, 2013, J AFFECT DISORDERS, V145, P111, DOI 10.1016/j.jad.2012.05.003; Gradus JL, 2013, SUICIDE LIFE-THREAT, V43, P39, DOI 10.1111/j.1943-278X.2012.00126.x; Hazlett EA, 2016, PSYCHOPHYSIOLOGY, V53, P1524, DOI 10.1111/psyp.12698; Heckman JJ, 1990, ECONOMETRICS, DOI DOI 10.1007/978-1-349-20570-7_29; Hedegaard H., 1999, INCREASE SUICIDE MOR; Hochman E, 2014, J CLIN PSYCHIAT, V75, pE817, DOI 10.4088/JCP.13m08823; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holliday R, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01998; Horwitz AG, 2019, PSYCHOL SERV, V16, P321, DOI 10.1037/ser0000215; Hoyt T., 2020, PARAMETERS US ARMY W, V50, P7; Huang XYN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180793; Ireland RR, 2012, MIL MED, V177, P1149, DOI 10.7205/MILMED-D-12-00051; Joiner T.E., 2005, WHY PEOPLE DIE SUICI; Kang HK, 2015, ANN EPIDEMIOL, V25, P96, DOI 10.1016/j.annepidem.2014.11.020; Kim HM, 2012, J CLIN PSYCHIAT, V73, pE1269, DOI 10.4088/JCP.12m07658; Kimerling R, 2007, AM J PUBLIC HEALTH, V97, P2160, DOI 10.2105/AJPH.2006.092999; Kimerling R, 2016, AM J PREV MED, V50, P684, DOI 10.1016/j.amepre.2015.10.019; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Klonsky ED, 2015, INT J COGN THER, V8, P114, DOI 10.1521/ijct.2015.8.2.114; LeardMann CA, 2013, JAMA-J AM MED ASSOC, V310, P496, DOI 10.1001/jama.2013.65164; Lee SU, 2017, J EPIDEMIOL, V27, P258, DOI 10.1016/j.je.2016.06.008; Lemaire CM, 2011, J AFFECT DISORDERS, V130, P231, DOI 10.1016/j.jad.2010.10.021; Lewis MD, 2011, J CLIN PSYCHIAT, V72, P1585, DOI 10.4088/JCP.11m06879; Linehan M., 2018, COGNITIVE BEHAV TREA; Maguen S, 2012, PSYCHIAT SERV, V63, P1206, DOI 10.1176/appi.ps.201200051; Mahon MJ, 2005, AM J PSYCHIAT, V162, P1688, DOI 10.1176/appi.ajp.162.9.1688; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Millonig W., 2006, IMPACT RELIG POLITIC; Murray G, 2008, PERS INDIV DIFFER, V44, P1369, DOI 10.1016/j.paid.2007.12.005; Naifeh JA, 2019, DEPRESS ANXIETY, V36, P412, DOI 10.1002/da.22870; Naifeh JA, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-018-1978-2; Naifeh JA, 2017, SUICIDE LIFE-THREAT, V47, P589, DOI 10.1111/sltb.12307; Nock MK, 2018, J ABNORM PSYCHOL, V127, P139, DOI 10.1037/abn0000317; O'Connor RC, 2011, CRISIS, V32, P295, DOI 10.1027/0227-5910/a000120; Olson M.A., 2021, PSYCHOL REV; Oquendo MA., 2003, STANDARDIZED EVALUAT, V22, P103, DOI DOI 10.4088/jcp.14f09366; Panagioti M, 2012, COMPR PSYCHIAT, V53, P915, DOI 10.1016/j.comppsych.2012.02.009; Pew Research Center Washington D.C, 2021, REP DEM MOV FURTH AP; Pruitt LD, 2019, MIL MED, V184, P432, DOI 10.1093/milmed/usy296; Reger MA, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17l11790; Reger MA, 2018, SUICIDE LIFE-THREAT, V48, P21, DOI 10.1111/sltb.12322; Reger MA, 2015, JAMA PSYCHIAT, V72, P561, DOI 10.1001/jamapsychiatry.2014.3195; Ribeiro JD, 2016, PSYCHOL MED, V46, P225, DOI 10.1017/S0033291715001804; Ribeiro JD, 2018, BRIT J PSYCHIAT, V212, P279, DOI 10.1192/bjp.2018.27; Roberge EM, 2021, J TRAUMA STRESS, V34, P1228, DOI 10.1002/jts.22662; Schafer KM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249833; Schoenbaum M, 2014, JAMA PSYCHIAT, V71, P493, DOI 10.1001/jamapsychiatry.2013.4417; Shadish WR., 2002, EXPT QUASI EXPT DESI; Sharp ML, 2015, EPIDEMIOL REV, V37, P144, DOI 10.1093/epirev/mxu012; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Skopp NA, 2016, PSYCHIAT RES, V245, P194, DOI 10.1016/j.psychres.2016.08.031; Skopp NA, 2011, J SOC CLIN PSYCHOL, V30, P361, DOI 10.1521/jscp.2011.30.4.361; Stanley IH, 2019, J CONSULT CLIN PSYCH, V87, P67, DOI 10.1037/ccp0000350; Start AR, 2019, SUICIDE LIFE-THREAT, V49, P444, DOI 10.1111/sltb.12445; Stefanovics EA, 2019, J CLIN PSYCHIAT, V80, DOI 10.4088/JCP.19m12745; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Swann WB, 2012, PSYCHOL REV, V119, P441, DOI 10.1037/a0028589; Teo AR, 2018, J AFFECT DISORDERS, V230, P42, DOI 10.1016/j.jad.2018.01.003; Tucker RP, 2018, PSYCHOL MED, V48, P2329, DOI 10.1017/S0033291717003853; Umhau JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051543; Ursano RJ, 2018, JAMA PSYCHIAT, V75, P1022, DOI 10.1001/jamapsychiatry.2018.2069; Ursano RJ, 2018, JAMA PSYCHIAT, V75, P596, DOI 10.1001/jamapsychiatry.2018.0296; Ursano RJ, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1350-y; Ursano RJ, 2015, JAMA PSYCHIAT, V72, P917, DOI 10.1001/jamapsychiatry.2015.0987; VA Report, 2020, NATL VETERAN SUICIDE; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P603, DOI 10.1001/archpsyc.62.6.603; Watkins EY, 2018, AM J PUBLIC HEALTH, V108, P769, DOI 10.2105/AJPH.2018.304410; Witte TK, 2018, J CLIN PSYCHOL, V74, P1607, DOI 10.1002/jclp.22625; Witte TK, 2012, J RES PERS, V46, P384, DOI 10.1016/j.jrp.2012.03.004; Zivin K, 2007, AM J PUBLIC HEALTH, V97, P2193, DOI 10.2105/AJPH.2007.115477	100	0	0	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0899-5605	1532-7876		MIL PSYCHOL	Milit. Psychol.												10.1080/08995605.2021.1976544		NOV 2021	18	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	XC5GR	WOS:000722041800001					2022-02-06	
J	Miller, GF; Sarmiento, K; Haarbauer-Krupa, J; Jones, SE				Miller, Gabrielle F.; Sarmiento, Kelly; Haarbauer-Krupa, Juliet; Jones, Sherry Everett			The Association Between School District-Based Policies Related to Concussions and Concussions Among High School Students	JOURNAL OF SCHOOL HEALTH			English	Article; Early Access						concussions; TBI	EMERGENCY-DEPARTMENT VISITS; TRAUMATIC BRAIN-INJURIES; FOR-DISEASE-CONTROL; UNITED-STATES; SPORTS; MANAGEMENT; HEADS; IMPLEMENTATION; EPIDEMIOLOGY; DISPARITIES	BACKGROUND Little is known about the effectiveness of school district concussion policies on reducing the concussion prevalence among students. METHODS Data from the 2016 School Health Policies and Practices Study and 2017 Youth Risk Behavior Survey for 10 school districts were linked. The outcome variable was having a sports- or physical activity-related concussion during the 12 months before of the survey. Exposure variables were 2 district policies, including district-funded professional development and prioritizing return to the classroom before returning to athletics. Logistic regression models estimated the odds of a concussion among students in districts with one, both, or neither policy (referent). RESULTS In districts with district-funded professional development, the odds of students self-reporting >= 2 sports- or physical activity-related concussions were 1.4 times higher than in districts with neither policy. In districts with a policy prioritizing a return to the classroom before returning to athletics, the odds of students self-reporting >= 2 concussions were significantly lower (OR = 0.6) than in districts with neither policy. CONCLUSION School district concussion policies may have positive effects by identifying and reducing multiple concussions among students.	[Miller, Gabrielle F.] CDC, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE,MS S106-08, Atlanta, MS 30341 USA; [Sarmiento, Kelly; Haarbauer-Krupa, Juliet] CDC, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE,MS S106-09, Atlanta, MS 30341 USA; [Jones, Sherry Everett] CDC, Div Adolescent & Sch Hlth, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, 1600 Clifton Rd NE,MS US8-1, Atlanta, GA 30329 USA		Miller, GF (corresponding author), CDC, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE,MS S106-08, Atlanta, MS 30341 USA.	ygm3@cdc.gov; egz8@cdc.gov; wuk1@cdc.gov; sce2@cdc.gov		Haarbauer-Krupa, Juliet/0000-0002-2013-6453	Intramural CDC HHS [CC999999] Funding Source: Medline		Arakkal AT, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-00241-6; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Brener ND, 2013, MMWR RECOMM REP, V62, P1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Centers for Disease Control and Prevention, 2015, RES SCH HLTH POL PRA; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Chrisman SPD, 2019, J PEDIATR-US, V207, P176, DOI 10.1016/j.jpeds.2018.11.003; Coxe K, 2018, J ADOLESCENT HEALTH, V62, P255, DOI 10.1016/j.jadohealth.2017.07.003; Curry AE, 2019, J PEDIATR-US, V210, P13, DOI 10.1016/j.jpeds.2019.04.001; Daugherty J, 2020, J SAFETY RES, V74, P133, DOI 10.1016/j.jsr.2020.04.015; Daugherty J, 2019, HEALTH EDUC J, V78, P784, DOI 10.1177/0017896919846185; Davies S, 2018, J ATHL TRAINING, V53, P873, DOI 10.4085/1062-6050-529-17; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DePadilla L, 2020, J PUBLIC HEALTH MAN, V26, pE23, DOI 10.1097/PHH.0000000000000901; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Giza CC, 2001, J ATHL TRAINING, V36, P228; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Graff DM, 2016, J CHILD NEUROL, V31, P1569, DOI 10.1177/0883073816666205; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hartnett KP, 2020, MMWR-MORBID MORTAL W, V69, P699, DOI 10.15585/mmwr.mm6923e1; Harvey HH, 2015, J LAW MED ETHICS, V43, P87, DOI 10.1111/jlme.12225; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Lowry R, 2019, AM J PREV MED, V57, P733, DOI 10.1016/j.amepre.2019.08.016; McAvoy K, 2020, J SCHOOL HEALTH, V90, P849, DOI 10.1111/josh.12949; McCart M, 2020, DISABIL REHABIL, V42, P2430, DOI 10.1080/09638288.2019.1578423; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Romm KE, 2018, J SCHOOL HEALTH, V88, P813, DOI 10.1111/josh.12687; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sullivan L, 2020, J PUBLIC HEALTH MAN, V26, pS84, DOI 10.1097/PHH.0000000000001128; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P221, DOI 10.1007/s40615-017-0361-1; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Yaramothu C, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9100257	42	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4391	1746-1561		J SCHOOL HEALTH	J. Sch. Health												10.1111/josh.13113		NOV 2021	8	Education & Educational Research; Education, Scientific Disciplines; Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services; Public, Environmental & Occupational Health	XA6WD	WOS:000720783400001	34806180				2022-02-06	
J	Sullivan, L; Wysong, M; Yang, JZ				Sullivan, Lindsay; Wysong, Matthew; Yang, Jingzhen			Concussion Recovery in Children and Adolescents: A Qualitative Study of Parents' Experiences	JOURNAL OF SCHOOL HEALTH			English	Article; Early Access						concussion; concussion recovery; qualitative research; return-to-school; parents; youth	TRAUMATIC BRAIN-INJURIES; UNITED-STATES; SCHOOL; REST	BACKGROUND Although parents play an instrumental role in youth concussion management, few studies have qualitatively explored youth concussion recovery from the parents' perspective. This study explored parents' experiences with and perceptions of their child's recovery from concussion, particularly with regards to the return-to-school process. METHODS We conducted 11 face-to-face semi-structured interviews with the parents of concussed youth aged 11 to 17 years between October 2018 and April 2019. We used the methods of open coding, axial coding, and selective coding to analyze the data. RESULTS We identified 7 themes during data analysis, which we divided into 2 categories: at home (prior to school re-entry) and at school (during the school reintegration process). The at-home category included 4 themes: (1) physical and cognitive rest; (2) child-led decision-making; (3) the role of parent-child communication in recovery; and (4) feelings about returning to school following concussion. The at-school category included 3 themes: (1) availability and utilization of academic accommodations; (2) return-to-school policies and procedures; and (3) support from school officials and teachers. CONCLUSIONS Parents' experiences of their child's return-to-school post-concussion underscore the need for evidence-based guidelines for cognitive rest post-concussion and a collaborative, team-based approach to concussion management.	[Sullivan, Lindsay] Natl Univ Ireland, Discipline Childrens Studies, Sch Educ, Coll Arts Social Sci & Celt Stuides, Univ Rd,Arts Milenium Bldg,Room 342, Galway, Ireland; [Wysong, Matthew; Yang, Jingzhen] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Abigail VVexner Res Inst, Columbus, OH 43205 USA; [Wysong, Matthew] Nationwide Childrens Hosp, Dept Pedatr, Columbus, OH 43205 USA; [Yang, Jingzhen] Ohio State Univ, Coll Med, Cdt Rnbus, OH 43205 USA		Sullivan, L (corresponding author), Natl Univ Ireland, Discipline Childrens Studies, Sch Educ, Coll Arts Social Sci & Celt Stuides, Univ Rd,Arts Milenium Bldg,Room 342, Galway, Ireland.	Lindsaymarie.sullivan@nuigalway.ie; matthew.wysong@nationwidechildrens.org; ginger.yang@nationwidechildrens.org		Sullivan, Lindsay/0000-0001-8079-0388	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [R21HD086451]	This research work was partially supported by funding fromEunice Kennedy Shriver National Institute of ChildHealth & HumanDevelopment of theNational Institutes of Health under Award R21HD086451.	Conrick KM, 2020, J SCHOOL HEALTH, V90, P842, DOI 10.1111/josh.12948; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2018, JAMA NEUROL, V75, P399, DOI 10.1001/jamaneurol.2018.0006; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Holton JA., 2007, SAGE HDB GROUNDED TH, V3, P265, DOI DOI 10.4135/9781848607941; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Kita H, 2020, BRAIN INJURY, V34, P784, DOI 10.1080/02699052.2020.1753243; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; McAvoy K, 2020, J SCHOOL HEALTH, V90, P849, DOI 10.1111/josh.12949; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117745033; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Moghaddam A, 2006, ISS EDUC RES, V16, P52; Provvidenza C, 2019, SCHOOLFIRST ENABLING; Purcell LK, 2019, BRIT J SPORT MED, V53, P250, DOI 10.1136/bjsports-2017-097853; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Saldaa J., 2015, CODING MANUAL QUALIT; Sarmiento Kelly, 2019, J Concussion, V3, DOI 10.1177/2059700219861863; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Sarmiento K, 2019, J SAFETY RES, V68, P223, DOI 10.1016/j.jsr.2018.10.010; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Waltzman D, 2020, BRAIN INJURY, V34, P1193, DOI 10.1080/02699052.2020.1793388; Yang JZ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028386	25	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4391	1746-1561		J SCHOOL HEALTH	J. Sch. Health												10.1111/josh.13114		NOV 2021	8	Education & Educational Research; Education, Scientific Disciplines; Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services; Public, Environmental & Occupational Health	XA6IP	WOS:000720748200001	34806778				2022-02-06	
J	Zhu, J; Lin, XL; Chen, C; Tan, HL; Gao, YP; Li, D; Chen, G				Zhu, Jie; Lin, Xiaolong; Chen, Chen; Tan, Helian; Gao, Yanping; Li, Di; Chen, Gang			WNK3 Promotes Neuronal Survival after Traumatic Brain Injury in Rats	NEUROSCIENCE			English	Article						WNK3; NKCC1; neuroprotection; traumatic brain injury	CL-COTRANSPORTER; INHIBITION; EDEMA; DAMAGE; SUSCEPTIBILITY; CONTRIBUTES; EXPRESSION; INCREASES; APOPTOSIS; KINASES	With-no-kinase 3 (WNK3) is a key regulator of chloride ion transport and neuronal survival in diverse cell types. WNK3 was previously found to regulate the activity of Na+-K+-2Cl- cotransporter-1 (NKCC1) in ischemia-associated brain damage. However, the role of WNK3 in traumatic brain injury (TBI) has not yet been studied. A weight-drop TBI model was established in Sprague-Dawley rats. Overexpression and specific inhibition were used to investigate the role of WNK3 in TBI via Western blot, immunofluorescence, neuronal apoptosis, brain water content, and neurological score analyses. We found pronounced TBI-induced downregulation of WNK3 expression and upregulation of NKCC1 expression in neurons, especially at 48 h. Overexpression of WNK3 significantly ameliorated neuronal apoptosis, blood-brain barrier (BBB) disruption, brain edema and neurological deficits at 48 h after TBI. These effects were concomitant with reductions in p-NKCC1 and phosphorylated extracellular signal-regulated kinase (p-ERK1/2) expression. Furthermore, bumetanide administration enhanced the neuroprotective effects of WNK3 overexpression against brain injury. Thus, WNK3 plays a neuroprotective role in TBI, and overexpression of WNK3 may increase cell resistance to apoptotic insults and brain edema, thereby alleviating secondary brain injury. (C) 2021 IBRO. Published by Elsevier Ltd. All rights reserved.	[Zhu, Jie; Tan, Helian; Gao, Yanping] Soochow Univ, Dept Anesthesiol, Affiliated Zhangjiagang Hosp, Zhangjiagang, Peoples R China; [Lin, Xiaolong] Soochow Univ, Dept Orthopaed Surg, Affiliated Zhangjiagang Hosp, Zhangjiagang, Peoples R China; [Chen, Chen] Soochow Univ, Dept Intens Care Unit, Affiliated Zhangjiagang Hosp, Zhangjiagang, Peoples R China; [Li, Di] Soochow Univ, Dept Translat Med Ctr, Affiliated Zhangjiagang Hosp, Zhangjiagang, Peoples R China; [Chen, Gang] Soochow Univ, Dept Neurosurg, Affiliated Hosp 1, Suzhou, Peoples R China		Gao, YP (corresponding author), Soochow Univ, Dept Anesthesiol, Affiliated Zhangjiagang Hosp, Zhangjiagang, Peoples R China.; Li, D (corresponding author), Soochow Univ, Dept Translat Med Ctr, Affiliated Zhangjiagang Hosp, Zhangjiagang, Peoples R China.	drgaoyanping@126.com; lidilab@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801238]; Suzhou Science and Technology Development Project [SYSD2018007, SYSD2020008]; Suzhou Science and Technology Foundation for Young [KJXW2020058]; Zhangjiagang Science and Technology Foundation [ZKS1932, ZKS2018]	This work was supported by grants from National Natural Science Foundation of China (Nos.81801238) , Suzhou Science and Technology Development Project (SYSD2018007; SYSD2020008) , Suzhou Science and Technology Foundation for Young (KJXW2020058) , Zhangjiagang Science and Technology Foundation (ZKS1932; ZKS2018) .	Akamatsu Y, 2020, NEUROTHERAPEUTICS, V17, P446, DOI 10.1007/s13311-020-00840-7; Begum G, 2015, STROKE, V46, P1956, DOI 10.1161/STROKEAHA.115.008939; Benarroch EE, 2013, NEUROLOGY, V80, P756, DOI 10.1212/WNL.0b013e318283bb1c; Bhuiyan MIH, 2017, J CEREBR BLOOD F MET, V37, P2780, DOI 10.1177/0271678X16675368; Chen H, 2005, J CEREBR BLOOD F MET, V25, P54, DOI 10.1038/sj.jcbfm.9600006; Cruz-Rangel S, 2011, AM J PHYSIOL-CELL PH, V301, pC601, DOI 10.1152/ajpcell.00070.2011; de los Heros P, 2006, P NATL ACAD SCI USA, V103, P1976, DOI 10.1073/pnas.0510947103; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Foroutan S, 2005, AM J PHYSIOL-CELL PH, V289, pC1492, DOI 10.1152/ajpcell.00257.2005; Glover M, 2009, J AM SOC NEPHROL, V20, P1314, DOI 10.1681/ASN.2008050542; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Holden S, 2004, GENE, V335, P109, DOI 10.1016/j.gene.2004.03.009; Hu JJ, 2017, BRAIN RES BULL, V130, P188, DOI 10.1016/j.brainresbull.2017.01.022; Huang HC, 2019, STROKE, V50, P1021, DOI 10.1161/STROKEAHA.118.024287; Hui H, 2016, NEUROCHEM INT, V94, P23, DOI 10.1016/j.neuint.2016.02.002; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Kourdougli N, 2017, ANN NEUROL, V81, P251, DOI 10.1002/ana.24870; Lee AY, 2012, P NATL ACAD SCI USA, V109, P16841, DOI 10.1073/pnas.1215406109; Lenart B, 2004, J NEUROSCI, V24, P9585, DOI 10.1523/JNEUROSCI.2569-04.2004; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lu KT, 2007, NEUROL RES, V29, P404, DOI 10.1179/016164107X204738; Lu KT, 2017, J NEUROCHEM, V140, P718, DOI 10.1111/jnc.13920; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Ni HB, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00674; Pacheco-Alvarez D, 2020, AM J PHYSIOL-CELL PH, V319, pC371, DOI 10.1152/ajpcell.00488.2019; Qu WR, 2020, CEREB CORTEX, V30, P3859, DOI 10.1093/cercor/bhaa002; Rui Q, 2019, EXP NEUROL, V322, DOI 10.1016/j.expneurol.2019.113044; Sawant-Pokam PA, 2020, J CLIN INVEST, V130, P6005, DOI 10.1172/JCI134793; Sharma HS, 2020, PROG BRAIN RES, V258, P233, DOI 10.1016/bs.pbr.2020.09.009; Shekarabi M, 2017, CELL METAB, V25, P285, DOI 10.1016/j.cmet.2017.01.007; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Tang BL, 2016, BRAIN RES BULL, V125, P92, DOI 10.1016/j.brainresbull.2016.04.017; Verissimo F, 2006, ONCOGENE, V25, P4172, DOI 10.1038/sj.onc.1209449; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Wang DX, 2016, NEPHRON, V133, P287, DOI 10.1159/000447717; Wang Z, 2012, J PINEAL RES, V53, P129, DOI 10.1111/j.1600-079X.2012.00978.x; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wu DG, 2020, EXP NEUROL, V332, DOI 10.1016/j.expneurol.2020.113386; Wu J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0790-0; Wu JC, 2020, TRANSL STROKE RES, V11, P720, DOI 10.1007/s12975-019-00771-2; Xu WS, 2017, MOL NEUROBIOL, V54, P2406, DOI 10.1007/s12035-016-9819-0; Yamaguchi M, 2004, STROKE, V35, P1750, DOI 10.1161/01.STR.0000129898.68350.9f; Yan YP, 2003, BRAIN RES, V961, P22, DOI 10.1016/S0006-8993(02)03832-5; Yang XL, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00339; Zhang JW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13851-6; Zhang J, 2017, NEUROCHEM INT, V111, P23, DOI 10.1016/j.neuint.2017.05.020; Zhang ZH, 2013, J BIOL CHEM, V288, P12152, DOI 10.1074/jbc.M112.447771; Zhao HS, 2017, J CEREBR BLOOD F MET, V37, P550, DOI 10.1177/0271678X16631561; Zucker I, 2010, NATURE, V465, P690, DOI 10.1038/465690a	51	0	0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 21	2021	477						76	88		10.1016/j.neuroscience.2021.09.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WN9AE	WOS:000712057400007	34626749				2022-02-06	
J	Papo, D				Papo, David			Attaining the recesses of the cognitive space	COGNITIVE NEURODYNAMICS			English	Article; Early Access						Executive functions; Closed-head injury; Resource allocation; Degeneracy; Intermittency; Scaling	RANGE TEMPORAL CORRELATIONS; TRAUMATIC BRAIN-INJURY; CLIENT-THERAPIST INTERACTION; FRONTAL-LOBE DAMAGE; CLOSED-HEAD-INJURY; EXECUTIVE FUNCTION; ECOLOGICAL VALIDITY; NEUROPSYCHOLOGICAL TESTS; SCALING BEHAVIOR; CHAOTIC PROCESS	Existing neuropsychological tests of executive function often manifest a difficulty pinpointing cognitive deficits when these are intermittent and come in the form of omissions. We discuss the hypothesis that two partially interrelated reasons for this failure stem from relative inability of neuropsychological tests to explore the cognitive space and to explicitly take into account strategic and opportunistic resource allocation decisions, and to address the temporal aspects of both behaviour and task-related brain function in data analysis. Criteria for tasks suitable for neuropsychological assessment of executive function, as well as appropriate ways to analyse and interpret observed behavioural data are suggested. It is proposed that experimental tasks should be devised which emphasize typical rather than optimal performance, and that analyses should quantify path-dependent fluctuations in performance levels rather than averaged behaviour. Some implications for experimental neuropsychology are illustrated for the case of planning and problem-solving abilities and with particular reference to cognitive impairment in closed-head injury.	[Papo, David] Univ Ferrara, Dept Neurosci & Rehabil, Sect Physiol, Ferrara, Italy; [Papo, David] Fdn Ist Italiano Tecnol, Ferrara, Italy		Papo, D (corresponding author), Univ Ferrara, Dept Neurosci & Rehabil, Sect Physiol, Ferrara, Italy.; Papo, D (corresponding author), Fdn Ist Italiano Tecnol, Ferrara, Italy.	david.papo@unife.it					Allegrini P, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00128; ALLPORT A, 1993, ATTENTION PERFORM, V14, P183; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Anderson J. R., 1993, RULES MIND; Avci G, 2018, CLIN NEUROPSYCHOL, V32, P858, DOI 10.1080/13854046.2017.1373860; Baronchelli A, 2013, CHAOS SOLITON FRACT, V56, P101, DOI 10.1016/j.chaos.2013.07.013; Benichou O, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.81; Benson D.F., 1986, FRONTAL LOBES; Bilder RM, 2019, CLIN NEUROPSYCHOL, V33, P220, DOI 10.1080/13854046.2018.1521993; Boccaletti S, 2000, PHYS REP, V329, P103, DOI 10.1016/S0370-1573(99)00096-4; Brezina V, 1997, TRENDS NEUROSCI, V20, P538, DOI 10.1016/S0166-2236(97)01120-X; Brezina V, 2010, PHILOS T R SOC B, V365, P2363, DOI 10.1098/rstb.2010.0105; Buiatti M, 2007, NEUROSCIENCE, V146, P1400, DOI 10.1016/j.neuroscience.2007.02.048; Burgess P., 1997, METHODOLOGY FRONTAL, P81; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chen YQ, 1997, PHYS REV LETT, V79, P4501, DOI 10.1103/PhysRevLett.79.4501; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Cooper R, 1997, PROCEEDINGS OF THE NINETEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P131; Cooper R, 2000, COGN NEUROPSYCHOL, V17, P297, DOI 10.1080/026432900380427; Coscoy S, 2007, B MATH BIOL, V69, P2467, DOI 10.1007/s11538-007-9227-8; Costa AS, 2019, CLIN NEUROPSYCHOL, V33, P369, DOI 10.1080/13854046.2018.1533587; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Dunn JC, 2003, CORTEX, V39, P1, DOI 10.1016/S0010-9452(08)70070-4; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; EGETH H, 1975, AM J PSYCHOL, V88, P339, DOI 10.2307/1421603; Expert P, 2011, J R SOC INTERFACE, V8, P472, DOI 10.1098/rsif.2010.0416; Farole T, 2011, DIR DEV, P1; Fellows LK, 2019, HAND CLINIC, V163, P19, DOI 10.1016/B978-0-12-804281-6.00002-1; Flyvbjerg H, 1996, PHYS REV LETT, V76, P940, DOI 10.1103/PhysRevLett.76.940; Fodor J.A., 1983, MODULARITY MIND; Fraiman D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00307; Franzen M.D., 1996, ECOLOGICAL VALIDITY, P91; Freeman WJ, 2000, BEHAV BRAIN SCI, V23, P401, DOI 10.1017/S0140525X00243252; Freyer F, 2009, J NEUROSCI, V29, P8512, DOI 10.1523/JNEUROSCI.0754-09.2009; Gaurav G, COGN NEURODYNAMICS, P1; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Gilden DL, 2001, PSYCHOL REV, V108, P33, DOI 10.1037/0033-295X.108.1.33; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Gong P, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011904; Gutierrez R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77663-1; Gutierrez R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00396; Haken H., 1983, SYNERGETICS INTRO; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Howieson D, 2019, CLIN NEUROPSYCHOL, V33, P200, DOI 10.1080/13854046.2018.1552762; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jovanovski D, 2012, APPL NEUROPSYCH-ADUL, V19, P171, DOI 10.1080/09084282.2011.643955; KELSO JAS, 1995, CHAOS, V5, P64, DOI 10.1063/1.166087; Kelso JS, 1995, DYNAMIC PATTERNS SEL; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; Koirala N, 2018, BRAIN TOPOGR, V31, P311, DOI 10.1007/s10548-017-0597-4; Kostrubiec V, 2002, NEUROSCI LETT, V331, P193, DOI 10.1016/S0304-3940(02)00878-9; Kowalik ZJ, 1997, PSYCHOTHER RES, V7, P197, DOI 10.1080/10503309712331331973; Kozma R., 2016, COGNITIVE PHASE TRAN; Kozma R, 2015, CURR OPIN NEUROBIOL, V31, P181, DOI 10.1016/j.conb.2014.11.005; Lai YC, 2014, NATL SCI REV, V1, P339, DOI 10.1093/nsr/nwu023; Leroy F, 2005, PSYCHIAT RES, V133, P159, DOI 10.1016/j.psychres.2004.07.009; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Linkenkaer-Hansen K, 2004, EUR J NEUROSCI, V19, P203, DOI 10.1111/j.1460-9568.2004.03116.x; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Liu YY, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.035006; Lomholt MA, 2008, P NATL ACAD SCI USA, V105, P11055, DOI 10.1073/pnas.0803117105; Luria A.R., 1966, HIGHER CORTICAL FUNC; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; McKinney TL, 2020, CLIN NEUROPSYCHOL, V34, P619, DOI 10.1080/13854046.2019.1704434; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Mulligan BP, 2020, CLIN NEUROPSYCHOL, V34, P643, DOI 10.1080/13854046.2020.1723706; Novikov E, 1997, PHYS REV E, V56, pR2387, DOI 10.1103/PhysRevE.56.R2387; O'Hara KP, 1998, COGNITIVE PSYCHOL, V35, P34, DOI 10.1006/cogp.1997.0676; OTT E, 1990, PHYS REV LETT, V64, P1196, DOI 10.1103/PhysRevLett.64.1196; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; Ozga JE, 2018, BEHAV PHARMACOL, V29, P617, DOI 10.1097/FBP.0000000000000430; Palva JM, 2013, P NATL ACAD SCI USA, V110, P3585, DOI 10.1073/pnas.1216855110; Pantelis C, 1997, BRAIN, V120, P1823, DOI 10.1093/brain/120.10.1823; Papo D, 1998, THESIS U COLL LONDON; Papo D, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00509; Papo D, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00222; Papo D, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00112; Pillai AS, 2017, NEURON, V94, P1010, DOI 10.1016/j.neuron.2017.05.013; Popivanov D, 2006, BIOL CYBERN, V94, P149, DOI 10.1007/s00422-005-0037-5; Price CJ, 2002, TRENDS COGN SCI, V6, P416, DOI 10.1016/S1364-6613(02)01976-9; Puente AN, 2016, CLIN NEUROPSYCHOL, V30, P95, DOI 10.1080/13854046.2015.1133847; Purdy MH., 2016, COGNITIVE COMMUNICAT, P83; RAPP PE, 1991, MATH BIOSCI, V105, P207, DOI 10.1016/0025-5564(91)90082-T; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Reinvang I, 2000, NEUROPSYCHOLOGIA, V38, P995, DOI 10.1016/S0028-3932(99)00153-0; Rhodes T, 2007, PHYSICA A, V385, P255, DOI 10.1016/j.physa.2007.07.001; Rogers RD, 1998, BRAIN, V121, P815, DOI 10.1093/brain/121.5.815; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P25, DOI 10.1007/s12207-010-9068-x; Schiepek G, 1997, PSYCHOTHER RES, V7, P173, DOI 10.1080/10503309712331331953; Schmitter-Edgecombe M, 2020, CLIN NEUROPSYCHOL, V34, P678, DOI 10.1080/13854046.2020.1733097; Schwartz MF, 1998, NEUROPSYCHOLOGY, V12, P13, DOI 10.1037/0894-4105.12.1.13; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Shapiro Y, 2015, PSYCHOANAL DIALOGUES, V25, P83, DOI 10.1080/10481885.2015.991245; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; SIMON HA, 1956, PSYCHOL REV, V63, P129, DOI 10.1037/h0042769; Soto EF, 2020, NEUROPSYCHOLOGY, V34, P605, DOI 10.1037/neu0000681; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Stadler BMR, 2001, J THEOR BIOL, V213, P241, DOI 10.1006/jtbi.2001.2423; Stamenova V, 2019, NEUROPSYCHOL REHABIL, V29, P1569, DOI 10.1080/09602011.2018.1438294; Stanley H.E, 2011, PHYS FORAGING INTRO; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Thivierge JP, 2007, TRENDS NEUROSCI, V30, P251, DOI 10.1016/j.tins.2007.04.004; Tognoli E, 2014, NEURON, V81, P35, DOI 10.1016/j.neuron.2013.12.022; Tononi G, 1999, P NATL ACAD SCI USA, V96, P3257, DOI 10.1073/pnas.96.6.3257; Van Orden GC, 2003, J EXP PSYCHOL GEN, V132, P331, DOI 10.1037/0096-3445.132.3.331; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P579, DOI 10.3758/BF03196615; Ward G, 1997, Q J EXP PSYCHOL-A, V50, P49, DOI 10.1080/027249897392224; West R, 2000, CEREB CORTEX, V10, P748, DOI 10.1093/cercor/10.8.748; Ziemnik RE, 2019, PSYCHOL ASSESSMENT, V31, P1307, DOI 10.1037/pas0000751; Zoccolotti P, 2000, CORTEX, V36, P93, DOI 10.1016/S0010-9452(08)70839-6	127	0	0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1871-4080	1871-4099		COGN NEURODYNAMICS	Cogn. Neurodynamics												10.1007/s11571-021-09755-1		NOV 2021	12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XA5SE	WOS:000720705500002		Bronze			2022-02-06	
J	Tabet, S; Lague-Beauvais, M; Francoeur, C; Sheehan, A; Abouassaly, M; Marcoux, J; Dagher, JH; Ursulet, A; Colucci, E; de Guise, E				Tabet, Sabrina; Lague-Beauvais, Maude; Francoeur, Coralie; Sheehan, Audrey; Abouassaly, Michel; Marcoux, Judith; Dagher, Jehane H.; Ursulet, Adriana; Colucci, Emma; de Guise, Elaine			Longitudinal recovery of executive functions and social participation prediction following traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Executive function; recovery; Traumatic brain injury; social participation	WORKING-MEMORY; NEUROPSYCHOLOGICAL OUTCOMES; COGNITIVE SEQUELAE; MILD; DYSFUNCTION; PERFORMANCE; MODERATE; TBI; RECOMMENDATIONS; METAANALYSES	There is heterogeneity across studies and a lack of knowledge about recovery of EFs over time following traumatic brain injury (TBI). Also, EFs are associated with functional outcome, but there is still a gap in knowledge concerning the association between EFs and social participation following TBI. For this reason, we aim to (1) measure the recovery of the three executive function subcomponents of Miyake's model, namely flexibility, updating and inhibition between the acute phase (T1) and 6 months post TBI (T2) and (2) measure the relationship between EFs and social participation after TBI. Thus, a prospective longitudinal study that included 75 patients with TBI (mild and moderate-severe) and 50 patients with orthopedic injuries (controls) without brain damage was carried out. An extensive EFs test battery was administered at T1 and T2 whereas the Mayo-Portland Adaptability Inventory-4 (MPAI-4) was administered only at T2. In contrast with the controls, both TBI groups improved significantly between T1 and T2 on WMS-III Mental Control test (MC) and the D-KEFS Category Switching Condition of the Verbal Fluency task (SVF). Results also showed a simple time effect for the WAIS-IV Digit span and the Hayling tests. Moreover, there was an association between the SVF test and social participation (MPAI-4) at T2. In conclusion, the MC and SVF tests were found to be the best tools for measuring recovery of EFs following TBI. The SVF test was the most likely measure of EFs to give the neuropsychologist an idea of the patient's social participation.	[Tabet, Sabrina; Lague-Beauvais, Maude; Francoeur, Coralie; Sheehan, Audrey; Ursulet, Adriana; Colucci, Emma; de Guise, Elaine] Univ Montreal, Dept Psychol, Campus Laval 1700,Rue Jacques Tetreault,Bur 6230, Laval, PQ H7N 0B6, Canada; [Tabet, Sabrina; Francoeur, Coralie; Sheehan, Audrey; Dagher, Jehane H.; Ursulet, Adriana; Colucci, Emma; de Guise, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Lague-Beauvais, Maude; Abouassaly, Michel; Marcoux, Judith; Dagher, Jehane H.] McGill Univ, Traumat Brain Injury Program, Hlth Ctr, Montreal, PQ, Canada; [Dagher, Jehane H.] McGill Univ, Phys Med & Rehabil Serv, Hlth Ctr, Montreal Gen Hosp, Montreal, PQ, Canada; [de Guise, Elaine] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada		de Guise, E (corresponding author), Univ Montreal, Dept Psychol, Campus Laval 1700,Rue Jacques Tetreault,Bur 6230, Laval, PQ H7N 0B6, Canada.	elaine.de.guise@umontreal.ca					Adrover-Roig D, 2012, BRAIN COGNITION, V78, P284, DOI 10.1016/j.bandc.2012.01.005; Allanson F, 2017, NEUROPSYCHOL REV, V27, P187, DOI 10.1007/s11065-017-9353-5; Baum CM, 2017, NEUROPSYCHOL REHABIL, V27, P603, DOI 10.1080/09602011.2016.1176934; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Bunk S, 2019, Z NEUROPSYCHOL, V30, P169, DOI 10.1024/1016-264X/a000264; Burgess P.W., 1997, HAYLING BRIXTON TEST; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; Dajani DR, 2015, TRENDS NEUROSCI, V38, P571, DOI 10.1016/j.tins.2015.07.003; Delis DC., 2001, DELIS KAPLAN EXECUTI; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Fisk JE, 2004, J CLIN EXP NEUROPSYC, V26, P874, DOI 10.1080/13803390490510680; Francoeur C., 2020, CARACTERISATION FONC; Frazier K., 2018, J LIFE CARE PLANNING, V16; Garcia-Molina A, 2012, BRAIN INJURY, V26, P864, DOI 10.3109/02699052.2012.655362; Ghawami H, 2017, APPL NEUROPSYCH-ADUL, V24, P299, DOI 10.1080/23279095.2016.1157078; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Honan CA, 2017, BRAIN IMPAIR, V18, P74, DOI 10.1017/BrImp.2016.27; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kumar S, 2013, CLIN NEUROL NEUROSUR, V115, P1326, DOI 10.1016/j.clineuro.2012.12.038; Lane-Brown AT, 2011, BRAIN IMPAIR, V12, P43, DOI 10.1375/brim.12.1.43; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Lewis Frank D, 2013, J Spec Oper Med, V13, P56; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Liu-Ambrose T, 2008, ARCH PHYS MED REHAB, V89, P1335, DOI 10.1016/j.apmr.2007.11.052; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Morogiello J., 2018, J CLIN TRANSLATIONAL, V4, P113; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Podell K, 2010, PSYCHIAT CLIN N AM, V33, P855, DOI 10.1016/j.psc.2010.08.003; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rabinowitz AR, 2018, J INT NEUROPSYCH SOC, V24, P237, DOI 10.1017/S1355617717000996; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rojas N., 2017, VALIDITE BATTERIE RA; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sigurdardottir S, 2020, J INT NEUROPSYCH SOC, V26, P654, DOI 10.1017/S1355617720000193; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Uddin LQ, 2021, NAT REV NEUROSCI, V22, P167, DOI 10.1038/s41583-021-00428-w; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wechsler D., 1997, ADM SCORING MANUAL W; Williams MW, 2013, CLIN NEUROPSYCHOL, V27, P356, DOI 10.1080/13854046.2013.765507; Wood RL, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00195	67	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2021.2002866		NOV 2021	10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	XB2YI	WOS:000721197800001	34807801				2022-02-06	
J	Goodin, P; Gardner, AJ; Dokani, N; Nizette, B; Ahmadizadeh, S; Edwards, S; Iverson, GL				Goodin, Peter; Gardner, Andrew J.; Dokani, Nasim; Nizette, Ben; Ahmadizadeh, Saeed; Edwards, Suzi; Iverson, Grant L.			Development of a Machine-Learning-Based Classifier for the Identification of Head and Body Impacts in Elite Level Australian Rules Football Players	FRONTIERS IN SPORTS AND ACTIVE LIVING			English	Article						Australian football; brain concussion; instrumented mouthguard; kinematics; impacts; machine learning	CHRONIC TRAUMATIC ENCEPHALOPATHY; VIDEO ANALYSIS; CONCUSSION; MAGNITUDE	Background: Exposure to thousands of head and body impacts during a career in contact and collision sports may contribute to current or later life issues related to brain health. Wearable technology enables the measurement of impact exposure. The validation of impact detection is required for accurate exposure monitoring. In this study, we present a method of automatic identification (classification) of head and body impacts using an instrumented mouthguard, video-verified impacts, and machine-learning algorithms.Methods: Time series data were collected via the Nexus A9 mouthguard from 60 elite level men (mean age = 26.33; SD = 3.79) and four women (mean age = 25.50; SD = 5.91) from the Australian Rules Football players from eight clubs, participating in 119 games during the 2020 season. Ground truth data labeling on the captures used in this machine learning study was performed through the analysis of game footage by two expert video reviewers using SportCode and Catapult Vision. The visual labeling process occurred independently of the mouthguard time series data. True positive captures (captures where the reviewer directly observed contact between the mouthguard wearer and another player, the ball, or the ground) were defined as hits. Spectral and convolutional kernel based features were extracted from time series data. Performances of untuned classification algorithms from scikit-learn in addition to XGBoost were assessed to select the best performing baseline method for tuning.Results: Based on performance, XGBoost was selected as the classifier algorithm for tuning. A total of 13,712 video verified captures were collected and used to train and validate the classifier. True positive detection ranged from 94.67% in the Test set to 100% in the hold out set. True negatives ranged from 95.65 to 96.83% in the test and rest sets, respectively.Discussion and conclusion: This study suggests the potential for high performing impact classification models to be used for Australian Rules Football and highlights the importance of frequencies <150 Hz for the identification of these impacts.	[Goodin, Peter] Univ Melbourne, Sch Med, Parkville, Vic, Australia; [Goodin, Peter; Dokani, Nasim; Nizette, Ben; Ahmadizadeh, Saeed] HitIQ Ltd, S Melbourne, Vic, Australia; [Gardner, Andrew J.; Edwards, Suzi] Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Stroke & Brain Injury, Callaghan, NSW, Australia; [Gardner, Andrew J.] Calvary Mater Hosp, Hunter New England Local Hlth Dist Sports Concuss, Waratah, NSW, Australia; [Gardner, Andrew J.] Hunter Med Res Inst, New Lambton Hts, NSW, Australia; [Edwards, Suzi] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Edwards, Suzi] Univ Newcastle, Prior Res Ctr Phys Act & Nutr, Callaghan, NSW, Australia; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Home Base, Charlestown, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Charlestown, MA USA		Goodin, P (corresponding author), Univ Melbourne, Sch Med, Parkville, Vic, Australia.; Goodin, P (corresponding author), HitIQ Ltd, S Melbourne, Vic, Australia.	peter@hitiq.co		Gardner, Andrew/0000-0001-5031-5586	HitIQ Limited	& nbsp;Funding for this study was provided by HitIQ Limited.	Abraham A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00014; Bailey AM, 2020, ANN BIOMED ENG, V48, P2678, DOI 10.1007/s10439-020-02637-3; Bartsch A.J.C., 2016, US Patent, Patent No. [9,289,176, 9289176]; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Carey L, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0182-3; Caswell SV, 2017, AM J SPORT MED, V45, P3374, DOI 10.1177/0363546517724754; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Dai JB, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118815448; Davis GA, 2019, BRIT J SPORT MED, V53, P1264, DOI 10.1136/bjsports-2019-100628; Davis GA, 2019, BRIT J SPORT MED, V53, P1299, DOI 10.1136/bjsports-2018-099727; Dempster A, 2020, DATA MIN KNOWL DISC, V34, P1454, DOI 10.1007/s10618-020-00701-z; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Gabler LF, 2020, ANN BIOMED ENG, V48, P2599, DOI 10.1007/s10439-020-02654-2; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-018-0133-4; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Kieffer EE, 2020, ANN BIOMED ENG, V48, P2613, DOI 10.1007/s10439-020-02647-1; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; Lundberg SM, 2017, ADV NEUR IN, V30; Lundberg SM, 2020, NAT MACH INTELL, V2, P56, DOI 10.1038/s42256-019-0138-9; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Nevins D, 2018, P I MECH ENG P-J SPO, V232, P242, DOI 10.1177/1754337117739458; O'Connor KL, 2017, ANN BIOMED ENG, V45, P1985, DOI 10.1007/s10439-017-1843-3; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Patton DA, 2020, ANN BIOMED ENG, V48, P2497, DOI 10.1007/s10439-020-02642-6; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rahimi A., 2007, P 20 INT C NEUR INF, P1177; Ramkumar PN, 2019, AM J SPORT MED, V47, P2287, DOI 10.1177/0363546519859542; Rubin LH, 2019, BRAIN INJURY, V33, P456, DOI 10.1080/02699052.2019.1565895; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Stitt D, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21186028; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3	45	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-9367		FRONT SPORTS ACT LIV	Front. Sports Act. Living	NOV 19	2021	3								725245	10.3389/fspor.2021.725245			10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	YH0WV	WOS:000742897900001	34870193	Green Published, gold			2022-02-06	
J	Ibrahim, O; Sutherland, HG; Lea, RA; Nasrallah, F; Maksemous, N; Smith, RA; Haupt, LM; Griffiths, LR				Ibrahim, Omar; Sutherland, Heidi G.; Lea, Rodney A.; Nasrallah, Fatima; Maksemous, Neven; Smith, Robert A.; Haupt, Larisa M.; Griffiths, Lyn R.			Discriminating head trauma outcomes using machine learning and genomics	JOURNAL OF MOLECULAR MEDICINE-JMM			English	Article						Concussion; Machine learning; Genomics; Head trauma; Neurotrauma	CLASSIFICATION; MIGRAINE	A percentage of the population suffers prolonged and persistent post-concussion symptoms (PCS) following average head injuries or develops severe neurological dysfunction following minor head trauma. Genetic variants that may contribute to individual response to head trauma have been investigated in some studies, but to date none have explored the use of machine learning (ML) methods with genomic data to specifically explore outcomes of head trauma. Whole exome sequencing (WES) was completed for three groups of individuals (N = 60): (a) 16 individuals with severe neurological responses to minor head trauma, (b) 26 individuals with persistent PCS and (c) 18 individuals with normal recovery from concussion or mTBI. Gradient boosted tree algorithms were applied to the data using XGBoost. By using variants with CADD scores above 15 in the training set (randomly sampled 70%), we identified signatures that accurately distinguish to accurately distinguish the test groups with an average area under the curve (AUC) of 0.8 (SE = 0.019). Metrics including positive and negative prediction values, as well as kappa were all within acceptable range to support the prediction accuracy. This study illustrates how ML methods in combination with WES data have the potential to predict severe or prolonged responses to head trauma from healthy recovery. Key messages Linear association analysis has been inconclusive in concussion genetics. Non-linear methods as boosted trees can offer better insights in small samples. Strong discrimination trends can be achieved from exome data of cases and controls.	[Ibrahim, Omar; Sutherland, Heidi G.; Lea, Rodney A.; Maksemous, Neven; Smith, Robert A.; Haupt, Larisa M.; Griffiths, Lyn R.] Queensland Univ Technol, Genom Res Ctr, Ctr Genom & Personalised Hlth, Sch Biomed Sci, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia; [Nasrallah, Fatima] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia		Griffiths, LR (corresponding author), Queensland Univ Technol, Genom Res Ctr, Ctr Genom & Personalised Hlth, Sch Biomed Sci, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia.	lyn.griffiths@qut.edu.au	Ibrahim, Omar/ABB-6012-2021	Ibrahim, Omar/0000-0003-2495-9286; Haupt, Larisa/0000-0002-7735-8110; Griffiths, Lyn/0000-0002-6774-5475	Department of Defence [W81XWH1910098]; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [GNT1122387]	This work was supported by The Assistant Secretary of Defence for Health Affairs endorsed by the Department of Defence, through FY 2018 Peer Reviewed Medical Research Program Discovery Award, under Award No. W81XWH1910098. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. This work was supported by the National Health and Medical Research Council through grant GNT1122387-Identifying novel gene mutations for molecular diagnosis of familial hemiplegic migraine.	Ashley EA, 2015, JAMA-J AM MED ASSOC, V313, P2119, DOI 10.1001/jama.2015.3595; Auffray C, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0618-x; Ben-David A, 2008, EXPERT SYST APPL, V34, P825, DOI 10.1016/j.eswa.2006.10.022; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Chung RS, 2009, NEUROTOX RES, V15, P381, DOI 10.1007/s12640-009-9044-y; Coyle HL, 2018, NEUROSCI BIOBEHAV R, V92, P140, DOI 10.1016/j.neubiorev.2018.05.027; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Daneshjou R, 2017, HUM MUTAT, V38, P1182, DOI 10.1002/humu.23280; Er F, 2017, J CLIN NEUROSCI, V42, P186, DOI 10.1016/j.jocn.2017.03.021; Fado R, 2021, PROG LIPID RES, V81, DOI 10.1016/j.plipres.2020.101071; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gonzalez-Recio O, 2013, J DAIRY SCI, V96, P614, DOI 10.3168/jds.2012-5630; Ibrahim O, 2020, J NEUROTRAUM, V37, P1870, DOI 10.1089/neu.2019.6962; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kassahun Y, 2014, ARTIF INTELL MED, V61, P79, DOI 10.1016/j.artmed.2014.03.001; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Maksemous N., 2019, CEPHALALGIA REP, V2, p2515816319881630, DOI 10.1177/2515816319881630; McDevitt Jane, 2017, Concussion, V2, pCNC26, DOI 10.2217/cnc-2016-0020; Messina R, 2018, CURR OPIN NEUROL, V31, P379, DOI 10.1097/WCO.0000000000000573; Pare G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13056-1; Park JH, 2019, RESUSCITATION, V142, P127, DOI 10.1016/j.resuscitation.2019.07.020; Rasmussen AH, 2020, J MED GENET, V57, P610, DOI 10.1136/jmedgenet-2019-106640; Rocca MA, 2006, STROKE, V37, P1765, DOI 10.1161/01.STR.0000226589.00599.4d; Romagnoni A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46649-z; SEIGEL DG, 1992, AM J EPIDEMIOL, V135, P571, DOI 10.1093/oxfordjournals.aje.a116324; Sweadner KJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151429; Trakadis YJ, 2019, AM J MED GENET B, V180, P103, DOI 10.1002/ajmg.b.32638; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zareba N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239003; Zhang L, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.65	32	0	0	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0946-2716	1432-1440		J MOL MED	J. Mol. Med.	FEB	2022	100	2					303	312		10.1007/s00109-021-02158-z		NOV 2021	10	Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity; Research & Experimental Medicine	YJ6EW	WOS:000720596500002	34797388				2022-02-06	
J	Naghibi, T; Rostami, M; Jamali, B; Karimimoghaddam, Z; Zeraatchi, A; Rouhi, AJ				Naghibi, Taraneh; Rostami, Mina; Jamali, Behrad; Karimimoghaddam, Zhaleh; Zeraatchi, Alireza; Rouhi, Asghar Jafari			Predicting factors for abnormal brain computed tomography in children with minor head trauma	BMC EMERGENCY MEDICINE			English	Article						Minor head trauma; Children; Traumatic brain injury; Brain computed tomography scan	CT SCANS; INJURY; ADULT	Background Deciding whether a cranial Computed Tomography (CT) scan in a patient with minor head trauma (MHT) is necessary or not has always been challenging. Diagnosing Traumatic Brain Injury (TBI) is a fundamental part of MHT managing especially in children who are more vulnerable in terms of brain CT radiation consequences and TBI. Defining some indications to timely and efficiently predict the likelihood of TBI is necessary. Thus, we aimed to determine the impact of clinical findings to predict the need for brain CT in children with MHT. Methods In a prospective cohort study, 200 children (2 to 14 years) with MHT were included from 2019 to 2020. The data of MHT-related clinical findings were gathered. The primary and secondary outcomes were defined as a positive brain CT and any TBI requiring neurosurgery intervention, respectively. In statistical analysis, we performed Binary Logistic regression analysis, Fisher's exact test and independent samples t-test using SPSS V.26. Results The mean age of participants was 6.5 +/- 3.06 years. Ninety patients underwent brain CT. The most common clinical finding and injury mechanism were headache and falling from height, respectively. The results of brain CTs were positive in seven patients (3.5%). We identified three predicting factors for an abnormal brain CT including headache, decreased level of consciousness, and vomiting. Conclusion We showed that repetitive vomiting (>= 2), headache, and decreased level of consciousness are predicting factors for an abnormal brain CT in children with MHT.	[Naghibi, Taraneh] Zanjan Univ Med Sci, Ayatollah Mousavi Hosp, Sch Med, Dept Anesthesiol & Crit Care Med, Zanjan, Iran; [Rostami, Mina] Zanjan Univ Med Sci, Social Determinants Hlth Res Ctr, Zanjan, Iran; [Jamali, Behrad; Zeraatchi, Alireza; Rouhi, Asghar Jafari] Zanjan Univ Med Sci, Valiasr E Asr Hosp, Ayatollah Mousavi Hosp, Dept Emergency Med,Sch Med, Zanjan, Iran; [Karimimoghaddam, Zhaleh] Zanjan Univ Med Sci, Valiasr E Asr Hosp, Sch Med, Dept Radiat Oncol, Zanjan, Iran		Zeraatchi, A (corresponding author), Zanjan Univ Med Sci, Valiasr E Asr Hosp, Ayatollah Mousavi Hosp, Dept Emergency Med,Sch Med, Zanjan, Iran.	zeraatchi.zums@gmail.com	Naghibi, Taraneh/M-5900-2016	Naghibi, Taraneh/0000-0001-6882-7598			af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; Arambula SE, 2019, EXP NEUROL, V317, P168, DOI 10.1016/j.expneurol.2019.02.016; Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Borland ML, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3123; Bozan O, 2019, EUR J TRAUMA EMERG S, V45, P849, DOI 10.1007/s00068-017-0865-8; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Derakhshanfar H, 2020, EUR J TRANSL MYOL, V30, P159, DOI 10.4081/ejtm.2019.8613; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Gizli G, 2020, HONG KONG J EMERG ME, DOI 10.1177/1024907920930510; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Mohammaddoust M, 2020, ARCH ACAD EMERG MED, V8; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Sharif-Alhoseini Mahdi, 2011, J Emerg Trauma Shock, V4, P472, DOI 10.4103/0974-2700.86631; Shetty VS, 2016, J AM COLL RADIOL, V13, P668, DOI 10.1016/j.jacr.2016.02.023; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Subaiya S, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-17; Thiam DW, 2015, ANN ACAD MED SINGAP, V44, P335; Vaniyapong Tanat, 2019, Surg Neurol Int, V10, P64, DOI 10.25259/SNI-101-2019; Yildizhan S, 2019, ULUS TRAVMA ACIL CER, V25, P378, DOI 10.5505/tjtes.2018.94849	24	0	0	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-227X			BMC EMERG MED	BMC Emerg. Med.	NOV 19	2021	21	1							142	10.1186/s12873-021-00540-1			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XA4QK	WOS:000720633300001	34798828	gold, Green Published			2022-02-06	
J	Nimptsch, U; Blumel, M; Topf, T; Stepath, K; Busse, R				Nimptsch, Ulrike; Blumel, Miriam; Topf, Thomas; Stepath, Kai; Busse, Reinhard			Recording Trauma Care in German Hospital Discharge Data: Services Provided by Hospitals Owned by Workers' Compensation Funds and Financed through Statutory Accidental Insurance	GESUNDHEITSWESEN			German	Article; Early Access						hospital administrative data; DRG statistics; workers' compensation funds hospitals; statutory insurance for occupational accidents; trauma care		Zusammenfassung Hintergrund Mit der Fallpauschalenbezogenen Krankenhausstatistik (DRG-Statistik) verfugt Deutschland uber ein nahezu vollstandiges Register aller akutstationaren Krankenhausbehandlungen. Behandlungen zu Lasten der gesetzlichen Unfallversicherung, die in Krankenhausern der Berufsgenossenschaften (BG Kliniken) erbracht werden, sind jedoch von der von der Abrechnung nach dem DRG-System und damit von der Datenubermittlungspflicht ausgenommen. Daher ist davon auszugehen, dass die DRG-Statistik im Bereich der Verletztenversorgung das stationare Behandlungsaufkommen nicht vollstandig abbildet. Methode Zur Abbildung der Versorgung von Verletzungen und Verletzungsfolgen wurden Leistungsgruppen definiert, deren Fallzahlen sowohl in den Mikrodaten der DRG-Statistik als auch in den Leistungsdaten aller neun BG Kliniken berechnet wurden. Durch die Unterscheidung des Kostentragers in den Leistungsdaten der BG Kliniken (Gesetzliche Unfallversicherung vs. andere) lie ss en sich die Schnittmenge der beiden Datenbestande sowie der Anteil der nicht in der DRG-Statistik enthaltenen und damit nicht erfassten Behandlungsfalle quantifizieren. Einbezogen wurden die Datenjahre 2016 bis 2018. Ergebnisse Je nach Leistungsgruppe liegt die Untererfassung der Behandlungsfalle in der DRG-Statistik kumuliert uber die Jahre 2016 bis 2018 zwischen 0,1% und mehr als 60%. Die gro ss ten Anteile der nicht in der DRG-Statistik erfassten Behandlungsfalle betreffen die Fruhrehabilitation nach Schadel-Hirn-Verletzungen (Untererfassung 61%), die Versorgung von Querschnittverletzungen (Untererfassung 14% bei Erstversorgung, 23% bei Folgebehandlung), Amputationsverletzungen (Untererfassung 13%) und schwere Handverletzungen (Untererfassung 5%). Schlussfolgerung Die Mikrodaten der DRG-Statistik sind in Bezug auf Erkrankungen und Behandlungen, die nicht in die Leistungspflicht der gesetzlichen Unfallversicherung fallen, als nahezu vollstandig anzusehen. In der Verletztenversorgung ergeben sich jedoch gro ss ere Erfassungslucken durch die Versorgung in den BG Kliniken zu Lasten der gesetzlichen Unfallversicherung. Eine vollstandige Abbildung der Verletztenversorgung ist nur unter Einbeziehung der Leistungsdaten der BG Kliniken moglich. Abstract Background In Germany, the Diagnosis-Related Group Statistics (DRG Statistics) represent an almost complete discharge data-based registry of inpatient services in acute care hospitals. However, services of hospitals owned by workers' compensation funds and financed through the statutory insurance for occupational accidents are excluded from the obligation of submitting hospital discharge data. Hence, the DRG statistics might be incomplete regarding inpatient services for trauma care. Methods In order to illustrate trauma and post-trauma care in acute care hospitals, groups of specific inpatient services were defined. Numbers of cases according to these groups were identified in the microdata of the DRG statistics, as well as in the inpatient data of all nine workers' compensation funds hospitals in Germany. By dividing cases financed through the statutory insurance for occupational accidents from cases financed through other payers, the overlap of both databases as well as the share of cases not recorded in the DRG statistics were quantified. The analysis comprised data of 2016-2018. Results Depending on the type of service, the share of cases not recorded in the DRG statistics varied between 0.1% and more than 60% (accumulated 2016 to 2018). There was under-recording of early-stage rehabilitation for traumatic brain injury (61%), treatment for traumatic paraplegia (14% for initial treatment and 23% for subsequent treatment), treatment for amputation injury (13%) and treatment for severe hand injury (5%). Conclusion Regarding inpatient services that are not covered by the statutory insurance for occupational accidents, the microdata of the DRG statistics can be considered as virtually complete. However, inpatient services for trauma care are not completely recorded because discharge data are not submitted by hospitals run by workers' compensation funds when services are financed through the statutory insurance for occupational accidents. Analyses of trauma care can only be complete if data of hospitals financed by workers' compensation funds are included.	[Nimptsch, Ulrike; Blumel, Miriam; Busse, Reinhard] Tech Univ Berlin, Fachgebiet Management Gesundheitswesen, Berlin, Germany; [Blumel, Miriam; Busse, Reinhard] Tech Univ Berlin, Gesundheitsokon Zentrum Berlin, Berlin, Germany; [Topf, Thomas; Stepath, Kai] PD Berater Offentlichen Hand GmbH, Marktbereich Gesundheitswesen Wissensch & Forsch, Berlin, Germany		Nimptsch, U (corresponding author), TU Berlin, Strukturentwicklung & Qualitatsmanagement Gesundh, Fraunhoferstr 33-36, D-10587 Berlin, Germany.	ulrike.nimptsch@tu-berlin.de					[Anonymous], 2019, STAT SCHULERUNFALLGE; [Anonymous], 2018, FORSCHUNGSDATENZENTR; Forschungsdatenzentren der Statistischen Amter des Bundes und der Lander, 2019, MET TEIL I ALLG METH	3	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0941-3790	1439-4421		GESUNDHEITSWESEN	Gesundheitswesen												10.1055/a-1665-6874		NOV 2021	9	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	XA3AS	WOS:000720524900001	34798663				2022-02-06	
J	Paulus, MP; Kuplicki, R; Victor, TA; Yeh, HW; Khalsa, SS				Paulus, Martin P.; Kuplicki, Rayus; Victor, Teresa A.; Yeh, Hung-Wen; Khalsa, Sahib S.			Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial	BMC PSYCHIATRY			English	Article						Adherence; Computational psychiatry; Stimulant; Computational neuroscience; Pharmacotherapy	TRAUMATIC BRAIN-INJURY; SEQUENCED TREATMENT ALTERNATIVES; NECESSITY-CONCERNS FRAMEWORK; STAR-ASTERISK-D; MEDICATION ADHERENCE; FINANCIAL INCENTIVES; PSYCHOLOGICAL INTERVENTIONS; NEUROPSYCHIATRIC SEQUELAE; IMPROVING ADHERENCE; HABIT FORMATION	Background: Adherence to treatment, i.e. the extent to which a patient's therapeutic engagement coincides with the prescribed treatment, is among the most important problems in mental health care. The current study investigated the influence of pairing an acute positive reinforcing dopaminergic/noradrenergic effect (methylphenidate, MPH) with a standard antidepressant on the rates of adherence to medication treatment. The primary objective of this study was to determine whether MPH + escitalopram resulted in higher rates of medication adherence relative to placebo + escitalopram. Methods: Twenty participants with moderate to severe depression were 1-1 randomized to either (1) 5 mg MPH + 10 mg escitalopram or (2) placebo + 10 mg escitalopram with the possibility for a dose increase at 4 weeks. A Bayesian analysis was conducted to evaluate the outcomes. Results: First, neither percent Pill count nor Medication Electronic Monitoring System adherence showed that MPH was superior to placebo. In fact, placebo showed slightly higher adherence rates on the primary (7.82% better than MPH) and secondary (7.07% better than MPH) outcomes. There was a less than 25% chance of MPH augmentation showing at least as good or better adherence than placebo. Second, both groups showed a significant effect of treatment on the QIDS-SR with a median effect of an 8.6-point score reduction. Third, neither subjective measures of adherence attitudes nor socio-demographic covariates had a significant influence on the primary or secondary outcome variables. Conclusions: These data do not support the use of MPH to increase adherence to antidepressant medication in individuals with moderate to severe depression. identifier , registered on 01/02/2018.	[Paulus, Martin P.; Kuplicki, Rayus; Victor, Teresa A.; Yeh, Hung-Wen; Khalsa, Sahib S.] Laureate Inst Brain Res, 6655 S Yale Ave, Tulsa, OK 74136 USA; [Paulus, Martin P.; Khalsa, Sahib S.] Univ Tulsa, Oxley Coll Hlth Sci, Tulsa, OK 74104 USA; [Yeh, Hung-Wen] Childrens Mercy Hosp, Hlth Serv & Outcomes Res, Kansas City, MO 64108 USA		Paulus, MP (corresponding author), Laureate Inst Brain Res, 6655 S Yale Ave, Tulsa, OK 74136 USA.; Paulus, MP (corresponding author), Univ Tulsa, Oxley Coll Hlth Sci, Tulsa, OK 74104 USA.	mpaulus@laureateinstitute.org	Khalsa, Sahib S. S/Q-1434-2018	Khalsa, Sahib S. S/0000-0003-2124-8585	William K. Warren Foundation; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [U01 DA041089]; National Institute of General Medical Sciences CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [1P20GM121312]	This work has been supported in part by The William K. Warren Foundation, the National Institute on Drug Abuse (U01 DA041089), and the National Institute of General Medical Sciences Center Grant Award Number (1P20GM121312). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aikens JE, 2005, ANN FAM MED, V3, P23, DOI 10.1370/afm.238; Asch DA, 2015, JAMA-J AM MED ASSOC, V314, P1926, DOI 10.1001/jama.2015.14850; Bayley PJ, 2005, NATURE, V436, P550, DOI 10.1038/nature03857; Bosman J, 2014, THER ADV PSYCHOPHARM, V4, P61, DOI 10.1177/2045125313511486; Bosworth HB, 2008, INT J GERIATR PSYCH, V23, P129, DOI 10.1002/gps.1852; Bosworth HB, 2017, J GEN INTERN MED, V32, P93, DOI 10.1007/s11606-016-3851-7; Bosworth HB, 2011, AM HEART J, V162, P412, DOI 10.1016/j.ahj.2011.06.007; Branconnier R J, 1980, Proc Annu Meet Am Psychopathol Assoc, V69, P183; Brandstetter S, 2018, J HEALTH PSYCHOL, V23, P1185, DOI 10.1177/1359105316646440; Brignell CM, 2006, PSYCHOPHARMACOLOGY, V186, P504, DOI 10.1007/s00213-006-0363-x; Broadbent NJ, 2007, LEARN MEMORY, V14, P145, DOI 10.1101/lm.455607; Brook OH, 2005, PSYCHIAT SERV, V56, P487, DOI 10.1176/appi.ps.56.4.487; Brown C, 2005, MED CARE, V43, P1203, DOI 10.1097/01.mlr.0000185733.30697.f6; Burnett-Zeigler I, 2014, INT J GERIATR PSYCH, V29, P169, DOI 10.1002/gps.3984; Byrne KA, 2021, J BEHAV THER EXP PSY, V73, DOI 10.1016/j.jbtep.2021.101676; Castro A, 2020, J AFFECT DISORDERS, V260, P514, DOI 10.1016/j.jad.2019.09.023; CHAIT LD, 1994, BEHAV PHARMACOL, V5, P281, DOI 10.1097/00008877-199406000-00005; Challman TD, 2000, MAYO CLIN PROC, V75, P711; Clifford S, 2008, J PSYCHOSOM RES, V64, P41, DOI 10.1016/j.jpsychores.2007.05.004; Corrigan PW, 2014, REHABIL PSYCHOL, V59, P85, DOI 10.1037/a0034935; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Dodd S, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-84; Dupclay Leon, 2012, Patient Prefer Adherence, V6, P499, DOI 10.2147/PPA.S31417; Foot H, 2016, PATIENT EDUC COUNS, V99, P706, DOI 10.1016/j.pec.2015.11.004; Gearing RE, 2014, HARVARD REV PSYCHIAT, V22, P31, DOI [10.1097/HRP.0000000000000005, 10.1097/HRP.10.1097/HRP.0000000000000005]; Gibbons RD, 2005, ARCH GEN PSYCHIAT, V62, P165, DOI 10.1001/archpsyc.62.2.165; Glue P, 2010, AUST NZ J PSYCHIAT, V44, P697, DOI 10.3109/00048671003705441; Goodrich B., RSTANARM BAYESIAN AP; Hoo ZH, 2019, THORAX, V74, P197, DOI 10.1136/thoraxjnl-2017-211453; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Horne R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080633; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; Kahana S, 2008, J PEDIATR PSYCHOL, V33, P590, DOI 10.1093/jpepsy/jsm128; Kay M, 2021, TIDYBAYES TIDY DATA; Kim KH, 2011, J AFFECT DISORDERS, V132, P121, DOI 10.1016/j.jad.2011.02.016; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Klein NS, 2017, DEPRESS ANXIETY, V34, P227, DOI 10.1002/da.22598; Kraemer HC, 2006, ARCH GEN PSYCHIAT, V63, P484, DOI 10.1001/archpsyc.63.5.484; KRAUS MF, 1995, INT J PSYCHIAT MED, V25, P39, DOI 10.2190/BXRM-3M58-WBC5-A7EL; Kuczenski R, 1997, J NEUROCHEM, V68, P2032; Lally P, 2010, EUR J SOC PSYCHOL, V40, P998, DOI 10.1002/ejsp.674; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; LING TM, 1963, PRACTITIONER, V191, P201; Linnemayr S, 2017, AIDS, V31, P719, DOI 10.1097/QAD.0000000000001387; Marengoni A, 2016, J CLIN PSYCHIAT, V77, P1712, DOI 10.4088/JCP.15m10503; Markowitz JS, 2006, J CHILD ADOL PSYCHOP, V16, P687, DOI 10.1089/cap.2006.16.687; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; Mehta MA, 2000, J NEUROSCI, V20; Melfi CA, 1998, ARCH GEN PSYCHIAT, V55, P1128, DOI 10.1001/archpsyc.55.12.1128; Menon V, 2018, J PSYCHIATR RES, V104, P163, DOI 10.1016/j.jpsychires.2018.07.013; Milea D, 2010, CLIN THER, V32, P2057, DOI 10.1016/j.clinthera.2010.11.011; Noordraven EL, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1730-y; Novick D, 2015, PATIENT PREFER ADHER, V9, P421, DOI 10.2147/PPA.S68432; Olfson M, 2006, AM J PSYCHIAT, V163, P101, DOI 10.1176/appi.ajp.163.1.101; Organization WH, 2003, ADH LONG TERM THER E, P196; Pai ALH, 2014, J PEDIATR PSYCHOL, V39, P918, DOI 10.1093/jpepsy/jsu038; Pavlovskaya M, 2007, BRAIN INJURY, V21, P489, DOI 10.1080/02699050701311117; Pedersen ER, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0788-8; Petersen LA, 2013, JAMA-J AM MED ASSOC, V310, P1042, DOI 10.1001/jama.2013.276303; Phillips LA, 2014, ANN BEHAV MED, V48, P7, DOI 10.1007/s12160-013-9579-2; Poluzzi E, 2013, EUR J CLIN PHARMACOL, V69, P2095, DOI 10.1007/s00228-013-1567-8; Pompili M, 2009, EXPERT REV NEUROTHER, V9, P985, DOI [10.1586/ern.09.62, 10.1586/ERN.09.62]; Priebe S, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20700; Priebe S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5847; Pyne JM, 2018, J NERV MENT DIS, V206, P142, DOI 10.1097/NMD.0000000000000766; Ramsey RR, 2014, HEADACHE, V54, P795, DOI 10.1111/head.12353; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Russell J, 2008, NEW ZEAL MED J, V121, P14; Satpute Sachin, 2016, Perspect Clin Res, V7, P128, DOI 10.4103/2229-3485.184816; Serna MC, 2010, EUR PSYCHIAT, V25, P206, DOI 10.1016/j.eurpsy.2009.07.012; Siddall ORM, 2005, ANN PHARMACOTHER, V39, P1309, DOI 10.1345/aph.1E637; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; Sinyor M, 2010, CAN J PSYCHIAT, V55, P126, DOI 10.1177/070674371005500303; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Steinkamp JM, 2019, JMIR MENT HEALTH, V6, DOI 10.2196/12493; Stetler C, 2014, PSYCHOL HEALTH, V29, P127, DOI 10.1080/08870446.2013.830721; Treadway MT, 2016, CURR TOP BEHAV NEURO, V27, P337, DOI 10.1007/7854_2015_400; van Geffen Erica C G, 2010, Int J Pharm Pract, V18, P217, DOI 10.1111/j.2042-7174.2010.00035.x; Vergouwen ACM, 2003, J CLIN PSYCHIAT, V64, P1415, DOI 10.4088/JCP.v64n1203; Volkow N D, 2001, J Neurosci, V21, pRC121; Volkow ND, 1999, J PSYCHOPHARMACOL, V13, P337, DOI 10.1177/026988119901300406; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; Volkow ND, 1999, J PHARMACOL EXP THER, V288, P14; VOLKOW ND, 1995, ARCH GEN PSYCHIAT, V52, P456; Volpp KG, 2017, JAMA INTERN MED, V177, P1093, DOI 10.1001/jamainternmed.2017.2449; Wagenmakers EJ, 2018, PSYCHON B REV, V25, P58, DOI [10.3758/s13423-017-1323-7, 10.3758/s13423-017-1343-3]; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whitehead J, 2009, PHARM STAT, V8, P125, DOI 10.1002/pst.341; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Wood W, 2016, ANNU REV PSYCHOL, V67, P289, DOI 10.1146/annurev-psych-122414-033417; Yu XX, 2021, CEREB CORTEX, V31, P3551, DOI 10.1093/cercor/bhab031; Yue Z, 2014, CLIN RES CARDIOL, V103, P229, DOI 10.1007/s00392-013-0642-6; Zhang Z, 2014, CLIN TRIALS, V11, P195, DOI 10.1177/1740774513512565	96	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-244X		BMC PSYCHIATRY	BMC Psychiatry	NOV 19	2021	21	1							582	10.1186/s12888-021-03583-7			14	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	XA4RG	WOS:000720635500001	34798853	gold, Green Published			2022-02-06	
J	Schroeppel, TJ; Clement, LP; Douville, AA; Schmoekel, NH; Stassinopoulos, J; Decker, C; Stillman, ZE; Rodriquez, J; Brockman, VP; Hennessy, E; Heise, H; Khan, AD				Schroeppel, Thomas J.; Clement, Lesley P.; Douville, Alyssa A.; Schmoekel, Nathan H.; Stassinopoulos, Jerry; Decker, Cassandra; Stillman, Zachery E.; Rodriquez, Jennifer; Brockman, Valerie P.; Hennessy, Elizabeth; Heise, Holly; Khan, Abid D.			Time is of the Essence: Impact of a More Aggressive Chemical Venous Thromboembolism Prophylaxis Regimen on Trauma Patients	AMERICAN SURGEON			English	Article; Early Access						trauma; venous thromboembolism; prophylaxis	MOLECULAR-WEIGHT HEPARIN; PULMONARY-EMBOLISM; BRAIN-INJURY; IMPROVEMENT; SAFETY	Background Trauma patients are at high risk for venous thromboembolism (VTE). Opportunity for chemical VTE prophylaxis improvement was identified and practice was altered to start chemoprophylaxis on admission in most patients. The purpose of this study was to determine if early VTE prophylaxis is safe and reduces VTE. Methods The trauma registry was queried over a 12-month period for patients admitted greater than 1 day for traumatic injury. The study spanned 6 months on either side of instituting aggressive chemoprophylaxis. Patients were risk adjusted on demographics, Injury Severity Score, transfusions, procedure type, length of stay, and mortality. Pre-intervention patients were then compared to patients in the aggressive cohort with the primary outcome of VTE. Secondary outcomes included transfusions, mortality, and length of stay (LOS). Results 1597 patients were identified over the study period with 754 (47%) patients in the aggressive period. There were no differences in age, sex, Injury Severity Score, transfusions, procedures, or LOS between cohorts. Pre-algorithm patients were more likely to have penetrating mechanism (9.3% vs 6.6%; P = .009) and longer time to VTE prophylaxis (23.3 vs 13.9 hours; P < .001). No differences were noted in anticoagulant, VTE rate (2.0% vs 1.2%; P = .195), or mortality. Linear regression analysis identified time to chemical prophylaxis as significant predictor of VTE (beta = 43.9, P < .001). Conclusions Early aggressive chemical VTE prophylaxis is safe without increasing transfusions. Venous thromboembolism rates were decreased, but did not reach statistical significance.	[Schroeppel, Thomas J.; Schmoekel, Nathan H.; Stassinopoulos, Jerry; Khan, Abid D.] UCHlth Mem Hosp, Dept Surg, 1400 E Boulder St, Colorado Springs, CO 80909 USA; [Clement, Lesley P.; Douville, Alyssa A.] UCHlth Mem Hosp, Dept Pharm, Colorado Springs, CO 80909 USA; [Decker, Cassandra; Stillman, Zachery E.; Rodriquez, Jennifer; Brockman, Valerie P.; Hennessy, Elizabeth; Heise, Holly] UCHlth Mem Hosp, Dept Trauma Res, Colorado Springs, CO 80909 USA		Schroeppel, TJ (corresponding author), UCHlth Mem Hosp, Dept Surg, 1400 E Boulder St, Colorado Springs, CO 80909 USA.	thomas.schroeppel@uchealth.org		Rodriquez, Jennifer/0000-0002-4322-1271			Benjamin E, 2019, INJURY, V50, P697, DOI 10.1016/j.injury.2019.02.009; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Coleman JR, 2019, AM J SURG, V218, P1065, DOI 10.1016/j.amjsurg.2019.08.024; Cothren CC, 2007, WORLD J SURG, V31, P98, DOI 10.1007/s00268-006-0304-1; Davis ML., 2015, ACS TQIP BEST PRACTI; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Gritsiouk Y, 2014, AM J SURG, V207, P648, DOI 10.1016/j.amjsurg.2013.12.010; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Joseph B, 2015, AM J SURG, V209, P194, DOI 10.1016/j.amjsurg.2014.03.007; Menaker J, 2007, J TRAUMA, V63, P620, DOI 10.1097/TA.0b013e31812f60aa; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Sarkar B, 2011, J TRAUMA, V71, P1447, DOI 10.1097/TA.0b013e3182325d32; Schellenberg M, 2019, WORLD J SURG, V43, P2797, DOI 10.1007/s00268-019-05096-7; Shafi S, 2008, J TRAUMA, V64, P599, DOI 10.1097/TA.0b013e31816533f9; Skarupa D, 2019, J TRAUMA ACUTE CARE, V87, P1104, DOI 10.1097/TA.0000000000002438; Steele N, 2005, J BONE JOINT SURG BR, V87B, P209, DOI 10.1302/0301-620X.87B2.14447; Van Gent JM, 2017, J TRAUMA ACUTE CARE, V83, P1154, DOI 10.1097/TA.0000000000001652; Virchow R, 1856, GESAMMELLE ABHANDLUN; Zeeshan M, 2018, J TRAUMA ACUTE CARE, V85, P387, DOI 10.1097/TA.0000000000001916	20	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.											00031348211050839	10.1177/00031348211050839		NOV 2021	8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XC3MU	WOS:000721922000001	34797198				2022-02-06	
J	Zhang, HY; Huang, YY; Li, XJ; Han, X; Hu, J; Wang, B; Zhang, L; Zhuang, PW; Zhang, YJ				Zhang, Hanyu; Huang, Yingying; Li, Xiaojin; Han, Xu; Hu, Jing; Wang, Bin; Zhang, Lin; Zhuang, Pengwei; Zhang, Yanjun			Dynamic Process of Secondary Pulmonary Infection in Mice With Intracerebral Hemorrhage	FRONTIERS IN IMMUNOLOGY			English	Article						intracerebral hemorrhage; immunosuppression; intestinal barrier dysfunction; translocation of intestinal flora; pulmonary infection	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; GUT; TRANSLOCATION; ACTIVATION; MICROBIOTA; BACTERIA	Stroke is a common central nervous system disease in clinical practice. Stroke patients often have infectious complications, such as pneumonia and infections of the urinary tract and gastrointestinal tract. Although it has been shown that translocation of the host gut microbiota to the lungs and immune dysfunction plays a vital role in the development of infection after ischemic stroke, the occurrence and mechanism of pulmonary infection at different time points after hemorrhagic cerebral remain unclear. In this study, the changes in the immune system and intestinal barrier function in mice during disease development were investigated at 1 day (M 1 d), 3 days (M 3 d) and 7 days (M 7 d) following hemorrhagic stroke to clarify the mechanism of secondary pulmonary infection. The experimental results revealed that after hemorrhagic stroke, model mice showed increased brain damage from day 1 to 3, followed by a trend of brain recovery from day 3 to 7 . After hemorrhagic stroke, the immune system was disturbed in model mice. Significant immunosuppression of the peripheral immune system was observed in the M 3 d group but improved in the M 7 d group. Staining of lung tissues with hematoxylin and eosin (H&E) and for inflammatory factors revealed considerable disease and immune disorders in the M 7 d group. Stroke seriously impaired intestinal barrier function in mice and significantly changed the small intestine structure. From 1 to 7 d after stroke, intestinal permeability was increased, whereas the levels of markers for intestinal tight junctions, mucus and immunoglobulin A were decreased. Analysis based on 16S rRNA suggested that the microflora in the lung and ileum was significantly altered after stroke. The composition of microflora in lung and ileum tissue was similar in the M 7d group, suggesting that intestinal bacteria had migrated to lung tissue and caused lung infection at this time point after hemorrhagic stroke. In stroke mice, the aggravation of intestinal barrier dysfunction and immune disorders after intracerebral hemorrhage, promoted the migration of enteric bacteria, and increased the risk of pneumonia poststroke. Our findings reveal the dynamic process of infection after hemorrhagic stroke and provide clues for the optimal timing of intervention for secondary pulmonary infection in stroke patients.	[Zhang, Hanyu; Huang, Yingying; Li, Xiaojin; Han, Xu; Hu, Jing; Wang, Bin; Zhang, Lin; Zhuang, Pengwei; Zhang, Yanjun] Tianjin Univ Tradit Chinese Med, Coll Chinese Mat Med, Tianjin, Peoples R China; [Zhang, Hanyu; Huang, Yingying; Li, Xiaojin; Han, Xu; Hu, Jing; Wang, Bin; Zhang, Lin; Zhuang, Pengwei; Zhang, Yanjun] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Huang, Yingying] Anhui Univ Chinese Med, Coll Pharm, Hefei, Peoples R China; [Huang, Yingying] Anhui Acad Chinese Med, Hefei, Peoples R China		Zhuang, PW; Zhang, YJ (corresponding author), Tianjin Univ Tradit Chinese Med, Coll Chinese Mat Med, Tianjin, Peoples R China.; Zhuang, PW; Zhang, YJ (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China.	zhuangpengwei@163.com; zyjsunye@163.com					Bai W, 2018, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00755; Balami JS, 2018, INT J STROKE, V13, P348, DOI 10.1177/1747493017743051; Becker KJ, 2012, J NEUROCHEM, V123, P148, DOI 10.1111/j.1471-4159.2012.07953.x; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Branca JJV, 2019, AGEING RES REV, V54, DOI 10.1016/j.arr.2019.100938; Brandenberger C, 2018, AGING DIS, V9, P553, DOI 10.14336/AD.2017.0902; Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chapman KZ, 2009, J CEREBR BLOOD F MET, V29, P1764, DOI 10.1038/jcbfm.2009.113; Chen AL, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0743-z; Chen Y, 2020, MOL MED, V26, DOI 10.1186/s10020-020-00230-x; Crapser J, 2016, AGING-US, V8, P1049, DOI 10.18632/aging.100952; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; Ding MF, 2021, TRENDS MICROBIOL, V29, P725, DOI 10.1016/j.tim.2021.01.012; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Elmer J, 2013, CRIT CARE MED, V41, P1992, DOI 10.1097/CCM.0b013e31828a3f4d; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Furlan JC, 2006, SPINE, V31, P2674, DOI 10.1097/01.brs.0000244569.91204.01; Han XN, 2018, NEUROLOGIST, V23, P35, DOI 10.1097/NRL.0000000000000152; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Ionita CC, 2011, J STROKE CEREBROVASC, V20, P1, DOI 10.1016/j.jstrokecerebrovasdis.2009.09.011; Jin R, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00853; Jin WN, 2018, FASEB J, V32, P2757, DOI 10.1096/fj.201700962R; Kaur G, 2019, J NEUROL SCI, V399, P161, DOI 10.1016/j.jns.2019.02.016; Kishore AK, 2019, EUR STROKE J, V4, P318, DOI 10.1177/2396987319851335; Kishore AK, 2018, STROKE, V49, P1602, DOI 10.1161/STROKEAHA.117.020250; Krafft PR, 2014, BEHAV BRAIN RES, V264, P151, DOI 10.1016/j.bbr.2014.01.052; Lai NY, 2020, CELL, V180, P33, DOI 10.1016/j.cell.2019.11.014; Lee J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073544; Leon-Coria A, 2021, CELL MOL GASTROENTER, V11, P77, DOI 10.1016/j.jcmgh.2020.07.003; Li YN, 2020, J IMMUNOL RES, V2020, DOI 10.1155/2020/9132410; Lin Z, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24130-7; Lindner A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00817; Maier IL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116836; Marlicz W, 2018, THER ADV GASTROENTER, V11, DOI 10.1177/1756284818769076; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Murray KN, 2013, MOL CELL NEUROSCI, V53, P14, DOI 10.1016/j.mcn.2012.09.004; Qin TF, 2021, J CELL PHYSIOL, V236, P6507, DOI 10.1002/jcp.30325; Righetti RF, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01021; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Samary CS, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2164-0; Stanley D, 2016, NAT MED, V22, P1277, DOI 10.1038/nm.4194; Tsai AS, 2019, BRAIN, V142, P978, DOI 10.1093/brain/awz022; Vermeij JD, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008530.pub3; Vogelgesang A, 2008, STROKE, V39, P237, DOI 10.1161/STROKEAHA.107.493635; Wattoo MA, 2021, CUREUS, V13, DOI 10.7759/cureus.15214; Wen SW, 2019, AGING CELL, V18, DOI 10.1111/acel.12980; Wu BH, 2010, TRANSL STROKE RES, V1, P57, DOI 10.1007/s12975-009-0002-z; Xi YG, 2017, ONCOTARGET, V8, P81075, DOI 10.18632/oncotarget.19039; Xiang XL, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.529657; Yang G, 2017, CRIT REV FOOD SCI, V57, P3830, DOI 10.1080/10408398.2016.1152230; Yin J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002699; Zausinger S, 2000, BRAIN RES, V863, P94, DOI 10.1016/S0006-8993(00)02100-4; Zhang J, 2018, FASEB J, V32, P220, DOI 10.1096/fj.201700324R; Zhang JY, 2021, EVID-BASED COMPL ALT, V2021, DOI 10.1155/2021/1391384	57	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	NOV 19	2021	12								767155	10.3389/fimmu.2021.767155			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YG4OS	WOS:000742470700001	34868020	Green Published, gold			2022-02-06	
J	Zou, DD; Hu, WL; Qin, J; Wei, ZF; Wang, DY; Li, L				Zou, Dandan; Hu, Wenlong; Qin, Jie; Wei, Zongfang; Wang, Danyang; Li, Li			Rapid orderly migration of neutrophils after traumatic brain injury depends on MMP9/13	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Macrophage; Neutrophil; Migration; MMP9; MMP13; Injury	EXPRESSION; INFILTRATION; PROGRESSION; MMP-9; GENE; CELL	Macrophages and granulocytes play an important role in various injuries and post-traumatic repair. Due to the limited number of neutrophils in the brain, their role in traumatic brain injury has rarely been mentioned. Here, neutrophils were found to take over the role of macrophages after brain injury in the absence of macrophages. Neutrophils have the characteristics of long residence time and number advantage to actively remove the apoptotic debris. The number of neutrophils recruited was effectively reduced by inhibiting IL-1 beta. Interestingly, neutrophils migrated regularly and rapidly to the wound during the early stages of brain injury through three paths. They first infiltrated the wound mainly through blood circulation around the eyes, then became unscrupulous and began to move directly across the brain. In addition, MMP9 and MMP13 were found to be related to the migration of neutrophils, and inhibition of MMP could significantly inhibit the number and speed of neutrophils' migration. Our study showed that neutrophils rely on MMP9 and MMP13 for a rapid and orderly response to brain injury to maintain central nervous system stability in the absence or decrease of macrophages. (C) 2021 Elsevier Inc. All rights reserved.	[Zou, Dandan; Hu, Wenlong; Qin, Jie; Wei, Zongfang; Wang, Danyang] Southwest Univ, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Inst Dev Biol & Regenerat Med, Chongqing 400715, Peoples R China; [Li, Li] Chinese Acad Sci, Chongqing Inst Green & Intelligent Technol, Res Ctr Stem Cells & Ageing, Chongqing 400714, Peoples R China		Li, L (corresponding author), Chinese Acad Sci, Chongqing Inst Green & Intelligent Technol, Res Ctr Stem Cells & Ageing, Chongqing 400714, Peoples R China.	lili@cigit.ac.cn		Zou, Dandan/0000-0002-2530-9528	National Key Research and Development Project [2019YFA802703]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31822033, 31771623]	We thank H. Huang and H. Ruan for technical assistances. This work was supported by National Key Research and Development Project (2019YFA802703) and National Natural Science Foundation of China Grants (31822033, 31771623).	Alaseem A, 2019, SEMIN CANCER BIOL, V56, P100, DOI 10.1016/j.semcancer.2017.11.008; Alvarenga DM, 2018, CELL TISSUE RES, V371, P589, DOI 10.1007/s00441-017-2722-9; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Bradley LM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002641; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; de Oliveira S, 2016, NAT REV IMMUNOL, V16, P378, DOI 10.1038/nri.2016.49; Drummond RA, 2019, NAT IMMUNOL, V20, P559, DOI 10.1038/s41590-019-0377-2; Furman D, 2017, NAT MED, V23, P174, DOI 10.1038/nm.4267; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; He JB, 2020, NAT PROTOC, V15, P3361, DOI 10.1038/s41596-020-0376-7; Hou YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep36853; Hu CL, 2013, GENE, V517, P65, DOI 10.1016/j.gene.2012.12.085; Huang H, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18103249; Jin R, 2013, J CARDIOVASC TRANSL, V6, P834, DOI 10.1007/s12265-013-9508-6; Kong EY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081321; Li DT, 2018, NATURE, V564, P119, DOI 10.1038/s41586-018-0709-7; Li L, 2012, J BIOL CHEM, V287, P25353, DOI 10.1074/jbc.M112.349126; Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x; Medeiros NI, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00800; Miyabe C, 2019, J CLIN INVEST, V129, P3610, DOI 10.1172/JCI123778; Nourshargh S, 2016, TRENDS IMMUNOL, V37, P273, DOI 10.1016/j.it.2016.03.006; Rosell A, 2008, STROKE, V39, P1121, DOI 10.1161/STROKEAHA.107.500868; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Savage CD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00288; Silva JAF, 2012, J CELL PHYSIOL, V227, P2441, DOI 10.1002/jcp.22979; Silvestre-Roig C, 2019, TRENDS IMMUNOL, V40, P565, DOI 10.1016/j.it.2019.04.012; Song J, 2015, CELL REP, V10, P1040, DOI 10.1016/j.celrep.2015.01.037; Uderhardt S, 2019, CELL, V177, P541, DOI 10.1016/j.cell.2019.02.028; Walz W, 2017, NEUROCHEM RES, V42, P2560, DOI 10.1007/s11064-017-2265-1; Westman J, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03030; Zhao F, 2018, LEUKEMIA, V32, P149, DOI 10.1038/leu.2017.189; Zigrino P, 2009, J INVEST DERMATOL, V129, P2686, DOI 10.1038/jid.2009.130	32	0	0	5	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	NOV 19	2021	579						161	167		10.1016/j.bbrc.2021.09.044			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	WC3VR	WOS:000704188200005	34601201				2022-02-06	
J	Hind, K; Konerth, N; Entwistle, I; Hume, P; Theadom, A; Lewis, G; King, D; Goodbourn, T; Bottiglieri, M; Ferraces-Riegas, P; Ellison, A; Chazot, P				Hind, Karen; Konerth, Natalie; Entwistle, Ian; Hume, Patria; Theadom, Alice; Lewis, Gwyn; King, Doug; Goodbourn, Thomas; Bottiglieri, Marianna; Ferraces-Riegas, Paula; Ellison, Amanda; Chazot, Paul			Mental Health and Wellbeing of Retired Elite and Amateur Rugby Players and Non-contact Athletes and Associations with Sports-Related Concussion: The UK Rugby Health Project	SPORTS MEDICINE			English	Article; Early Access							INSOMNIA SEVERITY INDEX; TRAUMATIC BRAIN-INJURY; SLEEP DISTURBANCES; PROSPECTIVE COHORT; LEAGUE PLAYERS; ALCOHOL-USE; UNION; DEPRESSION; SYMPTOMS; DISORDERS	Background Concerns have intensified over the health and wellbeing of rugby union and league players, and, in particular, about the longer-term effects of concussion. The purpose of this study was to investigate whether there were differences in mental health, sleep and alcohol use between retired elite and amateur rugby code players and non-contact athletes, and to explore associations with sports-related concussion. Methods 189 retired elite (ER, n = 83) and amateur (AR, n = 106) rugby code players (rugby union n = 145; rugby league n = 44) and 65 former non-contact athletes (NC) were recruited to the UK Rugby Health Project between 2016 and 2018. Details on sports participation and concussion history were obtained by questionnaire, which also included questions on mental health, anger, sleep, mood, alcohol use, social connections and retirement from injury. Data were compared between sports groups (ER, AR and NC), between exposure of three or more or five or more concussions and for years in sport. Results ER reported more concussions than AR (5.9 +/- 6.3 vs. 3.7 +/- 6.3, p = 0.022) and NC (0.4 +/- 1.0, p < 0.001). ER had a higher overall negative mental health score (indicating poor mental health) than AR (10.4 +/- 6.3 vs. 7.4 +/- 6.5, d = 0.47, p = 0.003) and NC (7.1 +/- 4.8, d = 0.57, p = 0.006) and a lower overall positive score (indicating good mental health) than NC (8.9 +/- 4.1 vs. 10.7 +/- 3.4, d = 0.46, p = 0.021). Negative scores were highest and positive scores lowest in those reporting three or more concussions (d = 0.36, p = 0.008; d = 0.28, p = 0.040, respectively) or five or more concussions (d = 0.56, p < 0.001; d = 0.325, p = 0.035, respectively). Reported symptoms for sleep disruption were more prevalent in ER than NC, and in former athletes with three or more concussions (d = 0.41-0.605, p < 0.05). There were no significant differences in alcohol score (p = 0.733). Global anger score and covert anger expression was higher in former athletes with five or more concussions (d = 0.32, p = 0.035; d = 0.37, p = 0.016). AR reported greater attachment to friends than NC (d = 0.46, p = 0.033) and 20% of ER reported that they would not turn to anyone if they had a problem or felt upset about anything. Conclusion There was a significantly higher prevalence of adverse mental health and sleep disruption in ER and in former athletes who reported a higher number of concussions. Anger and irritability were more prevalent in former athletes with a history of five or more concussions. Strategies are needed to address mental health and sleep disturbance in elite rugby code athletes, who are also less likely to seek help should they need it. Further research is needed to elucidate causation, and the neurobiological connection between concussion, sub-concussions and longer-term psychological health and wellbeing.	[Hind, Karen; Konerth, Natalie; Entwistle, Ian; Goodbourn, Thomas; Bottiglieri, Marianna] Univ Durham, Dept Sport & Exercise Sci, 42 Old Elvet, Durham DH1 3HN, England; [Hind, Karen; Entwistle, Ian; King, Doug; Goodbourn, Thomas; Ellison, Amanda; Chazot, Paul] Univ Durham, Wolfson Res Inst Hlth & Wellbeing, Durham, England; [Hume, Patria] Auckland Univ Technol, Fac Hlth & Environm Sci, Sports Performance Res Inst New Zealand SPRINZ, Auckland, New Zealand; [Hume, Patria; Theadom, Alice; King, Doug] Auckland Univ Technol, TBI Network, Auckland, New Zealand; [Hume, Patria; King, Doug] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Lewis, Gwyn] Auckland Univ Technol, Fac Hlth & Environm Sci, Hlth & Rehabil Res Inst, Auckland, New Zealand; [King, Doug] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [Ferraces-Riegas, Paula; Chazot, Paul] Univ Durham, Dept Biosci, Stockton Rd, Durham DH1 3LE, England; [Ellison, Amanda] Univ Durham, Dept Psychol, Durham, England		Hind, K (corresponding author), Univ Durham, Dept Sport & Exercise Sci, 42 Old Elvet, Durham DH1 3HN, England.; Hind, K (corresponding author), Univ Durham, Wolfson Res Inst Hlth & Wellbeing, Durham, England.	karen.hind@durham.ac.uk			Auckland University of Technology; Wolfson Institute for Health and Wellbeing, Durham University	The project team received "UK Rugby Health-SRIF RCRG project" funding from Auckland University of Technology for NZ$15,000 via Professor Patria Hume, and from the Wolfson Institute for Health and Wellbeing, Durham University, for 4,400 pound via Dr Karen Hind.	Arvinen-Barrow M, 2017, J CLIN SPORT PSYCHOL, V11, P67, DOI 10.1123/jcsp.2016-0012; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Boden JM, 2011, ADDICTION, V106, P906, DOI 10.1111/j.1360-0443.2010.03351.x; Bodnar CN, 2018, NEURAL REGEN RES, V13, P1693, DOI 10.4103/1673-5374.238604; Brown JC, 2017, INT J SPORTS MED, V38, P582, DOI 10.1055/s-0043-103959; Burke SL, 2018, AGING MENT HEALTH, V22, P1577, DOI 10.1080/13607863.2017.1387760; Cahill N, 2013, J SPORT SCI, V31, P229, DOI 10.1080/02640414.2012.727456; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Du Preez EJ, 2017, CLIN J SPORT MED, V27, P530, DOI 10.1097/JSM.0000000000000411; Dugdale JR, 2002, SPORT PSYCHOL, V16, P20, DOI 10.1123/tsp.16.1.20; Fitzpatrick AC, 2018, J SCI MED SPORT, V21, P160, DOI 10.1016/j.jsams.2017.08.012; Forgays DG, 1997, J PERS ASSESS, V69, P497, DOI 10.1207/s15327752jpa6903_5; Forgays DK, 1998, ASSESSMENT, V5, P141, DOI 10.1177/107319119800500205; FUQUA DR, 1991, EDUC PSYCHOL MEAS, V51, P439, DOI 10.1177/0013164491512018; Gagnon C, 2013, J AM BOARD FAM MED, V26, P701, DOI 10.3122/jabfm.2013.06.130064; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Gouttebarge V, 2018, EUR J SPORT SCI, V18, P1004, DOI 10.1080/17461391.2018.1466914; Gouttebarge V, 2016, EUR J SPORT SCI, V16, P595, DOI 10.1080/17461391.2015.1086819; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hellewell SC, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00350; Hind K, 2020, SPORTS MED, V50, P2051, DOI 10.1007/s40279-020-01310-y; Hinds Andrea, 2016, Concussion, V1, pCNC15, DOI 10.2217/cnc-2016-0002; Holt NL, 2002, SPORT PSYCHOL, V16, P251, DOI 10.1123/tsp.16.3.251; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Jain A, 2014, ASIAN J PSYCHIATR, V8, P99, DOI 10.1016/j.ajp.2013.12.017; KAMMANN R, 1983, AUST J PSYCHOL, V35, P259, DOI 10.1080/00049538308255070; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kilic O, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2019-000693; Lucke-Wold BP, 2015, NEUROSCI BIOBEHAV R, V55, P68, DOI 10.1016/j.neubiorev.2015.04.010; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Medic G, 2017, NAT SCI SLEEP, V9, P151, DOI 10.2147/NSS.S134864; Mircioiu C, 2017, PHARMACY, V5, DOI 10.3390/pharmacy5020026; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Murray L, 2020, PHYSIOTHER THEOR PR, DOI 10.1080/09593985.2020.1825578; Nicholls AR, 2005, J APPL SPORT PSYCHOL, V17, P333, DOI 10.1080/10413200500313644; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; Pearce AJ, 2018, INT J SPORTS SCI MED, V2, P66; Peek RJ, 2021, INT J SPORTS SCI COA, V16, P1162, DOI 10.1177/17479541211004065; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Rawlings S, 2020, BRAIN RES BULL, V165, P56, DOI 10.1016/j.brainresbull.2020.09.021; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Rugby-League.com, 2019, RUGB FOOTB LEAG ANN; Sharma A, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00042; Spielberger C.D., 2010, CORSINI ENCY PSYCHOL, P1; Tennant R, 2007, QUAL LIFE RES, V16, P687, DOI 10.1007/s11136-006-9145-5; Viviers PL, 2018, SPORTS HEALTH, V10, P223, DOI 10.1177/1941738118757178; Wang CN, 2020, NEUROPSYCHOPHARMACOL, V45, P104, DOI 10.1038/s41386-019-0478-5; Willer BS, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000423; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; Winer JR, 2020, CURR BIOL, V30, P4291, DOI 10.1016/j.cub.2020.08.017; Winer JR, 2019, J NEUROSCI, V39, P6315, DOI 10.1523/JNEUROSCI.0503-19.2019; World Rugby, 2017, GLOB PART RUGB; Yeomans C, 2018, SPORTS MED, V48, P837, DOI 10.1007/s40279-017-0838-4	60	0	0	1	1	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.												10.1007/s40279-021-01594-8		NOV 2021	13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WZ8PB	WOS:000720222700001	34792798	Green Accepted, hybrid			2022-02-06	
J	Luo, XP; Lin, DZ; Xia, SW; Wang, DY; Weng, XM; Huang, WM; Ye, HD				Luo, Xiaoping; Lin, Dezhao; Xia, Shengwei; Wang, Dongyu; Weng, Xinmang; Huang, Wenming; Ye, Hongda			Machine Learning Classification of Mild Traumatic Brain Injury Using Whole-Brain Functional Activity: A Radiomics Analysis	DISEASE MARKERS			English	Article							DEFAULT-MODE NETWORK; REGIONAL HOMOGENEITY; GENDER-DIFFERENCES; WORKING-MEMORY; FMRI; CEREBELLUM; BIOMARKER; SYMPTOMS; VETERANS; EXPOSURE	Objectives. To investigate the classification performance of support vector machine in mild traumatic brain injury (mTBI) from normal controls. Methods. Twenty-four mTBI patients (15 males and 9 females; mean age, 38.88 +/- 13.33 years) and 24 age and sex-matched normal controls (13 males and 11 females; mean age, 40.46 +/- 11.4 years) underwent resting-state functional MRI examination. Seven imaging parameters, including amplitude of low-frequency fluctuation (ALFF), fractional amplitude of low-frequency fluctuation (fALFF), regional homogeneity (ReHo), degree centrality (DC), voxel-mirrored homotopic connectivity (VMHC), long-range functional connectivity density (FCD), and short-range FCD, were entered into the classification model to distinguish the mTBI from normal controls. Results. The ability for any single imaging parameters to distinguish the two groups is lower than multiparameter combinations. The combination of ALFF, fALFF, DC, VMHC, and short-range FCD showed the best classification performance for distinguishing the two groups with optimal AUC value of 0.778, accuracy rate of 81.11%, sensitivity of 88%, and specificity of 75%. The brain regions with the highest contributions to this classification mainly include bilateral cerebellum, left orbitofrontal cortex, left cuneus, left temporal pole, right inferior occipital cortex, bilateral parietal lobe, and left supplementary motor area. Conclusions. Multiparameter combinations could improve the classification performance of mTBI from normal controls by using the brain regions associated with emotion and cognition.	[Luo, Xiaoping; Xia, Shengwei; Wang, Dongyu; Weng, Xinmang; Huang, Wenming; Ye, Hongda] Wenzhou Chinese Med Hosp, Dept Radiol, Wenzhou 325000, Zhejiang, Peoples R China; [Lin, Dezhao] Wenzhou Chinese Med Hosp, Dept Emergency, Wenzhou 325000, Zhejiang, Peoples R China		Luo, XP (corresponding author), Wenzhou Chinese Med Hosp, Dept Radiol, Wenzhou 325000, Zhejiang, Peoples R China.	wzluoxp@163.com; 852997023@qq.com; 653629418@qq.com; 857871688@qq.com; 327234293@qq.com; 432832@qq.com; 529950955@qq.com			Zhejiang Provincial Medical and Health Science and Technology Project [2017KY632]	AcknowledgmentsThis work was supported by the Zhejiang Provincial Medical and Health Science and Technology Project (grant No. 2017KY632).	Bigler ED, 2021, NEUROPSYCHOL REV, DOI 10.1007/s11065-020-09474-0; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Braeckman K, 2019, JOVE-J VIS EXP, DOI 10.3791/60012; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Dai XJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01201; Dai XJ, 2020, BRAIN IMAGING BEHAV, V14, P1430, DOI 10.1007/s11682-019-00064-0; Dai XJ, 2016, J CLIN SLEEP MED, V12, P363, DOI 10.5664/jcsm.5586; Dai XJ, 2014, NEUROPSYCH DIS TREAT, V10, P2163, DOI 10.2147/NDT.S69681; Dai XJ, 2012, SLEEP MED, V13, P720, DOI 10.1016/j.sleep.2011.09.019; Dailey NS, 2018, NEUROREPORT, V29, P1413, DOI 10.1097/WNR.0000000000001127; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Koziol LF, 2014, CEREBELLUM, V13, P151, DOI 10.1007/s12311-013-0511-x; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Lee Gregory P, 2004, Cogn Behav Neurol, V17, P9, DOI 10.1097/00146965-200403000-00002; Li C, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01037; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Rausa VC, 2020, NEUROSCI BIOBEHAV R, V118, P643, DOI 10.1016/j.neubiorev.2020.08.017; Rosenthal S, 2018, NEUROIMAG CLIN N AM, V28, P107, DOI 10.1016/j.nic.2017.09.008; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Tate DF, 2017, MIL MED, V182, pE1651, DOI 10.7205/MILMED-D-16-00132; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; van der Horn HJ, 2017, J NEUROTRAUM, V34, P3262, DOI 10.1089/neu.2017.5185; Wang ZN, 2021, J NEUROTRAUM, V38, P464, DOI 10.1089/neu.2018.6196; Yang Z, 2012, J NEUROTRAUM, V29, P2124, DOI 10.1089/neu.2012.2395; Zhan J, 2015, J NERV MENT DIS, V203, P786, DOI 10.1097/NMD.0000000000000368; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	40	0	0	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0278-0240	1875-8630		DIS MARKERS	Dis. Markers	NOV 18	2021	2021								3015238	10.1155/2021/3015238			7	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental; Pathology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine; Pathology	XL3QS	WOS:000728062100002	34840627	Green Published, gold			2022-02-06	
J	Nalla, S; Huang, K; Spangenberg, J; Chen, LQ; Jayabalan, P				Nalla, Sindhoori; Huang, Kevin; Spangenberg, Jacqueline; Chen, Liqi; Jayabalan, Prakash			The demographic and disability characteristics of individuals who regularly attend an urban adaptive fitness center: An observational study	PM&R			English	Article; Early Access							QUALITY-OF-LIFE; RECREATION PARTICIPATION; PHYSICAL-ACTIVITY; SPORTS; EXERCISE; IMPACT; PERCEPTIONS; BENEFITS; OUTCOMES; PROGRAM	Introduction While it is well known that regular physical activity provides significant physical and psychosocial health benefits, people with disabilities have disproportionately lower rates of exercise compared to the able-bodied population. Reduced levels of physical activity can put this population at an increased risk of chronic health conditions, highlighting the importance of ensuring that our communities have accessible adaptive fitness opportunities. Objectives To evaluate the demographic and disability characteristics in individuals who regularly attend a specialized urban adaptive fitness center, to provide foundational understanding about the population that uses such resources. Design Cross-sectional study Setting Specialized urban adaptive fitness center Participants Sixty-three (n = 63) participants who regularly attend an urban Adaptive Sports and Fitness Center Intervention Not applicable Main Outcome Measure World Health Organization (WHO) Disability Assessment Schedule (WHODAS) 2.0, evaluating disability in six domains: cognition, mobility, self-care, getting along, life activities, and participation. Results were converted into scores ranging from 0 (no disability) to 100 (total disability) and compared to WHO published norms for the general population and a demographics intake form. Results Participants with mean age of 52.9 +/- 14.3 years were grouped into three diagnostic categories: spinal cord injury (30.2%), traumatic brain injury/stroke (36.5%), and other neurologic disease/chronic medical disease (33.3%). A total of 45.9% live alone, 96.8% exercise at least twice/week, and 43.5% participate in adaptive sports. Participants travel 8.0 miles on average for attendance. WHODAS disability summary score was 26.48 (86th percentile). Conclusions Although adaptive fitness center participants had a higher level of disability than 80% to 90% of the general population, regular participation was realistic and feasible. Further understanding of the barriers in those who do not engage in such facilities is needed.	[Nalla, Sindhoori; Huang, Kevin; Jayabalan, Prakash] Shirley Ryan AbilityLab, 355 E Erie St, Chicago, IL 60611 USA; [Nalla, Sindhoori; Huang, Kevin; Jayabalan, Prakash] Northwestern Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL USA; [Spangenberg, Jacqueline] Louisiana State Univ, Sch Med, New Orleans, LA USA; [Chen, Liqi] Northwestern Feinberg Sch Med, Biostat Collaborat Ctr, Chicago, IL USA		Jayabalan, P (corresponding author), Shirley Ryan AbilityLab, 355 E Erie St, Chicago, IL 60611 USA.	pjayabalan@sralab.org		Jayabalan, Prakash/0000-0002-0369-2896	Shirley Ryan AbilityLab Adaptive Sports and Fitness Center	We would like to thank the Shirley Ryan AbilityLab Adaptive Sports and Fitness Center for their assistance and support in conducting this research study at their facility.	Adam SL, 2018, DISABIL HEALTH J, V11, P301, DOI 10.1016/j.dhjo.2017.09.001; Anderson C, 2017, DISABIL HEALTH J, V10, P157, DOI 10.1016/j.dhjo.2016.09.006; [Anonymous], 2018, WHO DIS ASS SCHED 2; Blauwet CA, 2017, PM&R, V9, P668, DOI 10.1016/j.pmrj.2016.10.015; Bondar RZ, 2020, J INTELL DISABIL RES, V64, P69, DOI 10.1111/jir.12699; Declerck L, 2019, CURR SPORT MED REP, V18, P458, DOI 10.1249/JSR.0000000000000662; Diaz R, 2019, SPORTS MED ARTHROSC, V27, P73, DOI 10.1097/JSA.0000000000000242; Dolbow DR, 2015, SPINAL CORD, V53, P515, DOI 10.1038/sc.2015.26; Groff DG, 2009, DISABIL REHABIL, V31, P318, DOI 10.1080/09638280801976233; Hutzler Y., 1999, SPORT PSYCHOL LINKIN, P281; Jin J, 2012, AM J SURG, V204, P199, DOI 10.1016/j.amjsurg.2011.10.010; Jolly M, 2010, J RHEUMATOL, V37, P1150, DOI 10.3899/jrheum.090862; Laferrier JZ, 2015, AM J PHYS MED REHAB, V94, P1026, DOI 10.1097/PHM.0000000000000263; Lape EC, 2018, PM&R, V10, P507, DOI 10.1016/j.pmrj.2017.10.008; Lastuka A, 2016, DISABIL REHABIL, V38, P742, DOI 10.3109/09638288.2015.1059497; Lundberg NR, 2011, J LEISURE RES, V43, P205, DOI 10.1080/00222216.2011.11950233; Macko RF, 2008, J REHABIL RES DEV, V45, P323, DOI 10.1682/JRRD.2007.02.0025; Malone LA, 2012, DISABIL HEALTH J, V5, P254, DOI 10.1016/j.dhjo.2012.05.004; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Sahlin KB, 2015, PM&R, V7, P1081, DOI 10.1016/j.pmrj.2015.03.019; Tow S, 2020, PHYS MED REH CLIN N, V31, P143, DOI 10.1016/j.pmr.2019.09.003; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231	22	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R												10.1002/pmrj.12720		NOV 2021	7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	WZ5CW	WOS:000719986100001	34617406				2022-02-06	
J	Ross, M; Shahin, MN; O'Neill, BE; Liu, JJ				Ross, Miner; Shahin, Maryam N.; O'Neill, Brannan E.; Liu, Jesse J.			Lumbar Pneumorrhachis Associated With Basilar Skull Fractures	CUREUS			English	Article						traumatic csf leak; neurotrauma; pneumorrhachis; skull fracture	TRAUMATIC PNEUMOMYELOGRAM; AIR	Lumbar pneumorrhachis following head injury is rare and commonly asymptomatic but can be indicative of skull fracture and cerebrospinal fluid (CSF) leak, which may warrant intervention. A PubMed review of the literature was performed using a keyword search to identify cases examining lumbar pneumorrhachis following head injury. Our case series included two patients who had lumbar pneumorrhachis between September 2019 and May 2020 at our center. The literature review summarizes 16 patients from 14 prior reports of pneumorrhachis. In our two-patient case series, neither patient required direct intervention for either pneumorrhachis or CSF leak. Pneumorrhachis is rare following an isolated head injury and is associated with basilar skull fractures and CSF leak. Pneumorrhachis should alert clinicians to the possibility of a CSF leak, which may require intervention.	[Ross, Miner; Shahin, Maryam N.; O'Neill, Brannan E.; Liu, Jesse J.] Oregon Hlth & Sci Univ, Neurol Surg, Portland, OR 97201 USA		Liu, JJ (corresponding author), Oregon Hlth & Sci Univ, Neurol Surg, Portland, OR 97201 USA.	liu@ohsu.edu					Cayli SR, 2003, BRIT J NEUROSURG, V17, P72, DOI 10.3109/02688690309177976; Coskun Selcuk, 2009, Am J Emerg Med, V27, DOI 10.1016/j.ajem.2008.11.004; DAY CJE, 1994, ANAESTHESIA, V49, P1061, DOI 10.1111/j.1365-2044.1994.tb04357.x; Eroglu Umit, 2016, Asian J Neurosurg, V11, P172, DOI 10.4103/1793-5482.175641; GONZALES GR, 1994, NEUROLOGY, V44, P2409, DOI 10.1212/WNL.44.12.2409; GORDON IJ, 1977, NEURORADIOLOGY, V13, P107, DOI 10.1007/BF00339843; Hadjigeorgiou GF, 2016, J CLIN NEUROSCI, V34, P44, DOI 10.1016/j.jocn.2016.07.008; Inamasu J, 2002, AM J EMERG MED, V20, P64, DOI 10.1053/ajem.2001.29554; KENNEDY TM, 1988, ANESTH ANALG, V67, P1184; MANGIARDI JR, 1987, SURG NEUROL, V27, P587, DOI 10.1016/0090-3019(87)90161-3; NAY PG, 1993, ANAESTHESIA, V48, P402, DOI 10.1111/j.1365-2044.1993.tb07013.x; NEWBOLD RG, 1987, AM J ROENTGENOL, V148, P615, DOI 10.2214/ajr.148.3.615; Oertel MF, 2006, EUR SPINE J OFF P S5, V15, P636, DOI [DOI 10.1007/S00586-006-0160-6, 10.1007/s00586-006-0160-6]; Overdiek N, 2001, J CLIN ANESTH, V13, P392, DOI 10.1016/S0952-8180(01)00272-0; PRINS TR, 1989, NEURORADIOLOGY, V31, P290, DOI 10.1007/BF00344366; Sinha PA, 2000, CLIN RADIOL, V55, P569, DOI 10.1053/crad.1999.0099; Uemura K, 2000, BRIT J NEUROSURG, V14, P154; YIP L, 1990, AM J EMERG MED, V8, P332, DOI 10.1016/0735-6757(90)90089-I; Yousaf I, 2003, BRIT J NEUROSURG, V17, P248, DOI 10.1080/0268869031000153143; Yuce I, 2016, SPINE J, V16, pE3, DOI 10.1016/j.spinee.2015.08.004	20	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	NOV 18	2021	13	11							e19703	10.7759/cureus.19703			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	XB3BS	WOS:000721206800035	34934572	gold, Green Published			2022-02-06	
J	Singh, S; Babl, FE; Huang, L; Hearps, S; Cheek, JA; Hoch, JS; Anderson, V; Dalziel, K				Singh, Sonia; Babl, Franz E.; Huang, Li; Hearps, Stephen; Cheek, John Alexander; Hoch, Jeffrey S.; Anderson, Vicki; Dalziel, Kim			Paediatric traumatic brain injury severity and acute care costs	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article; Early Access						health care economics and organisations; paediatrics; paediatric emergency medicine			[Singh, Sonia; Babl, Franz E.; Cheek, John Alexander] Univ Melbourne, Dept Paediat, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Singh, Sonia] Univ Calif, Emergency Med, Davis Med Ctr, Sacramento, CA 95817 USA; [Babl, Franz E.] Murdoch Childrens Res Inst, Clin Sci, Emergency Res, Parkville, Vic, Australia; [Huang, Li; Dalziel, Kim] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Hearps, Stephen] Murdoch Childrens Res Inst, Child Neuropsychol, Parkville, Vic, Australia; [Cheek, John Alexander] Royal Childrens Hosp Melbourne, Emergency Dept, Parkville, Vic, Australia; [Hoch, Jeffrey S.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA USA; [Hoch, Jeffrey S.] Univ Calif Davis Hlth Syst, Ctr Healthcare Policy & Res, Sacramento, CA USA; [Anderson, Vicki] Murdoch Childrens Res Inst, Clin Sci, Parkville, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp Melbourne, Dept Psychol, Parkville, Vic, Australia; [Dalziel, Kim] Murdoch Childrens Res Inst, Ctr Community Child Hlth, Hlth Serv, Parkville, Vic, Australia		Singh, S (corresponding author), Univ Melbourne, Dept Paediat, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia.; Singh, S (corresponding author), Univ Calif, Emergency Med, Davis Med Ctr, Sacramento, CA 95817 USA.	singhsd@student.unimelb.edu.au		Singh, Sonia/0000-0003-2430-0262	National Health and Medical Research Council (Centre of Research Excellence for Paediatric Emergency Medicine), Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1046727, GNT1058560]; Murdoch Children's Research Institute, Melbourne, Australia; Emergency Medicine Foundation , Brisbane, Australia [EMPJ-11162]; Perpetual Philanthropic Services, Australia [2012/1140]; Auckland Medical Research Foundation, Auckland, New Zealand [3112011]; A+ Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; Australian Government Research Training Program ScholarshipAustralian GovernmentDepartment of Industry, Innovation and Science; PREDICT CRE Research Higher Degree scholarship; Royal Children's Hospital Foundation, Melbourne, Australia; Melbourne Campus Clinician Scientist Fellowship, Melbourne, Australia; NHMRC Practitioner Fellowship, Canberra, Australia	The work was supported by grants from the National Health and Medical Research Council (project grant GNT1046727, Centre of Research Excellence for Paediatric Emergency Medicine GNT1058560), Canberra, Australia; the Murdoch Children's Research Institute, Melbourne, Australia (no award/grant number); the Emergency Medicine Foundation (EMPJ-11162), Brisbane, Australia; Perpetual Philanthropic Services (2012/1140), Australia; Auckland Medical Research Foundation (No. 3112011) and the A+ Trust (Auckland District Health Board), Auckland, New Zealand (no award/grant number); WA Health Targeted Research Funds 2013, Perth, Australia (no award/grant number); the Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia (no award/grant number); and supported by the Victorian Government's Infrastructure Support Program, Melbourne, Australia (no award/grant number). SS was supported by an Australian Government Research Training Program Scholarship and a PREDICT CRE Research Higher Degree scholarship. FEB's time was partly funded by a grant from the Royal Children's Hospital Foundation and the Melbourne Campus Clinician Scientist Fellowship, Melbourne, Australia, and an NHMRC Practitioner Fellowship, Canberra, Australia.	Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Bierbaum M, 2019, HEALTH PROMOT J AUST, V30, P189, DOI 10.1002/hpja.186; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Rothman L, 2014, PEDIATRICS, V133, P776, DOI 10.1542/peds.2013-2317; Singh S, 2021, J PAEDIATR CHILD H, DOI 10.1111/jpc.15699	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.												10.1136/archdischild-2021-322966		NOV 2021	3	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	XC8CN	WOS:000722237100001	34799376				2022-02-06	
J	Thier, ZT; Drake-Lavelle, K; Prest, PJ; Jones, MA; Reeves, JM; McClung-Smith, CF; Goodwin, TM; Villani, N; Metz, J; Jackson, JB				Thier, Zachary T.; Drake-Lavelle, Kelan; Prest, Phillip J.; Jones, Mark A.; Reeves, Jeremy M.; McClung-Smith, Catherine F.; Goodwin, Tyler M.; Villani, Nolan; Metz, John; Jackson, J. Benjamin, III			Progression of Intracranial Hemorrhage After Chemical Prophylaxis Using Low-Molecular-Weight Heparin in Patients With Traumatic Brain Injury	AMERICAN SURGEON			English	Article; Early Access							VENOUS THROMBOEMBOLISM PROPHYLAXIS; ENOXAPARIN PROPHYLAXIS; SAFETY; RISK	Introduction Chemical prophylaxis using low-molecular-weight heparin (LMWH) is considered a standard of care for venous thromboembolism in trauma patients. Our center performs a head computed tomography (CT) scan 24 hours after initiation with prophylactic LMWH in the setting of a known traumatic brain injury (TBI). The purpose was to determine the overall incidence of ICH progression after chemoprophylaxis in patients with a TBI. Methods This retrospective study was performed at a Level I trauma center, from 1/1/2014 to 12/31/2017. Study patients were drawn from the institution's trauma registry based on Abbreviated Injury Score codes. Results 778 patients met all inclusion criteria after initial chart review. The proportion of patients with an observed radiographic progression of intracranial hemorrhage after LMWH was 5.8%. 3.1% of patients had a change in clinical management. Observed radiographic progression after LMWH prophylaxis and the presence of SDH on initial CT, the bilateral absence of pupillary response in the emergency department, and a diagnosis of dementia were found to have statistically significant correlation with bleed progression after LMWH was initiated. Conclusion Over a 4-year period, the use of CT to evaluate for radiographic progression of traumatic intracranial hemorrhage 24 hours after receiving LMWH resulted in a change in clinical management for 3.1% of patients. The odds of intracranial hemorrhage progression were approximately 6.5x greater in patients with subdural hemorrhage on initial CT, 3.1x greater in patients with lack of bilateral pupillary response in ED, and 4.2x greater in patients who had been diagnosed with dementia.	[Thier, Zachary T.] Lincoln Mem Univ DeBusk Coll Osteopath Med, 9737 Cogdill Rd, Knoxville, TN 37932 USA; [Thier, Zachary T.; Jackson, J. Benjamin, III] Univ South Carolina, Dept Orthopaed Surg, Sch Med, Columbia, SC USA; [Drake-Lavelle, Kelan; Prest, Phillip J.; Jones, Mark A.; Reeves, Jeremy M.; Goodwin, Tyler M.; Villani, Nolan; Metz, John; Jackson, J. Benjamin, III] Univ South Carolina, Sch Med, Columbia, SC 29208 USA; [Drake-Lavelle, Kelan] Prisma Hlth Upstate, Dept Emergency Med, Greenville, SC USA; [Prest, Phillip J.; Jones, Mark A.; Reeves, Jeremy M.] Prisma Hlth Richland, Div Trauma Surg Crit Care & Emergency Gen Surg, Dept Surg, Columbia, SC USA; [McClung-Smith, Catherine F.] Prisma Hlth Midlands, Dept Neurosurg, Columbia, SC USA; [Goodwin, Tyler M.] Univ Tennessee Hlth Sci Ctr, Dept Orthoped Surg, Chattanooga, TN USA; [Villani, Nolan] Eisenhower Army Med Ctr, Dept Orthoped Surg, Ft Gordon, GA USA; [Metz, John] Naval Med Ctr, Dept Orthopaed Surg, San Diego, CA USA		Thier, ZT (corresponding author), Lincoln Mem Univ DeBusk Coll Osteopath Med, 9737 Cogdill Rd, Knoxville, TN 37932 USA.	Zach.thier@gmail.com		Thier, Zachary/0000-0002-1472-0784; Goodwin, Tyler/0000-0002-6861-1364			Beckman MG, 2010, AM J PREV MED, V38, pS495, DOI 10.1016/j.amepre.2009.12.017; Chelladurai Yohalakshmi, 2013, F1000Res, V2, P132, DOI 10.12688/f1000research.2-132.v1; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Jordan BC, 2018, AM J SURG, V215, P48, DOI 10.1016/j.amjsurg.2017.07.012; Keskin I, 2017, NEURAL REGEN RES, V12, P761, DOI 10.4103/1673-5374.206646; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Louis SG, 2014, JAMA SURG, V149, P365, DOI 10.1001/jamasurg.2013.3963; Minshall CT, 2011, J TRAUMA, V71, P396, DOI 10.1097/TA.0b013e31822734c9; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Pastorek RA, 2014, J NEUROTRAUM, V31, P1737, DOI 10.1089/neu.2014.3366; Paul AB, 2015, J AM COLL RADIOL, V12, P453, DOI 10.1016/j.jacr.2014.12.016; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, pS122, DOI 10.1097/TA.0b013e3182606327; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Sahyouni R, 2017, WORLD NEUROSURG, V108, P954, DOI 10.1016/j.wneu.2017.09.063; Tracy BM, 2016, J SURG RES, V205, P221, DOI 10.1016/j.jss.2016.06.049; Walker CK, 2017, ANN PHARMACOTHER, V51, P323, DOI 10.1177/1060028016683970	25	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.											00031348211054078	10.1177/00031348211054078		NOV 2021	7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XB5AV	WOS:000721342800001	34791902				2022-02-06	
J	Wasfie, T; Fitzpatrick, N; Niasan, M; Hille, JL; Yapchai, R; Hella, J; Barber, K; Brimmier, A; Shapiro, B				Wasfie, Tarik; Fitzpatrick, Nicholas; Niasan, Mursal; Hille, Jennifer L.; Yapchai, Raquel; Hella, Jennifer; Barber, Kimberly; Brimmier, Alexis; Shapiro, Brian			Factors Favoring the Development of Chronic Subdural Hematoma After Traumatic Acute Subdural Hematoma in the Elderly	AMERICAN SURGEON			English	Article; Early Access						Chronic subdural hematoma; elderly patients; acute subdural hematoma	RISK-FACTORS	Introduction Traumatic acute subdural hematoma (TASDH) is by far the most common traumatic brain injury in elderly patients presented to the emergency department, and a number of those treated conservatively will develop chronic subdural hematoma (CSDH). The factors contributing to chronicity were not well studied in the elderly; therefore, we retrospectively analyzed our elderly patients with acute subdural hematomas to identify the risk factors which might contribute to the development of subsequent CSDH. Methods A retrospective analysis of 254 patients with TASDH admitted between 2012 and 2016 to our level 2 trauma department in a community hospital was collected. Data include age, sex, comorbid conditions, CT findings, anticoagulant therapy, surgical interventions, disposition after discharge, and mortality. Data on those readmitted within the first 2 months with the diagnosis of CSDH were also studied (group A), and compared to those not readmitted (group B). Multiple logistic regression was used to determine the risk factors associated with readmission at P <= .05. Institutional review board approval was obtained for this study. Results There were 254 patients who were admitted with TASDH, 144 male (56.7%) and 110 female (43.3%), with the mean age of 71.4 (SD +/- 19.38) years. Only 37 patients (14.6%) went for surgery in their initial admission. A total of 14 patients (5.6%) were readmitted subsequently with the diagnosis of CSDH within two months of initial discharge (group A). Only four patients (28.5%) were on anticoagulant therapy and these patients went for emergency craniotomy for evacuation of hematoma. All 14 patients had a history of coronary artery disease and hypertension and only 5 (35.7%) were diabetic. Review of head CT on initial admission of those patients revealed 4 patients (28.5%) had multiple lesions and 4 (28.5%) had tentorial/falax bleeding and 4 (28.5%) had a shift. The initial size and thickness of the bleeding was 1.4-5 mm. The adjusted model identified diabetes, race, and initial disposition as significant risk factors (P < .05). Conclusion Risk associated with the transformation of TASDH to CSDH is difficult to assess in those group of elderly patients because of the small number; however, diabetes, race, and initial disposition to home pointed toward a risk for future development of CSDH and those patients should be followed clinically and radiographically over the next few months after discharge, particularly those on anticoagulant therapy.	[Wasfie, Tarik; Fitzpatrick, Nicholas; Niasan, Mursal; Hille, Jennifer L.; Yapchai, Raquel; Shapiro, Brian] Ascens Genesys Hosp, Trauma Sect, Dept Surg, 1125 Kings Carriage, Grand Blanc, MI 48439 USA; [Hella, Jennifer; Barber, Kimberly] Ascens Genesys Hosp, Dept Acad Res, Grand Blanc, MI 48439 USA; [Brimmier, Alexis] Michigan State Univ, Sch Osteopath Med, Lansing, MI USA		Wasfie, T (corresponding author), Ascens Genesys Hosp, Trauma Sect, Dept Surg, 1125 Kings Carriage, Grand Blanc, MI 48439 USA.	twasfie@gmail.com					Ahmed Ehtisham, 2012, J Ayub Med Coll Abbottabad, V24, P71; Canner JK, 2016, BRAIN INJURY, V30, P1570, DOI 10.1080/02699052.2016.1199898; Castellani RJ, 2017, AM J FOREN MED PATH, V38, P126, DOI 10.1097/PAF.0000000000000300; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Hutchinson PJ, 2020, NEW ENGL J MED, V383, P2616, DOI 10.1056/NEJMoa2020473; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Kloss BT, 2010, INT J EMERG MED, V3, P511, DOI 10.1007/s12245-010-0230-8; Laviv Y, 2014, BRIT J NEUROSURG, V28, P733, DOI 10.3109/02688697.2014.918578; Son S, 2013, J KOREAN NEUROSURG S, V54, P211, DOI 10.3340/jkns.2013.54.3.211; Vega RA, 2017, NEUROSURG CLIN N AM, V28, P247, DOI 10.1016/j.nec.2016.11.007; Wasfie T, 2020, AM SURGEON, V86, P1647, DOI 10.1177/0003134820933560; Won SY, 2020, EUR J TRAUMA EMERG S, DOI 10.1007/s00068-020-01508-9; Won SY, 2019, ACTA NEUROL SCAND, V140, P194, DOI 10.1111/ane.13131; Won SY, 2017, SEIZURE-EUR J EPILEP, V45, P28, DOI 10.1016/j.seizure.2016.11.017	14	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.											00031348211056279	10.1177/00031348211056279		NOV 2021	4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XB5BC	WOS:000721343500001	34794326				2022-02-06	
J	Yu, TS; Tensaouti, Y; Stephanz, EP; Chintamen, S; Rafikian, EE; Yang, M; Kernie, SG				Yu, Tzong-Shiue; Tensaouti, Yacine; Stephanz, Elizabeth P.; Chintamen, Sana; Rafikian, Elizabeth E.; Yang, Mu; Kernie, Steven G.			Astrocytic ApoE underlies maturation of hippocampal neurons and cognitive recovery after traumatic brain injury in mice	COMMUNICATIONS BIOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; APOLIPOPROTEIN-E; DENTATE GYRUS; NEURODEGENERATION; NEUROGENESIS; EXPRESSION; CELLS	Tzong-Shiue Yu et al. assess the impact of astrocytic ApoE on hippocampal neurogenesis and behavior after traumatic brain injury (TBI) in mice. Their results suggest that postnatal ablation of astrocytic APOE reduces dendritic complexity in newborn dentate gyrus neurons and cognitive ability, providing further insight into a role for APOE in injury-induced neurogenesis following TBI. Polymorphisms in the apolipoprotein E (ApoE) gene confer a major genetic risk for the development of late-onset Alzheimer's disease (AD) and are predictive of outcome following traumatic brain injury (TBI). Alterations in adult hippocampal neurogenesis have long been associated with both the development of AD and recovery following TBI and ApoE is known to play a role in this process. In order to determine how ApoE might influence hippocampal injury-induced neurogenesis, we generated a conditional knockout system whereby functional ApoE from astrocytes was ablated prior to injury. While successfully ablating ApoE just prior to TBI in mice, we observed an attenuation in the development of the spines in the newborn neurons. Intriguingly, animals with a double-hit, i.e. injury and ApoE conditionally inactivated in astrocytes, demonstrated the most pronounced impairments in the hippocampal-dependent Morris water maze test, failing to exhibit spatial memory after both acquisition and reversal training trials. In comparison, conditional knockout mice without injury displayed impairments but only in the reversal phase of the test, suggesting accumulative effects of astrocytic ApoE deficiency and traumatic brain injury on AD-like phenotypes. Together, these findings demonstrate that astrocytic ApoE is required for functional injury-induced neurogenesis following traumatic brain injury.	[Yu, Tzong-Shiue; Tensaouti, Yacine; Stephanz, Elizabeth P.; Chintamen, Sana; Kernie, Steven G.] Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Rafikian, Elizabeth E.; Yang, Mu] Columbia Univ, Coll Phys & Surg, Inst Genom Med, Mouse Neurobehav Core, New York, NY 10032 USA; [Kernie, Steven G.] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA		Yu, TS; Kernie, SG (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA.; Kernie, SG (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.	ty2255@cumc.columbia.edu; sk3516@cumc.columbia.edu		Tensaouti, Yacine/0000-0001-6475-3245; Kernie, Steven/0000-0003-1371-0549	National Institutes of Health/National Institute of Neurological Disorders and Stroke GrantsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56-NS-089523, R01-NS-095803]; Paul Allen Foundation	This research was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke Grants R56-NS-089523 (S.G.K.) and R01-NS-095803 (S.G.K.) and the Paul Allen Foundation (S.G.K.).	Achariyar TM, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0138-8; Amrein I, 2004, EUR J NEUROSCI, V20, P3342, DOI 10.1111/j.1460-9568.2004.03795.x; Anderson R, 1998, NEUROSCIENCE, V85, P93, DOI 10.1016/S0306-4522(97)00598-8; Beyer F, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.713077; Bisler S, 2002, J CHEM NEUROANAT, V23, P187, DOI 10.1016/S0891-0618(01)00155-7; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bruinsma IB, 2010, BRAIN RES, V1315, P169, DOI 10.1016/j.brainres.2009.12.039; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Flowers SA, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104724; Foggetti A, 2019, CELL REP, V27, P3725, DOI 10.1016/j.celrep.2019.05.098; Foo LC, 2013, GLIA, V61, P1533, DOI 10.1002/glia.22539; Freire MAM, 2012, W INDIAN MED J, V61, P751; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; Hollands C, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0207-7; Jain S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059478; Jellinger KA, 2004, J NEUROL NEUROSUR PS, V75, P511; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kockx M, 2018, J MOL MED, V96, P361, DOI 10.1007/s00109-018-1632-y; Liao F, 2017, CURR OPIN LIPIDOL, V28, P60, DOI 10.1097/MOL.0000000000000383; Mahley RW, 2016, ARTERIOSCL THROM VAS, V36, P1305, DOI 10.1161/ATVBAHA.116.307023; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Masliah E, 1997, BRAIN RES, V751, P307, DOI 10.1016/S0006-8993(96)01420-5; MASLIAH E, 1995, EXP NEUROL, V136, P107, DOI 10.1006/exnr.1995.1088; Miller SM, 2019, NAT NEUROSCI, V22, P1565, DOI 10.1038/s41593-019-0484-2; Nelissen K, 2012, J NEUROSCI RES, V90, P60, DOI 10.1002/jnr.22743; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; Polis B, 2021, NEURAL REGEN RES, V16, P496, DOI 10.4103/1673-5374.293138; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Srinivasan R, 2016, NEURON, V92, P1181, DOI 10.1016/j.neuron.2016.11.030; Tensaouti Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229240; Tensaouti Y, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0155-18.2018; Vetere G, 2017, NEURON, V94, P363, DOI 10.1016/j.neuron.2017.03.037; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Yamazaki Y, 2019, NAT REV NEUROL, V15, P501, DOI 10.1038/s41582-019-0228-7; Yang CP, 2011, DEVELOPMENT, V138, P4351, DOI 10.1242/dev.065540; Yang M, 2012, J NEUROSCI, V32, P6525, DOI 10.1523/JNEUROSCI.6107-11.2012; Zaqout S, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00038	40	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY		2399-3642		COMMUN BIOL	Commun. Biol.	NOV 18	2021	4	1							1303	10.1038/s42003-021-02841-4			12	Biology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Science & Technology - Other Topics	XA1WX	WOS:000720447400008	34795427	Green Published, gold			2022-02-06	
J	Alkhachroum, A; Ganesan, SL; Koren, JP; Kromm, J; Massad, N; Reyes, RA; Miller, MR; Roh, D; Agarwal, S; Park, S; Claassen, J				Alkhachroum, Ayham; Ganesan, Saptharishi Lalgudi; Koren, Johannes P.; Kromm, Julie; Massad, Nina; Reyes, Renz A.; Miller, Michael R.; Roh, David; Agarwal, Sachin; Park, Soojin; Claassen, Jan			Quantitative EEG-Based Seizure Estimation in Super-Refractory Status Epilepticus	NEUROCRITICAL CARE			English	Article; Early Access						Status epilepticus; Super-refractory status epilepticus; Electroencephalogram; Quantitative electroencephalography; Seizure burden	DENSITY SPECTRAL ARRAY; TRAUMATIC BRAIN-INJURY; ELECTROGRAPHIC SEIZURES; NONCONVULSIVE SEIZURES; CONTINUOUS ELECTROENCEPHALOGRAPHY; CONSENSUS STATEMENT; ADULT EEGS; CARE; IDENTIFICATION; HEMORRHAGE	Background The objective of this study was to evaluate the accuracy of seizure burden in patients with super-refractory status epilepticus (SRSE) by using quantitative electroencephalography (qEEG). Methods EEG recordings from 69 patients with SRSE (2009-2019) were reviewed and annotated for seizures by three groups of reviewers: two board-certified neurophysiologists using only raw EEG (gold standard), two neurocritical care providers with substantial experience in qEEG analysis (qEEG experts), and two inexperienced qEEG readers (qEEG novices) using only a qEEG trend panel. Results Raw EEG experts identified 35 (51%) patients with seizures, accounting for 2950 seizures (3,126 min). qEEG experts had a sensitivity of 93%, a specificity of 61%, a false positive rate of 6.5 per day, and good agreement (kappa = 0.64) between both qEEG experts. qEEG novices had a sensitivity of 98.5%, a specificity of 13%, a false positive rate of 15 per day, and fair agreement (kappa = 0.4) between both qEEG novices. Seizure burden was not different between the qEEG experts and the gold standard (3,257 vs. 3,126 min), whereas qEEG novices reported higher burden (6066 vs. 3126 min). Conclusions Both qEEG experts and novices had a high sensitivity but a low specificity for seizure detection in patients with SRSE. qEEG could be a useful tool for qEEG experts to estimate seizure burden in patients with SRSE.	[Alkhachroum, Ayham; Massad, Nina; Reyes, Renz A.; Roh, David; Agarwal, Sachin; Park, Soojin; Claassen, Jan] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Alkhachroum, Ayham; Massad, Nina; Reyes, Renz A.; Roh, David; Agarwal, Sachin; Park, Soojin; Claassen, Jan] NewYork Presbyterian Hosp, New York, NY 10032 USA; [Alkhachroum, Ayham] Univ Miami, Dept Neurol, Miami, FL USA; [Alkhachroum, Ayham] Jackson Mem Hosp, Dept Neurol, Miami, FL 33136 USA; [Ganesan, Saptharishi Lalgudi; Miller, Michael R.] Childrens Hosp Western Ontario, London Hlth Sci Ctr, London, ON, Canada; [Ganesan, Saptharishi Lalgudi; Miller, Michael R.] Western Univ, Schulich Sch Med & Dent, Dept Paediat, London, ON, Canada; [Koren, Johannes P.] Clin Hietzing, Dept Neurol, Vienna, Austria; [Kromm, Julie] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Kromm, Julie] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada		Claassen, J (corresponding author), Columbia Univ, Dept Neurol, New York, NY 10032 USA.; Claassen, J (corresponding author), NewYork Presbyterian Hosp, New York, NY 10032 USA.	jc1439@columbia.edu			Miami Clinical and Translational Science Institute (National Center for Advancing Translational Sciences award) [UL1TR002736]; Lawson Health Research Institute; Children's Health Foundation; Children's Health Research Institute; Academic Medical Organizations of Southwestern Ontario; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS106014, R03 NS112760]; Dana Foundation	AA is supported by an institutional KL2 Career Development Award from the Miami Clinical and Translational Science Institute (National Center for Advancing Translational Sciences award UL1TR002736). SLG is supported by the Lawson Health Research Institute, Children's Health Foundation, Children's Health Research Institute, and the Academic Medical Organizations of Southwestern Ontario. JC is supported by grant funding from the National Institutes of Health (R01 NS106014 and R03 NS112760) and the Dana Foundation.	Alkhachroum A, 2020, J CLIN NEUROPHYSIOL, V37, P422, DOI 10.1097/WNP.0000000000000761; Amorim E, 2017, J CLIN NEUROPHYSIOL, V34, P359, DOI 10.1097/WNP.0000000000000368; Bourgoin P, 2020, J CLIN NEUROPHYSIOL, V37, P259, DOI 10.1097/WNP.0000000000000634; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Citerio G, 2017, INTENS CARE MED, V43, P1067, DOI 10.1007/s00134-017-4775-3; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; De Marchis GM, 2016, NEUROLOGY, V86, P253, DOI 10.1212/WNL.0000000000002281; Dericioglu N, 2015, EPILEPSY RES, V109, P48, DOI 10.1016/j.eplepsyres.2014.10.013; Du Pont-Thibodeau Genevieve, 2017, Pediatr Crit Care Med, V18, P363, DOI 10.1097/PCC.0000000000001099; Ganesan SL, 2019, EPILEPSY BEHAV, V101, DOI 10.1016/j.yebeh.2019.07.010; Ganesan SL, 2018, CRIT CARE MED, V46, pE1105, DOI 10.1097/CCM.0000000000003385; Gavvala J, 2014, EPILEPSIA, V55, P1864, DOI 10.1111/epi.12809; Glauser T, 2006, EPILEPSIA, V47, P1094, DOI 10.1111/j.1528-1167.2006.00585.x; Glauser T, 2016, EPILEPSY CURR, V16, P48, DOI 10.5698/1535-7597-16.1.48; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Herta J, 2017, CLIN NEUROPHYSIOL, V128, P1000, DOI [10.1016/j.clinph.2017.04.002, 10.1016/j.clinph.2017.04.012]; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Kang JH, 2019, NEUROCRIT CARE, V31, P312, DOI 10.1007/s12028-019-00673-z; Koren JP, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00454; Kramer AH, 2019, NEUROCRIT CARE, V30, P499, DOI 10.1007/s12028-019-00694-8; Kramer AH, 2012, CAN J NEUROL SCI, V39, P328, DOI 10.1017/S0317167100013469; Kromm J, 2021, NEUROCRIT CARE, V35, P894, DOI 10.1007/s12028-020-01172-2; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lybeck A, 2020, ACTA ANAESTH SCAND, V64, P85, DOI 10.1111/aas.13466; Moura LMVR, 2014, NEUROLOGY, V83, P56, DOI 10.1212/WNL.0000000000000537; Nitzschke R, 2011, J CLIN MONIT COMPUT, V25, P329, DOI 10.1007/s10877-011-9312-2; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042; Pensirikul AD, 2013, J CLIN NEUROPHYSIOL, V30, P371, DOI 10.1097/WNP.0b013e31829de01c; Stewart CP, 2010, NEUROLOGY, V75, P1501, DOI 10.1212/WNL.0b013e3181f9619e; Sun J, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012514; Sutter R, 2014, NEUROLOGY, V82, P656, DOI 10.1212/WNL.0000000000000009; Swisher CB, 2015, J CLIN NEUROPHYSIOL, V32, P324, DOI 10.1097/WNP.0000000000000144; Topjian AA, 2015, PEDIATR CRIT CARE ME, V16, P461, DOI 10.1097/PCC.0000000000000352; Trinka E, 2015, EPILEPSIA, V56, P1515, DOI 10.1111/epi.13121; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Williamson CA, 2014, NEUROCRIT CARE, V20, P32, DOI 10.1007/s12028-013-9912-4; Young GB, 1996, NEUROLOGY, V47, P83	43	0	0	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01395-x		NOV 2021	8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WZ2ET	WOS:000719785500004	34791594	Bronze			2022-02-06	
J	Balzano, RF; Mannatrizio, D; Castorani, G; Perri, M; Pennelli, AM; Izzo, R; Popolizio, T; Guglielmi, G				Balzano, Rosario Francesco; Mannatrizio, Domenico; Castorani, Giulia; Perri, Marco; Pennelli, Anna Maria; Izzo, Roberto; Popolizio, Teresa; Guglielmi, Giuseppe			Imaging of Cerebral Microbleeds: Primary Patterns and Differential Diagnosis	CURRENT RADIOLOGY REPORTS			English	Article						Cerebral amyloid angiopathy; Intracranial hemorrhage; MRI; Microbleeds	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; AUTOSOMAL-DOMINANT ARTERIOPATHY; AMYLOID ANGIOPATHY; RISK-FACTORS; NATURAL-HISTORY; CAVERNOUS MALFORMATIONS; SUBCORTICAL INFARCTS; CLINICAL-RELEVANCE; BLOOD-PRESSURE	Purpose of Review In this Article will be discussed the most common conditions related to CMBs and the main associated patterns. Recent Findings Cerebral microbleeds (CMBs) are an important finding of cerebral pathologies. Attention has been raised about their detection and characterization, since they may imply the presence of other underlying diseases. Magnetic Resonance Imaging, by mean of susceptivity-sensitive sequences, play a crucial role in the definition of CMBs, with the attempt to achieve the correct diagnosis.	[Balzano, Rosario Francesco; Mannatrizio, Domenico; Guglielmi, Giuseppe] Dimiccoli Hosp, Radiol Unit, Viale Ippocrate 15, I-70051 Barletta, Italy; [Mannatrizio, Domenico; Castorani, Giulia; Guglielmi, Giuseppe] Foggia Univ, Dept Clin & Expt Med, Sch Med, Viale L Pinto 1, I-71121 Foggia, Italy; [Castorani, Giulia; Pennelli, Anna Maria; Popolizio, Teresa; Guglielmi, Giuseppe] Fdn IRCCS Casa Sollievo Della Sofferenza, Dept Radiol, Viale Cappuccini 1, I-71013 San Giovanni Rotondo, Italy; [Perri, Marco] Osped SS Filippo & Nicola ASL 1 Avezzano, Dept Radiol, Via G Vittorio, I-67051 Laquila, Sulmona, Italy; [Izzo, Roberto] Emicenter, Via Taverna Rossa 169-171, I-80020 Neples, Italy; [Izzo, Roberto] Ctr Diagnost Ascione, Via Napoli 49, I-80059 Naples, Italy; [Izzo, Roberto] Studio Amato Via Giacomo Matteotti 82, I-81030 San Marcellino, Caserta, Italy; [Izzo, Roberto] CRTF, Via Pasquale Atenolfi 42-46, I-84013 Salerno, Italy; [Izzo, Roberto] Polidiagnost Iodice, Via Nazl Appia 28, I-81040 Caserta, Italy		Guglielmi, G (corresponding author), Dimiccoli Hosp, Radiol Unit, Viale Ippocrate 15, I-70051 Barletta, Italy.; Guglielmi, G (corresponding author), Foggia Univ, Dept Clin & Expt Med, Sch Med, Viale L Pinto 1, I-71121 Foggia, Italy.; Guglielmi, G (corresponding author), Fdn IRCCS Casa Sollievo Della Sofferenza, Dept Radiol, Viale Cappuccini 1, I-71013 San Giovanni Rotondo, Italy.	giuseppe.guglielmi@unifg.it					Attems J, 2011, NEUROPATH APPL NEURO, V37, P75, DOI 10.1111/j.1365-2990.2010.01137.x; BARTH H, 1994, NERVENARZT, V65, P854; Beitzke M, 2011, STROKE, V42, P3055, DOI 10.1161/STROKEAHA.111.621847; Berlit P, 2014, CLIN EXP IMMUNOL, V175, P419, DOI 10.1111/cei.12221; Bierman P, 2005, HEMATOL ONCOL CLIN N, V19, P597, DOI 10.1016/j.hoc.2005.05.003; Biffi A, 2015, JAMA-J AM MED ASSOC, V314, P904, DOI 10.1001/jama.2015.10082; Blitstein MK, 2007, AM J ROENTGENOL, V189, P720, DOI 10.2214/AJR.07.2249; Boulouis G, 2016, SEMIN NEUROL, V36, P233, DOI 10.1055/s-0036-1581993; Bousser MG, 2001, J NEUROL NEUROSUR PS, V70, P285, DOI 10.1136/jnnp.70.3.285; Britannica T., 2006, ENCYCL BRITANNICA; Calviere L, 2016, J STROKE CEREBROVASC, V25, P1009, DOI 10.1016/j.jstrokecerebrovasdis.2015.11.010; Campbell PG, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.5.FOCUS10120; Carare RO, 2013, NEUROPATH APPL NEURO, V39, P593, DOI 10.1111/nan.12042; Chao CP, 2006, RADIOGRAPHICS, V26, P1517, DOI 10.1148/rg.265055090; Charidimou A, 2014, NEUROLOGY, V82, P57, DOI 10.1212/01.wnl.0000438225.02729.04; Charidimou A, 2013, NEURORADIOLOGY, V55, P655, DOI 10.1007/s00234-013-1175-4; Charidimou A, 2012, J NEUROL NEUROSUR PS, V83, P124, DOI 10.1136/jnnp-2011-301308; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Cheng YCN, 2001, NMR BIOMED, V14, P468, DOI 10.1002/nbm.727; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; Cordonnier C, 2011, BRAIN, V134, P335, DOI 10.1093/brain/awq321; Cordonnier C, 2009, STROKE, V40, P94, DOI 10.1161/STROKEAHA.108.526996; Coulon A, 2002, EUR RADIOL, V12, P329, DOI 10.1007/s003300101037; de Souza JM, 2008, AM J NEURORADIOL, V29, P154, DOI 10.3174/ajnr.A0748; Dichgans M, 2002, STROKE, V33, P67, DOI 10.1161/hs0102.100885; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Elmsthl S, 2019, J CLIN HYPERTENS, V21, P1099, DOI 10.1111/jch.13606; Fink Kathleen R, 2013, Surg Neurol Int, V4, pS209, DOI 10.4103/2152-7806.111298; Fotiadis P, 2016, LANCET NEUROL, V15, P811, DOI 10.1016/S1474-4422(16)30030-8; Garg A, 2011, NEUROIMAG CLIN N AM, V21, P897, DOI 10.1016/j.nic.2011.07.007; Gault J, 2004, NEUROSURGERY, V55, P1, DOI 10.1227/01.NEU.0000126872.23715.E5; GOMORI JM, 1987, J COMPUT ASSIST TOMO, V11, P684, DOI 10.1097/00004728-198707000-00025; Goos JDC, 2011, STROKE, V42, P1894, DOI 10.1161/STROKEAHA.110.599837; Greenberg SM, 1998, NEUROLOGY, V50, P961, DOI 10.1212/WNL.50.4.961; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2007, J MAGN RESON IMAGING, V26, P256, DOI 10.1002/jmri.22987; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haacke EM., 1993, MAGNETIC RESONANCE A, P46; Haldorsen IS, 2011, AM J NEURORADIOL, V32, P984, DOI 10.3174/ajnr.A2171; Haller S, 2018, RADIOLOGY, V287, P11, DOI 10.1148/radiol.2018170803; Hawkes CA, 2014, BRAIN PATHOL, V24, P396, DOI 10.1111/bpa.12159; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; Hsu CCT, 2016, J NEUROIMAGING, V26, P383, DOI 10.1111/jon.12360; Imaoka K, 1999, J NEUROL, V246, P661, DOI 10.1007/s004150050428; Kim DS, 1997, SURG NEUROL, V48, P9, DOI 10.1016/S0090-3019(96)00425-9; Kimberly WT, 2009, NEUROLOGY, V72, P1230, DOI 10.1212/01.wnl.0000345666.83318.03; Kinnecom C, 2007, NEUROLOGY, V68, P1411, DOI 10.1212/01.wnl.0000260066.98681.2e; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Koppelmans V, 2015, J CLIN ONCOL, V33, P588, DOI 10.1200/JCO.2014.56.8345; Kraemer M, 2010, RHEUMATOL INT, V30, P1471, DOI 10.1007/s00296-009-1172-4; Labauge P, 2000, NEURORADIOLOGY, V42, P327, DOI 10.1007/s002340050893; Lee JM, 2006, NEUROLOGY, V66, P6, DOI 10.1212/01.wnl.0000196863.43951.44; Lee JS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00203; Lee Sulki, 2017, Journal of Neurocritical Care, V10, P129, DOI 10.18700/jnc.170025; Lehnhardt FG, 2005, ARCH NEUROL-CHICAGO, V62, P653, DOI 10.1001/archneur.62.4.653; Licata B, 2003, J Neurosurg Sci, V47, P201; Linn J, 2010, NEUROLOGY, V74, P1346, DOI 10.1212/WNL.0b013e3181dad605; Maki T, 2014, ANN CLIN TRANSL NEUR, V1, P519, DOI 10.1002/acn3.79; Marengo-Rowe Alain J, 2006, Proc (Bayl Univ Med Cent), V19, P239; Mazumdar Avi, 2006, Neurosurg Focus, V21, pE15; McCarron MO, 2004, LANCET NEUROL, V3, P484, DOI 10.1016/S1474-4422(04)00825-7; Moulin S, 2016, LANCET NEUROL, V15, P820, DOI 10.1016/S1474-4422(16)00130-7; Nelson D., 2017, LEHNINGER PRINCIPLES; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Nylander R, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00217; Oberstein SAJL, 2001, NEUROLOGY, V57, P1066, DOI 10.1212/WNL.57.6.1066; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Pasi M, 2017, NEUROLOGY, V88, P2162, DOI 10.1212/WNL.0000000000004007; Pasquini M, 2016, STROKE, V47, P689, DOI 10.1161/STROKEAHA.115.011843; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Pontes-Neto Octavio M, 2012, Eur Neurol Rev, V7, P134; PRELLI F, 1988, J NEUROCHEM, V51, P648, DOI 10.1111/j.1471-4159.1988.tb01087.x; Radbruch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063459; Ramos AR, 2013, CURR GERIATR REP, V2, P188, DOI 10.1007/s13670-013-0054-5; Razek AAKA, 2014, RADIOGRAPHICS, V34, P873, DOI 10.1148/rg.344135028; Remes TM, 2020, NEURO-ONCOL PRACT, V7, P415, DOI 10.1093/nop/npaa002; Revesz T, 2002, BRAIN PATHOL, V12, P343; Roberts KF, 2014, ANN NEUROL, V76, P837, DOI 10.1002/ana.24270; Romero JR, 2014, STROKE, V45, P1492, DOI 10.1161/STROKEAHA.114.004130; Rosand J, 2005, ANN NEUROL, V58, P459, DOI 10.1002/ana.20596; Ruchoux MM, 1997, J NEUROPATH EXP NEUR, V56, P947, DOI 10.1097/00005072-199709000-00001; Sandsmark DK, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0654-5; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schrag M, 2010, ACTA NEUROPATHOL, V119, P291, DOI 10.1007/s00401-009-0615-z; Schweitzer AD, 2019, RADIOGRAPHICS, V39, P1571, DOI 10.1148/rg.2019190076; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Shetty VS, 2016, J AM COLL RADIOL, V13, P668, DOI 10.1016/j.jacr.2016.02.023; Siemonsen S, 2016, CLIN NEURORADIOL, V26, P457, DOI 10.1007/s00062-015-0389-8; Smallman RE., 2014, PHYS PROPERTIES MODE, P317, DOI [10.1016/B978-0-08-098204-5.00008-0, DOI 10.1016/B978-0-08-098204-5.00008-0]; Smith Eric E, 2003, Curr Atheroscler Rep, V5, P260, DOI 10.1007/s11883-003-0048-4; Sotoudeh H, 2021, J NEUROIMAGING, V31, P459, DOI 10.1111/jon.12841; Sveinbjornsdottir S, 2008, J NEUROL NEUROSUR PS, V79, P1002, DOI 10.1136/jnnp.2007.121913; Takeda S, 2003, NEUROPATHOLOGY, V23, P254, DOI 10.1046/j.1440-1789.2003.00506.x; Thal DR, 2015, ACTA NEUROPATHOL, V129, P167, DOI 10.1007/s00401-014-1375-y; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; Viswanathan A, 2006, BRAIN, V129, P2375, DOI 10.1093/brain/awl177; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; Wang DN, 2015, J STROKE CEREBROVASC, V24, P2728, DOI 10.1016/j.jstrokecerebrovasdis.2015.08.003; WEISBERG LA, 1985, COMPUT RADIOL, V9, P105, DOI 10.1016/0730-4862(85)90006-X; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; Wong ET, 2005, CLIN CANCER RES, V11, p7151S, DOI 10.1158/1078-0432.CCR-1004-0002; Yakushiji Y, 2016, FRONT NEUROL NEUROSC, V37, P78, DOI 10.1159/000437115; Yakushiji Y, 2012, STROKE, V43, P1800, DOI 10.1161/STROKEAHA.111.647065; Yakushiji Y, 2011, J STROKE CEREBROVASC, V20, P214, DOI 10.1016/j.jstrokecerebrovasdis.2009.12.001; Yamada N, 1996, RADIOLOGY, V198, P171, DOI 10.1148/radiology.198.1.8539373; Yubi T, 2018, NEUROL-CLIN PRACT, V8, P223, DOI 10.1212/CPJ.0000000000000464; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; ZABRAMSKI JM, 1994, J NEUROSURG, V80, P422, DOI 10.3171/jns.1994.80.3.0422	112	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2167-4825		CURR RADIOL REP	Curr. Radiol. Rep.	NOV 17	2021	9	12							15	10.1007/s40134-021-00390-6			15	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	WZ3VW	WOS:000719899500002		Bronze			2022-02-06	
J	Frankowski, JC; Foik, AT; Tierno, A; Machhor, JR; Lyon, DC; Hunt, RF				Frankowski, Jan C.; Foik, Andrzej T.; Tierno, Alexa; Machhor, Jiana R.; Lyon, David C.; Hunt, Robert F.			Traumatic brain injury to primary visual cortex produces long-lasting circuit dysfunction	COMMUNICATIONS BIOLOGY			English	Article							CORTICAL IMPACT INJURY; DENTATE GRANULE CELLS; V PYRAMIDAL NEURONS; POSTTRAUMATIC EPILEPSY; FEATURE SELECTIVITY; EVOKED POTENTIALS; CRITICAL-PERIOD; INHIBITION; NETWORK; MOUSE	Primary sensory areas of the mammalian neocortex have a remarkable degree of plasticity, allowing neural circuits to adapt to dynamic environments. However, little is known about the effects of traumatic brain injury on visual circuit function. Here we used anatomy and in vivo electrophysiological recordings in adult mice to quantify neuron responses to visual stimuli two weeks and three months after mild controlled cortical impact injury to primary visual cortex (V1). We found that, although V1 remained largely intact in brain-injured mice, there was similar to 35% reduction in the number of neurons that affected inhibitory cells more broadly than excitatory neurons. V1 neurons showed dramatically reduced activity, impaired responses to visual stimuli and weaker size selectivity and orientation tuning in vivo. Our results show a single, mild contusion injury produces profound and long-lasting impairments in the way V1 neurons encode visual input. These findings provide initial insight into cortical circuit dysfunction following central visual system neurotrauma.	[Frankowski, Jan C.; Tierno, Alexa; Machhor, Jiana R.; Lyon, David C.; Hunt, Robert F.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Foik, Andrzej T.] Polish Acad Sci, Inst Phys Chem, Int Ctr Translat Eye Res, Ophthalm Biol Grp, Warsaw, Poland		Hunt, RF (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	robert.hunt@uci.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS096012, R01-EY024890, F31-NS106806]; Department of DefenseUnited States Department of Defense [W81XWH-21-1-0884]; European Union under the European Regional Development Fund, National Science Center, Poland [MAB/2019/12]	This work was supported by funding from the National Institutes of Health grants R01-NS096012, R01-EY024890, F31-NS106806, and Department of Defense grant W81XWH-21-1-0884. The International Centre for Translational Eye Research (MAB/2019/12) project is carried out within the International Research Agendas program of the Foundation for Polish Science co-financed by the European Union under the European Regional Development Fund, National Science Center, Poland (2019/34/E/NZ5/00434) for A.T.F. We thank Farideh Dehkordi-Vakil and the UCI Center for Statistical Consulting for assistance with data analysis. We thank members of the Hunt lab for helpful discussions and comments on earlier versions of this manuscript.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Ahrlund-Richter S, 2019, NAT NEUROSCI, V22, P657, DOI 10.1038/s41593-019-0354-y; Alitto HJ, 2004, J NEUROPHYSIOL, V91, P2797, DOI 10.1152/jn.00943.2003; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Butler CR, 2016, EXP NEUROL, V280, P30, DOI 10.1016/j.expneurol.2016.03.022; Cajal S.Ry., 1928, DEGENERATION REGENER, P656; Camillo D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30958-w; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Cone JJ, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0337-18.2019; Davis MF, 2015, NEURON, V86, P1055, DOI 10.1016/j.neuron.2015.03.062; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; Du T, 2005, BRAIN INJURY, V19, P1125, DOI 10.1080/02699050500149817; ECHLIN FA, 1963, ARCH NEUROL-CHICAGO, V9, P154, DOI 10.1001/archneur.1963.00460080064009; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Eysel UT, 1999, CEREB CORTEX, V9, P101, DOI 10.1093/cercor/9.2.101; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Foik AT, 2020, NEUROSCIENCE, V441, P117, DOI 10.1016/j.neuroscience.2020.06.030; Foik AT, 2018, J NEUROSCI, V38, P10709, DOI 10.1523/JNEUROSCI.1279-18.2018; Foik AT, 2015, INVEST OPHTH VIS SCI, V56, P1711, DOI 10.1167/iovs.14-15617; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Frankowski JC, 2019, NEUROBIOL DIS, V129, P208, DOI 10.1016/j.nbd.2018.07.022; GIRARD P, 1991, NEUROREPORT, V2, P81, DOI 10.1097/00001756-199102000-00004; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hafner G, 2021, CEREB CORTEX, V31, P1427, DOI 10.1093/cercor/bhaa280; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Imbrosci B, 2010, J PHYSIOL-LONDON, V588, P4695, DOI 10.1113/jphysiol.2010.198192; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Kleiner M, 2007, PERCEPTION, V36, P14; Koenig JB, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126506; Kordecka K, 2020, FRONT SYST NEUROSCI, V14, DOI 10.3389/fnsys.2020.00059; Larimer P, 2016, CELL REP, V16, P1391, DOI 10.1016/j.celrep.2016.06.071; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Liu YJ, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.3.031209; Liu YJ, 2015, J PHYSIOL-LONDON, V593, P4485, DOI 10.1113/JP271180; Liu YJ, 2013, CURR BIOL, V23, P1746, DOI 10.1016/j.cub.2013.07.033; Liu YJ, 2011, J NEUROPHYSIOL, V105, P1306, DOI 10.1152/jn.00692.2010; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Luo P, 2019, FRONT NEUROANAT, V13, DOI 10.3389/fnana.2019.00044; Lyon DC, 2002, NEURON, V33, P453, DOI 10.1016/S0896-6273(02)00580-9; McKenna K, 2006, BRAIN INJURY, V20, P507, DOI 10.1080/02699050600664368; Nichols J, 2018, J PHYSIOL-LONDON, V596, P1277, DOI 10.1113/JP275393; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Salin P, 1995, J NEUROSCI, V15, P8234; Sano K, 1967, Neurol Med Chir (Tokyo), V9, P21, DOI 10.2176/nmc.9.21; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; SILLITO AM, 1985, VISION RES, V25, P375, DOI 10.1016/0042-6989(85)90062-8; SILVERMAN IE, 1993, J NUCL MED, V34, P1447; Stanco A, 2014, NEURON, V84, P940, DOI 10.1016/j.neuron.2014.10.040; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Suh S, 2021, NAT BIOMED ENG, V5, DOI 10.1038/s41551-020-00632-6; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Toth Z, 1997, J NEUROSCI, V17, P8106; Tucker TR, 2006, J NEUROSCI, V26, P13537, DOI 10.1523/JNEUROSCI.3723-06.2006; Van den Bergh G, 2010, J COMP NEUROL, V518, P2051, DOI 10.1002/cne.22321; Vascak M, 2018, CEREB CORTEX, V28, P1625, DOI 10.1093/cercor/bhx058; Vogt D, 2014, NEURON, V82, P350, DOI 10.1016/j.neuron.2014.02.030; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Zhu BY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13170-w; ZIHL J, 1990, CLIN VISION SCI, V5, P185	86	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY		2399-3642		COMMUN BIOL	Commun. Biol.	NOV 17	2021	4	1							1297	10.1038/s42003-021-02808-5			12	Biology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Science & Technology - Other Topics	WZ4BU	WOS:000719915100001	34789835	Green Published, Green Submitted, gold			2022-02-06	
J	Nejtek, VA; James, RN; Salvatore, MF; Alphonso, HM; Boehm, GW				Nejtek, Vicki A.; James, Rachael N.; Salvatore, Michael F.; Alphonso, Helene M.; Boehm, Gary W.			Premature cognitive decline in specific domains found in young veterans with mTBI coincide with elder normative scores and advanced-age subjects with early-stage Parkinson's disease	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; FALSE DISCOVERY RATE; MINI-MENTAL-STATE; HEAD-INJURY; TRAIL; VALIDATION; SCALE; RISK; PERFORMANCE; IMPAIRMENT	Importance Epidemiologists report a 56% increased risk of veterans with (+) mild traumatic brain injury (mTBI) developing Parkinson's disease (PD) within 12-years post-injury. The most relevant contributors to this high risk of PD in veterans (+) mTBI is unknown. As cognitive problems often precede PD diagnosis, identifying specific domains most involved with mTBI-related PD onset is critical. Objectives To discern which cognitive domains underlie the mTBI-PD risk relationship proposed in epidemiology studies. Design and setting This exploratory match-controlled, cross-sectional study was conducted in a medical school laboratory from 2017-2020. Participants Age- and IQ-matched veterans with (+) and without mTBI, non-veteran healthy controls, and IQ-matched non-demented early-stage PD were compared. Chronic neurological, unremitted/debilitating diseases, disorders, dementia, and substance use among others were excluded. Exposure Veterans were or were not exposed to non-penetrating combat-related mTBI occurring within the past 7-years. No other groups had recent military service or mTBI. Main outcomes / measures Cognitive flexibility, attention, memory, visuospatial ability, and verbal fluency were examined with well-known standardized neuropsychological assessments. Results Out of 200 volunteers, 114 provided evaluable data. Groups significantly differed on cognitive tests [F (21,299) = 3.09, p<0.0001]. Post hoc tests showed veterans (+) mTBI performed significantly worse than matched-control groups on four out of eight cognitive tests (range: p = .009 to .049), and more often than not performed comparably to early-stage PD (range: p = .749 to .140). Conclusions and relevance We found subtle, premature cognitive decline occurring in very specific cognitive domains in veterans (+) mTBI that would typically be overlooked in a clinic setting, This result potentially puts them at-risk for continual cognitive decline that may portend to the eventual onset of PD or some other neurodegenerative disease.	[Nejtek, Vicki A.; James, Rachael N.; Salvatore, Michael F.; Alphonso, Helene M.] Univ North Texas Hlth Sci Ctr, Ft Worth, TX 76107 USA; [Alphonso, Helene M.] John Peter Smith Hlth Network, Ft Worth, TX 76107 USA; [Boehm, Gary W.] Texas Christian Univ, Ft Worth, TX 76129 USA		Nejtek, VA (corresponding author), Univ North Texas Hlth Sci Ctr, Ft Worth, TX 76107 USA.	vicki.nejtek@unthsc.edu		Nejtek, Vicki/0000-0001-6935-1739	Graham and Caroline Holloway Family Foundation; JES Edwards Foundation [RP20007]; Institute for Translational Research at UNT Health Science Center [RI10024]	VAN was the Principal Investigator funded, in part, by the Graham and Caroline Holloway Family Foundation, the JES Edwards Foundation under Grant # RP20007, and the Institute for Translational Research (formerly the Center for Alzheimer's and Neurodegenerative Disease Research) at UNT Health Science Center under Grant # RI10024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo-Rodriguez I, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010783.pub2; Ashendorf L, 2008, ARCH CLIN NEUROPSYCH, V23, P129, DOI 10.1016/j.acn.2007.11.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg D, 2018, J PARKINSON DIS, V8, pS19, DOI 10.3233/JPD-181457; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crowe M, 2010, ARCH CLIN NEUROPSYCH, V25, P610, DOI 10.1093/arclin/acq047; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Darweesh SKL, 2017, JAMA NEUROL, V74, P1431, DOI 10.1001/jamaneurol.2017.2248; Durcan R, 2019, EUR J NEUROL, V26, P979, DOI 10.1111/ene.13919; Fengler S, 2017, MOVEMENT DISORD, V32, P1655, DOI 10.1002/mds.27135; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Goldman JG, 2018, NPJ PARKINSON DIS, V4, DOI 10.1038/s41531-018-0055-3; Gregoire J, 1997, AGING NEUROPSYCHOL C, V4, P140, DOI 10.1080/13825589708256642; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Kalbe E, 2018, J PARKINSON DIS, V8, pS107, DOI 10.3233/JPD-181473; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lesiuk T, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6020035; Lezak MD., 2004, LORING DW NEUROPSYCH, V4th; Marchand DG, 2018, ANN NEUROL, V83, P1016, DOI 10.1002/ana.25239; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; McInnes K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218423; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Numbers for Traumatic Brain Injury Worldwide Totals, 2019, DEF MED SURV SYST DM; Pfeiffer HCV, 2014, ACTA NEUROL SCAND, V129, P307, DOI 10.1111/ane.12189; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; De Roy J, 2020, J PARKINSON DIS, V10, P1033, DOI 10.3233/JPD-191857; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; Salvatore MF, 2021, J PARKINSON DIS, V11, P405, DOI 10.3233/JPD-202449; Schwab KA, 2006, NEUROLOGY, V66, pA235; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shulman LM, 2010, ARCH NEUROL-CHICAGO, V67, P64, DOI 10.1001/archneurol.2009.295; Silveira CRA, 2018, BRAIN COGNITION, V122, P1, DOI 10.1016/j.bandc.2018.01.002; Silverberg ND, 2020, JAMA-J AM MED ASSOC, V323, P177, DOI 10.1001/jama.2019.18134; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wilmoth K, 2018, CLIN NEUROPSYCHOL, V32, P524, DOI 10.1080/13854046.2017.1378371; Writer BW, 2010, J REHABIL RES DEV, V47, P841, DOI 10.1682/JRRD.2009.10.0162; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	55	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0258851	10.1371/journal.pone.0258851			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW9HJ	WOS:000735920500007	34788310	gold, Green Published			2022-02-06	
J	Perrotta, F; Perrini, MP; Cantatore, LP				Perrotta, Francesco; Perrini, Marco Paolo; Cantatore, Lea Pia			Acute Parkinsonism in a Patient with Spinal Cord Injury: A Case Report	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article; Early Access						Parkinson's disease; parkinsonism; spinal cord injury	TRAUMATIC BRAIN-INJURY; DISEASE	Parkinson's disease (PD) is the most common cause of parkinsonism, a clinical syndrome that includes bradykinesia, tremor, and postural instability. Secondary causes of parkinsonism include chronic traumatic encephalopathy. However, clear physiopathologic association between spinal cord injury (SCI) and PD has not been well described yet. We describe a rare/unusual case of a patient with C7-D1 fracture/listhesis who, 12 days after the trauma, developed a progressive cognitive impairment together with mandibular tremor. Seven days after the onset of symptoms, because of the persistence of mandibular tremor and Glasgow Coma Scale (GCS) score of 4, therapy with L-DOPA/benserazide was started, which resulted in gradual reduction of symptoms and complete recovery of consciousness. This could be the first report of PD appearing only 12 days after an SCI in the acute stage. Early differential diagnosis on the first manifestations of this kind of symptoms should be considered in patients with SCI to set up the right therapy essential for improving the outcome and preventing devastating consequences. This might also provide insights into the potential pathophysiologic responses of the brain after primary (immediate) and secondary (delayed) damages.	[Perrotta, Francesco] Osped Casa Sollievo Sofferenza, Emergenza Urgenza, Viale Cappuccini, I-71013 San Giovanni Rotondo, Italy; [Perrini, Marco Paolo; Cantatore, Lea Pia] Univ Foggia, Fac Med & Chirurg, Anestesia & Rianimaz, Foggia, Italy		Perrotta, F (corresponding author), Osped Casa Sollievo Sofferenza, Emergenza Urgenza, Viale Cappuccini, I-71013 San Giovanni Rotondo, Italy.	francperr72@yahoo.it					Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Gallegos S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00059; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; IGARASHI M, 1972, LARYNGOSCOPE, V82, P1609, DOI 10.1288/00005537-197209000-00004; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Yeh TS, 2016, SPINAL CORD, V54, P1215, DOI 10.1038/sc.2016.74	8	0	0	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A												10.1055/s-0041-1724108		NOV 2021	3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WY8ZF	WOS:000719565300003	34788867				2022-02-06	
J	Summaka, M; Harati, H; Hannoun, S; Zein, H; Koubaisy, N; Fares, Y; Nasser, Z				Summaka, Marwa; Harati, Hayat; Hannoun, Salem; Zein, Hiba; Koubaisy, Nour; Fares, Youssef; Nasser, Zeina			Assessment of non-progressive dysarthria: practice and attitude of speech and language therapists in Lebanon	BMC NEUROLOGY			English	Article						Non-progressive dysarthria; Assessment; Speech and language therapy; Survey; ICF; Lebanon	POSTSTROKE DYSARTHRIA; STROKE; PREVALENCE; PEOPLE; IMPACT	Background Non-progressive dysarthria is an acquired motor speech disorder resulting from neurological diseases such as stroke and traumatic brain injury. The evidence base for the assessment of non-progressive dysarthria remains limited with professional practices relying mainly on therapists' clinical experience. Limited information on the assessment practices of Lebanese speech and language therapists (SLTs) is available. Such information is crucial for the development of adequate therapy services for clients with non-progressive dysarthria. This study aims to explore the assessment practices and attitudes of Lebanese SLTs working with adults with non-progressive dysarthria and to investigate their adherence to the framework of the World Health Organization's International Classification of Functioning, Disability and Health (ICF). Methods A cross-sectional study was conducted in Lebanon between March and May 2021. Data was collected through an online survey that included information on socio-demographic characteristics, practices, and attitudes of SLTs who assess adults with non-progressive dysarthria. Results A total of 50 Lebanese SLTs responded to the survey. The majority of SLTs (78%) assessed clients with non-progressive dysarthria across all ICF domains. SLTs reported dissatisfaction with the available assessment tools (64%) and reliance on informal tools (84%). In addition, 68% of the SLTs suggested the crucial need for the development of Arabic formal assessments that can quantitatively evaluate dysarthria and determine severity. The survey also showed that the respondents demonstrated a preference for the use of impairment-based tools. Conclusion It can be concluded that the assessment practices of Lebanese SLTs, generally, follow the international trend and the recommended professional guidelines. Further research initiatives should be held to develop Arabic formal assessment tools for non-progressive dysarthria.	[Summaka, Marwa] Lebanese Univ, Doctoral Sch Sci & Technol, Hadath, Lebanon; [Harati, Hayat; Fares, Youssef; Nasser, Zeina] Lebanese Univ, Fac Med Sci, Neurosci Res Ctr, Hadath, Lebanon; [Hannoun, Salem] Amer Univ Beirut, Fac Hlth Sci, Div Hlth Profess, Med Imaging Sci Program, Beirut, Lebanon; [Zein, Hiba; Koubaisy, Nour] Hlth Rehabil Integrat & Res Ctr HRIR, Dept Rehabil, Beirut, Lebanon		Nasser, Z (corresponding author), Lebanese Univ, Fac Med Sci, Neurosci Res Ctr, Hadath, Lebanon.	z.nasser@ul.edu.lb	Hannoun, Salem/I-2761-2016	Hannoun, Salem/0000-0002-5982-3242			Abou-Abbass H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005342; Arefyeva A P, 2019, Zh Nevrol Psikhiatr Im S S Korsakova, V119, P32, DOI 10.17116/jnevro201911909232; Auzou P., 2006, BATTERIE EVALUATION; Balchin R, 2020, INT J SPEECH-LANG PA, V22, P347, DOI 10.1080/17549507.2020.1739333; Baylor CR, 2009, J SPEECH LANG HEAR R, V52, P1302, DOI 10.1044/1092-4388(2009/07-0275); Brady MC, 2011, DISABIL REHABIL, V33, P178, DOI 10.3109/09638288.2010.517897; Clark HM, 2003, AM J SPEECH-LANG PAT, V12, P400, DOI 10.1044/1058-0360(2003/086); Collis J, 2012, INT J LANG COMM DIS, V47, P725, DOI 10.1111/j.1460-6984.2012.00183.x; Conway A, 2015, INT J LANG COMM DIS, V50, P374, DOI 10.1111/1460-6984.12143; Coster WJ, 2013, AM J OCCUP THER, V67, P162, DOI 10.5014/ajot.2013.006015; Dashtipour K, 2018, NEURODEGENER DIS MAN, V8, P337, DOI 10.2217/nmt-2018-0021; Dickson S, 2008, INT J LANG COMM DIS, V43, P135, DOI 10.1080/13682820701862228; Dykstra Allyson D., 2007, Seminars in Speech and Language, V28, P301, DOI 10.1055/s-2007-986527; Enderby P, 1983, FRENCHAY DYSARTHRIA; Enderby P. M., 2008, FDA 2 FRENCHAY DYSAR; Flowers HL, 2013, J COMMUN DISORD, V46, P238, DOI 10.1016/j.jcomdis.2013.04.001; Geddes JML, 1996, J EPIDEMIOL COMMUN H, V50, P140, DOI 10.1136/jech.50.2.140; Kent RD, 2015, AM J SPEECH-LANG PAT, V24, P763, DOI 10.1044/2015_AJSLP-14-0179; Khalaf M, 2017, EUR ARCH OTO-RHINO-L, V274, P3139, DOI 10.1007/s00405-017-4585-9; Knuijt S, 2017, FOLIA PHONIATR LOGO, V69, P143, DOI 10.1159/000484556; Kuschmann A, 2021, INT J SPEECH-LANG PA, V23, P145, DOI 10.1080/17549507.2020.1750700; Lahoud N, 2016, J EPIDEMIOL GLOB HEA, V6, P169, DOI 10.1016/j.jegh.2015.10.001; Lawrence ES, 2001, STROKE, V32, P1279, DOI 10.1161/01.STR.32.6.1279; Mackenzie C, 2014, INT J LANG COMM DIS, V49, P602, DOI 10.1111/1460-6984.12096; Mackenzie C, 2011, INT J SPEECH-LANG PA, V13, P125, DOI 10.3109/17549507.2011.524940; Mackenzie C, 2011, DISABIL REHABIL, V33, P187, DOI 10.3109/09638288.2010.508555; Miller N, 2017, INT J LANG COMM DIS, V52, P800, DOI 10.1111/1460-6984.12316; Mitchell C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002088.pub3; Murdoch BE, 2001, TRAUMATIC BRAIN INJU; O'Mahony PG, 1999, J PUBLIC HEALTH MED, V21, P166, DOI 10.1093/pubmed/21.2.166; Pinto S, 2004, LANCET NEUROL, V3, P547, DOI 10.1016/S1474-4422(04)00854-3; Rumbach AF, 2019, J COMMUN DISORD, V79, P46, DOI 10.1016/j.jcomdis.2019.03.002; Rusz J, 2019, BRAIN LANG, V194, P58, DOI 10.1016/j.bandl.2019.04.009; Sellars C, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.cd002088, DOI 10.1002/14651858.CD002088]; Soliveri P, 2003, NEUROL SCI, V24, P211, DOI 10.1007/s10072-003-0135-X; Walshe M, 2011, DISABIL REHABIL, V33, P195, DOI 10.3109/09638288.2010.511685; Walshe M, 2009, INT J LANG COMM DIS, V44, P693, DOI 10.1080/13682820802317536; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955; World Health O, 2001, ICF INT CLASS FUNCT; Yorkston KM, 1996, J SPEECH HEAR RES, V39, pS46, DOI 10.1044/jshr.3905.s46; Ziegler W, 2002, BRAIN LANG, V80, P556, DOI 10.1006/brln.2001.2614	41	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	NOV 17	2021	21	1							450	10.1186/s12883-021-02484-2			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WZ3OJ	WOS:000719880000001	34789195	Green Published, gold			2022-02-06	
J	Troyanskaya, M; Pastorek, NJ; Wilde, EA; Tombridge, KA; Day, AM; Levin, HS; Scheibel, RS				Troyanskaya, Maya; Pastorek, Nicholas J.; Wilde, Elisabeth A.; Tombridge, Kathryn A.; Day, Alyssa M.; Levin, Harvey S.; Scheibel, Randall S.			Risk factors for decline in cognitive performance following deployment-related mild traumatic brain injury: A preliminary report	NEUROCASE			English	Article						Mild traumatic brain injury; cognitive performance; veterans; risk factors; memory function	POSTTRAUMATIC-STRESS-DISORDER; CHECKLIST; SYMPTOMS; DEMENTIA; VETERANS; ALCOHOL; OBESITY; HEALTH	Thorough identification of risk factors for delayed decline in cognitive performance following combat-related mild traumatic brain injury (mTBI) is important for guiding comprehensive post-deployment rehabilitation. In a sample of veterans who reported at least one deployment-related mTBI, preliminary results indicate that factors including a history of loss of consciousness over 1 min, current obesity and hypertension, and Black race were more prevalent in those with decreased scores on a measure of memory function. These factors should be considered by clinicians and researchers working with current and former military personnel.	[Troyanskaya, Maya; Pastorek, Nicholas J.; Tombridge, Kathryn A.; Day, Alyssa M.; Levin, Harvey S.; Scheibel, Randall S.] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Troyanskaya, Maya; Pastorek, Nicholas J.; Wilde, Elisabeth A.; Levin, Harvey S.; Scheibel, Randall S.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Wilde, Elisabeth A.] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT USA; [Day, Alyssa M.] Univ Houston, Dept Psychol, Houston, TX USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA		Troyanskaya, M (corresponding author), Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA.	mayat@bcm.edu			United States (U. S.) Department of Veterans Affairs Merit Review Awards [I01 CX001820, O1062-I]	This material is based upon work supported in part by the United States (U. S.) Department of Veterans Affairs Merit Review Awards Numbers I01 CX001820 (PI Scheibel, RS) and O1062-I (PI-Scheibel RS)	Ali R, 2002, ADDICTION, V97, P1183; Belanger HG, 2016, CLIN NEUROPSYCHOL, V30, P1063, DOI 10.1080/13854046.2016.1193632; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Christensen H, 1997, INT J GERIATR PSYCH, V12, P323, DOI 10.1002/(SICI)1099-1166(199703)12:3<323::AID-GPS492>3.0.CO;2-N; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cole WR., 2016, TRANSLATIONAL RES TR, DOI DOI 10.1201/B18959-20; Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Dreer LE, 2018, J HEAD TRAUMA REHAB, V33, P246, DOI 10.1097/HTR.0000000000000408; Dye L, 2017, P NUTR SOC, V76, P443, DOI 10.1017/S0029665117002014; Forte G, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010034; Green P., 2005, WORD MEMORY TEST WIN; Howard JT, 2020, J HYPERTENS, V38, P1293, DOI 10.1097/HJH.0000000000002364; Iacono D, 2020, J NEUROPATH EXP NEUR, V79, P144, DOI 10.1093/jnen/nlz122; Lange RT, 2020, NEUROPSYCHOL REHABIL, V30, P1762, DOI 10.1080/09602011.2019.1604385; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Robbins MA, 2005, PSYCHOSOM MED, V67, P707, DOI 10.1097/01.psy.0000171164.50990.80; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schnittker, 2018, SOCIUS, V4; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Snyder HM, 2018, ALZHEIMERS DEMENT, V14, P1651, DOI 10.1016/j.jalz.2018.08.011; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Veitch DP, 2013, CURR ALZHEIMER RES, V10, P907, DOI 10.2174/15672050113109990142; Yaffe K, 2014, ALZHEIMERS DEMENT, V10, pS111, DOI 10.1016/j.jalz.2014.04.010; Zahodne LB, 2016, J AM GERIATR SOC, V64, P959, DOI 10.1111/jgs.14113	28	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase	NOV 2	2021	27	6					457	461		10.1080/13554794.2021.2002912		NOV 2021	5	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	YN8SO	WOS:000719247100001	34783300				2022-02-06	
J	Karakaya, D; Cakir-Aktas, C; Uzun, S; Soylemezoglu, F; Mut, M				Karakaya, Dicle; Cakir-Aktas, Canan; Uzun, Sennur; Soylemezoglu, Figen; Mut, Melike			Tailored Therapeutic Doses of Dexmedetomidine in Evolving Neuroinflammation after Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article; Early Access						Traumatic brain injury; Neuroinflammation; Inflammasome; NLRP3; Microglia; T cells; Dexmedetomidine	ISCHEMIA-REPERFUSION INJURY; NF-KAPPA-B; NLRP3 INFLAMMASOME; HEAD-INJURY; T-CELLS; NEUROPROTECTION; ACTIVATION; EXPRESSION; PATHWAY; RECRUITMENT	Background Understanding the secondary damage mechanisms of traumatic brain injury (TBI) is essential for developing new therapeutic approaches. Neuroinflammation has a pivotal role in secondary brain injury after TBI. Activation of NLRP3 inflammasome complexes results in the secretion of proinflammatory mediators and, in addition, later in the response, microglial activation and migration of the peripheral immune cells into the injured brain are observed. Therefore, these components involved in the inflammatory process are becoming a new treatment target in TBI. Dexmedetomidine (Dex) is an effective drug, widely used over the past few years in neurocritical care units and during surgical operations for sedation and analgesia, and has anti-inflammatory effects, which are shown in in vivo studies. The aim of this original research is to discuss the anti-inflammatory effects of different Dex doses over time in TBI. Methods Brain injury was performed by using a weight-drop model. Half an hour after the trauma, intraperitoneal saline was injected into the control groups and 40 and 200 mu g/kg of Dex were given to the drug groups. Neurological evaluations were performed with the modified Neurological Severity Score before being killed. Then, the mice were killed on the first or the third day after TBI and histopathologic (hematoxylin-eosin) and immunofluorescent (Iba1, NLRP3, interleukin-1 beta, and CD3) findings of the brain tissues were examined. Nonparametric data were analyzed by using the Kruskal-Wallis test for multiple comparisons, and the Mann-Whitney U-test was done for comparing two groups. The results are presented as mean +/- standard error of mean. Results The results showed that low doses of Dex suppress NLRP3 and interleukin-1 beta in both terms. Additionally, high doses of Dex cause a remarkable decrease in the migration and motility of microglial cells and T cells in the late phase following TBI. Interestingly, the immune cells were influenced by only high-dose Dex in the late phase of TBI and it also improves neurologic outcome in the same period. Conclusions In the mice head trauma model, different doses of Dex attenuate neuroinflammation by suppressing distinct components of the neuroinflammatory process in a different timecourse that contributes to neurologic recovery. These results suggest that Dex may be an appropriate choice for sedation and analgesia in patients with TBI.	[Karakaya, Dicle; Mut, Melike] Hacettepe Univ, Fac Med, Dept Neurosurg, Ankara, Turkey; [Cakir-Aktas, Canan] Hacettepe Univ, Inst Neurol Sci & Psychiat, Ankara, Turkey; [Uzun, Sennur] Hacettepe Univ, Fac Med, Dept Anesthesiol & Reanimat, Ankara, Turkey; [Soylemezoglu, Figen] Hacettepe Univ, Fac Med, Dept Pathol, Ankara, Turkey		Mut, M (corresponding author), Hacettepe Univ, Fac Med, Dept Neurosurg, Ankara, Turkey.	melikem@hacettepe.edu.tr	Mut, Melike/E-9938-2013	Mut, Melike/0000-0002-9601-9907	Hacettepe University Scientific Research Projects Coordination UnitHacettepe University [THD-2017-16630]; Ankara, Turkey	This study was supported by Hacettepe University Scientific Research Projects Coordination Unit (Project Number: THD-2017-16630), Ankara, Turkey.	Abou El Fadl MH, 2018, NEUROSURG CLIN N AM, V29, P213, DOI 10.1016/j.nec.2017.11.002; Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Akpinar O, 2017, BRAIN RES BULL, V130, P1, DOI 10.1016/j.brainresbull.2016.12.005; Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Bell MT, 2014, J VASC SURG, V59, P1090, DOI 10.1016/j.jvs.2013.04.050; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Carbonell WS, 2005, J NEUROSCI, V25, P7040, DOI 10.1523/JNEUROSCI.5171-04.2005; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Chase Alex, 2015, Nat Rev Neurol, V11, P184, DOI 10.1038/nrneurol.2015.39; Chen Z, 2017, BIOCHEM BIOPH RES CO, V493, P1143, DOI 10.1016/j.bbrc.2017.08.017; Cheng F, 2019, PHARM BIOL, V57, P649, DOI 10.1080/13880209.2019.1651874; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dahmani S, 2008, ANESTHESIOLOGY, V108, P457, DOI 10.1097/ALN.0b013e318164ca81; Diaz MF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67723-x; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Filiano AJ, 2017, NAT REV NEUROSCI, V18, P375, DOI 10.1038/nrn.2017.39; Freeman LC, 2016, J NEUROCHEM, V136, P29, DOI 10.1111/jnc.13217; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; GENTLEMAN D, 1992, INT SURG, V77, P297; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Harnod D, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193524; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Humble SS, 2016, BRAIN INJURY, V30, P1266, DOI 10.1080/02699052.2016.1187289; Irrera N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176204; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Jiang WW, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0410-7; Kiernan PT, 2015, SEMIN NEUROL, V35, P20, DOI 10.1055/s-0035-1545080; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kramer TJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1550-0; Kutanis D, 2016, J CLIN ANESTH, V34, P577, DOI 10.1016/j.jclinane.2016.06.031; Li Y, 2018, BIOCHEM BIOPH RES CO, V495, P2439, DOI 10.1016/j.bbrc.2017.12.090; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Liu WH, 2017, EXP THER MED, V14, P3602, DOI 10.3892/etm.2017.4954; Liu ZG, 2016, INT IMMUNOPHARMACOL, V35, P210, DOI 10.1016/j.intimp.2016.04.003; Liu ZG, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1598-y; Luo C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00197; Ma DQ, 2004, BRIT MED BULL, V71, P77, DOI 10.1093/bmb/ldh036; Ma J, 2015, INT J CLIN EXP MED, V8, P14741; Ma QY, 2014, ANN NEUROL, V75, P209, DOI 10.1002/ana.24070; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Madathil SK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00964; MAS F, 1993, CLIN ELECTROENCEPHAL, V24, P118, DOI 10.1177/155005949302400309; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; O'Brien WT, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01778-5; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Riquelme JA, 2016, PHARMACOL RES, V103, P318, DOI 10.1016/j.phrs.2015.11.004; Rong H, 2017, BRAIN BEHAV IMMUN, V64, P195, DOI 10.1016/j.bbi.2017.03.006; Salmond CH, 2006, J NEUROTRAUM, V23, P1049, DOI 10.1089/neu.2006.23.1049; Schoeler M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-20; Schwarzmaier SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00358; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Si Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164763; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Soares HD, 1995, J NEUROSCI, V15, P8223; Song LM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00063; Sun YJ, 2017, CLIN EXP PHARMACOL P, V44, P946, DOI 10.1111/1440-1681.12791; Talke P, 1996, ANESTHESIOLOGY, V85, P551, DOI 10.1097/00000542-199609000-00014; Wang D, 2018, NEURAL REGEN RES, V13, P819, DOI 10.4103/1673-5374.232529; Wang LJ, 2017, BIOMOL THER, V25, P383, DOI 10.4062/biomolther.2015.180; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Weiner Michael W, 2017, Alzheimers Dement (N Y), V3, P177, DOI 10.1016/j.trci.2017.02.005; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23003-3; Yeh CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191070; Zhu YJ, 2016, BRAIN RES, V1644, P1, DOI 10.1016/j.brainres.2016.04.074; Zhua YM, 2013, BRAIN RES, V1494, P1, DOI 10.1016/j.brainres.2012.11.047	72	0	0	2	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01381-3		NOV 2021	13	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WX7KS	WOS:000718770800001	34782991	Bronze			2022-02-06	
J	Kumar, SP; Babu, PP				Kumar, Simhadri Praveen; Babu, Phanithi Prakash			NADPH Oxidase: a Possible Therapeutic Target for Cognitive Impairment in Experimental Cerebral Malaria	MOLECULAR NEUROBIOLOGY			English	Article; Early Access						NADPH oxidase 2; Apocynin adjunctive therapy; Hippocampal neuronal density; Long-term cognitive impairment	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; REACTIVE OXYGEN; INTRAMUSCULAR ARTEMETHER; HIPPOCAMPAL SCLEROSIS; INTRAVENOUS QUININE; INHIBITOR APOCYNIN; NOX INHIBITORS; CA1 NEURONS; MOUSE MODEL	Long-term cognitive impairment associated with seizure-induced hippocampal damage is the key feature of cerebral malaria (CM) pathogenesis. One-fourth of child survivors of CM suffer from long-lasting neurological deficits and behavioral anomalies. However, mechanisms on hippocampal dysfunction are unclear. In this study, we elucidated whether gp91(phox) isoform of nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2) (a potent marker of oxidative stress) mediates hippocampal neuronal abnormalities and cognitive dysfunction in experimental CM (ECM). Mice symptomatic to CM were rescue treated with artemether monotherapy (ARM) and in combination with apocynin (ARM + APO) adjunctive based on scores of Rapid Murine Come behavior Scale (RMCBS). After a 30-day survivability period, we performed Barnes maze, T-maze, and novel object recognition cognitive tests to evaluate working and reference memory in all the experimental groups except CM. Sensorimotor tests were conducted in all the cohorts to assess motor coordination. We performed Golgi-Cox staining to illustrate cornu ammonis-1 (CA1) pyramidal neuronal morphology and study overall hippocampal neuronal density changes. Further, expression of NOX2, NeuN (neuronal marker) in hippocampal CA1 and dentate gyrus was determined using double immunofluorescence experiments in all the experimental groups. Mice administered with ARM monotherapy and APO adjunctive treatment exhibited similar survivability. The latter showed better locomotor and cognitive functions, reduced ROS levels, and hippocampal NOX2 immunoreactivity in ECM. Our results show a substantial increase in hippocampal NeuN immunoreactivity and dendritic arborization in ARM + APO cohorts compared to ARM-treated brain samples. Overall, our study suggests that overexpression of NOX2 could result in loss of hippocampal neuronal density and dendritic spines of CA1 neurons affecting the spatial working and reference memory during ECM. Notably, ARM + APO adjunctive therapy reversed the altered neuronal morphology and oxidative damage in hippocampal neurons restoring long-term cognitive functions after CM.	[Kumar, Simhadri Praveen; Babu, Phanithi Prakash] Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Neurosci Lab, F-23-71, Hyderabad 500046, Telangana, India		Babu, PP (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Neurosci Lab, F-23-71, Hyderabad 500046, Telangana, India.	prakash@uohyd.ac.in			Ministry of Science and Technology, Department of Science and Technology, Govt. of India, DST-CSRI [SR/CSRI/196/2016]; DST-SERB Core grant [CRG/2020/005021]; Department of Biotechnology, Govt. of IndiaDepartment of Biotechnology (DBT) India [BT/PR17686/MED/30/1664/2016]; Ministry of Education, Govt. of India [F11/9/2019-U3(A)]; INSPIRE student Fellowship, Government of India [DST/INSPIRE Fellowship/2013/710]	The authors wish to recognize the financial assistance from the Ministry of Science and Technology, Department of Science and Technology, Govt. of India, DST-CSRI file no. SR/CSRI/196/2016; DST-SERB Core grant, file no. CRG/2020/005021; and Department of Biotechnology, Govt. of India, BT/PR17686/MED/30/1664/2016, and financial support to the University of Hyderabad-IoE by the Ministry of Education, Govt. of India (F11/9/2019-U3(A), and INSPIRE student Fellowship (DST/INSPIRE Fellowship/2013/710), Government of India.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Akinlolu AA, 2010, ACTA HISTOCHEM, V112, P193, DOI 10.1016/j.acthis.2008.09.006; Aldieri E, 2008, CURR DRUG METAB, V9, P686, DOI 10.2174/138920008786049285; Alturkistani Hani A, 2015, Glob J Health Sci, V8, P72, DOI 10.5539/gjhs.v8n3p72; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Anand KS, 2012, ANN INDIAN ACAD NEUR, V15, P239, DOI 10.4103/0972-2327.104323; Ansari MA, 2011, FREE RADICAL BIO MED, V51, P171, DOI 10.1016/j.freeradbiomed.2011.03.025; Antoine T, 2014, J ANTIMICROB CHEMOTH, V69, P1005, DOI 10.1093/jac/dkt486; Balkaya M, 2013, J CEREBR BLOOD F MET, V33, P330, DOI 10.1038/jcbfm.2012.185; Barbieri SS, 2004, FREE RADICAL BIO MED, V37, P156, DOI 10.1016/j.freeradbiomed.2004.04.020; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bartsch T, 2015, J CEREBR BLOOD F MET, V35, P1836, DOI 10.1038/jcbfm.2015.137; Bartsch T, 2011, P NATL ACAD SCI USA, V108, P17562, DOI 10.1073/pnas.1110266108; Barua S, 2019, IBRO REP, V7, P59, DOI 10.1016/j.ibror.2019.07.1721; Beckhauser TF, 2016, J EXP NEUROSCI, V10, P23, DOI 10.4137/JEN.S39887; Belarbi K, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0225-5; Bian GL, 2007, BRAIN RES, V1150, P55, DOI 10.1016/j.brainres.2007.02.078; Bitta Mary A, 2017, Wellcome Open Res, V2, P13, DOI [10.12688/wellcomeopenres.10658.1, 10.12688/wellcomeopenres.10658.2]; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Cabrales P, 2013, VIRULENCE, V4, P686, DOI 10.4161/viru.26348; Cardiff Robert D, 2014, Cold Spring Harb Protoc, V2014, P655, DOI 10.1101/pdb.prot073411; Casas AI, 2019, J CLIN INVEST, V129, P1772, DOI 10.1172/JCI124283; Casas AI, 2017, P NATL ACAD SCI USA, V114, P12315, DOI 10.1073/pnas.1705034114; Chen XH, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6643171; Chen YC, 2010, P NATL ACAD SCI USA, V107, P13123, DOI 10.1073/pnas.1003825107; Chidambaram SB, 2019, PROG NEURO-PSYCHOPH, V92, P161, DOI 10.1016/j.pnpbp.2019.01.005; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Choi BY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0325-5; CLARK IA, 1990, IMMUNOL LETT, V25, P195, DOI 10.1016/0165-2478(90)90114-6; Dang DK, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0478-x; Das D, 2015, JOVE-J VIS EXP, DOI 10.3791/52371; Davis KE, 2017, BEHAV BRAIN RES, V331, P54, DOI 10.1016/j.bbr.2017.05.005; Davoli MA, 2002, NEUROSCIENCE, V115, P125, DOI 10.1016/S0306-4522(02)00376-7; DAVOLIO C, 1995, NEUROSCI LETT, V192, P29, DOI 10.1016/0304-3940(95)11600-2; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; DellaValle B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1544-7; Denninger JK, 2018, JOVE-J VIS EXP, DOI 10.3791/58593; Di Filippo M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20926; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Dranka BP, 2014, NEUROSCI LETT, V583, P159, DOI 10.1016/j.neulet.2014.09.042; Duan W, 2016, MOL NEUROBIOL, V53, P1637, DOI 10.1007/s12035-015-9122-5; EBMEIER KP, 1990, ACTA NEUROL SCAND, V81, P294; Efferth T, 2010, CRIT REV TOXICOL, V40, P405, DOI 10.3109/10408441003610571; Feldman AT, 2014, METHODS MOL BIOL, V1180, P31, DOI 10.1007/978-1-4939-1050-2_3; Feng Y, 2017, NEUROCHEM RES, V42, P3296, DOI 10.1007/s11064-017-2372-z; Fischer R, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/610813; Fleming SM, 2013, JOVE-J VIS EXP, DOI 10.3791/50303; Francischetti IMB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087140; Freret T, 2009, BEHAV NEUROSCI, V123, P224, DOI 10.1037/a0014157; Gawel K, 2019, N-S ARCH PHARMACOL, V392, P1, DOI 10.1007/s00210-018-1589-y; Gay F, 2012, REV NEUROL-FRANCE, V168, P239, DOI 10.1016/j.neurol.2012.01.582; Geng L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58422-8; Ghazanfari N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02016; Gopalakrishnan AM, 2015, ANTIMICROB AGENTS CH, V59, P317, DOI 10.1128/AAC.03663-14; Hatanpaa KJ, 2014, J NEUROPATH EXP NEUR, V73, P136, DOI [10.1093/jnen/73.2.136, 10.1097/OPX.0000000000000170]; Head E, 2009, NEUROCHEM RES, V34, P670, DOI 10.1007/s11064-008-9808-4; Hernandes MS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-36; Hidalgo C, 2016, PHYSIOLOGY, V31, P201, DOI 10.1152/physiol.00038.2015; Hou LY, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101134; Hougee S, 2006, EUR J PHARMACOL, V531, P264, DOI 10.1016/j.ejphar.2005.11.061; Huttenrauch M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.65; Idro R, 2006, ARCH DIS CHILD, V91, P142, DOI 10.1136/adc.2005.077784; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Idro R, 2010, PEDIATR RES, V68, P267, DOI [10.1203/PDR.0b013e3181eee738, 10.1203/00006450-201011001-00524]; Imai T, 2014, INT J PARASITOL, V44, P681, DOI 10.1016/j.ijpara.2014.06.002; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; John CC, 2010, EXPERT REV ANTI-INFE, V8, P997, DOI 10.1586/ERI.10.90; Kapoor M, 2018, BIOMED PHARMACOTHER, V97, P458, DOI 10.1016/j.biopha.2017.10.123; Kasaragod VB, 2019, NEURON, V101, P673, DOI 10.1016/j.neuron.2019.01.001; Kavishe RA, 2017, FEBS J, V284, P2579, DOI 10.1111/febs.14097; Kihara M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-273; Kim JY, 2017, EXP NEUROBIOL, V26, P195, DOI 10.5607/en.2017.26.4.195; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Kumar SP, 2020, MOL NEUROBIOL, V57, P5069, DOI 10.1007/s12035-020-02076-0; Kuriakose M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44147-w; Kweon JH, 2017, BMB REP, V50, P5, DOI 10.5483/BMBRep.2017.50.1.131; Lambeth JD, 2014, ANNU REV PATHOL-MECH, V9, P119, DOI 10.1146/annurev-pathol-012513-104651; Langfitt JT, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-1026; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Laverse E, 2013, POSTGRAD MED J, V89, P671, DOI 10.1136/postgradmedj-2013-131758; Lee SH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103087; Li QG, 2010, PHARMACEUTICALS, V3, P2322, DOI 10.3390/ph3072322; Li S, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/1862437; Lillemoe K, 2019, NEUROLOGY, V93, pE112, DOI 10.1212/WNL.0000000000007725; Lin YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164164; Lopez-Domenech G, 2016, CELL REP, V17, P317, DOI 10.1016/j.celrep.2016.09.004; Lou J, 2001, CLIN MICROBIOL REV, V14, P810, DOI 10.1128/CMR.14.4.810-820.2001; Lu BW, 2019, NEURAL REGEN RES, V14, P1494, DOI 10.4103/1673-5374.255960; Lu XY, 2014, NEUROCHEM INT, V69, P14, DOI 10.1016/j.neuint.2014.02.006; Lueptow LM, 2017, JOVE-J VIS EXP, DOI 10.3791/55718; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Ma MW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0150-7; Maraldi T, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/271602; Martins YC, 2016, AM J PATHOL, V186, P2957, DOI 10.1016/j.ajpath.2016.07.020; McIntosh H M, 2000, Cochrane Database Syst Rev, pCD000527, DOI 10.1002/14651858.CD000527; McPhail LT, 2004, EXP NEUROL, V185, P182, DOI 10.1016/j.expneurol.2003.10.001; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Medawar E, 2019, EBIOMEDICINE, V39, P422, DOI 10.1016/j.ebiom.2018.12.006; Acosta AM, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000752; Merlini M, 2019, NEURON, V101, P1099, DOI 10.1016/j.neuron.2019.01.014; Moodley KK, 2014, FRONT NEUROL NEUROSC, V34, P95, DOI 10.1159/000356430; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; Nag Sukriti, 2003, Methods Mol Med, V89, P133; Nanduri J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119762; Nayernia Z, 2014, ANTIOXID REDOX SIGN, V20, P2815, DOI 10.1089/ars.2013.5703; Nenov MN, 2015, J NEUROPHYSIOL, V113, P1712, DOI 10.1152/jn.00419.2014; Nishanth G, 2019, TRENDS PARASITOL, V35, P516, DOI 10.1016/j.pt.2019.04.010; Okorji UP, 2016, MOL NEUROBIOL, V53, P6426, DOI 10.1007/s12035-015-9543-1; Olumese PE, 1999, ACTA TROP, V73, P231, DOI 10.1016/S0001-706X(99)00031-5; Oluwayemi IO, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.88.1897; Oswald MCW, 2018, ELIFE, V7, DOI 10.7554/eLife.39393; Oswald MCW, 2018, FEBS LETT, V592, P679, DOI 10.1002/1873-3468.12972; Parastan Rovie Hikari, 2020, Asian J Neurosurg, V15, P10, DOI 10.4103/ajns.AJNS_231_19; Paterniti I, 2010, J LEUKOCYTE BIOL, V88, P993, DOI 10.1189/jlb.0610322; Percario S, 2012, INT J MOL SCI, V13, P16346, DOI 10.3390/ijms131216346; Pioli EY, 2014, BEHAV BRAIN RES, V261, P249, DOI 10.1016/j.bbr.2013.12.009; Planche V, 2018, HUM BRAIN MAPP, V39, P1814, DOI 10.1002/hbm.23970; Postma NS, 1996, PHARM WORLD SCI, V18, P121, DOI 10.1007/BF00717727; Potter SM, 2005, INFECT IMMUN, V73, P4941, DOI 10.1128/IAI.73.8.4941-4947.2005; Pratico D, 2002, ARCH NEUROL-CHICAGO, V59, P972, DOI 10.1001/archneur.59.6.972; Receno CN, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13702; Reis PA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003099; Reis PA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000963; Reza-Zaldivar EE, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00255; Rudrapal M, 2016, DRUG DES DEV THER, V10, P3575, DOI 10.2147/DDDT.S118116; Sanni LA, 1999, J INFECT DIS, V179, P217, DOI 10.1086/314552; Sarkar Tiyasha, 2020, Biol Open, V9, DOI 10.1242/bio.054130; Schiess N, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03336-z; Shahraz A, 2021, GLIA, V69, P137, DOI 10.1002/glia.23890; Shikani HJ, 2012, AM J PATHOL, V181, P1484, DOI 10.1016/j.ajpath.2012.08.010; Sivakumaran MH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30030-7; Solleiro-Villavicencio H, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00114; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Sorce S, 2017, FREE RADICAL BIO MED, V112, P387, DOI 10.1016/j.freeradbiomed.2017.08.006; Steenland K, 2010, NEUROEPIDEMIOLOGY, V35, P28, DOI 10.1159/000306055; Stefanska J, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/106507; Sugawara T, 2002, J NEUROTRAUM, V19, P85, DOI 10.1089/089771502753460268; Tang FL, 2020, CELL DEATH DIFFER, V27, P2099, DOI 10.1038/s41418-019-0487-2; Tang XN, 2008, NEUROSCIENCE, V154, P556, DOI 10.1016/j.neuroscience.2008.03.090; Tejada-Simon MV, 2005, MOL CELL NEUROSCI, V29, P97, DOI 10.1016/j.mcn.2005.01.007; Valencia A, 2013, HUM MOL GENET, V22, P1112, DOI 10.1093/hmg/dds516; Van Den Herrewegen Y, 2019, NEUROCHEM RES, V44, P600, DOI 10.1007/s11064-018-2610-z; vanHensbroek MB, 1997, J PEDIATR-US, V131, P125, DOI 10.1016/S0022-3476(97)70135-5; Varo R, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2195-7; Wahl D, 2017, CLIN INTERV AGING, V12, P1419, DOI 10.2147/CIA.S145247; WALKER O, 1993, T ROY SOC TROP MED H, V87, P564, DOI 10.1016/0035-9203(93)90092-5; Wang HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17383; Wang HL, 2014, J PSYCHIATR RES, V53, P119, DOI 10.1016/j.jpsychires.2014.02.016; Wang SS, 2019, JOVE-J VIS EXP, DOI 10.3791/57139; Wilson C, 2015, J CELL SCI, V128, P2989, DOI 10.1242/jcs.168567; Wilson MD, 2017, J NEUROSCI METH, V279, P33, DOI 10.1016/j.jneumeth.2017.01.003; Wu DC, 2006, P NATL ACAD SCI USA, V103, P12132, DOI 10.1073/pnas.0603670103; Yang T, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00951; YUAN F, 1994, CANCER RES, V54, P4564; Yuan GX, 2011, J CELL PHYSIOL, V226, P2925, DOI 10.1002/jcp.22640; Zaqout S, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00038; Zhao S, 2019, NANO LETT, V19, P8887, DOI 10.1021/acs.nanolett.9b03774	159	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.												10.1007/s12035-021-02598-1		NOV 2021	21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WX6UU	WOS:000718729400001	34782951	Green Submitted			2022-02-06	
J	Salmon, DM; Badenhorst, M; Walters, S; Clacy, A; Chua, J; Register-Mihalik, J; Romanchuk, J; Kerr, ZY; Keung, S; Sullivan, SJ; Whatman, C				Salmon, Danielle M.; Badenhorst, Marelise; Walters, Simon; Clacy, Amanda; Chua, Jason; Register-Mihalik, Johna; Romanchuk, Janelle; Kerr, Zachary Y.; Keung, Sierra; Sullivan, S. John; Whatman, Chris			The rugby tug-of-war: Exploring concussion-related behavioural intentions and behaviours in youth community rugby union in New Zealand	INTERNATIONAL JOURNAL OF SPORTS SCIENCE & COACHING			English	Article; Early Access						Attitudes; sports injury; team sport; theory of planned behaviour; traumatic brain injury	SPORT-RELATED CONCUSSION; SYSTEMS-APPROACH; KNOWLEDGE; INJURY; COACHES; RISK; EDUCATION; PAIN	Rugby union is a popular team sport, with a high rate of concussions. In adolescents, concussions are further complicated by issues of under-reporting. To encourage more responsible concussion behaviours, it is imperative to understand the factors that influence youth players' behaviours, including the attitudes and behaviours of their coaches and parents. The aim of this study was to explore concussion-related behavioural intentions and behaviours that may influence effective concussion management across a youth rugby system. The study adopted a pragmatic, descriptive qualitative design and included high schools from four youth rugby catchment areas in New Zealand. Nineteen focus groups and 2 individual interviews were conducted with n = 75 players, n = 22 parents, and n = 8 coaches (N = 105) during the 2018 rugby season. A thematic analysis was conducted, guided by a system's approach and the Theory of Planned Behaviour. The themes generated reflected a 'tug-of war' between various behavioural intentions and reported behaviours present in a youth rugby system. Additionally, the behavioural intentions and reported behaviours of coaches, parents, players and their teammates are intricately linked and collectively influence effective concussion management. Being aware of concussions and caring about their management and consequences was a strong theme present across the system. However, these favourable attitudes and behaviours were countered by players, parents and coaches disregarding the system, downplaying the seriousness of concussion, being competitive and driven to win, regardless of the risks. In players the warrior mentality theme, which included bravado, being tough, and playing through the pain further complicated effective concussion management. The findings suggest that there is not always a strong, favourable network in place that would facilitate similarly favourable concussion-related behaviours. To effect change, a system-wide approach, that takes the unique needs of each stakeholder into account and ultimately aims to reconcile performance and brotherhood with positive concussion related behaviours, is needed.	[Salmon, Danielle M.; Chua, Jason; Romanchuk, Janelle; Sullivan, S. John] New Zealand Rugby, POB 2172, Wellington 6140, New Zealand; [Badenhorst, Marelise; Walters, Simon; Keung, Sierra; Whatman, Chris] Auckland Univ Technol, Sch Sport & Recreat, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [Clacy, Amanda] Univ Sunshine Coast, Sch Law & Soc, Maroochydore, Australia; [Register-Mihalik, Johna; Kerr, Zachary Y.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Register-Mihalik, Johna; Kerr, Zachary Y.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA; [Register-Mihalik, Johna; Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA		Salmon, DM (corresponding author), New Zealand Rugby, POB 2172, Wellington 6140, New Zealand.	Danielle.salmon@nzrugby.co.nz		Chua, Jason/0000-0002-0224-2818	New Zealand Rugby Foundation; Accident Compensation Corporation; World Rugby	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work is sponsored by the New Zealand Rugby Foundation, The Accident Compensation Corporation, and World Rugby.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2011, BASIC APPL SOC PSYCH, V33, P101, DOI 10.1080/01973533.2011.568834; [Anonymous], NZ HERALD; Beakey M, 2017, EUR J SPORT MED, V4, P65; Bittencourt NFN, 2016, BRIT J SPORT MED, V50, P1309, DOI 10.1136/bjsports-2015-095850; Bolling C, 2018, SPORTS MED, V48, P2227, DOI 10.1007/s40279-018-0953-x; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Braun V., 2014, SUCCESSFUL QUALITATI; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Clacy A, 2017, J SPORT SCI, V35, P2232, DOI 10.1080/02640414.2016.1265140; Cunningham J, 2020, J ATHL TRAINING, V55, P132, DOI 10.4085/1062-6050-297-18; Delahunty SE, 2015, J SCHOOL HEALTH, V85, P17, DOI 10.1111/josh.12219; Feilzer MY, 2010, J MIX METHOD RES, V4, P6, DOI 10.1177/1558689809349691; Jessiman-Perreault G., 2016, Advances in Physical Education, V6, P178, DOI 10.4236/ape.2016.63020; Kelly MP, 2016, PUBLIC HEALTH, V136, P109, DOI 10.1016/j.puhe.2016.03.030; Kneavel M, 2021, J AM COLL HEALTH, V69, P435, DOI 10.1080/07448481.2019.1679816; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Liamputtong P., 2015, FOCUS GROUP METHODOL, P31; Liston K, 2018, INT REV SOCIOL SPORT, V53, P668, DOI 10.1177/1012690216679966; Malcom NL, 2006, J CONTEMP ETHNOGR, V35, P495, DOI 10.1177/0891241605283571; Malpas K., 2016, SPORT NZ INJURY PART; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McEachan RRC, 2011, HEALTH PSYCHOL REV, V5, P97, DOI 10.1080/17437199.2010.521684; McGlashan AJ, 2010, SPORTS MED, V40, P841, DOI 10.2165/11534960-000000000-00000; Morgan D., METHODSPACE; NIXON HL, 1994, SOCIOL SPORT J, V11, P79, DOI 10.1123/ssj.11.1.79; Oddo A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00698; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Pringle R, 2001, INT REV SOCIOL SPORT, V35, P425; Quarrie K, 2020, SPORTS MED, V50, P227, DOI 10.1007/s40279-019-01177-8; Rasmussen J, 1997, SAFETY SCI, V27, P183, DOI 10.1016/S0925-7535(97)00052-0; Register-Mihalik JK, 2018, J ATHL TRAINING, V53, P768, DOI 10.4085/1062-6050-223-17; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rigby J, 2013, J ATHL TRAINING, V48, P636, DOI 10.4085/1062-6050-48.3.10; Rugby World Cup, NZ HERALD; Salmon D, 2020, BRIT J SPORT MED, V54, P300, DOI 10.1136/bjsports-2019-100949; Salmon D, 2020, BRIT J SPORT MED, V54, P298, DOI 10.1136/bjsports-2019-100950; Salmon DM, 2021, INT J SPORTS SCI COA, V16, P54, DOI 10.1177/1747954120961200; Salmon DM, 2020, J SPORT SCI, V38, P1585, DOI 10.1080/02640414.2020.1749409; Salmon PM, 2017, APPL ERGON, V59, P637, DOI 10.1016/j.apergo.2015.07.017; Sarmiento K., 2019, J ATHL DEV EXP, V1, P1; Savin-Baden M., 2013, QUALITATIVE RES ESSE; Walters SR, 2012, PSYCHOL SPORT EXERC, V13, P208, DOI 10.1016/j.psychsport.2011.11.008; Whatman C, 2018, PHYS THER SPORT, V32, P1, DOI 10.1016/j.ptsp.2018.01.011; Yeo PC, 2020, J SPORT SCI MED, V19, P65	47	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-9541	2048-397X		INT J SPORTS SCI COA	Int. J. Sports Sci. Sci. Coach.											17479541211047661	10.1177/17479541211047661		NOV 2021	13	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	XA9YP	WOS:000720994800001					2022-02-06	
J	Breuskin, D; Ketter, R; Oertel, J				Breuskin, David; Ketter, Ralf; Oertel, Joachim			Surviving a Self-inflicted Transorbital Pen Intrusion to the Cerebellum: Case Report	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article; Early Access						pen; brain trauma; transorbital; cerebellum	FOREIGN-BODY; INJURY; MANAGEMENT	Background Although intracranial traumas by penetrating foreign objects are not absolute rarities, the nature of trauma, the kind of object, and its trajectory make them a one of a kind case every time they occur. Whereas high-velocity traumas mostly result in fatalities, it is the low-velocity traumas that demand an individualized surgical strategy. Methods We present a case report of a 33-year-old patient who was admitted to our department with a self-inflicted transorbital pen injury to the brain. The authors recall the incident and the technique of the pen removal. Results Large surgical exposure of the pen trajectory was considered too traumatic. Therefore, we opted to remove the pen and have an immediate postoperative computed tomography (CT) scan. Due to its fragility, the pen case could only be removed with a screwdriver, inserted into the case. Post-op CT scan showed a small bleeding in the right peduncular region, which was treated conservatively. The patient was transferred back to intensive care unit and woken up the next day. She lost visual function on her right eye, but suffered from no further neurologic deficit. Conclusion Surgical management of removal of intracranial foreign bodies is no routine procedure. Although some would favor a large surgical exposure, we could not think of an approach to do so without maximum surgical efforts. We opted for a minimal surgical procedure with immediate CT scan and achieved an optimal result. We find this case to be worth considering when deciding on a strategy in the future.	[Breuskin, David; Ketter, Ralf; Oertel, Joachim] Univ Klinikum Saarlandes, Dept Neurosurg, Klin Neurochirurg, Kirrberger Str, D-66421 Homburg, Germany		Breuskin, D (corresponding author), Univ Klinikum Saarlandes, Dept Neurosurg, Klin Neurochirurg, Kirrberger Str, D-66421 Homburg, Germany.	David.Breuskin@uks.eu					Behera Sanjay Kumar, 2016, Asian J Neurosurg, V11, P321, DOI 10.4103/1793-5482.145092; Borkar SA, 2014, CHILD NERV SYST, V30, P1441, DOI 10.1007/s00381-014-2364-0; Davis GA, 2000, J CLIN NEUROSCI, V7, P545, DOI 10.1054/jocn.2000.0692; Ghadersohi S, 2017, AM J RHINOL ALLERGY, V31, pE29, DOI 10.2500/ajra.2017.31.4421; Harrington BM, 2021, J NEUROSURG, V134, P1658, DOI 10.3171/2020.4.JNS20122; Lee YC, 2017, HONG KONG MED J, V23, P313, DOI 10.12809/hkmj154644; MILLER CF, 1977, SURG NEUROL, V7, P95; Moussa WMM, 2016, ACTA NEUROCHIR, V158, P895, DOI 10.1007/s00701-016-2764-x; Mzimbiri JM, 2016, NEUROSURGERY, V78, pE753, DOI 10.1227/NEU.0000000000001198; Nishio Y, 2004, ACTA NEUROCHIR, V146, P847, DOI 10.1007/s00701-004-0283-7; Santander XA, 2019, WORLD NEUROSURG, V126, P530, DOI 10.1016/j.wneu.2019.02.154; Sathish K, 2018, AM J FOREN MED PATH, V39, P253, DOI 10.1097/PAF.0000000000000419; Sun GZ, 2016, WORLD NEUROSURG, V95, DOI 10.1016/j.wneu.2016.07.104	13	0	0	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A												10.1055/s-0041-1735859		NOV 2021	4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WX4OE	WOS:000718576200001	34781401				2022-02-06	
J	Chihi, M; Oppong, MD; Pierscianek, D; Dinger, TF; Ahmadipour, Y; Gembruch, O; Deuschl, C; Li, Y; Schmidt, B; Wrede, KH; Sure, U; Jabbarli, R				Chihi, Mehdi; Darkwah Oppong, Marvin; Pierscianek, Daniela; Dinger, Thiemo Florin; Ahmadipour, Yahya; Gembruch, Oliver; Deuschl, Cornelius; Li, Yan; Schmidt, Boerge; Wrede, Karsten H.; Sure, Ulrich; Jabbarli, Ramazan			Analysis of Brain Natriuretic Peptide Levels after Traumatic Acute Subdural Hematoma and the Risk of Post-Operative Cerebral Infarction	JOURNAL OF NEUROTRAUMA			English	Article						acute subdural hematoma; brain natriuretic peptide; biomarker; head trauma; stroke; volumetry	BLOOD-FLOW; ISCHEMIC-STROKE; HEAD-INJURY; COMATOSE PATIENTS; MORTALITY; HEMORRHAGE; DAMAGE; MODEL; METABOLISM; REDUCTION	Traumatic acute subdural hematoma (aSDH) is associated with a high mortality rate caused by post-operative cerebral infarction. Recently, brain natriuretic peptide (BNP) was considered a reliable biomarker in the acute phase of traumatic brain injuries. We therefore aimed in this study to analyze BNP levels on admission, identify the predictors of their elevation, and assess the relationship between BNP and the risk of post-operative cerebral infarction. Patients with isolated, unilateral, traumatic aSDH who were admitted to our department between July 2017 and May 2020 were enrolled in this study. On admission, cranial computer tomography (CCT) and BNP sampling were simultaneously performed. Additionally, the time between head trauma and BNP sampling (TTS) was assessed. Admission radiographic variables included hematoma volumes, midline shift, and degree of brain edema. Cerebral infarction was detected on postoperative CCT. In total, 130 patients were included in this study. Surgical treatment was performed in 82.3% (n = 107) of cases. The multiple regression analysis showed that larger hematoma volumes (p = 0.032) and advanced age (p = 0.005) were independent predictors of elevated BNP when TTS <24 h. The binomial logistical regression analysis identified BNP with a cutoff value of <29.4 pg/mL (TTS = 3-12 h, adjusted odds ratio [aOR] = 16.5, p = 0.023) as an independent predictor of post-operative cerebral infarction. Elevated BNP levels in the first 24 h post-trauma were related to larger hematoma volumes and advanced age. Further, an increased risk of post-operative cerebral infarction was identified in patients with lower BNP levels in the post-traumatic period 3-12 h.	[Chihi, Mehdi; Darkwah Oppong, Marvin; Pierscianek, Daniela; Dinger, Thiemo Florin; Ahmadipour, Yahya; Gembruch, Oliver; Wrede, Karsten H.; Sure, Ulrich; Jabbarli, Ramazan] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurosurg & Spine Surg, Hufelandstr 55, D-45147 Essen, Germany; [Deuschl, Cornelius; Li, Yan] Univ Duisburg Essen, Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Schmidt, Boerge] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany		Chihi, M (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Neurosurg & Spine Surg, Hufelandstr 55, D-45147 Essen, Germany.	mehdi.chihi@uk-essen.de	Wrede, Karsten/AAZ-2154-2020; Dinger, Thiemo/AAD-5619-2022	Wrede, Karsten/0000-0001-7076-3503; Dinger, Thiemo/0000-0002-7009-9099			Abe M, 2003, SURG NEUROL, V59, P464, DOI 10.1016/S0090-3019(03)00078-8; Ahn SH, 2018, NEUROSURGERY, V83, P137, DOI 10.1093/neuros/nyx364; Alessandri B, 2006, BRAIN RES, V1111, P196, DOI 10.1016/j.brainres.2006.06.105; Anne M, 2007, CURR NEUROVASC RES, V4, P170, DOI 10.2174/156720207781387169; Ay H, 2002, STROKE, V33, P286, DOI 10.1161/hs0102.101544; Azzay HME, 2003, HEART FAIL REV, V8, P315, DOI 10.1023/A:1026182912461; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; CHAMBERS JW, 1951, J NEUROSURG, V8, P263, DOI 10.3171/jns.1951.8.3.0263; Fukuhara Kousuke, 2020, eNeurologicalSci, V18, P100217, DOI 10.1016/j.ensci.2019.100217; Fukui S, 2004, J CLIN NEUROSCI, V11, P507, DOI 10.1016/S0967-5868(03)00111-5; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Giannakoulas G, 2005, ANGIOLOGY, V56, P723, DOI 10.1177/000331970505600610; Gregorio T, 2019, J NEUROL SCI, V399, P51, DOI 10.1016/j.jns.2019.02.014; Guo S, 2015, PEPTIDES, V74, P33, DOI 10.1016/j.peptides.2015.09.008; Iemolo F, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0074-z; Iltumur K, 2006, AM HEART J, V151, P1115, DOI 10.1016/j.ahj.2005.05.022; JAMIESON KG, 1972, J NEUROSURG, V37, P137, DOI 10.3171/jns.1972.37.2.0137; Khalid F, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19517; Kirchhoff C, 2006, J NEUROTRAUM, V23, P943, DOI 10.1089/neu.2006.23.943; Ko N.U., 2014, CARDIAC MANIFESTATIO, P183; KOLIN A, 1984, STROKE, V15, P990, DOI 10.1161/01.STR.15.6.990; KURODA Y, 1992, J NEUROSURG, V76, P471, DOI 10.3171/jns.1992.76.3.0471; LEE KR, 1995, J NEUROSURG, V83, P1045, DOI 10.3171/jns.1995.83.6.1045; Lee KR, 1996, J NEUROSURG, V84, P91, DOI 10.3171/jns.1996.84.1.0091; Li F, 2018, J INTENSIVE CARE MED, V33, P663, DOI 10.1177/0885066616683677; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; Maruyama K, 2014, J STROKE CEREBROVASC, V23, P967, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.003; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Montaner J, 2012, CEREBROVASC DIS, V34, P240, DOI 10.1159/000341858; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Okada Yumiko, 2016, Osaka City Med J, V62, P95; Patel TR, 1999, BRAIN RES, V829, P125, DOI 10.1016/S0006-8993(99)01378-5; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Rost NS, 2012, STROKE, V43, P441, DOI 10.1161/STROKEAHA.111.629212; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; SALVANT JB, 1993, NEUROSURGERY, V33, P387; Sayan Saadet, 2016, Arch Med Sci Atheroscler Dis, V1, pe16, DOI 10.5114/amsad.2016.59751; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sen S, 1998, CURR OPIN NEUROL, V11, P51; Sencer A, 2008, NEUROL RES, V30, P497, DOI 10.1179/016164107X251664; Shibazaki K, 2013, EUR NEUROL, V70, P218, DOI 10.1159/000351777; Shibazaki K, 2009, INTERNAL MED, V48, P1601, DOI 10.2169/internalmedicine.48.2166; Sviri GE, 2006, ACTA NEUROCHIR, V148, P529, DOI 10.1007/s00701-005-0666-4; Sviri GE, 2000, STROKE, V31, P118, DOI 10.1161/01.STR.31.1.118; Sviri GE, 2003, ACTA NEUROCHIR, V145, P851, DOI 10.1007/s00701-003-0101-7; Takahashi T, 2009, ATHEROSCLEROSIS, V207, P298, DOI 10.1016/j.atherosclerosis.2009.04.029; Tomita H, 2008, HYPERTENS RES, V31, P1695, DOI 10.1291/hypres.31.1695; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1317, DOI 10.2174/156802609789869646; Wang C, 2020, BRAIN RES, V1742, DOI 10.1016/j.brainres.2020.146901; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Wu X, 2011, J TRAUMA, V71, P820, DOI 10.1097/TA.0b013e3182277b69; Yokobori S, 2018, BEHAV BRAIN RES, V340, P23, DOI 10.1016/j.bbr.2016.05.055; Yokobori S, 2013, J NEUROSURG, V118, P370, DOI 10.3171/2012.10.JNS12725	58	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2021	38	22					3068	3076		10.1089/neu.2021.0169			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WY7FJ	WOS:000719443900004	34477001				2022-02-06	
J	de Souza, NL; Buckman, JF; Dennis, EL; Parrott, JS; Velez, C; Wilde, EA; Tate, DF; Esopenko, C				de Souza, Nicola L.; Buckman, Jennifer F.; Dennis, Emily L.; Parrott, J. Scott; Velez, Carmen; Wilde, Elisabeth A.; Tate, David F.; Esopenko, Carrie			Association between white matter organization and cognitive performance in athletes with a history of sport-related concussion	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Diffusion tensor imaging; cognition; sport; mild TBI	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; TRACT ABNORMALITIES; INTEGRITY; MICROSTRUCTURE; RECOVERY; MEMORY	Introduction Impairments in cognitive performance after sport-related concussion (SRC) typically resolve within weeks of the injury, whereas alterations to white matter (WM) organization have been found to persist longer into the chronic injury stage. However, longer-term associations between cognition and WM organization following SRC have not been studied. The objective of this study was to compare WM organization and cognitive performance in collegiate athletes an average of almost 4 years post-SRC to athletes with no history of SRC. Method National Collegiate Athletic Association Division III athletes (n = 71, age = 19.3 +/- 1.2; 14 with self-reported SRC) completed a neurocognitive assessment and diffusion tensor imaging (DTI). WM organization was assessed by extracting measures of fractional anisotropy (FA), mean diffusivity (MD), and radial diffusivity (RD) from 20 WM regions of interest (ROIs). Multivariate partial least squares analyses were used to compare athletes with and without a history of SRC and assess relationships between DTI-derived metrics of WM organization and cognitive measures. Results Cognitive performance and ROI metrics did not differ between athletes with and without prior SRC. However, among athletes with a history of SRC, better executive function, processing speed, and memory but worse choice reaction time were associated with higher FA and lower MD and RD in several WM tracts. Conclusion Athletes with a history of SRC demonstrated greater associations between cognitive performance and WM organization, but also variability in the domains showing associations. Taken together, the findings demonstrate the importance of examining brain-behavior relationships several years after SRC to better gauge how WM organization supports cognition.	[de Souza, Nicola L.] Rutgers Biomed & Hlth Sci, Sch Grad Studies, Biomed Sci, Newark, NJ 07107 USA; [Buckman, Jennifer F.] Rutgers Univ New Brunswick, Dept Kinesiol & Hlth, Piscataway, NJ USA; [Dennis, Emily L.; Velez, Carmen; Wilde, Elisabeth A.; Tate, David F.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Dennis, Emily L.; Wilde, Elisabeth A.; Tate, David F.] George E Wahlen Vet Affairs Salt Lake City Health, Salt Lake City, UT USA; [Parrott, J. Scott] Dept Interdisciplinary Studies, St Louis, MO USA; [Velez, Carmen; Tate, David F.] Univ Missouri, Missouri Inst Mental Hlth, St Louis, MO 63121 USA; [Esopenko, Carrie] Rutgers Biomed & Hlth Sci, Dept Rehabil & Movement Sci, Sch Hlth Profess, 65 Bergen St, Newark, NJ 07107 USA		Esopenko, C (corresponding author), Rutgers Biomed & Hlth Sci, Dept Rehabil & Movement Sci, Sch Hlth Profess, 65 Bergen St, Newark, NJ 07107 USA.	nicola.desouza@rutgers.edu		Esopenko, Carrie/0000-0001-8607-5633	School of Health Professions at Rutgers Biomedical and Health Sciences; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K02AA025123]	Financial support was provided to CE through the School of Health Professions at Rutgers Biomedical and Health Sciences. JFB was provided financial support through a grant from the National Institutes of Health [K02AA025123].	Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; Benito-Leon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02596-1; Brett BL, 2021, J NEUROTRAUM, V38, P474, DOI 10.1089/neu.2020.7376; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Cremers LGM, 2016, NEUROBIOL AGING, V39, P108, DOI 10.1016/j.neurobiolaging.2015.11.021; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; de Souza NL, 2020, NEUROTRAUMA REP, V1, P232, DOI 10.1089/neur.2020.0025; Dennis EL, 2021, MOL PSYCHIATR, V26, P4315, DOI 10.1038/s41380-019-0631-x; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Esopenko C, 2017, CORTEX, V89, P1, DOI 10.1016/j.cortex.2017.01.007; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hegde RR, 2020, PSYCHIAT RES-NEUROIM, V305, DOI 10.1016/j.pscychresns.2020.111159; Hellewell SC, 2021, BRAIN IMAGING BEHAV, V15, P1685, DOI 10.1007/s11682-020-00336-0; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kovacevic N, 2013, SPRINGER P MATH STAT, V56, P159, DOI 10.1007/978-1-4614-8283-3_10; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Lancaster MA, 2018, HUM BRAIN MAPP, V39, P4276, DOI 10.1002/hbm.24245; Laporta-Hoyos O, 2017, NEUROIMAGE-CLIN, V15, P789, DOI 10.1016/j.nicl.2017.05.005; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Nolze-Charron G, 2020, EXP GERONTOL, V130, DOI 10.1016/j.exger.2019.110792; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Owens JA, 2018, BRAIN INJURY, V32, P776, DOI 10.1080/02699052.2018.1451656; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; SAMPSON PD, 1989, NEUROTOXICOL TERATOL, V11, P477, DOI 10.1016/0892-0362(89)90025-1; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wu YC, 2020, NEUROLOGY, V95, pE781, DOI 10.1212/WNL.0000000000009930; Zeng WY, 2020, J CEREBR BLOOD F MET, V40, P2454, DOI 10.1177/0271678X19893600; Zhu J, 2019, ACS CHEM NEUROSCI, V10, P4864, DOI 10.1021/acschemneuro.9b00584	54	0	0	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG 9	2021	43	7					704	715		10.1080/13803395.2021.1991893		NOV 2021	12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	XW6GB	WOS:000718227000001	34779351				2022-02-06	
J	Ferlini, L; Su, FH; Creteur, J; Taccone, FS; Gaspard, N				Ferlini, Lorenzo; Su, Fuhong; Creteur, Jacques; Taccone, Fabio Silvio; Gaspard, Nicolas			Cerebral and systemic hemodynamic effect of recurring seizures	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; NONCONVULSIVE SEIZURES; STATUS EPILEPTICUS; ISCHEMIC-STROKE; TISSUE HYPOXIA; CARDIAC-OUTPUT; SHEEP MODEL; HEMORRHAGE; METABOLISM; ACTIVATION	The increase in neuronal activity induced by a single seizure is supported by a rise in the cerebral blood flow and tissue oxygenation, a mechanism called neurovascular coupling (NVC). Whether cerebral and systemic hemodynamics are able to match neuronal activity during recurring seizures is unclear, as data from rodent models are at odds with human studies. In order to clarify this issue, we used an invasive brain and systemic monitoring to study the effects of chemically induced non-convulsive seizures in sheep. Despite an increase in neuronal activity as seizures repeat (Spearman's rho coefficient 0.31, P < 0.001), ictal variations of cerebral blood flow remained stable while it progressively increased in the inter-ictal intervals (rho = 0.06, P = 0.44 and rho = 0.22; P = 0.008). We also observed a progressive reduction in the inter-ictal brain tissue oxygenation (rho = - 0.18; P = 0.04), suggesting that NVC was unable to compensate for the metabolic demand of these closely repeating seizures. At the systemic level, there was a progressive reduction in blood pressure and a progressive rise in cardiac output (rho = - 0.22; P = 0.01 and rho = 0.22; P = 0.01, respectively), suggesting seizure-induced autonomic dysfunction.	[Ferlini, Lorenzo; Gaspard, Nicolas] Free Univ Brussels, Erasme Hosp, Dept Neurol, Brussels, Belgium; [Su, Fuhong; Creteur, Jacques; Taccone, Fabio Silvio] Free Univ Brussels, Erasme Hosp, Dept Intens Care, Brussels, Belgium		Gaspard, N (corresponding author), Free Univ Brussels, Erasme Hosp, Dept Neurol, Brussels, Belgium.	nicolas.gaspard@erasme.ulb.ac.be		ferlini, lorenzo/0000-0002-6461-8796	Fonds Erasme pour la Recherche Medicale-Convention de Recherche d'Excellence; Fonds National pour la Recherche ScientifiqueFonds de la Recherche Scientifique - FNRS	This work was supported by the Fonds Erasme pour la Recherche Medicale-Convention de Recherche d'Excellence and the Fonds National pour la Recherche Scientifique.	Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bahar S, 2006, NEUROREPORT, V17, P499, DOI 10.1097/01.wnr.0000209010.78599.f5; Balbi M, 2017, J CEREBR BLOOD F MET, V37, P3625, DOI 10.1177/0271678X16686595; Bankstahl M, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0123-18.2018; BENOWITZ NL, 1986, ANN NEUROL, V19, P197, DOI 10.1002/ana.410190216; Berman A, 2003, J DAIRY SCI, V86, P3605, DOI 10.3168/jds.S0022-0302(03)73966-6; Bunemann M, 1999, ANNU REV PHYSIOL, V61, P169, DOI 10.1146/annurev.physiol.61.1.169; Caillard A, 2015, BRIT J ANAESTH, V114, P893, DOI 10.1093/bja/aev001; Camm AJ, 1996, CIRCULATION, V93, P1043; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Claassen J, 2014, ANN NEUROL, V75, P771, DOI 10.1002/ana.24166; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; Ferlini L, 2020, INTENS CARE MED EXP, V8, DOI 10.1186/s40635-020-00332-0; Franceschini MA, 2010, NEUROIMAGE, V51, P1367, DOI 10.1016/j.neuroimage.2010.03.060; Gaspard N, 2021, JAMA NEUROL, V78, P369, DOI 10.1001/jamaneurol.2020.5348; Hill CE, 2019, NEUROLOGY, V92, pE9, DOI 10.1212/WNL.0000000000006689; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Jefferys JGR, 2020, EPILEPSIA, V61, P798, DOI 10.1111/epi.16479; JOBSIS FF, 1971, J NEUROPHYSIOL, V34, P735, DOI 10.1152/jn.1971.34.5.735; JOHNSTON SC, 1995, ANN NEUROL, V37, P531, DOI 10.1002/ana.410370416; Kaiser EE, 2020, NEURAL REGEN RES, V15, P1377, DOI 10.4103/1673-5374.274324; Kaya CA, 2005, EPILEPSIA, V46, P367, DOI 10.1111/j.0013-9580.2005.32904.x; Ko SB, 2011, ARCH NEUROL-CHICAGO, V68, P1323, DOI 10.1001/archneurol.2011.240; Kobayashi E, 2006, NEUROLOGY, V66, P1049, DOI 10.1212/01.wnl.0000204232.37720.a4; KREISMAN NR, 1991, J CEREBR BLOOD F MET, V11, P77, DOI 10.1038/jcbfm.1991.9; KREISMAN NR, 1993, BRAIN RES, V626, P295, DOI 10.1016/0006-8993(93)90590-J; LEWIS DV, 1974, ELECTROEN CLIN NEURO, V36, P347, DOI 10.1016/0013-4694(74)90184-9; LEWIS DV, 1975, J NEUROPHYSIOL, V38, P405, DOI 10.1152/jn.1975.38.2.405; Loscher W, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020591; LOTHMAN E, 1975, BRAIN RES, V88, P15, DOI 10.1016/0006-8993(75)90943-9; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Myers KA, 2018, EPILEPSIA, V59, P2169, DOI 10.1111/epi.14587; Nass RD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00501; Opdam HI, 2002, EPILEPSIA, V43, P779, DOI 10.1046/j.1528-1157.2002.04202.x; Patel N., STATPEARLS, V2021; Prager O, 2019, EPILEPSIA, V60, P322, DOI 10.1111/epi.14631; Rossetti AO, 2020, JAMA NEUROL, V77, P1225, DOI 10.1001/jamaneurol.2020.2264; Salinet ASM, 2013, J NEUROL, V260, P2588, DOI 10.1007/s00415-013-7022-z; Sevcencu C, 2010, EPILEPSIA, V51, P725, DOI 10.1111/j.1528-1167.2009.02479.x; Sharp CD, 2005, AM J PHYSIOL-HEART C, V288, pH1893, DOI 10.1152/ajpheart.01110.2003; Taccone FS, 2014, CRIT CARE MED, V42, pE114, DOI 10.1097/CCM.0b013e3182a641b8; Taccone FS, 2010, CRIT CARE, V14, DOI 10.1186/cc9205; Tang CS, 1998, AM J PHYSIOL-REG I, V274, pR1078, DOI 10.1152/ajpregu.1998.274.4.R1078; Toth P, 2016, AM J PHYSIOL-HEART C, V311, pH1118, DOI 10.1152/ajpheart.00267.2016; TSUDA A, 1994, NEUROCHEM RES, V19, P1, DOI 10.1007/BF00966719; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; van Vliet EA, 2015, SEMIN CELL DEV BIOL, V38, P26, DOI 10.1016/j.semcdb.2014.10.003; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Winkler MKL, 2012, EPILEPSIA, V53, P22, DOI 10.1111/j.1528-1167.2012.03699.x; Yang H, 2013, NEURAL REGEN RES, V8, P1316, DOI 10.3969/j.issn.1673-5374.2013.14.008; Zeiler FA, 2016, J NEUROSURG ANESTH, V28, P123, DOI 10.1097/ANA.0000000000000234; Zerbet A, 2003, COMMUN STAT-THEOR M, V32, P573, DOI 10.1081/STA-120018552; Zhao MR, 2011, J NEUROSCI, V31, P13292, DOI 10.1523/JNEUROSCI.2597-11.2011; Zhao MR, 2009, J NEUROSCI, V29, P2814, DOI 10.1523/JNEUROSCI.4667-08.2009	56	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	NOV 15	2021	11	1							22209	10.1038/s41598-021-01704-6			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XA4MX	WOS:000720624200020	34782705	Green Published, gold			2022-02-06	
J	Hindhede, AL; Poulsen, I				Hindhede, Anette Lykke; Poulsen, Ingrid			The value of social networks to individuals with a severe traumatic brain injury: a mixed methods approach	DISABILITY AND REHABILITATION			English	Article; Early Access						Social network analysis; case study design; traumatic brain injury; experiences of care; inequality in health	HEALTH INEQUALITY; PERSONAL NETWORKS; INTEGRATION; SUPPORT; LIFE; EXPERIENCES; ADULTS	Purpose In this study, we investigate the nature and strength of the social relations of working-age individuals who have survived a severe traumatic brain injury. Materials and methods Fifty-three survivors diagnosed with severe traumatic brain injury completed the social network analysis questionnaire, enabling us to map their social networks using the software program EgoNet.QF. This was combined with interviews with four survivors and their significant members of their network and constructed narrative cases of the resources gained from their network. Results Half the survivors lost friends because of the brain injury. The most common social network post injury comprised parents followed by spouses. Close relatives experienced a dramatic change in the nature of their relationships with the survivor. They also struggled greatly with the rehabilitation health system, which in many cases affected their own careers. Conclusion Persons with severe traumatic brain injury and their close relatives predominantly learn to manage the new situation, with functionality driving social interaction. However, as social networks often are limited to the close family, these individuals are placed in a vulnerable position.	[Hindhede, Anette Lykke] Aalborg Univ, Dept Culture & Learning, AC Meyers Vaenge 15A, DK-2450 Copenhagen, Denmark; [Poulsen, Ingrid] Univ Copenhagen, Res Unit Nursing & Hlth Care, Hvidovre, Denmark		Hindhede, AL (corresponding author), Aalborg Univ, Dept Culture & Learning, AC Meyers Vaenge 15A, DK-2450 Copenhagen, Denmark.	anlh@hum.aau.dk		Hindhede, Anette Lykke/0000-0002-0658-4858; Poulsen, ingrid/0000-0002-0342-017X			Batchos E, 2018, DISABIL REHABIL, V40, P2062, DOI 10.1080/09638288.2017.1326175; Bellotti E., 2014, QUALITATIVE NETWORKS; Bidart C, 2005, SOC NETWORKS, V27, P359, DOI 10.1016/j.socnet.2004.11.003; Bidart C, 2011, FIELD METHOD, V23, P266, DOI 10.1177/1525822X11408513; Borgatti SP., 2018, ANAL SOCIAL NETWORKS; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Brown J, 2017, NEUROREHABILITATION, V41, P483, DOI 10.3233/NRE-162065; Bystrup MR., 2019, NEW DYNAMICS DISABIL; Bystrup MR., 2021, THESIS AALBORG U; Chung KKS., 2005, 2 INT C KNOW MAN AS; Clarke AE, 2003, SYMB INTERACT, V26, P553, DOI 10.1525/si.2003.26.4.553; Diderichsen F, 2012, SCAND J PUBLIC HEALT, V40, P12, DOI 10.1177/1403494812457734; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Donati P, 2015, RELATIONAL SUBJECT, P1, DOI 10.1017/CBO9781316226780; Doser K, 2018, BRAIN INJURY, V32, P64, DOI 10.1080/02699052.2017.1363408; FISCHER CS, 1982, SOC NETWORKS, V3, P287, DOI 10.1016/0378-8733(82)90004-1; Fowler JH, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2338; Gagnon A, 2016, DISABIL REHABIL, V38, P433, DOI 10.3109/09638288.2015.1044035; Graff HJ, 2018, DISABIL REHABIL, V40, P926, DOI 10.1080/09638288.2017.1280542; Guldager R., 2018, THESIS AALBORG U; Hagen C, 1979, LEVELS COGNITIVE FUN; Haggstrom A, 2008, J REHABIL MED, V40, P89, DOI 10.2340/16501977-0138; Kadushin C, 2005, SOC NETWORKS, V27, P139, DOI 10.1016/j.socnet.2005.01.005; KAPLAN SP, 1990, REHABIL COUNS BULL, V34, P16; Kaplan SP, 1991, CLIN NEUROPSYCHOL, V5, P360; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Levack WMM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004630; Lin N., 2002, SOCIAL CAPITAL THEOR, P41; Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; Merriam S.B., 2009, QUALITATIVE RES GUID, V4th ed.; Norup A, 2015, NEUROREHABILITATION, V36, P203, DOI 10.3233/NRE-151208; Odgaard L, 2015, CLIN EPIDEMIOL, V7, P225, DOI 10.2147/CLEP.S78141; Pow J, 2012, J CLIN NURS, V21, P2772, DOI 10.1111/j.1365-2702.2011.04036.x; Radley A, 2001, SOC SCI MED, V53, P321, DOI 10.1016/S0277-9536(00)00320-8; Rauch RJ, 2001, NEUROREHABILITATION, V16, P11; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P1, DOI 10.1097/HTR.0b013e3182068588; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Scheibelhofer E, 2008, INT J SOC RES METHOD, V11, P403, DOI 10.1080/13645570701401370; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Song LJ, 2011, J HEALTH SOC BEHAV, V52, P478, DOI 10.1177/0022146511411921; Song LJ, 2009, J HEALTH SOC BEHAV, V50, P149, DOI 10.1177/002214650905000203; Stake E. R., 2006, MULTIPLE CASE STUDY; Steinmetz G, 2004, SOCIOL THEOR, V22, P371, DOI 10.1111/j.0735-2751.2004.00225.x; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yin R.K., 2013, CASE STUDY RES DESIG	46	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2021.2002442		NOV 2021	10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	WZ1UB	WOS:000719757200001	34812660				2022-02-06	
J	Joormann, J; Ziobrowski, HN; King, AJ; Gildea, SM; Lee, S; Sampson, NA; House, SL; Beaudoin, FL; An, XM; Stevens, JS; Zeng, DL; Neylan, TC; Clifford, GD; Linnstaedt, SD; Germine, LT; Bollen, KA; Rauch, SL; Haran, JP; Storrow, AB; Musey, PI; Hendry, PL; Sheikh, S; Jones, CW; Punches, BE; McGrath, ME; Hudak, LA; Pascual, JL; Seamon, MJ; Chang, AM; Pearson, C; Peak, DA; Domeier, RM; Rathlev, NK; O'Neil, BJ; Sanchez, LD; Bruce, SE; Miller, MW; Pietrzak, RH; Barch, DM; Pizzagalli, DA; Harte, SE; Elliott, JM; Koenen, KC; McLean, SA; Kessler, RC				Joormann, Jutta; Ziobrowski, Hannah N.; King, Andrew J.; Gildea, Sarah M.; Lee, Sue; Sampson, Nancy A.; House, Stacey L.; Beaudoin, Francesca L.; An, Xinming; Stevens, Jennifer S.; Zeng, Donglin; Neylan, Thomas C.; Clifford, Gari D.; Linnstaedt, Sarah D.; Germine, Laura T.; Bollen, Kenneth A.; Rauch, Scott L.; Haran, John P.; Storrow, Alan B.; Musey, Paul I. Jr Jr; Hendry, Phyllis L.; Sheikh, Sophia; Jones, Christopher W.; Punches, Brittany E.; McGrath, Meghan E.; Hudak, Lauren A.; Pascual, Jose L.; Seamon, Mark J.; Chang, Anna M.; Pearson, Claire; Peak, David A.; Domeier, Robert M.; Rathlev, Niels K.; O'Neil, Brian J.; Sanchez, Leon D.; Bruce, Steven E.; Miller, Mark W.; Pietrzak, Robert H.; Barch, Deanna M.; Pizzagalli, Diego A.; Harte, Steven E.; Elliott, James M.; Koenen, Karestan C.; McLean, Samuel A.; Kessler, Ronald C.			Prior histories of posttraumatic stress disorder and major depression and their onset and course in the three months after a motor vehicle collision in the AURORA study	DEPRESSION AND ANXIETY			English	Article						major depression; motor vehicle collision; posttraumatic stress disorder; trauma	CONCUSSION SYMPTOMS; RISK RATIOS; HEAD-INJURY; PTSD; DISTRESS; TRAUMA	Background A better understanding of the extent to which prior occurrences of posttraumatic stress disorder (PTSD) and major depressive episode (MDE) predict psychopathological reactions to subsequent traumas might be useful in targeting posttraumatic preventive interventions. Methods Data come from 1306 patients presenting to 29 U.S. emergency departments (EDs) after a motor vehicle collision (MVC) in the advancing understanding of recovery after trauma study. Patients completed self-reports in the ED and 2-weeks, 8-weeks, and 3-months post-MVC. Associations of pre-MVC probable PTSD and probable MDE histories with subsequent 3-months post-MVC probable PTSD and probable MDE were examined along with mediation through intervening peritraumatic, 2-, and 8-week disorders. Results 27.6% of patients had 3-month post-MVC probable PTSD and/or MDE. Pre-MVC lifetime histories of these disorders were not only significant (relative risk = 2.6-7.4) but were dominant (63.1% population attributable risk proportion [PARP]) predictors of this 3-month outcome, with 46.6% prevalence of the outcome among patients with pre-MVC disorder histories versus 9.9% among those without such histories. The associations of pre-MVC lifetime disorders with the 3-month outcome were mediated largely by 2- and 8-week probable PTSD and MDE (PARP decreasing to 22.8% with controls for these intervening disorders). Decomposition showed that pre-MVC lifetime histories predicted both onset and persistence of these intervening disorders as well as the higher conditional prevalence of the 3-month outcome in the presence of these intervening disorders. Conclusions Assessments of pre-MVC PTSD and MDE histories and follow-ups at 2 and 8 weeks could help target early interventions for psychopathological reactions to MVCs.	[Joormann, Jutta] Yale Univ, Dept Psychol, New Haven, CT USA; [Ziobrowski, Hannah N.; King, Andrew J.; Gildea, Sarah M.; Lee, Sue; Sampson, Nancy A.; Kessler, Ronald C.] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [House, Stacey L.] Washington Univ, Sch Med, Dept Emergency Med, St Louis, MO USA; [Beaudoin, Francesca L.] Brown Univ, Dept Emergency Med, Alpert Med Sch, Providence, RI 02912 USA; [Beaudoin, Francesca L.] Brown Univ, Alpert Med Sch, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Beaudoin, Francesca L.] Rhode Isl Hosp, Dept Emergency Med, Providence, RI USA; [Beaudoin, Francesca L.] Miriam Hosp, Dept Emergency Med, Providence, RI 02906 USA; [An, Xinming; Linnstaedt, Sarah D.; McLean, Samuel A.] Univ North Carolina Chapel Hill, Inst Trauma Recovery, Dept Anesthesiol, Chapel Hill, NC USA; [Stevens, Jennifer S.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Zeng, Donglin] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC USA; [Neylan, Thomas C.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Neylan, Thomas C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Clifford, Gari D.] Emory Univ, Sch Med, Dept Biomed Informat, Atlanta, GA USA; [Clifford, Gari D.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Germine, Laura T.] Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA; [Germine, Laura T.; Rauch, Scott L.] McLean Hosp, Inst Technol Psychiat, 115 Mill St, Belmont, MA 02178 USA; [Germine, Laura T.] Many Brains Project Inc, Belmont, MA USA; [Bollen, Kenneth A.; Rauch, Scott L.; Pizzagalli, Diego A.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Bollen, Kenneth A.] Univ N Carolina, Dept Psychol & Neurosci, Chapel Hill, NC USA; [Bollen, Kenneth A.] Univ N Carolina, Dept Sociol, Chapel Hill, NC USA; [Rauch, Scott L.] McLean Hosp, Dept Psychiat, 115 Mill St, Belmont, MA 02178 USA; [Haran, John P.] Univ Massachusetts, Med Sch, Dept Emergency Med, Worcester, MA 01605 USA; [Storrow, Alan B.] Vanderbilt Univ, Dept Emergency Med, Med Ctr, Nashville, TN USA; [Musey, Paul I. Jr Jr] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA; [Hendry, Phyllis L.; Sheikh, Sophia] Univ Florida, Dept Emergency Med, Coll Med Jacksonville, Jacksonville, FL USA; [Jones, Christopher W.] Rowan Univ, Cooper Med Sch, Dept Emergency Med, Camden, NJ USA; [Punches, Brittany E.] Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH USA; [Punches, Brittany E.] Univ Cincinnati, Coll Nursing, Cincinnati, OH USA; [McGrath, Meghan E.] Boston Med Ctr, Dept Emergency Med, Boston, MA USA; [Hudak, Lauren A.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA; [Pascual, Jose L.] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [Pascual, Jose L.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Pascual, Jose L.; Seamon, Mark J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Seamon, Mark J.] Univ Penn, Dept Surg, Div Traumatol Surg Crit Care & Emergency Surg, Philadelphia, PA 19104 USA; [Chang, Anna M.] Jefferson Univ Hosp, Dept Emergency Med, Philadelphia, PA USA; [Pearson, Claire; O'Neil, Brian J.] Wayne State Univ, Dept Emergency Med, Detroit, MI USA; [Peak, David A.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Domeier, Robert M.] St Joseph Mercy Hosp, Dept Emergency Med, Ypsilanti, MI USA; [Rathlev, Niels K.] Univ Massachusetts, Med Sch Baystate, Dept Emergency Med, Springfield, MA USA; [Sanchez, Leon D.] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Sanchez, Leon D.] Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA; [Bruce, Steven E.] Univ Missouri, Dept Psychol Sci, St Louis, MO 63121 USA; [Miller, Mark W.] VA Boston Healthcare Syst, Natl Ctr PTSD, Behav Sci Div, Boston, MA USA; [Miller, Mark W.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Pietrzak, Robert H.] VA Connecticut Healthcare Syst, Natl Ctr PTSD, Clin Neurosci Div, West Haven, CT USA; [Pietrzak, Robert H.] Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Barch, Deanna M.] Washington Univ, Dept Psychol & Brain Sci, St Louis, MO 63110 USA; [Pizzagalli, Diego A.] McLean Hosp, Div Depress & Anxiety, 115 Mill St, Belmont, MA 02178 USA; [Harte, Steven E.] Univ Michigan, Dept Anesthesiol, Med Sch, Ann Arbor, MI 48109 USA; [Harte, Steven E.] Univ Michigan, Med Sch, Dept Internal Med Rheumatol, Ann Arbor, MI 48109 USA; [Elliott, James M.] Univ Sydney, Kolling Inst Med Res, Sydney, NSW, Australia; [Elliott, James M.] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia; [Elliott, James M.] Northern Sydney Local Hlth Dist, Allied Hlth Network, Sydney, NSW, Australia; [Elliott, James M.] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Koenen, Karestan C.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [McLean, Samuel A.] Univ North Carolina Chapel Hill, Dept Emergency Med, Chapel Hill, NC USA		Kessler, RC (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	kessler@hcp.med.harvard.edu	Stevens, Jennifer/T-4290-2018	Stevens, Jennifer/0000-0003-4674-0314; Clifford, Gari/0000-0002-5709-201X	NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH110925]; U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); One Mind Foundation; Mayday Fund	AURORA is supported by NIMH U01MH110925, the U.S. Army Medical Research and Materiel Command, The One Mind Foundation, and The Mayday Fund. Verily Life Sciences and Mindstrong Health provide some of the hardware and software used to perform study assessments.	Bedaso A, 2020, BMC EMERG MED, V20, DOI 10.1186/s12873-020-00348-5; Beliveau PJH, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2146-z; Benjamini Y, 2001, ANN STAT, V29, P1165; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Breslau N, 2008, ARCH GEN PSYCHIAT, V65, P431, DOI 10.1001/archpsyc.65.4.431; Brody Debra J, 2018, NCHS Data Brief, P1; Bromet Evelyn, 2011, BMC Med, V9, P90, DOI 10.1186/1741-7015-9-90; Bronner Madelon B, 2009, Child Adolesc Psychiatry Ment Health, V3, P33, DOI 10.1186/1753-2000-3-33; Brunet A, 2001, AM J PSYCHIAT, V158, P1480, DOI 10.1176/appi.ajp.158.9.1480; Bryant RA, 2021, AUST NZ J PSYCHIAT, V55, P666, DOI 10.1177/0004867420969815; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Heron-Delaney M, 2013, INJURY, V44, P1413, DOI 10.1016/j.injury.2013.07.011; Ho FYY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29281; Ikin JF, 2010, J AFFECT DISORDERS, V125, P279, DOI 10.1016/j.jad.2009.12.005; Joormann J., 2020, PSYCHOL MED, P1; Kenardy J, 2018, J AFFECT DISORDERS, V236, P172, DOI 10.1016/j.jad.2018.04.090; Kessler RC, 2018, MOL PSYCHIATR, V23, DOI 10.1038/mp.2017.194; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2021, MOL PSYCHIATR, V26, P3108, DOI 10.1038/s41380-020-00911-3; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Knol MJ, 2012, CAN MED ASSOC J, V184, P895, DOI 10.1503/cmaj.101715; Koenen KC, 2017, PSYCHOL MED, V47, P2260, DOI 10.1017/S0033291717000708; Leon AC, 1997, INT J PSYCHIAT MED, V27, P93, DOI 10.2190/T8EM-C8YH-373N-1UWD; Loftis KL, 2018, TRAFFIC INJ PREV, V19, pS109, DOI 10.1080/15389588.2018.1512747; Lowe SR, 2021, PSYCHOL MED, V51, P1129, DOI 10.1017/S0033291719004008; McLean SA, 2020, MOL PSYCHIATR, V25, P283, DOI 10.1038/s41380-019-0581-3; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Pozzato I, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02601-4; Price Matthew, 2018, Mhealth, V4, P22, DOI 10.21037/mhealth.2018.06.03; Price Matthew, 2017, J Technol Behav Sci, V2, P41, DOI 10.1007/s41347-016-0008-9; PROMIS Cooperative Group, 2021, PROM INT SCOR; Robbins J.M., 1991, CURRENT CONCEPTS SOM, P21; Rubin DB., 1987, MULTIPLE IMPUTATION; SAS Institute Inc, 2017, SAS STAT SOFTW VERS; Schindel-Allon I, 2010, PSYCHOL MED, V40, P1669, DOI 10.1017/S0033291709992248; van der Velden PG, 2008, CLIN PSYCHOL REV, V28, P1009, DOI 10.1016/j.cpr.2008.02.006; Vance MC, 2018, J CLIN PSYCHOL, V74, P1457, DOI 10.1002/jclp.22612; Zuromski KL, 2019, DEPRESS ANXIETY, V36, P790, DOI 10.1002/da.22942	41	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1091-4269	1520-6394		DEPRESS ANXIETY	Depress. Anxiety	JAN	2022	39	1					56	70		10.1002/da.23223		NOV 2021	15	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	YB2NY	WOS:000718652200001	34783142				2022-02-06	
J	Rowland, JA; Stapleton-Kotloski, JR; Martindale, SL; Rogers, EE; Ord, AS; Godwin, DW; Taber, KH				Rowland, Jared A.; Stapleton-Kotloski, Jennifer R.; Martindale, Sarah L.; Rogers, Emily E.; Ord, Anna S.; Godwin, Dwayne W.; Taber, Katherine H.			Alterations in the Topology of Functional Connectomes Are Associated with Post-Traumatic Stress Disorder and Blast-Related Mild Traumatic Brain Injury in Combat Veterans	JOURNAL OF NEUROTRAUMA			English	Article						connectome; deployment; network; PTSD; TBI	TEST-RETEST RELIABILITY; NETWORK CONNECTIVITY; SYMPTOM SEVERITY; EXPOSURE; VOLUME; RESILIENCE; VALIDATION; CONCUSSION; DYNAMICS; PATTERNS	Post-traumatic stress disorder (PTSD) is a common condition in post-deployment service members (SM). SMs of the conflicts in Iraq and Afghanistan also frequently experience traumatic brain injury (TBI) and exposure to blasts during deployments. This study evaluated the effect of these conditions and experiences on functional brain connectomes in post-deployment, combat-exposed veterans. Functional brain connectomes were created using 5-min resting-state magnetoencephalography data. Well-established clinical interviews determined current PTSD diagnosis, as well as deployment-acquired mild TBI and history of exposure to blast. Linear regression examined the effect of these conditions on functional brain connectomes beyond covariates. There were significant interactions between blast-related mild TBI and PTSD after correction for multiple comparisons including number of nodes (non-standardized parameter estimate [PE] = -12.47), average degree (PE = 0.05), and connection strength (PE = 0.05). A main effect of blast-related mild TBI was observed on the threshold level. These results demonstrate a distinct functional connectome presentation associated with the presence of both blast-related mild TBI and PTSD. These findings suggest the possibility that blast-related mild TBI alterations in functional brain connectomes affect the presentation or progression of recovery from PTSD. The current results offer mixed support for hyper-connectivity in the chronic phase of deployment TBI.	[Rowland, Jared A.; Stapleton-Kotloski, Jennifer R.; Martindale, Sarah L.; Ord, Anna S.; Taber, Katherine H.] WG Bill Hefner VA Healthcare Syst, Res & Acad Affairs, Salisbury, NC USA; [Rowland, Jared A.; Martindale, Sarah L.; Ord, Anna S.; Taber, Katherine H.] Mid Atlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Rowland, Jared A.; Stapleton-Kotloski, Jennifer R.; Rogers, Emily E.; Godwin, Dwayne W.; Taber, Katherine H.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27101 USA; [Stapleton-Kotloski, Jennifer R.; Ord, Anna S.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27101 USA; [Martindale, Sarah L.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27101 USA; [Taber, Katherine H.] Edward Via Coll Osteopath Med, Div Biomed Sci, Blacksburg, VA USA		Rowland, JA (corresponding author), WG Bill Hefner VA Healthcare Syst, 1601 Brenner Ave, Salisbury, NC 28144 USA.	jared.rowland@va.gov	Martindale, Sarah L/O-8553-2018	Martindale, Sarah L/0000-0002-0059-3454			(2009), TEST PREMORBID FUNCT; Alhourani A, 2016, J NEUROPHYSIOL, V116, P1840, DOI 10.1152/jn.00513.2016; Antonakakis M, 2017, NEUROSCIENCE, V356, P275, DOI 10.1016/j.neuroscience.2017.05.032; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Boone KB, 2000, ARCH CLIN NEUROPSYCH, V15, P227, DOI 10.1016/S0887-6177(99)00014-1; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Candelaria-Cook FT, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.551952; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Colclough GL, 2016, NEUROIMAGE, V138, P284, DOI 10.1016/j.neuroimage.2016.05.070; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Crocker LD, 2019, J PSYCHIATR RES, V116, P7, DOI 10.1016/j.jpsychires.2019.05.022; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Deuker L, 2009, NEUROIMAGE, V47, P1460, DOI 10.1016/j.neuroimage.2009.05.035; Dunkley BT, 2014, NEUROIMAGE-CLIN, V5, P377, DOI 10.1016/j.nicl.2014.07.017; Dunkley BT, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00280; Dunkley BT, 2015, PSYCHIAT RES-NEUROIM, V234, P172, DOI 10.1016/j.pscychresns.2015.09.002; Engdahl B, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066005; Garces P, 2016, BRAIN CONNECT, V6, P448, DOI 10.1089/brain.2015.0416; Glenn DE, 2017, DEPRESS ANXIETY, V34, P723, DOI 10.1002/da.22642; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gros DF, 2017, COMPR PSYCHIAT, V78, P48, DOI 10.1016/j.comppsych.2017.07.004; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Huang MX, 2017, J NEUROTRAUM, V34, P1412, DOI 10.1089/neu.2016.4581; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; James LM, 2013, JAMA PSYCHIAT, V70, P410, DOI 10.1001/jamapsychiatry.2013.878; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; Lei D, 2015, RADIOLOGY, V276, P818, DOI 10.1148/radiol.15141700; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Logue MW, 2018, BIOL PSYCHIAT, V83, P244, DOI 10.1016/j.biopsych.2017.09.006; Martindale SL, 2021, REHABIL PSYCHOL, V66, P128, DOI 10.1037/rep0000374; Martindale SL, 2018, ARCH PHYS MED REHAB, V99, P2485, DOI 10.1016/j.apmr.2018.04.029; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Misic B, 2016, J NEUROSCI, V36, P419, DOI 10.1523/JNEUROSCI.1506-15.2016; Morey RA, 2012, ARCH GEN PSYCHIAT, V69, P1169, DOI 10.1001/archgenpsychiatry.2012.50; Nelson NW, 2020, NEUROPSYCHOLOGY, V34, P116, DOI 10.1037/neu0000594; Pagulayan KF, 2018, J INT NEUROPSYCH SOC, V24, P324, DOI 10.1017/S1355617717001217; Pitman RK, 2006, ANN NY ACAD SCI, V1071, P242, DOI 10.1196/annals.1364.019; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; PRICHARD D, 1994, PHYS REV LETT, V73, P951, DOI 10.1103/PhysRevLett.73.951; Ragsdale KA, 2018, BEHAV THER, V49, P617, DOI 10.1016/j.beth.2017.09.008; Rangaprakash D, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00803; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Robinson ME, 2017, J NEUROTRAUM, V34, pS53, DOI 10.1089/neu.2016.4709; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Robinson S.E., 1998, FUNCTIONAL NEUROIMAG; Rowland JA, 2020, J NEUROTRAUM, V37, P1797, DOI 10.1089/neu.2019.6972; Rowland JA, 2020, BRAIN INJURY, V34, P642, DOI 10.1080/02699052.2020.1729418; Rowland JA, 2018, BRAIN CONNECT, V8, P205, DOI 10.1089/brain.2017.0556; Rowland JA, 2017, BRAIN CONNECT, V7, P45, DOI 10.1089/brain.2015.0406; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; SEIDMAN SB, 1983, SOC NETWORKS, V5, P269, DOI 10.1016/0378-8733(83)90028-X; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Sporns O, 2018, DIALOGUES CLIN NEURO, V20, P111; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tsao JW, 2017, NEUROLOGY, V89, P2010, DOI 10.1212/WNL.0000000000004616; Tursich M, 2015, ACTA PSYCHIAT SCAND, V132, P29, DOI 10.1111/acps.12387; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046833	81	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2021	38	22					3086	3096		10.1089/neu.2020.7450			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	WY7FJ	WOS:000719443900006	34435885				2022-02-06	
J	Turtzo, LC; Luby, M; Jikaria, N; Griffin, AD; Greenman, D; Bokkers, RPH; Parikh, G; Peterkin, N; Whiting, M; Latour, LL				Turtzo, L. Christine; Luby, Marie; Jikaria, Neekita; Griffin, Allison Diane; Greenman, Danielle; Bokkers, Reinoud P. H.; Parikh, Gunjan; Peterkin, Nicole; Whiting, Mark; Latour, Lawrence L.			Cytotoxic Edema Associated with Hemorrhage Predicts Poor Outcome after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						apparent diffusion coefficient; cytotoxic edema; diffusion-weighted imaging; hemorrhage; magnetic resonance imaging; traumatic brain injury	DIFFUSE AXONAL INJURY; CEREBRAL-ISCHEMIA; CORPUS-CALLOSUM; TIME-COURSE; COEFFICIENT; PATHOPHYSIOLOGY; STROKE; MRI	Magnetic resonance imaging (MRI) is used rarely in the acute evaluation of traumatic brain injury (TBI) but may identify findings of clinical importance not detected by computed tomography (CT). We aimed to characterize the association of cytotoxic edema and hemorrhage, including traumatic microbleeds, on MRI obtained within hours of acute head trauma and investigated the relationship to clinical outcomes. Patients prospectively enrolled in the Traumatic Head Injury Neuroimaging Classification study (NCT01132937) with evidence of diffusion-related findings or hemorrhage on neuroimaging were included. Blinded interpretation of MRI for diffusion-weighted lesions and hemorrhage was conducted, with subsequent quantification of apparent diffusion coefficient (ADC) values. Of 161 who met criteria, 82 patients had conspicuous hyperintense lesions on diffusion-weighted imaging (DWI) with corresponding regions of hypointense ADC in proximity to hemorrhage. Median time from injury to MRI was 21 (10-30) h. Median ADC values per patient grouped by time from injury to MRI were lowest within 24 h after injury. The ADC values associated with hemorrhagic lesions are lowest early after injury, with an increase in diffusion during the subacute period, suggesting transformation from cytotoxic to vasogenic edema during the subacute post-injury period. Of 118 patients with outcome data, 60 had Glasgow Outcome Scale Extended scores <= 6 at 30/90 days post-injury. Cytotoxic edema on MRI (odds ratio [OR] 2.91 [1.32-6.37], p = 0.008) and TBI severity (OR 2.51 [1.32-4.74], p = 0.005) were independent predictors of outcome. These findings suggest that in patients with TBI who had findings of hemorrhage on CT, patients with DWI/ADC lesions on MRI are more likely to do worse.	[Turtzo, L. Christine; Luby, Marie; Latour, Lawrence L.] NINDS, NIH, 10 Ctr Dr,Bldg 10,Room B1D733, Bethesda, MD 20892 USA; [Jikaria, Neekita; Griffin, Allison Diane; Greenman, Danielle; Peterkin, Nicole; Whiting, Mark; Latour, Lawrence L.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Bokkers, Reinoud P. H.] Univ Groningen, Univ Med Ctr Groningen, Med Imaging Ctr, Dept Radiol, Groningen, Netherlands; [Parikh, Gunjan] Univ Maryland, Sch Med, R Adams Shock Trauma Ctr, Baltimore, MD 21201 USA; [Parikh, Gunjan] Univ Maryland, Sch Med, Div Neurocrit Care & Emergency Neurol, Baltimore, MD 21201 USA		Latour, LL (corresponding author), NINDS, NIH, 10 Ctr Dr,Bldg 10,Room B1D733, Bethesda, MD 20892 USA.	LatourL@ninds.nih.gov		Bokkers, Reinoud/0000-0001-6130-7311			ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; Andreasen SH, 2020, J NEUROTRAUM, V37, P581, DOI 10.1089/neu.2019.6608; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Babikian T, 2009, PEDIATR NEUROL, V41, P406, DOI 10.1016/j.pediatrneurol.2009.06.002; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Budohoski KP, 2014, J NEUROL NEUROSUR PS, V85, P1343, DOI 10.1136/jnnp-2014-307711; Bullock M.R., 2018, JAMA NETW OPEN, P1; Cota MR, 2019, J NEUROTRAUM, V36, P1335, DOI 10.1089/neu.2018.5772; Francoeur CL, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1447-6; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Gonzalez RG, 2012, J MAGN RESON IMAGING, V36, P259, DOI 10.1002/jmri.23595; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Hahnel S, 2008, AM J NEURORADIOL, V29, P388, DOI 10.3174/ajnr.A0799; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Hsia AW, 2019, STROKE, V50, P2086, DOI 10.1161/STROKEAHA.119.025784; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Ironside N, 2019, STROKE, V50, P1626, DOI 10.1161/STROKEAHA.119.024965; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jolly AE, 2021, BRAIN, V144, P92, DOI 10.1093/brain/awaa372; Kinoshita T, 2005, EUR J RADIOL, V56, P5, DOI 10.1016/j.ejrad.2005.04.001; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lansberg MG, 2001, AM J NEURORADIOL, V22, P637; Launey Y, 2020, JAMA NEUROL, V77, P339, DOI 10.1001/jamaneurol.2019.3854; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Muir KW, 2006, LANCET NEUROL, V5, P755, DOI 10.1016/S1474-4422(06)70545-2; Nagesh V, 1998, STROKE, V29, P1778, DOI 10.1161/01.STR.29.9.1778; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Provenzale JM, 1999, AM J ROENTGENOL, V173, P1459, DOI 10.2214/ajr.173.6.10584783; Ricciardi MC, 2017, J NEUROTRAUM, V34, P23, DOI 10.1089/neu.2015.4338; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Spitz G, 2017, J NEUROTRAUM, V34, P807, DOI 10.1089/neu.2016.4527; Takayama H, 2000, CLIN NEUROL NEUROSUR, V102, P135, DOI 10.1016/S0303-8467(00)00079-2; Tokutomi T, 1997, ACT NEUR S, V70, P80; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; van Everdingen KJ, 1998, STROKE, V29, P1783, DOI 10.1161/01.STR.29.9.1783; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Yue JK, 2020, NEUROTRAUMA REP, V1, P32, DOI 10.1089/neur.2020.0004; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	50	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2021	38	22					3107	3118		10.1089/neu.2021.0037			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WY7FJ	WOS:000719443900008	34541886	Green Submitted			2022-02-06	
J	Wada, T; Shiraishi, A; Gando, S; Yamakawa, K; Fujishima, S; Saitoh, D; Kushimoto, S; Ogura, H; Abe, T; Mayumi, T; Sasaki, J; Kotani, J; Takeyama, N; Tsuruta, R; Takuma, K; Shiraishi, SI; Shiino, Y; Nakada, TA; Okamoto, K; Sakamoto, Y; Hagiwara, A; Fujimi, S; Umemura, Y; Otomo, Y				Wada, Takeshi; Shiraishi, Atsushi; Gando, Satoshi; Yamakawa, Kazuma; Fujishima, Seitaro; Saitoh, Daizoh; Kushimoto, Shigeki; Ogura, Hiroshi; Abe, Toshikazu; Mayumi, Toshihiko; Sasaki, Junichi; Kotani, Joji; Takeyama, Naoshi; Tsuruta, Ryosuke; Takuma, Kiyotsugu; Shiraishi, Shin-ichiro; Shiino, Yasukazu; Nakada, Taka-aki; Okamoto, Kohji; Sakamoto, Yuichiro; Hagiwara, Akiyoshi; Fujimi, Satoshi; Umemura, Yutaka; Otomo, Yasuhiro			Pathophysiology of Coagulopathy Induced by Traumatic Brain Injury Is Identical to That of Disseminated Intravascular Coagulation With Hyperfibrinolysis	FRONTIERS IN MEDICINE			English	Article						disseminated intravascular coagulation; fibrinolysis; shock; thrombin; trauma-induced coagulopathy; traumatic brain injury	HYPOPERFUSION; HEMOSTASIS; MANAGEMENT; THROMBOSIS; CRITERIA; SOCIETY; FUTURE	Background: Traumatic brain injury (TBI)-associated coagulopathy is a widely recognized risk factor for secondary brain damage and contributes to poor clinical outcomes. Various theories, including disseminated intravascular coagulation (DIC), have been proposed regarding its pathomechanisms; no consensus has been reached thus far. This study aimed to elucidate the pathophysiology of TBI-induced coagulopathy by comparing coagulofibrinolytic changes in isolated TBI (iTBI) to those in non-TBI, to determine the associated factors, and identify the clinical significance of DIC diagnosis in patients with iTBI.Methods: This secondary multicenter, prospective study assessed patients with severe trauma. iTBI was defined as Abbreviated Injury Scale (AIS) scores >= 4 in the head and neck, and <= 2 in other body parts. Non-TBI was defined as AIS scores >= 4 in single body parts other than the head and neck, and the absence of AIS scores >= 3 in any other trauma-affected parts. Specific biomarkers for thrombin and plasmin generation, anticoagulation, and fibrinolysis inhibition were measured at the presentation to the emergency department (0 h) and 3 h after arrival.Results: We analyzed 34 iTBI and 40 non-TBI patients. Baseline characteristics, transfusion requirements and in-hospital mortality did not significantly differ between groups. The changes in coagulation/fibrinolysis-related biomarkers were similar. Lactate levels in the iTBI group positively correlated with DIC scores (rho = -0.441, p = 0.017), but not with blood pressure (rho = -0.098, p = 0.614). Multiple logistic regression analyses revealed that the injury severity score was an independent predictor of DIC development in patients with iTBI (odds ratio = 1.237, p = 0.018). Patients with iTBI were further subdivided into two groups: DIC (n = 15) and non-DIC (n = 19) groups. Marked thrombin and plasmin generation were observed in all patients with iTBI, especially those with DIC. Patients with iTBI and DIC had higher requirements for massive transfusion and emergency surgery, and higher in-hospital mortality than those without DIC. Furthermore, DIC development significantly correlated with poor hospital survival; DIC scores at 0 h were predictive of in-hospital mortality.Conclusions: Coagulofibrinolytic changes in iTBI and non-TBI patients were identical, and consistent with the pathophysiology of DIC. DIC diagnosis in the early phase of TBI is key in predicting the outcomes of severe TBI.	[Wada, Takeshi; Gando, Satoshi] Hokkaido Univ, Div Acute & Crit Care Med, Dept Anesthesiol & Crit Care Med, Fac Med, Sapporo, Hokkaido, Japan; [Shiraishi, Atsushi] Kameda Med Ctr, Emergency & Trauma Ctr, Kamogawa, Japan; [Gando, Satoshi] Sapporo Higashi Tokushukai Hosp, Dept Acute & Crit Care Med, Sapporo, Hokkaido, Japan; [Yamakawa, Kazuma] Osaka Med & Pharmaceut Univ, Dept Emergency Med, Takatsuki, Osaka, Japan; [Fujishima, Seitaro] Keio Univ, Ctr Gen Med Educ, Sch Med, Tokyo, Japan; [Saitoh, Daizoh] Natl Def Med Coll, Res Inst, Div Traumatol, Tokorozawa, Saitama, Japan; [Kushimoto, Shigeki] Tohoku Univ, Div Emergency & Crit Care Med, Grad Sch Med, Sendai, Miyagi, Japan; [Ogura, Hiroshi] Osaka Univ, Dept Traumatol & Acute Crit Med, Grad Sch Med, Suita, Osaka, Japan; [Abe, Toshikazu] Tsukuba Mem Hosp, Dept Emergency & Crit Care Med, Tsukuba, Ibaraki, Japan; [Abe, Toshikazu] Univ Tsukuba, Hlth Serv Res & Dev Ctr, Tsukuba, Ibaraki, Japan; [Mayumi, Toshihiko] Univ Occupat & Environm Hlth, Sch Med, Dept Emergency Med, Kitakyushu, Fukuoka, Japan; [Sasaki, Junichi] Keio Univ, Dept Emergency & Crit Care Med, Sch Med, Tokyo, Japan; [Kotani, Joji] Kobe Univ, Div Disaster & Emergency Med, Dept Surg Related, Grad Sch Med, Kobe, Hyogo, Japan; [Takeyama, Naoshi] Aichi Med Univ Hosp, Adv Crit Care Ctr, Nagakute, Aichi, Japan; [Tsuruta, Ryosuke] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Ube, Yamaguchi, Japan; [Takuma, Kiyotsugu] Kawasaki Municipal Hosp, Emergency & Crit Care Ctr, Kawasaki, Kanagawa, Japan; [Shiraishi, Shin-ichiro] Aizu Chuo Hosp, Dept Emergency & Crit Care Med, Aizu Wakamatsu, Japan; [Shiino, Yasukazu] Kawasaki Med Sch, Dept Acute Med, Kurashiki, Okayama, Japan; [Nakada, Taka-aki] Chiba Univ, Dept Emergency & Crit Care Med, Grad Sch Med, Chiba, Japan; [Okamoto, Kohji] Kitakyushu City Yahata Hosp, Dept Surg, Ctr Gastroenterol & Liver Dis, Kitakyushu, Fukuoka, Japan; [Sakamoto, Yuichiro] Saga Univ Hosp, Emergency & Crit Care Med, Saga, Japan; [Hagiwara, Akiyoshi] Natl Ctr Global Hlth & Med, Ctr Hosp, Tokyo, Japan; [Fujimi, Satoshi; Umemura, Yutaka] Osaka Gen Med Ctr, Div Trauma & Surg Crit Care, Sumiyoshi, Japan; [Otomo, Yasuhiro] Tokyo Med & Dent Univ, Med Hosp, Trauma & Acute Crit Care Ctr, Tokyo, Japan		Wada, T (corresponding author), Hokkaido Univ, Div Acute & Crit Care Med, Dept Anesthesiol & Crit Care Med, Fac Med, Sapporo, Hokkaido, Japan.	twada1@med.hokudai.ac.jp	Abe, Toshikazu/ABH-1639-2021		Japanese Association for Acute Medicine (JAAM); JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)	This study was supported by the Japanese Association for Acute Medicine (JAAM, 2014-01). This work was also supported in part by JSPS KAKENHI (Grant-in-Aid (C) 2020, 20K09260).	BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Esnault P, 2020, NEUROCRIT CARE, V33, P182, DOI 10.1007/s12028-019-00882-6; Gando S, 2001, SEMIN THROMB HEMOST, V27, P585, DOI 10.1055/s-2001-18864; Gando S, 1999, J TRAUMA, V46, P1070, DOI 10.1097/00005373-199906000-00018; Gando S, 1999, ANN SURG, V229, P121, DOI 10.1097/00000658-199901000-00016; Gando S, 2008, CRIT CARE MED, V36, P145, DOI 10.1097/01.CCM.0000295317.97245.2D; Gando S, 2020, J THROMB HAEMOST, V18, P2232, DOI 10.1111/jth.14931; Gando S, 2016, SEMIN THROMB HEMOST, V42, P155, DOI 10.1055/s-0035-1564831; Gando S, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0735-x; Gando S, 2015, SEMIN THROMB HEMOST, V41, P26, DOI 10.1055/s-0034-1398378; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; Gando S, 2009, J TRAUMA, V67, P381, DOI 10.1097/TA.0b013e3181a84f63; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; Maegele M, 2020, SEMIN THROMB HEMOST, V46, P155, DOI 10.1055/s-0040-1702178; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Moore HB, 2020, J THROMB HAEMOST, V18, P740, DOI 10.1111/jth.14690; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Wada T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90492-0; Wada T, 2019, J THROMB HAEMOST, V17, P1571, DOI 10.1111/jth.14571; Wada T, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1808-9; Zou ZM, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02192-1	36	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-858X		FRONT MED-LAUSANNE	Front. Med.	NOV 15	2021	8								767637	10.3389/fmed.2021.767637			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XI4ZZ	WOS:000726122900001	34869481	Green Published, gold			2022-02-06	
J	Smaakjaer, P; Wachner, LG; Rasmussen, RS				Smaakjaer, Peter; Wachner, Lone Gronnegaard; Rasmussen, Rune Skovgaard			Vision therapy improves binocular visual dysfunction in patients with mild traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article; Early Access						Commotio; vision therapy; oculomotor dysfunction; convergence insufficiency	OCULOMOTOR REHABILITATION; CONCUSSION; RESPONSIVITY; MECHANISMS; SYMPTOMS; BLAST	Objective To evaluate benefits of binocular vision and ocular motility training in patients with long-term sequelae after mild traumatic brain injury (mTBI). Methods Twenty-eight mTBI (concussion) patients from 25 to 61 years of age with oculomotor dysfunction were selected by optometric examination. The vision therapy was designed to improve convergence, pursuit and saccades as well as to increase fusional reserves. The vision therapy was conducted by a neurooptometrist and a speech therapist, and took place weekly for 1 hour during 10 continuous weeks. Between vision training sessions, patients trained at home for 15-20 minutes daily. Before and after vision therapy, patients completed a test battery including the Groffman Visual Tracing Test, King-Devick test (K-D), a reading speed test, Multidimensional Fatigue Inventory (MFI-20) and patient interviews based on a modified version of the Canadian Occupational Performance Measure (COPM). Results Twenty-seven patients completed the vision therapy. After the therapy, improvements were measured on all test parameters, e.g. Groffman Visual Tracing Test (p < 0.05), K-D-Test (p = 0.01), Reading Speed Test (p < 0.01) and MFI-20 total (p < 0.05). The results for the modified COPM were significantly improved for both performance and satisfaction (0.0001 < p < 0.01). Conclusion Vision therapy improved fixation stability and endurance. Reading speed measured by the numbers of saccades and regressions time consumption per read word increased. There was also an improvement in visual attention, possibly making patients safer in traffic and outdoor activities.	[Smaakjaer, Peter] CSU Slagelse, Dept Vis, Ctr Commun, Slagelse, Denmark; [Wachner, Lone Gronnegaard; Rasmussen, Rune Skovgaard] CSU Slagelse, Dept Speech & Brain Pathol, Ctr Commun, Slagelse, Denmark		Smaakjaer, P (corresponding author), CSU Slagelse, Dept Vis, Rosenkildevej 88 B, DK-4200 Slagelse, Denmark.	pesma@slagelse.dk		Smaakjaer, Peter/0000-0002-0861-4010; Rasmussen, Rune/0000-0002-5630-122X	Center for Special Education (CSU), Slagelse, Denmark	The study has been supported by the Center for Special Education (CSU), Slagelse, Denmark.	Barnett BP, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0329-y; Barrett BT, 2009, OPHTHAL PHYSL OPT, V29, P4, DOI 10.1111/j.1475-1313.2008.00607.x; Bruner E, 2018, INTERDISC EVOL RES, V5, P299, DOI 10.1007/978-3-319-93776-2_19; Calabrese V, 2000, J NEUROSCI RES, V60, P613, DOI 10.1002/(SICI)1097-4547(20000601)60:5<613::AID-JNR6>3.0.CO;2-8; Capo-Aponte JE, 2017, OPTOMETRY VISION SCI, V94, P7, DOI 10.1097/OPX.0000000000000825; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Conrad JS, 2017, OPTOMETRY VISION SCI, V94, P101, DOI 10.1097/OPX.0000000000000937; COOPER J, 1992, OPTOMETRY VISION SCI, V69, P300, DOI 10.1097/00006324-199204000-00008; Cooper Jeffrey, 2012, Optometry, V83, P137; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; D'Amico R, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10060898; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Galili SF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017735; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Groffman S., 1966, J AM OPTOM ASSOC, V37, P139; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Johansson J, 2017, CLIN EXP OPTOM, V100, P234, DOI 10.1111/cxo.12458; Law M, 1990, Can J Occup Ther, V57, P82; Lee KH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197152; Lin Jin-Mann S, 2009, Popul Health Metr, V7, P18, DOI 10.1186/1478-7954-7-18; Luu Chi D, 2003, Strabismus, V11, P109, DOI 10.1076/stra.11.2.109.15105; Maples W C, 2002, Optometry, V73, P492; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Merezhinskaya, 2019, OPTOMETRY VISION SCI, V96, P1; Nabie R, 2019, J OPHTHAL VIS RES, V14, P48, DOI 10.4103/jovr.jovr_189_17; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Padula WV, 1996, NEUROREHABILITATION, V6, P165, DOI 10.3233/NRE-1996-6302; Paulus JK, 2014, RES SYNTH METHODS, V5, P152, DOI 10.1002/jrsm.1101; Permenter CM., 2021, POSTCONCUSSIVE SYNDR; Pinner M., 2003, KONSENSUSRAPPORT COM; RON S, 1978, SCAND J REHABIL MED, V10, P39; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Staab JP, 2014, CURR OPIN NEUROL, V27, P118, DOI 10.1097/WCO.0000000000000055; Thiagarajan P, 2014, J REHABIL RES DEV, V51, P175, DOI 10.1682/JRRD.2013.01.0027; Thiagarajan P, 2014, NEUROREHABILITATION, V34, P129, DOI 10.3233/NRE-131025; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235	40	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.												10.1080/01616412.2021.2000825		NOV 2021	7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WY4II	WOS:000719241700001	34781837				2022-02-06	
J	van Wessem, KJP; Jochems, D; Leenen, LPH				van Wessem, Karlijn J. P.; Jochems, Denise; Leenen, Luke P. H.			The effect of prehospital tranexamic acid on outcome in polytrauma patients with associated severe brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Tranexamic acid; Polytrauma; TBI; Morbidity; Mortality	HEMORRHAGE	Introduction Tranexamic acid (TXA) has shown to be beneficial in selected patients with hemorrhagic shock. Recently, TXA has gained interest in isolated traumatic brain injury (TBI) patients with variable results. There are limited data on TXA in polytrauma with associated TBI. This study investigated the role of TXA in severely injured patients with associated severe TBI. Methods A 7.5-year prospective cohort study was performed to investigate the relation between prehospital TXA and mortality in consecutive trauma patients with associated severe TBI (Abbreviated Injury Scale (AIS)head >= 3) admitted to a Level-1 Trauma Center ICU. Indication for prehospital TXA administration was (suspicion of) hemorrhagic shock, and/or systolic blood pressure (SBP) <= 90 mmHg. Demographics, data on physiology, resuscitation, and outcomes were prospectively collected. Results Two hundred thirty-four patients (67% males) with median age of 49 years and ISS 33 (98% blunt injuries) were included. Thirteen patients (6%) developed thromboembolic complications; mortality rate was 24%. Fifty-one percent of patients received prehospital TXA. TXA patients were younger, had more deranged physiology on arrival, and received more crystalloids and blood products <= 24 h. There was, however, no difference in overall outcome between TXA patients and no-TXA patients. Conclusions Despite having a more deranged physiology TXA patients had similar outcome compared to no-TXA patients who were much older. Thromboembolic complication rate was low. Prehospital tranexamic acid has no evident effect on outcome in polytrauma patients with associated critical brain injury.	[van Wessem, Karlijn J. P.; Jochems, Denise; Leenen, Luke P. H.] Univ Med Ctr Utrecht, Dept Trauma Surg, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands		van Wessem, KJP (corresponding author), Univ Med Ctr Utrecht, Dept Trauma Surg, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	kwessem@umcutrecht.nl; D.Jochems-2@umcutrecht.nl; L.P.H.Leenen@umcutrecht.nl		van Wessem, Karlijn/0000-0002-1166-0990; Leenen, Luke/0000-0001-8385-1801			[Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Beks RB, 2019, J TRAUMA ACUTE CARE, V87, P730, DOI 10.1097/TA.0000000000002347; Bossers SM, 2021, JAMA NEUROL, V78, P338, DOI 10.1001/jamaneurol.2020.4596; Brenner A, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03243-4; Gunning AC, 2015, WORLD J SURG, V39, P2677, DOI 10.1007/s00268-015-3162-x; Jochems D, 2018, INJURY, V49, P1661, DOI 10.1016/j.injury.2018.05.012; King KL, 2021, WORLD J SURG, V45, P3031, DOI 10.1007/s00268-021-06253-7; Lawati KA, 2021, INTENS CARE MED, V47, P14, DOI 10.1007/s00134-020-06279-w; Mojallal Fatemeh, 2020, Med J Islam Repub Iran, V34, P107, DOI 10.34171/mjiri.34.107; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Ramirez RJ, 2017, CRIT CARE CLIN, V33, P85, DOI 10.1016/j.ccc.2016.08.004; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Rowell SE, 2020, JAMA-J AM MED ASSOC, V324, P961, DOI 10.1001/jama.2020.8958; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; van Wessem KJP, 2021, WORLD J SURG, V45, P2398, DOI 10.1007/s00268-021-06143-y; Volovici V, 2021, NEUROSURGERY, V88, pE484, DOI 10.1093/neuros/nyab034; Yokobori S, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00460-5; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	20	0	0	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-021-01827-5		NOV 2021	11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	WW9LD	WOS:000718227800001	34775510	Bronze, Green Published			2022-02-06	
J	Fan, LW; Xu, HZ; Su, JP; Qin, J; Gao, K; Ou, M; Peng, S; Shen, H; Li, N				Fan, Liangwei; Xu, Huaze; Su, Jianpo; Qin, Jian; Gao, Kai; Ou, Min; Peng, Song; Shen, Hui; Li, Na			Discriminating mild traumatic brain injury using sparse dictionary learning of functional network dynamics	BRAIN AND BEHAVIOR			English	Article						dynamic functional connectivity; functional brain network; mild traumatic brain injury; sliding window analysis; sparse representation	DEFAULT-MODE NETWORK; CONNECTIVITY ANALYSIS; TIME; MRI; INDIVIDUALS; DISRUPTION; PREDICTION; FMRI	Mild traumatic brain injury (mTBI) is usually caused by a bump, blow, or jolt to the head or penetrating head injury, and carries the risk of inducing cognitive disorders. However, identifying the biomarkers for the diagnosis of mTBI is challenging as evident abnormalities in brain anatomy are rarely found in patients with mTBI. In this study, we tested whether the alteration of functional network dynamics could be used as potential biomarkers to better diagnose mTBI. We propose a sparse dictionary learning framework to delineate spontaneous fluctuation of functional connectivity into the subject-specific time-varying evolution of a set of overlapping group-level sparse connectivity components (SCCs) based on the resting-state functional magnetic resonance imaging (fMRI) data from 31 mTBI patients in the early acute phase (<3 days postinjury) and 31 healthy controls (HCs). The identified SCCs were consistently distributed in the cohort of subjects without significant inter-group differences in connectivity patterns. Nevertheless, subject-specific temporal expression of these SCCs could be used to discriminate patients with mTBI from HCs with a classification accuracy of 74.2% (specificity 64.5% and sensitivity 83.9%) using leave-one-out cross-validation. Taken together, our findings indicate neuroimaging biomarkers for mTBI individual diagnosis based on the temporal expression of SCCs underlying time-resolved functional connectivity.	[Fan, Liangwei; Xu, Huaze; Su, Jianpo; Qin, Jian; Gao, Kai; Ou, Min; Shen, Hui] Natl Univ Def Technol, Coll Intelligence Sci & Technol, Changsha 410073, Hunan, Peoples R China; [Peng, Song; Li, Na] Cent South Univ, Xiangya Hosp 3, Radiol Dept, Changsha 410073, Hunan, Peoples R China		Shen, H (corresponding author), Natl Univ Def Technol, Coll Intelligence Sci & Technol, Changsha 410073, Hunan, Peoples R China.; Li, N (corresponding author), Cent South Univ, Xiangya Hosp 3, Radiol Dept, Changsha 410073, Hunan, Peoples R China.	shenhui@nudt.edu.cn; lina2864@foxmail.com		Fan, Liangwei/0000-0002-0874-3947	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61773391, 62036013]; Hunan Innovative Province Construction Special Project [2020SK2097]	National Natural Science Foundation of China, Grant/Award Numbers: 61773391, 62036013; Hunan Innovative Province Construction Special Project, Grant/AwardNumber: 2020SK2097	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coalson DL, 2010, PRACT RESOUR MENT, P3, DOI 10.1016/B978-0-12-375035-8.10001-1; Damaraju E, 2014, NEUROIMAGE-CLIN, V5, P298, DOI 10.1016/j.nicl.2014.07.003; Das JP, 2015, COGNITION, INTELLIGENCE, AND ACHIEVEMENT: A TRIBUTE TO J. P. DAS, P19; Daubechies I, 2009, P NATL ACAD SCI USA, V106, P10415, DOI 10.1073/pnas.0903525106; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Demakis GJ, 2001, J CLIN PSYCHOL, V57, P387, DOI 10.1002/jclp.1020; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Gursel T, 2008, GAZI MED J, V19, P93; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kaza E, 2011, J MAGN RESON IMAGING, V34, P173, DOI 10.1002/jmri.22614; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lee K, 2011, IEEE T MED IMAGING, V30, P1076, DOI 10.1109/TMI.2010.2097275; Leonardi N, 2015, NEUROIMAGE, V104, P430, DOI 10.1016/j.neuroimage.2014.09.007; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Liu J, 2018, HUM BRAIN MAPP, V39, P902, DOI 10.1002/hbm.23890; Lv JL, 2015, MED IMAGE ANAL, V20, P112, DOI 10.1016/j.media.2014.10.011; Madhavan R, 2019, J NEUROTRAUM, V36, P650, DOI 10.1089/neu.2018.5739; Mairal J, 2010, J MACH LEARN RES, V11, P19; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCrea M., 2008, MILD TRAUMATIC BRAIN; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Palacios EM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6892; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; Qin J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00418; Qin J, 2015, NEUROREPORT, V26, P675, DOI 10.1097/WNR.0000000000000407; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Shen H, 2017, HUM BRAIN MAPP, V38, P4671, DOI 10.1002/hbm.23693; Shen H, 2016, NEUROIMAGE, V124, P367, DOI 10.1016/j.neuroimage.2015.09.010; Shi J, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.639760; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Su JP, 2016, NEUROREPORT, V27, P843, DOI 10.1097/WNR.0000000000000622; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Thompson GJ, 2013, HUM BRAIN MAPP, V34, P3280, DOI 10.1002/hbm.22140; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Xu HZ, 2018, NEUROIMAGE, V173, P127, DOI 10.1016/j.neuroimage.2018.02.036; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	59	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	DEC	2021	11	12							e2414	10.1002/brb3.2414		NOV 2021	12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	XO3CM	WOS:000718058100001	34775693	Green Published, gold			2022-02-06	
J	Jonsdottir, MK; Kristofersdottir, KH; Runolfsdottir, S; Kristensen, ISU; Sigurjonsdottir, HA; Claessen, LOE; Kristjansdottir, H				Jonsdottir, Maria K.; Kristofersdottir, Kristin Hulda; Runolfsdottir, Silja; Kristensen, Ingunn S. U.; Sigurjonsdottir, Helga A.; Claessen, Lara Osk Eggertsdottir; Kristjansdottir, Hafrun			Concussion among female athletes in Iceland: Stress, depression, anxiety, and quality of life	NORDIC PSYCHOLOGY			English	Article; Early Access						concussion; athletes; stress; depression; anxiety; quality of life	SPORT-RELATED CONCUSSION; RECURRENT CONCUSSION; RISK; DISORDER; DIAGNOSIS; INCREASES; PROFILE; PHQ-9	The objective of the study was to examine the relationship between self-reported concussion history and stress, depression, anxiety, and quality of life among Icelandic female athletes. Participants were 508 Icelandic female athletes, aged 18-45 (M = 26.99, SD = 7.14), that had, or were currently training and competing in the two top leagues in basketball, soccer, and handball, in the top league in ice-hockey and national tournaments in mixed martial arts, taekwondo, karate, and boxing. Participants completed an online questionnaire regarding their age, sport, and concussion history before answering standard mental health scales concerning stress (PSS), depression (PHQ-9), anxiety (GAD-7), and quality of life (QOLS). Female athletes reporting a history of concussions scored higher on PSS, PHQ-9, and GAD-7 than those reporting no history of concussion. Scores on the QOLS were not significantly different between the groups. Female athletes that had sustained a concussion were 3.48 to 4.85 times more likely (depending on the number of concussions) to score above the clinical cut-off on PHQ-9 than those that had not sustained a concussion. Athletes that reported 2-3 or >= 4 concussions were 3.52 and 3.40 times more likely to score above the clinical cut-off on GAD-7, respectively. Results indicate that Icelandic female athletes with a history of concussion report more symptoms of distress than those with no history of concussion, and the higher number of concussions sustained, the worse they feel.	[Jonsdottir, Maria K.; Runolfsdottir, Silja; Kristensen, Ingunn S. U.] Reykjavik Univ, Sch Social Sci, Dept Psychol, Reykjavik, Iceland; [Jonsdottir, Maria K.; Sigurjonsdottir, Helga A.] Landspitali Natl Univ Hosp Iceland, Reykjavik, Iceland; [Kristofersdottir, Kristin Hulda] Univ Iceland, Sch Hlth Sci, Dept Psychol, Reykjavik, Iceland; [Sigurjonsdottir, Helga A.; Claessen, Lara Osk Eggertsdottir] Univ Iceland, Fac Med, Sch Hlth Sci, Reykjavik, Iceland; [Claessen, Lara Osk Eggertsdottir] Hamraborg Primary Hlth Care Ctr, Kopavogur, Iceland; [Kristjansdottir, Hafrun] Reykjavik Univ, Phys Act Phys Educ Sport & Hlth PAPESH Res Ctr, Sports Sci Dept, Sch Social Sci, Reykjavik, Iceland		Kristjansdottir, H (corresponding author), Reykjavik Univ, Dept Sports Sci, Menntavegur 1, IS-102 Reykjavik, Iceland.	hafrunkr@ru.is		Jonsdottir, Maria K./0000-0003-0383-007X			Benson B., 2018, SPORT RELATED CONCUS; Burckhardt Carol S, 2003, Health Qual Life Outcomes, V1, P60, DOI 10.1186/1477-7525-1-60; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Farace E, 2000, Neurosurg Focus, V8, pe6; Field A, 2013, DISCOVERING STAT USI; Filbay S, 2019, SPORTS MED, V49, P1723, DOI 10.1007/s40279-019-01163-0; Gahagan J, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0144-4; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P443, DOI 10.1080/00913847.2017.1376572; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Helmich I, 2018, J SPORT MED PHYS FIT, V58, P172, DOI 10.23736/S0022-4707.16.06677-9; Herring S, 2021, BRIT J SPORT MED, V55, P1251, DOI 10.1136/bjsports-2021-104235; Hofmeijer-Sevink MK, 2012, J AFFECT DISORDERS, V137, P106, DOI 10.1016/j.jad.2011.12.008; Hrafnsson O.V., 2007, THESIS U ICELAND; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Hutchison MG, 2018, INT J PSYCHOPHYSIOL, V132, P55, DOI 10.1016/j.ijpsycho.2017.11.006; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Ingolfsdottir R., 2014, THESIS REYKJAVIK U; Institute of Medicine and National Research Council, 2014, SPORTS RELATED CONCU, DOI [https://doi.org/10.17226/18377, DOI 10.17226/18377, 10.17226/18377]; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Kristjansdottir H, 2020, CLIN NEUROPSYCHOL, V34, P70, DOI 10.1080/13854046.2020.1814873; Kristjansdottir H, 2019, BEHAV COGN PSYCHOTH, V47, P1, DOI 10.1017/S1352465818000450; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGroarty NK, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120932306; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Palsdottir V.E., 2007, THESIS U ICELAND; Purcell R, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0220-1; Reardon CL, 2020, BRIT J SPORT MED, V54, P49, DOI 10.1136/bjsports-2019-101087; Resch JE, 2017, CLIN SPORT MED, V36, P717, DOI 10.1016/j.csm.2017.05.002; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Skidmore ST, 2013, BEHAV RES METHODS, V45, P536, DOI 10.3758/s13428-012-0257-2; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Strohle A, 2019, EUR ARCH PSY CLIN N, V269, P485, DOI 10.1007/s00406-018-0891-5; Taehtinen R.E., 2018, J CLIN SPORT PSYCHOL, V13, P134, DOI [10.1123/jcsp.2017-0028, DOI 10.1123/JCSP.2017-0028]; Todd R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192125; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02	50	0	0	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1901-2276	1904-0016		NORD PSYCHOL	Nord. Psychol.												10.1080/19012276.2021.2004916		NOV 2021	17	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	XD5QH	WOS:000722762800001					2022-02-06	
J	Simpson, S; Furlong, M; Giebel, C				Simpson, Suzanne; Furlong, Moira; Giebel, Clarissa			Exploring the enablers and barriers to social prescribing for people living with long-term neurological conditions: a focus group investigation	BMC HEALTH SERVICES RESEARCH			English	Article						Neurological conditions; Social prescribing; Enablers; Barriers; Link workers; Wellbeing; Occupational therapy	TRAUMATIC BRAIN; MULTIPLE-SCLEROSIS; PEER SUPPORT; CARE; OUTCOMES; STIGMA; INJURY; INTERVENTIONS; THERAPY; SERVICE	Background People living with Long Term Neurological Conditions (LTNCs) value peer support and social activities. Psychological support and wellbeing enables them to manage their condition. Social prescribing is a formal process of referring patients to a link worker to co-design a plan to improve their health and wellbeing. Intervention involves supporting participation in activities based within the individual's local community. This study aimed to explore the barriers and enablers to accessing social prescribing for people living with LTNCs (plwLTNCs). Methods A total of four focus groups were carried out with 17 participants, including different neurological conditions such as multiple sclerosis, Fragile X Syndrome, epilepsy, and traumatic brain injury. Two participants were family carers and supported people living with epilepsy and motor neurone disease. Findings were analysed using thematic analysis. Results Five themes were identified: (1) Lack of knowledge; (2) Service provision difficulties; (3) Benefits of social prescribing activities; (4) Physical barriers and (5) Psychological barriers. There was a lack of knowledge about social prescribing and what it actually was. Participants anticipated service provision difficulties relating to funding, link workers need for knowledge of LTNC's and for activities to be varied and individualised. The potential benefits of social prescribing activities were recognised across the groups especially its potential to tackle loneliness and to offer plwLTNC's purpose. Participants highlighted a number of physical barriers such as transport and accessibility; and psychological barriers such as anxiety and stigma. Conclusion Social prescribing aims to address the health inequalities of those living with long-term conditions, however currently it is likely to exclude plwLTNCs. Recommendations for practice and future research are made.	[Simpson, Suzanne] Walton Ctr NHS Fdn Trust, Lower Lane, Liverpool L9 7LJ, Merseyside, England; [Simpson, Suzanne; Furlong, Moira; Giebel, Clarissa] NIHR ARC NWC, Liverpool, Merseyside, England; [Furlong, Moira] MND Assoc, Northampton, England; [Giebel, Clarissa] Univ Liverpool, Dept Primary Care & Mental Hlth, Liverpool, Merseyside, England		Simpson, S (corresponding author), Walton Ctr NHS Fdn Trust, Lower Lane, Liverpool L9 7LJ, Merseyside, England.; Simpson, S (corresponding author), NIHR ARC NWC, Liverpool, Merseyside, England.	suzanne.simpson12@nhs.net			Brain Charity	Thank you to all the plwLTNCs and family carers who participated in this study. Thank you to The Brain Charity for advertising and hosting the focus groups. Thank you to The Walton Centre medical secretary's Lisa Fletcher and Nicola Preston for transcribing the recordings. The author would like to dedicate this paper to her father Frank Rawlinson who passed away on the 12th December 2020 with Advanced Dementia.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Association of British Neurologists, 2020, GUID COVID 19 PEOPL; Bay E, 2019, J PSYCHOSOC NURS MEN, V57, P26, DOI 10.3928/02793695-20180924-03; Berg J, 2019, SOC SCI-BASEL, V8, DOI 10.3390/socsci8020058; Bertotti M, 2018, PRIM HEALTH CARE RES, V19, P232, DOI 10.1017/S1463423617000706; Bickerdike L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013384; Bowe M, 2020, EUR J SOC PSYCHOL, V50, P1523, DOI 10.1002/ejsp.2706; Brandling J, 2009, BRIT J GEN PRACT, V59, P454, DOI 10.3399/bjgp09X421085; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cader Z, 2016, TRANSFORMING COMMUNI; Changing Places UK, 2020, CHANG PLAC PRACT GUI; Cook L., 2013, DEMENTIA 2013 HIDDEN; Dam SL, 2020, INT J THER REHABIL, V27, DOI 10.12968/ijtr.2016.0049; Department of Health, 2005, NAT SERV FRAM LONG T; Dunbar W, 2020, INT J STD AIDS, V31, P712, DOI 10.1177/0956462420924984; Evans SC, 2019, DEMENTIA-LONDON, V18, P1181, DOI 10.1177/1471301217710531; George DR, 2011, AM J GERIAT PSYCHIAT, V19, P392, DOI 10.1097/JGP.0b013e3181f17f20; Giebel C, 2021, AGING MENT HEALTH, V25, P1281, DOI 10.1080/13607863.2020.1822292; Gonzalez MT, 2014, J CLIN NURS, V23, P2698, DOI 10.1111/jocn.12388; Government Office for Science, 2008, FORESIGHT MENTAL CAP; Hall J, 2018, DEMENTIA-LONDON, V17, P611, DOI 10.1177/1471301216643847; Her Majesty's Government, 2018, STRATEGY TACKLING LO CONN SOC STRAT TACKL; Holding E, 2020, HEALTH SOC CARE COMM, V28, P1535, DOI 10.1111/hsc.12976; Husk K, 2020, HEALTH SOC CARE COMM, V28, P309, DOI 10.1111/hsc.12839; Jackson K, 2019, DISABIL REHABIL, V41, P2731, DOI 10.1080/09638288.2018.1473508; Jacoby A, 2005, LANCET NEUROL, V4, P171, DOI 10.1016/S1474-4422(05)01014-8; Jones D., 2021, LESSONS LOCKDOWN CON; Julian LJ, 2008, J NEUROL, V255, P1354, DOI 10.1007/s00415-008-0910-y; Kilgarriff-Foster A, 2015, J PUBLIC MENT HEALTH, V14, P127, DOI 10.1108/JPMH-06-2014-0027; Locock L, 2010, SOC SCI MED, V71, P1498, DOI 10.1016/j.socscimed.2010.06.043; Mental Health Foundation, 2012, DEV PEER SUPP LONG T; Michels K, 2018, COMPLEMENT THER MED, V40, P248, DOI 10.1016/j.ctim.2018.07.005; Mihaila I, 2020, J APPL RES INTELLECT, V33, P865, DOI 10.1111/jar.12706; Morris-Bankole H, 2021, NEUROL THER, V10, P279, DOI 10.1007/s40120-021-00241-8; National Health Service, 2019, NHS LONG TERM PLAN; National Health Service, 2019, UN PERS CAR IMPL COM; National Institute for Health and Care Excellence (NICE), 2008, MENT WELLB 65S OCC T; Neurological Alliance, 2018, LONG TERM PLAN NHS G; Neurological Alliance, 2017, PAR EST PEOPL AFF NE; Neurological Alliance, 2019, NEUR NUMB 2019; Ng L, 2011, INT J THER REHABIL, V18, P429, DOI 10.12968/ijtr.2011.18.8.429; NHS England, 2020, UPD GP CONTR AGR 202; NHS England, 2019, SOC PRESCR COMM BAS; NHS RightCare, 2019, RIGHTCARE PROGR NEUR; Ni M, 2016, COMPLEMENT THER MED, V25, P126, DOI 10.1016/j.ctim.2016.01.007; Olsson A, 2013, AGING MENT HEALTH, V17, P793, DOI 10.1080/13607863.2013.801065; Polley M, 2017, MAKING SENSE SOCIAL; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Relyea-Chew A, 2009, ARCH PHYS MED REHAB, V90, P413, DOI 10.1016/j.apmr.2008.07.031; Royal College of General Practitioners, 2018, SPOTL 10 HIGH IMP AC; Royal College of Occupational Therapists, 2019, MAK PERS CAR REAL RO; Royal College of Psychiatrists, 2021, POS STAT PS01 21 SOC; Royal Society of Public Health, 2019, DRIV FORW SOC PRESCR; Ryan J, 2019, TRAVEL BEHAV SOC, V14, P107, DOI 10.1016/j.tbs.2018.10.003; Salas CE, 2018, NEUROPSYCHOL REHABIL, V28, P1161, DOI 10.1080/09602011.2016.1247730; Shanahan J, 2017, J PARKINSONISM RESTL, V7, P43, DOI 10.2147/JPRLS.S125387; Sharma Neena K, 2015, Int J Yoga, V8, P74, DOI 10.4103/0973-6131.146070; Siette J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014304; Simpson R, 2019, J NEUROL NEUROSUR PS, V90, P1051, DOI 10.1136/jnnp-2018-320165; Simpson S, 2020, HEALTH SOC CARE COMM, V28, P2282, DOI 10.1111/hsc.13049; Skivington K, 2018, BRIT J GEN PRACT, V68, pE487, DOI 10.3399/bjgp18X696617; Smith-Carriers TA, 2021, DEMENTIA-LONDON, V20, P130, DOI 10.1177/1471301219869121; Social Care Institute for Excellence, 2020, ROL PRINC REABL; South J., 2008, PRIM HEALTH CARE RES, V9, DOI [10.1017/S146342360800087X, DOI 10.1017/S146342360800087X, DOI 10.1017/S1463.42360800087X]; Spitzer E, 2018, CLIN PSYCHOL-UK, V22, P182, DOI 10.1111/cp.12108; Stroke Association, 2020, STROK REC RISK COVID; The King's Fund, 2017, WHAT IS SOC PRESCR; Thew M, 2017, BRIT J OCCUP THER, V80, P523, DOI 10.1177/0308022617700905; Thornicroft G, 2016, LANCET, V387, P1123, DOI 10.1016/S0140-6736(15)00298-6; Turner M., 2005, USER CONTROLLED RES; van der Steen JT, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003477.pub4; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Victor CR., 2018, OVERVIEW REV EFFECTI; Wakefield JRH, 2022, J HEALTH PSYCHOL, V27, P386, DOI 10.1177/1359105320944991; Watts G, 2020, LANCET DIGIT HEALTH, V2, pE395, DOI 10.1016/S2589-7500(20)30169-2; Wildman JM, 2019, HEALTH SOC CARE COMM, V27, P991, DOI 10.1111/hsc.12716; Windle G, 2018, INT PSYCHOGERIATR, V30, P409, DOI 10.1017/S1041610217002162; Woodall J, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3437-7; World Health Organization, 2010, ACT SOC DET HLTH LEA; Young CA, 2019, AMYOTROPH LAT SCL FR, V20, P317, DOI 10.1080/21678421.2019.1615951	80	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6963		BMC HEALTH SERV RES	BMC Health Serv. Res.	NOV 13	2021	21	1							1230	10.1186/s12913-021-07213-6			14	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	WW7MU	WOS:000718096600001	34774034	Green Submitted, gold, Green Published			2022-02-06	
J	Walton, SR; Kerr, ZY; Mannix, R; Brett, BL; Chandran, A; DeFreese, JD; McCrea, MA; Guskiewicz, KM; Meehan, WP; Echemendia, RJ				Walton, Samuel R.; Kerr, Zachary Y.; Mannix, Rebekah; Brett, Benjamin L.; Chandran, Avinash; DeFreese, Jonathan D.; McCrea, Michael A.; Guskiewicz, Kevin M.; Meehan, William P., III; Echemendia, Ruben J.			Subjective Concerns Regarding the Effects of Sport-Related Concussion on Long-Term Brain Health among Former NFL Players: An NFL-LONG Study	SPORTS MEDICINE			English	Article; Early Access							LIFE COGNITIVE IMPAIRMENT; FOOTBALL PLAYERS; MENTAL-HEALTH; RECURRENT CONCUSSION; 1ST EXPOSURE; HISTORY; ASSOCIATION; DEPRESSION; SYMPTOMS; MEMORY	Background Potential links between a history of sport-related concussions and later-life neurobiological and psychological brain health have been studied in former collision-sport athletes. However, empirical studies of how former athletes perceive the future of their brain health as a result of these injuries are missing. Objectives We aimed to (1) identify the extent to which former National Football League players currently have concerns about their long-term psychological and cognitive functioning as a result of concussions sustained while playing football; (2) examine whether current concerns are different than concerns they had while playing football; (3) examine the relationship between current brain health concerns and self-reported concussion history (SR-CHx); and (4) explore other important factors associated with these concerns. Methods In this cross-sectional study, former National Football League players with a SR-CHx of one or more concussions (n = 1514; aged mean [standard deviation] = 52.3 [15.7] years) completed a general health questionnaire. Participants reported their lifetime concussion history, as well as both their current concerns and concerns while playing football (i.e., retrospective concerns) regarding the long-term effects of concussions on their memory, thinking skills, and risk of developing chronic traumatic encephalopathy. Current and retrospective concerns were self-reported on a five-point Likert scale. Four concussion history categories were created based on SR-CHx: 1-2 (n = 309); 3-5 (n = 413); 6-9 (n = 356); and 10 + (n = 436) lifetime concussions. Proportions of participants reporting each level of current and retrospective concerns were examined to identify whether concerns presently exist in these former players, and whether their current concerns are different than retrospective concerns. Next, we explored associations between current concerns and SR-CHx. Results More than one-third of participants reported being currently "extremely concerned" about memory problems (36.9%), thinking skills (37.8%), and developing chronic traumatic encephalopathy (39.5%). In contrast, when asked about concerns while playing, most reported being "not at all concerned" regarding memory = 61.2%, thinking skills = 56.1%, and developing chronic traumatic encephalopathy = 71.2%. Of those who retrospectively endorsed being "not at all" or "slightly" concerned regarding memory (n = 1159/1514), thinking skills (n = 1080/1514), and developing chronic traumatic encephalopathy (n = 1219/1514), approximately half reported being currently "moderately" or "extremely" concerned about those same issues (n = 586/1159; n = 534/1080; n = 619/1219, respectively). Current concerns regarding memory (chi(2)(16) = 316.61; p < 0.001; V = 0.264), thinking skills (chi(2)(16) = 333.17; p < 0.001; V = 0.271), and developing chronic traumatic encephalopathy (chi(2)(16) = 280.85; p < 0.001; V = 0.249) were significantly related to SR-CHx, with more concussions being associated with greater current concerns. Conclusions Former National Football League players reported significant concerns regarding the potential effects of their prior concussions on long-term brain health, and these concerns are more prevalent now than when they were playing football. Cognitive and mental health concerns are readily identifiable targets for clinical intervention. Clinicians working with former players may wish to explore the extent to which individual players experience these concerns, the nature and depth of these concerns, and the impact of these concerns on the player's functioning and well-being.	[Walton, Samuel R.; Kerr, Zachary Y.; Chandran, Avinash; DeFreese, Jonathan D.; Guskiewicz, Kevin M.] Univ N Carolina, Ctr Study Retired Athletes, Chapel Hill, NC 27515 USA; [Mannix, Rebekah] Harvard Med Sch, Pediat & Emergency Med, Boston, MA 02115 USA; [Brett, Benjamin L.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Waltham, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat & Orthoped, Boston, MA 02115 USA; [Echemendia, Ruben J.] Univ Missouri, Dept Psychol, Kansas City, MO 64110 USA; [Echemendia, Ruben J.] Univ Orthoped Ctr, Concuss Clin, 101 Regent Ct, State Coll, PA 16801 USA		Echemendia, RJ (corresponding author), Univ Missouri, Dept Psychol, Kansas City, MO 64110 USA.; Echemendia, RJ (corresponding author), Univ Orthoped Ctr, Concuss Clin, 101 Regent Ct, State Coll, PA 16801 USA.	rechemendia@comcast.net		Walton, Samuel/0000-0003-2647-5701	National Football League	Funding for this study came from the National Football League. No funding was received for the expressed purpose of writing this paper, and the funding source had no direct involvement or oversight of the preparation of this paper.	Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Baugh CM., 2021, ORTHOP J SPORTS MED, V9, p232596712110011; Brett BL, 2021, J NEUROL NEUROSUR PS, V92, P282, DOI 10.1136/jnnp-2020-324244; Brett BL, 2019, J NEUROPSYCH CLIN N, V31, P17, DOI 10.1176/appi.neuropsych.18040080; Carone DA, 2014, ROLE RAMIFICATIONS M, DOI [10.1093/oxfordhb/9780199896585.001.0001/oxfordhb-9780199896585-e-2, DOI 10.1093/OXFORDHB/9780199896585.001.0001/OXFORDHB-9780199896585-E-2]; Castaldelli-Maia JM, 2019, BRIT J SPORT MED, V53, P707, DOI 10.1136/bjsports-2019-100710; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; Clark MD, 2018, RADIOLOGY, V286, P975, DOI 10.1148/radiol.2017170539; Cramer H., 1946, MATH METHODS STAT; Crumley JJ, 2014, PSYCHOL AGING, V29, P250, DOI 10.1037/a0035908; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM., 2020, KINESIOL REV, V9, P79; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hays RD, 2018, QUAL LIFE RES, V27, P1885, DOI 10.1007/s11136-018-1842-3; Hinton PS, 2011, PHYSICIAN SPORTSMED, V39, P11, DOI 10.3810/psm.2011.09.1916; Kalaf S, 2014, DEADSPIN 0102; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Lai JS, 2014, PSYCHO-ONCOLOGY, V23, P1133, DOI 10.1002/pon.3522; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Nguyen VT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4223; Nicholas SJ, 2007, AM J SPORT MED, V35, P1674, DOI 10.1177/0363546507302219; Roberts AL, 2020, ANN EPIDEMIOL, V51, P48, DOI 10.1016/j.annepidem.2020.07.013; Roberts AL, 2021, J NEUROTRAUM, V38, P189, DOI 10.1089/neu.2020.7070; Rosenblum DJ, 2020, J NEUROTRAUM, V37, P1211, DOI 10.1089/neu.2019.6813; Rosenthal G., 2011, NBCSPORTS 0222; Scheier LM, 2019, J NEUROTRAUM, V36, P408, DOI 10.1089/neu.2017.5465; Smith GE, 1996, PSYCHOL AGING, V11, P272, DOI 10.1037/0882-7974.11.2.272; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Steptoe A, 2015, LANCET, V385, P640, DOI 10.1016/S0140-6736(13)61489-0; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stewart W, 2019, LANCET NEUROL, V18, P231, DOI 10.1016/S1474-4422(19)30020-1; Stillman AM, 2020, J NEUROTRAUM, V37, P305, DOI 10.1089/neu.2018.5925; Todd R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192125; Walton SR, 2021, BRIT J SPORT MED, V55, P683, DOI 10.1136/bjsports-2020-103400; Willer BS, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000421; Willer BS, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000423	45	0	0	4	4	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.												10.1007/s40279-021-01589-5		NOV 2021	15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WW7NU	WOS:000718099200001	34773581				2022-02-06	
J	Gallagher, J; Fine, P; Ashley, P; Needleman, I				Gallagher, Julie; Fine, Peter; Ashley, Paul; Needleman, Ian			Developing the role of the sports dentist	BRITISH DENTAL JOURNAL			English	Article							ORAL-HEALTH; CONSENSUS STATEMENT; ELITE; PERFORMANCE; INJURY; IMPACT	Sports dentistry has traditionally focused on orofacial trauma. There is now increasing evidence that participation in sport, particularly at elite level, may significantly increase the risks to oral health. The negative impact of poor oral health on athlete-reported wellbeing and performance is clear. The risks to athlete oral health can and should be mitigated and the role of the sports dentist is evolving to meet these new challenges. Custom-made mouthguards provide protection against orofacial trauma and potentially, concussion. Oral health screening should be included in athlete pre-season preparation. As integrated members of the athlete support team, dentists and dental care professionals can provide sport-specific oral health advice, encouraging athletes to take ownership of their oral health. The potential for translational health and wellbeing benefits to the wider population is also substantial, particularly with youth groups and recreational athletes. Sports dentistry requires distinctive skills. A UK-wide network of dentists and other oral health professionals with an interest in sport is important, to ensure that both appropriate advice and treatment is evidence-based and to further develop the research and clinical foundations.	[Gallagher, Julie; Ashley, Paul; Needleman, Ian] UCL, Ctr Oral Hlth & Performance, Eastman Dent Inst, Rockefeller Bldg,21 Univ St, London WC1E 6DE, England; [Fine, Peter] UCL, Ctr Continuing Profess Dev, Eastman Dent Inst, London, England		Gallagher, J (corresponding author), UCL, Ctr Oral Hlth & Performance, Eastman Dent Inst, Rockefeller Bldg,21 Univ St, London WC1E 6DE, England.	julie.gallagher@ud.ac.uk		Needleman, Ian/0000-0003-4696-1651; Gallagher, Julie/0000-0003-4891-738X; Ashley, Paul/0000-0003-0312-5311			Allison P, 2020, BRIT J SPORT MED, V54, DOI 10.1136/bjsports-2020-102041; Bartlett D, 2008, CLIN ORAL INVEST, V12, pS65, DOI 10.1007/s00784-007-0181-5; Bergeron MF, 2015, BRIT J SPORT MED, V49, P843, DOI 10.1136/bjsports-2015-094962; British Society of Periodontology, 2016, GOOD PRACT GUID PER; Burke LM, 2019, INT J SPORT NUTR EXE, V29, P73, DOI 10.1123/ijsnem.2019-0065; Burns L, 2019, BRIT J SPORT MED, V53, P818, DOI 10.1136/bjsports-2018-099217; Chisholm DA, 2020, BRIT J SPORT MED, V54, P866, DOI 10.1136/bjsports-2019-101011; Clarsen B, 2013, BRIT J SPORT MED, V47, P495, DOI 10.1136/bjsports-2012-091524; Donaldson A, 2017, INJURY PREV, V23, P273, DOI 10.1136/injuryprev-2015-041737; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Fernandes LM, 2019, DENT TRAUMATOL, V35, P54, DOI 10.1111/edt.12441; Ferreira GB, 2019, INT DENT J, V69, P25, DOI 10.1111/idj.12406; Finch C F, 2016, BMJ OPEN SPORT EXERC, DOI [10.1136/bmjsem-2016-000168, 10.1136/ bmjsem-2016-000168, DOI 10.1136/BMJSEM-2016-000168]; Gallagher J, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2020-000759; Gallagher J, 2019, BRIT DENT J, V227, P276, DOI 10.1038/s41415-019-0617-8; Gallagher J, 2018, COMMUNITY DENT ORAL, V46, P563, DOI 10.1111/cdoe.12392; Gallagher J, 2017, SPORTS MED, V47, P1335, DOI 10.1007/s40279-016-0651-5; Haughey John Patrick, 2020, BMJ Open Sport Exerc Med, V6, pe000886, DOI 10.1136/bmjsem-2020-000886; Ismail AI, 2007, COMMUNITY DENT ORAL, V35, P170, DOI 10.1111/j.1600-0528.2007.00347.x; Jepsen S, 2017, J CLIN PERIODONTOL, V44, pS85, DOI 10.1111/jcpe.12687; Knapik JJ, 2019, SPORTS MED, V49, P1217, DOI 10.1007/s40279-019-01121-w; Ljungqvist A, 2009, BRIT J SPORT MED, V43, P631, DOI 10.1136/bjsm.2009.064394; Needleman I, 2013, BRIT J SPORT MED, V47, P1054, DOI 10.1136/bjsports-2013-092891; Needleman I, 2018, BRIT J SPORT MED, V52, P1483, DOI 10.1136/bjsports-2017-098919; Needleman I, 2016, BRIT J SPORT MED, V50, DOI 10.1136/bjsports-2015-094953; Needleman I, 2015, BRIT J SPORT MED, V49, P3, DOI 10.1136/bjsports-2014-093804; Stamos A, 2020, DENT TRAUMATOL, V36, P680, DOI 10.1111/edt.12593	27	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0007-0610	1476-5373		BRIT DENT J	Br. Dent. J.	NOV 12	2021	231	9					544	546		10.1038/s41415-021-3612-9			3	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	WW5ZG	WOS:000717993700011	34773016	Bronze			2022-02-06	
J	Putri, SNV; Fauzi, AR; Paramita, DK; Dachlan, I; Seswandhana, R				Putri, Sandy Nur Vania; Fauzi, Aditya Rifqi; Paramita, Dewi Kartikawati; Dachlan, Ishandono; Seswandhana, Rosadi			Maxillofacial trauma severity effects in patients with head injury in a tertiary care center in Yogyakarta, Indonesia	EUROPEAN JOURNAL OF PLASTIC SURGERY			English	Article; Early Access						Maxillofacial injuries; Maxillary fractures; Craniocerebral trauma; Intracranial hemorrhages; Glasgow Coma Scale	FACIAL FRACTURES; BRAIN-INJURY; PATTERN	Background Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide. In various combinations, a high frequency of facial bone fractures has been reported. However, the results are still conflicting. Methods We retrospectively reviewed medical records of patients with maxillofacial trauma who were admitted to Dr. Sardjito Hospital, Yogyakarta, Indonesia, between January 2016 and December 2017. Results A total of 70 patients with maxillofacial trauma were involved (57 males and 13 females, 18-65 years). Moreover, most of them were 18-25-year-old males (34.3%). The average patient age was 35.5 +/- 14 years. No significant association was found between the sex and age group of the patient (p = 0.774). Motorcycle accident was the most frequent cause of maxillofacial fractures (84%) with midfacial and multiple maxillofacial fractures being the most frequent types found in patients (40% and 40%, respectively). The most common facial fracture was in the zygomatic bone (28%) and most cases showed mild facial injury (81%). A significant association was found between the Glasgow Coma Scale (GCS) and types of traumatic brain injury (TBI) (p = 0.031). However, when GCS was compared with facial injury, no statistically significant level was reached and its correlation was low (p = 0.267, r = 0.134). Conclusions There was a significant association between types of traumatic brain injury with head injury severity. However, we found no correlation between head injury severity and facial injury severity. To explain and validate our results, further multicenter studies with a larger sample size are required. Level of evidence: Level IV, Risk/Prognostic.	[Putri, Sandy Nur Vania; Fauzi, Aditya Rifqi; Dachlan, Ishandono; Seswandhana, Rosadi] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Surg, Plast Reconstruct & Aesthet Surg Div,Dr Sardjito, Jl Kesehatan 1, Yogyakarta 55281, Indonesia; [Paramita, Dewi Kartikawati] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Histol & Cell Biol, Yogyakarta 55281, Indonesia		Seswandhana, R (corresponding author), Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Surg, Plast Reconstruct & Aesthet Surg Div,Dr Sardjito, Jl Kesehatan 1, Yogyakarta 55281, Indonesia.	rosadi_seswandhana@ugm.ac.id	Seswandhana, Rosadi/AAH-4064-2020; Fauzi, Aditya Rifqi/AAI-8430-2020	Seswandhana, Rosadi/0000-0002-5138-7802; Fauzi, Aditya Rifqi/0000-0002-2081-6141			Abhinav Rajendra Prabhu, 2019, Ann Maxillofac Surg, V9, P114, DOI 10.4103/ams.ams_233_18; Agrawal A., 2009, East and Central African Journal of Surgery, V14, P57; Ariobimo BN., 2021, BIOMOL HLTH SCI J, V4, P1, DOI [10.20473/bhsj.v4i1.26723, DOI 10.20473/BHSJ.V4I1.26723]; Bagheri SC, 2006, J ORAL MAXIL SURG, V64, P408, DOI 10.1016/j.joms.2005.11.013; Bangun K, 2012, JURNAL PLASTIK REKON, V1, P162; Bither S, 2008, DENT TRAUMATOL, V24, P468, DOI 10.1111/j.1600-9657.2008.00606.x; CHANG CJ, 1994, J TRAUMA, V37, P807, DOI 10.1097/00005373-199411000-00017; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Devadiga A., 2008, INTERNET J EPIDEMIOL, V5, P6174; Farzaneh E, 2017, EMERG MED INT, V2017, DOI 10.1155/2017/1439486; GWYN PP, 1971, PLAST RECONSTR SURG, V47, P225, DOI 10.1097/00006534-197103000-00004; Hasnat A., 2017, UPDATE DENT COLL J, V7, P14, DOI [10.3329/updcj.v7i1.33304, DOI 10.3329/UPDCJ.V7I1.33304]; Irawan H., 2010, MAJALAH KEDOKTERAN I, V60, P437; Jayaraju RM., 2014, PANAM J TRAUMA CRIT, V3, P53, DOI [10.5005/jp-journals-10030-1088, DOI 10.5005/JP-JOURNALS-10030-1088]; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Kloss F, 2008, J CRANIO MAXILL SURG, V36, P372, DOI 10.1016/j.jcms.2007.12.002; Kong DY, 2013, HONG KONG J EMERG ME, V20, P204, DOI 10.1177/102490791302000403; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; Manalu EE., 2018, ADAM MALIK MEDAN, V25, P11; Mehta R, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1296; Melek LN., 2016, TANTA DENT J, V13, P28, DOI [10.4103/1687-8574.186943, DOI 10.4103/1687-8574.186943]; Pappachan B, 2012, J MAXILLOFAC ORAL SU, V11, P224, DOI 10.1007/s12663-011-0289-7; Patil Satishkumar G, 2016, Indian J Dent, V7, P116; Rahman Sajjad A, 2014, Dent Res J (Isfahan), V11, P336; Setiadi JA, 2017, BMC SURG, V17, DOI 10.1186/s12893-017-0267-1; Singaram M, 2016, J KOR ASSOC ORAL MAX, V42, P174, DOI 10.5125/jkaoms.2016.42.4.174; Supomo Aryandono T, 2017, J MED SCI, V49, P8; Tana L., 2021, HLTH SCI J INDONES, V12, P56, DOI [10.22435/hsji.v12i1.4655, DOI 10.22435/HSJI.V12I1.4655]; Tangkudung E, P E ASIA SOC TRANSPO, V7, P410; Tanuhendrata A, 2016, JURNAL BIOMEDIK, V8; Waghmode AH., 2017, INDIAN J FORENS COMM, V4, P221; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Wazir, 2016, PAK ORAL DENT J, V36, P188; Wu G, 2018, WORLD NEUROSURG, V111, pE47, DOI 10.1016/j.wneu.2017.11.166; Yadav SK, 2012, TURK J MED SCI, V42, P1505, DOI 10.3906/sag-1202-63; Yamamoto K, 2013, CRANIOMAX TRAUM REC, V6, P37, DOI 10.1055/s-0033-1333881	36	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0930-343X	1435-0130		EUR J PLAST SURG	Eur. J. Plast. Surg.												10.1007/s00238-021-01904-3		NOV 2021	6	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	WW5GL	WOS:000717944600003					2022-02-06	
J	Sarkulova, Z; Tokshilykova, A; Khamidulla, A; Utepkaliyeva, A; Ayaganov, D; Sarkulov, M; Tamosuitis, T				Sarkulova, Zhanslu; Tokshilykova, Ainur; Khamidulla, Alima; Utepkaliyeva, Aigul; Ayaganov, Dinmukhamed; Sarkulov, Marat; Tamosuitis, Tomas			Establishing prognostic significance of hypoxia predictors in patients with acute cerebral pathology	NEUROLOGICAL RESEARCH			English	Article; Early Access						Strokes; traumatic brain injuries; neuron-specific markers; diagnostic criteria; prognostic criteria; stroke outcome	TRAUMATIC BRAIN-INJURY	Objectives This research aims to study the prognostic role of serum S100 as a predictor of mortality in vascular and traumatic brain injuries. Methods This prospective cohort study involved 219 patients. In the blood serum, neuron-specific markers (S100, NSE) and glucose, acid-base state and gas composition of arterial blood were obtained at admission, on the 3rd, 5th and 7th days of patients' stay in the intensive care unit. Results The most significant risk factor for an unfavorable outcome is the marker S100 with a cut-off point of 0.2 mcg/l. The analysis results indicate a statistically significant direct relationship between S100 > 0.2 mcg/l and NSE >= 18.9 ng/ml compared to other variables, while the chance ratio (OR) is 11.9 (95%CI:3.2927-1.6693;). With blood sugar increase above 7.4 mmol/l, the OR is 3.82 (95% CI: 2.1289-0.5539;); with a Glasgow scale below 13 points, the OR is 3.69 (95% CI: 2.1316-0.4819;); with an increase in pCO2 < 43.5 mm Hg, the OR was 3.15 (95% CI: 1.8916- 0.4062;). The obtained model certainty measure according to pseudo R2 Nagelkerke criterion is 263.5, showing the excellent quality of the mathematical model's predictive ability. The developed prognostic model, including the dependent variable S100 and independent variables as predictors of a poor outcome of NSE, pCO2, GCS and Hb, reached a cut-off point of 84.51%, AUC - 0.88 with high levels of sensitivity and specificity: 91.89% and 64.14%, respectively. Novelty This model can be used to predict the outcome in patients with acute cerebral pathology.	[Sarkulova, Zhanslu; Tokshilykova, Ainur] West Kazakhstan Marat Ospanov Med Univ, Dept Anesthesiol & Resuscitat, 70 Maresyeva St, Aktobe, Kazakhstan; [Khamidulla, Alima; Utepkaliyeva, Aigul] West Kazakhstan Marat Ospanov Med Univ, Neurol Dept, Aktobe, Kazakhstan; [Ayaganov, Dinmukhamed] West Kazakhstan Marat Ospanov Med Univ, Dept Neurol, Aktobe, Kazakhstan; [Sarkulov, Marat] West Kazakhstan Marat Ospanov Med Univ, Urol Dept, Aktobe, Kazakhstan; [Tamosuitis, Tomas] Lithuanian Univ Hlth Sci, Organ Procurement Program, Dept Intens Care Med,Kaunas Clin, Neurosurg Intens Care Unit,Neurosurg Dept,Hosp Li, Kaunas, Lithuania		Tokshilykova, A (corresponding author), West Kazakhstan Marat Ospanov Med Univ, Dept Anesthesiol & Resuscitat, 70 Maresyeva St, Aktobe, Kazakhstan.	tokshilykova@yandex.ru	; Utepkaliyeva, Aigul/E-3050-2018	Khamidulla, Alima/0000-0002-5007-8151; Utepkaliyeva, Aigul/0000-0002-3230-0433			Abanto C, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.105285; Alcock Susan, 2021, BMJ Open, V11, pe047305, DOI 10.1136/bmjopen-2020-047305; Bajamal AH, 2021, CHIN J TRAUMATOL, V24, P344, DOI 10.1016/j.cjtee.2021.07.005; Bell AH, 2018, NEUROPSYCHOLOGIA, V115, P211, DOI 10.1016/j.neuropsychologia.2017.09.019; Boot E, 2020, J NEUROL NEUROSUR PS, V91, P411, DOI 10.1136/jnnp-2019-322424; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Cash A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093344; Chalos V, 2020, TRIALS, V21, DOI [10.1186/s13063-020-04514-9, 10.1186/s13063-020-04514]; Dulf D, 2021, WORLD NEUROSURG, V146, pE517, DOI 10.1016/j.wneu.2020.10.115; Dumitru I, 2020, ROM J MORPHOL EMBRYO, V61, P729, DOI 10.47162/RJME.61.3.11; Haigh JL, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.580879; Herpich F, 2020, CRIT CARE MED, V48, P1654, DOI 10.1097/CCM.0000000000004597; Kempuraj D, 2021, NEUROTOX RES, V39, P359, DOI 10.1007/s12640-020-00288-9; Koepsell H, 2020, PFLUG ARCH EUR J PHY, V472, P1299, DOI 10.1007/s00424-020-02441-x; Kurtz P, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00190; Lamade AM, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113307; Maegawa Tatsuya, 2021, Surg Neurol Int, V12, P361, DOI 10.25259/SNI_859_2020; Mann O, 2022, J FELINE MED SURG, V24, P91, DOI 10.1177/1098612X211005306; Nelson LD, 2020, J NEUROTRAUM, V37, P675, DOI 10.1089/neu.2019.6719; Nishioka N, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80774-4; Okada Y, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00451-6; Park JS, 2020, J CRIT CARE, V57, P49, DOI 10.1016/j.jcrc.2020.02.001; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Porto I, 2021, INTERN EMERG MED, V16, P463, DOI 10.1007/s11739-020-02459-0; Rochmah TN, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18147552; Roumes H, 2021, J CEREBR BLOOD F MET, V41, P342, DOI 10.1177/0271678X20908355; Sadykov AM., 2013, J NEUROSURG NEUROL K, V2, P28; Sawant-Pokam PA, 2020, J CLIN INVEST, V130, P6005, DOI 10.1172/JCI134793; Sewalt CA, 2021, SCAND J TRAUMA RESUS, V29, DOI 10.1186/s13049-021-00930-1; Sivandzade F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082721; Szenasi A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126624; Tan C, 2021, MICROMACHINES-BASEL, V12, DOI 10.3390/mi12020208; Tokshilykova AB, 2020, J MOL NEUROSCI, V70, P1267, DOI 10.1007/s12031-020-01536-5; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wu X, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.613027; You YH, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000026260; Yuan XF, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95867-x; Zampieri FG, 2020, J CRIT CARE, V59, P94, DOI 10.1016/j.jcrc.2020.05.016; Zhusupova AS., 2011, KAZAKHSTAN, V3, P6	39	0	0	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.												10.1080/01616412.2021.1996981		NOV 2021	9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WV6ID	WOS:000717337500001	34758699				2022-02-06	
J	Yu, YM; Zheng, WH; Tan, XF; Li, XX; Zhang, XT; Gao, J; Pan, G; Wu, D; Luo, BY				Yu, Yamei; Zheng, Weihao; Tan, Xufei; Li, Xiaoxia; Zhang, Xiaotong; Gao, Jian; Pan, Gang; Wu, Dan; Luo, Benyan			Microstructural profiles of thalamus and thalamocortical connectivity in patients with disorder of consciousness	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						7T; disorder of consciousness; fixel-based analysis; microstructure; thalamic nuclei; thalamocortical connectivity	TRAUMATIC BRAIN-INJURY; DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; VEGETATIVE STATE; SPHERICAL-DECONVOLUTION; CINGULATE CORTEX; RESTING-STATE; DIFFUSION; NUCLEI; PAIN	Thalamus and thalamocortical connectivity are crucial for consciousness; however, their microstructural changes in patients with a disorder of consciousness (DOC) have not yet been thoroughly characterized. In the present study, we applied the novel fixel-based analysis to comprehensively investigate the thalamus-related microstructural abnormalities in 10 patients with DOC using 7-T diffusion-weighted imaging data. We found that compared to healthy controls, patients with DOC showed reduced fiber density (FD) and fiber density and cross-section (FDC) in the mediodorsal, anterior, and ventral anterior thalamic nuclei, while fiber-bundle cross-section (FC) was not significantly altered in the thalamus. Impaired thalamocortical connectivity in the DOC cohort was mainly connected to the middle frontal gyrus, anterior cingulate gyrus, fusiform gyrus, and sensorimotor cortices, including the precentral gyrus and postcentral gyrus, with predominant microstructural abnormalities in FD and FDC. Correlation analysis showed that FC of the right mediodorsal thalamus was negatively correlated with the level of consciousness. Our results suggest that microstructural abnormalities of thalamus and thalamocortical connectivity in DOC were mainly attributed to axonal injury. In particular, the microstructural integrity of the thalamus is a vital factor in consciousness generation.	[Yu, Yamei; Li, Xiaoxia; Wu, Dan; Luo, Benyan] Zhejiang Univ, Affiliated Hosp 1, Dept Neurol, Sch Med, Hangzhou 310000, Zhejiang, Peoples R China; [Yu, Yamei; Li, Xiaoxia; Wu, Dan; Luo, Benyan] Zhejiang Univ, Affiliated Hosp 1, Brain Med Ctr, Sch Med, Hangzhou 310000, Zhejiang, Peoples R China; [Zheng, Weihao] Lanzhou Univ, Sch Informat Sci & Egineering, Lanzhou, Peoples R China; [Tan, Xufei] Zhejiang Univ City Coll, Sch Med, Dept Clin Med, Hangzhou, Peoples R China; [Zhang, Xiaotong] Zhejiang Univ, Interdisciplinary Inst Neurosci & Technol, Key Lab Biomed Engn, Minist Educ, Hangzhou, Peoples R China; [Gao, Jian] Hangzhou Ming Zhou Nao Kang Rehabil Hosp, Hangzhou, Peoples R China; [Pan, Gang] Zhejiang Univ, Coll Comp Sci & Technol, Hangzhou, Peoples R China		Wu, D; Luo, BY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Neurol, Sch Med, Hangzhou 310000, Zhejiang, Peoples R China.; Wu, D; Luo, BY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Brain Med Ctr, Sch Med, Hangzhou 310000, Zhejiang, Peoples R China.	danwu.bme@zju.edu.cn; luobenyan@zju.edu.cn		Wu, Dan/0000-0002-9303-5821; Zheng, Weihao/0000-0003-2996-5909	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870817]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2019-XZZX-001-01-02]; China postdoctoral science foundationChina Postdoctoral Science Foundation [2202M671727]; postdoctoral science foundation of Zhejiang Province, ChinaChina Postdoctoral Science Foundation [514000-X81901]	This work was supported by grants from the National Natural Science Foundation of China (81870817) and the Fundamental Research Funds for the Central Universities + 2019-XZZX-001-01-02. W. Z. was additionally supported by the China postdoctoral science foundation (2202M671727, to W. Z.), and the postdoctoral science foundation of Zhejiang Province, China (514000-X81901, to W.Z.).	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Andersson J.L.R., 2010, TR07JA2 FMRIB; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Annen J, 2016, HUM BRAIN MAPP, V37, P3707, DOI 10.1002/hbm.23269; Annen J, 2019, BRAIN INJURY, V33, P1409, DOI 10.1080/02699052.2019.1644376; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Cai M, 2021, NEUROIMAGE-CLIN, V30, DOI 10.1016/j.nicl.2021.102667; Carrera E, 2006, NEUROLOGY, V66, P1817, DOI 10.1212/01.wnl.0000219679.95223.4c; Collin G., 2013, Society for Neuroscience Abstract Viewer and Itinerary Planner, V43, DOI 10.1093/schbul/sbt162; Cui Y, 2018, NEUROIMAGE-CLIN, V20, P260, DOI 10.1016/j.nicl.2018.07.025; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Dresler M, 2017, NEURON, V93, P1227, DOI 10.1016/j.neuron.2017.02.003; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Fernandez-Espejo D, 2010, J NEUROTRAUM, V27, P1187, DOI 10.1089/neu.2010.1297; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Knudson D.V., 2014, COMPREHENSIVE PSYCHO, V3, DOI [10.2466/03.CP.3.1, DOI 10.2466/03.CP.3.1]; Lant ND, 2016, NEUROIMAGE-CLIN, V10, P27, DOI 10.1016/j.nicl.2015.11.004; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2007, CURR OPIN NEUROL, V20, P609, DOI 10.1097/WCO.0b013e3282f1d6dd; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Luo CY, 2015, HUM BRAIN MAPP, V36, P3104, DOI 10.1002/hbm.22831; Lutkenhoff Evan S, 2020, Psychol Med, P1, DOI 10.1017/S003329172000330X; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Lutkenhoff ES, 2013, NEUROIMAGE-CLIN, V3, P396, DOI 10.1016/j.nicl.2013.09.010; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; Monti MM, 2015, NEUROLOGY, V84, P167, DOI 10.1212/WNL.0000000000001123; Naro A, 2015, J PAIN, V16, P1022, DOI 10.1016/j.jpain.2015.06.014; Raffelt D, 2012, MAGN RESON MED, V67, P844, DOI 10.1002/mrm.23058; Raffelt D, 2011, NEUROIMAGE, V56, P1171, DOI 10.1016/j.neuroimage.2011.02.014; Raffelt DA, 2017, NEUROIMAGE, V144, P58, DOI 10.1016/j.neuroimage.2016.09.029; Raffelt DA, 2015, NEUROIMAGE, V117, P40, DOI 10.1016/j.neuroimage.2015.05.039; Rangarajan V, 2014, J NEUROSCI, V34, P12828, DOI 10.1523/JNEUROSCI.0527-14.2014; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith RE, 2013, NEUROIMAGE, V67, P298, DOI 10.1016/j.neuroimage.2012.11.049; Spencer APC, 2021, NEUROIMAGE-CLIN, V30, DOI 10.1016/j.nicl.2021.102582; Stafford CA, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101791; Tolomeo S, 2016, BRAIN, V139, P1844, DOI 10.1093/brain/aww069; Tournier J.D., 2010, P INT SOC MAGNETIC R, P1670; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; van der Eerden AW, 2014, RADIOLOGY, V270, P506, DOI 10.1148/radiol.13122720; van der Kolk AG, 2013, EUR J RADIOL, V82, P708, DOI 10.1016/j.ejrad.2011.07.007; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weng L, 2017, CORTEX, V90, P71, DOI 10.1016/j.cortex.2017.02.011; Yao S, 2015, J NEUROL SCI, V356, P168, DOI 10.1016/j.jns.2015.06.044; Yuk V, 2020, MOL AUTISM, V11, DOI 10.1186/s13229-020-00400-y; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhang Z, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01398-4; Zheng WH, 2020, CEREB CORTEX, V30, P2804, DOI 10.1093/cercor/bhz276; Zheng ZS, 2017, HUM BRAIN MAPP, V38, P431, DOI 10.1002/hbm.23370	78	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	DEC	2021	99	12					3261	3273		10.1002/jnr.24921		NOV 2021	13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XT9OE	WOS:000717546800001	34766648				2022-02-06	
J	Hakiki, B; Grippo, A; Scarpino, M; Liuzzi, P; Mannini, A; Macchi, C; Cecchi, F				Hakiki, Bahia; Grippo, Antonello; Scarpino, Maenia; Liuzzi, Piergiuseppe; Mannini, Andrea; Macchi, Claudio; Cecchi, Francesca			Effects of COVID-19 pandemic on intensive rehabilitation after severe acquired brain injuries	NEUROLOGICAL SCIENCES			English	Article						COVID-19; Severe acquired brain injuries; Disorders of consciousness; Rehabilitation	VALIDATION; DIAGNOSIS; RECOVERY; SCALE	Purpose COVID-19 pandemic has affected most components of health systems including rehabilitation. The study aims to compare demographic and clinical data of patients admitted to an intensive rehabilitation unit (IRU) after severe acquired brain injuries (sABIs), before and during the pandemic. Materials and methods In this observational retrospective study, all patients admitted to the IRU between 2017 and 2020 were included. Demographics were collected, as well as data from the clinical and functional assessment at admission and discharge from the IRU. Patients were grouped in years starting from March 2017, and the 2020/21 cohort was compared to those admitted between March 2017/18, 2018/19, and 2019/20. Lastly, the pooled cohort March 2017 to March 2020 was compared with the COVID-19 year alone. Results This study included 251 patients (F: 96 (38%): median age 68 years [IQR = 19.25], median time post-onset at admission: 42 days, [IQR = 23]). In comparison with the pre-pandemic years, a significant increase of hemorrhagic strokes (p < 0.001) and a decrease of traumatic brain injuries (p = 0.048), a reduction of the number of patients with a prolonged disorder of consciousness admitted to the IRU (p < 0.001) and a lower length of stay (p < 0.001) were observed in 2020/21. Conclusions These differences in the case mix of sABI patients admitted to IRU may be considered another side-effect of the pandemic. Facing this health emergency, rehabilitation specialists need to adapt readily to the changing clinical and functional needs of patients' addressing the IRUs.	[Hakiki, Bahia; Grippo, Antonello; Scarpino, Maenia; Liuzzi, Piergiuseppe; Mannini, Andrea; Macchi, Claudio; Cecchi, Francesca] IRCCS Fdn Don Carlo Gnocchi ONLUS, Via Scandicci 269, I-50143 Florence, Italy; [Macchi, Claudio; Cecchi, Francesca] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Liuzzi, Piergiuseppe; Mannini, Andrea] Scuola Super Sant Anna, Ist Biorobot, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy		Scarpino, M (corresponding author), IRCCS Fdn Don Carlo Gnocchi ONLUS, Via Scandicci 269, I-50143 Florence, Italy.	maeniascarpino@tiscali.it	Liuzzi, Piergiuseppe/AAD-2973-2022; Hakiki, Bahia/AAB-8461-2022; Mannini, Andrea/AAU-9901-2020; Liuzzi, Piergiuseppe/AAD-2038-2022	Hakiki, Bahia/0000-0001-8540-7405; Mannini, Andrea/0000-0003-0760-052X; Liuzzi, Piergiuseppe/0000-0002-6067-474X; Grippo, Antonello/0000-0002-9997-8564	RICERCA CORRENTE 2020 from IRCCS Don Gnocchi	This study was funded by RICERCA CORRENTE 2020 from IRCCS Don Gnocchi.	Baracchini C, 2020, NEUROL SCI, V41, P1003, DOI 10.1007/s10072-020-04375-9; Bartolo M, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00423; Battel I, 2018, FOLIA PHONIATR LOGO, V70, P117, DOI 10.1159/000490792; Carda S, 2020, EUR J PHYS REHAB MED, V56, P515, DOI 10.23736/S1973-9087.20.06317-0; de Sousa DA, 2020, EUR STROKE J, V5, P230, DOI 10.1177/2396987320933746; Estraneo A, 2015, EUR J PHYS REHAB MED, V51, P627; Estraneo A, 2021, J NEUROL, V268, P27, DOI 10.1007/s00415-020-10077-1; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Grippo A, 2020, NEUROL SCI, V41, P2345, DOI 10.1007/s10072-020-04585-1; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; Jasne AS, 2020, STROKE, V51, P2664, DOI 10.1161/STR.0000000000000347; Lazzerini M, 2020, LANCET GLOB HEALTH, V8, pE641, DOI 10.1016/S2214-109X(20)30110-8; Leira EC, 2020, NEUROLOGY, V95, P124, DOI 10.1212/WNL.0000000000009713; Leocani L, 2020, EUR J NEUROL, V27, pE50, DOI 10.1111/ene.14320; Masroor S, 2020, J CARDIAC SURG, V35, P1345, DOI 10.1111/jocs.14638; Munari M, 2021, MINERVA ANESTESIOL, V87, P489, DOI 10.23736/S0375-9393.20.15148-4; Pinggera D, 2021, EUR J TRAUMA EMERG S, V47, P653, DOI 10.1007/s00068-020-01445-7; Scarpino M, 2021, ACTA NEUROL SCAND, V144, P161, DOI 10.1111/ane.13433; Talevi D, 2020, RIV PSICHIATR, V55, P137, DOI 10.1708/3382.33569; Tenforde AS, 2020, AM J PHYS MED REHAB, V99, P977, DOI 10.1097/PHM.0000000000001571; Uchino K, 2020, STROKE, V51, P2544, DOI 10.1161/STROKEAHA.120.030331; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wang CC, 2020, J CHIN MED ASSOC, V83, P822, DOI 10.1097/JCMA.0000000000000376; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Zhao H, 2020, LANCET NEUROL, V19, P383, DOI 10.1016/S1474-4422(20)30109-5	28	0	0	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	FEB	2022	43	2					791	798		10.1007/s10072-021-05709-x		NOV 2021	8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YQ4IP	WOS:000717391100001	34762195	Bronze, Green Published			2022-02-06	
J	Horton, L; Rhodes, J; Menon, DK; Maas, AIR; Wilson, L				Horton, Lindsay; Rhodes, Jonathan; Menon, David K.; Maas, Andrew I. R.; Wilson, Lindsay			Questionnaires vs Interviews for the Assessment of Global Functional Outcomes After Traumatic Brain Injury	JAMA NETWORK OPEN			English	Article							INITIAL CONSERVATIVE TREATMENT; HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; EARLY SURGERY; CENTER-TBI; TRIAL; MULTICENTER; COEFFICIENT; RELIABILITY; AGREEMENT	IMPORTANCE An interview is considered the gold standard method of assessing global functional outcomes in clinical trials among patients with acute traumatic brain injury (TBI). However, several multicenter clinical trials have used questionnaires completed by a patient or caregiver to assess the primary end point. OBJECTIVE To examine agreement between interview and questionnaire formats for assessing TBI outcomes and to consider whether an interview has advantages. DESIGN, SETTING, AND PARTICIPANTS This cohort study used data from patients enrolled in the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) project from December 2014 to December 2017. Data were analyzed from December 2020 to April 2021. Included patients were aged 16 years or older with TBI and a clinical indication for computed tomography imaging. Outcome assessments were completed using both an interview and a questionnaire at follow-up 3 and 6 months after injury. EXPOSURES Traumatic brain injury of all severities. MAIN OUTCOMES AND MEASURES Ratings on the Glasgow Outcome Scale-Extended (GOSE) administered as a structured interview rated by an investigator and as a questionnaire completed by patients or caregivers and scored centrally were compared, and the strength of agreement was evaluated using weighted kappa statistics. Secondary outcomes included comparison of different sections of the GOSE assessments and the association of GOSE ratings with baseline factors and patient-reported mental health, health-related quality of life, and TBI symptoms. RESULTS Among the 3691 eligible individuals in the CENTER-TBI study, both GOSE assessment formats (interview and questionnaire) were completed by 994 individuals (26.9%) at 3 months after TBI (654 [65.8%] male; median age, 53 years [IQR, 33-66 years]) and 628 (17.0%) at 6 months (409 [65.1%] male; median age, 51 years [IQR, 31-64 years]). Outcomes of the 2 assessment methods agreed well at both 3 months (weighted kappa, 0.77; 95% CI, 0.73-0.80) and 6 months (weighted kappa, 0.82; 95% CI, 0.78-0.86). Furthermore, item-level agreement between the 2 methods was good for sections regarding independence in everyday activities (kappa, 0.70-0.79 across both time points) and moderate for sections regarding subjective aspects of functioning such as relationships and symptoms (kappa, 0.41-0.51 across both time points). Compared with questionnaires, interviews recorded more problems with work (294 [30.5%] vs 233 [24.2%] at 3 months and 161 [26.8%] vs 136 [22.7%] at 6 months), fewer limitations in social and leisure activities (330 [33.8%] vs 431 [44.1%] at 3 months and 179 [29.7%] vs 219 [36.4%] at 6 months), and more symptoms (524 [53.6%] vs 324 [33.1%] at 3 months and 291 [48.4%] vs 179 [29.8%] at 6 months). Interviewers sometimes assigned an overall rating based on judgment rather than interview scoring rules, particularly for patients with potentially unfavorable TBI outcomes. However, for both formats, correlations with baseline factors (rho, -0.13 to 0.42) and patient-reported outcomes (rho, 0.29 to 0.65) were similar in strength. CONCLUSIONS AND RELEVANCE In this cohort study, GOSE ratings obtained by questionnaire and interview methods were in good agreement. The similarity of associations of the ratings obtained by both GOSE methods with baseline factors and other TBI outcome measures suggests that despite some apparent differences, the core information collected by both interviews and questionnaires was similar. The findings support the use of questionnaires in studies in which this form of contact may offer substantial practical advantages compared with interviews.	[Horton, Lindsay; Wilson, Lindsay] Univ Stirling, Div Psychol, Stirling FK9 4LA, Scotland; [Rhodes, Jonathan] Univ Edinburgh, Dept Anaesthesia, Western Gen, Edinburgh, Midlothian, Scotland; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Maas, Andrew I. R.] Univ Antwerp Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium		Wilson, L (corresponding author), Univ Stirling, Div Psychol, Stirling FK9 4LA, Scotland.	l.wilson@stir.ac.uk	Volovici, Victor/AAZ-8901-2020; Posti, Jussi P./Y-2908-2019; Ercole, Ari/B-6288-2009	Volovici, Victor/0000-0002-5798-5360; Posti, Jussi P./0000-0002-5925-5193; Radoi, Andreea/0000-0002-0677-3544; Zeiler, Frederick/0000-0003-1737-0510; Dark, Paul/0000-0003-3309-0164; Rossi, Sandra/0000-0002-9963-8121; Ercole, Ari/0000-0001-8350-8093	EC grant from the European Union 7th Framework Programme [602150]	This study was funded by EC grant 602150 from the European Union 7th Framework Programme.	Acquadro C., 2012, LINGUISTIC VALIDATIO; Allanson F, 2017, NEUROPSYCHOL REV, V27, P187, DOI 10.1007/s11065-017-9353-5; Altman D.G., 1990, PRACTICAL STAT MED R; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; [Anonymous], Ethical approval; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boase K, 2021, J NEUROTRAUM, V38, P2419, DOI 10.1089/neu.2020.7528; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Edwards P, 2005, LANCET, V365, P1957; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Ekegren CL, 2016, INJURY, V47, P130, DOI 10.1016/j.injury.2015.08.002; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Horton L, 2018, J NEUROTRAUM, V35, P2005, DOI 10.1089/neu.2018.5648; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kondiles BR, 2015, HEALTH PSYCHOL BEHAV, V3, P1, DOI 10.1080/21642850.2014.966717; Kreitzer NP, 2019, J HEAD TRAUMA REHAB, V34, pE10, DOI 10.1097/HTR.0000000000000457; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Langham J, 2009, STROKE, V40, P111, DOI 10.1161/STROKEAHA.108.517805; Lilja G, 2020, RESUSCITATION, V150, P104; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mendelow AD, 2015, J NEUROTRAUM, V32, P1312, DOI 10.1089/neu.2014.3644; Mendelow AD, 2005, LANCET, V365, P387; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Prigatano GP, 2005, ACT NEUR S, V93, P39; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; SECHZER PH, 1963, ANESTHESIOLOGY, V24, P779, DOI 10.1097/00000542-196311000-00005; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; TEASDALE G, 1974, LANCET, V2, P81; Turner-Bowker, 2007, USERS MANUAL SF 36V2; Vande Vyvere T, 2019, J NEUROTRAUM, V36, P1080, DOI 10.1089/neu.2018.6061; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wilcox RR, 2016, BRIT J MATH STAT PSY, V69, P215, DOI 10.1111/bmsp.12069; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wilson L, 2021, J NEUROTRAUM, V38, P2435, DOI 10.1089/neu.2020.7527	43	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	NOV 11	2021	4	11							e2134121	10.1001/jamanetworkopen.2021.34121			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	WW2BN	WOS:000717729000004	34762111	Green Published, gold			2022-02-06	
J	Sarkis, GA; Lees-Gayed, N; Banoub, J; Abbatielo, SE; Robertson, C; Haskins, WE; Yost, RA; Wang, KKW				Sarkis, George Anis; Lees-Gayed, Nicholas; Banoub, Joseph; Abbatielo, Susan E.; Robertson, Claudia; Haskins, William E.; Yost, Richard A.; Wang, Kevin K. W.			Generation and Release of Neurogranin, Vimentin, and MBP Proteolytic Peptides, Following Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article; Early Access						TBI; Biomarker; NRGN; Vim; MBP; Peptidomics	BASIC-PROTEIN ISOFORMS; CASPASE-3 PROTEOLYSIS; CEREBROSPINAL-FLUID; DUAL VULNERABILITY; CALPAIN; IDENTIFICATION; PEPTIDOMICS; ASTROCYTES; BIOMARKERS; MANAGEMENT	Traumatic brain injury (TBI) is a major neurological disorder without FDA-approved therapies. In this study, we have examined the concept that TBI might trigger global brain proteolysis in the acute post-injury phase. Thus, we conducted a systemic proteolytic peptidomics analysis using acute cerebrospinal fluid (CSF) samples from TBI patients and normal control samples. We employed ultrafiltration-based low molecular weight (LMW; < 10 kDa) peptide enrichment, coupled with nano-reversed-phase liquid chromatography/tandem mass spectrometry analysis, followed with orthogonal quantitative immunoblotting-based protein degradation analysis. We indeed identified novel patterns of injury-dependent proteolytic peptides derived from neuronal components (pre- and post-synaptic terminal, dendrites, axons), extracellular matrix, oligodendrocytes, microglial cells, and astrocytes. Among these, post-synaptic protein neurogranin was identified for the first time converted to neurogranin peptides including neurogranin peptide (aa 16-64) that is phosphorylated at Ser-36/48 (P-NG-fragment) in acute human TBI CSF samples vs. normal control with a receiver operating characteristic area under the curve of 0.957. We also identified detailed processing of astroglia protein (vimentin) and oligodendrocyte protein (MBP and Golli-MBP) to protein breakdown products (BDPs) and/or LMW proteolytic peptides after TBI. In addition, using MS/MS selected reaction monitoring method, two C-terminally released MBP peptides TQDENPVVHFF and TQDENPVVHF were found to be elevated in acute and subacute TBI CSF samples as compared to their normal control counterparts. These findings imply that future therapeutic strategies might be placed on the suppression of brain proteolysis as a target. The endogenous proteolytic peptides discovered in human TBI biofluid could represent useful diagnostic and monitoring tools for TBI.	[Sarkis, George Anis; Wang, Kevin K. W.] Univ Florida, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Emergency Med, Gainesville, FL 32611 USA; [Sarkis, George Anis; Yost, Richard A.; Wang, Kevin K. W.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Sarkis, George Anis; Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Sarkis, George Anis; Lees-Gayed, Nicholas] Alexandria Univ, Fac Sci, Dept Chem, POB 426, Alexandria 21321, Egypt; [Banoub, Joseph] Fisheries & Oceans Canada, Sci Branch, Northwest Atlantic Fisheries Ctr, St John, NF, Canada; [Banoub, Joseph] Mem Univ Newfoundland, Biochem Dept, St John, NF, Canada; [Abbatielo, Susan E.] Northeastern Univ, Barnett Inst Chem & Biol Anal, 360 Huntington Ave, Boston, MA 02115 USA; [Robertson, Claudia] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Haskins, William E.] Gryphon Bio Inc, 611 Gateway Blvd Suite 120 253, San Francisco, CA 94080 USA; [Yost, Richard A.] Univ Florida, Southeast Ctr Integrated Metabol, Gainesville, FL 32610 USA; [Wang, Kevin K. W.] Malcom Randall Vet Affairs Med Ctr, Brain Rehabil Res Ctr, 1601 SW Archer Rd, Gainesville, FL 32608 USA		Sarkis, GA; Wang, KKW (corresponding author), Univ Florida, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Emergency Med, Gainesville, FL 32611 USA.; Sarkis, GA; Wang, KKW (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.; Sarkis, GA; Wang, KKW (corresponding author), Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA.; Sarkis, GA (corresponding author), Alexandria Univ, Fac Sci, Dept Chem, POB 426, Alexandria 21321, Egypt.; Wang, KKW (corresponding author), Malcom Randall Vet Affairs Med Ctr, Brain Rehabil Res Ctr, 1601 SW Archer Rd, Gainesville, FL 32608 USA.	gasarkis@mit.edu; kwang@ufl.edu			Department of Chemistry, Psychiatry and Emergency Medicine, UF; U.S. DOD TED Seed Project [TED1506, DOD W81XWH-14-2-0176]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS085455-01, 1U01 NS086090-01]; VA Merit AwardUS Department of Veterans Affairs [I01 RX001859-02]; Florida State/McKnight Brain Institute BSCIRT Fund [110587]; DODUnited States Department of Defense [W81XWH-14-2-0176]; NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS38660]	Departmental funding from the Department of Chemistry, Psychiatry and Emergency Medicine, UF, is gratefully recognized. This study is also supported in part by U.S. DOD TED Seed Project TED1506 (DOD W81XWH-14-2-0176) (KKW); NIH R21NS085455-01 (KKW); VA I01 RX001859-02 Merit Award (KKW); Florida State/McKnight Brain Institute BSCIRT Fund (#110587) (KKW); NIH 1U01 NS086090-01 (KKW, PI Geoff T Manley (GTM)), DOD Grant W81XWH-14-2-0176 (KKW, GTM); and NIH-NINDS (#P01-NS38660) (CSR).	Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Cafe-Mendes CC, 2014, CURR TOP MED CHEM, V14, P369, DOI 10.2174/1568026613666131204120747; Chen CD, 2014, BIOCHEMISTRY-US, V53, P5579, DOI 10.1021/bi500409n; Chen MH, 2013, ASN NEURO, V5, DOI 10.1042/AN20130032; Conant K, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00305; De Vos A, 2015, ALZHEIMERS DEMENT, V11, P1461, DOI 10.1016/j.jalz.2015.05.012; DOD-DVBIC, 2014, DVBIC WORLD TBI 2000, P1; Ekmark-Lewen S, 2010, RESTOR NEUROL NEUROS, V28, P311, DOI 10.3233/RNN-2010-0529; Fricker LD, 2010, MOL BIOSYST, V6, P1355, DOI 10.1039/c003317k; Harauz G, 2013, J NEUROCHEM, V125, P334, DOI 10.1111/jnc.12195; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Hoffman L, 2014, J BIOL CHEM, V289, P14644, DOI 10.1074/jbc.M114.560656; Diez-Guerra FJ, 2010, IUBMB LIFE, V62, P597, DOI 10.1002/iub.357; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Liu MC, 2011, ASN NEURO, V3, P25, DOI 10.1042/AN20100012; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; NeunerJehle M, 1996, BRAIN RES, V733, P149, DOI 10.1016/S0006-8993(96)00786-X; Ottens AK, 2005, ANAL CHEM, V77, P4836, DOI 10.1021/ac050478r; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Sarkis GA, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0736-z; Schafer MKE, 2018, MATRIX BIOL, V68-69, P571, DOI 10.1016/j.matbio.2017.10.002; SCHIFFER D, 1986, BRAIN RES, V374, P110, DOI 10.1016/0006-8993(86)90399-9; Shaw G, 2004, BIOCHEM BIOPH RES CO, V325, P619, DOI 10.1016/j.bbrc.2004.09.223; Shibayama M, 1997, ACT NEUR S, V70, P220; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Slemmon JR, 2000, MOL NEUROBIOL, V22, P99, DOI 10.1385/MN:22:1-3:099; Svensson M, 2007, ANAL CHEM, V79, P14, DOI 10.1021/ac071856q; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang KKW, 2000, TRENDS NEUROSCI, V23, P59, DOI 10.1016/S0166-2236(99)01536-2; Wijte D, 2012, METHODS, V56, P500, DOI 10.1016/j.ymeth.2012.03.018; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105; Zhang Z, 2020, BIOMARKERS BRAIN INJ, P652; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762	46	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.												10.1007/s12035-021-02600-w		NOV 2021	17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WV8AB	WOS:000717451900001	34762230	Bronze			2022-02-06	
J	Zhang, K; Wang, Z; Zhu, K; Dong, SB; Pan, XD; Sun, LZ; Li, Q				Zhang, Kai; Wang, Zhu; Zhu, Kai; Dong, Songbo; Pan, Xudong; Sun, Lizhong; Li, Qing			Neurofilament Light Chain Protein Is a Predictive Biomarker for Stroke After Surgical Repair for Acute Type A Aortic Dissection	FRONTIERS IN CARDIOVASCULAR MEDICINE			English	Article						type A aortic dissection; aortic operation; stroke; biomarker (BM); neurofilaments (NFs)	TRAUMATIC BRAIN-INJURY; CARDIAC-SURGERY; NEUROBIOCHEMICAL MARKERS; REGISTRY; DAMAGE	Background: Although great progress has been made in surgery and perioperative care, stroke is still a fatal complication of acute type A aortic dissection (ATAAD). Serum biomarkers may help assess brain damage and predict patient's prognosis.Methods: From March, 2019 to January, 2020, a total of 88 patients underwent surgical treatment at the Department of Cardiovascular Surgery of Beijing Anzhen Hospital, China, and were enrolled in this study. Patients were divided into two groups according to whether they had suffered a stroke after the operation. Blood samples were collected at 8 time points within 3 days after surgery to determine the level of S100 beta, neuron-specific enolase (NSE) and neurofilament light chain protein (NFL). Receiver operating characteristic curves (ROC) were established to explore the biomarker predictive value in stroke. The area under the curve (AUC) was used to quantify the ROC curve.Results: The patient average age was 48.1 +/- 11.0 years old and 70 (79.6%) patients were male. Fifteen (17.0%) patients suffered stroke after surgery. The NFL levels of patients in the stroke group at 12 and 24 h after surgery were significantly higher than those in the non-stroke group (all P < 0.001). However, the NSE and S100 beta levels did not differ significantly at any time point between the two groups. The predictive value of NFL was the highest at 12 and 24 h after surgery, and the AUC was 0.834 (95% CI, 0.723-0.951, P < 0.001) and 0.748 (95% CI, 0.603-0.894, P = 0.004), respectively. Its sensitivity and specificity at 12 h were 86.7 and 71.6%, respectively. The NFL cutoff value for the diagnosis of stroke at 12 h after surgery was 16.042 ng/ml.Conclusions: This study suggests that NFL is an early and sensitive serum marker for predicting post-operative neurological prognosis of ATAAD patients. Further studies, including large-scale prospective clinical trials, are necessary to test whether the NFL can be used as a biomarker for clinical decision-making.	[Zhang, Kai; Wang, Zhu; Li, Qing] Xuzhou Med Univ, Dept Cardiothorac Surg, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China; [Zhang, Kai; Wang, Zhu; Li, Qing] Xuzhou Med Univ, Jiangsu Prov Inst Hlth Emergency, Xuzhou, Jiangsu, Peoples R China; [Zhang, Kai; Zhu, Kai; Dong, Songbo; Pan, Xudong; Sun, Lizhong] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiovasc Surg, Beijing, Peoples R China		Li, Q (corresponding author), Xuzhou Med Univ, Dept Cardiothorac Surg, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China.; Li, Q (corresponding author), Xuzhou Med Univ, Jiangsu Prov Inst Hlth Emergency, Xuzhou, Jiangsu, Peoples R China.	liqing6565@126.com					Abe A, 2009, J HUM GENET, V54, P94, DOI 10.1038/jhg.2008.13; Alifier M, 2020, J ALZHEIMERS DIS, V74, P1211, DOI 10.3233/JAD-191165; An SA, 2013, CLIN BIOCHEM, V46, P710, DOI 10.1016/j.clinbiochem.2013.02.005; Cata JP, 2011, BRIT J ANAESTH, V107, P844, DOI 10.1093/bja/aer338; Dassan P, 2009, CEREBROVASC DIS, V27, P295, DOI 10.1159/000199468; Duering M, 2018, J STROKE, V20, P228, DOI 10.5853/jos.2017.02565; Dumfarth J, 2018, EUR J CARDIO-THORAC, V53, P1013, DOI 10.1093/ejcts/ezx465; Durandy Y, 2011, PERFUSION-UK, V26, P441, DOI 10.1177/0267659111408755; Evangelista A, 2018, CIRCULATION, V137, P1846, DOI 10.1161/CIRCULATIONAHA.117.031264; Feneberg E, 2018, NEUROLOGY, V90, pE22, DOI 10.1212/WNL.0000000000004761; Gattringer T, 2017, NEUROLOGY, V89, P2108, DOI 10.1212/WNL.0000000000004645; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; Goncalves Carlos Alberto, 2010, Cardiovasc Psychiatry Neurol, V2010, P790431, DOI 10.1155/2010/790431; Herrmann M, 2000, STROKE, V31, P645, DOI 10.1161/01.STR.31.3.645; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Kruger T, 2011, CIRCULATION, V124, P434, DOI 10.1161/CIRCULATIONAHA.110.009282; Malaisrie SC, 2021, J THORAC CARDIOV SUR, V162, P735, DOI 10.1016/j.jtcvs.2021.04.053; Merluzzi AP, 2018, NEUROLOGY, V91, pE436, DOI 10.1212/WNL.0000000000005901; Moseby-Knappe M, 2019, JAMA NEUROL, V76, P64, DOI 10.1001/jamaneurol.2018.3223; Pelinka LE, 2004, SHOCK, V22, P88, DOI 10.1097/01.shk.0000130157.34382.3f; Rosen H, 2004, J NEUROL SCI, V221, P19, DOI 10.1016/j.jns.2004.03.003; Saller T, 2019, BIOMED PAP, V163, P241, DOI 10.5507/bp.2019.043; Selnes OA, 2012, NEW ENGL J MED, V366, P250, DOI 10.1056/NEJMra1100109; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Sievers HH, 2020, INTERACT CARDIOV TH, V30, P451, DOI 10.1093/icvts/ivz281; STEFANSSON K, 1982, NATURE, V295, P63, DOI 10.1038/295063a0; Sun LZ, 2011, CIRCULATION, V123, P971, DOI 10.1161/CIRCULATIONAHA.110.015081; Tullberg M, 1998, NEUROLOGY, V50, P1122, DOI 10.1212/WNL.50.4.1122; Westaby S, 1996, ANN THORAC SURG, V61, P88, DOI 10.1016/0003-4975(95)00904-3; Zhang K, 2020, J CARDIOTHORAC SURG, V15, DOI 10.1186/s13019-020-01100-7	31	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2297-055X			FRONT CARDIOVASC MED	Front. Cardiovasc. Med.	NOV 11	2021	8								754801	10.3389/fcvm.2021.754801			8	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XT6ZH	WOS:000733732600001	34859071	Green Published, gold			2022-02-06	
J	Lenell, S; Lewen, A; Howells, T; Enblad, P				Lenell, Samuel; Lewen, Anders; Howells, Timothy; Enblad, Per			Neurointensive care of traumatic brain injury in the elderly-age-specific secondary insult levels and optimal physiological levels to target need to be defined	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Elderly; Outcome; Secondary insults; Geriatric neurointensive care; Neurointensive care monitoring	SEVERE HEAD-INJURY; OLDER-ADULTS; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; EPIDEMIOLOGY; MANAGEMENT; REGISTER; EFFICACY; OUTCOMES; TRIAL	Background Elderly patients with traumatic brain injury increase. Current targets and secondary insult definitions during neurointensive care (NIC) are mostly based on younger patients. The aim was therefore to study the occurrence of predefined secondary insults and the impact on outcome in different ages with particular focus on elderly. Methods Patients admitted to Uppsala 2008-2014 were included. Patient characteristics, NIC management, monitoring data, and outcome were analyzed. The percentage of monitoring time for ICP, CPP, MAP, and SBP above-/below-predefined thresholds was calculated. Results Five hundred seventy patients were included, 151 elderly >= 65 years and 419 younger 16-64 years. Age >= 65 had significantly higher percentage of CPP > 100, MAP > 120, and SBP > 180 and age 16-64 had higher percentage of ICP >= 20, CPP <= 60, and MAP <= 80. Age >= 65 contributed independently to the different secondary insult patterens. When patients in all ages were analyzed, low percentage of CPP > 100 and SBP > 180, respectively, was significant predictors of favorable outcome and high percentage of ICP >= 20, CPP > 100, SBP <= 100, and SBP > 180, respectively, was predictors of death. Analysis of age interaction showed that patients >= 65 differed and had a higher odds for favorable outcome with large proportion of good monitoring time with SBP > 180. Conclusions Elderly >= 65 have different patterns of secondary insults/physiological variables, which is independently associated to age. The finding that SBP > 180 increased the odds of favorable outcome in the elderly but decreased the odds in younger patients may indicate that blood pressure should be treated differently depending on age.	[Lenell, Samuel; Lewen, Anders; Howells, Timothy; Enblad, Per] Uppsala Univ, Uppsala Univ Hosp, Dept Neurosci Neurosurg, Sect Neurosurg, S-75185 Uppsala, Sweden		Lenell, S (corresponding author), Uppsala Univ, Uppsala Univ Hosp, Dept Neurosci Neurosurg, Sect Neurosurg, S-75185 Uppsala, Sweden.	samuel.lenell@neuro.uu.se		Lenell, Samuel/0000-0001-8914-5086	Uppsala University; Uppsala university hospital	Open access funding provided by Uppsala University. The study was supported by grants from the Uppsala university hospital.	ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; BOWERS SA, 1980, NEUROSURGERY, V6, P237; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; de Grenoble C, SEVERE HEAD INJURIES, P5; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Gaastra B, 2016, BRIT J NEUROSURG, V30, P221, DOI 10.3109/02688697.2015.1119240; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Howells T. P., 1995, Journal of Neurotrauma, V12, P471; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Lenell S, 2015, ACTA NEUROCHIR, V157, P417, DOI 10.1007/s00701-014-2329-9; Lennartsson C, 2012, SCAND J PUBLIC HEALT, V40, P95, DOI 10.1177/1403494812459468; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; Merzo A, 2016, ACTA NEUROCHIR, V158, P125, DOI 10.1007/s00701-015-2639-6; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nordstrom C H, 1989, Brain Inj, V3, P267, DOI 10.3109/02699058909029640; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Peeters W, 2017, NEUROEPIDEMIOLOGY, V48, P63, DOI 10.1159/000471877; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; Ryttlefors M, 2007, NEUROSURGERY, V61, P704, DOI 10.1227/01.NEU.0000298898.38979.E3; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Wan XY, 2016, WORLD NEUROSURG, V89, P147, DOI 10.1016/j.wneu.2016.01.084; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; You WD, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0199-9; Young HF, 1977, J NEUROSURG, V4, P12	40	0	0	2	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JAN	2022	164	1					117	128		10.1007/s00701-021-05047-z		NOV 2021	12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YH5HB	WOS:000716840500002	34757477	hybrid, Green Accepted			2022-02-06	
J	Prajapati, P; Wang, WX; Pesina, SA; Geleta, U; Springer, JE				Prajapati, Paresh; Wang, Wang-Xia; Pesina, Steven A.; Geleta, Urim; Springer, Joe E.			Sex-Specific Alterations in Inflammatory MicroRNAs in Mouse Brain and Bone Marrow CD11b+Cells Following Traumatic Brain Injury	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article; Early Access						MicroRNAs; Traumatic brain injury (TBI); Inflammation; CD11b; Sexual dimorphism; Bone marrow	DIFFERENTIATION; PERSIST; MICE	Sex is a key biological variable in traumatic brain injury (TBI) and plays a significant role in neuroinflammatory responses. However, the molecular mechanisms contributing to this sexually dimorphic neuroinflammatory response remain elusive. Here we describe a significant and previously unreported tissue enrichment and sex-specific alteration of a set of inflammatory microRNAs (miRNAs) in CD11b+ cells of brain and bone marrow isolated from naive mice as well as mice subjected to TBI. Our data from naive mice demonstrated that expression levels of miR-146a-5p and miR-150-5p were relatively higher in brain CD11b+ cells, and that miR-155-5p and miR-223-3p were highly enriched in bone marrow CD11b+ cells. Furthermore, while miR-150-5p and miR-155-5p levels were higher in male brain CD11b+ cells, no significant sexual difference was observed for miR-146a-5p and miR-223-3p. However, TBI resulted in sex-specific differential responses of these miRNAs in brain CD11b+ cells. Specifically, miR-223-3p levels in brain CD11b+ cells were markedly elevated in both sexes in response to TBI at 3 and 24 h, with levels in females being significantly higher than males at 24 h. We then focused on analyzing several miR-223-3p targets and inflammation-related marker genes following injury. Corresponding to the greater elevation of miR-223-3p in females, the miR-223-3p targets, TRAF6 and FBXW7 were significantly reduced in females compared to males. Interestingly, anti-inflammatory genes ARG1 and IL4 were higher in females after TBI than in males. These observations suggest miR-223-3p and other inflammatory responsive miRNAs may play a key role in sex-specific neuroinflammatory response following TBI.	[Prajapati, Paresh; Wang, Wang-Xia; Pesina, Steven A.; Geleta, Urim; Springer, Joe E.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA; [Prajapati, Paresh; Pesina, Steven A.; Springer, Joe E.] Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA; [Wang, Wang-Xia] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Wang, Wang-Xia] Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY 40506 USA		Wang, WX; Springer, JE (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA.; Springer, JE (corresponding author), Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA.; Wang, WX (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.; Wang, WX (corresponding author), Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY 40506 USA.	wwangc@uky.edu; jspring@uky.edu	Wang, Wang-Xia/AAD-6900-2019	Wang, Wang-Xia/0000-0002-8104-3779	Kentucky Spinal Cord and Head Injury Research Trust	This work is supported by a Grant (18-8A) from the Kentucky Spinal Cord and Head Injury Research Trust to JES and WXW.	Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Cardoso AL, 2012, IMMUNOLOGY, V135, P73, DOI 10.1111/j.1365-2567.2011.03514.x; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Jablonski KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159724; Jiao P, 2021, INT J BIOL SCI, V17, P2308, DOI 10.7150/ijbs.59876; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kodama L, 2020, NAT NEUROSCI, V23, P167, DOI 10.1038/s41593-019-0560-7; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar V, 2014, LEUKEMIA, V28, P2324, DOI 10.1038/leu.2014.133; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Liu NK, 2011, PHYSIOL GENOMICS, V43, P571, DOI 10.1152/physiolgenomics.00168.2010; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Shakerian L, 2018, J NEUROIMMUNOL, V323, P167, DOI 10.1016/j.jneuroim.2018.06.010; Sharma S, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/2042-6410-5-3; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Sun YX, 2012, IMMUNOL LETT, V146, P25, DOI 10.1016/j.imlet.2012.04.007; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Truettner JS, 2017, J CEREBR BLOOD F MET, V37, P2952, DOI 10.1177/0271678X16680003; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wang WX, 2020, MOL NEUROBIOL, V57, P2996, DOI 10.1007/s12035-020-01937-y; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104; Zhou WQ, 2018, CELL REP, V22, P1810, DOI 10.1016/j.celrep.2018.01.058	35	0	0	2	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.												10.1007/s10571-021-01164-6		NOV 2021	7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	WU8WG	WOS:000716819100001	34761332	Green Submitted			2022-02-06	
J	Yasmin, A; Pitkanen, A; Andrade, P; Paananen, T; Grohn, O; Immonen, R				Yasmin, Amna; Pitkanen, Asla; Andrade, Pedro; Paananen, Tomi; Grohn, Olli; Immonen, Riikka			Post-injury ventricular enlargement associates with iron in choroid plexus but not with seizure susceptibility nor lesion atrophy-6-month MRI follow-up after experimental traumatic brain injury	BRAIN STRUCTURE & FUNCTION			English	Article						Brain-CSF barrier; Epileptogenesis; Heme; Idiopathic normal pressure hydrocephalus; Ventriculomegaly	POSTTRAUMATIC HYDROCEPHALUS; FLUID-PERCUSSION; MODEL; HIPPOCAMPUS; IMPAIRMENT; CLEARANCE; EPILEPSY; INVASION; ATROPHY; IMPACT	Ventricular enlargement is one long-term consequence of a traumatic brain injury, and a risk factor for memory disorders and epilepsy. One underlying mechanisms of the chronic ventricular enlargement is disturbed cerebrospinal-fluid secretion or absorption by choroid plexus. We set out to characterize the different aspects of ventricular enlargement in lateral fluid percussion injury (FPI) rat model by magnetic resonance imaging (MRI) and discovered choroid plexus injury in rats that later developed hydrocephalus. We followed the brain pathology progression for 6 months and studied how the ventricular growth was associated with the choroid plexus injury, cortical lesion expansion, hemorrhagic load or blood perfusion deficits. We correlated MRI findings with the seizure susceptibility in pentylenetetrazol challenge and memory function in Morris water-maze. Choroid plexus injury was validated by ferric iron (Prussian blue) and cytoarchitecture (Nissl) stainings. We discovered choroid plexus injury that accumulates iron in 90% of FPI rats by MRI. The amount of the choroid plexus iron remained unaltered 1-, 3- and 6-month post-injury. During this time, the ventricles kept on growing bilaterally. Ventricular growth did not depend on the cortical lesion severity or the cortical hemorrhagic load suggesting a separate pathology. Instead, the results indicate choroidal injury as one driver of the post-traumatic hydrocephalus, since the higher the choroid plexus iron load the larger were the ventricles at 6 months. The ventricle size or the choroid plexus iron load did not associate with seizure susceptibility. Cortical hypoperfusion and memory deficits were worse in rats with greater ventricular growth.	[Yasmin, Amna; Pitkanen, Asla; Andrade, Pedro; Paananen, Tomi; Grohn, Olli; Immonen, Riikka] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio 1627, Finland		Immonen, R (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio 1627, Finland.	riikka.immonen@uef.fi		Immonen, Riikka/0000-0002-9855-7098	University of Eastern Finland (UEF); Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science; Epilepsy research foundation; Medical Research Council of the Academy of FinlandAcademy of Finland [272249, 273909, 298007]; European UnionEuropean Commission [602102]; National Institute of Neurological Disorders and Stroke (NINDS) Center without Walls of the National Institutes of Health (NIH) [U54NS100064]; Kuopio University Hospital	Open access funding provided by University of Eastern Finland (UEF) including Kuopio University Hospital. Study was supported by Finnish Cultural Foundation, both Central fund and Northern Savo regional fund (RI and AY), Epilepsy research foundation (AY), the Medical Research Council of the Academy of Finland (Grants 272249 and 273909, AP; Grant 298007, OG), the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 602102 (EPITARGET)(AP) and National Institute of Neurological Disorders and Stroke (NINDS) Center without Walls of the National Institutes of Health (NIH) under Award Number U54NS100064 (EpiBioS4Rx) (AP).	Andrade P, 2018, J NEUROSCI METH, V307, P37, DOI 10.1016/j.jneumeth.2018.06.015; Apostolova LG, 2012, ALZ DIS ASSOC DIS, V26, P17, DOI 10.1097/WAD.0b013e3182163b62; Boespflug EL, 2018, BIOL PSYCHIAT, V83, P328, DOI 10.1016/j.biopsych.2017.11.031; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Chen LJ, 2017, BRAIN PATHOL, V27, P419, DOI 10.1111/bpa.12414; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; Dadas A, 2019, NEUROBIOL DIS, V123, P20, DOI 10.1016/j.nbd.2018.06.022; Damkier HH, 2013, PHYSIOL REV, V93, P1847, DOI 10.1152/physrev.00004.2013; Daou B, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.6.FOCUS16189; Ding GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061241; Eide PK, 2020, J CEREBR BLOOD F MET, V40, P1849, DOI 10.1177/0271678X19874790; Ge RM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0909-3; Glushakova OY, 2020, J NEUROTRAUM, V37, P2401, DOI 10.1089/neu.2018.6145; Henning EC, 2009, J CEREBR BLOOD F MET, V29, P1229, DOI 10.1038/jcbfm.2009.48; Hladky SB, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0040-3; Hu Q, 2014, MED GAS RES, V4, DOI 10.1186/2045-9912-4-12; Hubert V, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00034; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Kaur C, 1996, ARCH HISTOL CYTOL, V59, P239, DOI 10.1679/aohc.59.239; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kowalsky RJ, 2018, J PHYS ACT HEALTH, V15, P788, DOI [10.1123/jpah.2017-0639, 10.3171/2017.7.JNS17555]; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Lapinlampi N, 2017, EPILEPSY RES, V129, P87, DOI 10.1016/j.eplepsyres.2016.11.010; Liu S, 2014, J HISTOCHEM CYTOCHEM, V62, P767, DOI 10.1369/0022155414546692; Luikku AJ, 2019, J ALZHEIMERS DIS, V71, P1233, DOI 10.3233/JAD-190334; Malm J, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-22; Marchi N, 2016, J NEUROSCI METH, V260, P118, DOI 10.1016/j.jneumeth.2015.06.011; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Millward JM, 2019, NEUROSCIENCE, V403, P136, DOI 10.1016/j.neuroscience.2017.12.014; Millward JM, 2013, ASN NEURO, V5, P89, DOI 10.1042/AN20120081; Mishra M, 2013, EPILEPSY RES, V106, P83, DOI 10.1016/j.eplepsyres.2013.06.008; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murtha LA, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-12; Nestor SM, 2008, BRAIN, V131, P2443, DOI 10.1093/brain/awn146; Olopade FE, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-19; Piatt JH, 1996, NEUROSURGERY, V39, P722, DOI 10.1097/00006123-199610000-00014; Qi ZH, 2017, NEUROSCI LETT, V637, P120, DOI 10.1016/j.neulet.2016.11.038; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Ringstad G, 2017, BRAIN, V140, P2691, DOI 10.1093/brain/awx191; Sharma V, 2007, SEIZURE-EUR J EPILEP, V16, P680, DOI 10.1016/j.seizure.2007.05.012; Stadler A, 2007, EUR RADIOL, V17, P1242, DOI 10.1007/s00330-006-0470-4; Sullan MJ, 2018, NEUROSCI BIOBEHAV R, V84, P316, DOI 10.1016/j.neubiorev.2017.08.016; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; Wang Y, 2021, EPILEPSY RES, V172, DOI 10.1016/j.eplepsyres.2021.106600; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478; Wiart M, 2007, STROKE, V38, P131, DOI 10.1161/01.STR.0000252159.05702.00; WILLMORE LJ, 1981, NEUROLOGY, V31, P63, DOI 10.1212/WNL.31.1.63; Xiang JM, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-017-0056-3; Zhang C, 2014, EPILEPSY RES, V108, P1806, DOI 10.1016/j.eplepsyres.2014.09.030; Zhao JB, 2014, TRANSL STROKE RES, V5, P586, DOI 10.1007/s12975-014-0353-y	55	0	0	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2653	1863-2661		BRAIN STRUCT FUNCT	Brain Struct. Funct.	JAN	2022	227	1					145	158		10.1007/s00429-021-02395-5		NOV 2021	14	Anatomy & Morphology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Neurosciences & Neurology	YD3MS	WOS:000716835400001	34757444	Green Accepted, hybrid			2022-02-06	
J	Dhar, R; Sandler, RH; Manwaring, K; Kostick, N; Mansy, HA				Dhar, Rajkumar; Sandler, Richard H.; Manwaring, Kim; Kostick, Nathan; Mansy, Hansen A.			Noninvasive detection of elevated ICP using spontaneous tympanic membrane pulsation	SCIENTIFIC REPORTS			English	Article							INTRACRANIAL-PRESSURE ICP; TRAUMATIC BRAIN INJURY; COCHLEAR AQUEDUCT; PULSE AMPLITUDE; WAVE-FORM; DISPLACEMENT	Neurological conditions such as traumatic brain injury (TBI) and hydrocephalus may lead to intracranial pressure (ICP) elevation. Current diagnosis methods rely on direct pressure measurement, while CT, MRI and other expensive imaging may be used. However, these invasive or expensive testing methods are often delayed because symptoms of elevated ICP are non-specific. Invasive methods, such as intraventricular catheter, subdural screw, epidural sensor, lumbar puncture, are associated with an increased risk of infection and hemorrhage. On the other hand, noninvasive, low-cost, accurate methods of ICP monitoring can help avoid risks and reduce costs while expediting diagnosis and treatment. The current study proposes and evaluates a novel method for noninvasive ICP monitoring using tympanic membrane pulsation (TMp). These signals are believed to be transmitted from ICP to the auditory system through the cochlear aqueduct. Fifteen healthy subjects were recruited and TMp signals were acquired noninvasively while the subjects performed maneuvers that are known to change ICP. A custom made system utilizing a stethoscope headset and a pressure transducer was used to perform these measurements. Maneuvers included head-up-tilt, head-down-tilt and hyperventilation. When elevated ICP was induced, significant TMp waveform morphological changes were observed in each subject (p < 0.01). These changes include certain waveform slopes and high frequency wave features. The observed changes were reversed by the maneuvers that decreased ICP (p < .01). The study results suggest that TMp waveform measurement and analysis may offer an inexpensive, noninvasive, accurate tool for detection and monitoring of ICP elevations. Further studies are warranted to validate this technique in patients with pathologically elevated ICP.	[Dhar, Rajkumar; Sandler, Richard H.; Mansy, Hansen A.] Univ Cent Florida, Biomed Acoust Res Lab, Orlando, FL 32816 USA; [Manwaring, Kim] Arnold Palmer Childrens Hosp, Pediat Neurosurg, Orlando, FL 32806 USA; [Kostick, Nathan] Univ Cent Florida, Coll Med, Orlando, FL 32827 USA		Dhar, R (corresponding author), Univ Cent Florida, Biomed Acoust Res Lab, Orlando, FL 32816 USA.	rajkumar.dhar@knights.ucf.edu			UCF College of Graduate Studies Open Access Publishing Fund	Article processing charges were provided in part by the UCF College of Graduate Studies Open Access Publishing Fund.	Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; [Anonymous], 2021, LABSCRIBE DAT ACQ AN; [Anonymous], 2021, MATLAB STAT TOOLB RE; Arani A, 2018, MAGN RESON MED, V79, P1043, DOI 10.1002/mrm.26738; Azad M. K, 2018, SOUTHEASTCON 2018; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; BEENTJES BI, 1972, ACTA OTO-LARYNGOL, V73, P112, DOI 10.3109/00016487209138919; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Carrera E, 2010, J NEUROTRAUM, V27, P317, DOI 10.1089/neu.2009.0951; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; Czosnyka Z, 2008, ACTA NEUROCHIR SUPPL, V102, P137, DOI 10.1007/978-3-211-85578-2_28; Daugherty J, 2019, MMWR-MORBID MORTAL W, V68, P1050, DOI 10.15585/mmwr.mm6846a2; Dhar R, 2019, IEEE SIG PROC MED; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Eide PK, 2006, ACTA NEUROCHIR, V148, P1267, DOI 10.1007/s00701-006-0908-0; Eide PK, 2006, ACTA NEUROCHIR, V148, P1151, DOI 10.1007/s00701-006-0896-0; El-Bouri WK, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aad308; Evensen KB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34083-6; Finch LC, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaa9f8; Freeman W David, 2015, Continuum (Minneap Minn), V21, P1299, DOI 10.1212/CON.0000000000000235; Geeraerts T, 2008, CRIT CARE, V12, DOI [10.1186/cc6893, 10.1186/cc7006]; Gopen Q, 1997, HEARING RES, V107, P9, DOI 10.1016/S0378-5955(97)00017-8; Gwer S, 2013, CHILD NERV SYST, V29, P927, DOI 10.1007/s00381-013-2036-5; HARGENS AR, 1994, ACTA PHYSIOL SCAND, V150, P103; Holm S, 2008, MED ENG PHYS, V30, P164, DOI 10.1016/j.medengphy.2007.03.003; HOMMERICH K W, 1964, Arch Ohren Nasen Kehlkopfheilkd, V183, P86, DOI 10.1007/BF02104159; Kawai Y, 2003, YONAGO ACTA MED, V5, P46; Khan Marium Naveed, 2017, Surg Neurol Int, V8, P51, DOI 10.4103/sni.sni_403_16; Kirkness C J, 2000, J Neurosci Nurs, V32, P271; KLINGELHOFER J, 1987, KLIN WOCHENSCHR, V65, P542, DOI 10.1007/BF01727619; Kostick N, 2021, CUREUS, V13, DOI 10.7759/cureus.13865; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Manwaring P, 2005, P ANN INT IEEE EMBS, P6687, DOI 10.1109/IEMBS.2005.1616037; Marchbanks RJ, 1996, INTRACRANIAL AND INTRALABYRINTHINE FLUIDS, P51; Morgalla MH, 1999, J NEUROL SCI, V168, P90, DOI 10.1016/S0022-510X(99)00137-9; Nag DS, 2019, WORLD J CLIN CASES, V7, P1535, DOI 10.12998/wjcc.v7.i13.1535; Raichle ME, 1972, STROKE, V3, P566, DOI 10.1161/01.STR.3.5.566; REID A, 1990, British Journal of Audiology, V24, P123, DOI 10.3109/03005369009077853; Rodriguez-Boto G, 2015, NEUROLOGIA, V30, P16, DOI 10.1016/j.nrl.2012.09.002; Samuel M, 1998, J NEUROSURG, V88, P983, DOI 10.3171/jns.1998.88.6.0983; Sharif SJ, 2018, ACTA NEUROCHIR SUPPL, V126, P103, DOI 10.1007/978-3-319-65798-1_22; Shimbles S, 2005, PHYSIOL MEAS, V26, P1085, DOI 10.1088/0967-3334/26/6/017; Stettin E, 2011, J CLIN MONIT COMPUT, V25, P203, DOI 10.1007/s10877-011-9297-x; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Taebi A, 2016, J Bioeng Biomed Sci, V6, DOI 10.4172/2155-9538.1000202; Tatebayashi K, 2003, BRAIN RES, V977, P55, DOI 10.1016/S0006-8993(03)02723-9; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; Westhout FD, 2008, SURG NEUROL, V70, P70, DOI 10.1016/j.surneu.2007.04.020; WLODYKA J, 1978, ANN OTO RHINOL LARYN, V87, P22	49	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	NOV 9	2021	11	1							21957	10.1038/s41598-021-01079-8			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WU6QA	WOS:000716666700006	34753976	Green Submitted, gold, Green Published			2022-02-06	
J	Filben, TM; Pritchard, NS; Miller, LE; Miles, CM; Urban, JE; Stitzel, JD				Filben, Tanner M.; Pritchard, N. Stewart; Miller, Logan E.; Miles, Christopher M.; Urban, Jillian E.; Stitzel, Joel D.			Header biomechanics in youth and collegiate female soccer	JOURNAL OF BIOMECHANICS			English	Article						Head impact; Subconcussion; Mouthpiece; Wearable sensor; Finite element modeling	CONCUSSION INCIDENCE; NECK STRENGTH; ACCELERATION; SCENARIO; PLAYERS; IMPACTS	Concerns about the effects of intentional heading in soccer have led to regulatory restrictions on headers for youth players. However, there is limited data describing how header exposure varies across age levels, and few studies have attempted to compare head impact exposure across different levels of play with the same sensor. Additionally, little is known about the biomechanical response of the brain to header impacts. The objective of this study was to evaluate head kinematics and the resulting tissue-level brain strain associated with intentional headers among youth and collegiate female soccer players. Six youth and 13 collegiate participants were instrumented with custom mouthpiece-based sensors measuring six-degree-of-freedom head kinematics of headers during practices and games. Kinematics of film-verified headers were used to drive impact simulations with a detailed brain finite element model to estimate tissue-level strain. Linear and rotational head kinematics and strain metrics, specifically 95th percentile maximum principal strain (epsilon(1,95)) and the area under the cumu-lative strain damage measure curve (VSM1), were compared across levels of play (i.e., youth vs. collegiate) while adjusting for session type and ball delivery method. A total of 483 headers (n = 227 youth, n = 256 collegiate) were analyzed. Level of play was significantly associated with linear acceleration, rotational acceleration, rotational velocity, epsilon(1,95), and VSM1. Headers performed by collegiate players had significantly greater mean head kinematics and strain metrics compared to those performed by youth players (all p < .001). Targeted in-terventions aiming to reduce head impact magnitude in soccer should consider factors associated with the level of play.	[Filben, Tanner M.; Pritchard, N. Stewart; Miller, Logan E.; Miles, Christopher M.; Urban, Jillian E.; Stitzel, Joel D.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC 27101 USA; [Filben, Tanner M.; Pritchard, N. Stewart; Miller, Logan E.; Urban, Jillian E.; Stitzel, Joel D.] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Winston Salem, NC 27101 USA; [Miles, Christopher M.] Wake Forest Sch Med, Dept Family & Community Med, Winston Salem, NC 27101 USA		Pritchard, NS (corresponding author), 575 N Patterson Ave,Suite 530, Winston Salem, NC 27101 USA.	npritcha@wakehealth.edu		Miller, Logan/0000-0002-6348-7536; Filben, Tanner/0000-0002-2572-0093			Allison W, 2019, THESIS, V6740; [Anonymous], 2020, US YOUTH SOCCER POLI; [Anonymous], 2020, NATL COLLEGIATE ATHL; Auger J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240162; Beckwith J, 2018, ANN BIOMED ENG, V46, P819, DOI 10.1007/s10439-018-1999-5; Buzas D, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114528460; Caccese JB, 2020, J NEUROTRAUM, V37, P2656, DOI 10.1089/neu.2020.7001; Cecchi NJ, 2020, SPORTS ENG, V23, DOI 10.1007/s12283-020-00331-0; Chrisman SPD, 2019, CLIN J SPORT MED, V29, P3, DOI 10.1097/JSM.0000000000000497; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dudley J, 2020, BRAIN CONNECT, V10, P292, DOI 10.1089/brain.2019.0729; Gayzik FS, 2015, J BIOMECH, V48, P4173, DOI 10.1016/j.jbiomech.2015.09.017; Harriss A, 2019, MUSCULOSKEL SCI PRAC, V40, P53, DOI 10.1016/j.msksp.2019.01.009; Hassan MHA, 2015, PROCEDIA ENGINEER, V112, P46, DOI 10.1016/j.proeng.2015.07.174; Hildenbrand KJ, 2013, J STRENGTH COND RES, V27, P3173, DOI 10.1519/JSC.0b013e31828a1fe2; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Knowles BM, 2017, ANN BIOMED ENG, V45, P2146, DOI 10.1007/s10439-017-1848-y; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Kuo C, 2017, J NEUROTRAUM, V34, P3198, DOI 10.1089/neu.2016.4893; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Miller LE, 2021, ANN BIOMED ENG, V49, P1083, DOI 10.1007/s10439-020-02685-9; Miller LE, 2020, RES SPORTS MED, V28, P55, DOI 10.1080/15438627.2019.1590833; Miller LE, 2019, J NEUROTRAUM, V36, P1561, DOI 10.1089/neu.2018.6037; Miller LE, 2017, COMPUT METHOD BIOMEC, V20, P1273, DOI 10.1080/10255842.2017.1340462; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Nelson K. M., 2020, INT J ATHL THER TRAI, P1; Nevins D., 2019, ATHLETIC TRAINING SP, V11, P174, DOI [10.3928/19425864-20180802-02, DOI 10.3928/19425864-20180802-02]; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Peek K, 2020, J SCI MED SPORT, V23, P453, DOI 10.1016/j.jsams.2019.11.004; Ponce E, 2014, IEEE COMPUT GRAPH, V34, P8, DOI 10.1109/MCG.2014.96; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Rich AM, 2019, ANN BIOMED ENG, V47, P2109, DOI 10.1007/s10439-019-02313-1; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Saunders TD, 2020, CLIN BIOMECH, V74, P14, DOI 10.1016/j.clinbiomech.2020.02.003; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	44	0	0	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	NOV 9	2021	128								110782	10.1016/j.jbiomech.2021.110782			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	WO4FT	WOS:000712412600003	34656012				2022-02-06	
J	Hoffe, B; Mazurkiewicz, A; Thomson, H; Banton, R; Piehler, T; Petel, OE; Holahan, MR				Hoffe, Brendan; Mazurkiewicz, Ashley; Thomson, Hannah; Banton, Rohan; Piehler, Thuvan; Petel, Oren E.; Holahan, Matthew R.			Relating strain fields with microtubule changes in porcine cortical sulci following drop impact	JOURNAL OF BIOMECHANICS			English	Article						Porcine; Traumatic Brain Injury; Strain Fields; Microtubule; Translational Model; Ex Vivo	TRAUMATIC BRAIN-INJURY; MAXIMUM PRINCIPAL STRAIN; DIFFUSE AXONAL INJURY; CORPUS-CALLOSUM; PROTEIN-2; MAP2; IMMUNOREACTIVITY; VULNERABILITY; ORGANIZATION; INHIBITION	The biomechanical response of brain tissue to strain and the immediate neural outcomes are of fundamental importance in understanding mild traumatic brain injury (mTBI). The sensitivity of neural tissue to dynamic strain events and the resulting strain-induced changes are considered to be a primary factor in injury. Rodent models have been used extensively to investigate impact-induced injury. However, the lissencephalic structure is inconsistent with the human brain, which is gyrencephalic (convoluted structure), and differs considerably in strain field localization effects. Porcine brains have a similar structure to the human brain, containing a similar ratio of white-grey matter and gyrification in the cortex. In this study, coronal brain slabs were extracted from female pig brains within 2hrs of sacrifice. Slabs were implanted with neutral density radiopaque markers, sealed inside an elastomeric encasement, and dropped from 0.9 m onto a steel anvil. Particle tracking revealed elevated tensile strains in the sulcus. One hour after impact, decreased microtubule associated protein 2 (MAP2) was found exclusively within the sulcus with no increase in cell death. These results suggest that elevated tensile strain in the sulcus may result in compromised cytoskeleton, possibly indicating a vulnerability to pathological outcomes under the right circumstances. The results demonstrated that the observed changes were unrelated to shear strain loading of the tissues but were more sensitive to tensile load.	[Hoffe, Brendan; Holahan, Matthew R.] Carleton Univ, Dept Neurosci, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada; [Mazurkiewicz, Ashley; Thomson, Hannah; Petel, Oren E.] Carleton Univ, Dept Mech & Aerosp Engn, Ottawa, ON K1S 5B6, Canada; [Banton, Rohan; Piehler, Thuvan] US Army Res Lab, Aberdeen Proving Ground, MD 21005 USA		Hoffe, B (corresponding author), Carleton Univ, Dept Neurosci, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada.	Brendan.hoffe@carleton.ca		Thomson, Hannah/0000-0002-7468-7269; Mazurkiewicz, Ashley/0000-0003-3505-2823; Petel, Oren/0000-0003-2169-2424	Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-17-2-0222]	Acknowledgements Research was sponsored by the Army Research Laboratory and was accomplished under Cooperative Agreement Number W911NF-17-2-0222. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Laboratory or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation herein. The authors acknowledge Mikaela Ethier-Gagnon and Bobby Koops-Lalande for their help in data quanti-fication and experimental assistance.	Atarod D, 2015, J MOL NEUROSCI, V56, P313, DOI 10.1007/s12031-015-0535-4; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bjarkam CR, 2017, JOVE-J VIS EXP, DOI 10.3791/55511; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Bray G. M., 2014, MAPPING CONNECTIONS; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Chee MJS, 2015, J NEUROSCI, V35, P3644, DOI 10.1523/JNEUROSCI.4187-14.2015; Chen LJ, 2010, J NEUROTRAUM, V27, P1657, DOI 10.1089/neu.2010.1308; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Davoli MA, 2002, NEUROSCIENCE, V115, P125, DOI 10.1016/S0306-4522(02)00376-7; Dehmelt L, 2005, GENOME BIOL, V6; Duan W, 2016, MOL NEUROBIOL, V53, P1637, DOI 10.1007/s12035-015-9122-5; Dutrisac S, 2021, J BIOMECH ENG-T ASME, V143, DOI 10.1115/1.4051527; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Fagan BT, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00998; Ganpule S, 2018, SHOCK WAVES, V28, P127, DOI 10.1007/s00193-017-0791-z; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Guadagnoli T, 2016, BRAIN RES BULL, V127, P177, DOI 10.1016/j.brainresbull.2016.09.013; GUNDERSEN HJG, 1988, J MICROSC-OXFORD, V151, P3, DOI 10.1111/j.1365-2818.1988.tb04609.x; Hajiaghamemar M, 2021, J NEUROTRAUM, V38, P144, DOI 10.1089/neu.2019.6791; Hajiaghamemar M, 2020, BIOMECH MODEL MECHAN, V19, P1109, DOI 10.1007/s10237-019-01273-8; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Huh JW, 2003, J NEUROTRAUM, V20, P975, DOI 10.1089/089771503770195821; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kazmierczak-Baranska J, 2015, FEBS LETT, V589, P222, DOI 10.1016/j.febslet.2014.12.003; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lauret C, 2009, MED ENG PHYS, V31, P392, DOI 10.1016/j.medengphy.2008.05.004; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lippert SA, 2004, BIORHEOLOGY, V41, P681; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Mazurkiewicz A, 2021, J BIOMECH ENG-T ASME, V143, DOI 10.1115/1.4050283; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Mudrakola HV, 2009, STRUCTURE, V17, P1433, DOI 10.1016/j.str.2009.09.008; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Palchesko RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051499; Pierozan P, 2017, MOL NEUROBIOL, V54, P5752, DOI 10.1007/s12035-016-0101-2; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Ramkumar A, 2018, DEV DYNAM, V247, P138, DOI 10.1002/dvdy.24599; RICE JR, 1968, J APPL MECH, V35, P379, DOI 10.1115/1.3601206; Sawyer TW, 2018, SHOCK WAVES, V28, P85, DOI 10.1007/s00193-017-0756-2; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schartz ND, 2016, SCI REP-UK, V6, DOI 10.1038/srep24988; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Soheilypour M, 2015, BIOPHYS J, V108, P1718, DOI 10.1016/j.bpj.2015.01.030; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Sugawara T, 2002, J NEUROTRAUM, V19, P85, DOI 10.1089/089771502753460268; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tuplin EWN, 2019, BEHAV BRAIN RES, V361, P14, DOI 10.1016/j.bbr.2018.12.031; WEISSHAAR B, 1993, J NEUROCYTOL, V22, P727, DOI 10.1007/BF01181318; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; Zhao S, 2016, MOL NEUROBIOL, V53, P1884, DOI 10.1007/s12035-015-9128-z; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239; Zhou Z., 2020, WHITE MATTER TRACT O, DOI [10.1101/2020.09.01.271502, DOI 10.1101/2020.09.01.271502]	76	0	0	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	NOV 9	2021	128								110708	10.1016/j.jbiomech.2021.110708			10	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	WC6JJ	WOS:000704362200002	34492445				2022-02-06	
J	Powers, KC; Pfaff, LM; Cinelli, ME				Powers, Kaley C.; Pfaff, Lana M.; Cinelli, Michael E.			Collision avoidance behaviors of recently concussed female rugby players with an approaching person	JOURNAL OF BIOMECHANICS			English	Article						Sport related concussion; Collision avoidance; Time-to-contact; Human locomotion; Person-person interaction	PART	Background: Successful collision avoidance requires individuals to use readily available perceptual information to make decisions and act within their action capabilities. Female varsity rugby players use time-to-collision information to get closer to an obstacle before deviating; however, following a sport-related concussion (SRC), individuals may not be able to use the same strategies due to poorer action boundary perception. The current study examined the effects of a SRC on collision avoidance with an approaching person. Methods: Non-concussed female varsity rugby athletes (ATH, n = 10) and recently concussed but asymptomatic teammates (CONC, n = 3) were instructed to walk at a comfortable pace and avoid colliding with an approaching confederate. Time-to-collision (TTC), rate of medial-lateral (ML) avoidance, and ML spatial requirement were calculated and analyzed using mixed repeated measures ANOVAs. Findings: There were no physical characteristic differences between groups (p < 0.05) and no collisions occurred on any of the trials. However, CONC displayed larger TTC than ATH (p = 0.03), indicative of a more cautious avoidance strategy. Interpretation: While rugby players are trained to avoid opponents, a more cautious strategy following a SRC may reflect visuomotor detraining and changes in embodiment. This suggests that despite being asymptomatic, there is a reduced sense of agency during dynamic perception-action tasks and persistent alterations between preconcussion and post-concussion self.	[Powers, Kaley C.; Pfaff, Lana M.; Cinelli, Michael E.] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, Waterloo, ON, Canada		Cinelli, ME (corresponding author), Wilfrid Laurier Univ, Dept Kinesiol & Phys Ed, 75 Univ Ave W, Waterloo, ON N2L 3C5, Canada.	mcinelli@wlu.ca					Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Barrett, 2011, BRAIN BODY ENV SHAPE; Cinelli ME, 2007, GAIT POSTURE, V26, P186, DOI 10.1016/j.gaitpost.2006.08.012; Eagle SR, 2021, CLIN J SPORT MED, V31, P273, DOI 10.1097/JSM.0000000000000731; Ellis MJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01115; Fuller CW, 2017, BRIT J SPORT MED, V51, P51, DOI 10.1136/bjsports-2016-096275; Gibson J. J., 1979, ECOLOGICAL APPROACH; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; Mujika I, 2000, SPORTS MED, V30, P79, DOI 10.2165/00007256-200030020-00002; Pfaff LM, 2018, HUM MOVEMENT SCI, V62, P105, DOI 10.1016/j.humov.2018.09.010; Sanderson M., 2013, EMBODIMENT POSTCONCU; Sivertsen M., 2014, PHYSIOTHERAPY THEORY, P1; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Stoffregen TA, 2000, ECOL PSYCHOL, V12, P1, DOI 10.1207/S15326969ECO1201_1; van Andel S, 2017, HUM MOVEMENT SCI, V51, P59, DOI 10.1016/j.humov.2016.11.004	16	0	0	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	NOV 9	2021	128								110776	10.1016/j.jbiomech.2021.110776			5	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	WK4ZG	WOS:000709734800008	34628199				2022-02-06	
J	Wu, LM; Chung, JY; Cao, T; Jin, G; Edmiston, WJ; Hickman, S; Levy, ES; Whalen, JA; Abrams, ESL; Degterev, A; Lo, EH; Tozzi, L; Kaplan, DL; El Khoury, J; Whalen, MJ				Wu, Limin; Chung, Joon Yong; Cao, Tian; Jin, Gina; Edmiston, William J.; Hickman, Suzanne; Levy, Emily S.; Whalen, Jordyn A.; Abrams, Eliza Sophie LaRovere; Degterev, Alexei; Lo, Eng H.; Tozzi, Lorenzo; Kaplan, David L.; El Khoury, Joseph; Whalen, Michael J.			Genetic inhibition of RIPK3 ameliorates functional outcome in controlled cortical impact independent of necroptosis	CELL DEATH & DISEASE			English	Article							TRAUMATIC BRAIN-INJURY; MIXED LINEAGE KINASE; CELL-DEATH; PROGRAMMED NECROSIS; DOMAIN-LIKE; NEUTRALIZATION; HISTOPATHOLOGY; INFLAMMATION; DOWNSTREAM; DEFICIENCY	Traumatic brain injury (TBI) is a leading cause of death and disability with no specific effective therapy, in part because disease driving mechanisms remain to be elucidated. Receptor interacting protein kinases (RIPKs) are serine/threonine kinases that assemble multi-molecular complexes that induce apoptosis, necroptosis, inflammasome and nuclear factor kappa B activation. Prior studies using pharmacological inhibitors implicated necroptosis in the pathogenesis of TBI and stroke, but these studies cannot be used to conclusively demonstrate a role for necroptosis because of the possibility of off target effects. Using a model of cerebral contusion and RIPK3 and mixed lineage kinase like knockout (MLKL-/-) mice, we found evidence for activation of RIPK3 and MLKL and assembly of a RIPK1-RIPK3-MLKL necrosome complex in pericontusional brain tissue. Phosphorylated forms of RIPK3 and MLKL were detected in endothelium, CD11b + immune cells, and neurons, and RIPK3 was upregulated and activated in three-dimensional human endothelial cell cultures subjected to CCI. RIPK3(-/-) and MLKL-/- mice had reduced blood-brain barrier damage at 24 h (p < 0.05), but no differences in neuronal death (6 h, p = ns in CA1, CA3 and DG), brain edema (24 h, p = ns), or lesion size (4 weeks, p = ns) after CCI. RIPK3(-/-), but not MLKL-/- mice, were protected against postinjury motor and cognitive deficits at 1-4 weeks (RIPK3(-/-) vs WT: p < 0.05 for group in wire grip, Morris water maze hidden platform trials, p < 0.05 for novel object recognition test, p < 0.01 for rotarod test). RIPK3(-/-) mice had reduced infiltrating leukocytes (p < 0.05 vs WT in CD11b + cells, microglia and macrophages), HMGB1 release and interleukin-1 beta activation at 24-48 h (p < 0.01) after CCI. Our data indicate that RIPK3 contributes to functional outcome after cerebral contusion by mechanisms involving inflammation but independent of necroptosis.	[Wu, Limin; Chung, Joon Yong; Cao, Tian; Jin, Gina; Edmiston, William J.; Levy, Emily S.; Whalen, Jordyn A.; Abrams, Eliza Sophie LaRovere; Whalen, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Cao, Tian] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610041, Sichuan, Peoples R China; [Hickman, Suzanne; El Khoury, Joseph] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Dept Med, Boston, MA USA; [Degterev, Alexei] Tufts Univ, Sch Med, Dev Mol & Chem Biol, Boston, MA 02111 USA; [Lo, Eng H.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA; [Lo, Eng H.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Tozzi, Lorenzo; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA		Whalen, MJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.	mwhalen@mgh.harvard.edu		Chung, Joon Yong/0000-0002-3980-2065	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1NS121792-01, RF1AG051506, RO1AI119065, R01NS092847-01]	This work was supported by NIH grants to Dr. Whalen (RO1NS121792-01), Dr. El Khoury (RF1AG051506 and RO1AI119065) and Dr. Kaplan (R01NS092847-01). We thank Dr. Siddharth Balachandran at Fox Chase Cancer Center (Philadelphia, PA) for kindly sharing MLKL<SUP>-/-</SUP> mice.	Akamatsu Y, 2020, NEUROTHERAPEUTICS, V17, P446, DOI 10.1007/s13311-020-00840-7; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Aneja RK, 2019, J NEUROTRAUM, V36, P360, DOI 10.1089/neu.2018.5664; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Boytard L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18088-2; Brault M, 2017, IMMUNOL CELL BIOL, V95, P131, DOI 10.1038/icb.2016.117; Chan FKM, 2015, ANNU REV IMMUNOL, V33, P79, DOI 10.1146/annurev-immunol-032414-112248; Chen T, 2018, BIOMED PHARMACOTHER, V107, P563, DOI 10.1016/j.biopha.2018.08.056; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.64; Chung JY, 2019, J NEUROTRAUM, V36, P370, DOI 10.1089/neu.2018.5659; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cruz SA, 2018, NEURAL REGEN RES, V13, P252, DOI 10.4103/1673-5374.226394; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Faul M, 2010, TRAUMATIC BRAIN INJU; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Godwin A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140514; Hainsworth AH, 2005, J CEREBR BLOOD F MET, V25, P1030, DOI 10.1038/sj.jcbfm.9600104; Hanggi K, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.20; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kenny EM, 2019, CRIT CARE MED, V47, P410, DOI 10.1097/CCM.0000000000003555; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim EJ, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00313; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Krajewska M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024341; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Lee JM, 2018, AM J RESP CELL MOL, V59, P215, DOI 10.1165/rcmb.2017-0034OC; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Liaudanskaya V, 2020, ADV HEALTHC MATER, V9, DOI 10.1002/adhm.202000122; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Liu ZM, 2018, BIOCHEM BIOPH RES CO, V499, P112, DOI 10.1016/j.bbrc.2018.02.150; Lule S, 2021, J CEREBR BLOOD F MET, V41, P1623, DOI 10.1177/0271678X20973609; Lule S, 2017, STROKE, V48, P2549, DOI 10.1161/STROKEAHA.117.017702; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Mifflin L, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025102118; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Moriwaki K, 2017, INT REV CEL MOL BIO, V328, P253, DOI 10.1016/bs.ircmb.2016.08.007; Moriwaki K, 2017, CELL REP, V18, P2441, DOI 10.1016/j.celrep.2017.02.015; Moriwaki K, 2016, CELL MOL LIFE SCI, V73, P2325, DOI 10.1007/s00018-016-2203-4; Muendlein HI, 2020, CELL REP, V30, P699, DOI 10.1016/j.celrep.2019.12.073; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Najjar M, 2016, IMMUNITY, V45, P46, DOI 10.1016/j.immuni.2016.06.007; Newton K, 2016, CELL DEATH DIFFER, V23, P1565, DOI 10.1038/cdd.2016.46; Newton K, 2019, NATURE, V574, P428, DOI 10.1038/s41586-019-1548-x; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Parker TM, 2017, BRAIN INJURY, V31, P2, DOI 10.1080/02699052.2016.1217045; Piao CS, 2012, NEUROBIOL DIS, V46, P745, DOI 10.1016/j.nbd.2012.03.018; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Shlomovitz I, 2017, IMMUNOL CELL BIOL, V95, P166, DOI 10.1038/icb.2016.124; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Vitner EB, 2014, NAT MED, V20, P204, DOI 10.1038/nm.3449; Wang QW, 2015, CIRC RES, V116, P600, DOI 10.1161/CIRCRESAHA.116.304899; Wu LM, 2019, J CEREBR BLOOD F MET, V39, P2196, DOI 10.1177/0271678X18786633; Yager PH, 2008, J CEREBR BLOOD F MET, V28, P1030, DOI 10.1038/sj.jcbfm.9600605; Ying ZX, 2018, MOL CELL, V72, P457, DOI 10.1016/j.molcel.2018.09.011; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Yuan JY, 2019, NAT REV NEUROSCI, V20, P19, DOI 10.1038/s41583-018-0093-1; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	68	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	NOV 9	2021	12	11							1064	10.1038/s41419-021-04333-z			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	WU3LV	WOS:000716450800004	34753914	Green Published, gold			2022-02-06	
J	Barnes, S; Bransby-Bell, J; Gallagher-Beverley, Z; Mullay, J; McNeil, R; Taylor, C				Barnes, Scott; Bransby-Bell, Jason; Gallagher-Beverley, Zia; Mullay, Janine; McNeil, Rebecca; Taylor, Christine			Verbosity, traumatic brain injury, and conversation: A preliminary investigation	APHASIOLOGY			English	Article; Early Access						Traumatic brain injury; cognitive-communication disorder; conversation; assessment	TURN-TAKING; COMMUNICATION PARTNERS; ABILITY; ADULTS; ORGANIZATION; COMPETENCE; MANAGEMENT; DISCOURSE; COGNITION; EMERGENT	Background Cognitive-communication disorders resulting from traumatic brain injury may cause speakers to produce excessive verbal output, i.e., to be verbose. There is little evidence on the specific behaviours through which speakers achieve verbosity in conversation. Specifying verbosity-related behaviours can provide an improved basis for diagnosis, treatment, and measuring change in communication over the course of recovery. Aims This study explores whether people with verbosity caused by traumatic brain injury adopt behaviours that violate the normative organisation of turn-taking in conversation. Methods & Procedures Using conversation analysis, this study examines 1 hour and 40 minutes of conversations involving two participants with cognitive communication disorders characterised by verbosity following severe traumatic brain injury. Outcomes & Results Overlapping talk, self-initiated self-repair, parenthetical inserts, and practices for turn continuation are identified as candidate signs of verbosity. There is also evidence that verbose speakers employ practices to manage topical discontinuity caused by verbosity. Conclusions Verbose behaviour involves a complex interplay between cognitive impairment, communicative activity, and the communicative environment. Clinical measures for verbosity should be developed with reference to empirical findings about typical conversation.	[Barnes, Scott; Gallagher-Beverley, Zia; McNeil, Rebecca; Taylor, Christine] Macquarie Univ, Dept Linguist, Sydney, NSW, Australia; [Bransby-Bell, Jason] Royal Rehab, Brain Injury Community Rehabil Team, Ryde, Australia; [Mullay, Janine] Royal Rehab, Brain Injury Unit, Ryde, Australia		Barnes, S (corresponding author), Macquarie Univ, Dept Linguist, N Ryde, NSW 2109, Australia.	scott.barnes@mq.edu.au		Barnes, Scott/0000-0001-5299-0550			Arbuckle TY, 2004, GERONTOLOGY, V50, P291, DOI 10.1159/000079126; Barnes S., 2020, ATYPICAL INTERACTION, P225; Barnes S, 2022, DISABIL REHABIL, V44, P261, DOI 10.1080/09638288.2020.1766123; Barnes S, 2019, J NEUROLINGUIST, V52, DOI 10.1016/j.jneuroling.2019.100850; Barnes S, 2019, CLIN LINGUIST PHONET, V33, P219, DOI 10.1080/02699206.2018.1498541; Body R, 2005, CLIN LINGUIST PHONET, V19, P379, DOI 10.1080/02699200400027189; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho C.A., 1993, CLIN APHASIOLOGY, V21, P183; Doedens WJ, 2020, APHASIOLOGY, V34, P492, DOI 10.1080/02687038.2019.1702848; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Drew P, 1998, LANG SOC, V27, P495, DOI 10.1017/S0047404500020200; Duff MC, 2012, SEMIN SPEECH LANG, V33, P44, DOI 10.1055/s-0031-1301162; Ellmo W, 1995, MEASURE COGNITIVE LI; Enfield N. J., 2017, CONCEPT ACTION; Ferguson A, 1998, APHASIOLOGY, V12, P1007, DOI 10.1080/02687039808249466; Frankel T, 2007, APHASIOLOGY, V21, P814, DOI 10.1080/02687030701192448; Friedland D, 1998, BRAIN INJURY, V12, P1, DOI 10.1080/026990598122818; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Gardner R, 2001, LISTENERS TALK RESPO; GOODWIN C, 1996, INTERACTION GRAMMAR, P370; Hepburn Alexa, 2017, TRANSCRIBING SOCIAL; Heritage John, 2002, LANGUAGE TURN SEQUEN, P196; Joanette Y, 2015, MONTREAL PROTOCOL EV; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Lausberg H, 2009, BEHAV RES METHODS, V41, P841, DOI 10.3758/BRM.41.3.841; Levinson SC, 2016, TRENDS COGN SCI, V20, P6, DOI 10.1016/j.tics.2015.10.010; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Mazeland H, 2007, J PRAGMATICS, V39, P1816, DOI 10.1016/j.pragma.2007.05.005; McDonald S., 2014, SOCIAL COMMUNICATION, P89; Murphy A, 2015, APHASIOLOGY, V29, P151, DOI 10.1080/02687038.2014.959411; Perkins MR, 2005, CLIN LINGUIST PHONET, V19, P367, DOI 10.1080/02699200400027155; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Schegloff E., 1987, TALK SOCIAL ORG, P70; Schegloff EA, 2000, LANG SOC, V29, P1, DOI 10.1017/S0047404500001019; Schegloff EA, 2007, SEQUENCE ORGANIZATION IN INTERACTION: A PRIMER IN CONVERSATION ANALYSIS I, P265; Schegloff EA, 2010, DISCOURSE PROCESS, V47, P130, DOI 10.1080/01638530903223380; Schegloff Emanuel A., 1996, INTERACTION GRAMMAR, P52, DOI 10.1017/cbo9780511620874.002; Selting M, 2000, LANG SOC, V29, P477, DOI 10.1017/S0047404500004012; Sidnell, 2013, CONVERSATIONAL REPAI, P41, DOI DOI 10.1017/CBO9780511757464.002; Sim P, 2013, BRAIN INJURY, V27, P717, DOI 10.3109/02699052.2013.775485; Steel J, 2019, BRAIN INJURY, V33, P48, DOI 10.1080/02699052.2018.1531304; Stivers T, 2009, P NATL ACAD SCI USA, V106, P10587, DOI 10.1073/pnas.0903616106; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Turkstra L.S., 2006, BRAIN IMPAIR, V7, P234, DOI [DOI 10.1375/BRIM.7.3.234, 10.1375/brim.7.3.234]; Vatanen A, 2018, RES LANG SOC INTERAC, V51, P107, DOI 10.1080/08351813.2018.1413894	51	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology												10.1080/02687038.2021.1977233		NOV 2021	24	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	WT1JC	WOS:000715626600001					2022-02-06	
J	Gadot, R; Shofty, B; Najera, RA; Anand, A; Banks, G; Khan, AB; LoPresti, MA; Arroyave, NV; Sheth, SA				Gadot, Ron; Shofty, Ben; Najera, Ricardo A.; Anand, Adrish; Banks, Garrett; Khan, Abdul Basit; LoPresti, Melissa A.; Arroyave, Nora Vanegas; Sheth, Sameer A.			Case Report: Dual Target Deep Brain Stimulation With Externalized Programming for Post-traumatic Complex Movement Disorder	FRONTIERS IN NEUROSCIENCE			English	Article						deep brain stimulation; trauma; tremor; movement disorder; DRTT = dentato-rubro-thalamic tract	HOLMES TREMOR; NUCLEUS; STROKE; SERIES	Introduction: Movement disorders can be common, persistent, and debilitating sequelae of severe traumatic brain injury. Post-traumatic movement disorders are usually complex in nature, involving multiple phenomenological manifestations, and can be difficult to control with medical management alone. Deep brain stimulation (DBS) has been used to treat these challenging cases, but distorted brain anatomy secondary to trauma can complicate effective targeting. In such cases, use of diffusion tractography imaging and inpatient testing with externalized DBS leads can be beneficial in optimizing outcomes.Case Description: We present the case of a 42-year-old man with severe, disabling post-traumatic tremor who underwent bilateral, dual target DBS to the globus pallidus internus (GPi) and a combined ventral intermediate nucleus of the thalamus (Vim)/dentato-rubro-thalamic tracts (DRTT) target. DRTT fiber tracts were reconstructed preoperatively to assist in surgical targeting given the patient's distorted anatomy. Externalization and survey of the four leads extra-operatively with inpatient testing allowed for internalization of the leads that demonstrated benefit. Six months after surgery, the patient's tremor and dystonic burden had decreased by 67% in the performance sub-score of The Essential Tremor Rating Scale (TETRAS).Conclusion: A patient-tailored approach including target selection guided by individualized anatomy and tractography as well as extra-operative externalized lead interrogation was shown to be effective in optimizing clinical outcome in a patient with refractory post-traumatic tremor.	[Gadot, Ron; Shofty, Ben; Najera, Ricardo A.; Anand, Adrish; Khan, Abdul Basit; LoPresti, Melissa A.; Sheth, Sameer A.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Banks, Garrett] Columbia Univ, Med Ctr, Dept Neurol Surg, New York, NY USA; [Arroyave, Nora Vanegas] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA		Sheth, SA (corresponding author), Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA.	sameer.sheth@bcm.edu					Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Artusi CA, 2018, J NEUROL, V265, P2473, DOI 10.1007/s00415-018-8823-x; Bargiotas P, 2021, NEUROMODULATION, V24, P392, DOI 10.1111/ner.13352; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Boccard SGJ, 2016, WORLD NEUROSURG, V96, DOI 10.1016/j.wneu.2016.09.079; Choi SM, 2016, J MOV DISORD, V9, P80, DOI 10.14802/jmd.16004; Coenen VA, 2011, ACTA NEUROCHIR, V153, P1579, DOI 10.1007/s00701-011-1036-z; Coenen VA, 2020, ACTA NEUROCHIR, V162, P1053, DOI 10.1007/s00701-020-04248-2; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Martinez JAE, 2015, NEUROSURG REV, V38, P753, DOI 10.1007/s10143-015-0636-0; Fenoy AJ, 2017, NEUROMODULATION, V20, P429, DOI 10.1111/ner.12585; Foote KD, 2005, NEUROSURGERY, V56, P415, DOI 10.1227/01.NEU.0000147978.67424.42; GhikaSchmid F, 1997, J NEUROL SCI, V146, P109, DOI 10.1016/S0022-510X(96)00290-0; Horn A, 2019, NEUROIMAGE, V184, P293, DOI 10.1016/j.neuroimage.2018.08.068; Javalkar V, 2014, NEUROL CLIN, V32, P871, DOI 10.1016/j.ncl.2014.07.012; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Karas PJ, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.590825; Kashanian A, 2021, OPER NEUROSURG, V20, P141, DOI 10.1093/ons/opaa268; Kipfer S, 2013, MOVEMENT DISORD, V28, P1347, DOI 10.1002/mds.25621; Krauss JK, 2002, NEUROSURGERY, V50, P927, DOI 10.1097/00006123-200205000-00003; Kudo M, 2001, MOVEMENT DISORD, V16, P170, DOI 10.1002/1531-8257(200101)16:1<170::AID-MDS1033>3.0.CO;2-P; Kubler D, 2021, PARKINSONISM RELAT D, V89, P54, DOI 10.1016/j.parkreldis.2021.06.019; Rojas-Medina LM, 2016, STEREOT FUNCT NEUROS, V94, P379, DOI 10.1159/000448078; Mendonca MD, 2018, PARKINSONISM RELAT D, V47, P8, DOI 10.1016/j.parkreldis.2017.12.014; Morishita T, 2019, J NEUROL SCI, V398, P148, DOI 10.1016/j.jns.2019.01.025; Ondo W, 2018, MOV DISORD CLIN PRAC, V5, P60, DOI 10.1002/mdc3.12560; Plaha P, 2008, J NEUROL NEUROSUR PS, V79, P504, DOI 10.1136/jnnp.2006.112334; Puschmann A, 2011, SEMIN NEUROL, V31, P65, DOI 10.1055/s-0031-1271312; Raina GB, 2016, NEUROLOGY, V86, P931, DOI 10.1212/WNL.0000000000002440; Ramirez-Zamora A, 2016, EXPERT REV NEUROTHER, V16, P983, DOI 10.1080/14737175.2016.1194756; Wang KL, 2020, NEUROMODULATION, DOI 10.1111/ner.13220	32	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	NOV 8	2021	15								774073	10.3389/fnins.2021.774073			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB1BX	WOS:000721071200001	34819837	Green Published, gold			2022-02-06	
J	List, JA				List, John A.			Enhancing critical thinking skill formation: Getting fast thinkers to slow down	JOURNAL OF ECONOMIC EDUCATION			English	Article							TRAUMATIC BRAIN-INJURY		[List, John A.] Univ Chicago, Kenneth C Griffin Dept Econ, Chicago, IL 60637 USA; [List, John A.] NBER, Cambridge, MA 02138 USA		List, JA (corresponding author), Univ Chicago, Kenneth C Griffin Dept Econ, Chicago, IL 60637 USA.	jlist@uchicago.edu					Abrami PC, 2015, REV EDUC RES, V85, P275, DOI 10.3102/0034654314551063; Alevy JE, 2007, J FINANC, V62, P151, DOI 10.1111/j.1540-6261.2007.01204.x; Angeli C, 2009, LEARN INSTR, V19, P322, DOI 10.1016/j.learninstruc.2008.06.010; Bauwens E E, 1987, J Nurs Educ, V26, P278; Bertenshaw C, 2009, ANTHROZOOS, V22, P59, DOI 10.2752/175303708X390473; CACIOPPO JT, 1982, J PERS SOC PSYCHOL, V42, P116, DOI 10.1037/0022-3514.42.1.116; Charness G, 2019, J ECON BEHAV ORGAN, V166, P174, DOI 10.1016/j.jebo.2019.08.025; Cowell JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117947; Elder L, 2010, J DEV ED, V34, P38; Harrison GW, 2004, J ECON LIT, V42, P1009, DOI 10.1257/0022051043004577; Holmes NG, 2015, P NATL ACAD SCI USA, V112, P11199, DOI 10.1073/pnas.1505329112; Kahneman D, 2011, THINKING FAST SLOW; Klauer, 1996, LEARN INSTR, V6, P37, DOI [DOI 10.1016/S0959-4752(96)80003-X, 10.1016/S0959-4752(96)80003-X, DOI 10.1016/0959-4752(95)00015-1]; Laibson D, 2015, AM ECON REV, V105, P385, DOI 10.1257/aer.p20151047; Leighton JP, 2006, J EXP EDUC, V74, P109; List, 2013, WHY AXIS HIDDEN MOTI; List D, 2020, ECONOMICS; List J. A, 1954, MOTIVATION PERSONALI; List JA, 2004, J POLIT ECON, V112, P1131, DOI 10.1086/422564; List JA, 2014, J ECON EDUC, V45, P81, DOI 10.1080/00220485.2014.889538; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; Miri B, 2007, RES SCI EDUC, V37, P353, DOI 10.1007/s11165-006-9029-2; Paul R., 1996, J DEV ED, V20, P34; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Siegfried J, 2022, J ECON EDUC, V53, P71, DOI 10.1080/00220485.2021.2004278; SMITH VL, 1962, J POLIT ECON, V70, P111, DOI 10.1086/258609; TERENZINI PT, 1995, RES HIGH EDUC, V36, P23, DOI 10.1007/BF02207765; Vas A, 2016, NEUROPSYCHOL REHABIL, V26, P502, DOI 10.1080/09602011.2015.1044013; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d	29	0	0	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-0485	2152-4068		J ECON EDUC	J. Econ. Educ.	JAN 2	2022	53	1					100	108		10.1080/00220485.2021.2004282		NOV 2021	9	Economics; Education & Educational Research	Social Science Citation Index (SSCI)	Business & Economics; Education & Educational Research	YS4AT	WOS:000721172900001		Green Submitted			2022-02-06	
J	Monette, S; Bertrand, JA; Perreau-Linck, E; Ramos-Usuga, D; Rivera, D; Arango-Lasprilla, JC				Monette, Sebastien; Bertrand, Josie-Anne; Perreau-Linck, Elisabeth; Ramos-Usuga, Daniela; Rivera, Diego; Carlos Arango-Lasprilla, Juan			The profession of neuropsychologist in Canada: Findings of a national survey	CLINICAL NEUROPSYCHOLOGIST			English	Article; Early Access						Clinical neuropsychology; neuropsychological practice; professional practice; culture; education	FOLLOW-UP SURVEY; CLINICAL NEUROPSYCHOLOGY; UNITED-STATES; SALARY SURVEY; HOUSTON CONFERENCE; PSYCHOLOGY; EDUCATION; BELIEFS; INCOMES; CHALLENGES	Objective: The purpose of this study was to investigate the demographic characteristics, academic training and types of professional activities of clinical neuropsychologists in Canada. Method: 282 participants completed an online-based survey. Results: Respondents were women for the most part and had a mean age of 43 years. They typically had doctoral-level training (85%) and about one-quarter had postdoctoral training (23%). Nearly half (47%) had a lifespan practice, over one-third (37%) had an adults-only practice, and about one-sixth (16%) had an exclusively pediatric practice. Most worked full-time (79%). Respondents were almost evenly split three ways between those who worked in the public sector, those who worked in the private sector, and those who worked in both. The most common professional activities related to assessment (95%), although clinical supervision (43%) and rehabilitation (42%) were also quite frequent, whereas research (27%) and teaching (18%) were less so. The most common reason for referral was to determine a diagnosis (79%). Pediatric neuropsychologists worked primarily with individuals with neurodevelopmental disorders and neuropsychologists working with adult populations worked primarily with individuals with emotional disorders, acquired neuropsychological disorders (traumatic brain injury, stroke/vascular), and neurocognitive disorders (dementia). Conclusions: At time of study, Canadian neuropsychologists seemed to enjoy a fairly balanced situation: Their level of training and the ratio of neuropsychologists per population were both high. However, these varied widely across Canada. This suggests that the profession and public interest would stand to gain from seeing training standardized to some extent nationwide.	[Monette, Sebastien] Univ Quebec Montreal, Dept Psychol, Montreal, PQ, Canada; [Monette, Sebastien] Inst Univ Jeunes Difficulte, CIUSSS Ctr Sud de Iile de Montreal, Montreal, PQ, Canada; [Bertrand, Josie-Anne] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Bertrand, Josie-Anne] Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; [Perreau-Linck, Elisabeth] Ctr Hosp Univ St Justine, Montreal, PQ, Canada; [Ramos-Usuga, Daniela] Univ Basque Country, Biomed Res Doctorate Program, Leioa, Spain; [Ramos-Usuga, Daniela; Carlos Arango-Lasprilla, Juan] Biocruces Bizkaia Hlth Res Inst, Baracaldo, Spain; [Rivera, Diego] Univ Publ Navarra, Dept Hlth Sci, Pamplona, Spain; [Carlos Arango-Lasprilla, Juan] IKERBASQUE, Basque Fdn Sci, Bilbao, Spain; [Carlos Arango-Lasprilla, Juan] Univ Basque Country, Dept Cell Biol & Histol, Leioa, Spain		Monette, S (corresponding author), Univ Quebec Montreal UQAM, Dept Psychol, Succ Ctr Ville, CP 8888, Montreal, PQ QCH3C 3P8, Canada.	monette.sebastien@uqam.ca	Rivera, Diego/U-8872-2017	Rivera, Diego/0000-0001-7477-1893			Aube W, 2017, NEUROPSYCHOLOGIE CLI, V1, P10, DOI [10.46278/j.ncacn.20170910, DOI 10.46278/J.NCACN.20170910]; Block C, 2017, ARCH CLIN NEUROPSYCH, V32, P369, DOI 10.1093/arclin/acx002; Bodin D, 2016, CLIN NEUROPSYCHOL, V30, P1371, DOI 10.1080/13854046.2016.1199739; Buckman LR, 2018, PROF PSYCHOL-RES PR, V49, P321, DOI 10.1037/pro0000214; Canadian Institute for Health Information (CIHI), 2021, INFORMATION; Canadian Psychological Association, 2021, CLINICALNEUROPSYCHOL; Arango-Lasprilla JC, 2017, APPL NEUROPSYCH-ADUL, V24, P318, DOI 10.1080/23279095.2016.1185423; Chartrand J.-P, 2019, NEUROPSYCHOLOGIE CLI, V3, P10, DOI [10.46278/j.ncacn.20190901, DOI 10.46278/J.NCACN.20190901]; College of psychologists of Ontario, 2019, ANN REP 2018 2019; Dobson KS, 2016, CAN PSYCHOL, V57, P211, DOI 10.1037/cap0000061; Drapeau M, 2016, CAN PSYCHOL, V57, P143, DOI 10.1037/cap0000062; FUERST KB, 1995, CAN PSYCHOL, V36, P12, DOI 10.1037/0708-5591.36.1.12; Gauthier B, 2021, CLIN NEUROPSYCHOL, V35, P1232, DOI 10.1080/13854046.2020.1732467; Grote CL, 2016, CLIN NEUROPSYCHOL, V30, P1356, DOI 10.1080/13854046.2016.1213885; Grote CL, 2016, CLIN NEUROPSYCHOL, V30, P1380, DOI 10.1080/13854046.2016.1235727; Hannay HJ, 1998, ARCH CLIN NEUROPSYCH, V13, P157, DOI 10.1016/S0887-6177(98)00003-1; Hayman-Abello BA, 2003, CAN PSYCHOL, V44, P100, DOI 10.1037/h0086931; Hokkanen L, 2019, CLIN NEUROPSYCHOL, V33, P32, DOI 10.1080/13854046.2018.1484169; Hokkanen L, 2016, CLIN NEUROPSYCHOL, V30, P1214, DOI 10.1080/13854046.2016.1196733; Hunsley J, 2013, PROF PSYCHOL-RES PR, V44, P118, DOI 10.1037/a0029672; Janzen LA, 2016, CLIN NEUROPSYCHOL, V30, P1193, DOI 10.1080/13854046.2016.1175668; Lopes AB, 2021, APPL NEUROPSYCH-ADUL, V28, P328, DOI 10.1080/23279095.2019.1633329; Fernandez AL, 2016, CLIN NEUROPSYCHOL, V30, P1154, DOI 10.1080/13854046.2016.1197313; Nelson NW, 2021, CLIN NEUROPSYCHOL, V35, P1205, DOI 10.1080/13854046.2021.1926543; Norup A, 2017, CLIN NEUROPSYCHOL, V31, P20, DOI 10.1080/13854046.2017.1291857; Olabarrieta-Landa L, 2016, CLIN NEUROPSYCHOL, V30, P1335, DOI 10.1080/13854046.2016.1183049; Onida A, 2019, APPL NEUROPSYCH-ADUL, V26, P543, DOI 10.1080/23279095.2018.1466782; OPQ, 2020, ATT NEUR EX FORM THE; Ponsford J, 2016, CLIN NEUROPSYCHOL, V30, P1179, DOI 10.1080/13854046.2016.1195015; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rourke B.P., 1981, CANADIAN PSYCHOL, V22, P85, DOI [https://doi.org/10.1037/h0081139, DOI 10.1037/H0081139]; Sakamoto M, 2016, CLIN NEUROPSYCHOL, V30, P1278, DOI 10.1080/13854046.2016.1204012; Statistics Canada, 2021, STAT OFF LANG CAN; Statistics Canada, 2021, TABL 1 AV WEEKL EARN; Statistics Canada, 2021, POPULATION ESTIMATES; Statistics Canada, 2021, TABL 11 10 0066 01 M, DOI [10.25318/1110006601-eng, DOI 10.25318/1110006601-ENG]; Statistics Canada, 2021, TABL 14 10 0306 01 E, DOI [10.25318/1410030601-eng, DOI 10.25318/1410030601-ENG]; Sweet JJ, 2006, CLIN NEUROPSYCHOL, V20, P325, DOI 10.1080/13854040600760488; Sweet JJ, 2021, CLIN NEUROPSYCHOL, V35, P7, DOI 10.1080/13854046.2020.1849803; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; Sweet JJ, 2012, CLIN NEUROPSYCHOL, V26, P1055, DOI 10.1080/13854046.2012.705565; Sweet JJ, 2011, CLIN NEUROPSYCHOL, V25, P12, DOI 10.1080/13854046.2010.544165; Sweet JJ, 2000, CLIN NEUROPSYCHOL, V14, P18, DOI 10.1076/1385-4046(200002)14:1;1-8;FT018; Sweet JJ, 1996, CLIN NEUROPSYCHOL, V10, P202, DOI 10.1080/13854049608406681; Sweet JJ, 2000, CLIN NEUROPSYCHOL, V14, P479, DOI 10.1076/clin.14.4.479.7201; SWEET JJ, 1990, CLIN NEUROPSYCHOL, V4, P101, DOI DOI 10.1080/13854049008401504; Votta-Bleeker L, 2016, CAN PSYCHOL, V57, P172, DOI 10.1037/cap0000059; WADE TC, 1977, AM PSYCHOL, V32, P874, DOI 10.1037/0003-066X.32.10.874	48	0	0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.												10.1080/13854046.2021.2002934		NOV 2021	33	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	WZ8FL	WOS:000720197700001	34791971				2022-02-06	
J	Vale, A; Post, A; Cournoyer, J; Hoshizaki, TB; Gilchrist, MD				Vale, Adam; Post, Andrew; Cournoyer, Janie; Hoshizaki, T. Blaine; Gilchrist, Michael D.			Influence of play type on the magnitude and number of head impacts sustained in youth American football	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article; Early Access						Brain trauma; play type; position; concussion; subconcussive; repetitive head trauma	SERUM NEUROFILAMENT LIGHT; TRAUMATIC BRAIN-INJURY; WHITE-MATTER; SINGLE SEASON; AXONAL INJURY; EXPOSURE; MODEL; BIOMECHANICS; FREQUENCY	The magnitude and number of head impacts experienced by young American football players are associated with negative brain health outcomes and may be affected by play-type strategies. The purpose of this research was to examine how play type affects the magnitude and number of head impacts in youth American tackle football. Head impacts were recorded for 30 games in the 5-9 age category and 30 games in the 9-14 age category. Impacts using physical and finite element models were conducted to determine the brain strain. Run plays had a higher head impact frequency in both age groups (p < 0.05). This increase in head impacts was consistent for all positions (p < 0.05), except wide receiver, and offensive line and defensive back in the 9-14 age group (p > 0.05). Both age groups experienced significantly different magnitude proportions with higher numbers of very low and low strain magnitude impacts during run plays (p < 0.05), and a higher proportion of moderate magnitude impacts in the 5-9 age category (p < 0.05). This data can be used to inform and educate teams and coaches and influence decisions around the use of runs and passing plays that may lead to a decrease in head impacts.	[Vale, Adam; Post, Andrew; Cournoyer, Janie; Hoshizaki, T. Blaine] Univ Ottawa, Human Kinet, Ottawa, ON, Canada; [Post, Andrew; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), Univ Ottawa, Human Kinet, Ottawa, ON, Canada.	apost@uottawa.ca					Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Champagne AA, 2020, J CEREBR BLOOD F MET, V40, P1453, DOI 10.1177/0271678X19862861; Chen WS, 2020, SPORT BIOMECH, DOI 10.1080/14763141.2020.1754450; Cournoyer J, 2021, J BIOMECH, V127, DOI 10.1016/j.jbiomech.2021.110689; Cournoyer J, 2019, J ATHL TRAINING, V54, P765, DOI 10.4085/1062-6050-253-18; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Fryar CD., 2007, VITAL HLTH STAT, V11, P1; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Karton C., 2016, TRAUMATIC BRAIN INJU; Karton C., 2018, DESCRIBING HEAD TRAU; Karton C, 2021, J BIOMECH, V116, DOI 10.1016/j.jbiomech.2020.110203; Karton C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-54874-9; Karton C, 2018, HAND CLINIC, V158, P39, DOI 10.1016/B978-0-444-63954-7.00005-7; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kerr ZY, 2017, J ATHL TRAINING, V52, P955, DOI 10.4085/1062-6050-52.7.06; Khatib A., 2019, COMP BRAIN TRAUMA CH; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koncan D, 2019, P I MECH ENG P-J SPO, V233, P277, DOI 10.1177/1754337118822940; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Le RK, 2021, PEDIATR NEUROL, V121, P33, DOI 10.1016/j.pediatrneurol.2021.04.005; Lynall RC, 2019, J NEUROTRAUM, V36, P1752, DOI 10.1089/neu.2018.6236; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; NELLHAUS G, 1968, PEDIATRICS, V41, P106; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Post A., 2019, 42 CAN MED BIOL ENG; Post A, 2021, COMPUT METHOD BIOMEC, V24, P1, DOI 10.1080/10255842.2020.1805442; Post A, 2019, COMPUT METHOD BIOMEC, V22, P631, DOI 10.1080/10255842.2019.1577827; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Post A, 2017, J NEUROSURG-PEDIATR, V19, P641, DOI 10.3171/2016.11.PEDS16383; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Reed DD, 2006, J APPL BEHAV ANAL, V39, P281, DOI 10.1901/jaba.2006.146-05; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Schmidt JD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4231; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Teramoto M, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115620365; Tsushima WT, 2019, ARCH CLIN NEUROPSYCH, V34, P60, DOI 10.1093/arclin/acy019; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zanetti K., 2013, INT RES COUNC BIOM I; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	65	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.												10.1080/10255842.2021.2003345		NOV 2021	16	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	WY9VC	WOS:000719623400001	34788175				2022-02-06	
J	Ware, AL; Yeates, KO; Geeraert, B; Long, XY; Beauchamp, MH; Craig, W; Doan, Q; Freedman, SB; Goodyear, BG; Zemek, R; Lebel, C				Ware, Ashley L.; Yeates, Keith Owen; Geeraert, Bryce; Long, Xiangyu; Beauchamp, Miriam H.; Craig, William; Doan, Quynh; Freedman, Stephen B.; Goodyear, Bradley G.; Zemek, Roger; Lebel, Catherine		Pediat Emergency Res Canada A-CAP	Structural connectome differences in pediatric mild traumatic brain and orthopedic injury	HUMAN BRAIN MAPPING			English	Article						diffusion MRI; graph theory; orthopedic injury; pediatric mild traumatic brain injury; structural connectome	SEX-DIFFERENCES; HEAD IMPACTS; CHILDREN; SYMPTOMS; RECOMMENDATIONS; REGISTRATION; CHILDHOOD; MOTION; TESTS; SCALE	Sophisticated network-based approaches such as structural connectomics may help to detect a biomarker of mild traumatic brain injury (mTBI) in children. This study compared the structural connectome of children with mTBI or mild orthopedic injury (OI) to that of typically developing (TD) children. Children aged 8-16.99 years with mTBI (n = 83) or OI (n = 37) were recruited from the emergency department and completed 3T diffusion MRI 2-20 days postinjury. TD children (n = 39) were recruited from the community and completed diffusion MRI. Graph theory metrics were calculated for the binarized average fractional anisotropy among 90 regions. Multivariable linear regression and linear mixed effects models were used to compare groups, with covariates age, hemisphere, and sex, correcting for multiple comparisons. The two injury groups did not differ on graph theory metrics, but both differed from TD children in global metrics (local network efficiency: TD > OI, mTBI, d = 0.49; clustering coefficient: TD < OI, mTBI, d = 0.49) and regional metrics for the fusiform gyrus (lower degree centrality and nodal efficiency: TD > OI, mTBI, d = 0.80 to 0.96; characteristic path length: TD < OI, mTBI, d = -0.75 to -0.90) and in the superior and middle orbital frontal gyrus, paracentral lobule, insula, and thalamus (clustering coefficient: TD > OI, mTBI, d = 0.66 to 0.68). Both mTBI and OI demonstrated reduced global and regional network efficiency and segregation as compared to TD children. Findings suggest a general effect of childhood injury that could reflect pre- and postinjury factors that can alter brain structure. An OI group provides a more conservative comparison group than TD children for structural neuroimaging research in pediatric mTBI.	[Ware, Ashley L.; Yeates, Keith Owen] Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N OV2, Canada; [Ware, Ashley L.; Geeraert, Bryce; Long, Xiangyu; Goodyear, Bradley G.; Lebel, Catherine] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Ware, Ashley L.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] CHU St Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Craig, William] Univ Alberta, Edmonton, AB, Canada; [Craig, William] Stollery Childrens Hosp, Edmonton, AB, Canada; [Doan, Quynh] Univ British Columbia, Pediat Emergency Med, Vancouver, BC, Canada; [Freedman, Stephen B.] Univ Calgary, Cumming Sch Med, Dept Emergency Med, Calgary, AB, Canada; [Zemek, Roger] Univ Ottawa, Childrens Hosp, Dept Pediat & Emergency Med, Eastern Ontario Res Inst, Ottawa, ON, Canada		Ware, AL (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N OV2, Canada.	ashley.ware@ucalgary.ca			Natural Sciences and Engineering Research Council (NSERC) of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC); Killam Postdoctoral Fellowship at the University of Calgary; Alberta Children's Hospital Foundation; Hotchkiss Brain Institute; Canada Research Chair ProgramCanada Research Chairs; Canadian Institute of Health Research (CIHR) FoundationCanadian Institutes of Health Research (CIHR) [FDN143304]; Alberta Children's Hospital Research Institute	Natural Sciences and Engineering Research Council (NSERC) of Canada; Killam Postdoctoral Fellowship at the University of Calgary; Alberta Children's Hospital Foundation and Research Institute; Hotchkiss Brain Institute; Canada Research Chair Program; Canadian Institute of Health Research (CIHR) Foundation, Grant/Award Number: FDN143304	Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bruce B, 2007, PAED CHILD HEALT-CAN, V12, P749, DOI 10.1093/pch/12.9.749; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chung AW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54950-0; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Foss KDB, 2019, CLIN J SPORT MED, V29, P442, DOI 10.1097/JSM.0000000000000753; Geeraert BL, 2019, HUM BRAIN MAPP, V40, P4345, DOI 10.1002/hbm.24706; Geeraert BL, 2018, NEUROIMAGE, V182, P343, DOI 10.1016/j.neuroimage.2017.09.019; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Konigs M, 2017, HUM BRAIN MAPP, V38, P3603, DOI 10.1002/hbm.23614; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lebel C, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.3778; Leemans A., 2009, 17 ANN M INT SOC MAG, DOI DOI 10.1093/OCCMED/KQR069; LODER RT, 1995, J PEDIATR ORTHOPED, V15, P41, DOI 10.1097/01241398-199501000-00010; Long XY, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.102082; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; R Development Core Team, 2012, R LANG ENV STAT COMP; Raji CA, 2020, PEDIATR RADIOL, V50, P1594, DOI 10.1007/s00247-020-04743-9; Reuter M, 2015, NEUROIMAGE, V107, P107, DOI 10.1016/j.neuroimage.2014.12.006; Roalf DR, 2016, NEUROIMAGE, V125, P903, DOI 10.1016/j.neuroimage.2015.10.068; Rosen AFG, 2018, NEUROIMAGE, V169, P407, DOI 10.1016/j.neuroimage.2017.12.059; RStudio Team, 2020, RSTUDIO INT DEV R; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schmidt J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3406; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Sun MJ, 2018, BRAIN BEHAV IMMUN, V69, P618, DOI 10.1016/j.bbi.2018.01.007; TEASDALE G, 1974, LANCET, V2, P81; Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799; Wang JH, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.2015.00386, 10.3389/fnhum.2015.00458]; Watson CG, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101673; Wechsler D., 2011, WECHSLER ABBREVIATED; Wilde EA, 2019, J NEUROTRAUM, V36, P239, DOI 10.1089/neu.2017.5513; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yeates KO, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017012; Yuan WH, 2017, J HEAD TRAUMA REHAB, V32, P378, DOI 10.1097/HTR.0000000000000318; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664	56	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	FEB 15	2022	43	3					1032	1046		10.1002/hbm.25705		NOV 2021	15	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	YH9TB	WOS:000715383800001	34748258	gold, Green Accepted			2022-02-06	
J	Chen, SG; Shu, XK; Wang, HW; Ding, L; Fu, JH; Jia, J				Chen, Shugeng; Shu, Xiaokang; Wang, Hewei; Ding, Li; Fu, Jianghong; Jia, Jie			The Differences Between Motor Attempt and Motor Imagery in Brain-Computer Interface Accuracy and Event-Related Desynchronization of Patients With Hemiplegia	FRONTIERS IN NEUROROBOTICS			English	Article						BCI accuracies; event-related desynchronization; motor attempt; motor imagery; brain-computer interface	EXECUTION; MOVEMENTS; HAND; REORGANIZATION; IMPAIRMENT; RESPONSES; PROGRAMS; RECOVERY; FNIRS	Background: Motor attempt and motor imagery (MI) are two common motor tasks used in brain-computer interface (BCI). They are widely researched for motor rehabilitation in patients with hemiplegia. The differences between the motor attempt (MA) and MI tasks of patients with hemiplegia can be used to promote BCI application. This study aimed to explore the accuracy of BCI and event-related desynchronization (ERD) between the two tasks.Materials and Methods: We recruited 13 patients with stroke and 3 patients with traumatic brain injury, to perform MA and MI tasks in a self-control design. The BCI accuracies from the bilateral, ipsilesional, and contralesional hemispheres were analyzed and compared between different tasks. The cortical activation patterns were evaluated with ERD and laterality index (LI).Results: The study showed that the BCI accuracies of MA were significantly (p < 0.05) higher than MI in the bilateral, ipsilesional, and contralesional hemispheres in the alpha-beta (8-30 Hz) frequency bands. There was no significant difference in ERD and LI between the MA and MI tasks in the 8-30 Hz frequency bands. However, in the MA task, there was a negative correlation between the ERD values in the channel CP1 and ipsilesional hemispheric BCI accuracies (r = -0.552, p = 0.041, n = 14) and a negative correlation between the ERD values in channel CP2 and bilateral hemispheric BCI accuracies (r = -0.543, p = 0.045, n = 14). While in the MI task, there were negative correlations between the ERD values in channel C4 and bilateral hemispheric BCI accuracies (r = -0.582, p = 0.029, n = 14) as well as the contralesional hemispheric BCI accuracies (r = -0.657, p = 0.011, n = 14). As for motor dysfunction, there was a significant positive correlation between the ipsilesional BCI accuracies and FMA scores of the hand part in 8-13 Hz (r = 0.565, p = 0.035, n = 14) in the MA task and a significant positive correlation between the ipsilesional BCI accuracies and FMA scores of the hand part in 13-30 Hz (r = 0.558, p = 0.038, n = 14) in the MI task.Conclusion: The MA task may achieve better BCI accuracy but have similar cortical activations with the MI task. Cortical activation (ERD) may influence the BCI accuracy, which should be carefully considered in the BCI motor rehabilitation of patients with hemiplegia.	[Chen, Shugeng; Wang, Hewei; Ding, Li; Fu, Jianghong; Jia, Jie] Fudan Univ, Huashan Hosp, Dept Rehabil Med, Shanghai, Peoples R China; [Shu, Xiaokang] Shanghai Jiao Tong Univ, Sch Mech Engn, Shanghai, Peoples R China; [Jia, Jie] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China; [Jia, Jie] Natl Ctr Neurol Disorders, Shanghai, Peoples R China		Jia, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Rehabil Med, Shanghai, Peoples R China.; Jia, J (corresponding author), Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China.; Jia, J (corresponding author), Natl Ctr Neurol Disorders, Shanghai, Peoples R China.	shannonjj@126.com					Anastasi AA, 2017, STROKE RES TREAT, V2017, DOI 10.1155/2017/8276136; Antelis JM, 2017, IEEE T BIO-MED ENG, V64, P99, DOI 10.1109/TBME.2016.2541084; Bai ZF, 2020, J NEUROENG REHABIL, V17, DOI 10.1186/s12984-020-00686-2; Battaglia C, 2014, HUM MOVEMENT SCI, V38, P225, DOI 10.1016/j.humov.2014.10.001; Biasiucci A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04673-z; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blokland Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12815; Blokland Y, 2014, IEEE T NEUR SYS REH, V22, P222, DOI 10.1109/TNSRE.2013.2292995; Bundy DT, 2017, STROKE, V48, P1908, DOI 10.1161/STROKEAHA.116.016304; Caria A, 2011, PSYCHOPHYSIOLOGY, V48, P578, DOI 10.1111/j.1469-8986.2010.01117.x; Cassim F, 2000, CLIN NEUROPHYSIOL, V111, P2032, DOI 10.1016/S1388-2457(00)00455-7; Chen SG, 2021, CLIN EEG NEUROSCI, DOI 10.1177/15500594211019917; Cicinelli P, 1997, ELECTROMYOGR MOTOR C, V105, P438, DOI 10.1016/S0924-980X(97)00052-0; Del Gratta C, 2000, NEUROREPORT, V11, P2035, DOI 10.1097/00001756-200006260-00046; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Di Rienzo F, 2019, NEUROSCIENCE, V418, P82, DOI 10.1016/j.neuroscience.2019.08.025; Frolov AA, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00400; Hanakawa T, 2008, CEREB CORTEX, V18, P2775, DOI 10.1093/cercor/bhn036; Hotz-Boenden-Naker S, 2008, NEUROIMAGE, V39, P383, DOI 10.1016/j.neuroimage.2007.07.065; Hummel F, 2002, BRAIN, V125, P404, DOI 10.1093/brain/awf030; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Johnson NN, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aa8ce3; Kaiser V, 2014, NEUROIMAGE, V85, P432, DOI 10.1016/j.neuroimage.2013.04.097; Kaiser V, 2012, STROKE, V43, P2735, DOI 10.1161/STROKEAHA.112.665489; Kaplan A, 2016, LECT NOTES ARTIF INT, V9743, P46, DOI 10.1007/978-3-319-39955-3_5; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kraeutner S, 2014, BRAIN RES, V1588, P81, DOI 10.1016/j.brainres.2014.09.001; Li MF, 2014, INT J NEUROSCI, V124, P403, DOI 10.3109/00207454.2013.850082; Li W, 2019, BRAIN RES, V1722, DOI 10.1016/j.brainres.2019.146338; Lopez-Larraz E, 2017, P ANN INT IEEE EMBS, P3065, DOI 10.1109/EMBC.2017.8037504; Lopez-Larraz E, 2012, IEEE ENG MED BIO, P1798, DOI 10.1109/EMBC.2012.6346299; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Mizuno K, 2018, JMIR RES PROTOC, V7, DOI 10.2196/12339; Muller-Putz GR, 2007, BRAIN RES, V1137, P84, DOI 10.1016/j.brainres.2006.12.052; Muralidharan A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00039; Niazi IK, 2012, IEEE T NEUR SYS REH, V20, P595, DOI 10.1109/TNSRE.2012.2194309; Nikulin VV, 2008, NEUROPSYCHOLOGIA, V46, P727, DOI 10.1016/j.neuropsychologia.2007.10.008; Ono T, 2015, BRAIN TOPOGR, V28, P340, DOI 10.1007/s10548-014-0382-6; Peng WW, 2019, NEUROIMAGE, V195, P396, DOI 10.1016/j.neuroimage.2019.03.077; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pichiorri F, 2015, ANN NEUROL, V77, P851, DOI 10.1002/ana.24390; PIVIK RT, 1993, PSYCHOPHYSIOLOGY, V30, P547, DOI 10.1111/j.1469-8986.1993.tb02081.x; Ramos-Murguialday A, 2019, NEUROREHAB NEURAL RE, V33, P188, DOI 10.1177/1545968319827573; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Rathee D, 2019, IEEE T NEUR SYS REH, V27, P1020, DOI 10.1109/TNSRE.2019.2908125; Rimbert S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00622; Rimbert S, 2018, PEERJ, V6, DOI 10.7717/peerj.4492; Rimbert S, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02341; Rossini PM, 2003, LANCET NEUROL, V2, P493, DOI 10.1016/S1474-4422(03)00485-X; Schomer DL., 2012, NIEDERMEYERS ELECTRO; Shu XK, 2019, IEEE T BIO-MED ENG, V66, P1987, DOI 10.1109/TBME.2018.2882075; Shu XK, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00093; Spuler M, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0438-z; Takemi M, 2013, J NEUROPHYSIOL, V110, P1158, DOI 10.1152/jn.01092.2012; Tecchio F, 1997, BRAIN RES, V767, P100, DOI 10.1016/S0006-8993(97)00741-5; Wang L, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3870863; Wong WW, 2013, BRAIN INJURY, V27, P651, DOI 10.3109/02699052.2013.771796; Yao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064784	60	0	0	5	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5218			FRONT NEUROROBOTICS	Front. Neurorobotics	NOV 5	2021	15								706630	10.3389/fnbot.2021.706630			13	Computer Science, Artificial Intelligence; Robotics; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Robotics; Neurosciences & Neurology	XA1SV	WOS:000720436800001	34803647	gold, Green Published			2022-02-06	
J	Lirani-Silva, E; Stuart, S; Parrington, L; Campbell, K; King, L				Lirani-Silva, Ellen; Stuart, Samuel; Parrington, Lucy; Campbell, Kody; King, Laurie			Saccade and Fixation Eye Movements During Walking in People With Mild Traumatic Brain Injury	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article						saccades; traumatic brain injury; gait; eye tracking; vision	PARKINSONS-DISEASE; DUAL-TASK; CONCUSSION; GAIT; SPORT; IMPAIRMENT; STABILITY; SYMPTOMS; SINGLE; FMRI	Background: Clinical and laboratory assessment of people with mild traumatic brain injury (mTBI) indicate impairments in eye movements. These tests are typically done in a static, seated position. Recently, the use of mobile eye-tracking systems has been proposed to quantify subtle deficits in eye movements and visual sampling during different tasks. However, the impact of mTBI on eye movements during functional tasks such as walking remains unknown.Objective: Evaluate differences in eye-tracking measures collected during gait between healthy controls (HC) and patients in the sub-acute stages of mTBI recovery and to determine if there are associations between eye-tracking measures and gait speed.Methods: Thirty-seven HC participants and 67individuals with mTBI were instructed to walk back and forth over 10-m, at a comfortable self-selected speed. A single 1-min trial was performed. Eye-tracking measures were recorded using a mobile eye-tracking system (head-mounted infra-red Tobbii Pro Glasses 2, 100 Hz, Tobii Technology Inc. VA, United States). Eye-tracking measures included saccadic (frequency, mean and peak velocity, duration and distance) and fixation measurements (frequency and duration). Gait was assessed using six inertial sensors (both feet, sternum, right wrist, lumbar vertebrae and the forehead) and gait velocity was selected as the primary outcome. General linear model was used to compare the groups and association between gait and eye-tracking outcomes were explored using partial correlations.Results: Individuals with mTBI showed significantly reduced saccade frequency (p = 0.016), duration (p = 0.028) and peak velocity (p = 0.032) compared to the HC group. No significant differences between groups were observed for the saccade distance, fixation measures and gait velocity (p > 0.05). A positive correlation was observed between saccade duration and gait velocity only for participants with mTBI (p = 0.025).Conclusion: Findings suggest impaired saccadic eye movement, but not fixations, during walking in individuals with mTBI. These findings have implications in real-world function including return to sport for athletes and return to duty for military service members. Future research should investigate whether or not saccade outcomes are influenced by the time after the trauma and rehabilitation.	[Lirani-Silva, Ellen; Parrington, Lucy; Campbell, Kody; King, Laurie] Oregon Hlth & Sci Univ, Dept Neurol, Balance Disorders Lab, Portland, OR 97201 USA; [Stuart, Samuel] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne, Tyne & Wear, England; [Stuart, Samuel] Northumbria Healthcare NHS Fdn Trust, North Shields, England; [Parrington, Lucy; Campbell, Kody; King, Laurie] Vet Affairs Portland Oregon Hlth Care Syst, Portland, OR USA		Lirani-Silva, E (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Balance Disorders Lab, Portland, OR 97201 USA.	ellenlirani@gmail.com		Stuart, Samuel/0000-0001-6846-9372	US Department of DefenseUnited States Department of Defense [W81XWH-17-1-0424]	Funding Funding was provided by the US Department of Defense (#W81XWH-17-1-0424).	Association A.P., 2013, AM PSYCH ASS DIAGN S; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Bigler ED, 2018, INT J PSYCHOPHYSIOL, V132, P105, DOI 10.1016/j.ijpsycho.2017.09.006; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Campbell KR, 2021, J VESTIBUL RES-EQUIL, V31, P519, DOI 10.3233/VES-201590; Cao LY, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.561755; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Cochrane GD, 2019, OPTOMETRY VISION SCI, V96, P256, DOI 10.1097/OPX.0000000000001364; Di Fabio RP, 2003, J MOTOR BEHAV, V35, P383, DOI 10.1080/00222890309603158; DiCesare CA, 2017, BEHAV RES METHODS, V49, P258, DOI 10.3758/s13428-015-0693-x; Dowiasch S, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00046; Drewes J, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.656913; Durant S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228345; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Foulsham T, 2011, VISION RES, V51, P1920, DOI 10.1016/j.visres.2011.07.002; Hadley E, 1985, Clin Geriatr Med, V1, P497; Hecimovich M, 2019, PHYSICIAN SPORTSMED, V47, P78, DOI 10.1080/00913847.2018.1525261; Howell David R, 2018, Concussion, V3, pCNC54, DOI 10.2217/cnc-2017-0014; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Hunt D, 2018, BEHAV BRAIN RES, V348, P82, DOI 10.1016/j.bbr.2018.03.003; Injury T.M.o.C.-m.T.B., 2016, VA DOD CLIN PRACTIC; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Kelly KM, 2019, J HEAD TRAUMA REHAB, V34, P176, DOI 10.1097/HTR.0000000000000437; Kennedy PM, 2003, EXP BRAIN RES, V153, P113, DOI 10.1007/s00221-003-1633-z; Kimmig H, 2001, EXP BRAIN RES, V141, P184, DOI 10.1007/s002210100844; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kribus-Shmiel L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192049; Kroneberg D, 2019, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00435; Lord S, 2013, MOVEMENT DISORD, V28, P1534, DOI 10.1002/mds.25545; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Morris R, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab4023; Morris R, 2016, NEUROSCI BIOBEHAV R, V64, P326, DOI 10.1016/j.neubiorev.2016.02.012; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mullen SJ, 2014, CAN J NEUROL SCI, V41, P58, DOI 10.1017/S0317167100016279; Murray NG, 2017, CLIN BIOMECH, V44, P21, DOI 10.1016/j.clinbiomech.2017.03.002; Nelson J.D., 2004, J VISUAL-JAPAN, V4, P741, DOI [10.1167/4.8.741, DOI 10.1167/4.8.741]; Nunes F, 2017, CHEST, V152, p486A, DOI 10.1016/j.chest.2017.08.513; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Pelz JB, 2001, VISION RES, V41, P3587, DOI 10.1016/S0042-6989(01)00245-0; Rabinowitz AR, 2014, ANNU REV PSYCHOL, V65, P301, DOI 10.1146/annurev-psych-010213-115103; Snegireva N, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaef44; Srivastava A, 2018, J MOV DISORD, V11, P93, DOI 10.14802/jmd.18018; Stuart S., 2015, F1000RES, V4, P1379, DOI [10.12688/f1000research.7320.210.12688/f1000research.7320.1, DOI 10.12688/F1000RESEARCH.7320.210.12688/F1000RESEARCH.7320.1]; Stuart S, 2020, FRONT SPORTS ACT LIV, V2, DOI 10.3389/fspor.2020.00005; Stuart S, 2020, HUM MOVEMENT SCI, V69, DOI 10.1016/j.humov.2019.102557; Stuart S, 2019, MOVEMENT DISORD, V34, P1690, DOI 10.1002/mds.27813; Stuart S, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab159d; Stuart S, 2017, EUR J NEUROSCI, V46, P1703, DOI 10.1111/ejn.13589; Stuart S, 2016, NEUROSCI BIOBEHAV R, V62, P76, DOI 10.1016/j.neubiorev.2016.01.002; Stuart S, 2014, IEEE ENG MED BIO, P5739, DOI 10.1109/EMBC.2014.6944931; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Wang ML, 2016, J NEUROL SCI, V370, P244, DOI 10.1016/j.jns.2016.09.049; Webb B, 2018, J NEUROTRAUM, V35, P1874, DOI 10.1089/neu.2018.5673; Whitney SL, 2019, J NEUROL PHYS THER, V43, pS31, DOI 10.1097/NPT.0000000000000272	60	0	0	5	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.	NOV 5	2021	9								701712	10.3389/fbioe.2021.701712			8	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	XB7XT	WOS:000721538800001	34805104	gold, Green Accepted, Green Published			2022-02-06	
J	Seguin, CM; Culver, DM				Seguin, Cassandra M.; Culver, Diane M.			The lived experience of sport-related concussion: A collaborative inquiry in elite sport	JOURNAL OF APPLIED SPORT PSYCHOLOGY			English	Article; Early Access							ATHLETES EXPERIENCES; EXERCISE; PERFORMANCE; KNOWLEDGE; SYMPTOMS	Sport-related concussion(s) (SRCs) pose a complex problem to researchers and practitioners alike. The psychological and emotional experience of these injuries requires individualized and multidisciplinary intervention to promote wellbeing and effective recovery. These interventions require a thorough understanding of the SRC experience. Thus, collaborative inquiry, a novel approach in the SRC domain, was employed to give athletes a voice in how their experience is portrayed and understood within the research and applied communities. Data were generated over two years through on-going discussion and reflection between the researchers and twelve elite athletes who experienced SRCs. Athletes advocated for a broader view of their injury that considers the interplay of sociocultural factors and the individual's psychosocial experience. Mutual engagement through interviews, member reflections, focus groups, follow-up emails, and further reflective conversations generated two composite narratives. These narratives are interpreted using Bronfenbrenner's Ecological Systems Theory to underline the interplay of factors: (1) microsystem (athletic identity), (2) mesosystem ((dis)trust in relationships), (3) exosystem (concussion protocols), (4) macrosystem (sport culture), and (5) chronosystem (timing related to major events and recovery). Through this unique combination of methodology and theory within SRC research, we aim to highlight opportunities for applied intervention, multidisciplinary collaboration, and future scientific exploration Lay summary: Elite athletes who experienced concussions collaboratively created stories which highlight the complexity of concussions. These stories and accompanying analysis are intended to help practitioners and researchers further understand some of the psychological, social, and cultural factors that contribute to injury experience and recovery. Practical Implications: This article aims to facilitate an understanding of some of the complex and interacting factors that impact an elite athlete's experience with concussion. Through a narrative exploration of athletes' experiences and a multi-systems theory, this article highlights potential targets for applied sport psychology and rehabilitative interventions. Specifically, psychological, social, and cultural barriers and factors are identified as potential intervention areas, all of which have been largely ignored in existing return-to-sport protocols.	[Seguin, Cassandra M.; Culver, Diane M.] Univ Ottawa, Dept Human Kinet, Ottawa, ON, Canada		Seguin, CM (corresponding author), Univ Ottawa, Sch Human Kinet, 125 Univ, Ottawa, ON K1N 6N5, Canada.	csegu043@uottawa.ca		Seguin, Cassandra/0000-0001-5863-6923; Culver, Diane M/0000-0002-8117-2722			Adams A, 2020, INT REV SOCIOL SPORT, V55, P147, DOI 10.1177/1012690218791139; Andre-Morin D, 2017, SPORT EXERC PERFORM, V6, P289, DOI 10.1037/spy0000106; Bloom GA, 2020, J APPL SPORT PSYCHOL, DOI 10.1080/10413200.2020.1843200; Bolling C, 2018, SPORTS MED, V48, P2227, DOI 10.1007/s40279-018-0953-x; Bray JN., 2000, COLLABORATIVE INQUIR; Bridel W, 2020, ROUT RES SPORT EXERC, P97; Brofenbrenner Urie, 2000, ANN CHILD DEV PP, P129, DOI 10.1111/j.1467-8624.1992.tb01638.x; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Burke S, 2016, ROUT INT HANDB, P330; Caron JG, 2021, PSYCHOL SPORT EXERC, V52, DOI 10.1016/j.psychsport.2020.101824; Caron JG, 2017, J LOSS TRAUMA, V22, P501, DOI 10.1080/15325024.2017.1335150; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Cassilo D, 2019, COMMUN SPORT, V7, P678, DOI 10.1177/2167479518790039; Cooper JN, 2017, SOCIOL SPORT J, V34, P59, DOI 10.1123/ssj.2016-0015; Craig DI, 2020, RES SPORTS MED, V28, P181, DOI 10.1080/15438627.2019.1586706; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Davies SC, 2020, J EDUC PSYCHOL CONS, V30, P156, DOI 10.1080/10474412.2019.1649598; Dean NA, 2019, SOCIOL SPORT J, V36, P22, DOI 10.1123/ssj.2018-0033; Ellis MJ, 2017, CLIN J SPORT MED, V27, P179, DOI 10.1097/JSM.0000000000000305; Engstrom Asa, 2020, Concussion, V5, pCNC74, DOI 10.2217/cnc-2019-0014; Foster CA., 2019, J CONCUSSION, V3, p2059700219882876, DOI [10.1177/2059700219882876, DOI 10.1177/2059700219882876]; Frank A.W., 2010, LETTING STORIES BREA; Gerbing KK, 2016, EUR J SPORT SCI, V16, P141, DOI 10.1080/17461391.2014.989278; Heil J, 2016, SPORT EXERC PERFORM, V5, P281, DOI 10.1037/spy0000078; Heron J., 1997, QUAL INQ, V3, P274, DOI [10.1177/10778004, 10.1177/10778-0049700300302, DOI 10.1177/107780049700300302]; Kerr G., 2019, KINESIOLOGY REV, V8, P237, DOI [10.1123/kr.2019-0016, DOI 10.1123/KR.2019-0016]; Kerr G, 2019, J APPL SPORT PSYCHOL, V31, P367, DOI 10.1080/10413200.2018.1559255; Kontos A., 2019, PSYCHOL ASPECTS SPOR, P37, DOI DOI 10.4324/9781351200516-4; Krebs RJ, 2009, INT J SPORT PSYCHOL, V40, P108; LaVoi N.M., 2019, WOMEN SPORT PHYS ACT, V27, P136, DOI 10.1123/wspaj.2019-0030; Lincoln Y.S., 2017, SAGE HDB QUALITATIVE, P108; Liston K., 2019, SPORTS RELATED BRAIN, V12, P89; Liston K, 2018, INT REV SOCIOL SPORT, V53, P668, DOI 10.1177/1012690216679966; Malcolm D., 2020, CONCUSSION CRISIS SP, DOI [10.4324/9780429292408, DOI 10.4324/9780429292408]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117745033; MOON JA, 2013, REFLECTION LEARNING, DOI DOI 10.4324/9780203822296; O'Connor S, 2020, PHYSICIAN SPORTSMED, V48, P186, DOI 10.1080/00913847.2019.1671141; Onwuegbuzie Anthony J., 2013, INT J MULTIPLE RES A, V7, P2, DOI DOI 10.5172/MRA.2013.7.1.2; Patton MQ, 2015, QUALITATIVE RES EVAL, V4th edn, P244; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Roiger T, 2015, J ATHL TRAINING, V50, P256, DOI 10.4085/1062-6050-49.3.83; Ronkainen NJ, 2016, INT REV SPORT EXER P, V9, P45, DOI 10.1080/1750984X.2015.1096414; Scarneo SE, 2019, J ATHL TRAINING, V54, P356, DOI 10.4085/1062-6050-173-18; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Smith B, 2016, ROUT INT HANDB, P103; Smith B, 2016, ROUT INT HANDB, P260; Swann C, 2015, PSYCHOL SPORT EXERC, V16, P3, DOI 10.1016/j.psychsport.2014.07.004; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Tjong VK, 2017, JAAOS GLOB RES REV, V1, DOI 10.5435/JAAOSGlobal-D-17-00070; Ventresca M, 2020, ROUT RES SPORT EXERC, P170; Wayment HA, 2020, J AM COLL HEALTH, V68, P438, DOI 10.1080/07448481.2019.1577863; Wertz MS, 2011, INT J QUAL STUD HEAL, V6, DOI 10.3402/qhw.v6i2.5882; Wiese-Bjornstal D.M., 2015, KINESIOL REV, V4, P169, DOI [https://doi.org/10.1123/kr.2015-0012, DOI 10.1123/KR.2015-0012]; Willis R, 2019, QUAL RES, V19, P471, DOI 10.1177/1468794118787711; Yeo PC, 2020, J SPORT SCI MED, V19, P65; Zanin AC, 2020, SMALL GR RES, V51, P342, DOI 10.1177/1046496419883948	58	0	0	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1041-3200	1533-1571		J APPL SPORT PSYCHOL	J. Appl. Sport Psychol.												10.1080/10413200.2021.1998804		NOV 2021	22	Hospitality, Leisure, Sport & Tourism; Psychology, Applied; Psychology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology; Sport Sciences	WR9CJ	WOS:000714790500001					2022-02-06	
J	Song, SJ; Kong, XY; Wang, BM; Sanchez-Ramos, J				Song, Shijie; Kong, Xiaoyuan; Wang, Bangmei; Sanchez-Ramos, Juan			Administration of Delta(9)-Tetrahydrocannabinol Following Controlled Cortical Impact Restores Hippocampal-Dependent Working Memory and Locomotor Function	CANNABIS AND CANNABINOID RESEARCH			English	Article; Early Access						controlled cortical impact; traumatic brain injury; neurotrophic factors; BDNF; GDNF; G-CSF; endocannabinoid system; phytocannabinoids; working memory	COLONY-STIMULATING FACTOR; TRAUMATIC BRAIN-INJURY; FACTOR G-CSF; MOUSE MODEL; ENDOCANNABINOID SYSTEM; AMYLOID BURDEN; RECOVERY; ACTIVATION; IMPAIRMENT; MICROGLIA	Hypothesis: Administration of the phytocannabinoid Delta(9)-tetrahydrocannabinol (Delta(9)-THC) will enhance brain repair and improve short-term spatial working memory in mice following controlled cortical impact (CCI) by upregulating granulocyte colony-stimulating factor (G-CSF) and other neurotrophic factors (brain-derived neurotrophic factor [BDNF], glial-derived neurotrophic factor [GDNF]) in hippocampus (HP), cerebral cortex, and striatum. Materials and Methods: C57BL/6J mice underwent CCI and were treated for 3 days with Delta(9)-THC 3 mg/kg intraperitoneally (i.p.). Short-term working memory was determined using the spontaneous alternations test during exploratory behavior in a Y-maze. Locomotor function was measured as latency to fall from a rotating drum (rotometry). These behaviors were recorded at baseline and 3, 7, and 14 days after CCI. Groups of mice were euthanized at 7 and 14 days. Extent of microgliosis, astrocytosis, and G-CSF, BDNF, and GDNF expression were measured at 7 and 14 days in cerebral cortex, striatum, and HP on the side of the trauma. Levels of the most abundant endocannabinoid (2-arachidonoyl-glycerol [2-AG]) was also measured at these times. Results: Delta(9)-THC-treated mice exhibited marked improvement in performance on the Y-maze indicating that treatment with the phytocannabinoid could reverse the deficit in working memory caused by the CCI. Delta(9)-THC-treated mice ran on the rotarod longer than vehicle-treated mice and recovered to normal rotarod performance levels at 2 weeks. Delta(9)-THC-treated mice, compared with vehicle-treated animals, exhibited significant upregulation of G-CSF as well as BDNF and GDNF in the cerebral cortex, striatum, and HP. Levels of 2-AG were also increased in the Delta(9)-THC-treated mice. Conclusion: Administration of the phytocannabinoid Delta(9)-THC promotes significant functional recovery from traumatic brain injury (TBI) in the realms of working memory and locomotor function. This beneficial effect is associated with upregulation of brain 2-AG, G-CSF, BDNF, and GDNF. The latter three neurotrophic factors have been previously shown to mediate brain self-repair following TBI and stroke.	[Song, Shijie; Kong, Xiaoyuan; Wang, Bangmei] Univ S Florida, James Haley VA Med Ctr, Tampa, FL 33612 USA; [Song, Shijie; Wang, Bangmei; Sanchez-Ramos, Juan] Univ S Florida, Dept Neurol, Tampa, FL 33612 USA		Song, SJ (corresponding author), Univ S Florida, James Haley VA Med Ctr, Tampa, FL 33612 USA.	ssong@usf.edu			Veteran Affairs Merit Review grant [BX004037-01A1]	This study was funded by the Veteran Affairs Merit Review grant BX004037-01A1 to Shijie Song, MD.	ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Azevedo MD, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020456; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Churchwell JC, 2011, BEHAV BRAIN RES, V225, P389, DOI 10.1016/j.bbr.2011.07.045; Cintron-Colon AF, 2020, CELL TISSUE RES, V382, P47, DOI 10.1007/s00441-020-03287-6; Cristino L, 2020, NAT REV NEUROL, V16, P9, DOI 10.1038/s41582-019-0284-z; Di Marzo V, 2015, NEUROTHERAPEUTICS, V12, P692, DOI 10.1007/s13311-015-0374-6; Floresco SB, 1997, J NEUROSCI, V17, P1880; Gilgun-Sherki Y, 2003, PHARMACOL TOXICOL, V93, P66, DOI 10.1034/j.1600-0773.2003.930202.x; Hansen HS, 2002, PHARMACOL THERAPEUT, V95, P119, DOI 10.1016/S0163-7258(02)00251-6; Hartung T, 1998, Curr Opin Hematol, V5, P221, DOI 10.1097/00062752-199805000-00013; Hegde VL, 2010, EUR J IMMUNOL, V40, P3358, DOI 10.1002/eji.201040667; Jin JJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00170; Kaminska B, 2016, BBA-MOL BASIS DIS, V1862, P339, DOI 10.1016/j.bbadis.2015.10.026; Leszczynski M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00168; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Lu HC, 2021, BIOL PSYCHIAT-COGN N, V6, P607, DOI 10.1016/j.bpsc.2020.07.016; Maia J, 2019, ARCH TOXICOL, V93, P649, DOI 10.1007/s00204-019-02389-7; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Prieur EAK, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3162; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; SARTER M, 1988, PSYCHOPHARMACOLOGY, V94, P491, DOI 10.1007/BF00212843; Sasi M, 2017, PFLUG ARCH EUR J PHY, V469, P593, DOI 10.1007/s00424-017-1964-4; Savinainen JR, 2012, ACTA PHYSIOL, V204, P267, DOI 10.1111/j.1748-1716.2011.02280.x; Schabitz WR, 2008, J CEREBR BLOOD F MET, V28, P29, DOI 10.1038/sj.jcbfm.9600496; Schabitz WR, 2007, TRENDS PHARMACOL SCI, V28, P157, DOI 10.1016/j.tips.2007.02.007; Schneider A, 2005, CELL CYCLE, V4, P1753, DOI 10.4161/cc.4.12.2213; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Schurman LD, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00069; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Song SJ, 2021, CANNABIS CANNABINOID, V6, P48, DOI 10.1089/can.2019.0090; Song SJ, 2016, CELL TRANSPLANT, V25, P1853, DOI 10.3727/096368916X691114; Song SJ, 2016, RESTOR NEUROL NEUROS, V34, P415, DOI 10.3233/RNN-150607; Song SJ, 2016, J NEUROSCI RES, V94, P409, DOI 10.1002/jnr.23714; Song SJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/205878; Song SJ, 2011, NEUROSCI LETT, V487, P153, DOI 10.1016/j.neulet.2010.10.012; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Torrens A, 2020, J PHARMACOL EXP THER, V374, P151, DOI 10.1124/jpet.120.265892; Yamada A, 2003, GENES CELLS, V8, P985, DOI 10.1046/j.1356-9597.2003.00690.x; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	43	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2578-5125	2378-8763		CANNABIS CANNABINOID	Cannabis Cannabinoid Res.												10.1089/can.2021.0053		NOV 2021	12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	WV6GV	WOS:000717334100001	34747647				2022-02-06	
J	Tessier, A; Croteau, C; Le Dorze, G; Power, E; Weiss, M				Tessier, Alexandra; Croteau, Claire; Le Dorze, Guylaine; Power, Emma; Weiss, Melanie			Exploring the effects of a communication partner training programme for adapted transport drivers	APHASIOLOGY			English	Article; Early Access						Communication partner training; Transport; Communication disability; Communication strategies; Communication access	TRAUMATIC BRAIN-INJURY; MEDICAL-STUDENTS; SOCIAL-PARTICIPATION; NURSES WORKING; PEOPLE; APHASIA; DISORDERS; DEMENTIA; CARE; CONVERSATION	Background Public transportation plays an essential role in the social participation of people living with a communication disability. However, the attitudes and communication skills of public transport drivers may influence access to the service. A communication partner training programme offered to public transportation staff may help drivers better interact with people living with a communication disability. Aims To explore the effects of communication partner training on adapted transport drivers: 1) knowledge about communication and strategies to use with persons living with a communication disability, 2) relational communication, and 3) communication behaviours with passengers living with a communication disability in authentic communication contexts. Methods & Procedures An exploratory single group naturalistic design was used. Thirteen drivers were provided with a novel communication partner training programme. Participants' knowledge about communication with individuals living with a communication disability was assessed with written situational scenarios presenting passengers with either an expressive, receptive, or pragmatic communication profile. Videos of the participants interacting with passengers living with a communication disability during real-life trips were captured and analysed using the Relational Communication Scale. The videos were further analysed to determine if the participants' use of gestures had changed after training. Paired-sample t-tests were undertaken for each measure to identify any post-training changes. Outcomes & Results Drivers' knowledge about communication with people living with a communication disability significantly increased after training. Also, significant behavioural changes occurred in drivers post-training videos as indicated by the better evaluation of all dimensions of the Relational Communication Scale and the increased use of gestures. Emblematic gestures were the most frequently employed. Conclusions This study suggests that the communication partner training programme for adapted transport drivers could improve their communication with people living with a communication disability. Future studies are needed to replicate these findings and further determine their external validity.	[Tessier, Alexandra; Croteau, Claire; Le Dorze, Guylaine; Weiss, Melanie] Univ Montreal, Fac Med, Ecole Orthophonie & Audiol, Montreal, PQ, Canada; [Tessier, Alexandra; Croteau, Claire; Le Dorze, Guylaine] Inst Univ Sur Readaptat Deficience Phys Montreal, Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Power, Emma] Univ Technol, Fac Hlth, Grad Sch Hlth, Sydney, NSW, Australia		Tessier, A (corresponding author), Univ Montreal, Fac Med, Ecole Orthophonie & Audiol, Montreal, PQ, Canada.; Tessier, A (corresponding author), Inst Univ Sur Readaptat Deficience Phys Montreal, Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada.	alexandra.tessier@umontreal.ca	Power, Emma/A-9263-2015	Power, Emma/0000-0002-2638-0406	Fonds de recherche du Quebec - Societe et culture [198779]; Universite de Montreal; Fonds Antoine G. Massabki-Projet Societe Inclusive	This work was supported by the Fonds de recherche du Quebec - Societe et culture [198779]; Fonds Antoine G. Massabki-Projet Societe Inclusive; Universite de Montreal.	Ahmad F, 2019, J WORKPLACE LEARN, V31, P207, DOI 10.1108/JWL-07-2018-0096; Anglade C, 2021, CLIN LINGUIST PHONET, V35, P84, DOI 10.1080/02699206.2020.1745894; Anglade C, 2019, APHASIOLOGY, V33, P1061, DOI 10.1080/02687038.2018.1532068; [Anonymous], ARES61106 UN GEN ASS; [Anonymous], Studiocode (Version 4) [Computer software]; Ashton C, 2008, APHASIOLOGY, V22, P305, DOI 10.1080/02687030701382841; Beckley F, 2013, INT J LANG COMM DIS, V48, P220, DOI 10.1111/j.1460-6984.2012.00204.x; Behn N, 2021, J HEAD TRAUMA REHAB, V36, P56, DOI 10.1097/HTR.0000000000000580; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Bigby C, 2019, DISABIL REHABIL, V41, P125, DOI 10.1080/09638288.2017.1380721; Bourgeois MS., 2004, CLIN GERONTOLOGIST, V27, P119, DOI DOI 10.1300/J018V27N01_10; Brady MC, 2011, DISABIL REHABIL, V33, P178, DOI 10.3109/09638288.2010.517897; Burgoon J.K., 1978, UNSPOKEN DIALOGUE IN; BURGOON JK, 1987, COMMUN MONOGR, V54, P19, DOI 10.1080/03637758709390214; Burgoon JK., 1991, SO J COMMUNICATION, V56, P96, DOI DOI 10.1080/10417949109372822; Chang HF, 2018, INT J LANG COMM DIS, V53, P1094, DOI 10.1111/1460-6984.12421; Chao HC, 2016, J NURS RES, V24, P163, DOI 10.1097/jnr.0000000000000109; Chu CH, 2018, REHABIL NURS, V43, pE25, DOI 10.1097/rnj.0000000000000041; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Clayman S.E., 2004, HDB DATA ANAL, P586; Collier B, 2012, AUGMENT ALTERN COMM, V28, P205, DOI 10.3109/07434618.2012.732611; Conway ER, 2016, J CLIN NURS, V25, P1145, DOI 10.1111/jocn.13134; Croteau C., 2017, EFFETS FORMATION OFF; Croteau C, 2007, APHASIOLOGY, V21, P791, DOI 10.1080/02687030701192398; Croteau C, 2018, APHASIOLOGY, V32, P247, DOI 10.1080/02687038.2017.1350629; Dalemans RJP, 2010, INT J LANG COMM DIS, V45, P537, DOI 10.3109/13682820903223633; Damico JS, 1995, CLIN APHASIOL, V23, P83; Eggenberger E, 2013, INT PSYCHOGERIATR, V25, P345, DOI 10.1017/S1041610212001664; Eraut M., 2010, STUD CONTIN EDUC, V26, P247, DOI DOI 10.1080/158037042000225245; Eriksson K, 2016, DISABIL REHABIL, V38, P1187, DOI 10.3109/09638288.2015.1089952; Finch E, 2017, J COMMUN DISORD, V68, P1, DOI 10.1016/j.jcomdis.2017.05.004; Forsgren E, 2017, INT J SPEECH-LANG PA, V19, P541, DOI 10.1080/17549507.2016.1216602; Gallagher TJ, 2005, PATIENT EDUC COUNS, V57, P262, DOI 10.1016/j.pec.2004.06.008; Gallagher TJ, 2001, PATIENT EDUC COUNS, V45, P211, DOI 10.1016/S0738-3991(01)00126-4; Garcia LJ, 2002, J COMMUN DISORD, V35, P187, DOI 10.1016/S0021-9924(02)00064-3; Goldblum G, 2009, APHASIOLOGY, V23, P87, DOI 10.1080/02687030802024094; Hale JL, 2005, SOURCEBOOK OF NONVERBAL MEASURES: GOING BEYOND WORDS, P127; Harmon TG, 2020, APHASIOLOGY, V34, P1270, DOI 10.1080/02687038.2020.1752906; Harpe SE, 2015, CURR PHARM TEACH LEA, V7, P836, DOI 10.1016/j.cptl.2015.08.001; Hartmark-Hill J., 2013, MEDEDPORTAL, V9, DOI [https://doi.org/10.15766/mep_2374-8265.9454, DOI 10.15766/MEP_2374-8265.9454]; Hegde M.N., 2019, CLIN RES COMMUNICATI, V4th Ed; Nguyen H, 2019, J CLIN NURS, V28, P1050, DOI 10.1111/jocn.14697; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Howe TJ, 2008, APHASIOLOGY, V22, P1, DOI 10.1080/02687030701640941; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Knowles M. S., 2015, ADULT LEARNER; Kolb AY, 2014, SIMULAT GAMING, V45, P204, DOI 10.1177/1046878114534383; Kolb D. A, 1984, EXPERIENTIAL LEARNIN; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Le Dorze G, 2014, APHASIOLOGY, V28, P421, DOI 10.1080/02687038.2013.869305; Legg C, 2005, APHASIOLOGY, V19, P559, DOI 10.1080/02687030544000029; Machiels M, 2017, INT J NURS STUD, V66, P37, DOI 10.1016/j.ijnurstu.2016.11.017; McGilton K, 2011, INT J OLDER PEOPLE N, V6, P13, DOI 10.1111/j.1748-3743.2010.00210.x; Morgan M.Q., 2020, THESIS BOWLING GREEN; O'Halloran R, 2009, INT J SPEECH-LANG PA, V11, P438, DOI 10.3109/17549500902741363; O'Rourke A, 2018, INT J LANG COMM DIS, V53, P1150, DOI 10.1111/1460-6984.12428; Perry A., 2013, AUSTOMS SPEECH PATHO, V2nd Edition; Pink J, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2438; Power E, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007641; Robey RR, 2004, J COMMUN DISORD, V37, P401, DOI 10.1016/j.jcomdis.2004.04.003; Saldert C, 2016, INT J SPEECH-LANG PA, V18, P571, DOI 10.3109/17549507.2016.1143975; Sekine K, 2013, AM J SPEECH-LANG PAT, V22, P662, DOI 10.1044/1058-0360(2013/12-0030); Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Shrubsole K, 2017, APHASIOLOGY, V31, P1, DOI 10.1080/02687038.2016.1143083; Simmons-Mackie N, 2017, APHASIOLOGY, V31, P131, DOI 10.1080/02687038.2016.1180662; Simmons-Mackie N, 2016, ARCH PHYS MED REHAB, V97, P2202, DOI 10.1016/j.apmr.2016.03.023; Solarsh B, 2017, TOP LANG DISORD, V37, P52, DOI 10.1097/TLD.0000000000000108; Sorin-Peters R, 2010, APHASIOLOGY, V24, P1511, DOI 10.1080/02687038.2010.494829; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Teasell R, 2020, INT J STROKE, V15, P763, DOI 10.1177/1747493019897843; Tessier A, 2021, J WORKPLACE LEARN, V33, P577, DOI 10.1108/JWL-10-2020-0163; Tessier A, 2020, J COMMUN DISORD, V83, DOI 10.1016/j.jcomdis.2019.105951; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Tourmen C., 2013, EXERIENCES ADULTES P, P117; Vasse E, 2010, INT PSYCHOGERIATR, V22, P189, DOI 10.1017/S1041610209990615; Whitehill TL, 2010, J MED SPEECH-LANG PA, V18, P141; Wilkinson R, 2011, INT J SPEECH-LANG PA, V13, P74, DOI 10.3109/17549507.2011.551140; Williams KN, 2018, WESTERN J NURS RES, V40, P1012, DOI 10.1177/0193945917697226; Yorkston KM, 2010, PHYS MED REH CLIN N, V21, P309, DOI 10.1016/j.pmr.2009.12.011	80	0	0	2	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology												10.1080/02687038.2021.1994916		NOV 2021	26	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	WS4NW	WOS:000715160600001					2022-02-06	
J	Tierney, GJ; Tucker, R				Tierney, Gregory J.; Tucker, Ross			The role of player mass and contact speed on head kinematics and neck dynamics in rugby union tackling	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						biomechanics; computational modeling; injury	INJURY ASSESSMENT; VIDEO ANALYSIS; IMPACT; RECONSTRUCTION; CONCUSSION; EVENTS; RISK; FOOTBALL; MOTION	Tackling is the most common cause of general injuries in rugby union, with player speed and mass identified as risk factors. This study aimed to use multibody modeling simulations to examine how tackler and ball carrier mass and contact speed affect inertial head kinematics and neck dynamics. Simulations were run by independently varying the ball carrier and tackler mass (from 60 to 110kg) and speed (from 0 to 10 m/s). Peak resultant inertial neck dynamics (force and moment) and head kinematics (linear acceleration, angular acceleration, and angular velocity) were extracted from each simulation. The greatest inertial head kinematics and neck dynamics sustained by a player was when there was the greatest mass disparity in the tackle, with the lighter player experiencing greatest inertial neck dynamics and head kinematics by up to 24% in comparison with the scenario when both players were the lightest mass (60 kg). As a player's mass increased, the magnitude of their head kinematics and neck dynamics diminished, but increased for their direct opponent, irrespective of whether they were the tackler or ball carrier. For speed, the greatest inertial head kinematics and neck dynamics sustained by the ball carrier and tackler were when they were both traveling at the highest speed. In theory, large discrepancies in mass of players, and high speeds into a tackle should be avoided.	[Tierney, Gregory J.] Ulster Univ, Sch Sport, Belfast BT15 1ED, Antrim, North Ireland; [Tierney, Gregory J.] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England; [Tierney, Gregory J.] Trinity Coll Dublin, Trinity Ctr Biomed Engn, Dublin, Ireland; [Tucker, Ross] World Rugby, Dublin, Ireland		Tierney, GJ (corresponding author), Ulster Univ, Sch Sport, Belfast BT15 1ED, Antrim, North Ireland.	g.tierney@ulster.ac.uk		Tierney, Gregory/0000-0002-4666-4473	World Rugby	This study was funded by World Rugby	Beusenberg MC., 2000, P INT RES C BIOM IMP; Bonnoit J., 1995, COMPUTER SIMULATION, P3130; Bonugli E., 2007, P INT RES COUNC BIOM; BOUQUET R, 1994, FOURTEENTH INTERNATIONAL TECHNICAL CONFERENCE ON ENHANCED SAFETY OF VEHICLES, PROCEEDINGS, VOLS 1 AND 2, P100; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Burger N, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2019-000645; Chawla A., 2011, P EXP SAF VEH C; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Cumming SP, 2017, STRENGTH COND J, V39, P34; Elliott JR, 2012, P I MECH ENG K-J MUL, V226, P266, DOI 10.1177/1464419311430176; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Fuller CW, 2020, SA J. Sports Med., V32, P1, DOI [10.17159/2078-516x/2020/v32i1a8062, 10.17159/2078-516X/2020/v32i1a8062]; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Fuller CW, 2010, J SCI MED SPORT, V13, P36, DOI 10.1016/j.jsams.2008.09.008; Gardner A, 2010, ARCH CLIN NEUROPSYCH, V25, P174, DOI 10.1093/arclin/acq007; Ghanouchi S., 1993, P 1993 INT C BIOM IM; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; Hill NE, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000459; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Lark SD, 2007, J SPORT SCI, V25, P887, DOI 10.1080/02640410600944543; Martin R., 2005, P EXP SAF VEH C; McIntosh A., 2007, P ENH SAF VEH C; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McIntosh AS, 2005, BRIT J SPORT MED, V39, P2, DOI 10.1136/bjsm.2004.016188; Meissner M., 2003, P EXP SAF VEH C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Preatoni E., 2016, ISBS C P ARCH; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Seminati E, 2017, SPORT BIOMECH, V16, P58, DOI 10.1080/14763141.2016.1194453; Simms CK., 2017, IRCOBI C P; Simms CK., 2016, ISBS C P ARCH, DOI DOI 10.1016/J.PUHE.2015.10.038; Sportsman, 2020, 6 NAT 2020 IS IT TIM; Stokes KA, 2021, BRIT J SPORT MED, V55, P220, DOI [10.1136/bjsports-2019-101557, 10.1136/bjsports-2020-101983]; Tierney, 2018, THESIS; Tierney GJ, 2019, INT J SPORTS SCI COA, V14, P190, DOI 10.1177/1747954119833477; Tierney GJ, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9040726; Tierney GJ, 2018, J SCI MED SPORT, V21, P1210, DOI 10.1016/j.jsams.2018.05.010; Tierney GJ, 2018, J BIOMECH, V72, P29, DOI 10.1016/j.jbiomech.2018.02.023; Tierney GJ, 2018, MED SCI SPORT EXER, V50, P603, DOI 10.1249/MSS.0000000000001461; Tierney GJ, 2017, BRAIN INJURY, V31, P1925, DOI 10.1080/02699052.2017.1385853; Tierney Gregory J, 2018, Sports Biomech, V17, P33, DOI 10.1080/14763141.2016.1271905; Tierney GJ, 2016, BRAIN INJURY, V30, P1350, DOI 10.1080/02699052.2016.1193630; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Tucker R, 2017, BRIT J SPORT MED, V51, P1147, DOI 10.1136/bjsports-2017-097883; Usman J, 2011, J SCI MED SPORT, V14, P547, DOI 10.1016/j.jsams.2011.05.006; Viano, 1989, BIOMECHANICAL RESPON, P1690; Voiglio E., 1998, P C ENH SAF VEH; Yin S, 2017, ACCIDENT ANAL PREV, V106, P285, DOI 10.1016/j.aap.2017.06.005	50	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	FEB	2022	32	2					298	312		10.1111/sms.14090		NOV 2021	15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	YE9FH	WOS:000714784000001	34741337				2022-02-06	
J	Aron, A; Harper, B; Andrews, R; Boggs, E; Stanley, A				Aron, Adrian; Harper, Brent; Andrews, Rachel; Boggs, Erica; Stanley, Andrea			The Effect of Whole-Body Fatigue on King-Devick Test and Balance	RESEARCH QUARTERLY FOR EXERCISE AND SPORT			English	Article; Early Access						Balance; fatigue; King-Devick	SCREENING TOOL; CONCUSSION; YOUTH	Purpose: Fatigue may mimic suboptimal brain functioning seen after a concussion and lead to false-positive King-Devick (K-D) scores and decreased balance. The purpose of this study was to investigate if whole-body fatigue has an effect on K-D scores or postural sway. Method: A total of 38 healthy participants (20 females; age = 23.5 +/- 2.63 y; height = 170 +/- 0.1 cm; mass = 75.2 +/- 10.3 kg) volunteered for the study. Participants completed the King-Devick (K-D) test and the modified Clinical Test of Sensory Interaction of Balance (mCTSIB) on the Biodex BioSway(TM) Portable Balance System prior to and immediately following the completion of a fatigue protocol on a Concept2 Rower. Results: Half of the participants demonstrated a positive K-D test post-fatigue. Balance scores were poorer post-fatigue. No difference was found between participants based on history of concussion. Among the participants that had a positive post-fatigue K-D test, 71% had also a worse composite sway index score (chi(2) = 6.3, p = .02). Conclusions: Whole-body fatigue may negatively impact a person's ability to perform the K-D test and balance assessments. It is recommended that the athlete is allowed a period of time to accommodate for the acute effects of fatigue before administering these assessments following a suspected concussion.	[Aron, Adrian; Harper, Brent; Andrews, Rachel; Boggs, Erica; Stanley, Andrea] Radford Univ, Roanoke, VA USA; [Harper, Brent] Chapman Univ, Orange, CA USA		Aron, A (corresponding author), Radford Univ, Dept Phys Therapy, 101 Elm Ave, Roanoke, VA 24013 USA.	aaron@radford.edu					Abd-Elfattah HM, 2015, J ADV RES, V6, P351, DOI 10.1016/j.jare.2015.01.011; [Anonymous], 2014, BIOSWAY PORT BAL SYS; Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Beltz Nicholas M, 2016, J Sports Med (Hindawi Publ Corp), V2016, P3968393, DOI 10.1155/2016/3968393; Connell CJW, 2016, SCI REP-UK, V6, DOI 10.1038/srep26614; Corwin DJ, 2020, MED SCI SPORT EXER, V52, P542, DOI 10.1249/MSS.0000000000002163; Dewan Birendra M, 2019, Biomed Res Int, V2019, P8185710, DOI 10.1155/2019/8185710; Dhawan PS, 2017, NEUROL-CLIN PRACT, V7, P464, DOI 10.1212/CPJ.0000000000000381; Eddy R, 2020, CLIN J SPORT MED, V30, P239, DOI 10.1097/JSM.0000000000000586; Evans K.M., 2015, INT J PHYS MED REHAB, V3, P568, DOI [10.4172/2329-9096.1000268, DOI 10.4172/2329-9096.1000268, https://doi.org/10.4172/2329-9096.1000268]; Froyd C, 2013, J PHYSIOL-LONDON, V591, P1339, DOI 10.1113/jphysiol.2012.245316; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King-Devick Technologies I, KING DEV ONL SYST V5; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099222; Marinides Zoe, 2015, Neurol Clin Pract, V5, P25, DOI 10.1212/CPJ.0000000000000060; May KH, 2014, INT J SPORTS PHYS TH, V9, P242; Miner DG, 2021, J SPORT REHABIL, V30, P516, DOI 10.1123/jsr.2020-0227; Paillard T, 2012, NEUROSCI BIOBEHAV R, V36, P162, DOI 10.1016/j.neubiorev.2011.05.009; Paniccia M, 2018, SPORTS HEALTH, V10, P175, DOI 10.1177/1941738117741651; Pau M, 2014, J ATHL TRAINING, V49, P454, DOI 10.4085/1062-6050-49.2.12; Santamaria LJ, 2010, J ORTHOP SPORT PHYS, V40, P464, DOI 10.2519/jospt.2010.3295; Schneiders AG, 2012, SCAND J MED SCI SPOR, V22, P85, DOI 10.1111/j.1600-0838.2010.01141.x; Taylor JL, 2006, CLIN EXP PHARMACOL P, V33, P400, DOI 10.1111/j.1440-1681.2006.04363.x; VICKERS JN, 1995, STUD VIS INFORM PROC, V6, P527; Wassinger CA, 2014, INT J SPORTS PHYS TH, V9, P40; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Wilson F, 2012, J SPORT SCI, V30, P1481, DOI 10.1080/02640414.2012.711486	34	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0270-1367	2168-3824		RES Q EXERCISE SPORT	Res. Q. Exerc. Sport												10.1080/02701367.2021.1921103		NOV 2021	7	Hospitality, Leisure, Sport & Tourism; Psychology, Applied; Psychology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology; Sport Sciences	WQ5UN	WOS:000713881200001	34727010				2022-02-06	
J	Hennessy, MJ; Sullivan, KA				Hennessy, Maria Jeannette; Sullivan, Karen A.			A 'Network of Understanding and Compassion': A Qualitative Study of Survivor Perspectives on Unmet Needs After Traumatic Brain Injury (TBI) in Regional Communities	BRAIN IMPAIRMENT			English	Article; Early Access						Brain injury; head injury; rehabilitation; qualitative research; service delivery	HEALTH-CARE; OF-LIFE; PEOPLE; EXPERIENCES; INDIVIDUALS; REHABILITATION; PROFESSIONALS; ATTITUDES; FAMILIES; SELF	Objective: This qualitative study aimed to identify the service and support needs of people with a recent history of traumatic brain injury (TBI) living in the community. Methods: A postal survey was sent to 662 people 6-18 months after hospital admission for a mild-to-severe TBI. The survey included an open-ended item ('wish-basket') for collecting ideas about important unmet needs. Results: Responses from 53 individuals were coded and processed using thematic analysis. Five themes (n = 39) were identified, three of which were related to personal needs. These personal wishes were about being symptom-free, independent and emotionally supported by, and connected to, loved ones. The remaining themes were about the wished-for changes to the health system and society, such as wishing for health care continuity (as opposed to being abandoned), and for greater understanding and support by society. Conclusions: There is scope to improve the services and support for people living with TBI in the community. This includes reconsidering the way that discharge occurs, addressing the personal needs that remain when living in the community and promoting greater social awareness of TBI to counteract disadvantage.	[Hennessy, Maria Jeannette] James Cook Univ Australia Singapore, Dept Psychol, Singapore, Singapore; [Sullivan, Karen A.] Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld, Australia		Hennessy, MJ (corresponding author), James Cook Univ Australia Singapore, Dept Psychol, Singapore, Singapore.	mariahennessy67@gmail.com					Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; [Anonymous], 2002, Aging Male, V5, P1; Australian Government Department of Health, 2010, PRINC REC OR MENT HL; Beck C T, 1993, West J Nurs Res, V15, P263, DOI 10.1177/019394599301500212; Brenner E, 2003, PROF PSYCHOL-RES PR, V34, P240, DOI 10.1037/0735-7028.34.3.240; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Burgess P, 2011, AUST NZ J PSYCHIAT, V45, P267, DOI 10.3109/00048674.2010.549996; Conneeley AL, 2012, BRAIN IMPAIR, V13, P72, DOI 10.1017/BrImp.2012.3; Creswell JW., 1998, QUAL INQ; Denzin N., 2018, SAGE HDB QUALITATIVE, V5th ed.; Dijkers M., 2000, COMMUNITY INTEGRATIO; Epping-Jordan JE, 2004, QUAL SAF HEALTH CARE, V13, P299, DOI 10.1136/qshc.2004.010744; Facey K, 2010, INT J TECHNOL ASSESS, V26, P334, DOI 10.1017/S0266462310000395; Fadyl JK, 2019, NEUROPSYCHOL REHABIL, V29, P1095, DOI 10.1080/09602011.2017.1364653; Fleming J, 2012, SCAND J OCCUP THER, V19, P184, DOI 10.3109/11038128.2011.611531; Fresson M, 2017, J APPL SOC PSYCHOL, V47, P539, DOI 10.1111/jasp.12459; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Hall AE, 2018, HEALTH EXPECT, V21, P707, DOI 10.1111/hex.12665; HALL JM, 1991, ADV NURS SCI, V13, P16, DOI 10.1097/00012272-199103000-00005; Hellweg S, 2008, BRAIN INJURY, V22, P365, DOI 10.1080/02699050801998250; Hennessy M., AUST J RURAL HEALTH; Holloway M, 2019, BRAIN INJURY, V33, P401, DOI 10.1080/02699052.2019.1566967; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Jones K, 2020, BRAIN IMPAIR, V21, P154, DOI 10.1017/BrImp.2019.27; Kidd S.D., 2019, HERMENEUTIC RES EXPE; KOCH T, 1995, J ADV NURS, V21, P827, DOI 10.1046/j.1365-2648.1995.21050827.x; Kreutzer J. S., 2000, SERVICE OBSTACLES SC; Laverty S.M., 2003, INT J QUAL METH, V2, P21, DOI [10.1177/160940690300200303, DOI 10.1177/160940690300200303]; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Liamputtong P., 2013, QUALITATIVE RES METH, V4; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Linden MA, 2006, ARCH CLIN NEUROPSYCH, V21, P763, DOI 10.1016/j.acn.2006.08.010; McLellan T, 2010, J INT NEUROPSYCH SOC, V16, P705, DOI 10.1017/S1355617710000524; Milte R, 2019, AGEING SOC, V39, P138, DOI 10.1017/S0144686X17000861; Minney MJ, 2019, BRAIN INJURY, V33, P168, DOI 10.1080/02699052.2018.1540794; Mueller C, 2017, BRAIN INJURY, V31, P1863, DOI 10.1080/02699052.2017.1346290; Muganga L., 2015, J SOCIAL RES POLICY, V6, P65; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Piccenna L, 2016, BRAIN INJURY, V30, P241, DOI 10.3109/02699052.2015.1113569; Polkinghorne D., 1983, METHODOLOGY HUMAN SC; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Proctor CJ, 2019, DISABIL HEALTH J, V12, P387, DOI 10.1016/j.dhjo.2019.01.001; Queensland Health, 2016, STAT AD BRAIN INJ RE; Queensland Health, NDIS ROLL OUT QUEENS; Redpath SJ, 2010, BRAIN INJURY, V24, P802, DOI 10.3109/02699051003709623; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4; Slettebo A, 2009, J ADV NURS, V65, P2426, DOI 10.1111/j.1365-2648.2009.05110.x; Stiekema APM, 2020, BRAIN INJURY, V34, P421, DOI 10.1080/02699052.2020.1725125; VanManen M, 2014, DEV QUAL INQ, P1; Wilkin D., 1987, AGEING SOC, V7, P175, DOI [10.1017/S0144686X00012551, DOI 10.1017/S0144686X00012551]; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]	60	0	0	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.											PII S1443964621000188	10.1017/BrImp.2021.18		NOV 2021	12	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	YI3TB	WOS:000743772900001					2022-02-06	
J	Subramaniam, DR; Unnikrishnan, G; Sundaramurthy, A; Rubio, JE; Kote, VB; Reifman, J				Subramaniam, Dhananjay Radhakrishnan; Unnikrishnan, Ginu; Sundaramurthy, Aravind; Rubio, Jose E.; Kote, Vivek Bhaskar; Reifman, Jaques			Cerebral Vasculature Influences Blast-Induced Biomechanical Responses of Human Brain Tissue	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article						blast-induced traumatic brain injury; blast overpressure; shock tube; brain biomechanical responses; finite-element model; human cerebral vasculature	HUMAN HEAD; INJURY; MODEL; IMPACT; MECHANISMS; DAMAGE; BODY	Multiple finite-element (FE) models to predict the biomechanical responses in the human brain resulting from the interaction with blast waves have established the importance of including the brain-surface convolutions, the major cerebral veins, and using non-linear brain-tissue properties to improve model accuracy. We hypothesize that inclusion of a more detailed network of cerebral veins and arteries can further enhance the model-predicted biomechanical responses and help identify correlates of blast-induced brain injury. To more comprehensively capture the biomechanical responses of human brain tissues to blast-wave exposure, we coupled a three-dimensional (3-D) detailed-vasculature human-head FE model, previously validated for blunt impact, with a 3-D shock-tube FE model. Using the coupled model, we computed the biomechanical responses of a human head facing an incoming blast wave for blast overpressures (BOPs) equivalent to 68, 83, and 104 kPa. We validated our FE model, which includes the detailed network of cerebral veins and arteries, the gyri and the sulci, and hyper-viscoelastic brain-tissue properties, by comparing the model-predicted intracranial pressure (ICP) values with previously collected data from shock-tube experiments performed on cadaver heads. In addition, to quantify the influence of including a more comprehensive network of brain vessels, we compared the biomechanical responses of our detailed-vasculature model with those of a reduced-vasculature model and a no-vasculature model for the same blast-loading conditions. For the three BOPs, the predicted ICP values matched well with the experimental results in the frontal lobe, with peak-pressure differences of 4-11% and phase-shift differences of 9-13%. As expected, incorporating the detailed cerebral vasculature did not influence the ICP, however, it redistributed the peak brain-tissue strains by as much as 30% and yielded peak strain differences of up to 7%. When compared to existing reduced-vasculature FE models that only include the major cerebral veins, our high-fidelity model redistributed the brain-tissue strains in most of the brain, highlighting the importance of including a detailed cerebral vessel network in human-head FE models to more comprehensively account for the biomechanical responses induced by blast exposure.	[Subramaniam, Dhananjay Radhakrishnan; Unnikrishnan, Ginu; Sundaramurthy, Aravind; Rubio, Jose E.; Kote, Vivek Bhaskar; Reifman, Jaques] US Army, Dept Def, Biotechnol High Performance Comp Software Applica, Telemed & Adv Technol Res Ctr,Res & Dev Command, Ft Detrick, MD 21702 USA; [Subramaniam, Dhananjay Radhakrishnan; Unnikrishnan, Ginu; Sundaramurthy, Aravind; Rubio, Jose E.; Kote, Vivek Bhaskar] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA		Reifman, J (corresponding author), US Army, Dept Def, Biotechnol High Performance Comp Software Applica, Telemed & Adv Technol Res Ctr,Res & Dev Command, Ft Detrick, MD 21702 USA.	jaques.reifman.civ@mail.mil		Sundaramurthy, Aravind/0000-0002-0359-8680			Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Begley DJ, 2003, PROG DRUG RES, V61, P39; Bir C., 2011, MEASURING BLAST RELA; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chandra N., 2015, BRAIN NEUROTRAUMA MO; Cotton RT, 2016, COMPUT METHOD BIOMEC, V19, P101, DOI 10.1080/10255842.2014.994118; de Rooij R, 2016, APPL MECH REV, V68, DOI 10.1115/1.4032436; DECHOW PC, 1993, AM J PHYS ANTHROPOL, V90, P291, DOI 10.1002/ajpa.1330900304; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Elsheikh A, 2007, J REFRACT SURG, V23, P808, DOI 10.3928/1081-597X-20071001-11; ESTES MS, 1970, MECH ENG, V92, P58; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Ganpule S.G., 2013, THESIS U NEBRASKA LI; Garimella HT, 2019, ANN BIOMED ENG, V47, P1889, DOI 10.1007/s10439-018-02166-0; Garimella HT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190881; Gehre C., 2009, 21 ESV C STUTTG, V1, P09; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hua Y, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/928236; Hyde, 1991, CONVENTIONAL WEAPONS; Jazi MS, 2016, COMPUT METHOD BIOMEC, V19, P1019, DOI 10.1080/10255842.2015.1088525; Kok S, 2014, INT J NUMER METH BIO, V30, P1460, DOI 10.1002/cnm.2667; Leonardi A., 2012, THESIS WAYNE STATE U; Martin Elisabeth Moy, 2008, J Trauma Nurs, V15, P94, DOI 10.1097/01.JTN.0000337149.29549.28; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Mobius Jan, 2012, Curves and Surfaces. 7th International Conference, Curves and Surfaces 2010. Revised Selected Papers, P488, DOI 10.1007/978-3-642-27413-8_31; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Ottenio M, 2015, J MECH BEHAV BIOMED, V41, P241, DOI 10.1016/j.jmbbm.2014.10.006; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Ramzanpour M, 2020, MED BIOL ENG COMPUT, V58, P2107, DOI 10.1007/s11517-020-02228-3; Ritenour AE, 2010, ANN SURG, V251, P1140, DOI 10.1097/SLA.0b013e3181e01270; Rodriguez-Millan M, 2017, MATER DESIGN, V117, P58, DOI 10.1016/j.matdes.2016.12.081; Rubio JE, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.573647; Sarvghad-Moghaddam H, 2017, SHOCK WAVES, V27, P919, DOI 10.1007/s00193-017-0749-1; Sharma S., 2011, THESIS WAYNE STATE U; Singh D, 2014, INT J NUMER METH BIO, V30, P470, DOI 10.1002/cnm.2612; Subramaniam DR, 2021, BIOMED ENG ONLINE, V20, DOI 10.1186/s12938-021-00847-x; Tan LB, 2014, INT J NUMER METH BIO, V30, P1476, DOI 10.1002/cnm.2668; Tan XG, 2017, SHOCK WAVES, V27, P889, DOI 10.1007/s00193-017-0740-x; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tong JF, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4043668; Tse KM, 2017, MED BIOL ENG COMPUT, V55, P641, DOI 10.1007/s11517-016-1536-3; U.S. Department of Defense, 2020, NUMB TRAUM BRAIN INJ; Unnikrishnan G, 2021, J BIOMECH ENG-T ASME, V143, DOI 10.1115/1.4049889; Unnikrishnan G, 2019, ANN BIOMED ENG, V47, P2033, DOI 10.1007/s10439-019-02277-2; Wang CZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113264; Yu XC, 2020, EXTREME MECH LETT, V38, DOI 10.1016/j.eml.2020.100739; Yu XC, 2019, INT J NUMER METH BIO, V35, DOI 10.1002/cnm.3258; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088; Zhao W, 2020, J BIOMECH, V104, DOI 10.1016/j.jbiomech.2020.109732	60	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.	NOV 4	2021	9								744808	10.3389/fbioe.2021.744808			15	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	WZ9YJ	WOS:000720314900001	34805106	Green Published, gold			2022-02-06	
J	Baum, KT; Smith-Paine, J; Tlustos, SJ; Johnson, A; Petranovich, C				Baum, Katherine T.; Smith-Paine, Julia; Tlustos, Sarah J.; Johnson, Abigail; Petranovich, Christine			Clinical and training practices: A survey of pediatric neuropsychologists serving inpatient rehabilitation	CHILD NEUROPSYCHOLOGY			English	Article; Early Access						Clinical practice; rehabilitation medicine; child; training; outpatient	COMA RECOVERY SCALE; LINGUISTIC SCALE; FOLLOW COMMANDS; UNITED-STATES; SCORES 1; BRAIN; CHILDREN; TIME; RECOMMENDATIONS; EDUCATION	Neuropsychologists in inpatient pediatric rehabilitation settings collaborate with an interdisciplinary team to educate, evaluate, and provide intervention to patients with acquired brain injury and their families, but there are no known studies that describe or define these clinical services. Thirty-one neuropsychologists in pediatric inpatient rehabilitation settings completed an online survey. Neuropsychologists (68.2% female; 86.4% with PhD versus PsyD) from the U.S. and Canada, who represented 22 pediatric inpatient rehabilitation sites comprised the final sample. Most sites (63.6%) were embedded within medical centers, with providers dedicating 2 to 32 hours (M = 14.25, SD = 9.26) weekly to onsite inpatient rehabilitation efforts. Providers most often saw patients with traumatic brain injury and other acquired brain injuries, including stroke and brain tumor. Trainees from various levels, most commonly post-doctoral fellows, provided clinical services on inpatient units, many with some degree of independence. Clinical practices that were standard across all or most sites included targeted discharge evaluations, serial cognitive monitoring, neuropsychology consultation to rehabilitation and non-rehabilitation units, and follow-up clinics. Provision of services was influenced by multiple factors including patient diagnosis, timing of return to school, inpatient census, and payor's effect on length of stay. Findings highlight many programmatic consistencies across sites and serve as an important initial step to guiding pediatric neuropsychology providers seeking to understand the current landscape of clinical care. Future efforts are needed to establish a true clinical guideline for practice. Although preliminary, data also support establishment of neuropsychology training programs, justify administrative resources, and serve to educate recipients of neuropsychology services.	[Baum, Katherine T.] Childrens Hosp Philadelphia, 1219 S 46th St, Philadelphia, PA 19143 USA; [Smith-Paine, Julia] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Tlustos, Sarah J.; Petranovich, Christine] Childrens Hosp Colorado, Aurora, CO USA; [Tlustos, Sarah J.; Petranovich, Christine] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Johnson, Abigail] Univ Michigan Med, Dept Phys Med & Rehabil, Ann Arbor, MI USA		Baum, KT (corresponding author), Childrens Hosp Philadelphia, 1219 S 46th St, Philadelphia, PA 19143 USA.	drkatherinebaum@gmail.com					Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; [Anonymous], 2020, US NEWS; Association of Academic Physiatrists, 2020, PEDIAT REHABILITATIO; Austin CA, 2013, BRAIN INJURY, V27, P1056, DOI 10.3109/02699052.2013.794964; Baum KT, 2018, CLIN NEUROPSYCHOL, V32, P345, DOI 10.1080/13854046.2017.1413208; Biffl SE, 2015, PATIENT SAF SURG, V9, DOI 10.1186/s13037-015-0078-1; Blackwell LS, 2020, DISABIL REHABIL, DOI 10.1080/09638288.2020.1788176; Block C, 2017, ARCH CLIN NEUROPSYCH, V32, P369, DOI 10.1093/arclin/acx002; Block CK, 2017, CLIN NEUROPSYCHOL, V31, P487, DOI 10.1080/13854046.2016.1267803; CARF International, 2020, ADV PROV SEARCH PROG; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Davis KC, 2016, J HEAD TRAUMA REHAB, V31, pE39, DOI 10.1097/HTR.0000000000000159; Deidrick KKM, 2005, PREV SCH FAIL, V49, P23, DOI 10.3200/PSFL.49.4.23-33; Donders J, 2020, CLIN NEUROPSYCHOL, V34, P56, DOI 10.1080/13854046.2019.1575471; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hannay HJ, 1998, ARCH CLIN NEUROPSYCH, V13, P157, DOI 10.1016/S0887-6177(98)00003-1; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Johnson-Greene D, 2018, ARCH CLIN NEUROPSYCH, V33, P310, DOI 10.1093/arclin/acx126; Koterba C.K., 2020, ED TOOL; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Mindt MR, 2010, CLIN NEUROPSYCHOL, V24, P429, DOI 10.1080/13854040903058960; Novack TA., 2010, HDB REHABILITATION P, P165; Prigatano G.P., 2003, NEUROPSYCHOLOGY COST, DOI [https://doi.org/10.4324/9781315787039, DOI 10.4324/9781315787039]; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rappaport M., 2000, COMA NEAR COMA SCALE; Rey-Casserly C, 2012, PROF PSYCHOL-RES PR, V43, P422, DOI 10.1037/a0028721; Reynolds C. R., 2015, BEHAV ASSESSMENT CHI; Roebuck-Spencer TM, 2017, ARCH CLIN NEUROPSYCH, V32, P491, DOI 10.1093/arclin/acx021; Slomine B, 2008, J HEAD TRAUMA REHAB, V23, P286, DOI 10.1097/01.HTR.0000336841.53338.2f; Slomine BS, 2019, BRAIN INJURY, V33, P1640, DOI 10.1080/02699052.2019.1658221; Slomine BS, 2016, REHABIL PSYCHOL, V61, P328, DOI 10.1037/rep0000096; Smith G, 2019, ARCH CLIN NEUROPSYCH, V34, P418, DOI 10.1093/arclin/acy075; Stiers W, 2015, REHABIL PSYCHOL, V60, P111, DOI 10.1037/a0038353; Sweet JJ, 2006, CLIN NEUROPSYCHOL, V20, P325, DOI 10.1080/13854040600760488; Sweet JJ, 2021, CLIN NEUROPSYCHOL, V35, P7, DOI 10.1080/13854046.2020.1849803; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P109, DOI 10.1076/clin.16.2.109.13237; Wade SL, 2017, J HEAD TRAUMA REHAB, V32, P433, DOI 10.1097/HTR.0000000000000323; Watson WD, 2021, J HEAD TRAUMA REHAB, V36, P253, DOI 10.1097/HTR.0000000000000650; Wilson BA, 2008, APPL NEUROPSYCHOL, V15, P229, DOI 10.1080/09084280802325017; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	48	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.												10.1080/09297049.2021.1993809		NOV 2021	25	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WQ5MA	WOS:000713859000001	34724886				2022-02-06	
J	Farooqi, A; Talwar, D; Tata, R; Harwood, K; Maguire, K				Farooqi, Ali; Talwar, Divya; Tata, Ravi; Harwood, Kathleen; Maguire, Kathleen			Comparison of pediatric performance athlete injuries presenting to emergency departments	PHYSICIAN AND SPORTSMEDICINE			English	Article; Early Access						Pediatric; athlete; gymnastics; dance; cheerleading; sports; injury prevention	UNITED-STATES; OVERUSE INJURIES; CHILDREN; RISK; PREVENTION; AGE	Objective Pediatric injuries in performance sports represent a significant healthcare burden and account for over 50,000 annual Emergency Department (ED) visits in the United States. The objective of this study was to characterize and compare pediatric injury presentation across the most common performance sports. Methods The National Electronic Injury Surveillance System (NEISS) database was retrospectively analyzed for pediatric injuries (3-18 years) related to gymnastics, dance, or cheerleading from 2015-2019. Cases were categorized as children (<11 years) or adolescent (>= 11 years). Injuries were categorized as orthopedic (fractures, dislocations, sprain, strains), non-orthopedic (contusion, internal injury, laceration), concussion, or other/unknown. Case narratives were used to categorize mechanism of injury as contact or non-contact. Appropriate sample NEISS weights estimation was applied for statistical analysis and Confidence Intervals (CI). Results A total of 393,110 injuries were observed over the five-year study period, with a mean of 78,622 annual injuries. Gymnastics, dance, and cheerleading accounted for 136,422 injuries, 96,416 injuries, and 160,272 injuries, respectively. Most cases were adolescent (71%; 95% CI: 68-74%) and occurred in a sports-related setting (65%, 95% CI: 57-72%). Gymnastics had the highest proportion of injuries among children (50%) as compared to dancers (25%) or cheerleaders (12%) (p < 0.01). Non-contact injuries most affected the lower extremity (43-68%) and resulted in an orthopedic diagnosis (63-71%), and contact injuries had a higher proportion of injuries affecting the head, neck, and face (29-51%) and non-orthopedic diagnoses (29-38%). Gymnastics had the most upper extremity non-contact injuries (42%) and dance the most lower extremity non-contact injuries (68%) (p < 0.01). Cheerleading had the highest incidence of overall concussions (8%), contact injuries (47%), and concussions due to contact injury (15%). Conclusion Pediatric gymnasts, cheerleaders, and dancers have important similarities and differences in injury pattern which may lead to the development of sport-specific injury prevention programs for pediatric performance athletes.	[Farooqi, Ali; Maguire, Kathleen] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Talwar, Divya; Harwood, Kathleen; Maguire, Kathleen] Childrens Hosp Penn, Clin Orthopaed Surg, Dept Orthopaed, Philadelphia, PA USA; [Tata, Ravi] Drexel Sch Med, Philadelphia, PA USA		Maguire, K (corresponding author), Childrens Hosp Philadelphia, Dept Orthopaed, Clin Orthopaed Surg, 2nd Floor,Wood Bldg,3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	maguirek@chop.edu		Farooqi, Ali/0000-0001-7763-6152			Arnold A, 2017, SPORTS HEALTH, V9, P139, DOI 10.1177/1941738117690847; Benjamin HJ, 2017, CURR SPORT MED REP, V16, P322, DOI 10.1249/JSR.0000000000000398; Cassel M, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00544; Cheron C, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0122-y; Corso Melissa, 2018, J Can Chiropr Assoc, V62, P150; DALTON SE, 1992, SPORTS MED, V13, P58, DOI 10.2165/00007256-199213010-00006; Desai N, 2019, J AM ACAD ORTHOP SUR, V27, P459, DOI 10.5435/JAAOS-D-18-00147; DOBYNS JH, 1990, HAND CLIN, V6, P493; Emery CA, 2019, BEST PRACT RES CL RH, V33, P3, DOI 10.1016/j.berh.2019.02.009; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Foss KDB, 2018, J ATHL TRAINING, V53, P20, DOI 10.4085/1062-6050-173-16; Hoang Quynh B, 2012, Adv Pediatr, V59, P359, DOI 10.1016/j.yapd.2012.04.005; Jayanthi N, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120922764; Jayanthi NA, 2015, AM J SPORT MED, V43, P794, DOI 10.1177/0363546514567298; Jones C., 2020, ARCH MED RES, V8, P2020; Knox CL, 2006, PEDIATRICS, V118, P549, DOI 10.1542/peds.2005-2913; Kox LS, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2616-y; Kristin JR., 2013, J PHYS ACT HEALTH, V10, P143; McLeod TCV, 2011, J ATHL TRAINING, V46, P206, DOI 10.4085/1062-6050-46.2.206; Nalliah RP, 2014, PEDIATR EMERG CARE, V30, P511, DOI 10.1097/PEC.0000000000000180; Ohta-Fukushima M, 2002, J SPORT MED PHYS FIT, V42, P198; Popkin CA, 2019, J AM ACAD ORTHOP SUR, V27, pE995, DOI 10.5435/JAAOS-D-18-00187; Roberts KJ, 2013, J PHYS ACT HEALTH, V10, P143, DOI 10.1123/jpah.10.2.143; Ryan JL, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2018-000491; Saeed W, 2020, ELBOW FRACTURES OVER; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Singh S, 2008, PEDIATRICS, V121, pE954, DOI 10.1542/peds.2007-0767; Stracciolini A, 2015, PHYSICIAN SPORTSMED, V43, P342, DOI 10.1080/00913847.2015.1076326; Stracciolini A, 2015, CLIN J SPORT MED, V25, P30, DOI 10.1097/JSM.0000000000000105; Watkins J, 1996, J SPORT MED PHYS FIT, V36, P43; Wu M, 2016, SPORTS MED ARTHROSC, V24, P150, DOI 10.1097/JSA.0000000000000129; Yang JZ, 2007, PEDIATRICS, V119, pE813, DOI 10.1542/peds.2006-2140; Yin AX, 2016, PM&R, V8, P348, DOI 10.1016/j.pmrj.2015.08.012	33	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.												10.1080/00913847.2021.1996863		NOV 2021	9	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	WQ0JX	WOS:000713510400001	34696657				2022-02-06	
J	Hsieh, CC; Chan, PY; Liou, L; Chen, YK; Tsao, MJ; Chen, LF; Lin, KH				Hsieh, Chih-Chuan; Chan, Pi-Yun; Liou, Li-Ren; Chen, Ying-Kai; Tsao, Min-Jen; Chen, Lap-For; Lin, Kung-Hung			A Case of Penetrating Head Wound Due to Helicopter Rotor Blade Injury in a 34-Year-Old Naval Helicopter Pilot Who Returned to Active Service 5 Years Later	AMERICAN JOURNAL OF CASE REPORTS			English	Article						Acupuncture; Advanced Trauma Life Support Care; Craniotomy; Military Personnel; Occipital Bone; Pilots	TRAUMATIC BRAIN-INJURY; UNITED-STATES	Objective: Unusual clinical course Background: Head trauma, defined as damage to the brain, skull, or scalp when the head is hit by an external force, is a major cause of mortality in military personnel. Therefore, we report a novel case involving a naval helicopter pilot who sustained a helicopter propeller rotor blade injury. Case Report: We describe a case involving a pilot struck on the head by a helicopter rotor blade. He received care from medical staff shortly after the injury and was en route to the nearest trauma center. Cranial computed tomography (CT) scans revealed a comminuted fracture of the right occipital bone, with bone fragment retention in the right cerebral hemispheres. We performed an emergency right occipital craniotomy. The visual field patterns demonstrated right homonymous hemianopia when the patient was discharged. The patient underwent delayed titanium mesh cranioplasty about 3 months after the right occipital craniotomy. From discharge to 5 years, the patient had performed rehabilitation exercise for at least 3 days every week. The patient's continued recovery was confirmed at the 5-year follow-up in 2019. The bilateral visual acuity was 20/20, and the right homonymous hemianopia problem also disappeared. In the same year, after a physical and psychological assessment by an aviation doctor, he was able to resume flying. Conclusions: This report has shown that despite safety regulations for military and civilian helicopter personnel, which include the wearing of helmets, helicopter rotor blade injuries still occur and can have long-term consequences due to the severity of head injury.	[Hsieh, Chih-Chuan; Chan, Pi-Yun; Chen, Lap-For; Lin, Kung-Hung] Zuoying Branch Kaohsiung Armed Forces Gen Hosp, Dept Surg, Div Neurosurg, Kaohsiung, Taiwan; [Hsieh, Chih-Chuan] Serv Gen Hosp, Natl Def Med Ctr, Dept Neurosurg, Taipei, Taiwan; [Chan, Pi-Yun] Fooyin Univ, Sch Nursing, Kaohsiung, Taiwan; [Liou, Li-Ren; Tsao, Min-Jen; Lin, Kung-Hung] Zuoying Branch Kaohsiung Armed Forces Gen Hosp, Dept Surg, Div Gen Surg, Kaohsiung, Taiwan; [Chen, Ying-Kai] Zuoying Branch Kaohsiung Armed Forces Gen Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Chen, Ying-Kai] Natl Def Med Ctr, Dept, Taipei, Taiwan; [Chen, Ying-Kai] Natl Def Med Ctr, Grad Inst Biochem, Taipei, Taiwan		Lin, KH (corresponding author), Zuoying Branch Kaohsiung Armed Forces Gen Hosp, Dept Surg, Div Neurosurg, Kaohsiung, Taiwan.; Lin, KH (corresponding author), Zuoying Branch Kaohsiung Armed Forces Gen Hosp, Dept Surg, Div Gen Surg, Kaohsiung, Taiwan.	doctorlin0831@gmail.com					Baxter D, 2012, SURG OXFORD, V30, P116; Bullock M Ross, 2006, Neurosurgery, V58, pS56; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Carr DJ, 2017, J ROY ARMY MED CORPS, V163, P13, DOI 10.1136/jramc-2015-000600; Carson HJ, 2009, J FORENSIC LEG MED, V16, P115, DOI 10.1016/j.jflm.2008.08.013; CROWLEY JS, 1993, AVIAT SPACE ENVIR MD, V64, P854; Galvagno Samuel M Jr, 2019, Anesthesiol Clin, V37, P13, DOI 10.1016/j.anclin.2018.09.009; Gibbons J R, 1997, J R Army Med Corps, V143, P122; Green SM, 2017, ANN EMERG MED, V70, P158, DOI 10.1016/j.annemergmed.2016.12.016; Jiang JY, 2007, SURG NEUROL, V68, P2, DOI 10.1016/j.surneu.2007.09.016; KARGER B, 1995, INT J LEGAL MED, V108, P53, DOI 10.1007/BF01369905; Madea B, 2015, FORENSIC SCI MED PAT, V11, P622, DOI 10.1007/s12024-015-9721-5; NELSON JM, 1995, MIL MED, V160, P644, DOI 10.1093/milmed/160.12.644; Snow Ryan W, 2018, J Spec Oper Med, V18, P19; Taneja N, 2003, AVIAT SPACE ENVIR MD, V74, P337; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Walrath B, 2017, MIL MED, V182, P162, DOI 10.7205/MILMED-D-16-00047; Wiegmann DA, 2003, ACCIDENT ANAL PREV, V35, P571, DOI 10.1016/S0001-4575(02)00037-4	18	0	0	0	0	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA		1941-5923		AM J CASE REP	Am. J. Case Rep.	NOV 3	2021	22								e933862	10.12659/AJCR.933862			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WV9BL	WOS:000717524100002	34731159	Green Published			2022-02-06	
J	Huie, JR; Chou, A; Torres-Espin, A; Nielson, JL; Yuh, EL; Gardner, RC; Diaz-Arrastia, R; Manley, GT; Ferguson, AR				Huie, J. Russell; Chou, Austin; Torres-Espin, Abel; Nielson, Jessica L.; Yuh, Esther L.; Gardner, Raquel C.; Diaz-Arrastia, Ramon; Manley, Geoff T.; Ferguson, Adam R.		TRACK-TBI Investigators	FAIR Data Reuse in Traumatic Brain Injury: Exploring Inflammation and Age as Moderators of Recovery in the TRACK-TBI Pilot	FRONTIERS IN NEUROLOGY			English	Article						leveraging data science for traumatic brain injury prevention; evidence based healthcare; precision medicine; data sharing; aging; inflammation; proteomics; outcomes	COMMON DATA ELEMENTS; BIG-DATA; KNOWLEDGE; BIOMARKERS; PACKAGE; PANEL; RISK	The guiding principle for data stewardship dictates that data be FAIR: findable, accessible, interoperable, and reusable. Data reuse allows researchers to probe data that may have been originally collected for other scientific purposes in order to gain novel insights. The current study reuses the Transforming Research and Clinical Knowledge for Traumatic Brain Injury (TRACK-TBI) Pilot dataset to build upon prior findings and ask new scientific questions. Specifically, we have previously used a multivariate analytics approach to multianalyte serum protein data from the TRACK-TBI Pilot dataset to show that an inflammatory ensemble of biomarkers can predict functional outcome at 3 and 6 months post-TBI. We and others have shown that there are quantitative and qualitative changes in inflammation that come with age, but little is known about how this interaction affects recovery from TBI. Here we replicate the prior proteomics findings with improved missing value analyses and non-linear principal component analysis and then expand upon this work to determine whether age moderates the effect of inflammation on recovery. We show that increased age correlates with worse functional recovery on the Glasgow Outcome Scale-Extended (GOS-E) as well as increased inflammatory signature. We then explore the interaction between age and inflammation on recovery, which suggests that inflammation has a more detrimental effect on recovery for older TBI patients.	[Huie, J. Russell; Chou, Austin; Torres-Espin, Abel; Yuh, Esther L.; Manley, Geoff T.; Ferguson, Adam R.] Univ Calif San Francisco, Dept Neurosurg, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [Huie, J. Russell; Ferguson, Adam R.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Nielson, Jessica L.] Univ Minnesota, Dept Psychiat & Behav Sci, Minneapolis, MN USA; [Nielson, Jessica L.] Univ Minnesota, Inst Hlth Informat, Minneapolis, MN USA; [Yuh, Esther L.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Gardner, Raquel C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA		Ferguson, AR (corresponding author), Univ Calif San Francisco, Dept Neurosurg, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA.; Ferguson, AR (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.	adam.ferguson@ucsf.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS088475, R01NS122888, UH3NS106899, U24NS122732]; Department of Veterans AffairsUS Department of Veterans Affairs [1I01RX002245, I01RX002787]; Wings for Life Foundation; Craig H. Neilsen Foundation; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS117728]	This study was supported by National Institutes of Health Grants: R01NS088475 (AF); R01NS122888 (AF); UH3NS106899 (AF); and U24NS122732 (AF); Department of Veterans Affairs: 1I01RX002245 (AF) and I01RX002787 (AF); and Wings for Life Foundation and Craig H. Neilsen Foundation (AF), NIH/NINDS F32NS117728 (AC).	Chou A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061616; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Ferguson AR, 2014, NAT NEUROSCI, V17, P1442, DOI 10.1038/nn.3838; Fox J., 2019, R COMPANION APPL REG, V3 rd; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588; Hawkins BE, 2020, J NEUROTRAUM, V37, P2414, DOI 10.1089/neu.2018.6192; Hooshmand MJ, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-15; Huie JR, 2019, J NEUROTRAUM, V36, P100, DOI 10.1089/neu.2017.5449; Huie JR, 2018, CURR OPIN NEUROL, V31, P702, DOI 10.1097/WCO.0000000000000614; Huie JR, 2018, J NEUROTRAUM, V35, pA, DOI [10.1089/neu.2018.29013.abstracts, DOI 10.1089/NEU.2018.29013.ABSTRACTS]; Jackson CH, 2011, J STAT SOFTW, V38, P1; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Mair P, 2010, J STAT SOFTW, V32, P1; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Norgeot B, 2019, NAT MED, V25, P14, DOI 10.1038/s41591-018-0320-3; R Core Team, 2020, R LANG ENV STAT COMP; Sayed Nazish, 1800, Nat Aging, V1, P598, DOI 10.1038/s43587-021-00082-y; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Sievert C., 2020, INTERACTIVE WEB BASE; Thammisetty SS, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1350-y; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tierney NJ, 2018, 180902264 ARXIV; Torres-Espin A, 2021, ELIFE, V10, DOI 10.7554/eLife.61812; Wallis JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067332; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zhang B, 2015, EXP NEUROL, V273, P83, DOI 10.1016/j.expneurol.2015.08.001	37	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 3	2021	12								768735	10.3389/fneur.2021.768735			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WZ2VE	WOS:000719829500001	34803899	gold, Green Published			2022-02-06	
J	Mohamed, AZ; Cumming, P; Nasrallah, FA				Mohamed, Abdalla Z.; Cumming, Paul; Nasrallah, Fatima A.			Traumatic brain injury augurs ill for prolonged deficits in the brain's structural and functional integrity following controlled cortical impact injury	SCIENTIFIC REPORTS			English	Article							AXONAL INJURY; PROGRESSIVE ATROPHY; ATTENTION DEFICITS; WHITE-MATTER; MOUSE MODEL; DIFFUSION; CONNECTIVITY; MRI; REORGANIZATION; ANISOTROPY	Previous neuroimaging studies in rodents investigated effects of the controlled cortical impact (CCI) model of traumatic brain injury (TBI) within one-month post-TBI. This study extends this temporal window to monitor the structural-functional alterations from two hours to six months post-injury. Thirty-seven male Sprague-Dawley rats were randomly assigned to TBI and sham groups, which were scanned at two hours, 1, 3, 7, 14, 30, 60 days, and six months following CCI or sham surgery. Structural MRI, diffusion tensor imaging, and resting-state functional magnetic resonance imaging were acquired to assess the dynamic structural, microstructural, and functional connectivity alterations post-TBI. There was a progressive increase in lesion size associated with brain volume loss post-TBI. Furthermore, we observed reduced fractional anisotropy within 24 h and persisted to six months post-TBI, associated with acutely reduced axial diffusivity, and chronic increases in radial diffusivity post-TBI. Moreover, a time-dependent pattern of altered functional connectivity evolved over the six months' follow-up post-TBI. This study extends the current understanding of the CCI model by confirming the long-term persistence of the altered microstructure and functional connectivity, which may hold a strong translational potential for understanding the long-term sequelae of TBI in humans.	[Mohamed, Abdalla Z.; Nasrallah, Fatima A.] Univ Queensland, Queensland Brain Inst, Bldg 79,Upland Rd, Brisbane, Qld 4072, Australia; [Mohamed, Abdalla Z.] Univ Sunshine Coast, Thompson Inst, Birtinya, Qld 4575, Australia; [Cumming, Paul] Bern Univ Hosp, Dept Nucl Med, Bern, Switzerland; [Cumming, Paul] Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld, Australia		Nasrallah, FA (corresponding author), Univ Queensland, Queensland Brain Inst, Bldg 79,Upland Rd, Brisbane, Qld 4072, Australia.	f.nasrallah@uq.edu.au	Mohamed, Abdalla/ABG-8718-2021; Mohaned, Abdalla/AAL-8721-2020	Mohaned, Abdalla/0000-0003-4499-672X	Motor Accident Insurance Commission (MAIC), The Queensland Government, Australia [2014000857]	This research was supported by Motor Accident Insurance Commission (MAIC), The Queensland Government, Australia (grant number: 2014000857).	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Chou N, 2011, IEEE T IMAGE PROCESS, V20, P2554, DOI 10.1109/TIP.2011.2126587; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Dickson TC, 2007, NEUROREPORT, V18, P283, DOI 10.1097/WNR.0b013e3280143cdb; Duncan KA, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.681599; EDNA TH, 1987, ACTA NEUROCHIR, V85, P40, DOI 10.1007/BF01402368; Frey L, 2014, NEUROL RES, V36, P26, DOI 10.1179/1743132813Y.0000000269; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Grafman J, 2000, J COMMUN DISORD, V33, P345, DOI 10.1016/S0021-9924(00)00030-7; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Harris NG, 2013, J NEUROTRAUM, V30, P1137, DOI 10.1089/neu.2012.2785; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Holschneider DP, 2013, J NEUROTRAUM, V30, P907, DOI 10.1089/neu.2012.2657; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Huttunen JK, 2018, J NEUROTRAUM, V35, P2708, DOI 10.1089/neu.2017.5308; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Ledig C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188152; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Missault S, 2019, J NEUROTRAUM, V36, P768, DOI 10.1089/neu.2018.5704; Mohamed AZ, 2022, J NEUROL, V269, P873, DOI 10.1007/s00415-021-10669-5; Mohamed AZ, 2021, BIOL PSYCHIAT-COGN N, V6, P1100, DOI 10.1016/j.bpsc.2021.04.014; Mohamed AZ, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102136; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Park CH, 2011, STROKE, V42, P1357, DOI 10.1161/STROKEAHA.110.596155; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Qin Y, 2018, BEHAV BRAIN RES, V340, P41, DOI 10.1016/j.bbr.2016.08.008; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Sargolzaei Saman, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P5414, DOI 10.1109/EMBC.2018.8513500; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2017, EXP BRAIN RES, V235, P799, DOI 10.1007/s00221-016-4841-z; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Soni N, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00153; Soni N, 2019, J NEUROTRAUM, V36, P1306, DOI 10.1089/neu.2018.5972; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Sullivan DR, 2018, J INT NEUROPSYCH SOC, V24, P662, DOI 10.1017/S1355617718000279; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Thompson WH, 2016, NEUROIMAGE-CLIN, V12, P1004, DOI 10.1016/j.nicl.2016.05.005; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Verley DR, 2019, J NEUROTRAUM, V36, P789, DOI 10.1089/neu.2018.5769; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhao JB, 2014, TRANSL STROKE RES, V5, P586, DOI 10.1007/s12975-014-0353-y	79	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	NOV 3	2021	11	1							21559	10.1038/s41598-021-00660-5			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WR3PJ	WOS:000714415600049	34732737	Green Published, gold			2022-02-06	
J	Ogino, Y; Bernas, T; Greer, JE; Povlishock, JT				Ogino, Yasuaki; Bernas, Tytus; Greer, John E.; Povlishock, John T.			Axonal injury following mild traumatic brain injury is exacerbated by repetitive insult and is linked to the delayed attenuation of NeuN expression without concomitant neuronal death in the mouse	BRAIN PATHOLOGY			English	Article; Early Access						axonal injury; mild traumatic brain injury; NeuN; neuronal death; p-c-Jun; repetitive traumatic brain injury	N-TERMINAL KINASES; C-JUN; POSTTRAUMATIC HYPOTHERMIA; TRANSCRIPTION FACTORS; UNITED-STATES; CELL NUMBERS; ACTIVATION; MODEL; ADULT; INFLAMMATION	Mild traumatic brain injury (mTBI) affects brain structure and function and can lead to persistent abnormalities. Repetitive mTBI exacerbates the acute phase response to injury. Nonetheless, its long-term implications remain poorly understood, particularly in the context of traumatic axonal injury (TAI), a player in TBI morbidity via axonal disconnection, synaptic loss and retrograde neuronal perturbation. In contrast to the examination of these processes in the acute phase of injury, the chronic-phase burden of TAI and/or its implications for retrograde neuronal perturbation or death have received little consideration. To critically assess this issue, murine neocortical tissue was investigated at acute (24-h postinjury, 24hpi) and chronic time points (28-days postinjury, 28dpi) after singular or repetitive mTBI induced by central fluid percussion injury (cFPI). Neurons were immunofluorescently labeled for NeuroTrace and NeuN (all neurons), p-c-Jun (axotomized neurons) and DRAQ5 (cell nuclei), imaged in 3D and quantified in automated manner. Single mTBI produced axotomy in 10% of neurons at 24hpi and the percentage increased after repetitive injury. The fraction of p-c-Jun+ neurons decreased at 28dpi but without neuronal loss (NeuroTrace), suggesting their reorganization and/or repair following TAI. In contrast, NeuN+ neurons decreased with repetitive injury at 24hpi while the corresponding fraction of NeuroTrace+ neurons decreased over 28dpi. Attenuated NeuN expression was linked exclusively to non-axotomized neurons at 24hpi which extended to the axotomized at 28dpi, revealing a delayed response of the axotomized neurons. Collectively, we demonstrate an increased burden of TAI after repetitive mTBI, which is most striking in the acute phase response to the injury. Our finding of widespread axotomy in large fields of intact neurons contradicts the notion that repetitive mTBI elicits progressive neuronal death, rather, emphasizing the importance of axotomy-mediated change.	[Ogino, Yasuaki; Bernas, Tytus; Povlishock, John T.] Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, 1101 E Marshall St,POB 980709, Richmond, VA 23298 USA; [Greer, John E.] Virginia Commonwealth Univ, Sch Med, Dept Neurosurg, Richmond, VA USA; [Greer, John E.] Hunter Holmes McGuire Vet Affairs Med Ctr, Dept Surg, Richmond, VA USA		Ogino, Y (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, 1101 E Marshall St,POB 980709, Richmond, VA 23298 USA.	yasuaki.ogino@vcuhealth.org		Ogino, Yasuaki/0000-0002-2268-3119	National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS077675]; NIH-NINDS Center Core Grants [5P30NS047463]; NIH-NCI Cancer Center Support GrantsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA016059]	This research was funded by National Institute of Health (NIH) Grants NS077675. Also, the microscopy performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility, was supported, in part, by funding from NIH-NINDS Center Core Grants (5P30NS047463), and by funding from NIH-NCI Cancer Center Support Grants (P30CA016059)	Akamatsu Y, 2020, NEUROTHERAPEUTICS, V17, P446, DOI 10.1007/s13311-020-00840-7; Alvarez FJ, 2011, J NEUROPHYSIOL, V106, P2450, DOI 10.1152/jn.01095.2010; Ara T., 2020, BRUNNERMUNZEL PERMUT; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Barron KD, 2004, J NEUROL SCI, V220, P119, DOI 10.1016/j.jns.2004.03.009; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Canty AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3038; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Collombet JM, 2006, NEUROSCI LETT, V398, P337, DOI 10.1016/j.neulet.2006.01.029; Cotter D, 2001, ARCH GEN PSYCHIAT, V58, P545, DOI 10.1001/archpsyc.58.6.545; Darlot F, 2017, EUR J NEUROSCI, V46, P2729, DOI 10.1111/ejn.13737; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dougherty SE, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113089; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Garcia-Amado M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038692; Garcia-Cabezas MA, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00107; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Ghadiri T, 2020, IRAN J BASIC MED SCI, V23, P63, DOI 10.22038/IJBMS.2019.37558.8932; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Haeusgen W, 2009, NEUROSCIENCE, V161, P951, DOI 10.1016/j.neuroscience.2009.04.014; Hahn YK, 2015, CURR HIV RES, V13, P10, DOI 10.2174/1570162X13666150311163733; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Herdegen T, 2001, ONCOGENE, V20, P2424, DOI 10.1038/sj.onc.1204387; Herdegen T, 1998, J NEUROSCI, V18, P5124, DOI 10.1523/JNEUROSCI.18-14-05124.1998; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hernandez ML, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01238; Hope R. M, 2013, RMISC RMISC RYAN MIS; Hothorn T., 2019, EXACTRANKTESTS EXACT; Hughes PE, 1999, PROG NEUROBIOL, V57, P421, DOI 10.1016/S0301-0082(98)00057-4; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jacko M, 2018, NEURON, V97, P853, DOI 10.1016/j.neuron.2018.01.020; Jin YJ, 2016, NEURON, V91, P748, DOI 10.1016/j.neuron.2016.07.024; Kajstura TJ, 2018, J NEUROSCI RES, V96, P512, DOI 10.1002/jnr.24059; Kenney AM, 1998, J NEUROSCI, V18, P1318; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Konopaske GT, 2007, NEUROPSYCHOPHARMACOL, V32, P1216, DOI 10.1038/sj.npp.1301233; Lieberman A R, 1971, Int Rev Neurobiol, V14, P49, DOI 10.1016/S0074-7742(08)60183-X; Lin YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164164; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lyck L, 2007, EUR J NEUROSCI, V26, P1749, DOI 10.1111/j.1460-9568.2007.05763.x; Ma M, 2009, EXP NEUROL, V215, P119, DOI 10.1016/j.expneurol.2008.09.024; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McPhail LT, 2004, EXP NEUROL, V185, P182, DOI 10.1016/j.expneurol.2003.10.001; Meyer D., VCD VISUALIZING CATE; Meyer D, 2006, J STAT SOFTW, V17; Meyer RE., 2017, VET ANESTHESIA ANALG, P130; Moore DL, 2011, DEV NEUROBIOL, V71, P1186, DOI 10.1002/dneu.20934; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; Ogino Y, 2018, J NEUROPATH EXP NEUR, V77, P782, DOI 10.1093/jnen/nly054; Pelvig DP, 2008, NEUROBIOL AGING, V29, P1754, DOI 10.1016/j.neurobiolaging.2007.04.013; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; R Core Team, 2020, R LANG ENV STAT COMP; Raivich G, 2008, J NEUROCHEM, V107, P898, DOI 10.1111/j.1471-4159.2008.05684.x; Raivich G, 2006, PROG NEUROBIOL, V78, P347, DOI 10.1016/j.pneurobio.2006.03.006; Re A.C.D., 2013, COMPUTEES COMPUTE EF; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Sakurai A, 2012, J NEUROTRAUM, V29, P313, DOI 10.1089/neu.2011.2152; Sarkar C, 2020, AUTOPHAGY, V16, P466, DOI 10.1080/15548627.2019.1628538; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Tan M, 2015, J MOL NEUROSCI, V57, P142, DOI 10.1007/s12031-015-0588-4; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Titus DJ, 2015, EXP NEUROL, V263, P254, DOI 10.1016/j.expneurol.2014.10.020; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Truettner JS, 2018, J NEUROTRAUM, V35, P940, DOI 10.1089/neu.2017.5303; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; Vascak M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00157; Vascak M, 2018, CEREB CORTEX, V28, P1625, DOI 10.1093/cercor/bhx058; Waetzig V, 2006, PROG NEUROBIOL, V80, P84, DOI 10.1016/j.pneurobio.2006.08.002; Wang HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17383; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Yuan QJ, 2014, J ANAT, V224, P575, DOI 10.1111/joa.12165; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	89	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.											e13034	10.1111/bpa.13034		NOV 2021	20	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	WQ6YW	WOS:000713960900001	34729854	gold			2022-02-06	
J	Sharma, AA; Goodman, AM; Allendorfer, JB; Philip, NS; Correia, S; LaFrance, WC; Szaflarski, JP				Sharma, Ayushe A.; Goodman, Adam M.; Allendorfer, Jane B.; Philip, Noah S.; Correia, Stephen; LaFrance, W. Curt, Jr.; Szaflarski, Jerzy P.			Regional brain atrophy and aberrant cortical folding relate to anxiety and depression in patients with traumatic brain injury and psychogenic nonepileptic seizures	EPILEPSIA			English	Article						cortical folding; gray matter volume; neuromorphometry; psychogenic nonepileptic seizures; traumatic brain injury; voxel-based morphometry	TRAIT ANXIETY; THICKNESS; DISORDERS; DIAGNOSIS; CORTEX; STATE	Objective Psychogenic nonepileptic seizures (PNES) are characterized by multifocal and global abnormalities in brain function and connectivity. Only a few studies have examined neuroanatomic correlates of PNES. Traumatic brain injury (TBI) is reported in 83% of patients with PNES and may be a key component of PNES pathophysiology. In this study, we included patients with TBI preceding the onset of PNES (TBI-PNES) and TBI without PNES (TBI-only) to identify neuromorphometric abnormalities associated with PNES. Methods Adults diagnosed with TBI-PNES (n = 62) or TBI-only (n = 59) completed psychological questionnaires and underwent 3-T magnetic resonance imaging. Imaging data were analyzed by voxel- and surface-based morphometry. Voxelwise general linear models computed group differences in gray matter volume, cortical thickness, sulcal depth, fractal dimension (FDf), and gyrification. Statistical models were assessed with permutation-based testing at 5000 iterations with the Threshold-Free Cluster Enhancement toolbox. Logarithmically scaled p-values corrected for multiple comparisons using familywise error were considered significant at p < .05. Post hoc analyses determined the association between structural and psychological measures (p < .05). Results TBI-PNES participants demonstrated atrophy of the left inferior frontal gyrus and the right cerebellum VIII. Relative to TBI-only, TBI-PNES participants had decreased FDf in the right superior parietal gyrus and decreased sulcal depth in the left insular cortex. Significant clusters were positively correlated with global assessment of functioning scores, and demonstrated varying negative associations with measures of anxiety, depression, somatization, and global severity of symptoms. Significance The diagnosis of PNES was associated with brain atrophy and reduced cortical folding in regions implicated in emotion processing, regulation, and response inhibition. Cortical folds primarily develop during the third trimester of pregnancy and remain relatively constant throughout the remainder of one's life. Thus, the observed aberrations in FDf and sulcal depth could originate early in development. The convergence of environmental, developmental, and neurobiological factors may coalesce to reflect the neuropathophysiological substrate of PNES.	[Sharma, Ayushe A.; Goodman, Adam M.; Allendorfer, Jane B.; Szaflarski, Jerzy P.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Szaflarski, Jerzy P.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Allendorfer, Jane B.; Szaflarski, Jerzy P.] Univ Alabama Birmingham, Epilepsy Ctr, Birmingham, AL 35294 USA; [Philip, Noah S.; Correia, Stephen; LaFrance, W. Curt, Jr.] Vet Affairs Rehabil Res, Providence, RI USA; [Philip, Noah S.; Correia, Stephen; LaFrance, W. Curt, Jr.] Vet Affairs Rehabil Res & Dev Ctr Neurorestorat &, Providence, RI USA; [Philip, Noah S.; Correia, Stephen; LaFrance, W. Curt, Jr.] Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Providence, RI 02912 USA; [LaFrance, W. Curt, Jr.] Brown Univ, Dept Neurol, Providence, RI USA; [Szaflarski, Jerzy P.] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA		Sharma, AA; Szaflarski, JP (corresponding author), Univ Alabama Birmingham, UAB Epilepsy Ctr, Dept Neurol, 1719 6th Ave South,CIRC 312, Birmingham, AL 35294 USA.	sharma87@uab.edu; jszallarski@uabmc.edu		LaFrance, Jr., W Curt/0000-0002-4901-3852; Sharma, Ayushe/0000-0001-8194-2232	Epilepsy Research Program [W81XWH-17-1-0619]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5T32NS061788-14]	Epilepsy Research Program, Grant/Award Number: W81XWH-17-1-0619; National Institute of Neurological Disorders and Stroke, Grant/Award Number: 5T32NS061788-14	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anzellotti F, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00461; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Balachandran N, 2021, EPILEPSIA, V62, P107, DOI 10.1111/epi.16758; Barzegaran E, 2016, J NEUROL NEUROSUR PS, V87, P332, DOI 10.1136/jnnp-2014-309483; Beck A.T., 1996, BECK DEPRESSION INVE, DOI DOI 10.1037/T00742-000; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bowman ES, 1996, AM J PSYCHIAT, V153, P57; Dahnke R, 2013, NEUROIMAGE, V65, P336, DOI 10.1016/j.neuroimage.2012.09.050; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90, V3rd ed.; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Ding JR, 2014, EPILEPSY RES, V108, P1184, DOI 10.1016/j.eplepsyres.2014.05.006; Fales CL, 2010, COGNITION EMOTION, V24, P200, DOI 10.1080/02699930903384691; Goodman AM, 2020, ANN CLIN TRANSL NEUR, V7, P1973, DOI 10.1002/acn3.51198; HALL RCW, 1995, PSYCHOSOMATICS, V36, P267, DOI 10.1016/S0033-3182(95)71666-8; Hatton SN, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-45; Hellewell SC, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00350; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; Hu YF, 2017, SOC COGN AFFECT NEUR, V12, P775, DOI 10.1093/scan/nsx008; Klein AP, 2016, AM J NEURORADIOL, V37, P1005, DOI 10.3174/ajnr.A4720; Labate A, 2012, EPILEPSIA, V53, P377, DOI 10.1111/j.1528-1167.2011.03347.x; LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356; LaFrance WC, 2013, EPILEPSIA, V54, P718, DOI 10.1111/epi.12053; Lee S, 2015, BRAIN RES, V1620, P169, DOI 10.1016/j.brainres.2015.04.050; McGonigal A, 2004, J NEUROL NEUROSUR PS, V75, P771, DOI 10.1136/jnnp.2003.024893; Mokleby K, 2002, EPILEPSIA, V43, P193, DOI 10.1046/j.1528-1157.2002.20901.x; Perez DL, 2021, NEUROIMAGE-CLIN, V30, DOI 10.1016/j.nicl.2021.102623; Perez DL, 2016, CNS SPECTRUMS, V21, P239, DOI 10.1017/S109285291600002X; Popkirov S, 2018, SEIZURE-EUR J EPILEP, V58, P127, DOI 10.1016/j.seizure.2018.04.009; Reuber M, 2011, EPILEPSIA, V52, P2028, DOI 10.1111/j.1528-1167.2011.03162.x; Ristic AJ, 2015, EPILEPSY RES, V112, P84, DOI 10.1016/j.eplepsyres.2015.02.015; Salinsky M, 2018, EPILEPSIA, V59, P1945, DOI 10.1111/epi.14542; Shang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093432; Sharma AA, 2019, EPILEPSY BEHAV REP, V12, DOI 10.1016/j.ebr.2019.100341; Szaflarski JP, 2018, EPILEPSY CURR, V18, P211, DOI 10.5698/1535-7597.18.4.211; Szaflarski JP, 2003, EPILEPSIA, V44, P236, DOI 10.1046/j.1528-1157.2003.35302.x; van der Kruijs SJM, 2014, J PSYCHIATR RES, V54, P126, DOI 10.1016/j.jpsychires.2014.03.010; Voon V, 2016, J NEUROPSYCH CLIN N, V28, P168, DOI 10.1176/appi.neuropsych.14090217; Yotter RA, 2011, NEUROIMAGE, V56, P961, DOI 10.1016/j.neuroimage.2011.02.007	40	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	JAN	2022	63	1					222	236		10.1111/epi.17109		NOV 2021	15	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD2XZ	WOS:000714075500001	34730239				2022-02-06	
J	Adame, BJ; Adame, EA; Zanin, AC; Martinez, LV; Corman, SR				Adame, Bradley J.; Adame, Elissa A.; Zanin, Alaina C.; Martinez, Laura, V; Corman, Steven R.			Perceived organizational influences on Western US collegiate athletes' attitudes toward concussion risks and concussion reporting	JOURNAL OF APPLIED COMMUNICATION RESEARCH			English	Article; Early Access						Cultural narrative; organizational influence; risk perception; concussion reporting; collegiate athletics	HEALTH BEHAVIOR; METAANALYSIS; PERCEPTION; REPETITION; INJURY	This paper investigates how cultural narratives from people at varying positions in a team culture affect athletes' attitudes toward concussion injures and concussion reporting. Power Five National Collegiate Athletic Association (NCAA) athletes (N = 226) competing in high-concussion risk sports completed a survey exploring the frequency with which they heard performance or safety narratives from three distinct organizational sources: coaches, Athletic Trainers (ATs), and teammates. Athletes then completed scales measuring perceived immediacy of concussion consequences, perceived probability of suffering short- and long-term consequences of concussions, and three distinct dimensions of attitudes toward concussion-reporting behavior. Regression analyses revealed that both message frequency and source matter to athletes when forming attitudes and perceptions about the concussion-reporting behaviors that universities are advocating. Implications and recommendations for organizations designed to motivate athletes to report concussions to conclude the paper.	[Adame, Bradley J.; Adame, Elissa A.; Zanin, Alaina C.; Martinez, Laura, V; Corman, Steven R.] Arizona State Univ, Hugh Downs Sch Human Commun, Tempe, AZ 85287 USA		Adame, BJ (corresponding author), Arizona State Univ, Hugh Downs Sch Human Commun, Tempe, AZ 85287 USA.	badame@asu.edu		Zanin, Alaina/0000-0001-8463-9853; Adame, Bradley/0000-0002-9825-7300	National Collegiate Athletic Association; US Department of Defense under the Mind Matters Challenge grant program	This work was supported by the National Collegiate Athletic Association and the US Department of Defense under the Mind Matters Challenge grant program.	Abbott, 2002, CAMBRIDGE INTRO NARR; Adame BJ, 2019, HEALTH COMMUN, V34, P1673, DOI 10.1080/10410236.2018.1517707; ARMENAKIS AA, 1993, HUM RELAT, V46, P681, DOI 10.1177/001872679304600601; Braddock K, 2016, COMMUN MONOGR, V83, P446, DOI 10.1080/03637751.2015.1128555; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Bruner Jerome, 1985, ACTUAL MINDS POSSIBL; CACIOPPO JT, 1989, BASIC APPL SOC PSYCH, V10, P3, DOI 10.1207/s15324834basp1001_2; Centers for Disease Control and Prevention, 2016, TRAUMATIC BRAIN INJU; Chiaburu DS, 2008, J APPL PSYCHOL, V93, P1082, DOI 10.1037/0021-9010.93.5.1082; Cohen J., 2003, APPL MULTIPLE REGRES, V3; Corman SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215424; Crano WD, 2006, ANNU REV PSYCHOL, V57, P345, DOI 10.1146/annurev.psych.57.102904.190034; Dattalo P., 2013, ANAL MULTIPLE DEPEND; Dillard JP, 2005, COMMUN MONOGR, V72, P144, DOI 10.1080/03637750500111815; Eagly A.H., 1993, PSYCHOL ATTITUDES; Eckel C.C., 2008, HDB EXPT EC RESULTS, V1, P1061, DOI DOI 10.1016/S1574-0722(07)00113-8; Green MC, 2000, J PERS SOC PSYCHOL, V79, P701, DOI 10.1037/0022-3514.79.5.701; Hagger MS, 2016, PREV MED, V89, P154, DOI 10.1016/j.ypmed.2016.05.020; Halverson JR, 2011, MASTER NARRATIVES OF ISLAMIST EXTREMISM, P1; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Keller PA, 2008, J PUBLIC POLICY MARK, V27, P117, DOI 10.1509/jppm.27.2.117; Kline RB., 2011, PRINCIPLES PRACTICE, V3; Koch T, 2013, J COMMUN, V63, P993, DOI 10.1111/jcom.12063; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lawton R, 2009, HEALTH PSYCHOL, V28, P56, DOI 10.1037/a0013424; Lininger MR, 2019, J ATHL TRAINING, V54, P21, DOI 10.4085/1062-6050-47-18; McCroskey JC, 1999, COMMUN MONOGR, V66, P90, DOI 10.1080/03637759909376464; Miller C., 2013, ELECT J COMMUNICATIO, V23, P1; Miller CH, 2013, DISASTERS, V37, P1, DOI 10.1111/j.1467-7717.2012.01290.x; National Collegiate Athletic Association Membership Affairs Staff, 2018, NCAA DIV MAN; National Collegiate Athletic Association Membership Affairs Staff, 2014, CONC DIAGN MAN BEST; Parmer LL, 2019, LEADERSHIP ORG DEV J, V40, P2, DOI 10.1108/LODJ-08-2018-0312; Patterson W., 2008, DOING NARRATIVE RES, P1, DOI DOI 10.4135/9780857024992.D3; PETTY RE, 1983, J CONSUM RES, V10, P135, DOI 10.1086/208954; Pfau M, 2010, COMMUN Q, V58, P1, DOI 10.1080/01463370903520307; Pitney WA, 2006, J ATHL TRAINING, V41, P189; Ploeger NA, 2013, MANAGE COMMUN Q, V27, P155, DOI 10.1177/0893318912469770; Polkinghorne D.E, 1995, LIFE HIST NARRATIVE, V8, P5, DOI 10.1080/0951839950080103; Rahim MA, 2009, POWER AND INTERDEPENDENCE IN ORGANIZATIONS, P224, DOI 10.1017/CBO9780511626562.015; Rauch SM, 2013, COMPUT HUM BEHAV, V29, P610, DOI 10.1016/j.chb.2012.11.011; Ruston SW, 2019, COMMUN SPORT, V7, P529, DOI 10.1177/2167479518786709; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Schwarz A., 2007, NEW YORK TIMES; Sheeran P, 2014, PSYCHOL BULL, V140, P511, DOI 10.1037/a0033065; Shen, 2013, SAGE HDB PERSUASION, P200, DOI DOI 10.4135/9781452218410.N13; Sias P.M., 2009, ORG RELATIONSHIPS TR; Sias PM, 2004, HUM COMMUN RES, V30, P589; Sjoberg L, 2000, RISK ANAL, V20, P1, DOI 10.1111/0272-4332.00001; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Spohr SA, 2015, J SUBST ABUSE TREAT, V56, P1, DOI 10.1016/j.jsat.2015.01.011; Tucker S, 2008, J OCCUP HEALTH PSYCH, V13, P319, DOI 10.1037/1076-8998.13.4.319; Wayment HA, 2019, INT J ATHL THER TRAI, V24, P256, DOI 10.1123/ijatt.2018-0121; Zanin AC, 2020, SMALL GR RES, V51, P342, DOI 10.1177/1046496419883948; Zanin AC, 2020, HEALTH COMMUN, V35, P935, DOI 10.1080/10410236.2019.1598742; Zanin AC, 2018, J APPL COMMUN RES, V46, P267, DOI 10.1080/00909882.2018.1465578; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	56	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0090-9882	1479-5752		J APPL COMMUN RES	J. Appl. Commun. Res.												10.1080/00909882.2021.1990373		NOV 2021	20	Communication	Social Science Citation Index (SSCI)	Communication	WW3XK	WOS:000717853500001					2022-02-06	
J	Anderson, JFI; Jordan, AS				Anderson, Jacqueline F. I.; Jordan, Amy S.			Sex predicts post-concussion symptom reporting, independently of fatigue and subjective sleep disturbance, in premorbidly healthy adults after mild traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Mild traumatic brain injury; Post-concussion symptoms; Sex; Sleep disturbance; Fatigue	CENTER-TASK-FORCE; QUALITY; POPULATION; MOOD; PERFORMANCE; INSTRUMENT; INVENTORY; PROGNOSIS; CAFFEINE	The relationship between sex and post-concussion symptom (PCS) reporting after mild traumatic brain injury (mTBI) is not well understood. Subjective sleep disturbance and fatigue impact PCS reporting after mTBI and show sex differences in the normal population. This study investigated whether sex had a relationship with PCS reporting after mTBI, independently of self-reported sleep disturbance and fatigue. Ninety-two premorbidly healthy adults in the post-acute period after mTBI completed the Rivermead Post-Concussion Symptoms Questionnaire, the Pittsburgh Sleep Quality Index, the Multidimensional Fatigue Inventory and measures of depression, anxiety and post-traumatic stress symptomatology. Females (n = 23) demonstrated higher levels of fatigue (p = .019) and greater psychological distress (p = .001) than males (n = 69), but equivalent levels of sleep disturbance (p = .946). Bootstrapping analyses were undertaken because PCS responses were not normally distributed. Female sex predicted greater PCS reporting (p = .001), independently of subjective sleep disturbance, fatigue, psychological distress and litigation status. The current findings support and extend previous work showing premorbidly healthy females are at higher risk of experiencing elevated PCS after mTBI than males in the post-acute period after mTBI. It may be beneficial for clinicians to be particularly sensitive to increased symptom reporting after mTBI in females, irrespective of sleep quality, fatigue or psychological status.	[Anderson, Jacqueline F. I.; Jordan, Amy S.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Anderson, Jacqueline F. I.] Alfred Hosp, Psychol Dept, Commercial Rd, Prahran, Vic, Australia; [Jordan, Amy S.] Austin Hlth, Inst Breathing & Sleep, Heidelberg, Vic, Australia		Anderson, JFI (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.; Anderson, JFI (corresponding author), Alfred Hosp, Psychol Dept, Commercial Rd, Prahran, Vic, Australia.	jfande@unimelb.edu.au		Jordan, Amy/0000-0001-8561-9766	Melbourne School of Psychological Sciences, The University of Melbourne	This work was supported by the Melbourne School of Psychological Sciences, The University of Melbourne.	Altemus M, 2014, FRONT NEUROENDOCRIN, V35, P320, DOI 10.1016/j.yfrne.2014.05.004; Anderson JFI, 2021, NEUROPSYCHOL REHABIL, V31, P1444, DOI 10.1080/09602011.2020.1781665; Anderson JFI, 2020, NEUROPSYCHOL REHABIL, V30, P1115, DOI 10.1080/09602011.2018.1556706; Arbabi M, 2020, BRAIN INJURY, V34, P1139, DOI 10.1080/02699052.2020.1797168; Ashbaugh AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161645; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beaulieu-Bonneau S, 2017, NEUROPSYCHOL REHABIL, V27, P983, DOI 10.1080/09602011.2016.1162176; Beck AT, 1993, BECK ANXIETY INVENTO; Bright P, 2020, NEUROPSYCHOL REHABIL, V30, P1, DOI 10.1080/09602011.2018.1445650; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chernick M.R., 2008, BOOTSTRAP METHODS GU, V2nd; Childs E, 2008, EXP CLIN PSYCHOPHARM, V16, P13, DOI 10.1037/1064-1297.16.1.13; Distelberg Brian J., 2017, Journal of Caffeine Research, V7, P59, DOI 10.1089/jcr.2016.0023; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hajali V, 2019, HORM BEHAV, V108, P50, DOI 10.1016/j.yhbeh.2018.12.013; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kobayashi I, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-29; Levin HS, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.3046; Lichstein KL, 1997, BEHAV RES THER, V35, P733, DOI 10.1016/S0005-7967(97)00029-6; Mallampalli MP, 2014, J WOMENS HEALTH, V23, P553, DOI 10.1089/jwh.2014.4816; Manierre M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227511; Mong JA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0110; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Saunders EFH, 2015, J AFFECT DISORDERS, V180, P90, DOI 10.1016/j.jad.2015.03.048; Schiehser DM, 2017, NEUROPSYCHOL REHABIL, V27, P1031, DOI 10.1080/09602011.2016.1215999; Schnurr, 2013, PTSD CHECKLIST DSM 5; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; Schwarz R, 2003, ONKOLOGIE, V26, P140, DOI 10.1159/000069834; Silva-Costa A, 2020, ARCH PUBLIC HEALTH, V78, DOI 10.1186/s13690-020-00429-8; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Steward KA, 2017, ARCH CLIN NEUROPSYCH, V32, P98, DOI 10.1093/arclin/acw081; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Suh S, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0940-9; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; WechslerD, 2001, WECHSLER TEST ADULT; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3	53	0	0	3	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2021.1993274		NOV 2021	16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	WQ5NM	WOS:000713862800001	34724887				2022-02-06	
J	Atia, A; Halligan, L; Brezina, L; Levites, H; Hollins, A; Blau, J; Hernandez, JA; Lohmeier, S; Suresh, V; Powers, DB				Atia, Andrew; Halligan, Lauren; Brezina, Libor; Levites, Heather; Hollins, Andrew; Blau, Jared; Hernandez, J. Andres; Lohmeier, Steven; Suresh, Visakha; Powers, David B.			Distribution of wounding patterns in casualties from mass shooting events	TRAUMA-ENGLAND			English	Article; Early Access						Mass shooting; mass casualty incident; location of gunshot wounds in mass casualty incident; hospital emergency response to mass casualty incident	GUNSHOT WOUNDS; DEATH; CARE; PROFILE	Introduction: The incidence and severity of public mass shootings, and mass casualty incidents (MCI), continues to rise. Understanding the wounding pattern and incidence of potentially preventable death after these incidents is key not only to Health System and Trauma Center emergency response planning but also to community outreach and initial emergency interventions. Methods: A retrospective study of autopsy reports after events with at least 10 fatalities exclusive of the assailants identified via the Federal Bureau of Investigation database from 1 January 1999 to 31 December 2020 was performed. Sites of injury, identification of weaponry, and identification of potentially survivable wounds were compiled. Results: Nine events including 203 victims were reviewed. Overall, 56% of gunshots were to the head/neck/face; 37% were to the chest; 43% were to the abdomen/torso/back; 31% were to the lower extremity; and 36% were to the upper extremity. On average, there were 29 fatalities per event. Conclusion: Emergency response disaster care strategy should focus on immediate point of care at the site of wounding by both the civilian population and medical personnel, as well as rapid extrication of victims for definitive medical care. Review of these autopsy results indicates exsanguination, often treatable, is the primary cause of death-supporting community education efforts in hemorrhage control. The location of the wounding patterns seen in this study warrants primary integration of craniomaxillofacial, orthopedic trauma, neurotrauma, and surgical critical care/trauma surgical specialists into the initial response team for MCI.	[Atia, Andrew; Levites, Heather; Hollins, Andrew; Blau, Jared; Hernandez, J. Andres; Lohmeier, Steven; Powers, David B.] Duke Univ Hosp, Div Plast Maxillofacial & Oral Surg, DUMC 2955 Room 110 Baker House, Durham, NC 27710 USA; [Halligan, Lauren] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Brezina, Libor; Suresh, Visakha] Duke Univ, Sch Med, Durham, NC 27710 USA; [Brezina, Libor] Barts Hlth NHS Trust, London, England; [Suresh, Visakha] Johns Hopkins Univ Hosp, Dept Plast Surg, Baltimore, MD 21287 USA		Powers, DB (corresponding author), Duke Univ Hosp, Div Plast Maxillofacial & Oral Surg, DUMC 2955 Room 110 Baker House, Durham, NC 27710 USA.	david.powers@duke.edu		Suresh, Visakha/0000-0002-0950-2272			AmyCohen PDA., RATE MASS SHOOTINGS; [Anonymous], 1993, BATTLE MOGADISHU CAS; Bauchner H, 2017, JAMA PSYCHIAT, V74, P1195, DOI 10.1001/jamapsychiatry.2017.3616; Booty M, 2019, INJURY EPIDEMIOL, V6, DOI 10.1186/s40621-019-0226-7; Callaway DW, 2017, WILD ENVIRON MED, V28, pS140, DOI 10.1016/j.wem.2016.11.008; Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27; Chavez N., THE CNN; DiMaggio C, 2019, J TRAUMA ACUTE CARE, V87, P1003, DOI 10.1097/TA.0000000000002374; DiMaggio C, 2019, J TRAUMA ACUTE CARE, V86, P11, DOI 10.1097/TA.0000000000002060; DOLIN J, 1992, J TRAUMA, V33, P508, DOI 10.1097/00005373-199210000-00004; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Fung K., 2021, NEWSWEEK ONLINE 0323; General Methodology, GUN VIOL ARCH; Kates G., REPORT US AVERAGES N; Klarevas L, 2019, J TRAUMA ACUTE CARE, V86, P926, DOI 10.1097/TA.0000000000002220; Lacanlale R, 2020, LAS VEGAS REV J; Lin PI, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204722; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Melmer P, 2019, J MULTIDISCIP HEALTH, V12, P1013, DOI 10.2147/JMDH.S219021; Myers SR, 2020, JAMA SURG, V155, P446, DOI 10.1001/jamasurg.2020.0095; Orthopoulos G, 2013, WORLD J SURG, V37, P2348, DOI 10.1007/s00268-013-2139-x; Rivara FP, 2018, JAMA-J AM MED ASSOC, V320, P764, DOI 10.1001/jama.2018.9942; Seamon MJ, 2007, J TRAUMA, V63, P113, DOI 10.1097/TA.0b013e31806842a1; Smith CP, 2020, J TRAUMA ACUTE CARE, V88, P372, DOI 10.1097/TA.0000000000002574; Smith ER, 2018, PREHOSP EMERG CARE, V22, P662, DOI 10.1080/10903127.2018.1459980; Smith ER, 2019, J AM COLL SURGEONS, V229, P244, DOI 10.1016/j.jamcollsurg.2019.04.016; Smith ER, 2016, J TRAUMA ACUTE CARE, V81, P86, DOI 10.1097/TA.0000000000001031; Taichman DB, 2017, NEW ENGL J MED, V377, P2090, DOI 10.1056/NEJMe1713355; Todd M., PACIFIC STANDARD; Torjesen I, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2628; Turner CDA, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1543-7	31	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma											14604086211049636	10.1177/14604086211049636		NOV 2021	9	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	WT5XE	WOS:000715936300001					2022-02-06	
J	Brandt, AE; Finnanger, TG; Hypher, RE; Ro, TB; Skovlund, E; Andersson, S; Risnes, K; Stubberud, J				Brandt, Anne E.; Finnanger, Torun G.; Hypher, Ruth E.; Ro, Torstein B.; Skovlund, Eva; Andersson, Stein; Risnes, Kari; Stubberud, Jan			Rehabilitation of executive function in chronic paediatric brain injury: a randomized controlled trial	BMC MEDICINE			English	Article						Executive function; Cognition; Paediatric acquired brain injury; Goal management training; Cognitive rehabilitation	BEHAVIOR RATING INVENTORY; QUALITY-OF-LIFE; GOAL MANAGEMENT; COGNITIVE REHABILITATION; INDIVIDUAL-DIFFERENCES; EMOTIONAL REGULATION; CHILDREN; DYSFUNCTION; TBI; INTERVENTIONS	Background Impaired executive functions (EFs, i.e., purposeful, goal-directed behaviour) cause significant disability after paediatric acquired brain injury (pABI) warranting efficient interventions. Goal Management Training (GMT) is a metacognitive protocol proven effective for executive dysfunction in adults. This pre-registered, blinded, parallel-randomized controlled trial evaluated efficacy of a paediatric adaptation (pGMT) compared to a psychoeducative control (paediatric Brain Health Workshop, pBHW) to improve EF. Methods Children aged 10 to 17 years with pABI (e.g., traumatic brain injury, brain tumour), >= 1 year post-onset or ended treatment, with parent-reported EF complaints were eligible. Participants were randomized (computer-algorithm) to either group-based pGMT (n = 38) or pBHW (n = 38). The active control was tailored to keep non-specific factors constant. Thus, both treatments comprised of 7 sessions at hospitals over 3 consecutive weeks, followed by 4 weeks of telephone counselling of participants, parents, and teachers. Parent-reported daily life EF, assessed by the questionnaire Behavior Rating Inventory of Executive Function (BRIEF; Behavioral Regulation Index (BRI) and Metacognition Index (MI)), were co-primary outcomes 6 months post-intervention. Secondary outcomes included neuropsychological tests and a complex naturalistic task (Children's Cooking Task). Results Seventy-three participants (96%) completed allocated interventions and 71 (93%) attended the 6-month follow-up. The results demonstrated no significant difference in effectiveness for the two interventions on parent-reported EF: For BRIEFBRI, mean (SD) raw score for pGMT was 42.7 (8.8) and 38.3 (9.3) for pBHW. Estimated difference was - 2.3 (95% CI - 5.1 to 0.6). For BRIEFMI, the corresponding results were 80.9 (20.4) for GMT and 75.5 (19.3) for pBHW. Estimated difference was - 1.4 (95% CI -8.5 to 5.8). In performance-based tests, pGMT was associated with improved inhibition and executive attention, while pBHW was associated with fewer errors in the naturalistic task. Conclusions In pABI, metacognitive training (pGMT) did not demonstrate additional effectiveness on parent-reported daily life EF at 6-month follow-up, when compared to a psychoeducative control. Both interventions were well-tolerated and demonstrated distinct improvements at different EF assessment levels. To conclude on pGMT efficacy, larger studies are needed, including further investigation of appropriate assessment levels and possible differences in effect related to treatment duration, developmental factors, and injury characteristics.	[Brandt, Anne E.; Finnanger, Torun G.; Ro, Torstein B.; Risnes, Kari] Trondheim Reg & Univ Hosp, St Olavs Hosp, Childrens Clin, POB 3250, NO-7006 Trondheim, Norway; [Brandt, Anne E.; Ro, Torstein B.; Risnes, Kari] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway; [Hypher, Ruth E.; Stubberud, Jan] Oslo Univ Hosp, Dept Clin Neurosci Children, Oslo, Norway; [Skovlund, Eva] Norwegian Univ Sci & Technol, NTNU, Dept Publ Hlth & Nursing, Trondheim, Norway; [Andersson, Stein; Stubberud, Jan] Univ Oslo, Dept Psychol, Oslo, Norway; [Stubberud, Jan] Lovisenberg Diaconal Hosp, Dept Res, Oslo, Norway		Brandt, AE (corresponding author), Trondheim Reg & Univ Hosp, St Olavs Hosp, Childrens Clin, POB 3250, NO-7006 Trondheim, Norway.; Brandt, AE (corresponding author), Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway.	anne.elisabeth.brandt@stolav.no	Stubberud, Jan/ABE-6922-2021	Brandt, Anne Elisabeth/0000-0001-9278-2238	Research Council of NorwayResearch Council of Norway [260680/H10]	All phases of this study were supported by The Research Council of Norway [grant number 260680/H10]. Funding organization had no role in the design and conduct of the study; data collection, management, analysis, or interpretation; or manuscript review or preparation. Sponsor is a governmental hospital and employer of the research team at St. Olavs hospital, Trondheim University Hospital. St. Olavs sponsor representative did not participate in the work.	Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; [Anonymous], PSYKTESTBARN, V2, P6, DOI [10.21337/0037, DOI 10.21337/0037]; [Anonymous], 2009, WORLD HLTH STAT; [Anonymous], 2020, EMACHMPICH4362212017; BABER N, 1994, BRIT J CLIN PHARMACO, V37, P401, DOI 10.1111/j.1365-2125.1994.tb05705.x; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Bannert M, 2009, COMPUT HUM BEHAV, V25, P829, DOI 10.1016/j.chb.2008.07.002; Becker F, 2014, NEUROREHABILITATION, V34, P87, DOI 10.3233/NRE-131015; Bell ML, 2019, PATIENT-RELAT OUTCOM, V10, P129, DOI 10.2147/PROM.S178963; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Boot WR, 2013, PERSPECT PSYCHOL SCI, V8, P445, DOI 10.1177/1745691613491271; Braga LW, 2012, NEUROREHABILITATION, V30, P205, DOI 10.3233/NRE-2012-0746; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Brown H., 2014, APPL MIXED MODELS ME, DOI [10.1002/9781118778210, DOI 10.1002/9781118778210]; Burgess P., 1997, METHODOLOGY FRONTAL, P81; Campbell JM, 2014, BEST PRACTICES SCH P, P287; Catroppa C, 1999, Pediatr Rehabil, V3, P167; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Chevignard MP, 2012, BRAIN INJURY, V26, P1033, DOI 10.3109/02699052.2012.666366; Chevignard MP, 2010, BRAIN IMPAIR, V11, P125, DOI 10.1375/brim.11.2.125; Chevignard MP, 2009, DEV NEUROREHABIL, V12, P76, DOI 10.1080/17518420902777019; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Conners C., 2014, CONNERS CONTINUOUS P; Dams-O'Connor K, 2013, BRAIN IMPAIR, V14, P51, DOI 10.1017/BrImp.2013.9; Delis DC., 2001, DELIS KAPLAN EXECUTI; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Gioia GA, 2001, PSYCHOLOGICAL AND DEVELOPMENTAL ASSESSMENT, P317; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; GLICK ID, 1994, BRIT J PSYCHIAT, V164, P104, DOI 10.1192/bjp.164.1.104; Haller EP., 1988, EDUC RESEARCHER, V17, P5, DOI [10.3102/0013189X017009005, DOI 10.3102/0013189X017009005]; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Hypher RE, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029273; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kolb B, 2004, BRAIN COGNITION, V55, P104, DOI 10.1016/s0278-2626(03)00278-1; Krasny-Pacini A, 2014, DISABIL REHABIL, V36, P105, DOI 10.3109/09638288.2013.777807; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Laatsch L, 2020, NEUROPSYCHOL REHABIL, V30, P130, DOI 10.1080/09602011.2019.1678490; Lehto JE, 2003, BRIT J DEV PSYCHOL, V21, P59, DOI 10.1348/026151003321164627; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lewis MW, 2011, NEUROPSYCHOL REHABIL, V21, P145, DOI 10.1080/09602011.2010.543867; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; Lindsay S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124679; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; McConaughy SH, 2014, BEST PRACTICES SCH P, P367; Michaeli O, 2014, PEDIATRICS, V133, pE546, DOI 10.1542/peds.2013-3010; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Naismith SL, 2011, AM J GERIAT PSYCHIAT, V19, P240, DOI 10.1097/JGP.0b013e3181dba587; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 1998, ATTENTIVE BRAIN, P401; Pozzi M, 2019, BRAIN INJURY, V33, P1522, DOI 10.1080/02699052.2019.1658128; Puente AN, 2016, CLIN NEUROPSYCHOL, V30, P95, DOI 10.1080/13854046.2015.1133847; Resch C, 2018, BRAIN INJURY, V32, P679, DOI 10.1080/02699052.2018.1458335; Robertson IH, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P631; Robertson IH, 2013, PRINCIPLES FRONTAL L, P742; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Snyder HR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00328; Sohlberg MM., 2014, CLIN PRACT PEDIAT PS, V2, P263, DOI [10.1037/cpp0000072, DOI 10.1037/CPP0000072]; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stamenova V, 2019, NEUROPSYCHOL REHABIL, V29, P1569, DOI 10.1080/09602011.2018.1438294; Stubberud J, 2021, NEUROPSYCHOL REHABIL, V31, P601, DOI 10.1080/09602011.2020.1723649; Stubberud J, 2013, J INT NEUROPSYCH SOC, V19, P672, DOI 10.1017/S1355617713000209; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Toplak ME, 2008, CLIN PSYCHOL REV, V28, P801, DOI 10.1016/j.cpr.2007.10.008; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Tornas S, 2019, J INT NEUROPSYCH SOC, V25, P1082, DOI 10.1017/S1355617719000626; Tornas S, 2016, ARCH PHYS MED REHAB, V97, P1841, DOI 10.1016/j.apmr.2016.06.014; Tornas S, 2016, J INT NEUROPSYCH SOC, V22, P436, DOI 10.1017/S1355617715001344; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wechsler D., 2014, WECHSLER INTELLIGENC, V5th; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Wolfe KR, 2015, J PEDIATR PSYCHOL, V40, P272, DOI 10.1093/jpepsy/jsu060; World Health Organization, 2007, INT CLASS FUNCT DIS; Wu G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00010; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	92	0	0	3	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1741-7015			BMC MED	BMC Med.	NOV 2	2021	19	1							253	10.1186/s12916-021-02129-8			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WQ1QP	WOS:000713596700001	34724955	gold, Green Published			2022-02-06	
J	Giugni, A; Gamberini, L; Carrara, G; Antiga, L; Brissy, O; Buldini, V; Calamai, I; Csomos, A; De Luca, A; Ferri, E; Fleming, JM; Gradisek, P; Kaps, R; Kyprianou, T; Lagomarsino, S; Lazar, I; Martino, C; Mikaszewska-Sokolewicz, M; Montis, A; Nardai, G; Nattino, G; Nattino, G; Paci, G; Portolani, L; Xirouchaki, N; Chieregato, A; Bertolini, G				Giugni, Aimone; Gamberini, Lorenzo; Carrara, Greta; Antiga, Luca; Brissy, Obou; Buldini, Virginia; Calamai, Italo; Csomos, Akos; De Luca, Alessandra; Ferri, Enrico; Fleming, Joanne M.; Gradisek, Primoz; Kaps, Rafael; Kyprianou, Theodoros; Lagomarsino, Silvia; Lazar, Isaac; Martino, Costanza; Mikaszewska-Sokolewicz, Malgorzata; Montis, Andrea; Nardai, Gabor; Nattino, Giovanni; Nattino, Giuseppe; Paci, Giulia; Portolani, Laila; Xirouchaki, Nektaria; Chieregato, Arturo; Bertolini, Guido		CREACTIVE Consortium	Hospitals with and without neurosurgery: a comparative study evaluating the outcome of patients with traumatic brain injury	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Brain injuries; Traumatic; Outcome assessment; GOS-E; Prospective studies; Rehabilitation	PREHOSPITAL TRIAGE; NEUROTRAUMA; IMPACT; CARE; MORTALITY; SYSTEMS	Background We leveraged the data of the international CREACTIVE consortium to investigate whether the outcome of traumatic brain injury (TBI) patients admitted to intensive care units (ICU) in hospitals without on-site neurosurgical capabilities (no-NSH) would differ had the same patients been admitted to ICUs in hospitals with neurosurgical capabilities (NSH). Methods The CREACTIVE observational study enrolled more than 8000 patients from 83 ICUs. Adult TBI patients admitted to no-NSH ICUs within 48 h of trauma were propensity-score matched 1:3 with patients admitted to NSH ICUs. The primary outcome was the 6-month extended Glasgow Outcome Scale (GOS-E), while secondary outcomes were ICU and hospital mortality. Results A total of 232 patients, less than 5% of the eligible cohort, were admitted to no-NSH ICUs. Each of them was matched to 3 NSH patients, leading to a study sample of 928 TBI patients where the no-NSH and NSH groups were well-balanced with respect to all of the variables included into the propensity score. Patients admitted to no-NSH ICUs experienced significantly higher ICU and in-hospital mortality. Compared to the matched NSH ICU admissions, their 6-month GOS-E scores showed a significantly higher prevalence of upper good recovery for cases with mild TBI and low expected mortality risk at admission, along with a progressively higher incidence of poor outcomes with increased TBI severity and mortality risk. Conclusions In our study, centralization of TBI patients significantly impacted short- and long-term outcomes. For TBI patients admitted to no-NSH centers, our results suggest that the least critically ill can effectively be managed in centers without neurosurgical capabilities. Conversely, the most complex patients would benefit from being treated in high-volume, neuro-oriented ICUs.	[Giugni, Aimone; Gamberini, Lorenzo; Buldini, Virginia; Ferri, Enrico] Maggiore Hosp, Anesthesia Intens Care & Prehosp Emergency, Bologna, Italy; [Carrara, Greta; Brissy, Obou; Fleming, Joanne M.; Nattino, Giovanni; Paci, Giulia; Bertolini, Guido] Ist Ric Farmacol Mario Negri IRCCS, Dept Publ Hlth, Lab Clin Epidemiol, Via GB Camozzi 3, I-24020 Bergamo, Italy; [Antiga, Luca] Orobix, Bergamo, Italy; [Calamai, Italo] San Giuseppe Hosp, AUSL Toscana Ctr, Anesthesia & Intens Care Unit, Florence, Italy; [Csomos, Akos] Hungarian Army Med Ctr, Budapest, Hungary; [De Luca, Alessandra; Lagomarsino, Silvia] AOU Careggi, Dept Anesthesia & Intens Care Unit, Neurointens Care Unit, Florence, Italy; [Gradisek, Primoz] Univ Med Ctr Ljubljana, Clin Dept Anaesthesiol & Intens Therapy, Ljubljana, Slovenia; [Gradisek, Primoz] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Kaps, Rafael] Gen Hosp Novo Mesto, Novo Mesto, Slovenia; [Kyprianou, Theodoros] Univ Nicosia, Med Sch, Nicosia, Cyprus; [Kyprianou, Theodoros] Univ Hosp Bristol & Weston NHS Fdn Trust, Bristol, Avon, England; [Lazar, Isaac] Ben Gurion Univ Negev, Soroka Med Ctr, Pediat Intens Care Unit, Beer Sheva, Israel; [Lazar, Isaac] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Martino, Costanza; Portolani, Laila] Maurizio Bufalini Hosp, AUSL Romagna, Anesthesia & Intens Care Unit, Cesena, Italy; [Mikaszewska-Sokolewicz, Malgorzata] Med Univ Warsaw, Clin Anaesthesia & Intens Care, Warsaw, Poland; [Montis, Andrea] ATS Sardegna, ASSL Oristano, Dept Neurorehabil, Oristano, Italy; [Nardai, Gabor] Peterfy Hosp & Trauma Ctr, Dept Anaesthesiol & Intens Care, Budapest, Hungary; [Nattino, Giuseppe] Azienda Socio Sanit Terr Lecco, Intens Care Unit, Lecce, Italy; [Xirouchaki, Nektaria] Univ Hosp Heraklion, Iraklion, Greece; [Chieregato, Arturo] Grande Osped Metropolitano Niguarda, Neurointens Care Unit, Milan, Italy		Nattino, G (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Dept Publ Hlth, Lab Clin Epidemiol, Via GB Camozzi 3, I-24020 Bergamo, Italy.	giovanni.nattino@marionegri.it	Nattino, Giovanni/T-7306-2019; Gamberini, Lorenzo/S-5476-2017; Lazar, Isaac/N-6133-2016; Mikaszewska-Sokolewicz, Malgorzata/U-7927-2018	Nattino, Giovanni/0000-0002-3034-6251; Gamberini, Lorenzo/0000-0002-4364-9163; Castioni, Carlo Alberto/0000-0002-8895-425X; Lazar, Isaac/0000-0001-9450-5226; Mikaszewska-Sokolewicz, Malgorzata/0000-0002-1148-7817	European Union Seventh Framework Programme (FP7/2007-2013) [602714]	The study was funded by the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement Number 602714.	Chalouhi N, 2020, NEUROSURGERY, V86, P107, DOI 10.1093/neuros/nyy634; Chieregato A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016415; Clement RC, 2013, J NEUROSURG, V118, P687, DOI 10.3171/2012.10.JNS12682; Doumouras AG, 2012, PREHOSP EMERG CARE, V16, P456, DOI 10.3109/10903127.2012.695431; Ernstberger A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194292; Esposito TJ., 2012, J TRAUMA TREAT, V1, P137, DOI [10.4172/2167-1222.1000137, DOI 10.4172/2167-1222.1000137]; Finazzi S, 2020, MINERVA ANESTESIOL, V86, P1305, DOI 10.23736/S0375-9393.20.14112-9; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hansen BB, 2006, J COMPUT GRAPH STAT, V15, P609, DOI 10.1198/106186006X137047; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnson CO, 2019, LANCET NEUROL, V18, P439, DOI 10.1016/S1474-4422(19)30034-1; Kaufman EJ, 2018, J AM COLL SURGEONS, V226, P741, DOI 10.1016/j.jamcollsurg.2018.01.055; Leppaniemi A, 2005, CURR OPIN CRIT CARE, V11, P576, DOI 10.1097/01.ccx.0000186918.00382.58; Madhok DY, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10050269; Nijboer JMM, 2009, EUR J TRAUMA EMERG S, V35, P49, DOI 10.1007/s00068-008-7069-1; Nishijima DK, 2020, ACAD EMERG MED, V27, P207, DOI 10.1111/acem.13915; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; ROSENBAUM PR, 1989, J AM STAT ASSOC, V84, P1024, DOI 10.2307/2290079; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Schellenberg M, 2019, J TRAUMA ACUTE CARE, V87, P865, DOI 10.1097/TA.0000000000002393; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Sturms LM, 2006, LANGENBECK ARCH SURG, V391, P343, DOI 10.1007/s00423-006-0057-1; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Triebel KL, 2014, ARCH PHYS MED REHAB, V95, P2296, DOI 10.1016/j.apmr.2014.07.413; Utter GH, 2006, J TRAUMA, V60, P529, DOI 10.1097/01.ta.0000204022.36214.9e; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Voskens FJ, 2018, JAMA SURG, V153, P322, DOI 10.1001/jamasurg.2017.4472; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Yoder A, 2020, J TRAUMA ACUTE CARE, V88, P704, DOI 10.1097/TA.0000000000002602	34	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	NOV 2	2021	29	1							158	10.1186/s13049-021-00959-2			15	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	WQ7TF	WOS:000714014300001	34727955	gold, Green Published			2022-02-06	
J	Kim, YT; Kim, H; Lee, CH; Yoon, BC; Kim, JB; Choi, YH; Cho, WS; Oh, BM; Kim, DJ				Kim, Young-Tak; Kim, Hakseung; Lee, Choel-Hui; Yoon, Byung C.; Kim, Jung Bin; Choi, Young Hun; Cho, Won-Sang; Oh, Byung-Mo; Kim, Dong-Joo			Intracranial Densitometry-Augmented Machine Learning Enhances the Prognostic Value of Brain CT in Pediatric Patients With Traumatic Brain Injury: A Retrospective Pilot Study	FRONTIERS IN PEDIATRICS			English	Article						pediatric traumatic brain injury; computed tomography; densitometric analysis; prognostic modeling; machine learning	LOGISTIC-REGRESSION; COMPUTED-TOMOGRAPHY; CLASSIFICATION; CHILDREN; MORTALITY; MODELS; EDEMA	Background: The inter- and intrarater variability of conventional computed tomography (CT) classification systems for evaluating the extent of ischemic-edematous insult following traumatic brain injury (TBI) may hinder the robustness of TBI prognostic models.Objective: This study aimed to employ fully automated quantitative densitometric CT parameters and a cutting-edge machine learning algorithm to construct a robust prognostic model for pediatric TBI.Methods: Fifty-eight pediatric patients with TBI who underwent brain CT were retrospectively analyzed. Intracranial densitometric information was derived from the supratentorial region as a distribution representing the proportion of Hounsfield units. Furthermore, a machine learning-based prognostic model based on gradient boosting (i.e., CatBoost) was constructed with leave-one-out cross-validation. At discharge, the outcome was assessed dichotomously with the Glasgow Outcome Scale (favorability: 1-3 vs. 4-5). In-hospital mortality, length of stay (>1 week), and need for surgery were further evaluated as alternative TBI outcome measures.Results: Densitometric parameters indicating reduced brain density due to subtle global ischemic changes were significantly different among the TBI outcome groups, except for need for surgery. The skewed intracranial densitometry of the unfavorable outcome became more distinguishable in the follow-up CT within 48 h. The prognostic model augmented by intracranial densitometric information achieved adequate AUCs for various outcome measures [favorability = 0.83 (95% CI: 0.72-0.94), in-hospital mortality = 0.91 (95% CI: 0.82-1.00), length of stay = 0.83 (95% CI: 0.72-0.94), and need for surgery = 0.71 (95% CI: 0.56-0.86)], and this model showed enhanced performance compared to the conventional CRASH-CT model.Conclusion: Densitometric parameters indicative of global ischemic changes during the acute phase of TBI are predictive of a worse outcome in pediatric patients. The robustness and predictive capacity of conventional TBI prognostic models might be significantly enhanced by incorporating densitometric parameters and machine learning techniques.	[Kim, Young-Tak; Kim, Hakseung; Lee, Choel-Hui; Kim, Dong-Joo] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Yoon, Byung C.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Kim, Jung Bin; Kim, Dong-Joo] Korea Univ, Coll Med, Dept Neurol, Anam Hosp, Seoul, South Korea; [Choi, Young Hun] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Radiol, Coll Med, Seoul, South Korea; [Cho, Won-Sang] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Neurosurg, Coll Med, Seoul, South Korea; [Oh, Byung-Mo] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Rehabil Med, Coll Med, Seoul, South Korea; [Oh, Byung-Mo] Natl Traff Injury Rehabil Hosp, Yangpyeong, South Korea; [Kim, Dong-Joo] Korea Univ, Dept Artificial Intelligence, Seoul, South Korea		Kim, DJ (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.; Kim, DJ (corresponding author), Korea Univ, Coll Med, Dept Neurol, Anam Hosp, Seoul, South Korea.; Kim, DJ (corresponding author), Korea Univ, Dept Artificial Intelligence, Seoul, South Korea.	dongjookim@korea.ac.kr			National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT, MSIT) [2019R1A2C1003399, 2020R1C1C1006773]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C1561]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science and ICT, MSIT) (Grant number 2019R1A2C1003399 and Grant number 2020R1C1C1006773) and a grant of the Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI17C1561).	ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Amann J, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01332-6; Barras CD, 2013, AM J NEURORADIOL, V34, P1139, DOI 10.3174/ajnr.A3375; Bauer R, 1999, EXP TOXICOL PATHOL, V51, P143, DOI 10.1016/S0940-2993(99)80088-8; Brock GN, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-144; Broocks G, 2018, INVEST RADIOL, V53, P207, DOI 10.1097/RLI.0000000000000430; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Chabok SY, 2017, CHIN J TRAUMATOL, V20, P339, DOI 10.1016/j.cjtee.2017.04.011; Chen C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061171; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Dorogush AV, 2018, CATBOOST GRADIENT BO; Garcia-Perez D., 2020, J NEUROSURG, V134, P1940, DOI [10.3171/2020.4.JNS193445, DOI 10.3171/2020.4.JNS193445]; Govind AS., 2015, INT J CURR RES, V7, P17874; Nguyen HS, 2016, NEURORADIOL J, V29, P372, DOI 10.1177/1971400916658795; Hale AT, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.8.FOCUS17773; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hanning U, 2016, RESUSCITATION, V104, P91, DOI 10.1016/j.resuscitation.2016.03.018; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Kannan Nithya, 2014, Int J Crit Illn Inj Sci, V4, P131, DOI 10.4103/2229-5151.134152; Kayhanian S, 2019, PEDIATR RES, V86, P641, DOI 10.1038/s41390-019-0510-9; Kayhanian S, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00032; Kim H, 2019, J NEUROSURG, V131, P1243, DOI 10.3171/2018.5.JNS172711; Kim H, 2018, NEUROSURGERY, V83, P226, DOI 10.1093/neuros/nyx379; Kim H, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0186-2; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Liu H, 2014, BMC SYST BIOL, V8, DOI [10.1186/1752-0509-8-S3-S5, 10.1186/1752-0509-8-S1-S5]; LONG DM, 1982, CLIN NEUR, V29, P174; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marincowitz C, 2021, EMERG MED J, DOI 10.1136/emermed-2020-210776; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Midi H, 2010, J INTERDISCIP MATH, V13, P253, DOI 10.1080/09720502.2010.10700699; Mikkonen ED, 2019, J NEUROSURG-PEDIATR, V24, P330, DOI 10.3171/2019.4.PEDS1983; Miller GF, 2021, INJURY, V52, P1138, DOI 10.1016/j.injury.2021.01.042; Naidich T.P., 2012, IMAGING BRAIN EXPERT, Vfirst; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Prasad G Lakshmi, 2021, Surg Neurol Int, V12, P46, DOI 10.25259/SNI_756_2020; Prokhorenkova L., 2017, ARXIV170609516; Ray S, 2018, EXPERT SYST APPL, V97, P325, DOI 10.1016/j.eswa.2017.12.032; RIETH KG, 1980, RADIOLOGY, V135, P343, DOI 10.1148/radiology.135.2.6768102; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stoel BC, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.1.014004; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Talari HR, 2016, WORLD NEUROSURG, V87, P195, DOI 10.1016/j.wneu.2015.11.055; Tanaka C, 2006, AM J NEURORADIOL, V27, P40; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; Tunthanathip T, 2021, CHIN J TRAUMATOL, V24, P350, DOI 10.1016/j.cjtee.2021.06.003; UNGER E, 1988, AM J NEURORADIOL, V9, P687; Vellido A, 2020, NEURAL COMPUT APPL, V32, P18069, DOI 10.1007/s00521-019-04051-w; Viechtbauer W, 2015, J CLIN EPIDEMIOL, V68, P1375, DOI 10.1016/j.jclinepi.2015.04.014; Wanifuchi H, 2002, J NEUROSURG, V97, P607, DOI 10.3171/jns.2002.97.3.0607; Westfall PH, 2014, AM STAT, V68, P191, DOI 10.1080/00031305.2014.917055; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Young AMH, 2016, J NEUROSURG-PEDIATR, V18, P558, DOI 10.3171/2016.5.PEDS15427	57	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-2360			FRONT PEDIATR	Front. Pediatr.	NOV 2	2021	9								750272	10.3389/fped.2021.750272			16	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	WY9LU	WOS:000719599200001	34796154	Green Published, gold			2022-02-06	
J	Lui, HCH; He, ZX; Zhuang, TF; Ng, CF; Wong, GKC				Lui, Hannaly Cheuk-Hang; He, Zhexi; Zhuang, Tin Fong; Ng, Chat Fong; Wong, George Kwok-Chu			Tracheostomy decannulation outcomes in 131 consecutive neurosurgical patients	BRITISH JOURNAL OF NEUROSURGERY			English	Article; Early Access						Tracheostomy; neurosurgery; stroke; traumatic brain injury	INTRACEREBRAL HEMORRHAGE; MECHANICAL VENTILATION; STROKE	Objectives This study was a retrospective study to investigate factors related to difficult tracheostomy decannulation, and to evaluate outcomes of tracheostomized neurosurgical patients. Methods All consecutive tracheostomized neurosurgical patients in the Prince of Wales Hospital between 1st September 2016 and 31st August 2019 were reviewed retrospectively. Patients were grouped into easy decannulation and difficult decannulation groups using 3 months as cut-off time. Risk factors were analysed and outcomes were compared. Results One hundred thirty-one patients were included. In univariate analyses, male gender, GCS less than or equal to 8 on admission, the presence of vocal cord palsy at 3 months, and pneumonia within 1-month post-tracheostomy were associated with difficult decannulation. In multivariable logistic regression for difficult decannulation, GCS on admission, the presence of vocal cord palsy at 3 months, and the presence of pneumonia within 1-month post-tracheostomy remained statistically significant. The easy decannulation group had a shorter length of in-patient stay, higher survival rate, and more favourable neurological outcome (GOS 4-5) than the difficult decannulation group at both 6 months and 1 year. The majority of easy decannulation group patients (54%) were discharged to home, while the majority of the difficult decannulation group (42%) of patients were discharged to the infirmary. Conclusion GCS less than or equal to 8 on admission, the presence of vocal cord palsy, and the presence of pneumonia were associated with difficult tracheostomy decannulation in neurosurgical patients. Difficult decannulation is associated with a longer length of in-patient stay and poor neurological outcomes.	[Lui, Hannaly Cheuk-Hang; He, Zhexi; Zhuang, Tin Fong; Ng, Chat Fong; Wong, George Kwok-Chu] Chinese Univ Hong Kong, Dept Surg, Div Neurosurg, Hong Kong, Peoples R China; [He, Zhexi] Tuen Mun Hosp, Dept Neurosurg, Hong Kong, Peoples R China; [Zhuang, Tin Fong] Queen Mary Hosp, Dept Neurosurg, Hong Kong, Peoples R China; [Ng, Chat Fong] Queen Elizabeth Hosp, Dept Neurosurg, Hong Kong, Peoples R China		Wong, GKC (corresponding author), Prince Wales Hosp, Dept Surg, Lui Che Woo Clin Sci Bldg, Shatin, 4-F,30-32 Ngan Shing St, Hong Kong, Peoples R China.	georgewong@surgury.cuhk.edu.hk					Arozullah AM, 2001, ANN INTERN MED, V135, P847, DOI 10.7326/0003-4819-135-10-200111200-00005; Berney L, 2014, NEUROREHABILITATION, V34, P809, DOI 10.3233/NRE-141081; Bosel J, 2013, STROKE, V44, P21, DOI 10.1161/STROKEAHA.112.669895; BURTIN P, 1994, INTENS CARE MED, V20, P32, DOI 10.1007/BF02425052; de Franca SA, 2021, CLIN NEUROL NEUROSUR, V203, DOI 10.1016/j.clineuro.2021.106554; Enrichi C, 2017, RESP CARE, V62, P1255, DOI 10.4187/respcare.05470; Gujjar AR, 1998, NEUROLOGY, V51, P447, DOI 10.1212/WNL.51.2.447; Heidler MD, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-018-0527-3; Humble SS, 2016, BRAIN INJURY, V30, P1642, DOI 10.1080/02699052.2016.1199915; Kumar Veldurti Ananta Kiran, 2019, Bull Emerg Trauma, V7, P355, DOI 10.29252/beat-070403; Lee HS, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0475-9; Murthy SB, 2016, NEUROCRIT CARE, V25, P178, DOI 10.1007/s12028-016-0282-6; Quinones-Ossa GA, 2020, J NEUROSCI RURAL PRA, V11, P222, DOI 10.1055/s-0040-1709971; Robba C, 2020, INTENS CARE MED, V46, P983, DOI 10.1007/s00134-020-05935-5; Salik I, 2021, STATPEARLS; Seder DB, 2019, NEUROCRIT CARE, V30, P555, DOI 10.1007/s12028-019-00706-7; Szeder V, 2010, NEUROCRIT CARE, V13, P40, DOI 10.1007/s12028-010-9346-1; Taveira I, 2020, CUREUS, V12, DOI 10.7759/cureus.11654; Tomar Gaurav Singh, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2015-212292; Wang Y, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5895830; Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154; Zirpe KG, 2017, INDIAN J CRIT CARE M, V21, P6, DOI 10.4103/0972-5229.198309	22	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.												10.1080/02688697.2021.1995591		NOV 2021	5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WR1MF	WOS:000714270400001	34730454				2022-02-06	
J	Luostarinen, T; Vehvilainen, J; Lindfors, M; Reinikainen, M; Bendel, S; Laitio, R; Hoppu, S; Ala-Kokko, T; Skrifvars, M; Raj, R				Luostarinen, Teemu; Vehvilainen, Juho; Lindfors, Matias; Reinikainen, Matti; Bendel, Stepani; Laitio, Ruut; Hoppu, Sanna; Ala-Kokko, Tero; Skrifvars, Markus; Raj, Rahul			Trends in mortality after intensive care of patients with traumatic brain injury in Finland from 2003 to 2019: a Finnish Intensive Care Consortium study	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Intensive care unit; Critical care; Mortality; Prognosis; Finland	EMERGENCY-DEPARTMENT VISITS; TEMPORAL TRENDS; DECOMPRESSIVE CRANIECTOMY; HEAD-INJURY; EPIDEMIOLOGY; MANAGEMENT; GUIDELINES; OUTCOMES; PATTERNS; DEATHS	Background Several studies have suggested no change in the outcome of patients with traumatic brain injury (TBI) treated in intensive care units (ICUs). This is mainly due to the shift in TBI epidemiology toward older and sicker patients. In Finland, the share of the population aged 65 years and over has increased the most in Europe during the last decade. We aimed to assess changes in 12-month and hospital mortality of patients with TBI treated in the ICU in Finland. Methods We used a national benchmarking ICU database (Finnish Intensive Care Consortium) to study adult patients who had been treated for TBI in four tertiary ICUs in Finland during 2003-2019. We divided admission years into quartiles and used multivariable logistic regression analysis, adjusted for case-mix, to assess the association between admission year and mortality. Results A total of 4535 patients were included. Between 2003-2007 and 2016-2019, the patient median age increased from 54 to 62 years, the share of patients having significant comorbidity increased from 8 to 11%, and patients being dependent on help in activities of daily living increased from 7 to 15%. Unadjusted hospital and 12-month mortality decreased from 18 and 31% to 10% and 23%, respectively. After adjusting for case-mix, a reduction in odds of 12-month and hospital mortality was seen in patients with severe TBI, intracranial pressure monitored patients, and mechanically ventilated patients. Despite a reduction in hospital mortality, 12-month mortality remained unchanged in patients aged >= 70 years. Conclusion A change in the demographics of ICU-treated patients with TBI care is evident. The outcome of younger patients with severe TBI appears to improve, whereas long-term mortality of elderly patients with less severe TBI has not improved. This has ramifications for further efforts to improve TBI care, especially among the elderly.	[Luostarinen, Teemu] Helsinki Univ Hosp, Hyvinkaa Hosp, Anaesthesiol & Intens Care, Helsinki, Finland; [Luostarinen, Teemu; Vehvilainen, Juho; Lindfors, Matias; Raj, Rahul] Univ Helsinki, Helsinki, Finland; [Vehvilainen, Juho; Lindfors, Matias; Raj, Rahul] Helsinki Univ Hosp, Dept Neurosurg, Helsinki, Finland; [Reinikainen, Matti; Bendel, Stepani] Kuopio Univ Hosp, Dept Anaesthesiol & Intens Care, Kuopio, Finland; [Reinikainen, Matti; Bendel, Stepani] Univ Eastern Finland, Kuopio, Finland; [Laitio, Ruut] Turku Univ Hosp, Dept Perioperat Serv Intens Care & Pain Managemen, Turku, Finland; [Laitio, Ruut] Univ Turku, Turku, Finland; [Hoppu, Sanna] Tampere Univ Hosp, Dept Intens Care & Emergency Med Serv, Tampere, Finland; [Hoppu, Sanna] Univ Tampere, Tampere, Finland; [Ala-Kokko, Tero] Oulu Univ Hosp, Dept Intens Care, Oulu, Finland; [Ala-Kokko, Tero] Univ Oulu, Oulu, Finland; [Skrifvars, Markus] Univ Helsinki, Dept Emergency Care & Serv, Helsinki, Finland; [Skrifvars, Markus] Helsinki Univ Hosp, Helsinki, Finland		Luostarinen, T (corresponding author), Helsinki Univ Hosp, Hyvinkaa Hosp, Anaesthesiol & Intens Care, Helsinki, Finland.; Luostarinen, T (corresponding author), Univ Helsinki, Helsinki, Finland.	teemu.luostarinen@hus.fi	Raj, Rahul/K-7693-2012	Raj, Rahul/0000-0003-4243-9591	University of Helsinki; Helsinki University Central Hospital; Finska Lakaresallskapet; Svenska Kulturfonden; Medicinska Understodsforeningen Liv Halsa	Open Access funding provided by University of Helsinki including Helsinki University Central Hospital. The study was supported by grants from Finska Lakaresallskapet, Svenska Kulturfonden, and Medicinska Understodsforeningen Liv & Halsa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Seppala H, 2016, BRAIN INJURY, V30, P1062, DOI 10.3109/02699052.2016.1170880; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Beck B, 2018, J NEUROTRAUM, V35, P1021, DOI 10.1089/neu.2017.5287; Beqiri E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030727; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cadotte DW, 2011, J NEUROSURG, V114, P1502, DOI 10.3171/2010.12.JNS10808; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Cnossen MC, 2017, J REHABIL MED, V49, P395, DOI 10.2340/16501977-2216; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Depreitere B, 2021, NEUROCRIT CARE, V34, P731, DOI 10.1007/s12028-020-01185-x; Di Deo P, 2016, J NEUROTRAUM, V33, P2019, DOI 10.1089/neu.2015.4026; Eurostat, 2021, POPULATION STRUCTURE; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Flynn-O'Brien KT, 2015, NEUROSURGERY, V76, P451, DOI 10.1227/NEU.0000000000000693; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Gravesteijn BY, 2021, PREHOSP EMERG CARE, V25, P629, DOI 10.1080/10903127.2020.1817210; Hartings JA, 2020, JAMA NEUROL, V77, P489, DOI 10.1001/jamaneurol.2019.4476; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jonsdottir GM, 2017, ACTA ANAESTH SCAND, V61, P408, DOI 10.1111/aas.12869; Kadar R, 2019, CLIN EXP EMERG MED, V6, P113, DOI 10.15441/ceem.18.010; Kim HK, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176197; Kirkman Matthew A, 2016, Anesthesiol Clin, V34, P511, DOI 10.1016/j.anclin.2016.04.005; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Konigs M, 2018, ARCH PHYS MED REHAB, V99, P1149, DOI 10.1016/j.apmr.2018.01.013; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lindfors M, 2018, ACTA NEUROCHIR, V160, P2107, DOI 10.1007/s00701-018-3670-1; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Massenburg BB, 2017, NEUROL INDIA, V65, P305, DOI 10.4103/neuroindia.NI_719_16; Mauritz W, 2014, BRAIN INJURY, V28, P1096, DOI 10.3109/02699052.2014.904522; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Pakkanen T, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0590-x; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Peeters W, 2017, NEUROEPIDEMIOLOGY, V48, P63, DOI 10.1159/000471877; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Raj R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53889-6; Raj R, 2018, CRIT CARE MED, V46, pE302, DOI 10.1097/CCM.0000000000002959; Reinikainen M, 2012, ACTA ANAESTH SCAND, V56, P1114, DOI 10.1111/j.1399-6576.2012.02669.x; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sawadogo D, 2020, INJURY, V51, P76, DOI 10.1016/j.injury.2019.08.023; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stranjalis G, 2020, INJURY, V51, P2033, DOI 10.1016/j.injury.2020.05.045; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Thelin EP, 2017, AAPS J, V19, P367, DOI 10.1208/s12248-016-0027-7; Toida C, 2021, J CLIN MED, V10, DOI 10.3390/jcm10051072; Van den Brand CL, 2018, EUR J EMERG MED, V25, P355, DOI 10.1097/MEJ.0000000000000457; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]	57	0	0	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JAN	2022	164	1					87	96		10.1007/s00701-021-05034-4		NOV 2021	10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YH5HB	WOS:000713593100001	34725728	Green Accepted, hybrid			2022-02-06	
J	Mulligan, T; Barker-Collo, S; Gibson, K; Jones, K				Mulligan, Therese; Barker-Collo, Suzanne; Gibson, Kerry; Jones, Kelly			You Only Get One Brain: Adult Reflections on the Long-Term Impacts of Traumatic Brain Injury in Adolescence	BRAIN IMPAIRMENT			English	Article; Early Access						Adolescent; impacts; qualitative; traumatic brain injury	QUALITY-OF-LIFE; IDENTITY DEVELOPMENT; CORTICAL THICKNESS; SELF-IDENTITY; CHILDHOOD; MILD; CHILDREN; OUTCOMES; SYMPTOMS; HEALTH	Background: This research adds to scarce literature regarding adolescent experiences of traumatic brain injury (TBI). Retrospective accounts of young adults who had sustained a TBI in adolescence were analysed to explore the perceived impact this had on their lives and forming identities during this important developmental stage. Methods: Thirteen adults (aged 20-25 years; mean 23 years) who sustained a mild or moderate TBI during adolescence (i.e. aged 13-17 years at injury), approximately 7.7 years (range = 6.7-8.0 years) prior, participated in the research. Semi-structured individual interviews, analysed using thematic analysis, explored participants' experiences following their TBIs. Results: Thematic analysis of interview data produced two categories of themes: (1) Impacts on Important Areas of Life, which included: schoolwork suffered, career opportunities became limited, struggling with work and missing out socially; and (2) Impacts on Identity: with themes including feeling 'stupid', feeling self-conscious, loss of social identity and being dependent. Conclusions: TBI sustained during adolescence can have broad impacts on important areas of life and on developing identity.	[Mulligan, Therese; Barker-Collo, Suzanne; Gibson, Kerry] Univ Auckland, Sch Psychol, Clin Training Programme, Auckland, New Zealand; [Jones, Kelly] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand		Barker-Collo, S (corresponding author), Univ Auckland, Sch Psychol, Clin Training Programme, Auckland, New Zealand.	s.barker-collo@auckland.ac.nz					Albicini M., 2015, FRESH LOOK ANXIETY D, P199, DOI [10.5772/57353, DOI 10.5772/57353, DOI 10.5772/60426]; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Beadle EJ, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000158; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Blakemore SJ, 2014, ANNU REV PSYCHOL, V65, P187, DOI 10.1146/annurev-psych-010213-115202; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brenner LA, 2007, J HEAD TRAUMA REHAB, V22, P56, DOI 10.1097/00001199-200701000-00007; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chervonsky E, 2019, EMOTION, V19, P270, DOI 10.1037/emo0000432; Choudhury R, 2020, HEALTH EXPECT, V23, P1533, DOI 10.1111/hex.13138; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Chwalisz K, 2008, REHABIL PSYCHOL, V53, P387, DOI 10.1037/a0012998; Clarke V, 2017, J POSIT PSYCHOL, V12, P297, DOI 10.1080/17439760.2016.1262613; Davies SC, 2020, J EDUC PSYCHOL CONS, V30, P156, DOI 10.1080/10474412.2019.1649598; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Di Battista A, 2014, J REHABIL MED, V46, P975, DOI 10.2340/16501977-1883; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Dick B, 2015, J ADOLESCENT HEALTH, V56, P3, DOI 10.1016/j.jadohealth.2014.10.260; Doody Owen, 2013, Nurse Res, V20, P28; Dumontheil I, 2016, CURR OPIN BEHAV SCI, V10, P39, DOI 10.1016/j.cobeha.2016.04.012; Dumontheil I, 2014, DEV COGN NEUROS-NETH, V10, P57, DOI 10.1016/j.dcn.2014.07.009; Durish CL, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000343; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Erikson E., 1968, IDENTITY YOUTH CRISI; Erikson E., 1963, CHILD SOC, V2nd; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Flynn HK, 2017, YOUTH SOC, V49, P679, DOI 10.1177/0044118X14559900; Furlong A, 2011, J SOCIOL, V47, P355, DOI 10.1177/1440783311420787; Gauvin-Lepage J, 2010, BRAIN INJURY, V24, P1087, DOI 10.3109/02699052.2010.494593; Geeraert BL, 2019, HUM BRAIN MAPP, V40, P4345, DOI 10.1002/hbm.24706; Gibson BE, 2014, HEALTH-LONDON, V18, P95, DOI 10.1177/1363459313476967; Habermas T, 2000, PSYCHOL BULL, V126, P748, DOI 10.1037//0033-2909.126.5.748; Henry LC, 2015, J CLIN EXP NEUROPSYC, V37, P439, DOI 10.1080/13803395.2015.1025708; Hermanns H., 2008, COMPANION QUALITATIV, P295; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Inhelder B., 2013, GROWTH LOGICAL THINK, P334; Irons C, 2005, J ADOLESCENCE, V28, P325, DOI 10.1016/j.adolescence.2004.07.004; Jones KM, 2019, BRAIN INJURY, V33, P884, DOI 10.1080/02699052.2019.1606445; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; Klimstra TA, 2010, J YOUTH ADOLESCENCE, V39, P150, DOI 10.1007/s10964-009-9401-4; Krahn T.M., 2015, HDB NEUROETHICS, P1501, DOI [10.1007/978-94-007-4707-4_126, DOI 10.1007/978-94-007-4707-4_126]; Kroger J., 2007, IDENTITY DEV ADOLESC; Krongold M, 2017, CEREB CORTEX, V27, P1125, DOI 10.1093/cercor/bhv307; Kwon D, 2020, BRAIN IMAGING BEHAV, V14, P242, DOI 10.1007/s11682-018-9980-3; Lebel C, 2018, NEUROIMAGE, V182, P207, DOI 10.1016/j.neuroimage.2017.12.097; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Ledford H., 2018, NATURE, V554, P429, DOI DOI 10.1038/D41586-018-02169-W; Leech BL, 2002, PS, V35, P665, DOI 10.1017/S1049096502001129; Lefkovits AM, 2021, NEUROPSYCHOL REHABIL, V31, P1582, DOI 10.1080/09602011.2020.1787849; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lloyd J, 2015, BRAIN INJURY, V29, P539, DOI 10.3109/02699052.2014.1002003; Lodder GMA, 2017, J CLIN CHILD ADOLESC, V46, P709, DOI 10.1080/15374416.2015.1070352; Luyckx K, 2008, J ADOLESCENT HEALTH, V43, P451, DOI 10.1016/j.jadohealth.2008.04.005; Luyckx K, 2006, J ADOLESCENCE, V29, P361, DOI 10.1016/j.adolescence.2005.03.008; McClure J, 2011, J HEAD TRAUMA REHAB, V26, P392, DOI 10.1097/HTR.0b013e3181f8fd34; McPherson K, 2018, J HEAD TRAUMA REHAB, V33, pE44, DOI 10.1097/HTR.0000000000000321; Mealings M, 2010, BRAIN IMPAIR, V11, P1, DOI 10.1375/brim.11.1.1; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morrow SL, 2007, COUNS PSYCHOL, V35, P209, DOI 10.1177/0011000006286990; Nelson EE, 2005, PSYCHOL MED, V35, P163, DOI 10.1017/S0033291704003915; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Paterson J., 2002, REHABIL NURS, V27, P13, DOI DOI 10.1002/J.2048-7940.2002.TB01973.X; Rageliene T, 2016, J CAN ACAD CHILD ADO, V25, P97; Rennie BJ, 2020, RURAL SPEC EDUC Q, V39, P91, DOI 10.1177/8756870519892886; Roach A, 2018, ISSUES MENT HEALTH N, V39, P723, DOI 10.1080/01612840.2018.1496498; Rodset M, 2008, SCAND J DISABIL RES, V10, P90, DOI 10.1080/15017410801927807; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2018, PSYCHOL MED, V48, P679, DOI 10.1017/S0033291717002057; Sander AM, 2018, J HEAD TRAUMA REHAB, V33, P219, DOI 10.1097/HTR.0000000000000395; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Sawyer SM, 2018, LANCET CHILD ADOLESC, V2, P223, DOI 10.1016/S2352-4642(18)30022-1; Schwartz S.J., 2016, ENCY ADULTHOOD AGING, P1; Schwartz SJ, 2011, HANDBOOK OF IDENTITY THEORY AND RESEARCH, VOLS 1 AND 2, P1, DOI 10.1007/978-1-4419-7988-9; Silver C., 2014, USING SOFTWARE QUALI, DOI [10.4135/9781473906907, DOI 10.4135/9781473906907]; Srivastava P., 2009, INT J QUAL METHODS, V8, P76, DOI [DOI 10.1177/160940690900800107, 10.1177/160940690900800107]; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Theadom A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010453; Thomas EJ, 2014, QUAL HEALTH RES, V24, P1033, DOI 10.1177/1049732314542809; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; Twining P, 2017, COMPUT EDUC, V106, pA1, DOI 10.1016/j.compedu.2016.12.002; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Vijayakumar N, 2016, HUM BRAIN MAPP, V37, P2027, DOI 10.1002/hbm.23154; Villa D, 2021, DISABIL REHABIL, V43, P3298, DOI 10.1080/09638288.2020.1743773; Williams EN, 2009, PSYCHOTHER RES, V19, P576, DOI 10.1080/10503300802702113; Wyn J., 2006, J YOUTH STUD, V9, P495, DOI [10.1080/13676260600805713, DOI 10.1080/13676260600805713]; Yates L., 2010, KEEPING CONNECTED ID; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhou DM, 2015, NEUROIMAGE, V104, P138, DOI 10.1016/j.neuroimage.2014.10.005; Zimmer-Gembeck MJ, 2016, CHILD DEV PERSPECT, V10, P122, DOI 10.1111/cdep.12174; Zimmer-Gembeck MJ, 2015, J APPL DEV PSYCHOL, V41, P28, DOI 10.1016/j.appdev.2015.05.001	106	0	0	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.											PII S144396462100022X	10.1017/BrImp.2021.22		NOV 2021	18	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	YJ8WD	WOS:000744807500001					2022-02-06	
J	Aboghazleh, R; Parker, E; Yang, LT; Kaufer, D; Dreier, JP; Friedman, A; van Hameren, G				Aboghazleh, Refat; Parker, Ellen; Yang, Lynn T.; Kaufer, Daniela; Dreier, Jens P.; Friedman, Alon; van Hameren, Gerben			Brainstem and Cortical Spreading Depolarization in a Closed Head Injury Rat Model	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						cortical spreading depolarization; electrocorticography; traumatic brain injury; brainstem; oxidative stress	SUBARACHNOID HEMORRHAGE; DEPRESSION; CORTEX; CARE; SUSCEPTIBILITY; EPIDEMIOLOGY; CONCUSSION; ISCHEMIA; DISEASE; SHIFTS	Traumatic brain injury (TBI) is the leading cause of death in young individuals, and is a major health concern that often leads to long-lasting complications. However, the electrophysiological events that occur immediately after traumatic brain injury, and may underlie impact outcomes, have not been fully elucidated. To investigate the electrophysiological events that immediately follow traumatic brain injury, a weight-drop model of traumatic brain injury was used in rats pre-implanted with epidural and intracerebral electrodes. Electrophysiological (near-direct current) recordings and simultaneous alternating current recordings of brain activity were started within seconds following impact. Cortical spreading depolarization (SD) and SD-induced spreading depression occurred in approximately 50% of mild and severe impacts. SD was recorded within three minutes after injury in either one or both brain hemispheres. Electrographic seizures were rare. While both TBI- and electrically induced SDs resulted in elevated oxidative stress, TBI-exposed brains showed a reduced antioxidant defense. In severe TBI, brainstem SD could be recorded in addition to cortical SD, but this did not lead to the death of the animals. Severe impact, however, led to immediate death in 24% of animals, and was electrocorticographically characterized by non-spreading depression (NSD) of activity followed by terminal SD in both cortex and brainstem.	[Aboghazleh, Refat; Parker, Ellen; Friedman, Alon; van Hameren, Gerben] Dalhousie Univ, Fac Med, Dept Med Neurosci, Halifax, NS B3H 4H7, Canada; [Aboghazleh, Refat; Parker, Ellen; Friedman, Alon; van Hameren, Gerben] Dalhousie Univ, Brain Repair Ctr, Dept Med Neurosci, Halifax, NS B3H 4H7, Canada; [Aboghazleh, Refat] Al Balqa Appl Univ, Fac Med, Dept Basic Med Sci, Al Salt 19110, Jordan; [Parker, Ellen] Dalhousie Univ, Fac Med, Halifax, NS B3H 4R2, Canada; [Yang, Lynn T.; Kaufer, Daniela] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Dreier, Jens P.] Charite Univ Med Berlin, Ctr Stroke Res Berlin, D-10117 Berlin, Germany; [Dreier, Jens P.] Free Univ Berlin, Berlin, Germany; [Dreier, Jens P.] Humboldt Univ, Berlin, Germany; [Dreier, Jens P.] Berlin Inst Hlth, D-10117 Berlin, Germany; [Dreier, Jens P.] Charite Univ Med Berlin, Dept Expt Neurol, Berlin, Germany; [Dreier, Jens P.] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Dreier, Jens P.] Bernstein Ctr Computat Neurosci Berlin, D-10115 Berlin, Germany; [Dreier, Jens P.] Einstein Ctr Neurosci Berlin, D-10117 Berlin, Germany; [Friedman, Alon] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Friedman, Alon] Ben Gurion Univ Negev, Dept Cognit & Brain Sci, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel		Friedman, A (corresponding author), Dalhousie Univ, Fac Med, Dept Med Neurosci, Halifax, NS B3H 4H7, Canada.; Friedman, A (corresponding author), Dalhousie Univ, Brain Repair Ctr, Dept Med Neurosci, Halifax, NS B3H 4H7, Canada.; Friedman, A (corresponding author), Ben Gurion Univ Negev, Dept Physiol & Cell Biol, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel.; Friedman, A (corresponding author), Ben Gurion Univ Negev, Dept Cognit & Brain Sci, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel.	refat.aboghazleh@dal.ca; ellen.parker@dal.ca; lynn.yang@berkeley.edu; danielak@berkeley.edu; jens.dreier@charite.de; alon.friedman@dal.ca; GvanHameren@dal.ca		Aboghazleh, Refat/0000-0002-4398-1609; van Hameren, Gerben/0000-0003-0105-8098	Canadian Institute for Health ResearchCanadian Institutes of Health Research (CIHR) [PJT 148896]; U.S. Army Medical Research Acquisition Activity Office, 820 Chandler Street, Fort Detrick MD [21702-5014]; office of the Assistant Secretary of Defense for Health Affairs, through the Epilepsy Research Program [W81XWH-17-1-0684]; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG DR 323/5-1, DFG DR 323/10-1]; European CommissionEuropean CommissionEuropean Commission Joint Research Centre [602150]; BMBF Bundesministerium fuer Bildung und ForschungFederal Ministry of Education & Research (BMBF); BMBFFederal Ministry of Education & Research (BMBF) [01EW2004]; CIHRCanadian Institutes of Health Research (CIHR) [NDD-168164]; Mitacs Accelerate [IT13603]	This work was supported by the Canadian Institute for Health Research PJT 148896 and by the U.S. Army Medical Research Acquisition Activity Office, 820 Chandler Street, Fort Detrick MD 21702-5014, as the awarding and administering acquisition office of the Assistant Secretary of Defense for Health Affairs, through the Epilepsy Research Program, under Award No. W81XWH-17-1-0684. Opinions, interpretations, conclusions, and recommendations are those of the author, and are not necessarily endorsed by the Department of Defense. In addition, the study was supported by the Deutsche Forschungsgemeinschaft (DFG DR 323/5-1, DFG DR 323/10-1), the European Commission (FP7 no 602150 CENTER-TBI), BMBF Bundesministerium fuer Bildung und Forschung (Era-Net Neuron EBio2, with funds from BMBF 01EW2004 and CIHR NDD-168164), and Mitacs Accelerate (IT13603). In conducting research using animals, the investigators adhered to the laws of the United States and the regulations of the Department of Agriculture.	Aiba I, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4050; Balanca B, 2017, J CEREBR BLOOD F MET, V37, P1670, DOI 10.1177/0271678X16657571; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Bogdanov VB, 2016, J NEUROSCI, V36, P4733, DOI 10.1523/JNEUROSCI.3694-15.2016; Bouley J, 2019, J NEUROTRAUM, V36, P1008, DOI 10.1089/neu.2018.5844; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00373; Dreier JP, 2018, NEUROPHARMACOLOGY, V134, P189, DOI 10.1016/j.neuropharm.2017.09.027; Dreier JP, 2018, ANN NEUROL, V83, P295, DOI 10.1002/ana.25147; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2013, NEUROSCIENTIST, V19, P25, DOI 10.1177/1073858412453340; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Hartings JA, 2020, JAMA NEUROL, V77, P489, DOI 10.1001/jamaneurol.2019.4476; Hartings JA, 2017, BRAIN, V140, P2673, DOI 10.1093/brain/awx214; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Helbok R, 2017, J CEREBR BLOOD F MET, V37, P1871, DOI 10.1177/0271678X16651269; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jansen NA, 2019, J NEUROSCI, V39, P9633, DOI 10.1523/JNEUROSCI.1713-19.2019; Jia JM, 2018, EXP THER MED, V15, P2929, DOI 10.3892/etm.2018.5781; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kirov SA, 2020, CEREB CORTEX, V30, P5517, DOI 10.1093/cercor/bhaa134; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; LAURITZEN M, 1992, J CEREBR BLOOD F MET, V12, P223, DOI 10.1038/jcbfm.1992.32; Loonen ICM, 2019, BRAIN, V142, P412, DOI 10.1093/brain/awy325; Luckl J, 2018, BRAIN, V141, P1734, DOI 10.1093/brain/awy102; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mane M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043981; Maslarova A, 2011, STROKE, V42, P2917, DOI 10.1161/STROKEAHA.111.621581; Mayevsky A., 2015, RESPONSES NADH PHYSI, P111; McDaid J, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.652721; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; Mohammad LM, 2021, J NEUROSURG, V134, P1294, DOI 10.3171/2020.1.JNS192914; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Oliveira-Ferreira AI, 2020, J CEREBR BLOOD F MET, V40, P1274, DOI 10.1177/0271678X19861604; Oliveira-Ferreira AI, 2010, J CEREBR BLOOD F MET, V30, P1504, DOI 10.1038/jcbfm.2010.40; Pacheco JM, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0070-19.2019; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Petzold GC, 2008, STROKE, V39, P1292, DOI 10.1161/STROKEAHA.107.500710; Prager O, 2010, NEUROIMAGE, V49, P337, DOI 10.1016/j.neuroimage.2009.08.009; Reiffurth C, 2020, J CEREBR BLOOD F MET, V40, P622, DOI 10.1177/0271678X19833757; Revankar G.S., 2017, SEIZURES CRITICAL CA, P77, DOI DOI 10.1007/978-3-319-49557-6_5; Richter F, 2010, EXP NEUROL, V224, P146, DOI 10.1016/j.expneurol.2010.03.004; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Saito R, 1997, J CEREBR BLOOD F MET, V17, P857, DOI 10.1097/00004647-199708000-00004; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Takagaki M, 2014, EXP NEUROL, V252, P12, DOI 10.1016/j.expneurol.2013.11.003; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; Thomsen GM, 2016, J TRAUMA ACUTE CARE, V81, P1070, DOI 10.1097/TA.0000000000001248; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Valls-Lacalle L, 2016, CARDIOVASC RES, V109, P374, DOI 10.1093/cvr/cvv279; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Waziri A, 2009, ANN NEUROL, V66, P366, DOI 10.1002/ana.21721; Winkler MKL, 2012, EPILEPSIA, V53, P22, DOI 10.1111/j.1528-1167.2012.03699.x; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932; Zheng Z., 2018, NEUROPSYCHIATRY-LOND, V8, P302, DOI [10.4172/Neuropsychiatry.1000351, DOI 10.4172/NEUROPSYCHIATRY.1000351]	77	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	NOV	2021	22	21							11642	10.3390/ijms222111642			17	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	WY1NN	WOS:000719051800001	34769073	Green Published, gold			2022-02-06	
J	Ahluwalia, M; Kumar, M; Ahluwalia, P; Rahimi, S; Vender, JR; Raju, RP; Hess, DC; Baban, B; Vale, FL; Dhandapani, KM; Vaibhav, K				Ahluwalia, Meenakshi; Kumar, Manish; Ahluwalia, Pankaj; Rahimi, Scott; Vender, John R.; Raju, Raghavan P.; Hess, David C.; Baban, Babak; Vale, Fernando L.; Dhandapani, Krishnan M.; Vaibhav, Kumar			Rescuing mitochondria in traumatic brain injury and intracerebral hemorrhages-A potential therapeutic approach	NEUROCHEMISTRY INTERNATIONAL			English	Article						Mitochondrial biogenesis; Mitochondrial bioenergetics; Immune activation; Brain injury; Mitophagy; Therapeutic approach	ALPHA-LIPOIC ACID; PERMEABILITY TRANSITION PORE; ISCHEMIA-REPERFUSION MODEL; OXIDATIVE STRESS; CELL-DEATH; METHYLENE-BLUE; PROTEIN-KINASE; SMALL-MOLECULE; CEREBROSPINAL-FLUID; TRKB RECEPTOR	Mitochondria are dynamic organelles responsible for cellular energy production. Besides, regulating energy homeostasis, mitochondria are responsible for calcium homeostasis, signal transmission, and the fate of cellular survival in case of injury and pathologies. Accumulating reports have suggested multiple roles of mitochondria in neuropathologies, neurodegeneration, and immune activation under physiological and pathological conditions. Mitochondrial dysfunction, which occurs at the initial phase of brain injury, involves oxidative stress, inflammation, deficits in mitochondrial bioenergetics, biogenesis, transport, and autophagy. Thus, development of targeted therapeutics to protect mitochondria may improve functional outcomes following traumatic brain injury (TBI) and intracerebral hemorrhages (ICH). In this review, we summarize mitochondrial dysfunction related to TBI and ICH, including the mechanisms involved, and discuss therapeutic approaches with special emphasis on past and current clinical trials.	[Ahluwalia, Meenakshi; Kumar, Manish; Rahimi, Scott; Vender, John R.; Vale, Fernando L.; Dhandapani, Krishnan M.; Vaibhav, Kumar] Augusta Univ, Med Coll Georgia, Dept Neurosurg, 1120 15th St, Augusta, GA 30912 USA; [Ahluwalia, Pankaj] Augusta Univ, Dept Pathol, Med Coll Georgia, Augusta, GA USA; [Raju, Raghavan P.] Augusta Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, Augusta, GA USA; [Hess, David C.] Augusta Univ, Dept Neurol, Med Coll Georgia, Augusta, GA USA; [Baban, Babak; Vaibhav, Kumar] Augusta Univ, Dept Oral Biol & Diagnost Sci, Dent Coll Georgia, Augusta, GA USA		Vaibhav, K (corresponding author), Augusta Univ, Med Coll Georgia, Dept Neurosurg, 1120 15th St, Augusta, GA 30912 USA.	mahluwalia@augusta.edu; kvaibhav@augusta.edu	Ahluwalia, Pankaj Kumar/AAG-1949-2021	Ahluwalia, Pankaj Kumar/0000-0003-0060-6152; Dhandapani, Krishnan/0000-0001-7044-1117; Kumar, Manish/0000-0002-0855-3406	National Institutes of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS114560, NS065172, NS097825, NS099455, NS113356, NS112511, NS110378]; AURI Research Fund [MCGFD08343]	Authors' research is supported by grants from the National Institutes of Neurological Disorders and Stroke (NS114560 to KV; NS065172, NS097825 to KMD; NS099455, NS113356, NS112511 to DCH; and NS110378 to BB/KMD), and AURI Research Fund (MCGFD08343 to KV)	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Agranoff B.W., 1994, BASIC NEUROCHEMISTRY; Agrawal A, 2018, ELIFE, V7, DOI 10.7554/eLife.40986; Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2006, TRENDS BIOCHEM SCI, V31, P309, DOI 10.1016/j.tibs.2006.04.006; Alle H, 2009, SCIENCE, V325, P1405, DOI 10.1126/science.1174331; Almannai M, 2020, MOL GENET METAB, V131, P1, DOI 10.1016/j.ymgme.2020.10.002; Amadoro G, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00018; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Ashurst John, 2011, Del Med J, V83, P203; Averna M, 2016, ARCH BIOCHEM BIOPHYS, V604, P103, DOI 10.1016/j.abb.2016.06.015; Baban B, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.126766; Bambrick L, 2004, NEUROCHEM RES, V29, P601, DOI 10.1023/B:NERE.0000014830.06376.e6; Bando Y, 2019, NEUROCHEM INT, V131, DOI 10.1016/j.neuint.2019.104561; Barcena C, 2018, INT REV CEL MOL BIO, V340, P35, DOI 10.1016/bs.ircmb.2018.05.002; Bauernfeind AL, 2014, J HUM EVOL, V77, P132, DOI 10.1016/j.jhevol.2014.05.016; Bauernfeind AL, 2014, BRAIN STRUCT FUNCT, V219, P1149, DOI 10.1007/s00429-013-0662-z; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Bell SM, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9010063; Bell SM, 2020, J PERS MED, V10, DOI 10.3390/jpm10020032; Beltowski J, 2013, PPAR RES, V2013, DOI 10.1155/2013/628628; Ben Haim L, 2017, NAT REV NEUROSCI, V18, P31, DOI [10.1038/nrn.2016.159, 10.1038/nm.2016.159]; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Bernini A, 2020, J CEREBR BLOOD F MET, V40, P177, DOI 10.1177/0271678X18808947; Bertero E, 2018, CIRC RES, V122, P1460, DOI 10.1161/CIRCRESAHA.118.310082; Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025; Bhatti J, 2018, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00744; Bobinger T, 2018, CURR NEUROPHARMACOL, V16, P1267, DOI 10.2174/1570159X15666170602112851; Boland ML, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00292; Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; Bray N, 2019, NAT REV NEUROSCI, V20, P645, DOI 10.1038/s41583-019-0229-y; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Busquets-Garcia A, 2018, NEUROPSYCHOPHARMACOL, V43, P4, DOI 10.1038/npp.2017.206; Busquets-Garcia A, 2015, BIOESSAYS, V37, P1215, DOI 10.1002/bies.201500046; Cai CC, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4248529; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Callaway NL, 2004, PHARMACOL BIOCHEM BE, V77, P175, DOI 10.1016/j.pbb.2003.10.007; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Carinci M, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9020169; Castello NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091453; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Che W, 2017, BRAIN RES BULL, V131, P100, DOI 10.1016/j.brainresbull.2017.03.014; Chen HC, 2017, CELL METAB, V26, P39, DOI 10.1016/j.cmet.2017.05.016; Chen H, 2016, CLIN EXP PHARMACOL P, V43, P1107, DOI 10.1111/1440-1681.12650; Chen L, 2015, J NEUROPATH EXP NEUR, V74, P557, DOI 10.1097/NEN.0000000000000199; Chen W., 2020, FRONT AGING NEUROSCI, V12; Chen WX, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8285065; Chen YH, 2021, ANTIOXID REDOX SIGN, V34, P154, DOI 10.1089/ars.2019.7982; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chimeh U, 2018, INT J MED SCI, V15, P1384, DOI 10.7150/ijms.24702; Chitturi J, 2021, MITOCHONDRION, V57, P192, DOI 10.1016/j.mito.2021.01.003; Chitturi J, 2019, J NEUROTRAUM, V36, P1264, DOI 10.1089/neu.2018.6100; Christensen Jon, 2015, BMC Res Notes, V8, P322, DOI 10.1186/s13104-015-1284-8; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Clark RSB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180280; Court AC, 2020, EMBO REP, V21, DOI 10.15252/embr.201948052; Cruz Martin Paspe, 2018, P T, V43, P25; Cserep C, 2020, SCIENCE, V367, P528, DOI 10.1126/science.aax6752; Darlington CL, 2003, IDRUGS, V6, P976; Dash PK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00036; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Davila A, 2018, ELIFE, V7, DOI 10.7554/eLife.33246; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; Arnaiz GRD, 2014, CURR PROTEIN PEPT SC, V15, P761, DOI 10.2174/1389203715666140903145608; Breda CND, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101255; Deepmala, 2015, NEUROSCI BIOBEHAV R, V55, P294, DOI 10.1016/j.neubiorev.2015.04.015; Denzer K, 2000, J CELL SCI, V113, P3365; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Devanney NA, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113310; Devine MJ, 2018, NAT REV NEUROSCI, V19, P63, DOI 10.1038/nrn.2017.170; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; DiBona VL, 2021, NEUROSCI RES, V172, P99, DOI 10.1016/j.neures.2021.05.007; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Ding WS, 2017, BRAIN RES BULL, V128, P40, DOI 10.1016/j.brainresbull.2016.11.006; Doerrier C, 2018, METHODS MOL BIOL, V1782, P31, DOI 10.1007/978-1-4939-7831-1_3; Drose S, 2014, BBA-PROTEINS PROTEOM, V1844, P1344, DOI 10.1016/j.bbapap.2014.02.006; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fan HY, 2021, REDOX BIOL, V40, DOI 10.1016/j.redox.2021.101856; Fan L, 2017, CELL PHYSIOL BIOCHEM, V41, P1935, DOI 10.1159/000472380; Fan LF, 2017, FREE RADICAL BIO MED, V112, P336, DOI 10.1016/j.freeradbiomed.2017.08.003; Fecher C, 2019, NAT NEUROSCI, V22, P1731, DOI 10.1038/s41593-019-0479-z; Fenton AR, 2021, CURR OPIN CELL BIOL, V68, P28, DOI 10.1016/j.ceb.2020.08.014; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Frederich M, 2002, J BIOL CHEM, V277, P1928, DOI 10.1074/jbc.M107128200; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Galve-Roperh I, 2013, PROG LIPID RES, V52, P633, DOI 10.1016/j.plipres.2013.05.004; Geisler JG, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030280; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Geldenhuys WJ, 2017, ACS CHEM NEUROSCI, V8, P2759, DOI 10.1021/acschemneuro.7b00287; Geldenhuys WJ, 2016, BIOORG MED CHEM LETT, V26, P5350, DOI 10.1016/j.bmcl.2016.09.009; Gensini GF, 2007, J INFECTION, V54, P221, DOI 10.1016/j.jinf.2004.05.022; Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Golpich M, 2017, CNS NEUROSCI THER, V23, P5, DOI 10.1111/cns.12655; Goodfellow MJ, 2020, EXP NEUROL, V328, DOI 10.1016/j.expneurol.2020.113247; Goyal MS, 2018, ANNU REV NUTR, V38, P381, DOI 10.1146/annurev-nutr-082117-051652; Goyal MS, 2015, P NATL ACAD SCI USA, V112, P14105, DOI 10.1073/pnas.1511465112; Grazioli S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00832; Guilfoyle MR, 2015, J NEUROTRAUM, V32, P1553, DOI 10.1089/neu.2014.3764; Gurusamy N, 2010, CARDIOVASC RES, V86, P103, DOI 10.1093/cvr/cvp384; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Haas RH, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020048; Haber M, 2018, J CEREBR BLOOD F MET, V38, P1312, DOI 10.1177/0271678X17718106; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hall ED, 2019, NEUROPHARMACOLOGY, V145, P247, DOI 10.1016/j.neuropharm.2018.08.005; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Han DQ, 2020, STEM CELLS INT, V2020, DOI 10.1155/2020/8838046; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hayakawa K, 2018, STEM CELLS, V36, P1404, DOI 10.1002/stem.2856; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Hazeldine J, 2015, INJURY, V46, P975, DOI 10.1016/j.injury.2015.03.028; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He X., 2010, FASEB J, V24; He Z, 2020, FREE RADICAL BIO MED, V146, P45, DOI 10.1016/j.freeradbiomed.2019.11.005; Hebert-Chatelain E, 2016, NATURE, V539, P555, DOI 10.1038/nature20127; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Higgins GC, 2010, J ALZHEIMERS DIS, V20, pS453, DOI 10.3233/JAD-2010-100321; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263; Huang CY, 2015, MOL NEUROBIOL, V51, P1038, DOI 10.1007/s12035-014-8767-9; Huang Y, 2020, NEUROCHEM RES, V45, P322, DOI 10.1007/s11064-019-02916-z; Hubbard WB, 2018, J NEUROSCI RES, V96, P1677, DOI 10.1002/jnr.24271; Hussein OA, 2018, ULTRASTRUCT PATHOL, V42, P133, DOI 10.1080/01913123.2018.1427165; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Hyder F, 2016, J CEREBR BLOOD F MET, V36, P903, DOI 10.1177/0271678X15625349; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Jarrahi A, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100389; Jessen F, 2011, J ALZHEIMERS DIS, V27, P393, DOI 10.3233/JAD-2011-110398; Jiang ML, 2013, HUM MOL GENET, V22, P2462, DOI 10.1093/hmg/ddt098; Joshi DC, 2015, BRAIN RES, V1616, P1, DOI 10.1016/j.brainres.2015.04.042; Jung JE, 2020, J NEUROSCI, V40, P2154, DOI 10.1523/JNEUROSCI.2212-19.2020; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005; Katsu M, 2010, J CEREBR BLOOD F MET, V30, P1939, DOI 10.1038/jcbfm.2010.45; Kawane K, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016394; Kawoos U, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00650; Kelsen J, 2019, J NEUROTRAUM, V36, P3253, DOI 10.1089/neu.2018.6369; Khan A, 2012, MOL CELL BIOCHEM, V369, P55, DOI 10.1007/s11010-012-1368-x; Khatri N, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00199; Kim AS, 2011, J MOL CELL CARDIOL, V51, P24, DOI 10.1016/j.yjmcc.2011.03.003; Kim SH, 2013, TOX RESEARCH, V29, P229, DOI 10.5487/TR.2013.29.4.229; Kim-Han JS, 2006, STROKE, V37, P2457, DOI 10.1161/01.STR.0000240674.99945.4e; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030; Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x; Koutsilieri E, 2002, PARKINSONISM RELAT D, V8, P401, DOI 10.1016/S1353-8020(02)00021-4; Koza L, 2019, NEURAL REGEN RES, V14, P1701, DOI 10.4103/1673-5374.257520; Kulbe JR, 2018, J NEUROTRAUM, V35, P1280, DOI 10.1089/neu.2017.5353; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Ladak Z, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248777; Laird MD, 2008, FREE RADICAL BIO MED, V45, P1103, DOI 10.1016/j.freeradbiomed.2008.07.003; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Liu FK, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-037543; Liu HY, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9050489; Liu KM, 2014, MICROVASC RES, V92, P10, DOI 10.1016/j.mvr.2014.01.008; Liu X, 2013, PHARMACOLOGY, V91, P185, DOI 10.1159/000346920; Lou PH, 2007, BIOCHEM J, V407, P129, DOI 10.1042/BJ20070606; Lu HY, 2015, NEUROPSYCH DIS TREAT, V11, P2649, DOI 10.2147/NDT.S92158; Luo Xu, 2020, F1000Res, V9, DOI 10.12688/f1000research.25607.1; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Magistretti PJ, 2011, EXP PHYSIOL, V96, P407, DOI 10.1113/expphysiol.2010.053157; Magistretti PJ, 1999, NEWS PHYSIOL SCI, V14, P177, DOI 10.1152/physiologyonline.1999.14.5.177; Rodriguez-Vargas JM, 2012, CELL RES, V22, P1181, DOI 10.1038/cr.2012.70; Maynard ME, 2019, J NEUROTRAUM, V36, P2147, DOI 10.1089/neu.2018.6155; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; McAvoy K, 2019, MOL CELL NEUROSCI, V101, DOI 10.1016/j.mcn.2019.103417; Misgeld T, 2017, NEURON, V96, P651, DOI 10.1016/j.neuron.2017.09.055; Morita M, 2017, MOL CELL, V67, P922, DOI 10.1016/j.molcel.2017.08.013; Mukhopadhyay S, 2004, J BIOL CHEM, V279, P33139, DOI 10.1074/jbc.M405194200; Murugan M, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00019; Mustafa AG, 2018, BIOMED REP, V9, P421, DOI 10.3892/br.2018.1144; Mustafa AG, 2018, ARCH PHYSIOL BIOCHEM, V124, P418, DOI 10.1080/13813455.2017.1415939; Nardin A, 2016, CURR NEUROPHARMACOL, V14, P250, DOI 10.2174/1570159X13666151030104414; Nighoghossian N, 2015, NEUROLOGY, V84, P2216, DOI 10.1212/WNL.0000000000001639; Niu F, 2019, WORLD NEUROSURG, V122, pE1090, DOI 10.1016/j.wneu.2018.10.236; Norat P, 2020, NPJ REGEN MED, V5, DOI 10.1038/s41536-020-00107-x; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Omelchenko A, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1908-3; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Ozbal S, 2015, BIOTECH HISTOCHEM, V90, P206, DOI 10.3109/10520295.2014.977950; Paliwal S, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0429-1; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Parent M, 2020, J NEUROTRAUM, V37, P966, DOI 10.1089/neu.2019.6486; Patel SP, 2017, EXP NEUROL, V293, P74, DOI 10.1016/j.expneurol.2017.03.021; Bordone MP, 2019, J NEUROCHEM, V151, P139, DOI 10.1111/jnc.14829; Pekkurnaz G, 2014, CELL, V158, P54, DOI 10.1016/j.cell.2014.06.007; Peruzzotti-Jametti L, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001166; Pfleger J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.202; Picard M, 2014, P NATL ACAD SCI USA, V111, P7, DOI 10.1073/pnas.1321881111; Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712; Prins M, 2008, EPILEPSIA, V49, P111, DOI 10.1111/j.1528-1167.2008.01852.x; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Qi D, 2015, TRENDS ENDOCRIN MET, V26, P422, DOI 10.1016/j.tem.2015.05.010; Rabchevsky AG, 2017, NEURAL REGEN RES, V12, P1807, DOI 10.4103/1673-5374.219040; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Rambold AS, 2018, TRENDS IMMUNOL, V39, P6, DOI 10.1016/j.it.2017.08.006; Rangaraju V, 2019, CELL, V176, P73, DOI 10.1016/j.cell.2018.12.013; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Reddy V, 2020, EPMA J, V11, P217, DOI 10.1007/s13167-020-00203-4; Reinhard SM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00280; Ren HY, 2019, OPEN LIFE SCI, V14, P651, DOI 10.1515/biol-2019-0074; Ren J, 2019, EXP THER MED, V18, P2759, DOI 10.3892/etm.2019.7886; Riha PD, 2005, EUR J PHARMACOL, V511, P151, DOI 10.1016/j.ejphar.2005.02.001; Ristow M, 2014, NAT MED, V20, P709, DOI 10.1038/nm.3624; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Rizk M, 2021, NEURAL REGEN RES, V16, P926, DOI 10.4103/1673-5374.297057; Robledo-Menendez A, 2021, FEBS J, DOI 10.1111/febs.15907; Rocamonde B, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/521939; Rodriguez-Nuevo A, 2019, CELL STRESS, V3, P195, DOI 10.15698/cst2019.06.190; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; Rose J, 2017, TOXICOLOGY, V391, P109, DOI 10.1016/j.tox.2017.06.011; Roszek K, 2015, MINI-REV MED CHEM, V15, P5, DOI 10.2174/1389557515666150219114416; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Salihu AT, 2016, REV NEUROSCIENCE, V27, P317, DOI 10.1515/revneuro-2015-0046; Salman M, 2021, CELL MOL NEUROBIOL, V41, P765, DOI 10.1007/s10571-020-00884-5; Santos RX, 2010, J ALZHEIMERS DIS, V20, pS401, DOI 10.3233/JAD-2010-100666; Santuy A, 2018, CEREB CORTEX, V28, P3673, DOI 10.1093/cercor/bhy159; Satoh T, 2008, J NEUROCHEM, V104, P1116, DOI 10.1111/j.1471-4159.2007.05039.x; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Schousboe A, 2019, J NEUROSCI RES, V97, P890, DOI 10.1002/jnr.24402; Scott G, 2002, J CELL SCI, V115, P1441; Seager Richard, 2020, Neuronal Signal, V4, pNS20200008, DOI 10.1042/NS20200008; Sears ME, 2013, SCI WORLD J, DOI 10.1155/2013/219840; Shen JJ, 2019, BRAIN RES BULL, V146, P143, DOI 10.1016/j.brainresbull.2018.11.024; Shen J, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01133; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Shi RY, 2014, CNS NEUROSCI THER, V20, P1045, DOI 10.1111/cns.12325; Shin MK, 2021, CELL, V184, P2715, DOI 10.1016/j.cell.2021.03.032; Shrivastava P, 2013, J NUTR BIOCHEM, V24, P680, DOI 10.1016/j.jnutbio.2012.03.018; Siegel G.J., 1994, BASIC NEUROCHEMISTRY; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singhal NS, 2020, NEUROTHERAPEUTICS, V17, P457, DOI 10.1007/s13311-020-00832-7; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Springer JE, 2018, J NEUROTRAUM, V35, P492, DOI 10.1089/neu.2017.5167; Springer JE, 2018, NEURAL REGEN RES, V13, P1338, DOI 10.4103/1673-5374.235218; Srivastava S, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0104-7; Stawicki SP, 2008, MINI-REV MED CHEM, V8, P472, DOI 10.2174/138955708784223477; Steiner P, 2019, ANN NUTR METAB, V75, P8, DOI 10.1159/000508054; Stetson PD, 2001, J AM MED INFORM ASSN, P672; Sugden D, 2004, PIGM CELL RES, V17, P454, DOI 10.1111/j.1600-0749.2004.00185.x; Sukumari-Ramesh S, 2010, GLIA, V58, P1858, DOI 10.1002/glia.21055; Suliman HB, 2016, PHARMACOL REV, V68, P20, DOI 10.1124/pr.115.011502; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sun LQ, 2015, MOL MED REP, V11, P4419, DOI 10.3892/mmr.2015.3264; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Szczesny B, 2010, MECH AGEING DEV, V131, P330, DOI 10.1016/j.mad.2010.03.009; Takeda H, 2021, J PHARMACOL SCI, V145, P130, DOI 10.1016/j.jphs.2020.11.007; Teng LF, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00026; Tewari Anurag, 2014, J Anaesthesiol Clin Pharmacol, V30, P160, DOI 10.4103/0970-9185.130001; Thapa K, 2021, J MOL NEUROSCI, V71, P1725, DOI 10.1007/s12031-021-01841-7; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Torralba D, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00107; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Tretter L, 2014, METHOD ENZYMOL, V547, P199, DOI 10.1016/B978-0-12-801415-8.00012-6; Tucker D, 2018, MOL NEUROBIOL, V55, P5137, DOI 10.1007/s12035-017-0712-2; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Ullah H, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10040546; Uluc K, 2013, CNS NEUROL DISORD-DR, V12, P360, DOI 10.2174/18715273113129990061; Vaibhav K, 2018, J EXP MED, V215, P2636, DOI 10.1084/jem.20171905; Vaibhav K, 2013, PHARMACOL BIOCHEM BE, V113, P53, DOI 10.1016/j.pbb.2013.10.008; Vaibhav K, 2013, NEUROL SCI, V34, P1321, DOI 10.1007/s10072-012-1238-z; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Vasile F, 2017, BRAIN STRUCT FUNCT, V222, P2017, DOI 10.1007/s00429-017-1383-5; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002; Voigt A, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12796; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Walko TD, 2014, SHOCK, V41, P499, DOI 10.1097/SHK.0000000000000160; Wang HC, 2014, J NEUROTRAUM, V31, P1039, DOI 10.1089/neu.2013.3070; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; Wang WZ, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00376-6; Wang XL, 2012, J NEUROTRAUM, V29, P936, DOI 10.1089/neu.2011.1922; Wang Z, 2018, TRANSL STROKE RES, V9, P74, DOI 10.1007/s12975-017-0559-x; Watts LT, 2016, J NEUROTRAUM, V33, P194, DOI 10.1089/neu.2015.3904; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Watts LT, 2013, BRAIN SCI, V3, P540, DOI 10.3390/brainsci3020540; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wei CC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00851-z; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wilks DC, 2011, OBES REV, V12, pe119, DOI 10.1111/j.1467-789X.2010.00775.x; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Wu X, 2020, NEUROSCI BULL, V36, P1158, DOI 10.1007/s12264-020-00505-7; Wu X, 2020, TRANSL STROKE RES, V11, P924, DOI 10.1007/s12975-019-00768-x; Xia DY, 2019, J CELL MOL MED, V23, P4088, DOI 10.1111/jcmm.14296; Xiao AQ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83545-x; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xu F, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00416-0; Xu XJ, 2021, CHIN J TRAUMATOL, V24, P5, DOI 10.1016/j.cjtee.2020.10.001; Xu Z, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0257-8; Yang J, 2015, DEV NEUROREHABIL, V18, P330, DOI 10.3109/17518423.2013.830153; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yin F, 2013, BIOCHEM SOC T, V41, P101, DOI 10.1042/BST20120260; Ying W, 2010, CURR MED CHEM, V17, P2152, DOI 10.2174/092986710791299911; Ying W., 2007, 37 AM SOC NEUR ANN M; Ying WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P2728, DOI 10.2741/2267; Ying WH, 2007, FRONT BIOSCI-LANDMRK, V12, P1863, DOI 10.2741/2194; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Yonutas HM, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113243; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Younts TJ, 2014, CURR OPIN NEUROBIOL, V26, P42, DOI 10.1016/j.conb.2013.12.006; Yu C., TRANSL RES, V235, P102; Yu E, 2012, CARDIOVASC RES, V95, P173, DOI 10.1093/cvr/cvs111; Yu J, 2019, NEUROCHEM RES, V44, P1678, DOI 10.1007/s11064-019-02794-5; Yu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18981; Zeng ZQ, 2020, J CELL PHYSIOL, V235, P1973, DOI 10.1002/jcp.29173; Zhang TY, 2019, STROKE, V50, P978, DOI 10.1161/STROKEAHA.118.021590; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zhao CP, 2010, FASEB J, V24; Zhao S, 2016, MOL NEUROBIOL, V53, P1884, DOI 10.1007/s12035-015-9128-z; Zheng JW, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00414; Zheng Mingzhe, 2013, Acta Neurochir Suppl, V118, P169, DOI 10.1007/978-3-7091-1434-6_31; Zheng SY, 2021, NEUROSCI LETT, V756, DOI 10.1016/j.neulet.2021.135967; Zhou HR, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.589114; Zhou ZD, 2020, AGEING RES REV, V62, DOI 10.1016/j.arr.2020.101107; Zille M, 2017, STROKE, V48, P1033, DOI 10.1161/STROKEAHA.116.015609; Zuo W, 2014, NEUROPHARMACOLOGY, V86, P103, DOI 10.1016/j.neuropharm.2014.07.002	353	0	0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	NOV	2021	150								105192	10.1016/j.neuint.2021.105192			19	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	WK1EE	WOS:000709475500001	34560175				2022-02-06	
J	Akbar, A; Arain, SH; Narejo, MA; Ansari, NS				Akbar, Ali; Arain, Safdar Hussain; Narejo, Mumtaz Ali; Ansari, Najmus Saqib			Prognostic Factors after Acute Subdural Hematoma	PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES			English	Article						Prognostic factor; Acute subdural hematoma; Computed tomography (CT)	TRAUMATIC BRAIN-INJURY; CLASSIFICATION	Background: Acute subdural hematoma is a lesion caused by traumatic brain injury. Computed topography, hematoma thickness and midline shift analysis are important factors in evaluating its prognosis. Aim: To evaluate the factors involved in prognosis of acute subdural hematoma. Study design: Retrospective study Place and duration of study: Department of Neurosurgery, Chandka Medical College Hospital, Larkana from 1st October 2020 to 30the June 2021. Methodology: One hundred patients from both genders and between age 18-55 years were enrolled. Clinical examination and radiological complete examination was done in each patient. Zumkeller Index (ZI) was calculated and Glasgow scoring was performed. Results: The mean age were 44.1 +/- 15.8 years with 87% males having major reasoning of head injury as a motor cycle accident. Traumatic brain injury was recorded as >3mm ZI in 10 cases. The mean midline shift was 12.4 +/- 6.06 mm with a significant difference between three categories. Conclusion: Midline shift and hematoma thickness are useful predictors of prognosis related to acute subdural hematoma.	[Akbar, Ali] Shaheed Mohtarma Benazir Bhutto Med Univ, Chandka Med Coll, Neurosurg, Larkana, Sindh, Pakistan; [Arain, Safdar Hussain; Narejo, Mumtaz Ali] Pir Abdul Qadir Shah Jeelani Inst Med Sci, Dept Neurosurg, Gambat, Sindh, Pakistan; [Ansari, Najmus Saqib] Ghulam Muhammad Mahar Med Coll Sukkur, Dept Neurosurg, Sukkur, Sindh, Pakistan		Arain, SH (corresponding author), Pir Abdul Qadir Shah Jeelani Inst Med Sci, Dept Neurosurg, Gambat, Sindh, Pakistan.	drsafdararain@gmail.com					Bartels RHMA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0479-x; de Souza MR, 2021, TRAUMA SURG ACUTE CA, V6, DOI 10.1136/tsaco-2021-000707; Evans LR, 2019, J NEUROTRAUM, V36, P517, DOI 10.1089/neu.2018.5829; Hawryluk GWJ, 2020, NEUROSURGERY, V87, P427, DOI 10.1093/neuros/nyaa278; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; Kulesza B, 2021, EUR J TRAUMA EMERG S, V47, P1517, DOI 10.1007/s00068-020-01460-8; Lee D, 2017, NERVE, V3, P50; Liao CC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77667-x; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marbacher S, 2010, ACTA NEUROCHIR, V152, P501, DOI 10.1007/s00701-009-0521-0; Marion DW, 2006, NEUROSURGERY, V58, P655; Moussa WMM, 2018, NEUROSURG REV, V41, P483, DOI 10.1007/s10143-017-0873-5; Neurotrauma. world, 2016, NIHR GLOB HLTH RES G; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Santos Maria Emilia, 2003, Acta Med Port, V16, P71; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Won YD, 2018, WORLD NEUROSURG, V111, pE120, DOI 10.1016/j.wneu.2017.12.025; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	20	0	0	0	0	LAHORE MEDICAL RESEARCH CENTER LLP	LAHORE	590, Karim Block, Allama Iqbal Town, LAHORE, 00000, PAKISTAN	1996-7195			PAK J MED HEALTH SCI	Pak. J. Med. Health Sci.	NOV	2021	15	11					2979	2981		10.53350/pjmhs2115112979			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	YI9WJ	WOS:000744191000048					2022-02-06	
J	Allen, RS; Motz, CT; Singh, A; Feola, A; Hutson, L; Douglass, A; Rao, SR; Skelton, LA; Cardelle, L; Bales, KL; Chesler, K; Gudapati, K; Ethier, CR; Harper, MM; Fliesler, SJ; Pardue, MT				Allen, Rachael S.; Motz, Cara T.; Singh, Anayesha; Feola, Andrew; Hutson, Lauren; Douglass, Amber; Rao, Sriganesh Ramachandra; Skelton, Lara A.; Cardelle, Lidia; Bales, Katie L.; Chesler, Kyle; Gudapati, Kaavya; Ethier, C. Ross; Harper, Matthew M.; Fliesler, Steven J.; Pardue, Machelle T.			Dependence of visual and cognitive outcomes on animal holder configuration in a rodent model of blast overpressure exposure	VISION RESEARCH			English	Article						Blast; Traumatic brain injury; TBI; Retina; Eye	TRAUMATIC BRAIN-INJURY; MOUSE MODEL; EYE INJURIES; DAMAGE; DYSFUNCTION; VISION; RETINA; SYSTEM; ADULT; GLOBE	Blast-induced traumatic brain injury is the signature injury of modern military conflicts. To more fully understand the effects of blast exposure, we placed rats in different holder configurations, exposed them to blast overpressure, and assessed the degree of eye and brain injury. Anesthetized Long-Evans rats received blast exposures directed at the head (63 kPa, 195 dB-SPL) in either an "open holder" (head and neck exposed; n = 7), or an "enclosed holder" (window for blast exposure to eye; n = 15) and were compared to non-blast exposed (control) rats (n = 22). Outcomes included optomotor response (OMR), electroretinography (ERG), and spectral domain optical coherence tomography (SD-OCT) at 2, 4, and 6 months post-blast, and cognitive function (Y-maze) at 3 months. Spatial frequency and contrast sensitivity were reduced in ipsilateral blast-exposed eyes in both holders (p < 0.01), while contralateral eyes showed greater deficits with the enclosed holder (p < 0.05). Thinner retinas (p < 0.001) and reduced ERG a- and b- wave amplitudes (p < 0.05) were observed for both ipsilateral and contralateral eyes with the enclosed, but not the open, holder. Rats in the open holder showed cognitive deficits compared to rats in the enclosed holder (p < 0.05). Overall, the animal holder configuration used in blast exposure studies can significantly affect outcomes. Enclosed holders may cause secondary damage to the contralateral eye by concussive injury or blast wave reflection off the holder wall. Open holders may damage the brain via rapid head movement (contrecoup injury). These results highlight additional factors to be considered when evaluating patients with blast exposure or developing models of blast injury.	[Allen, Rachael S.; Motz, Cara T.; Singh, Anayesha; Feola, Andrew; Hutson, Lauren; Douglass, Amber; Cardelle, Lidia; Bales, Katie L.; Chesler, Kyle; Gudapati, Kaavya; Pardue, Machelle T.] Atlanta VA Healthcare Syst, Ctr Visual & Neurocognit Rehabil, Decatur, GA USA; [Allen, Rachael S.; Motz, Cara T.; Feola, Andrew; Chesler, Kyle; Ethier, C. Ross; Pardue, Machelle T.] Emory Univ, Sch Med, Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA USA; [Feola, Andrew; Bales, Katie L.; Ethier, C. Ross] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA USA; [Rao, Sriganesh Ramachandra; Skelton, Lara A.; Fliesler, Steven J.] VA Western NY Healthcare Syst, Res Serv, Buffalo, NY USA; [Rao, Sriganesh Ramachandra; Skelton, Lara A.; Fliesler, Steven J.] SUNY Buffalo, Ophthalmol Biochem & Neurosci Program, Buffalo, NY USA; [Harper, Matthew M.] Iowa City VA Hlth Care Syst Ctr Prevent & Treatme, Iowa City, IA USA; [Harper, Matthew M.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA		Pardue, MT (corresponding author), Atlanta VA Ctr Visual & Neurocognit Rehabil, 1670 Clairmont Rd, Decatur, GA 30033 USA.	machelle.pardue@bme.gatech.edu		Ramachandra Rao, Sriganesh/0000-0003-1029-1051	Georgia Research Alliance; NEIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY006360]; Department of Veterans Affairs [Biomedical Laboratory Research & Development Merit Award]US Department of Veterans Affairs [BX002439]; Department of Veterans AffairsUS Department of Veterans Affairs [15F-RCS-001, RX003134, RX002928, RX002342]	This work was supported by the Department of Veterans Affairs [Biomedical Laboratory Research & Development Merit Award (BX002439) to SJF & MTP and Research Career Scientist Award (15F-RCS-001 to SJF) ; Rehabilitation Research & Development Research Career Scientist Award (RX003134 to MTP) and Career Development Awards (RX002928 to RSA, RX002342 to AJF) ] , the Georgia Research Alliance (to CRE) , and NEI Core Grant P30EY006360.	Allen RS, 2020, JOVE-J VIS EXP, DOI 10.3791/61588; Allen RS, 2018, J NEUROTRAUM, V35, P2104, DOI 10.1089/neu.2017.5394; Aung MH, 2013, INVEST OPHTH VIS SCI, V54, P1370, DOI 10.1167/iovs.12-10927; Bailoor S, 2015, BIOMECH MODEL MECHAN, V14, P1227, DOI 10.1007/s10237-015-0667-z; Bhardwaj R, 2014, BIOMECH MODEL MECHAN, V13, P123, DOI 10.1007/s10237-013-0490-3; Bricker-Anthony C, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0704-6; Bricker-Anthony C, 2016, J OCUL PHARMACOL TH, V32, P286, DOI 10.1089/jop.2015.0104; Bricker-Anthony C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131921; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chandra N, 2017, MIL MED, V182, P105, DOI 10.7205/MILMED-D-16-00144; Chase RP, 2015, J HEAD TRAUMA REHAB, V30, pE57, DOI 10.1097/HTR.0000000000000061; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Coe CD, 2010, OPTOMETRY VISION SCI, V87, P604, DOI 10.1097/OPX.0b013e3181e61bc0; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; DeMar J, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00059; DeWalt GJ, 2017, J COMP NEUROL, V525, P2955, DOI 10.1002/cne.24252; Donat CK, 2021, BRAIN, V144, P70, DOI 10.1093/brain/awaa336; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Gan RZ, 2016, HEARING RES, V340, P25, DOI 10.1016/j.heares.2016.01.004; Ge XT, 2018, J NEUROSCI METH, V308, P162, DOI 10.1016/j.jneumeth.2018.07.021; Goldstein LE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0064-3; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Gudapati K, 2020, JOVE-J VIS EXP, DOI 10.3791/61806; Guley NM, 2019, EXP EYE RES, V182, P109, DOI 10.1016/j.exer.2019.03.013; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; IOM (Institutes of Medicine), 2014, GULF WAR HLTH, P33; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lemke S, 2016, OPHTHALMOLOGY, V123, P415, DOI 10.1016/j.ophtha.2015.10.003; Lemke S, 2013, JAMA OPHTHALMOL, V131, P1602, DOI 10.1001/jamaophthalmol.2013.5028; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MAURICE T, 1995, BEHAV PHARMACOL, V6, P167; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Morley MG, 2010, DISASTER MED PUBLIC, V4, P154, DOI 10.1001/dmp.v4n2.hra10003; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Pieramici DJ, 1997, AM J OPHTHALMOL, V123, P820, DOI 10.1016/S0002-9394(14)71132-8; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; SCHREMSER JL, 1992, EXP EYE RES, V55, P393, DOI 10.1016/0014-4835(92)90111-5; Tang XL, 2016, J NEUROPHYSIOL, V115, P3018, DOI 10.1152/jn.01137.2015; Thach AB, 2008, OPHTHALMOLOGY, V115, P377, DOI 10.1016/j.ophtha.2007.04.032; Tu CJ, 2013, MOL CELL PROTEOMICS, V12, P3583, DOI 10.1074/mcp.M113.027847; Turner PV, 2005, COMPARATIVE MED, V55, P175; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Zhou RZ, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00172; Zou YY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-79	62	0	0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	NOV	2021	188						162	173		10.1016/j.visres.2021.07.008			12	Neurosciences; Ophthalmology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology; Psychology	WJ4II	WOS:000709009800015	34333201				2022-02-06	
J	Assamadi, M; Benantar, L; El Qadi, AA; Hassan, TA; Aniba, K				Assamadi, M.; Benantar, L.; El Qadi, A. Ait; Hassan, T. Abou El; Aniba, K.			Epidemiological aspects and prognostic factors of severe traumatic brain injuries	NEUROCHIRURGIE			French	Article						Severe head injury; Glasgow coma scale; Prognostic factors; Mortality	SEVERE HEAD-INJURY	Objective. - To determine the severity factors in severe traumatic brain injuries. Methods. - A prospective descriptive study of severe head injuries admitted to the emergency department at Ibn Tofail Hospital at the University Hospital of Marrakech over a period of six months from May to October 2015. The following data was collected: circumstances, clinical, biology, radiology, treatment and evolution. Results. - One hundred and nineteen patients with severe traumatic brain injury were collected (101 males, 84,9%). The mean age was 37,73 +/- 15,7 years. Road accidents were the most common cause representing 84%. The median Glasgow coma scale (GCS) was 7 +/- 3. We noted 36 cases (30,3%) of anisocoria, 32 cases (26,9%) of bilateral mydriasis and 72 cases (60,5%) of hypoxia. Cerebral contusions (66,1%) and meningeal hemorrhage (66,6%) were the most frequent lesions on CT. Forty-seven patients (42%) had stage VI Marshall lesions. Twenty-four patients (20.1%) required a neurosurgical intervention, 12 extradural hematoma evacuations and 10 craniocerebral wounds. Mortality was 64.7% (77 deaths), the main cause was neurological (64,9%). In the latter group, we observed more frequently an older age (P = 0.00001), a management delay (P = 0.011), a low initial GCS (P = 0.000001), a bilateral nonreactive mydriasis (P = 0.0001), a hypoxia (P = 0.0002), a subarachnoid hemorrhage (P = 0.008), a high Marshall score (P = 0.017) and an anemia (P = 0.046). Conclusion. - Head trauma is a public health problem. The victims are young, and the sequelae are frequently disabling. Several parameters are associated with a poorer prognosis including age, neurological state and the initial delay in management. (C) 2021 Elsevier Masson SAS. All rights reserved.	[Assamadi, M.; Benantar, L.; El Qadi, A. Ait; Aniba, K.] Univ Cadi Ayyad Marrakech, Serv Neurochirurg, Hop Ibn Tofail, CHU Mohammed 6,Fac Med & Pharm Marrakech, Marrakech, Morocco; [Hassan, T. Abou El] Univ Cadi Ayyad, Serv Accueil Urgences Vitales, CHU Mohammed 6, Fac Med & Pharm Marrakech, Marrakech, Morocco		Assamadi, M (corresponding author), 306 Azli Sud, Marrakech 40000, Morocco.	as.mouhssine@gmail.com; lamiabenantar@gmail.com; azizaitelqadi@yahoo.fr; drabouelhassan@gmail.com; anibakhalid@yahoo.fr		assamadi, mouhssine/0000-0001-8036-1436			Aesch B, 1999, ENCY MED CHIR; Aguemon AR, 2005, ANN FR ANESTH, P36; Alliez J-R, 2008, ENCY MED CHIR; Bahloul M, 2009, INJURY, V40, P535, DOI 10.1016/j.injury.2008.04.018; Bernard F, 2006, BRIT J ANAESTH, V96, P72, DOI 10.1093/bja/aei277; Bouhours G, 2006, REANIMATION, V15, P552; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Degos V, ENCY MED CHIR; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Dunn J, ANAESTH INTENS CARE, V9, P197; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Geeraerts T, 2010, Ann Fr Anesth Reanim, V29, pe171, DOI 10.1016/j.annfar.2010.06.006; Jha S K, 2003, Med J Armed Forces India, V59, P326, DOI 10.1016/S0377-1237(03)80147-8; Laplace C, 2010, MAPAR, P445; Le Ministere de l'Equipement et du Transport et de la logistique, 2013, REC STAT ACC CORP CI; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Marescal C, 1998, ANN FR ANESTH, P234; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mathe JF, 2005, ANN FR ANESTH, V24, P688, DOI 10.1016/j.annfar.2005.03.029; Matillon Y., 1998, ANAES; MCKISSOCK W, 1960, LANCET, V2, P167; RACT C, PRIS CHARG TRAUM CRA; Saini NS, 2012, INDIAN J NEUROTRAUM, V9, P45, DOI 10.1016/j.ijnt.2012.04.009; Sanchez-Olmedo JI, 2005, TRANSPL P, V37, P1990, DOI 10.1016/j.transproceed.2005.03.048; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Solacroup J. C., 2003, Annales de Readaptation et de Medecine Physique, V46, P104, DOI 10.1016/S0168-6054(03)00018-7; Sousa J, 2002, NEUROL INDIA, V50, P430; Tentillier E, 2004, ANN FR ANESTH, V23, P109, DOI 10.1016/j.annfar.2003.11.019	29	0	0	1	1	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	NOV	2021	67	6					571	578		10.1016/j.neuchi.2021.04.005			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WJ6SZ	WOS:000709173800007	33901522				2022-02-06	
J	Babunovska, M; Boskovski, B; Kuzmanovski, I; Tanovska, N; Trencevska, GK; Cvetkovska, E				Babunovska, Marija; Boskovski, Bojan; Kuzmanovski, Igor; Tanovska, Nikolina; Trencevska, Gordana Kiteva; Cvetkovska, Emilija			Risk factors associated with new-onset epilepsy in young adults: Population-based study	EPILEPSY & BEHAVIOR			English	Article						Epilepsy; Etiology; Comorbidities; Young adults	UNPROVOKED SEIZURES; PREVALENCE; ETIOLOGY; AGE	Objective: Risk factors for childhood and late-onset epilepsy are thoroughly described in existing literature, while they are less defined and ambiguous for young adults. We aimed to evaluate the prevalence of various risk factors associated with new-onset epilepsy in adults aged 20-49 years. We included all incident cases in North Macedonia between 2015 and 2018. Methods: Study participants were ascertained through the nationwide healthcare platform. We performed a retrospective analysis of their Electronic Health Records and identified associated conditions which are considered putative risk factors for epilepsy. Results: Of 1691 included patients, 694 (41%) had at least one putative risk factor. The most common were neoplasms and cerebrovascular diseases (8% of cases, respectively), followed by intellectual disability (6%), alcohol/substance abuse (5%), and traumatic brain injury (4%). Infective and inflammatory diseases were infrequent in our cohort (1%). Other very rare risk factors included degenerative and metabolic disorders and malformations of cortical development (2%). Idiopathic (genetic) generalized epilepsies accounted for 7% of incident cases. Chronic alcoholism and illicit drugs abuse (dominantly opioids) were significantly more frequent in males than in females (p < 0.00001). Conclusion: Brain neoplasms and stroke were the most prevalent risk factors associated with new-onset epilepsy in young adults. Furthermore, adult-onset IGE were common in our cohort. The majority of patients did not have any of conventional risk factors and probably specific genetic causes might become increasingly recognized in adult-onset epilepsies in the future. (c) 2021 Elsevier Inc. All rights reserved.	[Babunovska, Marija; Boskovski, Bojan; Kuzmanovski, Igor; Tanovska, Nikolina; Trencevska, Gordana Kiteva; Cvetkovska, Emilija] Ss Cyril & Methodius Univ, Clin Neurol, Mother Theresa Str 17, Skopje 1000, North Macedonia		Cvetkovska, E (corresponding author), Ss Cyril & Methodius Univ, Clin Neurol, Mother Theresa Str 17, Skopje 1000, North Macedonia.						Asadi-Pooya AA, 2012, SEIZURE-EUR J EPILEP, V21, P417, DOI 10.1016/j.seizure.2012.04.004; Babunovska M, 2021, SEIZURE-EUR J EPILEP, V87, P56, DOI 10.1016/j.seizure.2021.03.003; Balestrini S, 2021, EPILEPTIC DISORD, V23, P1, DOI 10.1684/epd.2021.1255; Brodtkorb E, 1994, Seizure, V3, P277, DOI 10.1016/S1059-1311(05)80175-X; Caprara ALF, 2020, EPILEPSY BEHAV, V105, DOI 10.1016/j.yebeh.2020.106969; Cvetkovska E, 2014, SEIZURE-EUR J EPILEP, V23, P903, DOI 10.1016/j.seizure.2014.07.011; Giussani G, 2021, EPILEPSIA, V62, P2395, DOI 10.1111/epi.17022; Guekht A, 2010, EPILEPSY RES, V92, P209, DOI 10.1016/j.eplepsyres.2010.09.011; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; JOSEPHSON CB, EPILEPSIA, V62, P2036, DOI DOI 10.1111/EPI.V62.910.1111/EPI.16996; Marini C, 2003, J NEUROL NEUROSUR PS, V74, P192, DOI 10.1136/jnnp.74.2.192; Medina MT, 2005, EPILEPSIA, V46, P124, DOI 10.1111/j.0013-9580.2005.11704.x; NG SKC, 1990, AM J EPIDEMIOL, V132, P47, DOI 10.1093/oxfordjournals.aje.a115642; Olafsson E, 2005, LANCET NEUROL, V4, P627, DOI 10.1016/S1474-4422(05)70172-1; Olive-Gadea M, 2019, EPILEPSY BEHAV, V92, P327, DOI 10.1016/j.yebeh.2018.12.008; Raimon S, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10050599; Roivainen R, 2013, EUR J NEUROL, V20, P1247, DOI 10.1111/ene.12157; SANDER JWAS, 1990, LANCET, V336, P1267, DOI 10.1016/0140-6736(90)92959-L; Sokka Arja, 2017, Epilepsia Open, V2, P76, DOI 10.1002/epi4.12036; Stefan H, 2014, ACTA NEUROL SCAND, V129, P283, DOI 10.1111/ane.12218; Velinov G, 2015, STUD HEALTH TECHNOL, V210, P872, DOI 10.3233/978-1-61499-512-8-872	21	0	0	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	NOV	2021	124								108353	10.1016/j.yebeh.2021.108353			4	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	WP0CZ	WOS:000712812000007	34678568				2022-02-06	
J	Bagheri, SR; Abdi, A; Benson, J; Naghdi, N; Eden, SV; Arjmand, M; Amini, Z; Lawton, MT; Alimohammadi, E				Bagheri, Seyed Reza; Abdi, Alireza; Benson, Joseph; Naghdi, Negin; Eden, Sonia, V; Arjmand, Minoo; Amini, Zahra; Lawton, Michael T.; Alimohammadi, Ehsan			The significant impact of Coronavirus disease 2019 (COVID-19) on in-hospital mortality of elderly patients with moderate to severe traumatic brain injury: A retrospective observational study	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						COVID-19; Traumatic brain injury; In-hospital mortality; Elderly patients	HEAD-INJURY; OUTCOMES; PREDICTION; CLASSIFICATION; EPIDEMIOLOGY	Background: Traumatic brain injury (TBI) is one of the main causes of death and disability among the elderly patient population. This study aimed to assess the predictors of in-hospital mortality of elderly patients with moderate to severe TBI who presented during the Coronavirus disease 2019 (COVID-19) pandemic. Methods: In this retrospective analytical study, all elderly patients with moderate to severe TBI who were referred to our center between March 2nd, 2020 to August 1st, 2020 were investigated and compared against the TBI patients receiving treatment during the same time period within the year 2019. Patients were followed until discharge from the hospital or death. The demographic, clinical, radiological, and laboratory test data were evaluated. Data were analyzed using SPSS-21 software. Findings: In this study, 359 elderly patients were evaluated (n = 162, Post-COVID-19). Fifty-four patients of the cohort had COVID-19 disease with a mortality rate was 33.3%. The patients with COVID-19 were 5.45 times more likely to expire before discharge (P < 0.001) than the TBI patients who were not COVID-19 positive. Other variables such as hypotension (OR, 4.57P < 0.001), hyperglycemia (OR, 2.39, P = 0.002), and use of anticoagulant drugs (OR, 2.41P = 0.001) were also associated with in-hospital death. According to the binary logistic regression analysis Age (OR, 1.72; 95% CI: 1.26-2.18; P = 0.033), Coronavirus infection (OR, 2.21; 95% CI: 1.83-2.92; P = 0.011) and Glasgow Coma Scale (GCS) (OR, 3.11; 95% CI: 2.12-4.53; P < 0.001) were independent risk factors correlated with increased risk of in-hospital mortality of elderly patients with moderate to severe TBI. Conclusion: Our results showed that Coronavirus infection could increase the risk of in-hospital mortality of elderly patients with moderate to severe TBI significantly. (c) 2021 Elsevier Ltd. All rights reserved.	[Bagheri, Seyed Reza; Alimohammadi, Ehsan] Kermanshah Univ Med Sci, Dept Neurosurg, Kermanshah, Iran; [Abdi, Alireza] Kermanshah Univ Med Sci, Imam Reza Hosp, Nursing & Midwifery Sch, Kermanshah, Iran; [Benson, Joseph] Meharry Med Coll, Nashville, TN USA; [Naghdi, Negin] Kermanshah Univ Med Sci, Taleghani & Imam Ali Hosp, Clin Res Dev Ctr, Kermanshah, Iran; [Eden, Sonia, V] Wayne State Univ, Sch Med, Detroit, MI USA; [Arjmand, Minoo] Kermanshah Univ Med Sci, Taleghani Hosp, Kermanshah, Iran; [Amini, Zahra] Kermanshah Univ Med Sci, Imam Reza Hosp, Kermanshah, Iran; [Lawton, Michael T.] St Josephs Hosp, Dept Neurol Surg, Barrow Neurol Inst, Phoenix, AZ USA		Alimohammadi, E (corresponding author), Kermanshah Univ Med Sci, Dept Neurosurg, Kermanshah, Iran.	bjoseph19@email.mmc.edu; seden@dmc.org; michael.lawton@barrowbrainandspine.com; ehsan.alimohammadi@kums.ac.ir					Ahmad I, 2020, J CLIN NEUROSCI, V77, P8, DOI 10.1016/j.jocn.2020.05.017; Albitar O, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108293; Alimohammadi E, 2021, BR J NEUROSURG, V2019, P1; Avula A, 2020, BRAIN BEHAV IMMUN, V87, P115, DOI 10.1016/j.bbi.2020.04.077; Batey M, 2018, SURGERY, V164, P814, DOI 10.1016/j.surg.2018.05.060; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Charry JD, 2017, J NEUROSCI RURAL PRA, V8, P23, DOI 10.4103/jnrp.jnrp_434_16; Chen RC, 2020, J ALLERGY CLIN IMMUN, V146, P89, DOI 10.1016/j.jaci.2020.05.003; Doperalski AE, 2011, J NEUROTRAUM, V28, P1983, DOI 10.1089/neu.2010.1457; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Gao L, 2020, J NEUROTRAUM, V37, P1011, DOI 10.1089/neu.2019.6631; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Hanidziar D, 2020, ANESTH ANALG, V131, pE40, DOI 10.1213/ANE.0000000000004887; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kamal VK, 2016, J NEUROSCI RURAL PRA, V7, P515, DOI 10.4103/0976-3147.188637; Kang SJ, 2020, INFECT CHEMOTHER, V52, P154, DOI 10.3947/ic.2020.52.2.154; Karimii Z, 2020, RISK MANAG HEALTHC P, V13, P1271, DOI 10.2147/RMHP.S258785; Koudelka M, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57060633; Krishnamoorthy V, 2018, CRIT CARE MED, V46, P965, DOI 10.1097/CCM.0000000000003052; Lawton MT, 2021, BMC NEUROL, V21, DOI 10.1186/s12883-021-02109-8; Lenell S, 2019, ACTA NEUROCHIR, V161, P1243, DOI 10.1007/s00701-019-03893-6; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maben J, 2020, J CLIN NURS, V29, P2742, DOI 10.1111/jocn.15307; Mahat RK, 2021, CLIN EPIDEMIOL GLOB, V11, DOI 10.1016/j.cegh.2021.100727; Matsuo K, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6276; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; McNett MM, 2010, J NEUROSCI NURS, V42, P71, DOI 10.1097/JNN.0b013e3181ce5b8a; Muhammad S, 2020, BRAIN BEHAV IMMUN, V87, P150, DOI 10.1016/j.bbi.2020.05.015; Muhammad S, 2011, STROKE, V42, P783, DOI 10.1161/STROKEAHA.110.596783; Nizetic S, 2020, INT J ENERG RES, V44, P10953, DOI 10.1002/er.5706; Ostermann RC, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0975-y; Prexl O, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0487-0; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Rau Cheng-Shyuan, 2018, PLoS One, V13, pe0207192, DOI 10.1371/journal.pone.0207192; Rimaz Siamak, 2019, Anesth Pain Med, V9, pe90858, DOI 10.5812/aapm.90858; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Sadati AK, 2021, NURS OPEN, V8, P72, DOI 10.1002/nop2.604; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Smith Karen, 2012, JBI Libr Syst Rev, V10, P4610; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Taherifard E, 2020, NEUROL RES, V42, P905, DOI 10.1080/01616412.2020.1796405; Turale S, 2020, INT NURS REV, V67, P164, DOI 10.1111/inr.12598; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5	44	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2021	93						241	246		10.1016/j.jocn.2021.09.029			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WC7EP	WOS:000704417600039	34656255	Green Published, Bronze			2022-02-06	
J	Balasubramanian, N; Jadhav, G; Sakharkar, AJ				Balasubramanian, Nagalakshmi; Jadhav, Gouri; Sakharkar, Amul J.			Repeated mild traumatic brain injuries perturb the mitochondrial biogenesis via DNA methylation in the hippocampus of rat	MITOCHONDRION			English	Article						Mild traumatic brain injury; Mitochondrial biogenesis; Mitochondrial transcription factor A; DNA methylation; Heavy strand promoter; mitochondrial DNA	HEAVY-STRAND PROMOTER; TRANSCRIPTION-FACTOR; IMPROVES MEMORY; MTDNA; METABOLISM; MAINTENANCE; DYSFUNCTION; MECHANISMS; RECOVERY; NUCLEAR	Mitochondrial biogenesis in the brain is impaired in various neurological disorders including traumatic brain injury (TBI). The long-lasting effects of TBI may be, in part, attributed to epigenetic mechanisms such as DNA methylation. However, the role of DNA methylation on regulatory elements of nuclear and mitochondrial genome in mitochondrial biogenesis is not known. We examined the epigenetic regulation of mitochondrial transcription factor A (TFAM), and further probed its implications in mitochondrial dysfunction in the hippo campus of rats subjected to repeated mild TBI (rMTBI) using weight drop injury paradigm. rMTBI-induced hypermethylation at TFAM promoter resulted in deficits in its protein levels in mitochondria after immediate (48 h) and protracted (30 d) time points. Further, rMTBI also caused hypomethylation of mitochondrial DNA (mtDNA) promoters (HSP1 and HSP2), which further culminated into low binding of TFAM. rMTBI-induced changes weakened mitochondrial biogenesis in terms of reduced mtDNA-encoded rRNA, mRNA, and protein levels leading to shortages of ATP. To verify the potential role of mtDNA methylation in rMTBI-induced persistent mitochondrial dysfunction, rMTBI-induced rats were treated with methionine, a methyl donor. Methionine treatment restored the methylation levels on HSP1 and HSP2 resulting in efficient binding of TFAM and normalized the rRNA, mRNA, and protein levels. These findings suggest the crucial role of DNA methylation at nuclear and mitochondrial promoter regions in mitochondrial gene expression and ATP activity in the hippocampus after rMTBI.	[Balasubramanian, Nagalakshmi; Jadhav, Gouri; Sakharkar, Amul J.] Savitribai Phule Pune Univ, Dept Biotechnol, Pune 411007, Maharashtra, India		Sakharkar, AJ (corresponding author), Savitribai Phule Pune Univ, Dept Biotechnol, Pune 411007, Maharashtra, India.	amul.sakharkar@unipune.ac.in			University Grants Commission, Government of India (UGC, GOI) [F.4-5/151-FRP/2014/BSR]; Science and Engineering Research Board (SERB, GOI) [EMR/2017/000621]; Council for Scientific and Industrial Research (CSIR, GOI) [37[1718]/18/EMR-II]; Rashtriya Uchchatar Shiksha Abhiyan, Savitribai Phule Pune University (RUSA, GOI); UGC, GOIUniversity Grants Commission, India [2061330923, 805/CSIR-UGC NET JUNE 2018]	This work was supported by the grants from the University Grants Commission, Government of India (UGC, GOI; F.4-5/151-FRP/2014/BSR) ; Science and Engineering Research Board (SERB, GOI; EMR/2017/000621) ; Council for Scientific and Industrial Research (CSIR, GOI; 37 [1718] /18/EMR-II) and Rashtriya Uchchatar Shiksha Abhiyan, Savitribai Phule Pune University (RUSA, GOI) to AJS. NB thanks UGC, GOI for the award of Senior Research Fellowship (UGC-SRF, File No. 2061330923) . GJ thanks UGC, GOI for the award of Senior Research Fellowship (UGC-SRF, Ref No. 805/CSIR-UGC NET JUNE 2018) .	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Agrawal R, 2014, BBA-MOL BASIS DIS, V1842, P535, DOI 10.1016/j.bbadis.2013.12.004; Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Balasubramanian N, 2021, NEUROENDOCRINOLOGY, V111, P1187, DOI 10.1159/000513638; Balasubramanian N, 2021, MOL NEUROBIOL, V58, P1162, DOI 10.1007/s12035-020-02166-z; Balasubramanian N, 2020, NEUROSCI RES, V155, P34, DOI 10.1016/j.neures.2019.06.003; Bellizzi D, 2013, DNA RES, V20, P537, DOI 10.1093/dnares/dst029; Blanch M, 2016, AM J PATHOL, V186, P385, DOI 10.1016/j.ajpath.2015.10.004; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Choi YS, 2004, BIOCHEM BIOPH RES CO, V314, P118, DOI 10.1016/j.bbrc.2003.12.065; Cole WR., 2016, TRANSLATIONAL RES TR, DOI DOI 10.1201/B18959-20; Coppede F, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00086; D'Souza AR, 2018, ESSAYS BIOCHEM, V62, P309, DOI 10.1042/EBC20170102; Dimauro Ivan, 1800, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Dominy JE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015008; Dostal V, 2019, BBA-GENE REGUL MECH, V1862, P598, DOI 10.1016/j.bbagrm.2019.01.006; EHAMA R, 1993, B CHEM SOC JPN, V66, P814, DOI 10.1246/bcsj.66.814; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Grandhi R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120160; Grunewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Harmon JL, 2017, J NEUROTRAUM, V34, P487, DOI 10.1089/neu.2015.4395; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Infantino V, 2011, MOL GENET METAB, V102, P378, DOI 10.1016/j.ymgme.2010.11.166; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Pirola CJ, 2013, GUT, V62, P1356, DOI 10.1136/gutjnl-2012-302962; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kapogiannis D, 2011, LANCET NEUROL, V10, P187, DOI 10.1016/S1474-4422(10)70277-5; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Leary SC, 1998, BBA-BIOENERGETICS, V1365, P522, DOI 10.1016/S0005-2728(98)00105-4; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lodeiro MF, 2012, P NATL ACAD SCI USA, V109, P6513, DOI 10.1073/pnas.1118710109; Lu HY, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00085; Lunnon K, 2017, NEUROBIOL AGING, V53, P36, DOI 10.1016/j.neurobiolaging.2016.12.029; Mishra M, 2015, INVEST OPHTH VIS SCI, V56, P5133, DOI 10.1167/iovs.15-16937; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Nagalakshmi B, 2018, PROG MOL BIOL TRANSL, V157, P263, DOI 10.1016/bs.pmbts.2017.12.013; Parrish RR, 2015, ANN CLIN TRANSL NEUR, V2, P401, DOI 10.1002/acn3.183; Pedros I, 2014, BBA-MOL BASIS DIS, V1842, P1556, DOI 10.1016/j.bbadis.2014.05.025; Petrov D, 2016, MOL NEUROBIOL, V53, P6183, DOI 10.1007/s12035-015-9522-6; Riba A, 2019, P NATL ACAD SCI USA, V116, P15023, DOI 10.1073/pnas.1817299116; Sagarkar S, 2021, PROG NEUROBIOL, V202, DOI 10.1016/j.pneurobio.2021.102048; Sagarkar S, 2019, BRAIN RES, V1711, P183, DOI 10.1016/j.brainres.2019.01.022; Sagarkar S, 2017, NEUROBIOL DIS, V106, P101, DOI 10.1016/j.nbd.2017.06.016; Saha P, 2018, NEUROBIOL DIS, V118, P108, DOI 10.1016/j.nbd.2018.07.010; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; SOWERS LC, 1987, BIOCHEM BIOPH RES CO, V148, P790, DOI 10.1016/0006-291X(87)90945-4; Sun X, 2018, NUCLEIC ACIDS RES, V46, P5977, DOI 10.1093/nar/gky339; Tewari S, 2012, INVEST OPHTH VIS SCI, V53, P4881, DOI 10.1167/iovs.12-9732; Thomas RR, 2012, AGING-US, V4, P620, DOI 10.18632/aging.100488; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wen KX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167201; Wong VS, 2016, NEUROSCI LETT, V625, P26, DOI 10.1016/j.neulet.2016.04.009; Yamada H, 2019, FASEB J, V33, P11431, DOI 10.1096/fj.201901072R; Zhang L, 2019, J CELL MOL MED, V23, P2995, DOI 10.1111/jcmm.14206; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhao RZ, 2019, INT J MOL MED, V44, P3, DOI 10.3892/ijmm.2019.4188; Zhu H, 2016, NAT REV GENET, V17, P551, DOI 10.1038/nrg.2016.83; Zollo O, 2012, P NATL ACAD SCI USA, V109, P6508, DOI 10.1073/pnas.1118594109	74	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1567-7249	1872-8278		MITOCHONDRION	Mitochondrion	NOV	2021	61						11	24		10.1016/j.mito.2021.09.001			14	Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Genetics & Heredity	WC9QP	WOS:000704585100002	34508891				2022-02-06	
J	Batson, C; Froese, L; Gomez, A; Sainbhi, AS; Stein, KY; Alizadeh, A; Zeiler, FA				Batson, Carleen; Froese, Logan; Gomez, Alwyn; Sainbhi, Amanjyot Singh; Stein, Kevin Y.; Alizadeh, Arsalan; Zeiler, Frederick A.			Impact of Age and Biological Sex on Cerebrovascular Reactivity in Adult Moderate/Severe Traumatic Brain Injury: An Exploratory Analysis	NEUROTRAUMA REPORTS			English	Article						aging; biological sex; cerebrovascular reactivity; signal processing; TBI	NEUROTRAUMA EFFECTIVENESS RESEARCH; INTRACRANIAL-PRESSURE; CENTER-TBI; MANAGEMENT; CARE; AUTOREGULATION	Age and biological sex are two potential important modifiers of cerebrovascular reactivity post-traumatic brain injury (TBI) requiring close evaluation for potential subgroup responses. The goal of this study was to provide a preliminary exploratory analysis of the impact of age and biological sex on measures of cerebrovascular function in moderate/severe TBI. Forty-nine patients from the prospectively maintained TBI database at the University of Manitoba with archived high-frequency digital cerebral physiology were evaluated. Cerebrovascular reactivity indices were derived as follows: PRx (correlation between intracranial pressure [ICP] and mean arterial pressure [MAP]), PAx (correlation between pulse amplitude of ICP [AMP] and MAP), and RAC (correlation between AMP and cerebral perfusion pressure [CPP]). Time above clinically significant thresholds for each index was calculated over different periods of the acute intensive care unit stay. The association between PRx, PAx, and RAC measures with age was assessed using linear regression, and an age trichotomization scheme (<40, 40-60, >60) using Kruskal-Wallis testing. Similarly, association with biological sex was tested using Mann-Whitney U testing. Biological sex did not demonstrate an impact on any measures of cerebrovascular reactivity. Linear regression between age and PAx and RAC demonstrated a statistically significant positive linear relationship. Median PAx and RAC measures between trichotomized age categories demonstrated statistically significant increases with advancing age. The PRx failed to demonstrate any statistically significant relationship with age in this cohort, suggesting that in elderly patients with controlled ICP, PAx and RAC may be better metrics for detecting impaired cerebrovascular reactivity. Biological sex appears to not be associated with differences in cerebrovascular reactivity in this cohort. The PRx performed the worst in detecting impaired cerebrovascular reactivity in those with advanced age, where PAx and RAC appear to have excelled. Future work is required to validate these findings and explore the utility of different cerebrovascular reactivity indices.</p>	[Batson, Carleen; Gomez, Alwyn; Zeiler, Frederick A.] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Froese, Logan; Sainbhi, Amanjyot Singh] Univ Manitoba, Sect Neurosurg, Dept Surg, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Gomez, Alwyn; Stein, Kevin Y.; Alizadeh, Arsalan; Zeiler, Frederick A.] Univ Manitoba, Biomed Engn, Fac Engn, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Dept Med, Cambridge, England		Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada.	Frederick.Zeiler@umanitoba.ca		Sainbhi, Amanjyot Singh/0000-0003-3231-5683; Zeiler, Frederick/0000-0003-1737-0510	Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment; Health Sciences Centre Foundation Winnipeg, the United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS) [R03NS114335-01]; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [432061]; Canada Foundation for Innovation (CFI)Canada Foundation for Innovation [38583]; Research Manitoba [3906]; University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Rudy Falk Clinician-Scientist Professorship; University of Manitoba Clinician Investigator Program; University of ManitobaDepartment of Surgery GFT Research Grant; University of Manitoba Office of Research Services (ORS)University Research Grant Program (URGP); Centre on Aging at the University of Manitoba	Acknowledgments F.A.Z. receives research support from the Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment, the Health Sciences Centre Foundation Winnipeg, the United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS)(Grant #: R03NS114335-01), the Canadian Institutes of Health Research (CIHR)(Grant #: 432061), the Canada Foundation for Innovation (CFI)(Project #: 38583), Research Manitoba (Grant #: 3906), the University of Manitoba VPRI Research Investment Fund (RIF), the University of Manitoba Centre on Aging, and the University of Manitoba Rudy Falk Clinician-Scientist Professorship. A.G. is supported through the University of Manitoba Clinician Investigator Program. A.S.S. is supported through the University of Manitoba & ndash;Department of Surgery GFT Research Grant. L.F. is supported through the University of Manitoba & ndash;Department of Surgery GFT Research Grant and the University of Manitoba Office of Research Services (ORS)& ndash;University Research Grant Program (URGP). C.B. is supported through the Centre on Aging at the University of Manitoba.	Abdelmalik PA, 2019, TRANSFUSION, V59, P1529, DOI 10.1111/trf.15171; Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Akerlund CA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243427; [Anonymous], 2021, R PROJECT STAT COMPU; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Bennis FC, 2020, NEUROCRIT CARE, V33, P542, DOI 10.1007/s12028-020-00930-6; Bernard F, 2020, CAN J NEUROL SCI, V47, P551, DOI 10.1017/cjn.2020.54; BRICOLO A, 1977, J NEUROSURG, V47, P680, DOI 10.3171/jns.1977.47.5.0680; Cabella B, 2017, NEUROCRIT CARE, V27, P103, DOI 10.1007/s12028-016-0319-x; Calviello Leanne Alexis, 2021, Acta Neurochir Suppl, V131, P43, DOI 10.1007/978-3-030-59436-7_10; Cardoso AL, 2018, AGEING RES REV, V47, P214, DOI 10.1016/j.arr.2018.07.004; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2008, ACTA NEUROCHIR SUPPL, V102, P25, DOI 10.1007/978-3-211-85578-2_5; Deer RR, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/s13293-014-0012-8; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; Dijkland SA, 2021, J NEUROTRAUM, V38, P1377, DOI 10.1089/neu.2020.7300; Donnelly J, 2020, NEUROCRIT CARE, V32, P437, DOI 10.1007/s12028-019-00748-x; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Froese L, 2020, NEUROTRAUMA REP, V1, P157, DOI 10.1089/neur.2020.0028; Froese L, 2020, ACTA NEUROCHIR, V162, P2683, DOI 10.1007/s00701-020-04579-0; Froese L, 2021, NEUROCRIT CARE, V34, P325, DOI 10.1007/s12028-020-01003-4; Gomez A, 2021, CURR NEUROL NEUROSCI, V21, DOI 10.1007/s11910-021-01106-1; Hasen M, 2020, ACTA NEUROCHIR, V162, P1647, DOI 10.1007/s00701-020-04378-7; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jain V, 2019, INDIAN J CRIT CARE M, V23, pS136, DOI 10.5005/jp-journals-10071-23191; Kayhanian S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39848-1; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; LASSEN NA, 1971, ACTA ANAESTH SCAND, P78; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mikolic A, 2021, J NEUROTRAUM, V38, P235, DOI 10.1089/neu.2020.7228; Qi XM, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0091-7; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stovell MG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00426; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; University of Cambridge . ICM+, 2021, CAMBR ENT ICM; van Dijck JTJM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216743; Young AMH, 2018, ACTA NEUROCHIR SUPPL, V126, P7, DOI 10.1007/978-3-319-65798-1_2; Young AMH, 2018, ACTA NEUROCHIR SUPPL, V126, P29, DOI 10.1007/978-3-319-65798-1_7; Young AMH, 2018, PEDIATR RES, V83, P41, DOI 10.1038/pr.2017.215; Zeiler FA, 2018, NEUROCRIT CARE, V28, P194, DOI 10.1007/s12028-017-0472-x; Zeiler FA, 2021, J NEUROTRAUM, V38, P870, DOI 10.1089/neu.2020.7304; Zeiler FA, 2020, ACTA NEUROCHIR, V162, P2695, DOI 10.1007/s00701-020-04485-5; Zeiler FA, 2021, J NEUROTRAUM, V38, P272, DOI 10.1089/neu.2020.7249; Zeiler FA, 2020, J NEUROTRAUM, V37, P1597, DOI 10.1089/neu.2019.6959; Zeiler FA, 2020, J NEUROTRAUM, V37, P1233, DOI 10.1089/neu.2019.6808; Zeiler FA, 2018, J NEUROTRAUM, V35, P963, DOI 10.1089/neu.2017.5241; Zeiler FA, 2019, J NEUROTRAUM, V36, P1505, DOI 10.1089/neu.2018.6182; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1955, DOI 10.1007/s00701-019-03980-8; Zeiler FA, 2021, J NEUROSURG ANESTH, V33, P28, DOI 10.1097/ANA.0000000000000616; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1275, DOI 10.1007/s00701-019-03915-3; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1; Zeiler FA, 2019, NAT REV NEUROL, V15, P25, DOI 10.1038/s41582-018-0105-9; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2018, J NEUROTRAUM, V35, P1569, DOI 10.1089/neu.2017.5595; Zeiler FA, 2017, J NEUROTRAUM, V34, P3070, DOI 10.1089/neu.2017.5129	66	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	NOV 1	2021	00	00					488	501		10.1089/neur.2021.0039			14	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WW1JL	WOS:000717681700001	34901944	gold, Green Published			2022-02-06	
J	Bernstein, JPK; Sevigny, M; Novack, TA; Dreer, LE; Chung, J; Lamberty, GJ; Finn, JA				Bernstein, John P. K.; Sevigny, Mitch; Novack, Thomas A.; Dreer, Laura E.; Chung, Joyce; Lamberty, Greg J.; Finn, Jacob A.			Predictors of Driving Status in Service Members and Veterans at 1 Year Posttraumatic Brain Injury: A VA TBI Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						driving; PTSD; rehabilitation; traumatic brain injury; VA TBI Model Systems; veterans	MOTOR-VEHICLE CRASHES; STRESS-DISORDER; AFGHANISTAN; PERFORMANCE; RETURN; MILD; IRAQ; REHABILITATION; PREVALENCE; COMPLAINTS	Objective: To identify predictors of driving status in service members and veterans 1 year following a traumatic brain injury (TBI). Setting: The 5 Department of Veterans Affairs (VA) Polytrauma Rehabilitation Centers (PRCs). Participants: A total of 471 service members and veterans (128 with mild/complicated mild TBI and 343 with moderate/severe TBI) who received TBI-focused inpatient rehabilitation at one of the VA PRCs and who participated in a 1-year postinjury follow-up assessment. Design: Secondary analysis from the Department of Veterans Affairs Polytrauma Rehabilitation Centers Traumatic Brain Injury Model Systems (VA PRC TBIMS) national database. Main Measures: Primary outcome was a single item that assessed driving status at 1 year postinjury. Predictor variables included demographics; sensory impairment, substance use, and employment status at time of injury; PTSD symptoms reported at study enrollment; and functional impairment rated at rehabilitation discharge. Results: In unadjusted bivariate analyses, among those with a mild/complicated mild TBI, older age and greater functional impairment were associated with lower likelihood of driving. Among those with a moderate/severe TBI, discharge to a nonprivate residence, greater functional impairment, and higher PTSD symptoms were linked to lower likelihood of driving. Adjusted multivariate analyses indicated that functional impairment was uniquely associated with driving status in both TBI severity groups. After controlling for other predictors, self-reported PTSD symptoms, particularly dysphoria symptoms, were associated with lower likelihood of driving in both severity groups. Conclusion: Given the significance of clinician-rated functional impairment and self-reported PTSD symptoms to the prediction of driving status 1 year post-TBI among service members and veterans, rehabilitation efforts to improve functioning and reduce negative affect may have a positive impact on driving and community integration.	[Bernstein, John P. K.] Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA; [Bernstein, John P. K.; Lamberty, Greg J.] Minneapolis Vet Affairs Hlth Care Syst, Mental Hlth Serv Line, Minneapolis, MN USA; [Finn, Jacob A.] Minneapolis Vet Affairs Hlth Care Syst, Extended Care & Rehabil, One Vet Dr, Minneapolis, MN 55417 USA; [Sevigny, Mitch] Craig Hosp, TBI Model Syst Natl Data & Stat Ctr, Englewood, CO USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Sch Med, Birmingham, AL USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol & Visual Sci, Sch Med, Birmingham, AL USA; [Chung, Joyce] Vet Affairs Palo Alto Hlth Care Syst, Polytrauma Syst Care & Rehabil Serv, Palo Alto, CA USA; [Finn, Jacob A.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA		Finn, JA (corresponding author), Minneapolis Vet Affairs Hlth Care Syst, Extended Care & Rehabil, One Vet Dr, Minneapolis, MN 55417 USA.	Jacob.Finn@va.gov			Department of Veterans Affairs (National Institute on Disability, Independent Living, and Rehabilitation Research)US Department of Veterans Affairs; Department of Health & Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research); VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center (DVBIC) within the Defense Health Agency (DHA) [W91YTZ-13-C-0015]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DPTB0015]	The Veterans Affairs Polytrauma Rehabilitation Center Traumatic Brain Injury Model System (VA PRC TBIMS) is a funded collaboration between the Department of Veterans Affairs and the Department of Health & Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research). This research is sponsored by VHA Central Office VA TBI Model System Program of Research and a subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center (DVBIC) within the Defense Health Agency (DHA). The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an officialDepartment ofVeterans Affairs or Department of Defense position or any other federal agency, policy, or decision unless so designated by other official documentation.; The content of this article also was developed under grant support from the National Institute on Disability, Independent Living, and Rehabilitation Research (90DPTB0015: Novack and Dreer). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health& Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, and HHS, and you should not assume endorsement by the Federal Government.	American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU DIAGNOSTIC STAT MANU; Amick MM, 2013, J REHABIL RES DEV, V50, P463, DOI 10.1682/JRRD.2012.06.0108; [Anonymous], 1997, GUID UN DAT SET MED; [Anonymous], 2014, VERS 9 4; Baker A, 2015, BRIT J OCCUP THER, V78, P73, DOI 10.1177/0308022614562405; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bernstein JPK, 2018, PM&R, V10, P1153, DOI 10.1016/j.pmrj.2018.05.008; Carlson KF, 2016, NEUROREHABILITATION, V39, P351, DOI 10.3233/NRE-161367; Classen S, 2011, AM J OCCUP THER, V65, P419, DOI 10.5014/ajot.2011.000893; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Cullen N, 2014, BRAIN INJURY, V28, P189, DOI 10.3109/02699052.2013.862738; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS23, DOI 10.1016/j.apmr.2017.05.012; Galatzer-Levy IR, 2013, PERSPECT PSYCHOL SCI, V8, P651, DOI 10.1177/1745691613504115; Hannold EM, 2013, J REHABIL RES DEV, V50, P1315, DOI 10.1682/JRRD.2013.04.0084; Hart T, 2019, REHABIL PSYCHOL, V64, P435, DOI 10.1037/rep0000290; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; JOHNSTON MV, 1991, AM J PHYS MED REHAB, V70, P40, DOI 10.1097/00002060-199102000-00008; Juengst SB, 2017, PSYCHOL RES BEHAV MA, V10, P175, DOI 10.2147/PRBM.S113264; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Lincoln Andrew E, 2006, Traffic Inj Prev, V7, P31, DOI 10.1080/15389580500412028; McGarity S, 2017, J HEAD TRAUMA REHAB, V32, P34, DOI 10.1097/HTR.0000000000000242; McKay A, 2016, J HEAD TRAUMA REHAB, V31, pE44, DOI 10.1097/HTR.0000000000000209; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Ramanathan-Elion DM, 2020, BRAIN INJURY, V34, P1183, DOI 10.1080/02699052.2020.1793387; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Ross PE, 2015, ARCH PHYS MED REHAB, V96, P440, DOI 10.1016/j.apmr.2014.09.027; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Simms LJ, 2002, J ABNORM PSYCHOL, V111, P637, DOI 10.1037//0021-843X.111.4.637; Stolwyk RJ, 2019, DISABIL REHABIL, V41, P1313, DOI 10.1080/09638288.2018.1424955; Strypstein E., 2001, EUR J PHYS REHAB MED, V37, P227; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tessier Jillian M, 2017, Fed Pract, V34, P20; Van Voorhees EE, 2018, REHABIL PSYCHOL, V63, P160, DOI 10.1037/rep0000178; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Winter L, 2017, PM&R, V9, P901, DOI 10.1016/j.pmrj.2017.01.007; Woodall KA, 2014, AM J PREV MED, V46, P350, DOI 10.1016/j.amepre.2013.11.015	43	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2021	36	6			SI		437	446		10.1097/HTR.0000000000000668			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WV3QT	WOS:000717155100011	33741826				2022-02-06	
J	Bertelli, JA; Patel, N; Soldado, F; Duarte, ECW				Bertelli, Jayme A.; Patel, Neehar; Soldado, Francisco; Winkelmann Duarte, Elisa Cristiana			Patterns of median nerve branching in the cubital fossa: implications for nerve transfers to restore motor function in a paralyzed upper limb	JOURNAL OF NEUROSURGERY			English	Article						nerve grafting; median nerve paralysis; nerve transfer; brachial plexus; tetraplegia; peripheral nerve; anatomy	ANTERIOR INTEROSSEOUS NERVE; FLEXOR DIGITORUM SUPERFICIALIS; WRIST EXTENSION RECONSTRUCTION; CARPI RADIALIS BREVIS; BRACHIAL-PLEXUS; PRONATOR TERES; FINGER FLEXION; INJURY; FOREARM; MUSCLE	OBJECTIVE The purpose of this study was to describe the anatomy of donor and recipient median nerve motor branches for nerve transfer surgery within the cubital fossa. METHODS Bilateral upper limbs of 10 fresh cadavers were dissected after dyed latex was injected into the axillary artery. RESULTS In the cubital fossa, the first branch was always the proximal branch of the pronator teres (PPT), whereas the last one was the anterior interosseous nerve (AIN) and the distal motor branch of the flexor digitorum superficialis (DFDS) on a consistent basis. The PT muscle was also innervated by a distal branch (DPT), which emerged from the anterior side of the median nerve and provided innervation to its deep head. The palmaris longus (PL) motor branch was always the second branch after the PPT, emerging as a single branch together with the flexor carpi radialis (FCR) or the proximal branch of the flexor digitorum superficialis. The FCR motor branch was prone to variations. It originated proximally with the PL branch (35%) or distally with the AIN (35%), and less frequently from the DPT. In 40% of dissections, the FDS was innervated by a single branch (i.e., the DFDS) originating close to the AIN. In 60% of cases, a proximal branch originated together with the PL or FCR. The AIN emerged from the posterior side of the median nerve and had a diameter of 2.3 mm, twice that of other branches. When dissections were performed between the PT and FCR muscles at the FDS arcade, we observed the AIN lying lateral and the DFDS medial to the median nerve. After crossing the FDS arcade, the AIN divided into: 1) a lateral branch to the flexor pollicis longus (FPL), which bifurcated to reach the anterior and posterior surfaces of the FPL; 2) a medial branch, which bifurcated to reach the flexor digitorum profundus (FDP); and 3) a long middle branch to the pronator quadratus. The average numbers of myelinated fibers within each median nerve branch were as follows (values expressed as the mean +/- SD): PPT 646 +/- 249; DPT 599 +/- 150; PL 259 +/- 105; FCR 541 +/- 199; proximal FDS 435 +/- 158; DFDS 376 +/- 150; FPL 480 +/- 309; first branch to the FDP 397 +/- 12; and second branch to the FDP 369 +/- 33. CONCLUSIONS The median nerve's branching pattern in the cubital fossa is predictable. The most important variation involves the FCR motor branch. These anatomical findings aid during nerve transfer surgery to restore function when paralysis results from injury to the radial or median nerves, brachial plexus, or spinal cord.	[Bertelli, Jayme A.] Univ South Santa Catarina Unisul, Ctr Biol & Hlth Sci, Dept Neurosurg, Tubarao, SC, Brazil; [Bertelli, Jayme A.] Governador Celso Ramos Hosp, Dept Orthoped Surg, Florianopolis, SC, Brazil; [Patel, Neehar] Bombay Hosp Inst Med Sci, Dept Plast Surg, Mumbai, Maharashtra, India; [Soldado, Francisco] Barcelona Univ Childrens Hosp HM Nens, HM Hospitales, Pediat Hand Surg & Microsurg Unit, Barcelona, Spain; [Soldado, Francisco] Pediat Hand Surg & Microsurg Unit, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain; [Winkelmann Duarte, Elisa Cristiana] Univ Fed Santa Catarina, Dept Anat, Florianopolis, SC, Brazil		Bertelli, JA (corresponding author), Governador Celso Ramos Hosp, Florianopolis, SC, Brazil.	drbertelli@gmail.com					Bertelli JA, 2021, J NEUROSURG, V134, P251, DOI DOI 10.3171/2019.10.JNS192110.; Bertelli JA, 2017, J NEUROSURG-SPINE, V26, P55, DOI 10.3171/2016.5.SPINE151544; Bertelli JA, 2012, PLAST RECONSTR SURG, V130, P1269, DOI 10.1097/PRS.0b013e31826d16cf; Bertelli JA, 2010, J NEUROSURG, V113, P153, DOI 10.3171/2010.3.JNS10306; Bertelli JA, 2020, J HAND SURG-AM, V45, P418, DOI 10.1016/j.jhsa.2019.12.009; Bertelli JA, 2015, J HAND SURG-AM, V40, P323, DOI 10.1016/j.jhsa.2014.10.060; Bertelli JA, 2013, MICROSURG, V33, P39, DOI 10.1002/micr.22027; Bertelli JA, 2012, NEUROSURGERY, V70, P1011, DOI 10.1227/NEU.0b013e3182367642; Bertelli JA, 2020, J HAND SURG-AM, V45, DOI 10.1016/j.jhsa.2020.02.011; Brown JM, 2010, NEUROSURGERY, V66, P75, DOI 10.1227/01.NEU.0000354364.13224.C8; Caetano EB, 2019, EINSTEIN-SAO PAULO, V17, DOI [10.31744/einstein_journal/2019AO4489, 10.31744/einstein_journal/2019ao4489]; Caetano EB, 2018, ACTA ORTOP BRAS, V26, P222, DOI 10.1590/1413-785220182604191853; Chantelot C, 1999, SURG RADIOL ANAT, V21, P165, DOI 10.1007/BF01630894; Davidge KM, 2013, J HAND SURG-AM, V38A, P1812, DOI 10.1016/j.jhsa.2013.06.024; Emamhadi M, 2018, ACTA NEUROCHIR, V160, P2219, DOI 10.1007/s00701-018-3671-0; Emamhadi M, 2018, WORLD NEUROSURG, V109, P351, DOI 10.1016/j.wneu.2017.10.033; Garcia-Lopez A, 2014, J HAND SURG-AM, V39, P50, DOI 10.1016/j.jhsa.2013.10.011; Garcia-Lopez A, 2011, J HAND SURG-AM, V36A, P394, DOI 10.1016/j.jhsa.2010.11.030; GUNTHER SF, 1992, J HAND SURG-AM, V17A, P648, DOI 10.1016/0363-5023(92)90310-L; Hsiao Eugene C, 2009, Hand (N Y), V4, P92, DOI 10.1007/s11552-008-9128-9; Larson EL, 2019, J NEUROSURG-PEDIATR, V24, P209, DOI 10.3171/2019.3.PEDS18550; Li Zhongyu, 2016, J Hand Surg Am, V41, pe15, DOI 10.1016/j.jhsa.2015.12.023; Maarrawi J, 2006, J NEUROSURG, V104, P215, DOI 10.3171/jns.2006.104.2.215; Moore AM, 2014, PLAST RECONSTR SURG, V134, P721, DOI 10.1097/PRS.0000000000000509; Murphy RKJ, 2012, J NEUROSURG, V117, P886, DOI 10.3171/2012.8.JNS111356; Palazzi S, 2006, MICROSURG, V26, P330, DOI 10.1002/micr.20247; Parot C, 2016, SURG RADIOL ANAT, V38, P597, DOI 10.1007/s00276-015-1593-6; Ray Wilson Z, 2012, J Neurosurg, V117, P604, DOI 10.3171/2012.6.JNS111332; Ray WZ, 2016, NEUROSURGERY, V78, P1, DOI 10.1227/NEU.0000000000001029; Ray WZ, 2011, J HAND SURG-AM, V36A, P201, DOI 10.1016/j.jhsa.2010.09.034; Sallam Asser A, 2016, HSS J, V12, P2, DOI 10.1007/s11420-015-9459-3; Sananpanich K, 2018, J HAND SURG-AM, V43, P920, DOI 10.1016/j.jhsa.2018.07.013; Soldado F, 2020, MICROSURG, V40, P696, DOI 10.1002/micr.30577; Soldado F, 2016, HAND CLIN, V32, P209, DOI 10.1016/j.hcl.2015.12.008; Tubbs RS, 2006, J NEUROSURG, V104, P787, DOI 10.3171/jns.2006.104.5.787; Tung THH, 2001, J HAND SURG-AM, V26A, P1065, DOI 10.1053/jhsu.2001.28427; Ukrit A, 2009, J HAND SURG-AM, V34A, P1659, DOI 10.1016/j.jhsa.2009.07.004; Unver Dogan N, 2010, SURG RADIOL ANAT, V32, P225, DOI 10.1007/s00276-009-0580-1; van Zyl N, 2014, J HAND SURG-AM, V39, P1779, DOI 10.1016/j.jhsa.2014.06.017; Yang FJ, 2016, AM J TRANSL RES, V8, P5485; Yang JY, 2014, NEUROSURGERY, V75, P375, DOI 10.1227/NEU.0000000000000435; Zheng XY, 2008, CHINESE MED J-PEKING, V121, P99, DOI 10.1097/00029330-200801020-00001	42	0	0	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2021	135	5					1524	1533		10.3171/2020.9.JNS202742			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WS1ZI	WOS:000714987200003	33740763				2022-02-06	
J	Blaney, NA; Trbovich, A; Ernst, N; Eagle, SR; Collins, MW; Kontos, AP				Blaney, Nicholas A.; Trbovich, Alicia; Ernst, Nathan; Eagle, Shawn R.; Collins, Michael W.; Kontos, Anthony P.			Influence of Sleep Dysfunction on Concussion Assessment Outcomes Among Adolescent Athletes After Concussion and Healthy Controls	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; vestibular; neurocognitive; clinical outcomes; sleep dysfunction	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; BASE-LINE; DISTURBANCES; DISORDERS; SYMPTOMS; IMPACT; RELIABILITY; SPECIFICITY; SENSITIVITY	Background: Sleep dysfunction (SD) is associated with a high symptom burden and lower neurocognitive performance after concussion and on baseline testing without injury. However, few studies have compared concussed athletes and controls with and without SD on clinical outcomes. Objective: To evaluate differences in clinical outcomes among both concussed athletes and matched controls with and without SD. Design: Retrospective cross-sectional study. Participants: Participants aged 12 to 20 years were recruited from a concussion clinic (n = 50 patients) and research registry/flyers (n = 50 healthy age-/sex-matched controls). Participants were categorized by self-reported SD into one of 4 groups: sport-related concussion (SRC) + SD, SRC only, SD only, and controls. Main Outcome Measures: Post-Concussion Symptom Scale (PCSS), Vestibular/Oculomotor Screening (VOMS), and neurocognitive testing (Immediate Postconcussion Assessment Cognitive Test). Results: Compared with the SRC only group, the SRC + SD group performed worse on all neurocognitive domains, had a higher total symptom score, and endorsed more symptoms on most VOMS items. In addition, the SRC + SD group was at an increased likelihood of having at least 1 abnormal VOMS item compared with SRC only group. The SRC only group had neurocognitive test scores and symptom reports statistically similar to the SD only group. Conclusion: Sleep dysfunction after concussion is related to worse neurocognitive performance and higher concussion symptom reporting. This study extended findings to suggest vestibular symptomology is worse among athletes with SD after injury compared to injured athletes without SD. Similar performances on concussion assessments for the SRC only and SD only groups suggest SD may appear similar to clinical presentation of concussion, even at baseline in the absence of SRC.	[Blaney, Nicholas A.; Eagle, Shawn R.; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Pittsburgh, PA 15261 USA; [Trbovich, Alicia; Ernst, Nathan; Collins, Michael W.; Kontos, Anthony P.] UPMC Sports Med Concuss Program, Pittsburgh, PA USA		Kontos, AP (corresponding author), UPMC Ctr Sports Med, Dept Orthopaed Surg, 3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1K01DC012332-01A1]	Supported by the NIH (Award Number 1K01DC012332-01A1).	Albathi M, 2017, J VESTIBUL RES-EQUIL, V27, P127, DOI 10.3233/VES-170617; Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chan LG, 2015, J HEAD TRAUMA REHAB, V30, pE67, DOI 10.1097/HTR.0000000000000119; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Farrell-Carnahan L, 2015, BRAIN INJURY, V29, P1400, DOI 10.3109/02699052.2015.1063161; Holster JL, 2017, J HEAD TRAUMA REHAB, V32, P25, DOI 10.1097/HTR.0000000000000237; Hong CT, 2015, J NEUROL SCI, V358, P385, DOI 10.1016/j.jns.2015.09.376; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lowe CJ, 2017, NEUROSCI BIOBEHAV R, V80, P586, DOI 10.1016/j.neubiorev.2017.07.010; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; Micarelli A, 2017, J SLEEP RES, V26, P487, DOI 10.1111/jsr.12516; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Mollayeva T, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0657-2; Murdaugh DL, 2018, ARCH PHYS MED REHAB, V99, P960, DOI 10.1016/j.apmr.2018.01.005; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Singh K, 2016, PEDIATR NEUROL, V60, P30, DOI 10.1016/j.pediatrneurol.2016.02.013; Sufrinko A, 2015, AM J SPORT MED, V43, P830, DOI 10.1177/0363546514566193; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Tkachenko N, 2016, PEDIATR NEUROL, V57, P46, DOI 10.1016/j.pediatrneurol.2015.12.019; Tzischinsky O, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0206-8; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Yaeger K, 2014, AM J ROENTGENOL, V202, P614, DOI 10.2214/AJR.13.11091; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	35	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2021	31	6					481	487		10.1097/JSM.0000000000000860			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WM5NJ	WOS:000711131700032	32941365				2022-02-06	
J	Bogner, J; Corrigan, JD; Peng, J; Kane, C; Coxe, K				Bogner, Jennifer; Corrigan, John D.; Peng, Juan; Kane, Chelsea; Coxe, Kathryn			Comparative Effectiveness of a Brief Intervention for Alcohol Misuse Following Traumatic Brain Injury: A Randomized Controlled Trial	REHABILITATION PSYCHOLOGY			English	Article						alcohol abuse; substance abuse; traumatic brain injury; secondary prevention; intervention	LIFE-STYLE PROFILE; SUBSTANCE MISUSE; EMERGENCY-DEPARTMENT; HEALTH; VALIDITY; ABUSE; RISK; DRINKING; ADOLESCENTS; RELIABILITY	Purpose/Objective: Compare the effects of an adapted Screening, Education, and Brief Intervention (Adapted SBI) for alcohol misuse following traumatic brain injury (TBI) to a Screening and Education with Attention Control (SEA) condition. Study Design: A single-masked, parallel group, randomized controlled trial was conducted with 58 participants who were 18 and older, sustained a TBI requiring inpatient rehabilitation, had a history of alcohol misuse, were English-speaking, cleared posttraumatic amnesia, were free of language impairments precluding participation in the intervention, and who provided informed consent. Outcomes were collected at 3, 6, and 12 months postdischarge. The primary outcome was drinks per week at 12 months postdischarge. Results: Participants in both conditions reduced alcohol use following their injury. The number of drinks per week at 12 months did not differ between the treatment conditions; the number of drinks consumed across the entire sample was very low (median = 0). A lower percentage of participants in the Adapted SBI condition resumed alcohol use by 12 months postdischarge (32% vs. 62% in the SEA condition, p < .05). No significant differences were found on other outcomes (binging, facts recalled about the negative effects of alcohol, drug use). The inclusion of a booster session did not appear to alter the intervention effects. The interventions did not impact other healthy behaviors, however healthy eating and stress management practices were associated with abstaining from alcohol use at the 12-month follow-up. Conclusions/Implications: While alcohol misuse generally declines postinjury, by 12 months postdischarge many individuals resume alcohol use. Adapted SBI may slow the resumption of alcohol use. Impact and Implications One-third to one-half of individuals who have sustained a moderate-severe traumatic brain injury (TBI) have a history of alcohol misuse and are at risk for resumption of hazardous alcohol use postinjury. Screening and Brief Interventions (SBI) are the standard of care for preventing the resumption of alcohol misuse following traumatic injuries, however, prior studies indicated limited effectiveness when used with persons with TBI. While the current study did not find an effect for the primary outcome (amount of alcohol consumed each week), the study demonstrated that an Adapted SBI accommodated to cognitive problems can be effective in decreasing the likelihood that an individual will resume any alcohol use during the year following inpatient rehabilitation for TBI.	[Bogner, Jennifer; Corrigan, John D.; Kane, Chelsea] Ohio State Univ, Coll Med, Dept Phys Med & Rehabil, Div Rehabil Psychol, 2145 Dodd Hall,480 Med Ctr Dr, Columbus, OH 43210 USA; [Peng, Juan] Ohio State Univ, Coll Med, Ctr Biostat, Columbus, OH 43210 USA; [Coxe, Kathryn] Ohio State Univ, Coll Social Work, Columbus, OH 43210 USA		Bogner, J (corresponding author), Ohio State Univ, Coll Med, Dept Phys Med & Rehabil, Div Rehabil Psychol, 2145 Dodd Hall,480 Med Ctr Dr, Columbus, OH 43210 USA.	Bogner.1@osu.edu		Bogner, Jennifer/0000-0003-4675-7466; Corrigan, John/0000-0002-7591-5622; Coxe, Kathryn/0000-0002-7813-1081	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133A120086]	This work was funded via Grant H133A120086 from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR, formerly a Center in the U.S. Department of Education, currently in the Administration for Community Living [ACL]). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, US Department of Health and Human Services (HHS), and you should not assume endorsement by the Federal Government.	Adams RS, 2012, J SOC WORK PRACT ADD, V12, P28, DOI 10.1080/1533256X.2012.647580; Bannon SM, 2021, J HEAD TRAUMA REHAB, V36, pE50, DOI 10.1097/HTR.0000000000000586; Barata IA, 2017, WEST J EMERG MED, V18, P1143, DOI 10.5811/westjem.2017.7.34373; Barnett NP, 2010, ADDICTION, V105, P452, DOI 10.1111/j.1360-0443.2009.02814.x; Beaulieu-Bonneau S, 2018, J HEAD TRAUMA REHAB, V33, pE51, DOI 10.1097/HTR.0000000000000341; Bogner J, 2013, BRAIN IMPAIR, V14, P77, DOI 10.1017/BrImp.2013.5; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; Brenner LA, 2012, J HEAD TRAUMA REHAB, V27, pE57, DOI 10.1097/HTR.0b013e318273414c; Cabe N, 2021, ADDICT BEHAV, V113, DOI 10.1016/j.addbeh.2020.106667; Chang HK, 2019, J AFFECT DISORDERS, V250, P21, DOI 10.1016/j.jad.2019.02.059; Corrigan J.D., 2004, SUBSTANCE USE UNPUB; Corrigan J.D., 2003, TECHNICAL REPORT PRO; Corrigan J.D., 2005, REHABILITATION TRAUM, P133; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2010, J TRAUMA, V69, P722, DOI 10.1097/TA.0b013e3181e904cc; Dai CL, 2020, SUBST ABUS-RES TREAT, V14, DOI 10.1177/1178221820936681; Erdman J., 2011, NUTR TRAUMATIC BRAIN; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; GEORGE WH, 1995, J STUD ALCOHOL, V56, P177, DOI 10.15288/jsa.1995.56.177; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hulme Polly A, 2003, J Transcult Nurs, V14, P244, DOI 10.1177/1043659603014003011; Joint Commission, 2007, SPECIF MAN NAT HOSP; Kaner EFS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kennedy E, 2017, J HEAD TRAUMA REHAB, V32, P425, DOI 10.1097/HTR.0000000000000289; Kennedy E, 2017, EUR CHILD ADOLES PSY, V26, P1197, DOI 10.1007/s00787-017-0975-1; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lau K, 2010, GEN HOSP PSYCHIAT, V32, P86, DOI 10.1016/j.genhosppsych.2009.10.002; Lipari RN., 2019, KEY SUBSTANCE USE ME; MacLeod JBA, 2011, INJURY, V42, P922, DOI 10.1016/j.injury.2010.01.098; MAISTO SA, 1982, ADDICT BEHAV, V7, P33, DOI 10.1016/0306-4603(82)90022-3; Makdissi R, 2013, ADDICT SCI CLIN PRAC, V8, DOI 10.1186/1940-0640-8-11; Marcoux J, 2017, CAN J NEUROL SCI, V44, P311, DOI 10.1017/cjn.2016.241; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McQueen J, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005191.pub3, 10.1002/14651858.CD005191]; Miller W, 2003, MANUAL MOTIVATIONAL; Miller W. R., 2013, MOTIVATIONAL INTERVI, V3; Minugh PA, 1997, ACAD EMERG MED, V4, P1059, DOI 10.1111/j.1553-2712.1997.tb03680.x; Mokdad AH, 2018, JAMA-J AM MED ASSOC, V319, P1444, DOI 10.1001/jama.2018.0158; Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3; O'Connor EA, 2018, JAMA-J AM MED ASSOC, V320, P1910, DOI 10.1001/jama.2018.12086; O'Donnell A, 2014, ALCOHOL ALCOHOLISM, V49, P66, DOI 10.1093/alcalc/agt170; Olsen Jeanette M, 2010, Am J Health Promot, V25, pe1, DOI 10.4278/ajhp.090313-LIT-101; Olson-Madden J.H., 2012, SUBSTANCE USE TRAUMA, DOI [10.1155/2012/174579, DOI 10.1155/2012/174579, 10.1155/2012/174579.]; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Perez-Fortis A, 2012, RES NURS HEALTH, V35, P301, DOI 10.1002/nur.21470; Pinar R, 2009, NURS RES, V58, P184, DOI 10.1097/NNR.0b013e31819a8248; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ponsford J, 2013, J CLIN EXP NEUROPSYC, V35, P103, DOI 10.1080/13803395.2012.752437; Saitz R, 2010, DRUG ALCOHOL REV, V29, P631, DOI 10.1111/j.1465-3362.2010.00217.x; Saitz R, 2010, ANN INTERN MED, V153, P40, DOI 10.7326/0003-4819-153-1-201007060-00008; Sander AM, 2012, J HEAD TRAUMA REHAB, V27, P319, DOI 10.1097/HTR.0b013e318269838c; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Simonton AJ, 2018, SUBST USE MISUSE, V53, P2052, DOI 10.1080/10826084.2018.1452338; Singh R, 2019, CLIN NEUROL NEUROSUR, V186, DOI 10.1016/j.clineuro.2019.105526; Sobell LC, 2003, J STUD ALCOHOL, V64, P858, DOI 10.15288/jsa.2003.64.858; Sousa P, 2015, INT J NURS KNOWL, V26, P54, DOI 10.1111/2047-3095.12065; Tajik M, 2010, J IMMIGR MINOR HEALT, V12, P390, DOI 10.1007/s10903-008-9209-4; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tweedly L, 2012, J HEAD TRAUMA REHAB, V27, P331, DOI 10.1097/HTR.0b013e318262200a; Unsworth DJ, 2017, J CLIN EXP NEUROPSYC, V39, P547, DOI 10.1080/13803395.2016.1248812; WALKER SN, 1987, NURS RES, V36, P76; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Williams S, 2005, DRUG ALCOHOL DEPEN, V77, P205, DOI 10.1016/j.drugalcdep.2004.07.011; Zatzick D, 2014, ADDICTION, V109, P754, DOI 10.1111/add.12492	65	0	0	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2021	66	4					345	355		10.1037/rep0000405			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	XI0QC	WOS:000725826700004	34618511				2022-02-06	
J	Brown, J; Ackley, K; Knollman-Porter, K; Brown, J				Brown, Jessica; Ackley, Kristen; Knollman-Porter, Kelly; Brown, Jessica			Collaborative Goal Setting: A Clinical Approach for Adults With Mild Traumatic Brain Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							SPEECH-LANGUAGE PATHOLOGISTS; POST-CONCUSSION SYMPTOMS; SHARED DECISION-MAKING; QUALITY-OF-LIFE; POSTCONCUSSIONAL-SYNDROME; EMERGENCY-DEPARTMENT; OCCUPATIONAL-THERAPY; SELF-AWARENESS; REHABILITATION; HETEROGENEITY	Purpose: Speech-language pathologists (SLPs) have many available procedural options when setting treatment goals. Extant literature supports goal setting protocols that include and value the perspectives of the client; however, in practice, rehabilitation professionals may lean toward expert models of care when planning treatment. Our purpose is to describe a newly developed approach for SLPs and individuals with mild traumatic brain injury (mTBI) to work together to build meaningful, relevant goals. Method: We utilized a multiple case study format to exemplify goal setting procedures. Specifically, we describe procedures and outcomes for a 29-year-old female 28 days postinjury and a 70-year-old male 9 months postinjury. Results: Clients who engaged in this protocol worked collaboratively with a clinician to identify strengths and challenges postinjury, select and prioritize goal areas, and discuss and develop meaningful, personalized treatment activities. For both participants, use of the proposed protocol resulted in meaningful goals that addressed their self-reported deficits as well as their respective cognitive-linguistic deficits noted on objective, standardized measures. Conclusions: Clinician and client collaboration during treatment goal development can facilitate increased client motivation and functional outcomes. The described approach is feasible from a clinical resource standpoint and promotes a systematic approach to placing the client at the forefront of clinical decision making to enhance therapeutic gains. Such client-centered approaches may be particularly valuable for individuals with mTBI who experience substantial cognitive and communicative challenges but may maintain high levels of self-awareness postinjury.	[Brown, Jessica; Ackley, Kristen] Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ 85721 USA; [Knollman-Porter, Kelly] Miami Univ, Dept Speech Pathol & Audiol, Oxford, OH 45056 USA		Brown, J (corresponding author), Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ 85721 USA.	jessicabrown@arizona.edu		Brown, Jessica/0000-0002-0735-0703			American Speech-Language-Hearing Association, 2016, SCOP PRACT SPEECH LA; Barnes M. D., 2000, TXB REHABILITATION M; Baylor C, 2020, AM J SPEECH-LANG PAT, V29, P1335, DOI 10.1044/2020_AJSLP-19-00043; Benedict, 2001, HOPKINS VERBAL LEARN; Bergquist Thomas F., 1993, Brain Injury, V7, P275, DOI 10.3109/02699059309029680; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bosco FM, 2017, BRAIN LANG, V168, P73, DOI 10.1016/j.bandl.2017.01.007; Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Brown J, 2020, AM J SPEECH-LANG PAT, V29, P1389, DOI 10.1044/2020_AJSLP-19-00131; Brown J, 2019, DISABIL REHABIL-ASSI, V14, P255, DOI 10.1080/17483107.2018.1428371; Brown J, 2017, AM J SPEECH-LANG PAT, V26, P819, DOI 10.1044/2017_AJSLP-16-0092; Brown JA, 2016, NEUROREHABILITATION, V39, P191, DOI 10.3233/NRE-161351; Brownie S, 2013, CLIN INTERV AGING, V8, P1, DOI 10.2147/CIA.S38589; Cameron LJ, 2018, CLIN REHABIL, V32, P827, DOI 10.1177/0269215517752488; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cookson R, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2007.021790; D'Cruz K, 2016, INT J THER REHABIL, V23, P20, DOI 10.12968/ijtr.2016.23.1.20; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Doig E., 2016, AM J OCCUP THER, V70; Doig E., 2014, REHABILITATION GOAL, P181, DOI DOI 10.1201/B17166; Doig E, 2011, BRAIN INJURY, V25, P1114, DOI 10.3109/02699052.2011.607788; Doig E, 2010, AM J OCCUP THER, V64, P904, DOI 10.5014/ajot.2010.08156; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Doud AK, 2020, AM J SPEECH-LANG PAT, V29, P789, DOI 10.1044/2020_AJSLP-19-00042; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Evans JJ, 2012, CURR OPIN NEUROL, V25, P651, DOI 10.1097/WCO.0b013e3283598f75; Fowler FJ, 2011, HEALTH AFFAIR, V30, P699, DOI 10.1377/hlthaff.2011.0003; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Geytenbeek M, 2017, BRAIN INJURY, V31, P1791, DOI 10.1080/02699052.2017.1346297; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Grant M, 2014, NEUROPSYCHOL REHABIL, V24, P661, DOI 10.1080/09602011.2014.901228; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Hart T, 2018, BRAIN INJURY, V32, P1295, DOI 10.1080/02699052.2018.1493226; Hart T, 2014, ARCH PHYS MED REHAB, V95, pS33, DOI 10.1016/j.apmr.2013.05.032; Holliday RC, 2007, DISABIL REHABIL, V29, P389, DOI 10.1080/09638280600841117; Holliday RC, 2005, NEUROREHAB NEURAL RE, V19, P227, DOI 10.1177/1545968305279206; Hughes TM, 2018, AM J SURG, V216, P7, DOI 10.1016/j.amjsurg.2018.01.011; JOYCE BM, 1994, AM J PHYS MED REHAB, V73, P10, DOI 10.1097/00002060-199473010-00003; Kaderavek J. N., 2004, CONT ISSUES COMMUNIC, V31, P153, DOI [DOI 10.1044/CICSD_31_F_153, 10.1044/cicsd_31_F_153]; Kennedy M. R. T., 2017, COACHING COLL STUDEN; Kenny B, 2010, AM J SPEECH-LANG PAT, V19, P121, DOI 10.1044/1058-0360(2009/08-0007); Knollman-Porter K., 2018, AM C REH MED, V99, pE3, DOI DOI 10.1016/J.APMR.2018.07.011; Knollman-Porter K, 2019, TOP LANG DISORD, V39, P257, DOI 10.1097/TLD.0000000000000187; Kucheria P, 2020, NEUROPSYCHOL REHABIL, DOI 10.1080/09602011.2020.1838301; Leach E, 2010, DISABIL REHABIL, V32, P159, DOI 10.3109/09638280903036605; Legare F, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006732.pub4; Levack WMM, 2016, EUR J PHYS REHAB MED, V52, P400; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; Luterman D, 2020, AM J SPEECH-LANG PAT, V29, P903, DOI 10.1044/2019_AJSLP-19-00013; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Malec J. F., 1992, NEURO REHABILITATION, V2, P1, DOI [10.3233/NRE-1992-2303, DOI 10.3233/NRE-1992-2303]; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McClain Colleen, 2005, Top Stroke Rehabil, V12, P56, DOI 10.1310/ELB1-EGKF-QUQC-VFE9; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGill N, 2020, SPEECH LANG HEARING, V23, P2, DOI 10.1080/2050571X.2020.1716471; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McMillan TM, 2009, BRAIN INJURY, V23, P509, DOI 10.1080/02699050902970729; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; NORTHEN JG, 1995, AM J OCCUP THER, V49, P214, DOI 10.5014/ajot.49.3.214; Oliver I, 2012, IEEE IC COMP COM NET; Phillips D. T., 2008, CONT ISSUES COMMUNIC, V35, P44, DOI [10.1044/CICSD_35_S_44, DOI 10.1044/CICSD_35_S_44]; Playford ED, 2009, CLIN REHABIL, V23, P334, DOI 10.1177/0269215509103506; Poey JL, 2017, J AM MED DIR ASSOC, V18, P974, DOI 10.1016/j.jamda.2017.06.007; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Registered Nurse RN, 2018, DOS CALC LIQ OR MED; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Rose A, 2017, PATIENT EDUC COUNS, V100, P65, DOI 10.1016/j.pec.2016.07.030; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Roulstone S, 2011, INT J SPEECH-LANG PA, V13, P43, DOI 10.3109/17549507.2010.491130; SCHUT HA, 1994, DISABIL REHABIL, V16, P223, DOI 10.3109/09638289409166616; Scobbie L, 2011, CLIN REHABIL, V25, P468, DOI 10.1177/0269215510389198; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Simpson G, 2016, J SOC WORK DISABIL R, V15, P213, DOI 10.1080/1536710X.2016.1220888; Sohlberg M., 2001, COGNITIVE REHABILITA; STOLEE P, 1992, J AM GERIATR SOC, V40, P574, DOI 10.1111/j.1532-5415.1992.tb02105.x; Struhkamp R, 2004, HEALTH CARE ANAL, V12, P131, DOI 10.1023/B:HCAN.0000041187.93819.17; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Terrell PA, 2020, SEMIN SPEECH LANG, V41, P325, DOI 10.1055/s-0040-1713783; Vallino-Napoli L., 2004, ADV SPEECH LANGUAGE, V6, P107, DOI DOI 10.1080/14417040410001708530; van den Broek MD, 2005, J HEAD TRAUMA REHAB, V20, P464, DOI 10.1097/00001199-200509000-00007; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Victorino KR, 2019, AM J SPEECH-LANG PAT, V28, P108, DOI 10.1044/2018_AJSLP-18-0012; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Wade D. T., 2005, EFFECTIVENESS REHABI, P31, DOI [10.1093/acprof:oso/9780198526544.003.0004, DOI 10.1093/ACPROF:OSO/9780198526544.003.0004]; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; Wressle E, 2002, J REHABIL MED, V34, P5, DOI 10.1080/165019702317242640; Yeo YX, 2021, NEUROPSYCHOL REHABIL, V31, P453, DOI 10.1080/09602011.2019.1704421; Ylvisaker M, 2000, APHASIOLOGY, V14, P407, DOI 10.1080/026870300401432; Ylvisaker M., 2008, EXECUTIVE FUNCTIONS, P443, DOI [10.4324/9780203837863, DOI 10.4324/9780203837863]; Ylvisaker Mark, 1993, Seminars in Speech and Language, V14, P74, DOI 10.1055/s-2008-1064160	99	0	0	0	0	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	NOV	2021	30	6					2394	2413		10.1044/2021_AJSLP-21-00078			20	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	WT4GN	WOS:000715824500005	34529919				2022-02-06	
J	Burns, K; Tierney, R; McDevitt, J				Burns, Karlee; Tierney, Ryan; McDevitt, Jane			Prescription Medication for Posttraumatic Headache Following Concussion: A Critically Appraised Topic	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						amantadine; evidence-based; gabapentin; tricyclics	AMANTADINE; GABAPENTIN; MANAGEMENT; RECOVERY; SYMPTOMS	Clinical Question: In individuals with posttraumatic headache following concussion, what impact does medication have? Clinical Bottom Line: Prescription medications may be beneficial for those suffering posttraumatic headache following concussion by decreasing headache symptoms and improving cognitive function, though long-term outcomes were similar between those taking and not taking medications.	[Burns, Karlee; Tierney, Ryan; McDevitt, Jane] Temple Univ, Philadelphia, PA 19122 USA		Burns, K (corresponding author), Temple Univ, Philadelphia, PA 19122 USA.	karlee.burns@temple.edu		Burns, Karlee/0000-0003-1139-1564			[Anonymous], Gabapentin (Oral Route); [Anonymous], 2019, TRIC ANT TETR ANT; [Anonymous], Amantadine (Oral Route); Cai K, 2012, NEUROPSYCHOPHARMACOL, V37, P2764, DOI 10.1038/npp.2012.142; Carabenciov ID, 2019, MAYO CLIN PROC, V94, P275, DOI 10.1016/j.mayocp.2018.10.021; Cushman DM, 2019, HEADACHE, V59, P371, DOI 10.1111/head.13451; Ebell MH, 2004, J AM BOARD FAM PRACT, V17, P59, DOI 10.3122/jabfm.17.1.59; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Halstead ME, 2016, SPORTS HEALTH, V8, P50, DOI 10.1177/1941738115622158; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Hubsher G, 2012, NEUROLOGY, V78, P1096, DOI 10.1212/WNL.0b013e31824e8f0d; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Kristoffersen ES, 2014, J PAIN RES, V7, P367, DOI 10.2147/JPR.S46071; Nicholson K, 2001, NEUROREHABILITATION, V16, P225; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P270, DOI 10.1016/j.pediatrneurol.2014.10.015; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Register-Mihalik JK, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0724-2; Seifert TD, 2013, HEADACHE, V53, P726, DOI 10.1111/head.12087; Sharaf S, 2018, EGYPT J PSYCHIAT, V39, P73, DOI [10.4103/ ejpsy.ejpsy_29_17, DOI 10.4103/EJPSY.EJPSY_29_17]; Sufrinko A, 2018, J HEAD TRAUMA REHAB, V33, P7, DOI 10.1097/HTR.0000000000000315; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Tsao JW, 2014, NEUROLOGY, V83, P2196, DOI 10.1212/WNL.0000000000001086; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Yue JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00343	25	0	0	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	NOV	2021	26	6					314	317		10.1123/ijatt.2020-0060			4	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	WK2PQ	WOS:000709573500005					2022-02-06	
J	Calisan, M; Talu, MF; Pimenov, DY; Giasin, K				Calisan, Mucahit; Talu, Muhammed Fatih; Pimenov, Danil Yurievich; Giasin, Khaled			Skull Thickness Calculation Using Thermal Analysis and Finite Elements	APPLIED SCIENCES-BASEL			English	Article						ANSYS; skull thickness; thermal image analysis; finite element	TRAUMATIC BRAIN-INJURY; CRANIAL THICKNESS; INFANT SKULL; AGE; FRACTURE; SEX	In this study, the skull bone thicknesses of 150 patients ranging in age from 0 to 72 years were calculated using a novel approach (thermal analysis), and thickness changes were analyzed. Unlike conventional thickness calculation approaches (Beam Propagation, Hildebrand), a novel heat transfer-based approach was developed. Firstly, solid 3D objects with different thicknesses were modeled, and thermal analyses were performed on these models. To better understand the heat transfer of 3D object models, finite element models (FEM) of the human head have been reported in the literature. The FEM can more accurately model the complex geometry of a 3D human head model. Then, thermal analysis was performed on human skulls using the same methods. Thus, the skull bone thicknesses at different ages and in different genders from region to region were determined. The skull model was transferred to ANSYS, and it was meshed using different mapping parameters. The heat transfer results were determined by applying different heat values to the inner and outer surfaces of the skull mesh structure. Thus, the average thicknesses of skull regions belonging to a certain age group were obtained. With this developed method, it was observed that the temperature value applied to the skull was proportional to the thickness value. The average thickness of skull bones for men (frontal: 7.8 mm; parietal: 9.6 mm; occipital: 10.1 mm; temporal: 6 mm) and women (frontal: 8.6 mm; parietal: 10.1 mm; occipital: 10 mm; temporal: 6 mm) are given. The difference (10%) between men and women appears to be statistically significant only for frontal bone thickness. Thanks to the developed method, bone thickness information at any desired point on the skull can be obtained numerically. Therefore, the proposed method can be used to help pre-operative planning of surgical procedures.	[Calisan, Mucahit] Bingol Univ, Dept Informat, TR-12000 Bingol, Turkey; [Talu, Muhammed Fatih] Inonu Univ, Dept Comp Engn, TR-44280 Malatya, Turkey; [Pimenov, Danil Yurievich] South Ural State Univ, Dept Automated Mech Engn, Lenin Prosp 76, Chelyabinsk 454080, Russia; [Giasin, Khaled] Univ Portsmouth, Sch Mech & Design Engn, Portsmouth PO1 3DJ, Hants, England		Calisan, M (corresponding author), Bingol Univ, Dept Informat, TR-12000 Bingol, Turkey.	mcalisan@bingol.edu.tr; fatihtalu@gmail.com; danil_u@rambler.ru; khaled.giasin@port.ac.uk	Giasin, Khaled/D-8693-2017; Talu, Muhammed/W-2834-2017; Pimenov, Danil/D-9048-2013	Giasin, Khaled/0000-0002-3992-8602; Talu, Muhammed/0000-0003-1166-8404; Pimenov, Danil/0000-0002-5568-8928			Ahmed M, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11178120; Alexandratou I, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9091156; Antonakakis M, 2020, NEUROIMAGE, V223, DOI 10.1016/j.neuroimage.2020.117353; Baumer TG, 2010, J FORENSIC SCI, V55, P993, DOI 10.1111/j.1556-4029.2010.01391.x; Calderbank T, 2016, J FORENSIC RADIOL IM, V4, P70, DOI 10.1016/j.jofri.2015.12.002; Chen Y, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4028106; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Deffieux T, 2010, IEEE T ULTRASON FERR, V57, P2637, DOI 10.1109/TUFFC.2010.1738; Delye H, 2015, J NEUROSURG-PEDIATR, V16, P687, DOI 10.3171/2015.4.PEDS1493; Duffie JA, 2013, SOLAR ENGINEERING OF THERMAL PROCESSES, 4TH EDITION, P1, DOI 10.1002/9781118671603; Ebraheim NA, 2007, SPINE J, V7, P689, DOI 10.1016/j.spinee.2006.09.007; Eksi MS, 2021, J CRANIOFAC SURG, V32, P1683, DOI 10.1097/SCS.0000000000007256; Flores-Justa A, 2019, WORLD NEUROSURG, V132, pE670, DOI 10.1016/j.wneu.2019.08.050; Frank K, 2019, AESTHET SURG J, V39, P699, DOI 10.1093/asj/sjy270; Giuliano G, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11178265; Grothe T, 2020, J ENG FIBER FABR, V15, DOI 10.1177/1558925020933440; Gzik M, 2009, 11th International Congress of the IUPESM. Medical Physics and Biomedical Engineering. World Congress 2009. Neuroengineering, Neural Systems, Rehabilitation and Prosthetics, P68, DOI 10.1007/978-3-642-03889-1_19; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hollensteiner M, 2018, J MATER SCI-MATER M, V29, DOI 10.1007/s10856-018-6143-4; Imagawa N, 2021, MATERIALS, V14, DOI 10.3390/ma14185360; Kidder JH, 2004, J HUM EVOL, V46, P299, DOI 10.1016/j.jhevol.2003.12.003; Kung WM, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10051847; Li WP, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11188725; Lillie EM, 2016, J BONE MINER RES, V31, P299, DOI 10.1002/jbmr.2613; Lynnerup N, 2001, FORENSIC SCI INT, V117, P45, DOI 10.1016/S0379-0738(00)00447-3; Modi YK, 2018, J BRAZ SOC MECH SCI, V40, DOI 10.1007/s40430-018-1425-9; Moller T., 1997, J GRAPH TOOLS, V2, P21, DOI [10.1145/1198555.1198746, DOI 10.1080/10867651.1997.10487468, 10.1080/10867651.1997.10487468]; Ramadan AN, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11188501; Sagar Mulukuntla Vidya, 2017, INT J ENG RES, V6, P502, DOI DOI 10.17577/IJERTV6IS060283; Semeniuk BP, 2019, J ACOUST SOC AM, V146, P2540, DOI 10.1121/1.5129368; Shafiq-ul-Hassan M, 2017, MED PHYS, V44, P1050, DOI 10.1002/mp.12123; Shahzad Masood M., 2013, INT J SCI ENG RES, V4, P293; Smith K, 2012, IEEE ENG MED BIO, P4462, DOI 10.1109/EMBC.2012.6346957; Sommer HJ, 2006, AM J PHYS ANTHROPOL, V129, P189, DOI 10.1002/ajpa.20269; TIEDE U, 1993, AM J NEURORADIOL, V14, P551; Tornberg A, 2018, INT J OSTEOARCHAEOL, V28, P188, DOI 10.1002/oa.2646; Wang HY, 2019, J AM STAT ASSOC, V114, P393, DOI 10.1080/01621459.2017.1408468; Wang SH, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18084284; Webster J.G., 2000, MECH VARIABLES MEASU; Yang SD, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21186254; Yellinek S, 2016, J CLIN NEUROSCI, V25, P111, DOI 10.1016/j.jocn.2015.10.012	42	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3417		APPL SCI-BASEL	Appl. Sci.-Basel	NOV	2021	11	21							10483	10.3390/app112110483			20	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Chemistry; Engineering; Materials Science; Physics	WY7GW	WOS:000719447800001		gold			2022-02-06	
J	Carlozzi, NE; Graves, CM; Troost, JP; Ehde, DM; Miner, JA; Kratz, AL				Carlozzi, Noelle E.; Graves, Christopher M.; Troost, Jonathan P.; Ehde, Dawn M.; Miner, Jennifer A.; Kratz, Anna L.			Association of Physical and Mental Symptoms With Cognition in People With Spinal Cord Injury	REHABILITATION PSYCHOLOGY			English	Article						cognitive function; spinal cord injury; mental health; physical health	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; CHRONIC PAIN; NIH TOOLBOX; NEUROPSYCHOLOGICAL PERFORMANCE; DISPOSITIONAL NEGATIVITY; ANXIETY DISORDERS; HEAD-INJURY; DEPRESSION; PREVALENCE	Impact and Implications While spinal cord injury (SCI) can have a profound impact on mental and physical well-being, less is known about the associations between physical and mental symptoms and cognition in people with SCI. This is the first study, to our knowledge, to directly examine the relationships of physical and mental symptoms and cognition in individuals with SCI. This study shows that high levels of anxiety and fatigue are associated with poorer perceived cognition and that pain is associated with poorer cognitive performance in people with SCI. Also, among those with clinically significant cognitive problems, there are also associations between anxiety and fatigue and objective cognitive performance. Taken together, findings suggest that treatment of these symptoms may have downstream positive effects on cognition in people with SCI. It is important for researchers and clinicians to recognize that objective and subjective measures of cognition provide distinct information about cognition in persons with SCI. Purpose/Objective: To examine the association between physical and mental symptoms and cognition in people with spinal cord injury. Research Method/Design: One hundred seventy-four community-dwelling adults with spinal cord injury completed several self-reported measures of health-related quality of life (Patient-Reported Outcomes Measurement Information System [PROMIS] Cognitive Abilities, Anxiety, Depression, Fatigue, and Pain Intensity) as well as a traditional neuropsychological assessment (six tests that included assessments of processing speed, working memory, memory, executive function, and attention). A series of multivariable linear regressions were used to test for associations between physical and mental symptoms and the seven ratings of cognition (i.e., scores on PROMIS Cognitive Abilities, as well as the six scores from the neuropsychological tests) after controlling for age, gender, education, and injury classification. Results: There was generally no association between symptom measures and neuropsychological test performance with one exception: Greater pain was associated with poorer performance on attention. However, anxiety and fatigue were associated with lower self-perceived cognitive function. Among those individuals with evidence of cognitive impairment in at least one cognitive domain, anxiety was also associated with lower working memory score, and fatigue was associated with lower delayed memory performance. Conclusions/Implications: While the associations between pain and cognitive performance are consistent with general literature, the absence of a relationship between other symptoms (i.e., depression and fatigue) and cognitive performance was somewhat more surprising. Similarly, the associations between anxiety and fatigue with perceived cognitive function are consistent with the general literature, yet the absence of a relationship with depression was somewhat more surprising. Future work is needed to replicate these findings.	[Carlozzi, Noelle E.; Graves, Christopher M.; Miner, Jennifer A.; Kratz, Anna L.] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Troost, Jonathan P.] Univ Michigan, Michigan Inst Clin & Hlth Res, Ann Arbor, MI 48109 USA; [Ehde, Dawn M.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu		Miner, Jennifer/0000-0003-2722-1121; Troost, Jonathan/0000-0002-1183-8330; Ehde, Dawn/0000-0002-9555-2347	Craig H. Neilsen Foundation [440343]; National Center for Advancing Translational Sciences (NCATS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002240]	Research reported in this publication was supported by a grant from the Craig H. Neilsen Foundation under award number 440343 (PI: Carlozzi). The content is solely the responsibility of the authors and does not necessarily represent the views of the Craig H. Neilsen Foundation. Jonathan Troost was supported in part by the National Center for Advancing Translational Sciences (NCATS) for the Michigan Institute for Clinical and Health Research (UL1TR002240).	Avluk OC, 2014, ANN SAUDI MED, V34, P211, DOI 10.5144/0256-4947.2014.211; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett S, 2014, MATURITAS, V79, P184, DOI 10.1016/j.maturitas.2014.05.009; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Boyer B., 2000, TOP SPINAL CORD INJ, V6, P125, DOI [10.1310/4FJ8-3VCH-EE0N-HNCD, DOI 10.1310/4FJ8-3VCH-EE0N-HNCD]; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Burke D, 2018, EUR J PAIN, V22, P1662, DOI 10.1002/ejp.1248; Carlozzi N.E., ARCH PHYS MED REHABI; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; CELLA DF, 1995, SEMIN ONCOL, V22, P73; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen ML, 2017, REHABIL PSYCHOL, V62, P425, DOI 10.1037/rep0000140; Craig A, 2017, J NEUROTRAUM, V34, P1156, DOI 10.1089/neu.2016.4632; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Dijkers M, 2009, J REHABIL RES DEV, V46, P13, DOI 10.1682/JRRD.2008.04.0053; Dowler R N, 1995, Appl Neuropsychol, V2, P124, DOI 10.1207/s15324826an0203&4_4; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Dryden DM, 2005, NEUROEPIDEMIOLOGY, V25, P55, DOI 10.1159/000086284; Dudley-Javoroski S, 2022, PHYSIOTHER THEOR PR, V38, P36, DOI 10.1080/09593985.2020.1712755; Ferrans CE, 2005, J NURS SCHOLARSHIP, V37, P336, DOI 10.1111/j.1547-5069.2005.00058.x; Gaspar R, 2019, J SPORT REHABIL, V28, P505, DOI 10.1123/jsr.2017-0185; Grisart JM, 1999, EUR J PAIN-LONDON, V3, P325, DOI 10.1016/S1090-3801(99)90014-9; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Hammell KW, 2007, SPINAL CORD, V45, P124, DOI 10.1038/sj.sc.3101992; Hassanijirdehi M, 2015, KOREAN J PAIN, V28, P129, DOI 10.3344/kjp.2015.28.2.129; HEINEMANN AW, 1988, ARCH PHYS MED REHAB, V69, P619; Hess MJ, 2003, J SPINAL CORD MED, V26, P335, DOI 10.1080/10790268.2003.11753702; Hur J, 2019, PROG BRAIN RES, V247, P375, DOI 10.1016/bs.pbr.2019.03.012; Hutchinson AD, 2012, CANCER TREAT REV, V38, P926, DOI 10.1016/j.ctrv.2012.05.002; Jamison RN, 2003, J PAIN SYMPTOM MANAG, V26, P913, DOI 10.1016/S0885-3924(03)00310-5; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kouijzer M, 2018, RESP MED, V141, P47, DOI 10.1016/j.rmed.2018.06.011; Krause JS, 2010, ARCH PHYS MED REHAB, V91, P1182, DOI 10.1016/j.apmr.2010.05.012; Lai JS, 2014, PSYCHO-ONCOLOGY, V23, P1133, DOI 10.1002/pon.3522; LaMonica HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203343; LASFARGUES JE, 1995, PARAPLEGIA, V33, P62, DOI 10.1038/sc.1995.16; Lazzaro I, 2013, J CLIN NEUROPHYSIOL, V30, P59, DOI 10.1097/WNP.0b013e31827edb0c; Lee DM, 2010, PAIN, V151, P30, DOI 10.1016/j.pain.2010.04.024; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lim SW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169623; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Masri R, 2012, ADV EXP MED BIOL, V760, P74; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Migliorini C, 2015, INTERN MED J, V45, P1014, DOI 10.1111/imj.12825; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Murray RF, 2007, SPINAL CORD, V45, P429, DOI 10.1038/sj.sc.3102022; National Council on Measurement in Education, 2014, STAND ED PSYCH TEST; Park DC, 2001, ARTHRITIS RHEUM, V44, P2125, DOI 10.1002/1529-0131(200109)44:9<2125::AID-ART365>3.0.CO;2-1; Placeres AF, 2018, REV ESC ENFERM USP, V52, DOI 10.1590/S1980-220X2017037303388; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Rubin R, 2018, JAMA-J AM MED ASSOC, V320, P961, DOI 10.1001/jama.2018.11154; Sachdeva R, 2018, NEUROLOGY, V91, P611, DOI 10.1212/WNL.0000000000006244; Shackman AJ, 2016, J EXP PSYCHOPATHOL, V7, P311, DOI 10.5127/jep.054015; Sharma B, 2014, J REHABIL MED, V46, P370, DOI 10.2340/16501977-1261; Siddall PJ, 2015, PAIN MANAG, V5, P493, DOI 10.2217/pmt.15.47; Tassain V, 2003, PAIN, V104, P389, DOI 10.1016/S0304-3959(03)00047-2; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; Theander K, 2004, J ADV NURS, V45, P172, DOI 10.1046/j.1365-2648.2003.02878.x; Tulsky DS, 2014, J INT NEUROPSYCH SOC, V20, P599, DOI 10.1017/S135561771400040X; Tulsky DS, 2013, MONOGR SOC RES CHILD, V78, P70, DOI 10.1111/mono.12035; Weiner DK, 2006, PAIN MED, V7, P60, DOI 10.1111/j.1526-4637.2006.00091.x; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Yamashita M, 2017, BRAIN RES, V1675, P116, DOI 10.1016/j.brainres.2017.09.002; Yang G, 2014, SCIENCE, V344, P1173, DOI 10.1126/science.1249098	74	0	0	1	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2021	66	4					532	540		10.1037/rep0000416			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	XI0QC	WOS:000725826700025	34618509				2022-02-06	
J	Carlozzi, NE; Troost, JP; Singhal, N; Ehde, DM; Bakshi, R; Molton, IR; Miner, JA; Graves, CM; Kratz, AL				Carlozzi, Noelle E.; Troost, Jonathan P.; Singhal, Neena; Ehde, Dawn M.; Bakshi, Rishi; Molton, Ivan R.; Miner, Jennifer A.; Graves, Christopher M.; Kratz, Anna L.			The Association Between Medication Use and Cognitive Performance in People With SCI	REHABILITATION PSYCHOLOGY			English	Article						cognitive function; spinal cord injury; medication use	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; NIH TOOLBOX; HEAD-INJURY; INDIVIDUALS; POLYPHARMACY; BATTERY; IMPACT; BENZODIAZEPINES; VALIDATION	Purpose/Objective: Polypharmacy is common in people with spinal cord injury (SCI). Given the high rates of medication use, and the complicated side effect profile of many of the medications that are regularly prescribed in people with SCI, we were interested in the association between the use of different classes of medications and cognitive function in these individuals. Research Method/Design: One-hundred and 73 people with SCI participated in an observational study. Self-reported medications were provided by participants. Participants also completed several cognitive tests designed to capture multiple aspects of cognition (processing speed, attention, working memory, learning, free-recall memory, delayed free recall memory, executive function), as well as a self-report measure that captures participant perceptions of cognitive function. A series of multivariable linear regressions were used to test for associations between medications and the seven measures of cognition. Results: In general, there was not a robust relationship between medication use and cognitive function; the sole exception was an association between opioid use and subjective cognitive function. There was some preliminary support for an association between medication use, especially benzodiazepine and opioid analgesic use, and poorer cognitive performance. Specifically: Opioid analgesic use was associated with slowed processing speed, worse attention, poorer working memory, poorer executive function and more subjective cognitive complaints; benzodiazepine use was associated with slower processing speed, poorer working memory, and worse executive function; anticonvulsant use was related to worse delayed free recall memory; and the number of medication categories a person with SCI was taking was related to slower processing speed, and worse subjective cognitive function. Antidepressant, cannabis, skeletal muscle relaxant, sedative and stimulant use were not significantly related to cognitive performance, nor to subjective reports of cognitive function. Conclusions/Implications: Findings did not support a strong relationship between medication use and cognitive function in people with SCI. There is some preliminary support for an association between benzodiazepine use and cognitive performance, but this needs to be confirmed in future research. Impact and Implications While the complex medical needs of people with spinal cord injury commonly include complicated medication regimens, little is known about the impact that these medications may have on cognition. Contrary to expectations, in general, there were not strong relationships between medication use and cognitive function in people with SCI. Preliminary support for a significant association between medication use, especially benzodiazepine and opioid analgesic use, and poorer cognitive performance in people with spinal cord injury warrants further study in order to better understand the possible effects of medications on cognition in this population.	[Carlozzi, Noelle E.; Singhal, Neena; Bakshi, Rishi; Miner, Jennifer A.; Graves, Christopher M.; Kratz, Anna L.] Univ Michigan, Dept Phys Med & Rehabil, 2800 Plymouth Rd,Bldg NCRC B14,Room G216, Ann Arbor, MI 48109 USA; [Troost, Jonathan P.] Univ Michigan, Michigan Inst Clin & Hlth Res, Ann Arbor, MI 48109 USA; [Ehde, Dawn M.; Molton, Ivan R.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 2800 Plymouth Rd,Bldg NCRC B14,Room G216, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu		Troost, Jonathan/0000-0002-1183-8330; Miner, Jennifer/0000-0003-2722-1121	Craig H. Neilsen Foundation [440343]; National Center for Advancing Translational Sciences (NCATS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002240]	Research reported in this publication was supported by a grant from the Craig H. Neilsen Foundation under award number 440343 (PI: Carlozzi). The content is solely the responsibility of the authors and does not necessarily represent the views of the Craig H. Neilsen Foundation. Jonathan Troost was supported in part by the National Center for Advancing Translational Sciences (NCATS) for the Michigan Institute for Clinical and Health Research (UL1TR002240).	Advokat C, 2010, NEUROSCI BIOBEHAV R, V34, P1256, DOI 10.1016/j.neubiorev.2010.03.006; American Educational Research Association American Psychological Association and National Council on Measurement in Education (AERA APA NCME), 2014, STAND ED PSYCH TEST; Ancelin ML, 2006, BMJ-BRIT MED J, V332, P455, DOI 10.1136/bmj.38740.439664.DE; Atkins AM, 2014, J REHABIL RES DEV, V51, pVII, DOI [10.1682/JRRD.2014.08.0194, 10.1682/JRRD]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Broyd SJ, 2016, BIOL PSYCHIAT, V79, P557, DOI 10.1016/j.biopsych.2015.12.002; Campbell N, 2009, CLIN INTERV AGING, V4, P225; Carlozzi NE, 2017, ARCH CLIN NEUROPSYCH, V32, P555, DOI 10.1093/arclin/acx020; Carlozzi N.E., ARCH PHYS MED REHABI; Caron J, 2020, J CLIN PHARM THER, V45, P774, DOI 10.1111/jcpt.13165; Chiodo AE, 2007, ARCH PHYS MED REHAB, V88, pS76, DOI 10.1016/j.apmr.2006.12.015; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen ML, 2017, REHABIL PSYCHOL, V62, P425, DOI 10.1037/rep0000140; Craig A, 2017, J NEUROTRAUM, V34, P1156, DOI 10.1089/neu.2016.4632; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Dowler R N, 1995, Appl Neuropsychol, V2, P124, DOI 10.1207/s15324826an0203&4_4; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Fox C, 2014, AGE AGEING, V43, P604, DOI 10.1093/ageing/afu096; Fox C, 2011, J AM GERIATR SOC, V59, P1477, DOI 10.1111/j.1532-5415.2011.03491.x; Goldberg JF, 2001, J CLIN PSYCHIAT, V62, P27; Goodman BL, 2014, J WOUND CARE, V23, P165, DOI 10.12968/jowc.2014.23.4.165; Guilcher SJT, 2018, SPINAL CORD, V56, P1059, DOI 10.1038/s41393-018-0174-z; Hand BN, 2018, SPINAL CORD, V56, P591, DOI 10.1038/s41393-017-0050-2; Harari D, 1997, SPINAL CORD, V35, P394, DOI 10.1038/sj.sc.3100417; Hatch MN, 2018, ARCH PHYS MED REHAB, V99, P1099, DOI 10.1016/j.apmr.2017.12.036; Hess DW, 2003, REHABIL PSYCHOL, V48, P151, DOI 10.1037/0090-5550.48.3.151; Hester R, 2009, NEUROPSYCHOPHARMACOL, V34, P2450, DOI 10.1038/npp.2009.67; Jensen MP, 2007, ARCH PHYS MED REHAB, V88, P638, DOI 10.1016/j.apmr.2007.02.002; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kitzman P, 2017, J SPINAL CORD MED, V40, P147, DOI 10.1179/2045772314Y.0000000235; Kroll T, 2007, DISABIL REHABIL, V29, P1229, DOI 10.1080/09638280600950603; Lai JS, 2014, PSYCHO-ONCOLOGY, V23, P1133, DOI 10.1002/pon.3522; Lazzaro I, 2013, J CLIN NEUROPHYSIOL, V30, P59, DOI 10.1097/WNP.0b013e31827edb0c; Lee AKY, 2010, SPINAL CORD, V48, P429, DOI 10.1038/sc.2009.145; Leicht G, 2013, BIOL PSYCHIAT, V73, P337, DOI 10.1016/j.biopsych.2012.09.004; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Nightingale TE, 2020, PHYSIOL BEHAV, V213, DOI 10.1016/j.physbeh.2019.112742; Noonan VK, 2008, ARCH PHYS MED REHAB, V89, P1074, DOI 10.1016/j.apmr.2007.10.041; Pasina L, 2013, DRUG AGING, V30, P103, DOI 10.1007/s40266-012-0044-x; Patel T, 2017, J SPINAL CORD MED, V40, P54, DOI 10.1179/2045772315Y.0000000055; Robinson RG, 2016, AM J PSYCHIAT, V173, P221, DOI 10.1176/appi.ajp.2015.15030363; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Rosenblat JD, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv082; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Rouleau P, 2011, SPINAL CORD, V49, P186, DOI 10.1038/sc.2010.70; SABERS A, 1995, ACTA NEUROL SCAND, V92, P19; Sachdeva R, 2018, NEUROLOGY, V91, P611, DOI 10.1212/WNL.0000000000006244; Stewart SA, 2005, J CLIN PSYCHIAT, V66, P9; Stranks EK, 2014, J CLIN EXP NEUROPSYC, V36, P691, DOI 10.1080/13803395.2014.928268; Tulsky DS, 2014, J INT NEUROPSYCH SOC, V20, P599, DOI 10.1017/S135561771400040X; Tulsky DS, 2013, MONOGR SOC RES CHILD, V78, P70, DOI 10.1111/mono.12035; van Steenbergen H, 2017, PSYCHONEUROENDOCRINO, V80, P99, DOI 10.1016/j.psyneuen.2017.03.002; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0	62	0	0	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2021	66	4					541	549		10.1037/rep0000412			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	XI0QC	WOS:000725826700026	34618512				2022-02-06	
J	Carmichael, J; Hicks, AJ; Spitz, G; Gould, KR; Ponsford, J				Carmichael, Jai; Hicks, Amelia J.; Spitz, Gershon; Gould, Kate Rachel; Ponsford, Jennie			Moderators of gene-outcome associations following traumatic brain injury	NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS			English	Article						Genetics; Traumatic brain injury; Age; Sex; Ethnicity; Apolipoprotein E; APOE; Brain-derived neurotrophic factor BDNF; Catechol-O-methyltransferase COMT; Precision medicine; Antagonistic pleiotropy; Dopamine; Estrogen	CATECHOL-O-METHYLTRANSFERASE; BDNF VAL66MET POLYMORPHISM; NEUROTROPHIC FACTOR BDNF; APOLIPOPROTEIN-E POLYMORPHISM; TRKB MESSENGER-RNA; COMT VAL(158)MET POLYMORPHISM; ACTIVITY-DEPENDENT SECRETION; CONTROLLED CORTICAL IMPACT; DOPAMINE-RELATED GENES; E APOE GENE	The field of genomics is the principal avenue in the ongoing development of precision/personalised medicine for a variety of health conditions. However, relating genes to outcomes is notoriously complex, especially when considering that other variables can change, or moderate, gene-outcome associations. Here, we comprehensively discuss moderation of gene-outcome associations in the context of traumatic brain injury (TBI), a common, chronically debilitating, and costly neurological condition that is under complex polygenic influence. We focus our narrative review on single nucleotide polymorphisms (SNPs) of three of the most studied genes (apolipo-protein E, brain-derived neurotrophic factor, and catechol-O-methyltransferase) and on three demographic variables believed to moderate associations between these SNPs and TBI outcomes (age, biological sex, and ethnicity). We speculate on the mechanisms which may underlie these moderating effects, drawing widely from biomolecular and behavioural research (n = 175 scientific reports) within the TBI population (n = 72) and other neurological, healthy, ageing, and psychiatric populations (n = 103). We conclude with methodological recommendations for improved exploration of moderators in future genetics research in TBI and other populations.	[Carmichael, Jai; Hicks, Amelia J.; Spitz, Gershon; Gould, Kate Rachel; Ponsford, Jennie] Epworth HealthCare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Carmichael, Jai; Hicks, Amelia J.; Spitz, Gershon; Gould, Kate Rachel; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia		Carmichael, J (corresponding author), Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia.	jai.carmichael@monash.edu	Gould, Kate Rachel/AAA-5511-2020; Ponsford, Jennie/H-8341-2014; Spitz, Gershon/H-7755-2014	Gould, Kate Rachel/0000-0002-3564-7408; Ponsford, Jennie/0000-0003-0430-125X; Carmichael, Jai/0000-0002-3796-9240; Spitz, Gershon/0000-0002-7810-1480; Hicks, Amelia/0000-0002-1152-0576	Australian Government Research Training Program (RTP) ScholarshipAustralian GovernmentDepartment of Industry, Innovation and Science	J.J.C. was supported by an Australian Government Research Training Program (RTP) Scholarship. The authors would like to sincerely thank Dr Dean McKenzie for his suggestions regarding some of the statistical concepts discussed.	Al-Shawi R, 2008, EUR J NEUROSCI, V27, P2103, DOI 10.1111/j.1460-9568.2008.06152.x; Alexander DM, 2007, BIOL PSYCHOL, V75, P229, DOI 10.1016/j.biopsycho.2007.03.001; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; [Anonymous], 2014, EPIDEMIOL METHODS, V3, P33; Atwi S, 2016, NEUROSCIENTIST, V22, P46, DOI 10.1177/1073858414558065; Autry AE, 2009, BIOL PSYCHIAT, V66, P84, DOI 10.1016/j.biopsych.2009.02.007; AXELROD J, 1958, J BIOL CHEM, V233, P702; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Barth C, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00037; Bath KG, 2012, BIOL PSYCHIAT, V72, P499, DOI 10.1016/j.biopsych.2012.03.032; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Gonzalez-Castro TB, 2017, J PSYCHIATR RES, V94, P208, DOI 10.1016/j.jpsychires.2017.07.020; Begliuomini S, 2007, HUM REPROD, V22, P995, DOI 10.1093/humrep/del479; Belsky DW, 2014, BIODEMOGR SOC BIOL, V60, P137, DOI 10.1080/19485565.2014.946591; Bennett E.R., 2016, TRANSLATIONAL RES TR, DOI [10.1201/b18959-10, DOI 10.1201/B18959-10]; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Bodien YG, 2018, J HEAD TRAUMA REHAB, V33, P147, DOI 10.1097/HTR.0000000000000367; BRIGGS MH, 1973, EXPERIENTIA, V29, P278, DOI 10.1007/BF01926474; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Burchard E., 2002, GENOME BIOL, V3, P1, DOI DOI 10.1186/GB-2002-3-7-COMMENT2007; Cao JQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11654-7; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chan CB, 2017, J NEUROSCI RES, V95, P328, DOI 10.1002/jnr.23863; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Cortes D, 2021, NPJ REGEN MED, V6, DOI 10.1038/s41536-020-00114-y; Costa DD, 2016, PSYCHIAT RES, V246, P650, DOI 10.1016/j.psychres.2016.10.073; Covington NV, 2021, AM J SPEECH-LANG PAT, V30, P974, DOI 10.1044/2020_AJSLP-20-00081; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Dennis M, 2013, NEUROSCI BIOBEHAV R, V37, P2760, DOI 10.1016/j.neubiorev.2013.09.010; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Duncan KA, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00345; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Evans S, 2014, NEUROBIOL AGING, V35, P1615, DOI 10.1016/j.neurobiolaging.2014.01.145; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Fallon SJ, 2013, CEREB CORTEX, V23, P361, DOI 10.1093/cercor/bhs025; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Martinez MF, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-125; Finan JD, 2018, J ALZHEIMERS DIS, V65, P1055, DOI 10.3233/JAD-180585; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gabrys RL, 2019, CLIN J SPORT MED, V29, P494, DOI 10.1097/JSM.0000000000000550; Gagner C, 2021, J NEUROTRAUM, V38, P102, DOI 10.1089/neu.2019.6936; Gatt JM, 2015, J PSYCHIATR RES, V60, P1, DOI 10.1016/j.jpsychires.2014.09.014; Gilis-Januszewska A, 2020, ENDOCR CONNECT, V9, pR112, DOI 10.1530/EC-20-0117; Gillies GE, 2014, NEUROSCIENCE, V282, P69, DOI 10.1016/j.neuroscience.2014.05.033; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gomez A, 2021, CURR NEUROL NEUROSCI, V21, DOI 10.1007/s11910-021-01106-1; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Greenwood PM, 2014, SCAND J PSYCHOL, V55, P268, DOI 10.1111/sjop.12123; Gurvich C, 2015, BEHAV BRAIN RES, V281, P96, DOI 10.1016/j.bbr.2014.11.045; Gustafsson D, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073582; Haerian BS, 2013, PHARMACOGENOMICS, V14, P2055, DOI [10.2217/PGS.13.217, 10.2217/pgs.13.217]; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hawkins BE, 2020, J NEUROTRAUM, V37, P2414, DOI 10.1089/neu.2018.6192; Hicks AJ, 2017, BRAIN INJURY, V31, P1312, DOI 10.1080/02699052.2017.1317361; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Ho BC, 2005, MOL PSYCHIATR, V10, P287, DOI 10.1038/sj.mp.4001616; Hoofien D, 2001, BRAIN INJURY, V15, P189; Horsburgh K, 2002, J CEREBR BLOOD F MET, V22, P1189, DOI 10.1097/01.wcb.0000037991.07114.4e; Huie JR, 2021, J NEUROTRAUM, V38, P2514, DOI 10.1089/neu.2019.6762; Huie JR, 2018, CURR OPIN NEUROL, V31, P702, DOI 10.1097/WCO.0000000000000614; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; Jacobs E, 2011, J NEUROSCI, V31, P5286, DOI 10.1523/JNEUROSCI.6394-10.2011; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Jiang H, 2003, NEUROPHARMACOLOGY, V45, P1011, DOI 10.1016/S0028-3908(03)00286-7; Jiang R, 2017, PSYCHONEUROENDOCRINO, V79, P13, DOI 10.1016/j.psyneuen.2017.02.005; Jochemsen HM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.016; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kaasinen V, 2000, NEUROBIOL AGING, V21, P683, DOI 10.1016/S0197-4580(00)00149-4; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kang JH, 2012, NEUROBIOL AGING, V33, P1129, DOI 10.1016/j.neurobiolaging.2010.10.007; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Kurowski BG, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00481; Kurowski BG, 2017, J NEUROTRAUM, V34, P2280, DOI 10.1089/neu.2016.4856; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000162; Lagakos SW, 2006, NEW ENGL J MED, V354, P1667, DOI 10.1056/NEJMp068070; Laing KR, 2012, AGE, V34, P1011, DOI 10.1007/s11357-011-9275-8; Lamb YN, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00965; Lanctot KL, 2010, BRAIN INJURY, V24, P959, DOI 10.3109/02699051003789229; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Lee LO, 2014, PSYCHIAT GENET, V24, P52, DOI 10.1097/YPG.0000000000000018; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lee YH, 2014, NEUROL SCI, V35, P643, DOI 10.1007/s10072-014-1645-4; Lee YH, 2014, J MOTOR BEHAV, V46, P59, DOI 10.1080/00222895.2013.862199; Lefkovits AM, 2021, NEUROPSYCHOL REHABIL, V31, P1582, DOI 10.1080/09602011.2020.1787849; Li GD, 2017, NEUROBIOL AGING, V53, DOI 10.1016/j.neurobiolaging.2016.12.023; Li LZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002028; Li M, 2016, NEUROSCI BIOBEHAV R, V68, P218, DOI 10.1016/j.neubiorev.2016.05.031; Lin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094961; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu MY, 2014, SCI REP-UK, V4, DOI 10.1038/srep04383; Long AD, 1999, GENOME RES, V9, P720; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Marini S, 2019, JAMA NEUROL, V76, P480, DOI 10.1001/jamaneurol.2018.4519; Martin AR, 2017, AM J HUM GENET, V100, P635, DOI 10.1016/j.ajhg.2017.03.004; Martinez BI, 2019, J BIOL ENG, V13, DOI 10.1186/s13036-019-0145-8; Mbakile-Mahlanza L, 2015, NEUROPSYCHOL REHABIL, V25, P936, DOI 10.1080/09602011.2014.999000; McAllister T.W., 2018, TXB TRAUMATIC BRAIN, V3rd, P127, DOI [10.1176/appi.books.9781615372645, DOI 10.1176/APPI.BOOKS.9781615372645]; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McFadyen CA, 2021, J NEUROTRAUM, V38, P1124, DOI 10.1089/neu.2018.6052; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; Merritt VC, 2020, CLIN NEUROPSYCHOL, V34, P1226, DOI 10.1080/13854046.2020.1740324; Merritt VC, 2018, J NEUROTRAUM, V35, P2272, DOI 10.1089/neu.2017.5372; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Molendijk ML, 2012, WORLD J BIOL PSYCHIA, V13, P535, DOI 10.3109/15622975.2011.587892; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Mukherjee N, 2010, MOL PSYCHIATR, V15, P216, DOI 10.1038/mp.2008.64; Myrga JM, 2016, NEUROREHAB NEURAL RE, V30, P920, DOI 10.1177/1545968316648409; Myrga JM, 2016, J HEAD TRAUMA REHAB, V31, pE15, DOI 10.1097/HTR.0000000000000199; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nagel IE, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.001.2008; Narayanan V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158838; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; Nekrosius D, 2019, J NEUROPSYCH CLIN N, V31, P298, DOI 10.1176/appi.neuropsych.18080195; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; Nemoto K, 2006, NEUROSCI LETT, V397, P25, DOI 10.1016/j.neulet.2005.11.067; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Olsen A, 2021, BRAIN IMAGING BEHAV, V15, P526, DOI 10.1007/s11682-020-00313-7; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Padgett CR, 2016, NEUROPSYCHOLOGY, V30, P775, DOI 10.1037/neu0000270; Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0; Papaleo F, 2015, EUR NEUROPSYCHOPHARM, V25, P2349, DOI 10.1016/j.euroneuro.2015.10.005; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Plomin R, 2016, PERSPECT PSYCHOL SCI, V11, P3, DOI 10.1177/1745691615617439; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Ponsford J, 2020, NEUROPSYCHOL REHABIL, V30, P85, DOI 10.1080/09602011.2018.1453367; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raghava Narayan, 2017, Neurosci Neuroecon, V6, P15, DOI 10.2147/NAN.S105134; Rajabli F, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007791; Redell JB, 2007, NEUROSCI LETT, V413, P36, DOI 10.1016/j.neulet.2006.11.060; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Romanczyk TB, 2002, EUR J NEUROSCI, V15, P269, DOI 10.1046/j.0953-816x.2001.01858.x; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Rusted JM, 2013, NEUROIMAGE, V65, P364, DOI 10.1016/j.neuroimage.2012.10.010; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Sawada H, 1998, J NEUROSCI RES, V54, P707, DOI 10.1002/(SICI)1097-4547(19981201)54:5<707::AID-JNR16>3.0.CO;2-T; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Sirugo G, 2019, CELL, V177, P26, DOI 10.1016/j.cell.2019.02.048; Smith CT, 2012, PSYCHOPHARMACOLOGY, V222, P609, DOI 10.1007/s00213-012-2653-9; Smith-Paine J, 2020, J HEAD TRAUMA REHAB, V35, P262, DOI 10.1097/HTR.0000000000000564; Smith-Paine J, 2018, J NEUROTRAUM, V35, P2796, DOI 10.1089/neu.2017.5388; Sonoyama T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65531-x; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Srivastava RAK, 1997, J BIOL CHEM, V272, P33360, DOI 10.1074/jbc.272.52.33360; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Stone DJ, 1998, J NEUROSCI, V18, P3180; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor S, 2018, AM J MED GENET B, V177, P199, DOI 10.1002/ajmg.b.32556; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tenovuo O, 2021, J CLIN MED, V10, DOI 10.3390/jcm10010148; Tensaouti Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229240; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Thomas J., 2019, COCHRANE HDB SYSTEMA, P547; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Treble-Barna A, 2021, J NEUROTRAUM, DOI 10.1089/neu.2020.7466; Treble-Barna A, 2020, J NEUROTRAUM, V37, P1491, DOI 10.1089/neu.2019.6866; Treble-Barna A, 2017, J NEUROTRAUM, V34, P1919, DOI 10.1089/neu.2016.4840; Tsai SJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00156; Tuerk C, 2020, BRAIN RES, V1748, DOI 10.1016/j.brainres.2020.147061; Tuminello Elizabeth R, 2011, Int J Alzheimers Dis, V2011, P726197, DOI 10.4061/2011/726197; Turan B, 2016, PSYCHOL AGING, V31, P287, DOI 10.1037/pag0000085; Turney I.C., 2020, ALZH DEMENT-DADM, P12; Tzourio C, 2008, NEUROLOGY, V70, P1322, DOI 10.1212/01.wnl.0000308819.43401.87; van Bregt DR, 2012, EXP NEUROL, V234, P8, DOI 10.1016/j.expneurol.2011.12.003; van der Sluis S, 2013, MOL PSYCHIATR, V18, P2, DOI 10.1038/mp.2012.65; VanderWheele T.J., 2021, MODERN EPIDEMIOLOGY, V4th; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Wang JM, 2006, P NATL ACAD SCI USA, V103, P16983, DOI 10.1073/pnas.0608128103; Wang MQ, 2016, J NEUROIMMUNE PHARM, V11, P434, DOI 10.1007/s11481-016-9651-3; Wang YJ, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-017-0518-0; Waszczuk MA, 2020, J ABNORM PSYCHOL, V129, P143, DOI 10.1037/abn0000486; Weaver SM, 2014, BRAIN IMAGING BEHAV, V8, P420, DOI 10.1007/s11682-012-9197-9; Weaver SM, 2012, NEUROSCIENTIST, V18, P631, DOI 10.1177/1073858411435706; Webster MJ, 2006, GENE EXPR PATTERNS, V6, P941, DOI 10.1016/j.modgep.2006.03.009; Wei SM, 2018, MOL PSYCHIATR, V23, P1066, DOI 10.1038/mp.2017.72; Wheble JLC, 2016, J ROY ARMY MED CORPS, V162, P87, DOI 10.1136/jramc-2015-000472; White TP, 2014, NEUROPSYCHOPHARMACOL, V39, P2560, DOI 10.1038/npp.2014.107; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460; Willmott C, 2014, J NEUROTRAUM, V31, P1507, DOI 10.1089/neu.2013.3308; Willmott C, 2013, BRAIN INJURY, V27, P1281, DOI 10.3109/02699052.2013.809553; Winkler EA, 2017, J CLIN NEUROSCI, V35, P109, DOI 10.1016/j.jocn.2016.09.017; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Worda C, 2003, HUM REPROD, V18, P262, DOI 10.1093/humrep/deg059; Wright RO, 2003, PEDIATR RES, V54, P819, DOI 10.1203/01.PDR.0000090927.53818.DE; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Xie T, 1999, MOL PHARMACOL, V56, P31, DOI 10.1124/mol.56.1.31; Yaffe K, 2000, NEUROLOGY, V54, P1949, DOI 10.1212/WNL.54.10.1949; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Yousuf A, 2015, J MOL NEUROSCI, V56, P597, DOI 10.1007/s12031-015-0554-1; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zeiler FA, 2021, J NEUROTRAUM, V38, P1107, DOI 10.1089/neu.2017.5583; Zeng S, 2014, GENET TEST MOL BIOMA, V18, P202, DOI 10.1089/gtmb.2013.0421; Zhou R, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00085; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zokaei N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66114-6; Zokaei N, 2017, CORTEX, V88, P98, DOI 10.1016/j.cortex.2016.12.016; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	267	0	0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-7634	1873-7528		NEUROSCI BIOBEHAV R	Neurosci. Biobehav. Rev.	NOV	2021	130						107	124		10.1016/j.neubiorev.2021.08.015			18	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	WA9DI	WOS:000703182200009	34411558				2022-02-06	
J	Carrillo-Mora, P; Aldrete-Cortez, V; Guzman-Cortes, JA; Garcia-de la Torre, G; Tirado-Gomez, L; Navarro, L; Soto-Lara, M; Franyutti-Prado, KF; Barajas-Martinez, KG				Carrillo-Mora, Paul; Aldrete-Cortez, Vania; Guzman-Cortes, Jorge A.; Garcia-de la Torre, Guadalupe; Tirado-Gomez, Laura; Navarro, Luz; Soto-Lara, Maria; Franyutti-Prado, Kenia F.; Barajas-Martinez, Karina G.			High cognitive demand tasks may detect mild alterations in executive functions in American football players: A pilot study	REVISTA MEXICANA DE NEUROCIENCIA			English	Article						Traumatic brain injury; Concussion; Executive functions; Sports; Cognition	NEUROPSYCHOLOGICAL ASSESSMENT; CONCUSSION HISTORY; HIGH-SCHOOL; SPORT; OUTCOMES; INJURY	Background: Repeated head trauma associated with sports activities can cause subtle cognitive alterations in amateur players, but these are difficult to detect. Objective: The objective of this pilot study was to determine if there is an association between executive functions performance and different sports practice variables in a sample of amateur American football players. Methods: A pilot transversal study with amateur American football male players without previous neurological or psychiatric illnesses, drug abuse, or consumption of psychotropic medications were carried out and evaluated executive functions performance using automated test. In addition, the levels of stress, impulsivity, and symptoms of anxiety and depression were evaluated, as well as multiple variables related to sports practice such as previous concussions, time of sports practice, weekly training time, and position within the game. Results: Fourteen men players were assessed, with an average age of 20.57 (standard deviation [SD] +/- 1.61) years, played 7 (50%) in an offensive position, 7 (50%) in defensive position, and 3 (21%) presented previous sport-related brain trauma. The average time of practice football was of 35.07 (SD +/- 43.10) months, starting age of football playing 17.71 (SD +/- 3.64), and hours of training during the week 5.75 (SD +/- 2.83). There was no association between cognitive performance and any sports practice variable, however, the offensive position showed significant association with impairments in the highest span of visual working memory task (beta = 0.53, SE = 0.16, p = 0.001). Conclusion: The results suggest that executive tasks with high cognitive demand may reveal alterations in the short term in amateur American football players.	[Carrillo-Mora, Paul] Inst Nacl Rehabil LGII, Neurosci Div, Mexico City, DF, Mexico; [Aldrete-Cortez, Vania] Univ Panamer, Sch Psychol, Lab Neurosci & Cognit Dev, Mexico City, DF, Mexico; [Guzman-Cortes, Jorge A.] Univ Autonoma Estado Hidalgo, Escuela Super Actopan, Pachuca, Hidalgo, Mexico; [Garcia-de la Torre, Guadalupe; Tirado-Gomez, Laura; Navarro, Luz; Soto-Lara, Maria] Univ Nacl Autonoma Mexico, Fac Med, Mexico City, DF, Mexico; [Franyutti-Prado, Kenia F.] Hosp Gen Dr Fernando Quiroz Gutierrez, Inst Seguridad & Serv Sociales Trabajadores Estad, Internal Med Serv, Mexico City, DF, Mexico; [Barajas-Martinez, Karina G.] Hosp Fdn Nuestra Senora de la Luz, Dept Consulta Especialidad, Mexico City, DF, Mexico		Carrillo-Mora, P (corresponding author), Inst Nacl Rehabil LGII, Neurosci Div, Mexico City, DF, Mexico.	neuropolaco@yahoo.com.mx					Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Canseco Jose A, 2021, Clin J Sport Med, DOI 10.1097/JSM.0000000000000918; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Cunningham J, 2020, J ATHL TRAINING, V55, P132, DOI 10.4085/1062-6050-297-18; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guzman-Cortes JA, 2016, NEUROPSICOL CLIN, V1, P20; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kontos AP, 2019, J HEAD TRAUMA REHAB, V34, P394, DOI 10.1097/HTR.0000000000000536; Marklund N, 2021, NEUROIMAGE-CLIN, V30, DOI 10.1016/j.nicl.2021.102665; Moroni C, 2021, NEUROCHIRURGIE, V67, P244, DOI 10.1016/j.neuchi.2020.06.134; Nolan A, 2018, J NEUROTRAUM, V35, P2425, DOI 10.1089/neu.2018.5731; Orozco-Calderon G, 2019, CIENCIA FUTURO, V9, P116; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Solomon G, 2018, DEV NEUROPSYCHOL, V43, P279, DOI 10.1080/87565641.2018.1447575; Tapper A, 2017, J SPORT SCI, V35, P231, DOI 10.1080/02640414.2016.1161214; Terpstra AR, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00712; Verduyn C, 2021, NEUROLOGY, V96, P705, DOI 10.1212/WNL.0000000000011750; Zetterberg H, 2019, J INTERN MED, V285, P624, DOI 10.1111/joim.12863; Zimmerman KA, 2021, J BIOMECH, V118, DOI 10.1016/j.jbiomech.2021.110256	25	0	0	0	0	ACAD MEXICANA NEUROLOGIA	MEXICO	SAN FRANCISCO, 1384 TORRE B 7O PISO, COL VALLE, MEXICO, DF 03100, MEXICO	1665-5044			REV MEX NEUROCIENC	Rev. Mex. Neurocienc.	NOV-DEC	2021	22	6					219	223		10.24875/RMN.21000035			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WX1LJ	WOS:000718365100002		gold			2022-02-06	
J	Catta-Preta, R; Zdilar, I; Jenner, B; Doisy, ET; Tercovich, K; Nord, AS; Gurkoff, GG				Catta-Preta, Rinaldo; Zdilar, Iva; Jenner, Bradley; Doisy, Emily T.; Tercovich, Kayleen; Nord, Alex S.; Gurkoff, Gene G.			Transcriptional Pathology Evolves over Time in Rat Hippocampus after Lateral Fluid Percussion Traumatic Brain Injury	NEUROTRAUMA REPORTS			English	Article						differential expression; longitudinal; neurodegeneration; rat; TBI	GENE-EXPRESSION; AMYLOID-BETA; MOUSE CORTEX; RNA; MECHANISMS; DISEASE; NEUROINFLAMMATION; CHOLESTEROL; METHYLATION; RECOVERY	Traumatic brain injury (TBI) causes acute and lasting impacts on the brain, driving pathology along anatomical, cellular, and behavioral dimensions. Rodent models offer an opportunity to study the temporal progression of disease from injury to recovery. Transcriptomic and epigenomic analysis were applied to evaluate gene expression in ipsilateral hippocampus at 1 and 14 days after sham (n = 2 and 4, respectively per time point) and moderate lateral fluid percussion injury (n = 4 per time point). This enabled the identification of dynamic changes and differential gene expression (differentially expressed genes; DEGs) modules linked to underlying epigenetic response. We observed acute signatures associated with cell death, astrocytosis, and neurotransmission that largely recovered by 2 weeks. Inflammation and immune signatures segregated into upregulated modules with distinct expression trajectories and functions. Whereas most down-regulated genes recovered by 14 days, two modules with delayed and persistent changes were associated with cholesterol metabolism, amyloid beta clearance, and neurodegeneration. Differential expression was paralleled by changes in histone H3 lysine residue 4 trimethylation at the promoters of DEGs at 1 day post-TBI, with the strongest changes observed for inflammation and immune response genes. These results demonstrate how integrated genomics analysis in the pre-clinical setting has the potential to identify stage-specific biomarkers for injury and/or recovery. Though limited in scope here, our general strategy has the potential to capture pathological signatures over time and evaluate treatment efficacy at the systems level.	[Catta-Preta, Rinaldo; Zdilar, Iva; Jenner, Bradley; Nord, Alex S.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Doisy, Emily T.; Tercovich, Kayleen; Gurkoff, Gene G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Catta-Preta, Rinaldo; Zdilar, Iva; Jenner, Bradley; Tercovich, Kayleen; Nord, Alex S.; Gurkoff, Gene G.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Catta-Preta, Rinaldo] Harvard Med Sch, Blavatnik Inst, Dept Genet, Boston, MA 02115 USA		Gurkoff, GG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 4800 Y St,Suite 3740, Sacramento, CA 95817 USA.	gggurkoff@ucdavis.edu		Catta-Preta, Rinaldo/0000-0001-9833-1278	UC Davis; NIH NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R35GM119831]; CNPq (Brazil)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084026]	A.S.N. and R.C.-P. were supported by UC Davis institutional support (to A.S.N.) and NIH NIGMS R35GM119831. R.C.-P. was supported by a Science without Borders Fellowship from CNPq (Brazil). E.T.D., K.T., and G.G. were supported by UC Davis institutional support and NINDS R01NS084026.	Andrews S., 2010, BABRAHAM BIOINFORMAT; Arenas F, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00382; Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Arneson D, 2018, J GENET, V97, P795, DOI 10.1007/s12041-018-0963-3; Attilio PJ, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.636259; Aykac A, 2020, CLIN PSYCHOPHARM NEU, V18, P174, DOI 10.9758/cpn.2020.18.2.174; Barbero-Camps E, 2018, AUTOPHAGY, V14, P1129, DOI 10.1080/15548627.2018.1438807; Bezerra GA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08769; Blaze J, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.00160; Boone DR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214741; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Cacabelos R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030551; Castranio EL, 2017, NEUROBIOL DIS, V105, P1, DOI 10.1016/j.nbd.2017.05.006; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chen D., 2019, SINGLE CELL ATLAS DO, DOI [10.1101/2019.12.11.872721, DOI 10.1101/2019.12.11.872721]; Cho H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65916-y; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Defense and Veterans Brain Injury Center, 2019, DOD NUMB TRAUM BRAIN; Di Pietro V, 2010, J NEUROTRAUM, V27, P349, DOI 10.1089/neu.2009.1095; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Felderhoff-Mueser U, 2005, TRENDS NEUROSCI, V28, P487, DOI 10.1016/j.tins.2005.06.008; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gompers AL, 2017, NAT NEUROSCI, V20, P1062, DOI 10.1038/nn.4592; Guo X., 2020, SECONDARY SINGLE CEL, DOI [10.1101/2020.06.29.178855, DOI 10.1101/2020.06.29.178855]; Gurkoff G, 2013, PHARMACEUTICALS, V6, P788, DOI 10.3390/ph6070788; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Jiang YJ, 2019, J NEUROTRAUM, V36, P1018, DOI 10.1089/neu.2018.5647; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Kobeissy F., 2015, BRAIN NEUROTRAUMA MO; Krueger F, 2015, TRIM GALORE WRAPPER; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Lalli MA, 2012, HUM MUTAT, V33, P1630, DOI 10.1002/humu.22167; Lemche E, 2018, CURR GENOMICS, V19, P522, DOI 10.2174/1389202919666171229145156; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lipponen A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0519-z; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; Luo J, 2020, NAT REV MOL CELL BIO, V21, P225, DOI 10.1038/s41580-019-0190-7; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Malik B, 2012, NEUROCHEM INT, V61, P321, DOI 10.1016/j.neuint.2012.05.006; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; McGuire JL, 2019, MOL PSYCHIATR, V24, P995, DOI 10.1038/s41380-018-0239-6; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; Murray SC., 2019, H3K4ME3 NEITHER INST, DOI [10.1101/709014, DOI 10.1101/709014]; Nagalakshmi B, 2018, PROG MOL BIOL TRANSL, V157, P263, DOI 10.1016/bs.pmbts.2017.12.013; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; O'Brien WT, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01778-5; Pantaleo N, 2010, CNS NEUROL DISORD-DR, V9, P627, DOI 10.2174/187152710793361504; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Samal BB, 2015, J MOL NEUROSCI, V57, P282, DOI 10.1007/s12031-015-0626-2; Sarnowski C, 2018, NEUROLOGY, V90, pE188, DOI 10.1212/WNL.0000000000004820; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Takahata Keisuke, 2016, Brain Nerve, V68, P849, DOI 10.11477/mf.1416200517; Todd BP, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02197-w; Toutonji A, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01226-2; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Van KC, 2016, METHODS MOL BIOL, V1462, P231, DOI 10.1007/978-1-4939-3816-2_14; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Wang MX, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1610; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Wong VS, 2016, NEUROSCI LETT, V625, P26, DOI 10.1016/j.neulet.2016.04.009; Wood WG, 2014, J NEUROCHEM, V129, P559, DOI 10.1111/jnc.12637; Xicoy H, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010027; Xie Zhuorui, 2021, Curr Protoc, V1, pe90, DOI 10.1002/cpz1.90; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu JT, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-0554-0; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao RT, 2018, J NEUROTRAUM, V35, P2056, DOI 10.1089/neu.2017.5502; Zhao Zhi-Jie, 2021, Comput Math Methods Med, V2021, P5511598, DOI 10.1155/2021/5511598; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078	84	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	NOV 1	2021	2	1					512	525		10.1089/neur.2021.0021			14	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	XD6XT	WOS:000722849800001	34909768	gold, Green Published			2022-02-06	
J	Chang, T; Yan, XG; Zhao, C; Zhang, YF; Wang, B; Gao, L				Chang, Tao; Yan, Xigang; Zhao, Chao; Zhang, Yufu; Wang, Bao; Gao, Li			Noninvasive evaluation of intracranial pressure in patients with traumatic brain injury by transcranial Doppler ultrasound	BRAIN AND BEHAVIOR			English	Article						intracranial pressure; optic nerve sheath diameter; pulsatility index; transcranial Doppler ultrasound; traumatic brain injury	PULSATILITY INDEX; SONOGRAPHY; MANAGEMENT	Introduction The purpose of this study was to investigate the relationship between pulsatility index (PI) or optic nerve sheath diameter (ONSD) and intracranial pressure (ICP) in patients with traumatic brain injury (TBI), and the ability of ONSD and ICP to predict intracranial hypertension. Methods A total of 68 patients with TBI were included in this retrospective study. After receiving surgery treatment, they underwent transcranial Doppler ultrasound (TCD). The statistical correlation between PI or ONSD and ICP 1 week after surgery was analyzed. Furthermore, the areas under the curve (AUCs) of ONSD or PI or a combination of them were calculated to predict intracranial hypertension. Results There was a correlation between ONSD and ICP. This correlation still remained at ONSD >= 5 mm. Furthermore, there was a strong correlation between PI and ICP. There was a moderate correlation between ICP and PI on days 3, 4, and 5 after surgery (r = 0.508, p < .001), and a strong correlation on days 6 and 7 after surgery (r = 0.645, p < .001). Moreover, for predicting intracranial hypertension with PI >= 1.2 mm or ONSD >= 5 mm or a combination of them, the AUC was 0.729, 0.900, and 0.943, respectively (p < .001). Conclusions The correlation between ONSD or PI and invasive ICP was different with different levels of ICP in different periods in patients with TBI after surgery. When ONSD >= 5 mm and PI >= 1.2, it could predict elevated ICP more accurately.	[Chang, Tao] Air Force Med Univ, Affiliated Hosp 2, Dept Emergency, Xian, Peoples R China; [Yan, Xigang] Air Force Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Xian, Peoples R China; [Zhao, Chao] Air Force Med Univ, Affiliated Hosp 2, Dept Neurol, Xian, Peoples R China; [Zhang, Yufu; Wang, Bao; Gao, Li] Air Force Med Univ, Affiliated Hosp 2, Dept Neurosurg, 1 Xinsi Rd, Xian 710038, Shaanxi, Peoples R China		Gao, L (corresponding author), Air Force Med Univ, Affiliated Hosp 2, Dept Neurosurg, 1 Xinsi Rd, Xian 710038, Shaanxi, Peoples R China.	ggl38971@sohu.com			General Program of National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81971186]	This study was supported by General Program of National Natural Science Foundation of China (No. 81971186).	Agrawal A, 2019, CRIT CARE MED, V47, pE495, DOI 10.1097/CCM.0000000000003742; Behrens A, 2010, NEUROSURGERY, V66, P1050, DOI 10.1227/01.NEU.0000369519.35932.F2; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Blanco P, 2017, J ULTRAS MED, V36, P1251, DOI 10.7863/ultra.16.04050; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; D'Andrea A, 2016, J CARDIOVASC ECHOGR, V26, P28, DOI 10.4103/2211-4122.183746; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; Kim DJ, 2009, PHYSIOL MEAS, V30, P647, DOI 10.1088/0967-3334/30/7/009; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; Prunet B, 2012, AM J EMERG MED, V30, P936, DOI 10.1016/j.ajem.2011.05.005; Qayyum H, 2013, EUR J EMERG MED, V20, P91, DOI 10.1097/MEJ.0b013e32835105c8; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Robba C, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03105-z; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; Yuan Q, 2016, NEUROSURGERY, V78, P361, DOI 10.1227/NEU.0000000000001050; Zhou J, 2019, BMC MED IMAGING, V19, DOI 10.1186/s12880-019-0354-0	18	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	DEC	2021	11	12							e2396	10.1002/brb3.2396		NOV 2021	7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	XO3CM	WOS:000713509100001	34725957	gold, Green Published			2022-02-06	
J	Cheng, PW; Wu, YC; Wong, TY; Sun, GC; Tseng, CJ				Cheng, Pei-Wen; Wu, Yi-Chung; Wong, Tzyy-Yue; Sun, Gwo-Ching; Tseng, Ching-Jiunn			Mechanical Stretching-Induced Traumatic Brain Injury Is Mediated by the Formation of GSK-3 beta-Tau Complex to Impair Insulin Signaling Transduction	BIOMEDICINES			English	Article						mechanical stimulations; traumatic brain injury (TBI); stretching; neurons; GSK-3 beta; p-Tau	GLYCOGEN-SYNTHASE KINASE-3; LONG-TERM POTENTIATION; AMYLOID-BETA; ALZHEIMERS-DISEASE; TAU; DEMENTIA; PHOSPHORYLATION; INHIBITION; INSIGHTS; MODEL	Traumatic brain injury confers a significant and growing public health burden. It is a major environmental risk factor for dementia. Nonetheless, the mechanism by which primary mechanical injury leads to neurodegeneration and an increased risk of dementia-related diseases is unclear. Thus, we aimed to investigate the effect of stretching on SH-SY5Y neuroblastoma cells that proliferate in vitro. These cells retain the dopamine-beta-hydroxylase activity, thus being suitable for neuromechanistic studies. SH-SY5Y cells were cultured on stretchable membranes. The culture conditions contained two groups, namely non-stretched (control) and stretched. They were subjected to cyclic stretching (6 and 24 h) and 25% elongation at 1 Hz. Following stretching at 25% and 1 Hz for 6 h, the mechanical injury changed the mitochondrial membrane potential and triggered oxidative DNA damage at 24 h. Stretching decreased the level of brain-derived neurotrophic factors and increased amyloid-beta, thus indicating neuronal stress. Moreover, the mechanical injury downregulated the insulin pathway and upregulated glycogen synthase kinase 3 beta (GSK-3 beta)(S9)/p-Tau protein levels, which caused a neuronal injury. Following 6 and 24 h of stretching, GSK-3 beta(S9) was directly bound to p-Tau(S396). In contrast, the neuronal injury was improved using GSK-3 beta inhibitor TWS119, which downregulated amyloid-beta/p-Taus396 phosphorylation by enhancing ERK1/2T202/Y204 and AktS473 phosphorylation. Our findings imply that the neurons were under stress and that the inactivation of the GSK3 beta could alleviate this defect.	[Cheng, Pei-Wen; Wong, Tzyy-Yue; Tseng, Ching-Jiunn] Kaohsiung Vet Gen Hosp, Dept Educ & Res, Kaohsiung 813414, Taiwan; [Cheng, Pei-Wen; Tseng, Ching-Jiunn] Natl Sun Yat Sen Univ, Dept Biomed Sci, Kaohsiung 80424, Taiwan; [Wu, Yi-Chung] Kaohsiung Armed Forces Gen Hosp, Zuoying Branch, Sect Neurol, Kaohsiung 81342, Taiwan; [Wu, Yi-Chung] Natl Def Med Ctr, Sch Med, Taipei 11490, Taiwan; [Wong, Tzyy-Yue] Natl Cheng Kung Univ, Int Ctr Wound Repair & Regenerat, Tainan, Taiwan; [Sun, Gwo-Ching] Kaohsiung Med Univ Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Sun, Gwo-Ching] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan		Cheng, PW (corresponding author), Kaohsiung Vet Gen Hosp, Dept Educ & Res, Kaohsiung 813414, Taiwan.; Cheng, PW (corresponding author), Natl Sun Yat Sen Univ, Dept Biomed Sci, Kaohsiung 80424, Taiwan.	pwcheng@vghks.gov.tw; m870563@yahoo.com; gcsun39@yahoo.com.tw; cjtseng@vghks.gov.tw			National Science CouncilMinistry of Science and Technology, Taiwan [MOST108-2320-B-075B-001]; Zouying Branch of Kaohsiung Armed Forces General Hospital Kaohsiung [ZBH 108-05, KAFGH-ZY-A-109001, KAFGH-ZY-A-110001]; Kaohsiung Veterans General Hospital [KSVGH-IGA-110-1]	This work was supported by funding from the National Science Council (MOST108-2320-B-075B-001), the Zouying Branch of Kaohsiung Armed Forces General Hospital Kaohsiung (ZBH 108-05, KAFGH-ZY-A-109001, KAFGH-ZY-A-110001), and the Kaohsiung Veterans General Hospital (KSVGH-IGA-110-1).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; ADOLFSSON R, 1980, ACTA MED SCAND, V208, P387; Ahmed F, 2014, CNS NEUROL DISORD-DR, V13, P312, DOI 10.2174/18715273113126660133; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Atwood CS, 2003, BRAIN RES REV, V43, P1, DOI 10.1016/S0165-0173(03)00174-7; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; de la Monte SM, 2000, ALCOHOL CLIN EXP RES, V24, P716, DOI 10.1097/00000374-200005000-00017; de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Freund RK, 2016, MOL PHARMACOL, V89, P552, DOI 10.1124/mol.115.103085; FUJISAWA Y, 1991, BIOL PSYCHIAT, V30, P1219, DOI 10.1016/0006-3223(91)90158-I; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hall ED, 2016, J BIOENERG BIOMEMBR, V48, P169, DOI 10.1007/s10863-015-9600-5; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Jing Y, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01215; Koch JC, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.169; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Leng SH, 2010, J ENDOCRINOL, V206, P171, DOI 10.1677/JOE-09-0456; Lewitt MS, 2019, BIOCHEM INSIGHTS, V12, DOI 10.1177/1178626419842176; Liberman Z, 2005, J BIOL CHEM, V280, P4422, DOI 10.1074/jbc.M410610200; Ma MW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0150-7; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Medina M, 2010, CURR PHARM DESIGN, V16, P2790, DOI 10.2174/138161210793176581; Miranda M, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00363; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Moussaud S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-43; Mullins RJ, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00118; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Olczak M, 2017, FORENSIC SCI INT, V280, P1, DOI 10.1016/j.forsciint.2017.09.008; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Rosas-Hernandez H, 2019, NEUROCHEM RES, V44, P2546, DOI 10.1007/s11064-019-02872-8; Sadigh-Eteghad S, 2015, MED PRIN PRACT, V24, P1, DOI 10.1159/000369101; Shim SS, 2016, J NEUROTRAUM, V33, P2065, DOI 10.1089/neu.2015.4177; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang F, 2014, NEUROTOXICOLOGY, V41, P54, DOI 10.1016/j.neuro.2014.01.002; Wang TW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07544-7; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Xu J, 2003, J BIOL CHEM, V278, P26929, DOI 10.1074/jbc.M300401200; Xu XP, 2016, BRAIN RES BULL, V124, P214, DOI 10.1016/j.brainresbull.2016.05.010; Xu ZM, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0378-8	54	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9059		BIOMEDICINES	Biomedicines	NOV	2021	9	11							1650	10.3390/biomedicines9111650			17	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine; Pharmacology & Pharmacy	XJ9FX	WOS:000727085400001	34829879	gold, Green Published			2022-02-06	
J	Chiang, HS; Motes, M; O'Hair, R; Vanneste, S; Kraut, M; Hart, J				Chiang, Hsueh-Sheng; Motes, Michael; O'Hair, Rachel; Vanneste, Sven; Kraut, Michael; Hart, John Jr Jr			Baseline delayed verbal recall predicts response to high definition transcranial direct current stimulation targeting the superior medial frontal cortex	NEUROSCIENCE LETTERS			English	Article						HD-tDCS; tDCS; TBI; Verbal fluency; Delayed recall; Pre-SMA; dACC; Veterans	TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; CATEGORY FLUENCY; MEMORY DEFICITS; MOTOR AREA; RELIABILITY; DYSFUNCTION; SEQUELAE; DAMAGE	Anodal high definition transcranial direct current stimulation (HD-tDCS) targeting the pre-supplementary motor area/dorsal anterior cingulate cortex (pre-SMA/dACC) has recently been shown to improve verbal retrieval deficits in veterans with chronic traumatic brain injury (TBI) (Motes et al., 2020), but predictors of treatment response are unclear. We hypothesized that baseline delayed verbal recall, a sensitive measure for post-TBI chronic cognitive decline, would predict therapeutic effects of HD-tDCS targeting the pre-SMA/dACC for verbal retrieval deficits. Standardized verbal retrieval measures were administered at baseline, immediately after and 8 weeks after treatment completion. We applied mixed generalized linear modeling as a post-hoc subgroup analysis to the verbal retrieval scores that showed significant improvement in Motes at el. (2020) to examine effects of active stimulation across the groups with baseline-intact delayed recall (N = 10) and baseline-impaired delayed recall (N = 8), compared to sham (N = 7). Individuals with impaired baseline delayed recall showed significant improvement (compared to baseline) in both category fluency and color-word inhibition/switch, while individuals with intact delayed recall showed significant improvement only in color-word inhibition/switch. Baseline delayed verbal recall may therefore be considered as a predictor for future electromodulation studies targeting frontal structures to treat TBI-related verbal deficits.	[Chiang, Hsueh-Sheng; Hart, John Jr Jr] Univ Texas Southwestern Med Ctr, Dept Neurol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Chiang, Hsueh-Sheng; Motes, Michael; O'Hair, Rachel; Vanneste, Sven; Hart, John Jr Jr] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA; [Vanneste, Sven] Trinity Coll Dublin, Global Brain Hlth Inst, Dublin, Ireland; [Kraut, Michael] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21218 USA; [Hart, John Jr Jr] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Motes, Michael; O'Hair, Rachel; Hart, John Jr Jr] Univ Texas Dallas, Sch Behav & Brain Sci, 800 W Campbell Rd, Richardson, TX 75080 USA; [Vanneste, Sven] Univ Dublin, Trinity Coll Dublin, Dublin 2, Ireland; [Kraut, Michael] Johns Hopkins Univ, Dept Radiol, Sch Med, 601 N Caroline St, Baltimore, MD 21205 USA		Chiang, HS (corresponding author), Univ Texas Southwestern Med Ctr, Dept Neurol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	hschiang@utdallas.edu		Kraut, Michael/0000-0002-1255-0494; Motes, Michael/0000-0001-6635-6948; Vanneste, Sven/0000-0003-1513-5752; Hart, John/0000-0003-3919-8125; Chiang, Hsueh-Sheng/0000-0003-2211-6007	Boot Campaign; NINDS R25 under the UT Southwestern Integrated Program for the Advancement of Neuroscience Research Careers (UT SWANS) [NS09898702]	Partial study funding was provided by the Boot Campaign (Assessment and Treatment of Veterans with TBI and/or PTSD, Boot Campaign; $339963, 9/29/2016-no end date) and awarded to J. Hart, Jr. at 10% effort. H.-S. Chiang was supported for his research time by NINDS R25 (NS09898702) under the UT Southwestern Integrated Program for the Advancement of Neuroscience Research Careers (UT SWANS).	Asamoah B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08183-w; Baldo JV, 2006, J INT NEUROPSYCH SOC, V12, P896, DOI 10.1017/S1355617706061078; Baldo JV, 1998, NEUROPSYCHOLOGY, V12, P259, DOI 10.1037/0894-4105.12.2.259; Blecher T, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01607; Broadway JM, 2019, CORTEX, V120, P240, DOI 10.1016/j.cortex.2019.06.011; Cattaneo Z, 2011, NEUROSCIENCE, V183, P64, DOI 10.1016/j.neuroscience.2011.03.058; Chiang HS, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.678518; Chiang HS, 2013, NEUROREPORT, V24, P889, DOI 10.1097/WNR.0000000000000014; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Delis DC., 2001, DELIS KAPLAN EXECUTI; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Esmaeilpour Z, 2018, BRAIN STIMUL, V11, P310, DOI 10.1016/j.brs.2017.12.002; Filmer HL, 2014, TRENDS NEUROSCI, V37, P742, DOI 10.1016/j.tins.2014.08.003; Giordano J, 2017, DOSE-RESPONSE, V15, DOI 10.1177/1559325816685467; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Hamsher K., 1994, MULTILINGUAL APHASIA; Hart J, 2013, BRAIN LANG, V126, P89, DOI 10.1016/j.bandl.2012.08.002; Hertrich I, 2016, NEUROSCI BIOBEHAV R, V68, P602, DOI 10.1016/j.neubiorev.2016.06.030; Huang Y., BRAIN STIMUL, V14, P1005; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kaplan E, 1983, BOSTON NAMING TEST; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kave G, 2020, J COMMUN DISORD, V83, DOI 10.1016/j.jcomdis.2019.105968; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klaus J, 2018, BRAIN COGNITION, V123, P10, DOI 10.1016/j.bandc.2018.02.007; Kuo HI, 2013, BRAIN STIMUL, V6, P644, DOI 10.1016/j.brs.2012.09.010; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Leunissen I, 2013, HUM BRAIN MAPP, V34, P1254, DOI 10.1002/hbm.21508; Li SS, 2015, NEUROPSYCH DIS TREAT, V11, P1573, DOI 10.2147/NDT.S65816; Marsolais Y, 2014, CORTEX, V58, P123, DOI 10.1016/j.cortex.2014.05.007; Martin DM, 2016, J AFFECT DISORDERS, V203, P130, DOI 10.1016/j.jad.2016.05.072; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Meinzer M, 2009, J COGNITIVE NEUROSCI, V21, P2007, DOI 10.1162/jocn.2009.21219; Monti A, 2013, J NEUROL NEUROSUR PS, V84, P832, DOI 10.1136/jnnp-2012-302825; Motes MA, 2020, J NEUROTRAUM, V37, P170, DOI 10.1089/neu.2018.6331; Mueller KD, 2015, ARCH CLIN NEUROPSYCH, V30, P448, DOI 10.1093/arclin/acv030; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Penolazzi B, 2013, BEHAV BRAIN RES, V248, P129, DOI 10.1016/j.bbr.2013.04.007; Pestalozzi MI, 2018, NEUROREHAB NEURAL RE, V32, P913, DOI 10.1177/1545968318801551; Peterson A, 2019, SURVEILLANCE REPORT, P24; Price AR, 2015, BRAIN STIMUL, V8, P1093, DOI 10.1016/j.brs.2015.06.013; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Schmidt CSM, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101840; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Staresina BP, 2006, J NEUROSCI, V26, P9162, DOI 10.1523/JNEUROSCI.2877-06.2006; Thibaut A, 2015, BRAIN STIMUL, V8, P1116, DOI 10.1016/j.brs.2015.07.024; Thielscher A, 2015, IEEE ENG MED BIO, P222, DOI 10.1109/EMBC.2015.7318340; To WT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22730-x; Tremont G, 2000, CLIN NEUROPSYCHOL, V14, P295, DOI 10.1076/1385-4046(200008)14:3;1-P;FT295; Vakil E, 2019, NEUROPSYCHOL REV, V29, P270, DOI 10.1007/s11065-019-09413-8; Vannorsdall T.D., 2012, FRONT PSYCHIATRY, V3; Villamar MF, 2013, JOVE-J VIS EXP, DOI 10.3791/50309; Vonk JMJ, 2019, CEREB CORTEX, V29, P2694, DOI 10.1093/cercor/bhy138; Wagner S, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-19; Wammes JD, 2017, BRAIN COGNITION, V111, P112, DOI 10.1016/j.bandc.2016.11.004; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Yamagata B, 2020, J NEUROTRAUM, V37, P975, DOI 10.1089/neu.2019.6751; Zhao Q, 2021, NEUROMODULATION, V24, P923, DOI 10.1111/ner.13337	64	0	0	3	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 1	2021	764								136204	10.1016/j.neulet.2021.136204			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU2ST	WOS:000698651800003	34478816				2022-02-06	
J	Chiu, TL; Wang, YJ; Chang, TW; Lin, SZ; Tsai, ST				Chiu, Tsung-Lang; Wang, Ya-Jung; Chang, Tze-Wei; Lin, Shinn-Zong; Tsai, Sheng-Tzung			Granulocyte Colony-Stimulating Factor for Treatment of Patients with Chronic Traumatic Brain Injury: A Preliminary Pre-Post Study	BRAIN SCIENCES			English	Article						G-CSF; traumatic brain injury; outcome	GROWTH-FACTORS; RODENT MODEL; STEM-CELLS; G-CSF; STROKE; RELIABILITY; VALIDITY	Chronic traumatic brain injury (TBI) can cause permanent disability and thereby negatively affect patients, families, and society. Currently, there is no effective treatment for patients with chronic TBI. One possible option is granulocyte colony-stimulating factor (G-CSF), which has potential neuroregenerative and neuroprotective effects through its ability to mobilize hematopoietic stem cells and increase neurogenic growth factor levels. Previous studies have shown that G-CSF administration is safe for patients with neurological diseases such as stroke and dementia. The present study aimed to explore the safety and efficacy of G-CSF use in patients with chronic TBI. Methods: 38 patients with chronic TBI were administered 3-day rounds of G-CSF (10 mu g/kg per day) once a month for 6 months. These patients were clinically evaluated using the modified Rankin scale (mRS) and Karnofsky Performance Score (KPS). Laboratory measures of the leucocyte counts and differential count percentage were also assessed. Results: At the 6-month follow-up, further assessment showed that patients tolerated the treatment well with only mild and transient side effects being observed. Further clinical evaluation showed significant improvements in mRS and KPS after G-CSF treatment. Laboratory results also confirmed the action of the medication, with increased leukocytosis and band forms. Conclusions: The results suggest that 6-month chronic G-CSF treatment is safe for patients with chronic TBI and may provide clinical benefits and neurological improvements. The adverse effects of the treatment, however, are transient and usually tolerable. Thus, these preliminary findings suggest that future clinical trials of G-CSF use in patients with chronic TBI are warranted.	[Tsai, Sheng-Tzung] Tzu Chi Univ, Hualien Tzu Chi Hosp, Dept Neurosurg, Hualien 970, Taiwan		Tsai, ST (corresponding author), Tzu Chi Univ, Hualien Tzu Chi Hosp, Dept Neurosurg, Hualien 970, Taiwan.	poluschiou@gmail.com; guagua1019@gmail.com; kenny702187@gmail.com; shinnzong@yahoo.com.tw; flydream.tsai@gmail.com		Tsai, Sheng-Tzung/0000-0001-6611-9440			Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Chen DC, 2014, CELL TRANSPLANT, V23, P1599, DOI 10.3727/096368914X678562; Corrigan F, 2017, J NEUROTRAUM, V34, P971, DOI 10.1089/neu.2016.4589; dela Pena I, 2015, TRANSL STROKE RES, V6, P421, DOI 10.1007/s12975-015-0430-x; Deng J, 2011, NEUROL SCI, V32, P641, DOI 10.1007/s10072-011-0608-2; Duning T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017770; Floel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019767; Gonzales-Portillo GS, 2014, CELL TRANSPLANT, V23, P531, DOI 10.3727/096368914X678337; He JC, 2020, BRAIN RES, V1746, DOI 10.1016/j.brainres.2020.147000; Huang XT, 2020, NEUROREPORT, V31, P293, DOI 10.1097/WNR.0000000000001397; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Qiu XC, 2020, EXP NEUROL, V330, DOI 10.1016/j.expneurol.2020.113335; Sakowitz OW, 2006, ACTA NEUROCHIR SUPPL, V96, P139; Sanchez-Ramos J, 2012, J ALZHEIMERS DIS, V31, P843, DOI 10.3233/JAD-2012-120196; SCHAG CC, 1984, J CLIN ONCOL, V2, P187, DOI 10.1200/JCO.1984.2.3.187; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Sheibani N, 2004, CRIT CARE MED, V32, P2274, DOI 10.1097/01.CCM.0000145998.11686.ED; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; Sikoglu EM, 2014, BEHAV BRAIN RES, V259, P354, DOI 10.1016/j.bbr.2013.11.008; Song SJ, 2016, RESTOR NEUROL NEUROS, V34, P415, DOI 10.3233/RNN-150607; Sprigg N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161359; Toshkezi G, 2018, J NEUROSURG, V129, P1286, DOI 10.3171/2017.7.JNS17878; Wallner S, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00048; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001	27	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	NOV	2021	11	11							1441	10.3390/brainsci11111441			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XK0CL	WOS:000727144100001	34827440	Green Published, gold			2022-02-06	
J	Cho, HJ; Hwang, Y; Yang, S; Kim, M				Cho, Hang Joo; Hwang, Yunsup; Yang, Seiyun; Kim, Maru			A Comprehensive Analysis of the Association of Psoas and Masseter Muscles with Traumatic Brain Injury Using Computed Tomography Anthropometry	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Traumatic brain injury; Psoas; Masseter muscle; Computed tomography; Prognosis	QUALITY-OF-LIFE; SARCOPENIA; MORTALITY; FRAILTY; ICD-10	Objective : Psoas and masseter muscles are known markers of sarcopenia. However, the relative superiority of either muscle as a marker is unclear. Therefore, this study analyzed the two muscles in patients with a prognosis of traumatic brain injury (TBI). Methods : Patients with TBI visiting a regional trauma center between January 2017 and December 2018 were selected, and their medical records were reviewed. TBI patients with an abbreviated injury score (AIS) of 4 or 5 were selected. Patients with an AIS of 4 or 5 at the chest, abdomen, and extremity were excluded. Patients with a hospital stay of 1 to 2 days were excluded. Both muscle areas were measured based on the initial computed tomography. The psoas muscle index (PMI) and the masseter muscle index (MMI) were calculated by dividing both muscle areas by height in meters squared (cm(2)/m(2)). These muscle parameters along with other medical information were used to analyze mortality and the Glasgow outcome scale (GOS). Results : A total of 179 patients, including 147 males (82.1%), were analyzed statistically. The mean patient age was 58.0 years. The mortality rate was 16.8% (30 patients). The mean GOS score was 3.7. Analysis was performed to identify the parameters associated with mortality, which was a qualitative study outcome. The psoas muscle area (16.9 vs. 14.4 cm(2), p=0.028) and PMI (5.9 vs. 5.1 cm(2)/m(2), p=0.004) showed statistical differences between the groups. The PMI was also statistically significant as a risk factor for mortality in logistic regression analysis (p=0.023; odds ratio, 0.715; 95% confidence interval, 0.535-0.954). Quantitative analyses were performed with the GOS scores. Bivariate correlation analysis showed a statistically significant correlation between PMI and GOS scores (correlation coefficient, 0.168; p=0.003). PMI (p=0.004, variation inflation factor 1.001) was significant in multiple regression analysis. The masseter muscle area and MMI did not show significance in the study. Conclusion : Larger PMI was associated with statistically significant improved survival and GOS scores, indicating its performance as a superior prognostic marker. Further analyses involving a larger number of patients, additional parameters, and more precise settings would yield a better understanding of sarcopenia and TBI.	[Cho, Hang Joo; Kim, Maru] Catholic Univ Korea, Coll Med, Dept Trauma Surg, Uijeongbu St Marys Hosp, Seoul, South Korea; [Hwang, Yunsup] Catholic Univ Korea, Coll Med, Dept Radiol, Uijeongbu St Marys Hosp, Seoul, South Korea; [Yang, Seiyun] Catholic Univ Korea, Coll Med, Dept Neurourgery, Uijeongbu St Marys Hosp, Seoul, South Korea		Kim, M (corresponding author), Catholic Univ Korea, Coll Med, Uijeongbu St Marys Hosp, Dept Trauma Surg, 271 Cheonbo Ro, Uijongbu 11765, South Korea.	maru@catholic.ac.kr		CHO, HANGJOO/0000-0003-3322-744X; Hwang, Yunsup/0000-0002-6827-6463	Catholic Medical Center Research Foundation	The authors wish to acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2019.	Anker SD, 2016, J CACHEXIA SARCOPENI, V7, P512, DOI 10.1002/jcsm.12147; Baracos VE, 2017, J CACHEXIA SARCOPENI, V8, P527, DOI 10.1002/jcsm.12221; Beaudart C, 2017, J CACHEXIA SARCOPENI, V8, P238, DOI 10.1002/jcsm.12149; Bone AE, 2017, CHRON RESP DIS, V14, P85, DOI 10.1177/1479972316679664; Cruz-Jentoft AJ, 2019, LANCET, V393, P2636, DOI 10.1016/S0140-6736(19)31138-9; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Damluji AA, 2020, AM HEART J, V224, P171, DOI 10.1016/j.ahj.2020.03.021; Davis MP, 2019, ANN PALLIAT MED, V8, P86, DOI 10.21037/apm.2018.08.02; De Buyser SL, 2016, AGE AGEING, V45, P603, DOI 10.1093/ageing/afw071; Drudi LM, 2016, EUR J VASC ENDOVASC, V52, P764, DOI 10.1016/j.ejvs.2016.09.011; Gilligan LA, 2020, PEDIATR RADIOL, V50, P455, DOI 10.1007/s00247-019-04562-7; Hamaguchi Y, 2016, NUTRITION, V32, P1200, DOI 10.1016/j.nut.2016.04.003; Hu P, 2018, J NEUROTRAUM, V35, P2400, DOI 10.1089/neu.2017.5422; Hwang Y, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019069; Lee SJ, 2018, SUPPORT CARE CANCER, V26, P2313, DOI 10.1007/s00520-018-4083-7; Lindstrom I, 2021, J NEUROINTERV SURG, V13, P25, DOI 10.1136/neurintsurg-2020-015837; Oksala NKJ, 2019, EUR J VASC ENDOVASC, V57, P331, DOI 10.1016/j.ejvs.2018.11.011; Tanabe C, 2019, JAMA SURG, V154, P716, DOI 10.1001/jamasurg.2019.0988; Toptas M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5263208; Vellas B, 2018, J FRALITY AGING, V7, P2, DOI 10.14283/jfa.2017.30; Wallace JD, 2017, J TRAUMA ACUTE CARE, V82, P65, DOI 10.1097/TA.0000000000001297	21	0	0	0	0	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	NOV	2021	64	6					950	956		10.3340/jkns.2021.0004			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WS1WN	WOS:000714979900012	34689478	gold, Green Published			2022-02-06	
J	Chu, CS; Tsai, SJ; Cheng, CM; Su, TP; Chen, TJ; Bai, YM; Liang, CS; Chen, MH				Chu, Che-Sheng; Tsai, Shih-Jen; Cheng, Chih-Ming; Su, Tung-Ping; Chen, Tzeng-Ji; Bai, Ya-Mei; Liang, Chih-Sung; Chen, Mu-Hong			Dengue and dementia risk: A nationwide longitudinal study	JOURNAL OF INFECTION			English	Article						Alzheimer's disease; Causality; Dementia; Dengue	YOUNG-ADULTS; ADOLESCENTS; DISORDER; STROKE; VIRUS; CELLS	Background: Accumulating evidence suggests neurological manifestations after dengue infection. However, the relationship between dengue and long-term neurocognitive sequel remains unclear. Methods: We recruited 816 patients with dengue and 8,160 controls between 1997 and 2012 using data from Taiwan National Health Insurance Research Database and followed them up until the end of 2013. Individuals who exhibited any type of dementia were identified during the follow-up period. Cox regression analyses were performed with adjustments for demographic data and medical and mental comorbidities (cerebrovascular diseases, traumatic brain injury, hypertension, dyslipidemia, diabetes mellitus, depression, alcohol use disorder, and substance use disorder). The E-value for the causality of the evidence was calculated. Sensitivity analysis was conducted to exclude patients with prodromal dementia. Results: Patients with dengue were more likely to develop dementia (hazard ratio [HR]: 2.23, 95% confidence interval [CI]: 1.51-3.28), Alzheimer's disease (HR: 3.03, 95% CI: 1.08-8.45), and unspecified dementia (HR: 2.25, 95% CI: 1.43-3.53), but not vascular dementia compared to controls during the follow-up period. Sensitivity analyses after exclusion of the observation period over the first three years or first five years and after exclusion of patients' enrollment before 2010 or 2008 showed consistent findings. The E values for the HR (range 3.62-5.51) supported the association between dengue and subsequent dementia among the whole population, men, and women. Conclusion: The risk of dementia was 2.23-fold higher in patients diagnosed with dengue during the follow-up period than in the controls. Further studies are necessary to investigate the underlying pathophysiology of dengue and dementia. (c) 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved.	[Chu, Che-Sheng] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Chu, Che-Sheng] Kaohsiung Vet Gen Hosp, Ctr Geriatr & Gerontol, Kaohsiung, Taiwan; [Chu, Che-Sheng] Soc Psychophysiol, Noninvas Neuromodulat Consortium Mental Disorders, Taipei, Taiwan; [Chu, Che-Sheng] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Tsai, Shih-Jen; Cheng, Chih-Ming; Su, Tung-Ping; Bai, Ya-Mei; Chen, Mu-Hong] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Tsai, Shih-Jen; Cheng, Chih-Ming; Su, Tung-Ping; Bai, Ya-Mei; Chen, Mu-Hong] Natl Yang Ming Chiao Tung Univ, Coll Med, Dept Psychiat, Taipei, Taiwan; [Su, Tung-Ping] Gen Cheng Hsin Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Chiao Tung Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan; [Liang, Chih-Sung] Triserv Gen Hosp, Dept Psychiat, Beitou Branch, Taipei, Taiwan; [Liang, Chih-Sung] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan		Chen, MH (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.; Chen, MH (corresponding author), Natl Yang Ming Chiao Tung Univ, Coll Med, Dept Psychiat, Taipei, Taiwan.; Liang, CS (corresponding author), Triserv Gen Hosp, Dept Psychiat, Beitou Branch, Taipei, Taiwan.; Liang, CS (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	lcsyfw@gmail.com; kremer7119@gmail.com		Liang, Chih-Sung/0000-0003-1138-5586; Chen, Mu-Hong/0000-0001-6516-1073	Taipei Veterans General HospitalTaipei Veterans General Hospital [V106B-020, V107B-010, V107C-181, V108B-012, V110C025, V110B-002]; Kaohsiung Veterans General Hospital [KGVGH110-051, VGHKS-109-70]; Yen Tjing Ling Medical Foundation [CI109-21, CI-109-22, CI-110-30]; Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [107-2314-B-075 -063-MY3, 108 -2314-B-075 -037, MOST-109 -2314-B-075B-001-MY2]	The study was supported by grant from Taipei Veterans General Hospital (V106B-020, V107B-010, V107C-181, V108B-012, V110C025, V110B-002), Kaohsiung Veterans General Hospital (KGVGH110-051, VGHKS-109-70), Yen Tjing Ling Medical Foundation (CI109-21, CI-109-22, CI-110-30) and Ministry of Science and Technology, Taiwan (107-2314-B-075 -063-MY3, 108 -2314-B-075 -037, MOST-109 -2314-B-075B-001-MY2). The funding source had no role in any process of our study.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brunette G.W., 2017, CDC YELLOW BOOK 2018; Chang SH, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.14318; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen MH, 2018, J AM ACAD CHILD PSY, V57, P48, DOI 10.1016/j.jaac.2017.09.438; Chen MH, 2016, DIABETES CARE, V39, P788, DOI 10.2337/dc15-1807; Chen MH, 2015, BRIT J PSYCHIAT, V206, P302, DOI 10.1192/bjp.bp.113.143610; Cheng CM, 2018, MOL PSYCHIATR, V23, P1756, DOI 10.1038/mp.2017.217; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; Haneuse S, 2019, JAMA-J AM MED ASSOC, V321, P602, DOI 10.1001/jama.2018.21554; Hsu CL, 2020, ARCH GERONTOL GERIAT, V88, DOI 10.1016/j.archger.2020.104021; Huang JS, 2021, JAMA PEDIATR, V175, DOI 10.1001/jamapediatrics.2020.5371; Kuo HY, 2020, J CLIN PSYCHOPHARM, V40, P359, DOI 10.1097/JCP.0000000000001228; Li GH, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00449; Li HM, 2018, CAN MED ASSOC J, V190, pE285, DOI 10.1503/cmaj.170994; Liang CS, 2020, SCHIZOPHRENIA BULL, V46, P795, DOI 10.1093/schbul/sbz126; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; Messina JP, 2019, NAT MICROBIOL, V4, P1508, DOI 10.1038/s41564-019-0476-8; Murthy JMK, 2010, NEUROL INDIA, V58, P581, DOI 10.4103/0028-3886.68654; Patel H, 2015, LANCET INFECT DIS, V15, P951, DOI 10.1016/S1473-3099(15)00134-6; Puccioni-Sohler M, 2012, NEUROL INT, V4, P65, DOI 10.4081/ni.2012.e15; Roman M, 2020, BRAIN BEHAV IMMUN, V83, P7, DOI 10.1016/j.bbi.2019.09.016; Salimi H, 2016, NEUROTHERAPEUTICS, V13, P514, DOI 10.1007/s13311-016-0443-5; Smith GS, 2017, NEUROBIOL DIS, V105, P33, DOI 10.1016/j.nbd.2017.05.007; Toledo J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004284; Hung TM, 2018, TRENDS PARASITOL, V34, P904, DOI 10.1016/j.pt.2018.07.007; Ochoa MV, 2009, ARCH VIROL, V154, P919, DOI 10.1007/s00705-009-0396-7; Wang FX, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00376; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49	30	0	0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0163-4453	1532-2742		J INFECTION	J. Infect.	NOV	2021	83	5					601	606		10.1016/j.jinf.2021.08.037			6	Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases	XD7PM	WOS:000722896500016	34454958				2022-02-06	
J	Cogan, AM; Weaver, JA; Scholten, J; Pape, TB; Mallinson, T				Cogan, Alison M.; Weaver, Jennifer A.; Scholten, Joel; Pape, Theresa Bender; Mallinson, Trudy			Psychometric Properties and Sex Differences on the Mayo-Portland Adaptability Inventory Participation Subscale (M2PI) in Veterans With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; traumatic; Community participation; Psychomet-rics; Rehabilitation; Veterans	RATINGS; INDEX	Objective: To evaluate the structural validity of the Mayo-Portland Adaptability Inventory Participation Index (M2PI) in a sample of veterans and to assess whether the tool functioned similarly for male and female veterans. Design: Rasch analysis of M2PI records from the National Veterans Traumatic Brain Injury Health Registry database from 2012-2018. Setting: National VA Polytrauma System of Care outpatient settings. Participants: Veterans with a clinically confirmed history of traumatic brain injury (TBI) (N=6065; 94% male). Interventions: Not applicable. Main Outcome Measures: M2PI, a 5-point Likert-type scale with 8 items. For this analysis, the 2 employment items were treated individually for a total of 9 items. Results: The employment items misfit the Rasch Measurement model (paid employment mean square [MnSq]=1.40; other employment MnSq=1.34) and were removed from subsequent iterations. The final model had eigenvalue 1.87 on the first contrast, suggesting unidimensionality of the remaining 7 items. Item order from least to most participation restriction was transportation, self-care, residence management, financial management, initiation, leisure, and social contact. Wright's person separation reliability for nonnormal distributions was 0.93, indicating appropriateness of M2PI for making individual-level treatment decisions. Mean person measure was -0.92</n>1.34 logits, suggesting that participants did not report restrictions on most items (item mean=0 logits). A total of 3.8% of the sample had the minimum score (no impairment on all items), and 0.2% had the maximum score. Four items had different item calibrations (>= 0.25 logits) for female compared with male veterans, but the hierarchy of items was unchanged when the female sample was examined separately.	[Cogan, Alison M.; Scholten, Joel] Washington DC VA Med Ctr, Phys Med & Rehabil Serv, Washington, DC USA; [Weaver, Jennifer A.; Mallinson, Trudy] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Pape, Theresa Bender] US Dept Vet Affairs, Ctr Innovat Complex Chron Healthcare CINCCH, Edward Hines Jr VA Hosp, Hines, IL USA; [Pape, Theresa Bender] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Cogan, AM (corresponding author), VA Greater Los Angeles Healthcare Syst, Ctr Study Hlthcare Innovat Implementat & Policy, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	alison.cogan@va.gov	Weaver, Jennifer/M-1478-2017	Weaver, Jennifer/0000-0002-3964-1441	Polytrauma/TBI Fellowship through the VA Office of Academic Affiliations	Supported by a Polytrauma/TBI Fellowship through the VA Office of Academic Affiliations (Alison M. Cogan). There was no additional extramural funding for this project.	Baghaei P., 2008, RASCH MEASUREMENT T, V22, P1145; Bond T.G., 2021, APPL RASCH MODEL, V4th; Codina N, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142513; Cogan AM, 2020, ARCH PHYS MED REHAB, V101, P2071, DOI 10.1016/j.apmr.2020.06.030; Cogan AM, 2018, DISABIL REHABIL, V40, P2692, DOI 10.1080/09638288.2017.1342282; Departments of Veterans Affairs and Defense, VADOD CLIN PRACTICE; Hawkins BL, 2018, ARCH PHYS MED REHAB, V99, pS65, DOI 10.1016/j.apmr.2017.07.018; Horne RM, 2018, SEX ROLES, V78, P731, DOI 10.1007/s11199-017-0832-1; Kean J, 2013, ARCH PHYS MED REHAB, V94, P2417, DOI 10.1016/j.apmr.2013.08.006; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Linacre J, USERS GUIDE WINSTEPS; Linacre JM., HELP WINSTEPS RASCH; Linacre JM., SIMULATED FILE SPECI; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF., MANUAL MAYO PORTLAND; Mallinson T, 2010, ARCH PHYS MED REHAB, V91, pS29, DOI 10.1016/j.apmr.2010.04.027; McCulloch K, 2015, J HEAD TRAUMA REHAB, V30, P38, DOI 10.1097/HTR.0000000000000041; Messick S, 1993, FDN VALIDITY MEANING; O'Rourke J, 2019, J HEAD TRAUMA REHAB, V34, P30, DOI 10.1097/HTR.0000000000000405; Raiche G., 2005, RASCH MEASUREMENT T, V19, P1012, DOI DOI 10.1016/B978-012471352-9/50004-3; Smith R M, 1998, J Outcome Meas, V2, P66; Starmer AJ, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2018-2926; Waid-Ebbs JK, 2020, ARCH PHYS MED REHAB, V101, P789, DOI 10.1016/j.apmr.2019.10.191; World Health Organization, INT CLASSIFICATION F; Wright B, 1994, MEASUREMENT T, V8, P370; Wright B. D., 1996, RASCH MEASUREMENT T, V9; Wright BD, 2001, RASCH MEAS T, V14, P786	28	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2021	102	11					2193	+		10.1016/j.apmr.2021.06.003			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	WX9UN	WOS:000718933800016	34175272				2022-02-06	
J	Cohen, ML; Harnish, SM; Lanzi, AM; Brello, J; Victorson, D; Kisala, PA; Nandakumar, R; Tulsky, DS				Cohen, Matthew L.; Harnish, Stacy M.; Lanzi, Alyssa M.; Brello, Jennifer; Victorson, David; Kisala, Pamela A.; Nandakumar, Ratna; Tulsky, David S.			Adapting a Patient-Reported Outcome Bookmarking Task to be Accessible to Adults With Cognitive and Language Disorders	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article							ITEM BANK CALIBRATION; QUALITY-OF-LIFE; PROS USE SERIES; NEURO-QOL; MONTREAL ACCORD; TBI-QOL; SUPPORTED CONVERSATION; PROMISA(R) MEASURES; DECISION-MAKING; APHASIA	Background: Patient-reported outcome (PRO) measures produce scores that do not always have obvious clinical meaning. The PRO-bookmarking procedure is a new and promising way to make PRO measures more meaningful and interpretable. However, the materials and procedures of the task may benefit from adaptations to be more accessible to individuals with cognitive and language disorders. Aims: This study aims to provide an overview of the iterative refinement process used to modify the materials and procedures of the PRO-bookmarking task so that they are more accessible to adults with acquired cognitive and language impairments. Method and Procedures: Our team of health psychologists, neuropsychologists, and speech-lan guage pathologists (SLPs) conducted two focus groups with SLPs and care partners of people with aphasia using the same PRO-bookmarking materials and procedures as previous reports. These PRO-bookmarking materials and procedures were then refined iteratively based on discussion with those who participated in focus groups and among the research team, and three more times in the course of 16 additional focus groups of different stakeholders: people with Parkinson's disease, aphasia, or traumatic brain injury; care partners of people with those conditions; and SLPs who have experience with those, and other adult-acquired conditions. Outcomes and Results: The PRO-bookmarking materials and procedures underwent four iterations to make them clearer, simpler, and more accessible. For example, the materials included more structured text and graphic supports where appropriate and the procedures were clustered into smaller discrete tasks and displayed graphically when possible and appropriate. Conclusions: PRO-bookmarking materials and procedures were made simpler and more structured to increase their accessibility to adults with cognitive and language impairments. In fact, these adaptations made the tasks simpler and clearer for all types of stakeholders.	[Cohen, Matthew L.; Lanzi, Alyssa M.] Univ Delaware, Dept Commun Sci & Disorders, Newark, DE 19716 USA; [Cohen, Matthew L.; Kisala, Pamela A.; Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE 19716 USA; [Harnish, Stacy M.; Brello, Jennifer] Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA; [Victorson, David] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Nandakumar, Ratna] Univ Delaware, Sch Educ, Newark, DE 19716 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE 19716 USA		Cohen, ML (corresponding author), Univ Delaware, Dept Commun Sci & Disorders, Newark, DE 19716 USA.; Cohen, ML (corresponding author), Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE 19716 USA.	mlcohen@udel.edu		Cohen, Matthew/0000-0001-9609-2461; Victorson, David/0000-0002-3530-8633; Kisala, Pamela/0000-0003-3234-795X	Gordon and Betty Moore FoundationGordon and Betty Moore Foundation [5299]	This study was funded by the Gordon and Betty Moore Foundation under Grant GBMF #5299 to M. L. C. The authors would like to thank Hope Morrison, Teresa Highberger, Mariah Graham, Autumn Brown, Kiera Gran, and Haley Robinson for their hard work and contributions to this study.	Ayers DC, 2013, CLIN ORTHOP RELAT R, V471, P3419, DOI 10.1007/s11999-013-3143-z; Baylor C, 2013, J SPEECH LANG HEAR R, V56, P1190, DOI 10.1044/1092-4388(2012/12-0140); Bingham CO, 2017, J CLIN EPIDEMIOL, V89, P136, DOI 10.1016/j.jclinepi.2017.04.014; Bingham CO, 2016, QUAL LIFE RES, V25, P2109, DOI 10.1007/s11136-016-1246-1; Brennan AD, 2005, APHASIOLOGY, V19, P693, DOI 10.1080/02687030444000958; Cella D, 2015, PATIENT-REPORTED OUTCOMES IN PERFORMANCE MEASUREMENT, P1, DOI 10.3768/rtipress.2015.bk.0014.1509; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2014, QUAL LIFE RES, V23, P2651, DOI 10.1007/s11136-014-0732-6; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Clover K, 2018, QUAL LIFE RES, V27, P1357, DOI 10.1007/s11136-018-1803-x; Cohen ML, 2021, SEMIN SPEECH LANG, V42, P192, DOI 10.1055/s-0041-1731365; Cohen ML, 2020, AM J SPEECH-LANG PAT, V29, P357, DOI 10.1044/2019_AJSLP-19-00076; Cohen ML, 2019, J HEAD TRAUMA REHAB, V34, P326, DOI 10.1097/HTR.0000000000000528; Cook KF, 2019, MED CARE, V57, pS13, DOI 10.1097/MLR.0000000000001087; Cook KF, 2015, QUAL LIFE RES, V24, P575, DOI 10.1007/s11136-014-0790-9; Coon CD, 2018, QUAL LIFE RES, V27, P33, DOI 10.1007/s11136-017-1616-3; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Hula WD, 2015, J SPEECH LANG HEAR R, V58, P906, DOI 10.1044/2015_JSLHR-L-14-0235; Iturralde E, 2017, J ADOLESCENT HEALTH, V61, P591, DOI 10.1016/j.jadohealth.2017.05.030; Jensen RE, 2016, J CLIN ONCOL, V34, P527, DOI 10.1200/JCO.2015.64.9491; Jones RS, 2017, J AM COLL SURGEONS, V224, P245, DOI 10.1016/j.jamcollsurg.2016.11.015; Kagan A, 1998, APHASIOLOGY, V12, P816, DOI 10.1080/02687039808249575; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Karantonis A., 2006, EDUC MEAS-ISSUES PRA, V25, P4, DOI [DOI 10.1111/J.1745-3992.2006.00047.X, 10.1111/j.1745-3992.2006.00047.x]; Keller SD, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0125-0; Kisala P. A., 2020, ARCH PHYS MED REHABI; Mann CM, 2020, QUAL LIFE RES, V29, P2573, DOI 10.1007/s11136-020-02513-6; Mayo NE, 2017, J CLIN EPIDEMIOL, V89, P119, DOI 10.1016/j.jclinepi.2017.04.013; Morgan EM, 2017, QUAL LIFE RES, V26, P565, DOI 10.1007/s11136-016-1468-2; Nagaraja V, 2018, QUAL LIFE RES, V27, P755, DOI 10.1007/s11136-017-1709-z; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; National Institutes of Health, 2014, DEC DISC NIH ROADM C; Noonan VK, 2017, J CLIN EPIDEMIOL, V89, P125, DOI 10.1016/j.jclinepi.2017.04.017; Pothier L, 2008, INT J LANG COMM DIS, V43, P712, DOI 10.1080/13682820701726647; Purdy M, 2011, J MED SPEECH-LANG PA, V19, P45; Rodriguez-Correa C, 2017, J CARD FAIL, V23, pS29, DOI 10.1016/j.cardfail.2017.07.074; Rose T, 2010, TOP STROKE REHABIL, V17, P79, DOI 10.1310/tsr1702-79; Rose TA, 2012, INT J SPEECH-LANG PA, V14, P11, DOI 10.3109/17549507.2011.631583; Rose TA, 2011, INT J SPEECH-LANG PA, V13, P335, DOI 10.3109/17549507.2011.560396; Rothrock NE, 2019, QUAL LIFE RES, V28, P3355, DOI 10.1007/s11136-019-02261-2; Salsman JM, 2013, NEUROLOGY, V80, pS76, DOI 10.1212/WNL.0b013e3182872e11; Simmons-Mackie N, 2014, INT J SPEECH-LANG PA, V16, P82, DOI 10.3109/17549507.2013.831484; Swinburn K, 2004, COMPREHENSIVE APHASI, DOI [10.1037/t13733-000, DOI 10.1037/T13733-000]; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Tulsky DS, 2015, J SPINAL CORD MED, V38, P257, DOI [10.1179/2045772315Y.0000000023, 10.1179/2045772315Y.0000000035]; Victorson D, 2016, AM C REH MED; Wagner LI, 2015, CANCER-AM CANCER SOC, V121, P927, DOI 10.1002/cncr.29104; Wilson SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192773	50	0	0	0	0	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	NOV	2021	64	11					4403	4412		10.1044/2021_JSLHR-21-00071			10	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	WW8BZ	WOS:000718136100020	34699261	hybrid			2022-02-06	
J	Converse, MI; Nye, KS; Dahl, MJ; Albertine, KH; Monson, KL				Converse, Matthew I.; Nye, Kevin S.; Dahl, Mar Janna; Albertine, Kurt H.; Monson, Kenneth L.			Stretch-Induced Intimal Failure in Isolated Cerebral Arteries as a Function of Development	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Stroke; Overstretch; Internal elastic lamina; Microstructure; Damage; Failure; Development	INTERNAL ELASTIC LAMINA; TRANS-LUMINAL ANGIOPLASTY; TRAUMATIC BRAIN-INJURY; WALL; ENDOTHELIUM; MECHANISMS; SUBFAILURE; AORTA	Recent clinical studies have shown that traumatic brain injury is a significant risk factor for stroke. Motivated to better understand possible mechanisms of this association, we studied subfailure disruption of the intima in overstretched sheep cerebral arteries, as this has been implicated in the increased risk of stroke following blunt cerebrovascular injury. Middle cerebral arteries from four age groups (ranging from fetal to adult) were stretched axially to failure, and intimal disruption was captured with a video camera. All vessels demonstrated intimal disruption prior to catastrophic failure, with nearly all incurring disruption at stretch values well below those at ultimate stress (means of 1.56 and 1.73, respectively); the lowest stretch associated with intimal disruption was 1.29. The threshold of intimal failure was independent of age. Additional analysis showed that disruption included failure of both the endothelium and internal elastic lamina. Although our experiments were conducted at quasi-static rates, the results likely have important implications for vessel function following trauma. Future work should seek to identify subfailure disruption of the cerebrovasculature in head trauma.	[Converse, Matthew I.; Nye, Kevin S.; Monson, Kenneth L.] Univ Utah, Dept Mech Engn, 1495 E 100 S MEK 1550, Salt Lake City, UT 84112 USA; [Dahl, Mar Janna; Albertine, Kurt H.] Univ Utah, Dept Pediat, Div Neonatol, Salt Lake City, UT 84112 USA; [Albertine, Kurt H.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Albertine, Kurt H.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Monson, Kenneth L.] Univ Utah, Dept Biomed Engn, Salt Lake City, UT USA		Monson, KL (corresponding author), Univ Utah, Dept Mech Engn, 1495 E 100 S MEK 1550, Salt Lake City, UT 84112 USA.	ken.monson@utah.edu		Monson, Ken/0000-0002-8461-6034			Bell ED, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00002; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; CAJANDER S, 1976, ACTA NEUROL SCAND, V53, P171, DOI 10.1111/j.1600-0404.1976.tb04335.x; CAMPBELL GJ, 1981, STROKE, V12, P489, DOI 10.1161/01.STR.12.4.489; CASTANEDAZUNIGA WR, 1980, RADIOLOGY, V135, P565, DOI 10.1148/radiology.135.3.7384437; CHAN PDS, 1995, J NEUROSURG, V83, P522, DOI 10.3171/jns.1995.83.3.0522; Chavez L, 1990, Neurol Res, V12, P12; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Converse MI, 2021, J MECH BEHAV BIOMED, V118, DOI 10.1016/j.jmbbm.2021.104447; Converse MI, 2018, ACTA BIOMATER, V67, P307, DOI 10.1016/j.actbio.2017.11.052; de Wit C, 2006, BIOL CHEM, V387, P3, DOI 10.1515/BC.2006.002; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; HARKER LA, 1987, AM J CARDIOL, V60, pB20; Humphrey JD, 1995, CRIT REV BIOMED ENG, V23, P1; JAMAL A, 1992, ARTERIOSCLER THROMB, V12, P307, DOI 10.1161/01.ATV.12.3.307; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; LEVEEN RF, 1985, INVEST RADIOL, V20, P938, DOI 10.1097/00004424-198512000-00009; Monson KL, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002935; Nye K. S., 2015, MECH ENG; Nye KS, 2017, ANN BIOMED ENG, V45, P1101, DOI 10.1007/s10439-016-1741-0; Ohkawa M, 1996, RADIOLOGY, V198, P179, DOI 10.1148/radiology.198.1.8539374; OSBORNEPELLEGRIN MJ, 1986, EXP MOL PATHOL, V45, P171, DOI 10.1016/0014-4800(86)90057-2; POZZATI E, 1989, STROKE, V20, P412, DOI 10.1161/01.STR.20.3.412; Quinn KP, 2007, J BIOMECH, V40, P2299, DOI 10.1016/j.jbiomech.2006.10.015; ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681, DOI 10.1139/o57-080; Sandow SL, 2009, J ANAT, V214, P258, DOI 10.1111/j.1469-7580.2008.01020.x; Sandow SL, 2002, CIRC RES, V90, P1108, DOI 10.1161/01.RES.0000019756.88731.83; SCOTT RF, 1980, EXP MOL PATHOL, V33, P185, DOI 10.1016/0014-4800(80)90018-0; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Sliker CW, 2008, RADIOGRAPHICS, V28, P1689, DOI 10.1148/rg.286085521; SMITH EB, 1980, ATHEROSCLEROSIS, V37, P579, DOI 10.1016/0021-9150(80)90065-9; Steenhuijsen JLG, 1997, CATHETER CARDIO DIAG, V42, P92; Stemper BD, 2007, J BIOMECH, V40, P1806, DOI 10.1016/j.jbiomech.2006.07.005; Stemper BD, 2007, ANN BIOMED ENG, V35, P285, DOI 10.1007/s10439-006-9229-y; Tsze DS, 2011, EMERG MED INT, V2011, DOI 10.1155/2011/734506; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; YAHIA L, 1990, MATRIX, V10, P58, DOI 10.1016/S0934-8832(11)80138-1; Zhao W, 2020, J BIOMECH, V104, DOI 10.1016/j.jbiomech.2020.109732; Zitnay JL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14913; ZOLLIKOFER CL, 1984, RADIOLOGY, V151, P355, DOI 10.1148/radiology.151.2.6231654; ZOLLIKOFER CL, 1984, RADIOLOGY, V153, P369, DOI 10.1148/radiology.153.2.6237385	43	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2021	49	12			SI		3540	3549		10.1007/s10439-021-02869-x		NOV 2021	10	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	XO7FF	WOS:000713566900001	34725768				2022-02-06	
J	Cook, NE; Iverson, GL				Cook, Nathan E.; Iverson, Grant L.			Concussion Among Children in the United States General Population: Incidence and Risk Factors	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; head trauma; pediatric; traumatic injury; epidemiology	DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; BODY CHECKING; YOUTH SPORTS; INJURY	The objective of this study was to examine the incidence of concussion and risk factors for sustaining concussion among children from the United States general population. This prospective cohort study used data from the Adolescent Brain Cognitive Development (ABCD) Study. Children were recruited from schools across the US, sampled to reflect the sociodemographic variation of the US population. The current sample includes 11,013 children aged 9 to 10 years old (47.6% girls; 65.5% White) who were prospectively followed for an average of 1 year (mean = 367.9 days, SD = 40.8, range 249-601). The primary outcome was caregiver-reported concussion during a 1 year follow-up period. Logistic regression was used to determine which potential clinical, health history, and behavioral characteristics (assessed at baseline) were prospectively associated with concussion. In the 1 year follow-up period between ages 10 and 11, 1 in 100 children (n = 123, 1.1%) sustained a concussion. In univariate models, three baseline predictors (ADHD, prior concussion, and accident proneness) were significantly associated with sustaining a concussion. In a multivariate model, controlling for all other predictors, only prior concussion remained significantly associated with the occurrence of a concussion during the observation period (Odds Ratio = 5.49, 95% CI: 3.40-8.87). The most robust and only independent prospective predictor of sustaining a concussion was history of a prior concussion. History of concussion is associated with 5.5 times greater odds of sustaining concussion between ages 10 and 11 among children from the general US population.	[Cook, Nathan E.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Cook, Nathan E.; Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA 02114 USA; [Cook, Nathan E.; Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA 02129 USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA USA		Cook, NE (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Cook, NE (corresponding author), MassGen Hosp Children, Sports Concuss Program, Boston, MA 02114 USA.; Cook, NE (corresponding author), Spaulding Rehabil Hosp, Charlestown, MA 02129 USA.	necook@mgh.harvard.edu			Louis V. Gerstner III Research Scholar Award from Massachusetts General Hospital	NC acknowledges support from the Louis V. Gerstner III Research Scholar Award from Massachusetts General Hospital. GI acknowledges unrestricted philanthropic support from the Mooney-Reed Charitable Foundation, Heinz Family Foundation, Boston Bolts, ImPACT~R Applications, Inc., National Rugby League, and the Spaulding Research Institute. These entities were not involved in the study design, interpretation of data, the writing of this article or the decision to submit it for publication.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Barch DM, 2018, DEV COGN NEUROS-NETH, V32, P55, DOI 10.1016/j.dcn.2017.10.010; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Chrisman SPD, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-2402; Chrisman SPD, 2019, J PEDIATR-US, V207, P176, DOI 10.1016/j.jpeds.2018.11.003; Conde Crystal, 2011, Tex Med, V107, P37; Cook NE, 2021, J NEUROTRAUM, DOI 10.1089/neu.2021.0019; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dufour SC, 2020, CORTEX, V131, P237, DOI 10.1016/j.cortex.2020.07.003; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Iverson GL, 2021, CLIN J SPORT MED, V31, P438, DOI 10.1097/JSM.0000000000000773; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Kang JH, 2013, ACTA PAEDIATR, V102, P640, DOI 10.1111/apa.12213; Kids Count Data Center, 2021, CHILD POP SINGL AG U; McCradden MD, 2019, CAN J PUBLIC HEALTH, V110, P165, DOI 10.17269/s41997-019-00174-8; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; National Center for Health Statistics, 2000, BOD MASS IND FOR AG; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Pastor PN, 2006, AMBUL PEDIATR, V6, P38, DOI 10.1016/j.ambp.2005.07.002; Sarmiento K, 2019, J SAFETY RES, V68, P223, DOI 10.1016/j.jsr.2018.10.010; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Stelzer JW, 2019, NEUROSURGERY, V85, pE592, DOI 10.1093/neuros/nyz217; Tai YM, 2013, RES DEV DISABIL, V34, P1100, DOI 10.1016/j.ridd.2012.11.027; Terry DP, 2020, CLIN J SPORT MED, V30, pS69, DOI 10.1097/JSM.0000000000000594; Townsend L, 2020, J AM ACAD CHILD PSY, V59, P309, DOI 10.1016/j.jaac.2019.05.009; Tsushima WT, 2019, ARCH CLIN NEUROPSYCH, V34, P60, DOI 10.1093/arclin/acy019; van Ierssel J, 2021, BRIT J SPORT MED, V55, P663, DOI 10.1136/bjsports-2020-102967; Waltzman D, 2019, J SAFETY RES, V68, P157, DOI 10.1016/j.jsr.2018.11.005; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; Zucker RA, 2018, DEV COGN NEUROS-NETH, V32, P107, DOI 10.1016/j.dcn.2018.03.004	36	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 1	2021	12								773927	10.3389/fneur.2021.773927			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WY6OY	WOS:000719399800001	34790165	gold, Green Published			2022-02-06	
J	Corallo, F; Lo Buono, V; Calabro, RS; De Cola, MC				Corallo, Francesco; Lo Buono, Viviana; Calabro, Rocco Salvatore; De Cola, Maria Cristina			Can Cranioplasty Be Considered a Tool to Improve Cognitive Recovery Following Traumatic Brain Injury? A 5-Years Retrospective Study	JOURNAL OF CLINICAL MEDICINE			English	Article						cranioplasty; cognitive improvement; traumatic brain injury; neuropsychology	DECOMPRESSIVE CRANIECTOMY; NORMATIVE DATA; PERFUSION	Cranioplasty (CP) is a neurosurgical intervention of skull repairing following a decompressive craniectomy. Unfortunately, the impact of cranioplasty on cognitive and motor function is still controversial. Fifteen TBI subjects aged 26-54 years with CP after decompressive craniectomy were selected in this observational retrospective study. As per routine clinical practice, a neuropsychological evaluation carried out immediately before the cranioplasty (Pre CP) and one month after the cranioplasty (T0) was used to measure changes due to CP surgery. This assessment was performed each year for 5 years after discharge in order to investigate long-term cognitive changes (T1-T5). Before cranioplasty, about 53.3% of subjects presented a mild to severe cognitive impairment and about 40.0% a normal cognition. After CP, we found a significant improvement in all neuropsychological test scores. The more significant differences in cognitive recovery were detected after four years from CP. Notably, we found significant differences between T4 and T0-T1, as well as between T5 and T0-T1-T2 in all battery tests. This retrospective study further suggests the importance of CP in the complex management of patients with TBI showing how these patients might improve their cognitive function over a long period after the surgical procedure.	[Corallo, Francesco; Lo Buono, Viviana; Calabro, Rocco Salvatore; De Cola, Maria Cristina] IRCCS Ctr Neurolesi Bonino Pulejo, Via Palermo SS 113, I-98124 Messina, Italy		Lo Buono, V (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, Via Palermo SS 113, I-98124 Messina, Italy.	francesco.corallo@irccsme.it; viv.lobuono@gmail.com; roccos.calabro@irccsme.it; mariacristina.decola@irccsme.it	, viviana/K-5778-2016	, viviana/0000-0001-8027-6098; De Cola, Maria Cristina/0000-0002-7509-3833			Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; Alkhaibary A, 2020, WORLD NEUROSURG, V139, P445, DOI 10.1016/j.wneu.2020.04.211; Archavlis E, 2012, ACTA NEUROCHIR, V154, P1055, DOI 10.1007/s00701-012-1333-1; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Brown DA, 2017, HAND CLINIC, V140, P299, DOI 10.1016/B978-0-444-63600-3.00016-7; Champeaux C, 2020, NEUROCRIT CARE, V32, P522, DOI 10.1007/s12028-019-00774-9; Corallo F, 2020, REHABIL NURS, V45, P238, DOI 10.1097/rnj.0000000000000212; Corallo F, 2017, INT J NEUROSCI, V127, P688, DOI 10.1080/00207454.2016.1235045; Corallo F, 2014, FUNCT NEUROL, V29, P273, DOI 10.11138/FNeur/2014.29.4.273; Dang YY, 2021, ANN PALLIAT MED, V10, P8889, DOI 10.21037/apm-21-1822; De Cola MC, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1106; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Di Stefano C, 2012, BRIT J NEUROSURG, V26, P827, DOI 10.3109/02688697.2012.692838; Erdogan E, 2003, NEUROL INDIA, V51, P479; GAUDINO EA, 1995, J CLIN EXP NEUROPSYC, V17, P529, DOI 10.1080/01688639508405143; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Keute M, 2021, AUTON NEUROSCI-BASIC, V236, DOI 10.1016/j.autneu.2021.102876; Magni E, 1996, EUR J NEUROL, V3, P198, DOI 10.1111/j.1468-1331.1996.tb00423.x; Malcolm JG, 2018, NEUROSURGERY, V82, P278, DOI 10.1093/neuros/nyx182; McMinn MR., 1988, CLIN NEUROPSYCHOL, V2, P67, DOI DOI 10.1080/13854048808520087; Mokri B, 2010, HEADACHE, V50, P1206, DOI 10.1111/j.1526-4610.2010.01715.x; Morton RP, 2018, J NEUROSURG, V128, P1648, DOI 10.3171/2016.11.JNS161917; Naro A, 2021, NEUROL SCI, V42, P2785, DOI 10.1007/s10072-020-04875-8; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Panwar N, 2019, WORLD NEUROSURG, V122, pE96, DOI 10.1016/j.wneu.2018.09.108; Posti JP, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00223; Rossini Z, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00458; Rynkowski Carla B, 2021, Acta Neurochir Suppl, V131, P79, DOI 10.1007/978-3-030-59436-7_17; Sarubbo S, 2014, NEURORADIOLOGY, V56, P237, DOI 10.1007/s00234-014-1318-2; Shahid AH, 2018, J NEUROSURG, V128, P229, DOI 10.3171/2016.10.JNS16678; Su JH, 2017, KAOHSIUNG J MED SCI, V33, P344, DOI 10.1016/j.kjms.2017.05.002; Sveikata L, 2021, NEUROSURG REV, DOI 10.1007/s10143-021-01655-6; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002	36	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	NOV	2021	10	22							5437	10.3390/jcm10225437			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XJ3BF	WOS:000726667300001	34830718	Green Published			2022-02-06	
J	Cornwell, RE; Arango, JI; Eagye, CB; Hill-Pearson, C; Schwab, K; Souvignier, AR; Pazdan, RM				Cornwell, R. Elisabeth; Arango, Jorge, I; Eagye, C. B.; Hill-Pearson, Candace; Schwab, Karen; Souvignier, Alicia R.; Pazdan, Renee M.			Mild Traumatic Brain Injury and Postconcussive Symptom Endorsement: A Parallel Comparison Between Two Nonclinical Cohorts	MILITARY MEDICINE			English	Article							SERVICE MEMBERS; RISK-FACTORS; EPIDEMIOLOGY; CONCUSSION; SPORTS	Introduction: The prevalence of mild traumatic brain injury (mTBI) is commonly estimated based on indirect metrics such as emergency department visits and self-reporting tools. The study of postconcussive symptoms faces similar challenges because of their unspecific character and indistinct causality. In this article, we compare two nonclinical, epidemiological studies that addressed these two elements and were performed within a relatively narrow period in the state of Colorado. Materials and Methods: De-identified datasets were obtained from a random digit-dialed survey study conducted by the Craig Hospital and a study surveying soldiers returning from deployment by Defense and Veteran Traumatic Brain Injury Center. Information pertinent to participants' demographics, a history of mTBI, and symptom endorsement was extracted and homogenized in order to establish a parallel comparison between the populations of the two studies. Results: From the 1,558 (Warrior Strong, 679; Craig Hospital, 879) records selected for analysis, 43% reported a history of at least one mTBI. The prevalence was significantly higher among individuals from the Defense and Veteran Traumatic Brain Injury Center study independent of gender or race. Repetitive injuries were reported by 15% of the total combined cohort and were more prevalent among males. Symptom endorsement was significantly higher in individuals with a positive history of mTBI, but over 80% of those with a negative history of mTBI endorsed at least one of the symptoms interrogated. Significant differences were observed between the military and the civilian populations in terms of the types and frequencies of the symptoms endorsed. Conclusions: The prevalence of mTBI and associated symptoms identified in the two study populations is higher than that of previously reported. This suggests that not all individuals sustaining concussion seek medical care and highlights the limitations of using clinical reports to assess such estimates. The lack of appropriate mechanisms to determine symptom presence and causality remains a challenge. However, the differences observed in symptom reporting between cohorts raise questions about the nature of the symptoms, the impact on the quality of life for different individuals, and the effects on military health and force readiness.	[Cornwell, R. Elisabeth; Arango, Jorge, I; Hill-Pearson, Candace; Schwab, Karen; Souvignier, Alicia R.; Pazdan, Renee M.] Def & Vet Brain Injury Ctr, Ft Carson, CO 80913 USA; [Cornwell, R. Elisabeth; Arango, Jorge, I; Hill-Pearson, Candace; Schwab, Karen] Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA; [Eagye, C. B.] Craig Hosp, Englewood, CO 80113 USA; [Souvignier, Alicia R.; Pazdan, Renee M.] Evans Army Community Hosp, Warrior Recovery Ctr, Ft Carson, CO 80913 USA		Cornwell, RE (corresponding author), Def & Vet Brain Injury Ctr, Ft Carson, CO 80913 USA.				Defense and Veterans Brain Injury Center funds	This project received no external funding. Research personnel were supported by Defense and Veterans Brain Injury Center funds.	Agimi Y, 2018, AM J PUBLIC HEALTH, V108, P683, DOI 10.2105/AJPH.2018.304347; Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; American Psychiatric Association A, 1994, DIAGNOSTIC STAT MANU; Baldwin GT, 2018, HAND CLINIC, V158, P63, DOI 10.1016/B978-0-444-63954-7.00007-0; Bramley H, 2016, SPORTS MED ARTHROSC, V24, P123, DOI 10.1097/JSA.0000000000000111; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2016, RAT TBI REL EM DEP V; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Cota MR, 2019, J NEUROTRAUM, V36, P1335, DOI 10.1089/neu.2018.5772; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ferdosi H, 2019, AM J EPIDEMIOL, V188, P77, DOI 10.1093/aje/kwy199; Franke LM, 2016, INT J PSYCHOPHYSIOL, V106, P21, DOI 10.1016/j.ijpsycho.2016.05.010; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hsia RY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022297; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kirk B, 2018, SPORTS, V6, DOI 10.3390/sports6040102; Lamberty GJ, 2013, BEHAV SCI LAW, V31, P814, DOI 10.1002/bsl.2091; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Martelli MF, 2007, BRAIN INJURY MED PRI, P723; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Permenter CM, 2018, POSTCONCUSSIVE SYNDR; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Register-Mihalik JK, 2019, J SCI MED SPORT, V22, P509, DOI 10.1016/j.jsams.2018.11.003; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 1992, ICD10 WHO, V67, P227; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	41	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV-DEC	2021	186	11-12					E1191	E1198		10.1093/milmed/usaa504			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WV9KE	WOS:000717547200009	33269800				2022-02-06	
J	Coxe, KA; Pence, EK; Kagotho, N				Coxe, Kathryn A.; Pence, Erica K.; Kagotho, Njeri			Social Work Care in Traumatic Brain Injury and Substance Use Disorder Treatment: A Capacity-Building Model	HEALTH & SOCIAL WORK			English	Article						capacity building; community treatment; co-occurring disorders; substance use disorder; traumatic brain injury	CASE-MANAGEMENT; MENTAL-HEALTH; TBI; REHABILITATION; SURVIVORS; OHIO	Co-occurring traumatic brain injury (TBI) and substance use disorders (SUD) are a major public health concern, yet TBI is often underrecognized within SUD treatment organizations. Social workers in these organizations are well positioned to deliver tailored treatment, but little is known about what social workers are doing to address the needs of these clients. The purpose of this study was to examine current social work practices in providing care to clients with co-occurring TBI and SUD. Using grounded theory methodology, authors conducted semistructured interviews with 17 licensed social workers employed in various SUD treatment settings. Transcript coding was conducted through an iterative process and data were analyzed using NVivo (version 12.0). Results demonstrated that social workers lack basic knowledge on the relationship between TBI and SUD. Additional barriers to providing care included lack of skills to identify history of TBI, lack of community resources, poor agency collaboration, and access-to-care restrictions. Social workers identified their primary roles as advocacy, care coordination, and serving on multidisciplinary teams. These results informed development of a capacity-building model, with recommendations for social work situated in each level of the socioecological framework. This study has important implications for building workforce capacity and collaborative care systems to improve client outcomes.	[Coxe, Kathryn A.; Pence, Erica K.; Kagotho, Njeri] Ohio State Univ, Coll Social Work, 1947 Coll Rd, Columbus, OH 43210 USA		Coxe, KA (corresponding author), Ohio State Univ, Coll Social Work, 1947 Coll Rd, Columbus, OH 43210 USA.	coxe.6@osu.edu		Pence, Erica/0000-0003-2279-8984			American Association of Neurological Surgeons, 2020, TRAUM BRAIN INJ; Bogner J, 2020, J HEAD TRAUMA REHAB, V35, pE43, DOI 10.1097/HTR.0000000000000488; Bogner J, 2013, BRAIN IMPAIR, V14, P77, DOI 10.1017/BrImp.2013.5; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brorson HH, 2013, CLIN PSYCHOL REV, V33, P1010, DOI 10.1016/j.cpr.2013.07.007; Coxe KA, 2021, HEALTH SOC WORK, V46, P125, DOI 10.1093/hsw/hlab005; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Heinemann AW, 2004, REHABIL PSYCHOL, V49, P156, DOI 10.1037/0090-5550.49.2.156; Janosky JE, 2013, POPUL HEALTH MANAG, V16, P246, DOI 10.1089/pop.2012.0083; Lannin N, 2012, BRAIN IMPAIR, V13, P228, DOI 10.1017/BrImp.2012.19; Lewis S, 2015, HEALTH PROMOT PRACT, V16, P473, DOI 10.1177/1524839915580941; Li Ryan, 2017, F1000Res, V6, P231, DOI 10.12688/f1000research.10966.1; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; McHugo GJ, 2017, J HEAD TRAUMA REHAB, V32, pE65, DOI 10.1097/HTR.0000000000000249; Padgett D., 2008, QUALITATIVE METHODS, V2; QSR International Pty Ltd, 2020, NVIVO; Redpath SJ, 2010, BRAIN INJURY, V24, P802, DOI 10.3109/02699051003709623; Schell SF, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-15; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Vungkhanching M, 2007, J HEAD TRAUMA REHAB, V22, P167, DOI 10.1097/01.HTR.0000271117.19652.98; Vungkhanching M, 2016, J SOC WORK DISABIL R, V15, P370, DOI 10.1080/1536710X.2016.1220887; Yuhasz JE, 2013, J CORRECT HEALTH CAR, V19, P135, DOI 10.1177/1078345812474644	26	0	0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0360-7283	1545-6854		HEALTH SOC WORK	Health Soc. Work	NOV	2021	46	4					277	288		10.1093/hsw/hlab023			12	Social Work	Social Science Citation Index (SSCI)	Social Work	XL5GS	WOS:000728173400006	34652414				2022-02-06	
J	Cravedi, KD; May, MD; Abettan, JA; Huckleberry, KA; Trettel, SG; Vuong, CV; Altman, DE; Gauchan, S; Shansky, RM; Matson, LM; Sousa, JC; Lowery-Gionta, EG; Moore, NLT				Cravedi, Kevin D.; May, Matthew D.; Abettan, Jordan A.; Huckleberry, Kylie A.; Trettel, Sean G.; Vuong, Chau V.; Altman, Daniel E.; Gauchan, Sangeeta; Shansky, Rebecca M.; Matson, Liana M.; Sousa, Jason C.; Lowery-Gionta, Emily G.; Moore, Nicole L. T.			Response and recovery of endocrine, behavioral, and neuronal morphology outcomes after different traumatic stressor exposures in male rats	PSYCHONEUROENDOCRINOLOGY			English	Article						Stress; Elevated plus maze; Corticosterone; Prefrontal cortex; Amygdala; Plasticity	UNDERWATER TRAUMA; PREDATOR EXPOSURE; PLASTICITY; AMYGDALA; PTSD; PATTERNS; MEMORY; FEAR; NOREPINEPHRINE; CONSEQUENCES	Preclinical models of organismal response to traumatic stress (threat of death or serious injury) can be monitored using neuroendocrine, behavioral, and structural metrics. While many rodent models of traumatic stress have provided a glimpse into select components of the physiological response to acute and chronic stressors, few studies have directly examined the potential differences between stressors and their potential outcomes. To address this gap, we conducted a multi-level comparison of the immediate and longer-term effects of two types of acute traumatic stressors. Adult male rats were exposed to either underwater trauma (UWT), predator exposure (PE), or control procedural handling conditions. Over the next 7 days, yoked cohorts underwent either serial blood sampling for neuroendocrine evaluation across the circadian cycle, or repeated behavioral testing in the elevated plus maze. In addition, a subset of brains from the latter cohort were assessed for dendritic spine changes in the prefrontal cortex and basolateral amygdala. We observed stressor-dependent patterns of response and recovery across all measures, with divergence between endocrine responses despite similar behavioral outcomes. These results demonstrate that different stressors elicit unique behavioral, neuroendocrine, and neurostructural response profiles and suggest that specific stress models can be used to model desired responses for specific preclinical applications, such as evaluations of underlying mechanisms or therapeutic candidates.	[Cravedi, Kevin D.; May, Matthew D.; Altman, Daniel E.; Gauchan, Sangeeta; Matson, Liana M.; Lowery-Gionta, Emily G.; Moore, Nicole L. T.] Walter Reed Army Inst Res, Performance Assessment & Chem Evaluat PACE Lab, Behav Biol Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Abettan, Jordan A.; Huckleberry, Kylie A.; Trettel, Sean G.; Shansky, Rebecca M.] Northeastern Univ, Dept Psychol, Lab Neuroanat & Behav, Boston, MA 02115 USA; [Vuong, Chau V.; Sousa, Jason C.] Walter Reed Army Inst Res, Drug Metab & Distribut Lab, Silver Spring, MD 20910 USA; [Moore, Nicole L. T.] US Army Med Res Inst Chem Def, Aberdeen Proving Ground, MD 21010 USA		Lowery-Gionta, EG (corresponding author), Walter Reed Army Inst Res, Performance Assessment & Chem Evaluat PACE Lab, Behav Biol Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.	emily.g.lowery-gionta.civ@mail.mil			Military Operational Medicine Research Program, US Army Medical Research and Development Command [18350]	This work was supported by the Military Operational Medicine Research Program, US Army Medical Research and Development Command (project #18350) to MAJ (Dr.) Moore, responsibility assumed by Dr. Lowery-Gionta upon MAJ Moore's permanent change of station move. The funding body had no role in the design of the study, data collection or analysis, or decision to publish. The authors declare no competing interests.	Adamec R, 1997, NEUROSCI BIOBEHAV R, V21, P755, DOI 10.1016/S0149-7634(96)00055-3; Adamec RE, 2003, PROG NEURO-PSYCHOPH, V27, P1243, DOI 10.1016/j.pnpbp.2003.09.017; Adrian M, 2017, BIOPHYS J, V113, P2261, DOI 10.1016/j.bpj.2017.06.048; Altman DE, 2018, STRESS, V21, P267, DOI 10.1080/10253890.2018.1439012; ANISMAN H, 1990, PHARMACOL THERAPEUT, V46, P119, DOI 10.1016/0163-7258(90)90039-5; Ardi Z, 2014, INT J NEUROPSYCHOPH, V17, P571, DOI 10.1017/S1461145713001272; Baratta MV, 2019, BRAIN STRUCT FUNCT, V224, P1831, DOI 10.1007/s00429-019-01875-z; Chattarji S, 2015, NAT NEUROSCI, V18, P1364, DOI 10.1038/nn.4115; Chen YC, 2016, J NEUROSCI, V36, P11295, DOI 10.1523/JNEUROSCI.2542-16.2016; Debiec J, 2006, ANN NY ACAD SCI, V1071, P521, DOI 10.1196/annals.1364.056; Frank AC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02751-2; Gal RL, 2016, COMPREHENSIVE GUIDE TO POST-TRAUMATIC STRESS DISORDERS, VOLS 1 AND 2, P1515, DOI 10.1007/978-3-319-08359-9_121; Genovese RF, 2017, BEHAV PHARMACOL, V28, P521, DOI 10.1097/FBP.0000000000000329; Genovese RF, 2014, BEHAV PROCESS, V108, P105, DOI 10.1016/j.beproc.2014.09.032; Goswami S, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00089; Grippo AJ, 2009, STRESS, V12, P1, DOI 10.1080/10253890802046281; Gruene T, 2016, NEUROSCIENCE, V328, P157, DOI 10.1016/j.neuroscience.2016.04.045; Gruene TM, 2015, BIOL PSYCHIAT, V78, P186, DOI 10.1016/j.biopsych.2014.11.014; Hetzel-Riggin MD, 2013, J LOSS TRAUMA, V18, P41, DOI 10.1080/15325024.2012.679119; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Joels M, 2018, J ENDOCRINOL, V238, pR121, DOI 10.1530/JOE-18-0226; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; KLEIN SL, 1994, PHYSIOL BEHAV, V56, P291, DOI 10.1016/0031-9384(94)90197-X; Kolassa IT, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-54; Lehrner A, 2018, PSYCHOL TRAUMA-US, V10, P22, DOI 10.1037/tra0000302; Lieberman-Cribbin W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170965; Lowery-Gionta EG, 2019, TRANSL ISS PSYCH SCI, V5, P243, DOI 10.1037/tps0000199; MEYERHOFF JL, 1988, PSYCHOSOM MED, V50, P295, DOI 10.1097/00006842-198805000-00007; Moore NLT, 2016, STRESS, V19, P295, DOI 10.1080/10253890.2016.1191465; Moore NLT, 2014, PHARMACOL BIOCHEM BE, V120, P17, DOI 10.1016/j.pbb.2014.01.011; Moore NLT, 2012, PHARMACOL BIOCHEM BE, V102, P264, DOI 10.1016/j.pbb.2012.05.002; Morilak DA, 2003, LIFE SCI, V73, P715, DOI 10.1016/S0024-3205(03)00392-8; Nothling J, 2017, COMPR PSYCHIAT, V76, P138, DOI 10.1016/j.comppsych.2017.05.001; Raskind MA, 2013, AM J PSYCHIAT, V170, P1003, DOI 10.1176/appi.ajp.2013.12081133; Richter-Levin G, 1998, PSYCHIAT RES, V79, P73, DOI 10.1016/S0165-1781(98)00030-4; Ritov G, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00001; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schalinski I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136921; Schoner J, 2017, J CELL MOL MED, V21, P2248, DOI 10.1111/jcmm.13161; Schrader AJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207804; Shansky RM, 2009, CEREB CORTEX, V19, P2479, DOI 10.1093/cercor/bhp003; Southwick SM, 1999, BIOL PSYCHIAT, V46, P1192, DOI 10.1016/S0006-3223(99)00219-X; Vyas A, 2002, J NEUROSCI, V22, P6810; Wang J, 2000, PHYSIOL BEHAV, V70, P327, DOI 10.1016/S0031-9384(00)00274-2; Yehuda R, 2000, AM J PSYCHIAT, V157, P1252, DOI 10.1176/appi.ajp.157.8.1252; Yehuda R, 2006, ANN NY ACAD SCI, V1071, P137, DOI 10.1196/annals.1364.012; Zoladz PR, 2021, EXPERT OPIN DRUG DIS, V16, P135, DOI 10.1080/17460441.2020.1820982; Zoladz PR, 2019, HORM BEHAV, V115, DOI 10.1016/j.yhbeh.2019.104564	48	0	0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4530	1873-3360		PSYCHONEUROENDOCRINO	Psychoneuroendocrinology	NOV	2021	133								105394	10.1016/j.psyneuen.2021.105394			12	Endocrinology & Metabolism; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology; Psychiatry	US8UR	WOS:000697702200014	34474197				2022-02-06	
J	Cyriac, T; Raghavan, AP; Rao, SCS; Rajagopalawarrier, BK				Cyriac, Thomas; Raghavan, Anand Prabhavathy; Rao, Satheesh Chandra Sugatha; Rajagopalawarrier, Biju Krishnan			Intraoperative Prognostic Factors in Patients with Traumatic Acute Subdural Haematoma Undergoing Decompressive Craniectomy-A Pilot Study	JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH			English	Article						Head injury; Intracranial pressure; Primary brain injury; Prognostic indicators	BRAIN-INJURY; RISK-FACTORS; HYPOTENSION; RELAXATION; CRANIOTOMY; MANAGEMENT; MORTALITY; PREDICTORS; OUTCOMES	Introduction: Traumatic Acute Subdural Haematoma (TASH) remains one of the most lethal of all head injuries with high mortality and morbidity. The admission Glasgow Coma Score (GCS), age, pupillary response and size, hypoxia, hyperthermia, and raised Intra Cranial Pressure (ICP) are the conventional prognostic indicator markers for TASH. However these markers do not represent secondary brain injury. Aim: To identify the intraoperative prognostic markers and devise a scoring system based on these factors to aid in defining prognosis of patients with TASH undergoing Decompressive Craniectomy (DC). Materials and Methods: This pilot study was conducted in the Department of Neurosurgery, Government Medical College Thrissur, Kerala, India, over a period of one year (July 2018 to August 2019). Total 100 patients who presented with TASH and underwent DC were included in the present study. Intraoperative factors such as hypotension, saturation fall, brain bulge, brain pulsations, clot volume, Sub Arachnoid Haemorrhage (SAH) size were recorded. The primary outcome on the 30th day as alive or dead and functional outcome by Modified Rankin scale on 60th day was recorded. Based on these factors a scoring system was devised. Parameters were assessed using Chi-square test. Results: Among the 100 patients 95 were males and 5 females with maximum cases (76) clustered between 36 to 50 years. Intraoperative fall in Blood Pressure (BP) lasting >5 minutes, fall in saturation of O2, presence of brain bulge (moderate to severe), clot volume >30 mL, poor brain pulsation, presence of co-existant SAH and presence of brain contusion indicated unfavourable prognosis. Poor GCS score was associated with poor functional outcome of Modified Rankin Scale (MRS) 6. Based on intraoperative prognostic scoring, patients belonging to Grade A category had favourable prognosis (no death). Patents belonging to Grade C had poor prognosis (43 death). Conclusion: Intraoperative factors should serve as vital prognostic tools, hand in hand with the conventional admission GCS and Computer Tomography (CT) while managing a patient with TASH undergoing DC. Such an approach would mirror the maximum damage suffered by brain due to injury which is inclusive of primary brain injury and secondary insults as well, suffered up to and until the time of a durotomy.	[Cyriac, Thomas; Raghavan, Anand Prabhavathy; Rao, Satheesh Chandra Sugatha; Rajagopalawarrier, Biju Krishnan] Govt Med Coll, Dept Neurosurg, Trichur 680596, Kerala, India		Cyriac, T (corresponding author), Govt Med Coll, Dept Neurosurg, Trichur 680596, Kerala, India.	thomascyriac66@yahoo.com					Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Alvis-Miranda Hernando, 2013, Bull Emerg Trauma, V1, P60; BRISTOW A, 1987, ANESTH ANALG, V66, P413, DOI 10.1213/00000539-198705000-00007; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Doddamani RS, 2012, INDIAN J NEUROTRAUM, V9, P33, DOI 10.1016/j.ijnt.2012.04.007; Dostal P, 2015, J NEUROSURG ANESTH, V27, P51, DOI 10.1097/ANA.0000000000000091; Faleiro RM, 2008, ARQ NEURO-PSIQUIAT, V66, P369, DOI 10.1590/S0004-282X2008000300017; Hanif S, 2009, Ir Med J, V102, P255; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Kinoshita K, 2004, RESUSCITATION, V60, P151, DOI 10.1016/j.resuscitation.2003.07.005; Kuo JR, 2011, J FORMOS MED ASSOC, V110, P258, DOI 10.1016/S0929-6646(11)60038-7; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Li J, 2016, BRIT J ANAESTH, V116, P759, DOI 10.1093/bja/aew096; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Miller P, 2006, ANESTH ANALG, V103, P869, DOI 10.1213/01.ane.0000237327.12205.dc; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Potts MB, 2008, ACTA NEUROCHIR SUPPL, V102, P109, DOI 10.1007/978-3-211-85578-2_22; Prahaladu P, 2017, INT J RES MED SCI, V5, P857; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sharma D, 2012, J NEUROSURG ANESTH, V24, P178, DOI 10.1097/ANA.0b013e318254fb70; STENING WA, 1986, AUST NZ J SURG, V56, P549, DOI 10.1111/j.1445-2197.1986.tb07098.x; Tandon PN, 2001, NEUROL INDIA, V49, P3; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; Tong WS, 2011, NEURORADIOLOGY, V53, P305, DOI 10.1007/s00234-010-0659-8; Vignesh RS, 2017, INT J SCI STUDY, V5, P227, DOI 10.17354/ijss/2017/300; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD	32	0	0	0	0	PREMCHAND SHANTIDEVI RESEARCH FOUNDATION	DELHI	71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA	2249-782X	0973-709X		J CLIN DIAGN RES	J. Clin. Diagn. Res.	NOV	2021	15	11					PC13	PC17		10.7860/JCDR/2021/51557.15653			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	XD4OE	WOS:000722689700004		gold			2022-02-06	
J	Dabrowski, W; Siwicka-Gieroba, D; Schlegel, TT; Robba, C; Zaid, S; Bielacz, M; Jaroszynski, A; Badenes, R				Dabrowski, Wojciech; Siwicka-Gieroba, Dorota; Schlegel, Todd T.; Robba, Chiara; Zaid, Sami; Bielacz, Magdalena; Jaroszynski, Andrzej; Badenes, Rafael			Suppression of Electrographic Seizures Is Associated with Amelioration of QTc Interval Prolongation in Patients with Traumatic Brain Injury	JOURNAL OF CLINICAL MEDICINE			English	Article						seizure; traumatic brain injury; QTc interval; spatial QTS-T angle; brain-heart interaction	HEART-RATE; EEG; IDENTIFICATION; CARDIOMYOPATHY; GUIDELINES; MANAGEMENT; DIAGNOSIS; PROPOFOL	Introduction: Disorders in electroencephalography (EEG) are commonly noted in patients with traumatic brain injury (TBI) and may be associated with electrocardiographic disturbances. Electrographic seizures (ESz) are the most common features in these patients. This study aimed to explore the relationship between ESz and possible changes in QTc interval and spatial QRS-T angle both during ESz and after ESz resolution. Methods: Adult patients with TBI were studied. Surface 12-lead ECGs were recorded using a Cardiax device during ESz events and 15 min after their effective suppression using barbiturate infusion. The ESz events were diagnosed using Masimo Root or bispectral index (BIS) devices. Results: Of the 348 patients considered for possible inclusion, ESz were noted in 72, with ECG being recorded in 21. Prolonged QTc was noted during ESz but significantly ameliorated after ESz suppression (540.19 & PLUSMN; 60.68 ms vs. 478.67 & PLUSMN; 38.52 ms, p < 0.001). The spatial QRS-T angle was comparable during ESz and after treatment. Regional cerebral oximetry increased following ESz suppression (from 58.4% & PLUSMN; 6.2 to 60.5% & PLUSMN; 4.2 (p < 0.01) and from 58.2% & PLUSMN; 7.2 to 60.8% & PLUSMN; 4.8 (p < 0.05) in the left and right hemispheres, respectively). Conclusion: QTc interval prolongation occurs during ESz events in TBI patients but both it and regional cerebral oximetry are improved after suppression of seizures.	[Dabrowski, Wojciech; Siwicka-Gieroba, Dorota] Med Univ Lublin, Dept Anaesthesiol & Intens Therapy, PL-20954 Lublin, Poland; [Schlegel, Todd T.] Karolinska Inst, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden; [Schlegel, Todd T.] Nicollier Schlegel SARL, CH-1270 Trelex, Switzerland; [Robba, Chiara] Policlin San Martino, Dept Anaesthesia & Intens Care, I-16100 Genoa, Italy; [Zaid, Sami] Al Emadi Hosp, Dept Anaesthesia, D Ring Rd,POB 50000, Doha, Qatar; [Bielacz, Magdalena] State Vocat Coll Szymon Szymonowicz, Inst Tourism & Recreat, PL-22400 Zamosc, Poland; [Jaroszynski, Andrzej] Jan Kochanowski Univ Humanities & Sci, Inst Med Sci, Dept Nephrol, PL-25736 Kielce, Poland; [Badenes, Rafael] Univ Valencia, Hosp Clin Univ Valencia, Dept Anaesthesiol & Intens Care, Valencia 46010, Spain		Dabrowski, W (corresponding author), Med Univ Lublin, Dept Anaesthesiol & Intens Therapy, PL-20954 Lublin, Poland.	w.dabrowski5@yahoo.com; dsiw@wp.pl; ttschlegel@gmail.com; kiarobba@gmail.com; sami1zaid@gmail.com; magda.bielacz@gmail.com; jaroszynskiaj@interia.pl; rafaelbadenes@gmail.com		Badenes, Rafael/0000-0001-7017-0150; Dabrowski, Wojciech/0000-0003-0449-2375			Abrich VA, 2017, INT J CARDIOL, V232, P243, DOI 10.1016/j.ijcard.2017.01.011; Battaglini D, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02885-8; Brewster AL, 2016, EPILEPSIA, V57, P1907, DOI 10.1111/epi.13516; Brotherstone R, 2010, EPILEPSIA, V51, P221, DOI 10.1111/j.1528-1167.2009.02281.x; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen ZL, 2017, CIRC RES, V121, P451, DOI 10.1161/CIRCRESAHA.117.311170; Cortez DL, 2010, J ELECTROCARDIOL, V43, P302, DOI 10.1016/j.jelectrocard.2010.03.010; Dabrowski W, 2018, J ELECTROCARDIOL, V51, P499, DOI 10.1016/j.jelectrocard.2017.12.038; Davie S, 2021, J NEUROSURG ANESTH, V33, P258, DOI 10.1097/ANA.0000000000000652; Dericioglu N, 2015, EPILEPSY RES, V109, P48, DOI 10.1016/j.eplepsyres.2014.10.013; Dimitri Giovanna Maria, 2017, Appl Netw Sci, V2, P29, DOI 10.1007/s41109-017-0050-3; Dimitri GM, 2018, ACTA NEUROCHIR SUPPL, V126, P147, DOI 10.1007/978-3-319-65798-1_31; Dogan EA, 2010, EPILEPSY RES, V90, P157, DOI 10.1016/j.eplepsyres.2010.04.008; Etchegoyen CV, 2017, CURR CLIN PHARMACOL, V12, P210, DOI 10.2174/1574884713666180223123947; Georgakopoulos A, 2016, HELL J NUCL MED, V19, P189, DOI 10.1967/s0024499100400; Gopinath R, 2018, ANN CARD ANAESTH, V21, P228, DOI 10.4103/aca.ACA_176_17; Hernandez-Hernandez MA, 2016, SEIZURE-EUR J EPILEP, V34, P18, DOI 10.1016/j.seizure.2015.11.001; Hirsch LJ, 2021, J CLIN NEUROPHYSIOL, V38, P1, DOI 10.1097/WNP.0000000000000806; Hocker S, 2013, EPILEPSIA, V54, P518, DOI 10.1111/epi.12017; Hrishi AP, 2019, INDIAN J CRIT CARE M, V23, P329, DOI 10.5005/jp-journals-10071-23208; Jiang HT, 2020, CEREB CORTEX, V30, P439, DOI 10.1093/cercor/bhz095; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; Kang JH, 2019, NEUROCRIT CARE, V31, P312, DOI 10.1007/s12028-019-00673-z; Mazzeo AT, 2014, BRIT J ANAESTH, V112, P803, DOI 10.1093/bja/aeu046; Mohamed J, 2016, J NEUROSCI, V36, P8777, DOI 10.1523/JNEUROSCI.1448-16.2016; Moseley BD, 2011, EPILEPSY RES, V95, P237, DOI 10.1016/j.eplepsyres.2011.04.005; Owusu K, 2019, A A PRACT, V13, P281, DOI 10.1213/XAA.0000000000001056; Patron E, 2019, NEUROIMAGE, V188, P403, DOI 10.1016/j.neuroimage.2018.12.035; Pensirikul AD, 2013, J CLIN NEUROPHYSIOL, V30, P371, DOI 10.1097/WNP.0b013e31829de01c; Prichep L.S., 2000, MEMORY AWARENESS ANA, P97; Read MI, 2014, SEIZURE-EUR J EPILEP, V23, P55, DOI 10.1016/j.seizure.2013.09.012; Sadrnia S, 2013, ARYA ATHEROSCLER, V9, P7; Schuele SU, 2010, EPILEPSIA, V51, P170, DOI 10.1111/j.1528-1167.2009.02168.x; Simonassi F, 2021, J NEUROSURG ANESTH, V33, P285, DOI 10.1097/ANA.0000000000000679; Siniscalchi A, 2014, CLIN DRUG INVEST, V34, P879, DOI 10.1007/s40261-014-0243-9; Smith SJM, 2005, J NEUROL NEUROSUR PS, V76, P2, DOI 10.1136/jnnp.2005.069245; Stewart CP, 2010, NEUROLOGY, V75, P1501, DOI 10.1212/WNL.0b013e3181f9619e; Sun YR, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0382-0; Swisher CB, 2015, J CLIN NEUROPHYSIOL, V32, P324, DOI 10.1097/WNP.0000000000000144; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wutzler A, 2018, J ELECTROCARDIOL, V51, P170, DOI 10.1016/j.jelectrocard.2017.11.003; Xue JQ, 2006, COMPUT CARDIOL, V33, P385; Zimmermann LL, 2016, NEUROSURG CLIN N AM, V27, P499, DOI 10.1016/j.nec.2016.06.001; Zuluaga MT, 2010, PEDIATR CRIT CARE ME, V11, P514, DOI 10.1097/PCC.0b013e3181c51cf1	45	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	NOV	2021	10	22							5374	10.3390/jcm10225374			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XH2HX	WOS:000725262900001	34830656	Green Published, gold			2022-02-06	
J	Daia, C; Munteanu, C; Andone, I; Spinu, A; Popescu, C; Toader, C; Onose, G				Daia, Cristina; Munteanu, Constantin; Andone, Ioana; Spinu, Aura; Popescu, Cristina; Toader, Corneliu; Onose, Gelu			Polydipsia-polyuria syndrome associated with traumatic spinal cord injury	SIGNA VITAE			English	Article						Polyuria; Polydipsia; Spinal cord injury	DIABETES-INSIPIDUS; DIFFERENTIAL-DIAGNOSIS; HYPONATREMIA	Introduction: Polydipsia and polyuria associated with traumatic spinal cord injury (SCI) are rare consequences. The hypothetical pathophysiological mechanisms involve mild traumatic brain injury (TBI) and/ or vagus dysfunction associated with spinal cord injury. Methods: In a retrospective study of 11 patients, we investigated associations between polydipsia-polyuria syndrome and various clinical and therapeutic factors: medullary section syndrome, neurological level, medication, neurosurgical intervention, kinesitherapy program, associated comorbidities, functional level at discharge and patient quality of life (QoL). Results: The beginning of the kinetic program (Spearman correlation coefficient =0.631) and desmopressin treatment (Spearman correlation coefficient =0.708) had statistically significant effects on resolution of polydipsia-polyuria syndrome (PPS). Patient QoL was statistically significant improved after resolution of PPS (t-test, p =0.001). Conclusions: Mobilization programs appear to promote resolution of PPS. Desmopressin treatment is beneficial and, together, medication and kinesitherapy elevate patients' QoL. The association between SCI and transient PPS requires additional investigation in additional patients.	[Daia, Cristina; Andone, Ioana; Spinu, Aura; Popescu, Cristina; Onose, Gelu] Univ Med & Pharm Carol Davila, Dept Med Rehabil, Bucharest 4192910, Romania; [Daia, Cristina; Andone, Ioana; Spinu, Aura; Popescu, Cristina; Onose, Gelu] Clin Emergency Hosp Bagdasar Arseni, Neuromuscular Dept, Bucharest 041914, Romania; [Munteanu, Constantin] Romanian Assoc Balneol, Dept Res, Bucharest 022252, Romania; [Munteanu, Constantin; Onose, Gelu] Clin Emergency Hosp Bagdasar Arseni, Phys & Rehabil Med & Balneol Res Nucleus, Bucharest 041914, Romania; [Munteanu, Constantin] Univ Med & Pharm Grigore T Popa, Fac Med Bioengn, Iasi 700454, Romania; [Toader, Corneliu] Carol Davila Univ Med & Pharm, Dept Neurosurg, Bucharest 041914, Romania; [Toader, Corneliu] Natl Inst Cerebrovasc Dis, Neurosurg Dept, Bucharest 041914, Romania		Munteanu, C (corresponding author), Romanian Assoc Balneol, Dept Res, Bucharest 022252, Romania.; Munteanu, C (corresponding author), Clin Emergency Hosp Bagdasar Arseni, Phys & Rehabil Med & Balneol Res Nucleus, Bucharest 041914, Romania.; Munteanu, C (corresponding author), Univ Med & Pharm Grigore T Popa, Fac Med Bioengn, Iasi 700454, Romania.	constantin2378@yahoo.com	Constantin, Munteanu/F-4672-2011; Onose, Gelu/AAC-6786-2021; Daia, Cristina/R-6294-2018	Constantin, Munteanu/0000-0002-1084-7710; Onose, Gelu/0000-0002-6346-8941; Daia, Cristina/0000-0002-9872-6496			[Anonymous], 2012, J Spinal Cord Med, V35, P197, DOI 10.1179/1079026812Z.00000000063; Bauman WA, 2017, SPINAL CORD, V55, P466, DOI 10.1038/sc.2016.164; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; Burckhardt Carol S, 2003, Health Qual Life Outcomes, V1, P59; Closson B L, 1993, Rehabil Nurs, V18, P368; Decanter C, 1996, ANN ENDOCRINOL-PARIS, V57, P411; Diederich S, 2001, CLIN ENDOCRINOL, V54, P665, DOI 10.1046/j.1365-2265.2001.01270.x; Esposito P, 2011, NEPHRON CLIN PRACT, V119, pC62, DOI 10.1159/000324653; FARRELL CA, 1986, ARCH PHYS MED REHAB, V67, P132, DOI 10.1016/0003-9993(86)90126-7; Frisbie JH, 2007, SPINAL CORD, V45, P563, DOI 10.1038/sj.sc.3101984; Gormally Joseph F, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2014-203683; Iverson L.M., 2021, GLASGOW COMA SCALE; Juul KV, 2017, BJU INT, V119, P776, DOI 10.1111/bju.13718; Kalra Sanjay, 2016, Indian J Endocrinol Metab, V20, P9, DOI 10.4103/2230-8210.172273; Kansagara D., 2013, COMPLICATIONS MILD T; Kenny BJ, NEUROANATOMY CRANIAL, P2021; KIDD D, 1995, DISABIL REHABIL, V17, P10, DOI 10.3109/09638289509166622; Kuzeyli K, 2001, Spine (Phila Pa 1976), V26, pE510, DOI 10.1097/00007632-200111010-00023; Laczi Ferenc, 2002, Orvosi Hetilap, V143, P2579; Lude P, 2014, Top Spinal Cord Inj Rehabil, V20, P197, DOI 10.1310/sci2003-197; Makaryus AN, 2006, CLEV CLIN J MED, V73, P65, DOI 10.3949/ccjm.73.1.65; McCarty TS, 2021, DESMOPRESSIN; Nozaki A, 2016, ENDOCRINE, V51, P140, DOI 10.1007/s12020-015-0637-3; Ohbuchi Toyoaki, 2015, Interdiscip Inf Sci, V21, P225, DOI 10.4036/iis.2015.B.07; Oz B, 2005, AM J PHYS MED REHAB, V84, P817, DOI 10.1097/01.phm.0000179515.25335.af; Prasad VSSV, 1995, NEUROL INDIA, V43, P206; Roberts TT, 2017, CLIN ORTHOP RELAT R, V475, P1499, DOI 10.1007/s11999-016-5133-4; SITPRIJA V, 1966, ANN INTERN MED, V65, P62, DOI 10.7326/0003-4819-65-1-62; Tenny S, CEREBRAL SALT WASTIN, P2021; Yasir M, SYNDROME INAPPROPRIA, P2021	30	0	0	0	0	MRE PRESS	SINGAPORE	14 ROBINSON RD #08-01A FAR EAST FINANCE, SINGAPORE, SINGAPORE	1334-5605	1845-206X		SIGNA VITAE	Signa Vitae	NOV	2021	17	6					74	81		10.22514/sv.2021.104			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XA8US	WOS:000720916200010					2022-02-06	
J	Dalla Costa, FA; Gibson, TJ; Oliveira, SEO; Gregory, NG; Faucitano, L; Dalla Costa, OA				Dalla Costa, F. A.; Gibson, T. J.; Oliveira, S. E. O.; Gregory, N. G.; Faucitano, L.; Dalla Costa, O. A.			p On-farm culling methods used for pigs	ANIMAL WELFARE			English	Article						animal welfare; culling; killing; neonate; pig; suffering	NONPENETRATING CAPTIVE-BOLT; SOMATOSENSORY-EVOKED POTENTIALS; CARBON-DIOXIDE; ELECTROENCEPHALOGRAPHIC ASSESSMENT; BEHAVIORAL-RESPONSES; WELFARE IMPLICATIONS; BROILER-CHICKENS; STUNNING METHODS; HUMANE METHOD; BRAIN-DAMAGE	The culing of injured and non-viable pigs (Sus scrofa) (neonate to breeding stock) is a routine and necessary procedure on most farms. Usualy, pigs are culled using one of the following methods: blunt-force trauma (manual and mechanical), captive-bolt stunners, electrical stunning and electrocution or carbon dioxide. Manual blunt-force trauma is one of the most widely used methods due to its low or absent operational and investment costs. However, as a method, it has serious limitations, which include the risk of incomplete concussion, pain, and distress. Manual blunt-force trauma is also aesthetically unpleasant to operators and wider society. To address these issues there has been significant recent research into the development of alternatives to manual blunt-force trauma, these include: captive-bolt stunners, on-farm, gas-based controlled atmosphere systems, low atmospheric pressure systems and electrical stunning. Some of these are currently in commercial use while others are still in the developmental phase. This review brings together the relevant research in this field, evaluating the methods in terms of mechanism of action (mechanical and physiological), effectiveness and animal welfare.	[Dalla Costa, F. A.] MSD Anim Hlth, Dept Strategy & Innovat, Av Dr Chicri Zaidan 296, Sao Paulo, SP, Brazil; [Dalla Costa, F. A.; Oliveira, S. E. O.] Univ Estadual Paulista, Programa Posgrad Zootecnia, Fac Ciencias Agr & Vet, BR-14884900 Jaboticabal, SP, Brazil; [Dalla Costa, F. A.; Oliveira, S. E. O.] MANEJA, Maneja Bemestar Anim, BR-89710037 Concodia, SC, Brazil; [Gibson, T. J.; Gregory, N. G.] Univ London, Royal Vet Coll, Hawkshead Lane, Hatfield AL9 7TA, Herts, England; [Faucitano, L.] Agr & Agri Food Canada, 2000 Coll St, Sherbrooke, PQ J1M 0C8, Canada; [Dalla Costa, O. A.] Embrapa Swine & Poultry, BR 153,Km 110, BR-89700991 Concordia, Brazil		Dalla Costa, FA (corresponding author), MSD Anim Hlth, Dept Strategy & Innovat, Av Dr Chicri Zaidan 296, Sao Paulo, SP, Brazil.; Dalla Costa, FA (corresponding author), Univ Estadual Paulista, Programa Posgrad Zootecnia, Fac Ciencias Agr & Vet, BR-14884900 Jaboticabal, SP, Brazil.; Dalla Costa, FA (corresponding author), MANEJA, Maneja Bemestar Anim, BR-89710037 Concodia, SC, Brazil.	filipedallacosta@gmail.com			CNPq (FAPESP)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/24.910-4]; MAPA (Ministerio da Agricultura, Pecuaria e Abastecimento) [TED 21000.004262/2018-51]; Humane Slaughter Association Special Travel Award	This review was prepared as part of the PhD Thesis of the lead author in the Animal Science Graduate Program at the Faculty of Agricultural and Veterinary Sciences, UNESP, Jaboticabal, SP, Brazil. The research and review was partially funded by CNPq (that granted the scholarships to FADC and SEOO, by FAPESP (grant number 2016/24.910-4) for supporting Professor Neville G Gregory as a visiting professor at FCAV-UNESP, Jaboticabal campus and MAPA (Ministerio da Agricultura, Pecuaria e Abastecimento) for supporting the researchers lead by OADC at EMBRAPA Swine and Poultry (grant number TED 21000.004262/2018-51) . TJG and FADC were supported by a Humane Slaughter Association Special Travel Award. The authors also express their gratitude to Charlie Ludtke and Lizie PereirA Buss for their support and contribution during this review and projects about on-farm euthanasia of pigs.	American Veterinary Medical Association (AVMA, 2020, J AM VET MEDICAL ASS, V2013, P1; American Veterinary Medical Association (AVMA), 2008, LIT REV WELF IMPL EL, P1; ANIL MH, 1992, MEAT SCI, V31, P481, DOI 10.1016/0309-1740(92)90030-8; Anil MH, 2012, EBLEXA DIVISION AGR, P73; [Anonymous], 2010, MH0128 DEFRA; [Anonymous], 2016, MH0150 DEFRA; ANTON F, 1992, PAIN, V49, P53, DOI 10.1016/0304-3959(92)90187-G; BAKER HJ, 1995, CAN VET J, V36, P160; Banzett RB, 1996, RESP PHYSIOL, V103, P19, DOI 10.1016/0034-5687(95)00050-X; Banzett RB, 2007, J NEUROPHYSIOL, V97, P959, DOI 10.1152/jn.00970.2006; Beausoleil NJ, 2015, NEW ZEAL VET J, V63, P44, DOI 10.1080/00480169.2014.940410; Berg C, 2015, ANIMALS-BASEL, V5, P1207, DOI 10.3390/ani5040407; BETZ P, 1993, AM J FOREN MED PATH, V14, P54, DOI 10.1097/00000433-199303000-00013; BLACKMORE DK, 1985, VET REC, V116, P36, DOI 10.1136/vr.116.2.36; BLACKMORE DK, 1995, NEW ZEAL VET J, V43, P134, DOI 10.1080/00480169.1995.35872; BLACKMORE DK, 1981, NEW ZEAL VET J, V29, P219, DOI 10.1080/00480169.1981.34850; Blumbergs PC, 1997, HEAD INJURY PATHOPHY, P39; Bouwsema JA, 2019, ANIM WELFARE, V28, P421, DOI 10.7120/09627286.28.4.421; BURNETT BR, 1991, J FORENSIC SCI, V36, P1745; Buzzard BL., 2012, THESIS KANSAS STATE; Caird J, 2000, BRIT J NEUROSURG, V14, P349; Casey-Trott TM, 2014, J ANIM SCI, V92, P5166, DOI 10.2527/jas.2014-7980; Casey-Trott TM, 2013, J ANIM SCI, V91, P5477, DOI 10.2527/jas.2013-6320; CHEN XJ, 1995, EUR J NEUROSCI, V7, P1154, DOI 10.1111/j.1460-9568.1995.tb01105.x; Cooney KA, 2012, VET EUTHANASIA TECHN, P136, DOI [10.1002/9781118704585, DOI 10.1002/9781118704585]; Dalla Costa FA, 2016, PORKEXPO 2016, P323; Dalla Costa FA, 2020, J ANIM SCI, V98, DOI 10.1093/jas/skaa204; Dalla Costa FA, 2019, LIVEST SCI, V221, P1, DOI 10.1016/j.livsci.2019.01.007; Dalmau A, 2010, ANIM WELFARE, V19, P325; Danneman PJ, 1997, LAB ANIM SCI, V47, P376; Dawson MD, 2006, APPL ENG AGRIC, V22, P787; de la Cruz L, 2018, LIVEST SCI, V212, P22, DOI 10.1016/j.livsci.2018.03.014; Denicourt M, 2010, ANN M IMPL KNOWL, P451; DRIPPS RD, 1947, AM J PHYSIOL, V149, P43, DOI 10.1152/ajplegacy.1947.149.1.43; Edwards L, 2011, MOINES IOWA PORK CHE, P235, DOI DOI 10.1017/CB09781107415324.004; Engle TE, 2010, PORK CHECKOFF RES RE; European Food Safety Authority (EFSA), 2004, EFSA J, V2, P1, DOI [10.2903/j.efsa.2004.45, DOI 10.2903/J.EFSA.2004.45, DOI 10.2903/J.EFSA.2004.89]; Farouk MM, 2013, MEAT SCI, V95, P805, DOI 10.1016/j.meatsci.2013.04.028; Feng YW, 2003, INVEST OPHTH VIS SCI, V44, P529, DOI 10.1167/iovs.02-0003; Fiedler KJ, 2016, ANIM WELFARE, V25, P83, DOI 10.7120/09627286.25.1.083; Finnie J, 1999, J CLIN NEUROSCI, V6, P38, DOI 10.1016/S0967-5868(99)90601-X; Finnie JW, 2016, VET PATHOL, V53, P962, DOI 10.1177/0300985815612155; Finnie JW, 2000, AUST VET J, V78, P775, DOI 10.1111/j.1751-0813.2000.tb10451.x; FINNIE JW, 1993, J COMP PATHOL, V108, P93, DOI 10.1016/S0021-9975(08)80231-9; Finnie JW, 2003, AUST VET J, V81, P153, DOI 10.1111/j.1751-0813.2003.tb11078.x; Finnie JW, 2001, J COMP PATHOL, V124, P159, DOI 10.1053/jcpa.2000.0446; FORSLID A, 1987, ACTA PHYSIOL SCAND, V130, P1, DOI 10.1111/j.1748-1716.1987.tb08104.x; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gibson TJ, 2018, BRIT POULTRY SCI, V59, P13, DOI 10.1080/00071668.2017.1401215; Gibson TJ, 2012, ANIM WELFARE, V21, P35, DOI 10.7120/096272812X13353700593446; Gibson TJ, 2015, MEAT SCI, V108, P120, DOI 10.1016/j.meatsci.2015.06.007; Gibson TJ, 2015, J APPL ANIM WELF SCI, V18, P222, DOI 10.1080/10888705.2014.980579; Gibson TJ, 2015, MEAT SCI, V100, P227, DOI 10.1016/j.meatsci.2014.10.022; Gibson TJ, 2019, MEAT SCI, V151, P54, DOI 10.1016/j.meatsci.2019.01.006; Gnjidic Z, 2002, ACTA NEUROCHIR, V144, P1271, DOI 10.1007/s00701-002-1018-2; Graham DI, 1997, GREENFIELDS NEUROPAT, P197; Grandin T, 2002, J AM VET MED ASSOC, V221, P1258, DOI 10.2460/javma.2002.221.1258; GRANDIN T, 1980, INT J STUD ANIM PROB, V1, P242; GRANDIN T, 1994, J AM VET MED ASSOC, V204, P1354; Gregory N., 2000, Journal of Applied Animal Welfare Science, V3, P215, DOI 10.1207/S15327604JAWS0303_3; Gregory N. G., 2007, Animal welfare and meat production, P191, DOI 10.1079/9781845932152.0191; Gregory NG, 2007, MEAT SCI, V77, P499, DOI 10.1016/j.meatsci.2007.04.026; GREGORY NG, 1984, BRIT VET J, V140, P570, DOI 10.1016/0007-1935(84)90008-3; Grellner Wolfgang, 2000, Archiv fuer Kriminologie, V205, P162; Grist A, 2017, ANIM WELFARE, V26, P111, DOI 10.7120/09627286.26.1.111; Grist A, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9080552; Grist A, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8040048; Grist A, 2018, ANIMALS, V8, DOI 10.3390/ani8040049; Gurung S, 2018, ANIMALS, V8, DOI 10.3390/ani8010006; Gurung S, 2018, ANIMALS, V8, DOI 10.3390/ani8010011; Haley C, 2008, CAN J VET RES, V72, P377; Hoenderken R, 1978, THESIS U UTRECHT NET; Humane Slaughter Association (HSA), 2014, HUM KILL LIV US FIR, P1, DOI [10.1007/978-94-007-6167-4_377-1, DOI 10.1007/978-94-007-6167-4_377-1]; Janssen W, 1964, ARCH KRIMINOL, V134, P26; Kattimani Ravi Prasad, 2016, J Orthop Case Rep, V6, P6, DOI 10.13107/jocr.2250-0685.544; Kells N, 2018, ANIMALS, V8, DOI 10.3390/ani8030040; Kline HC, 2019, MEAT SCI, V155, P69, DOI 10.1016/j.meatsci.2019.05.004; Lambooij E, 1999, APPL ANIM BEHAV SCI, V62, P255, DOI 10.1016/S0168-1591(98)00214-7; Leach MC, 2004, ANIM WELFARE, V13, pS77; Leach MC, 2002, COMPARATIVE MED, V52, P249; Liotti M, 2001, P NATL ACAD SCI USA, V98, P2035, DOI 10.1073/pnas.98.4.2035; Llonch P, 2015, RES VET SCI, V98, P154, DOI 10.1016/j.rvsc.2014.12.009; Llonch P, 2012, ANIM WELFARE, V21, P33, DOI 10.7120/096272812799129475; Marahrens M, 2017, WELFARE IMPACTS CONT, P15; Martin JE, 2017, UFAW HSA M, DOI [10.1080/00071668.2016.1201200, DOI 10.1080/00071668.2016.1201200]; Martoft L, 2003, LAB ANIM-UK, V37, P241, DOI 10.1258/002367703766453092; Matthis JS, 2005, THESIS N CAROLINA ST; McKeegan DEF, 2013, POULTRY SCI, V92, P1145, DOI 10.3382/ps.2012-02587; McKeegan DEF, 2013, POULTRY SCI, V92, P858, DOI 10.3382/ps.2012-02749; Millar GI, 2000, VET REC, V146, P754, DOI 10.1136/vr.146.26.754; Millman ST., 2013, ANIMAL IND REPORT, V659, P76, DOI [10.31274/ans_air-180814-679, DOI 10.31274/ANS_AIR-180814-679]; More S, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5056; Mores MAZ, 2014, ORIENTACOES EUTANASI; National Pork Board, 2009, ONF EUTH SWIN REC PR; NILSSON B, 1977, J NEUROSURG, V47, P274, DOI 10.3171/jns.1977.47.2.0274; Oliveira SEO, 2018, MEAT SCI, V140, P9, DOI 10.1016/j.meatsci.2018.02.010; Oliveira SEO, 2017, MEAT SCI, V130, P64, DOI 10.1016/j.meatsci.2017.04.007; Oliveira SEO, 2017, AVALIACAO EFICIENCIA; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pearigen P, 1996, BRAIN RES, V725, P184; Purswell JL, 2007, J APPL POULTRY RES, V16, P509, DOI 10.3382/japr.2007-00026; RAJ ABM, 1995, ANIM WELFARE, V4, P273; Raj ABM, 1997, VET J, V153, P329, DOI 10.1016/S1090-0233(97)80067-6; Raj ABM, 1998, BRIT POULTRY SCI, V39, P686, DOI 10.1080/00071669888584; Raj ABM, 1999, VET REC, V144, P165, DOI 10.1136/vr.144.7.165; Raj M, 2008, WELFARE OF PIGS: FROM BIRTH TO SLAUGHTER, P225; Raj M, 2008, J APPL ANIM WELF SCI, V11, P112, DOI 10.1080/10888700801925679; Rault JL, 2017, J ANIM SCI, V95, P949, DOI 10.2527/jas.2016.0922; Rault JL, 2013, J ANIM SCI, V91, P1874, DOI 10.2527/jas.2012-5761; Rault JL, 2015, PHYSIOL BEHAV, V151, P29, DOI 10.1016/j.physbeh.2015.06.026; RAWNSLEY K, 1985, BRIT MED J, V291, P922, DOI 10.1136/bmj.291.6500.922; RING C, 1988, FLEISCHWIRTSCHAFT, V68, P1478; Sadler LJ, 2014, J ANIM SCI, V92, P793, DOI 10.2527/jas.2013-6598; Sandercock DA, 2014, PHYSIOL BEHAV, V133, P252, DOI 10.1016/j.physbeh.2014.05.030; Schiffer KJ, 2014, ANIM WELFARE, V23, P479, DOI 10.7120/09627286.23.4.479; Sharp TM, 2014, WILDLIFE RES, V41, P623, DOI 10.1071/WR14094; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Simic M, 2007, J FORENSIC SCI, V52, P1182, DOI 10.1111/j.1556-4029.2007.00519.x; Smith DC, 1965, METHODS ANIMAL EXPT, P167, DOI [10.1016/B978-1-4832-3220-1.50012-7, DOI 10.1016/B978-1-4832-3220-1.50012-7]; Smith RK, 2018, ANIMALS, V8, DOI 10.3390/ani8040052; Svendsen O, 2008, VET REC, V162, P90, DOI 10.1136/vr.162.3.90; Sweetman SC., 2012, MARTINDALE COMPLETE; Thomson DU, 2013, AM J VET RES, V74, P1385, DOI 10.2460/ajvr.74.11.1385; Thurauf N, 2002, BRAIN RES, V942, P79, DOI 10.1016/S0006-8993(02)02697-5; TORDRUP PJ, 1994, INJURY, V25, P497, DOI 10.1016/0020-1383(94)90088-4; Van Liere EJ., 1943, AM J MED SCI, V205, P433, DOI [10.1097/00000441-194303000-00027, DOI 10.1097/00000441-194303000-00027]; Velarde A, 2016, ANIMAL WELFARE SLAUG, P91; Velarde A, 2016, ANIMAL WELFARE SLAUG, VFirst, P133; Verhoeven M, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00038; Viel G, 2009, FORENSIC SCI INT, V187, pE7, DOI 10.1016/j.forsciint.2009.01.022; Viola L, 2004, J FORENSIC SCI, V49, P595; Vizzier-Thaxton Y, 2010, J APPL POULTRY RES, V19, P341, DOI 10.3382/japr.2010-00184; Wagner DR, 2019, MEAT SCI, V155, P109, DOI 10.1016/j.meatsci.2019.05.006; Walsh JL, 2017, ANIMALS, V7, DOI 10.3390/ani7120100; Whiting TL, 2011, CAN VET J, V52, P753; Widowski T, 2008, ALL D LEM SWIN C P, P107; Woods J., 2010, IMPROVING ANIMAL WEL, P195; Wotton SB., 1996, MEAT FOCUS INT, V12, P461; Young RJ, 2002, NEUROIMAG CLIN N AM, V12, P189, DOI 10.1016/S1052-5149(02)00003-5	139	0	0	0	0	UNIV FEDERATION ANIMAL WELFARE	WHEATHAMPSTEAD	OLD SCHOOL, BREWHOUSE HILL, WHEATHAMPSTEAD AL4 8AN, HERTS, ENGLAND	0962-7286			ANIM WELFARE	Anim. Welf.	NOV	2021	30	4					507	522		10.7120/09627286.30.3.008			16	Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences; Zoology	YI4MM	WOS:000743823500013					2022-02-06	
J	Dawson, J; Reed, N; Bauman, S; Seguin, R; Zemek, R				Dawson, Jennifer; Reed, Nick; Bauman, Shannon; Seguin, Ryan; Zemek, Roger		ONF Pediat Concussion Living Guide	Diagnosing and managing paediatric concussion: Key recommendations for general paediatricians and family doctors	PAEDIATRICS & CHILD HEALTH			English	Article						Brain; Concussion; Mild traumatic brain injury; Post-concussion syndrome	CHILDREN; INJURY	Concussion in children and adolescents is an important health concern. Most paediatric patients fully recover in 1 month or less following an acute concussion. However, some experience prolonged or persistent concussion symptoms for months. Those with prolonged post-concussion-related symptoms may have impaired quality of life, and limited involvement in social, academic, and physical activities with associated mental health implications. In this review, we share key updated clinical recommendations from the Living Guideline for Diagnosing and Managing Pediatric Concussion that will improve the way general paediatricians and family doctors diagnose and manage paediatric patients with suspected concussion.	[Dawson, Jennifer; Zemek, Roger] Childrens Hosp Eastern Ontario, Res Inst CHEO RI, Ottawa, ON, Canada; [Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Bauman, Shannon] Royal Victoria Hosp, Concuss North, Barrie, ON, Canada; [Bauman, Shannon] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Seguin, Ryan; Zemek, Roger] Univ Ottawa, Fac Med, Ottawa, ON, Canada		Zemek, R (corresponding author), CHEO Res Inst, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	rzemek@cheo.on.ca		Dawson, Jennifer/0000-0003-1141-9619	Ontario Neurotrauma Foundation	The Living Guideline for Diagnosing and Managing Pediatric Concussion is funded by the Ontario Neurotrauma Foundation.	[Anonymous], 2017, BRIT J SPORT MED, V51; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; DeMatteo C, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2019-000667; Farrell CA, 2013, PAED CHILD HEALT-CAN, V18, P253, DOI 10.1093/pch/18.5.253; Fridman L, 2018, J PEDIATR-US, V192, P184, DOI 10.1016/j.jpeds.2017.09.018; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langevin P, 2020, MED SCI SPORT EXER, V52, P2491, DOI 10.1249/MSS.0000000000002402; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Mannix R, 2020, J NEUROTRAUM, V37, P2029, DOI 10.1089/neu.2019.6956; McDonald CC, 2020, J ADOLESC HLTH; Osmond MH, 2018, CAN MED ASSOC J, V190, pE816, DOI 10.1503/cmaj.170406; Parachute, 2019, CAN GUID CONC SPORT; Parachute, 2018, STAT CONC BAS TEST C; Rausa VC, 2020, NEUROSCI BIOBEHAV R, V118, P643, DOI 10.1016/j.neubiorev.2020.08.017; Reed N, 2020, LIVING GUIDELINE DIA; Rosenbaum PE, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.21463; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	19	0	0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1205-7088	1918-1485		PAED CHILD HEALT-CAN	Paediatr. Child Health	NOV	2021	26	7					402	407		10.1093/pch/pxab024			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	XL8KG	WOS:000728389600012	34777657				2022-02-06	
J	Dick, AS; Silva, K; Gonzalez, R; Sutherland, MT; Laird, AR; Thompson, WK; Tapert, SF; Squeglia, LM; Gray, KM; Nixon, SJ; Cottler, LB; La Greca, AM; Gurwitch, RH; Comer, JS				Dick, Anthony Steven; Silva, Karina; Gonzalez, Raul; Sutherland, Matthew T.; Laird, Angela R.; Thompson, Wesley K.; Tapert, Susan F.; Squeglia, Lindsay M.; Gray, Kevin M.; Nixon, Sara Jo; Cottler, Linda B.; La Greca, Annette M.; Gurwitch, Robin H.; Comer, Jonathan S.			Neural vulnerability and hurricane-related media are associated with post-traumatic stress in youth	NATURE HUMAN BEHAVIOUR			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; AMYGDALA REACTIVITY; FUNCTIONAL CONNECTIVITY; PSYCHOMETRIC PROPERTIES; DISORDER; PTSD; SYMPTOMS; EXPOSURE; FEAR; ACTIVATION	The human toll of disasters extends beyond death, injury and loss. Post-traumatic stress (PTS) can be common among directly exposed individuals, and children are particularly vulnerable. Even children far removed from harm's way report PTS, and media-based exposure may partially account for this phenomenon. In this study, we examine this issue using data from nearly 400 9- to 11-year-old children collected before and after Hurricane Irma, evaluating whether pre-existing neural patterns moderate associations between hurricane experiences and later PTS. The 'dose' of both self-reported objective exposure and media exposure predicted PTS, the latter even among children far from the hurricane. Furthermore, neural responses in brain regions associated with anxiety and stress conferred particular vulnerability. For example, heightened amygdala reactivity to fearful stimuli moderated the association between self-reported media exposure and PTS. Collectively, these findings show that for some youth with measurable vulnerability, consuming extensive disaster-related media may offer an alternative pathway to disaster exposure that transcends geography and objective risk. Dick et al. show that in youth, post-traumatic stress related to Hurricane Irma was predicted by self-reported direct and media exposure. Furthermore, neural responses in brain regions associated with anxiety conferred particular vulnerability to media exposure.	[Dick, Anthony Steven; Gonzalez, Raul; Sutherland, Matthew T.; Laird, Angela R.; Comer, Jonathan S.] Florida Int Univ, Miami, FL 33199 USA; [Silva, Karina] Univ Houston, Houston, TX USA; [Thompson, Wesley K.; Tapert, Susan F.] Univ Calif San Diego, San Diego, CA 92103 USA; [Squeglia, Lindsay M.; Gray, Kevin M.] Med Univ South Carolina, Charleston, SC 29425 USA; [Nixon, Sara Jo; Cottler, Linda B.] Univ Florida, Gainesville, FL USA; [La Greca, Annette M.] Univ Miami, Coral Gables, FL 33124 USA; [Gurwitch, Robin H.] Duke Univ, Med Ctr, Durham, NC USA		Dick, AS (corresponding author), Florida Int Univ, Miami, FL 33199 USA.	adick@fiu.edu	; Laird, Angela/B-5800-2010	Dick, Anthony/0000-0001-9907-8155; Thompson, Wesley/0000-0002-1148-1976; Laird, Angela/0000-0003-3379-8744; Sutherland, Matthew/0000-0002-6091-4037	NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [U01 DA041148, U01 DA041156, U01 DA041174, U01 DA041048, U01 DA041028, U01 DA041117, U01 DA050988, U01 DA051038, U01 DA041089, U01 DA050989, U24 DA041147, U01 DA041022, U01 DA041134, U01 DA041025, U01 DA051039, U01 DA051016, U01 DA041106, U01 DA050987, U01 DA051037, U01 DA041093, U01 DA051018, U24 DA041123, U01 DA041120] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH112588] Funding Source: Medline		ABELSON RP, 1985, PSYCHOL BULL, V97, P129, DOI 10.1037/0033-2909.97.1.129; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Admon R, 2013, TRENDS COGN SCI, V17, P337, DOI 10.1016/j.tics.2013.05.005; Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; [Anonymous], 2018, WORLD DISASTERS REPO; Barch DM, 2018, DEV COGN NEUROS-NETH, V32, P55, DOI 10.1016/j.dcn.2017.10.010; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; Benjamini Y., 1995, J ROY STAT SOC, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bijanki KR, 2020, NEUROSURGERY, V87, P796, DOI 10.1093/neuros/nyaa051; Bonanno George A, 2010, Psychol Sci Public Interest, V11, P1, DOI 10.1177/1529100610387086; Bryant RA, 2008, HUM BRAIN MAPP, V29, P517, DOI 10.1002/hbm.20415; Busso DS, 2014, DEPRESS ANXIETY, V31, P551, DOI 10.1002/da.22282; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/nclimate2100, 10.1038/NCLIMATE2100]; Carpenter AL, 2017, J CLIN CHILD ADOLESC, V46, P331, DOI 10.1080/15374416.2015.1063432; Casey BJ, 2018, DEV COGN NEUROS-NETH, V32, P43, DOI 10.1016/j.dcn.2018.03.001; Cohen J., 2013, STAT POWER ANAL BEHA; Comer JS, 2007, CLIN PSYCHOL-SCI PR, V14, P179, DOI 10.1111/j.1468-2850.2007.00078.x; Comer Jonathan S, 2016, Evid Based Pract Child Adolesc Ment Health, V1, P86, DOI 10.1080/23794925.2016.1203737; Comer JS, 2014, PEDIATRICS, V134, P7, DOI 10.1542/peds.2013-4115; Coney MI, 2018, PSYCHIAT RES, V270, P1059, DOI 10.1016/j.psychres.2018.04.066; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Delahanty DL, 2006, ANN NY ACAD SCI, V1071, P27, DOI 10.1196/annals.1364.003; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Dick AS, 2021, NEUROIMAGE, V239, DOI 10.1016/j.neuroimage.2021.118262; Dosenbach NUF, 2017, NEUROIMAGE, V161, P80, DOI 10.1016/j.neuroimage.2017.08.025; Elhai JD, 2013, J TRAUMA STRESS, V26, P10, DOI 10.1002/jts.21755; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Funder DC, 2019, ADV METH PRACT PSYCH, V2, P156, DOI 10.1177/2515245919847202; Furr JM, 2010, J CONSULT CLIN PSYCH, V78, P765, DOI 10.1037/a0021482; Garavan H, 2018, DEV COGN NEUROS-NETH, V32, P16, DOI 10.1016/j.dcn.2018.04.004; Goldmann E, 2014, ANNU REV PUBL HEALTH, V35, P169, DOI 10.1146/annurev-publhealth-032013-182435; GREEN BL, 1994, PSYCHIAT CLIN N AM, V17, P301; Hagler DJ, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116091; Hare TA, 2008, BIOL PSYCHIAT, V63, P927, DOI 10.1016/j.biopsych.2008.03.015; Heller A. S., 2018, POSTTRAUMATIC STRESS, P315; Hiser J, 2018, BIOL PSYCHIAT, V83, P638, DOI 10.1016/j.biopsych.2017.10.030; Holman EA, 2014, P NATL ACAD SCI USA, V111, P93, DOI 10.1073/pnas.1316265110; Jovanovic T, 2013, CORTEX, V49, P1884, DOI 10.1016/j.cortex.2012.08.011; Kavanagh J., 2019, NEWS DIGITAL AGE COM; Kessel EM, 2018, CHILD DEV, V89, P339, DOI 10.1111/cdev.12691; Kessler RC, 2008, MOL PSYCHIATR, V13, P374, DOI 10.1038/sj.mp.4002119; Killgore WDS, 2014, DEPRESS ANXIETY, V31, P150, DOI 10.1002/da.22156; Koenigs M, 2009, NEUROSCIENTIST, V15, P540, DOI 10.1177/1073858409333072; Kujawa A, 2016, BIOL PSYCHIAT, V80, P381, DOI 10.1016/j.biopsych.2015.09.008; La Greca AM, 2019, DISASTER MED PUBLIC, V13, P63, DOI 10.1017/dmp.2019.9; La Greca AM, 2010, J CONSULT CLIN PSYCH, V78, P794, DOI 10.1037/a0020775; Lai BS, 2017, J TRAUMA STRESS, V30, P571, DOI 10.1002/jts.22242; LeDoux JE, 2016, AM J PSYCHIAT, V173, P1083, DOI 10.1176/appi.ajp.2016.16030353; Maroun M, 2006, EUR J NEUROSCI, V24, P2917, DOI 10.1111/j.1460-9568.2006.05169.x; Mattson WI, 2016, SOC COGN AFFECT NEUR, V11, P892, DOI 10.1093/scan/nsw018; McLaughlin KA, 2014, DEPRESS ANXIETY, V31, P834, DOI 10.1002/da.22284; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; North CS, 2013, JAMA-J AM MED ASSOC, V310, P507, DOI 10.1001/jama.2013.107799; Orengo-Aguayo R, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.2619; Parry DA, 2021, NAT HUM BEHAV, V5, P1535, DOI 10.1038/s41562-021-01117-5; Pfefferbaum B, 2000, PSYCHIATRY, V63, P358, DOI 10.1080/00332747.2000.11024929; R Core Team, 2020, R LANG ENV STAT COMP; Robinson OJ, 2019, J NEUROL NEUROSUR PS, V90, P1353, DOI 10.1136/jnnp-2019-321400; Robinson OJ, 2014, LANCET PSYCHIAT, V1, P294, DOI 10.1016/S2215-0366(14)70305-0; Sakamoto H, 2005, NEUROIMAGE, V26, P813, DOI 10.1016/j.neuroimage.2005.02.032; Schuster MA, 2001, NEW ENGL J MED, V345, P1507, DOI 10.1056/NEJM200111153452024; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Shin LM, 2004, HIPPOCAMPUS, V14, P292, DOI 10.1002/hipo.10183; Sripada RK, 2012, J PSYCHIATR NEUROSCI, V37, P241, DOI 10.1503/jpn.110069; Steinberg Alan M, 2004, Curr Psychiatry Rep, V6, P96, DOI 10.1007/s11920-004-0048-2; Steinberg AM, 2013, J TRAUMA STRESS, V26, P1, DOI 10.1002/jts.21780; Stevens JS, 2017, BIOL PSYCHIAT, V81, P1023, DOI 10.1016/j.biopsych.2016.11.015; Stevens JS, 2013, J PSYCHIATR RES, V47, P1469, DOI 10.1016/j.jpsychires.2013.05.031; Suvak M, 2008, J TRAUMA STRESS, V21, P30, DOI 10.1002/jts.20289; Swartz JR, 2015, AM J PSYCHIAT, V172, P276, DOI 10.1176/appi.ajp.2014.14020195; Swartz JR, 2015, NEURON, V85, P505, DOI 10.1016/j.neuron.2014.12.055; Thome J, 2020, DEPRESS ANXIETY, V37, P321, DOI 10.1002/da.22977; Thompson RR, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3502; Thompson RR, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6228; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Vasterman P, 2005, EPIDEMIOL REV, V27, P107, DOI 10.1093/epirev/mxi002; Vernberg EM, 1996, J ABNORM PSYCHOL, V105, P237, DOI 10.1037/0021-843X.105.2.237; Wilcox R.R., 2012, INTRO ROBUST ESTIMAT; Wong SD, 2020, TRANSPORT RES D-TR E, V79, DOI 10.1016/j.trd.2020.102227	81	0	0	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2397-3374			NAT HUM BEHAV	Nat. Hum. Behav.	NOV	2021	5	11					1578	+		10.1038/s41562-021-01216-3			16	Psychology, Biological; Multidisciplinary Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Science & Technology - Other Topics; Neurosciences & Neurology	XA1ZZ	WOS:000720455400021	34795422				2022-02-06	
J	Donnelly, K; Donnelly, JP				Donnelly, Kerry; Donnelly, James P.			Path Analysis of the Mediating Roles of Personality, Distress, and Cognitive Flexibility in the Subjective Well-Being of Combat Veterans With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anxiety; depression; executive function; personality; PTSD; quality of life; TBI; traumatic brain injury; veterans; well-being	PTSD; SYMPTOMS; TBI; DEPRESSION; LIFE	Objective: To determine the interrelationships among traumatic brain injury (TBI), maladaptive personality traits (MPT), psychological distress, and cognitive flexibility in the prediction of subjective well-being of post-9/11 veterans concurrently and over time. Setting: Five Veterans Affairs (VA) medical centers and 1 VA outpatient clinic in urban, suburban, and rural areas. Participants: Five hundred Operation Enduring Freedom/Operation Iraqi Freedom veterans at baseline (219 with TBI), 292 at 18-month follow-up (108 with TBI), drawn from a regional registry and clinic referrals. Design: Path analysis of data from a prospective cohort study. Main Measures: Satisfaction with Life Scale, 36-ltem Short-Form Health Survey (SF-36) Health Scale, Personality Assessment Screener, Beck Depression Inventory-II, Beck Anxiety Inventory, Posttraumatic Stress Disorder Checklist-Military, Trail Making Test, Part B, Delis-Kaplan Executive Function System (D-KEFS) Category-Switching Verbal Fluency, and D-KEFS Color-Word Interference Test. Results: There was no direct effect of TBI on well-being at baseline or 18 months later. Psychological distress, MPT, and cognitive flexibility had significant direct effects on well-being at baseline and 18 months. Baseline model accounted for 66% of the variance in well-being; follow-up model accounted for 43% of well-being variance. Negative influence of distress significantly decreased from baseline to follow-up. Direct negative effect of MPT diminished slightly over 18 months; effect of cognitive flexibility increased. Significant relationships were estimated in prediction of distress by MPT, cognitive flexibility, and TBI. TBI predicted MPT. MPT, cognitive flexibility, and TBI had indirect effects on well-being. TBI had a positive indirect influence on distress. Total effects included 4 significant predictors of well-being at baseline and 18 months: distress, MPT, cognitive flexibility, and TBI. Conclusion: Experience of TBI alone did not predict subjective well-being at baseline or 18 months later. Psychological distress, MPT, and cognitive flexibility had direct effects on well-being at both time points. Interventions aimed at reducing distress and bolstering resilience and cognitive flexibility are recommended to increase subjective well-being in this population.	[Donnelly, Kerry] VA Western New York Healthcare Syst, Behav VA Care Line, 3495 Bailey Ave, Buffalo, NY 14215 USA; [Donnelly, Kerry] SUNY Buffalo, Dept Psychiat, Buffalo, NY USA; [Donnelly, James P.] Canisius Coll, Inst Autism Res, Dept Counseling & Human Serv, Buffalo, NY USA		Donnelly, K (corresponding author), VA Western New York Healthcare Syst, Behav VA Care Line, 3495 Bailey Ave, Buffalo, NY 14215 USA.	kerry.donnelly@va.gov			VA Health Services Research DevelopmentUS Department of Veterans Affairs [SDR 06-162]	This study was supported by VA Health Services Research & Development, under Grant SDR 06-162: Cognitive Assessment of Veterans after Traumatic Brain Injury.	BECK A, 1993, BECK ANXIETY INDEX; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Caska CM, 2013, ANXIETY STRESS COPIN, V26, P36, DOI 10.1080/10615806.2011.638053; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; DELIS DC, 2000, CVLT 2 MANUAL; Department of Defense, 2020, DOD WORLDW NUMB TBI; DeViva JC, 2016, PSYCHOL TRAUMA-US, V8, P310, DOI 10.1037/tra0000075; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Diener E, 2009, SOC INDIC RES SER, V39, P1, DOI 10.1007/978-90-481-2354-4; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Donnelly K, 2018, CLIN NEUROPSYCHOL, V32, P436, DOI 10.1080/13854046.2017.1390163; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; GREEN P, 2007, MED SYMPTOM VALIDITY; Jackson CE, 2016, J TRAUMA STRESS, V29, P309, DOI 10.1002/jts.22110; Jones D, 2001, J Ambul Care Manage, V24, P68; Krauss S. W., 2018, TRAUMATOLOGY, DOI [10.1037/trm0000173, DOI 10.1037/TRM0000173]; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Mattson E, 2018, MIL MED, V183, pE475, DOI 10.1093/milmed/usx201; Mattson EK, 2019, NEUROPSYCHOLOGY, V33, P913, DOI 10.1037/neu0000560; Merritt VC, 2019, J CLIN EXP NEUROPSYC, V41, P665, DOI 10.1080/13803395.2019.1610161; Morey LC., 1990, PERSONALITY ASSESSME; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Nunnink SE, 2012, INT J SEX HEALTH, V24, P14, DOI 10.1080/19317611.2011.639441; Oster C, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1547-0; Pittman JOE, 2012, QUAL LIFE RES, V21, P99, DOI 10.1007/s11136-011-9918-3; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tombaugh T.N., 1996, TEST MEMORY MALINGER; US Census Bureau, 2018, VET WHO HAV SERV 9 1; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weathers F.W., 1993, ANN M INT SOC TRAUM; Weber DJ., 2012, THESIS ARIZONA STATE	35	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2021	36	6			SI		E381	E390		10.1097/HTR.0000000000000688			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WV3QT	WOS:000717155100003	33935226				2022-02-06	
J	Eagle, SR; Sparto, PJ; Holland, CL; Alkathiry, AA; Blaney, NA; Bitzer, HB; Collins, MW; Furman, JM; Kontos, AP				Eagle, Shawn R.; Sparto, Patrick J.; Holland, Cynthia L.; Alkathiry, Abdulaziz A.; Blaney, Nicholas A.; Bitzer, Hannah B.; Collins, Michael W.; Furman, Joseph M.; Kontos, Anthony P.			Utility of a Postural Stability/Perceptual Inhibition Dual Task for Identifying Concussion in Adolescents	JOURNAL OF SPORT REHABILITATION			English	Article						mild traumatic brain injury; postural sway; attention; clinical assessment	CONTROL DEFICITS; GAIT; PERFORMANCE; ASSOCIATION	Context: Research in the area of dual-task paradigms to assess sport-related concussion (SRC) status is growing, but additional assessment of this paradigm in adolescents is warranted. Design: This case-control study compared 49 adolescent athletes aged 12-20 years with diagnosed SRC to 49 age- and sex-matched controls on visual-spatial discrimination and perceptual inhibition (PIT) reaction time tasks performed while balancing on floor/foam pad conditions. Methods: The SRC group completed measures at a single time point between 1 and 10 days postinjury. Primary outcomes were dual-task reaction time, accuracy, and sway. General linear models evaluated differences between groups (P < .05). Logistic regression identified predictors of concussion from outcomes. Area under the curve evaluated discriminative ability of identifying SRC. Results: Results supported significantly higher anterior-posterior (AP) sway values in concussed participants for visual-spatial discrimination and PIT when balancing on the floor (P = .03) and foam pad (P = .03), as well as mediolateral sway values on the floor during visual-spatial discrimination (P = .01). Logistic regression analysis (R2 = .15; P = .001) of all dual-task outcomes identified AP postural sway during the PIT foam dual task as the only significant predictor of concussed status (ss = -2.4; P = .004). Total symptoms (area under the curve = 0.87; P < .001) and AP postural sway on foam (area under the curve = 0.70; P = .001) differentiated concussed from controls. Conclusion: The AP postural sway on foam during a postural stability/PIT dual task can identify concussion in adolescents between 1 and 10 days from injury.	[Eagle, Shawn R.] Univ Pittsburgh, Dept Orthopaed Surg, Concuss Res Program, Pittsburgh, PA 15260 USA; [Blaney, Nicholas A.; Bitzer, Hannah B.; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Sparto, Patrick J.; Collins, Michael W.] Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA USA; [Holland, Cynthia L.; Furman, Joseph M.; Kontos, Anthony P.] UPMC Rooney Ctr Sports Med, Concuss Clin, Pittsburgh, PA USA; [Alkathiry, Abdulaziz A.] Majmaah Univ, Dept Phys Therapy & Hlth Rehabil, Al Majmaa, Saudi Arabia; [Alkathiry, Abdulaziz A.] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Phys Therapy, Pittsburgh, PA USA; [Furman, Joseph M.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA		Eagle, SR (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, Concuss Res Program, Pittsburgh, PA 15260 USA.	seagle@pitt.edu	Alkathiry, Abdulaziz A/Z-4078-2019	Alkathiry, Abdulaziz A/0000-0001-7715-6773	National Institutes for Health/National Institute on Deafness and Other Communication Disorders - Deanship of Scientific Research at Majmaah University [R-2021-157]	This work was funded by the National Institutes for Health/National Institute on Deafness and Other Communication Disorders. A.A. Alkathiry is funded by the Deanship of Scientific Research at Majmaah University (R-2021-157) . The authors declare no conflicts of interest.	Alkathiry AA, 2018, J ATHL TRAINING, V53, P1166, DOI 10.4085/1062-6050-518-17; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corwin DJ, 2020, MED SCI SPORT EXER, V52, P542, DOI 10.1249/MSS.0000000000002163; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Doherty C, 2017, CLIN BIOMECH, V42, P79, DOI 10.1016/j.clinbiomech.2017.01.007; Eagle SR, 2020, J SPORT SCI, V38, P1799, DOI 10.1080/02640414.2020.1756675; Eagle SR, 2021, CLIN J SPORT MED, V31, P273, DOI 10.1097/JSM.0000000000000731; Fino PC, 2020, J BIOMECH, V112, DOI 10.1016/j.jbiomech.2020.110045; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2020, GAIT POSTURE, V79, P53, DOI 10.1016/j.gaitpost.2020.04.013; Howell DR, 2020, MED SCI SPORT EXER, V52, P1015, DOI 10.1249/MSS.0000000000002225; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2017, J NEUROTRAUM, V34, P3288, DOI 10.1089/neu.2017.5191; Howell DR, 2016, J HEAD TRAUMA REHAB, V31, P262, DOI 10.1097/HTR.0000000000000176; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Jennings JR, 2011, EXP AGING RES, V37, P179, DOI 10.1080/0361073X.2011.554512; Johnston W, 2020, J NEUROTRAUM, V37, P2549, DOI 10.1089/neu.2020.7040; Johnston W, 2019, SPORTS MED, V49, P783, DOI 10.1007/s40279-019-01095-9; Khanna NK, 2015, SPORTS HEALTH, V7, P341, DOI 10.1177/1941738115571508; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Morelli N, 2020, PHYSIOL MEAS, V41, DOI 10.1088/1361-6579/ab8050; Oldham JR, 2021, CLIN J SPORT MED, DOI [10.1097/JSM.0000000000000836, DOI 10.1097/JSM.0000000000000836]; Parrington L, 2019, J ATHL TRAINING, V54, P429, DOI 10.4085/1062-6050-46-18; Petrini K, 2010, BRAIN RES, V1323, P139, DOI 10.1016/j.brainres.2010.02.012; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.3.CO;2-S; Wingerson Mathew J, 2020, J Athl Train, DOI 10.4085/323-20	35	0	0	1	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	NOV	2021	30	8					1191	1196		10.1123/jsr.2021-0084			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	WM6MX	WOS:000711198600012	34525453				2022-02-06	
J	Elcivan, M; Kowark, A; Coburn, M; Hamou, HA; Kremer, B; Clusmann, H; Hoellig, A				Elcivan, Meltem; Kowark, Ana; Coburn, Mark; Hamou, Hussam Aldin; Kremer, Benedikt; Clusmann, Hans; Hoellig, Anke			A Retrospective Analysis of Randomized Controlled Trials on Traumatic Brain Injury: Evaluation of CONSORT Item Adherence	BRAIN SCIENCES			English	Article						TBI; randomized controlled trial; CONSORT criteria; methodology	DOUBLE-BLIND; PHASE-II; DECOMPRESSIVE CRANIECTOMY; THERAPEUTIC HYPOTHERMIA; HYPERTONIC SALINE; CONTUSION VOLUME; TRANEXAMIC ACID; MODERATE; PROGESTERONE; ERYTHROPOIETIN	Traumatic brain injury (TBI) contributes to death and disability, resulting in an enormous individual and socio-economic challenges. Despite huge efforts, there are still controversies on treatment strategies and early outcome estimation. We evaluate current randomized controlled trials (RCTs) on TBI according to their fulfillment of the CONSORT (Consolidated Statement of Reporting Trials) statement's criteria as a marker of transparency and the quality of study planning and realization. A PubMed search for RCTs on TBI (January 2014-December 2019) was carried out. After screening of the abstracts (n = 1.926), the suitable full text manuscripts (n = 72) were assessed for the fulfillment of the CONSORT criteria. The mean ratio of consort statement fulfillment was 59% (& PLUSMN;13%), 31% of the included studies (n = 22) complied with less than 50% of the CONSORT criteria. Citation frequency was moderately related to ratio of CONSORT item fulfillment (r = 0.4877; p < 0.0001) and citation frequency per year (r = 0.5249; p < 0.0001). The ratio of CONSORT criteria fulfillment was associated with the impact factor of the publishing journal (r = 0.6428; p < 0.0001). Essential data for study interpretation, such as sample size determination (item 7a), participant flow (item 13a) as well as losses and exclusions (item 13b), were only reported in 53%, 60% and 63%, respectively. Reporting and methodological aspects in RCTs on TBI still may be improved. Thus, the interpretation of study results may be hampered due to methodological weaknesses.	[Elcivan, Meltem; Hamou, Hussam Aldin; Kremer, Benedikt; Clusmann, Hans; Hoellig, Anke] Univ Hosp RWTH Aachen, Dept Neurosurg, Pauwelsstr 30, D-52074 Aachen, Germany; [Kowark, Ana] Univ Hosp RWTH Aachen, Dept Anaesthesiol, Pauwelsstr 30, D-52074 Aachen, Germany; [Coburn, Mark] Univ Hosp Bonn, Dept Anaesthesiol & Intens Care Med, Venusberg Campus 1, D-53127 Bonn, Germany		Hoellig, A (corresponding author), Univ Hosp RWTH Aachen, Dept Neurosurg, Pauwelsstr 30, D-52074 Aachen, Germany.	meltem.elcivan@rwth-aachen.de; akowark@ukaachen.de; mark.coburn@ukbonn.de; hhamou@ukaachen.de; bkremer@ukaachen.de; hclusmann@ukaachen.de; ahoellig@ukaachen.de		Hoellig, Anke/0000-0001-6798-5703; Coburn, Mark/0000-0002-7930-0270	Hannelore Kohl Stiftung [2019012]	This project was funded by the "Hannelore Kohl Stiftung" (project number 2019012).	Abdoli Ali, 2019, Bull Emerg Trauma, V7, P124, DOI 10.29252/beat-070206; Aloizos S, 2015, TURK NEUROSURG, V25, P552, DOI 10.5137/1019-5149.JTN.9685-14.4; Altman DG, 1996, BRIT MED J, V313, P570; Aminmansour Bahram, 2014, Adv Biomed Res, V3, P35, DOI 10.4103/2277-9175.125031; ANDREW E, 1994, JAMA-J AM MED ASSOC, V272, P1926, DOI 10.1001/jama.1994.03520240054041; Andrews PJD, 2018, HEALTH TECHNOL ASSES, V22, P1, DOI 10.3310/hta22450; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Babamohamadi H, 2019, COMPLEMENT THER MED, V47, DOI 10.1016/j.ctim.2019.102223; Baharvahdat Humain, 2019, Surg Neurol Int, V10, P10, DOI 10.4103/sni.sni_112_18; Bai XF, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009532; Beca J, 2015, CRIT CARE MED, V43, P1458, DOI 10.1097/CCM.0000000000000947; Bisri Tatang, 2016, Asian J Neurosurg, V11, P151, DOI 10.4103/1793-5482.145375; Boutron I, 2017, ANN INTERN MED, V167, P40, DOI 10.7326/M17-0046; Chakroun-Walha O, 2019, EUR J TRAUMA EMERG S, V45, P719, DOI 10.1007/s00068-018-0974-z; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; FACKLER ML, 1994, ANN INTERN MED, V121, P894, DOI 10.7326/0003-4819-121-11-199412010-00015; Fakharian E, 2018, WORLD NEUROSURG, V109, pE748, DOI 10.1016/j.wneu.2017.10.075; Fan Ming-chao, 2016, Chinese Medical Sciences Journal, V31, P213; Farzanegan GR, 2017, J CLIN NEUROSCI, V44, P143, DOI 10.1016/j.jocn.2017.06.010; Feng JZ, 2017, J TRAUMA ACUTE CARE, V83, P296, DOI 10.1097/TA.0000000000001522; Gao J, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017012; Garner AA, 2015, EMERG MED J, V32, P869, DOI 10.1136/emermed-2014-204390; Ghalaenovi H, 2018, BRAIN INJURY, V32, P1050, DOI 10.1080/02699052.2018.1476733; Gobatto ALN, 2019, CRIT CARE, V23, DOI 10.1186/s13054-018-2273-9; Gregson BA, 2015, HEALTH TECHNOL ASSES, V19, DOI 10.3310/hta19700; Hassan MH, 2017, MALAYS J MED SCI, V24, P83, DOI 10.21315/mjms2017.24.5.9; Hassan WMNW, 2017, MALAYS J MED SCI, V24, P73, DOI 10.21315/mjms2017.24.5.8; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Hewitt C, 2005, BMJ-BRIT MED J, V330, P1057, DOI 10.1136/bmj.38413.576713.AE; Hoffmann TC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3755; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Horton L, 2018, J NEUROTRAUM, V35, P2005, DOI 10.1089/neu.2018.5648; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jagannatha AT, 2016, J CLIN NEUROSCI, V27, P68, DOI 10.1016/j.jocn.2015.08.035; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jauch K, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00991; John PA, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j408; Jokar A, 2017, CHIN J TRAUMATOL, V20, P49, DOI 10.1016/j.cjtee.2016.02.005; Khalili H, 2017, WORLD NEUROSURG, V101, P130, DOI 10.1016/j.wneu.2017.01.103; Khan Abdul Alim, 2017, Anesth Essays Res, V11, P964, DOI 10.4103/aer.AER_103_17; Khazdouz Maryam, 2018, Journal of Dietary Supplements, V15, P1, DOI 10.1080/19390211.2017.1304486; Kiehna EN, 2011, J NEUROSURG, V114, P280, DOI 10.3171/2010.8.JNS091770; Kumar Manoj, 2016, Anesth Essays Res, V10, P207, DOI 10.4103/0259-1162.172335; Kumar Neeraj, 2018, Int J Crit Illn Inj Sci, V8, P17, DOI 10.4103/IJCIIS.IJCIIS_24_17; Kumar SA, 2019, CHILD NERV SYST, V35, P999, DOI 10.1007/s00381-019-04121-3; Lin CM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/529580; Lu J, 2015, ARCH PHYS MED REHAB, V96, P702, DOI 10.1016/j.apmr.2014.10.026; Lumba-Brown A, 2014, PEDIATR EMERG CARE, V30, P139, DOI 10.1097/PEC.0000000000000084; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Mansouri A, 2016, J NEUROSURG, V124, P558, DOI 10.3171/2014.12.JNS142465; Mendelow AD, 2015, J NEUROTRAUM, V32, P1312, DOI 10.1089/neu.2014.3644; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Mofid B, 2016, INT IMMUNOPHARMACOL, V32, P103, DOI 10.1016/j.intimp.2016.01.015; Moghaddam OM, 2017, INDIAN J CRIT CARE M, V21, P75, DOI [10.4103/ijccm.IJCCM_391_16, 10.4103/ijccm.ijccm_391_16]; Mokhtari M, 2018, J CLIN PHARMACOL, V58, P42, DOI 10.1002/jcph.980; Mousavi SN, 2014, IRAN J BASIC MED SCI, V17, P119; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Plummer MP, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1933-5; Poon W, 2020, NEUROL SCI, V41, P281, DOI 10.1007/s10072-019-04053-5; Prasetyo E, 2017, NEUROL MED-CHIR, V57, P612, DOI 10.2176/nmc.oa.2016-0322; Rai VRH, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0369-4; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rocca A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0684-2; Salmani F, 2017, INT J NURS STUD, V74, P44, DOI 10.1016/j.ijnurstu.2017.05.014; Schroeppel TJ, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000307; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Shamseer L, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1408-z; Shokouhi G, 2014, ULUS TRAVMA ACIL CER, V20, P410, DOI 10.5505/tjtes.2014.05769; Silva PE, 2019, J INTENSIVE CARE, V7, DOI 10.1186/s40560-019-0417-x; Simera I, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-24; Singh S, 2018, J ANESTH, V32, P518, DOI 10.1007/s00540-018-2505-9; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stover JF, 2014, J NEUROTRAUM, V31, P1599, DOI 10.1089/neu.2014.3344; Taher A, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.26772; Taheri A, 2019, J NEUROL, V266, P1988, DOI 10.1007/s00415-019-09366-1; Tang CH, 2017, J CRIT CARE, V39, P267, DOI 10.1016/j.jcrc.2016.12.012; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Tomar GS, 2019, PHYS THER, V99, P388, DOI 10.1093/ptj/pzy141; Vieira E, 2018, J NEUROSURG, V129, P1017, DOI 10.3171/2017.4.JNS152954; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wang HF, 2017, AM J EMERG MED, V35, P1404, DOI 10.1016/j.ajem.2017.04.020; Wang Y, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006458; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xu GZ, 2014, J CRANIOFAC SURG, V25, P1836, DOI 10.1097/SCS.0b013e3182a21056; Younus Syed Muneeb, 2018, Asian J Neurosurg, V13, P1096, DOI 10.4103/ajns.AJNS_125_17; Zafardoost P, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.25113; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zamani M, 2015, EMERGENCY, V3, P137; Zhang LM, 2019, WORLD NEUROSURG, V132, pE21, DOI 10.1016/j.wneu.2019.09.024	94	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	NOV	2021	11	11							1504	10.3390/brainsci11111504			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ8ZL	WOS:000727068500001	34827503	gold, Green Published			2022-02-06	
J	Eom, KS; Kim, JH; Yoon, SH; Lee, SJ; Park, KJ; Ha, SK; Choi, JG; Jo, KW; Kim, J; Kang, SH; Kim, JH				Eom, Ki Seong; Kim, Jang Hun; Yoon, Sang Hoon; Lee, Seong-Jong; Park, Kyung-Jae; Ha, Sung-Kon; Choi, Jin-Gyu; Jo, Kwang-Wook; Kim, JongYeon; Kang, Suk Hyung; Kim, Jong-Hyun			Gender differences in adult traumatic brain injury according to the Glasgow coma scale: A multicenter descriptive study	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Traumatic brain injuries; Gender; Epidemiology; Glasgow coma scale	HEAD-INJURY; EPIDEMIOLOGY; IMPACT	Purpose: Patients' gender, which can be one of the most important determinants of traumatic brain injury (TBI) outcomes, is also likely to interact with many other outcome variables of TBI. This multi-center descriptive study investigated gender differences in epidemiological, clinical, treatment, mortality, and variable characteristics in adult TBI patients. Methods: The selection criteria were defined as patients who had been diagnosed with TBI and were admitted to the hospital between January 1, 2016 and December 31, 2018. A total of 4468 adult TBI patients were enrolled at eight University Hospitals. Based on the list of enrolled patients, the medical records of the patients were reviewed and they were registered online at each hospital. The registered patients were classified into three groups according to the Glasgow coma scale (GCS) score: mild (13-15), moderate (9-12), and severe (3-8), and the differences between men and women in each group were investigated. The risk factors of moderated and severe TBI compared to mild TBI were also investigated. Results: The study included 3075 men and 1393 women and the proportion of total males was 68.8%. Among all the TBI patients, there were significant differences between men and women in age, past history, and GCS score. While the mild and severe TBI groups showed significant differences in age, past history, and clinical symptoms, the moderate TBI group showed significant differences in age, past history, cause of justice, and diagnosis. Conclusion: To the best of our knowledge, this multicenter study is the first to focus on gender differences of adult patients with TBI in Korea. This study shows significant differences between men and women in many aspects of adult TBI. Therefore, gender differences should be strongly considered in TBI studies. (C) 2021 Production and hosting by Elsevier B.V. on behalf of Chinese Medical Association.	[Eom, Ki Seong] Wonkwang Univ, Inst Wonkwang Med Sci, Dept Neurosurg, Sch Med, Iksan, South Korea; [Kim, Jang Hun; Yoon, Sang Hoon] Armed Forces Capital Hosp, Dept Neurosurg, Seongnam, South Korea; [Lee, Seong-Jong] Armed Force Hosp, Dept Neurosurg, Yangju, South Korea; [Park, Kyung-Jae] Korea Univ, Dept Neurosurg, Anam Hosp, Seoul, South Korea; [Ha, Sung-Kon] Korea Univ, Dept Neurosurg, Ansan Hosp, Ansan, South Korea; [Choi, Jin-Gyu] Catholic Univ, Dept Neurosurg, Yeouido St Marys Hosp, Seoul, South Korea; [Jo, Kwang-Wook] Catholic Univ, Dept Neurosurg, St Marys Hosp, Bucheon, South Korea; [Kim, JongYeon] Wonju Severance Christian Hosp, Dept Neurosurg, Wonju, South Korea; [Kang, Suk Hyung] Hallym Univ, Dept Neurosurg, Sacred Heart Hosp, Chunchon, South Korea; [Kim, Jong-Hyun] Korea Univ, Dept Neurosurg, Guro Hosp, Seoul, South Korea		Eom, KS (corresponding author), Wonkwang Univ, Inst Wonkwang Med Sci, Dept Neurosurg, Sch Med, Iksan, South Korea.	kseom@wonkwang.ac.kr			Wonkwang University	This paper was supported by Wonkwang University in 2020.	Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Chase S, 2012, HEALTH CARE WOMEN IN, V33, P631, DOI 10.1080/07399332.2012.673652; Eom KS, 2019, J KOREAN NEUROSURG S, V62, P243, DOI 10.3340/jkns.2018.0017; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; Henry P C, 1992, J Neurosci Nurs, V24, P311; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; KLAUBER MR, 1981, NEUROSURGERY, V9, P236, DOI 10.1227/00006123-198109000-00003; Kraus J F, 2000, Neurosurg Focus, V8, pe5; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Song SY, 2016, J KOREAN NEUROSURG S, V59, P485, DOI 10.3340/jkns.2016.59.5.485; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	19	0	0	1	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	NOV	2021	24	6					333	343		10.1016/j.cjtee.2021.06.004			11	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	XC8VW	WOS:000722290800004	34275712	Green Published, gold			2022-02-06	
J	Estrella, MJ; Kirsh, B; Kontos, P; Grigorovich, A; Colantonio, A; Chan, VY; Nalder, EJ				Estrella, Maria Jennifer; Kirsh, Bonnie; Kontos, Pia; Grigorovich, Alisa; Colantonio, Angela; Chan, Vincy; Nalder, Emily Joan			Critical Characteristics of Housing and Housing Supports for Individuals with Concurrent Traumatic Brain Injury and Mental Health and/or Substance Use Challenges: A Qualitative Study	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						housing; homelessness; traumatic brain injury; mental illness; substance use; concurrent disorders; health services; qualitative	HOMELESS ADULTS; COMMUNITY; 1ST; LANDLORDS; TENANTS; ILLNESS; PEOPLE	Traumatic brain injury (TBI) and mental health and/or substance use challenges (MHSU) are commonly co-occurring and prevalent in individuals experiencing homelessness; however, evidence suggests that systems of care are siloed and organized around clinical diagnoses. Research is needed to understand how housing and housing supports are provided to this complex and understudied group in the context of siloed service systems. This study aimed to describe critical characteristics of housing and housing supports for individuals with concurrent TBI and MHSU from the perspectives of service users with TBI and MHSU and housing service providers. Using basic qualitative description, in-depth interviews were conducted with 16 service users and 15 service providers. Data were analyzed using thematic analysis techniques. Themes capture core processes in finding and maintaining housing and the critical housing supports that enabled them: (1) overcoming structural barriers through service coordination, education and awareness raising, and partnerships and collaborations; and (2) enabling engagement in meaningful activity and social connection through creating opportunities, training and skills development, and design of home and neighborhood environments. Implications for practice, including the urgent need for formalized TBI and MHSU education, support for service providers, and potential interventions to further enable core housing processes are discussed.	[Estrella, Maria Jennifer; Kirsh, Bonnie; Colantonio, Angela; Nalder, Emily Joan] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G1V7, Canada; [Kirsh, Bonnie; Colantonio, Angela; Chan, Vincy; Nalder, Emily Joan] Univ Toronto, Rehabil Sci Inst, Toronto, ON M5G 1V7, Canada; [Kirsh, Bonnie] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; [Kontos, Pia; Grigorovich, Alisa; Colantonio, Angela; Chan, Vincy; Nalder, Emily Joan] Univ Hlth Network, Toronto Rehabil Inst, KITE Res Inst, Toronto, ON M5G 2A2, Canada; [Kontos, Pia; Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; [Grigorovich, Alisa] Brock Univ, Dept Recreat & Leisure Studies, St Catharines, ON L2S 3A1, Canada; [Colantonio, Angela; Chan, Vincy] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada		Estrella, MJ (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G1V7, Canada.	majennifer.estrella@utoronto.ca; bonnie.kirsh@utoronto.ca; pia.kontos@uhn.ca; agrigorovich@brocku.ca; angela.colantonio@utoronto.ca; vincy.chan@uhn.ca; emily.nalder@utoronto.ca			Canada Research Chairs ProgramCanada Research Chairs; Ministry of Health and Long-Term Care Health System Research Fund Program Awards, "Integrating Brain Injury, Mental Health, and Addictions" [267]	This research has been funded in part by the Canada Research Chairs Program and the 2071/18 Ministry of Health and Long-Term Care Health System Research Fund Program Awards, "Integrating Brain Injury, Mental Health, and Addictions," Ministry Grant No. 267. The views expressed in this publication are those of the authors and do not necessarily reflect those of the Minsitry of Health and Long-Term Care.	Aubry T, 2015, CAN J PSYCHIAT, V60, P467, DOI 10.1177/070674371506001102; Aubry T, 2015, AM J COMMUN PSYCHOL, V55, P292, DOI 10.1007/s10464-015-9714-2; Berens M.J., 2016, REV RES DESIGNING BU; Boland L, 2018, AM J PUBLIC HEALTH, V108, pE1, DOI 10.2105/AJPH.2018.304652; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Braun V, 2021, QUAL RES PSYCHOL, V18, P328, DOI 10.1080/14780887.2020.1769238; Brown M, 2015, J SOC SERV RES, V41, P498, DOI 10.1080/01488376.2015.1039102; Canadian Observatory on Homelessness, HOUS 1; Canadian Observatory on Homelessness, WHAT NEEDS BE DON EN; Chan DV, 2020, REHABIL COUNS BULL, V63, P102, DOI 10.1177/0034355218814927; Colantonio Angela, 2010, Healthc Policy, V5, pe120; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Employment and Social Development Canada, 2017, LANDL ENG TOOLK GUID; Employment and Social Development Canada, 2018, TOOLK INT CAS MAN CA; Gaetz S., 2016, STATE HOMELESSNESS C; Gaetz Stephen, 2013, HOUSING 1 CANADA SUP; Gerber G.J., 2016, CANADIAN J COMMUNITY, V35, P69, DOI DOI 10.7870/CJCMH-2016-034; Gonzalez MT, 2015, ISSUES MENT HEALTH N, V36, P971, DOI 10.3109/01612840.2015.1067262; Goodwin N, 2016, INT J INTEGR CARE, V16, DOI 10.5334/ijic.2530; Gutwinski S, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003750; Habitat U., HOUSING RIGHTS; Huffman T, 2018, J SOC DISTRESS HOMEL, V27, P44, DOI 10.1080/10530789.2018.1445507; Jakubec SL, 2012, HOUS CARE SUPPORT, V15, P99, DOI 10.1108/14608791211268518; Kennedy J, 2017, INT J HOUS POLICY, V17, P396, DOI 10.1080/14616718.2016.1248528; Kerman N., 2017, Canadian Journal of Community Mental Health, V36, P61, DOI 10.7870/cjcmh-2017-009; Kim H, 2017, RES NURS HEALTH, V40, P23, DOI 10.1002/nur.21768; Kirsh B., 2011, CAN J COMMUNITY MENT, V30, P15, DOI [10.7870/cjcmh-2011-0002, DOI 10.7870/CJCMH-2011-0002]; Kloos B, 2002, PSYCHIATR REHABIL J, V25, P235, DOI 10.1037/h0095019; Kovacs-Burns K, 2012, CANADIAN DEFINITION; Lannin N.A., 2013, MODELS CARE PEOPLE S; Laver K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-397; Lukersmith S, 2016, DISABIL HEALTH J, V9, P272, DOI 10.1016/j.dhjo.2015.09.006; Macnaughton E., 2016, HOME CHEZ SOI PROJEC; Macnaughton E, 2016, AM J PSYCHIATR REHAB, V19, P136, DOI 10.1080/15487768.2016.1162759; Marchand D.K., 2020, CARE ACQUIRED BRAIN; Mejia-Lancheros C, 2022, SOC PSYCH PSYCH EPID, V57, P67, DOI 10.1007/s00127-021-02093-x; Munce SEP, 2014, BRAIN INJURY, V28, P1042, DOI 10.3109/02699052.2014.890744; National Academies of Sciences Engineering and Medicine, 2016, EV STIGM CHANG, DOI [10.17226/23442, DOI 10.17226/23442]; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; O'Donovan J, 2019, COMMUNITY MENT HLT J, V55, P1218, DOI 10.1007/s10597-019-00406-8; OECD, 2020, BETT DAT POL FIGHT H; Padgett DK, 2012, QUALITATIVE MIXED ME; Patterson ML, 2015, PSYCHIATR REHABIL J, V38, P81, DOI 10.1037/prj0000101; Patterson ML., 2012, MENT HLTH SUBST USE, V5, P85; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Petrovich JC, 2017, J SOC DISTRESS HOMEL, V26, P65, DOI 10.1080/10530789.2016.1260879; Piat M, 2015, URBAN STUD, V52, P2366, DOI 10.1177/0042098014548138; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; SANDELOWSKI M, 1986, ADV NURS SCI, V8, P27, DOI 10.1097/00012272-198604000-00005; Schtz C, 2019, J DUAL DIAGN, V15, P88, DOI 10.1080/15504263.2019.1579948; Stubbs JL, 2021, CAN J PSYCHIAT, DOI 10.1177/07067437211000665; Stubbs JL, 2020, LANCET PUBLIC HEALTH, V5, pE19, DOI 10.1016/S2468-2667(19)30188-4; Topolovec-Vranic J, 2017, J PSYCHIATR RES, V87, P53, DOI 10.1016/j.jpsychires.2016.12.004; Topolovec-Vranic J, 2013, BRAIN INJURY, V27, P1600, DOI 10.3109/02699052.2013.823666; Tsai J, 2010, AM J PSYCHIATR REHAB, V13, P258, DOI 10.1080/15487768.2010.523357; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Vasileiou K, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0594-7; Wiseman-Hakes Catherine, 2020, Arch Rehabil Res Clin Transl, V2, P100036, DOI 10.1016/j.arrct.2019.100036; Wright CJ, 2017, HEALTH PLACE, V46, P234, DOI 10.1016/j.healthplace.2017.06.001	59	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2021	18	22							12211	10.3390/ijerph182212211			19	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	XG8CP	WOS:000724976100001	34831967	Green Published, gold			2022-02-06	
J	Ettenhofer, ML; Hungerford, LD; Agtarap, S				Ettenhofer, Mark L.; Hungerford, Lars D.; Agtarap, Stephanie			Multimodal Neurocognitive Screening of Military Personnel With a History of Mild Traumatic Brain Injury Using the Bethesda Eye & Attention Measure	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive assessment; concussion; eye tracking; mild traumatic brain injury; military; screening	NEUROPSYCHOLOGICAL OUTCOMES; REACTION-TIME; POSTCONCUSSION SYNDROME; SERVICE MEMBERS; VARIABILITY; PERFORMANCE; DEPLOYMENT; MOVEMENTS; SACCADES; TASK	Objective: To evaluate a neurocognitive eye tracking task, the Bethesda Eye & Attention Measure (BEAM), for use in cognitive screening of patients with a history of mild traumatic brain injury (TBI). Setting: US military TBI rehabilitation clinic. Design/Participants: Cross-sectional study of 191 military personnel receiving outpatient services related to history of mild TBI. Main measures: BEAM; neuropsychological screening measures of attention, processing speed, executive function, and memory. Results: Medium effect sizes were found for partial correlations (controlling for age) between key BEAM metrics and neuropsychological screening tests. Linear regression analyses demonstrated that BEAM saccadic eye movements and manual (button press) metrics each provided complementary value in measurement of cognitive performance, above and beyond effects of demographic factors and clinical characteristics. Conclusion: This study provides initial support for the use of BEAM neurocognitive eye tracking in cognitive screening of adults with a history of mild TBI. BEAM saccadic metrics appear to be particularly well-suited for the assessment of visual attention. Study findings also highlight opportunities for greater cognitive sensitivity or testing efficiency that may be missed by tests measuring only one response modality at a time.	[Ettenhofer, Mark L.; Hungerford, Lars D.; Agtarap, Stephanie] DHA Traumat Brain Injury Ctr Excellence, 34730 Bob Wilson Dr,Ste 201, Silver Spring, MD 92134 USA; [Ettenhofer, Mark L.; Hungerford, Lars D.; Agtarap, Stephanie] Naval Med Ctr San Diego, San Diego, CA USA; [Ettenhofer, Mark L.; Hungerford, Lars D.; Agtarap, Stephanie] Gen Dynam Informat Technol, Falls Church, VA USA; [Ettenhofer, Mark L.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Ettenhofer, Mark L.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Ettenhofer, ML (corresponding author), DHA Traumat Brain Injury Ctr Excellence, 34730 Bob Wilson Dr,Ste 201, Silver Spring, MD 92134 USA.	mark.l.ettenhofer.ctr@mail.mil			DHA Traumatic Brain Injury Center of Excellence; Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-20-2-0060, W81XWH-19-10656, W81XWH-18-2-0069]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1R43AG066427]	Support for this study was provided by the DHA Traumatic Brain Injury Center of Excellence. Drs Ettenhofer and Hungerford currently receive funding from the Congressionally Directed Medical Research Program (W81XWH-20-2-0060, W81XWH-19-10656, W81XWH-18-2-0069). Dr Ettenhofer currently receives funding from the National Institute on Aging (1R43AG066427). The authors thank J. Trotta, C. Monasterio, and L. Dandurand for their valued contributions to this study.	Bowling AC, 2015, AGING NEUROPSYCHOL C, V22, P201, DOI 10.1080/13825585.2014.901290; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Cole WR, 2018, J INT NEUROPSYCH SOC, V24, P156, DOI 10.1017/S1355617717001187; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Defense and Veterans Brain Injury Center, 2020, DOD WORLDW NUMB TBI DOD WORLDW NUMB TBI; Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; Doebler P, 2016, LEARN INDIVID DIFFER, V52, P157, DOI 10.1016/j.lindif.2015.02.009; Ettenhofer ML, 2020, ANN CLIN TRANSL NEUR, V7, P507, DOI 10.1002/acn3.51020; Ettenhofer ML, 2018, BRAIN INJURY, V32, P1740, DOI 10.1080/02699052.2018.1511067; Ettenhofer ML, 2016, J NEUROPSYCH CLIN N, V28, P223, DOI 10.1176/appi.neuropsych.15100243; Ettenhofer ML, 2016, J CLIN EXP NEUROPSYC, V38, P96, DOI 10.1080/13803395.2015.1089978; Ettenhofer ML., 2018, 46 ANN M INT NEUR SO; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Giza CC, 2001, J ATHL TRAINING, V36, P228; Hershaw JN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171752; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Heuer HW, 2013, NEUROLOGY, V81, P1235, DOI 10.1212/WNL.0b013e3182a6cbfe; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; JENSEN AR, 1992, PERS INDIV DIFFER, V13, P869, DOI 10.1016/0191-8869(92)90004-9; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; MacDonald SWS, 2006, J CLIN EXP NEUROPSYC, V28, P655, DOI 10.1080/13803390590954245; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Mani R, 2018, BRAIN INJURY, V32, P1315, DOI 10.1080/02699052.2018.1483030; Martindale SL, 2020, NEUROPSYCHOLOGY, V34, P735, DOI 10.1037/neu0000672; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; Mirsky JB, 2011, COGN BEHAV NEUROL, V24, P50, DOI 10.1097/WNN.0b013e318223f6c6; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Radomski MV, 2013, MIL MED, V178, P246, DOI 10.7205/MILMED-D-12-00144; Regasa LE, 2016, J HEAD TRAUMA REHAB, V31, pE28, DOI 10.1097/HTR.0000000000000155; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith, 1973, SYMBOL DIGIT MODALIT; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Taghdiri F, 2018, J NEUROTRAUM, V35, P719, DOI 10.1089/neu.2017.5274; Taghdiri F, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000286; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; WALKER R, 1995, EXP BRAIN RES, V103, P294; WEBER H, 1995, VISION RES, V35, P987, DOI 10.1016/0042-6989(94)00186-P; Williams IM, 1997, J CLIN NEUROSCI, V4, P186, DOI 10.1016/S0967-5868(97)90072-2	48	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2021	36	6			SI		447	455		10.1097/HTR.0000000000000683			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WV3QT	WOS:000717155100012	33935223				2022-02-06	
J	Evans, KHC; McAdams, RJ; Roberts, KJ; McKenzie, LB				Evans, Kris H. C.; McAdams, Rebecca J.; Roberts, Kristin J.; McKenzie, Lara B.			Sledding-Related Injuries Among Children and Adults Treated in US Emergency Departments From 2008 to 2017	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sledding injuries; NEISS; adults; children	TRAUMATIC BRAIN-INJURY; HEAD-INJURIES; UNITED-STATES; RISK-FACTORS; CHILDHOOD	Objective: To describe the epidemiology of sledding-related injuries among children and adults treated in US emergency departments (EDs). Design: The researchers performed a retrospective analysis using data from the National Electronic Injury Surveillance System (NEISS). Setting: The NEISS collects data on consumer products-related and sports-related injuries treated in US EDs from approximately 100 hospitals that represent a probability sample of >5000 hospitals. Patients: Children (<= 19 years of age) and adults who were treated for sledding-related injuries in EDs from 2008 to 2017. Independent Variables: The researchers analyzed characteristics that included sex, body part injured, injury diagnosis, disposition from the ED, injury locale, injury mechanism, and sled type. Main Outcome Measures: All cases of sledding-related injuries were identified using NEISS product codes for sleds (1217), toboggans (1273), snow disks (1274), and snow tubes (1299). Results: An estimated 220 488 patients [95% confidence interval (CI): 169 839-271 137] were treated in EDs for sledding-related injuries. Overall, the injury rate decreased significantly for both children and adults. Children accounted for 69.7% of the injury cases. Fractures were the most common injury diagnosis for children (23.9%) and adults (27.4%). Compared to adults, children were more likely to sustain a head injury [relative risk (RR): 1.91 (95% CI: 1.73-2.13)] and be diagnosed with a concussion or closed-head injury (CHI) [RR: 1.58 (95% CI: 1.35-1.84)]. Most patients were injured by a collision (63.2%). Snow tube and disk riders were more likely to sustain a concussion or CHI compared to sled and toboggan riders [RR: 1.53 (95% CI: 1.18-1.99)]. Injuries predominantly occurred when patients collided with objects in the environment (47.2%). Conclusions: Although sledding-related injuries decreased over the study period, more research and education to prevent these injuries is needed. The injury patterns and risk of injury type differed by age, with more head injuries sustained by children. Sledding should be performed in obstacle-free areas to reduce the risk of collision and while wearing helmets to mitigate head injuries.	[Evans, Kris H. C.; McAdams, Rebecca J.; Roberts, Kristin J.; McKenzie, Lara B.] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Abigail Wexner Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA; [McKenzie, Lara B.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [McKenzie, Lara B.] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA		McKenzie, LB (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Abigail Wexner Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	Lara.McKenzie@NationwideChildrens.org					American Academy of Orthopaedic Surgeons, 2000, WINT SPORTS SAF HELM; Bernardo L M, 1998, J Trauma Nurs, V5, P34; Chaze B, 2008, NEUROL CLIN, V26, P325, DOI 10.1016/j.ncl.2007.11.009; Cimpello LB, 2009, J TRAUMA, V66, pS23, DOI 10.1097/TA.0b013e318160f856; City of Louisville in Kentucky, 2018, PARKS RECREATION ANN; Commission USCPS, NAT EL INJ SURV SYST; Corra Stefano, 2007, J Trauma Manag Outcomes, V1, P5, DOI 10.1186/1752-2897-1-5; Council of the District of Columbia, 2005, HELM REQ MISC VEH; Crone EA, 2017, TRENDS COGN SCI, V21, P205, DOI 10.1016/j.tics.2017.01.003; DeFroda SF, 2016, INJURY, V47, P2283, DOI 10.1016/j.injury.2016.07.005; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Graves JM, 2013, INJURY PREV, V19, P399, DOI 10.1136/injuryprev-2012-040727; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Heim D, 2014, INJURY, V45, P338, DOI 10.1016/j.injury.2012.08.027; Herman R, 2015, PEDIATR SURG INT, V31, P237, DOI 10.1007/s00383-014-3639-y; Hoshizaki B, 2012, J NEUROSURG-PEDIATR, V9, P133, DOI 10.3171/2011.11.PEDS11299; Howell CA, 2010, PEDIATRICS, V126, P517, DOI 10.1542/peds.2009-1499; Huelke DF, 1998, P ANN C ASS, P93; Juang D, 2010, J TRAUMA, V69, pS206, DOI 10.1097/TA.0b013e3181f1e81f; Koyama S, 2011, AM J SPORT MED, V39, P2656, DOI 10.1177/0363546511422331; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lee F, 1999, Inj Prev, V5, P198; MANARY MJ, 1993, PEDIATR EMERG CARE, V9, P155, DOI 10.1097/00006565-199306000-00011; McBeth PB, 2009, AM J SURG, V197, P560, DOI [10.1016/j.amjsurg.2008.12.016, 10.1016/j.amjsurg.2008.08.010]; McCradden MD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00772; McKenzie Lara B, 2016, Inj Epidemiol, V3, P10; Noffsinger Dana, 2008, J Trauma Nurs, V15, P58, DOI 10.1097/01.JTN.0000327328.60405.f9; Ortega HW, 2005, PEDIATR EMERG CARE, V21, P839, DOI 10.1097/01.pec.0000190233.27857.6a; Patrick E, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115588280; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Rubia K, 2013, NEUROIMAGE, V83, P690, DOI 10.1016/j.neuroimage.2013.06.078; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Seleznev A, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.04.32; Shorter NA, 1999, AM J EMERG MED, V17, P32, DOI 10.1016/S0735-6757(99)90010-4; SHUGERMAN RP, 1992, PEDIATR EMERG CARE, V8, P283, DOI 10.1097/00006565-199210000-00009; Shuman KM, 2015, PHYSICIAN SPORTSMED, V43, P317, DOI 10.1080/00913847.2015.1050953; Skarbek-Borowska S, 2006, ACAD EMERG MED, V13, P181, DOI 10.1111/j.1553-2712.2006.tb01669.x; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Summers Z, 2017, J PEDIATR SURG, V52, P2038, DOI 10.1016/j.jpedsurg.2017.08.038; The U.S. Consumer Product Safety Commision, 2017, NEISS DAT HIGHL 2017; U. S. Census Bureau, 2018, NAT POP CHAR 2010 20; U.S. Consumer Product Safety Commission, 1999, SKIING HELM EV POT R; United States Census Bureau, 2016, NAT INT TABL 2000 20; Verrees M, 2004, PEDIATR NEUROSURG, V40, P2, DOI 10.1159/000076570; WHO, 2019, DEF KEY TERMS; Wikipedia, SNOWM; Wikipedia, 2019, ALL TERR VEH; WYNNE AD, 1994, J TRAUMA, V37, P820, DOI 10.1097/00005373-199411000-00019; Yard EE, 2009, J SAFETY RES, V40, P63, DOI 10.1016/j.jsr.2008.12.004	49	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2021	31	6					E460	E466		10.1097/JSM.0000000000000864			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WM5NJ	WOS:000711131700025	33323755				2022-02-06	
J	Fahey, AM; Bain, KM; Critchfield, EA				Fahey, Amber M.; Bain, Kathleen M.; Critchfield, Edan A.			"I Couldn't Be Better": Assessing Self-Awareness With the Mayo-Portland Adaptability Inventory-4 Following TBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						awareness; brain injury; community reintegration; MPAI; polytrauma; rehabilitation	TRAUMATIC BRAIN-INJURY; WORKING-AGE INDIVIDUALS; LONG-TERM DISABILITY; UNITED-STATES; COMMUNITY INTEGRATION; IMPAIRED AWARENESS; HEAD-INJURY; REHABILITATION; PREVALENCE; SEVERITY	Introduction/Objective: To describe level of awareness, as assessed by the Mayo-Portland Adaptability Inventory-4 (MPAI-4), across physical, cognitive, functional, and emotional domains in individuals with mild, moderate, and severe traumatic brain injury (TBI) participating in a residential rehabilitation program. In addition, this study aimed to examine the relationship between time since injury and awareness. A novel way the MPAI-4 can be used to measure self-awareness is also presented. Method: Retrospective analysis of existing data. The MPAI-4 was completed by the patient on admission, as well as by provider consensus within 2 weeks of admission. Level of awareness was determined by discrepancy scores, computed as MPAI-4 provider consensus score minus self-report MPAI-4 score, for the total score and for each index score: Ability, Adjustment, and Participation. Participants: A total of 101 military veterans and active duty service members admitted to a Veterans Affairs community reintegration rehabilitation program. Results: Discrepancies between patient and provider reports of functioning were found among all severities of TBI across the MPAI-4 total score and index domains measuring Ability, Adjustment, and Participation. Interestingly, those with mild TBI endorsed greater impairments than their providers, while those with moderate and severe TBI reported less impairment on the MPAI-4 than providers. The effect of time varied across domains, and those who were more than 1 year postinjury displayed greater self-awareness. Conclusion: This study highlights the importance of measuring awareness of functional ability over time and across TBI severity and introduces a novel method for doing so, using the MPAI-4 for comparison between staff and patient reports.	[Fahey, Amber M.; Bain, Kathleen M.; Critchfield, Edan A.] South Texas Vet Hlth Care Syst, Psychol Serv, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA		Fahey, AM (corresponding author), South Texas Vet Hlth Care Syst, Psychol Serv, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA.	afahey@uab.edu					[Anonymous], 2015, C TRAUM BRAIN INJ US; Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Assistant Secretary of Defense, 2015, TRAUMATIC BRAIN INJU; Critchfield Edan, 2019, Phys Med Rehabil Clin N Am, V30, P43, DOI 10.1016/j.pmr.2018.08.009; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Duchnick JJ, 2015, PSYCHOL SERV, V12, P313, DOI 10.1037/ser0000034; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Gorgoraptis N, 2019, NEUROREHABILITATION, V44, P321, DOI 10.3233/NRE-182618; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Jones SJ., 2008, BRIT J OCCUP THER, V71, P44, DOI DOI 10.1177/030802260807100202; Malec J., 2005, MAYO PORTLAND ADAPTA; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2002, ARCH PHYS MED REHAB, V83, P1759, DOI 10.1053/apmr.2002.36072; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Nakase-Richardson R, 2017, J HEAD TRAUMA REHAB, V32, P221, DOI 10.1097/HTR.0000000000000334; Nash RP, 2019, PSYCHOSOMATICS, V60, P139, DOI 10.1016/j.psym.2018.11.009; Osborne-Crowley K, 2018, J NEUROPSYCHOL, V12, P176, DOI 10.1111/jnp.12113; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Richardson C, 2015, J HEAD TRAUMA REHAB, V30, pE43, DOI 10.1097/HTR.0000000000000048; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Roy D, 2019, BRAIN INJURY, V33, P1064, DOI 10.1080/02699052.2019.1606447; Rubin E, 2020, NEUROREHABILITATION, V46, P511, DOI 10.3233/NRE-203093; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Yue JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00343; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	47	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2021	36	6			SI		E373	E380		10.1097/HTR.0000000000000670			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WV3QT	WOS:000717155100002	33782347				2022-02-06	
J	Faulkner, JW; Snell, DL; Theadom, A; Mahon, S; Barker-Collo, S				Faulkner, Josh W.; Snell, Deborah L.; Theadom, Alice; Mahon, Susan; Barker-Collo, Suzanne			The Role of Psychological Flexibility in Recovery Following Mild Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						psychological flexibility; mild traumatic brain injury; postconcussion symptoms; outcomes	FUNCTIONAL DIMENSIONAL APPROACH; POST-CONCUSSION SYMPTOMS; COMMITMENT THERAPY; EXPERIENTIAL AVOIDANCE; CHRONIC PAIN; ACCEPTANCE; DEPRESSION; POPULATION; PREDICTORS; ANXIETY	Impact and Implications There is a growing need to identify the psychological mechanisms that explain the relationship between psychological factors and mild traumatic brain injury (mTBI) recovery outcomes; psychological flexibility may be one such mechanism. This study found that psychological flexibility significantly contributes to postconcussion symptoms and functional status in people after mTBI. Additionally, psychological flexibility partly mediated the relationship between psychological distress and postconcussion symptoms and functional status. The present study provides novel evidence that psychological flexibility may be an important psychological mechanism that contributes to recovery outcomes in individuals with mTBI. Psychological flexibility may be an important treatment target in mTBI interventions. Purpose and Objective: Psychological distress is known to contribute to recovery following mild traumatic brain injury (mTBI) and there is a need to understand the mechanisms that contribute to this relationship. The present study examined psychological flexibility, as a hypothesized psychological mechanism, in 169 treatment-seeking adults with mTBI. Research Method/Design: Participants completed self-report measures of postconcussion symptoms, psychological distress (anxiety, stress, and depression) and functional status within four weeks of entry to an mTBI outpatient clinic. A general measure (Acceptance and Action Questionnaire), as well as a context-specific (Acceptance and Action Questionnaire-Acquired Brain Injury) measure of psychological flexibility were administered. Results: Simple linear regression analysis showed that psychological flexibility made a significant contribution to the prediction of postconcussion symptoms and functional status. A series of multiple mediation analyses also found that psychological flexibility had a significant indirect effect on the relationships between psychological distress and postconcussion symptoms, and functional status. The context-specific, rather than the general measure of psychological flexibility, was consistently shown to contribute to these findings. Conclusions/Implications: These results suggest that psychological flexibility is a psychological mechanism that contributes to recovery outcomes in individuals with mTBI and could therefore be an important treatment target in mTBI interventions.	[Faulkner, Josh W.] Massey Univ, Coll Humanities & Social Sci, Sch Psychol, POB 756, Wellington 6140, New Zealand; [Snell, Deborah L.] Univ Otago, Dept Orthoped Surg & Musculoskeletal Med, Christchurch Campus, Dunedin, New Zealand; [Theadom, Alice; Mahon, Susan] Auckland Univ Technol, Traumat Brain Injury Network, Auckland, New Zealand; [Barker-Collo, Suzanne] Auckland Univ Technol, Sch Psychol, Auckland, New Zealand		Faulkner, JW (corresponding author), Massey Univ, Coll Humanities & Social Sci, Sch Psychol, POB 756, Wellington 6140, New Zealand.	j.faulkner1@massey.ac.nz		Faulkner, Josh/0000-0001-9555-4628	Proactive Rehabilitation; Health Research Council of New Zealand Foxley Clinical Fellowship [20/041]	We thank Proactive Rehabilitation for their support and collaboration with this research. The study was funded by a Health Research Council of New Zealand Foxley Clinical Fellowship (20/041).	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Arbabi M, 2020, BRAIN INJURY, V34, P1139, DOI 10.1080/02699052.2020.1797168; Arch JJ, 2012, BEHAV RES THER, V50, P469, DOI 10.1016/j.brat.2012.04.007; Barker-Collo S, 2015, BRAIN INJURY, V29, P859, DOI 10.3109/02699052.2015.1004759; Barker-Collo S, 2013, BRAIN IMPAIR, V14, P425, DOI 10.1017/BrImp.2013.27; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Berrigan L, 2011, BRAIN INJURY, V25, P742, DOI 10.3109/02699052.2011.580317; Bluett EJ, 2016, EAT BEHAV, V23, P150, DOI 10.1016/j.eatbeh.2016.10.002; Bohlmeijer ET, 2011, BEHAV RES THER, V49, P62, DOI 10.1016/j.brat.2010.10.003; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassetta BD, 2021, REHABIL PSYCHOL, V66, P160, DOI 10.1037/rep0000372; Chawla N, 2007, J CLIN PSYCHOL, V63, P871, DOI 10.1002/jclp.20400; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; de Boer MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087445; Densham S, 2016, J PSYCHOSOM RES, V88, P42, DOI 10.1016/j.jpsychores.2016.07.009; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Duvall, 1993, BOOTSTRAPPING NONPAR; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Faulkner J.W., 2021, PSYCHOL FLEXIBILITY; Faulkner JW, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.110141; Federici S, 2017, DISABIL REHABIL, V39, P2347, DOI 10.1080/09638288.2016.1223177; Field A, 2013, DISCOVERING STAT USI; Forman EM, 2012, BEHAV THER, V43, P341, DOI 10.1016/j.beth.2011.07.004; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gentili C, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02016; Greenberg J, 2020, PSYCHOSOMATICS, V61, P49, DOI 10.1016/j.psym.2019.09.004; Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hayes Andrew F., 2012, CISC VIS NETW IND GL; Hayes S.C., 2011, ACCEPTANCE COMMITMEN; Hayes S. C., 2009, ACCEPTANCE COMMITMEN; Hayes SC, 2004, PSYCHOL REC, V54, P553, DOI 10.1007/BF03395492; Hayes SC, 1996, J CONSULT CLIN PSYCH, V64, P1152, DOI 10.1037/0022-006X.64.6.1152; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Houghton DC, 2014, PSYCHIAT RES, V220, P356, DOI 10.1016/j.psychres.2014.08.003; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Karr JE, 2020, J NEUROTRAUM, V37, P1183, DOI 10.1089/neu.2019.6834; Kashdan TB, 2020, PSYCHOL ASSESSMENT, V32, P829, DOI 10.1037/pas0000834; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Krpan KM, 2011, BRAIN INJURY, V25, P989, DOI 10.3109/02699052.2011.597045; Leahy RL, 2012, INT J COGN THER, V5, P362, DOI 10.1521/ijct.2012.5.4.362; Leonidou C, 2019, J HEALTH PSYCHOL, V24, P175, DOI 10.1177/1359105316666657; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lovibond SH., 1995, PSYCHOL FDN MONOGRAP, V2nd; Luoma J, 2011, ADDICT RES THEORY, V19, P3, DOI 10.3109/16066359.2010.524956; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Mah K, 2018, DISABIL REHABIL, V40, P960, DOI 10.1080/09638288.2016.1277402; Mantua J, 2019, BRAIN INJURY, V33, P1467, DOI 10.1080/02699052.2019.1646434; Masuda A, 2012, J EVID-BASED INTEGR, V17, P66, DOI 10.1177/2156587211423400; McCracken LM, 2014, J PAIN, V15, P221, DOI 10.1016/j.jpain.2013.10.014; McCracken LM, 2011, PAIN MED, V12, P904, DOI 10.1111/j.1526-4637.2011.01115.x; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Merz ZC, 2019, BRAIN INJURY, V33, P1003, DOI 10.1080/02699052.2019.1581949; Morris L, 2018, J EXP PSYCHOPATHOL, V9, DOI 10.1177/2043808718779431; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Ong CW, 2019, J CONTEXT BEHAV SCI, V12, P329, DOI 10.1016/j.jcbs.2019.02.007; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ozkan S, 2017, ANN BEHAV MED, V51, P547, DOI 10.1007/s12160-017-9877-1; Polich G, 2020, AM J PHYS MED REHAB, V99, P71, DOI 10.1097/PHM.0000000000001290; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Randall D, 2017, J HEAD TRAUMA REHAB, V32, P134, DOI 10.1097/HTR.0000000000000250; Rickards TA, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1748032; Rolffs JL, 2018, ASSESSMENT, V25, P458, DOI 10.1177/1073191116645905; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sandera AM, 2021, NEUROPSYCHOL REHABIL, V31, P1105, DOI 10.1080/09602011.2020.1762670; Sandoz EK, 2013, J CONTEXT BEHAV SCI, V2, P39, DOI 10.1016/j.jcbs.2013.03.002; Scott KL, 2016, CLIN NEUROPSYCHOL, V30, P66, DOI 10.1080/13854046.2015.1127427; Scott W, 2016, J CONTEMP PSYCHOTHER, V46, P139, DOI 10.1007/s10879-016-9328-5; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Snell DL, 2020, BRAIN INJURY, V34, P610, DOI 10.1080/02699052.2020.1729417; Snell DL, 2015, BRAIN INJURY, V29, P291, DOI 10.3109/02699052.2014.976594; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Stubbs JL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00043; Sullivan KA, 2020, DISABIL REHABIL, V42, P2243, DOI 10.1080/09638288.2018.1558292; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Sylvester M., 2011, THESIS U NEVADA; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Teo SH, 2020, BRAIN INJURY, V34, P1305, DOI 10.1080/02699052.2020.1802668; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Twohig MP, 2015, J CONTEXT BEHAV SCI, V4, P196, DOI 10.1016/j.jcbs.2015.07.001; Ustun T. B., 2010, Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0); van der Horn HJ, 2020, J NEUROL, V267, P2497, DOI 10.1007/s00415-019-09335-8; Vowles KE, 2008, J CONSULT CLIN PSYCH, V76, P397, DOI 10.1037/0022-006X.76.3.397; Whiting D, 2020, NEUROPSYCHOL REHABIL, V30, P1348, DOI 10.1080/09602011.2019.1583582; Whiting DL, 2017, NEUROPSYCHOL REHABIL, V27, P263, DOI 10.1080/09602011.2015.1062115; Whiting DL, 2015, PSYCHOL ASSESSMENT, V27, P415, DOI 10.1037/pas0000050; Wicksell RK, 2013, EUR J PAIN, V17, P599, DOI 10.1002/j.1532-2149.2012.00224.x; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Yehene E, 2020, APPL NEUROPSYCH-ADUL, V27, P468, DOI 10.1080/23279095.2019.1569523; Young G, 2020, PSYCHOL INJ LAW, V13, P427, DOI 10.1007/s12207-020-09395-6	107	0	0	1	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2021	66	4					479	490		10.1037/rep0000406			12	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	XI0QC	WOS:000725826700020	34591526				2022-02-06	
J	Felix, RB; Rao, AI; Khalid, M; Wang, Y; Colloca, L; Murthi, SB; Morris, NA				Felix, Ryan B.; Rao, Aniruddha; Khalid, Mazhar; Wang, Yang; Colloca, Luana; Murthi, Sarah B.; Morris, Nicholas A.			Adjunctive virtual reality pain relief following traumatic injury: protocol for a randomised within-subjects clinical trial	BMJ OPEN			English	Article						neurological injury; neurological pain; pain management; clinical trials; trauma management	OPIOID USE; UNITED-STATES; BRAIN-INJURY; OVERDOSE DEATHS; USE DISORDERS; RISK-FACTORS; PRESCRIPTION; DRUG; INTERVENTIONS; DEPENDENCE	Introduction The annual mortality and national expense of the opioid crisis continue to rise in the USA (130 deaths/day, $50 billion/year). Opioid use disorder usually starts with the prescription of opioids for a medical condition. Its risk is associated with greater pain intensity and coping strategies characterised by pain catastrophising. Non-pharmacological analgesics in the hospital setting are critical to abate the opioid epidemic. One promising intervention is virtual reality (VR) therapy. It has performed well as a distraction tool and pain modifier during medical procedures; however, little is known about VR in the acute pain setting following traumatic injury. Furthermore, no studies have investigated VR in the setting of traumatic brain injury (TBI). This study aims to establish the safety and effect of VR therapy in the inpatient setting for acute traumatic injuries, including TBI. Methods and analysis In this randomised within-subjects clinical study, immersive VR therapy will be compared with two controls in patients with traumatic injury, including TBI. Affective measures including pain catastrophising, trait anxiety and depression will be captured prior to beginning sessions. Before and after each session, we will capture pain intensity and unpleasantness, additional affective measures and physiological measures associated with pain response, such as heart rate and variability, pupillometry and respiratory rate. The primary outcome is the change in pain intensity of the VR session compared with controls. Ethics and dissemination Dissemination of this protocol will allow researchers and funding bodies to stay abreast in their fields through exposure to research not otherwise widely publicised. Study protocols are compliant with federal regulation and University of Maryland Baltimore's Human Research Protections and Institutional Review Board (protocol number HP-00090603). Study results will be published on completion of enrolment and analysis, and deidentified data can be shared by request to the corresponding author.	[Felix, Ryan B.; Rao, Aniruddha; Khalid, Mazhar; Morris, Nicholas A.] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Rao, Aniruddha; Wang, Yang; Colloca, Luana] Univ Maryland, Dept Pain & Translat Symptom Sci, Sch Nursing, Baltimore, MD 21201 USA; [Murthi, Sarah B.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA		Morris, NA (corresponding author), Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA.	nicholas.morris@som.umaryland.edu			Accelerated Translational Incubator Pilot Award from the University of Maryland, Baltimore Institute for Clinical and Translational Research (ICTR); National Center for Advancing Translational Sciences (NCATS) Clinical Translational Science Award (CTSA) [1UL1TR003098]	This study is funded through the Accelerated Translational Incubator Pilot Award from the University of Maryland, Baltimore Institute for Clinical and Translational Research (ICTR) and the National Center for Advancing Translational Sciences (NCATS) Clinical Translational Science Award (CTSA) (grant number 1UL1TR003098).	Adams RS, 2019, MIL MED, V184, pE101, DOI 10.1093/milmed/usy162; Aida J, 2018, NEUROREHABILITATION, V42, P441, DOI 10.3233/NRE-172361; Alghnam S, 2017, INJURY PREV, V23, P87, DOI 10.1136/injuryprev-2016-042059; Brockmyer JH, 2009, J EXP SOC PSYCHOL, V45, P624, DOI 10.1016/j.jesp.2009.02.016; Carrougher GJ, 2009, J BURN CARE RES, V30, P785, DOI 10.1097/BCR.0b013e3181b485d3; Dascal Julieta, 2017, Innov Clin Neurosci, V14, P14; Dharmarajan S, 2019, STAT MED, V38, P956, DOI 10.1002/sim.8030; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; DUPONT WD, 1988, BIOMETRICS, V44, P1157, DOI 10.2307/2531743; Edlund MJ, 2014, CLIN J PAIN, V30, P557, DOI 10.1097/AJP.0000000000000021; Edlund MJ, 2013, CLIN J PAIN, V29, P689, DOI 10.1097/AJP.0b013e318270fa77; Farrar JT, 2003, J PAIN SYMPTOM MANAG, V25, P406, DOI 10.1016/S0885-3924(03)00162-3; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Gupta A, 2018, PAIN MED, V19, P151, DOI 10.1093/pm/pnx109; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; Hansen RN, 2011, CLIN J PAIN, V27, P194, DOI 10.1097/AJP.0b013e3181ff04ca; Helmerhorst GTT, 2014, J BONE JOINT SURG AM, V96A, P495, DOI 10.2106/JBJS.L.01406; Hoffman HG, 2011, ANN BEHAV MED, V41, P183, DOI 10.1007/s12160-010-9248-7; Hoffman HG, 2009, CYBERPSYCHOL BEHAV, V12, P47, DOI 10.1089/cpb.2008.0056; Honzel E, 2019, PAIN, V160, P1909, DOI 10.1097/j.pain.0000000000001539; Jaffa MN, 2021, NEUROCRIT CARE, V35, P806, DOI 10.1007/s12028-021-01282-5; Jaffa MN, 2021, NEUROLOGY, V96, pE2355, DOI 10.1212/WNL.0000000000011906; Kotov R.I., 2004, MULTIDIMENSIONAL IOW; Larson EB, 2011, BRAIN INJURY, V25, P274, DOI 10.3109/02699052.2010.551648; Liszio S, 2018, ANN REV CYBERTHERAPY, V16, P87; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Mattson CL, 2021, MMWR-MORBID MORTAL W, V70, P202, DOI 10.15585/mmwr.mm7006a4externalicon; National Center for Health Statistics Centers for Disease Control and Prevention U.S. Department of Health and Human Services, 2018, NATL HOSP AMBULATORY; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Patterson DR, 2010, INT J CLIN EXP HYP, V58, P288, DOI 10.1080/00207141003760595; PF H., 2017, J MED SYST, V41, P1; Pourmand A, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0708-2; Ringham BM, 2016, STAT MED, V35, P2921, DOI 10.1002/sim.6811; Rosenbloom BN, 2017, J PAIN, V18, P956, DOI 10.1016/j.jpain.2017.03.006; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Shah A, 2017, J PAIN, V18, P1374, DOI 10.1016/j.jpain.2017.06.010; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Stumbo SP, 2017, J SUBST ABUSE TREAT, V73, P47, DOI 10.1016/j.jsat.2016.11.003; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; von Oelreich E, 2020, BRIT J SURG, V107, P413, DOI 10.1002/bjs.11507; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Weiss RD, 2014, J SUBST ABUSE TREAT, V47, P140, DOI 10.1016/j.jsat.2014.03.004; Wiederhold BK, 2014, CYBERPSYCH BEH SOC N, V17, P331, DOI 10.1089/cyber.2014.1512; Wilson N, 2020, MMWR-MORBID MORTAL W, V69, P290, DOI 10.15585/mmwr.mm6911a4; Wright JL, 2005, UROLOGY, V66, P13201, DOI 10.1016/j.urolog.2005.06.123; Yildirim C, 2019, ENTERTAIN COMPUT, V31, DOI 10.1016/j.entcom.2019.100308; Zanier ER, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00345	49	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	NOV	2021	11	11							e056030	10.1136/bmjopen-2021-056030			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XG9RR	WOS:000725083500016	34848527				2022-02-06	
J	Fortin, J; Grondin, S; Blanchet, S				Fortin, J.; Grondin, S.; Blanchet, S.			Level of processing's effect on episodic retrieval following traumatic brain injury in the elderly: An event-related potential study	BRAIN AND COGNITION			English	Article						Recognition; Episodic memory; Old; new effect; Electrophysiology; Brain injury; Aging	SOURCE MEMORY RETRIEVAL; AGE-RELATED-CHANGES; STEM CUED-RECALL; OLDER-ADULTS; RECOGNITION MEMORY; ELECTROPHYSIOLOGICAL EVIDENCE; AUTOBIOGRAPHICAL MEMORY; ASSOCIATIVE DEFICIT; DIVIDED ATTENTION; HEAD-INJURY	Individuals who have sustained a traumatic brain injury (TBI) can suffer from episodic memory impairments. Until now, the neural correlates underlying episodic retrieval in individuals with TBI remained scarce, particularly in older adults. We aimed to fill this gap by recording event-related potentials during an old/new episodic recognition task in 26 older adults, 13 healthy and 13 with TBI. The task manipulated the level of processing in encoding with the use of semantic organizational strategies (deep guided, deep self-guided, and shallow encoding). For all encoding conditions, behavioral data analyses on the discrimination rate indicated that older adults with TBI were globally impaired compared with healthy older adults. The electrophysiological results indicated that the left-parietal effect was larger in the deep guided condition than in the shallow condition. In addition, the results show that the mid-frontal and left-parietal positive old/new effects were absent in both groups. The main findings are the observation, in the control group only, of an early frontal old/new effect (P200; 150-300 ms) and of a late frontal old/new effect on the left hemisphere, only in the Spontaneous condition. Together, results suggest an impairment of the allocation of attentional resources and working memory necessary for retrieving and monitoring items in the elderly with TBI.	[Fortin, J.; Grondin, S.; Blanchet, S.] Univ Laval, Ecole Psychol, Quebec City, PQ, Canada; [Fortin, J.; Grondin, S.] CIRRIS, Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [Blanchet, S.] Univ Paris, Inst Psychol, Lab Memoire Cerveau & Cognit LMC2, Paris, France		Fortin, J (corresponding author), CIRRIS, 525 Blvd Wilfrid Hamel Est, Quebec City, PQ G1M 2S8, Canada.; Fortin, J (corresponding author), Grp Rech Interdisciplinaire Malad Neuromusculaire, 2230 Hop Cp 1200, Quebec City, PQ G7X 7X2, Canada.	julie.fortin22@ulaval.ca; Simon.Grondin@psy.ulaval.ca; sophie.blanchet@u-paris.fr			Fonds de recherche du Quebec-Sante (FRQ-S); FRQ-S (Consortium program); Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [RGPIN-2016-05028]	This study was supported by a scholarship from Fonds de recherche du Quebec-Sante (FRQ-S) to JF, by a research grant from FRQ-S (Consortium program) to SB, and by a research grant from the Natural Sciences and Engineering Research Council of Canada to SG [grant number RGPIN-2016-05028].	Alibran E, 2018, NEUROREPORT, V29, P768, DOI 10.1097/WNR.0000000000001029; Ally BA, 2008, NEUROPSYCHOLOGIA, V46, P679, DOI 10.1016/j.neuropsychologia.2007.09.011; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P139, DOI 10.1097/01.HTR.0000319930.69343.64; Blanchet S, 2002, REV NEUROL-FRANCE, V158, P29; Blanchet S, 2007, BRAIN RES, V1170, P59, DOI 10.1016/j.brainres.2007.07.024; Breed S, 2008, J HEAD TRAUMA REHAB, V23, P149, DOI 10.1097/01.HTR.0000319931.76966.ff; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; CAMP CJ, 1983, EDUC GERONTOL, V9, P57, DOI 10.1080/0380127830090106; Craik F I, 1990, Adv Neurol, V51, P201; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Craik FIM, 1977, HDB PSYCHOL AGING, P384; Delis DC., 2001, DELIS KAPLAN EXECUTI; Desrochers A., 2006, CAHIERS LINGUISTIQUE, V34, P25; Diana RA, 2005, COGNITIVE BRAIN RES, V24, P674, DOI 10.1016/j.cogbrainres.2005.04.001; Duarte A, 2006, J COGNITIVE NEUROSCI, V18, P33, DOI 10.1162/089892906775249988; Duarte A, 2013, PSYCHOPHYSIOLOGY, V50, P465, DOI 10.1111/psyp.12034; Fay S, 2005, COGNITIVE BRAIN RES, V24, P615, DOI 10.1016/j.cogbrainres.2005.03.014; Fortin J, 2021, BRAIN RES, V1766, DOI 10.1016/j.brainres.2021.147504; Fratantoni JM, 2017, J NEUROTRAUM, V34, P1017, DOI 10.1089/neu.2016.4651; Friedman D, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00111; Friedman D, 2010, BRAIN RES, V1310, P124, DOI 10.1016/j.brainres.2009.11.016; Gaastra B, 2016, BRIT J NEUROSURG, V30, P221, DOI 10.3109/02688697.2015.1119240; Gardiner JM, 1996, CAN J EXP PSYCHOL, V50, P114, DOI 10.1037/1196-1961.50.1.114; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Geary EK, 2011, J INT NEUROPSYCH SOC, V17, P709, DOI 10.1017/S1355617711000646; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; Greve A, 2007, NEUROIMAGE, V34, P801, DOI 10.1016/j.neuroimage.2006.07.043; Guillaume C, 2009, NEUROREPORT, V20, P191, DOI 10.1097/WNR.0b013e32831b44ca; Guo CY, 2004, NEUROSCI LETT, V356, P79, DOI 10.1016/j.neulet.2003.09.049; Gutchess AH, 2007, J COGNITIVE NEUROSCI, V19, P1089, DOI 10.1162/jocn.2007.19.7.1089; Harris JD, 2009, INT J PSYCHOPHYSIOL, V71, P132, DOI 10.1016/j.ijpsycho.2008.08.005; Hayama HR, 2008, NEUROPSYCHOLOGIA, V46, P1211, DOI 10.1016/j.neuropsychologia.2007.11.021; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Li BY, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00054; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Luo L, 2008, CAN J PSYCHIAT, V53, P346, DOI 10.1177/070674370805300603; Makeig S., 2000, INTEGRATED HUMAN BRA; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; Mark RE, 1998, BRAIN, V121, P861, DOI 10.1093/brain/121.5.861; MAZZUCCHI A, 1992, J NEUROL, V239, P256; Mecklinger A, 2010, NEUROSCI BIOBEHAV R, V34, P1055, DOI 10.1016/j.neubiorev.2009.11.020; Naveh-Benjamin M, 2004, PSYCHON B REV, V11, P1067, DOI 10.3758/BF03196738; Naveh-Benjamin M, 2000, J EXP PSYCHOL LEARN, V26, P1170, DOI 10.1037/0278-7393.26.5.1170; Naveh-Benjamin M, 2007, PSYCHOL AGING, V22, P202, DOI 10.1037/0882-7974.22.1.202; Nessler D, 2008, NEUROSCI LETT, V432, P151, DOI 10.1016/j.neulet.2007.12.016; Nessler D, 2007, NEUROREPORT, V18, P1837, DOI 10.1097/WNR.0b013e3282f16d9f; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; Osorio A, 2009, BRAIN RES, V1289, P56, DOI 10.1016/j.brainres.2009.07.013; Palermo D.S., 1970, PSYCHON MONOGR, V3, P107; Parker A., 2005, COGNITIVE NEUROSCIEN; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; Piolino P, 2006, PSYCHOL AGING, V21, P510, DOI 10.1037/0882-7974.21.3.510; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Schmidt M., 1996, REY AUDITORY VERBAL; Schmitter-Edgecombe M, 2007, NEUROPSYCHOLOGY, V21, P224, DOI 10.1037/0894-4105.21.2.224; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Swick D, 2006, BRAIN RES, V1107, P161, DOI 10.1016/j.brainres.2006.06.013; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Toth JP, 1996, CAN J EXP PSYCHOL, V50, P123, DOI 10.1037/1196-1961.50.1.123; Tsivilis D, 2001, NEURON, V31, P497, DOI 10.1016/S0896-6273(01)00376-2; Tsivilis D, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00532; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Vilberg KL, 2006, BRAIN RES, V1122, P161, DOI 10.1016/j.brainres.2006.09.023; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2011, WECHSLER ADULT INTEL; Wegesin DJ, 2002, COGNITIVE BRAIN RES, V13, P323, DOI 10.1016/S0926-6410(01)00126-4; Wieser S, 2003, CLIN NEUROPHYSIOL, V114, P1144, DOI 10.1016/S1388-2457(03)00044-0; Wolk DA, 2009, BRAIN RES, V1250, P218, DOI 10.1016/j.brainres.2008.11.014; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Zacks R.T., 2006, LIFESPAN COGNITION M, P162, DOI [10.1093/acprof:oso/9780195169539.003.0011, DOI 10.1093/ACPROF:OSO/9780195169539.003.0011]; Zheng ZW, 2015, NEUROBIOL LEARN MEM, V121, P59, DOI 10.1016/j.nlm.2015.03.006	84	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626	1090-2147		BRAIN COGNITION	Brain Cogn.	NOV	2021	154								105805	10.1016/j.bc.2021.105805			14	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	XE9TJ	WOS:000723723800001	34638050				2022-02-06	
J	Gandy, M; Heriseanu, AI; Dudeney, J; Bisby, MA; Scott, AJ; Fisher, A; Hathway, T; Karin, E; Titov, N; Dear, BF				Gandy, Milena; Heriseanu, Andreea, I; Dudeney, Joanne; Bisby, Madelyne A.; Scott, Amelia J.; Fisher, Alana; Hathway, Taylor; Karin, Eyal; Titov, Nick; Dear, Blake F.			Disability and life satisfaction in neurological disorders: The role of depression and perceived cognitive difficulties	GENERAL HOSPITAL PSYCHIATRY			English	Article						Quality of life; Predictors; Neuropsychiatric; Neurology; Mental health; Subjective cognitive complaints	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; BEHAVIORAL THERAPY; EPILEPSY; ANXIETY; DISEASE; PEOPLE; MEMORY; IMPAIRMENT	Background: This study assessed factors associated with disability and life satisfaction in a large cohort of 2246 Australian adults with neurological disorders who completed an online survey of mental health and wellbeing. It was hypothesised that depressive symptoms and perceived cognitive difficulties would be significantly associated with both outcomes, even after controlling for significant demographic/medical covariates (e.g., age, maritalstatus, employment, multi-morbidity, medication). Differences in profiles of four neurological subgroups (i.e., multiple sclerosis; n = 738, epilepsy; n = 672, Parkinson's disease; n = 263, and Acquired Bran Injury; n = 278) were explored. Methods: Multiple hierarchical linear regressions were run using cross-sectional data. Results: Depressive symptoms made a significant and large unique contribution to higher levels of disability (13 = 0.333, p < .001), and poorer life satisfaction (13 = -0.434, p < .001), in the overall sample and across all four neurological subgroups (13 = 0.349 to 0.513, p < .001) Greater perceived cognitive difficulties were associated with disability in the overall sample (13 = 0.318, p < .001) and across all neurological subgroups (13 = 0.231 to 0.354, p < .001), but only life satisfaction in epilepsy (13 = -0.107, p = 006). Conclusions: The findings underscore the importance of managing psychological/neuropsychiatric comorbidities in neurological disorders.	[Gandy, Milena; Heriseanu, Andreea, I; Dudeney, Joanne; Bisby, Madelyne A.; Scott, Amelia J.; Fisher, Alana; Hathway, Taylor; Karin, Eyal; Titov, Nick; Dear, Blake F.] Macquarie Univ, Fac Med Hlth & Human Sci, Dept Psychol, 4 First Walk, Sydney, NSW 2019, Australia		Gandy, M (corresponding author), Macquarie Univ, Fac Med Hlth & Human Sci, Dept Psychol, 4 First Walk, Sydney, NSW 2019, Australia.	milena.gandy@mq.edu.au; andreea.heriseanu@mq.edu.au; joanne.dudeney@mq.edu.au; madelyne.bisby@mq.edu.au; amelia.scott@mq.edu.au; alana.fisher@mq.edu.au; taylor.hathway@mq.edu.au; eyal.karin@mq.edu.au; nick.titov@mq.edu.au; blake.dear@mq.edu.au	Gandy, Milena/AAV-3617-2020	Gandy, Milena/0000-0003-2161-3298; Karin, Eyal/0000-0002-6152-9704; Bisby, Madelyne/0000-0002-4354-3684; Scott, Amelia/0000-0001-6018-0160; Dudeney, Joanne/0000-0001-8552-5022; Heriseanu, Andreea I/0000-0002-0325-9005; Dear, Blake/0000-0001-9324-3092; Fisher, Alana/0000-0002-6027-659X; Titov, Nickolai/0000-0002-7268-729X	Macquarie University Research Fellowship	This research was supported by a Macquarie University Research Fellowship to Dr Gandy.	Agrawal N, 2016, EPILEPSY BEHAV, V62, P246, DOI 10.1016/j.yebeh.2016.07.020; Agtarap SD, 2021, J NEUROTRAUM, V38, P546, DOI 10.1089/neu.2020.7055; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Aydin T, 2020, SAKARYA MED J, V10, P705; Azouvi P, 2016, BRAIN INJURY, V30, P1665, DOI 10.1080/02699052.2016.1201593; Baumeister H, 2010, J CLIN EPIDEMIOL, V63, P558, DOI 10.1016/j.jclinepi.2009.08.009; Bejot Y, 2019, NEUROEPIDEMIOLOGY, V52, P76, DOI 10.1159/000495813; Bermeo-Ovalle Adriana, 2019, Epilepsy Behav, V98, P306, DOI 10.1016/j.yebeh.2018.11.028; Brizzi K, 2018, SEMIN NEUROL, V38, P569, DOI 10.1055/s-0038-1668074; Butow P, 2017, BIOPSYCHOSOC MED, V11, DOI 10.1186/s13030-017-0100-1; Clary HMM, 2019, EPILEPSY BEHAV, V98, P309, DOI 10.1016/j.yebeh.2018.10.020; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fernie BA, 2015, J PSYCHOSOM RES, V78, P411, DOI 10.1016/j.jpsychores.2015.02.012; Gandy M, 2021, EPILEPSIA OPEN, V6, P127, DOI 10.1002/epi4.12455; Gandy M, 2020, J PSYCHOSOM RES, V136, DOI 10.1016/j.jpsychores.2020.110173; Gandy M, 2018, REHABIL PSYCHOL, V63, P563, DOI 10.1037/rep0000241; Garin O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-51; Gilliam FG, 2006, LANCET NEUROL, V5, P399, DOI 10.1016/S1474-4422(06)70415-X; Giovagnoli AR, 2000, ACTA NEUROL SCAND, V101, P295, DOI 10.1034/j.1600-0404.2000.90257a.x; Henneghan A, 2017, J NEUROSCI NURS, V49, P274, DOI 10.1097/JNN.0000000000000314; Hermann B, 2010, EPILEPSY BEHAV, V17, P1, DOI 10.1016/j.yebeh.2009.10.019; Hesdorffer DC, 2016, CNS SPECTRUMS, V21, P230, DOI 10.1017/S1092852915000929; Holmes GL, 2015, EPILEPTIC DISORD, V17, P101, DOI 10.1684/epd.2015.0739; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Kanner AM, 2014, EPILEPSY BEHAV, V34, P139, DOI 10.1016/j.yebeh.2014.02.029; Kidd T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185931; Kim DH, 2019, EPILEPSY BEHAV, V92, P61, DOI 10.1016/j.yebeh.2018.12.006; Kohrt BA, 2018, PAIN, V159, pS85, DOI 10.1097/j.pain.0000000000001296; Koychev I, 2017, EVID-BASED MENT HEAL, V20, P15, DOI 10.1136/eb-2016-102574; Lucas-Carrasco R, 2014, DISABIL REHABIL, V36, P1001, DOI 10.3109/09638288.2013.825650; Marrie RA, 2003, MULT SCLER, V9, P621, DOI 10.1191/1352458503ms971oa; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; Michaelis R, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012081.pub2; Middleton LS, 2006, ARCH CLIN NEUROPSYCH, V21, P487, DOI 10.1016/j.acn.2006.06.008; Mindgardens Neurosicence Network, 2019, REV BURD DIS NEUR ME; Mitchell AJ, 2010, ACTA NEUROPSYCHIATR, V22, P2, DOI 10.1111/j.1601-5215.2009.00439.x; Mula M, 2015, FUTUR NEUROL, V10, P41, DOI 10.2217/FNL.14.65; Mula M, 2017, EPILEPTIC DISORD, V19, P178, DOI 10.1684/epd.2017.0915; Naess S, 2015, ACTA SOCIOL, V58, P63, DOI 10.1177/0001699314563841; Nag N, 2021, J PERS MED, V11, DOI 10.3390/jpm11020144; Norstrom F, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6825-y; Norstrom F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1310; Pais-Ribeiro J, 2007, EPILEPSY BEHAV, V11, P33, DOI 10.1016/j.yebeh.2007.04.010; Patel V, 2016, LANCET, V387, P1672, DOI 10.1016/S0140-6736(15)00390-6; Price A, 2011, J NEUROL NEUROSUR PS, V82, P914, DOI 10.1136/jnnp.2010.230862; Prisnie JC, 2018, GEN HOSP PSYCHIAT, V52, P58, DOI 10.1016/j.genhosppsych.2018.03.009; Purri R, 2020, MOVEMENT DISORD, V35, P1618, DOI 10.1002/mds.28115; Radford K, 2012, J INT NEUROPSYCH SOC, V18, P738, DOI 10.1017/S1355617712000379; Radford K, 2011, EPILEPSY BEHAV, V22, P272, DOI 10.1016/j.yebeh.2011.06.021; Read JR, 2017, J AFFECT DISORDERS, V221, P36, DOI 10.1016/j.jad.2017.06.009; Samartzis L, 2014, REHABIL RES PRACT, V2014, DOI 10.1155/2014/128751; Sasseville M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023919; Sathanapally H, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-033445; Soh SE, 2011, PARKINSONISM RELAT D, V17, P1, DOI 10.1016/j.parkreldis.2010.08.012; Sullivan M, 1990, CAN J REHABIL, V4, P99; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Waldron B, 2013, NEUROPSYCHOL REHABIL, V23, P64, DOI 10.1080/09602011.2012.724196; Whiteford HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116820; WHO, 2020, 73 WORLD HLTH ASS; World Health Organisation, 2001, WHO DIS ASS SCH, V2nd; Yang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165341	62	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0163-8343	1873-7714		GEN HOSP PSYCHIAT	Gen. Hosp. Psych.	NOV	2021	73						16	23		10.1016/j.genhosppsych.2021.08.013			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	WB5DO	WOS:000703592600003	34508992				2022-02-06	
J	Glendon, K; Blenkinsop, G; Belli, A; Pain, M				Glendon, K.; Blenkinsop, G.; Belli, A.; Pain, M.			Prospective study with specific Re-Assessment time points to determine time to recovery following a Sports-Related Concussion in university-aged student-athletes	PHYSICAL THERAPY IN SPORT			English	Article						Sports-related concussion; Recovery; Vestibular ocular-motor function; Neurocognition; Academic impairment	MOTOR SCREENING VOMS; COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; SEX-DIFFERENCES; POSTURAL STABILITY; SYMPTOMS; YOUTH; HEAD	Background: Time to recovery for symptom burden and neurocognition following a Sports-Related Concussion (SRC) has previously been determined by consolidating varying re-assessment time points into a singular point, and has not been established for Vestibular-Ocular-Motor (VOM) function or academic ability. Objectives: Establish when recovery of symptom burden, neurocognition, VOM function, and academic ability occurs in university-aged student-athletes. Methods: Student-athletes completed an assessment battery (Post-Concussion Symptom Scale (PCSS), Immediate Post-Concussion Assessment and Cognitive Test (ImPACT), Vestibular Ocular-Motor Screening (VOMS), Perceived Academic Impairment Tool (PAIT)) during pre-season (n = 140), within 48 hours, 4, 8 and 14 days post-SRC and prior to Return To Play (RTP) and were managed according to the Rugby Football Union' community pathway (n = 42). Student-athletes were deemed recovered or impaired according to Reliable Change Index' (RCI) or compared to their individual baseline. Results: Symptom burden recovers by four days post-SRC on RCI and to baseline by eight days. VOM function and academic ability recovers by 8 days. Some student-athletes demonstrated worse performance at RTP on all tests by RCI and to baseline, except for on VOMS score and near point convergence by RCI change. Conclusions: Variation in individual university-aged student-athletes requires a multi-faceted approach to establish what dysfunctions post-SRC exist and when recovery occurs. (c) 2021 Elsevier Ltd. All rights reserved.	[Glendon, K.; Blenkinsop, G.; Pain, M.] Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Belli, A.] Univ Birmingham, Inst Inflammat & Ageing, Birmingham, W Midlands, England		Glendon, K (corresponding author), Loughborough Univ, Sch Sport Exercise & Hlth Sci, Performance Ctr, Epinal Way, Loughborough LE11 3TU, Leics, England.	k.glendon@lboro.ac.uk	Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933; Blenkinsop, Glen/0000-0002-1172-4819; Glendon, Kerry/0000-0003-4261-6420	Musculoskeletal Association of Chartered Physiotherapists (MACP); Physiotherapists in Sports and Exercise Medicine	Thank-you to the student-athletes and support staff in the mens and womens rugby union programs.; Funding, grant and award info;This study was funded by the Musculoskeletal Association of Chartered Physiotherapists (MACP) and Physiotherapists in Sports and Exercise Medicine.	[Anonymous], 2021, J HEAD TRAUMA REHAB; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Bevilacqua Zachary W, 2019, Concussion, V4, pCNC63, DOI 10.2217/cnc-2019-0004; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Chorney SR, 2017, LARYNGOSCOPE, V127, P2850, DOI 10.1002/lary.26564; Churchill NW, 2020, NEUROIMAGE-CLIN, V27, DOI 10.1016/j.nicl.2020.102258; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colllins C. L., 2017, DISSERT ABSTR, V77; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Czerniak LL, 2021, SPORTS MED, V51, P351, DOI 10.1007/s40279-020-01393-7; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Di Pietro V, 2021, BRIT J SPORT MED, V55, P1395, DOI 10.1136/bjsports-2020-103274; Duhaime Ann-Christine, 2015, Handb Clin Neurol, V127, P219, DOI 10.1016/B978-0-444-52892-6.00015-5; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Echemendia RJ, 2012, ARCH CLIN NEUROPSYCH, V27, P119, DOI 10.1093/arclin/acr077; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Farnsworth JL, 2017, J ATHL TRAINING, V52, P826, DOI 10.4085/1062-6050-52.6.03; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gallagher V, 2018, J NEUROTRAUM, V35, P1242, DOI 10.1089/neu.2017.5453; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hinton-Bayre AD, 2015, BRAIN IMPAIR, V16, P80, DOI 10.1017/BrImp.2015.14; Hoffman NL, 2020, CLIN J SPORT MED, V30, pS29, DOI 10.1097/JSM.0000000000000538; Honaker JA, 2015, CLIN J SPORT MED, V25, P361, DOI 10.1097/JSM.0000000000000138; Howell DR, 2020, J SCI MED SPORT, V23, P112, DOI 10.1016/j.jsams.2019.08.294; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Isokuortti H, 2016, J NEUROTRAUM, V33, P232, DOI 10.1089/neu.2015.3888; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kontos AP, 2018, MIL MED, V183, P333, DOI 10.1093/milmed/usx172; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Leung FT, 2019, MUSCULOSKEL SCI PRAC, V39, P144, DOI 10.1016/j.msksp.2018.12.007; Lopez-Guerrero AM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00331-4; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Merchant-Borna K, 2017, J ATHL TRAINING, V52, P245, DOI 10.4085/1062-6050-52.1.13; Merz Z., 2021, METHODOLOGICAL CONSI, DOI [10.1080/21622965.2021.1952413?casa_token=0fe4Un8hovEAAAAA:ImtPpJCzc8sg4hJXGd0ZrNbcUzSTsb, DOI 10.1080/21622965.2021.1952413?CASA_TOKEN=0FE4UN8HOVEAAAAA:IMTPPJCZC8SG4HJXGD0ZRNBCUZSTSB]; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Moran RN, 2019, J ATHL TRAINING, V54, P445, DOI 10.4085/1062-6050-220-18; Mucha A, 2019, J ORTHOP SPORT PHYS, V49, P787, DOI 10.2519/jospt.2019.8855; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murdaugh DL, 2018, J CHILD NEUROL, V33, P474, DOI 10.1177/0883073818766815; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; O'Connell B, 2018, CLIN J SPORT MED, V28, P561, DOI 10.1097/JSM.0000000000000478; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; Petit KM, 2019, ARCH CLIN NEUROPSYCH, V34, P744, DOI 10.1093/arclin/acz026.14; Resch JE, 2015, J ATHL TRAINING, V50, P1292, DOI 10.4085/1062-6050-50.12.03; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Rugby E., 2019, ADULT CONCUSSION MAN; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schneider KJ, 2019, MUSCULOSKEL SCI PRAC, V42, P140, DOI 10.1016/j.msksp.2019.05.007; Sinnott AM, 2019, J SCI MED SPORT, V22, P1292, DOI 10.1016/j.jsams.2019.08.004; Stringer G. A., 2015, DISSERT ABSTR, V76; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Wang Y, 2019, BRAIN IMAGING BEHAV, V13, P1375, DOI 10.1007/s11682-018-9946-5; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Wong CK, 2021, INT J SPORTS PHYS TH, V16, P12, DOI 10.26603/001c.18825; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	86	0	0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	NOV	2021	52						287	296		10.1016/j.ptsp.2021.10.008			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	WZ7AW	WOS:000720117900036	34715487				2022-02-06	
J	Godeanu, CS; Marin, D; Stanciulescu, L; Gane, D; Valeanu, A; Ghica, M; Lupuliasa, D; Gird, CE				Godeanu, Constantin Sorin; Marin, Doina; Stanciulescu, Luminita; Gane, Daniela; Valeanu, Andrei; Ghica, Manuela; Lupuliasa, Dumitru; Gird, Cerasela Elena			EFFICACY EVALUATION OF THE ASSOCIATION OF SOME VEGETAL EXTRACTS IN PATIENTS SUFFERING FROM TRAUMATIC BRAIN INJURY. PILOT STUDY (II)	FARMACIA			English	Article						traumatic brain injury; sea buckthorn juice	HYPERKALEMIA; HYPOKALEMIA; MORTALITY	The aim of the current study was to evaluate the effects of health supplements as add-on treatment in patients suffering from cranio-cerebral trauma. During the entire monitoring period (21 days), several serum biomarkers were determined: sodium, potassium, haemoglobin, leukocytes, lymphocytes, urea, creatinine, C-reactive protein, as well as a continuous response variable: Glasgow Coma Scale. The clinical results indicated an improvement in terms of Glasgow Coma Scale compared to the control group.	[Godeanu, Constantin Sorin; Marin, Doina; Stanciulescu, Luminita; Gane, Daniela] Floreasca Emergency Clin Hosp, Dept Anaesthesia & Intens Care Unit, Bucharest 014461, Romania; [Valeanu, Andrei; Ghica, Manuela; Lupuliasa, Dumitru; Gird, Cerasela Elena] Carol Davila Univ Med & Pharm, Fac Pharm, Bucharest 020956, Romania		Valeanu, A (corresponding author), Carol Davila Univ Med & Pharm, Fac Pharm, Bucharest 020956, Romania.	andrei.valeanu@umfcd.ro					Albeanu G, 2008, INT J COMPUT COMMUN, V3, P156; Chen JG, 2019, NEUROCRIT CARE, V30, P334, DOI 10.1007/s12028-018-0622-9; Ghica M, 2018, PROCEEDINGS OF THE ROMANIAN NATIONAL CONGRESS OF PHARMACY, 17TH EDITION, P84; Godeanu CS, 2020, FARMACIA, V68, P541, DOI 10.31925/farmacia.2020.3.21; Grande PO, 2011, J NEUROSURG ANESTH, V23, P358, DOI 10.1097/01.ana.0000405612.20356.84; Gul HF, 2021, TURK NEUROSURG, V31, P333, DOI 10.5137/1019-5149.JTN.29843-20.2; Ichai C, 1997, ANN FR ANESTH, V16, P435, DOI 10.1016/S0750-7658(97)81476-1; KRUSE JA, 1990, ARCH INTERN MED, V150, P613, DOI 10.1001/archinte.150.3.613; Leitgeb J, 2013, EUR J TRAUMA EMERG S, V39, P285, DOI 10.1007/s00068-013-0269-3; Mair P, 2020, BEHAV RES METHODS, V52, P464, DOI 10.3758/s13428-019-01246-w; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Paunescu C, 2021, FARMACIA, V69, P148, DOI 10.31925/farmacia.2021.1.20; Python Software Foundation, PYTHON LANGUAGE REFE; Sabri M, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/394036; Saika A, 2015, ACTA NEUROCHIR, V157, P1323, DOI 10.1007/s00701-015-2469-6; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; SCHAEFER M, 1995, INTENS CARE MED, V21, P235, DOI 10.1007/BF01701479; Shetty T, 2019, J HEAD TRAUMA REHAB, V34, pE28, DOI 10.1097/HTR.0000000000000450; Udy A, 2010, ANESTH ANALG, V111, P1505, DOI 10.1213/ANE.0b013e3181f7107d; Vaaroma K, 2015, J NEUROTRAUM, V32, P1; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Watanabe R, 2020, REV ASSOC MED BRAS, V66, pS31, DOI [10.1590/1806-9282.66.S1.31, 10.1590/1806-9282.66.s1.31]; Weigiang C, 2018, J HEAD TRAUMA REHAB, V33, pE53; Yilmaz R, 2012, EUR J CLIN NUTR, V66, P1214, DOI 10.1038/ejcn.2012.110; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	26	0	0	0	0	SOC STIINTE FARMACEUTICE ROMANIA	BUCURESTI	BUCURESTI, STR TRAIAN VUIA 6, SECT 1, BUCURESTI, 020956, ROMANIA	0014-8237	2065-0019		FARMACIA	Farmacia	NOV-DEC	2021	69	6					1139	1144		10.31925/farmacia.2021.6.18			6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	XU5LB	WOS:000734305000018		gold			2022-02-06	
J	Grimsley, LB; West, PC; McAdams, CD; Bush, CA; Kirkpatrick, SS; Arnold, JD; Buckley, MR; Dieter, RA; Freeman, MB; McNally, MM; Stevens, SL; Grandas, OH; Mountain, DJH				Grimsley, Lauren B.; West, Phillip C.; McAdams, Callie D.; Bush, Charles A.; Kirkpatrick, Stacy S.; Arnold, Joshua D.; Buckley, Michael R.; Dieter, Raymond A.; Freeman, Michael B.; McNally, Michael M.; Stevens, Scott L.; Grandas, Oscar H.; Mountain, Deidra J. H.			Liposomal Nanocarriers Designed for Sub-Endothelial Matrix Targeting under Vascular Flow Conditions	PHARMACEUTICS			English	Article						liposomes; targeted drug delivery; hemodynamic flow; vascular shear stress; vascular therapeutics	PACLITAXEL-ELUTING STENT; CELLULAR PROCESSES; CLICK CHEMISTRY; RESTENOSIS; NANOPARTICLES; DELIVERY; ANGIOPLASTY; EXPRESSION; PREVENTION; ESTROGEN	Vascular interventions result in the disruption of the tunica intima and the exposure of sub-endothelial matrix proteins. Nanoparticles designed to bind to these exposed matrices could provide targeted drug delivery systems aimed at inhibiting dysfunctional vascular remodeling and improving intervention outcomes. Here, we present the progress in the development of targeted liposomal nanocarriers designed for preferential collagen IV binding under simulated static vascular flow conditions. PEGylated liposomes (PLPs), previously established as effective delivery systems in vascular cells types, served as non-targeting controls. Collagen-targeting liposomes (CT-PLPs) were formed by conjugating established collagen-binding peptides to modified lipid heads via click chemistry (CTL), and inserting them at varying mol% either at the time of PLP assembly or via micellar transfer. All groups included fluorescently labeled lipid species for imaging and quantification. Liposomes were exposed to collagen IV matrices statically or via hemodynamic flow, and binding was measured via fluorometric analyses. CT-PLPs formed with 5 mol% CTL at the time of assembly demonstrated the highest binding affinity to collagen IV under static conditions, while maintaining a nanoparticle characterization profile of ~50 nm size and a homogeneity polydispersity index (PDI) of ~0.2 favorable for clinical translation. When liposomes were exposed to collagen matrices within a pressurized flow system, empirically defined CT-PLPs demonstrated significant binding at shear stresses mimetic of physiological through pathological conditions in both the venous and arterial architectures. Furthermore, when human saphenous vein explants were perfused with liposomes within a closed bioreactor system, CT-PLPs demonstrated significant ex vivo binding to diseased vascular tissue. Ongoing studies aim to further develop CT-PLPs for controlled targeting in a rodent model of vascular injury. The CT-PLP nanocarriers established here show promise as the framework for a spatially controlled delivery platform for future application in targeted vascular therapeutics.	[Grimsley, Lauren B.; West, Phillip C.; McAdams, Callie D.; Bush, Charles A.; Kirkpatrick, Stacy S.; Arnold, Joshua D.; Buckley, Michael R.; Dieter, Raymond A.; Freeman, Michael B.; McNally, Michael M.; Stevens, Scott L.; Grandas, Oscar H.; Mountain, Deidra J. H.] Univ Tennessee, Dept Surg, Grad Sch Med, 1924 Alcoa Highway Box U-11, Knoxville, TN 37920 USA		Mountain, DJH (corresponding author), Univ Tennessee, Dept Surg, Grad Sch Med, 1924 Alcoa Highway Box U-11, Knoxville, TN 37920 USA.	Lebenner13@gmail.com; pwest@utmck.edu; cmcadams@utmck.edu; cabush@utmck.edu; skirkpat@utmck.edu; jarnold@utmck.edu; mbuckley@utmck.edu; rdieter@utmck.edu; mfreeman@utmck.edu; mmcnally@utmck.edu; sstevens@utmck.edu; ograndas@utmck.edu; dmountain@utmck.edu			Women in Science Fund, UTMC Hospital Auxiliary (DMountain); Physicians' Medical Education and Research Foundation (DMountain)	This research was funded in part by an internal grant from the Women in Science Fund, UTMC Hospital Auxiliary (DMountain) and an internal grant from the Physicians' Medical Education and Research Foundation (DMountain).	Anseth KS, 2016, BIOMACROMOLECULES, V17, P1, DOI 10.1021/acs.biomac.5b01660; Aryasomayajula B, 2017, METHODS MOL BIOL, V1530, P41, DOI 10.1007/978-1-4939-6646-2_3; Best MD, 2009, BIOCHEMISTRY-US, V48, P6571, DOI 10.1021/bi9007726; Chan JM, 2010, P NATL ACAD SCI USA, V107, P2213, DOI 10.1073/pnas.0914585107; Chenoweth K, 2009, ORG BIOMOL CHEM, V7, P5255, DOI 10.1039/b911482c; Dangas G, 2002, CIRCULATION, V105, P2586, DOI 10.1161/01.CIR.0000019122.00032.DF; Fioole B, 2010, J VASC SURG, V51, P386, DOI 10.1016/j.jvs.2009.08.055; Fisher RK, 2017, J SURG RES, V219, P136, DOI 10.1016/j.jss.2017.05.111; Fisher RK, 2021, NANOMATERIALS-BASEL, V11, DOI 10.3390/nano11030825; Gabizon A, 2003, CLIN PHARMACOKINET, V42, P419, DOI 10.2165/00003088-200342050-00002; Givens C, 2016, ANTIOXID REDOX SIGN, V25, P373, DOI 10.1089/ars.2015.6493; Grandas OH, 2008, J SURG RES, V148, P94, DOI 10.1016/j.jss.2008.03.003; Grandas OH, 2009, J VASC SURG, V49, P185, DOI 10.1016/j.jvs.2008.07.080; Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1; Iden DL, 2001, BBA-BIOMEMBRANES, V1513, P207, DOI 10.1016/S0005-2736(01)00357-1; Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165; Klein WM, 2004, RADIOLOGY, V232, P491, DOI 10.1148/radiol.2322030725; Koren E, 2012, TRENDS MOL MED, V18, P385, DOI 10.1016/j.molmed.2012.04.012; Lee SH, 2016, BIOL PHARM BULL, V39, P1983, DOI 10.1248/bpb.b16-00462; Li SD, 2010, J CONTROL RELEASE, V145, P178, DOI 10.1016/j.jconrel.2010.03.016; Mattern-Schain SI, 2019, CHEM PHYS LIPIDS, V218, P149, DOI 10.1016/j.chemphyslip.2018.12.009; Moreira JN, 2002, PHARMACEUT RES, V19, P265, DOI 10.1023/A:1014434732752; Mountain DJH, 2013, J SURG RES, V184, P619, DOI 10.1016/j.jss.2013.05.070; Mountain DJH, 2013, ANN VASC SURG, V27, P337, DOI 10.1016/j.avsg.2012.05.010; Mountain DJH, 2012, J SURG RES, V173, P224, DOI 10.1016/j.jss.2011.05.037; Papaioannou Theodoros G, 2005, Hellenic J Cardiol, V46, P9; Pattni BS, 2015, CHEM REV, V115, P10938, DOI 10.1021/acs.chemrev.5b00046; Schiele TM, 2004, EXPERT OPIN PHARMACO, V5, P2221, DOI 10.1517/14656566.5.11.2221; Seedial SM, 2013, J VASC SURG, V57, P1403, DOI 10.1016/j.jvs.2012.12.069; Tepe G, 2008, NEW ENGL J MED, V358, P689, DOI 10.1056/NEJMoa0706356; Torchilin VP, 2006, ADV DRUG DELIVER REV, V58, P1532, DOI 10.1016/j.addr.2006.09.009; Torchilin VP, 2014, NAT REV DRUG DISCOV, V13, P813, DOI 10.1038/nrd4333; Torguson R, 2006, AM J CARDIOL, V98, P1340, DOI 10.1016/j.amjcard.2006.06.027; Tummers AM, 2010, J SURG RES, V160, P9, DOI 10.1016/j.jss.2009.04.003; Zylberberg C, 2017, GENE THER, V24, P441, DOI 10.1038/gt.2017.41	35	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1999-4923		PHARMACEUTICS	Pharmaceutics	NOV	2021	13	11							1816	10.3390/pharmaceutics13111816			14	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	XE7WU	WOS:000723594600001	34834231	Green Published, gold			2022-02-06	
J	Gudi, V; Schaefer, N; Gingele, S; Stangel, M; Skripuletz, T				Gudi, Viktoria; Schaefer, Nora; Gingele, Stefan; Stangel, Martin; Skripuletz, Thomas			Regenerative Effects of CDP-Choline: A Dose-Dependent Study in the Toxic Cuprizone Model of De- and Remyelination	PHARMACEUTICALS			English	Article						multiple sclerosis; CDP-choline; cuprizone; microglia; astrocytes; oligodendrocytes	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; ACUTE ISCHEMIC-STROKE; MULTIPLE-SCLEROSIS; MYELIN REGENERATION; WHITE-MATTER; CITICOLINE; CNS; CELLS; NEURODEGENERATION	Inflammatory attacks and demyelination in the central nervous system (CNS) are the key factors responsible for the damage of neurons in multiple sclerosis (MS). Remyelination is the natural regenerating process after demyelination that also provides neuroprotection but is often incomplete or fails in MS. Currently available therapeutics are affecting the immune system, but there is no substance that might enhance remyelination. Cytidine-S-diphosphate choline (CDP-choline), a precursor of the biomembrane component phospholipid phosphatidylcholine was shown to improve remyelination in two animal models of demyelination. However, the doses used in previous animal studies were high (500 mg/kg), and it is not clear if lower doses, which could be applied in human trials, might exert the same beneficial effect on remyelination. The aim of this study was to confirm previous results and to determine the potential regenerative effects of lower doses of CDP-choline (100 and 50 mg/kg). The effects of CDP-choline were investigated in the toxic cuprizone-induced mouse model of de- and remyelination. We found that even low doses of CDP-choline effectively enhanced early remyelination. The beneficial effects on myelin regeneration were accompanied by higher numbers of oligodendrocytes. In conclusion, CDP-choline could become a promising regenerative substance for patients with multiple sclerosis and should be tested in a clinical trial.	[Gudi, Viktoria; Schaefer, Nora; Gingele, Stefan; Stangel, Martin; Skripuletz, Thomas] Hannover Med Sch, Dept Neurol, D-30625 Hannover, Germany; [Stangel, Martin] Novartis Inst Bio Med Res, Translat Med, CH-4056 Basel, Switzerland		Skripuletz, T (corresponding author), Hannover Med Sch, Dept Neurol, D-30625 Hannover, Germany.	gudi.viktoria@mh-hannover.de; sylnora@t-online.de; gingele.stefan@mh-hannover.de; Stangel.Martin@mh-hannover.de; skripuletz.thomas@mh-hannover.de		Skripuletz, Thomas/0000-0001-8550-335X			Adibhatla R, 2005, NEUROCHEM RES, V30, P15, DOI 10.1007/s11064-004-9681-8; AGUT J, 1983, ARZNEIMITTEL-FORSCH, V33-2, P1045; Albert M, 2007, BRAIN PATHOL, V17, P129, DOI 10.1111/j.1750-3639.2006.00043.x; Baxi EG, 2015, J NEUROSCI, V35, P8626, DOI 10.1523/JNEUROSCI.3817-14.2015; Bhatt A, 2014, NEURAL REGEN RES, V9, P1347, DOI 10.4103/1673-5374.137586; Bieber AJ, 2003, ANN NEUROL, V53, P680, DOI 10.1002/ana.10578; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Bodini B, 2016, ANN NEUROL, V79, P726, DOI 10.1002/ana.24620; Bramanti V, 2008, NEUROCHEM RES, V33, P2601, DOI 10.1007/s11064-008-9829-z; Bramanti V, 2008, CLIN EXP HYPERTENS, V30, P798, DOI 10.1080/10641960802563576; Center for Drug Evaluation and Research Center for Biologics Evaluation and Research, 2005, GUID IND EST MAX SAF; Centonze D, 2010, CELL DEATH DIFFER, V17, P1083, DOI 10.1038/cdd.2009.179; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Chari DM, 2003, J NEUROPATH EXP NEUR, V62, P908, DOI 10.1093/jnen/62.9.908; Cho HJ, 2009, METHOD FIND EXP CLIN, V31, P171, DOI 10.1358/mf.2009.31.3.1364241; Cignarella F, 2020, ACTA NEUROPATHOL, V140, P513, DOI 10.1007/s00401-020-02193-z; Davalos A, 2012, LANCET, V380, P349, DOI 10.1016/S0140-6736(12)60813-7; DINSDALE JRM, 1983, ARZNEIMITTEL-FORSCH, V33-2, P1061; DINSDALE JRM, 1983, ARZNEIMITTEL-FORSCH, V33-2, P1066; Dombrowski Y, 2017, NAT NEUROSCI, V20, P674, DOI 10.1038/nn.4528; Duncan ID, 2009, P NATL ACAD SCI USA, V106, P6832, DOI 10.1073/pnas.0812500106; FERNANDEZ RL, 1983, ARZNEIMITTEL-FORSCH, V33-2, P1073; Fioravanti M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000269.pub3; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; Frischer JM, 2015, ANN NEUROL, V78, P710, DOI 10.1002/ana.24497; GALLETTI P, 1991, J NEUROL SCI, V103, pS19; Gan DQ, 2020, ZEBRAFISH, V17, P73, DOI 10.1089/zeb.2019.1793; Gingele S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040945; Gingele S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010012; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; GRAU T, 1983, ARZNEIMITTEL-FORSCH, V33-2, P1033; Grieb P, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14040326; Grieb P, 2014, CNS DRUGS, V28, P185, DOI 10.1007/s40263-014-0144-8; Gudi V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00073; Gudi V, 2017, J NEUROPATH EXP NEUR, V76, P109, DOI 10.1093/jnen/nlw114; Gudi V, 2009, BRAIN RES, V1283, P127, DOI 10.1016/j.brainres.2009.06.005; Haider L, 2016, BRAIN, V139, P807, DOI 10.1093/brain/awv398; Harnisch K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010154; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hurtado O, 2005, NEUROBIOL DIS, V18, P336, DOI 10.1016/j.nbd.2004.10.006; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Jasielski P, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103113; Kawachi I, 2017, J NEUROL NEUROSUR PS, V88, P137, DOI 10.1136/jnnp-2016-313300; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kesidou E, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0995-2; Lassmann H, 1983, Schriftenr Neurol, V25, P1; Lassmann H, 2017, ACTA NEUROPATHOL, V133, P223, DOI 10.1007/s00401-016-1631-4; Lee P, 2001, BRAIN RES, V892, P380, DOI 10.1016/S0006-8993(00)03257-1; Licht-Mayer S, 2020, ACTA NEUROPATHOL, V140, P143, DOI 10.1007/s00401-020-02179-x; Liu H, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.679413; Lloyd AF, 2019, NAT NEUROSCI, V22, P1046, DOI [10.1038/s41593-019-0418-Z, 10.1038/s41593-019-0418-z]; LOPEZCOVIELLA I, 1995, J NEUROCHEM, V65, P889; Lubetzki C, 2020, LANCET NEUROL, V19, P678, DOI 10.1016/S1474-4422(20)30140-X; Mei F, 2016, ELIFE, V5, DOI 10.7554/eLife.18246; Miller BA, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-28; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Patani R, 2007, NEUROPATH APPL NEURO, V33, P277, DOI 10.1111/j.1365-2990.2007.00805.x; PINKEL D, 1958, CANCER RES, V18, P853; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; PRINEAS JW, 1993, ANN NEUROL, V33, P137, DOI 10.1002/ana.410330203; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sarkar AK, 2012, J PHARMACEUT BIOMED, V71, P144, DOI 10.1016/j.jpba.2012.07.003; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Schirmer L, 2009, ANN NEUROL, V66, P698, DOI 10.1002/ana.21799; Schultz V, 2017, GLIA, V65, P1350, DOI 10.1002/glia.23167; Secades JJ, 2011, REV NEUROLOGIA, V52, pS1, DOI 10.33588/rn.52S02.2010787; Shields SA, 1999, GLIA, V28, P77, DOI 10.1002/(SICI)1098-1136(199910)28:1<77::AID-GLIA9>3.0.CO;2-F; Skripuletz T, 2015, BRAIN, V138, P398, DOI 10.1093/brain/awu358; Skripuletz T, 2013, BRAIN, V136, P147, DOI 10.1093/brain/aws262; Skripuletz T, 2011, HISTOL HISTOPATHOL, V26, P1585, DOI 10.14670/HH-26.1585; Stagi M, 2005, J NEUROSCI, V25, P352, DOI 10.1523/JNEUROSCI.3887-04.2005; Synoradzki K, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071569; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; van Horssen J, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.050; Wang CH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15508; WEISS GB, 1995, LIFE SCI, V56, P637, DOI 10.1016/0024-3205(94)00427-T; WEISS SB, 1958, J BIOL CHEM, V231, P53; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	82	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8247		PHARMACEUTICALS-BASE	Pharmaceuticals	NOV	2021	14	11							1156	10.3390/ph14111156			12	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	XG7NW	WOS:000724936700001	34832936	Green Published			2022-02-06	
J	Guo, RL; Wang, X; Fang, YN; Chen, XJ; Chen, K; Huang, WT; Chen, J; Hu, J; Liang, F; Du, JT; Dordoe, C; Tian, XX; Lin, L				Guo, Ruili; Wang, Xue; Fang, Yani; Chen, Xiongjian; Chen, Kun; Huang, Wenting; Chen, Jun; Hu, Jian; Liang, Fei; Du, Jingting; Dordoe, Confidence; Tian, Xianxi; Lin, Li			rhFGF20 promotes angiogenesis and vascular repair following traumatic brain injury by regulating Wnt/beta-catenin pathway	BIOMEDICINE & PHARMACOTHERAPY			English	Article						RhFGF20; Traumatic brain injury; Angiogenesis; Blood-brain barrier; Wnt/beta-catenin	ENDOTHELIAL PROGENITOR CELLS; GROWTH-FACTOR; STEM-CELLS; RAT MODEL; EXPRESSION; VEGF; PROTECTS; RECOVERY; DELIVERY; IMPROVES	The pathology of cerebrovascular disorders takes an important role in traumatic brain injury (TBI) by increasing intracranial pressure. Fibroblast growth factor 20 (FGF20) is a brain-derived neurotrophic factor, that has been shown to play an important role in the survival of dopaminergic neurons and the treatment of Parkinson's disease (PD). However, little is known about the role of FGF20 in the treatment of TBI and its underlying mechanism. The purpose of this study was to evaluate the protective effect of recombinant human FGF20 (rhFGF20) on protecting cerebral blood vessels after TBI. In this study, we indicated that rhFGF20 could reduce brain edema, Evans blue penetration and upregulated the expression of blood-brain barrier (BBB)-related tight junction (TJ) proteins, exerting a protective effect on the BBB in vivo after TBI. In the TBI repair phase, rhFGF20 promoted angiogenesis, neurological and cognitive function recovery. In tumor necrosis factor-alpha (TNF-alpha)-induced human brain microvascular endothelial cells (hCMEC/D3), an in vitro BBB disruption model, rhFGF20 reversed the impairment in cell migration and tube formation induced by TNF-alpha. Moreover, in both the TBI mouse model and the in vitro model, rhFGF20 increased the expression of beta-catenin and GSK3 beta, which are the two key regulators in the Wnt/beta-catenin signaling pathway. In addition, the Wnt/beta-catenin inhibitor IWR-1-endo significantly reversed the effects of rhFGF20. These results indicate that rhFGF20 may prevent vascular repair and angiogenesis through the Wnt/beta-catenin pathway.	[Guo, Ruili; Wang, Xue; Fang, Yani; Chen, Xiongjian; Chen, Kun; Chen, Jun; Hu, Jian; Liang, Fei; Du, Jingting; Dordoe, Confidence; Lin, Li] Wenzhou Med Univ, Sch Pharmaceut Sci, Chashan Higher Educ Pk, Wenzhou 325035, Zhejiang, Peoples R China; [Huang, Wenting; Tian, Xianxi; Lin, Li] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou 315020, Zhejiang, Peoples R China; [Lin, Li] Chinese Acad Med Sci, Res Units Clin Translat Cell Growth Factors & Dis, Beijing 100730, Peoples R China		Lin, L (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Chashan Higher Educ Pk, Wenzhou 325035, Zhejiang, Peoples R China.; Tian, XX (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou 315020, Zhejiang, Peoples R China.	drtxxwz@163.com; linliwz@163.com			National Natural Science Foundation of China, ChinaNational Natural Science Foundation of China (NSFC) [81971180]; Medical and Health Science and Technology Program of Zhejiang Province, China [WKJ-ZJ2130]; Natural Science Foundation of Zhejiang Province, ChinaNatural Science Foundation of Zhejiang Province [LQ19H090012]; Scientific Research Project of Wenzhou, China [ZY2019001, ZY2021006]; CAMS Innovation Fund for Medical Sciences, China [2019-I2M-5-028]	This work was supported by the by the National Natural Science Foundation of China, China (No. 81971180), Medical and Health Science and Technology Program of Zhejiang Province, China (No. WKJ-ZJ2130), Natural Science Foundation of Zhejiang Province, China (No. LQ19H090012), Scientific Research Project of Wenzhou, China (No. ZY2019001, No. ZY2021006), and CAMS Innovation Fund for Medical Sciences, China (No. 2019-I2M-5-028).	Chen J, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.590669; Chen J, 2018, J NEUROTRAUM, V35, P2091, DOI 10.1089/neu.2017.5271; Chopp M, 2007, STROKE, V38, P827, DOI 10.1161/01.STR.0000250235.80253.e9; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Du JR, 2018, EXP THER MED, V16, P1975, DOI 10.3892/etm.2018.6397; Du Q, 2009, CANCER RES, V69, P3764, DOI 10.1158/0008-5472.CAN-09-0014; Gong DS, 2012, BRAIN INJURY, V26, P291, DOI 10.3109/02699052.2011.648710; Gong D, 2011, J TRAUMA, V70, P1480, DOI 10.1097/TA.0b013e31821ac9e1; Goodwin A. M., 2002, Angiogenesis, V5, P1, DOI 10.1023/A:1021563510866; Grothe C, 2004, NEUROBIOL DIS, V17, P163, DOI 10.1016/j.nbd.2004.07.007; Guo DW, 2017, NEUROL RES, V39, P830, DOI 10.1080/01616412.2017.1330815; Guo SW, 2017, NEUROPSYCH DIS TREAT, V13, P2757, DOI 10.2147/NDT.S141534; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Han LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134543; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Henkin RI, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1866; Jeffers M, 2001, CANCER RES, V61, P3131; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; Krum JM, 2003, EXP NEUROL, V181, P241, DOI 10.1016/S0014-4886(03)00039-6; LeBlanc NJ, 2019, MOL NEUROBIOL, V56, P6521, DOI 10.1007/s12035-019-1539-9; Littlejohn EL, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00925-6; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Masckauchan THN, 2006, PHYSIOLOGY, V21, P181, DOI 10.1152/physiol.00058.2005; Matsumoto K, 2014, J BIOCHEM, V156, P1, DOI 10.1093/jb/mvu031; Ni HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00014; Ohmachi S, 2000, BIOCHEM BIOPH RES CO, V277, P355, DOI 10.1006/bbrc.2000.3675; Patel MM, 2017, CNS DRUGS, V31, P109, DOI 10.1007/s40263-016-0405-9; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Salehi A, 2018, J CEREBR BLOOD F MET, V38, P274, DOI 10.1177/0271678X17744124; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Sleeman IJ, 2012, NEUROPHARMACOLOGY, V63, P1268, DOI 10.1016/j.neuropharm.2012.07.029; Slevin M, 2006, CLIN SCI, V111, P171, DOI 10.1042/CS20060049; Song SS, 2021, PROG NEUROBIOL, V199, DOI 10.1016/j.pneurobio.2020.101963; Summers ME, 2020, FASEB J, V34, P10267, DOI 10.1096/fj.202000629R; Sweeney MD, 2018, NAT NEUROSCI, V21, P1318, DOI 10.1038/s41593-018-0234-x; Tran KA, 2016, CIRCULATION, V133, P177, DOI 10.1161/CIRCULATIONAHA.115.015982; Wang GQ, 2019, NEUROSCIENCE, V415, P135, DOI 10.1016/j.neuroscience.2019.06.038; Wang H, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01863-9; Wang L, 2015, TRANSL STROKE RES, V6, P50, DOI 10.1007/s12975-014-0362-x; Wang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063511; Wang Y, 2016, MOL VIS, V22; Wang ZG, 2016, MOL NEUROBIOL, V53, P7298, DOI 10.1007/s12035-015-9583-6; Wei ZZ, 2018, J CEREBR BLOOD F MET, V38, P404, DOI 10.1177/0271678X17702669; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yaqoob U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098130; Ye LX, 2019, EXP NEUROL, V317, P34, DOI 10.1016/j.expneurol.2019.02.013; Zhang YL, 2019, J NEUROTRAUM, V36, P589, DOI 10.1089/neu.2018.5790; Zhang YY, 2018, J CELL MOL MED, V22, P3866, DOI 10.1111/jcmm.13660; Zhao B, 2020, LIFE SCI, V260, DOI 10.1016/j.lfs.2020.118221	60	0	0	2	2	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	NOV	2021	143								112200	10.1016/j.biopha.2021.112200			14	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	WD4GU	WOS:000704902100009	34649342	gold			2022-02-06	
J	Han, J; Pu, CX; Xiao, QX; Tang, LJ; Liu, T; He, L; Ren, YB; Liu, Q; Zhang, Y				Han, Jiang; Pu, Cui-Xia; Xiao, Qiu-Xia; Tang, Li-Jia; Liu, Ting; He, Li; Ren, Ying-Bo; Liu, Qing; Zhang, Ying			miRNA-124-3p targeting of LPIN1 attenuates inflammation and apoptosis in aged male rats cardiopulmonary bypass model of perioperative neurocognitive disorders	EXPERIMENTAL GERONTOLOGY			English	Article						Perioperative neurocognitive disorder; MiR-124-3p; LPIN1; Apoptosis; Inflammation	POSTOPERATIVE COGNITIVE DYSFUNCTION; TRAUMATIC BRAIN-INJURY; MOUSE MODEL; MICRORNAS; CONTRIBUTES; PROGRESSION; AUTOPHAGY; INSIGHTS; DISEASE; ROLES	Perioperative neurocognitive disorder (PND) is recently recommended to define the cognitive decrease during the perioperative period. However, the disease's underlying mechanisms remain unclear. MicroRNAs (miRNAs) are noncoding RNAs that play a vital role in regulating neuroregeneration and neuronal apoptosis. In this study, miR-124-3p was significantly reduced in the PND rat model after a cardiopulmonary bypass (CPB) procedure. MicroRNA-124 (miR-124)-3p-overexpressed lentivirus was constructed and injected via the intracerebroventricular method before CPB. Morris Water Maze test (WMW) and the Open-Field test (OFT) were used to measure behavior changes, data shows decline of cognitive function of rats after CPB. PND rats expressed higher A beta and p-Tau Protein by using immunohistochemistry (IHC) analyses and Enzyme-Linked Immune Sorbent Assay (ELISA). Moreover, the results of IHC, ELISA, Western Blot analysis (WB) and Terminaldeoxynucleotidyl Transferase Mediated Nick End Labeling Assay (TUNEL) showed CPB procedure induced inflammation and apoptosis in rats with PND. The data also revealed the protective function of miR-124-3p overexpression against PND in relieving inflammation, cell apoptosis, and alleviating repaired cognitive function. Moreover, miR-124-3p was predicted by directly targeting LPIN1. This study gives a novel viewpoint that miR-124-3p could improve the state of PND via modulating LPIN1, therefore providing a new strategy for preventing and treating PND in a preclinical application.	[Han, Jiang; Pu, Cui-Xia; Xiao, Qiu-Xia; Tang, Li-Jia; Liu, Ting; He, Li; Ren, Ying-Bo; Liu, Qing; Zhang, Ying] Southwest Med Univ, Dept Anesthesiol, Hosp TCM, Luzhou 646000, Sichuan, Peoples R China		Zhang, Y (corresponding author), Southwest Med Univ, Dept Anesthesiol, Hosp TCM, Luzhou 646000, Sichuan, Peoples R China.	zhangying021210@163.com					Ambros V, 2000, CURR OPIN GENET DEV, V10, P428, DOI 10.1016/S0959-437X(00)00108-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bego T, 2011, MED GLAS, V8, P76; Chen Y, 2015, ANN NUTR METAB, V66, P10, DOI 10.1159/000368661; Colon E, 2017, PROG NEUROBIOL, V153, P121, DOI 10.1016/j.pneurobio.2017.01.005; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; de Lange F, 2008, ANESTH ANALG, V106, P739, DOI 10.1213/ane.0b013e318162d026; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Ghaffary Saba, 2015, J Tehran Heart Cent, V10, P85; Gunzinger R, 2007, BASIC RES CARDIOL, V102, P508, DOI 10.1007/s00395-007-0668-x; Habchi J, 2018, NAT CHEM, V10, P673, DOI 10.1038/s41557-018-0031-x; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hernandez-Rapp J, 2017, PROG NEURO-PSYCHOPH, V73, P79, DOI 10.1016/j.pnpbp.2016.04.011; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jiang YH, 2018, CELL PHYSIOL BIOCHEM, V46, P1398, DOI 10.1159/000489155; Kang QM, 2017, ONCOTARGET, V8, P24314, DOI 10.18632/oncotarget.15149; Kapoor I, 2019, INDIAN J CRIT CARE M, V23, pS162, DOI 10.5005/jp-journals-10071-23196; Kim JY, 2016, CARCINOGENESIS, V37, P1199, DOI 10.1093/carcin/bgw104; Krenk L, 2010, ACTA ANAESTH SCAND, V54, P951, DOI 10.1111/j.1399-6576.2010.02268.x; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; Liang YN, 2017, J STEROID BIOCHEM, V172, P62, DOI 10.1016/j.jsbmb.2017.05.014; Liu KL, 2011, NUCLEIC ACIDS RES, V39, P2869, DOI 10.1093/nar/gkq904; Loohuis NFMO, 2012, CELL MOL LIFE SCI, V69, P89, DOI 10.1007/s00018-011-0788-1; Lu SM, 2015, BRAIN BEHAV IMMUN, V44, P221, DOI 10.1016/j.bbi.2014.10.011; Luo AL, 2019, INFLAMMOPHARMACOLOGY, V27, P27, DOI 10.1007/s10787-018-00559-0; Mackensen GB, 2001, ANESTHESIOLOGY, V95, P1485, DOI 10.1097/00000542-200112000-00031; Mallick B, 2011, RNA BIOL, V8, P665, DOI 10.4161/rna.8.4.15584; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Moreau MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060480; Ni PF, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1374-3; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Papagiannakopoulos T, 2009, CELL STEM CELL, V4, P375, DOI 10.1016/j.stem.2009.04.007; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Salta E, 2016, EMBO MOL MED, V8, P1005, DOI 10.15252/emmm.201606520; Saxena S, 2019, BRIT MED BULL, V130, P125, DOI 10.1093/bmb/ldz010; Schratt G, 2009, CURR OPIN NEUROBIOL, V19, P213, DOI 10.1016/j.conb.2009.05.015; Smerkova K, 2015, INT J ONCOL, V46, P871, DOI 10.3892/ijo.2014.2756; Soreq H, 2011, TRENDS MOL MED, V17, P548, DOI 10.1016/j.molmed.2011.06.009; Sun Y, 2018, NEOPLASMA, V65, P505, DOI 10.4149/neo_2018_170705N462; Sun Y, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00193; Sun Y, 2013, CELL RES, V23, P1270, DOI 10.1038/cr.2013.116; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Wakabayashi M, 2005, BIOCHEM BIOPH RES CO, V328, P1019, DOI 10.1016/j.bbrc.2005.01.060; Wakabayashi M, 2007, J MOL BIOL, V371, P924, DOI 10.1016/j.jmb.2007.06.008; Wang HQ, 2016, BRAIN PATHOL, V26, P167, DOI 10.1111/bpa.12267; Wang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099855; Wang ZH, 2018, NEUROSCI LETT, V686, P1, DOI 10.1016/j.neulet.2018.08.032; Xiang XW, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00149; Xiong B, 2016, AM J TRANSL RES, V8, P70; Yang T, 2019, BRIT J ANAESTH, V122, P350, DOI 10.1016/j.bja.2018.10.062; Yao LP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1053-4; Zhang YQ, 2016, NEUROTOXICOLOGY, V56, P139, DOI 10.1016/j.neuro.2016.07.004	56	0	0	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0531-5565	1873-6815		EXP GERONTOL	Exp. Gerontol.	NOV	2021	155								111578	10.1016/j.exger.2021.111578			10	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	WD5UG	WOS:000705004700001	34601076	hybrid			2022-02-06	
J	Haran, FJ; Zampieri, C; Wassermann, EM; Polejaeva, E; Dell, KC; LoPresti, ML; Stone, JR; Ahlers, ST; Carr, W				Haran, F. J.; Zampieri, Cris; Wassermann, Eric M.; Polejaeva, Elena; Dell, Kristine C.; LoPresti, Matthew L.; Stone, James R.; Ahlers, Stephen T.; Carr, Walter			Chronic Effects of Breaching Blast Exposure on Sensory Organization and Postural Limits of Stability	JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article						balance; blast; breacher; limits of stability; posture	LOW-LEVEL BLAST; TRAUMATIC BRAIN-INJURY; ERROR SCORING SYSTEM	Objective: The goal of this effort to investigate if experienced breachers, professionals with a career history of exposure to repeated low-level blasts, exhibited postural instability. Methods: Postural data were examined using traditional tests of means and compared to normative data. Results: Breachers had significantly lower NeuroCom Sensory Organization Test (SOT) visual scores (within normative limits), prolonged Limits of Stability (LOS) test reaction time (30% of breachers and 7% of controls testing abnormal), and slower LOS movement velocity (21% of breachers and 0% of controls testing abnormal) compared to controls. Conclusion: Our LOS test findings are like those previously reported for students in the military breacher training course and seem to indicate that while acute effects of blasts on sensory control of balance fade away, effects on postural LOS persist over time.	[Haran, F. J.; Ahlers, Stephen T.] Naval Med Res Ctr, NeuroTrauma Dept, Silver Spring, MD 20910 USA; [Zampieri, Cris] NIH, Rehabil Med Dept, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA; [Wassermann, Eric M.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Polejaeva, Elena] Univ Florida, Clin & Hlth Psychol, Gainesville, FL USA; [Dell, Kristine C.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [LoPresti, Matthew L.; Carr, Walter] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA; [Stone, James R.] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA 22903 USA		Haran, FJ (corresponding author), Naval Med Res Ctr, NeuroTrauma Dept, Silver Spring, MD 20910 USA.	jay.haran@navy.mil			Joint Program Committee-5 Development of Exposure Standards to Repeated Blast Exposure program [603115HP-3730-001-A1118]; Office of Naval Research (ONR)Office of Naval Research [N00014-18-1-2440]; Cohen Veterans Bioscience, imaging resources from the Center for Neuroscience and Regenerative Medicine; Clinical Neurosciences Program of the National Institute of Neurological Disorders and Stroke [1ZIANS002977-21]	This work was supported/funded by the Joint Program Committee-5 Development of Exposure Standards to Repeated Blast Exposure program, work unit #603115HP-3730-001-A1118, Office of Naval Research (ONR) award #N00014-18-1-2440 with supplemental funding to the ONR award provided by Cohen Veterans Bioscience, imaging resources from the Center for Neuroscience and Regenerative Medicine, and the Clinical Neurosciences Program of the National Institute of Neurological Disorders and Stroke, Project #1ZIANS002977-21, to Dr Wassermann.	Baker AJ, 2011, J TRAUMA, V71, pS472, DOI 10.1097/TA.0b013e318232e7da; Carr W., 2011, J NEUROTRAUM, V71; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Cohen J., 1992, CURR DIR PSYCHOL SCI, V1, P98, DOI [DOI 10.2307/20182143, DOI 10.1111/1467-8721.EP10768783]; Eonta SE, 2020, MIL MED, V185, pE513, DOI 10.1093/milmed/usz185; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Haran FJ, 2021, APPL NEUROPSYCH-ADUL, V28, P297, DOI 10.1080/23279095.2019.1630627; Haran FJ, 2016, J NEUROTRAUM, V33, P705, DOI 10.1089/neu.2015.4060; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jacobson GP., 1993, HDB BALANCE FUNCTION; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; LaValle CR, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00949; Littlefield PD, 2016, J NEUROTRAUM, V33, P71, DOI 10.1089/neu.2014.3824; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Mancini M., 2008, GAIT POSTURE, V28, pS30; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Modica CM, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.588377; Nashner LM., 1993, HDB BALANCE FUNCTION; Ondo W, 2000, ARCH NEUROL-CHICAGO, V57, P1464, DOI 10.1001/archneur.57.10.1464; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pickerill ML, 2011, J ATHL TRAINING, V46, P600; Polejaeva E., 2019, J INT NEUROPSYCH SOC, pI; Rhea CK, 2018, NEUROMETHODS, V139, P283, DOI 10.1007/978-1-4939-8564-7_18; Row J, 2019, J NEUROTRAUM, V36, P2435, DOI 10.1089/neu.2018.5755; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; St Onge Paul, 2011, US Army Med Dep J, P97; Stone JR, 2020, J NEUROTRAUM, V37, P2468, DOI 10.1089/neu.2020.7141; Stone JR, 2013, J NEUROTRAUM, V30, pA120; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Thompson M., 2009, NEUROCOM CLIN INT GU; Tschiffely AE, 2020, J NEUROTRAUM, V37, P1091, DOI 10.1089/neu.2019.6512; Wang ZY, 2020, J NEUROTRAUM, V37, P1221, DOI 10.1089/neu.2019.6742	38	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-2752	1536-5948		J OCCUP ENVIRON MED	J. Occup. Environ. Med.	NOV	2021	63	11					944	950		10.1097/JOM.0000000000002266			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	WR7ZH	WOS:000714714600026	33990528				2022-02-06	
J	Hassan, MP; Abdollahifar, MA; Aliaghaei, A; Tabeie, F; Vafaei-Nezhad, S; Norouzian, M; Abbaszadeh, HA				Hassan, Mahnaz Poor; Abdollahifar, Mohammad-Amin; Aliaghaei, Abbas; Tabeie, Faraj; Vafaei-Nezhad, Saeed; Norouzian, Mohsen; Abbaszadeh, Hojjat Allah			Photobiomodulation therapy improved functional recovery and overexpression of interleukins-10 after contusion spinal cord injury in rats	JOURNAL OF CHEMICAL NEUROANATOMY			English	Article						Photobiomodulation; Spinal cord injury; Inflammation; Oxidative stress	LEVEL LASER THERAPY; MITOCHONDRIAL HEALTH; OXIDATIVE STRESS; MODEL; IRRADIATION; DYSFUNCTION; ACTIVATION; APOPTOSIS; ALTERS; BRAIN	Following severe Spinal Cord Injury (SCI), regeneration is inadequate, and functional recovery is incomplete. The occurrence of oxidative stress and the spread of inflammation play a crucial role in the failure to regenerate the injury site. In this way, we explored the neuroprotective effects of PhotoBioModulation (PBM), as the main factor in controlling these two destructive factors, on SCI. fifty-four female adult Wistar rats divided into three groups: sham group (just eliminate vertebra lamina, n = 18), SCI group (n = 18), and SCI-PBM group which exposed to PBM (150 MW, 50 min/day, 14 days, n = 18). After SCI induction at the endpoint of the study (the end of 8 week), we took tissue samples from the spinal cord for evaluating the biochemical profiles that include Catalase (CAT), Malondialdehyde (MDA), Superoxide Dismutase (SOD), Glutathione Peroxidase (GSH-PX) levels, immunohistochemistry for Caspase-3, gene expressions of Interleukin-1 beta (IL-1 beta), Tumor Necrosis Factor-alpha (TNF-alpha), and Interleukin (IL-10). Also, stereological assessments evaluated the spinal cord, central cavity volumes, and numerical density of the glial and neural cells in the traumatic area. The open-field test, rotarod test, Narrow Beam Test (NBT), Electromyography recording (EMG) test and the Basso-Beattie-Bresnehan (BBB) evaluated the neurological functions. Our results showed that the stereological parameters, biochemical profiles (except MDA), and neurological functions were markedly greater in the SCI-PBM group in comparison with SCI group. The transcript for the IL-10 gene was seriously upregulated in the SCI-PBM group compared to the SCI group. This is while gene expression of TNF-alpha and IL-1 beta, also density of apoptosis cells in Caspase-3 evaluation decreased significantly more in the SCI-PBM group compared to the SCI group. Overall, using PBM treatment immediately after SCI has neuroprotective effects by controlling oxidative stress and inflammation and preventing the spread of damage.	[Hassan, Mahnaz Poor; Abdollahifar, Mohammad-Amin; Norouzian, Mohsen] Shahid Beheshti Univ Med Sci, Sch Med, Dept Biol & Anat, Tehran, Iran; [Abdollahifar, Mohammad-Amin; Norouzian, Mohsen; Abbaszadeh, Hojjat Allah] Shahid Beheshti Univ Med Sci, Laser Applicat Med Sci Res Ctr, Tehran, Iran; [Aliaghaei, Abbas; Abbaszadeh, Hojjat Allah] Shahid Beheshti Univ Med Sci, Loghman Hakim Hosp, Hearing Disorders Res Ctr, Tehran, Iran; [Tabeie, Faraj] Shahid Beheshti Univ Med Sci, Sch Rehabil, Dept Basic Sci, Tehran, Iran; [Vafaei-Nezhad, Saeed] Birjand Univ Med Sci, Fac Med, Dept Anat Sci, Birjand, Iran		Norouzian, M (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Dept Biol & Anat, Tehran, Iran.; Abbaszadeh, HA (corresponding author), Shahid Beheshti Univ Med Sci, Laser Applicat Med Sci Res Ctr, Tehran, Iran.	norozian93@gmail.com; Dr.Abbaszadeh@sbmu.ac.ir		Abdollahifar, mohammad amin/0000-0001-6947-3285; Vafaei-Nezhad, Saeed/0000-0003-0970-9334	School of Medicine, Shahid Beheshti University of Medical Sciences [18049]; Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran	This article has been extracted from the Ph.D. thesis written by Mrs. Mahnaz poor Hassan and the present article is financially supported by School of Medicine, Shahid Beheshti University of Medical Sciences (Registration No: 18049) and Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.	Abbaszadeh Hojjat Allah, 2018, Iranian Biomedical Journal, V22, P246, DOI 10.22034/ibj.22.4.246; Abbaszadeh HA, 2018, ANAT CELL BIOL, V51, P180, DOI 10.5115/acb.2018.51.3.180; Ahmadi F, 2021, J SPINAL CORD MED, DOI 10.1080/10790268.2021.1896275; Ahmadi H, 2018, J MOL NEUROSCI, V65, P17, DOI 10.1007/s12031-018-1062-x; Ahuja CS, 2017, NEUROSURGERY, V80, pS9, DOI 10.1093/neuros/nyw080; Alenzi FQ, 2010, ASIAN PAC J CANCER P, V11, P271; Alizadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00282; Anwar MA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00098; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Brown AR, 2019, JOVE-J VIS EXP, DOI 10.3791/59738; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; da Silva FC, 2020, LASER MED SCI, V35, P1751, DOI 10.1007/s10103-020-02968-6; Sergio LPD, 2018, PHOTOCH PHOTOBIO SCI, V17, P975, DOI [10.1039/c8pp00109j, 10.1039/c8pp00109js]; Darabi S.H., 2017, J BABOL U MED SCI, V19, P41, DOI [10.22088/jbums.19.8.41, DOI 10.22088/JBUMS.19.8.41]; Farivar S, 2014, J LASERS MED SCI, V5, P58; Gorgey AS, 2019, EUR J APPL PHYSIOL, V119, P315, DOI 10.1007/s00421-018-4039-0; Howard V, 2004, UNBIASED STEREOLOGY; Ijaz S, 2020, J MOL NEUROSCI, V70, P458, DOI 10.1007/s12031-019-01437-2; Janzadeh A, 2020, PHYSIOL BEHAV, V227, DOI 10.1016/j.physbeh.2020.113141; Janzadeh A, 2017, NEUROPEPTIDES, V65, P90, DOI 10.1016/j.npep.2017.06.002; Kalayci M, 2005, NEUROCHEM RES, V30, P403, DOI 10.1007/s11064-005-2615-2; Keller AV, 2018, SPINAL CORD, V56, P560, DOI 10.1038/s41393-018-0069-z; Ketz AK, 2017, PAIN MED, V18, P932, DOI 10.1093/pm/pnw144; Lan WB, 2021, NEUROSCI LETT, V744, DOI 10.1016/j.neulet.2020.135615; Lapuente-Chala Catalina, 2018, rev.fac.med., V66, P269, DOI 10.15446/revfacmed.v66n2.61701; Li JL, 2017, INT J NANOMED, V12, P2443, DOI 10.2147/IJN.S128705; Li K, 2020, LASER MED SCI, V35, P1509, DOI 10.1007/s10103-019-02941-y; Li XW, 2020, BIOMATERIALS, V245, DOI 10.1016/j.biomaterials.2020.119978; Liu ZY, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01751-2; Livecchi Mark A, 2011, Continuum (Minneap Minn), V17, P568, DOI 10.1212/01.CON.0000399073.00062.9e; Macedo RS, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9303126; Mohamadi Y, 2019, J CHEM NEUROANAT, V97, P1, DOI 10.1016/j.jchemneu.2019.01.011; Mousavi M, 2019, METAB BRAIN DIS, V34, P1117, DOI 10.1007/s11011-019-00433-0; Nasiry D, 2021, BIOTECH HISTOCHEM, V96, P41, DOI 10.1080/10520295.2020.1755893; Neves LMS, 2018, MOL NEUROBIOL, V55, P5580, DOI 10.1007/s12035-017-0792-z; Noori L, 2021, NEUROSCI RES, V170, P87, DOI 10.1016/j.neures.2020.07.011; O'Brien LC, 2016, WORLD J ORTHOP, V7, P628, DOI 10.5312/wjo.v7.i10.628; Ormond DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088916; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Orr MB, 2018, NEUROTHERAPEUTICS, V15, P541, DOI 10.1007/s13311-018-0631-6; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Ozturk AM, 2018, INJURY, V49, P1038, DOI 10.1016/j.injury.2018.03.021; Paula AA, 2014, LASER MED SCI, V29, P1849, DOI 10.1007/s10103-014-1586-4; Pigatto GR, 2020, PAIN PRACT, V20, P371, DOI 10.1111/papr.12862; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Rabchevsky AG, 2020, EXP NEUROL, V330, DOI 10.1016/j.expneurol.2020.113332; Ramezani F, 2020, PHYSIOL BEHAV, V224, DOI 10.1016/j.physbeh.2020.112977; Raoofi A, 2019, EUR J TRANSL MYOL, V29, P33, DOI 10.4081/ejtm.2019.7945; Rashidiani-Rashidabadi A, 2019, NEURAL REGEN RES, V14, P1833, DOI 10.4103/1673-5374.257539; Rosso Marcelie Priscila de Oliveira, 2018, Bioengineering (Basel), V5, DOI 10.3390/bioengineering5020044; Salehpour F, 2020, REV NEUROSCIENCE, V31, P269, DOI 10.1515/revneuro-2019-0063; Scholpa NE, 2017, J PHARMACOL EXP THER, V363, P303, DOI 10.1124/jpet.117.244806; Seth N, 2018, COMPARATIVE MED, V68, P63; Shuaib A, 2020, PHOTOBIOMOD PHOTOMED, V38, P661, DOI 10.1089/photob.2020.4864; Soltani R, 2020, J CHEM NEUROANAT, V109, DOI 10.1016/j.jchemneu.2020.101820; Song J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42521; Sotoudeh A, 2015, ACTA CIR BRAS, V30, P611, DOI 10.1590/S0102-865020150090000005; Stewart AN, 2021, EXP NEUROL, V337, DOI 10.1016/j.expneurol.2021.113597; Sun GD, 2018, MAT SCI ENG C-MATER, V89, P194, DOI 10.1016/j.msec.2018.04.006; Topaloglu N, 2021, PHOTODERMATOL PHOTO, V37, P253, DOI 10.1111/phpp.12645; Torabi A, 2020, TOXICON, V183, P44, DOI 10.1016/j.toxicon.2020.05.012; Tripodi N, 2020, J BIOPHOTONICS, V13, DOI 10.1002/jbio.201960230; Tucker LD, 2018, J MOL NEUROSCI, V65, P514, DOI 10.1007/s12031-018-1121-3; Vafaei-Nezhad S, 2021, J CHEM NEUROANAT, V113, DOI 10.1016/j.jchemneu.2021.101924; Vafaei-Nezhad S, 2020, J LASERS MED SCI, V11, P363, DOI 10.34172/jlms.2020.59; Venkatesh K, 2019, CELL TISSUE RES, V377, P125, DOI 10.1007/s00441-019-03039-1; Veronez S, 2017, LASER MED SCI, V32, P343, DOI 10.1007/s10103-016-2120-7; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Wu XJ, 2009, LASER SURG MED, V41, P36, DOI 10.1002/lsm.20729; Yang LD, 2018, EXP NEUROL, V299, P86, DOI 10.1016/j.expneurol.2017.10.013; Zhang SQ, 2016, NEURAL REGEN RES, V11, P657, DOI 10.4103/1673-5374.180754; Zheng Q, 2021, J MOL NEUROSCI, V71, P1290, DOI 10.1007/s12031-020-01756-9	73	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0891-0618	1873-6300		J CHEM NEUROANAT	J. Chem. Neuroanat.	NOV	2021	117								102010	10.1016/j.jchemneu.2021.102010			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	WC5JY	WOS:000704294300003	34343596				2022-02-06	
J	Hermanides, J; Hong, YT; Trivedi, M; Outtrim, J; Aigbirhio, F; Nestor, PJ; Guilfoyle, M; Winzeck, S; Newcombe, VFJ; Das, T; Correia, MM; Carpenter, KLH; Hutchinson, PJA; Gupta, AK; Fryer, TD; Pickard, JD; Menon, DK; Coles, JP				Hermanides, Jeroen; Hong, Young T.; Trivedi, Monica; Outtrim, Joanne; Aigbirhio, Franklin; Nestor, Peter J.; Guilfoyle, Matthew; Winzeck, Stefan; Newcombe, Virginia F. J.; Das, Tilak; Correia, Marta M.; Carpenter, Keri L. H.; Hutchinson, Peter J. A.; Gupta, Arun K.; Fryer, Tim D.; Pickard, John D.; Menon, David K.; Coles, Jonathan P.			Metabolic derangements are associated with impaired glucose delivery following traumatic brain injury	BRAIN			English	Article						traumatic brain injury; PET; cerebral blood flow; glucose metabolism; microdialysis	CEREBRAL-BLOOD-FLOW; COMBINED MICRODIALYSIS; HEAD-INJURY; INSULIN THERAPY; FDG-PET; LACTATE; OXYGEN; HUMANS; DYSFUNCTION; ANESTHESIA	Metabolic derangements following traumatic brain injury are poorly characterized. In this single-centre observational cohort study we combined 18F-FDG and multi-tracer oxygen-15 PET to comprehensively characterize the extent and spatial pattern of metabolic derangements. Twenty-six patients requiring sedation and ventilation with intracranial pressure monitoring following head injury within a Neurosciences Critical Care Unit, and 47 healthy volunteers were recruited. Eighteen volunteers were excluded for age over 60 years (n = 11), movement-related artefact (n = 3) or physiological instability during imaging (n = 4). We measured cerebral blood flow, blood volume, oxygen extraction fraction, and F-18-FDG transport into the brain (K-1) and its phosphorylation (k(3)). We calculated oxygen metabolism, F-18-FDG influx rate constant (K-i), glucose metabolism and the oxygen/glucose metabolic ratio. Lesion core, penumbra and peri-penumbra, and normal-appearing brain, ischaemic brain volume and k(3) hotspot regions were compared with plasma and microdialysis glucose in patients. Twenty-six head injury patients, median age 40 years (22 male, four female) underwent 34 combined F-18-FDG and oxygen-15 PET at early, intermediate, and late time points (within 24 h, Days 2-5, and Days 6-12 post-injury; n = 12, 8, and 14, respectively), and were compared with 20 volunteers, median age 43 years (15 male, five female) who underwent oxygen-15, and nine volunteers, median age 56 years (three male, six female) who underwent F-18-FDG PET. Higher plasma glucose was associated with higher microdialysate glucose. Blood flow and K-1 were decreased in the vicinity of lesions, and closely related when blood flow was 525 ml/100 ml/min. Within normal-appearing brain, K-1 was maintained despite lower blood flow than volunteers. Glucose utilization was globally reduced in comparison with volunteers (P<0.001). k(3) was variable; highest within lesions with some patients showing increases with blood flow <25 ml/100 ml/min, but falling steeply with blood flow lower than 12 ml/100 ml/min. k(3) hotspots were found distant from lesions, with k(3) increases associated with lower plasma glucose (Rho -0.33, P<0.001) and microdialysis glucose (Rho -0.73, P = 0.02). k(3) hotspots showed similar K-1 and glucose metabolism to volunteers despite lower blood flow and oxygen metabolism (P<0.001, both comparisons); oxygen extraction fraction increases consistent with ischaemia were uncommon. We show that glucose delivery was dependent on plasma glucose and cerebral blood flow. Overall glucose utilization was low, but regional increases were associated with reductions in glucose availability, blood flow and oxygen metabolism in the absence of ischaemia. Clinical management should optimize blood flow and glucose delivery and could explore the use of alternative energy substrates.	[Hermanides, Jeroen; Trivedi, Monica; Outtrim, Joanne; Winzeck, Stefan; Newcombe, Virginia F. J.; Gupta, Arun K.; Menon, David K.; Coles, Jonathan P.] Univ Cambridge, Univ Div Anaesthesia, Cambridge, England; [Hong, Young T.; Aigbirhio, Franklin; Fryer, Tim D.] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England; [Nestor, Peter J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Guilfoyle, Matthew; Carpenter, Keri L. H.; Hutchinson, Peter J. A.; Pickard, John D.] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Winzeck, Stefan] Imperial Coll, Dept Comp, BioMedIA Grp, London, England; [Das, Tilak] Addenbrookes Hosp, Dept Radiol, Cambridge, England; [Correia, Marta M.] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England		Coles, JP (corresponding author), Univ Cambridge, Dept Med, Div Anaesthesia, Addenbrookes Hosp, Cambridge, England.	jpc44@cam.ac.uk		Das, Tilak/0000-0003-0655-412X; Coles, Jonathan/0000-0003-4013-679X	Horizon 2020; Novonordisk LtdNovo Nordisk; European Society of Anaesthesiology; Netherlands Organisation for Health Research and DevelopmentNetherlands Organization for Health Research and Development; University of Amsterdam; NIHR (Biomedical Research Centre Cambridge)National Institute for Health Research (NIHR); NIHR (Invention for Innovation); UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Royal College of Surgeons of England; British Brain and Spine Foundation; Academy of Medical Sciences/Health Foundation; NIHRNational Institute for Health Research (NIHR); NIHR (Cambridge BRC); NIHR (Global Health Research Group on Neurotrauma); Academy of Medical Sciences/Health Foundation Clinician Scientist Fellowship; Royal College of Anaesthetists/British Journal of Anaesthesia; National Institute of Academic Anaesthesia; Addenbrooke's Charities; Wellcome TrustWellcome TrustEuropean Commission; Beverley and Raymond Sackler; UK Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H008217/1]; University of Cambridge, UKUniversity of Cambridge; University of CambridgeUniversity of Cambridge	J.H. reports grants from Horizon 2020, Novonordisk Ltd, European Society of Anaesthesiology, The Netherlands Organisation for Health Research and Development, and the University of Amsterdam research fund. K.L.H.C. reports grants from the NIHR (Biomedical Research Centre Cambridge, and Invention for Innovation) and the UK Medical Research Council. P.J.H. reports grants from the Royal College of Surgeons of England, British Brain and Spine Foundation, Academy of Medical Sciences/Health Foundation, and NIHR (Research Professorship, Cambridge BRC, and Global Health Research Group on Neurotrauma). V.F.J.N. is supported by an Academy of Medical Sciences/Health Foundation Clinician Scientist Fellowship. T.D.F., F.I.A., J.P.C. and D.K.M. report grants from the UK Medical Research Council. J.P.C. reports grants from the Royal College of Anaesthetists/British Journal of Anaesthesia, National Institute of Academic Anaesthesia, Addenbrooke's Charities, the Wellcome Trust, Beverley and Raymond Sackler, and the Academy of Medical Sciences/Health Foundation. CamCAN funding was provided by the UK Biotechnology and Biological Sciences Research Council (grant number BB/H008217/1), together with support from the UK Medical Research Council and University of Cambridge, UK. This work was supported by researchers at the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre. Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge acted as the sponsor for this study, with responsibility for study conduct and management. Neither the funders nor the sponsor had input into study design; data collection, data analysis, data interpretation; writing of the report; or the decision to submit the paper for publication.	Abate MG, 2008, NEUROCRIT CARE, V9, P319, DOI 10.1007/s12028-008-9119-2; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Coles JP, 2006, CURR OPIN ANESTHESIO, V19, P473, DOI 10.1097/01.aco.0000245270.90377.00; Coles JP, 2009, J CEREBR BLOOD F MET, V29, P965, DOI 10.1038/jcbfm.2009.22; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Finnema SJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6667; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Green DM, 2010, NEUROCRIT CARE, V13, P299, DOI 10.1007/s12028-010-9417-3; Hartings JA, 2020, JAMA NEUROL, V77, P489, DOI 10.1001/jamaneurol.2019.4476; Hattori N, 2004, J NUCL MED, V45, P775; Hattori N, 2003, J NUCL MED, V44, P1709; HEISS WD, 1984, J CEREBR BLOOD F MET, V4, P212, DOI 10.1038/jcbfm.1984.30; Hermanides J, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1883-y; Hong YT, 2010, NEUROIMAGE, V51, P164, DOI 10.1016/j.neuroimage.2010.02.013; HUANG SC, 1980, AM J PHYSIOL, V238, pE69, DOI 10.1152/ajpendo.1980.238.1.E69; Hutchinson P, 2009, ACTA NEUROCHIR, V151, P51, DOI 10.1007/s00701-008-0169-1; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Jalloh I, 2018, J NEUROTRAUM, V35, P2025, DOI 10.1089/neu.2017.5459; Jalloh I, 2017, J CEREBR BLOOD F MET, V37, P2626, DOI 10.1177/0271678X16672665; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; JENNETT B, 1975, LANCET, V1, P480; Kaisti KK, 2002, ANESTHESIOLOGY, V96, P1358, DOI 10.1097/00000542-200206000-00015; Koepsell H, 2020, PFLUG ARCH EUR J PHY, V472, P1299, DOI 10.1007/s00424-020-02441-x; KUWABARA H, 1991, J NUCL MED, V32, P692; KUWABARA H, 1990, J CEREBR BLOOD F MET, V10, P180, DOI 10.1038/jcbfm.1990.33; Launey Y, 2020, JAMA NEUROL, V77, P339, DOI 10.1001/jamaneurol.2019.3854; Ledig C, 2015, MED IMAGE ANAL, V21, P40, DOI 10.1016/j.media.2014.12.003; Magnoni S, 2012, CRIT CARE MED, V40, P1785, DOI 10.1097/CCM.0b013e318246bd45; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Peeters SGJA, 2015, INT J RADIAT ONCOL, V91, P351, DOI 10.1016/j.ijrobp.2014.09.045; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; REIVICH M, 1979, CIRC RES, V44, P127, DOI 10.1161/01.RES.44.1.127; REIVICH M, 1982, J CEREBR BLOOD F MET, V2, P307, DOI 10.1038/jcbfm.1982.32; Rostami Elham, 2011, J Diabetes Sci Technol, V5, P596; Schlunzen L, 2012, ACTA ANAESTH SCAND, V56, P248, DOI 10.1111/j.1399-6576.2011.02561.x; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Smielewski Peter, 1800, J Clin Monit Comput, V17, P427, DOI 10.1023/A:1026293611455; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Stovell MG, 2020, J CEREBR BLOOD F MET, V40, P67, DOI 10.1177/0271678X18799176; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Wu HM, 2004, NEUROSURGERY, V55, P1306, DOI 10.1227/01.NEU.0000143028.08719.42; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263	60	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	NOV	2021	144		11				3492	3504		10.1093/brain/awab255			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH9YJ	WOS:000743514700025	34240124	Green Published, hybrid			2022-02-06	
J	Hiltunen, J; Ndode-Ekane, XE; Lipponen, A; Drexel, M; Sperk, G; Puhakka, N; Pitkanen, A				Hiltunen, Johanna; Ndode-Ekane, Xavier Ekolle; Lipponen, Anssi; Drexel, Meinrad; Sperk, Guenther; Puhakka, Noora; Pitkanen, Asla			Regulation of Parvalbumin Interactome in the Perilesional Cortex after Experimental Traumatic Brain Injury	NEUROSCIENCE			English	Article						gene expression; GABA-A receptors; parvalbumin; perilesional cortex; fluid-percussion injury	POSTTRAUMATIC EPILEPSY; RECEPTOR SUBUNITS; GABA(A) RECEPTOR; RAT; INTERNEURONS; NEURONS; MODEL; LOCALIZATION; HIPPOCAMPUS; INHIBITION	brain injury (TBI) causes 10-20% of structural epilepsy, with seizures typically originating in the cortex. Alterations in the neuronal microcircuits in the cortical epileptogenic zone, however, are poorly understood. Here, we assessed TBI-induced changes in perisomatic gamma aminobutyric acid (GABA)-ergic innervation in the perilesional cortex. We hypothesized that TBI will damage parvalbumin (PV)-immunoreactive inhibitory neurons and induce regulation of the associated GABAergic molecular interactome. TBI was induced in adult male Sprague-Dawley rats by lateral fluid-percussion injury. At 1-month post-TBI, the number of PV-positive somata was plotted on unfolded cortical maps and the distribution and density of immunopositive terminals analyzed. Qualitative analysis revealed either patchy microlesions of several hundred micrometers in diameter or diffuse neuronal loss. Quantitative analysis demonstrated a reduction in the number of PV-positive interneurons in patches down to 0% of that in sham-operated controls in the perilesional cortex. In the majority of patches, the cell numbers ranged from 71% to 90% that of the controls. The loss of PV-positive somata was accompanied by decreased axonal labeling. In situ hybridization revealed downregulated PV mRNA expression in the perilesional cortex. Gene Set Enrichment Analysis indicated a robustly downregulated expression profile of PV-related genes, which was confirmed by quantitative reverse transcriptase polymerase chain reaction. Specifically, we found that genes encoding postsynaptic GABA-A receptor genes, Gabrg2 and Gabrd, were down regulated in TBI animals compared with controls. Our data suggests that patchy reduction in PV-positive perisomatic inhibitory innervation contributes to the development of focal cortical inhibitory deficit after TBI. (c) 2021 IBRO. Published by Elsevier Ltd. All rights reserved.	[Hiltunen, Johanna; Ndode-Ekane, Xavier Ekolle; Lipponen, Anssi; Puhakka, Noora; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland; [Sperk, Guenther] Med Univ Innsbruck, Dept Pharmacol, Peter Mayr Str 1a, A-6020 Innsbruck, Austria; [Drexel, Meinrad] Med Univ Innsbruck, Inst Mol & Cellular Pharmacol, Peter Mayr Str 1, A-6020 Innsbruck, Austria		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi		Lipponen, Anssi/0000-0002-4403-9084	European UnionEuropean Commission [LSH-CT-2006-037315]; Medical Research Council of the Academy of FinlandAcademy of Finland [272249, 273909, 2285733-9]; Sigrid Juselius FoundationSigrid Juselius Foundation; Finnish Epilepsy Research Foundation	This research was funded by the European Union's Sixth Framework Programme EPICURE LSH-CT-2006-037315 (A.P.), the Medical Research Council of the Academy of Finland Grants 272249, 273909, and 2285733-9 (A.P.), the Sigrid Juselius Foundation (A.P.), and the Finnish Epilepsy Research Foundation (J.H.).	Andrioli A, 2007, NEUROSCIENCE, V149, P131, DOI 10.1016/j.neuroscience.2007.07.029; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; BERCHTOLD MW, 1982, EUR J BIOCHEM, V127, P381, DOI 10.1111/j.1432-1033.1982.tb06883.x; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carron SF, 2020, J COMP NEUROL, V528, P175, DOI 10.1002/cne.24746; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; CELIO MR, 1986, SCIENCE, V231, P995, DOI 10.1126/science.3945815; Chevaleyre V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00093; Dachet F, 2015, BRAIN, V138, P356, DOI 10.1093/brain/awu350; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; delRio MR, 1997, J NEUROSCI, V17, P5143; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Drexel M, 2011, NEUROSCIENCE, V189, P316, DOI 10.1016/j.neuroscience.2011.05.021; Drexel M, 2017, J NEUROSCI, V37, P8166, DOI 10.1523/JNEUROSCI.3456-16.2017; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FURRIOLS M, 1993, J BIOL CHEM, V268, P27060; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; HARTIG W, 1992, NEUROREPORT, V3, P869; Hsieh TH, 2017, CEREB CORTEX, V27, P5509, DOI 10.1093/cercor/bhw318; Huttunen JK, 2018, J NEUROTRAUM, V35, P2708, DOI 10.1089/neu.2017.5308; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Immonen R, 2013, J NEUROTRAUM, V30, P1305, DOI 10.1089/neu.2012.2815; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Karetko-Sysa M, 2011, EXP NEUROL, V231, P113, DOI 10.1016/j.expneurol.2011.05.022; Kerti-Szigeti K, 2016, ELIFE, V5, DOI 10.7554/eLife.18426; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magloczky Z, 2005, TRENDS NEUROSCI, V28, P334, DOI 10.1016/j.tins.2005.04.002; Magloczky Z, 2000, NEUROSCIENCE, V96, P7, DOI 10.1016/S0306-4522(99)00474-1; MATHERN GW, 1995, J NEUROSCI, V15, P3990; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MCDONALD JW, 1991, ANN NEUROL, V29, P529, DOI 10.1002/ana.410290513; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Miszczuk D, 2015, SFN 2015; Ndode-Ekane XE, 2017, J NEUROTRAUM, V34, P459, DOI 10.1089/neu.2016.4404; NUSSER Z, 1995, EUR J NEUROSCI, V7, P630, DOI 10.1111/j.1460-9568.1995.tb00667.x; OLSEN RW, 1992, EPILEPSY RES, P383; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pena-Llopis S, 2013, NAT PROTOC, V8, P2240, DOI 10.1038/nprot.2013.141; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; R Core Team, 2020, R LANG ENV STAT COMP; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwaller B, 2004, MOL CELL NEUROSCI, V25, P650, DOI 10.1016/j.mcn.2003.12.006; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Toth K, 2010, BRAIN, V133, P2763, DOI 10.1093/brain/awq149; Toth Z, 1997, J NEUROSCI, V17, P8106; Wang X, 2016, EPILEPSY RES, V128, P35, DOI 10.1016/j.eplepsyres.2016.10.002; Wasterlain CG, 1996, EPILEPSY RES, V26, P255, DOI 10.1016/S0920-1211(96)00058-7; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Zhang BL, 2011, CHINESE MED J-PEKING, V124, P740, DOI 10.3760/cma.j.issn.0366-6999.2011.05.020; Zhang NH, 2007, J NEUROSCI, V27, P7520, DOI 10.1523/JNEUROSCI.1555-07.2007	69	0	0	8	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 1	2021	475						52	72		10.1016/j.neuroscience.2021.08.018			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WB9KU	WOS:000703885000003	34455012				2022-02-06	
J	Hoersten, T; Gray, A; Payne, EK; Gear, W; Hageman, J				Hoersten, Tricia; Gray, Ashley; Payne, Ellen K.; Gear, William; Hageman, Jason			Investigating Concussion Knowledge in US Born Versus Internationally Born Collegiate Student-Athletes in the United States	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion education; RoCKAS	HIGH-SCHOOL	Objective: To compare concussion knowledge between US born and internationally born collegiate student-athletes. Furthermore, to investigate whether length of time in the United States impacted concussion knowledge. Design: Survey. Setting: Preparticipation physicals at a midwestern NAIA college. Participants: Three hundred one collegiate student-athletes. Interventions: Demographic questionnaire and the Rosenbaum Concussion Knowledge and Attitudes Survey (RoCKAS). Main Outcome Measures: t test was used to determine whether a difference in Concussion Knowledge Index (CKI) scores exists between US born and internationally born student-athletes. A one-way analysis of variance was used to determine significance for length of time in the United States. Results: A statistically significant difference was found for CKI scores between US born (19.22 +/- 2.38) and internationally born student-athletes (18.01 +/- 2.57) (t = 3.895, P = 0.000). Analysis of variance demonstrated statistically significant difference for CKI scores (F-2,F-300 = 13.883, P = 0.001). Post hoc analysis found significant differences in CKI scores between US born (19.22 +/- 2.38) and internationally born student-athletes in the United States less than 2 years (17.31 +/- 2.52) (P = 0.000), and between internationally born student-athletes in the United States 2 or more years (19.15 +/- 2.25) and internationally born student-athletes in the United States less than 2 years (17.31 +/- 2.52) (P = 0.002). Conclusion: Among this sample, being born in the United States and length of time in the United States contribute to student-athletes' concussion knowledge.	[Hoersten, Tricia] Wright State Univ, Boonshoft Sch Med, Dayton, OH 45435 USA; [Gray, Ashley; Payne, Ellen K.] Moravian Coll, 1200 Main St, Bethlehem, PA 18018 USA; [Gear, William] Univ Wisconsin, Green Bay, WI 54302 USA; [Hageman, Jason] Mercy Hlth St Ritas, Lima, OH USA		Payne, EK (corresponding author), Moravian Coll, 1200 Main St, Bethlehem, PA 18018 USA.	PayneE@moravian.edu					Beidler E, 2018, J ATHL TRAINING, V53, P866, DOI 10.4085/1062-6050-266-17; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Chapman EB, 2018, CLIN J SPORT MED, V28, P117, DOI 10.1097/JSM.0000000000000421; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Cusimano MD, 2017, SAGE OPEN MED, V5, DOI [10.1177/2050312117694794, 10.1177/2050312117699799]; Diggs K., 2019, NATA NEWS, P29; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Kirk B, 2018, SPORTS, V6, DOI 10.3390/sports6040102; Knollman-Porter K, 2018, AM J SPEECH-LANG PAT, V27, P778, DOI 10.1044/2018_AJSLP-17-0108; Leahy R, 2020, PHYS THER SPORT, V43, P236, DOI 10.1016/j.ptsp.2019.06.004; Lee HR, 2016, INT J ATHL THER TRAI, V21, P53, DOI 10.1123/ijatt.2014-0087; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; NAIA, 2018, NAIA CHAMP CONC POL; NCAA, 2017, CONC SAF PROT CHECKL; NCAA, 2018, DIAGNOSIS MANAGEMENT; Potteiger KL, 2018, INTERNET J ALLIED HE, V16; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Zuckerman SL, 2015, INT J SPORTS MED, V36, P419, DOI 10.1055/s-0034-1395587	21	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2021	31	6					E363	E366		10.1097/JSM.0000000000000863			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WM5NJ	WOS:000711131700010	32941377				2022-02-06	
J	Hope, AJ; Vashisth, U; Parker, MJ; Ralston, AB; Roper, JM; Ralston, JD				Hope, Alex J.; Vashisth, Utkarsh; Parker, Matthew J.; Ralston, Andreas B.; Roper, Joshua M.; Ralston, John D.			Phybrata Sensors and Machine Learning for Enhanced Neurophysiological Diagnosis and Treatment	SENSORS			English	Article						machine learning; wearable sensor; concussion; physiological impairment; vestibular; neurological	TRAUMATIC BRAIN-INJURY; FOLD CROSS-VALIDATION; POSTURAL CONTROL; BALANCE CONTROL; CONCUSSION; MANAGEMENT; BIOMARKER; DEFICITS; STATE; GAIT	Concussion injuries remain a significant public health challenge. A significant unmet clinical need remains for tools that allow related physiological impairments and longer-term health risks to be identified earlier, better quantified, and more easily monitored over time. We address this challenge by combining a head-mounted wearable inertial motion unit (IMU)-based physiological vibration acceleration ( "phybrata ") sensor and several candidate machine learning (ML) models. The performance of this solution is assessed for both binary classification of concussion patients and multiclass predictions of specific concussion-related neurophysiological impairments. Results are compared with previously reported approaches to ML-based concussion diagnostics. Using phybrata data from a previously reported concussion study population, four different machine learning models (Support Vector Machine, Random Forest Classifier, Extreme Gradient Boost, and Convolutional Neural Network) are first investigated for binary classification of the test population as healthy vs. concussion (Use Case 1). Results are compared for two different data preprocessing pipelines, Time-Series Averaging (TSA) and Non-Time-Series Feature Extraction (NTS). Next, the three best-performing NTS models are compared in terms of their multiclass prediction performance for specific concussion-related impairments: vestibular, neurological, both (Use Case 2). For Use Case 1, the NTS model approach outperformed the TSA approach, with the two best algorithms achieving an F1 score of 0.94. For Use Case 2, the NTS Random Forest model achieved the best performance in the testing set, with an F1 score of 0.90, and identified a wider range of relevant phybrata signal features that contributed to impairment classification compared with manual feature inspection and statistical data analysis. The overall classification performance achieved in the present work exceeds previously reported approaches to ML-based concussion diagnostics using other data sources and ML models. This study also demonstrates the first combination of a wearable IMU-based sensor and ML model that enables both binary classification of concussion patients and multiclass predictions of specific concussion-related neurophysiological impairments.</p>	[Hope, Alex J.; Vashisth, Utkarsh; Parker, Matthew J.] AltaML Inc, Edmonton, AB T5J 3N9, Canada; [Ralston, Andreas B.; Roper, Joshua M.; Ralston, John D.] PROTXX Inc, Menlo Pk, CA 94025 USA; [Ralston, John D.] PROTXX Med Ltd, 120,4838 Richard Rd SW, Calgary, AB T3E 6L1, Canada		Ralston, JD (corresponding author), PROTXX Inc, Menlo Pk, CA 94025 USA.; Ralston, JD (corresponding author), PROTXX Med Ltd, 120,4838 Richard Rd SW, Calgary, AB T3E 6L1, Canada.	alex@altaml.com; utkarsh.vashisth@live.in; mj3parker@gmail.com; andreas.ralston@protxx.com; josh.roper@protxx.com; john.ralston@protxx.com		Ralston, John/0000-0002-8092-9076	PROTXX Inc.; AltaML	This research was funded by PROTXX Inc. and AltaML.	Abdollah V, 2021, GAIT POSTURE, V90, P137, DOI 10.1016/j.gaitpost.2021.08.020; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Asslander L, 2014, J NEUROPHYSIOL, V111, P1852, DOI 10.1152/jn.00669.2013; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Banman CJ, 2021, J NEUROTRAUM, V38, P2291, DOI 10.1089/neu.2020.7432; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Baruch Martin, 2016, J Rehabil Res Dev, V53, P959, DOI 10.1682/JRRD.2015.06.0120; Berrar D., 2019, CROSS VALIDATION, DOI [10.1016/B978-0-12-809633-8.20349-X, DOI 10.1016/B978-0-12-809633-8.20349-X]; Boshra R, 2019, IEEE T NEUR SYS REH, V27, P1492, DOI 10.1109/TNSRE.2019.2922553; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Burke MJ, 2015, BRAIN INJURY, V29, P300, DOI 10.3109/02699052.2014.974673; BURMAN P, 1989, BIOMETRIKA, V76, P503, DOI 10.2307/2336116; Buster TW, 2016, BRAIN INJURY, V30, P1249, DOI 10.1080/02699052.2016.1183822; Cai YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197992; Castellanos J, 2021, SPORTS MED, V51, P567, DOI 10.1007/s40279-020-01390-w; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chancellor SE, 2019, SEMIN PEDIATR NEUROL, V30, P14, DOI 10.1016/j.spen.2019.03.004; Chen J, 2020, HEALTH SERV INSIGHTS, V13, DOI 10.1177/1178632920938674; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Cheng B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185063; Christy JB, 2019, J NEUROL PHYS THER, V43, P153, DOI 10.1097/NPT.0000000000000280; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; DIENER HC, 1984, ELECTROEN CLIN NEURO, V57, P134, DOI 10.1016/0013-4694(84)90172-X; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Filli L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22676-0; Fjeldstad C, 2011, INT J REHABIL RES, V34, P53, DOI 10.1097/MRR.0b013e32833d6ccb; Fortino G, 2013, IEEE T HUM-MACH SYST, V43, P115, DOI 10.1109/TSMCC.2012.2215852; Galea OA, 2018, NEUROREHAB NEURAL RE, V32, P115, DOI 10.1177/1545968318760728; Garcia GGP, 2020, NEUROSURGERY, V87, P971, DOI 10.1093/neuros/nyaa150; Godfrey A, 2011, MED ENG PHYS, V33, P1127, DOI 10.1016/j.medengphy.2011.05.002; Grafton ST, 2019, MED DEVICES-EVID RES, V12, P151, DOI 10.2147/MDER.S205357; Hajiaghamemar M, 2020, J BIOMECH ENG-T ASME, V142, DOI 10.1115/1.4046393; Hauenstein A., P IEEE EMBS 2019 INT; Hebert Jeffrey R, 2017, Int J MS Care, V19, P151, DOI 10.7224/1537-2073.2016-027; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell David R, 2018, Concussion, V3, pCNC54, DOI 10.2217/cnc-2017-0014; Jacob L, 2021, J HEAD TRAUMA REHAB, V36, pE139, DOI 10.1097/HTR.0000000000000624; Jacquin A, 2018, COMPUT BIOL MED, V102, P95, DOI 10.1016/j.compbiomed.2018.09.011; Jung Y, 2018, J NONPARAMETR STAT, V30, P197, DOI 10.1080/10485252.2017.1404598; Kanekar N, 2014, J NEUROSCI METH, V222, P91, DOI 10.1016/j.jneumeth.2013.10.020; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Keith J., 2019, J PEDIAT NEUROPSYCHO, V5, P177, DOI [10.1007/s40817-019-00075-1, DOI 10.1007/S40817-019-00075-1]; Kelly JC, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/371970; Khezrian M, 2017, GERIATRICS-BASEL, V2, DOI 10.3390/geriatrics2040036; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; Kolev OI, 2016, FUNCT NEUROL, V31, P75; Kouli A., 2018, PARKINSONS DIS PATHO, DOI [DOI 10.15586/CODONPUBLICATIONS.PARKINSONSDISEASE.2018.CH1, 10.17305/bjbms.2020.5181]; Landry AP, 2019, J NEUROSURG, V131, P1235, DOI 10.3171/2018.6.JNS18607; Lin IS, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0564-2; Lundberg SM, 2017, ADV NEUR IN, V30; Lynch SG, 2005, MULT SCLER J, V11, P469, DOI 10.1191/1352458505ms1182oa; Mang CS, 2019, J NEUROTRAUM, V36, P308, DOI 10.1089/neu.2017.5587; Mann A, 2017, CAN FAM PHYSICIAN, V63, P460; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McKee AC, 2020, SEMIN NEUROL, V40, P359, DOI 10.1055/s-0040-1713632; McNerney MW, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0187-y; Meier TB, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6471; Moe-Nilssen R, 1998, CLIN BIOMECH, V13, P320, DOI 10.1016/S0268-0033(98)00089-8; Nazarahari M, 2018, MED ENG PHYS, V57, P75, DOI 10.1016/j.medengphy.2018.04.008; Oba N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140235; Paraschiv-Ionescu A, 2004, GAIT POSTURE, V20, P113, DOI 10.1016/j.gaitpost.2003.07.005; Paszke A., 2017, P NIPS WORKSH; Peacock WF, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00641; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Radoi A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212541; Ralston JD, 2020, MED DEVICES-EVID RES, V13, P411, DOI 10.2147/MDER.S279521; Rand D, 2009, STROKE, V40, P163, DOI 10.1161/STROKEAHA.108.523621; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Rooks T.F., P ASME INT MECH ENG, DOI [10.1115/IMECE2019-12173, DOI 10.1115/IMECE2019-12173]; Rowe BH, 2018, AM J EMERG MED, V36, P2144, DOI 10.1016/j.ajem.2018.03.040; Schmid W, 2021, J NEURAL ENG, V18, DOI 10.1088/1741-2552/ac1982; Schrader Harald, 2009, BMC Med Imaging, V9, P11, DOI 10.1186/1471-2342-9-11; Schwab N, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0822-3; Shim VB, 2020, IEEE ACCESS, V8, P179457, DOI 10.1109/ACCESS.2020.3026350; Subhash S, 2020, 2020 IEEE SYMPOSIUM SERIES ON COMPUTATIONAL INTELLIGENCE (SSCI), P513, DOI 10.1109/SSCI47803.2020.9308473; Sutliff MH, 2010, CURR MED RES OPIN, V26, P109, DOI 10.1185/03007990903433528; Talkar T., 2020, P INTERSPEECH 2020 S, V2020, P135, DOI [10.21437/Interspeech.2020-2651, DOI 10.21437/INTERSPEECH.2020-2651]; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Vellinga MM, 2009, J MAGN RESON IMAGING, V29, P768, DOI 10.1002/jmri.21679; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Vienne-Jumeau A, 2020, ANN PHYS REHABIL MED, V63, P138, DOI 10.1016/j.rehab.2019.07.004; Visscher RMS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214525; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wile DJ, 2014, J NEUROSCI METH, V230, P1, DOI 10.1016/j.jneumeth.2014.04.021; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Yaramothu C, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9100257; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	92	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	NOV	2021	21	21							7417	10.3390/s21217417			21	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	WX5JX	WOS:000718633200001	34770729	gold, Green Published			2022-02-06	
J	Howell, DR; Potter, MN; Provance, AJ; Wilson, PE; Kirkwood, MW; Wilson, JC				Howell, David R.; Potter, Morgan N.; Provance, Aaron J.; Wilson, Pamela E.; Kirkwood, Michael W.; Wilson, Julie C.			Sleep Problems and Melatonin Prescription After Concussion Among Youth Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						pediatric concussion; mild traumatic brain injury; sleep disruption; melatonin; recovery	MANAGEMENT; SYMPTOMS; CHILDREN	Objectives: To examine the effect of sleep disturbances on concussion symptom recovery and to examine the effect of melatonin prescription on symptom improvement among concussed adolescents with sleep problems. Design: Longitudinal test-retest. Setting: Sports medicine clinic. Participants: Patients aged 8 to 18 years, diagnosed with a concussion, evaluated within 14 days after injury, and evaluated again 15 to 35 days after injury. Independent Variables: We grouped patients based on whether they reported sleep disturbances within 14 days of injury. Main Outcome Measures: Outcome measures included symptom severity, headache severity, melatonin prescription, and the change in symptom severity between visits. Results: Two hundred twenty-five patients were included: 36% who reported sleep problems (44% female; age = 14.4 +/- 2.0 years; evaluated 7.3 +/- 3.8 and 23.2 +/- 5.4 days after injury) and 64% who did not (32% female; age = 14.6 +/- 2.3 years; evaluated 7.2 +/- 3.4 and 23.0 +/- 5.3 days after injury). Those with sleep problems reported higher symptom severity than those without across the 2 visits (22.1 +/- 14.3 vs 14.6 +/- 12.5; P < 0.001). There was no significant difference in the change in symptom severity between visits among those who received [median = 9-point improvement; interquartile range (IQR) = 1-14] and did not (median = 9, IQR = 2-18) receive a melatonin prescription (P = 0.80). Conclusions: Sleep problems among pediatric patients within 2 weeks of concussion are associated with more severe symptoms. Melatonin prescription was not associated with faster symptom recovery.	[Howell, David R.; Potter, Morgan N.; Provance, Aaron J.; Wilson, Julie C.] Childrens Hosp Colorado, Sports Med Ctr, 13123 E 16th Ave,B060, Aurora, CO 80045 USA; [Howell, David R.; Potter, Morgan N.; Provance, Aaron J.; Wilson, Julie C.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO USA; [Wilson, Pamela E.; Kirkwood, Michael W.] Univ Colorado, Dept Phys Med & Rehabil, Sch Med, Aurora, CO USA; [Wilson, Pamela E.; Kirkwood, Michael W.] Childrens Hosp Colorado, Rehabil Med, Aurora, CO USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, 13123 E 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu			Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurological Disorders And StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100952, R41NS103698]	We appreciate the assistance of Gerald Clayton, PhD and Jacqueline Murray, RN, PhD, who helped develop and implement the concussion clinical registry. D. R. Howell receives research support not related to this study from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R03HD094560), the National Institute of Neurological Disorders And Stroke (R01NS100952 and R41NS103698).	Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Beebe DW, 2018, CLIN J SPORT MED, V28, P395, DOI 10.1097/JSM.0000000000000454; Berger Ivona, 2017, Glob Pediatr Health, V4, p2333794X17745973, DOI 10.1177/2333794X17745973; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Elbin RJ, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0320-7; Gozel D., 2005, PRINCIPLES PRACTICES, P27; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hoffman NL, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy222; Hoffman NL, 2020, CLIN J SPORT MED, V30, pS29, DOI 10.1097/JSM.0000000000000538; Howell DR, 2019, J CHILD NEUROL, V34, P256, DOI 10.1177/0883073818824000; Howell DR, 2018, GAIT POSTURE, V62, P291, DOI 10.1016/j.gaitpost.2018.03.038; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Stache S, 2016, CLIN J SPORT MED, V26, P381, DOI 10.1097/JSM.0000000000000270; Sufrinko AM, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000387; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P426, DOI 10.1080/23279095.2016.1172229; UNDERWOOD H, 1987, Journal of Biological Rhythms, V2, P279, DOI 10.1177/074873048700200404; Worster A, 2004, ACAD EMERG MED, V11, P187, DOI 10.1197/j.aem.2003.03.002	22	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2021	31	6					475	480		10.1097/JSM.0000000000000803			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WM5NJ	WOS:000711131700030	33055498				2022-02-06	
J	Hsu, FY; Mao, SH; Chuang, ADC; Wong, YC; Chen, CH				Hsu, Fang-Yu; Mao, Shih-Hsuan; Chuang, Andy Deng-Chi; Wong, Yon-Cheong; Chen, Chih-Hao			Shock Index as a Predictor for Angiographic Hemostasis in Life-Threatening Traumatic Oronasal Bleeding	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic oronasal bleeding; transarterial embolization; craniofacial trauma; shock index; systolic blood pressure; heart rate	FACIAL FRACTURE PATIENTS; TRANSARTERIAL EMBOLIZATION; MAXILLOFACIAL INJURIES; MASSIVE HEMORRHAGE; BRAIN-INJURY; MANAGEMENT; TRANSFUSION; EXTRAVASATION; COAGULOPATHY; MORTALITY	The objective of this retrospective study was to identify predictors of angiographic hemostasis among patients with life-threatening traumatic oronasal bleeding (ONB) and determine the threshold for timely referral or intervention. The diagnosis of traumatic, life-threatening ONB was made if the patient suffered from craniofacial trauma presenting at triage with unstable hemodynamics or required a definitive airway due to ONB, without other major bleeding identified. There were 4404 craniofacial trauma patients between January 2015 and December 2019, of which 72 (1.6%) fulfilled the diagnosis of traumatic life-threatening ONB. Of these patients, 39 (54.2%) received trans-arterial embolization (TAE), 11 (15.3%) were treated with other methods, and 22 (30.5%) were excluded. Motor vehicle accidents were the most common cause of life-threatening ONB (52%), and the internal maxillary artery was the most commonly identified hemorrhaging artery requiring embolization (84%). Shock index (SI) was significantly higher in the angiographic hemostasis group (p < 0.001). The AUC-ROC was 0.87 (95% CI, 0.88-1.00) for SI to predict angiographic hemostasis. Early recognition and timely intervention are crucial in post-traumatic, life-threatening ONB management. Patients initially presenting with SI > 0.95 were more likely to receive TAE, with the TAE group having statistically higher SI than the non-TAE group whilst receiving significantly more packed red blood cells. Hence, for patients presenting with life-threatening traumatic ONB and a SI > 0.95, TAE should be considered if preliminary attempts at hemostasis have failed.	[Hsu, Fang-Yu; Mao, Shih-Hsuan; Chen, Chih-Hao] Chang Gung Univ, Craniofacial Res Ctr, Taoyuan 333, Taiwan; [Hsu, Fang-Yu; Mao, Shih-Hsuan; Chen, Chih-Hao] Chang Gung Univ, Dept Plast & Reconstruct Surg, Chang Gung Mem Hosp Linkou, Coll Med, Taoyuan 333, Taiwan; [Chuang, Andy Deng-Chi; Chen, Chih-Hao] Chang Gung Mem Hosp Keelung, Dept Plast & Reconstruct Surg, Keelung 204, Taiwan; [Wong, Yon-Cheong] Chang Gung Mem Hosp Linkou, Coll Med, Dept Diagnost Radiol, Taoyuan 333, Taiwan		Chen, CH (corresponding author), Chang Gung Univ, Craniofacial Res Ctr, Taoyuan 333, Taiwan.; Chen, CH (corresponding author), Chang Gung Univ, Dept Plast & Reconstruct Surg, Chang Gung Mem Hosp Linkou, Coll Med, Taoyuan 333, Taiwan.; Chen, CH (corresponding author), Chang Gung Mem Hosp Keelung, Dept Plast & Reconstruct Surg, Keelung 204, Taiwan.	ycwong@cgmh.org.tw	Wong, Yon Cheong/F-8411-2010	Wong, Yon Cheong/0000-0001-8831-3295; Chen, Chih-Hao/0000-0001-7213-2596; Chuang, Andy Deng-Chi/0000-0002-0035-6723			Bachar G, 2013, LARYNGOSCOPE, V123, P1220, DOI 10.1002/lary.23996; Birkhahn RH, 2005, AM J EMERG MED, V23, P323, DOI 10.1016/j.ajem.2005.02.029; Bohm JK, 2021, NEUROCRIT CARE, V35, P184, DOI 10.1007/s12028-020-01151-7; Bouloux GF, 2009, J ORAL MAXIL SURG, V67, P1547, DOI 10.1016/j.joms.2009.03.014; Bynoe RP, 2003, J TRAUMA, V55, P74, DOI 10.1097/01.TA.0000026494.22774.A0; Chang R, 2019, J TRAUMA ACUTE CARE, V87, P342, DOI 10.1097/TA.0000000000002263; Chen YL, 2012, J CHIN MED ASSOC, V75, P376, DOI 10.1016/j.jcma.2012.06.005; Christie SA, 2017, J TRAUMA ACUTE CARE, V82, P1055, DOI 10.1097/TA.0000000000001423; Cogbill TH, 2008, J TRAUMA, V65, P994, DOI 10.1097/TA.0b013e318184ce12; Cole E, 2021, ANN SURG, V273, P1215, DOI 10.1097/SLA.0000000000003657; Dean NR, 2009, PLAST RECONSTR SURG, V123, P680, DOI 10.1097/PRS.0b013e31819565da; DeMuro JP, 2013, AM J EMERG MED, V31, P1260, DOI 10.1016/j.ajem.2013.05.027; Dubel GJ, 2013, SEMIN INTERVENT RAD, V30, P249, DOI 10.1055/s-0033-1353478; Ho K, 2006, J PLAST RECONSTR AES, V59, P1257, DOI 10.1016/j.bjps.2005.12.044; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Khanna S, 2012, ANN PLAS SURG, V69, P474, DOI 10.1097/SAP.0b013e31824a2171; Komiyama M, 1998, J TRAUMA, V44, P330, DOI 10.1097/00005373-199802000-00017; Kornblith LZ, 2019, J THROMB HAEMOST, V17, P852, DOI 10.1111/jth.14450; Kuo LW, 2016, INJURY, V47, P37, DOI 10.1016/j.injury.2015.07.043; Lai WH, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040357; Lee YH, 2014, CLIN RADIOL, V69, pE505, DOI 10.1016/j.crad.2014.08.013; Leyon JJ, 2014, CURR PROBL DIAGN RAD, V43, P35, DOI 10.1067/j.cpradiol.2013.10.003; Liao CC, 2008, INJURY, V39, P507, DOI 10.1016/j.injury.2007.07.020; Liao CC, 2007, J TRAUMA, V63, P827, DOI 10.1097/TA.0b013e31814b9466; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Malone DL, 2003, J TRAUMA, V54, P898, DOI 10.1097/01.TA.0000060261.10597.5C; Moore EE, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00264-3; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12851; Nakasone Y, 2007, CARDIOVASC INTER RAD, V30, P861, DOI 10.1007/s00270-007-9131-5; Perry M, 2005, INJURY, V36, P875, DOI 10.1016/j.injury.2004.09.018; Rau CS, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070683; Salsamendi Jason T, 2017, Radiol Case Rep, V12, P87, DOI 10.1016/j.radcr.2016.10.013; Scaramuzzi N, 2001, CLIN OTOLARYNGOL, V26, P307, DOI 10.1046/j.1365-2273.2001.00476.x; Shimoyama T, 2003, J TRAUMA, V54, P332, DOI 10.1097/01.TA.0000037097.23729.1F; Singam P, 2011, Biomed Imaging Interv J, V7, pe3, DOI 10.2349/biij.7.1.e3; Soyka MB, 2011, RHINOLOGY, V49, P474, DOI 10.4193/Rhino10.313; Tawfik KO, 2018, ANN OTO RHINOL LARYN, V127, P344, DOI 10.1177/0003489418761456; Tung TC, 2000, J TRAUMA, V49, P420, DOI 10.1097/00005373-200009000-00006; Vaidya Sandeep, 2008, Semin Intervent Radiol, V25, P204, DOI 10.1055/s-0028-1085930; Vandromme MJ, 2011, AM SURGEON, V77, P155; Willems PWA, 2009, AM J NEURORADIOL, V30, P1637, DOI 10.3174/ajnr.A1607; Wiratama BS, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18062998; Wu SC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112346; Wu SC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102285; Zou ZM, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02192-1	46	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2021	18	21							11051	10.3390/ijerph182111051			12	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	WY1LD	WOS:000719045600001	34769572	Green Published, gold			2022-02-06	
J	Huang, SL; Shen, Q; Watts, LT; Long, JSA; O'Boyle, M; Nguyen, T; Muir, E; Duong, TQ				Huang, Shiliang; Shen, Qiang; Watts, Lora Talley; Long, Justin A.; O'Boyle, Michael; Nguyen, Tony; Muir, Eric; Duong, Timothy Q.			Resting-State Functional Magnetic Resonance Imaging of Interhemispheric Functional Connectivity in Experimental Traumatic Brain Injury	NEUROTRAUMA REPORTS			English	Article						animal studies; behavior; MRI; recovery; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; BLOOD-FLOW; RECOVERY; NETWORK; MILD; REORGANIZATION; STROKE; RATS; MRI; BEHAVIOR	Although resting-state functional magnetic resonance imaging (rsfMRI) has the potential to offer insights into changes in functional connectivity networks after traumatic brain injury (TBI), there are few studies that examine the effects of moderate TBI for monitoring functional recovery in experimental TBI, and thus the neural correlates of brain recovery from moderate TBI remain incompletely understood. Non-invasive rsfMRI was used to longitudinally investigate changes in interhemispheric functional connectivity (IFC) after a moderate TBI to the unilateral sensorimotor cortex in rats (n = 9) up to 14 days. Independent component analysis of the rsfMRI data was performed. Correlations of rsfMRI sensorimotor networks were made with changes in behavioral scores, lesion volume, and T-2- and diffusion-weighted images across time. TBI animals showed less localized rsfMRI patterns in the sensorimotor network compared to sham (n = 6) and normal (n = 5) animals. rsfMRI clusters in the sensorimotor network showed less bilateral symmetry compared to sham and normal animals, indicative of IFC disruption. With time after injury, many of the rsfMRI patterns in the sensorimotor network showed more bilateral symmetry, indicative of IFC recovery. The disrupted IFC in the sensorimotor and subsequent partial recovery showed a positive correlation with changes in behavioral scores. Overall, rsfMRI detected widespread disruption and subsequent recovery of IFC within the sensorimotor networks post-TBI, which correlated with behavioral changes. Therefore, rsfMRI offers the means to probe functional brain reorganization and thus has the potential to serve as an imaging marker to longitudinally stage TBI and monitor for novel treatments.	[Huang, Shiliang; Shen, Qiang; Long, Justin A.; O'Boyle, Michael] UT Hlth San Antonio, Res Imaging Inst, San Antonio, TX USA; [Shen, Qiang] UT Hlth San Antonio, Dept Radiol, San Antonio, TX USA; [Watts, Lora Talley] Univ Incarnate Word, Sch Osteopath Med, Dept Clin & Appl Sci Educ, San Antonio, TX USA; [Nguyen, Tony; Duong, Timothy Q.] Montefiore Med Ctr, Dept Radiol, 111 East 210th St, Bronx, NY 10461 USA; [Nguyen, Tony; Duong, Timothy Q.] Albert Einstein Coll Med, 111 East 210th St, Bronx, NY 10461 USA; [Muir, Eric] Stony Brook Med, Dept Radiol, Stony Brook, NY USA		Duong, TQ (corresponding author), Montefiore Med Ctr, Dept Radiol, 111 East 210th St, Bronx, NY 10461 USA.; Duong, TQ (corresponding author), Albert Einstein Coll Med, 111 East 210th St, Bronx, NY 10461 USA.	tim.duong@einsteinmed.org			NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS45879]; Clinical Translational Science Award Pilot Grant [UL1TR000149]; Translational Technology Resource [KL2 TR001118]; National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health	This work was supported, in part, by the Stanley Glickman endowment, NIH/NINDS (R01-NS45879), a Clinical Translational Science Award Pilot Grant, a Translational Technology Resource grant (parent grant UL1TR000149), and by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2 TR001118.	ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal B., 1993, P SMRM 12 ANN SCI M; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dancause N, 2006, NEUROSCIENTIST, V12, P489, DOI 10.1177/1073858406292782; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510, DOI 10.1523/JNEUROSCI.23-02-00510.2003; Dougan L, 2011, P NATL ACAD SCI USA, V108, P9759, DOI [10.1073/pnas.1200506109, 10.1073/pnas.1101934108]; Forcione M, 2020, J CEREBR BLOOD F MET, V40, P1586, DOI 10.1177/0271678X20921973; Guilfoyle DN, 2013, J NEUROSCI METH, V214, P144, DOI 10.1016/j.jneumeth.2013.01.019; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Heffernan ME, 2013, J NEUROTRAUM, V30, P1007, DOI 10.1089/neu.2012.2366; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hutchison RM, 2014, HUM BRAIN MAPP, V35, P5754, DOI 10.1002/hbm.22583; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kulkarni P, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00034; Liu XA, 2011, CEREB CORTEX, V21, P374, DOI 10.1093/cercor/bhq105; Long JA, 2015, J CEREBR BLOOD F MET, V35, P1852, DOI 10.1038/jcbfm.2015.143; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Nudo RJ, 1999, CURR OPIN NEUROBIOL, V9, P740, DOI 10.1016/S0959-4388(99)00027-6; Paasonen J, 2018, NEUROIMAGE, V172, P9, DOI 10.1016/j.neuroimage.2018.01.014; Petrinovic MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24523; Rogers DC, 1997, STROKE, V28, P2060, DOI 10.1161/01.STR.28.10.2060; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shen Q, 2005, J CEREBR BLOOD F MET, V25, P1265, DOI 10.1038/sj.jcbfm.9600132; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sicard K, 2003, J CEREBR BLOOD F MET, V23, P472, DOI 10.1097/01.WCB.0000054755.93668.20; Sicard KM, 2006, J CEREBR BLOOD F MET, V26, P1451, DOI 10.1038/sj.jcbfm.9600299; Sicard KM, 2005, NEUROIMAGE, V25, P850, DOI 10.1016/j.neuroimage.2004.12.010; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; van Meer MPA, 2012, J NEUROSCI, V32, P4495, DOI 10.1523/JNEUROSCI.3662-11.2012; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Wu TL, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.591; Yamamoto S, 2018, CURR OPIN NEUROL, V31, P672, DOI 10.1097/WCO.0000000000000624	43	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	NOV 1	2021	2	1					526	540		10.1089/neur.2021.0023			15	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	XI3SU	WOS:000726036600001	34901946	Green Published, gold			2022-02-06	
J	Ishii, W; Hitosugi, M; Baba, M; Kandori, K; Arai, Y				Ishii, Wataru; Hitosugi, Masahito; Baba, Mineko; Kandori, Kenji; Arai, Yusuke			Factors Affecting Death and Severe Injury in Child Motor Vehicle Passengers	HEALTHCARE			English	Article						child; motor vehicle passenger; traffic accident; Japan Trauma Data Bank	TRAUMATIC BRAIN-INJURY; RESTRAINT USE; SEATING POSITION; UNITED-STATES; OUTCOMES; ADULT; MORTALITY; CRASHES; IMPACT	Saving children from motor vehicle collisions is a high priority because the injury rate among motor vehicle passengers has been increasing in Japan. This study aimed to examine the factors that influence death and serious injury in child motor vehicle passengers to establish effective preventive measures. To identify these factors, we performed a retrospective study using a nationwide medical database. The data of child motor vehicle passengers younger than 15 years (n = 1084) were obtained from the Japanese Trauma Data Bank, registered from 2004 to 2019. Physiological variables, outcomes, and injury severity were compared between fatal and non-fatal patients and between those with and without severe injuries. Multivariate logistic regression analysis was performed to determine factors affecting fatality and severe injury. The Glasgow Coma Scale score (odds ratio (OR): 1.964), body temperature (OR: 2.578), and the Abbreviated Injury Scale score of the head (OR: 0.287) were identified as independent predictors of a non-fatal outcome. Systolic blood pressure (OR: 1.012), the Glasgow Coma Scale score (OR: 0.705), and Focused Assessment with Sonography for Trauma positivity (OR: 3.236) were identified as independent predictors of having severe injury. Decreasing the severity of head injury is the highest priority for child motor vehicle passengers to prevent fatality and severe injury.	[Ishii, Wataru; Kandori, Kenji; Arai, Yusuke] Kyoto Daini Red Cross Hosp, Crit Care Ctr, Emergency Med, Kamazamarutamachi, Kyoto 6028026, Japan; [Hitosugi, Masahito] Shiga Univ Med Sci, Dept Legal Med, Otsu, Shiga 5202192, Japan; [Baba, Mineko] Keio Univ, Ctr Integrated Med Res, Sch Med, Tokyo 1608582, Japan		Ishii, W (corresponding author), Kyoto Daini Red Cross Hosp, Crit Care Ctr, Emergency Med, Kamazamarutamachi, Kyoto 6028026, Japan.	wataruaug0804@lily.ocn.ne.jp; hitosugi@belle.shiga-med.ac.jp; mineko@keio.jp; knj.kandori@gmail.com; sndlwd_1@yahoo.co.jp		Kandori, Kenji/0000-0003-0026-7437; Hitosugi, Masahito/0000-0001-5243-8766			Abe T., JAPAN TRAUMA DATE BA; Alonso F., 2017, AM J ED RES, V5, P273, DOI [10.12691/education-5-3-7, DOI 10.12691/EDUCATION-5-3-7]; Berg MD, 2000, PEDIATRICS, V105, P831, DOI 10.1542/peds.105.4.831; Boufous S, 2008, J SAFETY RES, V39, P65, DOI 10.1016/j.jsr.2007.10.010; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cabinet Office Government of Japan, BAS TRAFF SAF PLAN; Cabinet Office Government of Japan, BAS TRAFF SAF PLAN; Casado-Sanz N, 2019, RES TRANSP BUS MANAG, V30, DOI 10.1016/j.rtbm.2019.100377; Centers for Disease Control and Prevention, INJURY PREVENTION CO; Chang LY, 2006, ACCIDENT ANAL PREV, V38, P1019, DOI 10.1016/j.aap.2006.04.009; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Dulf D, 2020, INJURY PREV, V26, P18, DOI 10.1136/injuryprev-2018-042989; Durbin DR, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-2461; Durbin DR, 2001, PEDIATR EMERG CARE, V17, P474, DOI 10.1097/00006565-200112000-00021; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Evans SL, 2009, J TRAUMA, V66, P504, DOI 10.1097/TA.0b013e318166d295; GHAJAR J, 1992, PEDIATR CLIN N AM, V39, P1093; Hondo K, 2013, J AM COLL SURGEONS, V217, P850, DOI 10.1016/j.jamcollsurg.2013.05.026; Ishii W, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60222-z; Japan Trauma Care and Research, JAP TRAUM DAT; Japan Trauma Care and Research, JAP TRAUM DAT BANK A; Kashani Ali Tavakoli, 2012, J Inj Violence Res, V4, P36, DOI 10.5249/jivr.v4i1.67; Kojima M, 2019, ANN EMERG MED, V73, P281, DOI 10.1016/j.annemergmed.2018.09.034; Lennon A, 2008, ACCIDENT ANAL PREV, V40, P829, DOI 10.1016/j.aap.2007.09.024; Lichte P, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0159-8; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Ministry of Health, LAB WELF; Mitchell RJ, 2018, INJURY PREV, V24, P344, DOI 10.1136/injuryprev-2017-042451; Mitchell RJ, 2013, INJURY, V44, P97, DOI 10.1016/j.injury.2011.11.012; Moore L, 2015, WORLD J SURG, V39, P1397, DOI 10.1007/s00268-015-2977-9; Nagata I, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018635; Nahmani M, 2014, NEUROSCIENCE, V283, P4, DOI 10.1016/j.neuroscience.2014.04.029; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Purcell LN, 2020, WORLD NEUROSURG, V137, pE597, DOI 10.1016/j.wneu.2020.02.062; Sauber-Schatz EK, 2015, MMWR SURVEILL SUMM, V64, P1, DOI 10.15585/mmwr.ss6408a1; Sauber-Schatz EK, 2014, MMWR-MORBID MORTAL W, V63, P113; Sophie Su Y, 2016, TRANSLATIONAL RES TR; Takahashi H, 2018, INT J INJ CONTROL SA, V25, P427, DOI 10.1080/17457300.2018.1456469; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tesfay K, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7100-y; Tiwari G, 2020, INT J INJ CONTROL SA, V27, P35, DOI 10.1080/17457300.2020.1720255; Toida C, 2020, J CLIN MED, V9, DOI 10.3390/jcm9103273; World Health Organization, 2006, NEUR DIS PUBL HLTH C, P164; Yan Xuedong, 2006, Traffic Inj Prev, V7, P276, DOI 10.1080/15389580600660062; Yumoto T, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0341-1; Zeedyk MS, 2001, BRIT J EDUC PSYCHOL, V71, P573, DOI 10.1348/000709901158686	46	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9032		HEALTHCARE-BASEL	Healthcare	NOV	2021	9	11							1431	10.3390/healthcare9111431			10	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	XH6FZ	WOS:000725529300001	34828478	gold, Green Published			2022-02-06	
J	Iverson, GL; Cook, NE; Gilman, IG; Maxwell, B; Mannix, R; Zafonte, R; Berkner, PD; Brooks, BL				Iverson, Grant L.; Cook, Nathan E.; Gilman, Isabelle G.; Maxwell, Bruce; Mannix, Rebekah; Zafonte, Ross; Berkner, Paul D.; Brooks, Brian L.			Multiple Past Concussions in High School Hockey Players: Examining Cognitive Functioning and Symptom Reporting	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						child; adolescent; traumatic brain injury; sports; cumulative	SPORTS-RELATED CONCUSSION; COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; RECOVERY-TIME; PREDICTORS; ATTENTION; HEAD; EPIDEMIOLOGY; ADOLESCENTS; HISTORY	Objective: To investigate (1) if there are meaningful differences in baseline preseason cognitive functioning or symptom reporting between high school ice hockey players with and without prior concussions and (2) determine which health history variables predict symptom reporting. Design: Cross-sectional study. Setting: High schools across the state of Maine. Participants: Participants were 1616 male high school ice hockey players (mean age = 15.6 years; SD = 1.5 years) who completed baseline testing between 2009 and 2015. Independent Variables: Athletes were grouped according to their self-reported concussion history [0 (n = 1136), 1 (n = 321), 2 (n = 112), or 3+ (n = 47) previous concussions]. Main Outcome Measures: Cognitive functioning was measured by the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) battery, and symptom ratings were obtained from the Post-Concussion Symptom Scale. Results: There were no statistically significant differences between groups in cognitive functioning as measured by ImPACT. The group with >= 3 prior concussions endorsed higher total symptom scores, but the effect sizes were small and not statistically significant. In a multivariate model, prior treatment for headaches (not necessarily migraines), prior treatment for a psychiatric condition, and prior treatment for substance/alcohol use all significantly predicted total symptom scores, with concussion history being the weakest independent predictor. Conclusions: Players with a history of prior concussions performed similarly to players with no prior concussions on cognitive testing. Health history factors were more strongly associated with symptom reporting than concussion history.	[Iverson, Grant L.; Cook, Nathan E.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.; Cook, Nathan E.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.; Cook, Nathan E.] Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.] Red Sox Fdn, Home Base, Charlestown, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Charlestown, MA USA; [Iverson, Grant L.; Cook, Nathan E.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Gilman, Isabelle G.] Villanova Univ, Dept Psychol & Brain Sci, Villanova, PA 19085 USA; [Maxwell, Bruce] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA; [Mannix, Rebekah] Boston Childrens Hosp, Brain Injury Ctr, Div Emergency Med, Boston, MA USA; [Zafonte, Ross] Harvard Med Sch, Massachusetts Gen Hosp, Brigham & Womens Hosp, Spaulding Rehabil Hosp,Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Berkner, Paul D.] Colby Coll, Hlth Serv, Waterville, ME 04901 USA; [Berkner, Paul D.] Colby Coll, Dept Biol, Waterville, ME 04901 USA; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada		Iverson, GL (corresponding author), Harvard Med Sch, Ctr Hlth & Rehabil Res, Dept Phys Med & Rehabil, 79-96,13th St, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu			ImPACT Applications, Inc; Mooney-Reed Charitable Foundation; Heinz Family Foundation; Spaulding Research Institute; Maine Concussion Management Initiative from the Goldfarb Center for Public Policy and Civic Engagement/Colby College; Bill and Joan Alfond Foundation; Boston Bolts; Canadian Institutes of Health Research Embedded Clinician Research AwardCanadian Institutes of Health Research (CIHR); CNS Vital Signs; Psychological Assessment Resources (PAR, Inc)	G.L. Iverson acknowledges unrestricted philanthropic support from ImPACT Applications, Inc, the Mooney-Reed Charitable Foundation, Boston Bolts, Heinz Family Foundation, and Spaulding Research Institute. P.D. Berkner acknowledges funding for the Maine Concussion Management Initiative from the Goldfarb Center for Public Policy and Civic Engagement/Colby College and the Bill and Joan Alfond Foundation. B.L. Brooks is a principal investigator, coinvestigator, or collaborator on several grants relating to the study of mild traumatic brain injury (TBI)/concussion in youth. He acknowledges salary support from the Canadian Institutes of Health Research Embedded Clinician Research Award. He receives royalties for the sales of the Pediatric Forensic Neuropsychology textbook (2012, Oxford University Press) and pediatric neuropsychological tests [Child and Adolescent Memory Profile (Sherman and Brooks, 2015, PAR Inc), Memory Validity Profile (Sherman and Brooks, 2015, PAR Inc), and Multidimensional Everyday Memory Ratings for Youth (Sherman and Brooks, 2017, PAR Inc)]. He has previously received in-kind support (free test credits) from a different computerized cognitive test publisher (CNS Vital Signs, Chapel Hill, North Carolina). G.L. Iverson has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild TBI and sport-related concussion at meetings, scientific conferences, and symposiums. He has a clinical and consulting practice in forensic neuropsychology involving individuals who have sustained mild TBIs (including athletes). He has received research funding from several test publishing companies, including ImPACT Applications, Inc, CNS Vital Signs, and Psychological Assessment Resources (PAR, Inc). He serves as a scientific advisor for Sway Operations, LLC, Highmark, Inc, and BioDirection, Inc. R. Zafonte and G.L. Iverson have received salary support from the Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members. R. Zafonte acknowledges unrestricted philanthropic support from the Heinz Family Foundation. R. Zafonte serves on the Scientific Advisory Board of Myomo, Oxeia Pharma, and ElMInda. None of the authors nor their family members have a commercial or proprietary interest in ImPACT. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work. The remaining authors report no conflicts of interest.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Brook EM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117714445; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.3.CO;2-D; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Churchill NW, 2018, NEUROIMAGE-CLIN, V18, P518, DOI 10.1016/j.nicl.2018.02.011; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J, 1998, STAT POWER ANAL BEHA; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Cunningham J, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000356; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Ellis PD., 2018, EFFECT SIZE CALCULAT; Guay S, 2018, NEUROPSYCHOLOGIA, V108, P42, DOI 10.1016/j.neuropsychologia.2017.11.022; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hang B, 2015, PEDIATR EMERG CARE, V31, P688, DOI 10.1097/PEC.0000000000000438; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; ImPACT Applications Inc, 2011, IMM POSTC ASS COGN T; Iverson GL, 2016, J ATTEN DISORD; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Kerr ZY, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114544107; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lowe D., 2016, STATE WOMENS HOCKEY; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McDevitt J, 2015, BRAIN INJURY, V29, P1674, DOI 10.3109/02699052.2015.1075252; Mckay CD, 2014, J ORTHOP SPORT PHYS, V44, P329, DOI 10.2519/jospt.2014.5053; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Montgomery S, 2017, ANN NEUROL, V82, P554, DOI 10.1002/ana.25036; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Moore RD, 2016, BRAIN IMAGING BEHAV, V10, P1108, DOI 10.1007/s11682-015-9473-6; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Munia TTK, 2016, IEEE ENG MED BIO, P41, DOI 10.1109/EMBC.2016.7590635; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Reed N, 2010, INT J SPORTS MED, V31, P826, DOI 10.1055/s-0030-1263103; Rosene JM, 2017, AM J SPORT MED, V45, P2622, DOI 10.1177/0363546517710005; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Schmidt JD, 2018, PEDIATR NEUROL, V81, P19, DOI 10.1016/j.pediatrneurol.2017.12.017; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Simmons MM, 2017, J ATHL TRAINING, V52, P776, DOI 10.4085/1062-6050-52.4.03; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; USA Hockey, 2017, OFF RUL IC HOCK; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Wu T, 2018, BRAIN IMAGING BEHAV, V12, P962, DOI 10.1007/s11682-017-9752-5; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	63	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2021	31	6					E313	E320		10.1097/JSM.0000000000000806			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WM5NJ	WOS:000711131700003	32941379				2022-02-06	
J	Jaleel, MA; Zubeda, S; Grandhi, A; Hasan, Q				Jaleel, Momin Abdul; Zubeda, Syeda; Grandhi, Aditya; Hasan, Qurratulain			Role of Apolipoprotein E Gene variants in Cocnitive Outcome of Patients after Moderate Degree Diffuse Brain Injuries	JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH			English	Article						Genotyping; Mini mental status examination; Neurology; Polymorphism; Prognostic marker	APOE GENOTYPE; HEAD-INJURY; ALZHEIMERS-DISEASE; RECOVERY; POLYMORPHISM; ASSOCIATION; COMA	Introduction: Diffuse Brain Injury (DBI) has been shown to be the major form of the primary brain traumatic injury. Apolipoprotein E (APOE) is considered to be associated in the prognosis of DBI. Aim: To analyse change in cognitive outcome of moderate degree DBI patients and its association with APOE gene polymorphism. Materials and Methods: This prospective cohort study was conducted at the Department of Genetics and Molecular Medicine, Kamineni Hospitals. LB Nagar, Hyderabad, Telangana, India, from March 2018 to May 2019, in which 23 patients who had moderate DBI were included. Patients were genotyped for APOE polymorphism and intellectual function was assessed when the patient was being discharged using Mini Mental State Examination (MMSE) score and was repeated after three months. Wilcoxon Signed Rank Test was used to determine the change in MMSE score taken at the time of discharge and after three months in follow-up. Results: Of the total 23 patients, 19, 82.60% were males and 4, 17.40% were females. E2/E3 APOE genotype was present in 16, 69,56% subjects. The improvement of MMSE score at the end of three months following discharge showed that best recovery was in subjects with E2/E3 genotype with mean of 4.9 +/- 2.1, followed by E2/E2 i.e., 3.5 +/- 2.6. In order to evaluate the changes in MMSE score at the time of discharge and after three months due to the presence of APOE genotype E2/E3 a Wilcoxon Signed Rank Test was performed which revealed statistically significant positive change in MMSE score after three months, z=-3,512, p=0.00044, with a large effect size (r=0.620). Conclusion: This preliminary study indicated that APOE E2/E3 individuals showed a better recovery after traumatic brain injuries based on MMSE scores. However, extended studies are needed to establish this which may also give more weightage for genotyping APOE as a prognostic marker.	[Jaleel, Momin Abdul; Grandhi, Aditya] Kamineni Hosp, Dept Neurosurg, Hyderabad, Telangana, India; [Zubeda, Syeda; Hasan, Qurratulain] Kamineni Hosp, Dept Genet & Mol Med, Hyderabad, Telangana, India		Hasan, Q (corresponding author), Kamineni Hosp, Dept Genet & Mol Med, Hyderabad, Telangana, India.	qhasan2013@gmail.com			Kamineni Academy of Medical Sciences	Authors would like to thank Kamineni Academy of Medical Sciences for the financial support.	Achariyar TM, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0138-8; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Daram S, 2019, J CLIN DIAGN RES, V13, pGC1, DOI 10.7860/JCDR/2019/41564.13077; Flowers SA, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104724; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Johnson LW, 2020, BRAIN INJURY, V34, P1202, DOI 10.1080/02699052.2020.1795719; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Middleton PM, 2012, AUSTRALAS EMERG NURS, V15, P170, DOI 10.1016/j.aenj.2012.06.002; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Noe E, 2010, BRAIN INJURY, V24, P886, DOI 10.3109/02699051003724952; Pearce JMS, 2008, EUR NEUROL, V59, P113, DOI 10.1159/000111872; RALL SC, 1982, J BIOL CHEM, V257, P4171; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Shadli RM, 2011, BRAIN INJURY, V25, P596, DOI 10.3109/02699052.2011.572947; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Thathapudi S, 2014, GENET TEST MOL BIOMA, V18, P605, DOI 10.1089/gtmb.2014.0151; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Yue JK, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.791	34	0	0	0	0	PREMCHAND SHANTIDEVI RESEARCH FOUNDATION	DELHI	71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA	2249-782X	0973-709X		J CLIN DIAGN RES	J. Clin. Diagn. Res.	NOV	2021	15	11					GC01	GC04		10.7860/JCDR/2021/50680.15640			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	XA2IV	WOS:000720478400002		gold			2022-02-06	
J	Jang, SH; Bae, CH; Kim, JW; Kwon, HG				Jang, Sung-Ho; Bae, Chang-Hoon; Kim, Jae-Woon; Kwon, Hyeok-Gyu			Relationship between Dizziness and the Core Vestibular Projection Injury in Patients with Mild Traumatic Brain Injury	DIAGNOSTICS			English	Article						dizziness; core vestibular projection; vestibular nuclei; parieto-insular vestibular cortex; mild traumatic brain injury; diffusion tensor tractography	HEAD-INJURY; SYMPTOMS; VERTIGO; PREVALENCE; TRACTOGRAPHY; MODERATE; SYSTEM	Some studies have reported that a core vestibular projection (CVP) injury is associated with dizziness following a brain injury using diffusion tensor tractography (DTT). On the other hand, there has been no DTT study on dizziness caused by a CVP injury in patients with mild traumatic brain injury (TBI). In this study, DTT was used to examine the relationship between dizziness and CVP injury in patients with mild TBI. Forty-three patients with mild TBI and twenty-nine normal subjects were recruited. The patients were classified into two groups based on the dizziness score: group A, patients with a dizziness score less than 2 on the sub-item score for dizziness in the Rivermead Post-concussion Symptoms Questionnaire; group B, patients with a dizziness score above 2. The tract volume (TV) in group B was significantly lower than group A and the control group (p < 0.05). By contrast, the TV in group A was similar to the control group (p > 0.05). Regarding the correlation, the dizziness score of all patients showed a strong negative correlation with the TV of the CVP (r = -0.711, p < 0.05). DTT revealed the CVP injury in patients with dizziness after mild TBI. In addition, the severity of dizziness of these patients was closely related to the injury severity of the CVP.	[Jang, Sung-Ho] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Daegu 42415, South Korea; [Bae, Chang-Hoon] Yeungnam Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Daegu 42415, South Korea; [Kim, Jae-Woon] Yeungnam Univ, Dept Radiol, Coll Med, Daegu 42415, South Korea; [Kwon, Hyeok-Gyu] Eulji Univ, Coll Hlth Sci, Dept Phys Therapy, Sungnam Si 13135, South Korea		Kwon, HG (corresponding author), Eulji Univ, Coll Hlth Sci, Dept Phys Therapy, Sungnam Si 13135, South Korea.	strokerehab@hanmail.net; baich@med.yu.ac.kr; sungho1999@ynu.ac.kr; khg0715@hanmail.net			National Research Foundation of Korea (NRF) - Korean Government(MSIP) [2021R1A2B5B01001386]	FundingThis work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government(MSIP) (No. 2021R1A2B5B01001386).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Alshuhri MS, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.141159; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Barmack NH, 2003, BRAIN RES BULL, V60, P511, DOI 10.1016/S0361-9230(03)00055-8; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bergman K, 2013, J NEUROSCI NURS, V45, P124, DOI 10.1097/JNN.0b013e31828a418b; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., P567; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Endo K, 2006, EUR SPINE J, V15, P886, DOI 10.1007/s00586-005-0970-y; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Hitier M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00059; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hong CT, 2010, NEUROLOGY, V74, P437, DOI 10.1212/WNL.0b013e3181ccc746; Jang S.H., 2018, TRAUMATIC AXONAL INJ; Jonsson R, 2004, J VESTIBUL RES-EQUIL, V14, P47; Keser Z, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00041; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirsch V, 2016, BRAIN STRUCT FUNCT, V221, P1291, DOI 10.1007/s00429-014-0971-x; Kitchen P, 2020, CELL, V181, P784, DOI 10.1016/j.cell.2020.03.037; Kwon HG, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10040220; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Maskell F, 2007, BRAIN INJURY, V21, P741, DOI 10.1080/02699050701472109; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; Morris L., 2014, PHYS THERAPY MANAGEM; Pagani E, 2008, NEUROIMAGE, V41, P657, DOI 10.1016/j.neuroimage.2008.03.021; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Pfeiffer C, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00031; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Salman Mootaz M, 2021, Brain, DOI 10.1093/brain/awab311; Salman MM, 2021, NAT REV NEUROSCI, V22, P650, DOI 10.1038/s41583-021-00514-z; Salman MM, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.573775; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shinder ME, 2014, J NEUROPHYSIOL, V111, P2445, DOI 10.1152/jn.00731.2013; Siegner A, 2020, ENVIRON EDUC RES, V26, P511, DOI 10.1080/13504622.2019.1607258; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sylvain NJ, 2021, BBA-BIOMEMBRANES, V1863, DOI 10.1016/j.bbamem.2021.183573; Wijesinghe R, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00079; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yeo SS, 2020, BEHAV NEUROL, V2020, DOI 10.1155/2020/2825108; Yeo SS, 2018, NEUROSCI LETT, V665, P147, DOI 10.1016/j.neulet.2017.12.010; Yeo SS, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009349	50	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4418		DIAGNOSTICS	Diagnostics	NOV	2021	11	11							2070	10.3390/diagnostics11112070			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XG9NT	WOS:000725073300001	34829416	Green Published, gold			2022-02-06	
J	Jankovic, T; Dolenec, P; Bumber, JR; Grzeta, N; Kriz, J; Aupan, G; Pilipovic, K				Jankovic, Tamara; Dolenec, Petra; Rajic Bumber, Jelena; Grzeta, Nika; Kriz, Jasna; Zupan, Gordana; Pilipovic, Kristina			Differential Expression Patterns of TDP-43 in Single Moderate versus Repetitive Mild Traumatic Brain Injury in Mice	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						mice; microglia; NF-kappa B; postsynaptic density protein 95; traumatic brain injury; transactive response DNA-binding protein 43	FACTOR-KAPPA-B; AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN EXPRESSION; OXIDATIVE STRESS; MOUSE MODEL; HEAD-INJURY; BLOOD-FLOW; RAT MODEL; CASPASE 3; A-BETA	Traumatic brain injury (TBI) is a disabling disorder and a major cause of death and disability in the world. Both single and repetitive traumas affect the brain acutely but can also lead to chronic neurodegenerative changes. Clinical studies have shown some dissimilarities in transactive response DNA binding protein 43 (TDP-43) expression patterns following single versus repetitive TBI. We explored the acute cortical post-traumatic changes of TDP-43 using the lateral fluid percussion injury (LFPI) model of single moderate TBI in adult male mice and investigated the association of TDP-43 with post-traumatic neuroinflammation and synaptic plasticity. In the ipsilateral cortices of animals following LFPI, we found changes in the cytoplasmic and nuclear levels of TDP-43 and the decreased expression of postsynaptic protein 95 within the first 3 d post-injury. Subacute pathological changes of TDP-43 in the hippocampi of animals following LFPI and in mice exposed to repetitive mild TBI (rmTBI) were studied. Changes in the hippocampal TDP-43 expression patterns at 14 d following different brain trauma procedures showed pathological alterations only after single moderate, but not following rmTBI. Hippocampal LFPI-induced TDP-43 pathology was not accompanied by the microglial reaction, contrary to the findings after rmTBI, suggesting that different types of brain trauma may cause diverse pathophysiological changes in the brain, specifically related to the TDP-43 protein as well as to the microglial reaction. Taken together, our findings may contribute to a better understanding of the pathophysiological events following brain trauma.	[Jankovic, Tamara; Dolenec, Petra; Rajic Bumber, Jelena; Grzeta, Nika; Zupan, Gordana; Pilipovic, Kristina] Univ Rijeka, Dept Basic & Clin Pharmacol & Toxicol, Fac Med, Rijeka 51000, Croatia; [Kriz, Jasna] Univ Laval, Dept Psychiat & Neurosci, Fac Med, Quebec City, PQ G1V 0A6, Canada		Pilipovic, K (corresponding author), Univ Rijeka, Dept Basic & Clin Pharmacol & Toxicol, Fac Med, Rijeka 51000, Croatia.	tamara.jankovic@medri.uniri.hr; petra.dolenec@medri.uniri.hr; jelena.rajic@medri.uniri.hr; nika.grzeta@medri.uniri.hr; jasna.kriz@fmed.ulaval.ca; kristina.pilipovic@medri.uniri.hr	Pilipovic, Kristina/Q-5974-2018	Pilipovic, Kristina/0000-0002-7129-1621	University of Rijeka [uniribiomed-18-199]; Croatian Science Foundation [IP-2016-06-4602]	This research was equally funded by University of Rijeka, grant number project: uniribiomed-18-199 to K.P. and by the Croatian Science Foundation, grant number IP-2016-06-4602 to G.Z.	[Anonymous], 2012, LANCET NEUROL, V11, P651, DOI 10.1016/S1474-4422(12)70166-7; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bales KR, 1998, MOL BRAIN RES, V57, P63, DOI 10.1016/S0169-328X(98)00066-7; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Boersma MCH, 2011, J NEUROSCI, V31, P5414, DOI 10.1523/JNEUROSCI.2456-10.2011; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Brioschi S, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00149; Bumber JR, 2021, J NEUROPATH EXP NEUR, V80, P2, DOI 10.1093/jnen/nlaa130; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Correia AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140248; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dolenec P, 2020, J NEUROPATH EXP NEUR, V79, P1163, DOI 10.1093/jnen/nlaa111; Dolenec P, 2015, J NEUROPATH EXP NEUR, V74, P512, DOI 10.1097/NEN.0000000000000194; Dresselhaus EC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01043; El-Hussein AE, 2000, SCIENCE, V290, P1364; Engelmann C, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/7027949; Fogarty MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37968; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Gobbel GT, 2007, CHILD NERV SYST, V23, P1171, DOI 10.1007/s00381-007-0345-2; Handley EE, 2017, CEREB CORTEX, V27, P3630, DOI 10.1093/cercor/bhw185; Hang CH, 2005, NEUROL INDIA, V53, P312, DOI 10.4103/0028-3886.16930; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00766; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Jalin AMAA, 2019, EXP NEUROL, V314, P20, DOI 10.1016/j.expneurol.2019.01.002; Jamshidi P, 2020, J NEUROPATH EXP NEUR, V79, P585, DOI 10.1093/jnen/nlaa029; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kapeli K, 2017, HUM GENET, V136, P1193, DOI 10.1007/s00439-017-1830-7; Koza P, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104499; Lam AGM, 2001, NEUROBIOL AGING, V22, P765, DOI 10.1016/S0197-4580(01)00233-0; Lin SJ, 2018, ACUPUNCT MED, V36, P247, DOI 10.1136/acupmed-2017-011472; Ling SC, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/8413496; LoBue C, 2020, J NEUROL NEUROSUR PS, V91, P586, DOI 10.1136/jnnp-2019-321567; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Mackenzie IRA, 2008, CURR OPIN NEUROL, V21, P693, DOI 10.1097/WCO.0b013e3283168d1d; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moisse K, 2009, BRAIN RES, V1296, P176, DOI 10.1016/j.brainres.2009.07.023; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Obernier JA, 2006, ILAR J, V47, P364, DOI 10.1093/ilar.47.4.364; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pilipovic K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126584; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Ravanidis S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082280; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Saykally JN, 2018, J NEUROTRAUM, V35, P139, DOI 10.1089/neu.2017.5070; Semple BD, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00069; Snow WM, 2014, MOL NEUROBIOL, V49, P757, DOI 10.1007/s12035-013-8555-y; Sultana R, 2010, J NEUROSCI RES, V88, P469, DOI 10.1002/jnr.22227; Swarup V, 2011, J EXP MED, V208, P2429, DOI 10.1084/jem.20111313; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tan XL, 2019, J NEUROTRAUM, V36, P87, DOI 10.1089/neu.2017.5491; Thammisetty SS, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1350-y; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Uchida S, 2018, NEUROSCIENCE, V370, P4, DOI 10.1016/j.neuroscience.2017.07.023; Vile AR, 2017, J CLIN NEUROSCI, V41, P24, DOI 10.1016/j.jocn.2017.03.035; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep37063; Wang HK, 2015, NEUROSCIENCE, V300, P94, DOI 10.1016/j.neuroscience.2015.05.013; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Wiesner D, 2018, EXP NEUROL, V299, P15, DOI 10.1016/j.expneurol.2017.09.011; Wong CE, 2021, THERANOSTICS, V11, P330, DOI 10.7150/thno.51004; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Yadavilli S, 2007, DNA REPAIR, V6, P1453, DOI 10.1016/j.dnarep.2007.04.009; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105; Zhang CQ, 2021, INT J NEUROSCI, V131, P994, DOI 10.1080/00207454.2020.1766460; Zhao WH, 2015, EXP NEUROL, V273, P24, DOI 10.1016/j.expneurol.2015.07.019; Zhu JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142296; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	86	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	NOV	2021	22	22							12211	10.3390/ijms222212211			21	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	XH6GB	WOS:000725529500001	34830093	gold, Green Published			2022-02-06	
J	Jiang, XY; Pu, R; Wang, C; Xu, JL; Tang, YH; Qi, SH; Zhan, QQ; Wei, XB; Gu, BB				Jiang, Xinyan; Pu, Rui; Wang, Cheng; Xu, Jiale; Tang, Yaohui; Qi, Shuhong; Zhan, Qiuqiang; Wei, Xunbin; Gu, Bobo			Noninvasive and early diagnosis of acquired brain injury using fluorescence imaging in the NIR-II window	BIOMEDICAL OPTICS EXPRESS			English	Article							IN-VIVO	YY Acquired brain injury (ABI), which is the umbrella term for all brain injuries, is one of the most dangerous diseases resulting in high morbidity and mortality, making it extremely significant to early diagnosis of ABI. Current methods, which are mainly composed of X-ray computed tomography and magnetic resonance angiography, remain limited in diagnosis of ABI with respect to limited spatial resolution and long scanning times. Here, we reported through-skull fluorescence imaging of mouse cerebral vasculature without craniotomy, utilizing the fluorescence of down-conversion nanoparticles (DCNPs) in the 1.3 -1.7 mu m near-infrared window (NIR-II window). Due to its high spatial resolution of 22.79 mu m, the NIR-II fluorescence imaging method could quickly distinguish the brain injury region of mice after performing the stab wound injury (traumatic brain injury) and ischemic stroke (non-traumatic brain injury), enabling it a powerful tool in the noninvasive and early diagnosis of ABI. (C) 2021 Optical Society of America under the terms of the OSA Open Access Publishing Agreement	[Jiang, Xinyan; Wang, Cheng; Xu, Jiale; Tang, Yaohui; Wei, Xunbin; Gu, Bobo] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China; [Jiang, Xinyan; Wang, Cheng; Xu, Jiale; Tang, Yaohui; Wei, Xunbin; Gu, Bobo] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Pu, Rui; Zhan, Qiuqiang] South China Normal Univ, South China Acad Adv Optoelect, Ctr Opt & Electromagnet Res, Guangzhou 510006, Peoples R China; [Qi, Shuhong] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China; [Qi, Shuhong] Huazhong Univ Sci & Technol, Sch Engn Sci, MoE Key Lab Biomed Photon, Wuhan 430074, Hubei, Peoples R China; [Wei, Xunbin] Peking Univ, Biomed Engn Dept, Beijing 100081, Peoples R China; [Wei, Xunbin] Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Beijing 100142, Peoples R China		Gu, BB (corresponding author), Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China.; Gu, BB (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	bobogu@sjtu.edu.cn	ZHAN, Qiuqiang/E-5245-2013	ZHAN, Qiuqiang/0000-0002-5886-3795	Ministry of Science and Technology of the People's Republic of ChinaMinistry of Science and Technology, China [2019YFC1604604]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11974123, 61805135, 6212202]; Shanghai Jiao Tong University [ZH2018QNA43]; Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [19DZ2280300]; Shanghai Municipal Education CommissionShanghai Municipal Education Commission (SHMEC) [ZXWF082101]; Wuhan National Laboratory for Optoelectronics [2019WNLOKF019]; Guangdong Provincial Science Fund [2018B030306015]; Guangdong Provincial Science and Technology Project [2019A050510037]	Ministry of Science and Technology of the People's Republic of China (2019YFC1604604); National Natural Science Foundation of China (11974123, 61805135, 6212202); Shanghai Jiao Tong University (ZH2018QNA43); Science and Technology Commission of Shanghai Municipality (19DZ2280300); Shanghai Municipal Education Commission (ZXWF082101); Wuhan National Laboratory for Optoelectronics (2019WNLOKF019); Guangdong Provincial Science Fund (2018B030306015); Guangdong Provincial Science and Technology Project (2019A050510037).	Bashkatov AN, 2005, J PHYS D APPL PHYS, V38, P2543, DOI 10.1088/0022-3727/38/15/004; Chou SHY, 2014, NEUROCRIT CARE, V21, P187, DOI 10.1007/s12028-014-0039-z; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diao S, 2015, ANGEW CHEM INT EDIT, V54, P14758, DOI 10.1002/anie.201507473; Ding D, 2013, ACCOUNTS CHEM RES, V46, P2441, DOI 10.1021/ar3003464; Feng Z, 2021, ADV MATER, V33, DOI 10.1002/adma.202008123; Feng Z, 2019, THERANOSTICS, V9, P5706, DOI 10.7150/thno.31332; Franke D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12749; Gu BB, 2018, SMALL METHODS, V2, DOI 10.1002/smtd.201700392; Gu BB, 2016, ADV OPT PHOTONICS, V8, P328, DOI 10.1364/AOP.8.000328; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; He SQ, 2019, NANO LETT, V19, P2985, DOI 10.1021/acs.nanolett.9b00140; Hong GS, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0010; Hong GS, 2014, NAT PHOTONICS, V8, P723, DOI [10.1038/nphoton.2014.166, 10.1038/NPHOTON.2014.166]; Hong GS, 2014, CIRC-CARDIOVASC IMAG, V7, P517, DOI 10.1161/CIRCIMAGING.113.000305; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Jiang PF, 2021, ANAL CHIM ACTA, V1154, DOI 10.1016/j.aca.2021.338309; Kenry, 2018, ADV MATER, V30, DOI 10.1002/adma.201802394; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Li Y, 2020, CHEM SCI, V11, P2621, DOI 10.1039/c9sc06567a; Lin LY, 2021, ADV EXP MED BIOL, V1355, P1, DOI 10.1007/978-981-15-7627-0_1; Liu HL, 2019, ADV MATER, V31, DOI 10.1002/adma.201901015; Liu MX, 2020, CHEM MATER, V32, P6437, DOI 10.1021/acs.chemmater.0c01577; Ouzounov DG, 2017, NAT METHODS, V14, P388, DOI 10.1038/nmeth.4183; Pagan E, 2017, AM J CARDIOL, V119, P862, DOI 10.1016/j.amjcard.2016.11.040; Sheng ZH, 2018, ADV MATER, V30, DOI 10.1002/adma.201800766; Sowers MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6460; Splinter R., 2006, INTRO BIOMEDICAL OPT; Sun Y, 2015, CHEM SOC REV, V44, P1509, DOI 10.1039/c4cs00175c; Vilela P, 2017, EUR J RADIOL, V96, P162, DOI 10.1016/j.ejrad.2017.08.014; Wan H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03505-4; Wang W, 2021, J MATER CHEM B, V9, P2899, DOI 10.1039/d0tb02728f; Yu XM, 2021, NANO TODAY, V39, DOI 10.1016/j.nantod.2021.101235; Yu XM, 2019, J MATER CHEM B, V7, P6623, DOI 10.1039/c9tb01381d; Zeng XD, 2019, CHEM COMMUN, V55, P14287, DOI 10.1039/c9cc07694h; Zhang MX, 2018, P NATL ACAD SCI USA, V115, P6590, DOI 10.1073/pnas.1806153115; Zhang X, 2020, CHEM ENG J, V385, DOI 10.1016/j.cej.2019.123959; Zhong YT, 2019, NAT BIOTECHNOL, V37, P1322, DOI 10.1038/s41587-019-0262-4; Zhong YT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00917-6; Zhu CC, 2016, MAGN RESON MATER PHY, V29, P559, DOI 10.1007/s10334-016-0531-x	40	0	0	16	16	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	NOV 1	2021	12	11					6984	6994		10.1364/BOE.442657			11	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	WS1SE	WOS:000714968600002	34858693	Green Published, gold			2022-02-06	
J	Jo, KW; Jung, HJ; Yoo, D; Park, HK				Jo, Kwang Wook; Jung, Hyun-Ju; Yoo, Do Sung; Park, Hae-Kwan			Changes in Blood Pressure and Heart Rate during Decompressive Craniectomy	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Prognosis; Decompressive craniectomy; Heart rate; Intracranial pressure; Mean arterial blood pressure	TRAUMATIC BRAIN-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; MANAGEMENT; HEMICRANIECTOMY; GUIDELINES; INFARCTION; TRIAL; MULTICENTER; ISCHEMIA	Objective : Rapid increase in intracranial pressure (ICP) can result in hypertension, bradycardia and apnea, referred to as the Cushing phenomenon. During decompressive craniectomy (DC), rapid ICP decreases can cause changes in mean atrial blood pressure (mABP) and heart rate (HR), which may be an indicator of intact autoregulation and vasomotor reflex. Methods : A total of 82 patients who underwent DC due to traumatic brain injury (42 cases), hypertensive intracerebral hematoma (19 cases), or major infarction (21 cases) were included in this prospective study. Simultaneous ICP, mABP, and HR changes were monitored in one minute intervals during, prior to and 5-10 minutes following the DC. Results : After DC, the ICP decreased from 38.1 +/- 16.3 mmHg to 9.5 +/- 14.2 mmHg (p<0.001) and the mABP decreased from 86.4 +/- 14.5 mmHg to 72.5 +/- 11.4 mmHg (p<0.001). Conversly, overall HR was no significantly changed in HR, which was 100.1 +/- 19.7 rate/min prior to DC and 99.7 +/- 18.2 rate/min (p=0.848) after DC. Notably when the HR increased after DC, it correlated with a favorable outcome (p<0.001), however mortality was increased (p=0.032) when the HR decreased or remained unchanged. Conclusion : In this study, ICP was decreased in all patients after DC. Changes in HR were an indicator of preserved autoregulation and vasomotor reflex. The clinical outcome was improved in patients with increased HR after DC.	[Jo, Kwang Wook] Catholic Univ Korea, Coll Med, Bucheon St Marys Hosp, Dept Neurosurg, Seoul, South Korea; [Jung, Hyun-Ju] Catholic Univ Korea, Coll Med, Uijeongbu St Marys Hosp, Dept Anesthesiol, Seoul, South Korea; [Yoo, Do Sung; Park, Hae-Kwan] Catholic Univ Korea, Coll Med, Eunpyeong St Marys Hosp, Dept Neurosurg, 1021 Tongil Ro, Seoul 03312, South Korea		Yoo, D (corresponding author), Catholic Univ Korea, Coll Med, Eunpyeong St Marys Hosp, Dept Neurosurg, 1021 Tongil Ro, Seoul 03312, South Korea.	yooman@catholic.ac.kr		Yoo, Do-Sung/0000-0003-2569-6502; Park, Haekwan/0000-0001-7132-7009			Barbiro-Michaely E, 2003, NEUROL RES, V25, P42, DOI 10.1179/016164103101201102; Bharath S, 2020, WORLD NEUROSURG, V136, pE553, DOI 10.1016/j.wneu.2020.01.066; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Fodstad H, 2006, NEUROSURGERY, V59, P1132, DOI 10.1227/01.NEU.0000245582.08532.7C; Furuichi S, 1999, ACTA NEUROCHIR, V141, P415, DOI 10.1007/s007010050318; Georgiadis D, 2002, STROKE, V33, P1584, DOI 10.1161/01.STR.0000016970.51004.D9; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Guild SJ, 2018, AM J PHYSIOL-REG I, V315, pR1049, DOI 10.1152/ajpregu.00183.2018; Heymans C, 1928, AM J PHYSIOL, V85, P498, DOI 10.1152/ajplegacy.1928.85.3.498; Hofmeijer J, 2003, CRIT CARE MED, V31, P617, DOI 10.1097/01.CCM.0000050446.16158.80; Holtkamp M, 2001, J NEUROL NEUROSUR PS, V70, P226, DOI 10.1136/jnnp.70.2.226; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; JUVELA S, 1989, J NEUROSURG, V70, P755, DOI 10.3171/jns.1989.70.5.0755; Kalmar AF, 2005, BRIT J ANAESTH, V94, P791, DOI 10.1093/bja/aei121; Kim KT, 2009, ACTA NEUROCHIR, V151, P21, DOI 10.1007/s00701-008-0164-6; KOCSIS B, 1991, J APPL PHYSIOL, V70, P2181, DOI 10.1152/jappl.1991.70.5.2181; KRASNEY JA, 1976, AM J PHYSIOL, V230, P1695, DOI 10.1152/ajplegacy.1976.230.6.1695; MATSUURA S, 1984, BRAIN RES, V305, P291, DOI 10.1016/0006-8993(84)90435-9; McBryde FD, 2017, ACTA PHYSIOL, V219, P274, DOI 10.1111/apha.12706; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Reithmeier T, 2005, CHILD NERV SYST, V21, P249, DOI 10.1007/s00381-004-1044-x; Robertson SC, 2004, NEUROSURGERY, V55, P55, DOI 10.1227/01.NEU.0000126875.02630.36; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Schmidt EA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00011; Schwab S, 1996, NEUROLOGY, V47, P393, DOI 10.1212/WNL.47.2.393; Shelton BA, 2009, J NEUROSURG, V110, P391, DOI 10.3171/2008.8.JNS08773; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Stefini R, 1999, NEUROSURGERY, V45, P626, DOI 10.1097/00006123-199909000-00038; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Winter CD, 2005, J CLIN NEUROSCI, V12, P619, DOI 10.1016/j.jocn.2005.02.002; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953; Yumoto T, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0341-1	38	0	0	1	1	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	NOV	2021	64	6					957	965		10.3340/jkns.2020.0356			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WS1WN	WOS:000714979900013	34749485	gold, Green Published			2022-02-06	
J	Jochems, D; van Rein, E; Niemeijer, M; van Heijl, M; van Es, MA; Nijboer, T; Leenen, LPH; Houwert, RM; van Wessem, KJP				Jochems, Denise; van Rein, Eveline; Niemeijer, Menco; van Heijl, Mark; van Es, Michael A.; Nijboer, Tanja; Leenen, Luke P. H.; Houwert, Roderick M.; van Wessem, Karlijn J. P.			Epidemiology of paediatric moderate and severe traumatic brain injury in the Netherlands	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						Paediatric; Traumatic brain injury; Epidemiology; Incidence	GLASGOW COMA SCALE; MORTALITY; CHILDREN	Introduction: Traumatic brain injury (TBI) is the main cause of death in children around the world. The last Dutch epidemiological study described the incidence over 10 years ago. Mechanism of injury seems to change with the age of the child, therefore it is important to appreciate different age groups. To be able to lower the impact of childhood TBI, an understanding of current incidence, mechanism of injury and outcome is necessary. Methods: A nationwide retrospective cohort study was conducted. The Dutch National Trauma Database was used to identify all patients 18 years and younger who were admitted to a Dutch hospital with moderate-severe TBI (Abbreviated Injury Score>3) in the Netherlands, from January 2015 until December 2017. Subanalyses were done for different age groups. Results: In total, 1413 patients were included, of whom 5% died. The incidence rate of moderate-severe TBI was 14/100,000 person years. Median age was 10.4 years. Largest age group was patients <5 years, incidence rate was highest in patients >16 years. Falls were more common than road traffic accidents (RTA), but RTAs occurred far more frequently amongst children over 10. RTAs predominantly consisted of bicycle accidents. Mortality rates increased from youngest to oldest age groups, as did the chances of a Glasgow Outcome Scale score of 3. Conclusion: Paediatric moderate-severe TBI represents a significant problem in the Netherlands. Falls are the most common mechanism of injury amongst younger children and RTAs amongst older children. Unique for the Netherlands is the vast amount of bicycle accident related injuries. (c) 2021 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.	[Jochems, Denise; van Rein, Eveline; Niemeijer, Menco; van Heijl, Mark; Leenen, Luke P. H.; Houwert, Roderick M.; van Wessem, Karlijn J. P.] Univ Med Ctr Utrecht, Dept Surg, POB 85500, NL-3508 GA Utrecht, Netherlands; [van Es, Michael A.] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands; [Nijboer, Tanja] Univ Utrecht, Helmholtz Inst, Dept Expt Psychol, Utrecht, Netherlands; [Nijboer, Tanja] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, UMC Utrecht Brain Ctr, Utrecht, Netherlands; [Nijboer, Tanja] Hoogstr Rehabil, Utrecht, Netherlands		Jochems, D (corresponding author), Univ Med Ctr Utrecht, Dept Surg, POB 85500, NL-3508 GA Utrecht, Netherlands.	d.jochems-3@umcutrecht.nl					Carone L, 2019, INJURY, V50, P61, DOI 10.1016/j.injury.2018.08.015; Centraal Bureau voor Statistiek (CBS), BEV GESL LEEFT BURG; Cheng PX, 2020, J SAFETY RES, V72, P93, DOI 10.1016/j.jsr.2019.12.013; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Dodds N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027845; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; Foley J, 2020, INJURY, V51, P1158, DOI 10.1016/j.injury.2019.11.025; Forbes AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185367; Gennarelli TA., 2008, ABBREVIATED INJURY S; Haarbauer-Krupa J, 2019, J SAFETY RES, V70, P127, DOI 10.1016/j.jsr.2019.06.003; Hill CS, 2018, PEDIATR EMERG CARE, V34, P426, DOI [10.1097/PEC.0000000000000845, 10.1097/pec.0000000000000845]; Keenan H.T., 2019, TRAUMATIC BRAIN INJU, V292, P282; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kuipers E.J., 2018, LANDELIJKE TRAUMAREG; Le Fur C., 2019, ANN PHYS REHABIL MED; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Nederlandse Kankerregistratie (NKR) IKNL, 2018, NKR CIJF IKNL; Olthof D C, 2013, BMJ Qual Saf, V22, P752, DOI 10.1136/bmjqs-2013-001888; Petrie CA, 2020, J FIELD ARCHAEOL, V45, P1, DOI 10.1080/00934690.2019.1664848; Riemann L, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00345; Rogers S, 2017, J NURSING ED PRACTIC, V7, P23, DOI [10.5430/jnep. v7n11p23, DOI 10.5430/JNEP.V7N11P23]; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salottolo K, 2017, J CRIT CARE, V38, P197, DOI 10.1016/j.jcrc.2016.11.034; Sarnaik A, 2018, NEUROCRIT CARE, V28, P302, DOI 10.1007/s12028-017-0480-x; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; van Pelt ED, 2011, EUR J PAEDIATR NEURO, V15, P519, DOI 10.1016/j.ejpn.2011.05.005; van Rein EAJ, 2019, EUR J NEUROL, V26, P274, DOI 10.1111/ene.13804	32	0	0	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	NOV	2021	35						123	129		10.1016/j.ejpn.2021.10.004			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	WW8GP	WOS:000718148200001	34687976	hybrid			2022-02-06	
J	Kang, JT; Tang, YJ				Kang, Jingtian; Tang, Yanjun			Dynamic cavitation in soft solids under monotonically increasing pressure	INTERNATIONAL JOURNAL OF MECHANICAL SCIENCES			English	Article						Cavitation; Surface energy; Soft materials; Dynamic loading	POSSIBLE DAMAGE MECHANISM; LASER-INDUCED CAVITATION; CAVITY GROWTH; FAILURE; INSTABILITY; EXPANSION; RUPTURE; ONSET	Impact-induced cavitation can be widely found in soft solids and biological tissues and is very different from the cavitation problem under quasi-static loading. Experimental evidence has shown that the cavitation in brain tissue may be a potential mechanism for traumatic brain injury. In this work, we study the dynamic cavitation under monotonically increasing pressure and investigate the influence of loading rates on cavitation behaviors. The dynamic behavior of cavity surface with and without surface energy is investigated based on nonlinear dynamics. We find that the inertial effect introduced by the dynamic loading is not negligible at large pressure rate. Considering the surface effect, the cavity surface will expand, shrink, and then oscillate before the occurrence of infinite cavity expansion. Results will be helpful to better understand the cavitation phenomenon in biological tissues under dynamic loading.	[Kang, Jingtian; Tang, Yanjun] Northeastern Univ, Coll Sci, Dept Mech, Shenyang 110819, Liaoning, Peoples R China		Kang, JT (corresponding author), Northeastern Univ, Coll Sci, Dept Mech, Shenyang 110819, Liaoning, Peoples R China.	kangjt@mail.neu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11902070]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [N2105015]; Joint fund of Science & Technology Department of Liaoning Province; State Key Laboratory of Robotics, China [2020-KF-12-03]	J. Kang acknowledges financial supports from National Natural Science Foundation of China 11902070, the Fundamental Research Funds for the Central Universities N2105015, and Joint fund of Science & Technology Department of Liaoning Province and State Key Laboratory of Robotics, China, 2020-KF-12-03.	BALL JM, 1982, PHILOS T R SOC A, V306, P557, DOI 10.1098/rsta.1982.0095; Barney CW, 2020, P NATL ACAD SCI USA, V117, P9157, DOI 10.1073/pnas.1920168117; Barney CW, 2019, SOFT MATTER, V15, P7390, DOI 10.1039/c9sm01173k; Estrada JB, 2018, J MECH PHYS SOLIDS, V112, P291, DOI 10.1016/j.jmps.2017.12.006; Faye A, 2017, INT J NONLIN MECH, V92, P118, DOI 10.1016/j.ijnonlinmec.2017.04.005; Fu YM, 2020, J MECH PHYS SOLIDS, V137, DOI 10.1016/j.jmps.2019.103859; GENT AN, 1984, J MATER SCI, V19, P1947, DOI 10.1007/BF00550265; GENT AN, 1959, PROC R SOC LON SER-A, V249, P195, DOI 10.1098/rspa.1959.0016; GENT AN, 1969, J POLYM SCI A2, V7, P1483, DOI 10.1002/pol.1969.160070904; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Goyal S, 2013, INT J MECH SCI, V75, P233, DOI 10.1016/j.ijmecsci.2013.07.005; Horgan C, 1995, APPL MECH REV, V48, P471, DOI DOI 10.1115/1.3005108; HUANG Y, 1991, J MECH PHYS SOLIDS, V39, P223, DOI 10.1016/0022-5096(91)90004-8; Jakub M.T., 1965, ARCH RATION MECH AN, V18, P367; Kang JT, 2020, INT J MECH SCI, V188, DOI 10.1016/j.ijmecsci.2020.105934; Kang JT, 2018, SOFT MATTER, V14, DOI 10.1039/c8sm01464g; Kang JT, 2017, J APPL PHYS, V122, DOI 10.1063/1.5009747; Kang JT, 2017, SOFT MATTER, V13, P6372, DOI 10.1039/c7sm01479a; Kumar A, 2017, J ELASTICITY, V126, P201, DOI 10.1007/s10659-016-9589-y; Lefevre V, 2015, INT J FRACTURE, V192, P1, DOI 10.1007/s10704-014-9982-0; Long LF, 2018, INT J FRACTURE, V214, P105, DOI 10.1007/s10704-018-0321-8; Lopez-Pamies O, 2011, J MECH PHYS SOLIDS, V59, P1464, DOI 10.1016/j.jmps.2011.04.015; Lopez-Pamies O, 2011, J MECH PHYS SOLIDS, V59, P1488, DOI 10.1016/j.jmps.2011.04.016; Lopez-Pamies O, 2009, J ELASTICITY, V94, P115, DOI 10.1007/s10659-008-9187-8; Luo JC, 2020, SCI REP-UK, V10, P1; Mihai LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0486; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Noblin X, 2012, SCIENCE, V335, P1322, DOI 10.1126/science.1215985; Oguri R, 2018, PHYS FLUIDS, V30, DOI 10.1063/1.5026713; Peel CS, 2011, APPL PHYS A-MATER, V103, P1131, DOI 10.1007/s00339-010-6056-7; Poulain X, 2017, INT J FRACTURE, V205, P1, DOI 10.1007/s10704-016-0176-9; Poulain X, 2018, SOFT MATTER, V14, P4633, DOI 10.1039/c8sm00238j; Raayai-Ardakani S, 2019, SOFT MATTER, V15, P4999, DOI 10.1039/c9sm00570f; Raayai-Ardakani S, 2019, SOFT MATTER, V15, P381, DOI 10.1039/c8sm02142b; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Riccobelli D, 2020, J MECH PHYS SOLIDS, V134, DOI 10.1016/j.jmps.2019.103745; Sadeghi O, 2018, INT J MECH SCI, V137, P304, DOI 10.1016/j.ijmecsci.2018.01.036; Saint-Michel B, 2020, SOFT MATTER, V16, DOI 10.1039/d0sm01044h; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Stride EP, 2010, P I MECH ENG H, V224, P171, DOI 10.1243/09544119JEIM622; Style RW, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.011028; Tang XC, 2020, J MECH PHYS SOLIDS, V141, DOI 10.1016/j.jmps.2020.104023; Tiwari S, 2020, SOFT MATTER, V16, P9006, DOI 10.1039/d0sm00710b; Tvergaard V, 2000, INT J MECH SCI, V42, P381, DOI 10.1016/S0020-7403(98)00128-3; Tvergaard V, 2007, INT J MECH SCI, V49, P210, DOI 10.1016/j.ijmecsci.2006.08.004; Tvergaard V, 2020, INT J MECH SCI, V173, DOI 10.1016/j.ijmecsci.2020.105426; Tvergaard V, 2019, INT J MECH SCI, V152, P81, DOI 10.1016/j.ijmecsci.2018.12.014; Volokh KY, 2007, INT J SOLIDS STRUCT, V44, P5043, DOI 10.1016/j.ijsolstr.2006.12.022; Wang HM, 2015, J APPL PHYS, V117, DOI 10.1063/1.4918278; Wang HM, 2015, SOFT MATTER, V11, P1058, DOI 10.1039/c4sm02652g; Wei CW, 2014, OPT LETT, V39, P2599, DOI 10.1364/OL.39.002599; Wilkerson JW, 2017, INT J PLASTICITY, V95, P21, DOI 10.1016/j.ijplas.2017.03.008; WILLIAMS ML, 1965, INT J FRACT MECH, V1, P64, DOI 10.1007/BF00184154; Wu XY, 2003, J MECH PHYS SOLIDS, V51, P1, DOI 10.1016/S0022-5096(02)00079-0; Yang J, 2020, EXTREME MECH LETT, V39, DOI 10.1016/j.eml.2020.100839; Zheng Y, 2020, INT J NONLIN MECH, V126, DOI 10.1016/j.ijnonlinmec.2020.103562; Zhu J, 2011, J ADHESION, V87, P466, DOI 10.1080/00218464.2011.575332; Zimberlin JA, 2007, SOFT MATTER, V3, P763, DOI 10.1039/b617050a; Zimberlin JA, 2010, SOFT MATTER, V6, P3632, DOI 10.1039/b925407b; Zimberlin JA, 2010, J POLYM SCI POL PHYS, V48, P1423, DOI 10.1002/polb.21968	60	0	0	5	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7403	1879-2162		INT J MECH SCI	Int. J. Mech. Sci.	NOV 1	2021	209								106730	10.1016/j.ijmecsci.2021.106730			10	Engineering, Mechanical; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mechanics	UR8KG	WOS:000696990500003					2022-02-06	
J	Kerr, ZY; Ingram, BM; Callahan, CE; Nedimyer, AK; Chandran, A; Kossman, MK; Hoang, J; Gildner, P; Register-Mihalik, JK				Kerr, Zachary Y.; Ingram, Brittany M.; Callahan, Christine E.; Nedimyer, Aliza K.; Chandran, Avinash; Kossman, Melissa K.; Hoang, Julia; Gildner, Paula; Register-Mihalik, Johna K.			Reporting of Concussion Symptoms by a Nationwide Survey of United States Parents of Middle School Children	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						youth sports; recall; traumatic brain injury	COLLEGIATE FOOTBALL PLAYERS; RECURRENT CONCUSSION; KNOWLEDGE; DISCLOSURE; ATTITUDES	This cross-sectional study assessed concussion symptom knowledge of parents of middle school (MS) children (aged 10-15 years) through a free-response item that solicited concussion symptoms and compared findings to a pre-validated scale-based measure. A self-administered online questionnaire was sent to a panel of randomly selected United States residents who were recruited by a third-party company, aged & GE; 18 years, and identified as parents of MS children. Via a free-response item, parents listed what they believed were concussion symptoms. Multiple sections later, parents identified potential concussion symptoms via a scale measure, which featured 25 items (22 actual symptoms, three distractor symptoms) with three response options: yes, no, maybe. Free-response item responses were coded into specific symptoms. The 1062 eligible parents that provided complete data commonly identified the symptoms of dizziness (90.2%), blurred vision (87.4%), and balance problems (86.4%) on the scale-based measure. However, these and other symptoms were less commonly identified via the free-response item (dizziness: 44.4%; blurred vision: 16.5%; balance problems: 3.5%). Concussion symptoms commonly reported via the scale-based measure were reported less frequently within the free-response item. Future research must explore strategies to help clinicians working with parents and their children to measure and assess concussion symptom reporting and knowledge.	[Kerr, Zachary Y.; Hoang, Julia; Gildner, Paula; Register-Mihalik, Johna K.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Ingram, Brittany M.; Callahan, Christine E.; Nedimyer, Aliza K.] Univ N Carolina, Human Movement Sci Curriculum, Chapel Hill, NC 27599 USA; [Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN 46202 USA; [Kossman, Melissa K.] Univ Southern Mississippi, Sch Hlth Profess, Hattiesburg, MS 39406 USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu; bmingram@live.unc.edu; chriscal@live.unc.edu; askamman@live.unc.edu; avinashc@datalyscenter.org; melissa.k.kossman@usm.edu; hoangjulia6@gmail.com; pgildner@unc.edu; johnakay@email.unc.edu		Nedimyer, Aliza/0000-0002-2714-8529; Kerr, Zachary/0000-0003-1423-1259; Kossman, Melissa/0000-0001-6653-1363	Division of Unintentional Injury, Centers for Disease Control and Prevention [5U01CE002885-02]	FundingThis study was funded by the Division of Unintentional Injury, Centers for Disease Control and Prevention (Grant number: 5U01CE002885-02).	Bacon CEW, 2017, J INTERPROF CARE, V31, P725, DOI 10.1080/13561820.2017.1345873; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Beachy G, 2014, J ATHL TRAINING, V49, P493, DOI 10.4085/1062-6050-49.2.19; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chandratilake M, 2011, NATL MED J INDIA, V24, P225; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Cusimano MD, 2017, SAGE OPEN MED, V5, DOI [10.1177/2050312117694794, 10.1177/2050312117699799]; DePadilla L, 2020, J SCHOOL HEALTH, V90, P520, DOI 10.1111/josh.12900; Diaz Anne L, 2013, NASN Sch Nurse, V28, P110; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Kay MC, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117742370; Kerr ZY, 2021, J SPORT HEALTH SCI, V10, P113, DOI 10.1016/j.jshs.2020.09.001; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kerr ZY, 2019, AM J SPORT MED, V47, P933, DOI 10.1177/0363546518825361; Kerr Zachary Y, 2018, Inj Epidemiol, V5, P28, DOI 10.1186/s40621-018-0158-7; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Knollman-Porter K, 2018, AM J SPEECH-LANG PAT, V27, P778, DOI 10.1044/2018_AJSLP-17-0108; De Araujo AVL, 2021, ARQ NEURO-PSIQUIAT, V79, P469, DOI [10.1590/0004-282X-ANP-2019-0436, 10.1590/0004-282x-anp-2019-0436]; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; National Research Council, 2014, COMM SPORTS REL CONC; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Potteiger KL, 2018, INTERNET J ALLIED HE, V16; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2018, J ATHL TRAINING, V53, P768, DOI 10.4085/1062-6050-223-17; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rice T, 2019, J SAFETY RES, V69, P85, DOI 10.1016/j.jsr.2019.02.007; Salmon DM, 2021, INT J SPORTS SCI COA, V16, P54, DOI 10.1177/1747954120961200; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Wallace J, 2021, J HEAD TRAUMA REHAB, V36, P139, DOI 10.1097/HTR.0000000000000672; Wallace J, 2020, J SAFETY RES, V75, P166, DOI 10.1016/j.jsr.2020.09.007; Waltzman Dana, 2018, J Concussion, V2, P1, DOI 10.1177/2059700218769218; Weber Rawlins M.L., 2021, J ATHL TRAINING, DOI [10.4085/1062-6050-0685.20, DOI 10.4085/1062-6050-0685.20]; Wilkerson GB, 2018, J ATHL TRAINING, V53, P320, DOI 10.4085/1062-6050-8-17	44	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2021	18	22							12070	10.3390/ijerph182212070			13	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	XE5ER	WOS:000723411300001	34831822	Green Published, gold			2022-02-06	
J	Keys, ME; Delaplain, P; Kirby, KA; Boudreau, KI; Rosenbaum, K; Inaba, K; Lekawa, M; Nahmias, J				Keys, Megan Elizabeth; Delaplain, Patrick; Kirby, Katharine A.; Boudreau, Kate Irene; Rosenbaum, Kathryn; Inaba, Kenji; Lekawa, Michael; Nahmias, Jeffry			Early cognitive impairment is common in pediatric patients following mild traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; cognitive impairment; intracranial hemorrhage	EPIDEMIOLOGY; GUIDELINES; RECOVERY; CHILDREN; BIG	INTRODUCTION The incidence and factors related to early cognitive impairment (ECI) after mild traumatic brain injury (mTBI) in pediatric trauma patients (PTPs) are unknown. Prior data in the adult population demonstrated an ECI incidence of 51% after mTBI and strong correlation with initial Glasgow Coma Scale (GCS) and Brain Injury Guidelines (BIG) category. Therefore, we hypothesized that ECI is common after mTBI in PTPs and associated with initial GCS and BIG category. METHODS A single-center, retrospective review of PTPs (age, 8-17 years) from 2015 to 2019 with intracranial hemorrhage and mTBI (GCS score, 13-15) was performed. Primary outcome was ECI, defined as Ranchos Los Amigos score less than 8. Comparisons between ECI and non-ECI groups regarding Injury Severity Score (ISS), demographics, and cognitive and clinical outcomes were evaluated using chi(2) statistics and Wilcoxon rank sum tests. Odds of ECI were evaluated using multivariable logistic regression. RESULTS From 47 PTPs with mTBI, 18 (38.3%) had ECI. Early cognitive impairment patients had a higher ISS than non-ECI patients (19.7 vs. 12.6, p = 0.003). Injuries involving motor vehicles were more often related to ECI than non-auto-involved mechanisms (55% vs. 15%, p = 0.005). Lower GCS score (odds ratio [OR], 6.60; 95% confidence interval [CI], 1.34-32.51, p = 0.02), higher ISS (OR, 1.12; 95% CI, 1.01-1.24; p = 0.030), and auto-involved injuries (OR, 6.06; 95% CI, 1.15-31.94; p = 0.030) were all associated with increased risk of ECI. There was no association between BIG category and risk of ECI (p > 0.05). CONCLUSION Nearly 40% of PTPs with mTBI suffer from ECI. Lower initial GCS score, higher ISS, and autoinvolved mechanism of injury were associated with increased risk of ECI. Brain Injury Guidelines category was not associated with ECI in pediatric patients.	[Keys, Megan Elizabeth; Delaplain, Patrick; Boudreau, Kate Irene; Rosenbaum, Kathryn; Lekawa, Michael; Nahmias, Jeffry] Univ Calif Irvine, Div Trauma Burns & Surg Crit Care, Dept Surg, Orange, CA USA; [Kirby, Katharine A.] Univ Calif Irvine, Ctr Stat Consulting, Los Angeles, CA USA; [Inaba, Kenji] Dept Surg, Los Angeles, CA USA		Nahmias, J (corresponding author), Univ Calif, Irvine Med Ctr, Suite 1600,333 City Blvd West, Orange, CA 92868 USA.	keysm@uci.edu; pdelapla@hs.uci.edu; kathark@uci.edu; kboudrea@hs.uci.edu; kkrosenb@hs.uci.edu; kenji.inaba@med.usc.edu; melekawa@hs.uci.edu; jnahmias@hs.uci.edu					Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Appavu B, 2019, J NEUROSURG-PEDIATR, V23, P661, DOI 10.3171/2019.2.PEDS18384; Azim A, 2017, J TRAUMA ACUTE CARE, V83, P1200, DOI 10.1097/TA.0000000000001611; Delaplain PT, 2020, J TRAUMA ACUTE CARE, V89, P215, DOI 10.1097/TA.0000000000002641; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Ewing-Cobbs L, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0939; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Ismail FY, 2017, EUR J PAEDIATR NEURO, V21, P23, DOI 10.1016/j.ejpn.2016.07.007; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Minney MJ, 2019, BRAIN INJURY, V33, P168, DOI 10.1080/02699052.2018.1540794; Nesiama JAO, 2012, PEDIATR EMERG CARE, V28, P1027, DOI 10.1097/PEC.0b013e31826cac31; Patel Neil, 2013, Surg Neurol Int, V4, P128, DOI 10.4103/2152-7806.119055; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112	21	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2021	91	5					861	866		10.1097/TA.0000000000003266			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	WL8JL	WOS:000710645200021	34695063				2022-02-06	
J	Kieffer, EE; Brolinson, PG; Maerlender, AE; Smith, EP; Rowson, S				Kieffer, Emily E.; Brolinson, Per Gunnar; Maerlender, Arthur E.; Smith, Eric P.; Rowson, Steven			In-Season Concussion Symptom Reporting in Male and Female Collegiate Rugby Athletes	NEUROTRAUMA REPORTS			English	Article						concussion; sex-specific; subconcussion; symptoms	SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; SEX-DIFFERENCES; FOOTBALL PLAYERS; NEUROPSYCHOLOGICAL PERFORMANCE; NEUROCOGNITIVE PERFORMANCE; BRAIN-INJURY; BASE-LINE; RECOVERY; HISTORY	Symptom inventories are generally only collected after a suspected concussion, but regular in-season monitoring may allude to clinical symptoms associated with repetitive subconcussive impacts and potential undiagnosed concussions. Despite sex-specific differences in symptom presentation and outcome of concussion, no return-to-play protocol takes sex into account. The objective of this study was to monitor a cohort of contact-sport athletes and compare the frequency and severity of in-season concussion-like symptom reporting between sexes. Graded symptom checklists from 144 female and 104 male athlete-seasons were administered weekly to quantify the effect of subconcussive impacts on frequency and severity of in-season symptom reporting. In-season, mean symptom severity score (SSS) (p = 0.026, mean difference of 1.8), mean number of symptoms (p = 0.044, mean difference of 0.9), max SSS (p < 0.001, mean difference of 19.2), and max number of symptoms (p < 0.001, mean difference of 6.8) were higher in the females. The females' survey results showed differences between elevated and concussed SSS (p < 0.005, mean difference of 28.1) and number of symptoms reported (p = 0.001, mean difference of 6.6). The males did not have a difference in SSS (p = 0.97, mean difference of 1.12) nor in number of symptoms (p = 0.35, mean difference of 1.96) from elevated to concussed athletes. Rugby players report concussion-like symptoms in the absence of a diagnosed concussion in-season. Female athletes reported elevated symptom frequencies with greater severities than the males, but both sexes reported considerable levels throughout the season.	[Kieffer, Emily E.; Rowson, Steven] Virginia Tech, Sch Biomed Engn & Sci, 343 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA; [Smith, Eric P.] Virginia Tech, Dept Stat, Blacksburg, VA 24061 USA; [Brolinson, Per Gunnar] Edward Via Coll Osteopath Med, Blacksburg, VA USA; [Maerlender, Arthur E.] Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE USA		Kieffer, EE (corresponding author), Virginia Tech, Sch Biomed Engn & Sci, 343 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	kieffere@vt.edu					Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Brett BL, 2020, AM J SPORT MED, V48, P1476, DOI 10.1177/0363546520913252; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; D'Lauro C, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118760854; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gissane C., 2019, J SPORTS MED THER, V4, P024; Granito V.J., 2002, J SPORT BEHAV, V25, P243; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Iverson GL, 2021, FRONT SPORTS ACT LIV, V3, DOI 10.3389/fspor.2021.653743; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kieffer E.E., 2020, IRCOBI C; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Merritt VC, 2019, J INT NEUROPSYCH SOC, V25, P1094, DOI 10.1017/S1355617719000882; Piland SG, 2003, J ATHL TRAINING, V38, P104; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Rawlings S, 2020, BRAIN RES BULL, V165, P56, DOI 10.1016/j.brainresbull.2020.09.021; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Straume-Naesheim TM, 2009, NEUROSURGERY, V64, P719, DOI 10.1227/01.NEU.0000340681.12949.6D; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	49	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	NOV 1	2021	2	1					503	511		10.1089/neur.2021.0050			9	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WZ5EY	WOS:000719991500001	34901945	gold, Green Published, Green Submitted			2022-02-06	
J	Kirven, JC; Mundy, A; Conroy, M; Vasileff, WK				Kirven, James Caid; Mundy, Andrew; Conroy, Mark; Vasileff, W. Kelton			Injury rates and patterns in professional American rugby: a prospective observational study	CURRENT ORTHOPAEDIC PRACTICE			English	Article						professional rugby; injury rate; return-to-play	CONCUSSION; RETURN; EPIDEMIOLOGY; METAANALYSIS; FOOTBALL; LEAGUE; SPORT	Background: As American rugby becomes increasingly popular, an understanding of injury rates and patterns is essential for injury prevention, management, and player safety initiatives. We evaluated the injury characteristics and associated time loss sustained at the professional rugby level in the United States over one season. Methods: One professional rugby team was followed, and all injury data were prospectively collected over 13 consecutive weeks, with eight games during this period. Player involvement in games and practices was recorded by a licensed medical professional. For each described injury event, the timing, body area injured, and time lost from the sport caused by the injury were recorded. The Mid-P exact test was utilized to calculate injury rates with 95% confidence intervals as well as an injury rate ratio (IRR) to quantify differences in injury rates. Results: A total of 49 injuries over 2,456 athletic exposures (AEs) were included in our 13-week study period of one professional rugby season, with an overall injury rate of 19.95/1000 AEs. IRR between games versus practice was 5.21. Overall, 43% of the injuries occurred in the lower extremities and 18% in upper extremities, and there was a 12% incidence of concussion. Average time lost from sport was increased for game-related injuries (8.2 days) and concussion (7.8 days); however, severe injuries occurred more often in the lower extremity (n=4). Conclusions: The overall injury rates in this study correspond with previous amateur and international rugby literature showing a trend toward increased injury risk during gameplay at a professional level.	[Kirven, James Caid] Ohio State Univ, Coll Med, Columbus, OH 43202 USA; [Mundy, Andrew; Vasileff, W. Kelton] Ohio State Univ, Dept Orthopaed, Columbus, OH 43202 USA; [Conroy, Mark] Ohio State Univ, Dept Emergency Med, Columbus, OH 43202 USA; [Conroy, Mark; Vasileff, W. Kelton] Ohio State Univ, Sports Med Res Inst, Columbus, OH 43202 USA		Vasileff, WK (corresponding author), Ohio State Univ, Dept Orthopaed, Sports Med Res Inst, 2835 Fred Taylor Dr, Columbus, OH 43202 USA.	William.Vasileff@osumc.edu					Dick R, 2007, J ATHL TRAINING, V42, P173; Feeley BT, 2008, AM J SPORT MED, V36, P1597, DOI 10.1177/0363546508316021; Fuller CW, 2017, BRIT J SPORT MED, V51, P51, DOI 10.1136/bjsports-2016-096275; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Garraway WM, 2000, BRIT J SPORT MED, V34, P348, DOI 10.1136/bjsm.34.5.348; Hoskins W, 2006, J SCI MED SPORT, V9, P46, DOI 10.1016/j.jsams.2006.03.013; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; King DA, 2010, SPORTS MED, V40, P163, DOI 10.2165/11319740-000000000-00000; Lopez V, 2012, AM J SPORT MED, V40, P179, DOI 10.1177/0363546511427124; Marshall SW, 2001, J ATHL TRAINING, V36, P334; Mayer J, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01020; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Meredith SJ, 2020, KNEE SURG SPORT TR A, V28, P2403, DOI 10.1007/s00167-020-06009-1; Peck KY, 2013, SPORTS HEALTH, V5, P327, DOI 10.1177/1941738113487165; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Sabesan V, 2016, OPEN ACCESS J SPORTS, V7, P135, DOI 10.2147/OAJSM.S114019; Schwellnus MP, 2014, BRIT J SPORT MED, V48, P1306, DOI 10.1136/bjsports-2014-093745; Sclafani MP, 2016, INT J SPORTS PHYS TH, V11, P302; Toohey LA, 2019, AM J SPORT MED, V47, P1302, DOI 10.1177/0363546518825380; Watson S, 2016, SPORTS HEALTH, V8, P336, DOI 10.1177/1941738116651956; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; Willigenburg NW, 2016, AM J SPORT MED, V44, P753, DOI 10.1177/0363546515622389	24	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1940-7041	1941-7551		CURR ORTHOP PRACT	Curr. Orthop. Pract.	NOV-DEC	2021	32	6					573	577		10.1097/BCO.0000000000001037			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	WN7RS	WOS:000711965500007					2022-02-06	
J	Kunces, LJ; Keenan, J; Schmidt, CM; Schmidt, MA				Kunces, Laura J.; Keenan, John; Schmidt, Caleb M.; Schmidt, Michael A.			Molecular Deficits Relevant to Concussion Are Prevalent in Top-Ranked Football Players Entering the National Football League Draft	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						blood metabolites; precision nutrition; human performance; TBI	VITAMIN-D; DOCOSAHEXAENOIC ACID; HOMOCYSTEINE LEVELS; OMEGA-3-FATTY-ACIDS; SUPPLEMENTS	Kunces, LJ, Keenan, J, Schmidt, CM, and Schmidt, MA. Molecular deficits relevant to concussion are prevalent in top-ranked football players entering the National Football League draft. J Strength Cond Res 35(11): 3139-3144, 2021-Characterization of blood variants in athletes entering the highly competitive contact environment of professional football can help us understand the risk for brain injury. When coupled with longitudinal follow-up of future concussion incidence and trajectory, it may provide additional insight into factors that influence brain injury. We observed the metabolic phenotype of collegiate football players entering the 2016 National Football League (NFL) draft. The principal aims were to characterize the molecular status of individual athletes and quantify the prevalence of athletes with multiple concurrent molecular deficits. Blood was taken from 30 elite American collegiate football players 7 weeks before the NFL scouting combine and 15 weeks before entering the NFL draft. Average results revealed suboptimal values in Omega-3 Index (avg +/- std, 4.66 +/- 1.16%), arachidonic acid:eicosapentaenoic acid fatty acid ratio (29.13 +/- 10.78), homocysteine (11.4 +/- 3.4 mu mol center dot L-1), vitamin D (30 +/- 11.4 ng center dot ml(-1)), and red blood cell magnesium (4.1 +/- 0.8 mg center dot dl(-1)). Using sport-optimized reference ranges from previously published research, 10% presented with 3, 40% presented with 4, and 50% of athletes presented with 5 suboptimal values at once. We conclude molecular deficits in this cohort entering the NFL draft were common, with a significant number of athletes presenting with multiple suboptimal levels. The significant commonality of the suboptimal biomarkers is relevance to brain health and function. This data warrant extensive metabolic phenotyping and consideration of prophylactic precision nutrition countermeasures by the multidisciplinary staff for athletes entering contact environments.	[Kunces, Laura J.] Onegev Hlth, New York, NY 10019 USA; [Kunces, Laura J.] Thorne HealthTech, Summerville, SC 29483 USA; [Keenan, John] EXOS, Phoenix, AZ USA; [Schmidt, Caleb M.; Schmidt, Michael A.] Adv Pattern Anal & Countermeasures Grp, Boulder, CO USA		Kunces, LJ (corresponding author), Onegev Hlth, New York, NY 10019 USA.; Kunces, LJ (corresponding author), Thorne HealthTech, Summerville, SC 29483 USA.	LKunces@thorne.com			WellnessFX, San Francisco, CA	The authors thank Zung Vu Tran, PhD, for his statistical review of the article and Billy McCamy and Julian C. Schmidt for technical and editorial support. Blood work was supported by WellnessFX, San Francisco, CA. The authors declare no conflict or competing interest.	Arango MF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005400.pub3; Balion C, 2012, NEUROLOGY, V79, P1397, DOI 10.1212/WNL.0b013e31826c197f; Barrett EC, 2014, ADV NUTR, V5, P268, DOI 10.3945/an.113.005280; Borrione P, 2008, BRIT J SPORT MED, V42, P894, DOI 10.1136/bjsm.2007.045021; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dash PK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00036; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; Fu HJ, 2015, J MOL NEUROSCI, V56, P553, DOI 10.1007/s12031-015-0497-6; Hao L, 2013, NEURAL REGEN RES, V8, P2923, DOI 10.3969/j.issn.1673-5374.2013.31.005; Harris WS, 2013, PROSTAG LEUKOTR ESS, V88, P257, DOI 10.1016/j.plefa.2012.12.004; Jamall OA, 2016, CLIN ENDOCRINOL, V85, P636, DOI 10.1111/cen.13045; Johnston DT, 2013, NUTR NEUROSCI, V16, P30, DOI 10.1179/1476830512Y.0000000025; Kahraman S, 2003, CLIN CHIM ACTA, V334, P211, DOI 10.1016/S0009-8981(03)00235-3; Kriebitzsch C, 2011, J BONE MINER RES, V26, P2991, DOI 10.1002/jbmr.493; Lewis MD, 2016, J AM COLL NUTR, V35, P469, DOI 10.1080/07315724.2016.1150796; Malliaropoulos Nikolaos, 2013, Asian J Sports Med, V4, P49; Meyer BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120220; Nelson JR, 2019, POSTGRAD MED, V131, P268, DOI 10.1080/00325481.2019.1607414; Ogan D, 2013, NUTRIENTS, V5, P1856, DOI 10.3390/nu5061856; Oliver JM, 2016, MED SCI SPORT EXER, V48, P974, DOI 10.1249/MSS.0000000000000875; Rahmani A, 2016, WORLD NEUROSURG, V87, P507, DOI 10.1016/j.wneu.2015.09.016; Schmidt MA, 2013, METABOLOMICS, V9, P1134, DOI 10.1007/s11306-013-0556-3; Shirazi HA, 2015, EXP MOL PATHOL, V98, P240, DOI 10.1016/j.yexmp.2015.02.004; Stark KD, 2016, PROG LIPID RES, V63, P132, DOI 10.1016/j.plipres.2016.05.001; Trojian TH, 2017, CURR SPORT MED REP, V16, P247, DOI 10.1249/JSR.0000000000000387; Villacis D, 2014, SPORTS HEALTH, V6, P340, DOI 10.1177/1941738114524517; von Schacky C, 2014, INT J SPORT NUTR EXE, V24, P559, DOI 10.1123/ijsnem.2014-0041; Westermaier T, 2010, CRIT CARE MED, V38, P1284, DOI 10.1097/CCM.0b013e3181d9da1e; Yi LZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21320	30	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	NOV	2021	35	11					3139	3144		10.1519/JSC.0000000000004131			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	XV4AY	WOS:000734887800025	34533486	hybrid			2022-02-06	
J	Kvist, M; Vaelimaa, L; Harel, A; Posti, JP; Rahi, M; Saarenpaeaa, I; Visuri, M; Oestberg, A; Rinne, J				Kvist, Marten; Vaelimaa, Lasse; Harel, Adrian; Posti, Jussi P.; Rahi, Melissa; Saarenpaeaa, Ilkka; Visuri, Mikko; oestberg, Anna; Rinne, Jaakko			Glycans as Potential Diagnostic Markers of Traumatic Brain Injury	BRAIN SCIENCES			English	Article						TBI; lectin; glycan; biomarker; concussion; traumatic brain injury; clinical trial; diagnostic test	GUIDELINES	The diagnosis of mild traumatic brain injury (TBI) is challenging in the acute setting because the symptoms are nonspecific and often transient, or they develop with a delay. In these cases, the criteria for acute head imaging are frequently not fulfilled. This may lead to missed diagnoses in emergency care. There is a need for developing a rapid diagnostic test to verify the presence of TBI using body fluids. Blood, urine, and saliva samples from 11 adult patients (mean age 64 years, SD 24 years) with acute and clinically diagnosed TBI, and 12 healthy volunteers were collected at Turku University Hospital during a period of 5 months. The injuries necessitated hospitalization for at least one day. The TBIs were classified mild in nine cases and severe in two cases. The mean period between the trauma and the time for obtaining the samples was 27 h, SD 11 h. The samples were analyzed in an ISO-certified laboratory for the number of lectin-bound glycan molecules indicating destruction of nerve tissue. The screening was performed on several possible glycans for binding, and the measurement by degree of fluorescence. In the analysis, the group of patients with TBI was compared with healthy volunteers. The results showed a significant decrease (p < 0.05, Wilcoxon rank-sum two-sided test) in the level of two glycans in plasma, but no significant increase for any glycan; in saliva, one glycan showed a significant increase in the TBI group; in urine, three glycans were significantly different between the groups (one showed an increase, whereas two showed a decrease). The results support the idea of conducting more research on how diagnostic glycans could be detected in body fluids after TBI. As a proof-of-concept, significant changes in the concentration of five glycans were found in plasma, saliva, and urine between TBI patients and healthy controls. This may enable the development of a rapid body fluid-based point-of-care test to identify patients with TBI after a head injury.	[Kvist, Marten; Vaelimaa, Lasse; Harel, Adrian] Medicortex Finland Oy, Turku 20520, Finland; [Posti, Jussi P.; Rahi, Melissa; Saarenpaeaa, Ilkka; Visuri, Mikko; oestberg, Anna; Rinne, Jaakko] Univ Turku, Turku Univ Hosp, Dept Neurosurg, Neuroctr, Turku 20520, Finland		Kvist, M (corresponding author), Medicortex Finland Oy, Turku 20520, Finland.	marten.kvist@medicortex.fi; adrian.harel@medicortex.fi; melissa.rahi@tyks.fi; mikko.visuri@tyks.fi; jaakko.rinne@tyks.fi	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193	Business Finland [429/31/2016]; Academy of FinlandAcademy of FinlandEuropean Commission [17379]; Runar Baeckstroem Foundation	This research was funded by private investors, TEKES (now Business Finland) decision 429/31/2016, the Academy of Finland (Grant #17379) and the Runar Baeckstroem Foundation 2016 and 2017.	Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Duodecim, FINN TREATM GUID TRA; FDA, 2018, AUTH MARK 1 BLOOD TE; Harel A., 2017, P 19 EUR C TRAUM EM, DOI [10.1007/s00068-017-0781-y, DOI 10.1007/S00068-017-0781-Y]; Harel A, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0139-16.2016; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Katrlik J, 2010, MED RES REV, V30, P394, DOI 10.1002/med.20195; Le Sage N, 2019, CAN J NEUROL SCI, V46, P599, DOI 10.1017/cjn.2019.61; Minkkinen M, 2019, J NEUROTRAUM, V36, P2904, DOI 10.1089/neu.2018.6351; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; National Institute for Health and Care Excellence, 2019, HEAD INJ ASS EARL MA; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Posti JP, 2020, AGE AGEING, V49, P779, DOI 10.1093/ageing/afaa037; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Valimaa L., 2016, 1 SPORT CONC S FINL	19	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	NOV	2021	11	11							1480	10.3390/brainsci11111480			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XH1EV	WOS:000725185400001	34827479	gold, Green Published			2022-02-06	
J	Lam, C; Yen, JC; Wu, CC; Lin, HY; Hsu, MH				Lam, Carlos; Yen, Ju-Chuan; Wu, Chia-Chieh; Lin, Heng-Yu; Hsu, Min-Huei			Effects of the COVID-19 Pandemic on Treatment Efficiency for Traumatic Brain Injury in the Emergency Department: A Multicenter Study in Taiwan	JOURNAL OF CLINICAL MEDICINE			English	Article						COVID-19 pandemic; treatment efficiency; traumatic brain injury; emergency department		The coronavirus disease 2019 (COVID-19) pandemic has impacted emergency department (ED) practice, including the treatment of traumatic brain injury (TBI), which is commonly encountered in the ED. Our study aimed to evaluate TBI treatment efficiency in the ED during the COVID-19 pandemic. A retrospective observational study was conducted using the electronic medical records from three hospitals in metropolitan Taipei, Taiwan. The time from ED arrival to brain computed tomography (CT) and the time from ED arrival to surgical management were used as measures of treatment efficiency. TBI treatment efficiencies in the ED coinciding with a small-scale local COVID-19 outbreak in 2020 (P1) and large-scale community spread in 2021 (P2) were compared against the pre-pandemic efficiency recorded in 2019. The interval between ED arrival and brain CT was significantly shortened during P1 and P2 compared with the pre-pandemic interval, and no significant delay between ED arrival and surgical management was found, indicating increased treatment efficiency for TBI in the ED during the COVID-19 pandemic. Minimizing viral spread in the community and the hospital is vital to maintaining ED treatment efficiency and capacity. The ED should retain sufficient capacity to treat older patients with serious TBI during the COVID-19 pandemic.	[Lam, Carlos; Wu, Chia-Chieh] Taipei Med Univ, Wan Fang Hosp, Emergency Dept, Taipei 11696, Taiwan; [Lam, Carlos; Wu, Chia-Chieh] Taipei Med Univ, Dept Emergency, Sch Med, Coll Med, Taipei 11030, Taiwan; [Yen, Ju-Chuan] Taipei City Hosp, Dept Ophthalmol, Renai Branch, Taipei 10629, Taiwan; [Yen, Ju-Chuan] Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Technol, Taipei 11030, Taiwan; [Lin, Heng-Yu] Taipei Med Univ, Coll Med, Sch Med, Taipei 11030, Taiwan; [Hsu, Min-Huei] Taipei Med Univ, Grad Inst Data Sci, Coll Management, Taipei 11030, Taiwan		Hsu, MH (corresponding author), Taipei Med Univ, Grad Inst Data Sci, Coll Management, Taipei 11030, Taiwan.	lsk@w.tmu.edu.tw; m701061@tmu.edu.tw; setfreej@gmail.com; b101105091@tmu.edu.tw; 701056@tmu.edu.tw		Lam, Carlos/0000-0002-8051-7485	Taipei Medical University-Wan Fang Hospital [99TMU-WFH-15]; Taipei Medical University [TMU108-AE1-B49]	This research was jointly supported by grants from Taipei Medical University-Wan Fang Hospital (Grant number: 99TMU-WFH-15) and Taipei Medical University (Grant number: TMU108-AE1-B49).	Agarwal M, 2020, EMERG RADIOL, V27, P791, DOI 10.1007/s10140-020-01857-3; Ahmad Isra Asma, 1800, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2021.294; Al Saiegh F, 2021, WORLD NEUROSURG, V146, P20, DOI 10.1016/j.wneu.2020.10.095; [Anonymous], 2020, COVID 19 SITUATION R; [Anonymous], 2020, WEEKLY EPIDEMIOLOGIC; Bullrich MB, 2020, CAN J NEUROL SCI, V47, P693, DOI 10.1017/cjn.2020.101; Chang Y.C., 2021, TAIWANESE MED SECURI; Chen JYH, 2021, J CLIN MED, V10, DOI 10.3390/jcm10061150; Chen P, 2020, CHIN J TRAUMATOL, V23, P202, DOI 10.1016/j.cjtee.2020.05.006; Chen TY, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101635; Choi DH, 2021, J KOREAN MED SCI, V36, DOI 10.3346/jkms.2021.36.e44; Esteban Pedro L, 2020, Bone Jt Open, V1, P617, DOI 10.1302/2633-1462.110.BJO-2020-0120.R1; Faried Ahmad, 1800, Surg Neurol Int, V12, P18, DOI 10.25259/SNI_828_2020; Garcia S, 2020, J AM COLL CARDIOL, V75, P2871, DOI 10.1016/j.jacc.2020.04.011; Hernigou J, 2020, INT ORTHOP, V44, P1473, DOI 10.1007/s00264-020-04619-5; Horan J, 2021, IRISH J MED SCI, V190, P1281, DOI 10.1007/s11845-021-02504-7; Jayakumar N, 2020, WORLD NEUROSURG, V144, pE414, DOI 10.1016/j.wneu.2020.08.162; Jian SW, 2021, INT J INFECT DIS, V104, P746, DOI 10.1016/j.ijid.2021.01.042; Karthigeyan M, 2021, ACTA NEUROCHIR, V163, P1053, DOI 10.1007/s00701-021-04723-4; Kokudo Norihiro, 2021, Glob Health Med, V3, P56, DOI 10.35772/ghm.2021.01031; Lazzerini M, 2020, LANCET CHILD ADOLESC, V4, pE10, DOI 10.1016/S2352-4642(20)30108-5; Lin CF, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.604089; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McCabe R, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01781-w; Megaloikonomos PD, 2020, INT ORTHOP, V44, P1611, DOI 10.1007/s00264-020-04742-3; Pandor A, 2012, J NEUROTRAUM, V29, P707, DOI 10.1089/neu.2011.1967; Santana Rui, 2020, Port J Public Health, V38, P23, DOI 10.1159/000507764; Santing JAL, 2020, NEUROTRAUMA REP, V1, P5, DOI 10.1089/neur.2020.0001; Sen-Crowe B, 2021, J SURG RES, V260, P56, DOI 10.1016/j.jss.2020.11.062; Servadei F, 2021, ACTA NEUROCHIR, V163, P1051, DOI 10.1007/s00701-021-04724-3; Tan TW, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18073456	31	0	0	3	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	NOV	2021	10	22							5314	10.3390/jcm10225314			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XL2AS	WOS:000727952600001	34830592	gold, Green Published			2022-02-06	
J	Le Flao, E; Pichardo, AW; Ganpatt, S; Oranchuk, DJ				Le Flao, Enora; Pichardo, Andrew W.; Ganpatt, Sherwin; Oranchuk, Dustin J.			An Accessible, 16-Week Neck Strength Training Program Improves Head Kinematics Following Chest Perturbation in Young Soccer Athletes	JOURNAL OF SPORT REHABILITATION			English	Article						concussion; quasi-isometric; resistance training; youth	TRAUMATIC BRAIN-INJURY; SEGMENT DYNAMIC STABILIZATION; HIGH-SCHOOL; MUSCLE STRENGTH; UNITED-STATES; IMPACT; RISK; CONCUSSION; PERFORMANCE; PLAYERS	Context: Neck size and strength may be associated with head kinematics and concussion risks. However, there is a paucity of research examining neck strengthening and head kinematics in youths. In addition, neck training is likely lacking in youth sport due to a perceived inadequacy of equipment or time. Objective: Examine neck training effects with minimal equipment on neck strength and head kinematics following chest perturbations in youth athletes. Design: Single-group, pretest-posttest case series. Setting: Athlete training center. Participants: Twenty-five (14 men and 11 women) youth soccer athletes (9.8 [1.5] y). Intervention: Sixteen weeks of twice-weekly neck-focused resistance training utilizing bands, body weight, and manual resistance. Main Outcome Measures: Head kinematics (angular range of motion, peak anterior-posterior linear acceleration, and peak resultant linear acceleration) were measured by an inertial motion unit fixed to the apex of the head during torso perturbations. Neck-flexion and extension strength were assessed using weights placed on the forehead and a plate-loaded neck harness, respectively. Neck length and circumference were measured via measuring tape. Results: Neck extension (increase in median values for all: +4.5 kg, +100%, P < .001; females: +4.5 kg, +100%, P = .002; males: +2.2 kg, +36%, P = .003) and flexion (all: +3.6 kg, +114%, P < .001; females: +3.6 kg, +114%, P = .004; males: +3.6 kg, +114%, P = .001) strength increased following the intervention. Men and women both experienced reduced perturbation-induced head pitch (all: -84%, P < .001). However, peak resultant linear acceleration decreased in the female (-53%, P = .004), but not male (-31%, P = 1.0) subgroup. Preintervention peak resultant linear acceleration and extension strength (R2 = .21, P = .033) were the closest-to-significance associations between head kinematics and strength. Conclusions: Young athletes can improve neck strength and reduce perturbation-induced head kinematics following a 16-week neck strengthening program. However, further research is needed to determine the effect of improved strength and head stabilization on concussion injury rates.	[Le Flao, Enora; Pichardo, Andrew W.; Oranchuk, Dustin J.] Auckland Univ Technol, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [Ganpatt, Sherwin] Concuss Act Prevent Corp, Calgary, AB, Canada		Oranchuk, DJ (corresponding author), Auckland Univ Technol, Sports Performance Res Inst New Zealand, Auckland, New Zealand.	dustinoranchuk@gmail.com					Becker S, 2019, J SPORT SCI MED, V18, P729; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Debison-Larabie, 2016, EXAMINING RELATIONSH; Eckner JT, 2018, AM J PHYS MED REHAB, V97, P292, DOI 10.1097/PHM.0000000000000843; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Fukushima M, 2006, SPINE, V31, P903, DOI 10.1097/01.brs.0000209257.47140.fc; Geary K, 2014, CLIN J SPORT MED, V24, P502, DOI 10.1097/JSM.0000000000000071; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Han TS, 2015, KOREAN J FAM MED, V36, P7, DOI 10.4082/kjfm.2015.36.1.7; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Hrysomallis C, 2016, SPORTS MED, V46, P1111, DOI 10.1007/s40279-016-0490-4; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le Flao E, 2018, SPORTS MED, V48, P2641, DOI 10.1007/s40279-018-0984-3; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lisman P., 2012, INT J SPORTS SCI ENG, V6, P131; Mansell J, 2005, J ATHL TRAINING, V40, P310; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Mortensen JD, 2020, J BIOMECH, V100, DOI 10.1016/j.jbiomech.2019.109411; Muller C, 2021, J STRENGTH COND RES, V35, pS81, DOI 10.1519/JSC.0000000000003822; Nazarahari M, 2020, ANN BIOMED ENG, V48, P2310, DOI 10.1007/s10439-020-02504-1; Peek K, 2020, J ORTHOP SPORT PHYS, V50, P415, DOI 10.2519/jospt.2020.0608; Pelland, 2015, J ATHL ENHANCE, V4, P1; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Soccer UY, 2021, US YOUTH SOCC POL PL; Steele, 2016, J TRAINOL, V5, P13, DOI [10.17338/trainology.5.1_13, DOI 10.17338/TRAINOLOGY.5.1_13]; Stoykov ME, 2015, J NEUROL PHYS THER, V39, P33, DOI 10.1097/NPT.0000000000000065; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Versteegh TH, 2020, J STRENGTH COND RES, V34, P708, DOI 10.1519/JSC.0000000000003091; Wahlquist VE, 2021, SPORTS MED, V51, P51, DOI 10.1007/s40279-020-01376-8	34	0	0	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	NOV	2021	30	8					1158	1165		10.1123/jsr.2020-0537			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	WM6MX	WOS:000711198600007	34330102				2022-02-06	
J	Lecques, JD; Kerr, BJK; Hillyer, LM; Kang, JX; Robinson, LE; David, WL				Lecques, Jessica-Dominique; Kerr, Brynna J. K.; Hillyer, Lyn M.; Kang, Jing X.; Robinson, Lindsay E.; David, W. L.			N-3 Polyunsaturated Fatty Acids Ameliorate Neurobehavioral Outcomes Post-Mild Traumatic Brain Injury in the Fat-1 Mouse Model	NUTRIENTS			English	Article						concussion; mild traumatic brain injury; TBI; n-3 PUFA; neurological sensitivity score	PROFESSIONAL FOOTBALL; HEAD IMPACTS; CONCUSSION; BIOMECHANICS; EPIDEMIOLOGY; SUPPLEMENTATION; STABILITY; RECOVERY; PLAYER; SPORT	Concussions and mild traumatic brain injury (m-TBI) have been identified as a consequential public health concern because of their potential to cause considerable impairments in physical, cognitive, behavioral, and social functions. Given their prominent structural and functional roles in the brain, n-3 polyunsaturated fatty acids (PUFA) have been identified as a potentially viable prophylactic agent that may ameliorate the deleterious effects of m-TBI on brain function. The purpose of the present pilot study was to investigate the effect of n-3 PUFA on neurologic function using a weight drop injury (WDI) model. Fat-1 mice, capable of synthesizing n-3 PUFA endogenously from n-6 PUFA, and their wild-type (WT) counterparts, were subjected to a mild low-impact WDI on the closed cranium, and recovery was evaluated using the neurological severity score (NSS) to assess the motor and neurobehavioral outcomes. In comparison to the WT mice, the fat-1 mice had a significantly (p & LE; 0.05) lower NSS at all time points post-WDI, and significantly greater neurological restoration measured as the time to first movement. Overall, these findings demonstrate the protective effect of n-3 PUFA against mild brain injury.	[Lecques, Jessica-Dominique; Kerr, Brynna J. K.; Hillyer, Lyn M.; Robinson, Lindsay E.; David, W. L.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Kang, Jing X.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kang, Jing X.] Harvard Med Sch, Boston, MA 02114 USA		David, WL (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	jlecquO1@guelphhumber.ca; brynna@uoguelph.ca; lhillyer@uoguelph.ca; kang.jing@mgh.harvard.edu; lrobinson@uoguelph.ca; davidma@uoguelph.ca		Ma, David/0000-0002-1165-5972	University of Guelph-Humber Research Fund	This research was funded by the University of Guelph-Humber Research Fund to D.W.L.M.	Barrett EC, 2014, ADV NUTR, V5, P268, DOI 10.3945/an.113.005280; Cancelliere C, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-17; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, SEVERE MATERNAL MORB CTR DIS CONTR PREV; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Fisher M, 2011, STROKE, V42, P3300, DOI 10.1161/STROKEAHA.111.626655; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FOLCH J, 1957, J BIOL CHEM, V226, P497; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kriger B., 2012, COMPLETE WORKS, V1st ed., P653; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Lewis MD, 2016, J AM COLL NUTR, V35, P469, DOI 10.1080/07315724.2016.1150796; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Orr SK, 2010, NEUROCHEM RES, V35, P811, DOI 10.1007/s11064-010-0139-x; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Thau-Zuchman O, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6420; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yarnell Angela M, 1800, Curr Protoc Neurosci, V75, DOI 10.1002/cpns.10	41	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6643		NUTRIENTS	Nutrients	NOV	2021	13	11							4092	10.3390/nu13114092			11	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	XG8ES	WOS:000724981600001	34836347	Green Published, gold			2022-02-06	
J	Leonard, C; Desaulniers-Simon, JM; Tat, D; De Beaumont, L; Gosselin, N				Leonard, Camille; Desaulniers-Simon, Jeanne Marie; Tat, Diana; De Beaumont, Louis; Gosselin, Nathalie			Effects of Music Intervention on Stress in Concussed and Non-Concussed Athletes	BRAIN SCIENCES			English	Article						sport-related concussion; athletes; stress; musical intervention; music; emotions; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; HEART-RATE-VARIABILITY; SYMPTOMS QUESTIONNAIRE; PSYCHOSOCIAL STRESS; RELAXING MUSIC; BLOOD-PRESSURE; SPORT; EXERCISE; RECOVERY; ANXIETY	Sport-related concussion is a serious public health issue affecting millions of individuals each year. Among the many negative side effects, emotional symptoms, such as stress, are some of the most common. Stress management is repeatedly cited by expert groups as an important intervention for this population. It was shown that music has relaxing effects, reducing stress through the activation of brain areas involved in emotions and pleasure. The objective of this study was to explore the effects of a music-listening intervention compared with silence on experimentally induced stress in concussed and non-concussed athletes. To this aim, four groups of athletes (non-concussed music, non-concussed silence, concussed music, and concussed silence) performed the Trier Social Stress Test, for which both physiological (skin conductance level) and self-reported stress measurements were taken. No significant difference was found in the pattern of stress recovery for self-reported measurements. However, the skin conductance results showed greater and faster post-stress recovery after listening to music compared with silence for concussed athletes only. Taken together, these results suggest that music could be an efficient stress management tool to implement in the everyday life of concussed athletes to help them prevent stress accumulation.	[Leonard, Camille; Tat, Diana; Gosselin, Nathalie] Univ Montreal, Dept Psychol, Montreal, PQ H3T 1J4, Canada; [Leonard, Camille; Desaulniers-Simon, Jeanne Marie; Tat, Diana; Gosselin, Nathalie] Int Lab Brain Music & Sound Res BRAMS, Outremont, PQ H2V 2S9, Canada; [Leonard, Camille; Desaulniers-Simon, Jeanne Marie; Tat, Diana; Gosselin, Nathalie] Univ Montreal, Mus Emot & Cognit Res Lab MUSEC, Montreal, PQ H2V 2S9, Canada; [Desaulniers-Simon, Jeanne Marie] Univ Montreal, Fac Med, Montreal, PQ H3T 1J4, Canada; [De Beaumont, Louis] Univ Montreal, Dept Surg, Montreal, PQ H3T 1J4, Canada; [De Beaumont, Louis] Hop Sacre Coeur Montreal, CIUSSS Nord Ile Montreal Res Ctr, Montreal, PQ H4J 1C5, Canada; [Gosselin, Nathalie] McGill Univ, Ctr Res Brain Language & Mus CRBLM, Montreal, PQ H3G 2A8, Canada		Gosselin, N (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ H3T 1J4, Canada.; Gosselin, N (corresponding author), Int Lab Brain Music & Sound Res BRAMS, Outremont, PQ H2V 2S9, Canada.; Gosselin, N (corresponding author), Univ Montreal, Mus Emot & Cognit Res Lab MUSEC, Montreal, PQ H2V 2S9, Canada.; Gosselin, N (corresponding author), McGill Univ, Ctr Res Brain Language & Mus CRBLM, Montreal, PQ H3G 2A8, Canada.	camille.leonard@umontreal.ca; jeanne.marie.desaulniers-simon@umontreal.ca; diana.tat@umontreal.ca; louis.de.beaumont@umontreal.ca; nathalie.gosselin@umontreal.ca			Conseil de Recherche en Sciences Humaines du Canada (Programme Savoir); Fonds de Recherche du Quebec and Reseau provincial de recherche en adaptation-readaptation	Part of this research was funded by Conseil de Recherche en Sciences Humaines du Canada (Programme Savoir), Fonds de Recherche du Quebec and Reseau provincial de recherche en adaptation-readaptation.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V70; [Anonymous], 2007, PSYCHOL MUSIC, DOI [DOI 10.1177/0305735607070375, 10.1177/0305735607070375]; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bergeron J., 1976, CROSS CULT ANXIETY, V1, P41; Birkett MA, 2011, JOVE-J VIS EXP, DOI 10.3791/3238; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Bradt J., 2007, PRINCIPLES PRACTICE; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cacioppo JT, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P1, DOI 10.2277/ 0521844711; Campbell J, 2012, PSYCHONEUROENDOCRINO, V37, P1111, DOI 10.1016/j.psyneuen.2011.12.010; Chafin S, 2004, BRIT J HEALTH PSYCH, V9, P393, DOI 10.1348/1359107041557020; Chanda ML, 2013, TRENDS COGN SCI, V17, P179, DOI 10.1016/j.tics.2013.02.007; Chen G, 2019, UBICOMP/ISWC'19 ADJUNCT: PROCEEDINGS OF THE 2019 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING AND PROCEEDINGS OF THE 2019 ACM INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS, P907, DOI 10.1145/3341162.3346272; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Conder R, 2015, BRAIN INJURY, V29, P249, DOI 10.3109/02699052.2014.965209; Contrada R., 2011, HDB STRESS SCI BIOL; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davies SC, 2015, J CLIN SPORT PSYCHOL, V9, P101, DOI 10.1123/jcsp.2014-0037; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; de la Torre-Luque A, 2017, PSYCHOL MUSIC, V45, P795, DOI 10.1177/0305735617689953; de Witte M, 2020, HEALTH PSYCHOL REV, V14, P294, DOI 10.1080/17437199.2019.1627897; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Ferreri L, 2019, P NATL ACAD SCI USA, V116, P3793, DOI 10.1073/pnas.1811878116; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Grapperon J, 2012, ENCEPHALE, V38, P149, DOI 10.1016/j.encep.2011.05.004; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hellhammer, 2007, 10 YEARS RES TRIER S; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Ilie G., 2013, CAN J MUSIC THER, V19, P23; Jiang J, 2016, ART PSYCHOTHER, V48, P62, DOI 10.1016/j.aip.2016.02.002; Karageorghis CI, 2006, RES Q EXERCISE SPORT, V77, P240; Karageorghis CI, 2011, RES Q EXERCISE SPORT, V82, P274; Kemper KJ, 2005, SOUTH MED J, V98, P282, DOI 10.1097/01.SMJ.0000154773.11986.39; Khalfa S, 2003, ANN NY ACAD SCI, V999, P374, DOI 10.1196/annals.1284.045; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Knight WEJ, 2001, J MUSIC THER, V38, P254, DOI 10.1093/jmt/38.4.254; Koelsch S, 2015, EUR HEART J, V36, P3043, DOI 10.1093/eurheartj/ehv430; Koelsch S, 2014, NAT REV NEUROSCI, V15, P170, DOI 10.1038/nrn3666; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Kuan G, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00014; Kuhlmann AYR, 2018, BRIT J SURG, V105, P773, DOI 10.1002/bjs.10853; Labbe E, 2007, APPL PSYCHOPHYS BIOF, V32, P163, DOI 10.1007/s10484-007-9043-9; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laukka P, 2013, PSYCHOL MUSIC, V41, P198, DOI 10.1177/0305735611422507; Lee KS, 2016, J ALTERN COMPLEM MED, V22, P59, DOI 10.1089/acm.2015.0079; Lesage FX, 2012, INT J OCCUP MED ENV, V25, P178, DOI 10.2478/S13382-012-0024-8; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lupien SJ, 2009, CAN J PSYCHIAT, V54, P4, DOI 10.1177/070674370905400103; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucke M, 2018, SPORTS MED, V48, P2607, DOI 10.1007/s40279-018-0979-0; Murison R., 2016, NEUROSCIENCE PAIN ST, P29, DOI [10.1016/B978-0-12-800538-5.00002-9, DOI 10.1016/B978-0-12-800538-5.00002-9]; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Pelletier CL, 2004, J MUSIC THER, V41, P192, DOI 10.1093/jmt/41.3.192; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Radstaak M, 2014, PSYCHOSOM MED, V76, P529, DOI 10.1097/PSY.0000000000000094; Rimmele U, 2009, PSYCHONEUROENDOCRINO, V34, P190, DOI 10.1016/j.psyneuen.2008.08.023; Sandstrom G.M., 2010, MUSIC MED, V2, P137, DOI DOI 10.1177/1943862110371486; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Spielberger C.D., 2013, ANXIETY CURR TRENDS; Spielberger CD., 1970, STATE TRAIT ANXIETY; Tat D., 2015, 10 ANN S INT LAB BRA; Terry PC, 2020, PSYCHOL BULL, V146, P91, DOI 10.1037/bul0000216; Thompson C, 2016, BRAIN INJURY, V30, P770; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Villada C, 2016, STRESS HEALTH, V32, P90, DOI 10.1002/smi.2582; Wearne TA, 2019, INT J PSYCHOPHYSIOL, V141, P76, DOI 10.1016/j.ijpsycho.2019.04.012; Wiese-Bjornstal D.M., 2015, KINESIOL REV, V4, P169, DOI [https://doi.org/10.1123/kr.2015-0012, DOI 10.1123/KR.2015-0012]; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Zatorre RJ, 2013, P NATL ACAD SCI USA, V110, P10430, DOI 10.1073/pnas.1301228110	79	0	0	4	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	NOV	2021	11	11							1501	10.3390/brainsci11111501			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XL2SX	WOS:000728000200001	34827500	Green Published, gold			2022-02-06	
J	Ling, H; Yang, LJ; Huang, ZX; Zhang, BY; Dou, ZQ; Wu, JW; Jin, T; Sun, CR; Zheng, J				Ling, Hui; Yang, Lijun; Huang, Zhaoxu; Zhang, Buyi; Dou, Zhangqi; Wu, Jiawei; Jin, Taian; Sun, Chongran; Zheng, Jian			Contralateral subdural effusion after decompressive craniectomy: What is the optimal treatment?	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Contralateral subdural effusion; Decompressive craniectomy; Burr hole drainage; Cranioplasty; Shunting	TRAUMATIC BRAIN-INJURY; PARADOXICAL HERNIATION; CLINICAL-FEATURES; CRANIOPLASTY; SECONDARY	Objective: Contralateral subdural effusion after decompressive craniectomy (CSEDC) is rare, and the optimal treatment is not determined. We present 11 cases of CSEDC and give an overview of the English literature pertaining to this disease. Methods: We searched the database at our institution and performed a search of English literature in PubMed and Google Scholar. Keywords used were as follows (single word or combination): "subdural hygroma"; "subdural effusion"; "decompressive craniectomy". Only patients with CSEDC and contained adequate clinical information pertinent to the analysis were included. Results: 11 cases of CSEDC were recorded at our institution. They comprised ten men and one woman with an average age of 41.9 years. All the 8 symptomatic patients underwent surgery and the CSEDC resolved gradually. 68 cases of CSEDC were found in the literature. Including ours, a total of 79 patients were analyzed. Conservative treatment was effective in the asymptomatic patients. 41.7% of the symptomatic CSEDC underwent burr hole drainage and successfully drained the CSEDC. However, 76% of them received subsequent surgery to manage the reaccumulation of CSEDC. 25% of the symptomatic patients underwent cranioplasty, while 13.3% of them received Ommaya drainage later because of CSEDC recurrence. 18.3% of the symptomatic patients underwent cranioplasty plus subduroperitoneal shunting, and all CSEDC resolved completely. Conclusions: Burr hole drainage appears to be only a temporary measure. Early cranioplasty should be performed for patients with CSEDC. CSF shunting procedures may be required for patients in whom CSEDC have not been solved or hydrocephalus manifest after cranioplasty.	[Ling, Hui; Dou, Zhangqi; Wu, Jiawei; Jin, Taian; Sun, Chongran; Zheng, Jian] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China; [Yang, Lijun] JiangShan Peoples Hosp, Dept Neurosurg, 9 Daohang Rd, Jiangshan 324100, Zhejiang, Peoples R China; [Huang, Zhaoxu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Echocardiog, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China; [Zhang, Buyi] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pathol, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China		Zheng, J (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	linghui@zju.edu.cn; 37624713@qq.com; huangzhaoxu85@163.com; 2510174@zju.edu.cn; douzhangqi@zju.edu.cn; 21818268@zju.edu.cn; 22018425@zju.edu.cn; sun.chongran@zju.edu.cn; 2313065@zju.edu.cn			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701153]; Key Research andDevelopment Projects in Zhejiang Province, China [2021C03067]	This work was supported by the grant of the National Nature Science Foundation of China (Grant No. 81701153) ; and Key Research andDevelopment Projects in Zhejiang Province, China. (Grant No. 2021C03067) .	Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Avecillas-Chasin JM, 2015, ACTA NEUROCHIR, V157, P2121, DOI 10.1007/s00701-015-2537-y; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Cho Jun Beom, 2005, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V38, P273; Creutzfeldt CJ, 2015, J NEUROSURG, V123, P1170, DOI 10.3171/2014.11.JNS141810; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kilincer C, 2005, CLIN NEUROL NEUROSUR, V107, P412, DOI 10.1016/j.clineuro.2004.09.018; Krishnan P, 2015, BRIT J NEUROSURG, V29, P730, DOI 10.3109/02688697.2015.1039485; Lin M.S., 2015, SCI WORLD J, V2015; Nievas MNCY, 2006, NEUROL RES, V28, P139, DOI 10.1179/016164106X98008; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; Rahme R, 2010, NEUROSURGERY, V67, pE214, DOI 10.1227/01.NEU.0000370015.94386.1F; Salunke P, 2015, J NEUROSURG, V122, P602, DOI 10.3171/2014.10.JNS14780; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Su FW, 2008, J CLIN NEUROSCI, V15, P305, DOI 10.1016/j.jocn.2006.08.019; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Wan Y, 2016, CLIN NEUROL NEUROSUR, V149, P87, DOI 10.1016/j.clineuro.2016.08.004; Wang HK, 2012, INJURY, V43, P594, DOI 10.1016/j.injury.2010.06.004; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Wu RH, 2019, BMC SURG, V19, DOI 10.1186/s12893-019-0489-5; Yang XF, 2010, ACTA NEUROCHIR, V152, P555, DOI 10.1007/s00701-009-0475-2; Yang XF, 2009, MED PRIN PRACT, V18, P16, DOI 10.1159/000163040; Yuan Q, 2015, BRAIN INJURY, V29, P971, DOI 10.3109/02699052.2015.1004760; Zhu L, 2017, BRIT J NEUROSURG, V31, P628, DOI 10.1080/02688697.2016.1229742	25	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	NOV	2021	210								106950	10.1016/j.clineuro.2021.106950			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WD4XA	WOS:000704944300013	34583274				2022-02-06	
J	Lv, QW; Zheng, ZQ; Zhang, H; Guo, M; Shen, LJ				Lv, Qing-Wei; Zheng, Zi-Qiang; Zhang, Han; Guo, Mi; Shen, Liang-Jun			Serum hypoxia-inducible factor 1alpha emerges as a prognostic factor for severe traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Severe traumatic brain injury; Hypoxia-inducible factor 1alpha; Prognosis; Biomarker; Severity; Outcome	RECOMBINANT ADENOVIRUS; UP-REGULATION; STEM-CELLS; ISCHEMIA; HIF-1-ALPHA; EXPRESSION; AQUAPORIN; OXYGEN; EDEMA; MODEL	Background: Hypoxia-inducible factor 1alpha (HIF-1 alpha) is implicated in the cell's response to hypoxia. We investigated whether serum HIF-1 alpha concentrations are correlated with the severity and clinical outcome of severe traumatic brain injury (sTBI). Methods: Serum HIF-1 alpha concentrations were quantified in 104 sTBI patients and 80 healthy controls. Trauma severity was assessed using Glasgow coma scale (GCS). Glasgow outcome scale (GOS) score of 1-3 at post-trauma 90 days was defined as a poor outcome. Multivariate analyses were performed to discern the relationship between serum HIF-1 alpha concentrations and outcome. Results: Patients displayed significantly higher serum HIF-1 alpha concentrations than controls (median, 294.9 versus 102.7 pg/ml). HIF-1 alpha concentrations were intimately related to GCS scores (r =-0.62) and GOS scores (r =-0.64). 48 patients (46.2%) experienced a poor outcome. Serum HIF-1 alpha concentrations > 280.2 pg/ml significantly distinguished patients with the development of poor outcome with 77.1% sensitivity and 69.6% specificity (AUC, 0.750; 95% CI: 0.655-0.829). Serum HIF-1 alpha concentrations > 280.2 pg/ml emerged as an independent predictor for poor outcome (OR: 4.179; 95% CI: 1.024-17.052). Conclusions: Serum HIF-1 alpha concentrations are tightly associated with trauma severity and poor 90-day outcome, substantializing serum HIF-1 alpha as a promising prognostic biomarker for sTBI.	[Lv, Qing-Wei; Zheng, Zi-Qiang; Zhang, Han; Guo, Mi; Shen, Liang-Jun] Zhejiang Univ, Dept Neurosurg, Shengzhou Peoples Hosp, Affiliated Hosp 1,Shengzhou Branch, 666 Dangui Rd, Shengzhou 312400, Zhejiang, Peoples R China		Lv, QW (corresponding author), Zhejiang Univ, Dept Neurosurg, Shengzhou Peoples Hosp, Affiliated Hosp 1,Shengzhou Branch, 666 Dangui Rd, Shengzhou 312400, Zhejiang, Peoples R China.	lqw123202107@163.com					Godoy DA, 2018, NEUROSURG CLIN N AM, V29, P195, DOI 10.1016/j.nec.2017.12.001; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Cartagena CM, 2014, MOL CELL NEUROSCI, V60, P81, DOI 10.1016/j.mcn.2014.04.005; Chen CH, 2009, NEUROBIOL DIS, V33, P509, DOI 10.1016/j.nbd.2008.12.010; Cruz J, 1997, NEUROSURGERY, V40, P1104, DOI 10.1097/00006123-199705000-00054; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Dong YS, 2013, BRAIN RES, V1517, P114, DOI 10.1016/j.brainres.2013.04.024; Fan X, 2009, BRAIN RES REV, V62, P99, DOI 10.1016/j.brainresrev.2009.09.006; Haddad JJ, 2003, CRIT CARE, V7, P47, DOI 10.1186/cc1840; Halterman MW, 1999, J NEUROSCI, V19, P6818, DOI 10.1523/JNEUROSCI.19-16-06818.1999; Higashida T, 2011, CURR NEUROVASC RES, V8, P44, DOI 10.2174/156720211794520251; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Huang T, 2014, NEUROREPORT, V25, P1122, DOI 10.1097/WNR.0000000000000236; JENNETT B, 1975, LANCET, V1, P480; Jiang YJ, 2002, J CEREBR BLOOD F MET, V22, P689, DOI 10.1097/00004647-200206000-00007; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Li YQ, 2020, PHARM BIOL, V58, P438, DOI 10.1080/13880209.2020.1762667; Lv BK, 2017, AM J TRANSL RES, V9, P1521; Ramamoorthy P, 2019, NEUROCHEM RES, V44, P258, DOI 10.1007/s11064-018-2516-9; Ramamoorthy P, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-51; Sang XG, 2017, ANN CLIN BIOCHEM, V54, P584, DOI 10.1177/0004563216673087; Tang B, 2019, CLIN CHIM ACTA, V495, P227, DOI 10.1016/j.cca.2019.04.070; Wang Z, 2012, J MOL NEUROSCI, V48, P273, DOI 10.1007/s12031-012-9769-6; Xue LX, 2017, J NEUROL SCI, V375, P52, DOI 10.1016/j.jns.2017.01.039; Yu Z, 2013, ASIAN PAC J TROP MED, V6, P762, DOI 10.1016/S1995-7645(13)60134-0; Zhang L, 2009, NEUROSCI LETT, V461, P1, DOI 10.1016/j.neulet.2009.03.091; Zhu TN, 2014, J NEUROPATH EXP NEUR, V73, P975, DOI 10.1097/NEN.0000000000000118	29	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	NOV	2021	522						77	82		10.1016/j.cca.2021.08.017			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	WD3SV	WOS:000704865700010	34411556				2022-02-06	
J	Ma, HP; Ou, JC; Chen, KY; Liao, KH; Kang, SJ; Wang, JY; Chiang, YH; Wu, JCC				Ma, Hon-Ping; Ou, Ju-Chi; Chen, Kai-Yun; Liao, Kuo-Hsing; Kang, Shuo-Jhen; Wang, Jia-Yi; Chiang, Yung-Hsiao; Wu, John Chung-Che			Screening for Poor Self-Reported Sleep Quality at 12 Weeks in Post-Mild Traumatic Brain Injury Patients Using the HF-Age-Gender (HAG) Index	BRAIN SCIENCES			English	Article						mild traumatic brain injury; sleep quality; heart rate variability; Pittsburgh sleep quality index	HEART-RATE-VARIABILITY; PATHOPHYSIOLOGY; EPIDEMIOLOGY; INFLAMMATION; MORTALITY; CYTOKINES; IMPACT; TERM	To identify a screening tool for poor self-reported sleep quality at 12 weeks according to non-invasive measurements and patients' characteristics in the first week after mild traumatic brain injury (mTBI), data from 473 mTBI participants were collected and follow-ups were performed at 12 weeks. Patients with previous poor self-reported sleep quality prior to the injury were excluded. Patients were then divided into two groups at 12 weeks according to the Pittsburgh Sleep Quality Index based on whether or not they experienced poor sleep quality. The analysis was performed on personal profiles and heart rate variability (HRV) for 1 week. After analyzing the non-invasive measurements and characteristics of mTBI patients who did not complain of poor sleep quality, several factors were found to be relevant to the delayed onset of poor sleep quality, including age, gender, and HRV measurements. The HRV-age-gender (HAG) index was proposed and found to have 100% sensitivity (cut-off, 7; specificity, 0.537) to predicting whether the patient will experience poor sleep quality after mTBI at the 12-week follow-up. The HAG index helps us to identify patients with mTBI who have no sleep quality complaints but are prone to developing poor self-reported sleep quality. Additional interventions to improve sleep quality would be important for these particular patients in the future.	[Ma, Hon-Ping] Taipei Med Univ, Shuang Ho Hosp, Dept Emergency Med, New Taipei 235, Taiwan; [Ma, Hon-Ping] Taipei Med Univ, Sch Med, Dept Emergency Med, Taipei 110, Taiwan; [Ma, Hon-Ping] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei 110, Taiwan; [Ma, Hon-Ping; Ou, Ju-Chi; Chen, Kai-Yun; Liao, Kuo-Hsing; Kang, Shuo-Jhen; Wang, Jia-Yi; Chiang, Yung-Hsiao; Wu, John Chung-Che] Taipei Med Univ, Neurosci Res Ctr, Taipei 110, Taiwan; [Ou, Ju-Chi; Kang, Shuo-Jhen; Chiang, Yung-Hsiao; Wu, John Chung-Che] Taipei Med Univ, Sch Med, Coll Med, Dept Surg,Div Neurosurg, Taipei 110, Taiwan; [Liao, Kuo-Hsing] Taipei Med Univ, Grad Inst Neural Regenerat Med, Coll Med Sci & Technol, Taipei 110, Taiwan; [Liao, Kuo-Hsing] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei 116, Taiwan; [Wang, Jia-Yi; Chiang, Yung-Hsiao; Wu, John Chung-Che] Taipei Med Univ Hosp, Dept Neurosurg, Div Neurosurg, Taipei 110, Taiwan		Wu, JCC (corresponding author), Taipei Med Univ, Neurosci Res Ctr, Taipei 110, Taiwan.; Wu, JCC (corresponding author), Taipei Med Univ, Sch Med, Coll Med, Dept Surg,Div Neurosurg, Taipei 110, Taiwan.; Wu, JCC (corresponding author), Taipei Med Univ Hosp, Dept Neurosurg, Div Neurosurg, Taipei 110, Taiwan.	acls2000@tmu.edu.tw; juchi.tmu@gmail.com; kychen08@tmu.edu.tw; khliao@tmu.edu.tw; terbiun@gmail.com; jywang2010@tmu.edu.tw; ychiang@tmu.edu.tw; johnwu@tmu.edu.tw		Wang, Jia-Yi/0000-0002-9106-3351	Ministry of Science and Technology [MOST- 108-2321-B-038-008, 109-2314-B-038-050]; Taipei Medical University [DP2-108-21121-01-N-05-01]; Sunny Brain Tumor and Brain Disease Research and Development Fund	FundingThis work was supported by funding from the Taiwan Ministry of Health and Welfare (MOHW109-TDU-B-212-114007, MOHW110-TDU-B-212-124007); the Ministry of Science and Technology (MOST-108-2321-B-038-008, 108-2314-B-038-062, 109-2314-B-038-050); Taipei Medical University (DP2-108-21121-01-N-05-01); and the Sunny Brain Tumor and Brain Disease Research and Development Fund.	Bohnen NI, 2019, J PARKINSON DIS, V9, P603, DOI 10.3233/JPD-191627; Buysse D J, 1989, Psychiatry Res, V28, P193; Camm AJ, 1996, CIRCULATION, V93, P1043; Davalos A, 2005, STROKE, V36, P489; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Fei L, 1996, AM J CARDIOL, V77, P681, DOI 10.1016/S0002-9149(97)89199-0; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gorman JM, 2000, AM HEART J, V140, P577; Huang TY, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/378726; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Koch C, 2019, PSYCHOL MED, V49, P1948, DOI 10.1017/S0033291719001351; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; La Rovere MT, 1998, LANCET, V351, P478; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lombardi F, 1996, CARDIOVASC RES, V32, P208, DOI 10.1016/0008-6363(96)00116-2; Ma HP, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/4364592; Mallon L, 2002, J INTERN MED, V251, P207, DOI 10.1046/j.1365-2796.2002.00941.x; Medenwald D, 2017, EUROPACE, V19, P110, DOI 10.1093/europace/euv333; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Saber M, 2020, EUR J NEUROSCI, V52, P2791, DOI 10.1111/ejn.14611; Shaffer F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01040; Sung CW, 2016, CLIN NEUROPHYSIOL, V127, P1629, DOI 10.1016/j.clinph.2015.08.006; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tapp ZM, 2020, J NEUROTRAUM, V37, P1829, DOI 10.1089/neu.2020.7010; TEASDALE G, 1974, LANCET, V2, P81; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Urbanik D, 2019, SLEEP MED, V54, P8, DOI 10.1016/j.sleep.2018.09.014; Webster SJ, 2013, J NEUROTRAUM, V30, pA155; Wu WW, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15092055; Yasuda T, 2005, SLEEP, V28, P177, DOI 10.1093/sleep/28.2.177; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	35	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	NOV	2021	11	11							1369	10.3390/brainsci11111369			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XM6AS	WOS:000728908000001	34827369	Green Published			2022-02-06	
J	Martindale, SL; Shura, RD; Rostami, R; Taber, KH; Rowland, JA				Martindale, Sarah L.; Shura, Robert D.; Rostami, Ramona; Taber, Katherine H.; Rowland, Jared A.			Research Letter: Blast Exposure and Brain Volume	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						blast; concussion; explosion; hippocampus; military; posttraumatic stress disorder; traumatic brain injury; veteran	ABNORMALITIES	Objective: To determine whether blast exposure is associated with brain volume beyond posttraumatic stress disorder (PTSD) diagnosis and history of traumatic brain injury (TBI). Setting: Veterans Affairs Medical Center. Participants: One hundred sixty-three Iraq and Afghanistan combat veterans, 86.5% male, and 68.10% with a history of blast exposure. Individuals with a history of moderate to severe TBI were excluded. Main Measures: Clinician-Administered PTSD Scale (CAPS-5), Mid-Atlantic MIRECC Assessment of TBI (MMA-TBI), Salisbury Blast Interview (SBI), and magnetic resonance imaging. Maximum blast pressure experienced from a blast event represented blast severity. Methods: Hierarchical regression analysis evaluated effects of maximum pressure experienced from a blast event on bilateral volume of hippocampus, anterior cingulate cortex, amygdala, orbitofrontal cortex, precuneus, and insula. All analyses adjusted for effects of current and lifetime PTSD diagnosis, and a history of deployment mild TBI. Results: Maximum blast pressure experienced was significantly associated with lower bilateral hippocampal volume (left: Delta R2 = 0.032, P < .001; right: Delta R2 = 0.030, P < .001) beyond PTSD diagnosis and deployment mild TBI history. Other characteristics of blast exposure (time since most recent exposure, distance from closest blast, and frequency of blast events) were not associated with evaluated volumes. Conclusion: Exposure to a blast is independently associated with hippocampal volume beyond PTSD and mild TBI; however, these effects are small. These results also demonstrate that blast exposure in and of itself may be less consequential than severity of the exposure as measured by the pressure gradient.	[Martindale, Sarah L.; Shura, Robert D.; Taber, Katherine H.; Rowland, Jared A.] MidAtlantic Mental Illness Res Educ & Clin Ctr MA, Res & Acad Affairs Serv Line, Houston, NC USA; Mental Hlth & Behav Sci Serv Line, Salisbury, NC USA; [Rostami, Ramona] WG Bill Hefner VA Healthcare Syst, Salisbury, NC USA; [Martindale, Sarah L.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27101 USA; [Shura, Robert D.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27101 USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27101 USA; [Taber, Katherine H.] Edward Via Coll Osteopath Med, Div Biomed Sci, Blacksburg, VA USA; [Taber, Katherine H.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Martindale, SL (corresponding author), MidAtlantic Mental Illness Res Educ & Clin Ctr MA, Res & Acad Affairs Serv Line, Houston, NC USA.; Martindale, SL (corresponding author), WG Bill Hefner VA Healthcare Syst, Res & Acad Affairs Serv Line, 1601 Brenner Ave 11M, Salisbury, NC 28144 USA.	Sarah.Martindale-Supak@va.gov; robert.shura2@va.gov; ramona.rostami@va.gov; taber@maierlair.org; jared.rowland@va.gov	Martindale, Sarah L/O-8553-2018	Martindale, Sarah L/0000-0002-0059-3454	Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) AwardUnited States Department of Defense [W81XWH13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]	This work was supported by grant funding from Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH13-2-0095 and Department of Veterans Affairs CENC Award I01 CX001135. The authors thank the veterans and service members who contributed their time and effort to this research. The authors also thank Mary Peoples, David J. Curry, MSW, Christine Sortino, MS, Alana M. Higgins, MA, and G. Melissa Evans, MA, for their contributions to this project.	Badea A, 2018, NEUROIMAGE-CLIN, V18, P60, DOI 10.1016/j.nicl.2018.01.007; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Eierued C, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101793; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Martindale SL, 2020, J HEAD TRAUMA REHAB, V35, pE330, DOI 10.1097/HTR.0000000000000559; Ratliff WA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59252-4; Rowland JA, 2020, J NEUROTRAUM, V37, P1797, DOI 10.1089/neu.2019.6972; Rowland JA, 2020, BRAIN INJURY, V34, P642, DOI 10.1080/02699052.2020.1729418; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Stone JR, 2020, J NEUROTRAUM, V37, P2468, DOI 10.1089/neu.2020.7141; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Weathers FW, 2013, CLIN ADM PTSD SCALE; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	15	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2021	36	6			SI		424	428		10.1097/HTR.0000000000000660			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WV3QT	WOS:000717155100009	33656482				2022-02-06	
J	Martindale, SL; Ord, AS; Rule, LG; Rowland, JA				Martindale, Sarah L.; Ord, Anna S.; Rule, Lakeysha G.; Rowland, Jared A.			Effects of blast exposure on psychiatric and health symptoms in combat veterans	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Posttraumatic stress; Depression; Neurobehavioral symptoms; Sleep; Quality of life; Traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; FUNCTIONAL CONNECTIVITY; SERVICE MEMBERS; PAIN; MECHANISM; VALIDITY	Blast exposure is common among service members, but the chronic psychiatric effects associated with blast exposure are not well-characterized independent of a resulting mild traumatic brain injury (TBI). This analysis evaluated whether blast exposure severity was independently associated with or exacerbated symptom report beyond posttraumatic stress disorder (PTSD) and mild TBI. Participants were Iraq and Afghanistan combat veterans (N = 275; 86.55% male), 71.27% with history of blast exposure, 29.82% current diagnosis of PTSD, and 45.45% with mild TBI. All participants completed diagnostic interviews for PTSD, lifetime TBI, and lifetime blast exposure. Self-reported psychiatric and health outcomes included posttraumatic stress symptoms, depressive symptoms, neurobehavioral symptoms, sleep quality, pain interference, and quality of life. Blast severity was associated with PTSD (B = 2.00), depressive (B = 0.76), and neurobehavioral (B = 1.69) symptoms beyond PTSD diagnosis and mild TBI history. Further, blast severity accounted entirely (i.e., indirect/mediation effect) for the association between TBI and posttraumatic stress (B = 1.62), depressive (B = 0.61), and neurobehavioral (B = 1.38) symptoms. No interaction effects were present. Exposure to blast is an independent factor influencing psychiatric symptoms in veterans beyond PTSD and mild TBI. Results highlight that blast exposure severity may be a more relevant risk factor than deployment mild TBI in combat veterans and should be considered in the etiology of psychiatric symptom presentation and complaints. Further, severity of psychological distress due to the combat environment may be an explanatory mechanism by which blast exposure mediates the relationship between mild TBI and symptom outcomes.	[Martindale, Sarah L.; Ord, Anna S.; Rule, Lakeysha G.; Rowland, Jared A.] WG Bill Hefner VA Healthcare Syst, Midatlant Mental Illness Res Educ & Clin Ctr MA M, Salisbury, NC 28144 USA; [Martindale, Sarah L.; Ord, Anna S.; Rowland, Jared A.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27101 USA		Martindale, SL (corresponding author), WG Bill Hefner VA Healthcare Syst, Res & Acad Affairs Serv Line, 1601 Brenner Ave,11M, Salisbury, NC 28144 USA.	Sarah.Martindale-Supak@va.gov	Martindale, Sarah L/O-8553-2018	Martindale, Sarah L/0000-0002-0059-3454; Ord, Anna/0000-0003-3373-2016	Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) AwardUnited States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]	There are no conflicts of interest to disclose. This work was supported by grant funding from Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095 and Department of Veterans Affairs CENC Award I01 CX001135. This work was also supported by resources of the Salisbury Veterans Affairs Medical Center, Mid-Atlantic Mental Illness Research Education and Clinical Center (MIRECC), and Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness, Research, and Treatment (MIRT).	Amtmann D, 2010, PAIN, V150, P173, DOI 10.1016/j.pain.2010.04.025; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belding J.N., 2021, J HEAD TRAUMA REHAB; Belding JN, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.628782; Benjamini Y., 1995, J ROY STAT SOC, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Clark ME, 2009, PAIN MED, V10, P447, DOI 10.1111/j.1526-4637.2009.00590.x; Dismuke-Greer CE, 2018, BRAIN INJURY, V32, P1178, DOI 10.1080/02699052.2018.1482428; First M.B., 1996, STRUCTURED CLIN INTE; Greer N, 2016, PREVALENCE EPIDEMIOL; Greer N, 2018, J HEAD TRAUMA REHAB, V33, pE16, DOI 10.1097/HTR.0000000000000304; Gros DF, 2012, PSYCHIAT RES, V196, P267, DOI 10.1016/j.psychres.2011.10.022; Gros DF, 2010, J NERV MENT DIS, V198, P885, DOI 10.1097/NMD.0b013e3181fe7410; Haran FJ, 2021, APPL NEUROPSYCH-ADUL, V28, P297, DOI 10.1080/23279095.2019.1630627; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kontos Anthony P, 2015, J Trauma Acute Care Surg, V79, pS146, DOI 10.1097/TA.0000000000000667; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Maguen S, 2012, J TRAUMA STRESS, V25, P3, DOI 10.1002/jts.21669; Martindale SL, 2020, NEUROPSYCHOLOGY, V34, P735, DOI 10.1037/neu0000672; Martindale SL, 2020, MIL PSYCHOL, V32, P212, DOI 10.1080/08995605.2020.1724595; Martindale SL, 2018, ARCH PHYS MED REHAB, V99, P2485, DOI 10.1016/j.apmr.2018.04.029; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Robinson ME, 2017, J NEUROTRAUM, V34, pS53, DOI 10.1089/neu.2016.4709; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Rowland JA, 2020, J NEUROTRAUM, V37, P1797, DOI 10.1089/neu.2019.6972; Rowland JA, 2020, BRAIN INJURY, V34, P642, DOI 10.1080/02699052.2020.1729418; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; Stocker RPJ, 2016, J CLIN SLEEP MED, V12, P49, DOI 10.5664/jcsm.5392; Stone JR, 2020, J NEUROTRAUM, V37, P2468, DOI 10.1089/neu.2020.7141; Stratton KJ, 2014, J REHABIL RES DEV, V51, P1189, DOI 10.1682/JRRD.2014.04.0111; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Walker WC, 2015, BRAIN INJURY, V29, P1581, DOI 10.3109/02699052.2015.1075151; Weathers F., 2013, CLINICIAN ADMINISTER	44	0	0	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	NOV	2021	143						189	195		10.1016/j.jpsychires.2021.09.021			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	UY6ZM	WOS:000701669500002	34500348	hybrid			2022-02-06	
J	McKee, GB; Perrin, PB; Rodriguez-Agudelo, Y; Plaza, SLO; Quijano-Martinez, MC; Kuzu, D; Ohayagha, C; Pugh, M; Arango-Lasprilla, JC				McKee, Grace B.; Perrin, Paul B.; Rodriguez-Agudelo, Yaneth; Olivera Plaza, Silvia Leonor; Quijano-Martinez, Maria Cristina; Kuzu, Duygu; Ohayagha, Chimdindu; Pugh, Mickeal; Arango-Lasprilla, Juan Carlos			Suicidal Ideation After Acute Traumatic Brain Injury: A Longitudinal Actor-Partner Interdependence Model of Patients and Caregivers in Latin America	REHABILITATION PSYCHOLOGY			English	Article						TBI; suicidal ideation; family caregivers; Latin America	FAMILY CARERS; HEAD-INJURY; DEPRESSION; PEOPLE; BURDEN; RISK; DISORDERS; PREDICTORS; DEMENTIA; CONTEXT	Impact and Implications The current study highlights the importance of screening for suicidal ideation for both individuals with traumatic brain injury (TBI) and their caregivers, as findings suggest that thoughts of death and/or suicide are relatively common among both patients and caregivers up to a year post-injury. Moreover, patient suicidal ideation at hospitalization is predictive of reported caregiver suicidal ideation at later time points. Clinicians and rehabilitation specialists may wish to expanding practices of assessing suicide risk in patients to include caregivers, particularly caregivers of patients who endorsed suicidal ideation. Given that these findings demonstrate significant interdependence of suicidality between patients and caregivers, interventions for patients with TBI should include their respective caregivers or even incorporate family systems theories and approaches. Purpose/Objective: Traumatic brain injury (TBI) is associated with depression, anxiety, and even suicidality in individuals with TBI and in caregivers. Moreover, emotional functioning in individuals with TBI is linked with caregiver functioning. However, no known studies to date have examined linkages in suicidal ideation in individuals with TBI and family caregivers. This is especially important in Latin America, where TBI rates are high, and where cultural norms influence family caregiving. This study examined associations among self-reported suicidal ideation in individuals with TBI and their primary caregivers over time in Mexico and Colombia. Research Method/Design: A total of 109 individuals and their primary caregivers completed measures during hospitalization for TBI and at 2- and 4-months posthospitalization. The primary outcome was Item 9 from the Spanish version of the Patient Health Questionnaire-9, assessing for thoughts of death or suicide in the previous 2 weeks. Results: Patients and caregivers reported high levels of suicidal ideation (18.3%-22.4% and 12.4%-15.7%, respectively) at each time point, and suicidal ideation at one time point strongly predicted ideation at the next. When patients endorsed suicidal ideation in the hospital, their caregivers tended to endorse suicidal ideation 2 months later. Although unaccounted for variables could be driving these relationships, they may also provide possible evidence of causal preponderance between patient and caregiver suicidal ideation post-TBI. Conclusions/Implications: Clinicians and rehabilitation specialists can use these findings to inform suicide risk assessment by expanding these practices to caregivers of patients who endorsed suicidal ideation. Interventions after TBI should incorporate caregivers given this study showed significant interdependence of suicidality between patients and caregivers.	[McKee, Grace B.] Cent Virginia Vet Affairs Hlth Care Syst, Midatlantic Mental Illness Res Educ & Clin Ctr, Adv Fellowship Program Mental Illness Res & Treat, Richmond, VA USA; [McKee, Grace B.; Perrin, Paul B.; Kuzu, Duygu; Ohayagha, Chimdindu; Pugh, Mickeal] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Perrin, Paul B.] Cent Virginia Vet Affairs Hlth Care Syst, Polytrauma Rehabil Ctr, Richmond, VA USA; [Rodriguez-Agudelo, Yaneth] Natl Inst Neurol & Neurosurg, Dept Neuropsychol, Ciudad De Mexico, Mexico; [Olivera Plaza, Silvia Leonor] Univ Surcolombiana, Grp Invest Carlos Finlay, Neiva, Colombia; [Quijano-Martinez, Maria Cristina] Pontificia Univ Javeriana Cali, Dept Social Sci, Cali, Colombia; [Kuzu, Duygu] Istanbul Arel Univ, Dept Psychol, Istanbul, Turkey; [Arango-Lasprilla, Juan Carlos] BioCruces Bizkaia Hlth Res Inst, Plaza Cruces S-N, Baracaldo 48903, Bizkaia, Spain; [Arango-Lasprilla, Juan Carlos] Basque Fdn Sci, Ikerbasque, Bilbao, Spain		Arango-Lasprilla, JC (corresponding author), BioCruces Bizkaia Hlth Res Inst, Plaza Cruces S-N, Baracaldo 48903, Bizkaia, Spain.	jcalasprilla@gmail.com	; Perrin, Paul/L-5373-2015	Kuzu, Duygu/0000-0002-1134-1551; Perrin, Paul/0000-0003-2070-215X; McKee, Grace/0000-0001-5823-203X	Fogarty International Center of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R21TW009746]; Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and TreatmentUS Department of Veterans Affairs; Medical Research and Mental Health Services of the Veterans Affairs Central Virginia Health Care System; Department of Veterans Affairs Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC)US Department of Veterans Affairs	This study was funded by Grant R21TW009746 from Fogarty International Center of the National Institutes of Health and was supported by the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment, the Medical Research and Mental Health Services of the Veterans Affairs Central Virginia Health Care System, and the Department of Veterans Affairs Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC).	Antonucci TC., 2001, APPL DEV SCI, V5, P68, DOI [10.1207/S1532480XADS0502_2, DOI 10.1207/S1532480XADS0502_2]; Bethune A, 2017, ARCH SUICIDE RES, V21, P392, DOI 10.1080/13811118.2016.1199990; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Buhse M, 2008, J NEUROSCI NURS, V40, P25, DOI 10.1097/01376517-200802000-00005; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Finkelstein E.A., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; Fortuna LR, 2007, J CLIN PSYCHIAT, V68, P572, DOI 10.4088/JCP.v68n0413; Garza MJ, 2010, SUICIDE LIFE-THREAT, V40, P561, DOI 10.1521/suli.2010.40.6.561; Gulin SL, 2014, FAM SYST HEALTH, V32, P53, DOI 10.1037/a0032623; Hostetter TA, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000489; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hui SKA, 2007, REHABIL PSYCHOL, V52, P113, DOI 10.1037/0090-5550.52.1.113; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Judd C.M., 2000, HDB RES METHODS SOCI, P451, DOI DOI 10.1017/CBO9780511996481; Kenny D.A, LONGITUDINAL MODELS; Kenny D.A, 2014, WILEY STATSREF STAT, DOI [10.1002/9781118445112.stat06464, DOI 10.1002/9781118445112.STAT06464]; Kenny DA, 1996, J SOC PERS RELAT, V13, P279, DOI 10.1177/0265407596132007; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuipers P, 2000, J HEAD TRAUMA REHAB, V15, P1275, DOI 10.1097/00001199-200012000-00007; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Murray CJL., 1996, GLOBAL BURDEN DIS IN, V1; Nicholson K, 2000, NEUROREHABILITATION, V14, P95; Nolle AP, 2012, AM J ORTHOPSYCHIAT, V82, P319, DOI 10.1111/j.1939-0025.2012.01166.x; O'Dwyer S, 2013, AGING MENT HEALTH, V17, P753, DOI 10.1080/13607863.2013.789001; O'Dwyer ST, 2016, AGING MENT HEALTH, V20, P222, DOI 10.1080/13607863.2015.1063109; O'Dwyer ST, 2013, INT J GERIATR PSYCH, V28, P1182, DOI 10.1002/gps.3941; Park B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060230; PAVOT W, 1993, SOC INDIC RES, V28, P1, DOI 10.1007/BF01086714; Pena JB, 2011, SUICIDE LIFE-THREAT, V41, P330, DOI 10.1111/j.1943-278X.2011.00032.x; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perlis ML, 1997, PERCEPT MOTOR SKILL, V84, P595, DOI 10.2466/pms.1997.84.2.595; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G.K., 2019, SUICIDE PREVENTION N, P107; Simpson GK, 2007, MED J AUSTRALIA, V187, P229, DOI 10.5694/j.1326-5377.2007.tb01206.x; Stevens LF, 2012, NEUROREHABILITATION, V31, P443, DOI 10.3233/NRE-2012-00815; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tidemalm D, 2011, PSYCHOL MED, V41, P2527, DOI 10.1017/S0033291711000833; Voracek M, 2007, WIEN KLIN WOCHENSCHR, V119, P463, DOI 10.1007/s00508-007-0823-2; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wheaton B., 1977, SOCIOLOGICAL METHODO, V8, P84; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wood RLL, 2010, J INT NEUROPSYCH SOC, V16, P1108, DOI 10.1017/S1355617710001013	58	0	0	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2021	66	4					433	441		10.1037/rep0000395			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	XI0QC	WOS:000725826700015	34871029				2022-02-06	
J	Mi, ZP; Liu, H; Rose, ME; Ma, J; Reay, DP; Ma, XC; Henchir, JJ; Dixon, CE; Graham, SH				Mi, Zhiping; Liu, Hao; Rose, Marie E.; Ma, Jie; Reay, Daniel P.; Ma, Xiecheng; Henchir, Jeremy J.; Dixon, C. Edward; Graham, Steven H.			Mutation of a Ubiquitin Carboxy Terminal Hydrolase L1 Lipid Binding Site Alleviates Cell Death, Axonal Injury, and Behavioral Deficits After Trau-matic Brain Injury in Mice	NEUROSCIENCE			English	Article						deubiquitinating enzymes; protein ubiquitination; controlled cortical impact; ubiquitin proteasome pathway; axonal injury	CONTROLLED CORTICAL IMPACT; CYCLOPENTENONE PROSTAGLANDINS; PROTEASOME SYSTEM; OXIDATIVE STRESS; DYSTROPHY GAD; CYCLOOXYGENASE-2; MUTANT; DEGENERATION; AGGREGATION; DISEASE	Ubiquitin carboxy terminal hydrolase L1 (UCHL1) is a protein highly expressed in neurons that may play important roles in the ubiquitin proteasome pathway (UPP) in neurons, axonal integrity, and motor function after traumatic brain injury (TBI). Binding of reactive lipid species to cysteine 152 of UCHL1 results in unfolding, aggregation, and inactivation of the enzyme. To test the role of this mechanism in TBI, mice bearing a cysteine to alanine mutation at site 152 (C152A mice) that renders UCHL1 resistant to inactivation by reactive lipids were subjected to the controlled cortical impact model (CCI) of TBI and compared to wild type (WT) controls. Alterations in protein ubiquitination and activation of autophagy pathway markers in traumatized brain were detected by immunoblotting. Cell death and axonal injury were determined by histological assessment and anti-amyloid precursor protein (APP) immunohistochemistry. Behavioral outcomes were determined using the beam balance and Morris water maze tests. C152A mice had reduced accumulation of ubiquitinated proteins, decreased activation of the autophagy markers Beclin-1 and LC3B, a decreased number of abnormal axons, decreased CA1 cell death, and improved motor and cognitive function compared to WT controls after CCI; no significant change in spared tissue volume was observed. These results suggest that binding of lipid substrates to cysteine 152 of UCHL1 is important in the pathogenesis of injury and recovery after TBI and may be a novel target for future therapeutic approaches. Published by Elsevier Ltd on behalf of IBRO.	[Mi, Zhiping; Liu, Hao; Rose, Marie E.; Ma, Jie; Reay, Daniel P.; Ma, Xiecheng; Henchir, Jeremy J.; Dixon, C. Edward; Graham, Steven H.] VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Res Off Bldg 30,Mail Code 151,Univ Dr, Pittsburgh, PA 15240 USA; [Mi, Zhiping; Liu, Hao; Rose, Marie E.; Ma, Jie; Reay, Daniel P.; Graham, Steven H.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA; [Ma, Xiecheng; Henchir, Jeremy J.; Dixon, C. Edward] Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15213 USA; [Ma, Xiecheng; Henchir, Jeremy J.; Dixon, C. Edward] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15213 USA		Graham, SH (corresponding author), VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Res Off Bldg 30,Mail Code 151,Univ Dr, Pittsburgh, PA 15240 USA.	miz2@upmc.edu; RoseME@upmc.edu; maj5@upmc.edu; ReayDP@upmc.edu; jjhst22@pitt.edu; dixoec@UPMC.EDU; sgra@pitt.edu			National Institutes of Health/National Institute of Neurological Disorders and Stroke Grant [R01NS102195]	This work was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke Grant R01NS102195 (to S.H.G. and C.E.D.). The funding source had no role in study design, collection, analysis, and interpretation of data or in the writing of the report and the decision to submit the article for publication.	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Araki K, 1997, NUCLEIC ACIDS RES, V25, P868, DOI 10.1093/nar/25.4.868; Bheda A, 2010, CELL CYCLE, V9, P980, DOI 10.4161/cc.9.5.10934; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; Caballero OL, 2002, ONCOGENE, V21, P3003, DOI 10.1038/sj.onc.1205390; Chen FJ, 2010, P NATL ACAD SCI USA, V107, P1636, DOI 10.1073/pnas.0911516107; Coulin C, 2001, J COMP NEUROL, V439, P19, DOI 10.1002/cne.1332; Coulombe J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00129; Ding H, 2017, NEUROCHEM INT, V111, P32, DOI 10.1016/j.neuint.2017.04.016; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Figueiredo-Pereira ME, 2015, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00104; Frake RA, 2015, J CLIN INVEST, V125, P65, DOI 10.1172/JCI73944; FUKUSHIMA M, 1982, BIOCHEM BIOPH RES CO, V105, P956, DOI 10.1016/0006-291X(82)91063-4; Genc B, 2016, ANN CLIN TRANSL NEUR, V3, P331, DOI 10.1002/acn3.298; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gong B, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00004; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Goto A, 2009, NEUROCHEM INT, V54, P330, DOI 10.1016/j.neuint.2008.12.012; Goto Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7153; Graham SH, 2003, ARCH NEUROL-CHICAGO, V60, P628, DOI 10.1001/archneur.60.4.628; Graham SH, 2017, AGEING RES REV, V34, P30, DOI 10.1016/j.arr.2016.09.011; Hayashi T, 2015, INT J LEGAL MED, V129, P1085, DOI 10.1007/s00414-015-1245-8; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; Hu BR, 2000, J NEUROSCI, V20, P3191, DOI 10.1523/JNEUROSCI.20-09-03191.2000; Hughes ED, 2007, MAMM GENOME, V18, P549, DOI 10.1007/s00335-007-9054-0; Jara JH, 2015, CEREB CORTEX, V25, P4259, DOI 10.1093/cercor/bhu318; Jara JH, 2013, CELL BIOCHEM BIOPHYS, V67, P45, DOI 10.1007/s12013-013-9631-7; Kabuta T, 2008, AUTOPHAGY, V4, P827, DOI 10.4161/auto.6560; Kim YJ, 2019, MOL NEUROBIOL, V56, P7433, DOI 10.1007/s12035-019-1598-y; Koharudin LMI, 2010, P NATL ACAD SCI USA, V107, P6835, DOI 10.1073/pnas.1002295107; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Larsen CN, 1996, BIOCHEMISTRY-US, V35, P6735, DOI 10.1021/bi960099f; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Liu H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.323; Liu H, 2019, P NATL ACAD SCI USA, V116, P4643, DOI 10.1073/pnas.1821282116; Liu H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178049; Liu H, 2013, NEUROTOX RES, V24, P191, DOI 10.1007/s12640-013-9377-4; Liu H, 2011, NEUROBIOL DIS, V41, P318, DOI 10.1016/j.nbd.2010.09.020; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Mi ZP, 2021, EXP NEUROL, V336, DOI 10.1016/j.expneurol.2020.113524; Milne GL, 2005, ANTIOXID REDOX SIGN, V7, P210, DOI 10.1089/ars.2005.7.210; MIURA H, 1993, NEUROPATH APPL NEURO, V19, P41, DOI 10.1111/j.1365-2990.1993.tb00403.x; Mullally JE, 2001, J BIOL CHEM, V276, P30366, DOI 10.1074/jbc.M102198200; Nakayama M, 1998, P NATL ACAD SCI USA, V95, P10954, DOI 10.1073/pnas.95.18.10954; OGOROCHI T, 1984, J NEUROCHEM, V43, P71, DOI 10.1111/j.1471-4159.1984.tb06680.x; OHNO K, 1992, EICOSANOIDS, V5, P81; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Proctor CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013175; Pukass K, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00163; Reinicke AT, 2019, P NATL ACAD SCI USA, V116, P7963, DOI 10.1073/pnas.1812413116; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Sakai K, 2014, AM J FOREN MED PATH, V35, P38, DOI 10.1097/PAF.0000000000000067; Sakurai M, 2008, EUR J NEUROSCI, V27, P691, DOI 10.1111/j.1460-9568.2008.06047.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen H, 2006, APOPTOSIS, V11, P1049, DOI 10.1007/s10495-006-6303-8; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Solaroglu I, 2005, J CLIN NEUROSCI, V12, P273, DOI 10.1016/j.jocn.2004.12.002; Straus DS, 2001, MED RES REV, V21, P185, DOI 10.1002/med.1006.abs; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Walters BJ, 2008, MOL CELL NEUROSCI, V39, P539, DOI 10.1016/j.mcn.2008.07.028; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Xia YG, 2018, P NATL ACAD SCI USA, V115, pE9230, DOI 10.1073/pnas.1810693115; YAMAZAKI K, 1988, P SOC EXP BIOL MED, V187, P209; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x	69	0	0	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 1	2021	475						127	136		10.1016/j.neuroscience.2021.09.001			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WB9KU	WOS:000703885000009	34508847				2022-02-06	
J	Michinaga, S; Onishi, K; Shimizu, K; Mizuguchi, H; Hishinuma, S				Michinaga, Shotaro; Onishi, Kazuya; Shimizu, Kahori; Mizuguchi, Hiroyuki; Hishinuma, Shigeru			Pharmacological Inhibition of Transient Receptor Potential Vanilloid 4 Reduces Vasogenic Edema after Traumatic Brain Injury in Mice	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						vasogenic edema; transient receptor potential vanilloid 4; astrocyte; blood-brain barrier; traumatic brain injury	ENDOTHELIAL GROWTH-FACTOR; VEGF-A; EXPRESSION; BARRIER; MATRIX-METALLOPROTEINASE-9; FLUID; DISRUPTION; ASTROCYTES	Vasogenic edema results from blood-brain barrier (BBB) disruption after traumatic brain injury (TBI), and although it can be fatal, no promising therapeutic drugs have been developed as yet. Transient receptor potential vanilloid 4 (TRPV4) is a calcium-permeable channel that is sensitive to temperature and osmotic pressure. As TRPV4 is known to be responsible for various pathological conditions following brain injury, we investigated the effects of pharmacological TRPV4 antagonists on TBI-induced vasogenic edema in this study. A TBI model was established by inflicting fluid percussion injury (FPI) in the mouse cerebrum and cultured astrocytes. Vasogenic brain edema and BBB disruption were assessed based on brain water content and Evans blue (EB) extravasation into brain tissue, respectively. After FPI, brain water content and EB extravasation increased. Repeated intracerebroventricular administration of the specific TRPV4 antagonists HC-067047 and RN-1734 dose-dependently reduced brain water content and alleviated EB extravasation in FPI mice. Additionally, real-time PCR analysis indicated that administration of HC-067047 and RN-1734 reversed the FPI-induced increase in mRNA levels of endogenous causal factors for BBB disruption, includ-ing matrix metalloproteinase-9 (MMP-9), vascular endothelial growth factor-A (VEGF-A), and endothelin-1 (ET-1). In astrocytes, TRPV4 level was observed to be higher than that in brain microvascular endothelial cells. Treatment with HC-067047 and RN-1734 inhibited the increase in mRNA levels of MMP-9, VEGF-A, and ET-1 in cultured astrocytes subjected to in vitro FPI. These results suggest that pharmacological inhibi-tion of TRPV4 is expected to be a promising therapeutic strategy for treating TBI-induced vasogenic edema.	[Michinaga, Shotaro; Hishinuma, Shigeru] Meiji Pharmaceut Univ, Dept Pharmacodynam, 2-522-1 Noshio, Kyose, Tokyo 2048588, Japan; [Onishi, Kazuya; Mizuguchi, Hiroyuki] Osaka Ohtani Univ, Fac Pharm, Lab Pharmacol, 3-11-1 Nishikiori Kita, Tondabayashi, Osaka 5848540, Japan; [Shimizu, Kahori] Osaka Ohtani Univ, Fac Pharm, Lab Biochem, 3-11-1 Nishikiori Kita, Tondabayashi, Osaka 5848540, Japan		Michinaga, S (corresponding author), Meiji Pharmaceut Univ, Dept Pharmacodynam, 2-522-1 Noshio, Kyose, Tokyo 2048588, Japan.	michisho@my-pharm.ac.jp			Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [20K16016]	This work was supported by a Grantin-Aid for Young Scientists (Grant No. 20K16016) from the Japan Society for the Promotion of Science.	Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Borrachero-Conejo AI, 2020, FASEB J, V34, P6539, DOI 10.1096/fj.201903049R; Chen CK, 2018, MOL NEUROBIOL, V55, P4127, DOI 10.1007/s12035-017-0625-0; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Hatano N, 2013, LIFE SCI, V92, P317, DOI 10.1016/j.lfs.2013.01.002; Hirose T, 2013, NEUROL MED-CHIR, V53, P609; Hoshi Y, 2018, J NEUROSCI, V38, P5700, DOI 10.1523/JNEUROSCI.2888-17.2018; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Jie P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.146; Jie PH, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00141; Lee C, 2010, J NEUROTRAUM, V27, P541, DOI 10.1089/neu.2009.0905; Li J, 2012, ACTA PHARMACOL SIN, V33, P1030, DOI 10.1038/aps.2012.61; Liao WH, 2020, J ADV RES, V26, P15, DOI 10.1016/j.jare.2020.06.012; Lo ACY, 2005, J CEREBR BLOOD F MET, V25, P998, DOI 10.1038/sj.jcbfm.9600108; Lu KT, 2017, J NEUROCHEM, V140, P718, DOI 10.1111/jnc.13920; Men C, 2019, BRAIN RES BULL, V152, P128, DOI 10.1016/j.brainresbull.2019.07.004; Michinaga S, 2020, NEUROPHARMACOLOGY, V175, DOI 10.1016/j.neuropharm.2020.108182; Michinaga S, 2020, J NEUROCHEM, V154, P330, DOI 10.1111/jnc.14957; Michinaga S, 2018, J NEUROTRAUM, V35, P1481, DOI 10.1089/neu.2017.5421; Michinaga S, 2017, BIOL PHARM BULL, V40, P569, DOI 10.1248/bpb.b16-00991; Min H, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0116-z; Muir EM, 2002, MOL BRAIN RES, V100, P103, DOI 10.1016/S0169-328X(02)00132-8; Mukhopadhyay S, 2004, J BIOL CHEM, V279, P33139, DOI 10.1074/jbc.M405194200; Nag S, 2002, J NEUROPATH EXP NEUR, V61, P778, DOI 10.1093/jnen/61.9.778; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Pivonkova H, 2018, NEUROSCIENCE, V394, P127, DOI 10.1016/j.neuroscience.2018.10.028; Rakers C, 2017, GLIA, V65, P1550, DOI 10.1002/glia.23183; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Strait KA, 2007, AM J PHYSIOL-RENAL, V293, pF601, DOI 10.1152/ajprenal.00085.2007; Tanaka K, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00453; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wang LR, 2019, J NEUROTRAUM, V36, P565, DOI 10.1089/neu.2018.5757; Wang ZQ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1612-3; Xie H, 2018, NEUROPATHOLOGY, V38, P337, DOI 10.1111/neup.12469	38	0	0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158	1347-5215		BIOL PHARM BULL	Biol. Pharm. Bull.	NOV	2021	44	11					1759	1766					8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	YF2TV	WOS:000741666600006	34719652	gold			2022-02-06	
J	Miles, SR; Silva, MA; Lang, B; Hoffman, JM; Venkatesan, UM; Sevigny, M; Nakase-Richardson, R				Miles, Shannon R.; Silva, Marc A.; Lang, Brittany; Hoffman, Jeanne M.; Venkatesan, Umesh M.; Sevigny, Mitch; Nakase-Richardson, Risa			Sleep Apnea and Posttraumatic Stress After Traumatic Brain Injury (TBI): A Veterans Affairs TBI Model Systems Study	REHABILITATION PSYCHOLOGY			English	Article						brain injuries; traumatic; stress disorders; posttraumatic; sleep apnea	POSITIVE AIRWAY PRESSURE; PTSD CHECKLIST; DISORDER; IRAQ; DISTURBANCES; AFGHANISTAN; PREVALENCE; PREDICTORS; OUTCOMES; THERAPY	Impact and Implications Veterans and service members (V/SM) who have sustained a traumatic brain injury (TBI) are frequently diagnosed with comorbid sleep apnea and posttraumatic stress disorder (PTSD). Sleep apnea was related to greater severity of PTSD symptoms while controlling for relevant covariates. Inpatient rehabilitation centers and outpatient providers who work with V/SM with TBI should screen them for sleep apnea and PTSD. If sleep apnea and PTSD are present, they should be treated concurrently to enhance the health outcomes in this population. Objective: Traumatic brain injury (TBI) is a complex health problem in military veterans and service members (V/SM) that often co-occurs with psychological and medical conditions such as posttraumatic stress disorder (PTSD) and sleep apnea. We aimed to examine if sleep apnea is associated with the presence and severity of PTSD in V/SM with TBI of all severities. Research Method: The study examined participants at varying times since their TBI (N = 602) enrolled in the Veterans Affairs TBI Model Systems database. Frequency of self-reported sleep apnea diagnosis was calculated in a cross-sectional sample. Prevalence of co-occurring sleep apnea and probable PTSD was tested with a chi-square analysis. A multivariable regression model evaluated the association between sleep apnea and PTSD symptom severity while controlling for relevant covariates. Results: Almost 32% of the sample stated they had been diagnosed with sleep apnea. In those reporting sleep apnea, 32% also had probable PTSD; 19% of those without sleep apnea had probable PTSD. The regression demonstrated sleep apnea was significantly associated with PTSD symptom severity (p < .001). Greater number of TBIs, recent mental health treatment, being deployed to a combat zone, and greater years since TBI were also significant predictors of PTSD symptom severity (all p < .05). Conclusions: TBI, PTSD, and sleep apnea are often comorbid in V/SM. We expand the literature by demonstrating that sleep apnea was associated with PTSD severity. A multipronged approach to TBI rehabilitation that addresses sleep and psychological distress is recommended for enhancing health outcomes in this population.	[Miles, Shannon R.; Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci, 13000 Bruce B Downs Blvd 117, Tampa, FL 33612 USA; [Miles, Shannon R.; Silva, Marc A.] Univ S Florida, Morsani Coll Med, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Silva, Marc A.] Univ S Florida, Morsani Coll Med, Dept Internal Med, Tampa, FL 33620 USA; [Silva, Marc A.; Lang, Brittany] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Hoffman, Jeanne M.] Univ Washington, Dept Rehabil Med, Sch Med, Seattle, WA 98195 USA; [Venkatesan, Umesh M.] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Sevigny, Mitch] Craig Hosp, Res Dept, Englewood, CO USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Traumat Brain Injury Ctr Excellence, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Univ S Florida, Morsani Coll Med, Pulm & Sleep Med Div, Tampa, FL 33620 USA		Miles, SR (corresponding author), James A Haley Vet Hosp, Mental Hlth & Behav Sci, 13000 Bruce B Downs Blvd 117, Tampa, FL 33612 USA.	shannon.miles@va.gov		Venkatesan, Umesh/0000-0003-1869-8083; Hoffman, Jeanne/0000-0002-3525-3839	Department of Veterans Affairs (National Institute on Disability, Independent Living, and Rehabilitation Research)US Department of Veterans Affairs; Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research); VHA Central Office Veterans Affairs TBI Model System Program of Research; DHA Contracting Office (CO-NCR) [HT0014-19-C0004, HT0014]	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is a funded collaboration between the Department of Veterans Affairs and the Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research). This research is sponsored by VHA Central Office Veterans Affairs TBI Model System Program of Research and prepared under Contract HT0014-19-C0004 with DHA Contracting Office (CO-NCR) HT0014 and, therefore, is defined as U.S. Government work under Title 17 U.S.C. 101. Per Title 17 U. S.C. 105, copyright protection is not available for any work of the U.S. Government. For more information, please contactdha.TBICOEinfo@mail.mil.The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Department of Defense position or any other federal agency, policy, or decision unless so designated by other official documentation. The participating agencies' institutional review boards approved this study, and informed consent was obtained after the details of the study were thoroughly explained to participants. The authors report no financial conflicts of interest.	[Anonymous], 2014, NAT HLTH NUTR EX SUR; Belanger HG, 2016, CLIN NEUROPSYCHOL, V30, P1063, DOI 10.1080/13854046.2016.1193632; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bhatia M., 2019, SLEEP VIGILANCE, V3, P113, DOI [10.1007/s41782-019-00070-8, DOI 10.1007/S41782-019-00070-8]; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Clancy CP, 2006, J CLIN PSYCHIAT, V67, P1346, DOI 10.4088/JCP.v67n0904; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Colvonen PJ, 2015, J CLIN SLEEP MED, V11, P513, DOI 10.5664/jcsm.4692; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Department of Veteran Affairs and Department of Defense, 2017, VA DOD CLIN PRACT GU; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; Djonlagic I, 2020, J CLIN SLEEP MED, V16, P377, DOI 10.5664/jcsm.8210; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; E-Solh AA, 2017, SLEEP MED, V33, P145, DOI 10.1016/j.sleep.2016.12.025; Franklin KA, 2015, J THORAC DIS, V7, P1311, DOI 10.3978/j.issn.2072-1439.2015.06.11; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Gulati G, 2020, SLEEP, V43, pA428; Gupta MA, 2015, J CLIN SLEEP MED, V11, P165, DOI 10.5664/jcsm.4466; HALL CW, 1975, ARCH NEUROL-CHICAGO, V32, P57, DOI 10.1001/archneur.1975.00490430079016; Harpaz-Rotem I, 2011, PSYCHIAT SERV, V62, P22, DOI 10.1176/ps.62.1.pss6201_0022; Heatley EM, 2013, SLEEP MED REV, V17, P349, DOI 10.1016/j.smrv.2012.09.004; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P82, DOI 10.1097/HTR.0000000000000230; Hundt Natalie E, 2015, Psychol Trauma, V7, P539, DOI 10.1037/tra0000035; Kataria L., 2015, NEUROLOGY, V84; Kehle-Forbes SM, 2016, PSYCHOL TRAUMA-US, V8, P107, DOI 10.1037/tra0000065; Kelly M.R., 2016, CURR SLEEP MED REP, V2, P223, DOI [10.1007/s40675-016-0056-x, DOI 10.1007/S40675-016-0056-X]; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Lettieri CJ, 2016, CHEST, V149, P483, DOI 10.1378/chest.15-0693; Lin SY, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.10.88; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Loignon A, 2020, J HEAD TRAUMA REHAB, V35, pE21, DOI 10.1097/HTR.0000000000000514; Lu W, 2014, NEUROREHABILITATION, V35, P245, DOI 10.3233/NRE-141117; Macey PM, 2008, SLEEP, V31, P967; Madhok DY, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10050269; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mesa F, 2017, J TRAUMA STRESS, V30, P646, DOI 10.1002/jts.22245; Miles SR, 2020, J CLIN PSYCHOL, V76, P493, DOI 10.1002/jclp.22878; Miles SR, 2016, PSYCHOL TRAUMA-US, V8, P464, DOI 10.1037/tra0000132; Mollayeva T, 2019, NEUROSCI BIOBEHAV R, V99, P198, DOI 10.1016/j.neubiorev.2019.01.011; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Nakase-Richardson R, 2020, ARCH PHYS MED REHAB, V101, P1497, DOI 10.1016/j.apmr.2020.03.020; Nakase-Richardson R, 2020, ARCH PHYS MED REHAB, V101, P283, DOI 10.1016/j.apmr.2019.09.019; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Reist C, 2021, BEHAV BRAIN RES, V404, DOI 10.1016/j.bbr.2021.113172; Rizvi SL, 2009, BEHAV RES THER, V47, P737, DOI 10.1016/j.brat.2009.06.003; Ropacki S, 2018, ARCH PHYS MED REHAB, V99, P952, DOI 10.1016/j.apmr.2017.12.035; Schnurr, 2013, PTSD CHECKLIST DSM 5; Senaratna CV, 2017, SLEEP MED REV, V34, P70, DOI 10.1016/j.smrv.2016.07.002; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Tamanna S, 2014, J CLIN SLEEP MED, V10, P631, DOI 10.5664/jcsm.3786; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; van Liempt S, 2011, EUR J PSYCHOTRAUMATO, V2, DOI 10.3402/ejpt.v2i0.8451; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Walker JM, 2016, UNDERSEA HYPERBAR M, V43, P549; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270; Zayfert C, 2005, J TRAUMA STRESS, V18, P637, DOI 10.1002/jts.20072; Zhang Y, 2019, NEUROSCI BIOBEHAV R, V102, P172, DOI 10.1016/j.neubiorev.2019.03.019; Zhang Y, 2017, SLEEP MED, V36, P125, DOI 10.1016/j.sleep.2017.04.020	69	0	0	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2021	66	4					450	460		10.1037/rep0000389			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	XI0QC	WOS:000725826700017	34871026				2022-02-06	
J	Mohamed, T; Swed, S; Al-Mouakeh, A; Sawaf, B				Mohamed, Tasneem; Swed, Sarya; Al-Mouakeh, Ahmad; Sawaf, Bisher			Nontraumatic bilateral subdural hematoma: Case report	ANNALS OF MEDICINE AND SURGERY			English	Article						Subdural hematoma; Bilateral hematoma; Nontraumatic haemorrhage; A case report		A subdural hematoma (SDH) is a type of bleeding in which a collection of blood gathers between the inner layer of the dura mater and the arachnoid mater of the meninges surrounding the brain. Although most cases reported of subdural hematoma are due to traumatic brain injury, to the best of our knowledge this is a rare case of nontraumatic subdural hematoma. A 31 year-old-Male presented to the emergency department with a severe headache for 3 weeks, with the presence of oculomotor disorders. There is no history of major trauma, minor trauma or fights. Also, no history of hypertension, or Haematological diseases. Magnetic resonance imaging (MRI) showed bilateral subdural hematoma. The right-sided hematoma was treated conservatively and the Left-sided was treated by surgery. Follow-up for three months revealed no recurrence. Nontraumatic subdural hematoma is one of the challenging cases that neurosurgeons face. We presented a patient with idiopathic spontaneous subdural hematoma. Computed tomography (CT) is the first step for diagnosis and Magnetic resonance imaging (MRI) is considered an excellent imaging investigation to evaluate such patients. Symptomatic subdural hematomas require an emergent treatment by identifying and controlling sites of bleeding conservatively or by surgery. Subdural hematoma with no history of trauma should be treated emergently and evaluated strictly. Follow-up is essential in patients with neural symptoms. Massive symptomatic subdural hematoma (SDH) should be treated with surgery to control the bleeding.	[Mohamed, Tasneem] Ribt Univ Hosp, Neurosurg Dept, Burri, Khrtoum, Sudan; [Swed, Sarya] Aleppo Univ, Fac Human Med, Aleppo, Syria; [Al-Mouakeh, Ahmad] Aleppo Hosp, Dept Neurosurg, Aleppo, Syria; [Sawaf, Bisher] Syrian Private Univ, Fac Med, Damascus, Syria		Mohamed, T (corresponding author), Ribt Univ Hosp, Neurosurg Dept, Burri, Khrtoum, Sudan.	Tas.mohamed95@gmail.com; saryaswed1@gmail.com; Dr.ahmad.mouakeh97@gmail.com; bishersawaf.94@gmail.com	Swed, Sarya/ABA-9762-2021	Swed, Sarya/0000-0002-9983-2020			Agha RA, 2020, INT J SURG, V84, P226, DOI 10.1016/j.ijsu.2020.10.034; Coombs JB, 2014, J EMERG MED, V47, pE63, DOI 10.1016/j.jemermed.2014.04.026; de Beer MH, 2017, NEUROLOGIST, V22, P34, DOI 10.1097/NRL.0000000000000100; HESSELBROCK R, 1984, SURG NEUROL, V21, P363, DOI 10.1016/0090-3019(84)90115-0; Kreppel D, 2003, NEUROSURG REV, V26, P1, DOI 10.1007/s10143-002-0224-y; Kyriakides AE, 2007, SPINE, V32, pE619, DOI 10.1097/BRS.0b013e318154c618; Matsumoto H, 2012, J SPINAL CORD MED, V35, P262, DOI 10.1179/2045772312Y.0000000014; Miller JD, 2014, J NEUROSURG, V120, P1378, DOI 10.3171/2013.10.JNS13272; Munro D., 1934, NEW ENGL J MED, V210, P1145, DOI NEJM19340531210220143; Rascon-Ramirez F, 2018, NEUROCIRUGIA, V29, P209, DOI 10.1016/j.neucir.2017.09.002	10	0	0	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2049-0801			ANN MED SURG	Ann. Med. Surg.	NOV	2021	71								102907	10.1016/j.amsu.2021.102907			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WN8OH	WOS:000712026000007	34712475	gold, Green Published			2022-02-06	
J	Mostafa, J; Porter, J; Queener, HM; Ostrin, LA				Mostafa, Jakaria; Porter, Jason; Queener, Hope M.; Ostrin, Lisa A.			Intrinsically photosensitive retinal ganglion cell-driven pupil responses in patients with traumatic brain injury	VISION RESEARCH			English	Article						Intrinsically photosensitivity retinal ganglion; cells; Pupillography; Traumatic brain injury	NERVE-FIBER LAYER; SUPRACHIASMATIC NUCLEUS; MELANOPSIN CONTRIBUTIONS; CENTRAL PROJECTIONS; LIGHT ADAPTATION; ASSESSING ROD; OPTIC-NERVE; CONE; SENSITIVITY; THICKNESS	Previous findings regarding intrinsically photosensitive retinal ganglion cell (ipRGC) function after traumatic brain injury (TBI) are conflicting. We examined ipRGC-driven pupil responses in civilian TBI and control participants using two pupillography protocols that assessed transient and adaptive properties: (1) a one second (s) long wavelength "red" stimulus (651 nm, 133 cd/m2) and 10 increasing intensities of 1 s short wavelength "blue" stimuli (456 nm, 0.167 to 167 cd/m2) with a 60 s interstimulus interval, and (2) two minutes of 0.1 Hz red stimuli (33 cd/m2), followed by two minutes of 0.1 Hz blue stimuli (16 cd/m2). For Protocol 1, constriction amplitude and the 6 s post illumination pupil response (PIPR) were calculated. For Protocol 2, amplitudes and peak velocities of pupil constriction and redilation were calculated. For Protocol 1, constriction amplitude and the 6 s PIPR were not significantly different between TBI patients and control subjects for red or blue stimuli. For Protocol 2, pupil constriction amplitude attenuated over time for red stimuli and potentiated over time for blue stimuli across all subjects. Constriction and redilation velocities were similar between groups. Pupil constriction amplitude was significantly less in TBI patients compared to control subjects for red and blue stimuli, which can be attributed to age-related differences in baseline pupil size. While TBI, in addition to age, may have contributed to decreased baseline pupil diameter and constriction amplitude, responses to blue stimulation suggest no selective damage to ipRGCs.	[Mostafa, Jakaria; Porter, Jason; Queener, Hope M.; Ostrin, Lisa A.] Univ Houston, Coll Optometry, 4901 Calhoun Rd, Houston, TX 77004 USA		Ostrin, LA (corresponding author), Univ Houston, Coll Optometry, 4901 Calhoun Rd, Houston, TX 77004 USA.	Lostrin@central.uh.edu			NIH NEIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30 EY007551]; University of Houston College of Optometry	This study was supported by grant NIH NEI P30 EY007551 and the University of Houston College of Optometry. We thank Dr. Rosa Tang, Dr. Kassaundra Johnston, Dr. Suzanne Wickum, and Dr. Andrew Hart-wick for assistance on this project.	Abbott KS, 2018, OPTOMETRY VISION SCI, V95, P323, DOI 10.1097/OPX.0000000000001198; Adhikari P, 2019, TRANSL VIS SCI TECHN, V8, DOI 10.1167/tvst.8.5.29; Adhikari P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161175; Adhikari P, 2015, SCI REP-UK, V5, DOI 10.1038/srep17610; Adhikari P, 2015, INVEST OPHTH VIS SCI, V56, P3838, DOI 10.1167/iovs.14-16233; Al-Abdalla R., 2017, INVEST OPHTH VIS SCI, V58, pE; ALPERN M, 1962, J PHYSIOL-LONDON, V164, P478, DOI 10.1113/jphysiol.1962.sp007033; Ba-Ali S, 2020, ACTA OPHTHALMOL, V98, P477, DOI 10.1111/aos.14348; Barrionuevo PA, 2014, INVEST OPHTH VIS SCI, V55, P719, DOI 10.1167/iovs.13-13252; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bradley JC, 2011, J REFRACT SURG, V27, P202, DOI 10.3928/1081597X-20100511-01; Bradshaw D., 2008, REPORT SURG GEN TRAU; Brodal P, 2004, CENTRAL NERVOUS SYST; Buisset A, 2018, J FR OPHTALMOL, V41, P910, DOI 10.1016/j.jfo.2018.06.003; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Chakraborty Ranjay, 2021, J Optom, DOI 10.1016/j.optom.2020.12.001; Chan JW, 2019, INVEST OPHTH VIS SCI, V60, P2005, DOI 10.1167/iovs.18-26094; Cheng H, 2007, INVEST OPHTH VIS SCI, V48, P5798, DOI 10.1167/iovs.07-0738; Childs C, 2018, EYE BRAIN, V10, P101, DOI 10.2147/EB.S183042; Chougule PS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00360; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Cui Q, 2015, NEUROSCIENCE, V284, P845, DOI 10.1016/j.neuroscience.2014.11.002; Decramer T, 2018, J NEUROL, V265, P41, DOI 10.1007/s00415-017-8661-2; Du T, 2005, BRAIN INJURY, V19, P1125, DOI 10.1080/02699050500149817; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigl B, 2020, J PARKINSON DIS, V10, P1467, DOI 10.3233/JPD-202178; Feigl B, 2012, ACTA OPHTHALMOL, V90, pe230, DOI 10.1111/j.1755-3768.2011.02226.x; Flanagan SC, 2020, OPTOMETRY VISION SCI, V97, P198, DOI 10.1097/OPX.0000000000001486; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Gracitelli CPB, 2015, OPHTHALMOLOGY, V122, P1139, DOI 10.1016/j.ophtha.2015.02.030; GULDNER FH, 1978, CELL TISSUE RES, V194, P17, DOI 10.1007/BF00209231; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Hannibal J, 2014, J COMP NEUROL, V522, P2231, DOI [10.1002/cne.23588, 10.1002/cne.23555]; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Herbst Kristina, 2011, Front Neurol, V2, P10, DOI 10.3389/fneur.2011.00010; Joyce DS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26078-0; Joyce DS, 2016, INVEST OPHTH VIS SCI, V57, P5672, DOI 10.1167/iovs.16-19934; Kankipati L, 2011, INVEST OPHTH VIS SCI, V52, P2287, DOI 10.1167/iovs.10-6023; Kansagara D., 2013, COMPLICATIONS MILD T; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kardon R., 2011, ADLERS PHYSL EYE, P502; Kardon R, 2013, INVEST OPHTH VIS SCI, V54; Kardon R, 2009, OPHTHALMOLOGY, V116, P1564, DOI 10.1016/j.ophtha.2009.02.007; KIM YI, 1991, J PHYSIOL-LONDON, V444, P269, DOI 10.1113/jphysiol.1991.sp018877; Kirbas S, 2013, J NEURO-OPHTHALMOL, V33, P58, DOI 10.1097/WNO.0b013e318267fd5f; Lemke S, 2013, JAMA OPHTHALMOL, V131, P1602, DOI 10.1001/jamaophthalmol.2013.5028; Li SY, 2008, CELL MOL NEUROBIOL, V28, P1095, DOI 10.1007/s10571-008-9286-x; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Madsen HO, 2021, INT J BIPOLAR DISORD, V9, DOI 10.1186/s40345-020-00211-3; Markwell EL, 2010, CLIN EXP OPTOM, V93, P137, DOI 10.1111/j.1444-0938.2010.00479.x; Maynard ML, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20659; McDougal DH, 2010, VISION RES, V50, P72, DOI 10.1016/j.visres.2009.10.012; Merezhinskaya N, 2019, OPTOMETRY VISION SCI, V96, P542, DOI 10.1097/OPX.0000000000001407; Mostafa J, 2017, INVEST OPHTH VIS SCI, V58; Mostafa J, 2016, INVEST OPHTH VIS SCI, V57; Muller LPD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093274; Munch M, 2012, INVEST OPHTH VIS SCI, V53, P4546, DOI 10.1167/iovs.12-9494; Narayanan D, 2014, MULT SCLER J, V20, P1331, DOI 10.1177/1352458514523498; OGDEN TE, 1966, VISION RES, V6, P485, DOI 10.1016/0042-6989(66)90001-0; Ostrin LA, 2018, OPHTHAL PHYSL OPT, V38, P503, DOI 10.1111/opo.12583; Parisi V, 2001, CLIN NEUROPHYSIOL, V112, P1860, DOI 10.1016/S1388-2457(01)00620-4; Park JC, 2011, INVEST OPHTH VIS SCI, V52, P6624, DOI 10.1167/iovs.11-7586; Procyk CA, 2015, J NEUROPHYSIOL, V114, P1321, DOI 10.1152/jn.00368.2015; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schroder S, 2018, EUR J OPHTHALMOL, V28, P150, DOI 10.5301/ejo.5001027; Staal JA, 2011, J NEUROTRAUM, V28, P841, DOI 10.1089/neu.2010.1658; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; TEASDALE G, 1974, LANCET, V2, P81; Thiagarajan P, 2015, BRAIN INJURY, V29, P1420, DOI 10.3109/02699052.2015.1045029; Truong JQ, 2016, MIL MED, V181, P1382, DOI 10.7205/MILMED-D-15-00587; Vien L, 2017, OPTOMETRY VISION SCI, V94, P125, DOI 10.1097/OPX.0000000000000899; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Wang B, 2015, GRAEF ARCH CLIN EXP, V253, P1997, DOI 10.1007/s00417-015-3137-5; Yuhas PT, 2017, OPTOMETRY VISION SCI, V94, P108, DOI 10.1097/OPX.0000000000000934; Zele AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017860	80	0	0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	NOV	2021	188						174	183		10.1016/j.visres.2021.07.007			10	Neurosciences; Ophthalmology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology; Psychology	UQ8MI	WOS:000696312600001	34352476				2022-02-06	
J	Mousazadeh, Y; Sadeghi-Bazargani, H; Janati, A; Poustchis, H; Zakeri, R; Shafiee-Kandjani, A; Pourasghar, F; Shahedifar, N; Iraji, Z; Rezaei, M; Bazargan-Hejazi, S				Mousazadeh, Yalda; Sadeghi-Bazargani, Homayoun; Janati, Ali; Poustchis, Hossein; Zakeri, Raana; Shafiee-Kandjani, Alireza; Pourasghar, Faramarz; Shahedifar, Nasrin; Iraji, Zeynab; Rezaei, Mandi; Bazargan-Hejazi, Shahrzad			Functional Consequences of Road Traffic Injuries: Preliminary Results from PERSIAN Traffic Cohort (PTC)	TRAUMA MONTHLY			English	Article						Accidents; Road Traffic Injury; Traffic Accidents; Functional Status; WHODAS 2.0; Cohort Studies	TRAUMATIC BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; DISABILITY; ACCIDENTS; CARE	Introduction: Traffic injuries are one of the main causes of death worldwide. After decreasing mortality rates and improving the recovery of injured patients, long-term functional consequences need to be addressed. The purpose of this study was to assess the functional outcomes of road traffic injuries and their predictors six months after hospital discharge, based on the preliminary results from PTC. Methods: A cross-sectional study based on PERSIAN Traffic Health and Safety Cohort Study was performed. Data were collected using the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) with six domains (cognition, mobility, self-care, getting along with others, life activities, and participation), filled-in by 180 injured adults (age >18 years) at six-month follow-up after hospital discharge during October 2019. These patients were hospitalized after road accidents at two referral trauma centers, (from 23 September 2018 to 20 March 2019). Results: The majority of participants were men (82.7%), (Mean age =38.8). The mean score of WHODAS 2.0 was 17.8) SD=9.1). The highest score was estimated for the self-care dimension 3.3 (SD=1.8), and the lowest score for getting along with others 2.4 (SD=1.2). Age, gender, physiotherapy, injury localization including head and face, spinal cord, and upper extremity were predictors of WHODAS 2.0 score in various dimensions (p<0.05). Conclusion: The current study identified some functional disabilities among patients sustaining road traffic injuries. It is evident from the results that a proportion of patients do not recover six months after the injury and suffer a disability, especially in self-care, mobility, and life activities, which potentially prevent them from returning to normalcy. In addition, age, gender, physiotherapy, injury localization was related to WHODAS 2.0 scores	[Mousazadeh, Yalda] Khalkhal Univ Med Sci, Dept Publ Hlth, Khalkhal, Iran; [Mousazadeh, Yalda] Tabriz Univ Med Sci, Iranian Ctr Excellence Hlth Management, Sch Management & Med Informat, Dept Hlth Policy & Management, Tabriz, Iran; [Sadeghi-Bazargani, Homayoun; Zakeri, Raana; Shafiee-Kandjani, Alireza; Shahedifar, Nasrin; Rezaei, Mandi] Tabriz Univ Med Sci, Rd Traff Injury Res Ctr, Tabriz, Iran; [Janati, Ali] Tabriz Univ Med Sci, Iranian Ctr Excellence Hlth Management, Sch Management & Med Informat, Tabriz, Iran; [Poustchis, Hossein] Univ Tehran Med Sci, Shariati Hosp, Liver & Pancreatobiliary Dis Res Ctr, Digest Dis Res Inst, Tehran, Iran; [Pourasghar, Faramarz] Tabriz Univ Med Sci, Sch Management & Med Informat, Dept Med Informat, Tabriz, Iran; [Shahedifar, Nasrin] Turku Univ Hosp, Turku Brain Injury Ctr, Div Clin Neurosci, Injury Epidemiol & Prevent Res Grp, Turku, Finland; [Shahedifar, Nasrin] Univ Turku, Turku, Finland; [Iraji, Zeynab] Tabriz Univ Med Sci, Fac Hlth, Dept Stat & Epidemiol, Tabriz, Iran; [Bazargan-Hejazi, Shahrzad] Univ Calif Los Angeles, Charles R Drew Univ Med & Sci, Dept Psychiat & Human Behav, Los Angeles, CA USA; [Bazargan-Hejazi, Shahrzad] Univ Calif Los Angeles, David Geffen Med, Los Angeles, CA USA		Sadeghi-Bazargani, H (corresponding author), Tabriz Univ Med Sci, Rd Traff Injury Res Ctr, Tabriz, Iran.	homayoun.sadeghi@gmail.com			Iranian Ministry of Health and Medical Education; Tabriz University of Medical Sciences [63795]	The project of PERSIAN Traffic Cohort is jointly supported as a national project by the vice secretary of health, the Iranian Ministry of Health and Medical Education, and Tabriz University of Medical Sciences [grant number-63795] . It is also part of two research projects of Ph.D. theses conducted by Yalda Mousazadeh (under thesis number:58043) and Nasrin Shahedifar (under thesis number: 64813) .	Abedzadeh-kalahroudi M, 2016, INJURY, V47, P1104, DOI 10.1016/j.injury.2015.11.046; Alharbi R, 2019, TRANSPORT RES INTERD, V3, DOI [10.1016/j.trip.2019.100061, DOI 10.1016/J.TRIP.2019.100061]; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; [Anonymous], Road traffic crashes 2020 [Iranian legal medicine organization]; Axelsson E, 1979, PSYCHOSOM MED, V41, P209; Axelsson Erland, 2017, JMIR Ment Health, V4, pe58, DOI 10.2196/mental.7497; Barnes Jo, 2006, Annu Proc Assoc Adv Automot Med, V50, P253; Chahraoui K, 2015, J CRIT CARE, V30, P599, DOI 10.1016/j.jcrc.2015.02.016; Currens JAB, 2000, INJURY, V31, P93, DOI 10.1016/S0020-1383(99)00244-2; Derrett S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044909; Ehring T, 2008, J CONSULT CLIN PSYCH, V76, P219, DOI 10.1037/0022-006X.76.2.219; Elbers NA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1694-5; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Hung KKC, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10638-7; Kersten P, 2018, ANN PHYS REHABIL MED, V61, pe122; Kuo CY, 2015, INT J ENV RES PUB HE, V12, P4116, DOI 10.3390/ijerph120404116; Luciano JV, 2010, J AFFECT DISORDERS, V121, P52, DOI 10.1016/j.jad.2009.05.008; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Martino C, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-0289-3; Mayou R, 2003, INJURY, V34, P197, DOI 10.1016/S0020-1383(02)00285-1; Mayou R, 2001, BRIT J PSYCHIAT, V179, P528, DOI 10.1192/bjp.179.6.528; MCKINNEY LA, 1989, ARCH EMERG MED, V6, P27; Mousazadeh Y, 2019, THESIS TABRIZ U MED; Mousazadeh Y, 2019, ARCH TRAUMA RES, V8, P104, DOI 10.4103/atr.atr_5_19; Papadakaki M, 2017, INJURY, V48, P297, DOI 10.1016/j.injury.2016.11.011; Posl M, 2007, QUAL LIFE RES, V16, P1521, DOI 10.1007/s11136-007-9259-4; Rezaei Satar, 2014, J Inj Violence Res, V6, P57, DOI 10.5249/jivr.v6i2.191; Rissanen R, 2020, QUAL LIFE RES, V29, P1587, DOI 10.1007/s11136-020-02427-3; Ristner G, 2000, INJURY, V31, P751, DOI 10.1016/S0020-1383(00)00115-7; Saadat S, 2015, EMERGENCY, V3, P16; Sadeghi Bazargani H, PLOS ONE; Gonzalez MPS, 2018, ACCIDENT ANAL PREV, V118, P178, DOI 10.1016/j.aap.2018.02.015; Schluter PJ, 2006, ANZ J SURG, V76, P886, DOI 10.1111/j.1445-2197.2006.03900.x; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Tournier C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-015-2647-8; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; van Beeck E, 2004, EUR J EPIDEMIOL, V19, P401; WHOD V, 2009, GLOB STAT REP ROAD S; Ziyab AH, 2012, INJURY, V43, P2018, DOI 10.1016/j.injury.2011.09.023	39	0	0	0	0	NATL CENTER TRAUMA RESEARCH	TEHRAN	NATL CENTER TRAUMA RESEARCH, TEHRAN, IRAN	2251-7464	2251-7472		TRAUMA MON	Trauma Mon.	NOV-DEC	2021	26	6					294	304		10.30491/TM.2021.289262.1314			11	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	YI5IO	WOS:000743881400001					2022-02-06	
J	Nakae, R; Fujiki, Y; Takayama, Y; Kanaya, T; Igarashi, Y; Suzuki, G; Naoe, Y; Yokobori, S				Nakae, Ryuta; Fujiki, Yu; Takayama, Yasuhiro; Kanaya, Takahiro; Igarashi, Yutaka; Suzuki, Go; Naoe, Yasutaka; Yokobori, Shoji			Time course of coagulation and fibrinolytic parameters in pediatric traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injuries; age; pediatric; blood coagulation disorders; fibrin fibrinogen degradation products; trauma	SEVERE HEAD-INJURY; HEMORRHAGIC PROGRESSION; COAGULOPATHY; SEVERITY; SYSTEM; SCORE	OBJECTIVE Coagulopathy is a well-recognized risk factor for poor outcomes in patients with traumatic brain injury (TBI). Differences in the time courses of coagulation and fibrinolytic parameters between pediatric and adult patients with TBI have not been defined. METHODS Patients with TBI and an Abbreviated Injury Scale of the head score >= 3, in whom the prothrombin time (PT)-international normalized ratio (INR), activated partial thromboplastin time (APTT), fibrinogen concentration, and plasma D-dimer levels were measured on arrival and at 3, 6, and 12 hours after injury, were retrospectively analyzed. Propensity score-matched analyses were performed to adjust baseline characteristics between pediatric patients (aged < 16 years) and adult patients (aged >= 16 years). RESULTS A total of 468 patients (46 children and 422 adults) were included. Propensity score matching resulted in a matched cohort of 46 pairs. Higher PT-INR and APTT values at 1 to 12 hours after injury and lower fibrinogen concentrations at 1 to 6 hours after injury were observed in the pediatric group compared with the adult group. Plasma levels of D-dimer were elevated in both groups at 1 to 12 hours after injury, but no significant differences were seen between the groups. Multivariate logistic regression analysis of the initial coagulation and fibrinolytic parameters in the pediatric group revealed no prognostic significance of the coagulation parameter values, but elevation of the fibrinolytic parameter D-dimer was an independent negative prognostic factor. CONCLUSIONS In the acute phase of TBI, pediatric patients were characterized by prolongation of PT-INR and APTT and lower fibrinogen concentrations compared with adult patients, but these did not correlate with outcome. D-dimer was an independent prognostic outcome factor in terms of the Glasgow Outcome Scale in pediatric patients with TBI.	[Nakae, Ryuta; Takayama, Yasuhiro; Kanaya, Takahiro; Igarashi, Yutaka; Yokobori, Shoji] Nippon Med Sch, Dept Emergency & Crit Care Med, Bunkyo Ku, Tokyo, Japan; [Fujiki, Yu; Suzuki, Go; Naoe, Yasutaka] Kawaguchi Municipal Med Ctr, Emergency & Crit Care Ctr, Kawaguchi, Saitama, Japan		Nakae, R (corresponding author), Nippon Med Sch, Tokyo, Japan.	nakae@nms.ac.jp		Nakae, Ryuta/0000-0003-1820-2463	JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [19K18367]	This study was supported in part by JSPS KAKENHI grant no. 19K18367. We thank Libby Cone, MD, MA, from DMC Corp. for editing drafts of this manuscript.	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; ANDREW M, 1987, BLOOD, V70, P165, DOI 10.1182/blood.V70.1.165.165; ANDREW M, 1992, BLOOD, V80, P1998, DOI 10.1182/blood.V80.8.1998.1998; Association for the Advancement of Automotive Medicine, 1998, ABBREVIATED INJURY S; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Avarello JT, 2007, EMERG MED CLIN N AM, V25, P803, DOI 10.1016/j.emc.2007.06.013; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Guidelines Committee on the Management of Severe Head Injury Japan Society of Neurotraumatology, 2013, GUIDELINES MANAGEMEN, V3rd; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Katz MH, 2003, ANN INTERN MED, V138, P644, DOI 10.7326/0003-4819-138-8-200304150-00012; Kucuk U, 2016, INTERACT CARDIOV TH, V22, P258, DOI 10.1093/icvts/ivv403; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lipp G, 2007, SEMIN THROMB HEMOST, V33, P816, DOI 10.1055/s-2007-1000373; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Mace SE, 2001, ANN EMERG MED, V38, P405, DOI 10.1067/mem.2001.115882; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; Nakae R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165613; Nakae R, 2019, ACTA NEUROCHIR, V161, P1943, DOI 10.1007/s00701-019-04010-3; Nakae Ryuta, 2017, Surg Neurol Int, V8, P214, DOI 10.4103/sni.sni_56_17; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stephenson SCR, 2002, J TRAUMA, V53, P326, DOI 10.1097/00005373-200208000-00023; Strumwasser A, 2016, J TRAUMA ACUTE CARE, V81, P312, DOI 10.1097/TA.0000000000001060; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P13, DOI 10.1097/00008506-200101000-00003; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Yokobori S, 2021, J NIPPON MED SCH, V88, P194, DOI 10.1272/jnms.JNMS.2021_88-404	31	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2021	28	5					526	532		10.3171/2021.5.PEDS21125			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	XN1FJ	WOS:000729258300004	34416724				2022-02-06	
J	Necula, D; Cho, FS; He, A; Paz, JT				Necula, Deanna; Cho, Frances S.; He, Andrea; Paz, Jeanne T.			Secondary thalamic neuroinflammation after focal cortical stroke and traumatic injury mirrors corticothalamic functional connectivity	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article; Early Access						astrocytes; microglia; neuroinflammation; nucleus reticularis thalami; stroke; thalamus; traumatic brain injury	HIGHER-ORDER; RETICULAR NUCLEUS; RETROGRADE DEGENERATION; MICROGLIAL ACTIVATION; COGNITIVE IMPAIRMENT; MEDIODORSAL THALAMUS; PREFRONTAL CORTEX; BRAIN-INJURY; ORGANIZATION; NEURONS	While cortical injuries, such as traumatic brain injury (TBI) and neocortical stroke, acutely disrupt the neocortex, most of their consequent disabilities reflect secondary injuries that develop over time. Thalamic neuroinflammation has been proposed to be a biomarker of cortical injury and of the long-term cognitive and neurological deficits that follow. However, the extent to which thalamic neuroinflammation depends on the type of cortical injury or its location remains unknown. Using two mouse models of focal neocortical injury that do not directly damage subcortical structures-controlled cortical impact and photothrombotic ischemic stroke-we found that chronic neuroinflammation in the thalamic region mirrors the functional connections with the injured cortex, and that sensory corticothalamic regions may be more likely to sustain long-term damage than nonsensory circuits. Currently, heterogeneous clinical outcomes complicate treatment. Understanding how thalamic inflammation depends on the injury site can aid in predicting features of subsequent deficits and lead to more effective, customized therapies.	[Necula, Deanna; Cho, Frances S.; He, Andrea; Paz, Jeanne T.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Necula, Deanna; Cho, Frances S.; Paz, Jeanne T.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Necula, Deanna; Cho, Frances S.; Paz, Jeanne T.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Necula, Deanna; Cho, Frances S.; Paz, Jeanne T.] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA		Paz, JT (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	jeanne.paz@gladstone.ucsf.edu			U.S. Department of DefenseUnited States Department of Defense [W81XWH1610576, W81XWH2010160]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS096369, R21NS118379, F31NS11181901A1]; Hillblom/BARI graduate fellowship	Gladstone Institutes; U.S. Department of Defense, Grant/Award Numbers: W81XWH1610576, W81XWH2010160; National Institute of Neurological Disorders and Stroke, Grant/Award Numbers: R01 NS096369, R21NS118379, F31NS11181901A1; Hillblom/BARI graduate fellowship	Ahn LY, 2021, J NEUROSCI RES, V99, P110, DOI 10.1002/jnr.24747; Ahrens S, 2015, NAT NEUROSCI, V18, P104, DOI 10.1038/nn.3897; Bennett C, 2019, NEURON, V102, P477, DOI 10.1016/j.neuron.2019.02.010; Bickford ME, 2015, J NEUROSCI, V35, P10523, DOI 10.1523/JNEUROSCI.3375-14.2015; Binkofski F, 1996, ANN NEUROL, V39, P460, DOI 10.1002/ana.410390408; Bottcher C, 2019, NAT NEUROSCI, V22, P78, DOI 10.1038/s41593-018-0290-2; Bosch-Bouju C, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00163; Campbell PW, 2020, J NEUROPHYSIOL, V124, P404, DOI 10.1152/jn.00757.2019; Cao ZJ, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00236; Centers for Disease Control and Prevention, 2015, STROK FACTS; Clemente-Perez A, 2017, CELL REP, V19, P2130, DOI 10.1016/j.celrep.2017.05.044; Collins DP, 2018, NEURON, V98, P366, DOI 10.1016/j.neuron.2018.03.024; CORNWALL J, 1990, EXP BRAIN RES, V80, P157; Crabtree JW, 2018, FRONT SYST NEUROSCI, V12, DOI 10.3389/fnsys.2018.00041; CRABTREE JW, 1992, EUR J NEUROSCI, V4, P1352, DOI 10.1111/j.1460-9568.1992.tb00160.x; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dickerson MR, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00618; Escartin C, 2021, NAT NEUROSCI, V24, P312, DOI 10.1038/s41593-020-00783-4; Fama R, 2015, NEUROSCI BIOBEHAV R, V54, P29, DOI 10.1016/j.neubiorev.2015.03.008; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; Gauthier J, 2018, ANN NEUROL, V83, P1089, DOI 10.1002/ana.25204; Gentet LJ, 2003, J PHYSIOL-LONDON, V546, P801, DOI 10.1113/jphysiol.2002.032730; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Guillery RW, 1995, J ANAT, V187, P583; Gulcebi MI, 2012, BRAIN RES BULL, V87, P312, DOI 10.1016/j.brainresbull.2011.11.005; Halassa MM, 2016, TRENDS NEUROSCI, V39, P680, DOI 10.1016/j.tins.2016.08.001; Hazra A, 2016, NEUROBIOL AGING, V44, P96, DOI 10.1016/j.neurobiolaging.2016.04.016; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Hochstenbach JB, 2003, ARCH PHYS MED REHAB, V84, P1499, DOI 10.1016/S0003-9993(03)00370-8; Hoerder-Suabedissen A, 2018, CEREB CORTEX, V28, P1882, DOI 10.1093/cercor/bhy036; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Holden SS, 2021, SCIENCE, V373, P1217, DOI 10.1126/science.abj2685; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Hoseini MS, 2021, ELIFE, V10, DOI 10.7554/eLife.61437; HOUSER CR, 1980, BRAIN RES, V200, P341, DOI 10.1016/0006-8993(80)90925-7; Hwang K, 2017, J NEUROSCI, V37, P5594, DOI 10.1523/JNEUROSCI.0067-17.2017; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jourdan C, 2018, AM J PHYS MED REHAB, V97, P323, DOI 10.1097/PHM.0000000000000848; Kessner SS, 2019, STROKE, V50, P1116, DOI 10.1161/STROKEAHA.118.023750; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kirst C, 2020, CELL, V180, P780, DOI 10.1016/j.cell.2020.01.028; Kuchcinski G, 2017, BRAIN, V140, P1932, DOI 10.1093/brain/awx114; Lam YW, 2011, J NEUROSCI, V31, P6791, DOI 10.1523/JNEUROSCI.3073-10.2011; Langen KJ, 2007, J NUCL MED, V48, P1482, DOI 10.2967/jnumed.107.041699; Lee CC, 2013, BRAIN LANG, V126, P22, DOI 10.1016/j.bandl.2012.05.004; Lee JH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12496-9; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liepert J, 2005, STROKE, V36, P2648, DOI 10.1161/01.STR.0000189629.10603.02; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lindsay MP, 2019, INT J STROKE, V14, P806, DOI 10.1177/1747493019881353; Lindsay NM, 2019, NEURON, V104, P765, DOI 10.1016/j.neuron.2019.08.032; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; LOZSADI DA, 1994, J COMP NEUROL, V341, P520, DOI 10.1002/cne.903410408; Lutkenhoff ES, 2020, NEUROLOGY, V95, pE2398, DOI 10.1212/WNL.0000000000010825; Makinson CD, 2017, NEURON, V93, P1165, DOI 10.1016/j.neuron.2017.01.031; Manninen E, 2021, EPILEPSIA, V62, P1852, DOI 10.1111/epi.16986; Masuda T, 2020, CELL REP, V30, P1271, DOI 10.1016/j.celrep.2020.01.010; Matias I, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00059; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Mitchell AS, 2015, NEUROSCI BIOBEHAV R, V54, P76, DOI 10.1016/j.neubiorev.2015.03.001; Monavarfeshani A, 2017, VISUAL NEUROSCI, V34, DOI 10.1017/S0952523817000098; Muller A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145451; Nakajima M, 2017, CURR OPIN NEUROBIOL, V44, P127, DOI 10.1016/j.conb.2017.04.001; Nascimento LR, 2021, DISABIL REHABIL, V43, P525, DOI 10.1080/09638288.2019.1631396; Ohara T, 2010, J NEUROL SCI, V293, P87, DOI 10.1016/j.jns.2010.02.027; Pappata S, 2000, NEUROLOGY, V55, P1052, DOI 10.1212/WNL.55.7.1052; Parnaudeau S, 2018, BIOL PSYCHIAT, V83, P648, DOI 10.1016/j.biopsych.2017.11.008; Paxinos G., 2007, MOUSE BRAIN STEREOTA; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Paz JT, 2011, NAT NEUROSCI, V14, P1167, DOI 10.1038/nn.2896; Paz JT, 2010, J NEUROSCI, V30, P5465, DOI 10.1523/JNEUROSCI.5083-09.2010; Perry BAL, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00167; Power BD, 2015, AUST NZ J PSYCHIAT, V49, P502, DOI 10.1177/0004867415585857; Puelles L, 2012, MOUSE NERVOUS SYSTEM, P313, DOI 10.1016/B978-0-12-369497-3.10009-3; Ramcharan EJ, 2005, P NATL ACAD SCI USA, V102, P12236, DOI 10.1073/pnas.0502843102; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reinhold K, 2015, NAT NEUROSCI, V18, P1789, DOI 10.1038/nn.4153; Ritter-Makinson S, 2019, CELL REP, V26, P54, DOI 10.1016/j.celrep.2018.12.018; Rosa JM, 2021, BRIT J PHARMACOL, V178, P3395, DOI 10.1111/bph.15488; Rose C.R., 2015, E NEUROFORUM, V6, P59, DOI [10.1007/s13295-015-0012-0, DOI 10.1007/S13295-015-0012-0]; Rosenberg MF, 2020, TRENDS IMMUNOL, V41, P753, DOI 10.1016/j.it.2020.07.011; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schaechter JD, 2004, PROG NEUROBIOL, V73, P61, DOI 10.1016/j.pneurobio.2004.04.001; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Shapiro LA, 2009, BRAIN RES, V1266, P29, DOI 10.1016/j.brainres.2009.02.031; Sherman S.M., 2006, EXPLORING THALAMUS I, V2. ed; Sherman SM, 2007, CURR OPIN NEUROBIOL, V17, P417, DOI 10.1016/j.conb.2007.07.003; Sherman SM, 2016, NAT NEUROSCI, V19, P533, DOI 10.1038/nn.4269; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; SHERMAN SM, 1986, EXP BRAIN RES, V63, P1; Sherman SM, 2013, FUNCTIONAL CONNECTIO; Sorensen JC, 1996, EXP BRAIN RES, V112, P203; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Suarez-Mier GB, 2015, ASN NEURO, V7, DOI 10.1177/1759091415601636; Sul B, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00776; Van Horn SC, 2007, NEUROSCIENCE, V146, P463, DOI 10.1016/j.neuroscience.2007.01.026; Vantomme G, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00576; Walker DG, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0139-9; Weishaupt JH, 2016, TRENDS MOL MED, V22, P769, DOI 10.1016/j.molmed.2016.07.005; Wells MF, 2016, NATURE, V532, P58, DOI 10.1038/nature17427; Worker CJ, 2020, AM J PHYSIOL-ENDOC M, V318, pE765, DOI 10.1152/ajpendo.00406.2019; Xin WD, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00141; Yuan P, 2014, NEUROSCI BIOBEHAV R, V42, P180, DOI 10.1016/j.neubiorev.2014.02.005; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006; Zikopoulos B, 2012, J NEUROSCI, V32, P5338, DOI 10.1523/JNEUROSCI.4793-11.2012; Zimmerman EC, 2018, EUR J NEUROSCI, V48, P3255, DOI 10.1111/ejn.14111	117	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.												10.1002/cne.25259		NOV 2021	22	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	WP8AB	WOS:000713346700001	34633669				2022-02-06	
J	Noe, E; Navarro, MD; Amoros, D; Garcia-Blazquez, MC; O'Valle, M; Villarino, P; Cerezo, S; Colomer, C; Moliner, B; Ugart, P; Rodriguez, C; Llorens, R; Ferri, J				Noe, Enrique; Dolores Navarro, M.; Amoros, Desiree; Carmen Garcia-Blazquez, M.; O'Valle, Myrtha; Villarino, Pablo; Cerezo, Silvia; Colomer, Carolina; Moliner, Belen; Ugart, Patricia; Rodriguez, Clara; Llorens, Roberto; Ferri, Joan			Effectiveness, adherence and usability of a teleneurorehabilitation programme to ensure continuity of care for patients with acquired brain injury during the COVID-19 pandemic	REVISTA DE NEUROLOGIA			Spanish	Article						Acquired brain injury; COVID-19; Neurorrehabilitation; Stroke; Telerehabilitation; Traumatic brain injury	OLDER-ADULTS; STROKE; TELEREHABILITATION; REHABILITATION	Introduction. The health pandemic brought about by SARS-CoV-2 (COVID-19) has limited access to neurorehabilitation programmes for many patients who have suffered stroke, traumatic brain injury or acquired brain damage due to some other cause. As telerehabilitation allows for the provision of care in situations of social distancing, it may mitigate the negative effects of confinement. The aim of this study was to determine the efficacy, adherence and usability of a teleneurorehabilitation intervention for patients with acquired brain injury. Patients and methods. All patients included in a face-to-face neurorehabilitation programme at the time of the declaration of the state of alarm in Spain due to COVID-19 and who agreed to participate in the study were included in a teleneurorehabilitation programme. The effectiveness of the programme, understood as an improvement in independence, was quantified with the Barthel index. Adherence to the programme and usability of the tool were explored through questionnaires. Results. Altogether, 46 patients, accounting for 70.6% of the total, participated in the study. Participants significantly improved their independence and showed an improvement in the Barthel index between the start (77.3 +/- 28.6) and the end of the programme (82.3 +/- 26). Adherence to the intervention was very high (8.1 +/- 2.2 out of 10) and the online sessions were the most highly rated content. The tool used showed a high usability (50.1 +/- 9.9 out of 60) and could be used without assistance by more than half the participants. Conclusion. The teleneurorehabilitation intervention was found to be effective in improving patients' independence, and promoted a high degree of adherence and usability.	[Noe, Enrique; Dolores Navarro, M.; Amoros, Desiree; Carmen Garcia-Blazquez, M.; O'Valle, Myrtha; Villarino, Pablo; Cerezo, Silvia; Colomer, Carolina; Moliner, Belen; Ugart, Patricia; Rodriguez, Clara; Llorens, Roberto; Ferri, Joan] Fdn Hosp Vithas, Serv Neurorrehabil Hosp Vithas, NEURORHB, Valencia, Spain; [Llorens, Roberto] Univ Politecn Valencia, Inst Invest & Innovac Bioingn, Neurorehabil & Brain Res Grp, Valencia, Spain		Noe, E (corresponding author), Hosp Vithas Virgen del Consuelo, Serv Neurorrehabil, NEURORHB, C Callosa dEn Sarria 12,2a Planta, E-46007 Valencia, Spain.	quique@neurorhb.com	Llorens, Roberto/AAL-2604-2021	Llorens, Roberto/0000-0002-8677-8707			[Anonymous], 2013, DIAGNOSTIC STAT MANU; Assenza C, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.617276; Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Bellomo RG, 2020, J CENT NERV SYST DIS, V12, DOI 10.1177/1179573520979866; Boter H, 2004, STROKE, V35, P2867, DOI 10.1161/01.STR.0000147717.57531.e5; Brooke J., 1996, USABILITY EVALUATION, P189; Chang MC, 2020, AM J PHYS MED REHAB, V99, P582, DOI 10.1097/PHM.0000000000001468; Chen J, 2017, AM J PHYS MED REHAB, V96, P152, DOI 10.1097/PHM.0000000000000559; Ensenat-Cantallops A., NEUROLOGIA, V2021; Escoffery C, 2018, TELEMED E-HEALTH, V24, P335, DOI 10.1089/tmj.2017.0136; Kim J, 2017, J GERONTOL B-PSYCHOL, V72, P836, DOI 10.1093/geronb/gbw123; Klaic M, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.580832; Kontos Emily, 2014, J Med Internet Res, V16, pe172, DOI 10.2196/jmir.3117; Laver KE, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010255.pub3; Laxe S, 2020, BRAIN INJURY, V34, P1691, DOI 10.1080/02699052.2020.1830172; Lin KH, 2014, SENSORS-BASEL, V14, P12451, DOI 10.3390/s140712451; Mayo NE, 2008, AGE AGEING, V37, P32, DOI 10.1093/ageing/afm133; MCAULEY E, 1989, RES Q EXERCISE SPORT, V60, P48, DOI 10.1080/02701367.1989.10607413; Miller KK, 2017, TOP STROKE REHABIL, V24, P142, DOI 10.1080/10749357.2016.1200292; Nora M, 2021, AM J PHYS MED REHAB, V100, P214, DOI 10.1097/PHM.0000000000001679; Peretti Alessandro, 2017, JMIR Rehabil Assist Technol, V4, pe7, DOI 10.2196/rehab.7511; Rogante M, 2010, NEUROREHABILITATION, V27, P287, DOI 10.3233/NRE-2010-0612; Romero M, 2012, NEUROLOGIA, V27, P216, DOI 10.1016/j.nrl.2011.06.006; Sarker SJ, 2012, STROKE, V43, P1362, DOI 10.1161/STROKEAHA.111.645234; Simpson DB, 2020, TOP STROKE REHABIL, V27, P93, DOI 10.1080/10749357.2019.1690779; Tenforde AS, 2020, AM J PHYS MED REHAB, V99, P977, DOI 10.1097/PHM.0000000000001571; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Vroman KG, 2015, COMPUT HUM BEHAV, V43, P156, DOI 10.1016/j.chb.2014.10.018; Wade D, 2015, CLIN REHABIL, V29, P1145, DOI 10.1177/0269215515601175; Wang S, 2016, ARCH PHYS MED REHAB, V97, P1403, DOI 10.1016/j.apmr.2016.04.002; Wechsler LR, 2020, ANN NEUROL, V88, P656, DOI 10.1002/ana.25849	31	0	0	0	0	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	NOV	2021	73	10					345	350		10.33588/rn.7310.2021275			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XN4FU	WOS:000729463400002	34755887				2022-02-06	
J	O'Neil, ME; Cameron, D; Shirley, K; Sano, E; Twamley, E; Williams, R; Turner, A; Pagulayan, K; Roost, M; Jak, A; Storzbach, D; Huckans, M				O'Neil, Maya Elin; Cameron, David; Shirley, Kate; Sano, Emily; Twamley, Elizabeth; Williams, Rhonda; Turner, Aaron; Pagulayan, Kathleen; Roost, Mai; Jak, Amy; Storzbach, Daniel; Huckans, Marilyn			Change in Learning and Memory Partially Mediates Effects of Compensatory Cognitive Training on Self-Reported Cognitive Symptoms	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						compensatory cognitive training; mediation; mental health; objective cognitive functioning; self-reported cognitive symptoms; traumatic brain injury; Veterans	TRAUMATIC BRAIN-INJURY; RETROSPECTIVE MEMORY; QUESTIONNAIRE PRMQ; LATENT STRUCTURE; NORMATIVE DATA; COMPLAINTS; AFGHANISTAN; IMPAIRMENT; IRAQ; DEPRESSION	Objective: To examine associations among compensatory cognitive training (CCT), objective cognitive functioning, and self-reported cognitive symptoms. We examined whether change in objective cognitive functioning associated with participation in CCT at 10-week follow-up mediates change in self-reported cognitive symptoms associated with CCT at 15-week follow-up. Setting: Three VA outpatient mental health clinics. Participants: Veterans with a history of mild traumatic brain injury who reported cognitive deficits. Design: Randomized controlled trial post hoc causal mediation analysis. Main Measures: Self-reported cognitive symptoms were measured by the Prospective-Retrospective Memory Questionnaire and the Multiple Sclerosis Neuropsychological Screening Questionnaire. Objective cognitive functioning was measured using a battery of neuropsychological tests. Results: Improvement on the Hopkins Verbal Learning Test-Revised (HVLT-R) Delayed Recall test mediated the association between participation in CCT and decrease in the Prospective-Retrospective Memory Questionnaire total score. Improvement on the HVLT-R Total Recall and HVLT-R Delayed Recall tests both meditated the association between participation in CCT and decrease in the Multiple Sclerosis Neuropsychological Screening Questionnaire total score. No other measures of objective cognitive functioning were significant mediators. Conclusion: Patients' perceptions of cognitive symptom improvement due to CCT are partially mediated by learning and memory, though these subjective improvements occur regardless of other changes in objective cognitive functioning associated with CCT.	[O'Neil, Maya Elin; Cameron, David; Shirley, Kate; Sano, Emily; Roost, Mai; Storzbach, Daniel; Huckans, Marilyn] VA Portland Hlth Care Syst, Portland, OR USA; [O'Neil, Maya Elin; Storzbach, Daniel; Huckans, Marilyn] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [O'Neil, Maya Elin] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR USA; [Storzbach, Daniel] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Twamley, Elizabeth; Jak, Amy] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Twamley, Elizabeth; Jak, Amy] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Williams, Rhonda; Turner, Aaron; Pagulayan, Kathleen] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; [Pagulayan, Kathleen] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		O'Neil, ME (corresponding author), VA Portland Hlth Care Syst R&D 66, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	Maya.Oneil@va.gov	Pagulayan, Kati/AAR-9225-2020; Turner, Aaron/A-7902-2009	Turner, Aaron/0000-0001-6897-8003	VA Merit Review AwardUS Department of Veterans Affairs [1 I01 RX000254]; VA Career Development Award from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and DevelopmentUS Department of Veterans Affairs [1 IK2 RX002762]; VA Health Services Research and Development (HSR&D) Center to Improve Veteran Involvement in Care (CIVIC)US Department of Veterans Affairs; VA Merit Review Award from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Science Research and DevelopmentUS Department of Veterans Affairs [1 I01 CX001592-01]	This work was supported by VA Merit Review Award 1 I01 RX000254 to Daniel Storzbach and Elizabeth Twamley; VA Career Development Award 1 IK2 RX002762 to Maya O'Neil from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development; and VA Merit Review Award 1 I01 CX001592-01 to Marilyn Huckans and Elizabeth Twamley from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Science Research and Development. The VA Health Services Research and Development (HSR&D) Center to Improve Veteran Involvement in Care (CIVIC) provided support toMaya O'Neil and David Cameron. This material is the result of work supported with resources and the use of facilities at the Veterans Affairs Medical Centers in Portland, Oregon, San Diego, California, and Puget Sound, Washington. The contents do not represent the views of the US Department of Veterans Affairs or the United States Government.	[Anonymous], 2014, SAS SOFTW WIND VERS; Benedict RHB, 2003, MULT SCLER J, V9, P95, DOI 10.1191/1352458503ms861oa; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Buckley R, 2013, INT PSYCHOGERIATR, V25, P1307, DOI 10.1017/S1041610213000665; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Crawford JR, 2006, BRIT J CLIN PSYCHOL, V45, P83, DOI 10.1348/014466505X28748; Dardenne S, 2017, J ALZHEIMERS DIS, V60, P1567, DOI [10.3233/JAD-170229, 10.3233/jad-170229]; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Department of Defense, 2019, DOD WORLDW NUMB TRAU; Faul M, 2010, TRAUMATIC BRAIN INJU; Greer N, 2016, PREVALENCE EPIDEMIOL; Huckans M., 2016, MOTIVATIONALLY ENHAN; Huckans M, 2013, NEUROPSYCHOL REV, V23, P63, DOI 10.1007/s11065-013-9230-9; Kansagara D., 2013, COMPLICATIONS MILD T; Kline A, 2010, AM J PUBLIC HEALTH, V100, P276, DOI 10.2105/AJPH.2009.162925; Lotfus, 2009, NEUROTRAUMA CRITICAL, P3; Regasa LE, 2019, J HEAD TRAUMA REHAB, V34, P21, DOI 10.1097/HTR.0000000000000417; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Twamley EW, 2012, J CLIN PSYCHIAT, V73, P1212, DOI 10.4088/JCP.12m07686; VanderWeele T., 2019, CAUSAL MEDIATION ANA; VanderWeele TJ, 2016, INT J EPIDEMIOL, V45, P1904, DOI 10.1093/ije/dyw277; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Zlatar ZZ, 2014, J GERIATR PSYCH NEUR, V27, P181, DOI 10.1177/0891988714524628	35	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2021	36	6			SI		429	436		10.1097/HTR.0000000000000662			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WV3QT	WOS:000717155100010	33656484				2022-02-06	
J	Oldham, JR; Howell, DR; Knight, CA; Crenshaw, JR; Buckley, TA				Oldham, Jessie R.; Howell, David R.; Knight, Christopher A.; Crenshaw, Jeremy R.; Buckley, Thomas A.			Single-Task and Dual-Task Tandem Gait Performance Across Clinical Concussion Milestones in Collegiate Student-Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						gait; mild traumatic brain injury; postural control; cognitive	CONTROL DEFICITS; BALANCE CONTROL; INJURY; ADOLESCENTS; WALKING; YOUNG	Objective: To determine the length of time after concussion that impaired tandem gait performance is observed. Design: Clinical measurement, prospective longitudinal. Setting: NCAA collegiate athletic facility. Participants: Eighty-eight concussed NCAA Division I student-athletes and 30 healthy controls. Independent Variables: Group (concussion/control) and time (Baseline, Acute, Asymptomatic, and RTP). Main Outcome Measures: Participants completed 4 single-task and dual-task tandem gait trials. The concussion group completed tests at the following time points: preseason (Baseline), within 48 hours after concussion (Acute), on the day symptoms were no longer reported (Asymptomatic), and when cleared to return to sports (RTP). Controls completed the same protocol at similar intervals. The dual-task trials involved minimental style cognitive questions answered simultaneously during tandem gait. We analyzed the best time of the 4 trials, comparing groups with a linear mixed model. Results: Acutely after concussion, the concussion group performed single-task tandem gait slower (worse) than controls (concussion: 11.36 +/- 2.43 seconds, controls: 9.07 +/- 1.78 seconds, P < 0.001). The concussion group remained significantly slower than controls (9.95 +/- 2.21 vs 8.89 +/- 1.65 seconds, P = 0.03) at Asymptomatic day but not RTP. There were significant group (P < 0.001) and time (P < 0.001) effects for dual-task tandem gait. The groups were not significantly different at baseline for single-task (P = 0.95) or dual-task (P = 0.22) tandem gait. Conclusions: Our results indicate that tandem gait performance is significantly impaired acutely after concussion, compared with both preseason measures and controls. Postural control impairments were not present when the student-athletes were cleared for RTP. This information can assist clinicians when assessing postural control and determining recovery after a concussive injury.	[Oldham, Jessie R.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Oldham, Jessie R.] Boston Childrens Hosp, Dept Orthoped, Div Sports Med, Boston, MA USA; [Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Knight, Christopher A.; Crenshaw, Jeremy R.; Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Knight, Christopher A.; Crenshaw, Jeremy R.; Buckley, Thomas A.] Univ Delaware, Interdisciplinary Program Biomech & Movement Sci, Newark, DE USA		Oldham, JR (corresponding author), Boston Childrens Hosp, Dept Orthoped, Div Sports Med, Micheli Ctr Sports Injury Prevent, 20 Hope Ave, Waltham, MA 02453 USA.	Jessie.Oldham@childrens.harvard.edu	Crenshaw, Jeremy/AAC-9197-2019	Crenshaw, Jeremy/0000-0002-5108-3630	Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurological Disorders And Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100952, R41NS103698]; Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; ElMindA Ltd; Eastern Athletic Trainers Association Inc.; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS104371]; NCAA/DoD CARE Consortium [W81XWH-14-2-0151]	D. R. Howell receives research support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (R03HD094560) and the National Institute of Neurological Disorders And Stroke (R01NS100952 and R41NS103698) of the National Institutes of Health. He has previously received research support from a research contract between Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and ElMindA Ltd, and the Eastern Athletic Trainers Association Inc. T. A. Buckley has received funding from the NIH/NINDS (R03NS104371) and the NCAA/DoD CARE Consortium (W81XWH-14-2-0151). The remaining authors report no conflicts of interest.	ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; [Anonymous], 2013, Br J Sports Med, V47, P259; Atsumori H, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3462996; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; De Sanctis P, 2014, NEUROIMAGE, V94, P55, DOI 10.1016/j.neuroimage.2014.03.016; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Giza CC, 2001, J ATHL TRAINING, V36, P228; Hamacher D, 2015, NEUROSCI BIOBEHAV R, V57, P310, DOI 10.1016/j.neubiorev.2015.08.002; Holtzer R, 2011, J GERONTOL A-BIOL, V66, P879, DOI 10.1093/gerona/glr068; Howell DR, 2019, J ATHL TRAINING, V54, P1254, DOI 10.4085/1062-6050-525-18; Howell DR, 2019, J SCI MED SPORT, V22, P521, DOI 10.1016/j.jsams.2018.11.014; Howell DR, 2019, CLIN J SPORT MED, V29, P238, DOI 10.1097/JSM.0000000000000509; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kammerlind AS, 2005, EUR J PHYSIOTHER, V7, P96, DOI 10.1080/14038190510010403; la Fougere C, 2010, NEUROIMAGE, V50, P1589, DOI 10.1016/j.neuroimage.2009.12.060; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Margolesky J, 2018, NEUROL SCI, V39, P23, DOI 10.1007/s10072-017-3108-1; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Oldham JR, 2017, SPORTS HEALTH, V9, P305, DOI 10.1177/1941738116680999; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Santo A, 2017, J ATHL TRAINING, V52, P1096, DOI 10.4085/1062-6050-52.11.26; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Shumway-Cook A, 2012, MOTOR CONTROL TRANSL, P161; Slobounov S, 2005, NEUROSCI LETT, V383, P251, DOI 10.1016/j.neulet.2005.04.039; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; Zwergal A, 2012, NEUROBIOL AGING, V33, P1073, DOI 10.1016/j.neurobiolaging.2010.09.022	39	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2021	31	6					E392	E397		10.1097/JSM.0000000000000836			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WM5NJ	WOS:000711131700015	32852299				2022-02-06	
J	Oliveira, RV; Beaver, KM				Oliveira, Raquel V.; Beaver, Kevin M.			Exploring effects of psycho-bio-social risk factors on later offending	JOURNAL OF CRIMINAL JUSTICE			English	Article						Life-course; Cumulative effects; Risk factors	TRAUMATIC BRAIN-INJURY; LIFE-COURSE-PERSISTENT; ADVERSE CHILDHOOD EXPERIENCES; LOW SELF-CONTROL; ANTISOCIAL-BEHAVIOR; CUMULATIVE RISK; MENTAL-ILLNESS; SUBSTANCE USE; INTERGENERATIONAL TRANSMISSION; PSYCHOLOGICAL-RESEARCH	Different perspectives in criminology have explored how potential risk factors affect delinquency and criminal behavior over the life-course. Although many scholars look at risk factors individually and estimate how they may affect future criminal involvement, an emerging school of thought has proposed that risk factors may work in tandem to affect future criminality. This emerging line of research uses a cumulative approach to the study of crime, considering the role of multiple risk factors on criminal involvement. This study aims at using a cumulative stressor approach to look at the effect of summative biosocial, psychopathological, and family risk factors on later offending. To do so, a sample of high-risk offenders is used to estimate the role of cumulative biosocial, psychological, and family-related risk factors of violent and non-violent offending. The results suggest that biosocial and family risk factors seem to significantly predict offending frequency, while psychopathologies seem to have a crime-reducing effect. Additionally, offenders with more biosocial and family risk factors seem to offend more seriously and at a higher frequency.	[Oliveira, Raquel V.] Univ West England, Dept Social Sci, Frenchay Campus,Coldharbour Lane, Bristol BS16 1QY, Avon, England; [Oliveira, Raquel V.] Interdisciplinary Ctr Social Sci CICS NOVA, Lisbon, Portugal; [Beaver, Kevin M.] Florida State Univ, Coll Criminol & Criminal Justice, Tallahassee, FL 32306 USA; [Oliveira, Raquel V.] Anal & Metr Validat Res Grp, Araraquara, SP, Brazil; [Beaver, Kevin M.] King Abdulaziz Univ, Ctr Social & Humanities Res, Jeddah, Saudi Arabia		Oliveira, RV (corresponding author), Univ West England, Dept Social Sci, Frenchay Campus,Coldharbour Lane, Bristol BS16 1QY, Avon, England.	raquel.velezoliveira@uwe.ac.uk			Portuguese Foundation for Science and TechnologyPortuguese Foundation for Science and Technology [SFRH/BD/103388/2014]	This work was supported by the Portuguese Foundation for Science and Technology (SFRH/BD/103388/2014) .	Andershed AK, 2016, J CRIM JUST, V45, P78, DOI 10.1016/j.jcrimjus.2016.02.006; Arseneault L, 2000, ARCH GEN PSYCHIAT, V57, P979, DOI 10.1001/archpsyc.57.10.979; Ashman TA, 2006, MT SINAI J MED, V73, P999; Asscher JJ, 2011, J CHILD PSYCHOL PSYC, V52, P1134, DOI 10.1111/j.1469-7610.2011.02412.x; Bagaric M., 2016, HARVARD HUMAN RIGHTS, V29, P1; Bandura A, 1996, J PERS SOC PSYCHOL, V71, P364, DOI 10.1037/0022-3514.71.2.364; Barnard M, 1999, ADDICTION, V94, P1109; Beaver KM, 2013, CRIM JUSTICE BEHAV, V40, P139, DOI 10.1177/0093854812449405; Beaver KM, 2011, INTELLIGENCE, V39, P193, DOI 10.1016/j.intell.2011.03.005; Beaver KM, 2010, INT J OFFENDER THER, V54, P22, DOI 10.1177/0306624X08325349; Beaver KM, 2005, INT J OFFENDER THER, V49, P450, DOI 10.1177/0306624X05274687; Belenko S, 2005, DRUG ALCOHOL DEPEN, V77, P269, DOI 10.1016/j.drugalcdep.2004.08.023; Bellair PE, 2016, JUSTICE Q, V33, P455, DOI 10.1080/07418825.2014.918166; Bennett T, 2008, AGGRESS VIOLENT BEH, V13, P107, DOI 10.1016/j.avb.2008.02.001; Besemer S, 2017, AGGRESS VIOLENT BEH, V37, P161, DOI 10.1016/j.avb.2017.10.004; Boccio CM, 2018, INTELLIGENCE, V66, P24, DOI 10.1016/j.intell.2017.10.003; Boccio CM, 2018, YOUTH VIOLENCE JUV J, V16, P37, DOI 10.1177/1541204016684176; Boutwell BB, 2010, J CRIM JUST, V38, P489, DOI 10.1016/j.jcrimjus.2010.04.018; Brown GP, 2015, INT J OFFENDER THER, V59, P27, DOI 10.1177/0306624X13507040; Cameron A. C., 2013, REGRESSION ANAL COUN; Cauffman E, 2000, BEHAV SCI LAW, V18, P741, DOI 10.1002/bsl.416; Cauffman E, 2009, PSYCHOL ASSESSMENT, V21, P528, DOI 10.1037/a0017367; Chandler RK, 2009, JAMA-J AM MED ASSOC, V301, P183, DOI 10.1001/jama.2008.976; CHASSIN L, 1993, J ABNORM PSYCHOL, V102, P3, DOI 10.1037/0021-843X.102.1.3; CHASSIN L, 1991, J ABNORM PSYCHOL, V100, P449, DOI 10.1037/0021-843X.100.4.449; Cohen J., 2003, APPL MULTIPLE REGRES, V3; Coid J, 2009, INT J LAW PSYCHIAT, V32, P134, DOI 10.1016/j.ijlp.2009.02.008; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Craig JM, 2017, J CRIM JUST, V53, P34, DOI 10.1016/j.jcrimjus.2017.09.005; CRYSTAL S, 1990, GERONTOLOGIST, V30, P437, DOI 10.1093/geront/30.4.437; Dannefer D, 2003, J GERONTOL B-PSYCHOL, V58, pS327, DOI 10.1093/geronb/58.6.S327; DARLINGTON RB, 1968, PSYCHOL BULL, V69, P161, DOI 10.1037/h0025471; Dean K, 2012, PSYCHOL MED, V42, P571, DOI 10.1017/S0033291711001395; Dean K, 2010, ARCH GEN PSYCHIAT, V67, P822, DOI 10.1001/archgenpsychiatry.2010.86; DeLisi M, 2009, YOUTH VIOLENCE JUV J, V7, P256, DOI 10.1177/1541204009333834; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Douglas KS, 2009, PSYCHOL BULL, V135, P679, DOI 10.1037/a0016311; Evans GW, 2013, PSYCHOL BULL, V139, P1342, DOI 10.1037/a0031808; Fals-Stewart W, 2004, J FAM PSYCHOL, V18, P319, DOI 10.1037/0893-3200.18.2.319; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Farrington D. P, 2002, CRIM BEHAV MENT HEAL, V12, P10; Farrington D. P., 2002, NATO SCI SERIES, P23; Farrington DP, 2009, CRIM BEHAV MENT HEAL, V19, P109, DOI 10.1002/cbm.717; FARRINGTON DP, 1975, MED SCI LAW, V15, P177, DOI 10.1177/002580247501500306; FARRINGTON DP, 1986, CRIME JUSTICE, V7, P189, DOI 10.1086/449114; Fazel S, 2010, ARCH GEN PSYCHIAT, V67, P931, DOI 10.1001/archgenpsychiatry.2010.97; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fergusson DM, 2005, J CHILD PSYCHOL PSYC, V46, P850, DOI 10.1111/j.1469-7610.2005.01472.x; Field A, 2013, DISCOVERING STAT USI; Fleminger S, 2010, PSYCHIAT TIMES, V9, P1; Forth A. E., 2003, HARE PSYCHOPATHY CHE; Frieden T.R., 2015, CDC NIH REP C, P1, DOI [10.3171/2009.10.JNS091500, DOI 10.3171/2009.10.JNS091500]; Galea S, 2004, EPIDEMIOL REV, V26, P36, DOI 10.1093/epirev/mxh007; Glaze, 2006, MENTAL HLTH PROBLEMS; Glenn AL, 2014, PSYCHOPATHY INTRO BI; Glueck S., 1950, UNRAVELING JUVENILE; Golden C.J., 1978, STROOP COLOR WORD TE; Gottfredson M. R., 1990, GEN THEORY CRIME; GREENBERGER E, 1975, J YOUTH ADOLESCENCE, V4, P127, DOI 10.1007/BF01537437; Hahs-Vaughn D.L, 2012, INTRO STAT CONCEPTS; Hammersley R, 2011, J CRIM JUST, V39, P268, DOI 10.1016/j.jcrimjus.2011.02.006; Hare R.D., 1993, CONSCIENCE DISTURBIN; Hare RD, 1996, CRIM JUSTICE BEHAV, V23, P25, DOI 10.1177/0093854896023001004; Hatch SL, 2005, J GERONTOL B-PSYCHOL, V60, P130; Hay C., 2015, SELF CONTROL CRIME L; Haynie DL, 2009, J YOUTH ADOLESCENCE, V38, P269, DOI 10.1007/s10964-008-9343-2; Herrenkohl TI, 2000, J ADOLESCENT HEALTH, V26, P176, DOI 10.1016/S1054-139X(99)00065-8; Herrnstein RJ., 1994, BELL CURVE INTELLIGE; Hollingshead A. B., 1957, 2 FACTOR INDEX SOCIA; Howard R, 2017, SOC PSYCH PSYCH EPID, V52, P21, DOI 10.1007/s00127-016-1293-5; James D. J., 2006, BUREAU JUSTICE STAT, P1, DOI [10.1109/LGRS.2016.2516535, DOI 10.1109/LGRS.2016.2516535]; Johnson VA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121627; Junger M, 2013, EUR J CRIM POLICY RE, V19, P117, DOI 10.1007/s10610-012-9193-z; Kassing F, 2019, J ABNORM CHILD PSYCH, V47, P765, DOI 10.1007/s10802-018-0478-7; KAUFMAN J, 1987, AM J ORTHOPSYCHIAT, V57, P186, DOI 10.1111/j.1939-0025.1987.tb03528.x; Kelley SM, 2020, CRIM JUSTICE BEHAV, V47, P290, DOI 10.1177/0093854819887204; Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P674, DOI 10.1001/archpsyc.65.6.674; Kendler KS, 2013, ALCOHOL CLIN EXP RES, V37, P2118, DOI 10.1111/acer.12196; Kennealy PJ, 2010, PSYCHOL ASSESSMENT, V22, P569, DOI 10.1037/a0019618; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kilpatrick DG, 2000, J CONSULT CLIN PSYCH, V68, P19, DOI 10.1037/0022-006X.68.1.19; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lafortune D, 2010, INT J LAW PSYCHIAT, V33, P94, DOI 10.1016/j.ijlp.2009.12.004; Leistico AMR, 2008, LAW HUMAN BEHAV, V32, P28, DOI 10.1007/s10979-007-9096-6; Link B.G., 1994, VIOLENCE MENTAL DISO, P137; Liu JH, 2004, AM J PSYCHIAT, V161, P2005, DOI 10.1176/appi.ajp.161.11.2005; Loeber R, 2005, J CONSULT CLIN PSYCH, V73, P1074, DOI 10.1037/0022-006X.73.6.1074; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; LYNAM D, 1993, J ABNORM PSYCHOL, V102, P187, DOI 10.1037/0021-843X.102.2.187; Maccow G., 2011, OVERVIEW WASI 2; Macleod J, 2008, ADDICTION, V103, P1731, DOI 10.1111/j.1360-0443.2008.02301.x; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McCabe PJ, 2013, J AFFECT DISORDERS, V149, P367, DOI 10.1016/j.jad.2013.02.015; McGloin JM, 2003, INT J OFFENDER THER, V47, P253, DOI 10.1177/0306624X03047003002; MOFFITT TE, 1990, CRIME JUSTICE, V12, P99, DOI 10.1086/449165; Moffitt TE, 2001, DEV PSYCHOPATHOL, V13, P355, DOI 10.1017/S0954579401002097; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; MOFFITT TE, 1987, PSYCHIATRY, V50, P346, DOI 10.1080/00332747.1987.11024366; MOFFITT TE, 1988, J ABNORM CHILD PSYCH, V16, P553, DOI 10.1007/BF00914266; Mok PLH, 2016, JAMA PSYCHIAT, V73, P1015, DOI 10.1001/jamapsychiatry.2016.1728; Mulvey E. P, 2011, HIGHLIGHTS PATHWAYS, P4; Mulvey E.P., DOI 10.3886/ICPSR29961.v2; Mulvey EP, 2012, VICTIMS OFFENDERS, V7, P407, DOI 10.1080/15564886.2012.713903; Murray J, 2015, SOC PSYCH PSYCH EPID, V50, P579, DOI 10.1007/s00127-014-0976-z; Murrie DC, 2002, PSYCHOL ASSESSMENT, V14, P390, DOI 10.1037//1040-3590.14.4.390; Newman DL, 1998, J ABNORM PSYCHOL, V107, P305, DOI 10.1037/0021-843X.107.2.305; Nielssen OB, 2012, AUST NZ J PSYCHIAT, V46, P357, DOI 10.1177/0004867411433217; Nurius PS, 2015, CHILD ADOLESC SOC WO, V32, P567, DOI 10.1007/s10560-015-0396-2; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Olver ME, 2009, CRIM JUSTICE BEHAV, V36, P329, DOI 10.1177/0093854809331457; OSBORN SG, 1979, BRIT J CRIMINOL, V19, P120, DOI 10.1093/oxfordjournals.bjc.a046977; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Perron BE, 2015, ROUT INT HANDB, P300; Peterson JK, 2014, LAW HUMAN BEHAV, V38, P439, DOI 10.1037/lhb0000075; Piquero A, 2001, PSYCHOL CRIME LAW, V7, P193, DOI 10.1080/10683160108401794; Piquero AR, 2003, J CRIM JUST, V31, P399, DOI 10.1016/S0047-2352(03)00046-1; Pituch K.A., 2016, APPL MULTIVARIATE ST, V6th; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Raine A, 2005, J ABNORM PSYCHOL, V114, P38, DOI 10.1037/0021-843X.114.1.38; Reitan R., 1979, MANUAL ADM NEUROPSYC; Repo-Tiihonen E, 2010, J FORENSIC SCI, V55, P116, DOI 10.1111/j.1556-4029.2009.01208.x; Richter P, 1996, MED SCI LAW, V36, P337, DOI 10.1177/002580249603600413; Rowe DC, 1997, CRIMINOLOGY, V35, P177, DOI 10.1111/j.1745-9125.1997.tb00874.x; Rueve Marie E, 2008, Psychiatry (Edgmont), V5, P34; Salekin R. T., 1996, REV METAANALYSIS PSY, P1994; Sampson RobertJ., 1997, DEV THEORIES CRIME D, P133; Savolainen J, 2018, J ADOLESCENCE, V65, P16, DOI 10.1016/j.adolescence.2018.02.010; Schafer MH, 2011, AM J SOCIOL, V116, P1053, DOI 10.1086/655760; Schubert Carol A, 2004, Youth Violence Juv Justice, V2, P237, DOI 10.1177/1541204004265875; Selner-O'Hagan MB, 1998, J CHILD PSYCHOL PSYC, V39, P215, DOI 10.1017/S002196309700187X; Skeem JL, 2011, LAW HUMAN BEHAV, V35, P110, DOI 10.1007/s10979-010-9223-7; Smith VC, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1575; Spaans M, 2017, PSYCHOL CRIME LAW, V23, P56, DOI 10.1080/1068316X.2016.1220555; Steadman HJ, 2009, PSYCHIAT SERV, V60, P761, DOI 10.1176/ps.2009.60.6.761; Stoddard SA, 2013, AM J COMMUN PSYCHOL, V51, P57, DOI 10.1007/s10464-012-9541-7; Stoddard SA, 2012, J RES ADOLESCENCE, V22, P542, DOI 10.1111/j.1532-7795.2012.00786.x; Sutherland A, 2013, BRIT J CRIMINOL, V53, P1050, DOI 10.1093/bjc/azt050; Swanson JW, 2008, LAW HUMAN BEHAV, V32, P228, DOI 10.1007/s10979-007-9095-7; Teplin LA, 2002, ARCH GEN PSYCHIAT, V59, P1133, DOI 10.1001/archpsyc.59.12.1133; TEPLIN LA, 1990, AM J PUBLIC HEALTH, V80, P663, DOI 10.2105/AJPH.80.6.663; TZELGOV J, 1991, PSYCHOL BULL, V109, P524, DOI 10.1037/0033-2909.109.3.524; Varshney M, 2016, J EPIDEMIOL COMMUN H, V70, P223, DOI 10.1136/jech-2015-205546; Vaske J., 2011, GENES ABUSE CAUSES O; Vaughn MG, 2007, CRIM JUSTICE BEHAV, V34, P1296, DOI 10.1177/0093854807304624; Vaughn MG, 2014, CRIM BEHAV MENT HEAL, V24, P188, DOI 10.1002/cbm.1900; Vreugdenhil C, 2004, SCHIZOPHRENIA BULL, V30, P73, DOI 10.1093/oxfordjournals.schbul.a007069; Walsh A, 2009, CRIMINOL JUST STUD, P7; Wechsler D., 2011, WECHSLER ABBREVIATED; West D.J., 1977, DELINQUENT WAY LIFE; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wittchen HU, 1996, BRIT J PSYCHIAT, V168, P9, DOI 10.1192/S000712500029836X; Wright J. P., 2008, CRIMINALS MAKING CRI; Yang YL, 2005, BIOL PSYCHIAT, V57, P1103, DOI 10.1016/j.biopsych.2005.01.021; Zimmerman GM, 2016, AM J PUBLIC HEALTH, V106, P178, DOI 10.2105/AJPH.2015.302920	154	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0047-2352	1873-6203		J CRIM JUST	J. Crim. Justice	NOV-DEC	2021	77								101852	10.1016/j.jcrimjus.2021.101852			13	Criminology & Penology	Social Science Citation Index (SSCI)	Criminology & Penology	WC1GU	WOS:000704013200001					2022-02-06	
J	Paget, LM; Chin, F; Beltzer, N				Paget, Louis-Marie; Chin, Francis; Beltzer, Nathalie			Hospitalised traumatic brain injury victims in France: An analysis of the French hospital discharge database for 2011-2016	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Traumatic brain injury; Hospitalisation; Epidemiologic surveillance; Prevention	HEAD-INJURY; EPIDEMIOLOGY; REHABILITATION; DISABILITY; MORTALITY; PATTERNS; CHILDREN; TRENDS	Background: Traumatic brain injury (TBI) is a major public health problem because of its severity and frequency. No recent national epidemiological study on TBI victims is currently available in France. Objective: This study aimed to quantify and characterise TBI victims and analyse temporal trends. Methods: French hospitalisation data were used in this study. All hospitalised patients residing in France with at least one International Classification of Disease, 10th revision, code S06.0 to S06.9 during 2011-2016 were selected. Incidence and hospital case-fatality rates were calculated. Quasi-Poisson models were used to analyse temporal trends. Results: In 2016, the incidence rate was 230.6/100,000 people, higher among men than women regardless of age. Incidence and hospital case-fatality rates were also higher among older than younger people. Incidence rates increased during 2011-2016, mainly due to the higher incidence rate with age > 65 years than younger age. During 2011-2016, hospital case-fatality rates decreased, mainly due to the decrease in the older age group (> 65 years old). Conclusions: To our knowledge, this is the first national study in France to provide recent data on hospitalised TBI victims. Our study shows that TBI is a major public health concern in France. As a priority, older people represent a risk group that should be targeted with preventive actions because they have both the highest incidence and case-fatality rates and had the largest increase in incidence rates over the study period. (C) 2020 Elsevier Masson SAS. All rights reserved.	[Paget, Louis-Marie; Chin, Francis; Beltzer, Nathalie] Sante Publ France, 12 Rue Val dOsne, F-94415 St Maurice, France		Paget, LM (corresponding author), Sante Publ France, 12 Rue Val dOsne, F-94415 St Maurice, France.	louis-marie.paget@santepubliquefrance.fr					Agence nationale de se, 2015, ANT FRANC 2014 ET LI; Boudemaghe T, 2017, INT J EPIDEMIOL, V46, P392, DOI 10.1093/ije/dyw359; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Dargent Molina P, 2017, B EPIDEMIOL REC, P336; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gillespie LD, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007146.pub2; Jehle E, 2012, ANN FR MED URGENCE, V2, P199, DOI 10.1007/s13341-012-0202-4; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miekisiak G, 2016, BRAIN INJURY, V30, P79, DOI 10.3109/02699052.2015.1104550; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Orces CH, 2014, INJURY PREV, V20, P421, DOI 10.1136/injuryprev-2014-041268; Pedersen K, 2015, NEUROEPIDEMIOLOGY, V45, P20, DOI 10.1159/000381780; Peeters W, 2017, NEUROEPIDEMIOLOGY, V48, P63, DOI 10.1159/000471877; Pozzato I, 2019, AUST NZ J PUBL HEAL, V43, P382, DOI 10.1111/1753-6405.12878; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Routiere ONIdlS, 2016, ROUT ONIDIS SEC ROUT; Thelot B, 2017, B EPIDEMIOL REC, V16-17, P328; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Trefan L, 2016, ARCH DIS CHILD, V101, P527, DOI 10.1136/archdischild-2015-308424; Van den Brand CL, 2018, EUR J EMERG MED, V25, P355, DOI 10.1097/MEJ.0000000000000457; van den Brand Crispijn L, 2014, Ned Tijdschr Geneeskd, V158, pA6973	29	0	0	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	NOV	2021	64	6							101437	10.1016/j.rehab.2020.08.003			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	YE3UU	WOS:000741054400002	33049399				2022-02-06	
J	Prasad, C; Bindra, A; Singh, P; Singh, GP; Singh, PK; Mathur, P				Prasad, Chandrakant; Bindra, Ashish; Singh, Parul; Singh, Gyaninder P.; Singh, Pankaj K.; Mathur, Purva			Healthcare-associated Infections in Pediatric Patients in Neurotrauma Intensive Care Unit: A Retrospective Analysis	INDIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Healthcare-associated infection; Pediatric; Trauma; Traumatic brain injury	RISK-FACTORS; INJURY	Background: Healthcare-associated infections (HAIs) can impact the outcome following traumatic brain injury (TBI) in children. We undertook a retrospective observational study to see the incidence, risk factors, and microbiological profile for HAIs in pediatric TBI. We also studied the impact of baseline patient characteristics, HAIs on patient outcome, and antibiotic resistance of different types of bacteria. Methods: Data on pediatric TBI patients of age up to 12 years were collected via a computerized patient record system (CPRS) from January 2012 to December 2018. Descriptive Chi-square test and Wilcoxon signed rank test were used to characterize baseline parameters. General linear regression models were run to find an unadjusted and adjusted odds ratio (OR). Results: HAIs were found in 144 (34%) out of 423 patients. The most commonly seen infections were of the respiratory tract in 73 (17.26%) subjects. The most predominant microorganism isolated was Acinetobacter baumannii in 188 (41%) samples. A. baumannii was sensitive to colistin in 91 (48.4%) patients. Male gender (OR 0.630; p-value 0.035), fall from height (OR 0.374; p-value 0.008), and higher injury severity scale (ISS) (OR 1.040; p-value 0.002) were independent risk factors for development of HAIs. Severe TBI, higher ISS and Marshall grade, and HAIs were significantly associated with poor patient outcome. Conclusion: Severe TBI poses a significant risk of HAIs. The most common site was the respiratory tract, predominately infected with A. baumannii. HAIs in pediatric TBI patients resulted in poor patient outcome.	[Prasad, Chandrakant; Bindra, Ashish; Singh, Gyaninder P.] All India Inst Med Sci, Dept Neuroanesthesio & Crit Care, Delhi, India; [Singh, Parul] All India Inst Med Sci, Dept Microbiol, Delhi, India; [Singh, Pankaj K.] All India Inst Med Sci, Dept Neurosurg, Delhi, India; [Mathur, Purva] All India Inst Med Sci, Jai Prakash Narain Apex Trauma Ctr, Lab Med, Delhi, India		Bindra, A (corresponding author), All India Inst Med Sci, Dept Neuroanesthesio & Crit Care, Delhi, India.	dr_ashi2208@yahoo.com					Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Bedry T, 2020, EMERG MED INT, V2020, DOI 10.1155/2020/1965231; Boddie DE, 2003, BRIT J NEUROSURG, V17, P405, DOI 10.1080/02688690310001611198; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Cardozo Júnior Luis Carlos Maia, 2014, Rev. bras. ter. intensiva, V26, P148, DOI 10.5935/0103-507X.20140022; Cutler Gretchen J, 2017, Hosp Pediatr, V7, P164, DOI 10.1542/hpeds.2016-0072; Elward AM, 2005, PEDIATRICS, V115, P868, DOI 10.1542/peds.2004-0256; Gitau Wilfred, 2018, BMC Res Notes, V11, P226, DOI 10.1186/s13104-018-3337-2; Gondim R, 2018, INT BRAZ J UROL, V44, P378, DOI [10.1590/s1677-5538.ibju.2017.0434, 10.1590/S1677-5538.IBJU.2017.0434]; Green N, 2015, J PEDIAT INF DIS SOC, V4, P305, DOI 10.1093/jpids/piu073; Hamele M, 2016, J NEUROTRAUM, V33, P832, DOI 10.1089/neu.2015.4004; Lakshmi KS, 2007, J TROP PEDIATRICS, V53, P87, DOI 10.1093/tropej/fml073; Lecky F, 2014, BRIT J ANAESTH, V113, P286, DOI 10.1093/bja/aeu242; Mahadewa TGB, 2018, OPEN ACCESS EMERG M, V10, P135, DOI 10.2147/OAEM.S179090; Musyoki VM, 2019, PAN AFR MED J, V33, DOI 10.11604/pamj.2019.33.146.17220; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; Ortega HW, 2015, J TRAUMA ACUTE CARE, V78, P1149, DOI 10.1097/TA.0000000000000661; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; Sribnick EA, 2020, PEDIATR CRIT CARE ME, V21, P443, DOI 10.1097/PCC.0000000000002238; Sundberg J, 2011, AM J EMERG MED, V29, P1019, DOI 10.1016/j.ajem.2010.06.002; Wang CR, 2019, INFECT DRUG RESIST, V12, P391, DOI 10.2147/IDR.S189154	23	0	0	0	0	JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD	NEW DEHLI	4838-24, ANSARI RD, DARYAGANJ, NEW DEHLI, 110 002, INDIA	0972-5229	1998-359X		INDIAN J CRIT CARE M	Indian J. Crit. Care Med.	NOV	2021	25	11					1308	1313		10.5005/jp-journals-10071-24012			6	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WW5MC	WOS:000717959500018	34866831	gold, Green Published			2022-02-06	
J	Rabinowitz, A; Hart, T; Wilson, J				Rabinowitz, Amanda; Hart, Tessa; Wilson, Julianne			Ecological Momentary Assessment of Affect in Context After Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						brain injuries; ecological momentary assessment; depression; anxiety; time use	PHYSICAL-ACTIVITY; DEPRESSION SEVERITY; PARTICIPATION; INDIVIDUALS; DISORDERS; SYMPTOMS; ANXIETY; CARE	Purpose: To describe where, with whom, and how time was spent daily, and to characterize positive and negative affect, boredom, enjoyment, and perceived accomplishment as a function of time, activity, location, and social context, in people with chronic moderate-severe traumatic brain injury and depression/anxiety. Research Method: Participants (N = 23) responded to a smartphone app five times daily for approximately 2 weeks prior to treatment in a trial of Behavioral Activation. The app queried activity and physical/social context; concurrent positive and negative affect; and perceived boredom, enjoyment, and accomplishment. Descriptive statistics captured time use, and linear mixed models were used to analyze relations between affect and contextual factors. Results: Ecological Momentary Assessment (EMA) response rate was positively correlated with integrity of episodic memory and education. Participants spent most time at home versus elsewhere, and alone versus with others. The most frequent activity was watching TV. Mixed model results based on 17 participants with >33% response rate showed that positive affect was associated with being outside of home, and with other people; however, socializing was related to higher negative affect. TV watching was related to lower negative affect but also low accomplishment. Conclusions: EMA can provide unique information on the effects of social context and activity on mood in TBI. Clinicians should consider negative as well as positive affect associated with increasing social participation. Impact and Implications Ecological Momentary Assessment (EMA) is generally feasible for individuals with moderate-severe traumatic brain injury (TBI), but cognitive supports such as extra training and supervised practice might be needed to boost response rate for individuals with lower education or more severe memory impairment. Individuals with moderate-severe TBI may spend a large proportion of time alone and at home, and relatively little time engaged in outdoor activities and exercise. Positive affect is associated with productive activity such as working and doing chores. These findings point to the need for interventions that promote activity and community engagement after TBI. Spending time with others may be associated with both positive and negative emotional states, suggesting that clinicians might encourage a graded approach (beginning with lower-stress activities) to increasing socialization for people with moderate-severe TBI.	[Rabinowitz, Amanda; Hart, Tessa; Wilson, Julianne] Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA		Rabinowitz, A (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	rabinowa@einstein.edu		Wilson, Julianne/0000-0002-9433-7012			Bombardier CH, 2017, J HEAD TRAUMA REHAB, V32, P343, DOI 10.1097/HTR.0000000000000288; Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Derogatis L.R., 2000, BRIEF SYMPTOM INVENT; Driver S, 2018, J HEAD TRAUMA REHAB, V33, pE36, DOI 10.1097/HTR.0000000000000327; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Finch E, 2016, BRAIN INJURY, V30, P883, DOI 10.3109/02699052.2016.1146959; Forster SD, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00115; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Hart Tessa, 2019, Arch Rehabil Res Clin Transl, V1, P100027, DOI 10.1016/j.arrct.2019.100027; Hart T, 2017, J HEAD TRAUMA REHAB, V32, P319, DOI 10.1097/HTR.0000000000000316; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Juengst SB, 2015, BRAIN INJURY, V29, P1351, DOI 10.3109/02699052.2015.1045031; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kumar RG, 2020, INT J GERIATR PSYCH, V35, P553, DOI 10.1002/gps.5271; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lenaert B, 2019, NEUROPSYCHOL REHABIL, V29, P754, DOI 10.1080/09602011.2017.1330214; McKeon A, 2018, DISABIL REHABIL, V40, P974, DOI 10.1080/09638288.2017.1280545; Pacella M, 2018, J HEAD TRAUMA REHAB, V33, pE31, DOI 10.1097/HTR.0000000000000335; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rabinowitz AR, 2020, ARCH PHYS MED REHAB, V101, P1973, DOI 10.1016/j.apmr.2020.05.026; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A, 1958, EXAMEN CLIN PSYCHOL; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P1, DOI 10.1097/HTR.0b013e3182068588; Schmidt M., 1996, REY AUDITORY VERBAL; Suffoletto B, 2013, J HEAD TRAUMA REHAB, V28, P302, DOI 10.1097/HTR.0b013e3182847468; Sufrinko AM, 2019, J HEAD TRAUMA REHAB, V34, pE40, DOI 10.1097/HTR.0000000000000474; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Wechsler D., 2011, WECHSLER ABBREVIATED; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams MT, 2021, J MED INTERNET RES, V23, DOI 10.2196/17023; Winkler D, 2005, J OCCUP SCI, V12, P69, DOI 10.1080/14427591.2005.9686550; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009	40	0	0	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2021	66	4					442	449		10.1037/rep0000403			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	XI0QC	WOS:000725826700016	34516166				2022-02-06	
J	Rahimi, S; Dadfar, B; Tavakolian, G; Rad, AA; Shabkahi, AR; Siahposht-Khachaki, A				Rahimi, Siavash; Dadfar, Behzad; Tavakolian, Golvash; Rad, Arya Asadi; Shabkahi, Ali Rashid; Siahposht-Khachaki, Ali			Morphine attenuates neuroinflammation and blood-brain barrier disruption following traumatic brain injury through the opioidergic system	BRAIN RESEARCH BULLETIN			English	Article						Morphine; Traumatic brain injury; Neuroprotection; Opioid receptor; Naloxone	RECEPTOR ACTIVATION; MICRORNA EXPRESSION; COGNITIVE DEFICITS; RAT MODEL; PROTECTS; AGONIST; NEURONS; MICE	Endogenous opiates are suggested to have a role in the pathophysiology of traumatic brain injury (TBI). Furthermore, administration of opioidergic agents in TBI injured animals have been shown to affect the brain injury and provide neuroprotection post-TBI. This study aims to investigate the potential neuroprotective effects of morphine through inhibition of neuroinflammatory pathways in acute severe TBI. Male Wistar rats were divided into seven groups (24 rats per group): Sham, Vehicle (TBI + intraperitoneal (i.p) injection of normal saline), TBI + i.p injection of morphine in 1, 5 and 10 mg/kg doses (MOR 1, MOR 5 and MOR 10 groups), TBI + morphine (5 mg/kg i.p) + Naloxone (NAL + MOR), and TBI + morphine (5 mg/kg i.p) + Naltrindole (NALT + MOR). A severe diffuse TBI model (weight dropping Marmarou model) was used to induce TBI in rats. The veterinary coma scale (VCS), beam-walk, and beam-balance tasks were used to assess short-term neurological deficits. Histolopathological changes of brain tissue was evaluated using light microscopy and hematoxilin and eosin staining. Blood-Brain barrier (BBB) disruption was evaluated by the Evans Blue method 6 h post-injury. Brain water content and cerebrospinal fluid (CSF) content of IL-1 beta and IL-10 were assessed by the wet-dry method and enzyme-linked immunosorbent assay (ELISA), respectively. Morphine (1 and 5 mg/kg doses) attenuated BBB leakage, improved VCS score, pathological changes of brain tissue, and vestibulomotor function compared to the vehicle group (p < 0.0001). Only 5 mg/kg morphine attenuated brain edema (p < 0.0001). Furthermore, 1 and 5 mg/kg morphine significantly changed CSF concentration of IL-1 beta and IL-10 compared to the vehicle group (p < 0.0001). Inhibition of opioid receptors by naloxone and naltrindole abolished morphine neuroprotective effects (p < 0.0001 vs. MOR 5 group). This study suggests that morphine administration inhibits TBI-mediated neuroinflammation via opioid receptors and improves neurobehavioral function following TBI, which provides a potential therapeutic opportunity in the treatment of traumatic brain injury.	[Rahimi, Siavash; Rad, Arya Asadi; Shabkahi, Ali Rashid] Mazandaran Univ Med Sci, Dept Physiol & Pharmacol, Ramsar Campus, Sari, Iran; [Rahimi, Siavash] Univ Bern, Dept BioMed Res Mol Dermatol & Stem Cell Res, Bern, Switzerland; [Rahimi, Siavash] Univ Bern, Bern Univ Hosp, Dept Dermatol, Inselspital, Bern, Switzerland; [Dadfar, Behzad; Tavakolian, Golvash; Siahposht-Khachaki, Ali] Mazandaran Univ Med Sci, Fac Med, Dept Physiol, POB 48471-91971, Sari, Iran		Siahposht-Khachaki, A (corresponding author), Mazandaran Univ Med Sci, Fac Med, Dept Physiol, POB 48471-91971, Sari, Iran.	Siavash.rahimi@hotmail.com; Beh.dad69@yahoo.com; golvashtr2017@gmail.com; arya_ertejal@yahoo.com; Arsh.rus@gmail.com; a.siahposht@mazums.ac.ir	Rahimi, Siavash/AAF-2528-2021	Rahimi, Siavash/0000-0001-7631-8005; Dadfar, Behzad/0000-0002-8127-5369; siahposht-khachaki, ali/0000-0001-7505-3148	Ramsar Campus of Mazandaran University of Medical Sciences, vice-chancellor of research, Iran	This study was funded by Ramsar Campus of Mazandaran University of Medical Sciences, vice-chancellor of research, Iran.	Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Argyropoulou Ourania D, 2018, Mediterr J Rheumatol, V29, P193, DOI 10.31138/mjr.29.4.193; Asl SZ, 2013, J NEUROSURG, V119, P353, DOI 10.3171/2013.4.JNS121636; BAETHMANN A, 1988, CRIT CARE MED, V16, P972, DOI 10.1097/00003246-198810000-00008; Bardua M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02813; Barry U, 2005, CURR PHARM DESIGN, V11, P1343, DOI 10.2174/1381612053507459; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Benamar K, 2007, J PHARMACOL EXP THER, V323, P990, DOI 10.1124/jpet.107.129973; Chakrabarti S, 2001, P NATL ACAD SCI USA, V98, P4209, DOI 10.1073/pnas.071031798; Chao DM, 2007, J CEREBR BLOOD F MET, V27, P356, DOI 10.1038/sj.jcbfm.9600352; Chen YM, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00421; Consiglio AR, 2000, BRAIN RES PROTOC, V5, P109, DOI 10.1016/S1385-299X(99)00062-8; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Feng Y, 2012, CURR DRUG TARGETS, V13, P230, DOI 10.2174/138945012799201612; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gessi S, 2016, FEBS LETT, V590, P2813, DOI 10.1002/1873-3468.12313; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; He XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061080; Kao TK, 2008, NEUROCHEM INT, V52, P1256, DOI 10.1016/j.neuint.2008.01.007; Kennedy NM, 2018, J MED CHEM, V61, P8895, DOI 10.1021/acs.jmedchem.8b01136; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lesniak A, 2017, BEHAV BRAIN RES, V326, P209, DOI 10.1016/j.bbr.2017.03.015; Lesniak A, 2016, NEUROPHARMACOLOGY, V101, P506, DOI 10.1016/j.neuropharm.2015.10.014; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; LYETH BG, 1995, NEUROPEPTIDES, V29, P11, DOI 10.1016/0143-4179(95)90051-9; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Miller RD, 1996, J NEUROL SCI, V136, P37, DOI 10.1016/0022-510X(95)00309-P; Murray KN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00018; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Rahimi S, 2020, METAB BRAIN DIS, V35, P1135, DOI 10.1007/s11011-020-00594-3; ROBINSON SE, 1989, BRAIN RES, V503, P32, DOI 10.1016/0006-8993(89)91699-5; Rostami F, 2012, J MOL NEUROSCI, V48, P22, DOI 10.1007/s12031-012-9726-4; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Sesena E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00090; Sheng SY, 2018, CELL PHYSIOL BIOCHEM, V47, P302, DOI 10.1159/000489808; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shrivastava P, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0844-3; Soares HD, 1995, J NEUROSCI, V15, P8223; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Tang CW, 2011, TOHOKU J EXP MED, V224, P69, DOI 10.1620/tjem.224.69; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Zadina JE, 2002, JPN J PHARMACOL, V89, P203, DOI 10.1254/jjp.89.203; Zhang C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101523; Zhang JH, 2006, STROKE, V37, P1094, DOI 10.1161/01.STR.0000206444.29930.18; Zhang JH, 2000, BRAIN RES, V885, P143, DOI 10.1016/S0006-8993(00)02906-1; Zhi F, 2017, CELL PHYSIOL BIOCHEM, V44, P2296, DOI 10.1159/000486067; Zhi F, 2016, CELL PHYSIOL BIOCHEM, V39, P1118, DOI 10.1159/000447815; Zohar O, 2006, NEUROSCI LETT, V394, P239, DOI 10.1016/j.neulet.2005.10.099	54	0	0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	NOV	2021	176						103	111		10.1016/j.brainresbull.2021.08.010			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY7AL	WOS:000701672000004	34464684				2022-02-06	
J	Reavis, KM; Snowden, JM; Henry, JA; Gallun, FJ; Lewis, MS; Carlson, KF				Reavis, Kelly M.; Snowden, Jonathan M.; Henry, James A.; Gallun, Frederick J.; Lewis, M. Samantha; Carlson, Kathleen F.			Blast Exposure and Self-Reported Hearing Difficulty in Service Members and Veterans Who Have Normal Pure-Tone Hearing Sensitivity: The Mediating Role of Posttraumatic Stress Disorder	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; HANDICAP INVENTORY; NOISE OUTCOMES; EPIDEMIOLOGY; ATTENTION; TESTS; RISK; PTSD; SAS	Purpose: Evidence suggests that military blast exposure may lead to self-reported hearing difficulties despite audio -metrically normal hearing. Research identifying potential mechanisms of this association remains limited. The purpose of this article is to evaluate the associations between blast, posttraumatic stress disorder (PTSD), and self-reported hearing difficulty, and to examine PTSD as a possible mediator of the association between blast exposure and hearing difficulty. Method: We used baseline data from the Noise Outcomes in Service members Epidemiology (NOISE) study (n = 477). Participants in this study undergo a comprehensive hearing, and tinnitus if applicable, evaluation and complete a large number of surveys. Pertinent data extracted from these surveys included information on participant's demographics, military service history, including exposure to blast, and health conditions such as symptoms of PTSD. Using regression models and following a formal causal mediation framework, we estimated total associations, natural direct and indirect associations, and percent mediated. Results: We found that individuals with blast exposure had higher prevalence of both probable PTSD and self-reported hearing difficulty than individuals who were not blast exposed. Compared with participants without blast exposure, those with blast exposure had twice the prevalence of self-reported hearing difficulty, with 41% of the association mediated through probable PTSD. Conclusion: As PTSD is a possible mediator of the association between blast exposure and hearing difficulty, Service members and Veterans with normal pure-tone hearing sensitivity who report hearing difficulties and a history of blast exposure may benefit from evaluation for PTSD symptoms. Supplemental Material: https://doi.org/10.23641/asha. 16674247	[Reavis, Kelly M.; Henry, James A.; Gallun, Frederick J.; Lewis, M. Samantha; Carlson, Kathleen F.] VA Portland Hlth Care Syst, VA Rehabil Res & Dev, Natl Ctr Rehabil Auditory Res, Portland, OR 97239 USA; [Reavis, Kelly M.; Snowden, Jonathan M.; Carlson, Kathleen F.] Oregon Hlth & Sci Univ, OHSU PSU Sch Publ Hlth, Portland, OR 97201 USA; [Henry, James A.; Gallun, Frederick J.; Lewis, M. Samantha] Oregon Hlth & Sci Univ, Dept Otolaryngol, Portland, OR 97201 USA; [Lewis, M. Samantha] Pacific Univ, Sch Audiol, Hillsboro, OR USA; [Carlson, Kathleen F.] VA Portland Hlth Care Syst, VA Rehabil Res & Dev, Ctr Improve Vet Involvement Care, Portland, OR USA		Reavis, KM (corresponding author), VA Portland Hlth Care Syst, VA Rehabil Res & Dev, Natl Ctr Rehabil Auditory Res, Portland, OR 97239 USA.; Reavis, KM (corresponding author), Oregon Hlth & Sci Univ, OHSU PSU Sch Publ Hlth, Portland, OR 97201 USA.	Kelly.Reavis@va.gov	Gallun, Frederick/G-3792-2012	Gallun, Frederick/0000-0002-4145-2199; Reavis, Kelly/0000-0002-4906-1010	Department of Defense Con-gressionally Directed Medical Research Program Investigator-Initiated Research AwardUnited States Department of Defense [PR121146]; Joint Warfighter Medical Research Program Award [JW160036]; U.S. Department of Veterans Affairs (VA) Rehabilitation Research and Development (RR&D) Research Career Scientist AwardUS Department of Veterans Affairs [1 IK6 RX002990-01]; VA RR&D National Center for Rehabilita-tive Auditory Research (VA RR&D NCRAR Center Award [C9230C]	This work was supported by a Department of Defense Con-gressionally Directed Medical Research Program Investigator-Initiated Research Award (PR121146) , a Joint Warfighter Medical Research Program Award (JW160036) , and a U.S. Department of Veterans Affairs (VA) Rehabilitation Research and Development (RR&D) Research Career Scientist Award (1 IK6 RX002990-01) . This material is the result of work supported with resources and the use of facilities at the VA RR&D National Center for Rehabilita-tive Auditory Research (VA RR&D NCRAR Center Award; C9230C) at the VA Portland Health Care System in Portland, Oregon, as well as the Department of Defense, Hearing Center of Excellence in San Antonio, Texas. Portions of this article were presented at the American Auditory Society Annual Meeting, Scottsdale, AZ, March 5-7, 2020.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Ananth CV, 2011, AM J EPIDEMIOL, V174, P99, DOI 10.1093/aje/kwr045; Boyd R, 2020, RACISM NEW STANDARD, DOI [DOI 10.1377/HBLOG20200630.939347, 10.1377/hblog2020063 0.939347/full/, DOI 10.1377/HBLOG20200630.939347/FULL]; Bressler S, 2017, HEARING RES, V349, P98, DOI 10.1016/j.heares.2016.10.018; Carlson K. F., 2009, VA EVIDENCEBASED SYN; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Fox MP, 2020, AM J EPIDEMIOL, V189, P261, DOI 10.1093/aje/kwz233; Gallun FJ, 2017, BRAIN INJURY, V31, P1183, DOI 10.1080/02699052.2016.1274781; Gallun FJ, 2016, J REHABIL RES DEV, V53, P705, DOI 10.1682/JRRD.2014.12.0313; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gordon JS, 2017, HEARING RES, V349, P21, DOI 10.1016/j.heares.2016.11.014; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hafeman DM, 2009, INT J EPIDEMIOL, V38, P838, DOI 10.1093/ije/dyn372; Henry JA, 2021, EAR HEARING, V42, P870, DOI 10.1097/AUD.0000000000000974; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Institute of Medicine, 2014, GULF WAR HLTH LONG; Joseph AR, 2018, AM J EPIDEMIOL, V187, P7, DOI 10.1093/aje/kwx199; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Mathews ZR, 2015, J EMERG MED, V49, P573, DOI 10.1016/j.jemermed.2015.03.013; NEWMAN CW, 1990, EAR HEARING, V11, P430, DOI 10.1097/00003446-199012000-00004; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Petersen ML, 2006, EPIDEMIOLOGY, V17, P276, DOI 10.1097/01.ede.0000208475.99429.2d; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Schnurr P. P., 2015, EVIDENCE BASED TREAT, P87, DOI DOI 10.1007/978-3-319-07109-1_5; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Tepe V, 2020, J SPEECH LANG HEAR R, V63, P834, DOI 10.1044/2019_JSLHR-19-00293; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Valeri L, 2013, PSYCHOL METHODS, V18, P137, DOI 10.1037/a0031034; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P749, DOI 10.1097/EDE.0000000000000121; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; VENTRY IM, 1982, EAR HEARING, V3, P128, DOI 10.1097/00003446-198205000-00006; Veterans Health Administration, 2017, VHA DIRECTIVE 1184; Westreich D, 2017, AM J EPIDEMIOL, V186, P1010, DOI 10.1093/aje/kwx164	41	0	0	0	0	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	NOV	2021	64	11					4458	4467		10.1044/2021_JSLHR-20-00687			10	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	WW8BZ	WOS:000718136100023	34582257	hybrid			2022-02-06	
J	Reha, T; McNabb, C; Netto, K; Davey, P; Lavender, AP				Reha, Tahere; McNabb, Colm; Netto, Kevin; Davey, Paul; Lavender, Andrew P.			Head Accelerations during a 1-on-1 Rugby Tackling Drill Performed by Experienced Rugby Union Players	BRAIN SCIENCES			English	Article						rugby union; tackling; contrecoup effect; concussion; subconcussion; traumatic brain injury; neck injury	SEGMENT DYNAMIC STABILIZATION; NECK MUSCLE STRENGTH; BIOMECHANICS; CONCUSSION; FOOTBALL; CONTACT; EVENTS	Rugby Union is a popular sport played by males and females worldwide, from junior to elite levels. The highly physical skill of tackling occurs every few seconds throughout a match and various injuries associated with tackling are relatively common. Of particular interest are head injuries that result in a concussion. Recently, repeated non-injurious head impacts in sport have attracted the attention of researchers interested in brain health. Therefore, this study assessed head movement during repeated rugby tackle drills among experienced Rugby Union players. Experienced male and female participants performed 15 1-on-1 tackles in a motion analysis laboratory to measure the head movements of the ball carrier and tackler during each tackle, using three-dimensional motion capture. The average peak acceleration of the head for ball carriers was 28.9 & PLUSMN; 24.08 g and 36.67 & PLUSMN; 28.91 g for the tacklers. This study found that the type of head impacts common while performing a tackle in Rugby Union are similar to those experienced by soccer players during heading, which has been found to alter brain function that lasts hours after the event. This has important implications for player health and suggests that mitigation strategies should be considered for Rugby Union.	[Reha, Tahere; McNabb, Colm; Netto, Kevin; Davey, Paul; Lavender, Andrew P.] Curtin Univ, Curtin Sch Allied Hlth, Perth, WA 6102, Australia; [Netto, Kevin] Curtin Univ, Curtin enAble Inst, Perth, WA 6102, Australia; [Davey, Paul] Curtin Univ, Curtin Sch Nursing, Perth, WA 6102, Australia; [Lavender, Andrew P.] Federat Univ Australia, Sch Sci Psychol & Sport, Ballarat, Vic 3350, Australia		Lavender, AP (corresponding author), Curtin Univ, Curtin Sch Allied Hlth, Perth, WA 6102, Australia.; Lavender, AP (corresponding author), Federat Univ Australia, Sch Sci Psychol & Sport, Ballarat, Vic 3350, Australia.	tahere.reha@graduate.curtin.edu.au; colm.mcnabb@graduate.curtin.edu.au; kevin.netto@curtin.edu.au; p.davey@curtin.edu; a.lavender@federation.edu.au	Davey, Paul/B-2814-2015	Davey, Paul/0000-0002-2119-8066; Lavender, Andrew/0000-0001-6222-880X			De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Di Virgilio TG, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00294; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Hendricks S., 2017, BRIT J SPORT MED, V51, P328, DOI [10.1136/bjsports-2016-097372.113, DOI 10.1136/BJSPORTS-2016-097372.113]; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; Hiles-Murison B, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88854-9; Jin X, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037399; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Lavender AP, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00491; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mansell J, 2005, J ATHL TRAINING, V40, P310; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McNabb C, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10120960; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Netto K, 2010, PHYS THER SPORT, V11, P75, DOI 10.1016/j.ptsp.2010.02.006; Panjabi MM, 1998, CLIN BIOMECH, V13, P11, DOI 10.1016/S0268-0033(97)00057-0; Seng KY, 2002, CLIN BIOMECH, V17, P545, DOI 10.1016/S0268-0033(02)00067-0; Sperry E, 2010, MED SCI SPORT EXER, V42, P686, DOI 10.1249/01.MSS.0000385913.19094.3b; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tierney GJ, 2018, J BIOMECH, V72, P29, DOI 10.1016/j.jbiomech.2018.02.023; Tierney GJ, 2017, BRAIN INJURY, V31, P1925, DOI 10.1080/02699052.2017.1385853; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tong DC, 2015, J CLIN NEUROSCI, V22, P747, DOI 10.1016/j.jocn.2014.11.018; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	36	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	NOV	2021	11	11							1497	10.3390/brainsci11111497			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XG9QM	WOS:000725080400001	34827495	Green Published, gold			2022-02-06	
J	Remigio-Baker, RA; Babakhanyan, I; Gregory, E; Cole, WR; Ettenhofer, ML; West, T; Qashu, F; Mullins, L; Bailie, JM				Remigio-Baker, Rosemay A.; Babakhanyan, Ida; Gregory, Emma; Cole, Wesley R.; Ettenhofer, Mark L.; West, Therese; Qashu, Felicia; Mullins, Lynita; Bailie, Jason M.			Impact of Prior Brain Injury on Concussion Recovery in Military Personnel: Evaluation of Timing Between Concussions	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; mild traumatic brain injury; military; Neurobehavioral Symptom Inventory; service members; symptom; symptom recovery	UNITED-STATES; COMPLAINTS; SYMPTOMS; HEALTH; DAMAGE	Objective: To evaluate the potential impact of timing between the current and the most recent previous concussions on symptom severity among acutely concussed active duty military Service members (SMs). Setting: Three military installations. Participants: Eighty-four SMs aged 18 to 44 years who sustained a concussion within 72 hours of enrollment. No previous concussion within 1 year preenrollment. Design: Longitudinal study with enrollment within 72 hours of injury, and follow-up at 1 week and 1 month postinjury. Main Measures: Lifetime concussion history (yes/no) and recency of the latest concussion (no history, relatively more recent [1 to <6 years ago], and more remote [6+ years ago]) from the current concussion using the Ohio State University Traumatic Brain Injury Identification Method-Interview Form. Symptom severity (total and by categories: cognitive, affective, somatosensory, vestibular) at all time points using the Neurobehavioral Symptoms Inventory. Results: Concussion history assessed as having any previous concussion was not found significantly related to symptom severity (total or by categories) following a current concussion. However, when timing between concussion was taken into account, time since previous concussion was significantly related to symptomatology, whereby those with relatively more recent previous concussion had greater total symptoms within 72 hours of injury and at 1 week postinjury (though not at 1 month) than those with more remote previous concussion (<= 72 hours: difference = 15.4, 95% CI = 1.8 to 29.1; 1 week: difference = 15.2, 95% CI = 1.2 to 29.2) or no history (<= 72 hours: difference = 11.6, 95% CI = 0.4 to 22.8; 1 week: difference = 13.9, 95% CI = 2.4 to 25.4). When evaluated by symptom category, this relationship was particularly important on affective and somatosensory symptoms. Conclusion: In recently concussed active duty SMs, the timing between the current and previous concussions may be an important factor in determining prognosis. Clinical assessment of concussion history that accounts for the timing of the most recent event may be necessary to identify patients who may require a more conservative plan of care and more gradual return to activity in the acute recovery stage.	[Remigio-Baker, Rosemay A.; Babakhanyan, Ida; Gregory, Emma; Ettenhofer, Mark L.; Mullins, Lynita; Bailie, Jason M.] Traumat Brain Injury Ctr Excellence, Silver Spring, MD USA; [Remigio-Baker, Rosemay A.; Babakhanyan, Ida; Bailie, Jason M.] Naval Hosp Camp Pendleton, Camp Pendleton, CA USA; [Remigio-Baker, Rosemay A.] Henry M Jackson Fdn, Bethesda, MD USA; [Babakhanyan, Ida; Bailie, Jason M.] Gen Dynam Informat Technol, Fairfax, VA USA; [Cole, Wesley R.] Womack Army Med Ctr, Intrepid Spirit Ctr, Ft Bragg, NC USA; [Ettenhofer, Mark L.] Naval Med Ctr San Diego, San Diego, CA USA; [Ettenhofer, Mark L.; Mullins, Lynita] Univ Calif San Diego, San Diego, CA 92103 USA; [West, Therese] US Army Med Res & Mat Command, Ft Detrick, MD USA; [Qashu, Felicia] NIH, Bldg 10, Bethesda, MD 20892 USA		Remigio-Baker, RA (corresponding author), Henry M Jackson Fdn Adv Mil Med, Naval Hosp, Traumat Brain Injury Ctr Excellence, 2016 San Jacinto Rd, Camp Pendleton, CA 92058 USA.	rremigiobaker@gmail.com			Defense Health Program 6.7 [D6.7_14_C2_I_14_J9_ 1077]; Traumatic Brain Injury Center of Excellence	This work was supported by the Defense Health Program 6.7 (award no. D6.7_14_C2_I_14_J9_ 1077) and the Traumatic Brain Injury Center of Excellence.	Bailie JM, 2019, AM J SPORT MED, V47, P3505, DOI 10.1177/0363546519883259; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P343, DOI 10.1080/13854046.2013.774438; Blake AL, 2019, SLEEP HEALTH, V5, P72, DOI 10.1016/j.sleh.2018.10.011; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Defense and Veterans Brain Injury Center, DOD NUMB TRAUM BRAIN; Department of Defense, DEP DEF INSTR 649011; Department of Veterans Affairs/Department of Defense, VADOD CLIN PRACT GUI; Gregory E, 2017, CONTEMP CLIN TRIALS, V52, P95, DOI 10.1016/j.cct.2016.11.005; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kaminski TW, 2020, RES SPORTS MED, V28, P217, DOI 10.1080/15438627.2019.1635130; KASTE M, 1982, LANCET, V2, P1186; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; MORRISON RG, 1986, JAMA-J AM MED ASSOC, V255, P2475, DOI 10.1001/jama.255.18.2475; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Remigio-Baker RA, 2020, J HEAD TRAUMA REHAB, V35, P92, DOI 10.1097/HTR.0000000000000498; ROSS RJ, 1983, JAMA-J AM MED ASSOC, V249, P211, DOI 10.1001/jama.249.2.211; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031	31	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2021	36	6			SI		456	465		10.1097/HTR.0000000000000694			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WV3QT	WOS:000717155100013	34145155				2022-02-06	
J	Robert, A; Moroz, M; Correa, JA; Var, D; Delaney, JS				Robert, Antony; Moroz, Mickey; Correa, Jose A.; Var, Danny; Delaney, J. Scott			A New In-Skates Balance Error Scoring System for Ice Hockey Players	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; BESS; ice hockey; university	POSTURAL STABILITY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SPORT HELD; CONCUSSION; INJURY; RELIABILITY; PERFORMANCE; SYMPTOMS; FOOTBALL	Objective: Evaluate a new in-skates balance error scoring system (SBESS) for ice hockey players wearing their equipment. Design: Prospective, randomized, single blinded study. Setting: Sport Medicine Clinic. Participants: Eighty university hockey players. Intervention: A control group performed the SBESS assessment at rest on 2 separate occasions and an experimental group performed the assessment at rest and after exertion. The SBESS consists of maintaining different stances on ice skates for 20 seconds each, while wearing full equipment (no stick, gloves and helmet) and standing on a hard rubber surface. Three independent reviewers scored the video recorded assessments. Main Outcomes Measures: Primary outcome was the number of balance errors and the secondary outcome was the number of falls. Results: The control group's median SBESS scores were 2 and 3 on the first and second attempts at rest, respectively. The experimental group's median SBESS scores were 2 at rest and 2 after exertion. There was no fatigue effect and no athletes fell while performing the test. Of the 4 stances tested, the tandem stance had the highest variability in error scores between athletes and when repeated by the same athlete. The intraclass correlation coefficient (ICC) for interrater reliability was above 0.82, and the intrarater reliability ICC was above 0.86 for all SBESS scores. There was no concordance between the SBESS and the modified BESS. Conclusions: The SBESS, omitting the tandem stance, is a safe and reproducible sideline balance assessment of ice hockey players wearing full equipment.	[Robert, Antony; Delaney, J. Scott] McGill Univ, Dept Emergency Med, Hlth Ctr, Montreal, PQ, Canada; [Moroz, Mickey; Delaney, J. Scott] McGill Sport Med Clin, 475 Pine Ave West, Montreal, PQ H2W 1S4, Canada; [Correa, Jose A.] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Var, Danny] Univ Montreal, Family Med, Montreal, PQ, Canada		Delaney, JS (corresponding author), McGill Sport Med Clin, 475 Pine Ave West, Montreal, PQ H2W 1S4, Canada.	jscott.delaney@mcgill.ca					Biros MH, 2010, ROSENS EMERGENCY MED; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Delaney J Scott, 2005, Clin J Sport Med, V15, P216, DOI 10.1097/01.jsm.0000168077.74497.a4; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Delaney JS, 2014, CLIN J SPORT MED, V24, P233, DOI 10.1097/JSM.0000000000000017; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liao JJZ, 2011, INT J BIOSTAT, V7, DOI 10.2202/1557-4679.1295; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Putukian M, 2013, BRIT J SPORT MED, V47, P285, DOI 10.1136/bjsports-2013-092158; Riemann BL, 2000, J ATHL TRAINING, V35, P19; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Susco TM, 2004, J ATHL TRAINING, V39, P241; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Zimmer A, 2014, APPL NEUROPSYCH-ADUL, P1; Zimmer A, 2013, J ATHL TRAINING, V48, P659, DOI 10.4085/1062-6050-48.5.06	30	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2021	31	6					E447	E452		10.1097/JSM.0000000000000816			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WM5NJ	WOS:000711131700023	31842050				2022-02-06	
J	Saeed, K; Jo, MH; Park, JS; Alam, SI; Khan, I; Ahmad, R; Khan, A; Ullah, R; Kim, MO				Saeed, Kamran; Jo, Myeung Hoon; Park, Jun Sung; Alam, Sayed Ibrar; Khan, Ibrahim; Ahmad, Riaz; Khan, Amjad; Ullah, Rahat; Kim, Myeong Ok			17 beta-Estradiol Abrogates Oxidative Stress and Neuroinflammation after Cortical Stab Wound Injury	ANTIOXIDANTS			English	Article						traumatic brain injury; 17 beta-estradiol; neuroprotection; oxidative stress; neuroinflammation; astrocytosis; microglial polarization; neurodegeneration	TRAUMATIC BRAIN-INJURY; ACTIVATED PROTEIN-KINASE; MICROGLIA/MACROPHAGE POLARIZATION DYNAMICS; NEUROTROPHIC FACTOR; MICROGLIAL ACTIVATION; INFLAMMATORY RESPONSE; NLRP3 INFLAMMASOME; ESTROGEN; EXPRESSION; PATHWAY	Disruptions in brain energy metabolism, oxidative damage, and neuroinflammation are commonly seen in traumatic brain injury (TBI). Microglial activation is the hallmark of neuroinflammation. After brain injury, microglia also act as a double-edged sword with distinctive phenotypic changes. Therefore, therapeutic applications to potentiate microglia towards pro-inflammatory response following brain injury have become the focus of attention in recent years. Here, in the current study, we investigated the hypothesis that 17 beta-estradiol could rescue the mouse brain against apoptotic cell death and neurodegeneration by suppressing deleterious proinflammatory response probably by abrogating metabolic stress and oxidative damage after brain injury. Male C57BL/6N mice were used to establish a cortical stab wound injury (SWI) model. Immediately after brain injury, the mice were treated with 17 beta-estradiol (10 mg/kg, once every day via i.p. injection) for one week. Immunoblotting and immunohistochemical analysis was performed to examine the cortical and hippocampal brain regions. For the evaluation of reactive oxygen species (ROS), reduced glutathione (GSH), and oxidized glutathione (GSSG), we used specific kits. Our findings revealed that 17 beta-estradiol treatment significantly alleviated SWI-induced energy dyshomeostasis and oxidative stress by increasing the activity of phospho-AMPK (Thr172) and by regulating the expression of an antioxidant gene (Nrf2) and cytoprotective enzymes (HO-1 and GSH) to mitigate ROS. Importantly, 17 beta-estradiol treatment downregulated gliosis and proinflammatory markers (iNOS and CD64) while significantly augmenting an anti-inflammatory response as evidenced by the robust expression of TGF-beta and IGF-1 after brain injury. The treatment with 17 beta-estradiol also reduced inflammatory mediators (Tnf-alpha, IL-1 beta, and COX-2) in the injured mouse. Moreover, 17 beta-estradiol administration rescued p53-associated apoptotic cell death in the SWI model by regulating the expression of Bcl-2 family proteins (Bax and Bcl-2) and caspase-3 activation. Finally, SWI + 17 beta-estradiol-treated mice illustrated reduced brain lesion volume and enhanced neurotrophic effect and the expression of synaptic proteins. These findings suggest that 17 beta-estradiol is an effective therapy against the brain secondary injury-induced pathological cascade following trauma, although further studies may be conducted to explore the exact mechanisms.	[Saeed, Kamran; Jo, Myeung Hoon; Park, Jun Sung; Alam, Sayed Ibrar; Khan, Ibrahim; Ahmad, Riaz; Khan, Amjad; Ullah, Rahat; Kim, Myeong Ok] Gyeongsang Natl Univ, Coll Nat Sci, Div Life Sci & Appl Life Sci BK 21 FOUR, Jinju 52828, South Korea; [Kim, Myeong Ok] Alz Dementia Korea Co, Jinju 52828, South Korea		Kim, MO (corresponding author), Gyeongsang Natl Univ, Coll Nat Sci, Div Life Sci & Appl Life Sci BK 21 FOUR, Jinju 52828, South Korea.; Kim, MO (corresponding author), Alz Dementia Korea Co, Jinju 52828, South Korea.	kamran.biochem@gnu.ac.kr; audgns1217@gnu.ac.kr; jsp@gnu.ac.kr; ibrar@gnu.ac.kr; ibrahim1994@gnu.ac.kr; riazk0499@gnu.ac.kr; amjadkhan@gnu.ac.kr; rahatullah1414@gnu.ac.kr; mokim@gnu.ac.kr	Khan, Amjad/AAA-1816-2022		Neurological Disorder Research Program of the Na-tional Research Foundation (NRF) - Korean Government (MSIT) [2020M3E5D9080660]	This research was supported by the Neurological Disorder Research Program of the Na-tional Research Foundation (NRF) funded by the Korean Government (MSIT) (2020M3E5D9080660).	Abe H, 2020, NEURAL PLAST, V2020, DOI 10.1155/2020/7169025; Akinrinmade OA, 2017, BIOMEDICINES, V5, DOI 10.3390/biomedicines5030056; Alam SI, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9010047; Ali T, 2021, MOL NEURODEGENER, V16, DOI 10.1186/s13024-021-00445-4; Ali T, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1157-x; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Aryanpour R, 2017, INT IMMUNOPHARMACOL, V51, P131, DOI 10.1016/j.intimp.2017.08.007; Barha CK, 2010, BBA-GEN SUBJECTS, V1800, P1056, DOI 10.1016/j.bbagen.2010.01.006; Basu A, 1998, MOL HUM REPROD, V4, P1099, DOI 10.1093/molehr/4.12.1099; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Borras C, 2010, BBA-MOL BASIS DIS, V1802, P205, DOI 10.1016/j.bbadis.2009.09.007; Brandes MS, 2020, ASN NEURO, V12, DOI 10.1177/1759091419899782; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chanas SA, 2002, BIOCHEM J, V365, P405, DOI 10.1042/BJ20020320; Chen YX, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12781; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Chiueh CC, 2003, ENDOCRINE, V21, P27, DOI 10.1385/ENDO:21:1:27; Choi YC, 2004, FUND CLIN PHARMACOL, V18, P547, DOI 10.1111/j.1472-8206.2004.00284.x; Collmann FM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01236; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Crupi R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040297; Dai W, 2018, BRAIN RES BULL, V140, P65, DOI 10.1016/j.brainresbull.2018.03.020; Dinkova-Kostova AT, 2018, FEBS J, V285, P3576, DOI 10.1111/febs.14379; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Eastman CL, 2020, NEUROPHARMACOLOGY, V172, DOI 10.1016/j.neuropharm.2019.107907; Filichia E, 2015, NEUROSCIENCE, V295, P1, DOI 10.1016/j.neuroscience.2015.03.018; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Gunther M, 2015, ACTA NEUROCHIR, V157, P649, DOI 10.1007/s00701-014-2331-2; Guo JM, 2017, CNS NEUROSCI THER, V23, P360, DOI 10.1111/cns.12686; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hardie DG, 2014, PHYSIOLOGY, V29, P99, DOI 10.1152/physiol.00050.2013; Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040; Hill JL, 2016, J NEUROCHEM, V139, P106, DOI 10.1111/jnc.13726; Houlton J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00790; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ikram M, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6635552; Ikram M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090902; Jadid KD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00811; Jezierski MK, 2000, MOL BRAIN RES, V85, P77, DOI 10.1016/S0169-328X(00)00244-8; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kanazawa M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102135; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Khan I, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10060892; Khan M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080928; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kipp M, 2012, J NEUROENDOCRINOL, V24, P62, DOI 10.1111/j.1365-2826.2011.02163.x; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Lai SW, 2018, MOL NEUROBIOL, V55, P7487, DOI 10.1007/s12035-018-0933-z; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Li JP, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.691773; Li X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164237; Lu HH, 2018, J CELL PHYSIOL, V233, P1712, DOI 10.1002/jcp.26083; Manwani B, 2013, J NEUROSCI RES, V91, P1018, DOI 10.1002/jnr.23207; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; Muhammad T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030648; Muhammad T, 2019, J NEUROIMMUNE PHARM, V14, P278, DOI 10.1007/s11481-018-9824-3; Nadkarni S, 2013, CURR OPIN PHARMACOL, V13, P576, DOI 10.1016/j.coph.2013.05.007; Nakagawa Y, 2015, PHARMACOL THERAPEUT, V154, P21, DOI 10.1016/j.pharmthera.2015.06.010; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Ramara A, 2007, BRAIN RES, V1176, P71, DOI 10.1016/j.brainres.2007.08.036; Rehman SU, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070760; Rehman SU, 2018, CEREB CORTEX, V28, P2854, DOI 10.1093/cercor/bhx164; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Saeed K, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9523758; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Saito M, 2019, INT J DEV NEUROSCI, V77, P48, DOI 10.1016/j.ijdevneu.2019.01.007; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; Shah SA, 2017, MOL PSYCHIATR, V22, P407, DOI 10.1038/mp.2016.23; Simpson DSA, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080743; SINGH M, 1995, ENDOCRINOLOGY, V136, P2320, DOI 10.1210/en.136.5.2320; Skaper Stephen D, 2012, Methods Mol Biol, V846, P1, DOI 10.1007/978-1-61779-536-7_1; SOHRABJI F, 1995, P NATL ACAD SCI USA, V92, P11110, DOI 10.1073/pnas.92.24.11110; Song CH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221650; Stelmasiak Z, 2000, Med Sci Monit, V6, P426; Thakkar R, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4248526; Torihata Y, 2018, DIGEST DIS SCI, V63, P345, DOI 10.1007/s10620-017-4885-3; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vegeto E, 2008, FRONT NEUROENDOCRIN, V29, P507, DOI 10.1016/j.yfrne.2008.04.001; Villa A, 2016, ENDOCR REV, V37, P372, DOI 10.1210/er.2016-1007; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang J, 2021, MOL NEUROBIOL, V58, P1052, DOI 10.1007/s12035-020-02171-2; Wen L, 2018, J NEUROTRAUM, V35, P2330, DOI 10.1089/neu.2017.5540; Wise PM, 2001, FRONT NEUROENDOCRIN, V22, P33, DOI 10.1006/frne.2000.0207; Wu JJ, 2014, EXP CELL RES, V328, P351, DOI 10.1016/j.yexcr.2014.08.030; Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001; Xu HZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5405104; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Zhang B, 2010, J IMMUNOL, V184, P4087, DOI 10.4049/jimmunol.0902339; Zhang L, 2018, MOL NEUROBIOL, V55, P1773, DOI 10.1007/s12035-017-0456-z; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003; Zhao SC, 2017, ACTA PHARMACOL SIN, V38, P445, DOI 10.1038/aps.2016.162; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	109	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3921		ANTIOXIDANTS-BASEL	Antioxidants	NOV	2021	10	11							1682	10.3390/antiox10111682			19	Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology	XK8LZ	WOS:000727711200001	34829553	gold, Green Published			2022-02-06	
J	Sakamoto, MS; Delano-Wood, L; Sorg, SF; Schiehser, DM; Merritt, VC				Sakamoto, McKenna S.; Delano-Wood, Lisa; Sorg, Scott F.; Schiehser, Dawn M.; Merritt, Victoria C.			Unemployment Status Is Associated With Greater Cognitive Intraindividual Variability in Veterans With a History of Remote Mild TBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain concussion; cognition; employment; neuropsychology; veterans; veterans health	TRAUMATIC BRAIN-INJURY; RETURN; WORK; EMPLOYMENT; COGSMART	Objective: To examine the association between employment status and neuropsychological functioning in veterans with a history of remote mild traumatic brain injury (mTBI) using 2 approaches to assess cognitive performance: (a) standard, traditional mean cognitive performance; and (b) across-test intraindividual variability (IIV). Setting: Outpatient Veterans Affairs (VA) hospital. Participants: Eligibility criteria included veterans with a history of mTBI who performed adequately on performance validity tests. Participants (N = 75; 37 employed, 38 unemployed) were evaluated, on average, about 5.5 years after their most recent mTBI. Design: Observational cohort study; all participants completed a clinical interview and a comprehensive neuropsychological assessment. Main Measures: Primary outcomes of interest included mean cognitive composite test scores and IIV scores on tasks of memory, attention/processing speed, and executive functioning. Results: Logistic regression models showed that mean cognitive performance was not predictive of employment status; however, IIV indices were (chi 3,752 = 7.88, P = .048) and accounted for 13% of the variance. Greater memory-IIV was significantly associated with being unemployed (beta = -.16, SE = .07, P = .020, Exp(B) = 0.85; 95% CI, 0.74-0.98). Conclusion: These findings build upon prior work showing that IIV, or cognitive dispersion, is associated with important functional outcomes following mTBI, including employment status. Future studies are needed to verify these findings, but the present study suggests that IIV indices offer a clinically meaningful marker of cognitive functioning and should be considered when evaluating functional outcomes following head trauma.	[Sakamoto, McKenna S.; Delano-Wood, Lisa; Sorg, Scott F.; Schiehser, Dawn M.; Merritt, Victoria C.] VASDHS, Res & Psychol Serv, San Diego, CA 92161 USA; [Delano-Wood, Lisa; Schiehser, Dawn M.; Merritt, Victoria C.] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA; [Delano-Wood, Lisa; Sorg, Scott F.; Schiehser, Dawn M.; Merritt, Victoria C.] Univ Calif San Diego, Sch Med, Dept Psychiat, 9500 Gillman Dr, La Jolla, CA 92093 USA		Merritt, VC (corresponding author), VA San Diego Healthcare Syst, Res & Psychol Serv, 3350 La Jolla Village Dr,MC 151B, San Diego, CA 92161 USA.	victoria.merritt@va.gov			Department of Veterans AffairsUS Department of Veterans Affairs [CX000842-01A2, 829-MR-NB-25860]; Schiehser [CDA-2-065-10S]; Department of DefenseUnited States Department of Defense [W81XWH-10-2-0169]; VA Clinical Science Research& Development Service [IK2 CX001952, CX001508-02]	This work was supported by Department of Veterans Affairs grants awarded to Drs Delano-Wood (CX000842-01A2 and 829-MR-NB-25860) and Schiehser (CDA-2-065-10S). This work was further supported by a grant awarded by the Department of Defense (W81XWH-10-2-0169) to Dr Delano-Wood. DrsMerritt and Sorg received salary support during this work from Career Development Awards from the VA Clinical Science Research& Development Service (Dr Merritt: IK2 CX001952; Dr Sorg: CX001508-02).	Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; Clark JMR, 2020, ARCH PHYS MED REHAB, V101, P1383, DOI 10.1016/j.apmr.2020.04.008; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Merritt VC, 2020, REHABIL PSYCHOL, V65, P279, DOI 10.1037/rep0000323; Merritt VC, 2020, CLIN NEUROPSYCHOL, V34, P1226, DOI 10.1080/13854046.2020.1740324; Merritt VC, 2018, NEUROPSYCHOLOGIA, V119, P340, DOI 10.1016/j.neuropsychologia.2018.08.026; Morgan EE, 2012, CLIN NEUROPSYCHOL, V26, P654, DOI 10.1080/13854046.2012.680912; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Rentrop M, 2010, PSYCHIAT RES, V178, P27, DOI 10.1016/j.psychres.2010.04.009; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Sorg SF, 2021, J INT NEUROPSYCH SOC, V27, P305, DOI 10.1017/S1355617720000879; The Management of Concussion-Mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT CL; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Vandermorris S., 2015, HDB INTRAINDIVIDUAL, P145; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069	18	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2021	36	6			SI		E391	E396		10.1097/HTR.0000000000000693			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WV3QT	WOS:000717155100004	34145154				2022-02-06	
J	Sakamoto, MS; Delano-Wood, L; Schiehser, DM; Merritt, VC				Sakamoto, McKenna S.; Delano-Wood, Lisa; Schiehser, Dawn M.; Merritt, Victoria C.			Predicting Veteran Health-Related Quality of Life Following Mild Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						Veterans health; military psychology; head injury; TBI; QOL	POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYMPTOMS; POSTCONCUSSIVE SYMPTOMS; ASSOCIATIONS; AFGHANISTAN; DEPRESSION; OUTCOMES; BLAST; IRAQ; TBI	Impact and Implications This study examined the relationship between remote history of mild traumatic brain injury (mTBI) and health-related quality of life (HR-QOL) in Veterans before and after controlling for the effects of depressive and posttraumatic stress disorder symptoms and combat exposure. Even when adjusting for these variables, history of remote mTBI contributes to poorer HR-QOL-particularly in the domains of physical health and social functioning. Additionally, this study explored sociodemographic, injury-related, and psychiatric and neurobehavioral predictors of HR-QOL. Depression and neurobehavioral symptoms most consistently predicted HR-QOL, though employment status and number of lifetime mTBIs also predicted aspects of HR-QOL. Importantly, different combinations of predictors were associated with different HR-QOL domains. Our findings suggest that treatment and rehabilitation strategies for this population should be multimodal and should be individualized to best promote HR-QOL and improve long-term functionality. Purpose/Objective: To examine health-related quality of life (HR-QOL) in Veterans with and without a history of mild traumatic brain injury (mTBI) and investigate correlates and predictors of HR-QOL within the mTBI sample. Research Method/Design: Participants (N = 144) included 81 Veterans with a history of mTBI and 63 Veteran controls (VCs) without a history of mTBI. Primary outcomes of interest were the 8 subscales of the 36-Item Short Form Survey (SF-36). Participants also completed questionnaires measuring combat exposure, depressive and posttraumatic stress disorder (PTSD) symptoms, and neurobehavioral symptoms. Results: ANCOVAs adjusting for age found that, relative to VCs, the mTBI group demonstrated poorer HR-QOL across all SF-36 subscales (p's = <=.001-.006; eta p2 = .05-.21). After adjusting for age, combat exposure, and depressive and PTSD symptoms, the mTBI group endorsed poorer HR-QOL on the Physical Role Functioning, General Health, and Social Functioning subscales (p's = .011-.032; eta p2 = .03-.05). Within the mTBI sample, employment status, lifetime number of mTBIs, depression, PTSD, and neurobehavioral symptoms collectively predicted all 8 SF-36 subscales (p's < .001), accounting for 29-65% of the total variance. Although depression and neurobehavioral symptoms tended to be the strongest predictors of HR-QOL, lifetime number of mTBIs and employment status were also important predictors of specific HR-QOL domains. Conclusions: Results suggest that, above and beyond depression, PTSD, and combat exposure, history of remote mTBI contributes to aspects of HR-QOL-particularly in perceptions of physical health and social functioning. Furthermore, different combinations of predictor variables are associated with different HR-QOL domains, highlighting the need for multimodal treatments within this vulnerable population.	[Sakamoto, McKenna S.; Delano-Wood, Lisa; Schiehser, Dawn M.; Merritt, Victoria C.] VA San Diego Healthcare Syst, Res & Psychol Serv, 3350 La Jolla Village Dr,MC 151B, San Diego, CA 92161 USA; [Delano-Wood, Lisa; Schiehser, Dawn M.; Merritt, Victoria C.] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA		Merritt, VC (corresponding author), VA San Diego Healthcare Syst, Res & Psychol Serv, 3350 La Jolla Village Dr,MC 151B, San Diego, CA 92161 USA.	vmerritt@health.ucsd.edu		Merritt, Victoria/0000-0001-5683-4168			Amara JH, 2019, J HEAD TRAUMA REHAB, V34, P11, DOI 10.1097/HTR.0000000000000404; American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU DIAGNOSTIC STAT MANU; Brickell TA, 2014, MIL MED, V179, P827, DOI 10.7205/MILMED-D-13-00506; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Chen CL, 2020, J PSYCHOSOM RES, V136, DOI 10.1016/j.jpsychores.2020.110190; Chiang CC, 2016, QUAL LIFE RES, V25, P2009, DOI 10.1007/s11136-015-1215-0; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark AL, 2016, BRAIN INJURY, V30, P864, DOI 10.3109/02699052.2016.1144894; Collins B., 2014, EMPLOYMENT VETERANS; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Dismuke-Greer CE, 2018, BRAIN INJURY, V32, P1178, DOI 10.1080/02699052.2018.1482428; Dvbic, 2020, DOD WORLDW NUMB TBI; Farmer Carrie M, 2017, Rand Health Q, V6, P11; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hawley C.E., 2016, J APPL REHABIL COUS, V47, P28, DOI [10.1891/0047-2220.47.4.28, DOI 10.1891/0047-2220.47.4.28]; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kansagara D., 2013, COMPLICATIONS MILD T; Keane T.M., 1991, PCL M DSM 4; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Merritt VC, 2020, ARCH CLIN NEUROPSYCH, V35, P491, DOI 10.1093/arclin/acaa006; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Pittman JOE, 2012, QUAL LIFE RES, V21, P99, DOI 10.1007/s11136-011-9918-3; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seidl JNT, 2015, REHABIL PSYCHOL, V60, P335, DOI 10.1037/rep0000064; Sorg SF, 2016, J HEAD TRAUMA REHAB, V31, P297, DOI 10.1097/HTR.0000000000000189; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Tsai J, 2012, J CLIN PSYCHIAT, V73, P1110, DOI 10.4088/JCP.11m07587; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Voormolen DC, 2019, INJURY, V50, P1068, DOI 10.1016/j.injury.2018.12.002; Walker WC, 2018, BRAIN INJURY, V32, P1079, DOI 10.1080/02699052.2018.1479041; WARE JE, 1987, J CHRON DIS, V40, P473; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	47	0	0	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2021	66	4					461	469		10.1037/rep0000392			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	XI0QC	WOS:000725826700018	34871025				2022-02-06	
J	Sato, M; Kobayashi, Y; Fujita, K; Hitosugi, M				Sato, Mamiko; Kobayashi, Yasutaka; Fujita, Kazuki; Hitosugi, Masahito			Social Environmental Factors Related to Resuming Driving after Brain Injury: A Multicenter Retrospective Cohort Study	HEALTHCARE			English	Article						resuming driving; social environmental factors; International Classification of Functioning (ICF); brain injury	STROKE; PREDICTORS; CESSATION; DRIVERS; CHALLENGES; RETURN	Many patients resume driving after brain injury regardless of their ability to drive safely. Predictors for resuming driving in terms of actual resumption status and environmental factors are unclear. We evaluated the reasons for resuming driving after brain injury and examined whether social environmental factors are useful predictors of resuming driving. This retrospective cohort study was based on a multicenter questionnaire survey at least 18 months after discharge of brain injury patients with rehabilitation. A total of 206 brain injury patients (cerebrovascular disease and traumatic brain injury) were included in the study, which was conducted according to the International Classification of Functioning (ICF) items using log-binominal regression analysis, evaluating social environmental factors as associated factors of resuming driving after brain injury. Social environmental factors, inadequate public transport (risk ratio (RR), 1.38), and no alternative driver (RR, 1.53) were included as significant independent associated factors. We found that models using ICF categories were effective for investigating factors associated with resuming driving in patients after brain injury and significant association between resuming driving and social environmental factors. Therefore, social environmental factors should be considered when predicting driving resumption in patients after brain injury, which may lead to better counseling and environmental adjustment.	[Sato, Mamiko] Fukui Gen Hosp, Dept Rehabil Med, Fukui 9108561, Japan; [Kobayashi, Yasutaka; Fujita, Kazuki] Fukui Hlth Sci Univ, Grad Sch Hlth Sci, Fukui 9103190, Japan; [Hitosugi, Masahito] Shiga Univ Med Sci, Dept Legal Med, Otsu, Shiga 5202192, Japan		Sato, M (corresponding author), Fukui Gen Hosp, Dept Rehabil Med, Fukui 9108561, Japan.	satomoko@f-gh.jp; yasutaka_k@fukui-hsu.ac.jp; k.fujita@fukui-hsu.ac.jp; hitosugi@belle.shiga-med.ac.jp		Hitosugi, Masahito/0000-0001-5243-8766; Sato, Mamiko/0000-0002-2947-9743			Akinwuntan AE, 2002, ARCH PHYS MED REHAB, V83, P334, DOI 10.1053/apmr.2002.29662; Aufman EL, 2013, AM J PHYS MED REHAB, V92, P627, DOI 10.1097/PHM.0b013e318282bc0d; Bose S, 2013, INT J STROKE, V8, P240, DOI 10.1111/j.1747-4949.2012.00835.x; Caffo AO, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00917; Doucet T., 2012, Annals of Physical and Rehabilitation Medicine, V55, P112, DOI 10.1016/j.rehab.2012.01.007; Finestone HM, 2009, AM J PHYS MED REHAB, V88, P904, DOI 10.1097/PHM.0b013e3181aa001e; Fisk GD, 1997, ARCH PHYS MED REHAB, V78, P1338, DOI 10.1016/S0003-9993(97)90307-5; Fisk GD, 2002, ARCH PHYS MED REHAB, V83, P469, DOI 10.1053/apmr.2002.31179; GALSKI T, 1992, AM J OCCUP THER, V46, P324, DOI 10.5014/ajot.46.4.324; Hess DB, 2016, TRANSPORT RES A-POL, V88, P73, DOI 10.1016/j.tra.2016.03.011; Inoue T, 2018, WORK, V60, P393, DOI 10.3233/WOR-182747; Jee S, 2018, J REHABIL MED, V50, P800, DOI 10.2340/16501977-2373; JETTE AM, 2006, PHYS THER, V86, P726, DOI DOI 10.1093/PTJ/86.5.726; Johnson JE, 2008, J COMMUN HEALTH NURS, V25, P65, DOI 10.1080/07370010802017034; Korner-Bitensky N, 2000, AM J PHYS MED REHAB, V79, P253, DOI 10.1097/00002060-200005000-00007; Lee Nora, 2003, Conn Med, V67, P387; LEGHSMITH J, 1986, J ROY SOC MED, V79, P200, DOI 10.1177/014107688607900404; Lincoln N., 1992, CLIN REHABIL, V6, P275, DOI DOI 10.1177/026921559200600402; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; Moon S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197206; Nouri F, 1988, Int Disabil Stud, V10, P101; Perrier MJ, 2010, ARCH PHYS MED REHAB, V91, P868, DOI 10.1016/j.apmr.2010.03.009; Ratnapradipa KL, 2020, J GERONTOL B-PSYCHOL, V75, P2263, DOI 10.1093/geronb/gbz058; Ratnapradipa KL, 2018, INNOV AGING, V2, DOI 10.1093/geroni/igy030; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Simms B, 1985, Int Rehabil Med, V7, P187; Spano G, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00368; Specht U, 2020, ACTA NEUROL SCAND, V142, P541, DOI 10.1111/ane.13327; Strogatz D, 2020, J RURAL HEALTH, V36, P88, DOI 10.1111/jrh.12369; Sukhawathanakul P, 2018, TRANSPORT RES F-TRAF, V56, P74, DOI 10.1016/j.trf.2018.04.007; SUNDET K, 1995, SCAND J PSYCHOL, V36, P47, DOI 10.1111/j.1467-9450.1995.tb00967.x; Weeks LE, 2015, J APPL GERONTOL, V34, P501, DOI 10.1177/0733464813487255; Xiong T, 2008, EUR J PHYSIOTHER, V10, P152, DOI 10.1080/14038190802331401	33	0	0	7	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9032		HEALTHCARE-BASEL	Healthcare	NOV	2021	9	11							1469	10.3390/healthcare9111469			8	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	XG1KQ	WOS:000724519300001	34828515	gold, Green Published			2022-02-06	
J	Schussler, E; McCann, RS; Reilly, N; Campbell, TR; Martinez, JC				Schussler, Eric; McCann, Ryan S.; Reilly, Nicholas; Campbell, Thomas R.; Martinez, Jessica C.			Effect of Head Accelerations on Dynamic Balance in Collegiate Women's Rugby	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						athletic injuries; brain concussion; postural balance	FOOTBALL PLAYERS; CONCUSSION; IMPACTS; BIOMECHANICS; SCORES; SEASON; RISK	The effect of subconcussive impacts on balance are not well known. The purpose of this study is to determine the effect of subconcussive impacts on dynamic balance over the course of a rugby season. Significant negative linear correlations were found between total peak linear acceleration and dominant leg (r = -.585, p= .046) and bilateral score (r= -.615, p = .033); also between total impacts over 10g and dominant leg (r = -.653,p= .021), nondominant leg (r= -.687, p = .014), and the combined total (r = -.731, p= .007). Results indicate subconcussive impacts may affect dynamic balance over the course of a competitive season of women's collegiate rugby.	[Schussler, Eric; McCann, Ryan S.; Reilly, Nicholas; Campbell, Thomas R.; Martinez, Jessica C.] Old Dominion Univ, Hampton Blvd, Norfolk, VA 23505 USA		Schussler, E (corresponding author), Old Dominion Univ, Hampton Blvd, Norfolk, VA 23505 USA.	eschussl@odu.edu		Schussler, Eric/0000-0002-0101-0986; Martinez, Jessica/0000-0003-2737-0186			Alsop J C, 2000, J Sci Med Sport, V3, P97, DOI 10.1016/S1440-2440(00)80072-9; Avery M, 2018, J STRENGTH COND RES, V32, P3143, DOI 10.1519/JSC.0000000000002399; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Campolettano ET, 2020, ANN BIOMED ENG, V48, P92, DOI 10.1007/s10439-019-02382-2; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hoch Matthew C, 2017, J Sport Rehabil, V26, DOI 10.1123/jsr.2017-0004; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Jennings D, 2015, INT J SPORTS PHYS TH, V10, P667; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; King A. I., 2003, IRCOBI C LISB PORT; King D., AM J SPORT MED; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Matthew H, 2018, NEUROLOGY, V91, DOI 10.1212/01.wnl.0000550655.96792.92; McCrory P., BR J SPORTS MED; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Miyashita TL, 2017, SPORTS HEALTH, V9, P318, DOI 10.1177/1941738116685306; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Morrison R, 2020, J SPORT REHABIL, V29, P134, DOI 10.1123/jsr.2018-0304; Murray NG, 2018, INT J PSYCHOPHYSIOL, V132, P81, DOI 10.1016/j.ijpsycho.2017.09.018; Post A., 2012, INFLUENCE CENTRIC NO, P11; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Santos F, 2018, NEUROLOGY, V91, DOI 10.1212/01.wnl.0000550640.72136.29; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488	31	0	0	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	NOV	2021	26	6					332	337		10.1123/ijatt.2020-0095			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	WK2PQ	WOS:000709573500009					2022-02-06	
J	Scott, JC; Lynch, KG; Cenkner, DP; Kehle-Forbes, SM; Polusny, MA; Gur, RC; Chen, S; Foa, EB; Oslin, DW				Scott, J. Cobb; Lynch, Kevin G.; Cenkner, David P.; Kehle-Forbes, Shannon M.; Polusny, Melissa A.; Gur, Ruben C.; Chen, Shirley; Foa, Edna B.; Oslin, David W.			Neurocognitive Predictors of Treatment Outcomes in Psychotherapy for Comorbid PTSD and Substance Use Disorders	JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY			English	Article						psychotherapy; posttraumatic stress disorder; substance use treatment; episodic memory; neuropsychology	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; COGNITIVE FUNCTION; TREATMENT RESPONSE; VERBAL MEMORY; MOTIVATIONAL ENHANCEMENT; PSYCHOMETRIC PROPERTIES; BRIEF INTERVENTIONS; BEHAVIOR-THERAPY; VETERANS	Objective: Comorbidity between posttraumatic stress disorder (PTSD) and substance use disorders (SUD) is common, and both are associated with cognitive dysfunction. However, few studies examine the impact of cognitive deficits on treatment outcomes. Here, we leverage data from a randomized clinical trial of integrated versus phased psychotherapy for SUD and PTSD to examine the relation of cognitive functioning to treatment response. Method: One-hundred and thirteen veterans with co-occurring PTSD and SUD completed Penn Computerized Neurocognitive Battery tests assessing attention, executive control, memory, and spatial processing. Linear mixed-effects models examined interactions between cognitive functioning and time in predicting primary PTSD and SUD outcomes across both treatments. Results: Significant verbal immediate memory by time interactions were found for both PTSD symptoms (p = .01, f (2) = 0.020) and percent heavy drinking or drug use days (p = .004, f (2) = 0.020). There was a significant working memory by time interaction for percent heavy drinking or drug use days (p = .007, f (2) = 0.016). Participants with better verbal memory had greater reductions across time in PTSD symptoms and drinking/drug use, while those with better working memory had lesser reductions in their drinking/drug use across time. Conclusions: Individuals with lower verbal memory functioning had less robust PTSD and SUD symptom reductions in PTSD/SUD psychotherapy, with differences that were generally small in magnitude. Those with better working memory functioning had worse SUD outcomes. Together with prior literature, findings suggest that neurocognitive functioning may impact the effectiveness of PTSD and SUD treatment. What is the public health significance of this article? This study suggests that psychotherapy for veterans with PTSD and substance use disorders may be less effective in individuals with lower verbal memory functioning.	[Scott, J. Cobb; Cenkner, David P.; Chen, Shirley; Oslin, David W.] Corporal Michael J Crescenz VA Med Ctr, Mental Illness Res Educ & Clin Ctr VISN4, MIRECC 116,3900 Woodland Ave, Philadelphia, PA 19104 USA; [Scott, J. Cobb; Lynch, Kevin G.; Gur, Ruben C.; Foa, Edna B.; Oslin, David W.] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Kehle-Forbes, Shannon M.; Polusny, Melissa A.] VA Boston Healthcare Syst, Natl Ctr PTSD Womens Hlth Sci Div, Boston, MA USA; [Kehle-Forbes, Shannon M.] Minneapolis VA Healthcare Syst, Minneapolis, MN USA; [Kehle-Forbes, Shannon M.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Polusny, Melissa A.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA		Scott, JC (corresponding author), Corporal Michael J Crescenz VA Med Ctr, Mental Illness Res Educ & Clin Ctr VISN4, MIRECC 116,3900 Woodland Ave, Philadelphia, PA 19104 USA.	scott1@pennmedicine.upenn.edu			United States (U.S.) Department of Veterans Affairs Merit Review Awards [ZDA1-03-W10, I01RX002699]; Health Services Research & Development Career Development Award [09-020]; Mental Illness Research, Education, and Clinical Center at the Corporal Michael J. Crescenz VA Medical Center; Minneapolis VA Healthcare SystemUS Department of Veterans Affairs	This work was supported by a United States (U.S.) Department of Veterans Affairs Merit Review Awards to Dr. David W. Oslin (ZDA1-03-W10) and to Dr. J. Cobb Scott (I01RX002699). Dr. Shannon M. Kehle-Forbes was supported by a Health Services Research & Development Career Development Award (09-020). This work was supported with resources and the use of facilities at the Mental Illness Research, Education, and Clinical Center at the Corporal Michael J. Crescenz VA Medical Center (CMCVAMC) and the Minneapolis VA Healthcare System. The funder was not involved in the study design; collection, analysis, and interpretation of data; writing the report; or the decision to submit this article for publication. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs. The authors declare no conflicts of interest.	Aharonovich E, 2006, DRUG ALCOHOL DEPEN, V81, P313, DOI 10.1016/j.drugalcdep.2005.08.003; Aharonovich E, 2003, DRUG ALCOHOL DEPEN, V71, P207, DOI 10.1016/S0376-8716(03)00092-9; Aharonovich E, 2008, DRUG ALCOHOL DEPEN, V95, P279, DOI 10.1016/j.drugalcdep.2008.01.009; Almasy L, 2008, AM J PSYCHIAT, V165, P1185, DOI 10.1176/appi.ajp.2008.07121869; American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU DIAGNOSTIC STAT MANU; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Bender RE, 2007, AM J ADDICTION, V16, P503, DOI 10.1080/10550490701641058; Blume AW, 2005, ADDICT BEHAV, V30, P301, DOI 10.1016/j.addbeh.2004.05.019; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Bruijniks SJE, 2019, CLIN PSYCHOL SCI, V7, P668, DOI 10.1177/2167702619830391; Carroll KM, 2011, SUBST USE MISUSE, V46, P23, DOI 10.3109/10826084.2011.521069; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Desfosses M, 2014, AUST PSYCHOL, V49, P287, DOI 10.1111/ap.12071; DiClemente CC, 2017, PSYCHOL ADDICT BEHAV, V31, P862, DOI 10.1037/adb0000318; Dong L, 2017, BEHAV RES THER, V97, P189, DOI 10.1016/j.brat.2017.08.006; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Foa E.B., 2007, PROLONGED EXPOSURE T, DOI [10.1093/med:psych/9780195308501.001.0001, DOI 10.1093/MED:PSYCH/9780195308501.001.0001]; Gros DF, 2017, COMPR PSYCHIAT, V78, P48, DOI 10.1016/j.comppsych.2017.07.004; Gur RC, 2001, NEUROPSYCHOPHARMACOL, V25, P766, DOI 10.1016/S0893-133X(01)00278-0; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Gur RC, 2010, J NEUROSCI METH, V187, P254, DOI 10.1016/j.jneumeth.2009.11.017; Haaland KY, 2016, J INT NEUROPSYCH SOC, V22, P643, DOI 10.1017/S1355617716000424; Hamblen JL, 2019, PSYCHOTHERAPY, V56, P359, DOI 10.1037/pst0000231; Harvey AG, 2014, PERSPECT PSYCHOL SCI, V9, P161, DOI 10.1177/1745691614521781; Jak AJ, 2015, CONTEMP CLIN TRIALS, V45, P210, DOI 10.1016/j.cct.2015.10.009; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; Jovanovski D, 2005, J CLIN EXP NEUROPSYC, V27, P189, DOI 10.1080/13803390490515694; Keane T.M., 1991, PCL M DSM 4; Kehle-Forbes SM, 2019, DRUG ALCOHOL DEPEN, V205, DOI 10.1016/j.drugalcdep.2019.107647; Kehle-Forbes SM, 2016, CONTEMP CLIN TRIALS, V50, P45, DOI 10.1016/j.cct.2016.07.017; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kiluk BD, 2011, DRUG ALCOHOL DEPEN, V114, P169, DOI 10.1016/j.drugalcdep.2010.09.019; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Lane RD, 2015, BEHAV BRAIN SCI, V38, DOI 10.1017/S0140525X14000041; Miller W.R., 1995, MOTIVATIONAL ENHANCE; Moore TM, 2015, NEUROPSYCHOLOGY, V29, P235, DOI 10.1037/neu0000093; National Institute for Health and Care Excellence (NICE), 2018, GUID POSTTR STRESS D; Nijdam MJ, 2015, J CLIN PSYCHIAT, V76, pE1023, DOI 10.4088/JCP.14m09438; Pietrzak RH, 2011, J ANXIETY DISORD, V25, P456, DOI 10.1016/j.janxdis.2010.11.010; Roalf DR, 2014, NEUROPSYCHOLOGY, V28, P161, DOI 10.1037/neu0000011; Roberts NP, 2015, CLIN PSYCHOL REV, V38, P25, DOI 10.1016/j.cpr.2015.02.007; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Scott JC, 2007, NEUROPSYCHOL REV, V17, P275, DOI 10.1007/s11065-007-9031-0; Scott JC, 2017, BEHAV RES THER, V91, P24, DOI 10.1016/j.brat.2017.01.004; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; SMITH DE, 1991, ADDICT BEHAV, V16, P265, DOI 10.1016/0306-4603(91)90019-E; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Stavro K, 2013, ADDICT BIOL, V18, P203, DOI 10.1111/j.1369-1600.2011.00418.x; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Stefanovics EA, 2018, PSYCHIAT QUART, V89, P141, DOI 10.1007/s11126-017-9522-y; Swagerman SC, 2016, NEUROPSYCHOLOGY, V30, P53, DOI 10.1037/neu0000248; Teichner G, 2002, ADDICT BEHAV, V27, P751, DOI 10.1016/S0306-4603(01)00207-6; Teichner G, 2001, INT J NEUROSCI, V106, P253, DOI 10.3109/00207450109149753; Tevyaw TO, 2004, ADDICTION, V99, P63, DOI 10.1111/j.1360-0443.2004.00855.x; Thomas ML, 2013, J CLIN EXP NEUROPSYC, V35, P225, DOI 10.1080/13803395.2012.762974; Vergara-Moragues E, 2017, J SUBST ABUSE TREAT, V78, P48, DOI 10.1016/j.jsat.2017.04.014; Wild J, 2008, BRIT J PSYCHIAT, V193, P254, DOI 10.1192/bjp.bp.107.045922; Wolwer W, 2001, ACTA PSYCHIAT SCAND, V103, P30, DOI 10.1034/j.1600-0447.2001.00149.x	63	0	0	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0022-006X	1939-2117		J CONSULT CLIN PSYCH	J. Consult. Clin. Psychol.	NOV	2021	89	11					937	946		10.1037/ccp0000693			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	XL4WP	WOS:000728145900008	34881912				2022-02-06	
J	Selhorst, M; MacDonald, J; Martin, LC; Rodenberg, R; Krishnamurthy, R; Ravindran, R; Fischer, A				Selhorst, Mitchell; MacDonald, James; Martin, Lisa C.; Rodenberg, Richard; Krishnamurthy, Ramkumar; Ravindran, Reno; Fischer, Anastasia			Immediate functional progression program in adolescent athletes with a spondylolysis	PHYSICAL THERAPY IN SPORT			English	Article						Low back pain; Youth; Bone stress injury; Athlete	LOW-BACK-PAIN; NONOPERATIVE TREATMENT; LUMBAR SPONDYLOLYSIS; NATURAL-HISTORY; FOLLOW-UP; CHILDREN; SPONDYLOLISTHESIS; PARTICIPATION; CONCUSSION; ADULTS	Objective: To assess the preliminary evidence for the efficacy and safety of an immediate functional progression program to treat adolescent athletes with an active spondylolysis. Design: Prospective single-arm trial. Setting: Hospital-based sports medicine and physical therapy clinic. Participants: Twelve adolescent athletes (14.2 +/- 2 years, 25% female) with an active spondylolysis. Main outcome measures: Clinical outcomes included time out of sport, Micheli Functional Scale (Function and Pain) and adverse reactions. Clinical outcomes were assessed at baseline, 1 month, 3 months and 6 months. Magnetic resonance imaging was performed at baseline and 3 months to confirm diagnosis and assess healing of lesion. Results: Eleven participants (92%) fully returned to sport in a median time of 2.5 months (75 days; interquartile range 55 days, 85 days). All participants demonstrated marked improvements in pain and function by the end of the program. One participant (8%) had an adverse reaction during care with a significant recurrence of LBP and had not returned to sport by 6 months. Magnetic resonance imaging demonstrated improvement of the spondylolytic lesion in all but one participant. Conclusion: The immediate functional progression program appears a viable method for treating active spondylolysis and warrants future research. (c) 2021 Elsevier Ltd. All rights reserved.	[Selhorst, Mitchell] Nationwide Childrens Hosp, Sports & Orthoped Phys Therapy, Columbus, OH USA; [MacDonald, James; Rodenberg, Richard; Ravindran, Reno; Fischer, Anastasia] Nationwide Childrens Hosp, Div Sports Med, Columbus, OH USA; [Martin, Lisa C.; Krishnamurthy, Ramkumar] Nationwide Childrens Hosp, Dept Radiol, Columbus, OH USA		Selhorst, M (corresponding author), 6499 East Broad St,Suite 140, Columbus, OH 43213 USA.	Mitchell.Selhorst@Nationwidechildrens.org	Krishnamurthy, Ramkumar/C-9692-2015	Krishnamurthy, Ramkumar/0000-0002-0479-5213	American College of Sports Medicine Clinical Sports Medicine Endowment	American College of Sports Medicine Clinical Sports Medicine Endowment.	Berger RG, 2019, CURR OPIN PEDIATR, V31, P61, DOI 10.1097/MOP.0000000000000706; Beutler W. J., 1976, SPINE PHILA PA, V28, P1035; Beutler WJ, 2003, SPINE, V28, P1027, DOI 10.1097/00007632-200305150-00014; Brodke DS, 2017, SPINE J, V17, P321, DOI 10.1016/j.spinee.2016.09.020; d'Hemecourt PA, 2002, ORTHOPEDICS, V25, P653; d'Hemecourt PA, 2012, CLIN J SPORT MED, V22, P244, DOI 10.1097/JSM.0b013e318249a3ce; De Luigi AJ, 2014, PHYS MED REH CLIN N, V25, P763, DOI 10.1016/j.pmr.2014.06.004; Delitto A, 2012, J ORTHOP SPORT PHYS, V42, pA1, DOI 10.2519/jospt.2012.42.4.A1; El Rassi G, 2013, AM J PHYS MED REHAB, V92, P1070, DOI 10.1097/PHM.0b013e318296da7e; Ferrando AA, 1996, AM J PHYSIOL-ENDOC M, V270, pE627, DOI 10.1152/ajpendo.1996.270.4.E627; FREDRICKSON BE, 1984, J BONE JOINT SURG AM, V66A, P699, DOI 10.2106/00004623-198466050-00008; Fujii K, 2004, J BONE JOINT SURG BR, V86B, P225, DOI 10.1302/0301-620X.86B2.14339; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hagen KB, 2002, SPINE, V27, P1736, DOI 10.1097/00007632-200208150-00010; Hall AM, 2011, EUR SPINE J, V20, P79, DOI 10.1007/s00586-010-1521-8; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hides JA, 2011, EUR SPINE J, V20, P808, DOI 10.1007/s00586-010-1491-x; Hu SS, 2008, J BONE JOINT SURG AM, V90A, P656; Iwamoto J, 2004, SCAND J MED SCI SPOR, V14, P346, DOI 10.1111/j.1600-0838.2004.00379.x; Iwamoto J, 2010, WORLD J ORTHOP, V1, P26, DOI 10.5312/wjo.v1.i1.26; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Kent P, 2015, J REHABIL MED, V47, P356, DOI 10.2340/16501977-1935; Kessous E, 2017, SPINE, V42, pE1087, DOI 10.1097/BRS.0000000000002086; King HA, 1999, ORTHOP CLIN N AM, V30, P467, DOI 10.1016/S0030-5898(05)70099-7; Klein G, 2009, J PEDIATR ORTHOPED, V29, P146, DOI 10.1097/BPO.0b013e3181977fc5; Kraft DE, 2002, PEDIATR CLIN N AM, V49, P643, DOI 10.1016/S0031-3955(02)00007-X; Kurd MF, 2007, J SPINAL DISORD TECH, V20, P560, DOI 10.1097/BSD.0b013e31803dcddd; MacDonald JP, 2016, CLIN J SPORT MED, V26, P490, DOI 10.1097/JSM.0000000000000282; McTimoney C A Michelle, 2003, Curr Sports Med Rep, V2, P41; MICHELI LJ, 1995, ARCH PEDIAT ADOL MED, V149, P15, DOI 10.1001/archpedi.1995.02170130017004; Miller SF, 2004, AM J SPORT MED, V32, P928, DOI 10.1177/0363546503262194; MORITA T, 1995, J BONE JOINT SURG BR, V77B, P620, DOI 10.1302/0301-620X.77B4.7615609; Overley SC, 2018, GLOB SPINE J, V8, P190, DOI 10.1177/2192568217734520; Podlog L, 2006, J APPL SPORT PSYCHOL, V18, P44, DOI 10.1080/10413200500471319; Rossi F., 2001, RADIOGRAPHY, V7, P37, DOI DOI 10.1053/RADI.2000.0299; Sairyo K, 2009, J BONE JOINT SURG BR, V91B, P206, DOI 10.1302/0301-620X.91B2.21256; Schroeder GD, 2016, EUR SPINE J, V25, P2842, DOI 10.1007/s00586-016-4647-5; Selhorst M, 2019, CLIN J SPORT MED, V29, P421, DOI 10.1097/JSM.0000000000000546; Selhorst M, 2017, CLIN J SPORT MED, V27, P296, DOI 10.1097/JSM.0000000000000334; Selhorst M, 2016, J ORTHOP SPORT PHYS, V46, P1029, DOI 10.2519/jospt.2016.7028; Singh H, 2018, J APPL BIOMECH, V34, P429, DOI 10.1123/jab.2017-0230; Smith Jo, 2009, J Dance Med Sci, V13, P73; Standaert CJ, 2002, CLIN J SPORT MED, V12, P119, DOI 10.1097/00042752-200203000-00009; STEINER ME, 1985, SPINE, V10, P937, DOI 10.1097/00007632-198512000-00013; Sys J, 2001, EUR SPINE J, V10, P498, DOI 10.1007/s005860100326; van Belle G., 2002, STAT RULES THUMB; Wang YC, 2011, PHYS THER, V91, P675, DOI 10.2522/ptj.20100229	47	0	0	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	NOV	2021	52						140	146		10.1016/j.ptsp.2021.08.009			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	WZ7AW	WOS:000720117900016	34487947				2022-02-06	
J	Senthanar, S; Koehoorn, M; Tamburic, L; Premji, S; Bultmann, U; McLeod, CB				Senthanar, Sonja; Koehoorn, Mieke; Tamburic, Lillian; Premji, Stephanie; Bultmann, Ute; McLeod, Christopher B.			Differences in Work Disability Duration for Immigrants and Canadian-Born Workers in British Columbia, Canada	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						work disability; immigrant workers; workers' compensation; <p>sex/gender</p>; health equity	RETURN-TO-WORK; OCCUPATIONAL-HEALTH; STATUS MATTER; SAFETY; INJURY; EXPERIENCES; EMPLOYMENT; CONTEXT; COMPENSATION; DISPARITIES	This study aimed to investigate differences in work disability duration among immigrants (categorized as economic, family member or refugee/other classification upon arrival to Canada) compared to Canadian-born workers with a work-related injury in British Columbia. Immigrants and Canadian-born workers were identified from linked immigration records with workers' compensation claims for work-related back strain, connective tissue, concussion and fracture injuries requiring at least one paid day of work disability benefits between 2009 to 2015. Quantile regression investigated the relationship between immigration classification and predicted work disability days (defined from injury date to end of compensation claim, up to 365 days) and modeled at the 25th, 50th and 75th percentile of the distribution of the disability days. With a few exceptions, immigrants experienced greater predicted disability days compared to Canadian-born workers within the same injury cohort. The largest differences were observed for family and refugee/other immigrant classification workers, and, in particular, for women within these classifications, compared to Canadian-born workers. For example, at the 50th percentile of the distribution of disability days, we observed a difference of 34.1 days longer for refugee/other women in the concussion cohort and a difference of 27.5 days longer for family classification women in the fracture cohort. Economic immigrants had comparable disability days with Canadian-born workers, especially at the 25th and 50th percentiles of the distribution. Immigrant workers' longer disability durations may be a result of more severe injuries or challenges navigating the workers' compensation system with delays in seeking disability benefits and rehabilitation services. Differences by immigrant classification speak to vulnerabilities or inequities upon arrival in Canada that persist after entry to the workforce and warrant further investigation for early mitigation strategies.	[Senthanar, Sonja; Koehoorn, Mieke; Tamburic, Lillian; McLeod, Christopher B.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada; [Premji, Stephanie] McMaster Univ, Sch Labour Studies, Hamilton, ON L8S 4M4, Canada; [Bultmann, Ute] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, NL-9712 CP Groningen, Netherlands		Koehoorn, M (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada.	sonja.senthanar@ubc.ca; mieke.koehoorn@ubc.ca; lillian.tamburic@ubc.ca; spremji@mcmaster.ca; u.bultmann@umcg.n1; chris.mcleod@ubc.ca		McLeod, Christopher/0000-0001-9268-3694	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [PJT-152905]	FundingThis research was funded by a Canadian Institutes of Health Research (CIHR) Project Grant, Sponsor Identifier PJT-152905.	Abbott M., 2011, DO ADMISSION CRITERI, V22; Association of Workers' Compensation Boards of Canada, DET KEY STAT MEAS KS; British Columbia Ministry of Health [creator], 2019, CONS FIL MSP REG PRE; Canadian Institutes for Health Research, GEND SEX HLTH GUID T; Canadian Institutes for Health Research Government of Canada, WHAT DIFFERENCE SEX; Chiu M, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0375-3; Choi K, 2020, OCCUP ENVIRON MED, V77, P160, DOI 10.1136/oemed-2019-106211; Clark DE, 2006, INJURY PREV, V12, P111, DOI 10.1136/ip.2005.010058; Cote D., 2017, RELATIONS INTERCULTU, P156; Cote D, 2013, DISABIL REHABIL, V35, P153, DOI 10.3109/09638288.2012.687034; Cote D, 2010, DISABIL REHABIL, V32, P87, DOI 10.3109/09638280903026572; Edwards N, 2011, SCAND J PUBLIC HEALT, V39, P43, DOI 10.1177/1403494810393558; Engelman M, 2017, DEMOGRAPHY, V54, P2273, DOI 10.1007/s13524-017-0617-8; Evra R., 2019, ROLE SOCIAL CAPITAL; Fan JK, 2021, J OCCUP REHABIL, V31, P339, DOI 10.1007/s10926-020-09922-x; Fernandez-Esquer ME, 2015, INT J OCCUP ENV HEAL, V21, P5, DOI 10.1179/2049396714Y.0000000083; Fleras A., 2015, IMMIGRATION CANADA E; Flynn Michael A, 2014, Prof Saf, V59, P52; Frank K, 2011, CAN STUD POPUL, V38, P115, DOI 10.25336/P6T03K; Government of Canada, 2021, VERS NAT OCC CLASS; Gravel S., 2017, ALTERSTICE, V7, P21, DOI [10.7202/1040609ar, DOI 10.7202/1040609AR]; Gravel S, 2011, INT J WORKPLACE HEAL, V4, P164, DOI 10.1108/17538351111143321; Gravel S, 2010, J IMMIGR MINOR HEALT, V12, P707, DOI 10.1007/s10903-008-9208-5; Grieco E., 2004, WOMEN MIGRATION INCO; Guo SB, 2013, J EDUC WORK, V26, P162, DOI 10.1080/13639080.2011.630657; Herd P., 2020, HLTH AFF HLTH POLICY, DOI [10.1377/hpb20200904.405159, DOI 10.1377/HPB20200904.405159]; Hiebert D, 2009, IRPP CHOICES, V15; Houle R., 2010, PERSPECT LABOUR INCO, V22, P18; Immigration Refugees and Citizenship Canada [Creator], 2019, PERM RES DAT POP DAT; Kazi MR, 2019, INT HEALTH, V11, P203, DOI 10.1093/inthealth/ihy086; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Kosny A, 2020, J INT MIGR INTEGR, V21, P807, DOI 10.1007/s12134-019-00685-w; Kosny A, 2017, J INT MIGR INTEGR, V18, P483, DOI 10.1007/s12134-016-0482-0; Kosny A, 2012, ETHNIC HEALTH, V17, P267, DOI 10.1080/13557858.2011.614327; Krause N, 2001, AM J IND MED, V40, P464, DOI 10.1002/ajim.1116; Lay AM, 2018, CAN J PUBLIC HEALTH, V109, P303, DOI 10.17269/s41997-018-0063-4; Liebman AK, 2016, AM J IND MED, V59, P227, DOI 10.1002/ajim.22538; Liu JZ, 2019, CAN ETHN STUD, V51, P169, DOI 10.1353/ces.2019.0013; Maas ET, 2021, OCCUP ENVIRON MED, V78, P715, DOI 10.1136/oemed-2020-107014; Macpherson RA, 2021, OCCUP ENVIRON MED, V78, P583, DOI 10.1136/oemed-2020-106917; Macpherson RA, 2019, J OCCUP REHABIL, V29, P560, DOI 10.1007/s10926-018-9819-1; Morro M.M.S., 2011, THESIS MCMASTER U HA; Mustard C., 2021, IWH SPEAKER SERIES; O'Connor T, 2005, J OCCUP ENVIRON MED, V47, P272, DOI 10.1097/01.jom.0000150204.12937.f5; Ostlund G, 2004, SCAND J CARING SCI, V18, P49, DOI 10.1111/j.1471-6712.2004.00254.x; Population Data BC, 2021, POPDATA; Preibisch K, 2014, RURAL SOCIOL, V79, P174, DOI 10.1111/ruso.12043; Premji S., 2021, PISTES, V23, DOI [10.4000/pistes.7144, DOI 10.4000/PISTES.7144]; Premji S, 2014, JUST LABOUR CAN J WO, V22, P122; Premji S., 2008, PISTES, V10, DOI [10.4000/pistes.2193, DOI 10.4000/PISTES.2193]; Premji S., 2014, PISTES, V16, DOI [10.4000/pistes.3825, DOI 10.4000/PISTES.3825]; Premji S, 2008, INT J HEALTH SERV, V38, P1, DOI 10.2190/HS.38.1.a; Premji S, 2022, NEW SOLUT, V31, P452, DOI 10.1177/10482911211053020; Premji S, 2015, J OCCUP REHABIL, V25, P357, DOI 10.1007/s10926-014-9544-3; Premji S, 2010, AM J IND MED, V53, P960, DOI 10.1002/ajim.20860; Quandt SA, 2013, AM J IND MED, V56, P206, DOI 10.1002/ajim.22072; Ro A., 2012, RACE SOCIAL PROBLEMS, V4, P83, DOI [10.1007/s12552-012-9069-3, DOI 10.1007/S12552-012-9069-3]; Saffari N., BMJ OPEN; SALMINEN S, 2011, ERGON OPEN J, V4, P125, DOI DOI 10.2174/1875934301104010125; Seabury SA, 2017, HEALTH AFFAIR, V36, P266, DOI 10.1377/hlthaff.2016.1185; Senthanar S, 2020, J INT MIGR INTEGR, V21, P273, DOI 10.1007/s12134-019-00729-1; Smith JDR, 2012, AM J IND MED, V55, P537, DOI 10.1002/ajim.22033; Smith PM, 2009, INJURY PREV, V15, P252, DOI 10.1136/ip.2008.021451; StataCorp, 2019, STATA STAT SOFTWARE; Statistics Canada, 2016, IMM ETHN DIV CAN; Statistics Canada, 2021, TABL 14 10 0085 01 L; Statistics Canada, TABL 43 10 0016 01 I; Stergiou-Kita M, 2015, SAFETY SCI, V80, P213, DOI 10.1016/j.ssci.2015.07.029; Sterud T, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5703-3; Strong LL, 2005, AM J PUBLIC HEALTH, V95, P1226, DOI 10.2105/AJPH.2004.044396; Tucker S, 2013, J SAFETY RES, V45, P103, DOI 10.1016/j.jsr.2013.01.006; Werlen L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014431; Wilkinson L, 2017, EC INTEGRATION REFUG; Wilmsen C, 2019, J AGROMEDICINE, V24, P186, DOI 10.1080/1059924X.2019.1567421; WorkSafeBC [Creator], 2019, 2018 WORKSAFEBC CLAI; Xue L., 2008, INITIAL LABOUR MARKE; Xue L., 2006, PERSPECTIVE 2 WAVE L; Yanar B, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15092004	78	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2021	18	22							11794	10.3390/ijerph182211794			16	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	XE5LT	WOS:000723429700001	34831550	gold, Green Published			2022-02-06	
J	Seyid, M; Tiftikcioglu, Y; Erdem, M; Akdemir, O; Tatar, BE; Ercan, G; Uyamizgill, Y				Seyid, Mircafer; Tiftikcioglu, Yigit; Erdem, Mehmet; Akdemir, Ovunc; Tatar, Burak Ergun; Ercan, Gulinnaz; Uyamizgill, Yigit			The Effect of Ceruloplasmin Against Ischemia-Reperfusion Injury in Epigastric Island Flap in Rats	JOURNAL OF SURGICAL RESEARCH			English	Article						Ceruloplasmin; Ischemia-Reperfusion injury; Flap	ISCHEMIA/REPERFUSION INDUCED APOPTOSIS; BETA-CAROTENE; VITAMIN-C; TRANSFERRIN; INHIBITOR; DAMAGE; SERUM; HEAD	A B S T R A C T Background: Flap surgery is frequently used in plastic surgery to close tissue defects. Ischemia-reperfusion (I/R) injury is a significant problem resulting in partial or total flap necrosis. This study aimed to investigate the effect of ceruloplasmin on I/R injury in epigastric island flaps in rats. Material and method: A total of 32 male Sprague-Dawley rats were divided into four groups with eight rats in each group: The flap was not elevated in Group I; the flap was elevated without ischemia or any application in Group II, after the intraperitoneal saline and ceruloplasmin application the flaps were elevated and ischemia was created in group III-IV, respectively. Bilateral epigastric artery flap was elevated in all groups except Group I. After 6 h of ischemia, the flap was reperfused and inset. Samples were taken from the right and left side of the flap area in other groups at the postoperative 24th h for biochemical analysis (catalase and malondialdehyde-MDA) and the seventh postoperative day for histopathological analysis (Modified Verhofstad score and epidermal thicknesses), respectively. Image analysis for necrosis areas was performed on photos taken on the 7th d. Results: Catalase level was significantly higher in Group IV.(0.15 +/- 0.04 U/mg protein) ( P < 0.05) Necrosis area percentage(14.4% +/- 3.3%),MDA(3.6 +/- 0.9 nmol/mg protein), edema(3), necrosis(2.75), and polymorphonuclear leukocyte infiltration(2.87) scores were significantly	[Seyid, Mircafer] Dept Plast Surg, Baku Med Plaza, Baku, Azerbaijan; [Tiftikcioglu, Yigit] Ege Univ, Fac Med, Dept Plast Surg, Izmir, Turkey; [Erdem, Mehmet; Tatar, Burak Ergun] Univ Hlth Sci, Bagcilar Training & Res Hosp, Dept Plast Surg, Istanbul, Turkey; [Akdemir, Ovunc] Esenyurt Univ, Dept Plast Surg, Istanbul, Turkey; [Uyamizgill, Yigit] Ege Univ, Fac Med, Dept Histol & Embryol, Izmir, Turkey; [Ercan, Gulinnaz] Ege Univ, Fac Med, Dept Biochem, Izmir, Turkey		Seyid, M (corresponding author), Dept Plast Surg, Baku Med Plaza, Baku, Azerbaijan.	mircaferseyid@gmail.com	uyanikgil, Yigit/M-2746-2019	uyanikgil, Yigit/0000-0002-4016-0522; TATAR, Burak Ergun/0000-0002-5446-1940			Akdemir O, 2011, J PLAST RECONSTR AES, V64, P921, DOI 10.1016/j.bjps.2010.12.007; Assemand E, 2007, INT J RADIAT BIOL, V83, P309, DOI 10.1080/09553000701311229; Aydogan H, 2007, J PLAST RECONSTR AES, V60, P563, DOI 10.1016/j.bjps.2006.01.030; Ballestin A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209624; BARON P, 1994, ANN NY ACAD SCI, V723, P401, DOI 10.1111/j.1749-6632.1994.tb36758.x; Bielli P, 2002, CELL MOL LIFE SCI, V59, P1413, DOI 10.1007/s00018-002-8519-2; Burkitt MJ., 2007, ELECT PARAMAGNETIC R, V19, P33; Cabbaroglu D, 2019, EGE TIP DERGISI, V58, P154; Cavdar C, 1997, OFFICE J TURKISH NEP, V3, P92; Cetin C, 2001, ANN PLAS SURG, V47, P540; Cetin EO, 2013, PHARMAZIE, V68, P75, DOI 10.1691/ph.2013.2089; Chao JCJ, 2002, J NUTR BIOCHEM, V13, P427, DOI 10.1016/S0955-2863(02)00188-2; Cordeiro PG, 1997, PLAST RECONSTR SURG, V100, P1227, DOI 10.1097/00006534-199710000-00023; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Fowler JD, 1999, MICROSURG, V19, P135, DOI 10.1002/(SICI)1098-2752(1999)19:3<135::AID-MICR3>3.0.CO;2-Y; Fries CA, 2017, MICROSURG, V37, P142, DOI 10.1002/micr.30053; Gaware V., 2010, PATHOLOGY, V5, P6; Giakoustidis DE, 2010, J SURG RES, V159, P720, DOI 10.1016/j.jss.2008.08.038; Gursoy K, 2020, ANN PLAS SURG, V84, P208, DOI 10.1097/SAP.0000000000002013; Harder Y, 2008, J PLAST RECONSTR AES, V61, P503, DOI 10.1016/j.bjps.2007.11.032; Jones NF, 2007, PLAST RECONSTR SURG, V119, P2053, DOI 10.1097/01.prs.0000260591.82762.b5; Kahyaoglu A., 2011, DENEYSEL DIYABET OLU; Kang N, 2014, MOL MED REP, V9, P2124, DOI 10.3892/mmr.2014.2064; Koul Ashok Raj, 2013, Indian J Plast Surg, V46, P247, DOI 10.4103/0970-0358.118600; Liu H, 2019, J PLAST RECONSTR AES, V72, P194, DOI 10.1016/j.bjps.2018.10.019; Liu YQ, 2015, J PLAST RECONSTR AES, V68, pE147, DOI 10.1016/j.bjps.2015.03.001; Memisogullari R, 2004, J DIABETES COMPLICAT, V18, P193, DOI 10.1016/S1056-8727(03)00032-1; Osikov MV, 2006, B EXP BIOL MED+, V142, P416, DOI 10.1007/s10517-006-0380-0; PACHT ER, 1988, J APPL PHYSIOL, V64, P2092, DOI 10.1152/jappl.1988.64.5.2092; Petrovics L, 2018, CLIN HEMORHEOL MICRO, V69, P405, DOI 10.3233/CH-170335; Rapola JM, 1996, JAMA-J AM MED ASSOC, V275, P693, DOI 10.1001/jama.275.9.693; SHESTAK KC, 1991, PLAST RECONSTR SURG, V88, P259, DOI 10.1097/00006534-199108000-00014; Siemionow M, 2004, MICROSURG, V24, P468, DOI 10.1002/micr.20060; van den Heuvel MGW, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/504081; Wang WZ, 2011, PLAST RECONSTR SURG, V128, p685E, DOI 10.1097/PRS.0b013e318230c57b; Wang Y, 2013, J RECONSTR MICROSURG, V29, P341, DOI 10.1055/s-0033-1343830; Yagi K, 1996, J CLIN BIOCHEM NUTR, V20, P181; Yang M, 2010, MICROSURG, V30, P275, DOI 10.1002/micr.20779; Yoshida Winston Bonetti, 2005, Acta Cir. Bras., V20, P358, DOI 10.1590/S0102-86502005000500004; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176; Yu PR, 2009, HEAD NECK-J SCI SPEC, V31, P45, DOI 10.1002/hed.20927; ZACCARIA A, 1994, ANN PLAS SURG, V33, P620, DOI 10.1097/00000637-199412000-00010; Zhao G, 2018, INJURY, V49, P2147, DOI 10.1016/j.injury.2018.09.054	43	0	0	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	NOV	2021	267						627	635		10.1016/j.jss.2021.05.045			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	UZ0GT	WOS:000701892000037	34273792				2022-02-06	
J	Shahidi, B; Bursch, RW; Carmel, JS; Carranza, AC; Cooper, KM; Lee, JV; O'Connor, CN; Sorg, SF; Maluf, KS; Schiehser, DM				Shahidi, Bahar; Bursch, Robyn W.; Carmel, Jennifer S.; Carranza, Ashleigh C.; Cooper, Kelsey M.; Lee, Jayme, V; O'Connor, Colleen N.; Sorg, Scott F.; Maluf, Katrina S.; Schiehser, Dawn M.			Greater Severity and Functional Impact of Post-traumatic Headache in Veterans With Comorbid Neck Pain Following Traumatic Brain Injury	MILITARY MEDICINE			English	Article							CERVICOGENIC HEADACHE; FATIGUE; PREDICTORS; DISABILITY; PREVALENCE; SLEEP; SCALE	Background: Post-traumatic headache (PTH) is a commonly experienced symptom after mild traumatic brain injury (mTBI). Blast injury- or blunt injury-related mechanisms for mTBI in veterans can also affect musculoskeletal structures in the neck, resulting in comorbid neck pain (NP). However, it is unknown whether the presence of comorbid NP may be associated with a different pattern of headache symptoms, physical functioning, or emotional functioning compared to those without comorbid NP. The purpose of this study is to examine the role of comorbid NP in veterans with mTBI and PTH. Design and Methods: This was a cross-sectional investigation of an existing dataset that included 33 veterans who met inclusion criteria for PTH after mTBI. Standardized measures of headache severity and frequency, insomnia, fatigue, mood disorders, and physical and emotional role function were compared between groups with and without comorbid NP. Results: The majority of participants with PTH reported comorbid NP (n=22/33, 67%). Those with comorbid NP experienced more headache symptoms that were severe or incapacitating, as compared to mild or moderate for those without NP (f=0.343, P=.049); however, no differences in headache frequency (f=0.231, P=.231) or duration (f=0.129, P=.712) were observed. Participants with comorbid NP also reported greater insomnia (d=1.16, P=.003) and fatigue (d=0.868, P=.040) as well as lower physical functioning (d=0.802, P=.036) and greater bodily pain (d=0.762, P=.012). There were no differences in anxiety, depression, mental health, emotional role limitations, vitality, or social functioning between those with and without comorbid NP (d=0.656, P=.079). Conclusions: A majority of veterans with mTBI and PTH in our sample reported comorbid NP that was associated with greater headache symptom severity and physical limitations, but not with mood or emotional limitations. Preliminary findings from this small convenience sample indicate that routine assessment of comorbid NP and associated physical limitations should be considered in veterans with mTBI and PTH.	[Shahidi, Bahar] Univ Calif San Diego, Dept Orthopaed Surg, La Jolla, CA 92037 USA; [Bursch, Robyn W.; Carmel, Jennifer S.; Carranza, Ashleigh C.; Cooper, Kelsey M.; Lee, Jayme, V; O'Connor, Colleen N.; Maluf, Katrina S.] San Diego State Univ, Sch Exercise & Nutr Sci, Dept Phys Therapy, San Diego, CA 92182 USA; [Sorg, Scott F.; Schiehser, Dawn M.] Vet Assoc San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA; [Sorg, Scott F.] Vet Assoc San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA; [Schiehser, Dawn M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92037 USA		Shahidi, B (corresponding author), Univ Calif San Diego, Dept Orthopaed Surg, La Jolla, CA 92037 USA.				National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS109852]; VA Clinical Science Research & Development Career Development Award [IK2CX001508, 2-065-10S]; Department of Defense AwardUnited States Department of Defense [W81XWH-10-2-0169]	Funding from the following sources contributed to this project: National Institutes of Health R21NS109852; VA Clinical Science Research & Development Career Development Award (IK2CX001508 & 2-065-10S), and Department of Defense Award W81XWH-10-2-0169.	Afshar S, 2018, PSYCHOPHARMACOLOGY, V235, P2809, DOI 10.1007/s00213-018-4973-x; Aoun R, 2019, NAT SCI SLEEP, V11, P131, DOI 10.2147/NSS.S182158; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Biondi DM, 2005, J AM OSTEOPATH ASSOC, V105, pS16; Bogduk N, 2009, LANCET NEUROL, V8, P959, DOI 10.1016/S1474-4422(09)70209-1; Bomyea J, 2016, HEADACHE, V56, P699, DOI 10.1111/head.12799; Bragatto MM, 2019, CEPHALALGIA, V39, P1500, DOI 10.1177/0333102419854061; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Calhoun AH, 2010, HEADACHE, V50, P1273, DOI 10.1111/j.1526-4610.2009.01608.x; Capi M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072585; Center BN, 2012, PAT HEAD HIST QUEST; Cohen SP, 2010, SPINE, V35, P758, DOI 10.1097/BRS.0b013e3181bb11a8; Conidi FX, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0570-z; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Florencio LL, 2014, HEADACHE, V54, P1203, DOI 10.1111/head.12393; Ford S, 2008, HEADACHE, V48, P523, DOI 10.1111/j.1526-4610.2008.00859.x; Hj Ja O, 2015, J SLEEP DISORD TREAT, V4, P2; Jaramillo CA, 2016, HEADACHE, V56, P528, DOI 10.1111/head.12726; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kaufmann CN, 2019, BEHAV SLEEP MED, V17, P12, DOI 10.1080/15402002.2016.1266490; Kim SH, 2015, PAIN PHYSICIAN, V18, P593; King PR, 2015, MIL MED, V180, P863, DOI 10.7205/MILMED-D-14-00472; King PR, 2014, J NERV MENT DIS, V202, P231, DOI 10.1097/NMD.0000000000000103; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lampl C, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0566-9; Larsen EL, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1051-7; Lazarus R, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.9.FOCUS18396; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Ruff Robert L, 2016, F1000Res, V5, DOI 10.12688/f1000research.9017.1; Schiehser DM, 2017, NEUROPSYCHOL REHABIL, V27, P1031, DOI 10.1080/09602011.2016.1215999; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, P116, DOI 10.1097/HTR.0000000000000019; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Takasaki H, 2013, ARCH PHYS MED REHAB, V94, P1328, DOI 10.1016/j.apmr.2012.12.013; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Tkachenko N, 2016, PEDIATR NEUROL, V57, P46, DOI 10.1016/j.pediatrneurol.2015.12.019; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Zaninotto AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00095	43	0	0	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV-DEC	2021	186	11-12					E1207	E1214		10.1093/milmed/usaa532			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WV9KE	WOS:000717547200027	33306100	Green Published, Bronze, Green Submitted			2022-02-06	
J	Smith, MJ; Young, G; Batten, J; Parry, KD; Collins, R; Anderson, E; White, A				Smith, Matthew J.; Young, Georgia; Batten, John; Parry, Keith D.; Collins, Rosie; Anderson, Eric; White, Adam			Athletes with Neurodegenerative Disease: A Phenomenological Exploration of Family Members' Experiences	QUALITATIVE REPORT			English	Article						neurological health; stressors; phenomenology; ethnodrama; temporal analysis	TRAUMATIC BRAIN-INJURY; SPORT; STRESSORS; APPRAISALS; PLAYERS	This qualitative study involved in-depth interviews with 15 family members (mainly partners and children) of deceased athletes who experienced deterioration in their neurological health towards the end of their life. The purpose of this study was to examine the stressors these family members experienced with the ailed players, their emotional responses to their family member's condition, as well as the coping strategies they used. Vertical and horizontal thematic analyses were conducted on the data, which revealed five distinct temporal stages, a range of emotional responses, as well as accompanying stressors and coping strategies at each temporal stage. The findings are presented as an ethnodrama, capturing the lived experiences of participants. This ethnodrama aims to resonate with those caring for family members who are experiencing deteriorating neurological health, while also raising awareness of the various emotional responses of the individuals in these situations, as well as inviting dialogue and reflection about these issues.	[Smith, Matthew J.] Univ Winchester, Fac Hlth & Wellbeing, Sport & Exercise Psychol, Winchester, Hants, England; [Young, Georgia] Univ Winchester, Winchester, Hants, England; [Batten, John] Univ Winchester, Fac Hlth & Wellbeing, Winchester, Hants, England; [Parry, Keith D.] Bournemouth Univ, Dept Sport & Event Management, Poole, Dorset, England; [Collins, Rosie; White, Adam] Oxford Brookes Univ, Fac Hlth & Life Sci, Sport & Coaching Sci, Oxford, England; [Anderson, Eric] Univ Winchester, Fac Hlth & Wellbeing, Sport Masculin & Sexual, Winchester, Hants, England		Smith, MJ (corresponding author), Univ Winchester, Fac Hlth & Wellbeing, Sport & Exercise Psychol, Winchester, Hants, England.	matt.smith@winchester.ac.uk; G.Young.17@unimail.winchester.ac.uk; john.batten@winchester.ac.uk; kdparry@bournemouth.ac.uk; collins@brookes.ac.uk; Eric.Anderson@Winchester.ac.uk; adamwhite@brookes.ac.uk		Batten, John/0000-0001-7499-7817			Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Braun V, 2016, ROUT INT HANDB, P191; Braun V, 2013, PSYCHOL WOMEN QUART, V37, P478, DOI 10.1177/0361684313492950; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROWN BW, 1988, FAM RELAT, V37, P12, DOI 10.2307/584423; Carter G, 2020, HEALTH SOC CARE COMM, V28, P1134, DOI 10.1111/hsc.12944; Cavallerio F, 2016, PSYCHOL SPORT EXERC, V25, P100, DOI 10.1016/j.psychsport.2016.05.002; Curtiss G, 2000, J HEAD TRAUMA REHAB, V15, P1113, DOI 10.1097/00001199-200010000-00005; Dale GA, 1996, SPORT PSYCHOL, V10, P307, DOI 10.1123/tsp.10.4.307; Dowling F., 2012, EQUITY DIFFERENCE PH, P31; Duff Diane, 2002, Axone, V24, P14; Faure CE, 2019, QUAL REP, V24; Fenge LA, 2018, QUAL RES J, V18, P45, DOI 10.1108/QRJ-D-17-00037; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992; Folkman S., 1984, STRESS; Hayward FPI, 2017, PSYCHOL SPORT EXERC, V29, P56, DOI 10.1016/j.psychsport.2016.12.002; Krutter S, 2020, AGE AGEING, V49, P199, DOI 10.1093/ageing/afz165; Lazarus R.S., 1999, STRESS EMOTION NEW S; Lazarus RS., 2000, EMOTIONS SPORT, P39; McMahon J, 2017, SOCIOL SPORT J, V34, P108, DOI 10.1123/ssj.2015-0166; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Nicholls AR, 2010, SCAND J MED SCI SPOR, V20, P346, DOI 10.1111/j.1600-0838.2009.00894.x; Nicholls AR, 2009, SCAND J MED SCI SPOR, V19, P113, DOI 10.1111/j.1600-0838.2008.00772.x; Nicholls AR, 2006, SPORT PSYCHOL, V20, P314, DOI 10.1123/tsp.20.3.314; Pillemer S, 2018, AGING MENT HEALTH, V22, P1156, DOI 10.1080/13607863.2017.1337718; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; Smith B, 2018, INT REV SPORT EXER P, V11, P101, DOI [10.1080/1750984X.2017.1317357, 10.1080/1750984x.2017.1317357, 10.1109/ACSD.2018.000-4]; Smith B, 2016, ETHNOGRAPHIES IN SPORT AND EXERCISE RESEARCH, P59; Sparkes AC., 2014, QUALITATIVE RES METH; Sparkes AC, 2007, SPORT PSYCHOL, V21, P170, DOI 10.1123/tsp.21.2.170; Standring OJ, 2019, ACTA NEUROPATHOL, V138, P401, DOI 10.1007/s00401-019-02031-x; Szedlak C, 2020, INT SPORT COACH J, V7, P295, DOI 10.1123/iscj.2019-0059; Szedlak C, 2019, INT SPORT COACH J, V6, P199, DOI 10.1123/iscj.2018-0027; Thomas S., 2002, LISTENING PATIENTS P; Wadey R, 2019, SPORT PSYCHOL, V33, P244, DOI 10.1123/tsp.2018-0110; Whittaker AC, 2019, CURR OPIN BEHAV SCI, V28, P93, DOI 10.1016/j.cobeha.2019.02.002	36	0	0	0	0	NOVA SOUTHEASTERN UNIV	FORT LAUDERDALE-DAVIE	3301 COLLEGE AVE, FORT LAUDERDALE-DAVIE, FL 33314 USA	2160-3715			QUAL REP	Qual. Rep.	NOV	2021	26	11					3492	3518	10	10.46743/2160-3715/2021.4899			29	Social Sciences, Interdisciplinary	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	XG2GS	WOS:000724577200006		Green Submitted, gold, Green Accepted			2022-02-06	
J	Sorg, SF; Werhane, ML; Merritt, VC; Clark, AL; Holiday, KA; Hanson, KL; Jak, AJ; Schiehser, DM; Delano-Wood, L				Sorg, Scott F.; Werhane, Madeleine L.; Merritt, Victoria C.; Clark, Alexandra L.; Holiday, Kelsey A.; Hanson, Karen L.; Jak, Amy J.; Schiehser, Dawn M.; Delano-Wood, Lisa			Research Letter: PTSD Symptom Severity and Multiple Traumatic Brain Injuries Are Associated With Elevated Memory Complaints in Veterans With Histories of Mild TBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						memory; mild TBI; multiple TBI; PTSD; veterans	POSTCONCUSSION; PERSISTENT; OUTCOMES	Objective: The evaluation of memory complaints in mild traumatic brain injury (mTBI) remains an important clinical consideration, especially in the context of comorbid psychiatric symptoms such as posttraumatic stress disorder (PTSD). We compared subjective memory complaints in veterans with and without a history of mTBI, examined ratings between those with single versus multiple mTBIs, and investigated associations between memory complaints and PTSD symptom severity. Methods: 117 outpatient veterans (mTBI: n = 79 [single mTBI: n = 22, multiple mTBI: n = 57], military controls [MCs]: n = 38) completed a TBI history assessment, the Prospective-Retrospective Memory Questionnaire (PRMQ), and the PTSD Checklist-Military Version (PCL-M). Results: Hierarchical multiple regression showed that greater PCL-M scores significantly predicted elevated PRMQ-Total scores, accounting for 38% of the variance explained (P < .001). mTBI status predicted an additional 5% of variance in memory complaints (P < .01). The multiple-mTBI group endorsed more memory complaints than either MCs (P < .01) or the single-mTBI group (P < .05), who did not differ from MCs (P > .50). Conclusions: Comorbid PTSD symptoms are an important factor when considering memory complaints in veterans with a reported history of mTBI. However, independent of comorbid PTSD symptoms, mTBI status-particularly in the context of repetitive neurotrauma-uniquely contributes to memory complaints. Findings suggest that veterans with a history of multiple mTBIs may be a particularly vulnerable group in need of specialized interventions and/or psychoeducation.	[Sorg, Scott F.; Merritt, Victoria C.; Clark, Alexandra L.; Hanson, Karen L.; Jak, Amy J.; Schiehser, Dawn M.; Delano-Wood, Lisa] VA San Diego Healthcare Syst, Res & Psychol Serv, San Diego, CA 92161 USA; [Jak, Amy J.; Schiehser, Dawn M.; Delano-Wood, Lisa] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA; [Holiday, Kelsey A.] SDSU UC San Diego Joint Doctoral Program Clin Psy, San Diego, CA USA; [Sorg, Scott F.; Merritt, Victoria C.; Clark, Alexandra L.; Hanson, Karen L.; Jak, Amy J.; Schiehser, Dawn M.; Delano-Wood, Lisa] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Werhane, Madeleine L.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		Sorg, SF (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ssorg@ucsd.edu			Veterans AffairsUS Department of Veterans Affairs [CDA-2-034-07F, CDA-2-065-10S, IK2 CX001508]; Veterans Affairs Merit AwardUS Department of Veterans Affairs [CX000842-01A2]; Department of Defense Investigator-Initiated Research GrantUnited States Department of Defense [W81XWH-10-2-0169]; VA Clinical Science Research & Development Service [IK2 CX001952]	This work was supported by Veterans Affairs research grants including Career Development Awards to Drs Delano-Wood (CDA-2-034-07F), Schiehser (CDA-2-065-10S), and Sorg (IK2 CX001508), a Veterans Affairs Merit Award to Dr Delano-Wood (CX000842-01A2), as well as a Department of Defense Investigator-Initiated Research Grant awarded to Dr Delano-Wood (W81XWH-10-2-0169). This material is further supported by resources of the Veterans Affairs Center of Excellence for Stress andMentalHealth. DrMerritt received salary support during this work from a Career Development Award (IK2 CX001952) from the VA Clinical Science Research & Development Service. The authors sincerely thank the veterans who volunteered to participate in this study.	Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Donnelly K, 2018, CLIN NEUROPSYCHOL, V32, P436, DOI 10.1080/13854046.2017.1390163; Holiday KA, 2020, J CLIN EXP NEUROPSYC, V42, P556, DOI 10.1080/13803395.2020.1776847; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Merritt VC, 2020, ARCH CLIN NEUROPSYCH, V35, P491, DOI 10.1093/arclin/acaa006; Merritt VC, 2019, J CLIN EXP NEUROPSYC, V41, P665, DOI 10.1080/13803395.2019.1610161; Nijdam MJ, 2018, BRIT J CLIN PSYCHOL, V57, P436, DOI 10.1111/bjc.12183; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; The Management of Concussion-Mild Traumatic Brain Injury Working Group, 2016, VADOD CLIN PRACT GUI; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Weathers F.W., 1991, PTSD CHECKLIST MILIT	18	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2021	36	6			SI		418	423		10.1097/HTR.0000000000000659			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WV3QT	WOS:000717155100008	33656481				2022-02-06	
J	Soubh, AA; El-Gazar, AA; Mohamed, EA; Awad, AS; El-Abhar, HS				Soubh, Ayman A.; El-Gazar, Amira A.; Mohamed, Eman A.; Awad, Azza S.; El-Abhar, Hanan S.			Further insights for the role of Morin in mRTBI: Implication of non-canonical Wnt/PKC-alpha and JAK-2/STAT-3 signaling pathways	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Mild Repetitive traumatic brain injury; Non-canonical Wnt pathway; Wnt-1/PKC-alpha; JAK2/STAT3; GFAP; Morin	TRAUMATIC BRAIN-INJURY; PROTEIN-KINASE-C; ALZHEIMERS-DISEASE; GLYCOGEN-SYNTHASE; OXIDATIVE STRESS; NEURONAL DAMAGE; SERUM; MODEL; STAT3; MILD	The slightly available data about the pathogenesis process of mild repetitive traumatic brain injury (mRTBI) indicates to the necessity of further exploration of mRTBI consequences. Several cellular changes are believed to contribute to the cognitive disabilities, and neurodegenerative changes observed later in persons subjected to mRTBI. We investigated glial fibrillary acidic protein (GFAP), the important severity related biomarker, where it showed further increase after multiple trauma compared to single one. To authenticate our aim, Morin (10 mg/ kg loading dose, then twice daily 5 mg/kg for 7 days), MK-801 (1 mg/kg; i.p) and their combination were used. The results obtained has shown that all the chosen regimens opposed the upregulated dementia markers (A beta 1-40, p(Thr231)Tau) and inflammatory protein contents/expression of p(Ser53s6)NF-kappa Bp65, TNF-alpha, IL-6,and IL-1 beta and the elevated GFAP in immune stained cortex sections. Additionally, they exerted anti-apoptotic activity by decreasing caspase-3 activity and increasing Bcl-2 contents. Saving brain tissues was evident after these therapeutic agents via upregulating the non-canonical Wnt-1/PKC-alpha cue and IL-10/p(Tyr(1007/1008))JAK-2/p (Tyr705)STAT-3 signaling pathway to confirm enhancement of survival pathways on the molecular level. Such results were imitated by correcting the injury dependent deviated behavior, where Morin alone or in combination enhanced behavior outcome. On one side, our study refers to the implication of two survival signaling pathways; viz.,the non-canonical Wnt-1/PKC-alpha and p(Tyr(1007/1008))JAK-2/p(Tyr705)STAT-3 in single and repetitive mRTBI along with distorted dementia markers, inflammation and apoptotic process that finally disrupted behavior. On the other side, intervention through affecting all these targets by Morin alone or with MK-801 affords a promising neuroprotective effect.	[Soubh, Ayman A.] Ahram Canadian Univ, Fac Pharm, Dept Pharmacol & Toxicol, Giza, Egypt; [El-Gazar, Amira A.] October 6 Univ, Dept Pharmacol & Toxicol, Fac Pharm, Giza, Egypt; [Mohamed, Eman A.; Awad, Azza S.] Al Azhar Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt; [El-Abhar, Hanan S.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt		El-Abhar, HS (corresponding author), Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	Hanan.clabhar@pharma.cu.edu.eg		El-gazar, Amira/0000-0002-8372-4682			Ahmed MM, 2005, NEUROCHEM INT, V47, P248, DOI 10.1016/j.neuint.2005.04.025; Alam MP, 2018, ACS CHEM NEUROSCI, V9, P462, DOI 10.1021/acschemneuro.7b00350; Ali A.A., 2017, ALZHEIMERS DEMENTIA, V13, pP618; Alva-Sanchez C, 2014, ACTA NEUROBIOL EXP, V74, P111; Asiedu MN, 2011, J NEUROSCI, V31, P6646, DOI 10.1523/JNEUROSCI.6286-10.2011; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; BORNSCHEIN RL, 1980, TOXICOL APPL PHARM, V52, P29, DOI 10.1016/0041-008X(80)90244-6; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Chen K, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01417; Chiba T, 2009, MOL PSYCHIATR, V14, P206, DOI 10.1038/mp.2008.105; Chiba T, 2013, NEURODEGENER DIS; Chiba T, 2009, EXPERT OPIN THER TAR, V13, P1155, DOI 10.1517/14728220903213426; Choudhury A, 2017, INT J MED RES HEALTH, V6, P175; Cikriklar HI, 2016, TURK NEUROSURG, V26, P878, DOI 10.5137/1019-5149.JTN.13946-15.2; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; De Montigny A, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/261593; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dominique J.-F, 2012, P NATL ACAD SCI, V109, P8746; Durkin JP, 1996, J NEUROCHEM, V66, P951; El-Gazar AA, 2019, BRAIN RES, V1717, P104, DOI 10.1016/j.brainres.2019.04.003; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Fang H, 2019, CELL CYCLE, V18, P1001, DOI 10.1080/15384101.2019.1608128; Ferreira IL, 2012, CELL CALCIUM, V51, P95, DOI 10.1016/j.ceca.2011.11.008; Garofalo P, 1996, J PHARM PHARMACOL, V48, P1290, DOI 10.1111/j.2042-7158.1996.tb03938.x; Garrido JL, 2002, FASEB J, V16, P1982, DOI 10.1096/fj.02-0327fje; Goldstein LSB, 2012, PROG NEUROBIOL, V99, P186, DOI 10.1016/j.pneurobio.2012.03.006; Gong EJ, 2011, NEUROBIOL DIS, V44, P223, DOI 10.1016/j.nbd.2011.07.005; Gottlieb M, 2006, NEUROBIOL DIS, V23, P374, DOI 10.1016/j.nbd.2006.03.017; Grant DA, 2018, J NEUROTRAUM, V35, P94, DOI 10.1089/neu.2017.5042; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; Hassan MAM, 2020, BIOCHEM PHARMACOL, V180, DOI 10.1016/j.bcp.2020.114140; Hazafa A, 2021, LIFE SCI, V264, DOI 10.1016/j.lfs.2020.118679; Hermann DM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002886; Hixson KM, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6033-2; Inestrosa NC, 2007, IUBMB LIFE, V59, P316, DOI 10.1080/15216540701242490; Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Kapoor R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041663; Katsumoto A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00980; Kim JM, 2010, FREE RADICAL RES, V44, P454, DOI 10.3109/10715761003610737; Koistinaho J., 2011, INT J ALZHEIMERS DIS; Komiya Yuko, 2008, Organogenesis, V4, P68; Korulu S, 2013, EUR J NEUROSCI, V37, P1610, DOI 10.1111/ejn.12185; Lavoie L, 1999, J BIOL CHEM, V274, P28279, DOI 10.1074/jbc.274.40.28279; Lee KM, 2016, J NEUROSCI RES, V94, P865, DOI 10.1002/jnr.23764; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Liu S, 2018, INT J MOL MED, V42, P1379, DOI 10.3892/ijmm.2018.3743; Liu SJ, 2003, J NEUROCHEM, V87, P1333, DOI 10.1046/j.1471-4159.2003.02070.x; Lucke-Wold BP, 2015, J ALZHEIMERS DIS, V43, P711, DOI 10.3233/JAD-141422; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Maj Jerzy, 1992, Polish Journal of Pharmacology and Pharmacy, V44, P217; Marchetti B, 2013, TRENDS MOL MED, V19, P144, DOI 10.1016/j.molmed.2012.12.001; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Menet R, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.565667; Muscella A, 2015, BIOCHEM PHARMACOL, V98, P29, DOI 10.1016/j.bcp.2015.08.103; Ng L, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080826; Nicolas Celine S, 1800, JAKSTAT, V2, pe22925, DOI 10.4161/jkst.22925; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; Noelanders R, 2017, NEUROSCIENTIST, V23, P314, DOI 10.1177/1073858416667270; Noor H, 2012, PROTEIN SCI, V21, P373, DOI 10.1002/pro.2023; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; O'Callaghan JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102003; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Olonode ET, 2018, BASIC CLIN NEUROSCI, V9, P195, DOI 10.29252/NIRP.BCN.9.3.195; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Patton MS, 2017, NEUROPSYCHOPHARMACOL, V42, P1220, DOI 10.1038/npp.2016.236; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pozdnyakov DI, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55070386; Priya CS, 2019, INT IMMUNOPHARMACOL, V70, P396, DOI 10.1016/j.intimp.2019.02.053; Rehman SU, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070760; Rehman SU, 2019, MOL NEUROBIOL, V56, P2774, DOI 10.1007/s12035-018-1280-9; Robinson GW, 2007, DEV DYNAM, V236, P654, DOI 10.1002/dvdy.21058; Ruan W, 2020, NEUROCHEM INT, V134, DOI 10.1016/j.neuint.2019.104656; Saggu R, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0350-3; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Santos D, 2012, TOXICOLOGY, V292, P90, DOI 10.1016/j.tox.2011.11.017; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Shen YH, 2001, P NATL ACAD SCI USA, V98, P1543, DOI 10.1073/pnas.041588198; Song XQ, 2018, NATURE, V556, P515, DOI 10.1038/s41586-018-0039-9; Sonmez A, 2015, NEUROSCI LETT, V597, P137, DOI 10.1016/j.neulet.2015.05.001; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Sun MK, 2008, P NATL ACAD SCI USA, V105, P13620, DOI 10.1073/pnas.0805952105; Sun MK, 2014, PROG MOL BIOL TRANSL, V122, P31, DOI 10.1016/B978-0-12-420170-5.00002-7; Tremblay R, 2000, J NEUROSCI, V20, P7183; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang Y, 2019, NEURAL REGEN RES, V14, P1013, DOI 10.4103/1673-5374.250620; Wazea SA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23359-6; Wright DK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51267-w; Xu JG, 2014, BRAIN RES, V1582, P237, DOI 10.1016/j.brainres.2014.07.042; Zander NE, 2016, J NEUROSCI RES, V94, P827, DOI 10.1002/jnr.23786; Zhu Bao-Hua, 2005, Hepatobiliary Pancreat Dis Int, V4, P75	98	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	NOV	2021	100								108123	10.1016/j.intimp.2021.108123			12	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	WE4PJ	WOS:000705609300002	34560511				2022-02-06	
J	Spears, CA; Adil, SM; Kolls, BJ; Muhumza, ME; Haglund, MM; Fuller, AT; Dunn, TW				Spears, Charis A.; Adil, Syed M.; Kolls, Brad J.; Muhumza, Michael E.; Haglund, Michael M.; Fuller, Anthony T.; Dunn, Timothy W.			Surgical intervention and patient factors associated with poor outcomes in patients with traumatic brain injury at a tertiary care hospital in Uganda	JOURNAL OF NEUROSURGERY			English	Article						critical care outcomes; developing countries; global neurosurgery; survival analysis; surgical intervention; traumatic brain injury	SURVIVAL ANALYSIS; EPIDEMIOLOGY; COUNTRIES; MODERATE; FUTURE	OBJECTIVE The purpose of this study was to investigate whether neurosurgical intervention for traumatic brain injury (TBI) is associated with reduced risks of death and clinical deterioration in a low-income country with a relatively high neurosurgical capacity. The authors further aimed to assess whether the association between surgical intervention and acute poor outcomes differs according to TBI severity and various patient factors. METHODS Using TBI registry data collected from a national referral hospital in Uganda between July 2016 and April 2020, the authors performed Cox regression analyses of poor outcomes in admitted patients who did and did not undergo surgery for TBI, with surgery as a time-varying treatment variable. Patients were further stratified by TBI severity using the admission Glasgow Coma Scale (GCS) score: mild TBI (mTBI; GCS scores 13-15), moderate TBI (moTBI; GCS scores 9-12), and severe TBI (sTBI; GCS scores 3-8). Poor outcomes constituted Glasgow Outcome Scale scores 2-3, deterioration in TBI severity between admission and discharge (e.g., mTBI to sTBI), and death. Several clinical and demographic variables were included as covariates. Patients were observed for outcomes from admission through hospital day 10. RESULTS Of 1544 patients included in the cohort, 369 (24%) had undergone surgery. Rates of poor outcomes were 4% (n = 13) for surgical patients and 12% (n = 144) among nonsurgical patients (n = 1175). Surgery was associated with a 59% reduction in the hazard for a poor outcome (HR 0.41, 95% CI 0.23-0.72). Age, pupillary nonreactivity, fall injury, and TBI severity at admission were significant covariates. In models stratifying by TBI severity at admission, patients with mTBI had an 80% reduction in the hazard for a poor outcome with surgery (HR 0.20, 95% CI 0.04-0.90), whereas those with sTBI had a 65% reduction (HR 0.35, 95% CI 0.14-0.89). Patients with moTBI had a statistically nonsignificant 56% reduction in hazard (HR 0.44, 95% CI 0.17-1.17). CONCLUSIONS In this setting, the association between surgery and rates of poor outcomes varied with TBI severity and was influenced by several factors. Patients presenting with mTBI had the greatest reduction in the hazard for a poor outcome, followed by those presenting with sTBI. However, patients with moTBI had a nonsignificant reduction in the hazard, indicating greater variability in outcomes and underscoring the need for closer monitoring of this population. These results highlight the importance of accurate, timely clinical evaluation throughout a patient's admission and can inform decisions about whether and when to perform surgery for TBI when resources are limited.	[Spears, Charis A.; Adil, Syed M.; Kolls, Brad J.; Haglund, Michael M.; Fuller, Anthony T.; Dunn, Timothy W.] Duke Univ, Div Global Neurosurg & Neurol, Durham, NC USA; [Spears, Charis A.; Adil, Syed M.; Haglund, Michael M.; Fuller, Anthony T.] Dept Neurol, Durham, NC USA; [Kolls, Brad J.] Duke Univ, Sch Med, Durham, NC USA; [Muhumza, Michael E.] Mulago Hosp, Dept Neurosurg, Kampala, Uganda; [Haglund, Michael M.; Fuller, Anthony T.; Dunn, Timothy W.] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC USA; [Haglund, Michael M.; Fuller, Anthony T.] Duke Univ, Global Hlth Inst, Durham, NC USA; [Dunn, Timothy W.] Duke Univ, Sch Med, Duke Forge, Durham, NC USA; [Dunn, Timothy W.] Duke Univ, Dept Stat Sci, Durham, NC USA		Dunn, TW (corresponding author), Duke Univ, Durham, NC 27708 USA.	timothy.dunn@duke.edu			NuVasive; LifeNet	Dr. Haglund has received from NuVasive and LifeNet clinical or research support for the study described.	Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bull K, 1997, STAT MED, V16, P1041; Central Intelligence Agency, WORLD FACTB 2020; Clavijo A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00112; CROWLEY J, 1977, J AM STAT ASSOC, V72, P27, DOI 10.2307/2286902; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Djientcheu V, 2016, J NEUROL SCI, V371, P100, DOI 10.1016/j.jns.2016.10.016; Eaton J, 2017, WORLD NEUROSURG, V105, P257, DOI 10.1016/j.wneu.2017.05.153; Elahi C, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.7.FOCUS19316; Fuller Anthony, 2016, eNeurologicalSci, V3, P1, DOI 10.1016/j.ensci.2015.10.003; Haglund MM, 2017, NEUROSURGERY, V80, P656, DOI 10.1093/neuros/nyw159; Haglund MM, 2011, WORLD J SURG, V35, P1175, DOI 10.1007/s00268-011-1080-0; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; JENNETT B, 1975, LANCET, V1, P480; Karekezi C, 2020, NEUROSURG FOCUS, V48, DOI 10.3171/2019.12.FOCUS19853; KRIEGER D, 1993, CRIT CARE MED, V21, P1944, DOI 10.1097/00003246-199312000-00024; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Lund SB, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0269-5; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Purcell LN, 2020, WORLD NEUROSURG, V137, pE597, DOI 10.1016/j.wneu.2020.02.062; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Stel VS, 2011, NEPHRON CLIN PRACT, V119, pC255, DOI 10.1159/000328916; Stel VS, 2011, NEPHRON CLIN PRACT, V119, pC83, DOI 10.1159/000324758; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]	34	0	0	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2021	135	5					1569	1578		10.3171/2020.9.JNS201828			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WS1WU	WOS:000714980600001	33770754				2022-02-06	
J	Stelfa, G; Vavers, E; Svalbe, B; Serzants, R; Miteniece, A; Lauberte, L; Grinberga, S; Gukalova, B; Dambrova, M; Zvejniece, L				Stelfa, Gundega; Vavers, Edijs; Svalbe, Baiba; Serzants, Rinalds; Miteniece, Anna; Lauberte, Lasma; Grinberga, Solveiga; Gukalova, Baiba; Dambrova, Maija; Zvejniece, Liga			Reduced GFAP Expression in Bergmann Glial Cells in the Cerebellum of Sigma-1 Receptor Knockout Mice Determines the Neurobehavioral Outcomes after Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						sigma-1 receptor; traumatic brain injury; lateral fluid percussion injury; neurobehavior; cerebellum; astrocytes	NEURODEGENERATION; ASTROCYTES; NEUROINFLAMMATION; ACTIVATION; COGNITION; PROTECTS	Neuroprotective effects of Sigma-1 receptor (S1R) ligands have been observed in multiple animal models of neurodegenerative diseases. Traumatic brain injury (TBI)-related neurodegeneration can induce long-lasting physical, cognitive, and behavioral disabilities. The aim of our study was to evaluate the role of S1R in the development of neurological deficits after TBI. Adult male wild-type CD-1 (WT) and S1R knockout (S1R-/-) mice were subjected to lateral fluid percussion injury, and behavioral and histological outcomes were assessed for up to 12 months postinjury. Neurological deficits and motor coordination impairment were less pronounced in S1R-/- mice with TBI than in WT mice with TBI 24 h after injury. TBI-induced short-term memory impairments were present in WT but not S1R-/- mice 7 months after injury. Compared to WT animals, S1R-/- mice exhibited better motor coordination and less pronounced despair behavior for up to 12 months postinjury. TBI induced astrocyte activation in the cortex of WT but not S1R-/- mice. S1R-/- mice presented a significantly reduced GFAP expression in Bergmann glial cells in the molecular layer of the cerebellum compared to WT mice. Our findings suggest that S1R deficiency reduces TBI-induced motor coordination impairments by reducing GFAP expression in Bergmann glial cells in the cerebellum.	[Stelfa, Gundega; Vavers, Edijs; Svalbe, Baiba; Serzants, Rinalds; Miteniece, Anna; Lauberte, Lasma; Dambrova, Maija; Zvejniece, Liga] Latvian Inst Organ Synth, Lab Pharmaceut Pharmacol, Aizkraukles Str 21, LV-1006 Riga, Latvia; [Stelfa, Gundega] Latvia Univ Life Sci & Technol, Fac Vet Med, K Helmana Str 8, LV-3001 Jelgava, Latvia; [Serzants, Rinalds; Dambrova, Maija] Riga Stradins Univ, Dept Pharmaceut Chem, Dzirciema Str 16, LV-1007 Riga, Latvia; [Miteniece, Anna] Imperial Coll London, Dept Life Sci, Exhibit Rd, London SW7 2AZ, England; [Grinberga, Solveiga; Gukalova, Baiba] Latvian Inst Organ Synth, Lab Phys Organ Chem, Aizkraukles Str 21, LV-1006 Riga, Latvia		Stelfa, G (corresponding author), Latvian Inst Organ Synth, Lab Pharmaceut Pharmacol, Aizkraukles Str 21, LV-1006 Riga, Latvia.; Stelfa, G (corresponding author), Latvia Univ Life Sci & Technol, Fac Vet Med, K Helmana Str 8, LV-3001 Jelgava, Latvia.	gundega@farm.osi.lv; edijs.vavers@farm.osi.lv; baibas@farm.osi.lv; rinalds.serzants@farm.osi.lv; anna.miteniece18@imperial.ac.uk; lasma@farm.osi.lv; solveiga@osi.lv; baiba.gukalova@osi.lv; maija.dambrova@farm.osi.lv; liga@farm.osi.lv		Vavers, Edijs/0000-0003-1322-1307	EU-ERA-NET NEURON project [9642151]; European Unions Horizon 2020 research and innovation program [857394]	This study was supported by EU-ERA-NET NEURON project TRAINS No. 9642151 and the European Unions Horizon 2020 research and innovation program under grant agreement No. 857394.	Berkner J, 2016, METHODS MOL BIOL, V1462, P11, DOI 10.1007/978-1-4939-3816-2_2; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bravo-Caparros I, 2020, FASEB J, V34, P5951, DOI 10.1096/fj.201901921R; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Castany S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22217-9; Cerrato V, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030757; Cheng WH, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-018-0461-0; Chevallier N, 2011, J PSYCHOPHARMACOL, V25, P960, DOI 10.1177/0269881111400648; Cui W, 2001, GLIA, V34, P272, DOI 10.1002/glia.1061; Dong H, 2016, CELL MOL NEUROBIOL, V36, P639, DOI 10.1007/s10571-015-0244-0; Gaja-Capdevila N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22136956; Gawel K, 2019, N-S ARCH PHARMACOL, V392, P1, DOI 10.1007/s00210-018-1589-y; Hong J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.194; Jia J, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00314; Katnik C, 2014, NEUROBIOL DIS, V62, P354, DOI 10.1016/j.nbd.2013.10.011; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kupats E, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9364598; Langa F, 2003, EUR J NEUROSCI, V18, P2188, DOI 10.1046/j.1460-9568.2003.02950.x; Lattard A, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.614949; Nguyen L, 2015, J PHARMACOL SCI, V127, P17, DOI 10.1016/j.jphs.2014.12.005; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Maurice T, 2018, BEHAV BRAIN RES, V339, P1, DOI 10.1016/j.bbr.2017.11.010; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Moritz C, 2015, NEUROSCI LETT, V591, P13, DOI 10.1016/j.neulet.2015.02.004; Nardai S, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113245; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Nguyen L, 2017, ADV EXP MED BIOL, V964, P133, DOI 10.1007/978-3-319-50174-1_10; Nolte C, 2001, GLIA, V33, P72; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Rapoport M, 2000, J NEUROPSYCH CLIN N, V12, P193, DOI 10.1176/appi.neuropsych.12.2.193; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Roozenbeek Bob, 2012, Clin Investig (Lond), V2, P153; Rosa JM, 2021, BRIT J PHARMACOL, V178, P3395, DOI 10.1111/bph.15488; Ryskamp DA, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00862; Sanchez-Blazquez P, 2018, MOL NEUROBIOL, V55, P4940, DOI 10.1007/s12035-017-0697-x; Sasaki T, 2012, P NATL ACAD SCI USA, V109, P20720, DOI 10.1073/pnas.1213458109; Schetz JA, 2007, BRAIN RES, V1181, P1, DOI 10.1016/j.brainres.2007.08.068; Semple BD, 2019, NEUROBIOL DIS, V123, P27, DOI 10.1016/j.nbd.2018.07.018; Su T.P., 1994, SIGMA RECEPTORS CENT, P21; Tucker LB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00509; Tyszkiewicz C, 2021, LAB ANIM RES, V37, DOI 10.1186/s42826-021-00100-5; Vavers E, 2021, NEUROBIOL DIS, V150, DOI 10.1016/j.nbd.2020.105244; Vavers E, 2017, BEHAV BRAIN RES, V328, P13, DOI 10.1016/j.bbr.2017.04.008; Verollet Romain, 2008, Biotechniques, V44, P832, DOI 10.2144/000112893; Wang FS, 2012, P NATL ACAD SCI USA, V109, P7911, DOI 10.1073/pnas.1120380109; Wang XH, 2011, GLIA, V59, P857, DOI 10.1002/glia.21154; Wegleiter K, 2014, EXP NEUROL, V261, P501, DOI 10.1016/j.expneurol.2014.07.022; Weng TY, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4582135; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Zvejniece L, 2014, BRIT J PHARMACOL, V171, P761, DOI 10.1111/bph.12506; Zvejniece L, 2020, J NEUROTRAUM, V37, P295, DOI 10.1089/neu.2019.6524; Zvejniece L, 2011, BASIC CLIN PHARMACOL, V109, P407, DOI 10.1111/j.1742-7843.2011.00742.x	59	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	NOV	2021	22	21							11611	10.3390/ijms222111611			18	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	WZ5TZ	WOS:000720030600001	34769042	Green Published, gold			2022-02-06	
J	Stephenson, K; Womble, MN; Eagle, SR; Schatz, P; Gervase, T; Gustman, B; Castor, E; Kontos, AP; Elbin, RJ				Stephenson, Katie; Womble, Melissa N.; Eagle, Shawn R.; Schatz, Philip; Gervase, Tatiana; Gustman, Brett; Castor, Eric; Kontos, Anthony P.; Elbin, R. J.			Comparing Patient- and Clinician-Administered Near Point of Convergence After Concussion	JOURNAL OF SPORT REHABILITATION			English	Article						VOMS; vestibular; ocular		Objective: (1) To compare patient- and clinician-administered measurements of near point of convergence (NPC) distance including the percentage of patients exceeding clinical cutoffs among concussed adolescents and (2) to assess the reliability of patient- and clinician-measured NPC distances. Methods: A total of 762 patients (mean =15.51, SD = 3.09 y) within 30 days of concussion participated. The NPC distance was measured consecutively with the patient and clinician controlling the fixation target. The differences between patient (PT) and clinician (CLIN) measurements and cases exceeding cutoffs (ie, >_5 cm) were examined with a series of t tests and chi-square tests, respectively. Intraclass correlation coefficients and unbiased estimate of reliability were performed. Results: The NPC measurements were similar, t(761) = -.26, P = .79, between the PT (mean = 3.52, SD = 3.77 cm) and CLIN (mean = 3.54, SD = 3.97 cm) conditions. The number of measurements that exceeded cutoffs was similar among the PT (2.5%; 19/762) and CLIN conditions (3%; 23/762) (P = .10), and the number of measurements classified as abnormal/invalid was also similar among the PT (2.5%; 19/762) and CLIN conditions (3%; 23/762) (P = .10). There was excellent reliability between the methods (intraclass correlation coefficients = .85, unbiased estimate of reliability = .92). Conclusion: The findings support the application of this assessment in clinical settings where the clinician may not have direct contact with their patient and rely on the patient (eg, telehealth).	[Stephenson, Katie; Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA; [Womble, Melissa N.; Gervase, Tatiana; Gustman, Brett; Castor, Eric] Inova Sports Med Concuss Program, Fairfax, VA USA; [Eagle, Shawn R.; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA		Elbin, RJ (corresponding author), Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA.	rjelbin@uark.edu					Adler PM, 2007, OPHTHAL PHYSL OPT, V27, P22, DOI 10.1111/j.1475-1313.2006.00418.x; [Anonymous], 2017, NEAR POINT CONVERGEN; [Anonymous], 2011, NEAR POINT CONVERGEN; [Anonymous], 2016, SPORTS CONCUSSION EX; [Anonymous], 2015, VOMS VESTIBULAR OCUL; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Caze T II, 2020, JMIR PEDIAT PARENT, V3, DOI [10.2196/19924, DOI 10.2196/19924]; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Elbin R, 2021, J HEAD TRAUMA REHAB, DOI [10.1097/HTR.000000000, DOI 10.1097/HTR.000000000]; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Ernst N, 2020, J ATHL TRAINING, V55, P850, DOI 10.4085/1062-6050-431-19; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kutcher JS, 2013, BRIT J SPORT MED, V47, P299, DOI 10.1136/bjsports-2013-092257; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; Vargas BB, 2017, NEUROLOGY, V88, P1580, DOI 10.1212/WNL.0000000000003841	23	0	0	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	NOV	2021	30	8					1187	1190		10.1123/jsr.2021-0051			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	WM6MX	WOS:000711198600011	34552034				2022-02-06	
J	Stevens, LF; Ketchum, JM; Sander, AM; Callender, L; Dillahunt-Aspillaga, C; Dreer, LE; Finn, JA; Gary, KW; Graham, KM; Juengst, SB; Kajankova, M; Kolakowsky-Hayner, S; Lequerica, AH; Rabinowitz, AR				Stevens, Lillian Flores; Ketchum, Jessica M.; Sander, Angelle M.; Callender, Librada; Dillahunt-Aspillaga, Christina; Dreer, Laura E.; Finn, Jacob A.; Gary, Kelli W.; Graham, Kristin M.; Juengst, Shannon B.; Kajankova, Maria; Kolakowsky-Hayner, Stephanie; Lequerica, Anthony H.; Rabinowitz, Amanda R.			Race/Ethnicity and Community Participation Among Veterans and Service Members With Traumatic Brain Injury: A VA Traumatic Brain Injury Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	Annual Meeting of the American-Congress-of-Rehabilitation-Medicine	NOV, 2019	Chicago, IL	Amer Congress Rehabil Med		community participation; military personnel; racial disparities; traumatic brain injuries; veterans	EMPLOYMENT OUTCOMES; RACIAL-DIFFERENCES; MARITAL STABILITY; REHABILITATION; INDIVIDUALS; DISPARITIES; QUALITY; HEALTH; WORK; INTEGRATION	Objective: To examine racial/ethnic disparities in community participation among veterans and active duty service members with traumatic brain injury (TBI). Setting: Five Department of Veterans Affairs (VA) TBI Model Systems (TBIMS) Polytrauma Rehabilitation Centers (PRCs). Participants: Three hundred forty-two community-dwelling adults (251 White, 34 Black, and 57 Hispanic) with TBI enrolled in the VA TBIMS National Database who completed a 1-year follow-up interview. Mean age was 38.6 years (range, 19-84 years). Design: Cross-sectional analysis of a prospective observational cohort study. Main Measures: Community participation at 1 year postinjury assessed by 3 domains of the Participation Assessment with Recombined Tools-Objective (PART-O): Out & About, Productivity, and Social Relations. Results: Significant differences were observed among race/ethnicity groups in PART-O Productivity and Out & About domains without controlling for relevant participant characteristics; Productivity scores were significantly higher for non-Hispanic Black than for non-Hispanic White participants (t = 2.40, P = .0169). Out & About scores were significantly higher for Hispanic than for non-Hispanic White participants (t = 2.79, P = .0056). However, after controlling for demographic, injury severity, and 1-year follow-up characteristics, only differences in the Out & About domain remained statistically significant (t = 2.62, P = .0094), with scores being significantly higher for Hispanics than for non-Hispanic Whites. Conclusions: The results, which differ from findings from studies conducted in non-VA healthcare settings where there are greater racial/ethnic disparities in participation outcomes, could reflect differences between military and civilian samples that may reduce disparities.	[Stevens, Lillian Flores] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Stevens, Lillian Flores] Virginia Commonwealth Univ, Dept Phys Med, Richmond, VA USA; [Stevens, Lillian Flores] Hunter Holmes McGuire Vet Affairs Med Ctr, Def & Vet Brain Injury Ctr DVBIC, Richmond, VA USA; [Ketchum, Jessica M.] Craig Hosp, Res Dept, Englewood, CO USA; [Ketchum, Jessica M.; Dillahunt-Aspillaga, Christina] James A Haley Vet Hosp, Res Serv, Tampa, FL USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX USA; [Sander, Angelle M.] Baylor Coll Med, Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Herman, Brain Injury Res Ctr, Houston, TX USA; [Callender, Librada] Baylor Inst Rehabil, Baylor Res Inst, Dallas, TX USA; [Juengst, Shannon B.] UT Southwestern Med Ctr, Dept Phys Med & Rehabil, Dallas, TX USA; [Dillahunt-Aspillaga, Christina] Univ S Florida, Coll Family & Community Sci, Dept Child & Family Studies, Rehabil & Mental Hlth Counseling Program, Tampa, FL USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Phys Med, Birmingham, AL USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Rehabil, Birmingham, AL USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Visual Sci, Birmingham, AL USA; [Finn, Jacob A.] Univ Minnesota Twin Cities, Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN USA; [Finn, Jacob A.] Univ Minnesota Twin Cities, Dept Psychiat, Minneapolis, MN USA; [Gary, Kelli W.] Virginia Commonwealth Univ, Dept Rehabil Counseling, Richmond, VA USA; [Kajankova, Maria; Kolakowsky-Hayner, Stephanie] Icahn Sch Med Mount Sinai, Dept Rehabil & Human Performance, New York, NY USA; [Lequerica, Anthony H.] Kessler Fdn, E Hanover, NJ USA; [Lequerica, Anthony H.] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Rabinowitz, Amanda R.] Moss Rehabil Res Inst, Elkins, PA USA		Sander, AM (corresponding author), TIRR Mem Hermann Res Ctr, 1333 Moursund St, Houston, TX 77030 USA.	lillianfstevens221@yahoo.com; kketchum@craighospital.org; asander@bcm.tmc.edu; Librada.Callender@bswhealth.org; cdillahuntas@usf.edu; dreer@uab.edu; jacob.finn@va.gov; williamsjonk@vcu.edu; kristin.graham@vcuhealth.org; shannon.juengst@utsouthwestern.edu; maria.kajankova@mountsinai.org; momof1plus4@yahoo.com; alequerica@kesslerfoundation.org; rabinowa@einstein.edu			Department of Veterans Affairs (National Institute on Disability, Independent Living, and Rehabilitation Research [NIDILRR])US Department of Veterans Affairs; Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research [NIDILRR]); VHA Central Office VA TBIModel Systems Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center within the Defense Health Agency [W91YTZ-13-C-0015, HT001419-C-0004]; Defense and Veterans Brain Injury Center VA contract [VA119A-16-C-0083]; NIDILRRUnited States Department of Health & Human Services [90DPTB0016, 90DP0044, 90DPTB0009-01-00, 90DP0044-01-00, 90DP00303, 90DBPT0004, 90DPTB0013-01-00]	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model Systems collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research [NIDILRR]). This research is sponsored by VHA Central Office VA TBIModel Systems Program of Research, and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015; HT001419-C-0004) from the Defense and Veterans Brain Injury Center within the Defense Health Agency, and from the Defense and Veterans Brain Injury Center VA contract no. VA119A-16-C-0083 for Ketchum and DillahuntAspillaga.; The contents of this publication were developed under grants from NIDILRR (grant nos. 90DPTB0016 [PIs: Sherer and Sander], 90DP0044 [PI: Novack], 90DPTB0009-01-00 [PI: Dams-O'Connor]; 90DP0044-01-00 [PI: Novak]; 90DP00303 [PI: Kreutzer]; 90DBPT0004 [PI: Rabinowitz]; and 90DPTB0013-01-00 [PI: Driver]).	Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Bailey EK, 2017, J HEAD TRAUMA REHAB, V32, P245, DOI 10.1097/HTR.0000000000000317; Bogner J, 2013, J HEAD TRAUMA REHAB, V28, P337, DOI 10.1097/HTR.0b013e31829af969; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Boschen K, 2007, NEUROREHABILITATION, V22, P19; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Centers for Disease Control and Prevention, 1998, REPORT; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; Dismuke CE, 2016, GLOB J HLTH SCI, V8, P260; Dismuke CE, 2015, AM J PUBLIC HEALTH, V105, P1696, DOI 10.2105/AJPH.2014.302545; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Egede LE, 2012, AM J PUBLIC HEALTH, V102, pS266, DOI 10.2105/AJPH.2011.300176; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, P257, DOI 10.1097/HTR.0000000000000383; Gary KW, 2010, J VOCAT REHABIL, V33, P65, DOI 10.3233/JVR-2010-0516; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Hosmer DW, 2013, WILEY SER PROBAB ST, P153; Jamison L, 2012, BRAIN INJURY, V26, P805, DOI 10.3109/02699052.2012.655367; Jourdan C, 2017, J HEAD TRAUMA REHAB, V32, pE26, DOI 10.1097/HTR.0000000000000276; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Mascialino G, 2009, NEUROREHABILITATION, V24, P29, DOI 10.3233/NRE-2009-0451; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nakase-Richardson R, 2017, J HEAD TRAUMA REHAB, V32, P221, DOI 10.1097/HTR.0000000000000334; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Steiger JH, 2004, PSYCHOL METHODS, V9, P164, DOI 10.1037/1082-989X.9.2.164; Stevens LF, 2017, J HEAD TRAUMA REHAB, V32, P234, DOI 10.1097/HTR.0000000000000324; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Trivedi AN, 2011, HEALTH AFFAIR, V30, P707, DOI 10.1377/hlthaff.2011.0074; Uniform Data System for Medical Rehabilitation, 1997, GUID UN DAT SYST MED; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Washington DL, 2005, AM J PUBLIC HEALTH, V95, P2231, DOI 10.2105/AJPH.2004.043570; Wen PS, 2018, ARCH PHYS MED REHAB, V99, pS86, DOI 10.1016/j.apmr.2017.04.026; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P540, DOI 10.1016/j.apmr.2010.12.002; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	56	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2021	36	6			SI		408	417		10.1097/HTR.0000000000000657			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	WV3QT	WOS:000717155100007	33656479				2022-02-06	
J	Stopa, BM; Tahir, Z; Mezzalira, E; Boaro, A; Khawaja, A; Grashow, R; Zafonte, RD; Smith, TR; Gormley, WB; Izzy, S				Stopa, Brittany M.; Tahir, Zabreen; Mezzalira, Elisabetta; Boaro, Alessandro; Khawaja, Ayaz; Grashow, Rachel; Zafonte, Ross D.; Smith, Timothy R.; Gormley, William B.; Izzy, Saef			The Impact of Age and Severity on Dementia After Traumatic Brain Injury: A Comparison Study	NEUROSURGERY			English	Article						Dementia; Non-TBI orthopedic trauma; TBI; Traumatic brain injury	ALZHEIMERS-DISEASE; RISK-FACTOR; SCALE; LIFE; REHABILITATION; MORTALITY; OUTCOMES; STROKE; MEN	BACKGROUND. Growing evidence associates traumatic brain injury (TBI) with increased risk of dementia, but few studies have evaluated associations in patients younger than 55 yr using non-TBI orthopedic trauma (NTOT) patients as controls to investigate the influence of age and TBI severity, and to identify predictors of dementia after trauma. OBJECTIVE. To investigate the relationship between TBI and dementia in an institutional group. METHODS. Retrospective cohort study (2000-2018) of TBI patients aged 45 to 100 yr vs NTOT controls. Primary outcome was dementia after TBI (followed <= 10 yr). Cox proportional hazards models were used to assess risk of dementia; logistic regression models assessed predictors of dementia. RESULTS. Among 24 846 patients, TBI patients developed dementia (7.5% vs 4.6%) at a younger age (78.6 vs 82.7 yr) and demonstrated higher 10-yr mortality than controls (27% vs 14%; P < .001). Mild TBI patients had higher incidence of dementia (9%) than moderate/severe TBI (5.4%), with lower 10-yr mortality (20% vs 31%; P < .001). Risk of dementia was significant in all mild TBI age groups, even 45 to 54 yr (hazard ratio 4.1, 95% CI 2.7-7.8). A total of 10-yr cumulative incidence was higher in mild TBI (14.4%) than moderate/severe TBI (11.3%) and controls (6.8%) (P < .001). Predictors of dementia include TBI, sex, age, hypertension, hyperlipidemia, stroke, depression, anxiety, and Injury Severity Score. CONCLUSION. Mild and moderate/severe TBI patients experienced higher incidence of dementia, even in the youngest group (45-54 yr old), than NTOT controls. All TBI patients, especially middle-aged adults with minor injury who are more likely to be overlooked, should be monitored for dementia.	[Stopa, Brittany M.] Brigham & Womens Hosp, Computat Neurosci Outcomes Ctr Harvard, 75 Francis St, Boston, MA 02115 USA; [Stopa, Brittany M.; Mezzalira, Elisabetta; Boaro, Alessandro; Smith, Timothy R.; Gormley, William B.] Virginia Tech Carillon Sch Med, Roanoke, VA USA; [Tahir, Zabreen; Khawaja, Ayaz; Izzy, Saef] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Mezzalira, Elisabetta] Univ Verona, Dept Diagnost & Publ Hlth, Verona, Italy; [Boaro, Alessandro] Univ Verona, Dept Neurosci Biomed & Movement Sci, Inst Neurosurg, Verona, Italy; [Khawaja, Ayaz] Wayne State Univ, Dept Neurol, Detroit, MI USA; [Grashow, Rachel] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Grashow, Rachel; Zafonte, Ross D.] Harvard Univ, Harvard Med Sch, Football Players Hlth Study, Boston, MA 02115 USA; [Zafonte, Ross D.] Harvard Med Sch, Massachusetts Gen Hosp, Brigham & Womens Hosp, Dept Phys Med & Rehabil,Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Smith, Timothy R.; Gormley, William B.] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA; [Smith, Timothy R.; Gormley, William B.; Izzy, Saef] Harvard Med Sch, Boston, MA 02115 USA		Izzy, S (corresponding author), Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.	sizzy@partners.org	Boaro, Alessandro/AAA-1231-2022	Boaro, Alessandro/0000-0002-0856-1019			Almeida OP, 2015, INT J GERIATR PSYCH, V30, P1215, DOI 10.1002/gps.4276; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Beam CR, 2018, J ALZHEIMERS DIS, V64, P1077, DOI [10.3233/JAD-180141, 10.3233/jad-180141]; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; Carroll Christopher P, 2010, Ann Adv Automot Med, V54, P233; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Coburn K, 1992, AACN Clin Issues Crit Care Nurs, V3, P9; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Desmond DW, 2002, STROKE, V33, P2254, DOI 10.1161/01.STR.0000028235.91778.95; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Faraco G, 2013, HYPERTENSION, V62, P810, DOI 10.1161/HYPERTENSIONAHA.113.01063; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gennarelli TA., 2008, ABBREVIATED INJURY S; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Greene NH, 2015, INJURY PREV, V21, P325, DOI 10.1136/injuryprev-2014-041524; Gulpers B, 2016, AM J GERIAT PSYCHIAT, V24, P823, DOI 10.1016/j.jagp.2016.05.015; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Helmes E, 2011, BRAIN INJURY, V25, P338, DOI 10.3109/02699052.2011.556104; Hifumi T, 2016, J NEUROTRAUM, V33, P1047, DOI 10.1089/neu.2015.4033; Izzy S, 2021, J NEUROTRAUM, V38, P1834, DOI 10.1089/neu.2020.7484; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johnson VE, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2014.241; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; LoBue C, 2018, NEUROPSYCHOLOGY, V32, P401, DOI 10.1037/neu0000431; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Raj R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002316; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Strauss D, 2004, NEUROREHABILITATION, V19, P257; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Turgeon AF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013779; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X	44	0	0	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	NOV	2021	89	5					810	818		10.1093/neuros/nyab297			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	XL8HZ	WOS:000728383600026	34392366				2022-02-06	
J	Prieto, DWS; Fuentes, NG; Pereza, LAR; Garcia, LMR; Cardenas, JC				Suarez Prieto, David Wilfredo; Ghaddar Fuentes, Nabil; Rodriguez Pereza, Leyla Aurora; Rodriguez Garcia, Liz Marlyn; Cespedes Cardenas, Jarvin			Cerebral hemodynamic patterns in patients with head trauma and their relationship with mortality	MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS			Spanish	Article						brain injuries; traumatic; Glasgow coma scale; mortality	TRANSCRANIAL DOPPLER; FLOW VELOCITY; BLOOD-FLOW; INJURY	Background: mortality from severe head trauma is high and is due to the intracranial hemodynamic disorders that it causes. Objective: to determine the patterns of cerebral blood flow in the patient with head trauma and its relationship with mortality. Methods: descriptive, cross-sectional study carried out in the Arnaldo Milian Castro Clinical-Surgical Hospital Serious Care Units, Santa Clara, Villa Clara province, from 2004 to 2007 and from 2018 to 2020. The transcranial Doppler ultrasound was performed in 82 patients, in the first 24 hours after admission, after hemodynamic and respiratory stability. The Glasgow coma scale variables, cerebral blood flow patterns and mortality were determined. The information was processed using the statistical program SPSS / PC version 15 for Windows, statistical processing with univariate analysis was applied. Results: 82 patients were studied, with mortality of 37.8% of the total; the highest fatality occurred among patients older than 65 years (60%) (p = 0.01). The Glasgow coma scale of 8 or less points included 67 patients, with a mortality of 43% (p = 0.00). The cerebral ischemic pattern was the most diagnosed (43.9%) with a mortality of 74% (p = 0.03). Conclusions: the ischemic blood flow pattern is the most frequent and has a significant relationship with mortality. The Glasgow coma scale has a significant relationship with the mortality of patients with head trauma.	[Suarez Prieto, David Wilfredo; Ghaddar Fuentes, Nabil; Rodriguez Pereza, Leyla Aurora; Rodriguez Garcia, Liz Marlyn; Cespedes Cardenas, Jarvin] Hosp Clin Quirurg Arnaldo Milian Castro, Santa Clara, Villa Clara, Cuba		Prieto, DWS (corresponding author), Hosp Clin Quirurg Arnaldo Milian Castro, Santa Clara, Villa Clara, Cuba.	davidwsp@infomed.sld.cu					AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Alyssa Geslenny BN, 2019, REV CIENTIFICA MUNDO, V3; Bouzat P, 2011, NEUROSURGERY, V68, P1603, DOI 10.1227/NEU.0b013e31820cd43e; Chacon-Lozsan F, 2018, ACTA COLOMB CUID INT, V1, DOI [10.1016/j.acci.2018.01, DOI 10.1016/J.ACCI.2018.01]; Chesnut R., 2000, J NEUROTRAUM, V17, P557; D'Andrea A, 2016, J CARDIOVASC ECHOGR, V26, P28, DOI 10.4103/2211-4122.183746; Deines JJ, 2019, J NEUROTRAUM, V36, P135, DOI 10.1089/neu.2017.5577; Dijkla SA, 2020, J NEUROTRAUM, V38; Fatima Nida, 2019, Asian J Neurosurg, V14, P626, DOI 10.4103/ajns.AJNS_42_19; Gao GY, 2020, LANCET NEUROL, V19, P670, DOI 10.1016/S1474-4422(20)30182-4; Giner J, 2019, NEUROLOGIA REV; Herrera Martinez MP, 2018, REV CUBANA MED INTEN, V17; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Ojha BK, 2005, SURG NEUROL, V64, P174, DOI 10.1016/j.surneu.2004.11.030; Prasad BK, 2017, MED SURG RADIOL, V2, P139; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Shafe M, 2004, ACAD EMERG MED, V11, P774, DOI 10.1197/j.aem.2004.02.518; SORTEBERG W, 1989, ACTA NEUROCHIR, V97, P47, DOI 10.1007/BF01577739; SORTEBERG W, 1990, J ULTRAS MED, V9, P403; TEASDALE G, 1974, LANCET, V2, P81; Trabold F, 2004, INTENS CARE MED, V30, P108, DOI 10.1007/s00134-003-2057-8; Zaytoun T, 2017, JMSCR, V5; Ziegler D, 2017, J NEUROTRAUM, V34, P121, DOI 10.1089/neu.2015.3967	24	0	0	0	0	CENTRO PROVINCIAL INFORMACION CIENCIAS MEDICAS CINFUEGOS	CINFUEGOS	CALLE 51 A & AVENIDA 5 SEPTIEMBRE, CINFUEGOS, 55100, CUBA	1727-897X			MEDISUR-REV CIENC ME	Medisur-Rev. Cienc. Med. Cienfuegos	NOV-DEC	2021	19	6					937	947					11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	XO7TO	WOS:000730383400006					2022-02-06	
J	Sullivan, KA				Sullivan, Karen A.			Can Adults Recognize Concussion Symptoms? A Critical Review of Empirical Research Using the Rosenbaum Concussion Knowledge and Attitudes Survey	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						traumatic brain injury; head injury; concussion; sports-related injury; postconcussion symptoms; public education; injury prevention; RoCKAS	TRAUMATIC BRAIN-INJURY; PLAYERS	Objective: The correct identification of concussion symptoms is vital for mild traumatic brain injury recognition, diagnosis, and injury management. Numerous surveys of symptom recognition have been conducted, including with athletes at-risk for injury. This critical, methodologically focused review aimed to: (1) discover which concussion symptoms are recognized, and (2) provide recommendations for future research. Data Sources: A quasi-systematic literature search was conducted to identify studies that used the Rosenbaum Concussion Knowledge and Attitudes Survey. Study Selection: Eighty-five publications were identified, 8 of which were retained after screening. Data Extraction: The identification of individual concussion symptoms was coded as good (a correct response by >90% of the sample), moderate (a correct response by 75%-90% of the sample), or poor (a correct response by <75% of the sample). Data Synthesis: The pooled data comprised responses from more than 2000 individuals, most of whom were male, young adult, sport players. Overall, there was good recognition of 3 concussion symptoms (headaches, dizziness, and confusion), poor recognition of sleep disturbances, nausea, and loss of consciousness, and misattribution to concussion of 2 distractor symptoms (weakness of neck range of motion, difficulty speaking). The methodological evaluation revealed significant variability in symptom measurement. Conclusions: The identified trends for concussion symptom recognition must be regarded as tentative because of the significant methodological variation in the reviewed studies. This variability affected the number, wording, and classification of items, and it restricted the data synthesis. This problem must be addressed in future research and recommendations are provided.	[Sullivan, Karen A.] Queensland Univ Technol, Sch Psychol & Counselling, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia		Sullivan, KA (corresponding author), Queensland Univ Technol, Sch Psychol & Counselling, O Block B Wing,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au					Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Castriotta R.J., 2015, SLEEP MED COMPREHENS, P319; Chapman EB, 2018, CLIN J SPORT MED, V28, P117, DOI 10.1097/JSM.0000000000000421; Crawford MA, 2007, J INT NEUROPSYCH SOC, V13, P178, DOI 10.1017/S135561770707021X; Cusimano MD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00872; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; Gourley MM., 2010, ATHL TRAIN SPORTS HL, V25, P208; Graff HJ, 2018, DISABIL REHABIL, V40, P926, DOI 10.1080/09638288.2017.1280542; Howell DR, 2020, CLIN J SPORT MED, V30, pS42, DOI 10.1097/JSM.0000000000000570; Hurst HT., 2019, J SCI CYCLING, V8, P11; Hutchinson S, 2019, INT J SPORTS SCI COA, V14, P153, DOI 10.1177/1747954119826515; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jorgensen M, 2018, INT J SPORTS SCI COA, V13, P1134, DOI 10.1177/1747954118778771; Kraak W J, 2018, SA J. Sports Med., V30, P1, DOI 10.17159/2078-516x/2018/v30i1a4404; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Lystad Reidar P, 2018, Inj Epidemiol, V5, P25, DOI 10.1186/s40621-018-0155-x; Maraisc I, 2016, SPORT J, P1; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; Murphy KJ., 2015, WHAT SECONDARY SCH R; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Saunders EA, 2013, ATHLETIC TRAINING SP, V5, P11, DOI DOI 10.3928/19425864-20121217-02; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Sullivan L., 2017, INT J ADOLES MENT HL, V29; Tsao J., 2014, ATHLETIC INSIGHT, V6, P93; Viljoen C T, 2017, SA J. Sports Med., V29, P1, DOI 10.17159/2078-516x/2017/v29i0a1942; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Waltzman Dana, 2018, J Concussion, V2, P1, DOI 10.1177/2059700218769218; Williams JM, 2016, J SPORT HEALTH SCI, V5, P197, DOI 10.1016/j.jshs.2015.01.009	32	0	0	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2021	31	6					509	515		10.1097/JSM.0000000000000843			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WM5NJ	WOS:000711131700040	34009792				2022-02-06	
J	Sy, E; Amram, O; Baer, HJ; Hameed, SM; Griesdale, DEG				Sy, Eric; Amram, Ofer; Baer, Heather J.; Hameed, S. Morad; Griesdale, Donald E. G.			Transport Time and Mortality in Critically Ill Patients with Severe Traumatic Brain Injury	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Transportation time; Trauma; Pre-hospital care; Pre-hospital transportation; Critical care; Intensive care unit; Mortality	SEVERE HEAD-INJURY; GOLDEN HOUR; HELICOPTER TRANSPORT; LEVEL I; SURVIVAL; EPIDEMIOLOGY; CARE; IMPACT; GUIDELINES; MODERATE	Purpose: Severe traumatic brain injury (TBI) is a major cause of morbidity and mortality in critically ill patients. Pre-hospital care and transportation time may impact their outcomes. Methods: Using the British Columbia Trauma Registry, we included 2,860 adult (>= 18 years) patients with severe TBI (abbreviated injury scale head score >= 4), who were admitted to an intensive care unit (ICU) in a centre with neurosurgical services from January 1, 2000 to March 31, 2013. We evaluated the impact of transportation time (time of injury to time of arrival at a neurosurgical trauma centre) on in-hospital mortality and discharge disposition, adjusting for age, sex, year of injury, injury severity score (ISS), revised trauma score at the scene, location of injury, socio-economic status and direct versus indirect transfer. Results: Patients had a median age of 43 years (interquartile range [IQR] 26-59) and 676 (23.6%) were female. They had a median ISS of 33 (IQR 26-43). Median transportation time was 80 minutes (IQR 40-315). ICU and hospital length of stay were 6 days (IQR 2-12) and 20 days (IQR 7-42), respectively. Six hundred and ninety-six (24.3%) patients died in hospital. After adjustment, there was no significant impact of transportation time on in-hospital mortality (odds ratio 0.98, 95% confidence interval 0.95-1.01). There was also no significant effect on discharge disposition. Conclusions: No association was found between pre-hospital transportation time and in-hospital mortality in critically ill patients with severe TBI.	[Sy, Eric] Regina Gen Hosp, Dept Crit Care, Regina, SK, Canada; [Sy, Eric] Univ Saskatchewan, Coll Med, Saskatoon, SK, Canada; [Sy, Eric; Baer, Heather J.] Harvard Sch Publ Hlth, Boston, MA USA; [Amram, Ofer] Washington State Univ, Dept Nutr & Exercise Physiol, Elson S Floyd Sch Med, Spokane, WA USA; [Amram, Ofer] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Baer, Heather J.] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [Baer, Heather J.] Harvard Med Sch, Boston, MA 02115 USA; [Hameed, S. Morad; Griesdale, Donald E. G.] Univ British Columbia, Vancouver Gen Hosp, Div Crit Care Med, Dept Med, Vancouver, BC, Canada		Sy, E (corresponding author), Regina Gen Hosp, Dept Crit Care, Surg Intens Care Unit, 1440-14th Ave, Regina, SK S4P 0W5, Canada.	eric.julian.sy@gmail.com			Michael Smith Foundation for health researchMichael Smith Foundation for Health Research	DEGG is supported through a Heath-Professional Investigator Award through the Michael Smith Foundation for health research.	Amram O, 2015, INT J ENV RES PUB HE, V12, P15594, DOI 10.3390/ijerph121215009; [Anonymous], CCI Coding Structure; [Anonymous], 2016, POP CTR RUR AR CLASS; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Bekelis K, 2015, ANN SURG, V261, P579, DOI 10.1097/SLA.0000000000000672; Bell N, 2012, CAN J PUBLIC HEALTH, V103, pS28, DOI 10.1007/BF03403826; Brorsson C, 2011, ACTA ANAESTH SCAND, V55, P944, DOI 10.1111/j.1399-6576.2011.02451.x; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Carroll Christopher P, 2010, Ann Adv Automot Med, V54, P233; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; Cowley R A, 1975, Md State Med J, V24, P37; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Daban J-L., 2014, SOINS, V59, P14, DOI [10.1016/j.soin.2014.06.005, DOI 10.1016/J.SOIN.2014.06.005]; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fleet R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028512; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Fuller G, 2014, PREHOSP EMERG CARE, V18, P60, DOI 10.3109/10903127.2013.831507; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Gravesteijn BY, 2020, BRIT J ANAESTH, V125, P505, DOI 10.1016/j.bja.2020.05.067; Hameed SM, 2010, J TRAUMA, V69, P1350, DOI 10.1097/TA.0b013e3181e751f7; Hammell CL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1683; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Jordan J, 2020, CRIT CARE MED, V48; Kuenzler M., 2015, EMERG MED OPEN ACCES, V05, P1; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; Linn S, 2007, ANN EPIDEMIOL, V17, P142, DOI 10.1016/j.annepidem.2006.08.004; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Missios S, 2014, J NEUROTRAUM, V31, P1321, DOI 10.1089/neu.2014.3325; Moore L, 2017, JAMA SURG, V152, P168, DOI 10.1001/jamasurg.2016.4212; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Newgard CD, 2017, JAMA SURG, V152, P11, DOI 10.1001/jamasurg.2016.3329; Newgard CD, 2015, ANN EMERG MED, V66, P30, DOI 10.1016/j.annemergmed.2014.12.004; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; Provincial Health Services Authority, 2020, CRIT CAR PROGR; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Rogers FB, 2015, INJURY, V46, P525, DOI 10.1016/j.injury.2014.08.043; Rogers S, 2017, J NURSING ED PRACTIC, V7, P23, DOI [10.5430/jnep. v7n11p23, DOI 10.5430/JNEP.V7N11P23]; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; SAMPALIS JS, 1993, J TRAUMA, V34, P252, DOI 10.1097/00005373-199302000-00014; Schuurman N, 2008, CAN J SURG, V51, P389; Schuurman N, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-6; Shackelford SA, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.9.FOCUS18404; Shatney CH, 2002, J TRAUMA, V53, P817, DOI 10.1097/00005373-200211000-00002; Simons R, 2002, CAN J SURG, V45, P288; Simons R, 2010, J TRAUMA, V69, P11, DOI 10.1097/TA.0b013e3181e17b39; Stonko DP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207766; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Tansley G, 2019, CAN J SURG, V62, P123, DOI 10.1503/cjs.004218; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Wahlin RR, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00194; Zhu TH, 2018, ACAD EMERG MED, V25, P44, DOI 10.1111/acem.13307; Zimmerman JE, 2013, CRIT CARE, V17, DOI 10.1186/cc12695	59	0	0	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	NOV	2021	48	6					817	825	PII S0317167121000056	10.1017/cjn.2021.5			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB4QP	WOS:000721315600013	33431101				2022-02-06	
J	To, MS; Di Ubaldo, LJ; Wells, AJ; Jukes, A				To, Minh-Son; Di Ubaldo, Lucas J.; Wells, Adam J.; Jukes, Alistair			Absence of small study effects in neurosurgical meta-analyses: A meta-epidemiological study	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Meta-analysis; Publication bias; Epidemiology	TRAUMATIC BRAIN-INJURY; PUBLICATION BIAS; OUTCOMES; FUSION	Background: Small studies are prone to lower methodological quality and publication bias, and are more likely to report greater beneficial effects. A meta-epidemiological study was undertaken to investigate and quantify the impact of small study effects on meta-analyses in the neurosurgical literature. Methods: A PubMed search was used to procure meta-analyses from Journal of Neurosurgery, Neurosurgery, Spine, Acta Neurochirurgica and Journal of Neurotrauma. Outcome data were extracted from meta-analyses the effect of study size was estimated by calculating the ratio of odds ratios (RORs) between small and large studies. Results: 16 meta-analyses of 229 primary studies and 90,629 patients were included. All but two included pooled outcomes were significantly different from 1. On average small studies did not demonstrate greater beneficial effects, with an estimated pooled ROR of 1.32 (95% CI, 0.89 to 1.75). Stratification by meta-analysis effect size and heterogeneity yielded similar findings. Conclusions: The absence of small study effects in meta-analyses of neurosurgical studies may reflect widespread poor quality of the neurosurgical literature affecting both large and small studies, rather than an absence of publication bias. (c) 2021 Elsevier Ltd. All rights reserved.	[To, Minh-Son; Di Ubaldo, Lucas J.] Flinders Univ S Australia, Coll Med & Publ Hlth, Bedford Pk, SA, Australia; [To, Minh-Son] Flinders Med Ctr, Div Surg & Perioperat Med, Bedford Dr, Bedford Pk, SA 5042, Australia; [Wells, Adam J.] Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA, Australia; [Wells, Adam J.] Royal Adelaide Hosp, Dept Neurosurg D, Adelaide, SA, Australia; [Jukes, Alistair] Royal Prince Alfred Hosp, Dept Neurosurg, Camperdown, NSW, Australia		To, MS (corresponding author), Flinders Med Ctr, Div Surg & Perioperat Med, Bedford Dr, Bedford Pk, SA 5042, Australia.	minh-son.to@sa.gov.au					Bakker NA, RECURRENCE RATES SUR; Chavalarias D, 2016, JAMA-J AM MED ASSOC, V315, P1141, DOI 10.1001/jama.2016.1952; Gaberel T, 2012, ACTA NEUROCHIR, V154, P1, DOI 10.1007/s00701-011-1179-y; Golder S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001026; Goldstein CL, 2016, J NEUROSURG-SPINE, V24, P416, DOI 10.3171/2015.2.SPINE14973; Khan NR, 2016, J NEUROSURG-SPINE, V25, P383, DOI 10.3171/2016.1.SPINE151199; Khan NR, 2015, NEUROSURGERY, V77, P847, DOI 10.1227/NEU.0000000000000913; Khan NR, 2014, J NEUROSURG-SPINE, V21, P974, DOI 10.3171/2014.8.SPINE1445; Klimo P, 2011, J NEUROSURG-PEDIATR, V8, P600, DOI 10.3171/2011.8.PEDS11346; Madhugiri VS, 2013, J NEUROSURG, V119, P1274, DOI 10.3171/2013.8.JNS122379; Mansouri A, 2016, J NEUROSURG, V124, P558, DOI 10.3171/2014.12.JNS142465; Martin E, 2019, ACTA NEUROCHIR, V161, P627, DOI 10.1007/s00701-019-03849-w; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Olah E, 2018, J NEUROTRAUM, V35, P2407, DOI 10.1089/neu.2018.5649; Oliver JD, 2018, SPINE, V43, pE413, DOI 10.1097/BRS.0000000000002441; Papageorgiou SN, 2014, J CLIN EPIDEMIOL, V67, P984, DOI 10.1016/j.jclinepi.2014.04.002; Ratilal B, 2008, J NEUROS-PEDIATR, V1, P48, DOI 10.3171/PED-08/01/048; Sheppard JP, 2020, NEUROSURGERY, V86, P19, DOI 10.1093/neuros/nyy522; Shin BJ, 2012, J NEUROSURG-SPINE, V17, P113, DOI 10.3171/2012.5.SPINE11399; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; To MS, 2020, J NEUROSURG, V132, P662, DOI 10.3171/2018.8.JNS172897; Yarascavitch BA, 2012, NEUROSURGERY, V71, P1131, DOI 10.1227/NEU.0b013e318271bc99; Yoshimoto Y, 2003, ACTA NEUROCHIR, V145, P45, DOI 10.1007/s00701-002-1036-0; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Zhang ZH, 2013, CRIT CARE, V17, DOI 10.1186/cc11919; Zhu YH, 2016, SPINE, V41, P1493, DOI 10.1097/BRS.0000000000001537	27	0	0	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2021	93						137	140		10.1016/j.jocn.2021.09.006			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WC7EP	WOS:000704417600023	34656237				2022-02-06	
J	Triamvisit, S; Wongprasert, W; Puttima, C; Chiangmai, MN; Thienjindakul, N; Rodkul, L; Jetjumnong, C				Triamvisit, Suphannee; Wongprasert, Wassana; Puttima, Chalermwoot; Chiangmai, Matchima Na; Thienjindakul, Nawaphan; Rodkul, Laksika; Jetjumnong, Chumpon			Effect of modified care bundle for prevention of ventilator-associated pneumonia in critically-ill neurosurgical patients	ACUTE AND CRITICAL CARE			English	Article						chlorhexidine; critical care; intubation; neurosurgery; oral hygiene; ventilator-associated pneumonia	ENDOTRACHEAL-TUBE CUFF; TRAUMATIC BRAIN-INJURY; CHLORHEXIDINE GLUCONATE; ORAL RINSE; INFECTIONS; DECONTAMINATION; EPIDEMIOLOGY; PREVALENCE; PRESSURE	Background: Care bundles for ventilator-associated pneumonia (VAP) have been shown to minimize the rate of VAP in critically ill patients. Standard care bundles may need to be modified in resource-constrained situations. The goal of this study was to see if our modified VAP-care bundles lowered the risk of VAP in neurosurgical patients. Methods: A prospective cohort study was conducted in mechanically ventilated neurosurgical patients. The VAP bundle was adjusted in the cohort group by increasing the frequency of intermittent endotracheal tube cuff pressure monitoring to six times a day while reducing oral care with 0.12% chlorhexidine to three times a day. The rate of VAP was compared to the historical control group. Results: A total of 146 and 145 patients were enrolled in control and cohort groups, respectively. The mean age of patients was 52 +/- 16 years in both groups (P=0.803). The admission Glasgow coma scores were 7.79 +/- 2.67 and 7.80 +/- 2.77 in control and cohort group, respectively (P=0.969). VAP was found in nine patients in control group but only one patient in cohort group. The occurrence rate of VAP was significantly reduced in cohort group compared to control group (0.88/1,000 vs. 6.84/1,000 ventilator days, P=0.036). Conclusions: The modified VAP bundle is effective in lowering the VAP rate in critically ill neurosurgical patients. It requires low budget and manpower and can be employed in resource-constrained settings.	[Triamvisit, Suphannee; Wongprasert, Wassana; Puttima, Chalermwoot; Chiangmai, Matchima Na; Thienjindakul, Nawaphan; Rodkul, Laksika] Chiang Mai Univ Hosp, Div Nursing, Chiang Mai, Thailand; [Jetjumnong, Chumpon] Chiang Mai Univ, Fac Med, Dept Surg, Neurosurg Unit, 110 Intawaroros Rd, Chiang Mai 50200, Thailand		Jetjumnong, C (corresponding author), Chiang Mai Univ, Fac Med, Dept Surg, Neurosurg Unit, 110 Intawaroros Rd, Chiang Mai 50200, Thailand.	chumpon.j@cmu.ac.th					Athiraman UmeshKumar, 2015, Int J Crit Illn Inj Sci, V5, P237, DOI 10.4103/2229-5151.170841; Fortaleza CMCB, 2020, BRAZ J INFECT DIS, V24, P373, DOI 10.1016/j.bjid.2020.08.004; Chacko Ranjitha, 2017, Br J Nurs, V26, P594, DOI 10.12968/bjon.2017.26.11.594; Chlebicki MN, 2007, CRIT CARE MED, V35, P595, DOI 10.1097/01.CCM.0000253395.70708.AC; Craven DE, 2000, CHEST, V117, p186S, DOI 10.1378/chest.117.4_suppl_2.186S; DeRiso A, 1996, CHEST, V109, P1556, DOI 10.1378/chest.109.6.1556; Ferreira CR, 2016, BRAZ J INFECT DIS, V20, P267, DOI 10.1016/j.bjid.2016.03.004; Fourrier F, 2000, INTENS CARE MED, V26, P1239, DOI 10.1007/s001340000585; Hamilton VA, 2012, HEART LUNG, V41, P167, DOI 10.1016/j.hrtlng.2011.09.001; Houston S, 2002, AM J CRIT CARE, V11, P567, DOI 10.4037/ajcc2002.11.6.567; Jackson Laura, 2019, Br J Nurs, V28, P682, DOI 10.12968/bjon.2019.28.11.682; Jovanovic B, 2015, INT J INFECT DIS, V38, P46, DOI 10.1016/j.ijid.2015.07.005; Khan MU, 2016, SAUDI J ANAESTH, V10, P428, DOI 10.4103/1658-354X.179113; Kharel S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247832; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Li YT, 2020, NEUROCRIT CARE, V32, P272, DOI 10.1007/s12028-019-00773-w; Lorente L, 2014, CRIT CARE, V18, DOI 10.1186/cc13837; Magill SS, 2018, NEW ENGL J MED, V379, P1732, DOI 10.1056/NEJMoa1801550; Magill SS, 2013, CRIT CARE MED, V41, P2467, DOI 10.1097/CCM.0b013e3182a262db; Marjanovic N, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017003; Martin-Loeches I, 2018, CURR OPIN CRIT CARE, V24, P347, DOI 10.1097/MCC.0000000000000535; Nseir S, 2011, AM J RESP CRIT CARE, V184, P1041, DOI 10.1164/rccm.201104-0630OC; Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115; Rosenthal VD, 2006, AM J INFECT CONTROL, V34, P58, DOI 10.1016/j.ajic.2005.11.002; Rouze A, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0512-2; Scannapieco FA, 2009, CRIT CARE, V13, DOI 10.1186/cc7967; Segers P, 2006, JAMA-J AM MED ASSOC, V296, P2460, DOI 10.1001/jama.296.20.2460; Sultan Pervez, 2011, J Perioper Pract, V21, P379; Triamvisit Suphannee, 2016, Journal of the Medical Association of Thailand, V99, P1014; VALLES J, 1995, ANN INTERN MED, V122, P179, DOI 10.7326/0003-4819-122-3-199502010-00004; Zhang TT, 2014, J CLIN NURS, V23, P1461, DOI 10.1111/jocn.12312	31	0	0	0	0	KOREAN SOC CRITICAL CARE MEDICINE	SEOUL	806 YONG SEONG BIZTEL BLDG, 109 HANGANG-DAERO, YONGSAN-GU, SEOUL, 04376, SOUTH KOREA	2586-6052	2586-6060		ACUTE CRIT CARE	Acute Crit. Care	NOV	2021	36	4					294	299		10.4266/acc.2021.00983			6	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	XH4VW	WOS:000725435100003		gold			2022-02-06	
J	Tse, KM; Holder, D				Tse, Kwong Ming; Holder, Daniel			A Biomechanical Evaluation of a Novel Airbag Bicycle Helmet Concept for Traumatic Brain Injury Mitigation	BIOENGINEERING-BASEL			English	Article						biomechanics; head injury; traumatic brain injury (TBI); expandable bicycle helmet; inflatable bicycle helmet; airbag; helmet design; impact simulations; finite element (FE); protective equipment (PPE)		In this study, a novel expandable bicycle helmet, which integrates an airbag system into the conventional helmet design, was proposed to explore the potential synergetic effect of an expandable airbag and a standard commuter-type EPS helmet. The traumatic brain injury mitigation performance of the proposed expandable helmet was evaluated against that of a typical traditional bicycle helmet. A series of dynamic impact simulations on both a helmeted headform and a representative human head with different configurations were carried out in accordance with the widely recognised international bicycle helmet test standards. The impact simulations were initially performed on a ballast headform for validation and benchmarking purposes, while the subsequent ones on a biofidelic human head model were used for assessing any potential intracranial injury. It was found that the proposed expandable helmet performed admirably better when compared to a conventional helmet design-showing improvements in impact energy attenuation, as well as kinematic and biometric injury risk reduction. More importantly, this expandable helmet concept, integrating the airbag system in the conventional design, offers adequate protection to the cyclist in the unlikely case of airbag deployment failure.	[Tse, Kwong Ming; Holder, Daniel] Swinburne Univ Technol, Sch Engn, Dept Mech & Prod Design Engn, Melbourne, Vic 3122, Australia		Tse, KM (corresponding author), Swinburne Univ Technol, Sch Engn, Dept Mech & Prod Design Engn, Melbourne, Vic 3122, Australia.	ktse@swin.edu.au; 00597544@student.swin.edu.au	Tse, Kwong Ming/D-8669-2011	Tse, Kwong Ming/0000-0002-8170-0775			Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Avula X.J.R., 1999, NONLINEAR FINITE ELE; Bahrololoom S, 2020, ACCIDENT ANAL PREV, V144, DOI 10.1016/j.aap.2020.105597; Bambach MR, 2013, ACCIDENT ANAL PREV, V53, P78, DOI 10.1016/j.aap.2013.01.005; Bliven E., 2019, J FORENSIC BIOMED, V10, P8, DOI [10.4172/2090-2697.1000141, DOI 10.4172/2090-2697.1000141]; Bullock R., 1997, SCI FDN TRAUMA, P101; Cernicchi A, 2008, INT J CRASHWORTHINES, V13, P451, DOI 10.1080/13588260802055460; Corner J.P., 1987, MOTORCYCLE BICYCLE P; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Deck C, 2006, INT J CRASHWORTHINES, V11, P561, DOI 10.1533/ijcr.2006.0149; DORSCH MM, 1987, ACCIDENT ANAL PREV, V19, P183, DOI 10.1016/0001-4575(87)90002-9; Elvik R, 2011, ACCIDENT ANAL PREV, V43, P1245, DOI 10.1016/j.aap.2011.01.007; Fahlstedt M, 2016, ACCIDENT ANAL PREV, V91, P135, DOI 10.1016/j.aap.2016.02.025; Gohel G, 2021, COMPOS PART B-ENG, V221, DOI 10.1016/j.compositesb.2021.109008; Holbourn AHS, 1943, LANCET, V2, P438; Hopes P.D., 1989, P INT RES COUNCIL BI; Hoye A, 2018, ACCIDENT ANAL PREV, V120, P239, DOI 10.1016/j.aap.2018.08.001; Hoye A, 2018, ACCIDENT ANAL PREV, V117, P85, DOI 10.1016/j.aap.2018.03.026; IIHS, 2019, INSURANCE I HIGHWAY; JOHNSTON IH, 1974, J NEUROL NEUROSUR PS, V37, P585, DOI 10.1136/jnnp.37.5.585; Kassar S, 2017, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, 2016, VOL. 14; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kurt M, 2017, ANN BIOMED ENG, V45, P1148, DOI 10.1007/s10439-016-1732-1; McIntosh AS, 2013, J AUSTRALAS COLL ROA, V24, P11; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; McNally DS, 2013, ACCIDENT ANAL PREV, V60, P15, DOI 10.1016/j.aap.2013.07.011; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mertz H., 1996, SAE TECHNICAL PAPER; Mills NJ, 2008, INT J IMPACT ENG, V35, P1087, DOI 10.1016/j.ijimpeng.2007.05.006; MILLS NJ, 1991, ACCIDENT ANAL PREV, V23, P153, DOI 10.1016/0001-4575(91)90045-7; Milne G, 2012, Comput Methods Biomech Biomed Engin, V15 Suppl 1, P309; Mips Helmet Technology, WHY YOU WANT IT OUTD; Morgan D.E., 2001, IMPROVED SHOCK ABSOR; Najmon JC, 2018, SAE INT J TRANSP SAF, V6, P217, DOI 10.4271/2018-01-1057; Olivier J, 2013, ACCIDENT ANAL PREV, V50, P1128, DOI 10.1016/j.aap.2012.09.003; Organization WH, 2018, GLOBAL STATUS REPORT; Pamuk G, 2008, E J NEW WORLD SCI AC, V3, P225; Perez E., 2014, P INT CYCL SAF C GOT, P1; SA/SNZ, 2007, CS 097 TESTING HELME; Sandberg M, 2018, COMPUT METHOD BIOMEC, V21, P684, DOI 10.1080/10255842.2018.1511775; Stigson H., 2017, P INT RES COUNCIL BI, P13; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Totla SK, 2020, MATER TODAY-PROC, V32, P365, DOI 10.1016/j.matpr.2020.02.047; Tse K.M., 2013, DEV REALISTIC FINITE; Tse K.M., 2014, AM J ENG TECHNOL SOC, V1, P28; Tse KM, 2014, INT J NUMER METH BIO, V30, P397, DOI 10.1002/cnm.2609	46	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2306-5354		BIOENGINEERING-BASEL	Bioengineering-Basel	NOV	2021	8	11							173	10.3390/bioengineering8110173			14	Biotechnology & Applied Microbiology; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology; Engineering	XL0CD	WOS:000727820800001	34821739	gold, Green Published			2022-02-06	
J	Tsianaka, E; Singh, A; Drosos, E; Fountas, K				Tsianaka, Eleni; Singh, Ajit; Drosos, Evangelos; Fountas, Kostas			Direct Consequences of Cranioplasty to the Brain: Intracranial Pressure Study	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Craniectomy; cranioplasty; imaging; intracranial pressure; measurement	SINKING SKIN-FLAP; SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; BLOOD-FLOW; HEMICRANIECTOMY; EXPERIENCE; CHILDREN; RECOVERY; VOLUME	Intracranial pressure (ICP) is a crucial factor that we need to take into account in all major pathophysiological changes of the brain after decompressive craniectomy (DC) and cranioplasty (CP). The purpose of our study was to check ICP values before and after cranioplasty and its relation to various parameters (imaging, demographics, time of cranioplasty, and type of graft) as well as its possible relation to postsurgical complications. The authors performed a prospective study in which they selected as participants adults who had undergone unilateral frontotemporoparietal DC and were planned to have cranioplasty. Intracranial pressure was measured with optical fiber sensor in the epidural space and did not affect cranioplasty in any way. Twenty-five patients met the criteria. The mean vcICP (value change of ICP) was 1.2 mm Hg, the mean Delta ICP (absolute value change of the ICP) was 2.24 mm Hg and in the majority of cases there was an increase in ICP. The authors found 3 statistically significant correlations: between gender and Delta ICP, Delta time (time between DC and CP) and vcICP, and pre-ICP and +/- ICP (quantitative change of the ICP). Male patients tend to develop larger changes of ICP values during CP. As the time between the 2 procedures (DC and CP) gets longer, the vcICP is decreased. However, after certain time it shows a tendency to remain around zero. Lower pre-ICP values (close to or below zero) are more possible to increase after bone flap placement. It seems that the brain tends to restore its pre-DC conditions after CP by taking near-to-normal ICP values.	[Tsianaka, Eleni; Fountas, Kostas] Univ Hosp Larissa, Dept Neurosurg, Biopolis, Larisa, Thessaly, Greece; [Tsianaka, Eleni] Dar Al Shifa Hosp, Dept Neurosurg, Kuwait, Kuwait; [Singh, Ajit] GBH Amer Hosp, Dept Neurosurg, Udaipur, Rajasthan, India; [Drosos, Evangelos] Hlth Assurance Hosp Dhaman, Dept Family Med, Kuwait, Kuwait		Tsianaka, E (corresponding author), Mesochoras 18, Trikala 42100, Thessaly, Greece.	ariadniq@yahoo.gr					Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Andrabi Syed M, 2017, Surg Neurol Int, V8, P91, DOI 10.4103/sni.sni_45_17; Antes S, 2014, ACTA NEUROCHIR, V156, P1009, DOI 10.1007/s00701-013-1991-7; Bratton S, 2007, J NEUROTRAUM, V24, P55, DOI [DOI 10.1089/NEU.2007.9988, 10.1089/neu.2007.9988]; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Chun HJ, 2011, J CRANIOFAC SURG, V22, P203, DOI 10.1097/SCS.0b013e3181f753bd; Clausen I, 2014, SENSORS-BASEL, V14, P17686, DOI 10.3390/s140917686; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Fenoy AJ, 2014, J NEUROSURG, V120, P132, DOI 10.3171/2013.10.JNS131225; Figaji AA, 2008, ACTA NEUROCHIR SUPPL, V102, P77, DOI 10.1007/978-3-211-85578-2_15; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Filon JR, 2016, J NEUROPATH EXP NEUR, V75, P748, DOI 10.1093/jnen/nlw047; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Han PY, 2008, J KOREAN NEUROSURG S, V43, P51, DOI 10.3340/jkns.2008.43.1.51; HAYWARD RD, 1985, J NEUROL NEUROSUR PS, V48, P195; Ho MY, 2018, INT J BIOMED IMAGING, V2018, DOI 10.1155/2018/5237693; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; Jandial R, 2011, CORE TECHNIQUES OPER; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Krishnan P, 2006, NEUROL INDIA, V54, P291; Kunze E, 1998, ACT NEUR S, V71, P16; Lilja-Cyron A, 2020, J NEUROSURG, V133, P1548, DOI 10.3171/2019.7.JNS191077; Lilja-Cyron A, 2020, NEUROSURGERY, V86, P231, DOI 10.1093/neuros/nyz049; Mansson PK, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013389; Mitchell KAS, 2020, OPER NEUROSURG, V19, P341, DOI 10.1093/ons/opz431; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Monro A., 1783, OBSERVATIONS STRUCTU; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Prasad GL., 2016, BR J NEUROSURG, V17, P1; Quah BL, 2016, WORLD NEUROSURG, V94, P13, DOI 10.1016/j.wneu.2016.06.081; Reddy AK, 2002, NEUROL INDIA, V50, P66; Roth J, 2011, NEUROSURGERY, V68, pE271, DOI 10.1227/NEU.0b013e3181fe6165; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; van den Bedem H, 2017, CURR OPIN BIOMED ENG, V1, P23, DOI 10.1016/j.cobme.2017.02.003; Voss HU, 2011, CLIN IMAG, V35, P253, DOI 10.1016/j.clinimag.2010.07.008; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Xiao FR, 2012, CLIN NEUROL NEUROSUR, V114, P205, DOI 10.1016/j.clineuro.2011.10.003	48	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	NOV-DEC	2021	32	8					2779	2783		10.1097/SCS.0000000000007945			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	WP8DF	WOS:000713355900132	34727479				2022-02-06	
J	Tuborgh, A; Svendsen, SW; Elklit, A; Hunter, J; Jensen, JS; Schroder, A; Nielsen, JF; Thastum, MM; Naess-Schmidt, ET; Rask, CU				Tuborgh, A.; Svendsen, S. W.; Elklit, A.; Hunter, J.; Jensen, J. S.; Schroder, A.; Nielsen, J. F.; Thastum, M. M.; Naess-Schmidt, E. T.; Rask, C. U.			Attachment and symptom reporting in adolescents and young adults after a concussion	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article						Attachment dimensions; Concussion; Experiences in close relationships-relationship; structures questionnaire; Mild traumatic brain injury; Post-concussion symptoms	TRAUMATIC BRAIN-INJURY; HEALTH-CARE UTILIZATION; FEAR-AVOIDANCE MODEL; ILLNESS PERCEPTIONS; CHRONIC PAIN; HEAD-INJURY; INSECURITY; STYLE; QUESTIONNAIRE; ASSOCIATION	Background: The incidence of hospital-treated concussion is 100-300/100,000 person years. Reporting of longlasting post-concussion symptoms (PCS) is estimated at 5-15%. Attachment insecurity is a potential vulnerability factor for physical illness and poorer disease outcomes in general. This study aimed to explore associations between attachment insecurity and PCS in young people sustaining a concussion. Methods: This cross-sectional study was embedded in a cohort of 15-30-year-old patients (n = 3080) 3 months after sustaining a concussion. Data were obtained from a database and questionnaires. PCS were measured by the Rivermead Post-Concussion Symptoms Questionnaire and attachment dimensions (anxiety and avoidance) by the Experiences in Close Relationships-Relationship Structures Questionnaire. Multiple linear regression models were performed to investigate the association between the attachment dimensions and PCS with adjustment for demographic, injury-related and psychological factors and with additional testing for interaction between the attachment dimensions. Results: In the final study sample, comprising 973 patients (31.6%), we found an interaction between the attachment dimensions. Hence, the effect of attachment anxiety on PCS was statistically insignificant at low avoidance (25th percentile) but significant at high avoidance (75th percentile, beta = 0.64 (95%CI: 0.02; 1.26)), whereas the effect of attachment avoidance was significant regardless of level of attachment anxiety (25th percentile, beta = 1.09 (95%CI: 0.18; 2.01); 75th percentile, beta = 2.71 (95%CI: 1.80; 3.61)). Conclusion: Attachment insecurity, especially characterised by high avoidance in combination with high anxiety, also called fearful attachment, is associated with PCS. Considering the attachment perspective can potentially improve health care for this patient group.	[Tuborgh, A.; Rask, C. U.] Aarhus Univ Hosp, Dept Child & Adolescent Psychiat, Res Unit, Psychiat, Aarhus, Denmark; [Tuborgh, A.; Rask, C. U.] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Svendsen, S. W.; Nielsen, J. F.; Thastum, M. M.; Naess-Schmidt, E. T.] Aarhus Univ, Univ Res Clin, Hammel Neurorehabil Ctr, Aarhus, Denmark; [Svendsen, S. W.] Univ Copenhagen, Bispebjerg & Frederiksberg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Svendsen, S. W.] Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, Copenhagen, Denmark; [Elklit, A.] Univ Southern Denmark, Dept Psychol, Natl Ctr Psychotraumatol, Odense, Denmark; [Hunter, J.] Univ Toronto, Dept Psychiat, Sinai Hlth Syst, Toronto, ON, Canada; [Jensen, J. S.; Schroder, A.; Thastum, M. M.] Aarhus Univ Hosp, Res Clin Funct Disorders & Psychosomat, Aarhus, Denmark		Tuborgh, A (corresponding author), Aarhus Univ Hosp, Dept Child & Adolescent Psychiat, Res Unit, Psychiat, Aarhus, Denmark.	asttub@rm.dk	; Naess-Schmidt, Erhard/E-8425-2019	Nielsen, Jorgen Feldbaek/0000-0001-5339-171X; Naess-Schmidt, Erhard/0000-0002-2539-0362	Health Scientific Research Foundation in Central Denmark Region, Aarhus University; Psychiatric Research Foundation of the Department of Child and Adolescent Psychiatry, The Psychiatric Research Foundation in Central Denmark Region; Grocer Svend Hansen and wife Ina Hansen's Foundation	This project was supported by The Health Scientific Research Foundation in Central Denmark Region, Aarhus University, The Psychiatric Research Foundation of the Department of Child and Adolescent Psychiatry, The Psychiatric Research Foundation in Central Denmark Region and Grocer Svend Hansen and wife Ina Hansen's Foundation. The founding agencies had no role or say in the design or execution of the study.	Andersen TE, 2019, J PSYCHOSOM RES, V118, P56, DOI 10.1016/j.jpsychores.2019.01.008; Andersen TE, 2011, EUR J PSYCHOTRAUMATO, V2, DOI 10.3402/ejpt.v2i0.5633; Andersen TE, 2012, SOC SCI MED, V74, P1461, DOI 10.1016/j.socscimed.2012.01.009; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037/0022-3514.61.2.226; Bowlby J., 1969, ATTACHMENT LOSS; Brassil HE, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0200-y; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cabella B, 2017, NEUROCRIT CARE, V27, P103, DOI 10.1007/s12028-016-0319-x; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carstensen TBW, 2012, DAN MED J, V59; Ciechanowski P, 2004, PSYCHOSOM MED, V66, P720, DOI 10.1097/01.psy.0000138125.59122.23; Ciechanowski P, 2003, PAIN, V104, P627, DOI 10.1016/S0304-3959(03)00120-9; Ciechanowski PS, 2002, PSYCHOSOM MED, V64, P660, DOI 10.1097/01.PSY.0000021948.90613.76; Ciechanowski PS, 2002, PSYCHOSOMATICS, V43, P206, DOI 10.1176/appi.psy.43.3.206; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Davies KA, 2009, PAIN, V143, P200, DOI 10.1016/j.pain.2009.02.013; Del Giudice M, 2011, PERS SOC PSYCHOL B, V37, P193, DOI 10.1177/0146167210392789; Donbaek DF, 2014, ATTACH HUM DEV, V16, P58, DOI 10.1080/14616734.2013.850103; Efron B., 1993, INTRO BOOTSTRAP; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fraley RC, 2015, J PERS SOC PSYCHOL, V109, P354, DOI 10.1037/pspp0000027; Fraley RC, 2011, J PERS SOC PSYCHOL, V101, P974, DOI 10.1037/a0024150; Fraley RC, 2011, PSYCHOL ASSESSMENT, V23, P615, DOI 10.1037/a0022898; Fraley RC, 2004, PERS SOC PSYCHOL B, V30, P878, DOI 10.1177/0146167204264289; Fraley RC, 2002, PERS SOC PSYCHOL REV, V6, P123, DOI 10.1207/S15327957PSPR0602_03; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; Gehrt TB, 2015, CLIN J PAIN, V31, P14, DOI 10.1097/AJP.0000000000000085; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hunter JJ, 2001, GEN HOSP PSYCHIAT, V23, P177, DOI 10.1016/S0163-8343(01)00141-4; Hunter Maunder, 2016, IMPROVING PATIENT TR, VFirst; Hurter S, 2014, J PAIN, V15, P934, DOI 10.1016/j.jpain.2014.06.004; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Kowal J, 2015, J BEHAV MED, V38, P518, DOI 10.1007/s10865-015-9623-8; Larsen F.B, 2014, HVORDAN HAR DET 2013; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maunder R., 2015, LOVE FEAR HLTH OUR A; Maunder RG, 2001, PSYCHOSOM MED, V63, P556, DOI 10.1097/00006842-200107000-00006; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McWilliams LA, 2017, EUR J PAIN, V21, P1378, DOI 10.1002/ejp.1036; Meints SM, 2018, PROG NEURO-PSYCHOPH, V87, P168, DOI 10.1016/j.pnpbp.2018.01.017; Meredith P, 2006, PAIN, V123, P146, DOI 10.1016/j.pain.2006.02.025; Meredith P, 2008, CLIN PSYCHOL REV, V28, P407, DOI 10.1016/j.cpr.2007.07.009; Meredith PJ, 2007, EUR J PAIN, V11, P164, DOI 10.1016/j.ejpain.2006.01.004; Meredith PJ, 2019, CURR OPIN PSYCHOL, V25, P132, DOI 10.1016/j.copsyc.2018.04.018; Mikulincer M, 2016, ATTACHMENT IN ADULTHOOD, 2 EDITION, P1; Mikulincer M, 2003, MOTIV EMOTION, V27, P77, DOI 10.1023/A:1024515519160; Nohr EA, 2018, ACTA OBSTET GYN SCAN, V97, P407, DOI 10.1111/aogs.13319; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pietromonaco PR, 2019, CURR OPIN PSYCHOL, V25, P115, DOI 10.1016/j.copsyc.2018.04.004; Pinquart M, 2013, ATTACH HUM DEV, V15, P189, DOI 10.1080/14616734.2013.746257; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Porter LS, 2007, PAIN, V128, P195, DOI 10.1016/j.pain.2007.02.001; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Ravitz P, 2010, J PSYCHOSOM RES, V69, P419, DOI 10.1016/j.jpsychores.2009.08.006; Sandberg DA, 2010, J INTERPERS VIOLENCE, V25, P33, DOI 10.1177/0886260508329126; Sechi C, 2020, HEALTH PSYCHOL OPEN, V7, DOI 10.1177/2055102920947921; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Skandsen T, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00638; Smith MD, 2018, PSYCHO-ONCOLOGY, V27, P2442, DOI 10.1002/pon.4848; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Sockalingam S, 2013, OBES SURG, V23, P2026, DOI 10.1007/s11695-013-1009-9; Thastum MM, 2019, ECLINICALMEDICINE, V17, DOI 10.1016/j.eclinm.2019.11.007; Thastum MM, 2018, NEUROREHABILITATION, V43, P155, DOI 10.3233/NRE-172391; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Thomas RE, 2017, RESTOR NEUROL NEUROS, V35, P643, DOI 10.3233/RNN-170761; Thoresen S, 2010, SOC PSYCH PSYCH EPID, V45, P405, DOI 10.1007/s00127-009-0073-x; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vilchinsky N, 2013, ANXIETY STRESS COPIN, V26, P314, DOI 10.1080/10615806.2012.682649; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Winding TN, 2014, J EPIDEMIOL COMMUN H, V68, P137, DOI 10.1136/jech-2013-202707; Zale EL, 2015, CURR OPIN PSYCHOL, V5, P24, DOI 10.1016/j.copsyc.2015.03.014	75	0	0	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	NOV	2021	150								110603	10.1016/j.jpsychores.2021.110603			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	WJ8RE	WOS:000709304900006	34509710				2022-02-06	
J	Tunthanathip, T; Duangsuwan, J; Wattanakitrungroj, N; Tongman, S; Phuenpathom, N				Tunthanathip, Thara; Duangsuwan, Jarunee; Wattanakitrungroj, Niwan; Tongman, Sasiporn; Phuenpathom, Nakornchai			Comparison of intracranial injury predictability between machine learning algorithms and the nomogram in pediatric traumatic brain injury	NEUROSURGICAL FOCUS			English	Article						pediatric traumatic brain injury; machine learning; nomogram; prediction	GLASGOW COMA SCALE; CHILDREN; PERFORMANCE; SCORE	OBJECTIVE The overuse of head CT examinations has been much discussed, especially those for minor traumatic brain injury (TBI). In the disruptive era, machine learning (ML) is one of the prediction tools that has been used and applied in various fields of neurosurgery. The objective of this study was to compare the predictive performance between ML and a nomogram, which is the other prediction tool for intracranial injury following cranial CT in children with TBI. METHODS Data from 964 pediatric patients with TBI were randomly divided into a training data set (75%) for hyperparameter tuning and supervised learning from 14 clinical parameters, while the remaining data (25%) were used for validation purposes. Moreover, a nomogram was developed from the training data set with similar parameters. Therefore, models from various ML algorithms and the nomogram were built and deployed via web-based application. RESULTS A random forest classifier (RFC) algorithm established the best performance for predicting intracranial injury following cranial CT of the brain. The area under the receiver operating characteristic curve for the performance of RFC algorithms was 0.80, with 0.34 sensitivity, 0.95 specificity, 0.73 positive predictive value, 0.80 negative predictive value, and 0.79 accuracy. CONCLUSIONS The ML algorithms, particularly the RFC, indicated relatively excellent predictive performance that would have the ability to support physicians in balancing the overuse of head CT scans and reducing the treatment costs of pediatric TBI in general practice.	[Tunthanathip, Thara; Phuenpathom, Nakornchai] Prince Songkla Univ, Fac Med, Dept Surg, Div Neurosurg, Hat Yai, Thailand; [Duangsuwan, Jarunee; Wattanakitrungroj, Niwan] Prince Songkla Univ, Fac Sci, Dept Comp Sci, Hat Yai, Thailand; [Tongman, Sasiporn] Thammasat Univ, Dept Biotechnol, Fac Sci & Technol, Rangsit Campus, Khlong Luang, Thailand		Tunthanathip, T (corresponding author), Prince Songkla Univ, Hat Yai, Thailand.	tsus4@hotmail.com	Tongman, Sasiporn/ABF-4966-2021	Tongman, Sasiporn/0000-0001-9445-2179	Targeted Research Gants, Faculty of Medicine, Prince of Songkla University [62-065-10-1]	Targeted Research Gants, Faculty of Medicine, Prince of Songkla University (grant no. 62-065-10-1).	Adil SM, 2021, J NEUROTRAUM, V38, P928, DOI 10.1089/neu.2020.7262; Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Badawy MK, 2017, ACAD EMERG MED, V24, P595, DOI 10.1111/acem.13168; Beam AL, 2018, JAMA-J AM MED ASSOC, V319, P1317, DOI 10.1001/jama.2017.18391; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Borland ML, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3123; Chodick Gabriel, 2009, Pediatr Endocrinol Rev, V7, P29; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Fulkerson DH, 2015, J NEUROSURG-PEDIATR, V16, P410, DOI 10.3171/2015.3.PEDS14679; Gravesteijn BY, 2020, J CLIN EPIDEMIOL, V122, P95, DOI 10.1016/j.jclinepi.2020.03.005; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; Kirkham FJ, 2008, DEV MED CHILD NEUROL, V50, P267, DOI 10.1111/j.1469-8749.2008.02042.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Marques A, 2016, ARCH PHYS MED REHAB, V97, P2166, DOI 10.1016/j.apmr.2016.07.011; Matsuo K, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6276; Negida A, 2019, ADV J EMERG MED, V3, DOI 10.22114/ajem.v0i0.158; Niele N, 2020, EUR J PEDIATR, V179, P1597, DOI 10.1007/s00431-020-03649-w; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Rocha TAH, 2020, J NEUROSURG, V132, P1961, DOI 10.3171/2019.2.JNS182098; Rubin TG, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519844020; Schulze-Rath R, 2008, RADIAT ENVIRON BIOPH, V47, P301, DOI 10.1007/s00411-008-0171-2; Taweesomboonyat T, 2020, J HLTH SCI MED RES, V38, P267; Tunthanathip T, 2020, J PEDIATR NEUROSCI, V15, P409, DOI [10.4103/jpn.JPN_11_20, 10.4103/JPN.JPN_11_20]; Tunthanathip T, 2020, J NEUROSCI RURAL PRA, V11, P135, DOI 10.1055/s-0039-3403446; Tunthanathip T, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.5.FOCUS19241; Tunthanathip T, 2017, J NEUROSCI RURAL PRA, V8, P601, DOI 10.4103/jnrp.jnrp_381_17	29	0	0	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2021	51	5							E7	10.3171/2021.8.FOCUS2155			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WS2YB	WOS:000715051600003	34724640	gold			2022-02-06	
J	Vakhtin, AA; Zhang, Y; Wintermark, M; Ashford, JW; Furst, AJ				Vakhtin, Andrei A.; Zhang, Yu; Wintermark, Max; Ashford, John W.; Furst, Ansgar J.			Distant histories of mild traumatic brain injury exacerbate age-related differences in white matter properties	NEUROBIOLOGY OF AGING			English	Article						Mild Traumatic Brain Injury (mTBI); Aging; White Matter; Diffusion Tensor Imaging (DTI); Tractography	COGNITIVE DECLINE; OLDER-ADULTS; HEAD-INJURY; LIFE-SPAN; INTEGRITY; MICROSTRUCTURE; IMPACT; DYSFUNCTION; ASSOCIATION; AFGHANISTAN	We examined associations of distant histories of mild traumatic brain injury (mTBI) with non-linear and linear trajectories of white matter (WM) properties across a wide age range (23-77). Diffusion tensor imaging (DTI) data obtained from 171 Veterans with histories of clinically diagnosed mTBIs and 115 controls were subjected to tractography, isolating 20 major WM tracts. Non-linear and linear effects of age on each tract's diffusion properties were examined in terms of their interactions with group (mTBI and control). The non-linear model revealed 7 tracts in which the mTBI group's DTI metrics rapidly deviated from control trajectories in middle and late adulthoods, despite the injuries having occurred in the late 20s, on average. In contrast, no interactions between prior injuries and age were detected when examining linear trajectories. Distant mTBIs may thus accelerate normal age-related trajectories of WM degeneration much later in life. As such, life-long histories of head trauma should be assessed in all patients in their mid-to-late adulthoods, whether neurologically healthy or presenting with seemingly unrelated neuropathology. (c) 2021 Elsevier Inc. All rights reserved.	[Vakhtin, Andrei A.] Lovelace Biomed & Environm Res Inst, Mind Res Network, Albuquerque, NM USA; [Zhang, Yu; Ashford, John W.; Furst, Ansgar J.] Palo Alto Vet Affairs Hosp, War Related Illness & Injury Study Ctr WRIISC, Palo Alto, CA USA; [Wintermark, Max] Stanford Univ, Neuroradiol, Sch Med, Stanford, CA USA; [Ashford, John W.; Furst, Ansgar J.] Stanford Univ, Sch Med, Psychiat & Behav Sci, Stanford, CA USA; [Furst, Ansgar J.] Stanford Univ, Neurol & Neurol Sci, Sch Med, Stanford, CA USA; [Furst, Ansgar J.] Palo Alto Vet Affairs Hosp, Polytrauma Syst Care, Palo Alto, CA USA		Vakhtin, AA (corresponding author), Mind Res Network, Albuquerque, NM 87106 USA.	avakhtin@mrn.org		Ashford, J. Wesson/0000-0001-9600-6471	WRIISC; VA Office of Academic Affiliations (OAA); National Institute of General Medical Sciences (NIGMS) Centers of Biomedical Research Excellence [P30GM122734]	This work was funded by the WRIISC, the VA Office of Academic Affiliations (OAA), and the National Institute of General Medical Sciences (NIGMS) Centers of Biomedical Research Excellence (grant number P30GM122734). The views and opinions expressed here are of the authors and do not necessarily represent the views of the Department of Veterans Affairs, OAA, or NIGMS. These institutions had no roles in study design, data collection, analyses and interpretations of data, writing of this report, or the decision to submit this manuscript for publication.	Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Anderson CV, 1996, J NEUROTRAUM, V13, P35, DOI 10.1089/neu.1996.13.35; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bartzokis G, 2012, BIOL PSYCHIAT, V72, P1026, DOI 10.1016/j.biopsych.2012.07.010; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Bracht T, 2015, J AFFECT DISORDERS, V187, P45, DOI 10.1016/j.jad.2015.06.041; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; CORKIN S, 1989, J NEUROSCI, V9, P3876; Cox SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13629; David S, 2020, BRAIN STRUCT FUNCT, V225, P1401, DOI 10.1007/s00429-019-02016-2; Du AT, 2005, NEUROBIOL AGING, V26, P553, DOI 10.1016/j.neurobiolaging.2004.05.002; Esopenko C, 2015, J NEUROTRAUM, V32, P209, DOI 10.1089/neu.2014.3506; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fjell AM, 2013, NEUROBIOL AGING, V34, P2239, DOI 10.1016/j.neurobiolaging.2013.04.006; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Griesbach GS, 2018, J NEUROTRAUM, V35, P17, DOI 10.1089/neu.2017.5103; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hellewell SC, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2020.102253; Herbet G, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00077; Ikuta T, 2020, BRAIN IMAGING BEHAV, V14, P362, DOI 10.1007/s11682-019-00154-z; Ilie G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188908; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Kaup AR, 2019, J NEUROTRAUM, V36, P338, DOI 10.1089/neu.2018.5695; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Kochunov P, 2012, NEUROBIOL AGING, V33, P9, DOI 10.1016/j.neurobiolaging.2010.01.014; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Niida R, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00522; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Peters Matthew E, 2018, Concussion, V3, pCNC56, DOI 10.2217/cnc-2018-0001; Peters ME, 2016, INT PSYCHOGERIATR, V28, P1931, DOI 10.1017/S1041610216001666; Presson N, 2015, BRAIN IMAGING BEHAV, V9, P484, DOI 10.1007/s11682-015-9386-4; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Salami A, 2012, BBA-MOL BASIS DIS, V1822, P408, DOI 10.1016/j.bbadis.2011.09.001; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sexton CE, 2014, J NEUROSCI, V34, P15425, DOI 10.1523/JNEUROSCI.0203-14.2014; Staples JA, 2016, BRAIN INJURY, V30, P899, DOI 10.3109/02699052.2016.1146964; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stenberg J, 2020, ARCH PHYS MED REHAB, V101, P72, DOI 10.1016/j.apmr.2019.08.477; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Vakhtin AA, 2020, J NEUROTRAUM, V37, P373, DOI 10.1089/neu.2019.6487; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Weathers FW, 2014, PSYCHOL INJ LAW, V7, P93, DOI 10.1007/s12207-014-9191-1; West T.J.D., 2007, REBUILDING TRUST IND; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wood, 1997, EVALUATING STRESS BO, P23, DOI DOI 10.1007/978-0-387-79948-3_1972; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Yu QL, 2020, CEREB CORTEX, V30, P2674, DOI 10.1093/cercor/bhz268; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0213952; Zhang Y, 2010, NEUROBIOL AGING, V31, P1991, DOI 10.1016/j.neurobiolaging.2008.10.009; Ziebell JM, 2017, BRAIN BEHAV IMMUN, V59, P1, DOI 10.1016/j.bbi.2016.03.008	77	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	NOV	2021	107						30	41		10.1016/j.neurobiolaging.2021.07.002			12	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	WC5ZJ	WOS:000704335900004	34371285				2022-02-06	
J	van Ierssel, J; Ledoux, AA; Tang, K; Zemek, R				van Ierssel, Jacqueline; Ledoux, Andree-Anne; Tang, Ken; Zemek, Roger			Sex-Based Differences in Symptoms With Mouthguard Use After Pediatric Sport-Related Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injuries; symptom change; children; adolescents; Post-Concussion Symptom Inventory	PROTECTIVE EQUIPMENT; RISK; CHILDREN; INJURY; PREVENTION; STATEMENT; RECOVERY	Context: Current evidence regarding the protective effect of mouthguard use on symptom severity in children and adolescents who sustain sport-related concussions is insufficient to make clinical recommendations. Objective: To compare the association between mouth guard use and symptoms stratified by sex in the first 4 weeks after pediatric sport-related concussion. We hypothesized that mouthguard use would be associated with less severe symptoms. Design: Prospective cohort study. Setting: Nine Canadian pediatric emergency departments (EDs). Patients or Other Participants: Children aged 5 to 18 years who were assessed within 48 hours of concussions sustained during a collision or contact sport. Main Outcome Measure(s): Injury characteristics were collected using the Acute Concussion Evaluation. The primary outcome measure was symptom score (range = 0-6), measured using age-appropriate versions (5-7, 8-12, or 13-18 years) of the Post-Concussion Symptom Inventory. The independent variable was time postconcussion (initial assessment and 1, 2, and 4 weeks). Results: Of 1019 children (73% male; median [interquartile range] age = 13.43 years [11.01-15.27 years]), 42% wore a mouthguard at the time of injury. No significant group-by-sex-by time interaction was present for symptoms (chi(2)(3) = 0.27; P = .965). Male mouthguard users reported similar symptom scores in the ED (difference in Post-Concussion Symptom Inventory D scores [diff] = -0.07; 95% CI = -0.23, 0.09) and at weeks 1 (diff = -0.02; 95% CI = -0.18, 0.14), 2 (diff = -0.03; 95% CI = -0.19, 0.13), and 4 (diff = -0.13; 95% CI = -0.29, 0.04) compared with males who did not wear a mouthguard. Female mouthguard users described minimally higher symptom scores at week 1 compared with non-mouthguard users (diff = 0.29; 95% CI = 0.01, 0.56). In the ED, symptom scores were not different for females who wore a mouthguard and those who did not (diff = 0.22; 95% CI = -0.04, 0.48) or at weeks 2 (diff = 0.22; 95% CI = -0.06, 0.51) or 4 (diff = 0.08; 95% CI = - 0.20, 0.36). Conclusions: Wearing a mouthguard at the time of injury was not associated with reduced acute or subacute symptoms after sport-related concussion in either males or females who were treated in the ED compared with those who did not wear a mouthguard. Athletes are still encouraged to wear mouthguards during sports because overwhelming evidence supports their use in preventing dental injuries.	[van Ierssel, Jacqueline; Ledoux, Andree-Anne; Tang, Ken; Zemek, Roger] Childrens Hosp Eastern Ontario Res Inst, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada; [Ledoux, Andree-Anne; Zemek, Roger] Univ Ottawa, Fac Med, Ottawa, ON, Canada		van Ierssel, J (corresponding author), Childrens Hosp Eastern Ontario Res Inst, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	JMinnes@cheo.on.ca					[Anonymous], 1988, PEDIATRICS, V81, P737; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Benson B., 2005, CLIN J SPORT MED, V15, P392, DOI [10.1097/01.jsm.0000166346.90342.92, DOI 10.1097/01.JSM.0000166346.90342.92]; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Canadian Dental Hygienists Association, 2005, CAN J DENT HYG, V39, P257; Casson IR, 2015, NEUROLOGY, V85, P110, DOI 10.1212/WNL.0000000000001700; Chisholm DA, 2020, BRIT J SPORT MED, V54, P866, DOI 10.1136/bjsports-2019-101011; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gioia GA, 2009, TOP LANG DISORD, V29, P266, DOI 10.1097/TLD.0b013e3181b5322b; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Knapik JJ, 2019, SPORTS MED, V49, P1217, DOI 10.1007/s40279-019-01121-w; Lavallee AV, 2013, J BIOMECH, V46, P527, DOI 10.1016/j.jbiomech.2012.09.029; Lloyd JD, 2017, DENT TRAUMATOL, V33, P421, DOI 10.1111/edt.12375; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rosenbaum PE, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.21463; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Streissguth M, 2019, AMER MADE MUSIC SER, P1, DOI 10.2519/jospt.2019.8582; Winters Jackson, 2014, General Dentistry, V62, P34; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550	37	0	0	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV	2021	56	11					1188	1196		10.4085/1062-6050-0393.20			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WZ4WD	WOS:000719968500004	33848349	gold			2022-02-06	
J	Van Praag, DLG; van den Eede, F; Wouters, K; Wilson, L; Maas, AIR; Participants				Van Praag, Dominique L. G.; van den Eede, Filip; Wouters, Kristien; Wilson, Lindsay; Maas, Andrew I. R.; CTR-TBI Investigators and Participants			The Impact of Neurocognitive Functioning on the Course of Posttraumatic Stress Symptoms following Civilian Traumatic Brain Injury	JOURNAL OF CLINICAL MEDICINE			English	Article						assessment; cognition; neuropsychology; posttraumatic stress; concussion; head injury	DISORDER FOLLOWING MODERATE; CENTER-TBI; PTSD; OUTCOMES; PERFORMANCE; PREVALENCE; ANXIETY	Background: One out of seven individuals who have suffered a traumatic brain injury (TBI) develops a posttraumatic stress disorder (PTSD), which is often associated with neurocognitive impairment. The present study explores the impact of neurocognitive functioning after mild, moderate, and severe TBI on the course of PTSD symptoms. Methods: The data of 671 adults admitted to hospital for a TBI was drawn from the Collaborative European Neurotrauma Effectiveness Research (CENTER-TBI) study. After six- and 12-months post-injury, participants completed the PTSD Checklist-5 (PCL-5), from which change scores were calculated. At six months, participants also completed a neurocognitive assessment including the Rey Auditory Verbal Learning Test, the Trail Making Test, and the Cambridge Neuropsychological Test Automated Battery (CANTAB). Linear regressions were performed to identify associations between cognitive functioning and PCL-5 change scores. Results: Overall, mean PCL-5 change scores showed no clear change (-0.20 & PLUSMN; 9.88), but 87 improved and 80 deteriorated by a change score of 10 or more. CANTAB Rapid Visual Information Processing scores were significantly associated with PCL-5 change scores. Conclusions: Strong sustained attention was associated with improvement in PTSD symptoms. Assessing cognitive performance may help identify individuals at risk of developing (persisting) PTSD post-TBI and offer opportunities for informing treatment strategies.</p>	[Van Praag, Dominique L. G.] Antwerp Univ Hosp, Dept Psychol, B-2650 Edegem, Belgium; [Van Praag, Dominique L. G.; van den Eede, Filip] Univ Antwerp, Collaborat Antwerp Psychiat Res Inst, B-2610 Antwerp, Belgium; [van den Eede, Filip] Antwerp Univ Hosp, Dept Psychiat, B-2650 Edegem, Belgium; [Wouters, Kristien] Antwerp Univ Hosp, Clin Trial Ctr, Clin Res Ctr Antwerp, B-2650 Edegem, Belgium; [Wouters, Kristien] Univ Antwerp, Antwerp Res Ctr, Fac Med, B-2610 Antwerp, Belgium; [Wilson, Lindsay] Univ Stirling, Div Psychol, Stirling FK9 4LA, Scotland; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, B-2650 Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Translat Neurosci, B-2610 Antwerp, Belgium		Van Praag, DLG (corresponding author), Antwerp Univ Hosp, Dept Psychol, B-2650 Edegem, Belgium.; Van Praag, DLG (corresponding author), Univ Antwerp, Collaborat Antwerp Psychiat Res Inst, B-2610 Antwerp, Belgium.	dominique.vanpraag@uza.be; filip.vandeneede@uza.be; kristien.wouters@uza.be; l.wilson@stir.ac.uk; andrew.maas@uza.be	; Maas, Andrew I.R./C-5584-2013	Van Den Eede, Filip/0000-0002-1942-1601; Wilson, Lindsay/0000-0003-4113-2328; Maas, Andrew I.R./0000-0003-1612-1264; Van Praag, Dominique/0000-0002-4279-6532	European UnionEuropean Commission [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); department of psychiatry of the Antwerp University Hospital	The data used in the preparation of this manuscript were obtained in the context of CENTER-TBI, a large, collaborative research project supported by the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA). This research was additionally funded by the department of psychiatry of the Antwerp University Hospital.	Alway Y, 2016, J NEUROTRAUM, V33, P825, DOI 10.1089/neu.2015.3992; Alway Y, 2016, DEPRESS ANXIETY, V33, P19, DOI 10.1002/da.22396; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Ben-Zion Z, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00477; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Cambridge Cognition, 2014, CANTAB RES SUIT 6 TE; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Grant G., 2016, TRANSLATIONAL RES TR; Guo XY, 2017, NEUROPSYCHOLOGY, V31, P84, DOI 10.1037/neu0000305; Hoge CW, 2014, LANCET PSYCHIAT, V1, P269, DOI 10.1016/S2215-0366(14)70235-4; IBM Corp, 2019, IBM SPSS STAT WINDOW; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Marx BP, 2009, J INT NEUROPSYCH SOC, V15, P840, DOI 10.1017/S1355617709990488; Merz ZC, 2017, BRAIN INJURY, V31, P1422, DOI 10.1080/02699052.2017.1339124; Nijdam MJ, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.19979; Park J, 2017, NEUROSCIENCE, V345, P193, DOI 10.1016/j.neuroscience.2016.06.013; Parslow RA, 2007, AM J PSYCHIAT, V164, P509, DOI 10.1176/appi.ajp.164.3.509; Pineau H, 2014, BEHAV SCI-BASEL, V4, P471, DOI 10.3390/bs4040471; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Reitan RM, 1992, TRAIL MAKING TEST MA; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Schmidt M., 1996, REY AUDITORY VERBAL; Schnurr, 2013, PTSD CHECKLIST DSM 5; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Sherman EMS, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P873, DOI 10.1007/978-0-387-76978-3_30; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; TEASDALE G, 1974, LANCET, V2, P81; Van Praag D, 2021, J PSYCHOSOM RES, V145, DOI 10.1016/j.jpsychores.2021.110448; Van Praag DLG, 2019, J NEUROTRAUM, V36, P3220, DOI 10.1089/neu.2018.5759; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Visser E, 2017, J TRAUMA ACUTE CARE, V82, P1158, DOI 10.1097/TA.0000000000001447; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wisdom NM, 2014, CLIN NEUROPSYCHOL, V28, P128, DOI 10.1080/13854046.2013.863977; Wortmann JH, 2016, PSYCHOL ASSESSMENT, V28, P1392, DOI 10.1037/pas0000260	43	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	NOV	2021	10	21							5109	10.3390/jcm10215109			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WX2ST	WOS:000718452900001	34768628	Green Published, gold			2022-02-06	
J	Vervoordt, SM; Arnett, P; Engeland, C; Rabinowitz, AR; Hillary, FG				Vervoordt, Samantha M.; Arnett, Peter; Engeland, Christopher; Rabinowitz, Amanda R.; Hillary, Frank G.			Depression Associated With APOE Status and Hippocampal Volume but Not Cognitive Decline in Older Adults Aging With Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						depression; traumatic brain injury; aging; decline	APOLIPOPROTEIN-E; ALZHEIMER-DISEASE; HEAD-INJURY; RISK-FACTOR; FOLLOW-UP; DEMENTIA; MEMORY; MODERATE; LIFE; IMPAIRMENT	Objective: To examine the relationship between depression and cognition, genetic risk, and hippocampal differences in a sample of older adults with a history of traumatic brain injury (TBI). Method: Participants were 85 males and 35 females (91 Caucasian, 29 African-American) with a mean age of 65.04 (+/- 8.27) years and a history of moderate, severe, or complicated mild TBI. Participants were an average of 9.33 (+/- 7.27) years post injury (range: 0.78-45.63). Participants underwent genetic testing, a comprehensive neuropsychological battery, surveys, and a subset underwent MRI scanning. Results: Apolipoprotein E (APOE) e4 carrier status predicted clinically significant depressive symptomatology on the Geriatric Depression Scale (GDS) with an odds ratio of 3.63, 95% CI [1.33, 9.29]. GDS was not associated with scores on measures of executive function, list learning recall, or retention. Although GDS score was initially associated with poorer confrontation naming scores and story memory recall, these effect sizes were small, and this variance was better accounted for by age and cognitive reserve. Higher GDS scores were also associated with decreased hippocampal volume. Conclusions: APOE carrier status was predictive of depression in a sample of older adults with a history of TBI. Depressive symptoms were also associated with decreased hippocampal volume but did not predict cognitive deficits in the examined domains beyond the effects of cognitive reserve. Despite the relationship between GDS and biological risks for decline, depressive symptoms in this population showed no direct relationship with cognitive decline.	[Vervoordt, Samantha M.; Arnett, Peter; Hillary, Frank G.] Penn State Univ, Dept Psychol, 140 Moore Bldg, State Coll, PA 16801 USA; [Engeland, Christopher] Penn State Univ, Dept Biobehav Hlth, State Coll, PA 16801 USA; [Rabinowitz, Amanda R.] Penn State Univ, Moss Rehabil Res Inst, State Coll, PA 16801 USA		Vervoordt, SM; Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, 140 Moore Bldg, State Coll, PA 16801 USA.	smv5469@psu.edu; fhillary@psu.edu			Pennsylvania Department of Health	This project is funded, in part, under a Grant from the Pennsylvania Department of Health. The Department specifically disclaims responsibility for any analyses, interpretations, or conclusions.	[Anonymous], FREESURFER ANAL PIPE; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Barnes J, 2009, NEUROBIOL AGING, V30, P1711, DOI 10.1016/j.neurobiolaging.2008.01.010; Barnes LL, 2013, NEUROEPIDEMIOLOGY, V40, P211, DOI 10.1159/000342778; Basso M. R., 2013, SECONDARY INFLUENCES, P39; Bernier RA, 2016, BRAIN INJURY, V30, P414, DOI 10.3109/02699052.2015.1127998; Brites D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00476; Byers AL, 2014, ALZHEIMERS DEMENT, V10, pS166, DOI 10.1016/j.jalz.2014.04.007; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Deary IJ, 2009, BRIT MED BULL, V92, P135, DOI 10.1093/bmb/ldp033; Diniz BS, 2013, BRIT J PSYCHIAT, V202, P329, DOI 10.1192/bjp.bp.112.118307; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gottlieb S, 2000, BRIT MED J, V321, P1100; Grauwmeijer E, 2018, J NEUROTRAUM, V35, P1543, DOI 10.1089/neu.2017.5404; Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753; Haigh EAP, 2018, AM J GERIAT PSYCHIAT, V26, P107, DOI 10.1016/j.jagp.2017.06.011; Hart T, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000210; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Ilie G, 2015, J PSYCHIATR RES, V69, P174, DOI 10.1016/j.jpsychires.2015.08.004; ILSLEY JE, 1995, J AFFECT DISORDERS, V35, P1, DOI 10.1016/0165-0327(95)00032-I; Jones RN, 2011, J INT NEUROPSYCH SOC, V17, P593, DOI 10.1017/S1355617710001748; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Katzen H., 2019, HDB NEUROPSYCHOLOGY, P11, DOI [10.1007/978-3-319-93497-6_2, DOI 10.1007/978-3-319-93497-6_2]; Kaup AR, 2017, J INT NEUROPSYCH SOC, V23, P56, DOI 10.1017/S1355617716000849; Koponen S, 2004, NEUROLOGY, V63, P749, DOI 10.1212/01.WNL.0000134603.57107.2F; LACHNER G, 1994, ARCH CLIN NEUROPSYCH, V9, P1; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lansing AE, 1999, ARCH CLIN NEUROPSYCH, V14, P481, DOI 10.1016/S0887-6177(98)00022-5; Lippa SM, 2020, J NEUROTRAUM, V37, P608, DOI 10.1089/neu.2019.6696; Marsh NV, 2016, NEUROREHABILITATION, V38, P71, DOI 10.3233/NRE-151297; Mauricio M, 2000, AM J GERIAT PSYCHIAT, V8, P196, DOI 10.1176/appi.ajgp.8.3.196; McIntyre RS, 2013, DEPRESS ANXIETY, V30, P515, DOI 10.1002/da.22063; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; Merritt VC, 2018, J NEUROTRAUM, V35, P2272, DOI 10.1089/neu.2017.5372; Michaelson DM, 2014, ALZHEIMERS DEMENT, V10, P861, DOI 10.1016/j.jalz.2014.06.015; Moritz S, 2017, EXPERT REV NEUROTHER, V17, P839, DOI 10.1080/14737175.2017.1347040; Morris JC, 2019, JAMA NEUROL, V76, P264, DOI 10.1001/jamaneurol.2018.4249; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; O'Shea DM, 2015, INT J GERIATR PSYCH, V30, P614, DOI 10.1002/gps.4192; Peterson AB, 2019, SURVEILLANCE REPORT; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Reed BR, 2010, BRAIN, V133, P2196, DOI 10.1093/brain/awq154; Roe CM, 2007, NEUROLOGY, V68, P223, DOI 10.1212/01.wnl.0000251303.50459.8a; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Shi F, 2009, HIPPOCAMPUS, V19, P1055, DOI 10.1002/hipo.20573; Snowdon J, 2001, AUST NZ J PSYCHIAT, V35, P782, DOI 10.1046/j.1440-1614.2001.00968.x; Solhaug HI, 2012, INT PSYCHOGERIATR, V24, P151, DOI 10.1017/S1041610211001141; Steffens DC, 2006, ARCH GEN PSYCHIAT, V63, P130, DOI 10.1001/archpsyc.63.2.130; Steffens DC, 2000, BIOL PSYCHIAT, V48, P301, DOI 10.1016/S0006-3223(00)00829-5; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Tchakoute CT, 2017, COGN BEHAV NEUROL, V30, P81, DOI 10.1097/WNN.0000000000000131; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Wang WW, 2019, IRAN J BASIC MED SCI, V22, P112, DOI 10.22038/ijbms.2018.30825.7436; WILLIAMS BW, 1989, NEUROPSYCHOLOGIA, V27, P1073, DOI 10.1016/0028-3932(89)90186-3; Wolf H, 2001, NEUROBIOL AGING, V22, P177, DOI 10.1016/S0197-4580(00)00238-4	60	0	0	1	1	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	NOV	2021	35	8					863	875		10.1037/neu0000750			13	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	WX1FY	WOS:000718350600006	34570541				2022-02-06	
J	Vivaldi, N; Caiola, M; Solarana, K; Ye, MJ				Vivaldi, Nicolas; Caiola, Michael; Solarana, Krystyna; Ye, Meijun			Evaluating Performance of EEG Data-Driven Machine Learning for Traumatic Brain Injury Classification	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Electroencephalography; History; Stroke (medical condition); Brain modeling; Brain injuries; Matlab; Machine learning; EEG database; machine learning (ML); traumatic brain injury (TBI); stroke	BIG DATA; CONNECTIVITY; OSCILLATIONS; CONCUSSION; AMPLITUDE; NETWORKS; RECOVERY	Objectives: Big data analytics can potentially benefit the assessment and management of complex neurological conditions by extracting information that is difficult to identify manually. In this study, we evaluated the performance of commonly used supervised machine learning algorithms in the classification of patients with traumatic brain injury (TBI) history from those with stroke history and/or normal EEG. Methods: Support vector machine (SVM) and K-nearest neighbors (KNN) models were generated with a diverse feature set from Temple EEG Corpus for both two-class classification of patients with TBI history from normal subjects and three-class classification of TBI, stroke and normal subjects. Results: For two-class classification, an accuracy of 0.94 was achieved in 10-fold cross validation (CV), and 0.76 in independent validation (IV). For three-class classification, 0.85 and 0.71 accuracy were reached in CV and IV respectively. Overall, linear discriminant analysis (LDA) feature selection and SVM models consistently performed well in both CV and IV and for both two-class and three-class classification. Compared to normal control, both TBI and stroke patients showed an overall reduction in coherence and relative PSD in delta frequency, and an increase in higher frequency (alpha, mu, beta and gamma) power. But stroke patients showed a greater degree of change and had additional global decrease in theta power. Conclusions: Our study suggests that EEG data-driven machine learning can be a useful tool for TBI classification. Significance: Our study provides preliminary evidence that EEG ML algorithm can potentially provide specificity to separate different neurological conditions.	[Vivaldi, Nicolas; Caiola, Michael; Solarana, Krystyna; Ye, Meijun] US FDA, Ctr Devices & Radiol Hlth, Off Sci & Engn Lab, Silver Spring, MD 20993 USA		Ye, MJ (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Off Sci & Engn Lab, Silver Spring, MD 20993 USA.	nvivaldi16@gmail.com; meijun.ye@fda.hhs.gov			Office of Science and Engineering Laboratories (OSEL); Center for Devices and Radiological Health (CDRH); Food and Drug Administration (FDA)United States Department of Health & Human Services	The work of Meijun Ye was supported by research fund of Office of Science and Engineering Laboratories (OSEL), Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA).	Acharya UR, 2018, COMPUT BIOL MED, V100, P270, DOI 10.1016/j.compbiomed.2017.09.017; Agoston Denes V, 2017, Concussion, V2, pCNC45, DOI 10.2217/cnc-2016-0013; Amorim E, 2019, CLIN NEUROPHYSIOL, V130, P1908, DOI 10.1016/j.clinph.2019.07.014; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boshra R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53751-9; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Craik A, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab0ab5; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Faul M, 2010, TRAUMATIC BRAIN INJU; Fisher JAN, 2016, IEEE T NEUR SYS REH, V24, P1003, DOI 10.1109/TNSRE.2016.2529663; Franke LM, 2016, INT J PSYCHOPHYSIOL, V106, P21, DOI 10.1016/j.ijpsycho.2016.05.010; Gavert H., 2005, LAB COMP INF SCI; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P353; Harati A, 2014, IEEE SIG PROC MED; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Lawhern VJ, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aace8c; Lewine JD, 2019, J CLIN NEUROPHYSIOL, V36, P298, DOI 10.1097/WNP.0000000000000588; Liu S, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/2582478; Malafeev A, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00781; McBride J, 2013, IEEE T BIO-MED ENG, V60, P90, DOI 10.1109/TBME.2012.2223698; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McNerney MW, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0187-y; Modarres Mo H., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P59, DOI 10.1016/j.nbscr.2016.06.001; Munia TTK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17414-x; Nahmias DO, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab4af3; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Obeid I, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00196; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Rigon A, 2016, J NEUROTRAUM, V33, P977, DOI 10.1089/neu.2014.3847; Schirrmeister RT, 2017, HUM BRAIN MAPP, V38, P5391, DOI 10.1002/hbm.23730; Schmitt Sarah, 2015, Handb Clin Neurol, V127, P319, DOI 10.1016/B978-0-444-52892-6.00021-0; Siuly S, 2016, DATA SCI ENG, V1, P54, DOI 10.1007/s41019-016-0011-3; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Thornton KE, 1999, BRAIN INJURY, V13, P477, DOI 10.1080/026990599121395; Tong SB, 2003, PHYS LETT A, V314, P354, DOI 10.1016/S0375-9601(03)00949-6; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Williamson JR, 2012, EPILEPSY BEHAV, V25, P230, DOI 10.1016/j.yebeh.2012.07.007; Ye MJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51876-5	45	0	0	4	4	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	NOV	2021	68	11					3205	3216		10.1109/TBME.2021.3062502			12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WJ5JI	WOS:000709080500007	33635785	Bronze			2022-02-06	
J	Wade, SL; Jones, KM; Corti, C; Adlam, AR; Limond, J; Bardoni, A; Gies, LM				Wade, Shari L.; Jones, Kelly M.; Corti, Claudia; Adlam, Anna R.; Limond, Jennifer; Bardoni, Alessandra; Gies, Lisa M.			Adapting Intervention Approaches to New Contexts: Three Case Studies of International Adaptation of the Teen Online Problem Solving (TOPS) Program	REHABILITATION PSYCHOLOGY			English	Article						brain injury; adolescents; intervention; executive functioning; problem-solving	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONING INTERVENTION; PRELIMINARY EFFICACY; RANDOMIZED-TRIAL; ADOLESCENTS; INTERNET; CHILDREN; REHABILITATION; FEASIBILITY; POPULATION	Purpose/Objective: To describe the process of adapting the evidence-based Teen Online Problem Solving (TOPS) program, a telehealth problem-solving treatment addressing executive function and behavior regulation challenges in adolescents with traumatic brain injury, in Italy, New Zealand, and the United Kingdom. Research Method/Design: We describe the process of adapting and translating the TOPS program in 3 case studies with unique methods and samples. In Italy, 14 parents of adolescents with TBI participated in focus groups, and 2 adolescents with TBI and their parents and 2 physicians provided input on the resulting translation. In New Zealand, an independent Maori cultural advisor reviewed the content, and 6 adolescent-parent dyads and 2 health professionals completed the 10 modules independently over a five-week period to inform adaptation. In the United Kingdom, a team of neuropsychologists and a parent of an adolescent with ABI reviewed and adapted the content through successive iterations. Results: In Italy, suggested changes included greater emphasis on nonverbal communication and clearer examples of inappropriate problem-solving responses. In New Zealand, parents and adolescents rated the program as acceptable and helpful. Suggestions included incorporating familiar Maori settings, integrating religion, and developing videos with New Zealand adolescents. In the United Kingdom, iterative refinements focused on adapting TOPS for other acquired brain injuries and reflecting cross-national differences (e.g., drinking age). Conclusions/Implications: These 3 case studies suggest that programs such as TOPS developed in 1 cultural context can be broadly acceptable in other contexts, with adaptations focusing on tailoring to reflect the unique cultural and linguistic setting. Impact and Implications This paper is among the first to describe the adaptation of an evidenced-based, rehabilitation psychology intervention (Teen Online Problem Solving; TOPS) for use in other countries, cultures, and languages. It highlights the broad applicability of the program across cultures, as well as the need to tailor content to reflect unique contexts across countries. The 3 case studies describing adaptations of TOPS for delivery in Italy, New Zealand, and the United Kingdom provide a valuable roadmap for the adaptation of other evidenced-based rehabilitation programs as well as the broader implementation of TOPS. They also highlight the value of international partnerships and point to the need to establish broader networks to support widespread implementation.	[Wade, Shari L.; Gies, Lisa M.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Pediat Rehabil Med, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; [Wade, Shari L.; Gies, Lisa M.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Jones, Kelly M.] Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Corti, Claudia; Bardoni, Alessandra] Sci Inst IRCCS E Medea, Lecce, Italy; [Adlam, Anna R.; Limond, Jennifer] Univ Exeter, Dept Psychol, Exeter, Devon, England		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Pediat Rehabil Med, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	Shari.Wade@cchmc.org	BARDONI, ALESSANDRA/AAH-7233-2019; Corti, Claudia/AAH-7222-2019; Jones, Kelly/G-4127-2015	BARDONI, ALESSANDRA/0000-0001-8404-3857; Corti, Claudia/0000-0003-1466-3182; Jones, Kelly/0000-0001-5692-653X; Gies, Lisa/0000-0002-8996-4281; Adlam, Anna/0000-0001-7212-4051	National Institute on Disability and Rehabilitation Research Award [HG133G050239]; Patient-Centered Outcomes Research Institute (PCORI) Dissemination and Implementation Award [DI-2018C3-14566]; Italian Ministry of HealthMinistry of Health, Italy; AUT Contestable Research Funding (FHES) 2013	this work is supported by a Grant from the National Institute on Disability and Rehabilitation Research Award HG133G050239 and was partially funded through a Patient-Centered Outcomes Research Institute (PCORI) Dissemination and Implementation Award (DI-2018C3-14566). The statements in this report are solely the responsibility of the authors and do not necessarily represent the views of PCORI, its Board of Governors or Methodology Committee. For the authors Alessandra Bardoni, Claudia Corti, and Shari L. Wade, this work is supported by the Italian Ministry of Health (Ricerca Corrente 2021). For authors Kelly M. Jones and Shari L. Wade, the development of TOPS-NZ was made possible by AUT Contestable Research Funding (FHES) 2013. We would also like to acknowledge Stacey Ruru, the Maori cultural advisor that guided the TOPS-NZ adaptation.	Accident Compensation Corporation, 2017, TRAUMATIC BRAIN INJU; Alverson DC, 2008, TELEMED J E-HEALTH, V14, P957, DOI 10.1089/tmj.2008.0115; Bartholomew T. T., 2012, INT PERSPECTIVES PSY, V1, P177, DOI [10.1037/a0029219, DOI 10.1037/A0029219]; Bender JL, 2011, PAIN, V152, P1740, DOI 10.1016/j.pain.2011.02.012; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cavanagh K, 2004, J CLIN PSYCHOL, V60, P239, DOI 10.1002/jclp.10261; Corti C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57952-5; Corti C, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/1346987; Corti C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199001; Cuijpers P, 2008, J BEHAV MED, V31, P169, DOI 10.1007/s10865-007-9144-1; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gazzellini S, 2012, EUR J PHYS REHAB MED, V48, P423; Glaser NJ, 2017, J FORMATIVE DES LEAR, V1, P126, DOI 10.1007/s41686-017-0011-3; Griffiths KM, 2007, AUST J RURAL HEALTH, V15, P81, DOI 10.1111/j.1440-1584.2007.00859.x; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; InternetNZ, 2017, STAT INT NZ; Laatsch L, 2020, NEUROPSYCHOL REHABIL, V30, P130, DOI 10.1080/09602011.2019.1678490; Limond J, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029349; Maresca G, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.563375; Menon DK, 2019, LANCET NEUROL, V18, P28, DOI 10.1016/S1474-4422(18)30463-0; Modi AC, 2017, EPILEPSY BEHAV, V72, P114, DOI 10.1016/j.yebeh.2017.04.009; Narad ME, 2019, J DEV BEHAV PEDIATR, V40, P451, DOI 10.1097/DBP.0000000000000681; Narad ME, 2019, ARCH PHYS MED REHAB, V100, P811, DOI 10.1016/j.apmr.2019.01.010; Nezu CM, 2005, WILEY SER FOREN CLIN, P103; O'Cathain A, 2019, PILOT FEASIBILITY ST, V5, DOI 10.1186/s40814-019-0425-6; Pass L, 2015, COGN BEH THER, V8, DOI 10.1017/S1754470X15000446; Pecini C, 2019, DYSLEXIA, V25, P318, DOI 10.1002/dys.1619; Raj SP, 2018, J ADOLESC YOUNG ADUL, V7, P187, DOI 10.1089/jayao.2017.0084; Raj SP, 2018, J HEAD TRAUMA REHAB, V33, pE19, DOI 10.1097/HTR.0000000000000388; Rathod S, 2019, COGN BEH THER, V12, DOI 10.1017/S1754470X18000247; Robin AL, 1989, NEGOTIATING PARENT A; Robinson KE, 2014, J PEDIATR PSYCHOL, V39, P846, DOI 10.1093/jpepsy/jsu031; Simone M, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1087-3; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Sousa VD, 2011, J EVAL CLIN PRACT, V17, P268, DOI 10.1111/j.1365-2753.2010.01434.x; Tucci R., 2015, BPA APPL PSYCHOL B, V63, P53; van Daele T, 2014, HEALTH PROMOT INT, V29, P212, DOI 10.1093/heapro/das070; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2020, J PSYCHOTHER INTEGR, V30, P332, DOI 10.1037/int0000215; Wade SL, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28043; Wade SL, 2019, J INT NEUROPSYCH SOC, V25, P941, DOI 10.1017/S1355617719000778; Wade SL, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000487; Wade SL, 2019, REHABIL PSYCHOL, V64, P298, DOI 10.1037/rep0000268; Wade SL, 2019, J PEDIATR PSYCHOL, V44, P388, DOI 10.1093/jpepsy/jsy087; Wade SL, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0422; Wade SL, 2017, REHABIL PSYCHOL, V62, P290, DOI 10.1037/rep0000160; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wuthrich VM, 2012, J AM ACAD CHILD PSY, V51, P261, DOI 10.1016/j.jaac.2011.12.002; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zampolini M, 2012, BRAIN INJURY, V26, P27, DOI 10.3109/02699052.2011.635358; Zhang NH, 2019, J NEUROTRAUM, V36, P1147, DOI 10.1089/neu.2018.5885	56	0	0	1	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2021	66	4					356	365		10.1037/rep0000414			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	XI0QC	WOS:000725826700005	34871027	Green Accepted, Green Published			2022-02-06	
J	Wakam, GK; Biesterveld, BE; Pai, MJP; Kemp, MT; O'Connell, RL; Rajanayake, KK; Chtraklin, K; Vercruysse, CA; Alam, HB				Wakam, Glenn K.; Biesterveld, Ben E.; Pai, Manjunath P.; Kemp, Michael T.; O'Connell, Rachel L.; Rajanayake, Krishani K.; Chtraklin, Kiril; Vercruysse, Claire A.; Alam, Hasan B.			A single dose of valproic acid improves neurologic recovery and decreases brain lesion size in swine subjected to an isolated traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Neuroprotection; traumatic brain injury; valproic acid; preclinical swine model; swine	FRESH-FROZEN PLASMA; HEMORRHAGIC-SHOCK; UNITED-STATES; RESUSCITATION; MODEL	BACKGROUND We lack specific treatments for traumatic brain injury (TBI), which remains the leading cause of trauma-related morbidity and mortality. Treatment with valproic acid (VPA) improves outcomes in models of severe TBI with concurrent hemorrhage. However, it is unknown if VPA will have similar benefits after isolated nonlethal TBI, which is the more common clinical scenario. The goal of this study was to evaluate the effect of VPA treatment in a preclinical isolated TBI swine model on neurologic outcomes and brain lesion size and to perform detailed pharmacokinetic analyses for a future clinical trial. METHODS Yorkshire swine (n = 10; 5/cohort) were subjected to TBI (8-mm controlled cortical impact). An hour later, we randomized them to receive VPA (150 mg/kg) or saline placebo (control). Neuroseverity scores were assessed daily (0 [normal] to 36 [comatose]), brain lesion size was measured on postinjury 3, and serial blood samples were collected for pharmacokinetic studies. RESULTS Physiologic parameters and laboratory values were similar in both groups. Valproic acid-treated animals demonstrated significantly better neuroseverity scores on postinjury 1 (control, 9.2 +/- 4.4; VPA, 0 +/- 0; p = 0.001). Valproic acid-treated animals had significantly smaller brain lesion sizes (mean volume in microliter: control, 3,130 +/- 2,166; VPA, 764 +/- 208; p = 0.02). Pharmacokinetic data confirmed adequate plasma and tissue levels of VPA. CONCLUSION In this clinically relevant model of isolated TBI, a single dose of VPA attenuates neurological impairment and decreases brain lesion size.	[Wakam, Glenn K.; Biesterveld, Ben E.; Kemp, Michael T.; Vercruysse, Claire A.] Univ Michigan, Dept Surg, Ann Arbor, MI USA; [Pai, Manjunath P.; Rajanayake, Krishani K.] Univ Michigan, Dept Clin Pharm, Ann Arbor, MI USA; [O'Connell, Rachel L.; Chtraklin, Kiril; Alam, Hasan B.] Northwestern Univ, Dept Surg, Chicago, IL 60208 USA		Alam, HB (corresponding author), Northwestern Univ, Dept Surg, Chicago, IL 60208 USA.	gwakam@med.umich.edu; bbiester@med.umich.edu; amitpai@med.umich.edu; mikemp@med.umich.edu; Rachel.oconnell@northwestern.edu; krishani@med.umich.edu; kiril.chtraklin@northwestern.edu; clairevercruysse@email.arizona.edu; Hasan.Alam@nm.org			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-17-C-0246]; National Institute of GeneralMedical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [F32GM130010]	The authors declare no conflicts of interest. This work was supported by the US Army Medical Research and Materiel Command under contract number W81XWH-17-C-0246 to H.B.A. In addition, B.E.B. was supported by the National Institute of GeneralMedical Sciences of the National Institutes of Health under award number F32GM130010.; The views, opinions, and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy, or decision unless so designated by other documentation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Biesterveld B, 2019, J TRAUMA ACUTE CARE, V87, P1133, DOI 10.1097/TA.0000000000002460; CORNFORD EM, 1985, J NEUROCHEM, V44, P1541, DOI 10.1111/j.1471-4159.1985.tb08793.x; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Drisaldi A, 2019, NEUROCRIT CARE, V30, P301, DOI 10.1007/s12028-018-0627-4; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Li ZH, 2020, THER DRUG MONIT, V42, P610, DOI 10.1097/FTD.0000000000000749; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Peterson AB, 2019, SURVEILLANCE REPORT; Rhee P, 2000, J TRAUMA, V48, P439, DOI 10.1097/00005373-200003000-00011; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; VandenBerg A., 2018, MENT HLTH CLIN, V7, P13; Wakam GK, 2021, J TRAUMA ACUTE CARE, V90, P346, DOI 10.1097/TA.0000000000003036	16	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2021	91	5					867	871		10.1097/TA.0000000000003136			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	WL8JL	WOS:000710645200022	34695064				2022-02-06	
J	Wang, AR; Calandra, MJ; Friedman, BW				Wang, Andrew R.; Calandra, Mark J.; Friedman, Benjamin W.			Clinical predictors of poor 30-day headache outcomes after an emergency department visit for acute post-traumatic headache	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Post-traumatic headache; Head trauma; Traumatic brain injury	TRAUMATIC BRAIN-INJURY	Purpose: We investigated clinical risk factors that predict poor 30-day headache outcomes among patients evaluated in the emergency department (ED) for post-traumatic headache (PTH). Methods: This was an analysis of data from a randomized, placebo-controlled study of IV metoclopramide + diphenhydramine for acute PTH. Patients were enrolled during an ED visit and received telephone follow-up with a structured questionnaire 30 days later. The primary outcome was frequency of headaches 30 days after ED discharge. We used multivariable logistic regression models to determine which clinical variables were associated with frequent headaches at 30 days. Results: In total, 160 patients were enrolled in the study. 134 (84%) patients completed the 30-day questionnaire and were included in the analysis, including 90 females and 44 males. 30 patients (22%, 95% CI = 0.16 to 0.30) reported frequent headaches at 30-day follow-up. In the multivariable analysis, female sex (OR = 4.03, 95% CI = 1.23 +/- 13.13), patients who blamed themselves for their injury (OR = 0.13, 95% CI = 0.04 +/- 0.45), and patients who were unsure if they sustained loss of consciousness during the traumatic incident (OR = 5.63, 95% CI = 1.89 +/- 16.78) were found to be associated with poor 30-day outcomes. Medication received in the ED and age were not associated. Conclusions: More than 1 out of five patients treated in the ED for acute PTH experienced frequent headaches 30 days later. Women and patients who were uncertain as to whether they had experienced loss of consciousness were at increased risk of frequent PTH. Blaming oneself for the head trauma was associated with less frequent PTH. (C) 2021 Elsevier Inc. All rights reserved.	[Wang, Andrew R.] Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Calandra, Mark J.] AT Still Univ, Sch Osteopath Med Arizona, 5850 E Still Circle, Mesa, AZ 85206 USA; [Friedman, Benjamin W.] Montefiore, Dept Emergency Med, Albert Einstein Coll Med, 111 East 210th St, Bronx, NY 10467 USA		Wang, AR (corresponding author), 1925 Eastchester Rd,Apt 28B, Bronx, NY 10461 USA.	andrewraywang@gmail.com; befriedm@montefiore.org					Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bree D, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0720-6; Bryan CJ, 2011, HEADACHE, V51, P945, DOI 10.1111/j.1526-4610.2011.01887.x; Chan TLH, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-1080-2; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; D'Onofrio F, 2014, NEUROL SCI, V35, pS203, DOI 10.1007/s10072-014-1771-z; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Friedman BW, 2018, AM J EMERG MED, V36, P285, DOI 10.1016/j.ajem.2017.10.034; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Larsen EL, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1051-7; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Obermann M, 2009, EXPERT REV NEUROTHER, V9, P1361, DOI [10.1586/ern.09.84, 10.1586/ERN.09.84]; Sawyer K, 2015, ARCH PHYS MED REHAB, V96, P2000, DOI 10.1016/j.apmr.2015.07.006; Schwedt TJ, 2021, CEPHALALGIA, V41, P464, DOI 10.1177/0333102420970188; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Yilmaz T, 2017, EMERG MED J, V34, P800, DOI 10.1136/emermed-2015-205429	21	0	0	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	NOV	2021	49						158	162		10.1016/j.ajem.2021.05.075			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	WE1PW	WOS:000705400600032	34118783				2022-02-06	
J	Wang, RR; Poublanc, J; Crawley, AP; Sobczyk, O; Kneepkens, S; Mcketton, L; Tator, C; Wu, RH; Mikulis, DJ				Wang, Runrun; Poublanc, Julien; Crawley, Adrian P.; Sobczyk, Olivia; Kneepkens, Sander; Mcketton, Larissa; Tator, Charles; Wu, Renhua; Mikulis, David J.			Cerebrovascular reactivity changes in acute concussion: a controlled cohort study	QUANTITATIVE IMAGING IN MEDICINE AND SURGERY			English	Article						Concussion; blood oxygen level-dependent imaging; cerebrovascular reactivity; cerebral blood flow (CBF)	CEREBRAL-BLOOD-FLOW; BOLD; METABOLISM; INJURY	Background: Evidence suggests that cerebrovascular reactivity (CVR) increases within the first week after the incidence of concussion, indicating a disruption of normal autoregulation. We sought to extend these findings by investigating the effects of acute concussion on the speed of CVR response and by visualizing global and regional impairments in individual patients with acute concussion. Methods: Twelve patients aged 18-40 years who experienced concussion less than a week before this prospective study were included. Twelve age and sex-matched healthy subjects constituted the control group. In all subjects, CVR was assessed using blood oxygenation level-dependent (BOLD) echo-planar imaging with a 3.0T MRI scanner, in combination with changes in end-tidal partial pressure of CO2 (PETCO2). In each subject, we calculated the CVR amplitude and CVR response time in the gray and white matter using a step and ramp PETCO2 challenge. In addition, a separate group of 39 healthy controls who underwent the same evaluation was used to create atlases with voxel-wise mean and standard deviation of CVR amplitude and CVR response time. This allowed us to convert each metric of the 12 patients with concussion and the 12 healthy controls into z-score maps. These maps were then used to generate and compare z-scores for each of the two groups. Group differences were calculated using an unpaired t-test. Results: All studies were well tolerated without any serious adverse events. Anatomical MRI was normal in all study subjects. No differences in CO2 stimulus and O-2 targeting were observed between the two participant groups during BOLD MRI. With regard to the gray matter, the CVR magnitude step (P=0.117) and ramp + 10 (P=0.085) were not significantly different between patients with concussion and healthy controls. However, the tau value was significantly lower in patients with concussion than in the healthy controls (P=0.04). With regard to the white matter, the CVR magnitude step (P=0.003) and ramp + 10 (P=0.031) were significantly higher and the tau value (P=0.024) was significantly shorter in patients with concussion than in healthy controls. After z-score transformation, the z tau value was significantly lower in patients with concussion than in healthy controls (Grey matter P=0.021, White matter P=0.003). Comparison of the three parameters, z ramp + 10, z step, and z tau, between the two groups showed that z step (Grey matter P=0.035, White matter P=0.005) was the most sensitive parameter and that z ramp + 10 (Grey matter P=0.073, White matter P=0.126) was the least sensitive parameter. Conclusions: Concussion is associated with patient-specific abnormalities in BOLD cerebrovascular responsiveness that occur in the setting of normal global CVR. This study demonstrates that the measurement of CVR using BOLD MRI and precise CO2 control is a safe, reliable, reproducible, and clinically useful method for evaluating the state of patients with concussion. It has the potential to be an important tool for assessing the severity and duration of symptoms after concussion.	[Wang, Runrun; Poublanc, Julien; Crawley, Adrian P.; Sobczyk, Olivia; Kneepkens, Sander; Mcketton, Larissa; Mikulis, David J.] Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Joint Dept Med Imaging, Toronto, ON, Canada; [Wang, Runrun] Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Neurol, Peoples Hosp, Zhengzhou, Henan, Peoples R China; [Wang, Runrun; Wu, Renhua] Shantou Univ, Affiliated Hosp 2, Dept Med Imaging, Med Coll, Shantou 515041, Peoples R China; [Tator, Charles] Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Dept Surg,Div Neurosurg, Toronto, ON, Canada		Wu, RH (corresponding author), Shantou Univ, Affiliated Hosp 2, Dept Med Imaging, Med Coll, Shantou 515041, Peoples R China.; Mikulis, DJ (corresponding author), Toronto Western Hosp, Joint Dept Med Imaging, 3MC-431,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	rhwu@stu.edu.cn; David.Mikulis@uhn.ca			National Key Research and Development Program of China [2016YFC1305900]; National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31870981, 82020108016]	This research was supported by the National Key Research and Development Program of China (Grant No.: 2016YFC1305900) and the National Science Foundation of China (Grant No.: 31870981, 82020108016) .	Ainslie PN, 2009, AM J PHYSIOL-REG I, V296, pR1473, DOI 10.1152/ajpregu.91008.2008; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Boshra R, 2019, IEEE T NEUR SYS REH, V27, P1492, DOI 10.1109/TNSRE.2019.2922553; Chan ST, 2015, BRAIN INJURY, V29, P403, DOI 10.3109/02699052.2014.974209; Chen JJ, 2010, J CEREBR BLOOD F MET, V30, P1094, DOI 10.1038/jcbfm.2010.42; Churchill NW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58073-9; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Di Battista AP, 2018, J NEUROIMMUNOL, V319, P1, DOI 10.1016/j.jneuroim.2018.03.002; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Duffin J, 2015, NEUROIMAGE, V114, P207, DOI 10.1016/j.neuroimage.2015.04.029; Duffin J, 2017, HUM BRAIN MAPP, V38, P5590, DOI 10.1002/hbm.23751; Dumas A, 2012, ANN NEUROL, V72, P76, DOI 10.1002/ana.23566; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00061; Fisher JA, 2017, HUM BRAIN MAPP, V38, P3415, DOI 10.1002/hbm.23598; Fisher JA, 2016, J CEREBR BLOOD F MET, V36, P1004, DOI 10.1177/0271678X16639326; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Giza C, 2018, HAND CLINIC, V158, P51, DOI 10.1016/B978-0-444-63954-7.00006-9; Halani S, 2015, NEUROIMAGE, V110, P110, DOI 10.1016/j.neuroimage.2015.01.050; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Ito S, 2008, J PHYSIOL-LONDON, V586, P3675, DOI 10.1113/jphysiol.2008.154716; Leung J, 2016, J PHYSIOL-LONDON, V594, P2681, DOI 10.1113/JP271056; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lu HZ, 2011, CEREB CORTEX, V21, P1426, DOI 10.1093/cercor/bhq224; Mandell DM, 2011, AM J NEURORADIOL, V32, P721, DOI 10.3174/ajnr.A2365; McKetton L, 2018, NEUROIMAGE, V181, P132, DOI 10.1016/j.neuroimage.2018.07.007; McKetton L, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00226; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mu WY, 2017, J HEAD TRAUMA REHAB, V32, P55, DOI 10.1097/HTR.0000000000000213; Murdaugh DL, 2018, J INT NEUROPSYCH SOC, V24, P781, DOI 10.1017/S1355617718000413; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Nzou G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66487-8; Papa L, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000473; Pillai JJ, 2015, AM J NEURORADIOL, V36, P7, DOI 10.3174/ajnr.A3941; Poublanc J, 2015, J CEREBR BLOOD F MET, V35, P1746, DOI 10.1038/jcbfm.2015.114; Shafi R, 2021, J NEUROTRAUM, V38, P1036, DOI 10.1089/neu.2020.7272; Smith KJ, 2017, EXP PHYSIOL, V102, P1356, DOI 10.1113/EP086249; Sobczyk O, 2014, NEUROIMAGE, V92, P56, DOI 10.1016/j.neuroimage.2014.01.051; Sobczyk O, 2015, J CEREBR BLOOD F MET, V35, P213, DOI 10.1038/jcbfm.2014.184; Somogyi RB, 2005, ANAESTH INTENS CARE, V33, P726, DOI 10.1177/0310057X0503300604; Spano VR, 2013, RADIOLOGY, V266, P592, DOI 10.1148/radiol.12112795; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tasker RC, 2017, CURR OPIN ANESTHESIO, V30, P343, DOI 10.1097/ACO.0000000000000459; Teuho Jarmo, 2015, EJNMMI Phys, V2, pA26, DOI 10.1186/2197-7364-2-S1-A26; Thomas RE, 2017, RESTOR NEUROL NEUROS, V35, P643, DOI 10.3233/RNN-170761; Wang Y, 2019, BRAIN IMAGING BEHAV, V13, P1375, DOI 10.1007/s11682-018-9946-5; Wilde EA, 2020, J NEUROTRAUM, V37, P2093, DOI 10.1089/neu.2018.6365; Willie CK, 2012, J PHYSIOL-LONDON, V590, P3261, DOI 10.1113/jphysiol.2012.228551; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zuckerman SL, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0909-4	51	0	0	4	4	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2223-4292	2223-4306		QUANT IMAG MED SURG	Quant. Imaging Med. Surg.	NOV	2021	11	11					4530	4542		10.21037/qims-20-1296			13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	UA2GF	WOS:000684982000003	34737921	Green Published, gold			2022-02-06	
J	Whitney, K; Nikulina, E; Rahman, SN; Alexis, A; Bergold, PJ				Whitney, Kristen; Nikulina, Elena; Rahman, Syed N.; Alexis, Alisia; Bergold, Peter J.			Delayed dosing of minocycline plus N-acetylcysteine reduces neurodegeneration in distal brain regions and restores spatial memory after experimental traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Diffuse brain injury; Therapeutic time window; Hippocampus; Spatial learning and memory; Dendritic morphology; Dendritic spines; Neuroprotection	CONTROLLED CORTICAL IMPACT; DENDRITIC SPINES; PYRAMIDAL NEURONS; DEFICITS; CA1; HIPPOCAMPUS; DAMAGE; ACTIVATION; INFLAMMATION; PLASTICITY	Multiple drugs to treat traumatic brain injury (TBI) have failed clinical trials. Most drugs lose efficacy as the time interval increases between injury and treatment onset. Insufficient therapeutic time window is a major reason underlying failure in clinical trials. Few drugs have been developed with therapeutic time windows sufficiently long enough to treat TBI because little is known about which brain functions can be targeted if therapy is delayed hours to days after injury. We identified multiple injury parameters that are improved by first initiating treatment with the drug combination minocycline (MINO) plus N-acetylcysteine (NAC) at 72 h after injury (MN72) in a mouse closed head injury (CHI) experimental TBI model. CHI produces spatial memory deficits resulting in impaired performance on Barnes maze, hippocampal neuronal loss, and bilateral damage to hippocampal neurons, dendrites, spines and synapses. MN72 treatment restores Barnes maze acquisition and retention, protects against hippocampal neuronal loss, limits damage to dendrites, spines and synapses, and accelerates recovery of microtubule associated protein 2 (MAP2) expression, a key protein in maintaining proper dendritic architecture and synapse density. These data show that in addition to the structural integrity of the dendritic arbor, spine and synapse density can be successfully targeted with drugs first dosed days after injury. Retention of substantial drug efficacy even when first dosed 72 h after injury makes MINO plus NAC a promising candidate to treat clinical TBI.	[Whitney, Kristen; Nikulina, Elena; Rahman, Syed N.; Alexis, Alisia; Bergold, Peter J.] SUNY Downstate Hlth Sci Univ, Dept Physiol & Pharmacol, Box 29,450 Clarkson Ave, Brooklyn, NY 11215 USA; [Whitney, Kristen; Bergold, Peter J.] SUNY Downstate Hlth Sci Univ, Sch Grad Studies, Program Neural & Behav Sci, Brooklyn, NY 11215 USA		Bergold, PJ (corresponding author), SUNY Downstate Hlth Sci Univ, Dept Physiol & Pharmacol, Box 29,450 Clarkson Ave, Brooklyn, NY 11215 USA.	peter.bergold@downstate.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS108190-01]	The authors thank Drs. Julie Parato, Sheryl Smith and Mr. Matthew Evrard, for their assistance with the Golgi-Cox studies. This work was supported by NIH grant NS108190-01 (to P.J.B.)	Afroz S, 2016, ELIFE, V5, DOI 10.7554/eLife.15106; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; AUER RN, 1989, J NEUROSCI, V9, P1641; Avila JA, 2017, HIPPOCAMPUS, V27, P1224, DOI 10.1002/hipo.22768; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bloss EB, 2011, J NEUROSCI, V31, P7831, DOI 10.1523/JNEUROSCI.0839-11.2011; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; Chakroborty S, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0307-7; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Cherubini E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00019; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Failla M.D., 2015, BRAIN NEUROTRAUMA MO; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Gilbert PE, 2009, PROG NEURO-PSYCHOPH, V33, P774, DOI 10.1016/j.pnpbp.2009.03.037; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Grin'kina NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161053; Haber M, 2018, J CEREBR BLOOD F MET, V38, P1312, DOI 10.1177/0271678X17718106; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Klur S, 2009, HIPPOCAMPUS, V19, P800, DOI 10.1002/hipo.20562; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Le Duigou C, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00262; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Milani H, 1998, J NEUROSCI METH, V80, P19, DOI 10.1016/S0165-0270(97)00184-2; Mohamadpour M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00007; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Ouyang Z, 2019, 3 BIOTECH, V9, DOI 10.1007/s13205-019-1805-6; Poe GR, 2000, BEHAV NEUROSCI, V114, P940, DOI 10.1037//0735-7044.114.5.940; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Risher WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107591; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Sangobowale MA, 2018, J NEUROTRAUM, V35, P907, DOI 10.1089/neu.2017.5348; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Sebastian V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079077; Shinohara Y, 2012, HIPPOCAMPUS, V22, P117, DOI 10.1002/hipo.20886; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Stuart GJ, 2015, NAT NEUROSCI, V18, P1713, DOI 10.1038/nn.4157; Sun HS, 2006, J NEUROPHYSIOL, V95, P2590, DOI 10.1152/jn.00970.2005; Sunyer B, 2007, BARNES MAZE USEFUL T; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; White ER, 2017, J NEUROTRAUM, V34, P1111, DOI 10.1089/neu.2016.4638; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Wright DW, 2014, ACAD EMERG MED, V21, P1414, DOI 10.1111/acem.12532; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yi JH, 2005, BRAIN RES, V1033, P13, DOI 10.1016/j.brainres.2004.10.055	78	0	0	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2021	345								113816	10.1016/j.expneurol.2021.113816			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UQ3JC	WOS:000695962700002	34310944	Green Submitted			2022-02-06	
J	Williams, RM; Root, HJ; McLeod, TCV				Williams, Richelle M.; Root, Hayley J.; McLeod, Tamara C. Valovich			Athletic Administrators' Reporting of Emergency Preparedness Regarding Policies and Procedures in Iowa Secondary Schools	JOURNAL OF ATHLETIC TRAINING			English	Article						athletic trainer; emergency action plans; policies; concussion; heat illness	ASSOCIATION POSITION STATEMENT; PREVENTING SUDDEN-DEATH; CARDIAC-ARREST; TASK-FORCE; PROGRAMS; TRAINERS; ADOPTION	Context: Secondary schools that offer school-sponsored athletic events should follow best-practice guidelines to provide policies that promote student health and safety. Objective: To assess emergency preparedness from the perspective of athletic administrators (AAs) in Iowa secondary schools. Design: Cross-sectional study. Setting: Online survey. Patients or Other Participants: Ninety-eight AAs from Iowa completed the survey (age = 45.33 +/- 10.22 years, years as an AA = 9.37 +/- 8.14, years in current role = 7.72 +/- 7.09). Main Outcome Measures(s): The 6-section survey contained with questions about access to athletic trainers (ATs), emergency action plans (EAPs), cardiopulmonary resuscitation (CPR), automated external defibrillators (AEDs), concussions, heat illness, and other general policies. Descriptive statistics (percentages and frequencies) were reported. Relative risk was calculated to compare schools with and those without access to ATs (P , .05). Results: Most respondents (76.5%, n = 75/98) reported their school had access to a licensed AT. The majority had a written EAP (83.3%, n = 70/84), but fewer than half (39.2%, n = 31/79) reviewed it annually and fewer than 10% (n = 6/85) reported practicing it each year. All respondents (100%, N = 78/78) stated they had an AED on campus. All respondents (N = 77/77) indicated that they were familiar with the Iowa High School Athletic Association's (IHSAA's) concussion policy and had a concussion guideline in place. Many respondents (95.9%, n = 71/74) described being familiar with the IHSAA's heat illness policy, but more than half (62.1%, n = 41/66) noted they did not have a heat illness policy in place at their school. Conclusions: Most respondents indicated their school had access to ATs, followed the state-mandated concussion guidelines, and had an AED. Although participants reported having written EAPs in place, levels of annual EAP review and practice were low. These results suggest that schools would benefit from educational opportunities to improve safety policies.	[Williams, Richelle M.] Drake Univ, Dept Athlet Training, 2507 Univ Ave,Fitch Hall 124, Des Moines, IA 50311 USA; [Root, Hayley J.] No Arizona Univ, Dept Phys Therapy & Athlet Training, Phoenix, AZ USA; [McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Programs, Mesa, AZ 85206 USA; [McLeod, Tamara C. Valovich] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ 85206 USA		Williams, RM (corresponding author), Drake Univ, Dept Athlet Training, 2507 Univ Ave,Fitch Hall 124, Des Moines, IA 50311 USA.	Richelle.williams@drake.edu					Adams WM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117727262; Andersen JC, 2002, J ATHL TRAINING, V37, P99; [Anonymous], NAT C STAT LEG; [Anonymous], 2020, CONC BRAIN INJ POL; Armstrong LE, 2007, MED SCI SPORT EXER, V39, P556, DOI 10.1249/MSS.0b013e31802fa199; Aschieri D, 2018, HEART, V104, P1344, DOI 10.1136/heartjnl-2017-312441; Casa DJ, 2015, J ATHL TRAINING, V50, P986, DOI 10.4085/1062-6050-50.9.07; Casa DJ, 2013, J ATHL TRAINING, V48, P546, DOI 10.4085/1062-6050-48.4.12; Casa DJ, 2012, J ATHL TRAINING, V47, P96; Coaching, IOW BOARD ED EX; Drezner JA, 2007, HEART RHYTHM, V4, P549, DOI 10.1016/j.hrthm.2007.02.019; Huggins RA, 2019, J ATHL TRAINING, V54, P1129, DOI 10.4085/1062-6050-12-19; Johnson ST, 2017, SPORTS HEALTH, V9, P181, DOI 10.1177/1941738116686782; Kerr ZY, 2019, J ATHL TRAINING, V54, P921, DOI 10.4085/1062-6050-581-18; Kerr ZY, 2019, ENVIRON HEALTH PERSP, V127, DOI [10.1289/EHP4163, 10.1289/ehp4163]; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; Luhring KE, 2016, J ATHL TRAINING, V51, P946, DOI 10.4085/1062-6050-51.12.07; Mazerolle SM, 2011, J ATHL TRAINING, V46, P566; Mazerolle SM, 2010, J ATHL TRAINING, V45, P170, DOI 10.4085/1062-6050-45.2.170; McLeod TCV, 2019, J ATHL TRAINING, V54, P133, DOI 10.4085/1062-6050-35-18; Pike AM, 2017, J ATHL TRAINING, V52, P5, DOI 10.4085/1062-6050-51.11.15; Scarneo SE, 2019, J ATHL TRAINING, V54, P99, DOI 10.4085/1062-6050-82-18; Scarneo-Miller SE, 2020, J ATHL TRAINING, V55, P80, DOI 10.4085/1062-6050-484-18; Scarneo-Miller SE, 2019, J APPL SPORT MANAG, V11, P1, DOI 10.18666/JASM-2019-V11-I3-9240; Schneider K, 2017, RURAL REMOTE HEALTH, V17; Toresdahl BG, 2013, J ATHL TRAINING, V48, P242, DOI 10.4085/1062-6050-48.1.20; Wasilko SM, 2013, SPORTS HEALTH, V5, P548, DOI 10.1177/1941738113484250	27	0	0	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV	2021	56	11					1224	1231		10.4085/1062-6050-0494.20			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WZ4WD	WOS:000719968500008	34752627	gold			2022-02-06	
J	Wilson, JC; Carry, PM; Daoud, AK; Strunk, S; Sweeney, EA; Howell, DR; Comstock, RD				Wilson, Julie C.; Carry, Patrick M.; Daoud, Ariel Kiyomi; Strunk, Sydney; Sweeney, Emily A.; Howell, David R.; Comstock, R. Dawn			Single season re-injury risk after concussion and lower extremity injury among male, collision sport, high school athletes	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Concussion; Musculoskeletal injury; Re-injury; Adolescent athlete	MUSCULOSKELETAL INJURY; SUBSEQUENT INJURY; FOOTBALL; INCREASES; RETURN; PLAY	Objectives: Research suggests that a recent concussion increases subsequent lower extremity injury risk; however, data in high school athletes is limited. This study evaluates the association between concussion and subsequent injury risk among male, collision sport, high school athletes over a single season. Design: Retrospective cohort study. Methods: Data were obtained from 2005/06-2014/15 in the High School Reporting Information Online database. A two stage, multi-method matching process was used to identify athletes who suffered multiple injuries over a single athletic season. Demographics and injury characteristics were compared with Chi square and Student's t-tests. Multiple Cox Proportional Hazards regression analysis was used to test whether index injury type was associated with hazard of subsequent injury following return to play from index injury. Results: Overall 1364 HS athletes sustained 2 injuries over a single athletic season (subsequent injury within 45 days of the index injury). Index injuries included 686 (50.2%) lower extremity injuries, 417 (30.6%) upper extremity injuries, and 261 (19.1%) concussions. Hazard of subsequent concussion was increased in the index concussion group relative to the index lower extremity injury group [hazard ratio (HR): 1.60, 95% CI: 1.15-2.23, p = 0.0052]. Hazard of a subsequent lower extremity injury was not significantly different for the index lower extremity injury group relative to the index concussion group [HR: 1.27, 95% CI: 0.98-1.65, p = 0.0728]. Conclusions: History of recent concussion or recent lower extremity injury are both risk factors for subsequent lower extremity injury in male, collision sport, high school athletes. (c) 2021 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Wilson, Julie C.; Sweeney, Emily A.; Howell, David R.] Childrens Hosp Colorado, Ctr Sports Med, Aurora, CO 80045 USA; [Wilson, Julie C.; Daoud, Ariel Kiyomi; Sweeney, Emily A.; Howell, David R.] Univ Colorado, Sch Med, Boulder, CO 80309 USA; [Carry, Patrick M.] Childrens Hosp Colorado, Musculoskeletal Res Ctr, Aurora, CO USA; [Daoud, Ariel Kiyomi; Strunk, Sydney] Cornell Coll, Mt Vernon, IA 52314 USA; [Comstock, R. Dawn] Univ Colorado Anschutz, Colorado Sch Publ Hlth, Aurora, CO USA		Wilson, JC (corresponding author), Childrens Hosp Colorado, Ctr Sports Med, Aurora, CO 80045 USA.; Wilson, JC (corresponding author), Univ Colorado, Sch Med, Boulder, CO 80309 USA.	Julie.Wilson@childrenscolorado.org			National Federation of State High School Associations (Indianapolis, IN); National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); DJO LLC (Vista, CA); Centers for Disease Control and Prevention (Atlanta, GA)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]	There was no external funding for this study, although the HS RIO database has received funding from the National Federation of State High School Associations (Indianapolis, IN) , the National Operating Committee on Standards for Athletic Equipment (Overland Park, KS) , DJO LLC (Vista, CA) and the Centers for Disease Control and Prevention (Atlanta, GA) grants R49/CE000674-01 and R49/CE001172-01.	Bengtsson H, 2020, BRIT J SPORT MED, V54, P427, DOI 10.1136/bjsports-2019-100655; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Doherty C, 2014, SPORTS MED, V44, P123, DOI 10.1007/s40279-013-0102-5; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hagglund M, 2006, BRIT J SPORT MED, V40, P767, DOI 10.1136/bjsm.2006.026609; Hamilton GM, 2011, AM J EPIDEMIOL, V173, P941, DOI 10.1093/aje/kwq461; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Herman DC, 2015, CURR SPORT MED REP, V14, P194, DOI 10.1249/JSR.0000000000000157; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Hubbard-Turner T, 2019, J ATHL TRAINING, V54, P671, DOI 10.4085/1062-6050-428-17; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Murphy DF, 2003, BRIT J SPORT MED, V37, P13, DOI 10.1136/bjsm.37.1.13; National Federation of State High School Associations, 2019, 2018 19 HIGH SCH ATH; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Rauh MJ, 2007, J ATHL TRAINING, V42, P486; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Reneker JC, 2019, MUSCULOSKEL SCI PRAC, V42, P173, DOI 10.1016/j.msksp.2019.04.004; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Sugimoto D, 2016, BRIT J SPORT MED, V50, P1259, DOI 10.1136/bjsports-2015-095596; TAIMELA S, 1990, SPORTS MED, V9, P205, DOI 10.2165/00007256-199009040-00002; Turner C, 2004, ACCIDENT ANAL PREV, V36, P93, DOI 10.1016/S0001-4575(02)00131-8	30	0	0	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	NOV	2021	24	11					1105	1109		10.1016/j.jsams.2021.04.015			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WF8TQ	WOS:000706574300005	34074605				2022-02-06	
J	Wu, B; Lu, Y; Yu, Y; Yue, HL; Wang, J; Chong, YZ; Cui, WH				Wu, Bei; Lu, Yu; Yu, Yun; Yue, Hongli; Wang, Jie; Chong, Yingzi; Cui, Weihua			Effect of tranexamic acid on the prognosis of patients with traumatic brain injury undergoing craniotomy: study protocol for a randomised controlled trial	BMJ OPEN			English	Article						anaesthesia in neurology; neurological injury; neurosurgery; bleeding disorders & coagulopathies	DECOMPRESSIVE CRANIECTOMY; COAGULOPATHY; COAGULATION; MANAGEMENT; OUTCOMES; CRASH-2; EVENTS; SCORE	Introduction Abnormal coagulation function aggravates the prognosis of patients with traumatic brain injury (TBI). It was reported that the antifibrinolytic drug tranexamic acid (TXA) could reduce intracranial haemorrhage and mortality in non-operative patients with TBI. However, there is a lack of evaluation of TXA in patients with TBI undergoing craniotomy. Methods and analysis This is a single-centre randomised controlled, double-blind, parallel study aiming to investigate the effectiveness and safety of TXA in patients with TBI during the perioperative period. Blood loss and transfusion, neurological function, adverse events, mortality and serum immune-inflammatory cytokines will be collected and analysed. Ethics and dissemination Ethical approval has been granted by the Medical Ethics Committee of Beijing Tian Tan Hospital, Capital Medical University (reference number KY 2020-136-03). The results of this study will be disseminated through presentations at scientific conferences and publication in peer-reviewed journals.	[Wu, Bei; Lu, Yu; Yu, Yun; Yue, Hongli; Wang, Jie; Chong, Yingzi; Cui, Weihua] Capital Med Univ, Beijing Tian Tan Hosp, Dept Anaesthesiol, Beijing, Peoples R China		Lu, Y; Cui, WH (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Anaesthesiol, Beijing, Peoples R China.	luyutiantan@163.com; weihuacui@ccmu.edu.cn		Cui, Weihua/0000-0003-0893-3991	Beijing Hospital Authority Youth Programme [QML20190508]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870865]; Beijing Municipal Administration of Hospitals Incubating Program [PX2019019]	This work was supported by the following grants: Beijing Hospital Authority Youth Programme (grant number QML20190508), National Natural Science Foundation of China (grant number 81870865) and Beijing Municipal Administration of Hospitals Incubating Program (grant number PX2019019).	Abdelmalik PA, 2019, TRANSFUSION, V59, P1529, DOI 10.1111/trf.15171; Abdelmalik PA, 2016, NEUROCRIT CARE, V24, P361, DOI 10.1007/s12028-015-0191-0; Albert Venencia, 2019, Hematol Oncol Stem Cell Ther, V12, P32, DOI 10.1016/j.hemonc.2018.09.005; Albert Venencia, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6010005; Ardolino A, 2012, INJURY, V43, P1662, DOI 10.1016/j.injury.2012.05.008; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Baharoglu MI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001245.pub2; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Bodien YG, 2016, ARCH PHYS MED REHAB, V97, P490, DOI 10.1016/j.apmr.2015.08.422; Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2020, J NEUROTRAUM, V37, P810, DOI 10.1089/neu.2019.6869; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jaramillo S, 2019, TRANSFUSION, V59, P508, DOI 10.1111/trf.15052; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; Ker K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004896.pub4; Lawati KA, 2021, INTENS CARE MED, V47, P14, DOI 10.1007/s00134-020-06279-w; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Mazzeo AT, 2006, J NEUROSURG ANESTH, V18, P170, DOI 10.1097/01.ana.0000210999.18033.f6; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Sattin D, 2015, INT J REHABIL RES, V38, P350, DOI 10.1097/MRR.0000000000000135; Seule M, 2015, FACIAL PLAST SURG, V31, P325, DOI 10.1055/s-0035-1562884; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Singleton Q, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010063; Solomon C, 2011, THROMB HAEMOSTASIS, V106, P322, DOI 10.1160/TH11-03-0175; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Wada T, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1808-9; Walker PF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208249; Wang D, 2019, THROMB HAEMOSTASIS, V119, P92, DOI 10.1055/s-0038-1676625; Yeatts SD, 2020, J NEUROTRAUM, V37, P2674, DOI 10.1089/neu.2019.6969; Yokobori S, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00460-5; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Ziliotto N, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00409	48	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	NOV	2021	11	11							e049839	10.1136/bmjopen-2021-049839			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XF8YT	WOS:000724352600057	34824110	gold, Green Published			2022-02-06	
J	Yengo-Kahn, AM; Wallace, J; Jimenez, V; Totten, DJ; Bonfield, CM; Zuckerman, SL				Yengo-Kahn, Aaron M.; Wallace, Jessica; Jimenez, Viviana; Totten, Douglas J.; Bonfield, Christopher M.; Zuckerman, Scott L.			Exploring the outcomes and experiences of Black and White athletes following a sport-related concussion: a retrospective cohort study	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						racial disparities; health equity; concussion; sports; social determinant; trauma	BASE-LINE; DISPARITIES; AMERICAN; SYMPTOMS; CHILDREN; SUPPORT; SEX	OBJECTIVE Young American athletes, at risk of sport-related concussion (SRC), represent many races; however, it is unknown how race may influence the experience and outcome of SRC. The authors' objective was to compare White and Black athletes' recovery and subjective experiences after SRC. METHODS A retrospective study was performed using the Vanderbilt Sports Concussion registry. Self-reported White and Black young athletes (ages 12-23 years) who had been treated for SRC between 2012 and 2015 were included. Athletes with learning disabilities or psychiatric conditions were excluded. Data were collected by electronic medical record review and phone calls to athletes and parents or guardians. The primary outcomes were as follows: 1) days to symptom resolution (SR), 2) days to return to school, and changes in 3) any daily activity (binary) and 4) sport behavior (binary). Secondary outcomes were changes (more, unchanged, or less) in specific activities such as sleep, schoolwork, and television time, as well as equipment (binary) or playing style (more reckless, unchanged, or less reckless) and whether the athlete retired from sport. Descriptive analyses, multivariable Cox proportional hazards models, and logistic regression were performed. RESULTS The final cohort included 247 student-athletes (36 Black, 211 White). Black athletes were male (78% vs 58%) more often than White athletes, but both races were similar in age, sport, and medical/family histories. Black athletes more frequently had public insurance (33.3% vs 5.7%) and lived in areas with a low median income (41.2% vs 26.6%). After adjusting for age, sex, concussion history, insurance status, and zip code median income, Black athletes reached an asymptomatic status (HR 1.497, 95% CI 1.014-2.209, p = 0.042) and returned to school earlier (HR 1.522, 95% CI 1.020-2.270, p = 0.040). Black athletes were less likely to report a change in any daily activity than White athletes (OR 0.368, 95% CI 0.136-0.996, p = 0.049). Changes in sport behavior were comparable between the groups. CONCLUSIONS Racial differences appear to exist in the outcomes and experience of SRC for young athletes, as Black athletes reached SR and return to school sooner than White athletes. Race should be considered as an important social determinant in SRC treatment.	[Yengo-Kahn, Aaron M.; Bonfield, Christopher M.; Zuckerman, Scott L.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN USA; [Yengo-Kahn, Aaron M.; Jimenez, Viviana; Totten, Douglas J.; Bonfield, Christopher M.; Zuckerman, Scott L.] Vanderbilt Univ, Vanderbilt Sport Concuss Ctr, Med Ctr, Nashville, TN USA; [Wallace, Jessica] Univ Alabama, Athlet Training Program, Dept Hlth Sci, Tuscaloosa, AL USA; [Jimenez, Viviana] Vanderbilt Univ, Dept Neurol, Med Ctr, Nashville, TN USA; [Totten, Douglas J.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA		Yengo-Kahn, AM (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37212 USA.	a.yengo@vumc.org		Totten, Douglas/0000-0002-0665-9653			Aggarwal SS, 2020, BRAIN INJURY, V34, P811, DOI 10.1080/02699052.2020.1740942; [Anonymous], 2018, NCAA DEMOGRAPHICS DA; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Cook NE, 2020, J DEV BEHAV PEDIATR, V41, P571, DOI 10.1097/DBP.0000000000000808; Deichman Jacquelyn J, 2019, Concussion, V4, pCNC68, DOI 10.2217/cnc-2019-0010; DeMatteo CA, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00792; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ferdows NB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.12241; Hasson, 2018, KINESIOL REV, V7, P163, DOI [DOI 10.1123/KR.2018-0015, 10.1123/kr.2018-0015]; Hodges A, 2019, J SPEC PEDIATR NURS, V24, DOI 10.1111/jspn.12271; Holmes L, 2016, SPORTS MED-OPEN, V2, DOI 10.1186/s40798-016-0058-8; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kasamatsu T, 2016, J ATHL TRAINING, V51, P153, DOI 10.4085/1062-6050-51.4.02; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Legarreta AD, 2018, J NEUROSURG-PEDIATR, V22, P238, DOI 10.3171/2018.3.PEDS1850; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lyons TW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00690; McAvoy K, 2020, J SCHOOL HEALTH, V90, P849, DOI 10.1111/josh.12949; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; National Academies of Sciences Engineering and Medicine, 2017, STAT HLTH DISP US; Paradies Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138511; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Refakis CA, 2017, CLIN SPINE SURG, V30, P191, DOI 10.1097/BSD.0000000000000451; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Stanley J, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6664-x; Terry DP, 2019, J NEUROTRAUM, V36, P142, DOI 10.1089/neu.2017.5443; Veliz P, 2019, J ADOLESCENT HEALTH, V64, P272, DOI 10.1016/j.jadohealth.2018.08.023; Wallace J, 2020, J HLTH DISPAR RES PR, V13, P2; Wallace J, 2021, J RACIAL ETHN HEALTH, V8, P1079, DOI 10.1007/s40615-020-00864-x; Wallace J, 2020, J EMERG MED, V59, P783, DOI 10.1016/j.jemermed.2020.07.002; Wallace J, 2020, AM J SPORT MED, V48, P2774, DOI 10.1177/0363546520946753; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P894, DOI 10.1007/s40615-017-0437-y; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P221, DOI 10.1007/s40615-017-0361-1; Wallander JL, 2019, QUAL LIFE RES, V28, P1761, DOI 10.1007/s11136-019-02157-1; Watt TT, 2012, J HEALTH CARE POOR U, V23, P1793, DOI 10.1353/hpu.2012.0147; Women's Sports Foundation, 2019, STAT HIGH SCH SPORT; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2017, J NEUROSURG-PEDIATR, V19, P652, DOI 10.3171/2017.1.PEDS16611; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	44	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2021	28	5					516	525		10.3171/2021.2.PEDS2130			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	XN1FJ	WOS:000729258300003	34428742				2022-02-06	
J	Yuan, WH; Dudley, J; Slutsky-Ganesh, AB; Leach, J; Scheifele, P; Altaye, M; Foss, KDB; Diekfuss, JD; Rhea, CK; Myer, GD				Yuan, Weihong; Dudley, Jonathan; Slutsky-Ganesh, Alexis B.; Leach, James; Scheifele, Pete; Altaye, Mekibib; Foss, Kim D. Barber; Diekfuss, Jed D.; Rhea, Christopher K.; Myer, Gregory D.			White Matter Alteration Following SWAT Explosive Breaching Training and the Moderating Effect of a Neck Collar Device: A DTI and NODDI Study	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; NEURITE ORIENTATION DISPERSION; LEVEL BLAST EXPOSURE; COMPRESSION COLLAR; ABNORMALITIES; MICROSTRUCTURE; CONCUSSION; ACTIVATION; HISTORY; MEMORY	Introduction: Special Weapons and Tactics (SWAT) personnel who practice breaching with blast exposure are at risk for blastrelated head trauma. We aimed to investigate the impact of low-level blast exposure on underlying white matter (WM) microstructure based on diffusion tensor imaging (DTI) and neurite orientation and density imaging (NODDI) in SWAT personnel before and after breacher training. Diffusion tensor imaging is an advanced MRI technique sensitive to underlying WM alterations. NODDI is a novel MRI technique emerged recently that acquires diffusion weighted data from multiple shells modeling for different compartments in the microstructural environment in the brain. We also aimed to evaluate the effect of a jugular vein compression collar device in mitigating the alteration of the diffusion properties in the WM as well as its role as a moderator on the association between the diffusion property changes and the blast exposure. Materials and Methods: Twenty-one SWAT personnel (10 non-collar and 11 collar) completed the breacher training and underwent MRI at both baseline and after blast exposure. Diffusion weighted data were acquired with two shells (b = 1,000, 2,000 s/mm(2)) on 3T Phillips scanners. Diffusion tensor imaging metrices, including fractional anisotropy, mean, axial, and radial diffusivity, and NODDI metrics, including neurite density index (NDI), isotropic volume fraction (fiso), and orientation dispersion index, were calculated. Tract-based spatial statistics was used in the voxel-wise statistical analysis. Post hoc analyses were performed for the quantification of the pre- to post-blast exposure diffusion percentage change in the WM regions with significant group difference and for the assessment of the interaction of the relationship between blast exposure and diffusion alteration. Results: The non-collar group exhibited significant pre- to post-blast increase in NDI (corrected P <.05) in the WM involving the right internal capsule, the right posterior corona radiation, the right posterior thalamic radiation, and the right sagittal stratum. A subset of these regions showed significantly greater alteration in NDI and fiso in the non-collar group when compared with those in the collar group (corrected P <.05). In addition, collar wearing exhibited a significant moderating effect for the alteration of fiso for its association with average peak pulse pressure. Conclusions: Our data provided initial evidence of the impact of blast exposure on WM diffusion alteration based on both DTI and NODDI. The mitigating effect of WM diffusivity changes and the moderating effect of collar wearing suggest that the device may serve as a promising solution to protect WM against blast exposure.	[Yuan, Weihong; Dudley, Jonathan] Cincinnati Childrens Hosp Med Ctr, Div Radiol, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Slutsky-Ganesh, Alexis B.; Rhea, Christopher K.] Univ N Carolina, Dept Kinesiol, Greensboro, NC 27412 USA; [Leach, James] Cincinnati Childrens Hosp Med Ctr, Div Radiol, Cincinnati, OH 45229 USA; [Scheifele, Pete] Univ Cincinnati, Coll Allied Hlth Sci, Dept Commun Sci & Disorders, Cincinnati, OH 45219 USA; [Scheifele, Pete] Univ Cincinnati, Dept Med Educ, Coll Med, Cincinnati, OH 45219 USA; [Altaye, Mekibib] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Altaye, Mekibib] Univ Cincinnati, Dept Pediat, Coll Med, Cincinnati, OH 45229 USA; [Foss, Kim D. Barber; Diekfuss, Jed D.; Myer, Gregory D.] Emory Sports Performance & Res Ctr, Flowery Branch, GA 30542 USA; [Diekfuss, Jed D.; Myer, Gregory D.] Emory Univ, Dept Orthopaed, Sch Med, Atlanta, GA 30322 USA; [Myer, Gregory D.] Emory Sports Med Ctr, Atlanta, GA 30329 USA; [Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA; [Yuan, Weihong; Leach, James] Univ Cincinnati, Dept Radiol, Coll Med, Cincinnati, OH 45267 USA		Yuan, WH (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Radiol, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA.				Q30 Sports Innovations, LLC	Q30 Sports Innovations, LLC, provided the jugular compression collar used in the investigation and provided funding for the parent project from which these secondary data and analysis are derived.	Amsc N, 1999, SIGNAL, V44, P4; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bonnette S, 2018, EXP BRAIN RES, V236, P2691, DOI 10.1007/s00221-018-5328-x; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Delius M, 2002, EUR SURG RES, V34, P30, DOI 10.1159/000048884; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Genc S, 2017, NEUROIMAGE, V148, P373, DOI 10.1016/j.neuroimage.2017.01.023; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Kubli LR, 2017, NOISE HEALTH, V19, P227, DOI 10.4103/nah.NAH_58_16; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McClelland AC, 2018, NEURORADIOLOGY, V60, P1019, DOI 10.1007/s00234-018-2070-9; Miller DR, 2017, BRAIN IMAGING BEHAV, V11, P1129, DOI 10.1007/s11682-016-9593-7; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Nelson LA, 2013, NEUROPSYCHOLOGY, V27, P666, DOI 10.1037/a0034117; Pagulayan KF, 2018, J INT NEUROPSYCH SOC, V24, P324, DOI 10.1017/S1355617717001217; Palacios EM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6892; Peterson AL, 2018, CONTEMP CLIN TRIALS, V73, P27, DOI 10.1016/j.cct.2018.08.005; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Smith DW, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113511588; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Tang SY, 2017, J NEUROTRAUM, V34, P1972, DOI 10.1089/neu.2016.4650; Timmers I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167884; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Williams CS, 2016, UNDERSEA HYPERBAR M, V43, P521; Wu YC, 2018, J NEUROTRAUM, V35, P2377, DOI 10.1089/neu.2017.5566; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Yuan WH, 2019, J NEUROTRAUM, V36, P721, DOI 10.1089/neu.2018.5737; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859; Yuan WH, 2017, J NEUROTRAUM, V34, P2432, DOI 10.1089/neu.2016.4834; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	40	0	0	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV-DEC	2021	186	11-12					1183	1190		10.1093/milmed/usab168			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WV9KE	WOS:000717547200026	33939823				2022-02-06	
J	Zhang, H; Zhou, JY; Peng, Y				Zhang, Hong; Zhou, Jinyuan; Peng, Yun			Amide Proton Transfer- We ighted MR Imaging of Pediatric Central Nervous System Diseases	MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA			English	Article						APT-weighted imaging; CEST imaging; Pediatric brain development; Hypoxic-ischemic encephalopathy; Intracranial infection; Brain tumors	HIGH-GRADE GLIOMAS; MAGNETIZATION-TRANSFER; TRANSFER APT; QUANTITATIVE DESCRIPTION; ENDOGENOUS PROTEIN; GLOBUS-PALLIDUS; CONTRAST AGENTS; DENTATE NUCLEUS; DIFFUSE GLIOMAS; BRAIN-TUMORS	APTw imaging is a relatively new protein-based molecular MR imaging technique. The technique has the potential for noninvasive protein content imaging and pH imaging. APTw MR imaging, which does not require intravenous contrast, has great potential as an alternative to gadolinium enhanced MRI in the pediatric population. Brain tumors in children show a large histopathologic spectrum, such that grading and differential diagnosis of brain tumors with APTw requires further study. In the future, APTw imaging may be applied to more pediatric CNS diseases, such as infection, stroke, demyelinating disorders, traumatic brain injury, and metabolic encephalopathies.	[Zhang, Hong; Peng, Yun] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Radiol, 56 Nan Li Shi Rd, Beijing 100045, Peoples R China; [Zhou, Jinyuan] Johns Hopkins Univ, Dept Radiol, Div MR Res, Sch Med, 600 N Wolfe St,Pk 336, Baltimore, MD 21287 USA		Peng, Y (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Radiol, 56 Nan Li Shi Rd, Beijing 100045, Peoples R China.	ppengyun@yahoo.com					Chen SJ, 2019, EUR J RADIOL, V119, DOI 10.1016/j.ejrad.2019.07.021; Choi YS, 2017, EUR RADIOL, V27, P3181, DOI 10.1007/s00330-017-4732-0; Harston GWJ, 2015, BRAIN, V138, P36, DOI 10.1093/brain/awu374; Hedlund G L, 1999, Semin Pediatr Neurol, V6, P299, DOI 10.1016/S1071-9091(99)80028-X; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Heo HY, 2019, MAGN RESON MED, V82, P1812, DOI 10.1002/mrm.27875; Heo HY, 2017, MAGN RESON MED, V78, P871, DOI 10.1002/mrm.26799; Heo HY, 2017, MAGN RESON MED, V77, P1853, DOI 10.1002/mrm.26264; Hong XH, 2014, NEURO-ONCOLOGY, V16, P856, DOI 10.1093/neuonc/not245; Hu HCH, 2016, PEDIATR RADIOL, V46, P1590, DOI 10.1007/s00247-016-3646-3; Hua J, 2007, MAGN RESON MED, V58, P786, DOI 10.1002/mrm.21387; Jiang SS, 2019, CLIN CANCER RES, V25, P552, DOI 10.1158/1078-0432.CCR-18-1233; Jiang SS, 2017, MAGN RESON MED, V78, P1100, DOI 10.1002/mrm.26820; Jiang SS, 2017, EUR J CANCER, V83, P9, DOI 10.1016/j.ejca.2017.06.009; Jiang SS, 2016, EUR RADIOL, V26, P64, DOI 10.1007/s00330-015-3805-1; Jones KM, 2018, J MAGN RESON IMAGING, V47, P11, DOI 10.1002/jmri.25838; Karagulle-Kendi Ayse Tuba, 2010, Handb Clin Neurol, V96, P239, DOI 10.1016/S0072-9752(09)96015-8; Lee DH, 2017, MAGN RESON MED, V77, P855, DOI 10.1002/mrm.26131; Li CM, 2014, EUR RADIOL, V24, P2631, DOI 10.1007/s00330-014-3241-7; Ling W, 2008, P NATL ACAD SCI USA, V105, P2266, DOI 10.1073/pnas.0707666105; Ma B, 2016, J MAGN RESON IMAGING, V44, P456, DOI 10.1002/jmri.25159; Mori S, 1998, MAGNET RESON MED, V40, P36, DOI 10.1002/mrm.1910400105; Panigrahy A, 2009, J CHILD NEUROL, V24, P1343, DOI 10.1177/0883073809342129; Park JE, 2020, RADIOLOGY, V295, P397, DOI 10.1148/radiol.2020191376; Roberts DR, 2016, BRAIN DEV-JPN, V38, P331, DOI 10.1016/j.braindev.2015.08.009; Rodriguez FJ, 2013, ANNU REV PATHOL-MECH, V8, P361, DOI 10.1146/annurev-pathol-020712-164009; Sakata A, 2015, J NEURO-ONCOL, V122, P339, DOI 10.1007/s11060-014-1715-8; Sherry AD, 2008, ANNU REV BIOMED ENG, V10, P391, DOI 10.1146/annurev.bioeng.9.060906.151929; Sun PZ, 2007, J CEREBR BLOOD F MET, V27, P1129, DOI 10.1038/sj.jcbfm.9600424; Swinburne NC, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0756-8; Tang XL, 2020, PEDIATR INVEST, V4, P250, DOI 10.1002/ped4.12237; Togao O, 2017, EUR RADIOL, V27, P578, DOI 10.1007/s00330-016-4328-0; Togao O, 2014, NEURO-ONCOLOGY, V16, P441, DOI 10.1093/neuonc/not158; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Wen ZB, 2010, NEUROIMAGE, V51, P616, DOI 10.1016/j.neuroimage.2010.02.050; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Yan K, 2015, MOL IMAGING BIOL, V17, P479, DOI 10.1007/s11307-015-0828-6; Zhang H, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/6418343; Zhang H, 2016, EUR RADIOL, V26, P3368, DOI 10.1007/s00330-015-4188-z; Zhang Y, 2019, MAGN RESON MED, V82, P2046, DOI 10.1002/mrm.27881; Zheng Y, 2017, AM J NEURORADIOL, V38, P827, DOI 10.3174/ajnr.A5066; Zheng Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3052723; Zhou JY, 2008, MAGN RESON MED, V60, P842, DOI 10.1002/mrm.21712; Zhou JY, 2006, PROG NUCL MAG RES SP, V48, P109, DOI 10.1016/j.pnmrs.2006.01.001; Zhou JY, 2019, J MAGN RESON IMAGING, V50, P347, DOI 10.1002/jmri.26645; Zhou JY, 2013, J MAGN RESON IMAGING, V38, P1119, DOI 10.1002/jmri.24067; Zhou JY, 2013, MAGN RESON MED, V70, P320, DOI 10.1002/mrm.24784; Zhou JY, 2011, NAT MED, V17, P130, DOI 10.1038/nm.2268; Zhou JY, 2004, MAGN RESON MED, V51, P945, DOI 10.1002/mrm.20048; Zhou JY, 2003, MAGNET RESON MED, V50, P1120, DOI 10.1002/mrm.10651; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907; Zhu H, 2010, MAGN RESON MED, V64, P638, DOI 10.1002/mrm.22546; Zu ZL, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3934	53	0	0	3	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1064-9689	1557-9786		MAGN RESON IMAGING C	Magn. Reson. Imaging Clin. N. Am.	NOV	2021	29	4					631	641		10.1016/j.mric.2021.06.012			11	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	WW6DM	WOS:000718004700013	34717850				2022-02-06	
J	Zwirner, J; Bohnert, S; Franke, H; Garland, J; Hammer, N; Moebius, D; Tse, R; Ondruschka, B				Zwirner, Johann; Bohnert, Simone; Franke, Heike; Garland, Jack; Hammer, Niels; Moebius, Dustin; Tse, Rexson; Ondruschka, Benjamin			Assessing Protein Biomarkers to Detect Lethal Acute Traumatic Brain Injuries in Cerebrospinal Fluid	BIOMOLECULES			English	Article						biomarker combination; glial fibrillary acidic protein; interleukin-6; post mortem biochemistry; traumatic brain injury	COMPUTED-TOMOGRAPHY; LIKELIHOOD RATIOS; INTERLEUKIN-6; AUTOPSY; S100B; DIAGNOSIS; SERUM; BIOCHEMISTRY; MICROGLIA; CYTOKINE	Diagnosing traumatic brain injury (TBI) from body fluids in cases where there are no obvious external signs of impact would be useful for emergency physicians and forensic pathologists alike. None of the previous attempts has so far succeeded in establishing a single biomarker to reliably detect TBI with regards to the sensitivity: specificity ratio in a post mortem setting. This study investigated a combination of body fluid biomarkers (obtained post mortem), which may be a step towards increasing the accuracy of biochemical TBI detection. In this study, serum and cerebrospinal fluid (CSF) samples from 30 acute lethal TBI cases and 70 controls without a TBI-related cause of death were evaluated for the following eight TBI-related biomarkers: brain-derived neurotrophic factor (BDNF), ferritin, glial fibrillary acidic protein (GFAP), interleukin 6 (IL-6), lactate dehydrogenase, neutrophil gelatinase-associated lipocalin (NGAL), neuron-specific enolase and S100 calcium-binding protein B. Correlations among the individual TBI biomarkers were assessed, and a specificity-accentuated threshold value analysis was conducted for all biomarkers. Based on these values, a decision tree modelling approach was performed to assess the most accurate biomarker combination to detect acute lethal TBIs. The results showed that 92.45% of acute lethal TBIs were able to be diagnosed using a combination of IL-6 and GFAP in CSF. The probability of detecting an acute lethal TBI was moderately increased by GFAP alone and considerably increased by the remaining biomarkers. BDNF and NGAL were almost perfectly correlated (p = 0.002; R-2 = 0.944). This study provides evidence that acute lethal TBIs can be detected to a high degree of statistical accuracy using forensic biochemistry. The high inter-individual correlations of biomarkers may help to estimate the CSF concentration of an unknown biomarker, using extrapolation techniques.	[Zwirner, Johann] Univ Otago, Dept Anat, Dunedin 9016, New Zealand; [Zwirner, Johann; Moebius, Dustin; Ondruschka, Benjamin] Univ Med Ctr Hamburg Eppendorf, Inst Legal Med, D-22529 Hamburg, Germany; [Zwirner, Johann] Univ Leipzig, Inst Legal Med, D-04103 Leipzig, Germany; [Bohnert, Simone] Univ Wurzburg, Inst Forens Med, D-97078 Wurzburg, Germany; [Franke, Heike] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04107 Leipzig, Germany; [Garland, Jack] NSW Hlth Pathol, Forens & Analyt Sci Serv, Lidcombe 2141, Australia; [Hammer, Niels] Karl Franzens Univ Graz, Inst Macroscop & Clin Anat, A-8010 Graz, Austria; [Hammer, Niels] Univ Leipzig, Dept Orthoped & Trauma Surg, D-04103 Leipzig, Germany; [Hammer, Niels] Fraunhofer IWU, D-47720 Dresden, Germany; [Tse, Rexson] Auckland City Hosp, Dept Forens Pathol, LabPLUS, Auckland 1148, New Zealand		Zwirner, J (corresponding author), Univ Otago, Dept Anat, Dunedin 9016, New Zealand.; Zwirner, J; Ondruschka, B (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Legal Med, D-22529 Hamburg, Germany.; Zwirner, J (corresponding author), Univ Leipzig, Inst Legal Med, D-04103 Leipzig, Germany.	simone.bohnert@uni-wuerzburg.de; heike.franke@medizin.uni-leipzig.de; jack.garland@health.nsw.gov.au; niels.hammer@medunigraz.at; rexsont@adhb.govt.nz					Anim J T, 2015, Ghana Med J, V49, P112, DOI 10.4314/gmj.v49i2.9; BANKS WA, 1994, NEUROSCI LETT, V179, P53, DOI 10.1016/0304-3940(94)90933-4; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bazarian JJ, 2013, J NEUROTRAUM, V30, P1747, DOI 10.1089/neu.2013.2853; BENVENISTE EN, 1990, J NEUROIMMUNOL, V30, P201, DOI 10.1016/0165-5728(90)90104-U; Bohnert S, 2019, INT J LEGAL MED, V133, P1141, DOI 10.1007/s00414-019-02050-z; Bolliger SA, 2008, EUR RADIOL, V18, P273, DOI 10.1007/s00330-007-0737-4; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Davidoff MS, 2002, ACTA HISTOCHEM, V104, P39, DOI 10.1078/0065-1281-00630; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Elsafi SH, 2015, CLIN EXP GASTROENTER, V8, P279, DOI 10.2147/CEG.S86419; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184, DOI 10.1097/00004647-199902000-00010; Huang Y, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010249; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P39, DOI 10.1001/jama.276.1.39; Li DR, 2009, HISTOL HISTOPATHOL, V24, P1113, DOI 10.14670/HH-24.1113; Li Dong-Ri, 2006, Legal Medicine, V8, P71, DOI 10.1016/j.legalmed.2005.07.004; Li Dong-Ri, 2009, Leg Med (Tokyo), V11 Suppl 1, pS273, DOI 10.1016/j.legalmed.2009.02.042; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Maeda Hitoshi, 2009, Leg Med (Tokyo), V11 Suppl 1, pS46, DOI 10.1016/j.legalmed.2009.01.048; Maier B, 2005, J NEUROTRAUM, V22, P822, DOI 10.1089/neu.2005.22.822; McGee S, 2002, J GEN INTERN MED, V17, P646; Olczak M, 2021, FOLIA NEUROPATHOL, V59, P81, DOI 10.5114/fn.2021.105137; Olczak M, 2019, FORENSIC SCI INT, V301, P28, DOI 10.1016/j.forsciint.2019.05.010; Olczak M, 2017, FORENSIC SCI INT, V280, P1, DOI 10.1016/j.forsciint.2017.09.008; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Ondruschka B, 2018, J NEUROTRAUM, V35, P2044, DOI 10.1089/neu.2017.5441; Ondruschka B, 2019, INT J LEGAL MED, V133, P871, DOI 10.1007/s00414-018-1925-2; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; OSUNA E, 1992, FORENSIC SCI INT, V52, P193, DOI 10.1016/0379-0738(92)90107-8; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; SANCHEZRODRIGUEZ VF, 1995, AM J FOREN MED PATH, V16, P210, DOI 10.1097/00000433-199509000-00004; Sieber M, 2018, J FORENSIC LEG MED, V55, P65, DOI 10.1016/j.jflm.2018.02.016; Trautz F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48145-w; Weustink AC, 2009, RADIOLOGY, V250, P897, DOI 10.1148/radiol.2503080421; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Woydt L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31252-5; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zwirner J, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11071061; Zwirner J, 2021, INT J LEGAL MED, V135, P2323, DOI 10.1007/s00414-021-02568-1	44	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2218-273X		BIOMOLECULES	Biomolecules	NOV	2021	11	11							1577	10.3390/biom11111577			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	XF0FO	WOS:000723755500001	34827575	gold, Green Published			2022-02-06	
J	Bunt, SC; Meredith-Duliba, T; Didehhani, N; Hynan, LS; LoBue, C; Stokes, M; Miller, SM; Bell, K; Batjer, H; Cullum, CM				Bunt, Stephen C.; Meredith-Duliba, Tawny; Didehhani, Nyaz; Hynan, Linda S.; LoBue, Christian; Stokes, Mathew; Miller, Shane M.; Bell, Kathleen; Batjer, Hunt; Cullum, C. Munro			Resilience and recovery from sports related concussion in adolescents and young adults	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Concussion; resilience; symptoms; recovery; SCAT-5	TRAUMATIC BRAIN-INJURY; PSYCHOLOGICAL RESILIENCE; HIGH-SCHOOL; PREDICTORS; SYMPTOMS; ANXIETY; SCALE; MODEL	Introduction Recovery and return to play are important milestones for athletes who sustain sport-related concussions (SRC). Several factors have been shown to influence resolution of post-concussion related symptoms (PCS), but resilience, a trait that reflects the ability to overcome adversity, is another factor that may influence recovery. The aim of this study was to determine the relationship of resilience with resolution of symptoms during recovery in adolescents and young adults following SRC. Method This prospective study is part of the North Texas Concussion Registry (ConTex). Subjects (N = 332) aged 13 to 25 years who sustained a SRC within 10 days of presenting to clinic were evaluated at two time points: initial clinical visit and three-month follow-up. Resilience was measured by the self-report Brief Resilience Survey (BRS) and PCS by the Sport Concussion Assessment Tool-5 Symptom Evaluation Post-Concussion Symptom Scale (PCSS). Recovery was determined by self-reported return to sports/physical activity and percent back to normal. Results Repeated measures ANCOVA and linear regression models showed that lower resilience ratings at initial visit were associated with a greater number and severity of PCSS symptoms along with higher levels of anxiety and depression symptoms during recovery from SRC. At three months, subjects with lower initial resilience ratings were less likely to report feeling back to normal and had greater aggravation of symptoms from physical and cognitive activity even when they had returned to sports/physical activity. Conclusions Lower resilience was associated with greater symptoms and delayed recovery from SRC. Results suggest that resilience may be another important factor to address in recovery from SRC. Future research is needed to examine the extent to which resilience measured after SRC reflects pre-injury characteristics and to better inform the development of interventions to promote resilience during recovery.	[Bunt, Stephen C.; Meredith-Duliba, Tawny; Didehhani, Nyaz; Hynan, Linda S.; LoBue, Christian; Cullum, C. Munro] UT Southwestern Med Ctr, Dept Psychiat, Dallas, TX USA; [Hynan, Linda S.] UT Southwestern Med Ctr, Dept Populat & Data Sci, Dallas, TX USA; [LoBue, Christian; Batjer, Hunt; Cullum, C. Munro] UT Southwestern Med Ctr, Dept Neurol Surg, Dallas, TX USA; [Stokes, Mathew] UT Southwestern Med Ctr, Dept Pediat, Dallas, TX USA; [Stokes, Mathew; Cullum, C. Munro] UT Southwestern Med Ctr, Dept Neurol, Dallas, TX USA; [Miller, Shane M.] Texas Scottish Rite Hosp Children, Dept Orthoped, Dallas, TX 75219 USA; [Miller, Shane M.] UT Southwestern Med Ctr, Dept Orthopaed Surg, Dallas, TX USA; [Bell, Kathleen] UT Southwestern Med Ctr, Dept Phys Med & Rehabil, Dallas, TX USA		Bunt, SC (corresponding author), UT Southwestern Med Ctr, Div Psychol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	stephen.bunt@utsouthwestern.edu	; LoBue, Christian/M-4584-2017	Cullum, Munro/0000-0001-9706-5465; Bunt, Stephen/0000-0002-3631-4648; Miller, Shane/0000-0001-5002-5095; Hynan, Linda/0000-0002-4642-7769; LoBue, Christian/0000-0001-9671-5526; Bell, Kathleen/0000-0002-0928-2046; Stokes, Mathew/0000-0001-8655-9814	Texas Institute for Brain Injury and Repair (TIBIR); Peter J. O'Donnell Jr. Brain Institute at The University of Texas Southwestern Medical Center; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001105]	The North Texas Concussion Registry (ConTex) was funded by a grant from the Texas Institute for Brain Injury and Repair (TIBIR), a state-funded initiative as part of the Peter J. O'Donnell Jr. Brain Institute at The University of Texas Southwestern Medical Center. Support for the use of REDCap came from the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001105.	Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Breck J, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.17626; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cullum CM, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-032345; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Durish CL, 2019, J INT NEUROPSYCH SOC, V25, P346, DOI 10.1017/S1355617718001169; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Gillespie BM, 2007, CONTEMP NURSE, V25, P124, DOI 10.5172/conu.2007.25.1-2.124; Haase Joan E, 2004, J Pediatr Oncol Nurs, V21, P289, DOI 10.1177/1043454204267922; Haddadi P, 2010, PROCD SOC BEHV, V5, P639, DOI 10.1016/j.sbspro.2010.07.157; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hjemdal Odin, 2007, Clin Child Psychol Psychiatry, V12, P91, DOI 10.1177/1359104507071062; Howell DR, 2019, CLIN J SPORT MED, V29, P391, DOI 10.1097/JSM.0000000000000629; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kara S, 2020, CLIN J SPORT MED, V30, P96, DOI 10.1097/JSM.0000000000000811; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Plummer F, 2016, GEN HOSP PSYCHIAT, V39, P24, DOI 10.1016/j.genhosppsych.2015.11.005; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rainey EE, 2014, AM J SURG, V208, P517, DOI 10.1016/j.amjsurg.2014.05.016; Rodriguez-Rey R, 2016, PSYCHOL ASSESSMENT, V28, pE101, DOI 10.1037/pas0000191; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Smith B. W., 2013, RESILIENCE CHILDREN, DOI [10.1007/978-1, DOI 10.1007/978-1]; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Tokish JM, 2017, J SHOULDER ELB SURG, V26, P752, DOI 10.1016/j.jse.2016.12.070; Wagnild G M, 1993, J Nurs Meas, V1, P165; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Woods, 2017, BLS SPOTLIGHT STAT S; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Zar, 1996, BIOSTATISTICAL ANAL	49	0	0	2	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG 9	2021	43	7					677	688		10.1080/13803395.2021.1990214		OCT 2021	12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	XW6GB	WOS:000713469300001	34720048				2022-02-06	
J	Singh, R; Dawson, J; Mason, S; Lecky, F				Singh, Rajiv; Dawson, Jeremy; Mason, Suzanne; Lecky, Fiona			What are the functional consequences after TBI? The SHEFBIT cohort experience	BRAIN INJURY			English	Article						TBI; outcome; gose; follow-up; prognosis; cohort; icf; predictors	TRAUMATIC BRAIN-INJURY; GLASGOW OUTCOME SCALE; QUALITY-OF-LIFE; HEAD-INJURY; YOUNG-PEOPLE; MODERATE; DISABILITY; CARE; REHABILITATION; EPIDEMIOLOGY	Objectives To investigate functional outcome after TBI and identify variables that predict outcome in a multiordinal regression model. Background The results of global outcome studies after Traumatic Brain Injury(TBI) differ widely due to differences in outcome measure, attrition to follow-up and selection bias. Outcome information would inform patients/families, guide service development and target high-risk individuals Subjects/Setting prospective cohort of 1322 admissions with TBI, assessed by face to face interviews at 1 yr. Measures Extended Glasgow Outcome Scale (GOSE) by structured questionnaire. Results At 1 year, outcome was determined in 1207(91.3%). Mean age was 46.9(SD17.3); Almost half(49.2%) had mild injury. At one year, 42.9% achieved Good Recovery but GOSE declined in 11.4% of the cohort compared to 10 weeks including 60(4.9%) deaths. In an ordinal logistic regression, increasing TBI severity, etiology (assault), more prominent CT abnormality, past psychiatric history and alcohol intoxication were independent predictors of worse GOSE. A pseudo-R-2 of 0.38 suggested that many unmeasured factors also contribute to TBI outcome. Future work needs to identify other variables that may influence outcome. Conclusions In a large TBI cohort, there is still considerable functional disability at 1 year. It may be possible to target high-risk groups for rehabilitation	[Singh, Rajiv; Mason, Suzanne; Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res Scharr, Fac Med Dent & Hlth, Sheffield S1 4DA, S Yorkshire, England; [Singh, Rajiv] Sheffield Teaching Hosp, Dept Rehabil Med, Osborn Neurorehabil Unit, Sheffield S5 7AU, S Yorkshire, England; [Dawson, Jeremy] Univ Sheffield, Inst Work Psychol, Management Sch, Sheffield, S Yorkshire, England		Singh, R (corresponding author), Univ Sheffield, Sch Hlth & Related Res Scharr, Fac Med Dent & Hlth, Sheffield S1 4DA, S Yorkshire, England.; Singh, R (corresponding author), Sheffield Teaching Hosp, Dept Rehabil Med, Osborn Neurorehabil Unit, Sheffield S5 7AU, S Yorkshire, England.	rajiv.singh@sheffield.ac.uk					Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Chandola T, 2000, J PUBLIC HEALTH MED, V22, P182, DOI 10.1093/pubmed/22.2.182; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Forslund MV, 2017, BRAIN INJURY, V31, P329, DOI 10.1080/02699052.2016.1255778; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Godbolt AK, 2015, J HEAD TRAUMA REHAB, V30, pE41, DOI 10.1097/HTR.0000000000000050; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Raj R, 2013, CRIT CARE, V17, DOI 10.1186/cc12856; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; Seeley H, 2014, BRAIN INJURY, V28, P1559, DOI 10.3109/02699052.2014.939717; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Singh R, 2019, CLIN NEUROL NEUROSUR, V186, DOI 10.1016/j.clineuro.2019.105526; Singh R, 2012, DISABIL REHABIL, V34, P439, DOI 10.3109/09638288.2011.608146; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Stenberg M, 2017, BRAIN INJURY, V31, P351, DOI 10.1080/02699052.2016.1261303; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Turner-Stokes L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub3; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	43	0	0	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV 10	2021	35	12-13					1630	1636		10.1080/02699052.2021.1978549		OCT 2021	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XP4FK	WOS:000712691100001	34711118	hybrid, Green Accepted			2022-02-06	
J	van der Eerden, AW; van den Heuvel, TLA; Maas, MC; Vart, P; Vos, PE; Platel, B; Goraj, BM; Manniesing, R				van der Eerden, Anke W.; van den Heuvel, Thomas L. A.; Maas, Marnix C.; Vart, Priya; Vos, Pieter E.; Platel, Bram; Goraj, Bozena M.; Manniesing, Rashindra			The radiological interpretation of possible microbleeds after moderate or severe traumatic brain injury: a longitudinal study	NEURORADIOLOGY			English	Article; Early Access						Brain injuries; Traumatic; Cerebral hemorrhage; Traumatic; Diffuse axonal injury; Magnetic resonance imaging; Longitudinal studies	CEREBRAL MICROBLEEDS; RELIABILITY	Introduction In order to augment the certainty of the radiological interpretation of "possible microbleeds" after traumatic brain injury (TBI), we assessed their longitudinal evolution on 3-T SWI in patients with moderate/severe TBI. Methods Standardized 3-T SWI and T1-weighted imaging were obtained 3 and 26 weeks after TBI in 31 patients. Their microbleeds were computer-aided detected and classified by a neuroradiologist as no, possible, or definite at baseline and follow-up, separately (single-scan evaluation). Thereafter, the classifications were re-evaluated after comparison between the time-points (post-comparison evaluation). We selected the possible microbleeds at baseline at single-scan evaluation and recorded their post-comparison classification at follow-up. Results Of the 1038 microbleeds at baseline, 173 were possible microbleeds. Of these, 53.8% corresponded to no microbleed at follow-up. At follow-up, 30.6% were possible and 15.6% were definite. Of the 120 differences between baseline and follow-up, 10% showed evidence of a pathophysiological change over time. Proximity to extra-axial injury and proximity to definite microbleeds were independently predictive of becoming a definite microbleed at follow-up. The reclassification level differed between anatomical locations. Conclusions Our findings support disregarding possible microbleeds in the absence of clinical consequences. In selected cases, however, a follow-up SWI-scan could be considered to exclude evolution into a definite microbleed.	[van der Eerden, Anke W.; van den Heuvel, Thomas L. A.; Maas, Marnix C.; Platel, Bram; Goraj, Bozena M.; Manniesing, Rashindra] Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Nijmegen, Netherlands; [van der Eerden, Anke W.] Erasmus MC, Dept Radiol & Nucl Med, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Vart, Priya] Radboud Univ Nijmegen, Dept Epidemiol & Biostat, Nijmegen, Netherlands; [Vos, Pieter E.] Santiz Slingeland Hosp, Dept Neurol, Doetinchem, Netherlands		van der Eerden, AW (corresponding author), Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Nijmegen, Netherlands.; van der Eerden, AW (corresponding author), Erasmus MC, Dept Radiol & Nucl Med, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.vandereerden@erasmusmc.nl	Maas, Marnix C./J-5101-2014; Platel, Bram/D-2132-2009; Manniesing, Rashindra/G-9728-2015	Platel, Bram/0000-0002-1936-6825; Manniesing, Rashindra/0000-0002-4616-6298	Trauma Regio Oost, Radboudumc, Nijmegen	This is an investigator-initiated study, partly funded by Trauma Regio Oost, Radboudumc, Nijmegen. The funding organization did not participate in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, and approval of the manuscript; and the decision to submit the manuscript for publication.	Cordonnier C, 2009, STROKE, V40, P94, DOI 10.1161/STROKEAHA.108.526996; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Haghbayan H, 2017, CRIT CARE MED, V45, pe1280, DOI 10.1097/CCM.0000000000002731; Haller S, 2018, RADIOLOGY, V287, P11, DOI 10.1148/radiol.2018170803; Izzy S, 2017, NEUROCRIT CARE, V27, P199, DOI 10.1007/s12028-017-0399-2; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Ricciardi MC, 2017, J NEUROTRAUM, V34, P23, DOI 10.1089/neu.2015.4338; Righy C, 2016, CURR NEUROPHARMACOL, V14, P392, DOI 10.2174/1570159X14666151230110058; van den Heuvel TLA, 2016, NEUROIMAGE-CLIN, V12, P241, DOI 10.1016/j.nicl.2016.07.002; van der Eerden AW, 2021, AM J NEURORADIOL, V42, P861, DOI 10.3174/ajnr.A7028; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8	20	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology												10.1007/s00234-021-02839-z		OCT 2021	12	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	WP4NN	WOS:000713110700001	34719725	hybrid			2022-02-06	
J	Robinson, SA; Reilly, ED; Petrakis, BA; Wiener, RS; Castaneda-Sceppa, C; Quigley, KS				Robinson, S. A.; Reilly, E. D.; Petrakis, B. A.; Wiener, R. S.; Castaneda-Sceppa, C.; Quigley, K. S.			Daily physical activity and sleep in veterans: the role of insomnia severity	JOURNAL OF BEHAVIORAL MEDICINE			English	Article; Early Access						Insomnia; Exercise; Stepped care; Sleep disturbance; Walking	COGNITIVE-BEHAVIORAL THERAPY; TRAUMATIC BRAIN-INJURY; CBT-I COACH; OLDER-ADULTS; EXERCISE; VARIABILITY; INDEX	Physical activity (PA) is suggested as an easily accessible adjunctive lifestyle intervention for insomnia. It is not clear if PA is equally beneficial across different levels of insomnia severity. The current study examined the relationship between daily PA (steps) and sleep (duration, efficiency, and quality) across the spectrum of insomnia severity. Multilevel models estimated day-to-night relationships between PA and sleep, and if insomnia severity moderated these relationships. Days with greater PA were associated with nights with longer sleep duration. This was moderated by insomnia severity; PA was associated with longer sleep that night in participants with mild insomnia and associated with less sleep in those with severe insomnia. PA was not associated with sleep efficiency or quality. PA is potentially an easily accessible and impactful intervention to promote sleep duration in participants who are experiencing less severe sleep disturbance. More complex, resource-intensive interventions may be needed as insomnia severity increases.	[Robinson, S. A.; Reilly, E. D.; Petrakis, B. A.; Wiener, R. S.; Quigley, K. S.] VA Bedford Healthcare Syst, Ctr Healthcare Org & Implementat Res CHOIR, Bedford, MA 01730 USA; [Robinson, S. A.; Wiener, R. S.] Boston Univ, Sch Med, Pulm Ctr, Boston, MA 02118 USA; [Reilly, E. D.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Castaneda-Sceppa, C.; Quigley, K. S.] Northeastern Univ, Boston, MA 02115 USA		Robinson, SA (corresponding author), VA Bedford Healthcare Syst, Ctr Healthcare Org & Implementat Res CHOIR, Bedford, MA 01730 USA.; Robinson, SA (corresponding author), Boston Univ, Sch Med, Pulm Ctr, Boston, MA 02118 USA.	Stephanie.Robinson5@va.gov			National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [5P30AG048785-03]; Department of Veterans Affairs Office of Academic AffiliationsUS Department of Veterans Affairs; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL138049]	This material is based upon work supported by the National Institute on Aging (5P30AG048785-03) to KSQ, with additional funding from the Department of Veterans Affairs Office of Academic Affiliations and the National Heart, Lung, and Blood Institute (K12HL138049) to SAR.	Atoui S, 2021, SLEEP MED REV, V57, DOI 10.1016/j.smrv.2021.101426; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Baron KG, 2017, BEHAV SLEEP MED, V15, P144, DOI 10.1080/15402002.2015.1120200; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bisson ANS, 2019, SLEEP HEALTH, V5, P487, DOI 10.1016/j.sleh.2019.06.003; Buman MP, 2010, AM J LIFESTYLE MED, V4, P500, DOI 10.1177/1559827610375532; Espie CA, 2009, SLEEP, V32, P1549, DOI 10.1093/sleep/32.12.1549; Hartescu I, 2015, J SLEEP RES, V24, P526, DOI 10.1111/jsr.12297; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kay DB, 2013, BEHAV SLEEP MED, V11, P76, DOI 10.1080/15402002.2011.602775; Koffel Erin, 2020, Implement Sci Commun, V1, P107, DOI 10.1186/s43058-020-00096-4; Koffel E, 2018, HEALTH INFORM J, V24, P3, DOI 10.1177/1460458216656472; Kredlow MA, 2015, J BEHAV MED, V38, P427, DOI 10.1007/s10865-015-9617-6; Kuhn E, 2016, J CLIN SLEEP MED, V12, P597, DOI 10.5664/jcsm.5700; Markwald RR, 2018, ACSMS HEALTH FIT J, V22, P23, DOI 10.1249/FIT.0000000000000375; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Norton MC, 1999, NEUROPSY NEUROPSY BE, V12, P270; Passos GS, 2010, J CLIN SLEEP MED, V6, P270; Pigeon WR, 2013, J PSYCHOSOM RES, V75, P546, DOI 10.1016/j.jpsychores.2013.09.004; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Reed DL, 2016, J CLIN SLEEP MED, V12, P263, DOI 10.5664/jcsm.5498; Reilly E. D., JMIR FORM RES, DOI [10.2196/29573, DOI 10.2196/29573]; Wells D. L., 2019, INSOMNIA DISORDER VA	23	0	0	2	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0160-7715	1573-3521		J BEHAV MED	J. Behav. Med.												10.1007/s10865-021-00260-8		OCT 2021	6	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	WP2FP	WOS:000712954000001	34718912				2022-02-06	
J	Bath, S; Dinh, MM; Casley, S; Sarrami, P				Bath, Sally; Dinh, Michael M.; Casley, Stacey; Sarrami, Pooria			Predictors of mortality in older patients with isolated severe head injury: a data linkage study from New South Wales, Australia	AUSTRALIAN HEALTH REVIEW			English	Article						aging; epidemiology	TRAUMATIC BRAIN-INJURY; OUTCOMES; ADULTS; AGE	Objective. This study aimed to identify factors associated with 90-day mortality in older patients with a severe head injury. Methods. A data linkage study was performed with the New South Wales Trauma Registry, Admitted Patient Data Collection and Registry of Births Deaths and Marriages to identify patients aged >= 75 years with isolated severe head injury presenting to trauma hospitals between 2012 and 2016. The primary outcome was all-cause mortality at 90 days. Results. In all, 2045 patients were included in the analysis. The mean (+/- s.d.) age was 84.5 +/- 5.6 years. Falls accounted for 93.7% of this cohort. In-hospital mortality was 28.2% and 90-day mortality was 60.7%. Clinical variables associated with increased 90-day mortality were a Glasgow Coma Scale (GCS) score <9 on arrival (adjusted odds ratio (aOR) 1.43; 95% confidence interval (CI) 1.03 1.98; P = 0.03) and systolic blood pressure >= 180 mmHg on arrival (aOR 1.39; 95%CI 1.05-1.83; P = 0.02). The most important predictor of 90-day mortality was the presence of severe intracranial injury based on computed tomography (CT) imaging. Increasing age and comorbidities were not associated with increased mortality in this cohort. Conclusions. A GCS score <9, severe intracranial injury on CT imaging and severe hypertension on arrival to the emergency department were the variables most strongly predictive of mortality at 90 days after isolated severe head injury in older patients.	[Bath, Sally] Royal Prince Alfred Hosp, 50 Missenden Rd, Camperdown, NSW 2050, Australia; [Dinh, Michael M.; Sarrami, Pooria] New South Wales Inst Trauma & Injury Management, 1 Reserve Rd, St Leonards, NSW 2065, Australia; [Dinh, Michael M.] Univ Sydney, Sydney Med Sch, Anderson Stuart Bldg, Camperdown, NSW 2050, Australia; [Casley, Stacey] Wagga Wagga Base Hosp, Docker St, Wagga Wagga, NSW 2650, Australia; [Sarrami, Pooria] Univ New South Wales UNSW Sydney, Liverpool Hosp, South Western Sydney Clin Sch, Liverpool, NSW 2170, Australia		Sarrami, P (corresponding author), New South Wales Inst Trauma & Injury Management, 1 Reserve Rd, St Leonards, NSW 2065, Australia.; Sarrami, P (corresponding author), Univ New South Wales UNSW Sydney, Liverpool Hosp, South Western Sydney Clin Sch, Liverpool, NSW 2170, Australia.	sbat2975@gmail.com; michael.dinh@health.nsw.gov.au; Stacey.Casley@health.nsw.gov.au; pooria.sarrami@health.nsw.gov.au					Ali BA, 2021, EUR J TRAUMA EMERG S, V47, P1429, DOI 10.1007/s00068-019-01091-8; Australian Institute of Health and Welfare (AIHW), 2018, OLD AUSTR GLANC; Bardes JM, 2019, J EMERG MED, V57, P151, DOI 10.1016/j.jemermed.2019.04.003; Batey M, 2018, SURGERY, V164, P814, DOI 10.1016/j.surg.2018.05.060; Beedham W, 2019, CLIN MED, V19, P177, DOI 10.7861/clinmedicine.19-2-177; Bhullar IS, 2010, AM SURGEON, V76, P966; Bobeff EJ, 2019, WORLD NEUROSURG, V128, pE129, DOI 10.1016/j.wneu.2019.04.060; Bohensky MA, 2011, AUST NZ J PUBL HEAL, V35, P486, DOI 10.1111/j.1753-6405.2011.00741.x; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Brown CVR, 2016, AM SURGEON, V82, P1055; Burns E, 2018, MMWR-MORBID MORTAL W, V67, P509, DOI 10.15585/mmwr.mm6718a1; Bus S, 2019, BRIT J NEUROSURG, V33, P51, DOI 10.1080/02688697.2018.1522418; Centre for Health Record Linkage, 2020, REC LINK WORKS; Centre for Health Record Linkage, 2020, DAT DICT; de Munter L, 2018, INJURY, V49, P1648, DOI 10.1016/j.injury.2018.03.036; Dinh MM, 2012, EMERG MED AUSTRALAS, V24, P401, DOI 10.1111/j.1742-6723.2012.01559.x; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Gerrard P, 2012, J TRAUMA ACUTE CARE, V73, P1242, DOI 10.1097/TA.0b013e318265d234; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hecht JP, 2020, PHARMACOTHERAPY, V40, P604, DOI 10.1002/phar.2435; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Hsieh CH, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112426; Labib N, 2011, J TRAUMA, V71, P1908, DOI 10.1097/TA.0b013e31820989ed; Lenell S, 2019, ACTA NEUROCHIR, V161, P1243, DOI 10.1007/s00701-019-03893-6; Maeder MB, 2014, MORTALITY OUTCOME SE; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Mitra B, 2008, ANZ J SURG, V78, P588, DOI 10.1111/j.1445-2197.2008.04579.x; Narum S, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0094-1; NSW Institute of Trauma and Injury Managment, 2020, NSW TRAUM REG SYST; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Roe C, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/845491; St John AE, 2016, J SURG RES, V203, P95, DOI 10.1016/j.jss.2016.01.036; Staples JA, 2016, BRAIN INJURY, V30, P899, DOI 10.3109/02699052.2016.1146964; Tatikonda G, BRAIN TRAUMA NURSING, P2021; ter Avest E, 2021, EMERG MED J, V38, P21, DOI 10.1136/emermed-2020-209635; Unterhofer C, 2017, ACTA NEUROCHIR, V159, P1547, DOI 10.1007/s00701-017-3240-y; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Waseem, 2020, CUSHING REFLEX; Yokobori S, 2016, WORLD NEUROSURG, V86, P127, DOI 10.1016/j.wneu.2015.09.105	40	0	0	0	0	CSIRO PUBLISHING	CLAYTON	UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC 3168, AUSTRALIA	0156-5788	1449-8944		AUST HEALTH REV	Aust. Health Rev.		2022	46	1					107	114		10.1071/AH21131		OCT 2021	8	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	YS2NX	WOS:000712279500001					2022-02-06	
J	Honig, MG; Del Mar, NA; Henderson, DL; O'Neal, D; Doty, JB; Cox, R; Li, CY; Perry, AM; Moore, BM; Reiner, A				Honig, Marcia G.; Del Mar, Nobel A.; Henderson, Desmond L.; O'Neal, Dylan; Doty, John B.; Cox, Rachel; Li, Chunyan; Perry, Aaron M.; Moore, Bob M.; Reiner, Anton			Raloxifene Modulates Microglia and Rescues Visual Deficits and Pathology After Impact Traumatic Brain Injury	FRONTIERS IN NEUROSCIENCE			English	Article						traumatic brain injury; visual deficits; microglia; CB2 receptors; neuroinflammation; inflammatory responses; raloxifene; mouse model	RETINAL GANGLION-CELLS; CANNABINOID CB2 RECEPTOR; OPTIC-NERVE; MOUSE MODEL; RESPONSES; MEMORY; POLARIZATION; ASTROCYTES; PLASTICITY; BLAST	Mild traumatic brain injury (TBI) involves widespread axonal injury and activation of microglia, which initiates secondary processes that worsen the TBI outcome. The upregulation of cannabinoid type-2 receptors (CB2) when microglia become activated allows CB2-binding drugs to selectively target microglia. CB2 inverse agonists modulate activated microglia by shifting them away from the harmful pro-inflammatory M1 state toward the helpful reparative M2 state and thus can stem secondary injury cascades. We previously found that treatment with the CB2 inverse agonist SMM-189 after mild TBI in mice produced by focal cranial blast rescues visual deficits and the optic nerve axon loss that would otherwise result. We have further shown that raloxifene, which is Food and Drug Administration (FDA)-approved as an estrogen receptor modulator to treat osteoporosis, but also possesses CB2 inverse agonism, yields similar benefit in this TBI model through its modulation of microglia. As many different traumatic events produce TBI in humans, it is widely acknowledged that diverse animal models must be used in evaluating possible therapies. Here we examine the consequences of TBI created by blunt impact to the mouse head for visual function and associated pathologies and assess raloxifene benefit. We found that mice subjected to impact TBI exhibited decreases in contrast sensitivity and the B-wave of the electroretinogram, increases in light aversion and resting pupil diameter, and optic nerve axon loss, which were rescued by daily injection of raloxifene at 5 or 10 mg/ml for 2 weeks. Raloxifene treatment was associated with reduced M1 activation and/or enhanced M2 activation in retina, optic nerve, and optic tract after impact TBI. Our results suggest that the higher raloxifene dose, in particular, may be therapeutic for the optic nerve by enhancing the phagocytosis of axonal debris that would otherwise promote inflammation, thereby salvaging less damaged axons. Our current work, together with our prior studies, shows that microglial activation drives secondary injury processes after both impact and cranial blast TBI and raloxifene mitigates microglial activation and visual system injury in both cases. The results thus provide a strong basis for phase 2 human clinical trials evaluating raloxifene as a TBI therapy.	[Honig, Marcia G.; Del Mar, Nobel A.; Henderson, Desmond L.; O'Neal, Dylan; Doty, John B.; Cox, Rachel; Li, Chunyan; Perry, Aaron M.; Reiner, Anton] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Moore, Bob M.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN USA; [Reiner, Anton] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA		Reiner, A (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN 38163 USA.; Reiner, A (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA.	areiner@uthsc.edu			Methodist Hospitals Endowed Professorship in Neuroscience (AR)	Funding The research was supported by The Methodist Hospitals Endowed Professorship in Neuroscience (AR), UTHSC Neuroscience Institute (CL), NIH Medical Student Research Fellowship Program at UTHSC (JD and DON), and DOD grant W81XWH-16-1-0076 (AR and MH).	Anyaegbu CC, 2021, J NEUROSCI METH, V359, DOI 10.1016/j.jneumeth.2021.109223; Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Ashton JC, 2007, CURR NEUROPHARMACOL, V5, P73, DOI 10.2174/157015907780866884; Atwood BK, 2012, PROG NEURO-PSYCHOPH, V38, P16, DOI 10.1016/j.pnpbp.2011.12.001; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bruce BB, 2006, J NEUROL NEUROSUR PS, V77, P986, DOI 10.1136/jnnp.2006.088799; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Capo-Aponte J.E., 2013, J SPINE, V4, DOI [10.4172/2165-7939.S4-004, DOI 10.4172/2165-7939.S4-004]; Capo-Aponte JE, 2017, OPTOMETRY VISION SCI, V94, P7, DOI 10.1097/OPX.0000000000000825; Chadehumbe MA, 2016, CURR PROB PEDIATR AD, V46, P52, DOI 10.1016/j.cppeds.2015.11.004; Charles-Messance H, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-019-1655-5; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Collison FT, 2015, INVEST OPHTH VIS SCI, V56, P7130, DOI 10.1167/iovs.15-17467; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Crain JM, 2013, J NEUROSCI RES, V91, P1143, DOI 10.1002/jnr.23242; Cuenca N, 2014, PROG RETIN EYE RES, V43, P17, DOI 10.1016/j.preteyeres.2014.07.001; Das M, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1499-z; Davis BM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01747-8; del Mar N, 2015, EXP NEUROL, V271, P53, DOI 10.1016/j.expneurol.2015.04.023; Delpech JC, 2015, NEUROPHARMACOLOGY, V96, P19, DOI 10.1016/j.neuropharm.2014.12.034; Desai A, 2020, J NEUROTRAUM, V37, P286, DOI 10.1089/neu.2019.6602; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Donat CK, 2014, ACTA NEUROBIOL EXP, V74, P197; Draper MW, 1996, J BONE MINER RES, V11, P835; Evans LP, 2020, J NEUROTRAUM, V37, P1463, DOI 10.1089/neu.2019.6725; Evanson NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197346; Fernandez-Arjona MD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00235; Fouda AY, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00277; Fox Sandra M, 2019, Phys Med Rehabil Clin N Am, V30, P171, DOI 10.1016/j.pmr.2018.09.001; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Frick KM, 2015, LEARN MEMORY, V22, P472, DOI 10.1101/lm.037267.114; Gilmore CS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.30824; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Grajchen E, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01899-x; Gu C, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.610857; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Guley NM, 2019, EXP EYE RES, V182, P109, DOI 10.1016/j.exer.2019.03.013; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Habib P, 2015, J STEROID BIOCHEM, V146, P3, DOI 10.1016/j.jsbmb.2014.02.018; Hajiaghamemar M, 2019, EXP NEUROL, V318, P101, DOI 10.1016/j.expneurol.2019.04.019; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hanisch UK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00065; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Honig MG, 2021, EUR J NEUROSCI, V54, P5844, DOI 10.1111/ejn.14711; Honig MG, 2019, EXP NEUROL, V322, DOI 10.1016/j.expneurol.2019.113063; Hughes S, 2013, CURR BIOL, V23, P1696, DOI 10.1016/j.cub.2013.07.010; Im JH, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113082; Jacobs SM, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0389-5; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Jha MK, 2016, BIOCHEM PHARMACOL, V103, P1, DOI 10.1016/j.bcp.2015.11.003; Jurga AM, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00198; Komorowska-Muller JA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010019; Kulkarni Meghana M, 2011, Curr Protoc Mol Biol, VChapter 25, DOI 10.1002/0471142727.mb25b10s94; Kumar P, 2013, BIOCHEM BIOPH RES CO, V435, P76, DOI 10.1016/j.bbrc.2013.04.040; Lachapelle J, 2004, VISION RES, V44, P2835, DOI 10.1016/j.visres.2004.06.007; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Liu Y, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0387-16.2017; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lunn CA, 2008, BRIT J PHARMACOL, V153, P226, DOI 10.1038/sj.bjp.0707480; Lunn CA, 2006, J PHARMACOL EXP THER, V316, P780, DOI 10.1124/JPET.105.093500; Lyu JX, 2021, TRANSL STROKE RES, V12, P474, DOI 10.1007/s12975-020-00857-2; Madathil SK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00964; Magid L, 2019, J NEUROTRAUM, V36, P1836, DOI 10.1089/neu.2018.6063; Marco EM, 2013, NEUROPHARMACOLOGY, V68, P223, DOI 10.1016/j.neuropharm.2012.08.014; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Marquez-Ropero M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00506; Martenson ME, 2016, PAIN, V157, P868, DOI 10.1097/j.pain.0000000000000450; Matynia A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00060; Matynia A, 2015, EXP EYE RES, V137, P57, DOI 10.1016/j.exer.2015.05.025; Matynia A, 2012, EXP EYE RES, V105, P60, DOI 10.1016/j.exer.2012.09.012; Merezhinskaya N, 2019, OPTOMETRY VISION SCI, V96, P542, DOI 10.1097/OPX.0000000000001407; Mesquida-Veny F, 2021, PROG NEUROBIOL, V200, DOI 10.1016/j.pneurobio.2020.101970; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Presley C, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.159; Qin Q, 2021, MECH AGEING DEV, V195, DOI 10.1016/j.mad.2021.111438; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Risling M, 2019, J INTERN MED, V285, P594, DOI 10.1111/joim.12909; Rodriguez-Gomez JA, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071717; Saba ES, 2021, CLIN IMMUNOL, V230, DOI 10.1016/j.clim.2021.108815; Santos AM, 2010, J COMP NEUROL, V518, P477, DOI 10.1002/cne.22227; Schomberg D, 2012, EXP NEUROL, V234, P262, DOI 10.1016/j.expneurol.2011.12.021; Smith DH, 2021, J NEUROTRAUM, V38, P3204, DOI 10.1089/neu.2021.0094; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Sordillo PP, 2016, BRAIN INJURY, V30, P1043, DOI 10.3109/02699052.2016.1163618; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Tzekov R, 2016, BRAIN INJURY, V30, P1428, DOI 10.1080/02699052.2016.1219062; Tzekov R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153608; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Ulland TK, 2018, NAT REV NEUROL, V14, P667, DOI 10.1038/s41582-018-0072-1; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Wang J, 2021, MOL NEUROBIOL, V58, P1052, DOI 10.1007/s12035-020-02171-2; Weber MT, 2019, BRAIN PATHOL, V29, P437, DOI 10.1111/bpa.12677; Welsbie DS, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0345-1; Wooff Y, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01618; Xing GQ, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00161; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Zhao T, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00303-7	107	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	OCT 29	2021	15								701317	10.3389/fnins.2021.701317			27	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WW2XN	WOS:000717786200001	34776838	gold, Green Published			2022-02-06	
J	Mooney, SWJ; Alam, NM; Prusky, GT				Mooney, Scott W. J.; Alam, Nazia M.; Prusky, Glen T.			Tracking-Based Interactive Assessment of Saccades, Pursuits, Visual Field, and Contrast Sensitivity in Children With Brain Injury	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						eye movements; contrast sensitivity; TBI-traumatic brain injury; cerebral visual impairment; brain injured children; measurement; psychophysics; visual field	IMPAIRMENT; EYE; PREVALENCE; ETIOLOGY	Visual deficits in children that result from brain injury, including cerebral/cortical visual impairment (CVI), are difficult to assess through conventional methods due to their frequent co-occurrence with cognitive and communicative disabilities. Such impairments hence often go undiagnosed or are only determined through subjective evaluations of gaze-based reactions to different forms, colors, and movements, which limits any potential for remediation. Here, we describe a novel approach to grading visual health based on eye movements and evidence from gaze-based tracking behaviors. Our approach-the "Visual Ladder"-reduces reliance on the user's ability to attend and communicate. The Visual Ladder produces metrics that quantify spontaneous saccades and pursuits, assess visual field responsiveness, and grade spatial visual function from tracking responses to moving stimuli. We used the Ladder to assess fourteen hospitalized children aged 3 to 18 years with a diverse range of visual impairments and causes of brain injury. Four children were excluded from analysis due to incompatibility with the eye tracker (e.g., due to severe strabismus). The remaining ten children-including five non-verbal children-were tested multiple times over periods ranging from 2 weeks to 9 months, and all produced interpretable outcomes on at least three of the five visual tasks. The results suggest that our assessment tasks are viable in non-communicative children, provided their eyes can be tracked, and hence are promising tools for use in a larger clinical study. We highlight and discuss informative outcomes exhibited by each child, including directional biases in eye movements, pathological nystagmus, visual field asymmetries, and contrast sensitivity deficits. Our findings indicate that these methodologies will enable the rapid, objective classification and grading of visual impairments in children with CVI, including non-verbal children who are currently precluded from most vision assessments. This would provide a much-needed differential diagnostic and prognostic tool for CVI and other impairments of the visual system, both ocular and cerebral.</p>	[Mooney, Scott W. J.; Alam, Nazia M.; Prusky, Glen T.] Burke Neurol Inst, White Plains, NY 10605 USA; [Mooney, Scott W. J.; Alam, Nazia M.; Prusky, Glen T.] Blythedale Childrens Hosp, Valhalla, NY 10595 USA; [Mooney, Scott W. J.; Alam, Nazia M.; Prusky, Glen T.] Weill Cornell Med, New York, NY 10065 USA		Prusky, GT (corresponding author), Burke Neurol Inst, White Plains, NY 10605 USA.; Prusky, GT (corresponding author), Blythedale Childrens Hosp, Valhalla, NY 10595 USA.; Prusky, GT (corresponding author), Weill Cornell Med, New York, NY 10065 USA.	glp2004@med.cornell.edu					Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Barker F, 2017, OPTOMETRY VISION SCI, V94, P4, DOI 10.1097/OPX.0000000000001001; Bin Zahid A, 2020, CLIN J SPORT MED, V30, P433, DOI 10.1097/JSM.0000000000000639; Bosch DGM, 2016, EUR J HUM GENET, V24, P660, DOI 10.1038/ejhg.2015.186; Chang M, 2020, INVEST OPHTH VIS SCI, V61; Chang MY, 2021, CURR OPIN NEUROL, V34, P89, DOI 10.1097/WCO.0000000000000877; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P183, DOI 10.1113/jphysiol.1988.sp017285; Dakin SC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34514; de Faria JML, 1998, BRIT J OPHTHALMOL, V82, P168, DOI 10.1136/bjo.82.2.168; Foulsham T, 2008, VISION RES, V48, P1777, DOI 10.1016/j.visres.2008.05.018; Gegenfurtner KR, 2016, PERCEPTION, V45, P1333, DOI 10.1177/0301006616657097; GOOD WV, 1994, SURV OPHTHALMOL, V38, P351, DOI 10.1016/0039-6257(94)90073-6; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hatton DD, 2007, J AAPOS, V11, P351, DOI 10.1016/j.jaapos.2007.01.107; Hill NJ, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06236; Hill NJ, 2019, J NEUROSCI METH, V320, P79, DOI 10.1016/j.jneumeth.2019.03.020; Hunfalvay Melissa, 2019, Concussion, V4, pCNC60, DOI 10.2217/cnc-2019-0001; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Huo R, 1999, BRIT J OPHTHALMOL, V83, P670, DOI 10.1136/bjo.83.6.670; Kooiker MJG, 2016, JOVE-J VIS EXP, DOI 10.3791/54031; Leat SJ, 2009, J OPTOM, V2, P19, DOI 10.3921/joptom.2009.19; Lueck AH, 2010, J VISUAL IMPAIR BLIN, V104, P585, DOI 10.1177/0145482X1010401003; Marin-Franch I, 2018, DATA BRIEF, V21, P75, DOI 10.1016/j.dib.2018.09.079; McConnell EL, 2021, OPHTHAL PHYSL OPT, V41, P224, DOI 10.1111/opo.12776; Merabet LB, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00013; Mooney SWJ, 2020, J VISION, V20, DOI 10.1167/jov.20.13.17; Mooney SWJ, 2018, J VISION, V18, DOI 10.1167/18.12.7; Odom JV, 2016, DOC OPHTHALMOL, V133, P1, DOI 10.1007/s10633-016-9553-y; Pehere N, 2018, INDIAN J OPHTHALMOL, V66, P812, DOI 10.4103/ijo.IJO_1274_17; Roman-Lantzy C., 2007, CORTICAL VISUAL IMPA; Sakki HEA, 2018, BRIT J OPHTHALMOL, V102, P424, DOI 10.1136/bjophthalmol-2017-310694; Samadani Uzma, 2016, Concussion, V1, pCNC2, DOI 10.2217/cnc.15.2; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Nielsen LS, 2007, ACTA OPHTHALMOL SCAN, V85, P149, DOI 10.1111/j.1600-0420.2006.00867.x; Sarvananthan N, 2009, INVEST OPHTH VIS SCI, V50, P5201, DOI 10.1167/iovs.09-3486; Schutz AC, 2011, J VISION, V11, DOI 10.1167/11.5.9; Spering M, 2015, TRENDS NEUROSCI, V38, P247, DOI 10.1016/j.tins.2015.02.002; Spering M, 2011, VISION RES, V51, P836, DOI 10.1016/j.visres.2010.10.017; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; TELLER DY, 1986, DEV MED CHILD NEUROL, V28, P779; Witton C, 2017, PEERJ, V5, DOI 10.7717/peerj.3231	42	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	OCT 29	2021	15								737409	10.3389/fnhum.2021.737409			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	WW3KR	WOS:000717820400001	34776907	gold, Green Published			2022-02-06	
J	Shan, W; Guo, JW; Mao, XW; Zhang, YL; Huang, YK; Wang, S; Li, ZX; Meng, X; Zhang, PY; Wu, ZZ; Wang, Q; Liu, YO; He, KL; Wang, YJ				Shan, Wei; Guo, Jianwei; Mao, Xuewei; Zhang, Yulei; Huang, Yikun; Wang, Shuai; Li, Zixiao; Meng, Xia; Zhang, Pingye; Wu, Zhenzhou; Wang, Qun; Liu, Yaou; He, Kunlun; Wang, Yongjun			Automated Identification of Skull Fractures With Deep Learning: A Comparison Between Object Detection and Segmentation Approach	FRONTIERS IN NEUROLOGY			English	Article						skull fractures; deep learning algorithms; automated detection; CT bone algorithm sequences; retrospective study	TRAUMATIC BRAIN-INJURY; PEDIATRIC SKULL; UNIQUE FEATURES; CLASSIFICATION; IMAGES; COMPLICATIONS; MECHANISMS; PATTERNS; CANCER	Objective: Skull fractures caused by head trauma can lead to life-threatening complications. Hence, timely and accurate identification of fractures is of great importance. Therefore, this study aims to develop a deep learning system for automated identification of skull fractures from cranial computed tomography (CT) scans. Method: This study retrospectively analyzed CT scans of 4,782 patients (median age, 54 years; 2,583 males, 2,199 females; development set: n = 4,168, test set: n = 614) diagnosed with skull fractures between September 2016 and September 2020. Additional data of 7,856 healthy people were included in the analysis to reduce the probability of false detection. Skull fractures in all the scans were manually labeled by seven experienced neurologists. Two deep learning approaches were developed and tested for the identification of skull fractures. In the first approach, the fracture identification task was treated as an object detected problem, and a YOLOv3 network was trained to identify all the instances of skull fracture. In the second approach, the task was treated as a segmentation problem and a modified attention U-net was trained to segment all the voxels representing skull fracture. The developed models were tested using an external test set of 235 patients (93 with, and 142 without skull fracture). Results: On the test set, the YOLOv3 achieved average fracture detection sensitivity and specificity of 80.64, and 85.92%, respectively. On the same dataset, the modified attention U-Net achieved a fracture detection sensitivity and specificity of 82.80, and 88.73%, respectively. Conclusion: Deep learning methods can identify skull fractures with good sensitivity. The segmentation approach to fracture identification may achieve better results.	[Shan, Wei; Wang, Qun; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Shan, Wei; Zhang, Yulei; Huang, Yikun; Wang, Shuai; Li, Zixiao; Meng, Xia; Zhang, Pingye; Wu, Zhenzhou; Wang, Qun; Liu, Yaou; Wang, Yongjun] Natl Ctr Clin Med Neurol Dis, Beijing, Peoples R China; [Shan, Wei; Wang, Qun] Beijing Inst Brain Disorders, Beijing, Peoples R China; [Guo, Jianwei] Qingdao Univ, Dept Orthoped, Affiliated Hosp, Qingdao, Peoples R China; [Mao, Xuewei] Qingdao Univ, Sch Automat, Shandong Key Lab Ind Control Technol, Qingdao, Peoples R China; [He, Kunlun] Chinese Peoples Liberat Army Gen Hosp, Lab Translat Med, Beijing, Peoples R China; [He, Kunlun] Chinese Peoples Liberat Army Gen Hosp, Key Lab Minist Ind & Informat Technol Biomed Engn, Beijing, Peoples R China		Wang, YJ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.; Liu, YO; Wang, YJ (corresponding author), Natl Ctr Clin Med Neurol Dis, Beijing, Peoples R China.; He, KL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Lab Translat Med, Beijing, Peoples R China.; He, KL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Key Lab Minist Ind & Informat Technol Biomed Engn, Beijing, Peoples R China.	Yaou08@163.com; kunlunhe@plagh.org; weishantiantan@gmail.com			China National Neurological Clinical Research Center, Beijing Postdoctoral Research Foundation [ZZ 2019-09]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2019M660719]	Funding This study was funded by the China National Neurological Clinical Research Center, Beijing Postdoctoral Research Foundation (ZZ 2019-09), and China Postdoctoral Science Foundation (No. 2019M660719).	Baugnon KL, 2014, NEUROIMAG CLIN N AM, V24, P439, DOI 10.1016/j.nic.2014.03.001; Chilamkurthy S, 2018, LANCET, V392, P2388, DOI 10.1016/S0140-6736(18)31645-3; Chung SW, 2018, ACTA ORTHOP, V89, P468, DOI 10.1080/17453674.2018.1453714; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fujisawa Y, 2019, BRIT J DERMATOL, V180, P373, DOI 10.1111/bjd.16924; Gan KF, 2019, ACTA ORTHOP, V90, P394, DOI 10.1080/17453674.2019.1600125; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Hua KL, 2015, ONCOTARGETS THER, V8, P2015, DOI 10.2147/OTT.S80733; Kim DH, 2018, CLIN RADIOL, V73, P439, DOI 10.1016/j.crad.2017.11.015; Kooi T, 2017, MED IMAGE ANAL, V35, P303, DOI 10.1016/j.media.2016.07.007; Kuang Z., 2020, MED IMAGING DEEP LEA, P382; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; Li YX, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18020556; Nishio M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200721; Orman G, 2015, J NEUROSURG-PEDIATR, V16, P426, DOI 10.3171/2015.3.PEDS1553; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Ting DSW, 2017, JAMA-J AM MED ASSOC, V318, P2211, DOI 10.1001/jama.2017.18152; Urakawa T, 2019, SKELETAL RADIOL, V48, P239, DOI 10.1007/s00256-018-3016-3; Wang ZJ, 2018, GASTROINTEST ENDOSC, V88, P198, DOI 10.1016/j.gie.2018.01.029; Yamada A, 2018, J MED IMAG HEALTH IN, V8, P1069, DOI 10.1166/jmihi.2018.2410; Yap J, 2018, EXP DERMATOL, V27, P1261, DOI 10.1111/exd.13777; Yilmazlar S, 2006, NEUROSURG REV, V29, P64, DOI 10.1007/s10143-005-0396-3; Zaki WMDW, 2008, 2008 3RD INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEM AND KNOWLEDGE ENGINEERING, VOLS 1 AND 2, P1156, DOI 10.1109/ISKE.2008.4731105	26	0	0	5	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 29	2021	12								687931	10.3389/fneur.2021.687931			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW2WP	WOS:000717783800001	34777193	Green Published, gold			2022-02-06	
J	Alonge, KM; Herbert, MJ; Yagi, M; Cook, DG; Banks, WA; Logsdon, AF				Alonge, Kimberly M.; Herbert, Melanie J.; Yagi, Mayumi; Cook, David G.; Banks, William A.; Logsdon, Aric F.			Changes in Brain Matrix Glycan Sulfation Associate With Reactive Gliosis and Motor Coordination in Mice With Head Trauma	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						traumatic brain injury; extracellular matrix; glycosaminoglycans (GAGs); chondroitin sulfate (CS); perineuronal nets (PNNs)	CHONDROITINASE ABC; PLASTICITY; CNS; REGENERATION; INJURY	Perineuronal nets (PNNs) are extracellular matrix (ECM) structures that enmesh and regulate neurocircuits involved in motor and sensory function. Maladaptive changes to the composition and/or abundance of PNNs have been implicated in preclinical models of neuroinflammation and neurocircuit destabilization. The central nervous system (CNS) is limited in its capacity to repair and reorganize neural networks following traumatic brain injury (TBI) and little is known about mechanisms of ECM repair in the adult brain after TBI. In this study, adult male C57BL/6 mice were subjected to a TBI via a controlled cortical impact (CCI) to the right motor and somatosensory cortices. At 7 days following CCI, histological analysis revealed a loss of Wisteria floribunda agglutinin (WFA) positive PNN matrices in the ipsilateral cortex. PNNs are comprised of chondroitin sulfate (CS) and dermatan sulfate (DS)-glycosaminoglycans (GAGs), the composition of which are known to influence neuronal integrity and repair. Using an innovative liquid chromatography tandem mass spectrometry (LC-MS/MS) method, we analyzed the relative abundance of six specific CS/DS-GAG isomers (Delta 4S-, Delta 6S-, Delta 4S6S-, Delta 2S6S-, Delta 0S-CS, and Delta 2S4S-DS) from fixed-brain sections after CCI injury. We report a significant shift in CS/DS-GAG sulfation patterns within the rostro-caudal extent of the injury site from mice exposed to CCI at 7 days, but not at 1 day, post-CCI. In the ipsilateral thalamus, the appearance of WFA(+) puncta occurred in tandem with gliosis at 7 days post-CCI, but weakly colocalized with markers of gliosis. Thalamic WFA(+) puncta showed moderate colocalization with neuronal ubiquitin C-terminal hydrolase L1 (UCHL1), a clinical biomarker for TBI injury. A shift in CS/DS-GAG sulfation was also present in the thalamus including an increase of 6S-CS, which is a specific isomer that associates with the presence of glial scarring. Upregulation of the 6S-CS-specific sulfotransferase (CHST3) gene expression was accompanied by reactive gliosis in both the ipsilateral cortex and thalamus. Moreover, changes in 6S-CS extracted from the thalamus positively correlated with deficits in motor coordination after CCI. Collectively, these data argue that CCI alters CS/DS-GAG sulfation in association with the spatiotemporal progression of neurorepair. Therapeutic interventions targeting restoration of CS/DS-GAG sulfation patterns may improve outcomes from TBI.</p>	[Alonge, Kimberly M.] Univ Washington, Med Diabet Inst, Dept Med, Seattle, WA 98195 USA; [Herbert, Melanie J.; Yagi, Mayumi; Cook, David G.; Banks, William A.; Logsdon, Aric F.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr GRECC, Seattle, WA 98108 USA; [Cook, David G.; Banks, William A.; Logsdon, Aric F.] Univ Washington, Div Gerontol & Geriatr Med, Dept Med, Seattle, WA 98195 USA		Logsdon, AF (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr GRECC, Seattle, WA 98108 USA.; Logsdon, AF (corresponding author), Univ Washington, Div Gerontol & Geriatr Med, Dept Med, Seattle, WA 98195 USA.	alogsdon@uw.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK) [DK122662, DK017047]; National Institute on Aging (NIH-NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG066509, AG074152, AG046619, AG059088]; ITHS Young Investigator Catalyst Award [BR 013035]	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK) grants DK122662 (KA) and DK017047 (KA), the National Institute on Aging (NIH-NIA) grants AG066509 (KA), AG074152 (KA), AG046619 (WB), and AG059088 (WB), and the ITHS Young Investigator Catalyst Award to KA (BR 013035).	Alonge KM, 2020, NAT METAB, V2, P1025, DOI 10.1038/s42255-020-00275-6; Alonge KM, 2019, GLYCOBIOLOGY, V29, P847, DOI 10.1093/glycob/cwz060; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Bhowmick S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8010011; Biane JS, 2016, NEURON, V89, P1173, DOI 10.1016/j.neuron.2016.02.001; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Brown JM, 2012, P NATL ACAD SCI USA, V109, P4768, DOI 10.1073/pnas.1121318109; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Djerbal L, 2017, GLYCOCONJUGATE J, V34, P363, DOI 10.1007/s10719-017-9761-z; Foscarin S, 2017, AGING-US, V9, P1607, DOI 10.18632/aging.101256; Hamai A, 1997, J BIOL CHEM, V272, P9123; Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974; Lee KH, 2015, NEURON, V86, P529, DOI 10.1016/j.neuron.2015.03.010; Lin R, 2008, J NEUROCHEM, V104, P400, DOI 10.1111/j.1471-4159.2007.05066.x; Lin R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021499; Liu H, 2019, P NATL ACAD SCI USA, V116, P4643, DOI 10.1073/pnas.1821282116; Logsdon AF, 2021, ALZHEIMERS DEMENT, DOI 10.1002/alz.12451; Logsdon AF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66113-7; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Miyata S, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1305801; Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023; Nadanaka S, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10111499; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Prabhakar V, 2009, J BIOL CHEM, V284, P974, DOI 10.1074/jbc.M806630200; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Shida M, 2019, BBA-GEN SUBJECTS, V1863, P1319, DOI 10.1016/j.bbagen.2019.06.004; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Spliid CB, 2021, GLYCOBIOLOGY, V31, P103, DOI 10.1093/glycob/cwaa056; Tanaka YH, 2018, NEURON, V100, P244, DOI 10.1016/j.neuron.2018.08.016; Wang KKW, 2021, ACUTE MED SURG, V8, DOI 10.1002/ams2.622; Wiley CA, 2016, J NEUROTRAUM, V33, P1866, DOI 10.1089/neu.2015.4272; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Yang S, 2021, MOL PSYCHIATR, V26, P5658, DOI 10.1038/s41380-021-01208-9; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156	37	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	OCT 28	2021	15								745288	10.3389/fnbeh.2021.745288			12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	WW2CQ	WOS:000717731900001	34776892	gold, Green Published			2022-02-06	
J	Byom, L; Whaln, MS; Turkstra, L				Byom, Lindsey; Whaln, Meaghan S.; Turkstra, Lyn			Working memory for emotions in adolescents and young adults with traumatic brain injury	BRAIN IMPAIRMENT			English	Article; Early Access						Traumatic brain injury; adolescents; young adults; working memory; facial affect recognition	EMERGENCY-DEPARTMENT VISITS; SOCIAL COGNITION; PRAGMATIC LANGUAGE; UNITED-STATES; RECOGNITION; CHILDREN; MIND; IMPAIRMENTS; CHILDHOOD; PERSPECTIVE	Objective: The objective of this preliminary study was to investigate the interaction between working memory and social cognition in adolescents and young adults with traumatic brain injury (TBI). It was hypothesized that participants with or without TBI would better recognize social information when working memory or social cognitive load was low and that adolescents and young adults with TBI would be more affected by increased cognitive demand than their uninjured peers. Design: In this experimental study, eight adolescents and young adults with complicated mild-severe TBI (aged 14-22 years) and eight age- and sex-matched typically developing (TD) adolescents completed computer-based n-back tasks requiring recognition of either face identity or facial affect, with 0-back, 1-back and 2-back conditions. Results: The TBI group had lower scores overall than the TD group, and scores for both groups were lower for affect recognition than identity recognition. Scores for both groups were lower in conditions with a higher working memory load. There was a significant group by working memory interaction, with larger group differences in high-working memory conditions. Conclusions: Adolescents and young adults with TBI are at risk for social cognitive impairments and the ability to recognize affect may be influenced by working memory demands.	[Byom, Lindsey; Whaln, Meaghan S.] Univ N Carolina, Allied Hlth Sci, Sch Med, Chapel Hill, NC 27515 USA; [Turkstra, Lyn] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada		Byom, L (corresponding author), Univ N Carolina, Allied Hlth Sci, Sch Med, Chapel Hill, NC 27515 USA.	lindsey_byom@med.unc.edu			U.S. National Institute on Deafness and Other Communication Disorders (University of Wisconsin-Madison Department of Communication Sciences and Disorders) [NIDCD T32DC005359, NIDCD F31DC012481]; Walker Fund	This study was supported by the U.S. National Institute on Deafness and Other Communication Disorders (University of Wisconsin-Madison Department of Communication Sciences and Disorders, grant number NIDCD T32DC005359), (L.B., grant number NIDCD F31DC012481) and the Walker Fund.	Ackerman PL, 2005, PSYCHOL BULL, V131, P30, DOI 10.1037/0033-2909.131.1.30; Amado A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01363; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Biehl M, 1997, J NONVERBAL BEHAV, V21, P3, DOI 10.1023/A:1024902500935; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Binder AS, 2019, J INT NEUROPSYCH SOC, V25, P890, DOI 10.1017/S1355617719000559; Byom L, 2019, BRAIN INJURY, V33, P322, DOI 10.1080/02699052.2018.1553066; Centers for Disease Control and Prevention, 2010, INJURY PREVENTION CO; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; CLIFF N, 1993, PSYCHOL BULL, V114, P494, DOI 10.1037/0033-2909.114.3.494; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Conklin HM, 2007, DEV NEUROPSYCHOL, V31, P103, DOI 10.1207/s15326942dn3101_6; Cowan N, 2010, CURR DIR PSYCHOL SCI, V19, P51, DOI 10.1177/0963721409359277; Deighton S, 2019, J INT NEUROPSYCH SOC, V25, P931, DOI 10.1017/S135561771900064X; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; DONALDSON W, 1992, J EXP PSYCHOL GEN, V121, P275, DOI 10.1037/0096-3445.121.3.275; Ekman P., 1976, PICTURES FACIAL AFFE; Embury CM, 2019, NEUROIMAGE, V185, P191, DOI 10.1016/j.neuroimage.2018.10.038; Evans JL, 2011, BRAIN RES, V1389, P93, DOI 10.1016/j.brainres.2011.02.010; Feinberg I, 2010, BRAIN COGNITION, V72, P56, DOI 10.1016/j.bandc.2009.09.008; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; GAULIN CA, 1994, PERCEPT MOTOR SKILL, V79, P55, DOI 10.2466/pms.1994.79.1.55; Gordon ACL, 1998, J EXP CHILD PSYCHOL, V68, P70, DOI 10.1006/jecp.1997.2423; Gorman S, 2017, DEV NEUROPSYCHOL, V42, P127, DOI 10.1080/87565641.2017.1315581; Gorman S, 2012, J INT NEUROPSYCH SOC, V18, P29, DOI 10.1017/S1355617711001251; Hamm JV, 2014, DEV PSYCHOL, V50, P216, DOI 10.1037/a0032979; Humphrey G, 2016, DEV NEUROPSYCHOL, V41, P59, DOI 10.1080/87565641.2016.1161764; Im-Bolter N, 2016, J EXP CHILD PSYCHOL, V149, P98, DOI 10.1016/j.jecp.2015.12.006; Kaufman A.S., 2004, K BIT2 KAUFMAN BRIEF, V2nd; Kelly M, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000269; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kilford EJ, 2016, NEUROSCI BIOBEHAV R, V70, P106, DOI 10.1016/j.neubiorev.2016.08.016; Krause M, 2009, BEHAV BRAIN RES, V205, P280, DOI 10.1016/j.bbr.2009.08.009; Lawrence K, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00761; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; Master SL, 2020, DEV COGN NEUROS-NETH, V41, DOI 10.1016/j.dcn.2019.100732; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P528, DOI 10.1017/S1355617713000039; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; Meyer ML, 2020, SOC COGN AFFECT NEUR, V15, P63, DOI 10.1093/scan/nsaa022; Milders M, 2019, BRAIN INJURY, V33, P62, DOI 10.1080/02699052.2018.1531301; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Mu YG, 2012, NEURO-ONCOLOGY, V14, P81, DOI 10.1093/neuonc/nos215; Neta M, 2011, NEUROIMAGE, V56, P1685, DOI 10.1016/j.neuroimage.2011.02.051; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Philippi CL, 2009, J NEUROSCI, V29, P15089, DOI 10.1523/JNEUROSCI.0796-09.2009; Phillips NL, 2017, CHILD NEUROPSYCHOL, V23, P26, DOI 10.1080/09297049.2015.1085500; Rigon A, 2018, J CLIN EXP NEUROPSYC, V40, P805, DOI 10.1080/13803395.2018.1437120; Rogers A, 2019, BRAIN INJURY, V33, P649, DOI 10.1080/02699052.2019.1567936; Romer D, 2011, DEVELOPMENTAL SCI, V14, P1119, DOI 10.1111/j.1467-7687.2011.01061.x; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Rowley DA, 2017, BRAIN INJURY, V31, P1564, DOI 10.1080/02699052.2017.1341645; Ryan NP, 2021, J NEUROTRAUM, V38, P252, DOI 10.1089/neu.2020.7057; Ryan NP, 2017, SOC COGN AFFECT NEUR, V12, P1414, DOI 10.1093/scan/nsx066; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Simmonds DJ, 2017, NEUROIMAGE, V157, P695, DOI 10.1016/j.neuroimage.2017.01.016; Smith R, 2017, SOC COGN AFFECT NEUR, V12, P848, DOI 10.1093/scan/nsx011; Sohlberg MM, 2019, INT J SPEECH-LANG PA, V21, P115, DOI 10.1080/17549507.2019.1583280; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Steinberg L., 2010, ADOLESCENCE; Tamnes CK, 2017, J NEUROSCI, V37, P3402, DOI 10.1523/JNEUROSCI.3302-16.2017; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomas LA, 2007, DEVELOPMENTAL SCI, V10, P547, DOI 10.1111/j.1467-7687.2007.00614.x; Thornton MA, 2013, NEUROIMAGE, V70, P233, DOI 10.1016/j.neuroimage.2012.12.063; Tonks J, 2008, BRAIN INJURY, V22, P325, DOI 10.1080/02699050801968303; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Tousignant B, 2018, NEUROPSYCHOL REHABIL, V28, P429, DOI 10.1080/09602011.2016.1158114; Tousignant B, 2017, COGNITIVE DEV, V43, P214, DOI 10.1016/j.cogdev.2017.05.001; Tuerk C, 2020, HUM BRAIN MAPP, V41, P561, DOI 10.1002/hbm.24822; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Valentine T, 2006, NEUROPSYCHOL REHABIL, V16, P272, DOI 10.1080/09602010500176443; Vetter NC, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00956; Westerhof-Evers HJ, 2017, J HEAD TRAUMA REHAB, V32, P296, DOI 10.1097/HTR.0000000000000332; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	83	0	0	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.											PII S1443964621000206	10.1017/BrImp.2021.20		OCT 2021	15	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	YI3YX	WOS:000743788100001					2022-02-06	
J	Cheng, KC; Cheung, CHA; Chiang, HC				Cheng, Kuan-Chung; Cheung, Chun Hei Antonio; Chiang, Hsueh-Cheng			Early A beta 42 Exposure Causes Learning Impairment in Later Life	AGING AND DISEASE			English	Article; Early Access						A beta; learning and memory; XBP1; oxidative stress; aging	TRAUMATIC BRAIN-INJURY; UNFOLDED PROTEIN RESPONSE; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; A-BETA; MEMORY; TRANSCRIPTION; DYSFUNCTION; DROSOPHILA; ACCUMULATION	Amyloid cascade hypothesis proposes that amyloid beta (A beta) accumulation is the initiator and major contributor to the development of Alzheimer's disease (AD). However, this hypothesis has recently been challenged by clinical studies showing that reduction of A beta accumulation in the brain does not accompany with cognitive improvement, suggesting that therapeutically targeting A beta in the brain may not be sufficient for restoring cognitive function. Since the molecular mechanism underlying the progressive development of cognitive impairment after A beta clearance is largely unknown, the reason of why there is no behavioral improvement after A beta clearance remains elusive. In the current study, we demonstrated that transient A beta expression caused learning deficit in later life, despite the accumulated A beta was soon being removed after the expression. Early A beta exposure decreased the cellular expression of XBP1 and both the antioxidants, catalase, and dPrx5, which made cells more vulnerable to oxidative stress in later life. Early induction of XBP1, catalase, and dPrx5 prevented the overproduction of ROS, improved the learning performance, and preserved the viability of cells in the later life with the early A beta induction. Treating the early A beta exposed flies with antioxidants such as vitamin E, melatonin and lipoic acid, after the removal of A beta also preserved the learning ability in later life. Taken together, we demonstrated that early and transient A beta exposure can have a profound impact on animal behavior in later life and also revealed the cellular and molecular mechanism underlying the development of learning impairment by the early and transient A beta exposure.	[Cheng, Kuan-Chung; Cheung, Chun Hei Antonio; Chiang, Hsueh-Cheng] Natl Cheng Kung Univ, Dept Pharmacol, Tainan, Taiwan; [Cheng, Kuan-Chung; Cheung, Chun Hei Antonio; Chiang, Hsueh-Cheng] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan		Chiang, HC (corresponding author), Natl Cheng Kung Univ, Dept Pharmacol, Tainan, Taiwan.	chianghc@mail.ncku.edu.tw			Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 107-2320-B-006-049-MY3, MOST 108-2321-B-006025-MY2]; Brain Research Center under the Higher Education Sprout Project; Ministry of Science and Technology in TaiwanMinistry of Science and Technology, Taiwan; Ministry of Education	The authors acknowledge Drs. Yi Zhong, Pedro Fernandez-Funez, Stefan Marciniak, William C. Orr and Eduardo Moreno. Bloomington Drosophila Stock Center, VDRC. Special thanks to the technical services from the "Bio-image Core Facility of the National Core Facility Program for Biotechnology, Ministry of Science and Technology, Taiwan". This work was supported by Ministry of Science and Technology, Taiwan (MOST 107-2320-B-006-049-MY3 and MOST 108-2321-B-006025-MY2) and by the Brain Research Center under the Higher Education Sprout Project, co-funded by the Ministry of Education and the Ministry of Science and Technology in Taiwan.	Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af4; Baulch JE, 2020, J NEUROIMMUNE PHARM, V15, P852, DOI 10.1007/s11481-020-09908-9; Bray MJC, 2021, ALZHEIMERS DEMENT, V17, P686, DOI 10.1002/alz.12225; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Chen YR, 2019, AGING CELL, V18, DOI 10.1111/acel.12989; Cheng KC, 2018, MOL NEUROBIOL, V55, P7523, DOI 10.1007/s12035-018-0942-y; Cheng Y, 2020, TRANSL NEURODEGENER, V9, DOI 10.1186/s40035-020-00195-1; Chiang HC, 2010, P NATL ACAD SCI USA, V107, P7060, DOI 10.1073/pnas.0909314107; Cisse M, 2017, MOL PSYCHIATR, V22, P1562, DOI 10.1038/mp.2016.152; Davis RL, 2017, NEURON, V95, P490, DOI 10.1016/j.neuron.2017.05.039; Eguchi N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041509; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gerakis Y, 2018, FEBS J, V285, P995, DOI 10.1111/febs.14332; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Huang LK, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-019-0609-7; Huang YP, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0253-x; Iijima-Ando K, 2008, J BIOL CHEM, V283, P19066, DOI 10.1074/jbc.M710509200; Ji XR, 2018, FASEB J, V32, P1375, DOI 10.1096/fj.201700199RR; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Keller JN, 2005, NEUROLOGY, V64, P1152, DOI 10.1212/01.WNL.0000156156.13641.BA; Khalil MF, 2016, CELL BIOCHEM BIOPHYS, V74, P213, DOI 10.1007/s12013-016-0726-9; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; MacDonald CL, 2008, NEUROLOGY, V71, P1199, DOI 10.1212/01.wnl.0000327521.69520.7f; Mandal PK, 2019, J ALZHEIMERS DIS, V68, P531, DOI 10.3233/JAD-181054; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Misrani A, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.617588; Nakagawa Y, 2000, EXP NEUROL, V163, P244, DOI 10.1006/exnr.2000.7375; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Nunziante M, 2011, J BIOL CHEM, V286, P33942, DOI 10.1074/jbc.M111.272617; Owusu-Ansah E, 2008, PROTOCOL IN VIVO DET, P10; Raby CA, 1998, J NEUROCHEM, V71, P2505; Radyuk SN, 2009, BIOCHEM J, V419, P437, DOI 10.1042/BJ20082003; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Ray A, 2017, J NEUROSCI, V37, P11881, DOI 10.1523/JNEUROSCI.0862-17.2017; Reinhardt S, 2014, FASEB J, V28, P978, DOI 10.1096/fj.13-234864; Resende R, 2008, FREE RADICAL BIO MED, V44, P2051, DOI 10.1016/j.freeradbiomed.2008.03.012; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Tadokoro K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21061974; Tonnies E, 2017, J ALZHEIMERS DIS, V57, P1105, DOI 10.3233/JAD-161088; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Verfaillie Tom, 2010, Int J Cell Biol, V2010, P930509, DOI 10.1155/2010/930509; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032; Zhang JY, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253206; Zhong YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038616; Zuroff L, 2017, CELL MOL LIFE SCI, V74, P2167, DOI 10.1007/s00018-017-2463-7	49	0	0	2	2	INT SOC AGING & DISEASE	FORT WORTH	EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA	2152-5250			AGING DIS	Aging Dis.												10.14336/AD.2021.1015		OCT 2021	16	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	WZ6GY	WOS:000720064300001					2022-02-06	
J	Isokuortti, H; Iverson, GL; Posti, JP; Ruuskanen, JO; Brander, A; Kataja, A; Nikula, M; Ohman, J; Luoto, TM				Isokuortti, Harri; Iverson, Grant L.; Posti, Jussi P.; Ruuskanen, Jori O.; Brander, Antti; Kataja, Anneli; Nikula, Milaja; Ohman, Juha; Luoto, Teemu M.			Serotonergic Antidepressants and Risk for Traumatic Intracranial Bleeding	FRONTIERS IN NEUROLOGY			English	Article						brain injuries; traumatic; intracranial hemorrhages; antidepressant agents; anticoagulation; antithrombotic agents (MeSH)	REUPTAKE INHIBITORS; PLATELET-FUNCTION; COMPUTED-TOMOGRAPHY; BRAIN-INJURY; HEAD-INJURY; MILD; ASSOCIATION; HEMORRHAGE; GUIDELINES; MORTALITY	Background: Serotonergic antidepressants may predispose to bleeding but the effect on traumatic intracranial bleeding is unknown.Methods: The rate of intracranial bleeding in patients with antidepressant medication was compared to patients not antidepressants in a cohort of patients with acute head injury. This association was examined by using a consecutive cohort of head trauma patients from a Finnish tertiary center emergency department (Tampere University Hospital, Tampere, Finland). All consecutive (2010-2012) adult patients (n = 2,890; median age = 58; male = 56%, CT-positive = 22%, antithrombotic medication users = 25%, antidepressant users = 10%) who underwent head CT due to head trauma in the emergency department were included.Results: Male gender, GCS <15, older age, and anticoagulation were associated with an increased risk for traumatic intracranial bleeding. There were 17.8% of patients not taking antidepressants and 18.3% of patients on an antidepressant who had traumatic intracranial bleeding (p = 0.830). Among patients who were taking antithrombotic medication, 16.6% of the patients not taking antidepressant medication, and 22.5% of the patients taking antidepressant medication, had bleeding (p = 0.239). In a regression analysis, traumatic intracranial hemorrhage was not associated with antidepressant use.Conclusions: Serotonergic antidepressant use was not associated with an increased risk of traumatic intracranial hemorrhage.	[Isokuortti, Harri] Helsinki Univ Hosp, Dept Neurosurg, Helsinki, Finland; [Isokuortti, Harri] Univ Helsinki, Helsinki, Finland; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Ctr Hlth & Rehabil Res, Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] Home Base, Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Charlestown, MA USA; [Posti, Jussi P.] Turku Univ Hosp, Neuroctr, Turku Brain Injury Ctr, Dept Neurosurg, Turku, Finland; [Posti, Jussi P.; Ruuskanen, Jori O.] Univ Turku, Turku, Finland; [Ruuskanen, Jori O.] Turku Univ Hosp, Dept Neurol, Div Clin Neurosci, Turku, Finland; [Ruuskanen, Jori O.] Medbase Ltd, Turku, Finland; [Brander, Antti; Kataja, Anneli] Tampere Univ Hosp, Med Imaging Ctr, Dept Radiol, Tampere, Finland; [Nikula, Milaja] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Ohman, Juha; Luoto, Teemu M.] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Luoto, Teemu M.] Tampere Univ, Tampere, Finland		Isokuortti, H (corresponding author), Helsinki Univ Hosp, Dept Neurosurg, Helsinki, Finland.; Isokuortti, H (corresponding author), Univ Helsinki, Helsinki, Finland.	harri.isokuortti@gmail.com	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193	Government's Special Financial Transfer tied to academic research in Health Sciences (Finland) - Academy of Finland [17379]; Maire Taponen Foundation; Finnish Brain Foundation sr; Emil Aaltonen Foundation sr; Science Fund of the City of Tampere; Finnish Medical Society Duodecim	Funding TL and JP have received funding from Government's Special Financial Transfer tied to academic research in Health Sciences (Finland). JP was funded by the Academy of Finland (Grant #17379) and Maire Taponen Foundation. TL has received research grants from the Finnish Brain Foundation sr, the Emil Aaltonen Foundation sr, the Maire Taponen Foundation, the Science Fund of the City of Tampere, and the Finnish Medical Society Duodecim.	Andrade C, 2016, PSYCHIAT CLIN N AM, V39, P413, DOI 10.1016/j.psc.2016.04.010; Auerbach AD, 2013, JAMA INTERN MED, V173, P1075, DOI 10.1001/jamainternmed.2013.714; de Abajo FJ, 1999, BRIT MED J, V319, P1106, DOI 10.1136/bmj.319.7217.1106; de Abajo FJ, 2000, BRIT J CLIN PHARMACO, V50, P43, DOI 10.1046/j.1365-2125.2000.00216.x; de Abajo FJ, 2008, ARCH GEN PSYCHIAT, V65, P795, DOI 10.1001/archpsyc.65.7.795; de Abajo FJ, 2011, DRUG AGING, V28, P345, DOI 10.2165/11589340-000000000-00000; Douros A, 2018, CNS DRUGS, V32, P321, DOI 10.1007/s40263-018-0507-7; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Dunham CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109473; Fang MC, 2006, J AM GERIATR SOC, V54, P1231, DOI 10.1111/j.1532-5415.2006.00828.x; Foks KA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3527; Hallback I, 2012, PHARMACOL REP, V64, P979, DOI 10.1016/S1734-1140(12)70894-0; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hergovich N, 2000, CLIN PHARMACOL THER, V68, P435, DOI 10.1067/mcp.2000.110456; De la Blanca MAIP, 2018, BRAIN INJURY, V32, P99, DOI 10.1080/02699052.2017.1382716; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Isokuortti H, 2018, J NEUROSURG, V129, P1588, DOI 10.3171/2017.7.JNS17615; Isokuortti H, 2016, J NEUROTRAUM, V33, P232, DOI 10.1089/neu.2015.3888; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kharofa J, 2007, STROKE, V38, P3049, DOI 10.1161/STROKEAHA.107.491472; Laporte S, 2017, PHARMACOL RES, V118, P19, DOI 10.1016/j.phrs.2016.08.017; Lewer D, 2015, BRIT J PSYCHIAT, V207, P221, DOI 10.1192/bjp.bp.114.156786; Meijer WEE, 2004, ARCH INTERN MED, V164, P2367, DOI 10.1001/archinte.164.21.2367; Mortensen JK, 2013, STROKE, V44, P420, DOI 10.1161/STROKEAHA.112.674242; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; NICE, 2007, HEAD INJ TRIAG ASS I; Nieuwlaat R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub4; Posti JP, 2020, AGE AGEING, V49, P779, DOI 10.1093/ageing/afaa037; Pratt Laura A, 2017, NCHS Data Brief, P1; Rannanheimo PK, 2015, VALUE HEALTH, V18, P896, DOI 10.1016/j.jval.2015.06.002; Reikvam AG, 2012, PLATELETS, V23, P299, DOI 10.3109/09537104.2011.618852; Roose SP, 2016, J CLIN PSYCHOPHARM, V36, P704, DOI 10.1097/JCP.0000000000000575; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Tsivgoulis G, 2017, NEUROLOGY, V89, P1142, DOI 10.1212/WNL.0000000000004362; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x	39	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 28	2021	12								758707	10.3389/fneur.2021.758707			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB1NH	WOS:000721100800001	34777229	Green Published, gold			2022-02-06	
J	Kovacs, M; Peluso, L; Njimi, H; De Witte, O; Bogossian, EG; Cornejo, AQ; Creteur, J; Schuind, S; Taccone, FS				Kovacs, Matyas; Peluso, Lorenzo; Njimi, Hassane; De Witte, Olivier; Gouvea Bogossian, Elisa; Quispe Cornejo, Armin; Creteur, Jacques; Schuind, Sophie; Taccone, Fabio Silvio			Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement	FRONTIERS IN NEUROLOGY			English	Article						brain injury; brain oxygenation; optimal perfusion; individualized therapy; traumatic brain injury; intracranial hemorrhage; subarachnoid hemorrhage	TISSUE OXYGEN; MANAGEMENT; TENSION; GUIDELINES; METABOLISM; HEMORRHAGE; DIAGNOSIS; INJURY	Background: Although increasing cerebral perfusion pressure (CPP) is commonly accepted to improve brain tissue oxygen pressure (PbtO(2)), it remains unclear whether recommended CPP targets (i. e., >60 mmHg) would result in adequate brain oxygenation in brain injured patients. The aim of this study was to identify the target of CPP associated with normal brain oxygenation.</p> Methods: Prospectively collected data including patients suffering from acute brain injury and monitored with PbtO(2), in whom daily CPP challenge using vasopressors was performed. Initial CPP target was >60 mmHg; norepinephrine infusion was modified to have an increase in CPP of at least 10 mmHg at two different steps above the baseline values. Whenever possible, the same CPP challenge was performed for the following days, for a maximum of 5 days. CPP "responders" were patients with a relative increase in PbtO(2) from baseline values > 20%.</p> Results: A total of 53 patients were included. On the first day of assessment, CPP was progressively increased from 73 (70-76) to 83 (80-86), and 92 (90-96) mmHg, which resulted into a significant PbtO(2) increase [from 20 (17-23) mmHg to 22 (20-24) mmHg and 24 (22-26) mmHg, respectively; p < 0.001]. Median CPP value corresponding to PbtO(2) values > 20 mmHg was 79 (74-87) mmHg, with 2 (4%) patients who never achieved such target. Similar results of CPP targets were observed the following days. A total of 25 (47%) were PbtO(2) responders during the CPP challenge on day 1, in particular if low PbtO(2) was observed at baseline.</p> Conclusions: PbtO(2) monitoring can be an effective way to individualize CPP values to avoid tissue hypoxia. Low PbtO(2) values at baseline can identify the responders to the CPP challenge.</p>	[Kovacs, Matyas; Peluso, Lorenzo; Njimi, Hassane; Gouvea Bogossian, Elisa; Quispe Cornejo, Armin; Creteur, Jacques; Schuind, Sophie; Taccone, Fabio Silvio] Univ Libre Bruxelles, Hop Erasme, Dept Intens Care, Brussels, Belgium; [De Witte, Olivier] Univ Libre Bruxelles, Dept Neurosurg, Hop Erasme, Brussels, Belgium		Peluso, L (corresponding author), Univ Libre Bruxelles, Hop Erasme, Dept Intens Care, Brussels, Belgium.	lorenzopeluso80@gmail.com	Peluso, Lorenzo/AAC-5224-2019	Peluso, Lorenzo/0000-0001-6885-5353; Gouvea Bogossian, Elisa/0000-0002-2062-465X			Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Craven CL, 2021, WORLD NEUROSURG, V149, pE942, DOI 10.1016/j.wneu.2021.01.070; Dellazizzo L, 2019, J NEUROSURG, V131, P1639, DOI 10.3171/2018.5.JNS18651; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Eriksson EA, 2012, CLIN NEUROPHYSIOL, V123, P1255, DOI 10.1016/j.clinph.2011.08.035; Fiore M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035521; Helbok R, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0809-9; Hirschi R, 2019, J NEUROSURG, V131, P1216, DOI 10.3171/2018.4.JNS172604; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; JENNETT B, 1975, LANCET, V1, P480; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kirkman Matthew A, 2016, Anesthesiol Clin, V34, P537, DOI 10.1016/j.anclin.2016.04.007; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Maldonado JR, 2017, CRIT CARE CLIN, V33, P461, DOI 10.1016/j.ccc.2017.03.013; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Purkayastha S, 2012, SEMIN NEUROL, V32, P411, DOI 10.1055/s-0032-1331812; Radolovich DK, 2009, NEUROCRIT CARE, V10, P274, DOI 10.1007/s12028-009-9190-3; Reinstrup P, 2019, ACTA NEUROCHIR, V161, P635, DOI 10.1007/s00701-019-03856-x; Robba C, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03105-z; Robba C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2700-6; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Sokoloff C, 2020, NEUROCRIT CARE, V32, P486, DOI 10.1007/s12028-019-00763-y; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Stocchetti N, 1998, ACT NEUR S, V71, P162	29	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 28	2021	12								732830	10.3389/fneur.2021.732830			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW2EJ	WOS:000717736400001	34777201	Green Published, gold, Green Submitted			2022-02-06	
J	Li, J; Zhang, P; Liu, YY; Wu, SM; Yi, XY; Zhang, SH; Wang, C; Liu, M				Li, Jie; Zhang, Ping; Liu, Yingying; Wu, Simiao; Yi, Xingyang; Zhang, Shihong; Wang, Chun; Liu, Ming			Early amantadine treatment reduces the risk of death in patients with large hemisphere infarctions:a Chinese hospital-based study	BMC NEUROLOGY			English	Article						Amantadine hydrochloride; Large hemispheric infarction; Propensity score matching; Outcome	TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; ACUTE ISCHEMIC-STROKE; CONTROLLED-TRIAL; THERAPY; RECOMMENDATIONS; CONSCIOUSNESS; HYDROCHLORIDE; AROUSAL; OPTIONS	Background Amantadine hydrochloride is one of the most frequently prescribed drugs for patients with severe traumatic brain injury in restoring consciousness and accelerating the pace of functional recovery. However, there is a paucity of studies on the effectiveness of amantadine in patients with severe stroke especially large hemisphere infarction (LHI). The present study aimed to investigate whether amantadine treatment is associated with better clinical outcomes in conservatively treated LHI patients. Methods We retrospectively collected conservatively treated LHI patients according to inclusion/exclusion criteria. The patients were divided into two groups based on the treatment regimen, whether they did receive amantadine hydrochloride in addition to standard therapy (ST) or not. The primary outcomes were in-hospital death, 3-month mortality, and unfavorable outcome (defined as modified Rankin Scale score of 4 to 6). All outcomes were compared between the two groups before and after propensity score matching (PSM). Multivariate logistic regression was performed to identify the association between early amantadine hydrochloride treatment and clinical outcomes in LHI patients. Results Thirty-one LHI patients treated with amantadine combined with ST and 127 patients treated with ST were enrolled. Amantadine group had a shorter prehospital delay (median: 2 vs. 10 h), a higher baseline NIHSS score (21.71 +/- 4.76 vs. 17.49 +/- 5.84), and a higher rate of dominant hemisphere involvement (67.74% vs. 45.67%). After PSM, amantadine treatment significantly reduced the risk of in-hospital death (7.41% vs. 31.11%, p=0.019) and 3-month mortality (25.93% vs. 55.56%, p=0.008). Amantadine treatment yielded a significant decrease in death in-hospital (before PSM: OR 0.143, 95% CI 0.034 to 0.605; after PSM: OR 0.113, 95% CI 0.020 to 0.635) and 3-month mortality (before PSM: OR 0.214, 95% CI 0.077 to 0.598; after PSM: OR 0.176, 95% CI 0.053 to 0.586) in unmatched and matched multivariate analyses. Conclusion The results of our study provide initial evidence that early amantadine treatment was associated with a decrease in death in conservatively treated LHI patients. Considering the limitations of observational study, randomized controlled trials with a large sample size may help provide a clearer picture of the utility of amantadine in LHI patients.	[Li, Jie; Zhang, Ping; Liu, Yingying; Yi, Xingyang; Wang, Chun] Peoples Hosp Deyang City, Dept Neurol, 173 North Taishan Rd, Deyang 618000, Sichuan, Peoples R China; [Li, Jie; Wu, Simiao; Zhang, Shihong; Liu, Ming] Sichuan Univ, West China Hosp, Ctr Cerebrovasc Dis, Dept Neurol, 37 GuoXue Xiang, Chengdu 610041, Sichuan, Peoples R China		Wang, C (corresponding author), Peoples Hosp Deyang City, Dept Neurol, 173 North Taishan Rd, Deyang 618000, Sichuan, Peoples R China.; Liu, M (corresponding author), Sichuan Univ, West China Hosp, Ctr Cerebrovasc Dis, Dept Neurol, 37 GuoXue Xiang, Chengdu 610041, Sichuan, Peoples R China.	dysrmyysjnkwc@163.com; wyplmh@hotmail.com			Universal Application Program, Health and Family Planning Commission of Sichuan Province [17PJ084]; Key Research and Development Program, Science and Technology Department of Sichuan Province [2017SZ0007]; Applied Basic Research Program, Science and Technology Department of Sichuan Province [2018JY0389]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81974181]	This research was funded by Universal Application Program, Health and Family Planning Commission of Sichuan Province (17PJ084), Key Research and Development Program, Science and Technology Department of Sichuan Province (NO.2017SZ0007), Applied Basic Research Program, Science and Technology Department of Sichuan Province (NO. 2018JY0389), and National Natural Science Foundation of China (NO. 81974181). The funding bodies did not play a role in the design of the study and collection, analysis, and interpretation of data. The funding bodies also did not contribute to the writing of this manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Berrouschot J, 1998, INTENS CARE MED, V24, P620, DOI 10.1007/s001340050625; Cossu G, 2014, BRIT J NEUROSURG, V28, P187, DOI 10.3109/02688697.2013.841845; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; DEHAAN R, 1995, STROKE, V26, P2027, DOI 10.1161/01.STR.26.11.2027; DIMASCIO A, 1976, ARCH GEN PSYCHIAT, V33, P599; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DRAKE ME, 1991, ACTA NEUROL BELG, V91, P159; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2000, ARCH INTERN MED, V160, P3196, DOI 10.1001/archinte.160.21.3196; Fisher M, 2011, STROKE, V42, pS24, DOI 10.1161/STROKEAHA.110.592394; GELENBERG AJ, 1977, ARCH GEN PSYCHIAT, V34, P947; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; GIANUTSOS G, 1985, EUR J PHARMACOL, V110, P357, DOI 10.1016/0014-2999(85)90564-3; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Huttner HB, 2009, LANCET NEUROL, V8, P949, DOI 10.1016/S1474-4422(09)70224-8; Johnston KC, 1998, STROKE, V29, P447, DOI 10.1161/01.STR.29.2.447; Khasanova DR, 2009, ZH NEVROL PSIKHIATR, V109, P37; KORNHUBER J, 1993, J NEURAL TRANSM-GEN, V92, P57, DOI 10.1007/BF01245162; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Li J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70172-1; Li J, 2019, THER ADV NEUROL DISO, V12, DOI 10.1177/1756286419873264; Li J, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1148-7; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; PARKES JD, 1970, LANCET, V1, P259; Peeters M, 2002, BRAIN RES, V949, P32, DOI 10.1016/S0006-8993(02)02961-X; Rahme R, 2012, STROKE, V43, P550, DOI 10.1161/STROKEAHA.111.635185; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schnakers C, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.124099; SCHWAB RS, 1969, J AMER MED ASSOC, V208, P1168, DOI 10.1001/jama.208.7.1168; SHAHAR EM, 1992, J PEDIATR-US, V121, P819, DOI 10.1016/S0022-3476(05)81922-5; Steiner T, 2001, NEUROLOGY, V57, pS61, DOI 10.1212/WNL.57.suppl_2.S61; Sutherland BA, 2012, INT J STROKE, V7, P407, DOI 10.1111/j.1747-4949.2012.00770.x; Uhl E, 2004, J NEUROL NEUROSUR PS, V75, P270; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; Wu SM, 2019, LANCET NEUROL, V18, P394, DOI 10.1016/S1474-4422(18)30500-3; Zafonte RD, 2001, J HEAD TRAUMA REHAB, V16, P112, DOI 10.1097/00001199-200102000-00014	45	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	OCT 28	2021	21	1							419	10.1186/s12883-021-02444-w			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WO4CO	WOS:000712404300001	34711177	Green Published, gold			2022-02-06	
J	Longoria, AJ; Horton, A; Swan, AA; Kalvesmaki, A; Pugh, MJ				Longoria, Anthony J.; Horton, Avery; Swan, Alicia A.; Kalvesmaki, Andrea; Pugh, Mary Jo			Effect of Multimorbidity and Psychosocial Factors on Posttraumatic Stress Symptoms Among Post-9/11 Veterans	REHABILITATION PSYCHOLOGY			English	Article; Early Access						multimorbidity; PTSD; resilience; self-efficacy; reintegration	TRAUMATIC BRAIN-INJURY; SOCIAL SUPPORT; MENTAL-HEALTH; RESILIENCE; COMORBIDITY; PREVALENCE; MILITARY; DISORDER; IRAQ; CARE	Objectives: Examine the association of multimorbidity and psychosocial functioning with posttraumatic stress disorder (PTSD) symptom severity reported among post-9/11 veterans. Method: This was a secondary analysis of survey data collected from a national sample of post-9/11 veterans with at least 3 years of Department of Veterans Affairs care, stratified by comorbidity trajectory and sex (N = 1,989). Comorbidity trajectories were derived by latent class analysis to develop probabilistic combinations of physical and mental health conditions in a previous effort (Pugh et al., 2016). In this study, linear models analyzed symptom severity reported on the PTSD Checklist for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition by psychosocial factors (i.e., resilience, self-efficacy, and postdeployment social support) while controlling for sociodemographic characteristics and deployment experiences. Results: Veterans in the mental health, pain, and polytrauma clinical triad comorbidity trajectories reported more severe PTSD symptoms than the healthy comorbidity trajectory (p < .01). All psychosocial factors were significantly associated with PTSD symptom severity, accounting for nearly 43% of variability in follow-up analyses. Confidence in self-efficacy demonstrated the strongest association among them (p < .01). Conclusion: Veterans experiencing multimorbidity, particularly mental health distress, reported greater PTSD symptom severity after controlling for psychosocial factors, sociodemographics, and deployment experiences. The salience of psychosocial factors in reported PTSD symptom severity underscores resilience, self-efficacy and social support as potential facilitators of functional reintegration following military service. Our analyses underscore the need to address the systemic barriers in health care access and delivery for minority patient populations in future investigations.	[Longoria, Anthony J.; Horton, Avery; Swan, Alicia A.] Univ Texas San Antonio, Dept Psychol, One UTSA Circle Dr, San Antonio, TX 78249 USA; [Swan, Alicia A.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Kalvesmaki, Andrea; Pugh, Mary Jo] Univ Utah Med, Div Epidemiol, Salt Lake City, UT USA; [Kalvesmaki, Andrea; Pugh, Mary Jo] Salt Lake Vet Hlth Care Syst, Salt Lake City, UT USA		Swan, AA (corresponding author), Univ Texas San Antonio, Dept Psychol, One UTSA Circle Dr, San Antonio, TX 78249 USA.	Alicia.swan@utsa.edu		Pugh, Mary Jo/0000-0003-4196-7763; Longoria, Anthony/0000-0002-3665-2436; Swan, Alicia/0000-0003-2412-0499	Veterans Affairs Health Services Research and Development ServiceUS Department of Veterans Affairs [DHI 09-237]; Veterans Affairs Health Services Research and Development Service Grant [RCS 17-297]	Supported by Veterans Affairs Health Services Research and Development Service (DHI 09-237; PI Mary Jo Pugh), Research Career Scientist Award for Mary Jo Pugh from Veterans Affairs Health Services Research and Development Service Grant (RCS 17-297), and the United Services Automobile Association, who provided the gift card incentive to survey participants.	Alcantara C, 2016, ETHNOGR POLIT VIOLEN, P275; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bell CN, 2010, AM J HYPERTENS, V23, P534, DOI 10.1038/ajh.2010.28; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Britt, 2013, BUILDING PSYCHOL RES; Britt TW, 2016, IND ORGAN PSYCHOL-US, V9, P378, DOI 10.1017/iop.2015.107; Brown NB, 2016, PSYCHOL TRAUMA-US, V8, P276, DOI 10.1037/tra0000082; Carr MM, 2021, AM J ADDICTION, V30, P26, DOI 10.1111/ajad.13067; Chan MS, 2019, INT J EPIDEMIOL, V48, P1340, DOI 10.1093/ije/dyz052; Corrigan Patrick W, 2006, Expert Rev Neurother, V6, P993, DOI 10.1586/14737175.6.7.993; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; DeViva JC, 2016, PSYCHOL TRAUMA-US, V8, P310, DOI 10.1037/tra0000075; DILLMAN DA, 1991, ANNU REV SOCIOL, V17, P225, DOI 10.1146/annurev.so.17.080191.001301; Dillman DA., 2014, INTERNET PHONE MAIL, V4th; Finley EP, 2012, PSYCHOL MEN MASCULIN, V13, P143, DOI 10.1037/a0023607; Gibson CJ, 2016, WOMEN HEALTH ISS, V26, P225, DOI 10.1016/j.whi.2015.09.013; Hefner K, 2019, PSYCHIAT QUART, V90, P275, DOI 10.1007/s11126-019-09632-5; Hynes DM, 2007, MED CARE, V45, P214, DOI 10.1097/01.mlr.0000244657.90074.b7; Johnson DC, 2011, MIL MED, V176, P161, DOI 10.7205/MILMED-D-10-00258; Lang FR, 2001, J PERS SOC PSYCHOL, V81, P509, DOI 10.1037//0022-3514.81.3.509; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Maguen S., 2014, HASTINGS WOMENS LJ, V25, P27; Makovski TT, 2019, AGEING RES REV, V53, DOI 10.1016/j.arr.2019.04.005; Meredith Lisa S, 2011, Rand Health Q, V1, P2; Nelson C, 2011, J PSYCHIATR RES, V45, P1483, DOI 10.1016/j.jpsychires.2011.06.014; Nicholson K, 2019, J CLIN EPIDEMIOL, V105, P142, DOI 10.1016/j.jclinepi.2018.09.008; Olives C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060308; Pietrzak RH, 2009, DEPRESS ANXIETY, V26, P745, DOI 10.1002/da.20558; Pole Nnamdi, 2005, Cultur Divers Ethnic Minor Psychol, V11, P144, DOI 10.1037/1099-9809.11.2.144; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Ramchand R, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0575-z; Reyes MF, 2020, J APPL GERONTOL, V39, P269, DOI 10.1177/0733464819867554; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Salokangas RKR, 1997, ACTA PSYCHIAT SCAND, V96, P459, DOI 10.1111/j.1600-0447.1997.tb09948.x; Shackelford JL, 2019, J PSYCHOSOC NURS MEN, V57, P35, DOI 10.3928/02793695-20180924-02; Suls J, 2019, HEALTH PSYCHOL, V38, P772, DOI 10.1037/hea0000762; Swan AA, 2018, BRAIN INJURY, V32, P1637, DOI 10.1080/02699052.2018.1518539; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Trivedi RB, 2015, AM J PUBLIC HEALTH, V105, P2564, DOI 10.2105/AJPH.2015.302836; Tsai J, 2012, PSYCHIATRY, V75, P135, DOI 10.1521/psyc.2012.75.2.135; Uhlig K, 2014, J GEN INTERN MED, V29, P670, DOI 10.1007/s11606-013-2659-y; Vogt D., 2012, MANUAL DEPLOYMENT RI; Vyas KJ, 2016, MIL MED, V181, P1240, DOI 10.7205/MILMED-D-15-00585; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; World Health Organization, 2012, World Health Organ Tech Rep Ser, P1	47	0	0	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.												10.1037/rep0000346		OCT 2021	11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	XS9MG	WOS:000733223100001	34726456				2022-02-06	
J	Muller, AM; Panenka, WJ; Lange, RT; Iverson, GL; Brubacher, JR; Virji-Babul, N				Muller, Angela M.; Panenka, William J.; Lange, Rael T.; Iverson, Grant L.; Brubacher, Jeffrey R.; Virji-Babul, Naznin			Longitudinal changes in brain parenchyma due to mild traumatic brain injury during the first year after injury	BRAIN AND BEHAVIOR			English	Article						attention; concussion; gray matter volume; longitudinal; voxel-wise morphometry; white matter	GRAY-MATTER ABNORMALITIES; NEUROPSYCHOLOGICAL OUTCOMES; CONCUSSION; MODERATE; ATROPHY; CONTRAST; VOLUMES; IRON; MRI	Chronic gray matter (GM) atrophy is a known consequence of moderate and severe traumatic brain injuries but has not been consistently shown in mild traumatic brain injury (mTBI). The aim of this study was to investigate the longitudinal effect of uncomplicated mTBI on the brain's GM and white matter (WM) from 6 weeks to 12 months after injury. Voxel-based-morphometry (VBM) was computed with the T1-weighted images of 48 uncomplicated mTBI patients and 37 orthopedic controls. Over the period from 6 weeks to 12 months, only patients who experienced uncomplicated mTBI, but not control participants, showed significant GM decrease predominantly in the right hemisphere along the GM-CSF border in lateral and medial portions of the sensorimotor cortex extending into the rolandic operculum, middle frontal gyrus, insula, and temporal pole. Additionally, only mTBI patients, but not controls, experienced significant WM decrease predominantly in the right hemisphere in the superior fasciculus longitudinalis, arcuate fasciculus, and cortical-pontine tracts as well as a significant WM increase in left arcuate fasciculus and left capsula extrema. We did not observe any significant change in the controls for the same time interval or any significant group differences in GM and WM probability at each of the two timepoints. This suggests that the changes along the brain tissue borders observed in the mTBI group represent a reorganization associated with subtle microscopical changes in intracortical myelin and not a direct degenerative process as a result of mTBI.	[Muller, Angela M.; Virji-Babul, Naznin] Univ British Columbia, Fac Med, Djavad Mowafaghian Ctr Brain Hlth, Dept Phys Therapy, Vancouver, BC, Canada; [Panenka, William J.] Univ British Columbia, British Columbia Neuropsychiat Program, Vancouver, BC, Canada; [Panenka, William J.; Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Brubacher, Jeffrey R.] Univ British Columbia, Dept Emergency Med, Vancouver, BC, Canada		Muller, AM (corresponding author), San Francisco VA Med Ctr, VA Adv Imaging Res Ctr, Dept Radiol & Biomed Imaging, 4150Clement St,Bldg 13, San Francisco, CA 94121 USA.	angela.muller@ucsf.edu			Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [200903MOP-200377BSB-CAAA-161276]	Canadian Institute of Health Research, Grant/Award Number: 200903MOP-200377BSB-CAAA-161276	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Bansal R, 2013, MAGN RESON IMAGING, V31, P1709, DOI 10.1016/j.mri.2013.07.017; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Chung S, 2017, AM J NEURORADIOL, V38, P726, DOI 10.3174/ajnr.A5053; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Dall'Acqua P, 2017, J NEUROTRAUM, V34, P3270, DOI 10.1089/neu.2017.5124; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Espana LY, 2017, J NEUROTRAUM, V34, P3143, DOI 10.1089/neu.2017.5002; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Hellstrom T, 2017, BRAIN INJURY, V31, P674, DOI 10.1080/02699052.2017.1283537; Hellstrom T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13628-1; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Killgore WDS, 2016, NEUROSCI LETT, V612, P238, DOI 10.1016/j.neulet.2015.12.033; King JB, 2016, NEUROIMAGE-CLIN, V11, P81, DOI 10.1016/j.nicl.2016.01.003; Langer N, 2012, NEUROLOGY, V78, P182, DOI 10.1212/WNL.0b013e31823fcd9c; Ledig C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188152; Li HJ, 2017, HUM BRAIN MAPP, V38, P1269, DOI 10.1002/hbm.23453; Lindsey HM, 2021, NEUROPSYCHOL REV, DOI 10.1007/s11065-021-09485-5; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Lorio S, 2016, HUM BRAIN MAPP, V37, P1801, DOI 10.1002/hbm.23137; Lu LY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/470676; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; Micheva KD, 2016, ELIFE, V5, DOI 10.7554/eLife.15784; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Omelchenko A, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1908-3; Palacios EM, 2013, J NEUROTRAUM, V30, P1991, DOI 10.1089/neu.2012.2836; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Rolls ET, 2020, NEUROIMAGE, V206, DOI 10.1016/j.neuroimage.2019.116189; Salimi-Khorshidi G, 2009, LECT NOTES COMPUT SC, V5761, P992; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Silverberg ND, 2016, J INT NEUROPSYCH SOC, V22, P816, DOI 10.1017/S1355617716000692; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sprooten E, 2019, NEUROIMAGE, V185, P27, DOI 10.1016/j.neuroimage.2018.10.023; Sussman D, 2017, NEUROSCI LETT, V650, P52, DOI 10.1016/j.neulet.2017.04.026; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tomaiuolo F, 2021, J NEUROTRAUM, V38, P283, DOI 10.1089/neu.2020.7203; Tomaiuolo F, 2012, BRAIN RES BULL, V87, P373, DOI 10.1016/j.brainresbull.2012.01.008; Vascak M, 2018, CEREB CORTEX, V28, P1625, DOI 10.1093/cercor/bhx058; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; White T, 2003, NEUROPSYCHOLOGICAL A; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Yeh FC, 2018, NEUROIMAGE, V178, P57, DOI 10.1016/j.neuroimage.2018.05.027; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	59	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	DEC	2021	11	12							e2410	10.1002/brb3.2410		OCT 2021	12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	XO3CM	WOS:000711982500001	34710284	Green Published, gold			2022-02-06	
J	Carter, PN; Hall, EE; Ketcham, CJ; Ahmed, OH				Carter, Peyton N.; Hall, Eric E.; Ketcham, Caroline J.; Ahmed, Osman H.			Not Just for Dancing? A Content Analysis of Concussion and Head Injury Videos on TikTok	FRONTIERS IN SPORTS AND ACTIVE LIVING			English	Article						social media; concussion; head injury; healthcare education; public health	KNOWLEDGE TRANSFER; SPORTS CONCUSSION; SOCIAL MEDIA; MANAGEMENT	Social media platforms are an accessible and increasingly used way for the public to gather healthcare-related information, including on sports injuries. "TikTok" is currently one of the fastest-growing social media platforms worldwide, and it is especially popular amongst adolescents and young adults. The widespread use and popularity of TikTok suggests that this platform has potential to be a source for healthcare information for younger individuals. The aim of this study was to gain a preliminary understanding of the concussion/head injury-related information on TikTok, and to gauge if TikTok could serve as a platform for concussion education. This exploratory study used a systematic search strategy to understand more about how concussion is being portrayed through TikTok videos. Using the keywords "concussion" and "head injury," 200 videos were downloaded from TikTok and 43 videos were excluded. Of the 92 videos retrieved using the keyword "concussion," 95% (n = 88) had more than 100,000 views and 6% (n = 10) had been viewed more than 10 million times. Over half, 54% (n = 50) of the "concussion" videos depicted individuals "playing around" and getting hit in the head, whilst only 1% (n = 1) of the TikTok videos were categorized as "explaining concussion facts." The large numbers of views of concussion-related TikTok videos demonstrates the popularity of this platform and indicates that healthcare organizations should consider TikTok as a potential means for concussion education amongst younger individuals.</p>	[Carter, Peyton N.; Hall, Eric E.; Ketcham, Caroline J.] Elon Univ, Dept Exercise Sci, Elon, NC USA; [Carter, Peyton N.; Hall, Eric E.; Ketcham, Caroline J.; Ahmed, Osman H.] Elon Univ, Elon BrainCARE Res Inst, Elon, NC 27244 USA; [Ahmed, Osman H.] Univ Hosp Dorset NHS Fdn Trust, Dept Physiotherapy, Poole, Dorset, England; [Ahmed, Osman H.] Univ Portsmouth, Sch Sport Hlth & Exercise Sci, Portsmouth, Hants, England		Ahmed, OH (corresponding author), Elon Univ, Elon BrainCARE Res Inst, Elon, NC 27244 USA.; Ahmed, OH (corresponding author), Univ Hosp Dorset NHS Fdn Trust, Dept Physiotherapy, Poole, Dorset, England.; Ahmed, OH (corresponding author), Univ Portsmouth, Sch Sport Hlth & Exercise Sci, Portsmouth, Hants, England.	osman.hassan.ahmed@gmail.com					Ahmed OH, 2016, PHYS THER SPORT, V21, P82, DOI 10.1016/j.ptsp.2016.03.001; Ahmed OH, 2017, PHYS THER SPORT, V23, P7, DOI 10.1016/j.ptsp.2016.07.003; Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; Alla S, 2011, BRIT J SPORT MED, V45, P132, DOI 10.1136/bjsm.2010.074088; Basch CH, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/26392; Beer Chris, 2019, IS TIKTOK SETTING SC; Centers for Disease Control Prevention, 2020, CDC HEADS UP; Chen Q, 2021, J MED INTERNET RES, V23, DOI 10.2196/21463; Choudhary N., 2020, INT J MULTIDISCIPL E, V9, P189; Comp G, 2021, AEM EDUC TRAIN, V5, DOI 10.1002/aet2.10532; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Forbes, 2020, FORBES; Hayes M, 2020, SPORT MANAG REV, V23, P852, DOI 10.1016/j.smr.2019.12.006; Kollia B, 2018, INT J PREVENTIVE MED, V9, DOI 10.4103/ijpvm.IJPVM_265_17; Lovett JT, 2021, CURR PROBL DIAGN RAD, V50, P126, DOI 10.1067/j.cpradiol.2020.10.004; McCrea MA, 2017, PHYS MED REH CLIN N, V28, P271, DOI 10.1016/j.pmr.2016.12.005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nankervis B, 2018, J SCI MED SPORT, V21, P681, DOI 10.1016/j.jsams.2017.10.034; Oberlo, 2020, OBERLO; Pew Research Center, 2019, DEFINING GENERATIONS; Pew Research Center, 2019, DEMOGRAPHICS SOCIAL; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Rigamonti L, 2020, HEALTH PROMOT INT, V35, P470, DOI 10.1093/heapro/daz046; Shurlock J, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000456; Slate, 2018, SLATE; Statista, 2020, NUMB SOC MED US WORL; Sullivan SJ, 2012, PHYS THER SPORT, V13, P209, DOI 10.1016/j.ptsp.2011.10.004; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Wallaroo, 2021, WALLAROO; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Williams D, 2014, BRIT J SPORT MED, V48, P107, DOI 10.1136/bjsports-2012-091853; Zheng DX, 2021, PEDIATR DERMATOL, V38, P336, DOI 10.1111/pde.14471	33	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-9367		FRONT SPORTS ACT LIV	Front. Sports Act. Living	OCT 27	2021	3								692613	10.3389/fspor.2021.692613			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	WW0BG	WOS:000717591800001	34778757	Green Published, gold			2022-02-06	
J	Dhillon, NK; Hashim, YM; Conde, G; Phillips, G; Fierro, NM; Yong, F; Berezin, N; Ley, EJ				Dhillon, Navpreet K.; Hashim, Yassar M.; Conde, Geena; Phillips, George; Fierro, Nicole M.; Yong, Felix; Berezin, Naomi; Ley, Eric J.			Early Propranolol Is Associated With Lower Risk of Venous Thromboembolism After Traumatic Brain Injury	AMERICAN SURGEON			English	Article						Deep vein thrombosis; propranolol; trauma; traumatic brain injury; venous thromboembolism	BETA-RECEPTOR BLOCKADE; COAGULATION	Background Traumatic brain injury (TBI) results in an elaborate systemic cascade of secondary injury elicited in part by an intrinsic catecholamine response, which ultimately leads to changes in inflammation and coagulopathy. Attenuation of this catecholamine response with agents such as propranolol confers a survival advantage. The related impact of propranolol on venous thromboembolism (VTE) after TBI is largely unknown. Study Design A single institution retrospective review was conducted of all TBI patients requiring intensive care unit (ICU) admission with an injury severity scale (ISS) >= 25 from January 2013 to May 2015. Patients who received at least one dose of propranolol within 24 hours of admission (PROP) were compared to patients who did not receive any doses of propranolol (NPROP) during their hospitalization. Results Of the 131 patients analyzed, 31 (23.7%) patients received propranolol. The PROP cohort was more severely injured overall (ISS 29 vs 26.5, P = .02). While unadjusted VTE rates were similar (16.1% vs 19.0%, P = .72), the adjusted VTE rate was lower in the PROP cohort (AOR 0.20 (95% CI 0.04-0.97), adjusted P-value < .05). Conclusion Propranolol use in TBI patients who have sustained critical injuries may mitigate the risk of VTE. The mechanism by which this outcome is achieved requires further investigation.	[Dhillon, Navpreet K.; Hashim, Yassar M.; Conde, Geena; Phillips, George; Fierro, Nicole M.; Yong, Felix; Berezin, Naomi; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, 8700 Beverly Blvd,Suite 8215NT, Los Angeles, CA 90048 USA.	Eric.Ley@cshs.org					Alali AS, 2017, ANN SURG, V266, P952, DOI 10.1097/SLA.0000000000002286; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Hoppener MR, 2004, J THROMB HAEMOST, V2, P1316, DOI 10.1111/j.1538-7836.2004.00851.x; Hubbard WB, 2021, THROMB RES, V198, P62, DOI 10.1016/j.thromres.2020.10.041; Kraaijenhagen RA, 2000, THROMB HAEMOSTASIS, V83, P5; Ley EJ, 2020, J TRAUMA ACUTE CARE, V89, P971, DOI 10.1097/TA.0000000000002830; Ley EJ, 2018, J TRAUMA ACUTE CARE, V84, P234, DOI 10.1097/TA.0000000000001747; Liou DZ, 2016, NEUROCRIT CARE, V25, P145, DOI 10.1007/s12028-015-0223-9; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maegele M, 2020, SEMIN THROMB HEMOST, V46, P155, DOI 10.1055/s-0040-1702178; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; Midura EF, 2015, J SURG RES, V197, P25, DOI 10.1016/j.jss.2015.02.064; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; Samuels JM, 2019, J TRAUMA ACUTE CARE, V86, P686, DOI 10.1097/TA.0000000000002173; Schonauer V, 2003, THROMB HAEMOSTASIS, V89, P837, DOI 10.1055/s-0037-1613470; Subaiya S, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-17; Sumislawski JJ, 2018, J TRAUMA ACUTE CARE, V85, P907, DOI 10.1097/TA.0000000000002048; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Tran TY, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E8; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zhang M, 2020, J CLIN NEUROSCI, V75, P66, DOI 10.1016/j.jocn.2020.03.028	24	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	OCT	2021	87	10					1556	1560	00031348211051693	10.1177/00031348211051693		OCT 2021	5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XG8LF	WOS:000712313500001	34704840				2022-02-06	
J	Malinovic, M; Kallenberger, K; Sandall, J				Malinovic, Matea; Kallenberger, Kristine; Sandall, Justin			Refractory Paroxysmal Sympathetic Hyperactivity Following Traumatic Intracerebral Hemorrhage	CUREUS			English	Article						intracerebral hemorrhage; traumatic brain injury; paroxysmal sympathetic hyperactivity; dysautonomia; brain injury; autonomic nervous system diseases	PROGRESS	Paroxysmal sympathetic hyperactivity (PSH) is a complex and underrecognized phenomenon involving increased sympathetic activity leading to tachycardia, tachypnea, and hypertension. The frequency of nonrecognition is due to a lack of diagnostic criteria. In addition, the lack of evidence-based treatments has further complicated approaches to management. This case describes a patient who presented with a newonset seizure and intracerebral hemorrhage requiring burst suppression and decompressive craniotomy to attenuate intracranial hypertension (ICH). The patient continued to display paroxysmal dysautonomia requiring a multimodal regimen for control of episodes. He demonstrated neurological improvement and complete resolution of dysautonomic activity prior to being discharged to a rehabilitation facility. A delayed diagnosis. ICH, and refractory PSH status postdecompressive craniotomy presented unique challenges. Given that the number of episodes of paroxysmal "storms" directly correlates with morbidity and mortality, early detection is critical, and lack of recognition makes this a difficult disorder to diagnose and manage.	[Malinovic, Matea; Sandall, Justin] Univ Kansas, Sch Med Wichita, Anesthesiol, Wichita, KS 67214 USA; [Kallenberger, Kristine] Mem Surg Ctr, Anesthesiol, Tulsa, OK USA		Malinovic, M (corresponding author), Univ Kansas, Sch Med Wichita, Anesthesiol, Wichita, KS 67214 USA.	mmalinovic5@gmail.com					Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Choi HA, 2011, NEUROCRIT CARE, V14, P389, DOI 10.1007/s12028-010-9474-7; Feng Y, 2015, PEDIATR NEUROSURG, V50, P301, DOI 10.1159/000439282; Lump D, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0494-0; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Pozzi M, 2015, J HEAD TRAUMA REHAB, V30, P357, DOI 10.1097/HTR.0000000000000084; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Samuel S, 2016, J NEUROSCI NURS, V48, P82, DOI 10.1097/JNN.0000000000000207; Scott RA, 2020, SEMIN NEUROL, V40, P485, DOI 10.1055/s-0040-1713845	10	0	0	1	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	OCT 27	2021	13	10							e19086	10.7759/cureus.19086			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WO5XI	WOS:000712526500012	34824950	Green Published, gold			2022-02-06	
J	Williams, EMP; Petrie, FJ; Pennington, TN; Powell, DRL; Arora, H; Mackintosh, KA; Greybe, DG				Williams, Elisabeth M. P.; Petrie, Freja J.; Pennington, Thomas N.; Powell, David R. L.; Arora, Hari; Mackintosh, Kelly A.; Greybe, Desney G.			Sex differences in neck strength and head impact kinematics in university rugby union players	EUROPEAN JOURNAL OF SPORT SCIENCE			English	Article; Early Access						Biomechanics; data; gender; injury & prevention; technology	CONCUSSION	Globally, over three million women participate in rugby union, yet injury prevention and training strategies are predominantly based on androcentric data. These strategies may have limited generalisability to females, given the cervical spine is more susceptible to whiplash and less adept at resisting inertial loading. A total of 53 university rugby union players (25 female, 28 male, 20.7 +/- 1.8 years) had their isometric neck strength measured. Bespoke instrumented mouthguards were used to record the magnitude of head impact events in six female and seven male competitive matches. Mean female maximal isometric neck strength was 47% lower than male. Independent samples Mann-Whitney U tests showed no significant differences for peak linear head acceleration (female: median 11.7 g, IQR 7.9 g; male: median 12.5 g, IQR 7.0 g p=.23) or peak rotational head acceleration (female: median 800.2 rad center dot s(-2), IQR 677.7 rad center dot s(-2); male: median 849.4 rad center dot s(-2), IQR 479.8 rad center dot s(-2); p=.76), despite the mean male body mass being 24% greater than female. Coded video analysis revealed substantial differences in head-impact mechanisms; uncontrolled whiplash dominated >50% of all recorded female impact events and <0.5% in males. Direct head-to-ground impacts comprised 26.1% of female and 9.7% of male impacts, with whiplash occurring in 78.0% and 0.5%, respectively. Overall, the data provided in this study do not support the generalisation of male-derived training and injury-prevention data to female rugby athletes. These results suggest a considerable research effort is required to identify specific weakness of female rugby players and derive appropriate training, injury prevention and return to play protocols.	[Williams, Elisabeth M. P.; Petrie, Freja J.; Pennington, Thomas N.; Powell, David R. L.; Mackintosh, Kelly A.; Greybe, Desney G.] Swansea Univ, Appl Sports Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales; [Arora, Hari] Swansea Univ, Fac Sci & Engn, ZCCE, Swansea, W Glam, Wales		Williams, EMP (corresponding author), Swansea Univ, Fac Sci & Engn, Appl Sports Sci Technol & Med Res Ctr ASTEM, Bay Campus,Fabian Way, Swansea SA1 8EN, W Glam, Wales.	e.m.p.williams@swansea.ac.uk		Arora, Hari/0000-0002-9790-0907; Mackintosh, Kelly/0000-0003-0355-6357; Williams, Elisabeth/0000-0002-8422-5842	KESS II Wales MSc Scholarships	This work was supported by KESS II Wales MSc Scholarships.	Alsalaheen B, 2019, J ORTHOP SPORT PHYS, V49, P779, DOI 10.2519/jospt.2019.8760; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Bartsch AJ, 2019, IEEE ENG MED BIO, P2068, DOI 10.1109/EMBC.2019.8856907; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bradley EJ, 2020, J HUM KINET, V72, P185, DOI 10.2478/hukin-2019-0104; Brooks, 2018, ENGLAND PROFESSIONAL; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; de Rosario H, 2012, MED BIOL ENG COMPUT, V50, P1173, DOI 10.1007/s11517-012-0978-5; Ferretti MT, 2018, NAT REV NEUROL, V14, P457, DOI 10.1038/s41582-018-0032-9; Greybe D.G., EUR J SPORT SCI; Greybe DG, 2020, SPORTS ENG, V23, DOI 10.1007/s12283-020-00324-z; Hendricks S, 2020, BRIT J SPORT MED, V54, P566, DOI 10.1136/bjsports-2019-101293; Hendricks S, 2014, EUR J SPORT SCI, V14, P753, DOI 10.1080/17461391.2014.905982; Joodaki H, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4043038; Kemp S., 2018, RFU COMMUNITY RUGBY; Kieffer E.E., 2021, THESIS VIRGINIA POLY; Kuo C, 2018, BIOMECH MODEL MECHAN, V17, P235, DOI 10.1007/s10237-017-0957-8; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Mohan M, 2019, CURR PHYS MED REHAB, V7, P246, DOI 10.1007/s40141-019-00234-7; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; Norton K.I., 2018, KINANTHROPOMETRY EXE, V4th, P68, DOI [10.4324/9781315385662-4, DOI 10.4324/9781315385662-4]; Patton DA, 2020, ANN BIOMED ENG, V48, P2497, DOI 10.1007/s10439-020-02642-6; Patton DA, 2020, AM J SPORT MED, V48, P1246, DOI 10.1177/0363546520906406; Rowson S, 2019, ANN BIOMED ENG, V47, P2048, DOI 10.1007/s10439-019-02329-7; Stemper B., 2009, GENDER DEPENDENT CER; Stemper BD, 2004, SPINE, V29, P1764, DOI 10.1097/01.BRS.0000134563.10718.A7; Stemper BD, 2011, SPINE, V36, pS180, DOI 10.1097/BRS.0b013e3182387d98; Streissguth M, 2019, AMER MADE MUSIC SER, P1, DOI 10.2519/jospt.2019.8582; Women's Rugby Injury Survellance Project Steering Group, 2018, WOM RUGB INJ SURV PR; World Rugby, 2019, WORLD RUGB YEAR REV; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Wu LC, 2014, IEEE T BIO-MED ENG, V61, P2659, DOI 10.1109/TBME.2014.2320153	39	0	0	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1746-1391	1536-7290		EUR J SPORT SCI	Eur. J. Sport Sci.												10.1080/17461391.2021.1973573		OCT 2021	10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WO1BN	WOS:000712196800001	34463209				2022-02-06	
J	Eisenbaum, M; Pearson, A; Gratkowski, A; Mouzon, B; Mullan, M; Crawford, F; Ojo, J; Bachmeier, C				Eisenbaum, Maxwell; Pearson, Andrew; Gratkowski, Arissa; Mouzon, Benoit; Mullan, Michael; Crawford, Fiona; Ojo, Joseph; Bachmeier, Corbin			Influence of traumatic brain injury on extracellular tau elimination at the blood-brain barrier	FLUIDS AND BARRIERS OF THE CNS			English	Article						Mural cells; Tau; Pericytes; Endothelial cells; Traumatic brain injury; Blood-brain barrier; Caveolin-1; Angiopoietin-1; Angiopoietin-2; Mfsd2a	ANGIOPOIETIN-1; EXPRESSION; TRANSPORT; MICRODIALYSIS; ANGIOGENESIS; PERICYTES; NEURONS; CELLS; MODEL	Repetitive head trauma has been associated with the accumulation of tau species in the brain. Our prior work showed brain vascular mural cells contribute to tau processing in the brain, and that these cells progressively degenerate following repetitive mild traumatic brain injury (r-mTBI). The current studies investigated the role of the cerebrovasculature in the elimination of extracellular tau from the brain, and the influence of r-mTBI on these processes. Following intracranial injection of biotin-labeled tau, the levels of exogenous labeled tau residing in the brain were elevated in a mouse model of r-mTBI at 12 months post-injury compared to r-sham mice, indicating reduced tau elimination from the brain following head trauma. This may be the result of decreased caveolin-1 mediated tau efflux at the blood-brain barrier (BBB), as the caveolin inhibitor, methyl-beta-cyclodextrin, significantly reduced tau uptake in isolated cerebrovessels and significantly decreased the basolateral-to-apical transit of tau across an in vitro model of the BBB. Moreover, we found that the upstream regulator of endothelial caveolin-1, Mfsd2a, was elevated in r-mTBI cerebrovessels compared to r-sham, which coincided with a decreased expression of cerebrovascular caveolin-1 in the chronic phase following r-mTBI (> 3 months post-injury). Lastly, angiopoietin-1, a mural cell-derived protein governing endothelial Mfsd2a expression, was secreted from r-mTBI cerebrovessels to a greater extent than r-sham animals. Altogether, in the chronic phase post-injury, release of angiopoietin-1 from degenerating mural cells downregulates caveolin-1 expression in brain endothelia, resulting in decreased tau elimination across the BBB, which may describe the accumulation of tau species in the brain following head trauma.	[Eisenbaum, Maxwell; Pearson, Andrew; Gratkowski, Arissa; Mouzon, Benoit; Mullan, Michael; Crawford, Fiona; Ojo, Joseph; Bachmeier, Corbin] Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA; [Eisenbaum, Maxwell; Pearson, Andrew; Mouzon, Benoit; Mullan, Michael; Crawford, Fiona; Ojo, Joseph; Bachmeier, Corbin] Open Univ, Milton Keynes, Bucks, England; [Mouzon, Benoit; Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Bachmeier, Corbin] Bay Pines VA Healthcare Syst, Bay Pines, FL USA		Eisenbaum, M (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.; Eisenbaum, M (corresponding author), Open Univ, Milton Keynes, Bucks, England.	meisenbaum@roskampinstitute.org			Department of DefenseUnited States Department of Defense [W81XWH-16-1-0724-PRARP-CSRA]; Department of Veterans Affairs (VA) Biomedical Laboratory Research and Development ProgramUS Department of Veterans Affairs [I01BX003709]	This work was supported by the Department of Defense under award number W81XWH-16-1-0724-PRARP-CSRA. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. This work was also supported by Merit Review award number I01BX003709 from the Department of Veterans Affairs (VA) Biomedical Laboratory Research and Development Program. The contents do not represent the views of the Department of Veterans Affairs or the United States Government. Dr. Bachmeier is a Research Scientist at the Bay Pines VA Healthcare System, Bay Pines, FL. Dr. Mouzon is a Research Scientist at the James A. Haley Veterans Hospital, Tampa, FL. Dr. Crawford is a Research Career Scientist at the James A. Haley Veterans Hospital, Tampa, FL. Finally, we would like to thank the Roskamp Institute for their generosity in helping to make this work possible.	Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Andreone BJ, 2017, NEURON, V94, P581, DOI 10.1016/j.neuron.2017.03.043; ARTURSSON P, 1990, J PHARM SCI-US, V79, P476, DOI 10.1002/jps.2600790604; Bachmeier C, 2014, NEUROMOL MED, V16, P686, DOI 10.1007/s12017-014-8318-6; Bachmeier C, 2010, CYTOTECHNOLOGY, V62, P519, DOI 10.1007/s10616-010-9313-x; Badaut J, 2015, NEUROSCIENCE, V285, P215, DOI 10.1016/j.neuroscience.2014.10.035; Banks WA, 2015, BRAIN BEHAV IMMUN, V44, P1, DOI 10.1016/j.bbi.2014.08.007; Banks WA, 2017, J ALZHEIMERS DIS, V55, P411, DOI 10.3233/JAD-160542; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Bonds JA, 2019, J NEUROSCI, V39, P8576, DOI 10.1523/JNEUROSCI.0730-19.2019; Brickler TR, 2018, J NEUROSCI, V38, P9618, DOI 10.1523/JNEUROSCI.0914-18.2018; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Deane R, 2009, J CEREBR BLOOD F MET, V29, P25, DOI 10.1038/jcbfm.2008.117; Dolan PJ, 2010, J BIOL CHEM, V285, P21978, DOI 10.1074/jbc.M110.110940; Dore-Duffy P, 2007, NEUROL RES, V29, P395, DOI 10.1179/016164107X204729; Evans LD, 2018, CELL REP, V22, P3612, DOI 10.1016/j.celrep.2018.03.021; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Gong D, 2011, J TRAUMA, V70, P1480, DOI 10.1097/TA.0b013e31821ac9e1; Gu H, 2016, INT NEUROUROL J, V20, P288, DOI 10.5213/inj.1632692.346; Hansen TM, 2010, CELL SIGNAL, V22, P527, DOI 10.1016/j.cellsig.2009.11.007; Head BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015697; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jozic I, 2019, MOL THER, V27, P1992, DOI 10.1016/j.ymthe.2019.07.016; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kurmann L, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071784; Laksitorini MD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56075-w; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Medina M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00113; Mirbaha H, 2018, ELIFE, V7, DOI 10.7554/eLife.36584; Motulsky HJ, 2016, GRAPHPAD CURVE FITTI; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nag S, 2017, MOL NEUROBIOL, V54, P4232, DOI 10.1007/s12035-016-9973-4; Natarajan Reka, 2017, Curr Protoc Neurosci, V79, DOI 10.1002/cpns.25; Nimmo J, 2020, ALZH DEMENT-DADM, V12, DOI 10.1002/dad2.12070; Nourhaghighi N, 2003, LAB INVEST, V83, P1211, DOI 10.1097/01.LAB.0000082383.40635.FE; Ocak PE, 2020, EXP NEUROL, V326, DOI 10.1016/j.expneurol.2020.113203; Ocak PE, 2020, J NEUROSCI RES, V98, P29, DOI 10.1002/jnr.24327; Ojo J, 2021, NEUROBIOL DIS, V150, DOI 10.1016/j.nbd.2020.105237; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Paris D, 2011, MOL MED, V17, P149, DOI 10.2119/molmed.2010.00180; Park YS, 2016, BIOCHEM BIOPH RES CO, V469, P263, DOI 10.1016/j.bbrc.2015.11.108; Potje SR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43193-8; Sabirzhanov B, 2018, J NEUROTRAUM, V35, P2462, DOI 10.1089/neu.2017.5572; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sato C, 2018, NEURON, V97, P1284, DOI 10.1016/j.neuron.2018.02.015; Sui YT, 2014, PEPTIDES, V62, P197, DOI 10.1016/j.peptides.2014.09.018; Sun ZY, 2021, FLUIDS BARRIERS CNS, V18, DOI 10.1186/s12987-021-00255-2; Sundberg C, 2002, LAB INVEST, V82, P387, DOI 10.1038/labinvest.3780433; Tian XH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc4397; Wang J, 2018, ACTA NEUROPATHOL, V136, P525, DOI 10.1007/s00401-018-1891-2; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yamada K, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0052-5; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Yanamandra K, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2029; Yang YR, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005811; Zhao CS, 2020, TRANSL STROKE RES, V11, P1012, DOI 10.1007/s12975-019-00775-y	63	0	0	3	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-8118			FLUIDS BARRIERS CNS	Fluids Barriers CNS	OCT 26	2021	18	1							48	10.1186/s12987-021-00283-y			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WM9TX	WOS:000711421900002	34702292	gold, Green Submitted, Green Published, Green Accepted			2022-02-06	
J	Robles, DJ; Dharani, A; Rostowsky, KA; Chaudhari, NN; Van Ngo; Zhang, F; O'Donnell, LJ; Green, L; Sheikh-Bahaei, N; Chui, HC; Irimia, A				Robles, David J.; Dharani, Ammar; Rostowsky, Kenneth A.; Chaudhari, Nikhil N.; Van Ngo; Zhang, Fan; O'Donnell, Lauren J.; Green, Lauren; Sheikh-Bahaei, Nasim; Chui, Helena C.; Irimia, Andrei			Older age, male sex, and cerebral microbleeds predict white matter loss after traumatic brain injury	GEROSCIENCE			English	Article						Diffusion tensor imaging; Fractional anisotropy; Susceptibility-weighted imaging; Sensory integration; Executive function	MIDDLE LONGITUDINAL FASCICLE; DIFFUSION ANISOTROPY; MILD; MICROSTRUCTURE; ABNORMALITIES; VULNERABILITY; CONNECTIONS; PARIETAL; EXPOSURE; RECOVERY	Little is known on how mild traumatic brain injury affects white matter based on age at injury, sex, cerebral microbleeds, and time since injury. Here, we study the fractional anisotropy of white matter to study these effects in 109 participants aged 18-77 (46 females, age mu +/- sigma = 40 +/- 17 years) imaged within similar to 1 week and similar to 6 months post-injury. Age is found to be linearly associated with white matter degradation, likely due not only to injury but also to cumulative effects of other pathologies and to their interactions with injury. Age is associated with mean anisotropy decreases in the corpus callosum, middle longitudinal fasciculi, inferior longitudinal and occipitofrontal fasciculi, and superficial frontal and temporal fasciculi. Over similar to 6 months, the mean anisotropies of the corpus callosum, left superficial frontal fasciculi, and left corticospinal tract decrease significantly. Independently of other predictors, age and cerebral microbleeds contribute to anisotropy decrease in the callosal genu. Chronically, the white matter of commissural tracts, left superficial frontal fasciculi, and left corticospinal tract degrade appreciably, independently of other predictors. Our findings suggest that large commissural and intra-hemispheric structures are at high risk for post-traumatic degradation. This study identifies detailed neuroanatomic substrates consistent with brain injury patients' age-dependent deficits in information processing speed, interhemispheric communication, motor coordination, visual acuity, sensory integration, reading speed/comprehension, executive function, personality, and memory. We also identify neuroanatomic features underlying white matter degradation whose severity is associated with the male sex. Future studies should compare our findings to functional measures and other neurodegenerative processes.	[Robles, David J.; Dharani, Ammar; Rostowsky, Kenneth A.; Chaudhari, Nikhil N.; Van Ngo; Irimia, Andrei] Univ Southern Calif, Ethel Percy Andrus Gerontol Ctr, Leonard Davis Sch Gerontol, Los Angeles, CA 90089 USA; [Zhang, Fan; O'Donnell, Lauren J.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Green, Lauren; Sheikh-Bahaei, Nasim; Chui, Helena C.] Univ Southern Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA; [Sheikh-Bahaei, Nasim] Univ Southern Calif, Keck Sch Med, Dept Radiol, 1520 San Pablo St, Los Angeles, CA 90033 USA; [Irimia, Andrei] Univ Southern Calif, Dept Biomed Engn, Viterbi Sch Engn, Corwin D Denney Res Ctr, Los Angeles, CA 90089 USA		Irimia, A (corresponding author), Univ Southern Calif, Ethel Percy Andrus Gerontol Ctr, Leonard Davis Sch Gerontol, Los Angeles, CA 90089 USA.	irimia@usc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 100973]; Department of DefenseUnited States Department of Defense [W81-XWH-1810413]; James J. and Sue Femino Foundation; Hanson-Thorell Research Scholarship; Undergraduate Research Associate Program (URAP) at the University of Southern California; Center for Undergraduate Research in Viterbi Engineering (CURVE) at the University of Southern California; National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41 EB 015902, P41 EB 015898, P41 EB 028741]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH 074794, R01 MH 125860, R01 MH 119222]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	This work was supported by the National Institutes of Health (grant R01 NS 100973 to A.I.), by the Department of Defense (award W81-XWH-1810413 to A.I.), by a grant from the James J. and Sue Femino Foundation to A.I., by a Hanson-Thorell Research Scholarship to A.I., by the Undergraduate Research Associate Program (URAP) at the University of Southern California, and by the Center for Undergraduate Research in Viterbi Engineering (CURVE) at the University of Southern California. L.J.O. and F.Z. acknowledge funding from the National Institutes of Health, including the National Institute of Biomedical Imaging and Bioengineering (grants P41 EB 015902, P41 EB 015898, P41 EB 028741) and the National Institute of Mental Health (grants R01 MH 074794, R01 MH 125860, and R01 MH 119222).	Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bigler ED, 2010, BRAIN IMAGING BEHAV, V4, P270, DOI 10.1007/s11682-010-9105-0; Biswas RK, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0211-y; Butt AM, 2000, J NEUROSCI RES, V59, P477, DOI 10.1002/(SICI)1097-4547(20000215)59:4<477::AID-JNR2>3.0.CO;2-J; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Conta AC, 2004, J COMP NEUROL, V479, P347, DOI 10.1002/cne.20319; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Ewing-Cobbs L, 2006, AM J NEURORADIOL, V27, P879; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Freeze WM, 2019, STROKE, V50, P328, DOI 10.1161/STROKEAHA.118.023788; Funnell MG, 2000, BRAIN, V123, P920, DOI 10.1093/brain/123.5.920; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Gyanwali B, 2019, J ALZHEIMERS DIS, V71, P1309, DOI 10.3233/JAD-190540; Halgren E, 2011, HUM BRAIN MAPP, V32, P1260, DOI 10.1002/hbm.21106; Han ZZ, 2013, BRAIN, V136, P2952, DOI 10.1093/brain/awt205; Herbet G, 2017, BRAIN STRUCT FUNCT, V222, P1597, DOI 10.1007/s00429-016-1294-x; Irimia A, 2005, PHYS MED BIOL, V50, P4429, DOI 10.1088/0031-9155/50/18/012; Irimia A, 2015, BRAIN IMAGING BEHAV, V9, P678, DOI 10.1007/s11682-014-9321-0; Irimia A, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S79174; Jollife IT., 1973, APPL STATIST, V22, P21, DOI [10.2307/2346300, DOI 10.2307/2346300]; JOLLIFFE IT, 1972, J ROY STAT SOC C-APP, V21, P160; Lancaster MA, 2018, HUM BRAIN MAPP, V39, P4276, DOI 10.1002/hbm.24245; Lawrence TP, 2017, NEUROSCI LETT, V655, P143, DOI 10.1016/j.neulet.2017.06.046; Liao R, 2017, NEUROIMAGE-CLIN, V15, P819, DOI 10.1016/j.nicl.2017.06.027; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Liu H, 2017, AGEING RES REV, V34, P64, DOI 10.1016/j.arr.2016.11.006; Makris N, 2013, BRAIN IMAGING BEHAV, V7, P335, DOI 10.1007/s11682-013-9235-2; Makris N, 2017, BRAIN IMAGING BEHAV, V11, P1258, DOI 10.1007/s11682-016-9589-3; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Najem D, 2018, BIOCHEM CELL BIOL, V96, P391, DOI 10.1139/bcb-2016-0160; Nazeri A, 2015, NEUROBIOL AGING, V36, P2094, DOI 10.1016/j.neurobiolaging.2015.02.022; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Ota M, 2006, NEUROIMAGE, V31, P1445, DOI 10.1016/j.neuroimage.2006.02.008; Patel JB, 2020, AM J NEURORADIOL, V41, P92, DOI 10.3174/ajnr.A6346; Phillips OR, 2013, BRAIN CONNECT, V3, P146, DOI 10.1089/brain.2012.0111; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Rostowsky KA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00948; Shimizu Yuichiro, 2015, Brain Nerve, V67, P1147, DOI 10.11477/mf.1416200274; Skandsen T, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00638; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stojanovski S, 2019, NEUROIMAGE-CLIN, P24; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Tremblay S, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101907; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Vik A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00081; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092; Yin B, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00028; Zhang F, 2018, NEUROIMAGE, V179, P429, DOI 10.1016/j.neuroimage.2018.06.027	55	0	0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	2509-2715	2509-2723		GEROSCIENCE	GeroScience	FEB	2022	44	1			SI		83	102		10.1007/s11357-021-00459-2		OCT 2021	20	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	YR7XN	WOS:000711289100001	34704219				2022-02-06	
J	Zhao, YT; Fallas, JA; Saini, S; Ueda, G; Somasundaram, L; Zhou, ZB; Xavier, I; Ehnes, D; Xu, CF; Carter, L; Wrenn, S; Mathieu, J; Sellers, DL; Baker, D; Ruohola-Baker, H				Zhao, Yan Ting; Fallas, Jorge A.; Saini, Shally; Ueda, George; Somasundaram, Logeshwaran; Zhou, Ziben; Xavier, Infencia; Ehnes, Devon; Xu, Chunfu; Carter, Lauren; Wrenn, Samuel; Mathieu, Julie; Sellers, Drew L.; Baker, David; Ruohola-Baker, Hannele			F-domain valency determines outcome of signaling through the angiopoietin pathway	EMBO REPORTS			English	Article						Akt; angiogenesis; angiopoietins; self-assembled oligomer protein; Tie2	TRAUMATIC BRAIN-INJURY; ENDOTHELIAL-CELL SURVIVAL; IN-VITRO; VASCULAR-PERMEABILITY; PHASE-SEPARATION; STRUCTURAL BASIS; TIE2 RECEPTOR; ANGIOGENESIS; PROTEIN; BARRIER	Angiopoietins 1 and 2 (Ang1 and Ang2) regulate angiogenesis through their similar F-domains by activating Tie2 receptors on endothelial cells. Despite the similarity in the underlying receptor-binding interaction, the two angiopoietins have opposite effects: Ang1 induces phosphorylation of AKT, strengthens cell-cell junctions, and enhances endothelial cell survival while Ang2 can antagonize these effects, depending on cellular context. To investigate the molecular basis for the opposing effects, we examined the phenotypes of a series of computationally designed protein scaffolds presenting the Ang1 F-domain in a wide range of valencies and geometries. We find two broad phenotypic classes distinguished by the number of presented F-domains: Scaffolds presenting 3 or 4 F-domains have Ang2-like activity, upregulating pFAK and pERK but not pAKT, while scaffolds presenting 6, 8, 12, 30, or 60 F-domains have Ang1-like activity, upregulating pAKT and inducing migration and vascular stability. The scaffolds with 6 or more F-domains display super-agonist activity, producing stronger phenotypes at lower concentrations than Ang1. Tie2 super-agonist nanoparticles reduced blood extravasation and improved blood-brain barrier integrity four days after a controlled cortical impact injury.	[Zhao, Yan Ting; Fallas, Jorge A.; Saini, Shally; Ueda, George; Somasundaram, Logeshwaran; Zhou, Ziben; Xavier, Infencia; Ehnes, Devon; Xu, Chunfu; Carter, Lauren; Wrenn, Samuel; Baker, David; Ruohola-Baker, Hannele] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Zhao, Yan Ting; Saini, Shally; Somasundaram, Logeshwaran; Zhou, Ziben; Xavier, Infencia; Ehnes, Devon; Mathieu, Julie; Sellers, Drew L.; Ruohola-Baker, Hannele] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Zhao, Yan Ting; Ruohola-Baker, Hannele] Univ Washington, Sch Dent, Oral Hlth Sci, Seattle, WA 98195 USA; [Fallas, Jorge A.; Ueda, George; Carter, Lauren; Wrenn, Samuel; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Mathieu, Julie] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Sellers, Drew L.; Baker, David; Ruohola-Baker, Hannele] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA		Baker, D; Ruohola-Baker, H (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Sellers, DL; Ruohola-Baker, H (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.; Ruohola-Baker, H (corresponding author), Univ Washington, Sch Dent, Oral Hlth Sci, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.; Sellers, DL; Baker, D; Ruohola-Baker, H (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	drewfus@uw.edu; dabaker@uw.edu; Hannele@uw.edu	; Xu, Chunfu/B-5963-2012	Zhao, Yan Ting/0000-0001-9230-7066; Saini, Shally/0000-0002-0430-8788; Zhou, Ziben/0000-0001-8829-5330; Xu, Chunfu/0000-0002-8668-0566; somasundaram, logeshwaran/0000-0003-1924-8156; Xavier Raj, Infencia/0000-0002-4889-4643; Carter, Lauren/0000-0002-9837-9068	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01GM097372, R01GM083867, 1P01GM081619, U01HL099997, UO1HL099993]; Department of DefenseUnited States Department of Defense [PR203328]; NIH/NIDCRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [T90 DE021984, TR002318, 5R21NS099654, 1R01NS118247]	This work is supported by gift from Hahn Family and partly by grants from the National Institutes of Health R01GM097372, R01GM083867, 1P01GM081619, U01HL099997, UO1HL099993 for HR-B; Department of Defense PR203328 for HR-B and DB; NIH/NIDCR #T90 DE021984, TR002318 for YTZ; 5R21NS099654 and 1R01NS118247 for DLS.	Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Bale JB, 2016, SCIENCE, V353, P389, DOI 10.1126/science.aaf8818; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Ben-Sasson AJ, 2021, NATURE, V589, P468, DOI 10.1038/s41586-020-03120-8; Berthiaume AA, 2018, CELL REP, V22, P8, DOI 10.1016/j.celrep.2017.12.016; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Boyken SE, 2016, SCIENCE, V352, P680, DOI 10.1126/science.aad8865; Brickler TR, 2018, J NEUROSCI, V38, P9618, DOI 10.1523/JNEUROSCI.0914-18.2018; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Case LB, 2019, ANNU REV BIOPHYS, V48, P465, DOI 10.1146/annurev-biophys-052118-115534; Cho CH, 2005, CIRC RES, V97, P86, DOI 10.1161/01.RES.0000174093.64855.a6; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Dalton AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163732; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Davis S, 2003, NAT STRUCT BIOL, V10, P38, DOI 10.1038/nsb880; DeCicco-Skinner KL, 2014, JOVE-J VIS EXP, DOI 10.3791/51312; Engler-Chiurazzi EB, 2017, PROG NEUROBIOL, V157, P188, DOI 10.1016/j.pneurobio.2015.12.008; Fallas JA, 2017, NAT CHEM, V9, P353, DOI [10.1038/NCHEM.2673, 10.1038/nchem.2673]; Finn TE, 2012, J BIOL CHEM, V287, P21530, DOI 10.1074/jbc.M112.372961; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Fukuhara S, 2010, HISTOL HISTOPATHOL, V25, P387, DOI 10.14670/HH-25.387; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Gerald D, 2013, CANCER RES, V73, P1649, DOI 10.1158/0008-5472.CAN-12-4697; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Han S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9260; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Harfouche R, 2006, AM J PHYSIOL-HEART C, V291, pH1635, DOI 10.1152/ajpheart.01318.2005; Hartmann DA, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.4.041402; Hu E, 2019, BRAIN RES, V1708, P58, DOI 10.1016/j.brainres.2018.12.003; Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kim HZ, 2009, BBA-MOL CELL RES, V1793, P772, DOI 10.1016/j.bbamcr.2009.01.018; Kim I, 2000, CIRC RES, V86, P952, DOI 10.1161/01.RES.86.9.952; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kim J, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau6732; Kim KT, 2005, J BIOL CHEM, V280, P20126, DOI 10.1074/jbc.M500292200; Kim M, 2016, J CLIN INVEST, V126, P3511, DOI 10.1172/JCI84871; Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2; KOH B, 2020, NAT COMMUN, V11, P1; Lee J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006666; Leppanen VM, 2017, P NATL ACAD SCI USA, V114, P4376, DOI 10.1073/pnas.1616166114; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin PN, 1998, P NATL ACAD SCI USA, V95, P8829, DOI 10.1073/pnas.95.15.8829; Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mazurek R, 2017, Adv Pharmacol, V78, P323, DOI 10.1016/bs.apha.2016.08.001; Moore JO, 2017, P NATL ACAD SCI USA, V114, P4382, DOI 10.1073/pnas.1617800114; Moretti R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00040; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Ogle ME, 2014, ACTA BIOMATER, V10, P4704, DOI 10.1016/j.actbio.2014.08.007; Oh N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15291; Pang DF, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0145-7; Pop R, 2014, CARDIOVASC INTER RAD, V37, P829, DOI 10.1007/s00270-013-0746-4; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Procopio WN, 1999, J BIOL CHEM, V274, P30196, DOI 10.1074/jbc.274.42.30196; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Shreiber DI, 1999, NEUROSCI LETT, V259, P5, DOI 10.1016/S0304-3940(98)00853-2; Sok MCP, 2017, ACTA BIOMATER, V53, P109, DOI 10.1016/j.actbio.2017.02.020; Souma T, 2016, J CLIN INVEST, V126, P2575, DOI 10.1172/JCI85830; Stoeltzing O, 2003, CANCER RES, V63, P3370; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Tang T, 2007, BRAIN RES, V1175, P134, DOI 10.1016/j.brainres.2007.08.028; Teichert M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16106; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Valable S, 2005, J CEREBR BLOOD F MET, V25, P1491, DOI 10.1038/sj.jcbfm.9600148; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Wang YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19598; White BD, 2010, STEM CELLS, V28, P297, DOI 10.1002/stem.268; Xing YL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8058; Xu CF, 2020, NATURE, V585, P129, DOI 10.1038/s41586-020-2646-5; Xue GD, 2013, JNCI-J NATL CANCER I, V105, P393, DOI 10.1093/jnci/djs648; Yu XH, 2013, P NATL ACAD SCI USA, V110, P7205, DOI 10.1073/pnas.1216890110; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475; Zakeri B, 2012, P NATL ACAD SCI USA, V109, pE690, DOI 10.1073/pnas.1115485109; Zhang ZG, 2002, NEUROSCIENCE, V113, P683, DOI 10.1016/S0306-4522(02)00175-6; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	89	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-221X	1469-3178		EMBO REP	EMBO Rep.	DEC 6	2021	22	12							e53471	10.15252/embr.202153471		OCT 2021	18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	XJ7AL	WOS:000710981200001	34698433	Green Submitted			2022-02-06	
J	Disner, SG; Mattson, EK; Nelson, NW; Armistead-Jehle, P				Disner, Seth G.; Mattson, Elsa K.; Nelson, Nathaniel W.; Armistead-Jehle, Patrick			The role of posttraumatic stress symptoms on memory complaints and performance in active-duty service members	CLINICAL NEUROPSYCHOLOGIST			English	Article; Early Access						PTSD; depression; memory; free recall; memory complaints	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL STATUS RBANS; BEHAVIORAL HEALTH-CARE; PSYCHOMETRIC PROPERTIES; REPEATABLE BATTERY; CLINICAL UTILITY; COGNITIVE MODEL; WAR VETERANS; PTSD; IMPAIRMENT	Objective: Memory complaints are the most common form of cognitive limitation reported by military service members, but prior research suggests that posttraumatic stress symptoms (PTSS) may account for the link between subjective cognitive complaints and objective cognitive performance. The mechanisms underlying this relationship are largely unknown, including whether the finding applies to memory complaints and performance, which clinical dimensions are involved, and how the association varies when memory complaints are non-credible. Method: Using a sample of 196 US military service members, the present study aims to address these gaps by modeling the relationship between objective memory performance and plausible/implausible subjective memory complaints, then evaluating how the association is influenced by PTSS and clinical traits commonly found within PTSS (e.g. depression, anxiety, and somatic concerns). Results: Overall memory complaints were associated with immediate and delayed recall, but both associations were fully mediated by PTSS (95% CI -0.14, -0.01; 95% CI -0.14, -0.02, respectively). Implausible memory complaints, however, were inconsistently linked to memory performance, and no PTSS mediation was observed. Of the clinical traits, only depression moderated the impact of PTSS, specifically by influencing the link between PTSS and overall memory complaints (beta = -0.02, SE = 0.004, p < .001). Conclusions: These results corroborate the importance of assessment for PTSS and depression in service members who report subjective memory complaints and highlight how targeted intervention for these conditions may play a key role in the management of memory complaints.	[Disner, Seth G.; Mattson, Elsa K.] Minneapolis VA Hlth Care Syst, 1 Vet Dr,Bldg 68-2, Minneapolis, MN 55417 USA; [Disner, Seth G.] Univ Minnesota, Dept Psychiat & Behav Sci, Med Sch, Minneapolis, MN USA; [Mattson, Elsa K.] Case Western Reserve Univ, Dept Psychol Sci, Cleveland, OH USA; [Nelson, Nathaniel W.] Univ St Thomas, Minneapolis, MN USA; [Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Ft Leavenworth, KS USA		Disner, SG (corresponding author), Minneapolis VA Hlth Care Syst, 1 Vet Dr,Bldg 68-2, Minneapolis, MN 55417 USA.	Disne014@umn.edu		Disner, Seth/0000-0003-3635-9421	U.S. Department of Veterans Affairs Rehabilitation Research and Development Career Development AwardUS Department of Veterans Affairs [IK2RX002922]	This work was supported by U.S. Department of Veterans Affairs Rehabilitation Research and Development Career Development Award IK2RX002922 (PI: SGD) (Rehabilitation Research and Development Service).	Armistead-Jehle P, 2016, CLIN NEUROPSYCHOL, V30, P610, DOI 10.1080/13854046.2016.1177597; Ashby E.L, 2012, J PSYCHOL ISSUES ORG, V3, P17, DOI [https://doi.org/10.1002/jpoc.20097, DOI 10.1002/JPOC.20097]; Basford JR, 2015, ARCH PHYS MED REHAB, V96, P977, DOI 10.1016/j.apmr.2015.02.025; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Breshears RE, 2010, J PERS ASSESS, V92, P349, DOI 10.1080/00223891.2010.482011; Brewin CR, 2014, PSYCHOL BULL, V140, P69, DOI 10.1037/a0033722; Burke HS, 2009, J REHABIL, V75, P5; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Byrne B.M., 2013, STRUCTURAL EQUATION; Carlozzi NE, 2011, STRESS HEALTH, V27, pE287, DOI 10.1002/smi.1355; Chao LDL, 2017, MIL MED, V182, pE1625, DOI 10.7205/MILMED-D-16-00309; Clark DA, 2010, TRENDS COGN SCI, V14, P418, DOI 10.1016/j.tics.2010.06.007; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Disner SG, 2017, CLIN PSYCHOL SCI, V5, P650, DOI 10.1177/2167702617703436; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Donnelly K, 2018, CLIN NEUROPSYCHOL, V32, P436, DOI 10.1080/13854046.2017.1390163; Edens JF, 2001, BEHAV SCI LAW, V19, P519, DOI 10.1002/bsl.457; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Green P., 2019, USERS MANUAL MEMORY; Green P., 2004, MANUAL MED SYMPTOM V; Green P., 2004, MEMORY COMPLAINTS IN; Green P.J.E., 2008, MANUAL NONVERBAL MED; Hayes AF, 2018, COMMUN MONOGR, V85, P4, DOI 10.1080/03637751.2017.1352100; Huber BN, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1735388; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Johnson B. K., 2018, THESIS; Judah MR, 2018, J HEAD TRAUMA REHAB, V33, pE10, DOI 10.1097/HTR.0000000000000356; Jungwirth S, 2004, J AM GERIATR SOC, V52, P263, DOI 10.1111/j.1532-5415.2004.52066.x; Karlin BE, 2005, J CLIN PSYCHOL, V61, P1571, DOI 10.1002/jclp.20209; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Lange RT, 2020, J TRAUMA STRESS, V33, P318, DOI 10.1002/jts.22480; Luck T, 2015, ACTA PSYCHIAT SCAND, V131, P290, DOI 10.1111/acps.12328; Marshall GN, 2010, J ABNORM PSYCHOL, V119, P126, DOI 10.1037/a0018477; Mattson EK, 2019, NEUROPSYCHOLOGY, V33, P913, DOI 10.1037/neu0000560; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; MCNALLY RJ, 1995, BEHAV RES THER, V33, P619, DOI 10.1016/0005-7967(95)00007-K; Mitchell AJ, 2014, ACTA PSYCHIAT SCAND, V130, P439, DOI 10.1111/acps.12336; Mol MEM, 2006, INT J GERIATR PSYCH, V21, P432, DOI 10.1002/gps.1487; Morey L.C., 2014, PERSONALITY ASSESSME, V2nd, P181; Ord AS, 2021, NEUROPSYCHOLOGY, V35, P241, DOI 10.1037/neu0000722; Pearman A, 2009, J ADULT DEV, V16, P101, DOI 10.1007/s10804-009-9063-1; Ptak R, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00057; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Riley E, 2019, NEUROPSYCHOLOGY, V33, P534, DOI 10.1037/neu0000529; Roca V, 2001, AM J PSYCHIAT, V158, P1738, DOI 10.1176/appi.ajp.158.10.1738-a; Rodriguez P, 2012, J REHABIL RES DEV, V49, P649, DOI 10.1682/JRRD.2011.09.0162; Rubenzer S, 2009, PSYCHOL INJ LAW, V2, P114, DOI 10.1007/s12207-009-9045-4; Samuelson KW, 2017, J TRAUMA STRESS, V30, P521, DOI 10.1002/jts.22223; Seidman AJ, 2019, MIL PSYCHOL, V31, P11, DOI 10.1080/08995605.2018.1522927; Sharp ML, 2015, EPIDEMIOL REV, V37, P144, DOI 10.1093/epirev/mxu012; Sherman EMS, 2020, ARCH CLIN NEUROPSYCH, V35, P735, DOI 10.1093/arclin/acaa019; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Wade NG, 2015, PSYCHIATR REHABIL J, V38, P135, DOI 10.1037/prj0000131; Weathers F.W., 1993, ANN M INT SOC TRAUM	57	0	0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.												10.1080/13854046.2021.1998635		OCT 2021	16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	WX7IE	WOS:000718764200001	34779345				2022-02-06	
J	Estraneo, A; Magliacano, A; Fiorenza, S; Formisano, R; Grippo, A; Angelakis, E; Cassol, H; Thibaut, A; Gosseries, O; Lamberti, G; Noe, E; Bagnato, S; Edlow, BL; Chatelle, C; Lejeune, N; Veeramuthu, V; Bartolo, M; Mattia, D; Toppi, J; Zasler, N; Schnakers, C; Trojano, L				Estraneo, Anna; Magliacano, Alfonso; Fiorenza, Salvatore; Formisano, Rita; Grippo, Antonello; Angelakis, Efthymios; Cassol, Helena; Thibaut, Aurore; Gosseries, Olivia; Lamberti, Gianfranco; Noe, Enrique; Bagnato, Sergio; Edlow, Brian L.; Chatelle, Camille; Lejeune, Nicolas; Veeramuthu, Vigneswaran; Bartolo, Michelangelo; Mattia, Donatella; Toppi, Jlenia; Zasler, Nathan; Schnakers, Caroline; Trojano, Luigi			Risk factors for 2-year mortality in patients with prolonged disorders of consciousness: An international multicentre study	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						disorders of consciousness; minimally conscious state; mortality; prognosis; vegetative state	TRAUMATIC BRAIN-INJURY; UNRESPONSIVE WAKEFULNESS; GENDER-DIFFERENCES; RECOVERY; EEG; SCALE; COMA; PREDICTORS; STATE; PAIN	Background and purpose Patients with prolonged disorders of consciousness (pDoC) have a high mortality rate due to medical complications. Because an accurate prognosis is essential for decision-making on patients' management, we analysed data from an international multicentre prospective cohort study to evaluate 2-year mortality rate and bedside predictors of mortality. Methods We enrolled adult patients in prolonged vegetative state/unresponsive wakefulness syndrome (VS/UWS) or minimally conscious state (MCS) after traumatic and nontraumatic brain injury within 3 months postinjury. At enrolment, we collected demographic (age, sex), anamnestic (aetiology, time postinjury), clinical (Coma Recovery Scale-Revised [CRS-R], Disability Rating Scale, Nociception Coma Scale-Revised), and neurophysiologic (electroencephalogram [EEG], somatosensory evoked and event-related potentials) data. Patients were followed up to gather data on mortality up to 24 months postinjury. Results Among 143 traumatic (n = 55) and nontraumatic (n = 88) patients (VS/UWS, n = 68, 19 females; MCS, n = 75, 22 females), 41 (28.7%) died within 24 months postinjury. Mortality rate was higher in VS/UWS (42.6%) than in MCS (16%; p < 0.001). Multivariate regression in VS/UWS showed that significant predictors of mortality were older age and lower CRS-R total score, whereas in MCS female sex and absence of alpha rhythm on EEG at study entry were significant predictors. Conclusions This study demonstrated that a feasible multimodal assessment in the postacute phase can help clinicians to identify patients with pDoC at higher risk of mortality within 24 months after brain injury. This evidence can help clinicians and patients' families to navigate the complex clinical decision-making process and promote an international standardization of prognostic procedures for patients with pDoC.	[Estraneo, Anna; Magliacano, Alfonso; Grippo, Antonello] Don Carlo Gnocchi Fdn, Sci Inst Res & Hlth Care, Florence, Italy; [Estraneo, Anna] Santa Maria Pieta Gen Hosp, Neurol Unit, Nola, Italy; [Magliacano, Alfonso; Trojano, Luigi] Univ Campania Luigi Vanvitelli, Dept Psychol, Caserta, Italy; [Fiorenza, Salvatore] Maugeri Clin Sci Inst, Sci Inst Res & Hlth Care, Lab Multimodal Evaluat Disorders Consciousness, Telese Terme, Italy; [Formisano, Rita; Mattia, Donatella] Santa Lucia Fdn, Sci Inst Res & Hlth Care, Rome, Italy; [Angelakis, Efthymios] Univ Athens, Neurosurg Dept, Med Sch, Athens, Greece; [Cassol, Helena; Thibaut, Aurore; Gosseries, Olivia] Univ Liege, GIGA Consciousness, Coma Sci Grp, Liege, Belgium; [Cassol, Helena; Thibaut, Aurore; Gosseries, Olivia] Univ Hosp Liege, Liege, Belgium; [Lamberti, Gianfranco] Neurorehabil & Vegetat State Unit E Viglietta, Cuneo, Italy; [Noe, Enrique] Vithas Hosp, NEURORHB Neurorehabil Serv, Valencia, Spain; [Bagnato, Sergio] Giuseppe Giglio Fdn, Rehabil Dept, Unit Neurophysiol, Cefalu, Italy; [Bagnato, Sergio] Giuseppe Giglio Fdn, Rehabil Dept, Unit Severe Acquired Brain Injuries, Cefalu, Italy; [Edlow, Brian L.; Chatelle, Camille] Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA 02114 USA; [Lejeune, Nicolas] Ctr Hosp Neurol William Lennox, Ottignies, Belgium; [Veeramuthu, Vigneswaran] Univ Reading Malaysia, Dept Psychol, Iskandar Puteri, Malaysia; [Bartolo, Michelangelo] HABILITA Zingonia Ciserano, Neurorehabil Unit, Bergamo, Italy; [Toppi, Jlenia] Sapienza Univ Rome, Dept Comp Control & Management Engn, Rome, Italy; [Zasler, Nathan] Concuss Care Ctr Virginia, Richmond, VA USA; [Schnakers, Caroline] Casa Colina Hosp Rehabil Med, Res Inst, Pomona, CA USA; [Schnakers, Caroline] Ctr Healthcare, Pomona, CA USA		Estraneo, A (corresponding author), IRCCS Fdn Don Carlo Gnocchi, Florence, Italy.	aestraneo@gmail.com	Bagnato, Sergio/H-6842-2013; Magliacano, Alfonso AM/V-7498-2018; Trojano, Luigi/F-2396-2016; estraneo, anna/K-5409-2016	Bagnato, Sergio/0000-0002-6289-1887; Magliacano, Alfonso AM/0000-0003-3834-6392; Trojano, Luigi/0000-0002-0328-9642; Formisano, Rita/0000-0002-2516-0540; estraneo, anna/0000-0001-6646-5626	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska--Curie [778234]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP2HD101400, R21NS109627, RF1NS115268]; James S. McDonnell Foundation; Tiny Blue Dot Foundation; University Hospital of Liege; European UnionEuropean Commission [945539, SGA3]; Bial FoundationBial Foundation; King Baudouin Foundation; Fund for Scientific Research--Belgian National Fund for Scientific Research	This work was supported by grants from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska--Curie (grant agreement 778234)--DoCMA project, the National Institutes of Health (DP2HD101400, R21NS109627, RF1NS115268), the James S. McDonnell Foundation, the Tiny Blue Dot Foundation, University and University Hospital of Liege, the Fund for Scientific Research--Belgian National Fund for Scientific Research, the European Union's Horizon 2020 Framework Programme for Research and Innovation under Specific Grant Agreement 945539 (Human Brain Project SGA3), the Bial Foundation, and the Fund Generet of the King Baudouin Foundation	Azabou E, 2016, CLIN EEG NEUROSCI, V47, P75, DOI 10.1177/1550059415612375; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; Bagnato S, 2017, ARCH PHYS MED REHAB, V98, P665, DOI 10.1016/j.apmr.2016.09.132; Bagnato S, 2015, CLIN NEUROPHYSIOL, V126, P959, DOI 10.1016/j.clinph.2014.08.005; Beridze M, 2010, Georgian Med News, P28; Brown SB, 2012, HEALTH CARE WOMEN IN, V33, P896, DOI 10.1080/07399332.2012.673654; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; Chennu S, 2017, BRAIN, V140, P2120, DOI 10.1093/brain/awx163; Cruccu G, 2008, CLIN NEUROPHYSIOL, V119, P1705, DOI 10.1016/j.clinph.2008.03.016; D'Ippolito M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2824081; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Estraneo A, 2021, BRAIN INJURY, V35, P1, DOI 10.1080/02699052.2020.1861652; Estraneo A, 2019, BRAIN INJURY, V33, P1633, DOI 10.1080/02699052.2019.1658220; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2020, NEUROLOGY, V95, pE1488, DOI 10.1212/WNL.0000000000010254; Estraneo A, 2018, ARCH PHYS MED REHAB, V99, P2523, DOI 10.1016/j.apmr.2018.04.024; Estraneo A, 2016, CLIN NEUROPHYSIOL, V127, P2379, DOI 10.1016/j.clinph.2016.03.021; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faugeras F, 2018, BRAIN INJURY, V32, P72, DOI 10.1080/02699052.2017.1364421; Fingelkurts AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025967; Formisano R, 2020, NEUROPSYCHOL REHABIL, V30, P1893, DOI 10.1080/09602011.2019.1614464; Formisano R, 2018, NEUROL SCI, V39, P753, DOI 10.1007/s10072-017-3203-3; Gerrard P, 2014, ARCH PHYS MED REHAB, V95, P2335, DOI 10.1016/j.apmr.2014.06.018; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kondziella D, 2020, EUR J NEUROL, V27, P741, DOI 10.1111/ene.14151; Kotchoubey B, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00315; Laureys S., 2018, COMA DISORDERS CONSC, P17, DOI 10.1007/978-3-319-55964-3; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lopez-Rolon A, 2017, NEUROREHABILITATION, V40, P509, DOI 10.3233/NRE-171438; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Mikolic A, 2021, J NEUROTRAUM, V38, P235, DOI 10.1089/neu.2020.7228; Moretta P, 2014, CLIN REHABIL, V28, P717, DOI 10.1177/0269215514521826; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Noe E, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11010126; Portaccio E, 2018, BRAIN INJURY, V32, P730, DOI 10.1080/02699052.2018.1440420; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Scarpino M, 2020, ACTA NEUROL SCAND, V142, P221, DOI 10.1111/ane.13247; Scarpino M, 2019, NEUROPHYSIOL CLIN, V49, P317, DOI 10.1016/j.neucli.2019.07.001; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schnakers C, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10120930; Steppacher I, 2020, BRAIN INJURY, V34, P399, DOI 10.1080/02699052.2019.1695289; Steppacher I, 2014, ANN CLIN TRANSL NEUR, V1, P401, DOI 10.1002/acn3.63; Tsetsou S, 2015, RESUSCITATION, V97, P34, DOI 10.1016/j.resuscitation.2015.09.380; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962	49	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	FEB	2022	29	2					390	399		10.1111/ene.15143		OCT 2021	10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YE7QE	WOS:000710348500001	34657359				2022-02-06	
J	Straud, CL; Moring, JC; Hale, WJ; McMahon, C; Moore, BA; Baker, MT; Bryant, RA; Young-McCaughan, S; Isler, WC; Lara-Ruiz, J; Lancaster, CL; Mintz, J; Peterson, AL				Straud, Casey L.; Moring, John C.; Hale, Willie J.; McMahon, Chelsea; Moore, Brian A.; Baker, Monty T.; Bryant, Richard A.; Young-McCaughan, Stacey; Isler, William C.; Lara-Ruiz, Jose; Lancaster, Cynthia L.; Mintz, Jim; Peterson, Alan L.		STRONG STAR Consortium	Patterns of Acute Stress Disorder in a Sample of Blast-Injured Military Service Members: A Latent Profile Analysis	PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY			English	Article; Early Access						acute stress disorder; postconcussive symptoms; blast injury; military; latent profile analysis	TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; SELF-REPORT; NEUROPSYCHOLOGICAL OUTCOMES; PTSD SYMPTOMS; COMBAT; PREVALENCE; CONCUSSION; VETERANS; SUBTYPES	Objective: The primary aims of this study were to identify latent profiles of acute stress disorder (ASD) symptoms and to evaluate postconcussive symptom differences across the identified profiles as measured by the Acute Stress Disorder Scale and the Military Acute Concussion Evaluation, respectively. Method: Participants (N = 315) in the current study were predominantly active-duty (75.0%), enlisted (97.8%) males (97.4%) serving in the U.S. Army (87.8%). Approximately, half of the sample reported being married or engaged (51.1%) and was on average 25.94 (SD = 6.31) years old. Participants were referred to the Air Force Theater Hospital, 332nd Air Expeditionary Wing, Joint Base Balad, Iraq, to be evaluated as part of routine clinical assessment for neurocognitive and psychological symptoms following exposure to a blast. Results: A 3-profile solution was identified as the most parsimonious and best-fitting model based on statistical model fit indices. Blast injured service members in Profile 3 had greater ASD total and subscale severity compared to the other 2 subgroups, with effect size estimates largely differing by hyperarousal and reexperiencing symptoms. Furthermore, Profiles 2 and 3 were more likely to demonstrate postconcussive symptoms compared to Profile 1. Conclusions: Findings provide novel information on heterogenous ASD symptom profiles during the acute phase following a blast injury and highlight the relationship between psychological and physical symptoms. Classification of blast-injured service members may help identify at-risk individuals who would benefit from further clinical care and mitigate long-term psychological and neurocognitive issues. Clinical Impact Statement Findings suggest that more severe acute stress disorder symptoms following a blast injury are indicative of more severe postconcussive symptoms and cognitive functioning problems. The assessment of ASD and postconcussive symptoms during the acute phase following a blast in deployed settings may allow for the early identification of psychological and neurocognitive symptoms; which in turn may promote greater opportunities for early interventions to mitigate the long term consequences associated with posttraumatic stress disorder and mild traumatic brain injury.	[Straud, Casey L.; Moring, John C.; Hale, Willie J.; McMahon, Chelsea; Young-McCaughan, Stacey; Lara-Ruiz, Jose; Mintz, Jim; Peterson, Alan L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat & Behav Sci, 7550 1H-10 West,Suite 1325, San Antonio, TX 78229 USA; [Straud, Casey L.; Hale, Willie J.; McMahon, Chelsea] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Moring, John C.; Young-McCaughan, Stacey; Mintz, Jim; Peterson, Alan L.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Moore, Brian A.] Kennesaw State Univ, Dept Psychol Sci, Kennesaw, GA 30144 USA; [Baker, Monty T.; Isler, William C.] Wilford Hall Ambulatory Surg Ctr, Joint Base San Antonio Lackland, Lackland AFB, TX USA; [Bryant, Richard A.] Univ New South Wales Sydney, Sch Psychol, Sydney, NSW, Australia; [Lancaster, Cynthia L.] Univ Nevada, Dept Psychol, Reno, NV 89557 USA		Straud, CL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat & Behav Sci, 7550 1H-10 West,Suite 1325, San Antonio, TX 78229 USA.	straud@uthscsa.edu		Young-McCaughan, Stacey/0000-0002-3327-5233; Bryant, Richard/0000-0002-9607-819X; McMahon, Chelsea/0000-0003-3653-0735	United States Air Force Aerospace Medicine and Human Performance Integration Research Program [FA86-50-11-2-6162]; Defense Medical Research and Development Program Applied Research and Advanced Technology Development Awards [D10_I_AR_J6_577]	The views expressed herein are solely those of the authors and do not reflect an endorsement by or the official policy of the U.S. Air Force, the Department of Defense, the Department of Veterans Affairs, or the U.S. government. Funding for this work was made possible by the by research grants through the United States Air Force Aerospace Medicine and Human Performance Integration Research Program (FA86-50-11-2-6162) and the Defense Medical Research and Development Program Applied Research and Advanced Technology Development Awards (D10_I_AR_J6_577). We thank Julie Collins and Joel Williams for their assistance in the completion of this article.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Armour C, 2015, PSYCHIAT RES, V225, P476, DOI 10.1016/j.psychres.2014.11.063; Baker MT, 2018, MIL MED, V183, pE555, DOI 10.1093/milmed/usy100; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bolzenius JD, 2015, APPL NEUROPSYCH-ADUL, V22, P79, DOI 10.1080/23279095.2013.845823; Bryant RA, 2000, PSYCHOL ASSESSMENT, V12, P61, DOI 10.1037/1040-3590.12.1.61; Bryant RA, 2016, ACUTE STRESS DISORDE; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cohen J., 2013, STAT POWER ANAL BEHA; Defense and Veterans Brain Injury Center, 2019, DOD WORLDW NUMB TBI; Eskridge SL, 2013, J NEUROTRAUM, V30, P1391, DOI 10.1089/neu.2012.2537; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Hansen M, 2015, J ANXIETY DISORD, V31, P84, DOI 10.1016/j.janxdis.2015.02.005; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Maguen S, 2013, J AFFECT DISORDERS, V145, P344, DOI 10.1016/j.jad.2012.08.021; Masyn K. E., 2013, OXFORD HDB QUANTITAT, P551, DOI DOI 10.1093/OXFORDHB/9780199934898.013.0025; McCrea M., 2000, STANDARDIZED ASSESSM; McCrea M, 2014, MIL MED, V179, P990, DOI 10.7205/MILMED-D-13-00349; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Murphy D, 2019, EUR J PSYCHOTRAUMATO, V10, DOI 10.1080/20008198.2018.1558706; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Norris JN, 2014, BRAIN INJURY, V28, P1052, DOI 10.3109/02699052.2014.891761; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Peterson AL, 2020, BEHAV THER, V51, P882, DOI 10.1016/j.beth.2020.01.003; SAMUELSEN K, 2013, APPL QUANTITATIVE AN, P304; Shevlin M, 2014, PSYCHOL ASSESSMENT, V26, P1155, DOI 10.1037/a0037272; Steenkamp MM, 2012, BEHAV MODIF, V36, P857, DOI 10.1177/0145445512450908; Straud CL, 2019, J ANXIETY DISORD, V67, DOI 10.1016/j.janxdis.2019.102133; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; U.S. Department of Veterans Affairs and Department of Defense, 2016, VA DOD CLIN PRACT GU; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027	37	0	0	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1942-9681	1942-969X		PSYCHOL TRAUMA-US	Psychol. Trauma												10.1037/tra0001150		OCT 2021	11	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	XS7TP	WOS:000733106600001	34694833				2022-02-06	
J	Tomasiuk, R; Dzierzecki, S; Zaczynski, A; Zabek, M				Tomasiuk, Ryszard; Dzierzecki, Sebastian; Zaczynski, Artur; Zabek, Miroslaw			Usability of the Level of the S100B Protein, the Gosling Pulsatility Index, and the Jugular Venous Oxygen Saturation for the Prediction of Mortality and Morbidity in Patients with Severe Traumatic Brain Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							SEVERE HEAD-INJURY; NEURON-SPECIFIC ENOLASE; BLOOD-FLOW-VELOCITY; TRANSCRANIAL DOPPLER; EPIDEMIOLOGIC ASPECTS; EXTERNAL VALIDATION; OUTCOME PREDICTION; MANAGEMENT; PROGNOSIS; IMPACT	The high frequency of traumatic brain injury imposes severe economic stress on health and insurance services. The objective of this study was to analyze the association between the serum S100B protein, the Gosling pulsatility index (PI), and the level of oxygen saturation at the tip of the internal jugular vein (SjVO2%) in patients diagnosed with severe TBI. The severity of TBI was assessed by a GCS score <= 8 stratified by Glasgow outcome scale (GOS) measured on the day of discharge from the hospital. Two groups were included: GOS<4 (unfavorable group (UG)) and GOS >= 4 (favorable group (UG)). S100B levels were higher in the UG than in the FG. PI levels in the UG were also substantially higher than in the FG. There were similar levels of SjVO2 in the two groups. This study confirmed that serum S100B levels were higher in patients with unfavorable outcomes than in those with favorable outcomes. Moreover, a clear demarcation in PI between unfavorable and FGs was observed. This report shows that mortality and morbidity rates in patients with traumatic brain injury can be assessed within the first 4 days of hospitalization using the S100B protein, PI values, and SjVO2.	[Tomasiuk, Ryszard] Kazimierz Pulaski Univ Technol & Humanities Radom, Fac Med Sci & Hlth Sci, Radom, Poland; [Dzierzecki, Sebastian; Zabek, Miroslaw] Postgrad Med Ctr, Dept Neurosurg, Warsaw, Poland; [Dzierzecki, Sebastian; Zabek, Miroslaw] Brodno Masovian Hosp, Gamma Knife Ctr, Warsaw, Poland; [Zaczynski, Artur] Minist Interior & Adm, Cent Clin Hosp, Clin Dept Neurosurg, Warsaw, Poland		Dzierzecki, S (corresponding author), Postgrad Med Ctr, Dept Neurosurg, Warsaw, Poland.; Dzierzecki, S (corresponding author), Brodno Masovian Hosp, Gamma Knife Ctr, Warsaw, Poland.	r.tomasiuk@wp.pl; sebastianneurochirurgia@gmail.com; azaczynski@gmail.com; zabek.cmc@gmail.com			Commission for Scientific Research of the Medical Centre for Postgraduate Education in Warsaw, Poland [501-2-1-20-49/04]; Kazimierz Pulaski University of Technology and Humanities Radom, Faculty of Medical Sciences and Health Sciences, Radom, Poland [3529/188/P, DBUPB/2021/028]	Research reported in this publication was supported by the Commission for Scientific Research of the Medical Centre for Postgraduate Education in Warsaw, Poland, research grant no. 501-2-1-20-49/04 (SD), and by the Kazimierz Pulaski University of Technology and Humanities Radom, Faculty of Medical Sciences and Health Sciences, Radom, Poland (RT), research grants 3529/188/P and DBUPB/2021/028.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; CHAN KH, 1993, ACTA NEUROCHIR, P81; CHAN KH, 1992, J NEUROL NEUROSUR PS, V55, P787, DOI 10.1136/jnnp.55.9.787; Chang T, 2019, WORLD NEUROSURG, V126, pE116, DOI 10.1016/j.wneu.2019.02.005; Chappuis G, 2008, EUR SPINE J, V17, P1350, DOI 10.1007/s00586-008-0732-8; Chernick M.R., 2011, BOOTSTRAP METHODS; Chieregato A, 2003, J NEUROL NEUROSUR PS, V74, P784, DOI 10.1136/jnnp.74.6.784; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Dastur D.K., 1963, EFFECTS AGING CEREBR; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Dzierzecki S.M., UNPUB; Fatima Nida, 2019, Asian J Neurosurg, V14, P626, DOI 10.4103/ajns.AJNS_42_19; FISHER NI, 1991, J STAT PLAN INFER, V27, P157, DOI 10.1016/0378-3758(91)90013-5; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Gibbs EL, 1942, J BIOL CHEM, V144, P325; Golden Nyoman, 2018, Open Access Maced J Med Sci, V6, P2239, DOI 10.3889/oamjms.2018.432; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Hall P, 1992, BOOTSTRAP EDGEWORTH, DOI [10.1007/978-1-4612-4384-7, DOI 10.1007/978-1-4612-4384-7]; Harris A, 2017, FASEB J, V31; Jarus-Dziedzic K, 1999, Neurol Neurochir Pol, V33, P151; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kahouadji S, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00856; Kay M., 2016, R PACKAGE VERSION, V10; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Korfias S, 2006, CURR MED CHEM, V13, P3719, DOI 10.2174/092986706779026129; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2014, CRIT CARE, V18, DOI 10.1186/cc13915; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Moreno J A, 2000, Neurosurg Focus, V8, pe8; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Ojha BK, 2005, SURG NEUROL, V64, P174, DOI 10.1016/j.surneu.2004.11.030; Pace MC, 2006, MINERVA ANESTESIOL, V72, P235; Pape HC, 2009, EUR J TRAUMA EMERG S, V35, P61, DOI 10.1007/s00068-008-8013-0; Purkayastha S, 2012, SEMIN NEUROL, V32, P411, DOI 10.1055/s-0032-1331812; Raabe A, 2000, NEUROSURG REV, V23, P136, DOI 10.1007/PL00011944; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; RAO CJ, 1978, J NEUROL NEUROSUR PS, V41, P948, DOI 10.1136/jnnp.41.10.948; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P891, DOI 10.1089/neu.1995.12.891; Romodanov A P, 1983, Zh Vopr Neirokhir Im N N Burdenko, P3; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Saculinggan M, 2013, J PHYS CONF SER, V435, DOI 10.1088/1742-6596/435/1/012041; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Smith M, 2015, BRIT J ANAESTH, V115, P488, DOI 10.1093/bja/aev230; Sorci Guglielmo, 2013, World J Biol Chem, V4, P1, DOI 10.4331/wjbc.v4.i1.1; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tan H, 2001, Chin J Traumatol, V4, P156; TEASDALE G, 1974, LANCET, V2, P81; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Toccalino D, 2021, OCCUP ENVIRON MED, V78, P769, DOI 10.1136/oemed-2020-107005; Tyrak J, 2001, Folia Med Cracov, V42, P97; Voulgaris SG, 2005, MED SCI MONITOR, V11, pCR49; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757; Yokota H., 1995, NEUROCHEMICAL MONITO	70	0	0	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.	OCT 25	2021	2021								2398488	10.1155/2021/2398488			8	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	WW1LA	WOS:000717685800006	34734081	gold, Green Published			2022-02-06	
J	Ware, AL; Shukla, A; Guo, S; Onicas, A; Geeraert, BL; Goodyear, BG; Yeates, KO; Lebel, C				Ware, Ashley L.; Shukla, Ayushi; Guo, Sunny; Onicas, Adrian; Geeraert, Bryce L.; Goodyear, Bradley G.; Yeates, Keith Owen; Lebel, Catherine			Participant factors that contribute to magnetic resonance imaging motion artifacts in children with mild traumatic brain injury or orthopedic injury	BRAIN IMAGING AND BEHAVIOR			English	Article; Early Access						Mild traumatic brain injury; Orthopedic injury; Structural magnetic resonance imaging; Motion artifacts; Quality assurance	HEAD MOTION; RISK; QUALITY; IMPACT; RECOMMENDATIONS; CONCUSSIONS; REGRESSION	Motion can compromise image quality and confound results, especially in pediatric research. This study evaluated qualitative and quantitative approaches to motion artifacts detection and correction, and whether motion artifacts relate to injury history, age, or sex in children with mild traumatic brain injury or orthopedic injury relative to typically developing children. The concordance between qualitative and quantitative motion ratings was also examined. Children aged 8-16 years with mild traumatic brain injury (n = 141) or orthopedic injury (n = 73) were recruited from the emergency department and completed an MRI scan roughly 2 weeks post-injury. Typically developing children (n = 41) completed a single MRI scan. T1- and diffusion-weighted images were visually inspected and rated for motion artifacts by trained examiners. Quantitative estimates of motion artifacts were derived from FreeSurfer and FSL. Age (younger > older) and sex (boys > girls) were significantly associated with motion artifacts on both T1- and diffusion-weighted images. Children with mild traumatic brain or orthopedic injury had significantly more motion-corrupted diffusion-weighted volumes than typically developing children, but mild traumatic brain injury and orthopedic injury groups did not differ from each other. The exclusion of motion-corrupted volumes did not significantly change diffusion tensor imaging metrics. Results indicate that automated quantitative estimates of motion artifacts, which are less labour-intensive than manual methods, are appropriate. Results have implications for the reliability of structural MRI research and highlight the importance of considering motion artifacts in studies of pediatric mild traumatic brain injury.	[Ware, Ashley L.; Onicas, Adrian; Yeates, Keith Owen] Univ Calgary, Dept Psychol, 2500 Univ Dr NW, University, AB T2N 1N4, Canada; [Ware, Ashley L.; Shukla, Ayushi; Guo, Sunny; Geeraert, Bryce L.; Goodyear, Bradley G.; Yeates, Keith Owen; Lebel, Catherine] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Ware, Ashley L.; Shukla, Ayushi; Guo, Sunny; Geeraert, Bryce L.; Goodyear, Bradley G.; Yeates, Keith Owen; Lebel, Catherine] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Guo, Sunny] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Ware, Ashley L.] Univ Utah, Dept Neurol, Salt Lake City, UT 84132 USA; [Onicas, Adrian] IMT Sch Adv Studies Lucca, Lucca, Italy; [Shukla, Ayushi; Geeraert, Bryce L.; Goodyear, Bradley G.; Lebel, Catherine] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Goodyear, Bradley G.] Alberta Hlth Serv, Foothills Med Ctr, Seaman Family MR Res Ctr, Calgary, AB, Canada		Ware, AL (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, University, AB T2N 1N4, Canada.; Ware, AL (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.; Ware, AL (corresponding author), Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada.; Ware, AL (corresponding author), Univ Utah, Dept Neurol, Salt Lake City, UT 84132 USA.	Ashley.Ware@UCalgary.ca			Canadian Institute of Health Research (CIHR) Foundation GrantCanadian Institutes of Health Research (CIHR) [FDN143304]; Ronald and Irene Ward Chair in Pediatric Brain Injury from the Alberta Children's Hospital Foundation; Canada Research Chair programCanada Research Chairs; Hotchkiss Brain Institute; Alberta Children's Hospital Research Institute; Killam Postdoctoral Fellowship at the University of Calgary	This work is supported by a Canadian Institute of Health Research (CIHR) Foundation Grant (FDN143304), as well as by the Ronald and Irene Ward Chair in Pediatric Brain Injury from the Alberta Children's Hospital Foundation, the Canada Research Chair program, the Hotchkiss Brain Institute, Alberta Children's Hospital Research Institute, and the Killam Postdoctoral Fellowship at the University of Calgary.	Afacan O, 2016, PEDIATR RADIOL, V46, P1728, DOI 10.1007/s00247-016-3677-9; Alexander-Bloch A, 2016, HUM BRAIN MAPP, V37, P2385, DOI 10.1002/hbm.23180; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Barrio-Arranz G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137905; Beauchamp MH, 2017, J NEUROTRAUM, V34, P2545, DOI 10.1089/neu.2016.4868; Benner T, 2011, MAGN RESON MED, V66, P154, DOI 10.1002/mrm.22837; Blumenthal JD, 2002, NEUROIMAGE, V16, P89, DOI 10.1006/nimg.2002.1076; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen YR, 2015, NEUROIMAGE, V109, P160, DOI 10.1016/j.neuroimage.2015.01.010; Committee on Injury Scaling, 1998, ABBREVIATED INJURY S; Corwin DJ, 2017, PEDIATR EMERG CARE, V33, P643, DOI 10.1097/PEC.0000000000001252; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Ducharme S, 2016, NEUROIMAGE, V125, P267, DOI 10.1016/j.neuroimage.2015.10.010; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Elhabian S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00240; Engelhardt LE, 2017, DEV COGN NEUROS-NETH, V25, P58, DOI 10.1016/j.dcn.2017.01.011; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Geeraert BL, 2019, HUM BRAIN MAPP, V40, P4345, DOI 10.1002/hbm.24706; Geeraert BL, 2018, NEUROIMAGE, V182, P343, DOI 10.1016/j.neuroimage.2017.09.019; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Goodrich-Hunsaker NJ, 2018, J NEUROSCI RES, V96, P626, DOI 10.1002/jnr.24142; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee LC, 2008, RES DEV DISABIL, V29, P247, DOI 10.1016/j.ridd.2007.05.002; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Makowski C, 2019, J PSYCHIATR NEUROSCI, V44, P62, DOI 10.1503/jpn.180022; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Reuter M, 2015, NEUROIMAGE, V107, P107, DOI 10.1016/j.neuroimage.2014.12.006; Reynolds JE, 2019, NEUROIMAGE, V196, P49, DOI 10.1016/j.neuroimage.2019.04.004; Roalf DR, 2016, NEUROIMAGE, V125, P903, DOI 10.1016/j.neuroimage.2015.10.068; Rosen AFG, 2018, NEUROIMAGE, V169, P407, DOI 10.1016/j.neuroimage.2017.12.059; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; TEASDALE G, 1974, LANCET, V2, P81; Tijssen RHN, 2009, HUM BRAIN MAPP, V30, P2641, DOI 10.1002/hbm.20695; Wang JY, 2012, NEUROIMAGE, V60, P1127, DOI 10.1016/j.neuroimage.2011.12.062; Ware AL, 2020, J NEUROTRAUM, V37, P1892, DOI 10.1089/neu.2019.6850; Ware AL, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102106; Wilde EA, 2019, J NEUROTRAUM, V36, P239, DOI 10.1089/neu.2017.5513; Yeates KO, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017012; Yuan WH, 2009, HUM BRAIN MAPP, V30, P1481, DOI 10.1002/hbm.20616; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	52	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.												10.1007/s11682-021-00582-w		OCT 2021	12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WM1RA	WOS:000710869000001	34694520	Green Submitted			2022-02-06	
J	Wender, CLA; Sandroff, BM; Krch, D; Wylie, G; Cirnigliaro, CM; Wecht, J; Chiaravalloti, ND; DeLuca, J				Wender, Carly L. A.; Sandroff, Brian M.; Krch, Denise; Wylie, Glenn; Cirnigliaro, Christopher M.; Wecht, Jill; Chiaravalloti, Nancy D.; DeLuca, John			The preliminary effects of moderate aerobic training on cognitive function in people with TBI and significant memory impairment: a proof-of-concept randomized controlled trial	NEUROCASE			English	Article						TBI; aerobic exercise; memory; cognition; MRI	TRAUMATIC BRAIN-INJURY; OLDER-ADULTS; EXERCISE; METAANALYSIS; PERFORMANCE; INTEGRITY; DEMENTIA	This single-blinded RCT investigated cognitive effects of aerobic exercise in persons with TBI-related memory impairment. Five participants . were randomly assigned to 12-weeks of either supervised moderate intensity aerobic cycling or an active control. Outcome measures included neuropsychological assessments and structural neuroimaging (MRI,). The exercise group demonstrated greater improvements on auditory verbal learning (RAVLT; d=1.54) and processing speed (SDMT; d=1.58). The exercise group showed larger increases in volume of the left hippocampus (d=1.49) and right thalamus (d=1.44). These pilot data suggest that 12-weeks of moderate intensity aerobic cycling may improve memory and processing speed in those with TBI-related memory impairments.	[Wender, Carly L. A.; Krch, Denise; Chiaravalloti, Nancy D.; DeLuca, John] Kessler Fdn, Ctr Traumat Brain Injury Res, E Hanover, NJ 07936 USA; [Wender, Carly L. A.; Sandroff, Brian M.; Krch, Denise; Wylie, Glenn; Chiaravalloti, Nancy D.; DeLuca, John] Rutgers NJ Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Sandroff, Brian M.; Cirnigliaro, Christopher M.; Chiaravalloti, Nancy D.; DeLuca, John] Kessler Fdn, Ctr Neuropsychol & Neurosci Res, W Orange, NJ USA; [Wylie, Glenn] Kessler Fdn, Rocco Ortenzio Neuroimaging Ctr, W Orange, NJ USA; [Wylie, Glenn] War Related Illness & Injury Study Ctr, W Orange, NJ USA; [Cirnigliaro, Christopher M.] Natl Ctr Med Consequences Spinal Cord Injury, Rr&D Natl Ctr Med Consequences Sci, Dept Vet Affairs, Dept Vet Affairs Rehabil Res & Dev Serv, E Orange, NJ USA; [Wecht, Jill] James J Peters VAMC, New York, NY USA; [Wecht, Jill] Icahn Sch Med, Dept Med & Rehabil Med, New York, NY USA		Wender, CLA (corresponding author), Kessler Fdn, Ctr Traumat Brain Injury Res, E Hanover, NJ 07936 USA.	cwender@kesslerfoundation.org		Wender, Carly/0000-0003-3757-7746; Sandroff, Brian/0000-0002-2013-7632; DeLuca, John/0000-0003-3745-4156	New Jersey Commission on Brain Injury Research [CBIR13PIL013]	This work was supported by the New Jersey Commission on Brain Injury Research (CBIR13PIL013).	Anghinah R, 2018, ARQ NEURO-PSIQUIAT, V76, P100, DOI [10.1590/0004-282X20170196, 10.1590/0004-282x20170196]; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Chin LM, 2015, ARCH PHYS MED REHAB, V96, P754, DOI 10.1016/j.apmr.2014.11.009; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cohen J, 1988, STAT POWER ANAL BEHA; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Gates N, 2013, AM J GERIAT PSYCHIAT, V21, P1086, DOI 10.1016/j.jagp.2013.02.018; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Groot C, 2016, AGEING RES REV, V25, P13, DOI 10.1016/j.arr.2015.11.005; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Liang KJ, 2020, NEUROBIOL LEARN MEM, V170, DOI 10.1016/j.nlm.2019.01.004; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Magalhaes SD, 2012, CLIN NEUROPSYCHIATR, V9, P129; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Sandroff BM, 2018, NEUROREHAB NEURAL RE, V32, P847, DOI 10.1177/1545968318798938; Sheridan LK, 2006, ARCH CLIN NEUROPSYCH, V21, P23, DOI 10.1016/j.acn.2005.07.003; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Wogensen E, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/830871; Zhang J, 2019, J NEUROL NEUROSUR PS, V90, P98, DOI 10.1136/jnnp-2017-317691	24	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase	SEP 3	2021	27	5					430	435		10.1080/13554794.2021.1990964		OCT 2021	6	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	YM6RC	WOS:000711795300001	34704543				2022-02-06	
J	Adame, BJ; Liu, YQ; Adame, EA; Ruston, S; Corman, SR				Adame, Bradley J.; Liu, Yanqin; Adame, Elissa A.; Ruston, Scott; Corman, Steven R.			A Randomized Controlled Trial of A Theory-Based Concussion Education Video for NCAA Division I Athletes	HEALTH COMMUNICATION			English	Article; Early Access							SELF-REPORTED CONCUSSIONS; VESTED INTEREST; BEHAVIOR; INJURY; SPORT; RISK; TRANSPORTATION; EPIDEMIOLOGY; MOTIVATION; INCREASE	A large body of research demonstrates that concussions are exceedingly common and extremely difficult to detect. Despite medical efforts to develop sophisticated tools to detect concussions, research continues to demonstrate that proper detection relies on prompt and thorough symptom reporting from the injured athlete. In the context of sports, such reporting requirements are complicated by systems that reward athletic performance. This study seeks to provide student athletes who play NCAA Division I high-contact sports with a theoretically driven intervention to improve their attitudes and behavior toward concussion reporting. Division I student athletes (N = 345) viewed one of three conditions: an NCAA handout consistent with current practices, the experimental video, or a non-treatment control video, then responded to questions regarding attitudes and behaviors toward concussion reporting. Overall, results support the video's effectiveness in changing perceptions of concussion injuries. Nuances of the findings lead to a discussion for practical implications to transform concussion-reporting attitudes and behaviors among athletes.	[Adame, Bradley J.; Liu, Yanqin; Adame, Elissa A.; Corman, Steven R.] Arizona State Univ, Hugh Downs Sch Human Commun, POB 871205, Tempe, AZ 85287 USA; [Adame, Bradley J.; Adame, Elissa A.; Ruston, Scott; Corman, Steven R.] Arizona State Univ, Ctr Strateg Commun, Tempe, AZ 85287 USA; [Ruston, Scott] Arizona State Univ, Ctr Narrat Disinformat & Strateg Influence, Tempe, AZ 85287 USA		Adame, BJ (corresponding author), Arizona State Univ, Hugh Downs Sch Human Commun, POB 871205, Tempe, AZ 85287 USA.	badame@asu.edu		Liu, Yanqin/0000-0002-9436-8652; Adame, Bradley/0000-0002-9825-7300	National Collegiate Athletic Association; US Department of Defense under the Mind Matters Challenge grant program	This work was supported by the National Collegiate Athletic Association and the US Department of Defense under the Mind Matters Challenge grant program	Adame B.J., 2020, HDB APPL COMMUNICATI, V1st, P47, DOI [10.1002/9781119399926.ch3, DOI 10.1002/9781119399926.CH3]; Adame B, 2016, DISASTER PREV MANAG, V25, P282, DOI 10.1108/DPM-08-2015-0196; Adame BJ, 2019, HEALTH COMMUN, V34, P1673, DOI 10.1080/10410236.2018.1517707; Adame BJ, 2015, HEALTH COMMUN, V30, P271, DOI 10.1080/10410236.2013.842527; Atkin C. K., 2013, PUBLIC COMMUNICATION, V4th, P53; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Braddock K, 2016, COMMUN MONOGR, V83, P446, DOI 10.1080/03637751.2015.1128555; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Chinn N.R., 2016, BMJ OPEN SPORT EXERC, V2, P000118, DOI [10.1136/bmjsem-2016-000118, DOI 10.1136/BMJSEM-2016-000118]; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cohen J., 2003, APPL MULTIPLE REGRES, V3; Corman SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215424; CRANO WD, 1995, BASIC APPL SOC PSYCH, V17, P1, DOI 10.1207/s15324834basp1701&2_1; Cusimano MD, 2017, SAGE OPEN MED, V5, DOI [10.1177/2050312117694794, 10.1177/2050312117699799]; Dattalo P., 2013, ANAL MULTIPLE DEPEND; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Dillard AJ, 2018, PSYCHOL HEALTH, V33, P573, DOI 10.1080/08870446.2017.1380811; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Fishbein M, 2011, PREDICTING AND CHANGING BEHAVIOR: THE REASONED ACTION APPROACH, P1; FISHER WR, 1984, COMMUN MONOGR, V51, P1, DOI 10.1080/03637758409390180; Gebbers T, 2017, INT J COMMUN-US, V11, P4886; Green M.C., 2017, OXFORD RES ENCY COMM, DOI [10.1093/acrefore/9780190228613.013.261, DOI 10.1093/ACREFORE/9780190228613.013.261]; Green MC, 2000, J PERS SOC PSYCHOL, V79, P701, DOI 10.1037/0022-3514.79.5.701; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kim HS, 2012, J COMMUN, V62, DOI 10.1111/j.1460-2466.2012.01644.x; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Manasse-Cohick NJ, 2014, COMMUN DISORD Q, V35, P182, DOI 10.1177/1525740113506605; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Miller CH, 2013, DISASTERS, V37, P1, DOI 10.1111/j.1467-7717.2012.01290.x; NCAA, CONC SAF WHAT SAS NE; Ruston SW, 2019, COMMUN SPORT, V7, P529, DOI 10.1177/2167479518786709; RYAN RM, 1983, J PERS SOC PSYCHOL, V45, P736, DOI 10.1037/0022-3514.45.4.736; Schmidt JD, 2020, J NEUROTRAUM, V37, P593, DOI 10.1089/neu.2019.6637; Shen, 2013, SAGE HDB PERSUASION, P200, DOI DOI 10.4135/9781452218410.N13; SIVACEK J, 1982, J PERS SOC PSYCHOL, V43, P210, DOI 10.1037/0022-3514.43.2.210; Sullivan L, 2018, HEALTH EDUC RES, V33, P492, DOI 10.1093/her/cyy034; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	45	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1041-0236	1532-7027		HEALTH COMMUN	Health Commun.												10.1080/10410236.2021.1991640		OCT 2021	9	Communication; Health Policy & Services	Social Science Citation Index (SSCI)	Communication; Health Care Sciences & Services	WM0OB	WOS:000710793500001	34689669				2022-02-06	
J	Bithal, PK; Jan, R; Kumar, B; Rahman, IU				Bithal, Parmod K.; Jan, Ravees; Kumar, Bharani; Rahman, Insha Ur			Left Frontal Lobe Tumor-Induced Intraoperative Premature Ventricular Beats	JOURNAL OF NEUROANAESTHESIOLOGY AND CRITICAL CARE			English	Article						left frontal lobe tumor; premature ventricular contractions; lignocaine; autonomic nervous system imbalance	PREFRONTAL CORTEX	In the absence of cardiac pathology, premature ventricular contractions (PVCs) in neurosurgical patients frequently accompany subarachnoid hemorrhage, intracerebral hemorrhage, traumatic brain injury, or raised intracranial pressure. PVCs detected during preanesthesia assessment prompts detailed cardiac evaluation. Our 57-year-old patient, a case of left frontal meningioma, with controlled hypertension, diabetes and hypothyroidism, had normal preoperative ECG and potassium. However, immediately on anesthesia induction, she developed multiple refractory to treatment PVCs but with normal blood pressure. Anesthesia, which was maintained with sevoflurane and fentanyl, was deepened to exclude light anesthesia as the cause, without useful outcome. Two lignocaine boluses (100 mg each), followed by its infusion, also proved ineffective. Her blood gases and potassium, checked twice, were normal. Throughout, her hemodynamics remained stable. As soon as tumor was removed, the PVCs disappeared not to return. Her postoperative recovery was uneventful with normal ECG.	[Bithal, Parmod K.; Jan, Ravees; Kumar, Bharani; Rahman, Insha Ur] King Fahad Med City Riyadh, Dept Anesthesia & Perioperat Med, Riyadh 11525, Saudi Arabia		Jan, R (corresponding author), King Fahad Med City Riyadh, Dept Anesthesia & Perioperat Med, Riyadh 11525, Saudi Arabia.	janravees@gmail.com					BENARROCH EE, 1993, J CLIN NEUROPHYSIOL, V10, P39, DOI 10.1097/00004691-199301000-00005; Buchanan TW, 2010, PSYCHONEUROENDOCRINO, V35, P56, DOI 10.1016/j.psyneuen.2009.09.006; Chen Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004769; Dash M, 2003, J NEUROSURG ANESTH, V15, P270, DOI 10.1097/00008506-200307000-00017; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Ghaziri J, 2017, CEREB CORTEX, V27, P1216, DOI 10.1093/cercor/bhv308; Kannan L, 2017, HORM METAB RES, V49, P430, DOI 10.1055/s-0043-105275; Kweon KH, 2007, J KOREAN MED SCI, V22, P114, DOI 10.3346/jkms.2007.22.1.114; Laowattana S, 2006, NEUROLOGY, V66, P477, DOI 10.1212/01.wnl.0000202684.29640.60; NEAFSEY EJ, 1990, PROG BRAIN RES, V85, P147; Oppenheimer SM, 1996, CLIN AUTON RES, V6, P131, DOI 10.1007/BF02281899; Resstel LBM, 2006, AUTON NEUROSCI-BASIC, V126, P130, DOI 10.1016/j.autneu.2006.02.022; Staikou C, 2014, BRIT J ANAESTH, V112, P217, DOI 10.1093/bja/aet412; Tahsili-Fahadan P, 2017, CIRC RES, V120, P559, DOI 10.1161/CIRCRESAHA.116.308446; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004	15	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2348-0548	2348-926X		J NEUROANAESTH CRIT	J. Neuroanaesthesiol. Crit. Care	SEP	2021	08	03					220	222		10.1055/s-0041-1731978		OCT 2021	3	Anesthesiology; Critical Care Medicine; Clinical Neurology	Emerging Sources Citation Index (ESCI)	Anesthesiology; General & Internal Medicine; Neurosciences & Neurology	XH1LT	WOS:000710205000006		gold			2022-02-06	
J	Dhanda, A; Bindra, A; Dhakal, R; Chavali, S; Singh, GP; Singh, PK; Mathur, P				Dhanda, Ankur; Bindra, Ashish; Dhakal, Roshni; Chavali, Siddharth; Singh, Gyaninder Pal; Singh, Pankaj Kumar; Mathur, Purva			Patient Characteristics and Clinical and Intraoperative Variables Affecting Outcome in Pediatric Traumatic Brain Injury	JOURNAL OF NEUROANAESTHESIOLOGY AND CRITICAL CARE			English	Article; Early Access						Glasgow outcome score; intensive care unit; pediatric; traumatic brain injury	HEAD-INJURY; RISK-FACTORS; CHILDREN; EPIDEMIOLOGY; MORTALITY; ADOLESCENTS; AGE	Background Pediatric traumatic brain injury (TBI) has distinctive pathophysiology and characteristics that differ from adults. These can be attributed to age-related anatomical and physiological differences and distinct patterns of injuries seen in children. Our aim was to identify the patient characteristics, clinical variables during intensive care and intraoperative management associated with poor functional outcome in a cohort of pediatric TBI patients. Methods Retrospective chart review of pediatric TBI patients admitted to neurotrauma intensive care unit (NICU) over a period of 1 year. Results A total of 105 children (< 12 years) with head injury were admitted in the NICU during the study period. The most common mechanism of injury was fall in 78% cases. Fifty-four patients (51.4%) presented with a severe head injury (Glasgow coma scale [GCS] <less than or equal to> 8), while 31 (29.5%) and 20 (19.1%) had a mild and moderate head injury. The most common finding was skull fractures (59%), contusions (36.2%), and subdural hematoma (SDH) (30.4%). Forty nine patients (46.7%) required surgical management. The median duration of anesthesia was 205 (interquartile range [IQR] 65, 375) minutes, and median blood loss during the surgery was 16.7 mL/kg body weight with 41% requiring intraoperative blood transfusions. Median duration of ICU and hospital stay was 5 (IQR 1, 47) and 8 (IQR 1, 123) days, respectively. GOS at discharge <= 3 representing poor outcome was present in 35 patients (33.3%). Mortality was seen in 15 (14.3%) patients. Multivariate analysis identified postresuscitation GCS <= 8 on admission as independent predictor of mortality, and postresuscitation GCS <= 8 on admission and NICU stay of > 7 days as independent predictor of poor outcome. Conclusion Despite advances in neurointensive care, mortality and morbidity remains high in pediatric head trauma and is mainly dependent on postresuscitation GCS and NICU stay of more than 7 days. Multidimensional approach is required for its prevention and management.	[Dhanda, Ankur] Akash Superspecial Hosp, Dept Neuroanesthesia & Neurocrit Care, New Delhi, India; [Bindra, Ashish; Singh, Gyaninder Pal] All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Dept Neuroanaesthesiol & Crit Care, Room 118, Delhi 110029, India; [Dhakal, Roshni] All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, New Delhi, India; [Chavali, Siddharth] AIG Hosp, Neuroanaesthesia & Neurocrit Care, Hyderabad, Telangana, India; [Singh, Pankaj Kumar] All India Inst Med Sci, Dept Neurosurg, New Delhi, India; [Mathur, Purva] All India Inst Med Sci, Jai Prakash Naraian Apex Trauma Ctr, Lab Med, New Delhi, India		Bindra, A (corresponding author), All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Dept Neuroanaesthesiol & Crit Care, Room 118, Delhi 110029, India.	dr_ashi2208@yahoo.com					Agrawal A, 2008, Afr J Paediatr Surg, V5, P15, DOI 10.4103/0189-6725.41630; Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; Barton BK, 2007, J PEDIATR PSYCHOL, V32, P517, DOI 10.1093/jpepsy/jsm014; Bayreuther J, 2009, ARCH DIS CHILDHOOD-E, V94, P37, DOI 10.1136/adc.2007.132787; Chan H. C., 2005, SMJ Singapore Medical Journal, V46, P219; Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Ferreros I, 2012, REV NEUROLOGIA, V54, P719, DOI 10.33588/rn.5412.2011701; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Hill CS, 2018, PEDIATR EMERG CARE, V34, P426, DOI [10.1097/PEC.0000000000000845, 10.1097/pec.0000000000000845]; Isik HS, 2011, ULUS TRAVMA ACIL CER, V17, P166, DOI 10.5505/tjtes.2011.22800; Kim HB, 2012, J KOREAN MED SCI, V27, P437, DOI 10.3346/jkms.2012.27.4.437; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mitra B, 2006, ANZ J SURG, V76, P343, DOI 10.1111/j.1445-2197.2006.03723.x; NAKAYAMA DK, 1991, J TRAUMA, V31, P1521, DOI 10.1097/00005373-199111000-00010; Robertson Brian D, 2013, J Inj Violence Res, V5, P51, DOI 10.5249/jivr.v5i1.205; Schrieff L E, 2013, SAMJ, S. Afr. med. j., V103, P616, DOI 10.7196/samj.7137; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; Shein SL, 2012, J PEDIATR-US, V161, P716, DOI 10.1016/j.jpeds.2012.03.046; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; Slovis JC, 2018, PEDIATR CRIT CARE ME, V19, P353, DOI 10.1097/PCC.0000000000001490; Tabish A, 2006, INJURY, V37, P410, DOI 10.1016/j.injury.2006.01.039; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Trefan L, 2016, ARCH DIS CHILD, V101, P527, DOI 10.1136/archdischild-2015-308424; Tsai WC, 2004, J CLIN NEUROSCI, V11, P126, DOI 10.1016/S0967-5868(03)00156-5; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Zhu HP, 2014, INT J ENV RES PUB HE, V11, P3493, DOI 10.3390/ijerph110403493	32	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2348-0548	2348-926X		J NEUROANAESTH CRIT	J. Neuroanaesthesiol. Crit. Care												10.1055/s-0041-1732828		OCT 2021	8	Anesthesiology; Critical Care Medicine; Clinical Neurology	Emerging Sources Citation Index (ESCI)	Anesthesiology; General & Internal Medicine; Neurosciences & Neurology	WL1WU	WOS:000710205000005		gold			2022-02-06	
J	Swenson, AG; Pritchard, NS; Miller, LE; Urban, JE; Stitzel, JD				Swenson, Abigail G.; Pritchard, N. Stewart; Miller, Logan E.; Urban, Jillian E.; Stitzel, Joel D.			Characterization of head impact exposure in boys' youth ice hockey	RESEARCH IN SPORTS MEDICINE			English	Article; Early Access						Subconcussive impact; head impact exposure; youth; ice hockey; head kinematics	BODY-CHECKING; INJURY; CONTACT; BIOMECHANICS; CONCUSSION; KINEMATICS; COHORT; RISK	Ice hockey has one of the highest concussion rates among youth sports. Sensor technology has been implemented in contact and collision sports to inform the frequency and severity of head impacts experienced on-ice. However, existing studies have utilized helmet-mounted sensors with limited accuracy. The objective of this study was to characterize head kinematics of contact events in a sample of youth boys' hockey players using a validated instrumented mouthpiece with improved accuracy. Head kinematics from 892 video-verified events were recorded from 18 athletes across 127 sessions. Median peak resultant linear acceleration, rotational velocity, and rotational acceleration of video-verified events were 7.4 g, 7.7 rad/s, and 576 rad/s(2), respectively. Contact events occurred at a higher rate in games (2.48 per game) than practices (1.30 per practice). Scenarios involving head contact had higher peak kinematics than those without head contact. This study improves our understanding of head kinematics in boys' youth hockey.	[Swenson, Abigail G.] Wake Forest Sch Med, Dept Neurosci, Winston Salem, NC 27101 USA; [Pritchard, N. Stewart] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Winston Salem, NC USA; [Miller, Logan E.; Urban, Jillian E.; Stitzel, Joel D.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC 27101 USA		Swenson, AG (corresponding author), Wake Forest Sch Med, Dept Neurosci, Winston Salem, NC 27101 USA.	aswenson@wakehealth.edu		Swenson, Abigail/0000-0001-8925-9681	Childress Institute for Pediatric Trauma	This work was supported by the Childress Institute for Pediatric Trauma.	Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Black A.M., 2017, BRIT J SPORT MED, V51, P2983, DOI [10.1136/bjsports-2016-097372.39, DOI 10.1136/BJSPORTS-2016-097372.39]; Campolettano ET, 2020, ANN BIOMED ENG, V48, P92, DOI 10.1007/s10439-019-02382-2; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Gayzik FS, 2015, J BIOMECH, V48, P4173, DOI 10.1016/j.jbiomech.2015.09.017; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; Ingram BM, 2019, J SPORT REHABIL, V28, P774, DOI 10.1123/jsr.2018-0102; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; Kukaswadia A, 2010, PEDIATRICS, V125, P735, DOI 10.1542/peds.2009-2083; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Mihalik JP, 2020, ANN BIOMED ENG, V48, P104, DOI 10.1007/s10439-019-02343-9; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Miller LE, 2020, RES SPORTS MED, V28, P55, DOI 10.1080/15438627.2019.1590833; Miller LE, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039165; Reed N, 2010, INT J SPORTS MED, V31, P826, DOI 10.1055/s-0030-1263103; Rich AM, 2019, ANN BIOMED ENG, V47, P2109, DOI 10.1007/s10439-019-02313-1; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Schmidt JD, 2016, J ATHL TRAINING, V51, P366, DOI 10.4085/1062-6050-51.5.04; USA Hockey, 2019, MEMB STAT; USA Hockey, 604 USA HOCK; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004	25	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.												10.1080/15438627.2021.1989433		OCT 2021	11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WM1VF	WOS:000710879900001	34689676				2022-02-06	
J	Barton, DJ; Kumar, RG; Schuster, AA; Juengst, SB; Oh, BM; Wagner, AK				Barton, David J.; Kumar, Raj G.; Schuster, Alexandria A.; Juengst, Shannon B.; Oh, Byung-Mo; Wagner, Amy K.			Acute Cortisol Profile Associations With Cognitive Impairment After Severe Traumatic Brain Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury; cortisol; cognition; neuropsychological testing; hormone; outcome assessment	NEUROTROPHIC FACTOR; STRESS; RECEPTOR; MODERATE; TBI; HIPPOCAMPUS; PREDICTORS; CHALLENGE; MORTALITY; DOPAMINE	Background Cognitive impairments commonly occur after traumatic brain injury (TBI) and affect daily functioning. Cortisol levels, which are elevated during acute hospitalization for most individuals after severe TBI, can influence cognition, but this association has not been studied previously in TBI. Objective We hypothesized that serum and cerebral spinal fluid (CSF) cortisol trajectories over days 0-5 post-injury are associated with cognition 6-month post-injury. Methods We examined 94 participants with severe TBI, collected acute serum and/or CSF samples over days 0-5 post-injury, and compared cortisol levels to those in 17 healthy controls. N = 88 participants had serum, and n = 84 had CSF samples available for cortisol measurement and had neuropsychological testing 6 months post-injury. Group based trajectory analysis (TRAJ) was used to generate temporal serum and CSF cortisol profiles which were examined for associations with neuropsychological performance. We used linear regression to examine relationships between cortisol TRAJ groups and both overall and domain-specific cognition. Results TRAJ analysis identified a high group and a decliner group for serum and a high group and low group for CSF cortisol. Multivariable analysis showed serum cortisol TRAJ group was associated with overall cognitive composites scores (P = .024) and with executive function (P = .039) and verbal fluency (P = .029) domain scores. CSF cortisol TRAJ group was associated with overall cognitive composite scores (P = .021) and domain scores for executive function (P = .041), verbal fluency (P = .031), and attention (P = .034). Conclusions High acute cortisol trajectories are associated with poorer cognition 6 months post-TBI.	[Barton, David J.] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA 15213 USA; [Kumar, Raj G.; Schuster, Alexandria A.; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA; [Kumar, Raj G.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15213 USA; [Juengst, Shannon B.] Univ Texas Southwestern, Dept Phys Med & Rehabil, Dallas, TX USA; [Juengst, Shannon B.] Univ Texas Southwestern, Dept Appl Clin Res, Dallas, TX USA; [Oh, Byung-Mo] Seoul Natl Univ, Dept Rehabil Med, Seoul, South Korea; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15213 USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Wagner, Amy K.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA 15213 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Barton, David J/C-9282-2011	Barton, David J/0000-0003-0976-0383; Oh, Byung-Mo/0000-0001-9353-7541	National Institute on Disability and Rehabilitation Research; NIDILRRUnited States Department of Health & Human Services [90DP0041]; US Department of DefenseUnited States Department of Defense [W81XWH-07-1-0701]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [TL1TR001858, T32HL134615]; Centers for Disease ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CCR 323155]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: National Institute on Disability and Rehabilitation Research (Grant Number: NIDILRR 90DP0041, Wagner); US Department of Defense (Grant Number: W81XWH-07-1-0701, Wagner); National Institutes of Health (Grant Number: TL1TR001858, Kumar; Grant Number: T32HL134615, Barton); Centers for Disease Control (Grant Number: R49 CCR 323155).	Bauduin SEEC, 2018, CURR OPIN ENDOCRINOL, V25, P285, DOI 10.1097/MED.0000000000000414; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Conrad Cheryl D., 2005, Nonlinearity in Biology Toxicology and Medicine, V3, P57, DOI 10.2201/nonlin.003.01.004; Davies E, 2003, CLIN EXP PHARMACOL P, V30, P437, DOI 10.1046/j.1440-1681.2003.03867.x; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dong TT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0663-y; Dorn LD, 2007, ANN CLIN BIOCHEM, V44, P281, DOI 10.1258/000456307780480954; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Garrahy A, 2017, EUR J ENDOCRINOL, V176, pR217, DOI 10.1530/EJE-16-0962; Griesbach GS, 2012, NEUROSCIENCE, V210, P393, DOI 10.1016/j.neuroscience.2012.03.005; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Harvey Philip D, 2012, Dialogues Clin Neurosci, V14, P91; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Jung YH, 2019, NEUROCHEM RES, V44, P1192, DOI 10.1007/s11064-019-02762-z; Karssen AM, 2001, ENDOCRINOLOGY, V142, P2686, DOI 10.1210/en.142.6.2686; Kim JS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13639-8; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; Lowenstein Daniel H, 2009, Ann Neurol, V66, pA7, DOI 10.1002/ana.21876; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maria NSS, 2019, EXP NEUROL, V318, P78, DOI 10.1016/j.expneurol.2019.04.016; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; Miller GF, 2021, INJURY, V52, P1138, DOI 10.1016/j.injury.2021.01.042; Munoz MJ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00044; Myrga JM, 2016, J HEAD TRAUMA REHAB, V31, pE15, DOI 10.1097/HTR.0000000000000199; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Otte C, 2005, PSYCHONEUROENDOCRINO, V30, P80, DOI 10.1016/j.psyneuen.2004.06.002; Pascoe MC, 2017, J PSYCHIATR RES, V95, P156, DOI 10.1016/j.jpsychires.2017.08.004; PAVLIDES C, 1995, NEUROSCIENCE, V68, P387, DOI 10.1016/0306-4522(95)00151-8; Peeters B, 2018, INTENS CARE MED, V44, P2048, DOI 10.1007/s00134-018-5427-y; Riley KE, 2015, HEALTH PSYCHOL REV, V9, P224, DOI 10.1080/17437199.2014.895928; Roberts DJ, 2008, EXPERT OPIN DRUG MET, V4, P1245, DOI 10.1517/17425255.4.10.1245 ; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Sorrells SF, 2007, BRAIN BEHAV IMMUN, V21, P259, DOI 10.1016/j.bbi.2006.11.006; Sorrells SF, 2013, J NEUROSCI, V33, P7877, DOI 10.1523/JNEUROSCI.4705-12.2013; Starkman MN, 2013, ENDOCRIN METAB CLIN, V42, P477, DOI 10.1016/j.ecl.2013.05.010; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Symonds CS, 2012, EUR NEUROPSYCHOPHARM, V22, P867, DOI 10.1016/j.euroneuro.2012.03.008; Sze Y, 2020, EUR J NEUROSCI, V52, P2487, DOI 10.1111/ejn.14615; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Taylor AN, 2013, J NEUROTRAUM, V30, P1250, DOI 10.1089/neu.2012.2847; Turnbull AV, 1995, BRAIN BEHAV IMMUN, V9, P253, DOI 10.1006/brbi.1995.1026; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Van den Berghe G, 1998, J CLIN ENDOCR METAB, V83, P1827, DOI 10.1210/jc.83.6.1827; Vijapur SM, 2021, BRAIN BEHAV IMMUN, V95, P45, DOI 10.1016/j.bbi.2021.01.026; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wolfson D., 1985, HELSTEAD REITAN NEUR; Zhang B, 2020, NEUROSCIENCE, V424, P1, DOI 10.1016/j.neuroscience.2019.10.026; Zhang B, 2020, J NEUROTRAUM, V37, P262, DOI 10.1089/neu.2019.6556	59	0	0	2	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	DEC	2021	35	12					1088	1099	15459683211048771	10.1177/15459683211048771		OCT 2021	12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XU4YU	WOS:000711139500001	34689657	Green Accepted			2022-02-06	
J	Mulligan, R; Basso, MR; Hoffmeister, J; Lau, L; Whiteside, DM; Combs, D				Mulligan, Ryan; Basso, Michael R.; Hoffmeister, Jordan; Lau, Lily; Whiteside, Douglas M.; Combs, Dennis			Classification accuracy of the word memory test genuine memory impairment index	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Performance validity; word memory test; genuine memory impairment profile	SYMPTOM VALIDITY TEST; TRAUMATIC BRAIN-INJURY; BASE RATES; TEST MSVT; PERFORMANCE; PROFILE; POLICY	Objective The Word Memory Test (WMT) assesses non-credible performance in neuropsychological assessment. To mitigate risk of false positives among patients with severe cognitive dysfunction, the Genuine Memory Impairment Profile was derived. Only a modest number of investigations has evaluated classification accuracy among clinical samples, leaving the GMIP's accuracy largely uncertain. Accordingly, a simulation experiment evaluated the classification accuracy of the GMIP in a group of healthy individuals coached to simulate mild traumatic brain injury (TBI) related memory impairment on the WMT. Participants and Methods Eighty healthy individuals were randomly assigned to one of the four experimental groups. One group was provided superficial information concerning TBI symptoms (naive simulators), another was provided extensive information concerning TBI symptoms (sophisticated simulators), and a third group was provided extensive TBI symptom information and tactics to evade detection by performance validity tests (PVT) (test-coached). An honest responding control group was directed to give their best performance. All participants were administered the California Verbal Learning Test-2 (CVLT-2) and the WMT. Results Among the TBI simulators, 90% of the test-coached, 95% of the sophisticated simulators, and 100% of the naive simulators were correctly classified as exaggerating memory impairment on the primary WMT indices. The simulator groups performed worse than the honest responding group on the CVLT-2. Of those who exceeded the WMT cutoffs, 60%, 27%, and 6% of the naive-, sophisticated-, and test-coached simulators manifested the GMIP profile, respectively. Conclusions The GMIP is apt to misclassify individuals as having genuine memory impairment, especially if a naive or unsophisticated effort is made to exert non-credible performance. Indeed, individuals who employ the least sophisticated efforts to exaggerate cognitive impairment appear most likely to manifest the GMIP. The GMIP should be used cautiously to discriminate genuine impairment from non-credible performance, especially among people with mild TBI.	[Mulligan, Ryan; Hoffmeister, Jordan; Lau, Lily] Univ Tulsa, Dept Psychol, Tulsa, OK 74104 USA; [Basso, Michael R.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA; [Whiteside, Douglas M.] Univ Minnesota, Dept Rehabil Med, Minneapolis, MN USA; [Combs, Dennis] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA		Basso, MR (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	basso.michael@mayo.edu		Hoffmeister, Jordan/0000-0002-0227-1926; Whiteside, Douglas/0000-0002-8454-4413			Allen L., 1997, CARB 97 MANUAL COMPU; Alverson WA, 2019, CLIN NEUROPSYCHOL, V33, P1420, DOI 10.1080/13854046.2019.1599071; Armistead-Jehle P, 2015, APPL NEUROPSYCH-ADUL, V22, P415, DOI 10.1080/23279095.2014.953678; Astner K., 1996, MANUAL WORD MEMORY T; Barhon LI, 2015, APPL NEUROPSYCH-ADUL, V22, P114, DOI 10.1080/23279095.2013.863775; Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; Eichstaedt KE, 2014, CLIN NEUROPSYCHOL, V28, P941, DOI 10.1080/13854046.2014.942374; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Frederick R. I., 1991, PSYCHOL ASSESSMENT J, V3, P596, DOI DOI 10.1037/1040-3590.3.4.596; Green, 1999, 1999 SUPPLEMENT CARB; Green P., 2005, MANUAL WORD MEMORY T; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Grove WM, 1996, PSYCHOL PUBLIC POL L, V2, P293, DOI 10.1037/1076-8971.2.2.293; Hampson NE, 2014, APPL NEUROPSYCH-ADUL, V21, P183, DOI 10.1080/09084282.2013.787425; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Jelicic M, 2011, J CLIN PSYCHOL, V67, P850, DOI 10.1002/jclp.20805; Lau L, 2017, CLIN NEUROPSYCHOL, V31, P1412, DOI 10.1080/13854046.2017.1318954; LeesHaley PR, 1997, J CLIN PSYCHOL, V53, P745, DOI 10.1002/(SICI)1097-4679(199711)53:7<745::AID-JCLP13>3.3.CO;2-7; MEEHL PE, 1996, CLIN VERSUS STAT PRE; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; Reslan S, 2017, APPL NEUROPSYCH-ADUL, V24, P132, DOI 10.1080/23279095.2015.1107565; Robinson JS, 2018, ARCH CLIN NEUROPSYCH, V33, P238, DOI 10.1093/arclin/acx069; Schenk K, 2010, J CLIN EXP NEUROPSYC, V32, P752, DOI 10.1080/13803390903512678; Snow J, 2020, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2020.1829067; Suesse M, 2015, CLIN NEUROPSYCHOL, V29, P214, DOI 10.1080/13854046.2015.1022226; Sweet JJ, 2021, CLIN NEUROPSYCHOL, V35, P1053, DOI 10.1080/13854046.2021.1896036; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Youngjohn, 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]	35	0	0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG 9	2021	43	7					655	662		10.1080/13803395.2021.1988520		OCT 2021	8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	XW6GB	WOS:000710370900001	34686108				2022-02-06	
J	Xia, AQ; Huang, H; You, WJ; Liu, Y; Wu, HQ; Liu, S				Xia, Anqi; Huang, Huan; You, Wenjun; Liu, Ying; Wu, Hongqin; Liu, Su			The neuroprotection of hyperbaric oxygen therapy against traumatic brain injury via NF-kappa B/MAPKs-CXCL1 signaling pathways	EXPERIMENTAL BRAIN RESEARCH			English	Article						Hyperbaric oxygen; Traumatic brain injury; CXCL1; CXCR2	SPINAL-CORD-INJURY; RAT-BRAIN; ANIMAL-MODELS; APOPTOSIS; NEUROINFLAMMATION; EDEMA	It is well known that hyperbaric oxygen (HBO) therapy achieves neuroprotective effects by modulating neuroinflammatory responses. However, its underlying therapeutic mechanisms are not yet fully elucidated. Based on our previous studies, we further investigated whether HBO therapy exerts neuroprotective effects in vivo by regulating the nuclear factor-kappa B (NF-kappa B)/ mitogen-activated protein kinases (MAPKs) chemokine (C-X-C motif) ligand (CXCL)1 inflammatory pathway. In our study, a rat model of traumatic brain injury (TBI) was established by controlled cortical impact (CCI) to verify that the expression of CXCL1 and chemokine (C-X-C motif) receptor (CXCR)2 increased after TBI, and CXCL1 was mainly expressed in astrocytes, while CXCR2 was mainly expressed in neurons. Increased apoptosis of cortical nerve cells in the injured cortex was also found after TBI. Reduced nerve cell apoptosis with improved neurological function was observed after application of a CXCR2 antagonist. The expression of phospho-extracellular signal-regulated kinase (p-ERK), phospho-c-Jun N-terminal kinase (p-JNK) and p-NF-kappa B increased after TBI, and application of ERK, JNK and NF-kappa B inhibitors decreased expression of CXCL1 and CXCR2 in rats. We further found that HBO therapy down-regulated the expression of p-ERK, p-JNK, p-NF-kappa B, CXCL1, and CXCR2, and reduced nerve cell apoptosis, improved the neurological function of TBI rats, and ultimately alleviated the secondary injury. In conclusion, HBO therapy may exert neuroprotective effect by regulating the NF-kappa B/MAPKs (JNK and ERK)-CXCL1 inflammatory pathways following TBI, which probably provide the theoretical and experimental basis for the clinical application of HBO therapy in the treatment of TBI.	[Xia, Anqi; Huang, Huan; Wu, Hongqin; Liu, Su] Nantong Univ, Affiliated Hosp, Dept Rehabil Med, Nantong 226001, Jiangsu, Peoples R China; [Xia, Anqi; Huang, Huan] Nantong Univ, Sch Med, Nantong 226001, Jiangsu, Peoples R China; [You, Wenjun] Nantong Univ, Peoples Hosp Nantong 2, Dept Geriatr, Nantong 226001, Jiangsu, Peoples R China; [Liu, Ying] Nantong Univ, Affiliated Hosp, Dept Pathol, Nantong, Peoples R China		Liu, S (corresponding author), Nantong Univ, Affiliated Hosp, Dept Rehabil Med, Nantong 226001, Jiangsu, Peoples R China.	327202278@qq.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81702223]; Science and Technology Planning Project of Nantong [MS22019006]	This project was funded by National Natural Science Foundation of China (No. 81702223), and Science and Technology Planning Project of Nantong (MS22019006).	Baratz-Goldstein R, 2017, MOL CELL NEUROSCI, V83, P74, DOI 10.1016/j.mcn.2017.06.004; Beretta S, 2017, CELL TRANSPLANT, V26, P1247, DOI 10.1177/0963689717714107; Chen TJ, 2016, CLIN CHIM ACTA, V454, P6, DOI 10.1016/j.cca.2015.12.033; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Chen YH, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00202; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Crawford C, 2017, J HEAD TRAUMA REHAB, V32, pE27, DOI 10.1097/HTR.0000000000000256; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Daly S, 2018, J NEUROTRAUM, V35, P623, DOI 10.1089/neu.2017.5225; Deng YB, 2020, GENES DIS, V7, P253, DOI 10.1016/j.gendis.2019.05.002; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Dyhrfort P, 2019, J NEUROTRAUM, V36, P2872, DOI 10.1089/neu.2018.6320; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Fraunberger EA, 2020, J NEUROTRAUM, V37, P1315, DOI 10.1089/neu.2019.6714; Guan QH, 2005, BRAIN RES, V1035, P51, DOI 10.1016/j.brainres.2004.11.050; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; He H, 2019, NEUROPSYCH DIS TREAT, V15, P369, DOI 10.2147/NDT.S183632; Hu Q, 2016, MED GAS RES, V6, P102, DOI 10.4103/2045-9912.184720; Jalilzad M, 2019, NEUROPEPTIDES, V78, DOI 10.1016/j.npep.2019.101963; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Liang F, 2020, CELL STRESS CHAPERON, V25, P1013, DOI 10.1007/s12192-020-01137-6; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Lin CC, 2014, MOL NEUROBIOL, V49, P658, DOI 10.1007/s12035-013-8547-y; Liu S, 2018, INFLAMMATION, V41, P2003, DOI 10.1007/s10753-018-0843-2; Liu S, 2015, EXP BRAIN RES, V233, P3359, DOI 10.1007/s00221-015-4405-7; Liu S, 2013, NEURAL REGEN RES, V8, P3334, DOI 10.3969/j.issn.1673-5374.2013.35.008; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Manjavachi MN, 2010, EUR J PAIN, V14, P23, DOI 10.1016/j.ejpain.2009.01.007; Meng XE, 2016, MED SCI MONITOR, V22, P284, DOI 10.12659/MSM.894148; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Tan JW, 2014, INT J CLIN EXP PATHO, V7, P1911; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Valles A, 2006, NEUROBIOL DIS, V22, P312, DOI 10.1016/j.nbd.2005.11.015; Wee HY, 2015, J SURG RES, V197, P382, DOI 10.1016/j.jss.2015.04.052; Wolf EG, 2012, UNDERSEA HYPERBAR M, V39, P1075; Wu FJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0316-6; Xiang PC, 2018, ACTA CIR BRAS, V33, P341, DOI 10.1590/s0102-865020180040000006; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang J, 2013, SPINE, V38, pE1641, DOI 10.1097/BRS.0000000000000005; Zhang YM, 2014, NEUROCHEM RES, V39, P950, DOI 10.1007/s11064-014-1292-4	46	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	JAN	2022	240	1					207	220		10.1007/s00221-021-06249-8		OCT 2021	14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YS2OP	WOS:000710621200003	34687331				2022-02-06	
J	Basha, AK; Mahmoud, MA; Al Ashwal, MI; Aglan, O; ElShawady, SB; Abdel-Latif, AM; Elsayed, AM; AbdelGhany, W				Basha, Ahmed Kamel; Mahmoud, Mohamed Ashraf; Al Ashwal, Mohamed Ismail; Aglan, Osama; ElShawady, Sherif Bahaa; Abdel-Latif, Assem Mounir; Elsayed, Ahmed M.; AbdelGhany, Walid			Management of Severe Traumatic Brain Injury: A Single Institution Experience in a Middle-Income Country	FRONTIERS IN SURGERY			English	Article						traumatic brain injury; ICP monitoring; middle-income; management; decompressive surgery	EPIDEMIOLOGY; OUTCOMES	Introduction: Severe traumatic brain injury (TBI) is a major public health problem usually resulting in mortality or severe disabling morbidities of the victims. Intracranial pressure (ICP) monitoring is recently recognized as an imperative modality in the management of severe TBI, whereas growing evidence, based on randomized controlled trials (RCTs), suggests that ICP monitoring does not affect the outcome when compared with clinical and radiological data-based management. Also, ICP monitoring carries a considerable risk of intracranial infection that cannot be overlooked. The aim of this study is to assess the different aspects of our current local institutional management of severe TBI using non-invasive ICP monitoring for a potential need to change our management strategy. Methods: We retrospectively reviewed our data of TBI from June 2019 through January 2020. Patients with severe TBI were identified. Their demographics, Glasgow coma score (GCS) at presentation, treatments received, and imaging data were extracted from the charts. Glasgow outcome scale extended (GOS-E) at 6 months was also assessed for the patients. Results: Twenty patients with severe TBI were identified on chart review. Ten patients received only medical treatment measures to lower the ICP, whereas the other 10 patients had additional surgical interventions. In one patient, a ventriculostomy tube was inserted to monitor ICP and to drain cerebrospinal fluid (CSF). This was complicated by ventriculostomy-associated infection (VAI) and the tube was removed. In our cohort, the total mortality rate was 40%. The average GOS-E for the survivor patients managed without ICP monitoring based on the clinical and radiological data was 6.2 at 6 months follow-up. The 6-month overall good outcome, based on GOS-E, was 33.3%. Conclusion: Although recent guidelines advocate for the use of ICP monitoring in the management of severe TBI, they remain underutilized in our practice due to many factors. External ventricular drains were mainly used to drain CSF; however, the higher rates of VAIs in our institution compared with the literature-reported rates are not in favor of the use of ICP monitoring. We recommend doing a comparative study between our current practice using clinical-and radiological-based management and subdural or intraparenchymal bolts. More structured RCTs are needed to validate these findings in our setting.	[Basha, Ahmed Kamel; Mahmoud, Mohamed Ashraf; Al Ashwal, Mohamed Ismail; Aglan, Osama; ElShawady, Sherif Bahaa; Abdel-Latif, Assem Mounir; Elsayed, Ahmed M.; AbdelGhany, Walid] Ain Shams Univ, Neurosurg Dept, Cairo, Egypt		Basha, AK (corresponding author), Ain Shams Univ, Neurosurg Dept, Cairo, Egypt.	ahmedbasha@med.asu.edu.eg					Al Saiegh F, 2020, WORLD NEUROSURG, V136, pE535, DOI 10.1016/j.wneu.2020.01.070; Alunpipatthanachai B, 2019, WORLD NEUROSURG, V126, pE743, DOI 10.1016/j.wneu.2019.02.144; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Defillo A, 2012, J NEUROSURG, V116, P256, DOI 10.3171/2011.3.JNS102010; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; Guyot LL, 1998, ACT NEUR S, V71, P47; Harris OA, 2008, J NEUROSURG, V109, P433, DOI 10.3171/JNS/2008/109/9/0433; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Murray CJ., 1996, OMS, V1996, P1; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Sahuquillo Juan, 2014, Surg Neurol Int, V5, P86, DOI 10.4103/2152-7806.133993; Salim A, 2008, AM SURGEON, V74, P1088; Sorinola A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00226; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Wiesmann M, 2001, J CLIN NEUROSCI, V8, P126, DOI 10.1054/jocn.2000.0749; Zapata-Vazquez Rita Esther, 2017, Value Health Reg Issues, V14, P96, DOI 10.1016/j.vhri.2017.08.011	24	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-875X			FRONT SURG	Front. Surg.	OCT 22	2021	8								690723	10.3389/fsurg.2021.690723			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	WU5HA	WOS:000716574700001	34746219	gold, Green Published			2022-02-06	
J	FitzGerald, A; Main, L; Duff, U; Foggo, J; Rowney, F; Haire, N; McLean, R				FitzGerald, A.; Main, L.; Duff, U.; Foggo, J.; Rowney, F.; Haire, N.; McLean, R.			Does amantadine maintain function in long-established brain injury? A single case experimental design	BRAIN INJURY			English	Article						Traumatic brain injury; amantadine; cognition; awareness; functional status	FRONTAL-LOBE DYSFUNCTION; CONSCIOUSNESS	Objective The role of dopamine agonist (DA) in restoring consciousness and cognition in recovery phase following acquired brain injury (ABI) is established ((1-5)). The role in later recovery is less well defined. We report a single case experimental design (SCED) trial of amantadine demonstrating improvement in function, six years following ABI. Method A scoring system based on established abilities in personal care and interaction was used to identify tasks with component actions, 34 actions in total, each ranked in terms of quality of response to a request or prompt. Actions were scored on maintenance dose amantadine; on withdrawal; and after reintroduction. Daytime sleep duration was also recorded. Results At 3(rd) and 5(th) weeks post withdrawal, deterioration was noted in 27 of 34 graded activities. At 3(rd) and 5(th) weeks following reintroduction, all but 3 grades returned to baseline or better. Afternoon sleep duration increased from 35 to 80 minutes during withdrawal period returning towards baseline on amantadine resumption. Conclusion We believe this provides evidence for benefit of amantadine in sustaining function following ABI. The SCED model used provides a template for others to use to identify comparable change in similar trials.	[FitzGerald, A.; Main, L.; Duff, U.; McLean, R.] Astley Ainslie Hosp, Dept Neurol Rehabil, NHS Lothian, Edinburgh, Midlothian, Scotland; [Foggo, J.] Case Management Serv, Edinburgh, Midlothian, Scotland; [Rowney, F.] Balanced Movement, Edinburgh, Midlothian, Scotland; [Haire, N.] Queen Margaret Univ, Div Occupat Therapyand Arts Therapies, Sch Hlth Sci, Mus Therapy, Musselburgh, Scotland		FitzGerald, A (corresponding author), NHS Lothian, Astley Ainslie Hosp, Neurol Rehabil, Edinburgh EH9 2HL, Midlothian, Scotland.	alasdair.fitzgerald@nhslothian.scot.nhs.uk					Arciniegas DB, 2004, BRAIN INJURY, V18, P1309, DOI 10.1080/02699050410001720130; Beers SR, 2005, J HEAD TRAUMA REHAB, V20, P450, DOI 10.1097/00001199-200509000-00006; EDBY K, 1995, CHILD NERV SYST, V11, P607, DOI 10.1007/BF00301001; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Headway, 2018, ACQ BRAIN INJ NUMB D; Karli DC, 1999, BRAIN INJURY, V13, P63, DOI 10.1080/026990599121908; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Leone H, 2005, J CLIN PHARM THER, V30, P101, DOI 10.1111/j.1365-2710.2005.00628.x; Lobo MA, 2017, J NEUROL PHYS THER, V41, P187, DOI 10.1097/NPT.0000000000000187; Ma HM, 2020, BRAIN INJURY, V34, P299, DOI 10.1080/02699052.2020.1723697; Marino M, 2013, SLEEP, V36, P1747, DOI 10.5665/sleep.3142; McMahon MA, 2009, AM J PHYS MED REHAB, V88, P525, DOI 10.1097/PHM.0b013e3181a5ade3; Menon DK, 2019, LANCET NEUROL, V18, P28, DOI 10.1016/S1474-4422(18)30463-0; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Okigbo AA, 2019, NEUROSCI LETT, V694, P69, DOI 10.1016/j.neulet.2018.11.030; Reynolds JC, 2013, RESUSCITATION, V84, P818, DOI 10.1016/j.resuscitation.2012.11.014; Schneider WN, 1999, BRAIN INJURY, V13, P863; Talsky A., 2011, BRIT COLOMBIA MED J, V53, P26; Tate RL, 2017, NEUROPSYCHOL REHABIL, V27, P1, DOI 10.1080/09602011.2016.1190533; Ter Mors BJ, 2019, BRAIN INJURY, V33, P1137, DOI 10.1080/02699052.2019.1631482; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Williams SE, 2007, BRAIN INJURY, V21, P885, DOI 10.1080/02699050701553213; WRIGHT, 2000, CTR OUTCOME MEASUREM	28	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2021	35	11					1443	1450		10.1080/02699052.2021.1972341		OCT 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XO2HY	WOS:000710412800001	34686097				2022-02-06	
J	Kim, HJ; Eun, S; Yoon, SH; Kim, MK; Chung, HS; Koo, C				Kim, Heoung Jin; Eun, Sohyun; Yoon, Seo Hee; Kim, Moon Kyu; Chung, Hyun Soo; Koo, Chungmo			Paediatric Trauma Score as a non-imaging tool for predicting intracranial haemorrhage in patients with traumatic brain injury	SCIENTIFIC REPORTS			English	Article							HEAD-INJURY; CHILDREN	To identify a useful non-imaging tool to screen paediatric patients with traumatic brain injury for intracranial haemorrhage (ICH). We retrospectively analysed patients aged < 15 years who visited the emergency department with head trauma between January 2015 and September 2020. We divided patients into two groups (ICH and non-ICH) and compared their demographic and clinical factors. Among 85 patients, 21 and 64 were in the ICH and non-ICH groups, respectively. Age (p = 0.002), Pediatric trauma score (PTS; p < 0.001), seizure (p = 0.042), and fracture (p < 0.001) differed significantly between the two groups. Factors differing significantly between the groups were as follows: age (odds ratio, 0.84, p = 0.004), seizure (4.83, p = 0.013), PTS (0.15, p < 0.001), and fracture (69.3, p < 0.001). Factors with meaningful cut-off values were age (cut-off [sensitivity, specificity], 6.5 [0.688, 0.714], p = 0.003) and PTS [10.5 (0.906, 0.81), p < 0.001]. Based on the previously known value for critical injury (<= 8 points) and the cut-off value of the PTS identified in this study (<= 10 points), we divided patients into low-risk, medium-risk, and high-risk groups; their probabilities of ICH (95% confidence intervals) were 0.16-12.74%, 35.86-89.14%, and 100%, respectively. PTS was the only factor that differed significantly between mild and severe ICH cases (p = 0.012). PTS is a useful screening tool with a high predictability for ICH and can help reduce radiation exposure when used to screen patient groups before performing imaging studies.	[Kim, Heoung Jin; Eun, Sohyun; Yoon, Seo Hee; Kim, Moon Kyu; Chung, Hyun Soo; Koo, Chungmo] Yonsei Univ, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea; [Kim, Heoung Jin; Eun, Sohyun; Yoon, Seo Hee; Kim, Moon Kyu; Koo, Chungmo] Yonsei Univ, Div Pediat Emergency Med, Dept Pediat, Severance Childrens Hosp,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea; [Chung, Hyun Soo] Severance Hosp, Dept Emergency Med, 50-1 Yonsei Ro, Seoul, South Korea		Koo, C (corresponding author), Yonsei Univ, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.; Koo, C (corresponding author), Yonsei Univ, Div Pediat Emergency Med, Dept Pediat, Severance Childrens Hosp,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.	CM0904@yuhs.ac		Eun, Sohyun/0000-0002-9598-7519; Chung, Hyun Soo/0000-0001-6110-1495; Moon Kyu, Kim/0000-0001-6186-3991; Yoon, Seo Hee/0000-0002-8361-9815; Koo, Chungmo/0000-0003-1434-6988			APRAHAMIAN C, 1990, ARCH SURG-CHICAGO, V125, P1128; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Burns EC, 2019, PEDIATR EMERG CARE, V35, P161, DOI 10.1097/PEC.0000000000000950; Chen C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061171; Dalal PG, 2006, ANESTH ANALG, V103, P863, DOI 10.1213/01.ane.0000237311.15294.0e; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Goodman TR, 2019, PEDIATR RADIOL, V49, P469, DOI 10.1007/s00247-018-4281-y; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Gurses D, 2003, CAN J SURG, V46, P441; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Inan Mustafa, 2005, Ulus Travma Acil Cerrahi Derg, V11, P238; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mahesh M, 2015, PEDIATR RADIOL, V45, P370, DOI 10.1007/s00247-015-3379-8; Marin JR, 2014, ACAD EMERG MED, V21, P987, DOI 10.1111/acem.12458; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Mtaweh H, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0348-3; Nelson TR, 2014, J AM COLL RADIOL, V11, P292, DOI 10.1016/j.jacr.2013.10.011; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Rosen Claire B, 2018, Trauma Surg Acute Care Open, V3, pe000129, DOI 10.1136/tsaco-2017-000129; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Sookplung P, 2009, CURR OPIN ANESTHESIO, V22, P572, DOI 10.1097/ACO.0b013e3283303884; 박소영, 2012, [Journal of Trauma and Injury, 대한외상학회지], V25, P152; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4	28	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	OCT 22	2021	11	1							20911	10.1038/s41598-021-00419-y			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WL1SE	WOS:000710192900043	34686729	gold, Green Published			2022-02-06	
J	Libeson, L; Ross, P; Downing, M; Ponsford, J				Libeson, Lauren; Ross, Pamela; Downing, Marina; Ponsford, Jennie			Exploring employment following traumatic brain injury in persons who completed an insurer funded vocational rehabilitation program in Australia	DISABILITY AND REHABILITATION			English	Article; Early Access						Traumatic brain injury; vocational rehabilitation; employment; return to work; employment stability	WORK; RETURN; MILD; STABILITY	Purpose To extend the authors' previous research by investigating the maintenance of work performance over time and the long-term experience of employment following traumatic brain injury (TBI). Materials and methods Semi-structured interviews were conducted with a sample of 72 individuals with predominantly severe TBI, up to 10-years post-injury. Thematic analysis of transcribed interviews was conducted. Results Four key themes were identified: brain injury influences on work performance and long-term employment; factors optimising long-term employment; and need for compromise and acceptance, which all impacted the final theme, quality of life outcome. While TBI-related difficulties such as fatigue, cognitive, and emotional difficulties still impacted work many years post-injury, work modifications and employer and vocational rehabilitation (VR) support were important factors optimising long-term employment. The timing of return to work (RTW) was also an important and potentially modifiable factor influencing work performance, which appeared to have long-term effects on the maintenance of employment. Support for acceptance of altered career goals is needed. Conclusion Findings support the need for early VR to facilitate employer contact, to maximise adjustment and preparation time before RTW, to educate both employees and employers and to implement work modifications to support continuing employment after TBI.	[Libeson, Lauren; Downing, Marina; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia; [Libeson, Lauren; Ross, Pamela; Downing, Marina; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Richmond, Australia; [Ross, Pamela] Epworth HealthCare, Richmond, Australia		Libeson, L (corresponding author), 2-70 Durrant St, Brighton, Vic 3186, Australia.	lauren.libeson@monash.edu	; Ponsford, Jennie/H-8341-2014	Downing, Marina/0000-0002-3126-6632; Ponsford, Jennie/0000-0003-0430-125X			Agency for Clinical Innovation, 2016, INV VOC PROGR OUTC P; AIHW, 2019, AUSTR BURD DIS STUD; Australian Institute of Health and Welfare (AIHW), 2003, ICF AUSTR US GUID VE; Barbour RS, 2003, QUAL HEALTH RES, V13, P1019, DOI 10.1177/1049732303253331; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Burla L, 2008, NURS RES, V57, P113, DOI 10.1097/01.NNR.0000313482.33917.7d; Campbell JL, 2013, SOCIOL METHOD RES, V42, P294, DOI 10.1177/0049124113500475; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Collie A, 2010, INJURY PREV, V16, pA25, DOI 10.1136/ip.2010.029215.92; Conneeley AL., 2013, SOC CARE NEURODISABI, V4, P6; Donker-Cools BHPM, 2018, DISABIL REHABIL, V40, P185, DOI 10.1080/09638288.2016.1250118; Ellingsen KL., 2012, INT J DISABIL MANAG, V4, P1; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Gormley M, 2019, BRAIN INJURY, V33, P1567, DOI 10.1080/02699052.2019.1658222; Graham CW., 2016, CAMPBELL SYST REV, V12, DOI [10.4073/csr.2016.6, DOI 10.4073/CSR.2016.6]; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Howe EI, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01051; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Liaset IF, 2016, SCAND J OCCUP THER, V23, P446, DOI 10.3109/11038128.2016.1152294; Libeson L, 2021, DISABIL REHABIL, DOI 10.1080/09638288.2021.1965229; Libeson L, 2020, NEUROPSYCHOL REHABIL, V30, P412, DOI 10.1080/09602011.2018.1470987; Little Deborah M, 2015, Handb Clin Neurol, V131, P465, DOI 10.1016/B978-0-444-62627-1.00027-5; Lundqvist A, 2012, BRAIN INJURY, V26, P1574, DOI 10.3109/02699052.2012.698363; Lyons A.C., 2006, HLTH PSYCHOL CRITICA; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Materne M, 2017, WORK, V56, P125, DOI 10.3233/WOR-162468; Mcrae P, 2016, AUST J REHABIL COUNS, V22, P76, DOI 10.1017/jrc.2016.14; Moller Claire-Lynn, 2017, S. Afr. j. occup. ther., V47, P17, DOI 10.17159/2310-3833/2017/v47n3a4; Phillips J., 2014, ADV CLIN NEUROSCI RE, V14, P14; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Possl O, 2001, BRAIN INJURY, V15, P15; Ruet A, 2018, DISABIL REHABIL, V40, P2200, DOI 10.1080/09638288.2017.1327992; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Simpson GK, 2020, NEUROPSYCHOL REHABIL, V30, P995, DOI 10.1080/09602011.2018.1531769; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Terry G., 2017, SAGE HDB QUALITATIVE, P17; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001	44	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2021.1992516		OCT 2021	11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	WL4JH	WOS:000710372800001	34689670				2022-02-06	
J	Sarkis, GA; Zhu, T; Yang, ZH; Li, X; Shi, Y; Rubenstein, R; Yost, RA; Manley, GT; Wang, KK				Sarkis, George Anis; Zhu, Tian; Yang, Zhihui; Li, Xue; Shi, Yuan; Rubenstein, Richard; Yost, Richard A.; Manley, Geoffrey T.; Wang, Kevin K.			Characterization and standardization of multiassay platforms for four commonly studied traumatic brain injury protein biomarkers: a TBI Endpoints Development Study	BIOMARKERS IN MEDICINE			English	Article						biomarker qualification; GFAP; neurodegeneration; protein biomarkers; S100B; Tau; traumatic brain injury; UCH-L1	C-TERMINAL HYDROLASE-L1; INTRACRANIAL LESIONS; SERUM-LEVELS; S100B; MILD; GFAP; QUALIFICATION; PERFORMANCE; ASSAY; TAU	Aim: There is a critical need to validate biofluid-based biomarkers as diagnostic and drug development tools for traumatic brain injury (TBI). As part of the TBI Endpoints Development Initiative, we identified four potentially predictive and pharmacodynamic biomarkers for TBI: astroglial markers GFAP and S100B and the neuronal markers UCH-L1 and Tau. Materials & methods: Several commonly used platforms for these four biomarkers were identified and compared on analytic performance and ability to detect gold standard recombinant protein antigens and to pool control versus TBI cerebrospinal fluid (CSF). Results: For each marker, only some assay formats could differentiate TBI CSF from the control CSF. Also, different assays for the same biomarker reported divergent biomarker values for the same biosamples. Conclusion: Due to the variability of TBI marker assay in performance and reported values, standardization strategies are recommended when comparing reported biomarker levels across assay platforms. Lay abstract Traumatic brain injury (TBI) is a leading cause of mortality and morbidity around the world. There is a critical need to validate biofluid-based biomarker tests as diagnostic and drug development tools. For this study, we focused on four brain-derived proteins called GFAP, S100B, UCH-L1 and Tau. To measure these biomarker proteins in human biofluid, one relies on either commercial or home-brew assays. Here, we attempted to compare the performance of 2-4 assay formats for each biomarker. We compared their assay sensitivity, ability to detect 'gold standard' protein analyte we procured, as well as the ability to differentiated pooled TBI cerebrospinal fluid from healthy control cerebrospinal fluid. We found that there are high variabilities among TBI marker assays in assay performance, reported biomarker values, and ability to differentiate TBI versus control biofluid. Thus, a standardization strategy is needed when comparing reported biomarker levels across assay platforms.	[Sarkis, George Anis; Yost, Richard A.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Zhu, Tian; Yang, Zhihui; Li, Xue; Wang, Kevin K.] Univ Florida, Dept Emergency Med, 1149 Newell Dr,L4-100, Gainesville, FL 32611 USA; [Zhu, Tian; Shi, Yuan] Third Mil Med Univ, Daping Hosp, Dept Pediat, Chongqing, Peoples R China; [Li, Xue; Shi, Yuan] Chongqing Med Univ, Dept Neonatol, Childrens Hosp, Chongqing, Peoples R China; [Rubenstein, Richard] Suny Downstate Med Ctr, Dept Neurol, 450 Clarkson Ave, Brooklyn, NY 11203 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Wang, Kevin K.] Malcom Randall VA Med Ctr, South Georgia Vet Hlth Syst, Brain Rehabil Res Ctr, 1601 SW Archer Rd, Gainesville, FL 32608 USA		Sarkis, GA (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.; Wang, KK (corresponding author), Univ Florida, Dept Emergency Med, 1149 Newell Dr,L4-100, Gainesville, FL 32611 USA.; Wang, KK (corresponding author), Malcom Randall VA Med Ctr, South Georgia Vet Hlth Syst, Brain Rehabil Res Ctr, 1601 SW Archer Rd, Gainesville, FL 32608 USA.	gasarkis@mit.edu; georgekrekorian@gmail.com		Sarkis, George Anis/0000-0001-6835-0769	DOD TBI Endpoints Development (TED) Seed Project [TED1506/W81XWH-14-2-0176]; DODUnited States Department of Defense [W81XWH-14-2-0176]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1U01 NS086090-01]; DOD-Army grant [W81XWH-14-2-0166]	This study is mainly supported by DOD TBI Endpoints Development (TED) Seed Project TED1506/W81XWH-14-2-0176 (KK Wang) and DOD Grant W81XWH-14-2-0176 (KK Wang and Principal Investigator GT Manley). The study is also supported in part by NIH 1U01 NS086090-01 (KK Wang, overall Principal Investigator GT Manley) and DOD-Army grant W81XWH-14-2-0166 (R Rubenstein). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Amur S, 2015, CLIN PHARMACOL THER, V98, P34, DOI 10.1002/cpt.136; Amur SG, 2015, BIOMARK MED, V9, P1095, DOI 10.2217/bmm.15.90; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Cervellin G, 2012, CLIN BIOCHEM, V45, P408, DOI 10.1016/j.clinbiochem.2012.01.006; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Duan YL, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-24; FDA-NIH Biomarker Working Group, 2018, BEST BIOM ENDPOINTS; Giza CC, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.37731; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Korley FK, 2019, J NEUROTRAUM, V36, P182, DOI 10.1089/neu.2017.5623; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; McDonald SJ, 2021, BIOMARK RES, V9, DOI 10.1186/s40364-020-00256-7; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Stephenson, 2015, FDA BIOMARKERS RIF R; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wang KK, 2017, EXPERT OPIN THER TAR, V21, P627, DOI 10.1080/14728222.2017.1321635; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762	33	0	0	3	3	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1752-0363	1752-0371		BIOMARK MED	Biomark. Med.	DEC	2021	15	18					1721	1732		10.2217/bmm-2021-0284		OCT 2021	12	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	XF0AZ	WOS:000709817800001	34674546				2022-02-06	
J	Sowers, JL; Sowers, ML; Shavkunov, AS; Hawkins, BE; Wu, P; DeWitt, DS; Prough, DS; Zhang, KL				Sowers, James L.; Sowers, Mark L.; Shavkunov, Alexander S.; Hawkins, Bridget E.; Wu, Ping; DeWitt, Douglas S.; Prough, Donald S.; Zhang, Kangling			Traumatic brain injury induces region-specific glutamate metabolism changes as measured by multiple mass spectrometry methods	ISCIENCE			English	Article							OXIDATIVE-METABOLISM; ASTROCYTES; EXCITOTOXICITY; DEHYDROGENASE; HOMEOSTASIS; MECHANISMS; ASPARTATE; STROKE; CYCLE	The release of excess glutamate following traumatic brain injury (TBI) results in glutamate excitotoxicity and metabolic energy failure. Endogenous mechanisms for reducing glutamate concentration in the brain parenchyma following TBI are poorly understood. Using multiple mass spectrometry approaches, we examined TBI-induced changes to glutamate metabolism. We present evidence that glutamate concentration can be reduced by glutamate oxidation via a "truncated" tricarboxylic acid cycle coupled to the urea cycle. This process reduces glutamate levels, generates carbon for energy metabolism, leads to citrulline accumulation, and produces nitric oxide. Several key metabolites are identified by metabolomics in support of this mechanism and the locations of these metabolites in the injured hemisphere are demonstrated by MALDI-MS imaging. The results of this study establish the advantages of multiple mass spectrometry approaches and provide insights into glutamate metabolism following TBI that could lead to improved treatment approaches.	[Sowers, James L.; Sowers, Mark L.] Univ Texas Med Branch, MD PhD Combined Degree Program, Galveston, TX 77555 USA; [Sowers, James L.; Wu, Ping] Univ Texas Med Branch, Dept Neurosci Cell Biol & Anat, Galveston, TX 77555 USA; [Sowers, Mark L.; Shavkunov, Alexander S.; Zhang, Kangling] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Hawkins, Bridget E.; DeWitt, Douglas S.; Prough, Donald S.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Sowers, James L.; Hawkins, Bridget E.; Wu, Ping; DeWitt, Douglas S.; Prough, Donald S.; Zhang, Kangling] Univ Texas Med Branch, Moody Project Translat Traumat Brain Injury Res, Galveston, TX 77555 USA; [Hawkins, Bridget E.] Univ Texas Med Branch, Sch Nursing, Res Innovat & Sci Excellence RISE Ctr, Galveston, TX 77555 USA		Sowers, JL (corresponding author), Univ Texas Med Branch, MD PhD Combined Degree Program, Galveston, TX 77555 USA.; Sowers, JL (corresponding author), Univ Texas Med Branch, Dept Neurosci Cell Biol & Anat, Galveston, TX 77555 USA.; Sowers, JL (corresponding author), Univ Texas Med Branch, Moody Project Translat Traumat Brain Injury Res, Galveston, TX 77555 USA.	jlsowers@utmb.edu	; Hawkins, Bridget/H-4933-2015	Zhang, Kangling/0000-0003-2151-9218; Sowers, Mark/0000-0001-6474-017X; Sowers, James/0000-0002-1442-9882; Hawkins, Bridget/0000-0002-1887-3657	Moody Project for Translational Traumatic Brain Injury Research; UTMB MD-PhD combined degree program	We thank Dr. Lawrence Sowers for conceptual discussions as well as suggestions on editing of the manu-script. We thank Dr. Erin Seeley and the mass spectrometry imaging facility at the University of Texas at Austin. This work was supported by the Moody Project for Translational Traumatic Brain Injury Research, resources from the UTMB Department of Pharmacology and Toxicology and funding from the UTMB MD-PhD combined degree program (J.L.S., M.L.S.) . AUTHOR CONTRIBUTIONS Conceptualization of Methodology: All authors; Formal analysis and validation, data curation and visuali-zation: J.L.S., M.L.S., A.S.S., K.Z; Resources: B.E.H., D.S.D., D.S.P., K.Z.; Writing - original draft: J.L.S.; Writing - review and editing: All authors; Supervision, administration, and funding acquisition: D.S.D, D.S.P., K.Z. All authors approved the final version of the manuscript.	Andersen CR, 2021, J NEUROTRAUM, V38, P435, DOI 10.1089/neu.2020.7089; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Baker EW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206481; Bartnik-Olson BL, 2010, J NEUROTRAUM, V27, P2191, DOI 10.1089/neu.2010.1508; Baslow MH, 2002, NEUROCHEM INT, V40, P295, DOI 10.1016/S0197-0186(01)00095-X; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chitturi J, 2018, NEUROCHEM INT, V120, P75, DOI 10.1016/j.neuint.2018.08.003; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Croall Iain, 1800, Top Magn Reson Imaging, V24, P267, DOI 10.1097/RMR.0000000000000063; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DESHMUKH DR, 1980, MECH AGEING DEV, V13, P75, DOI 10.1016/0047-6374(80)90131-1; Di Pietro V, 2014, MOL MED, V20, P147, DOI 10.2119/molmed.2013.00153; Divakaruni AS, 2017, J CELL BIOL, V216, P1091, DOI 10.1083/jcb.201612067; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Gao JL, 2016, CELL TRANSPLANT, V25, P1863, DOI 10.3727/096368916X691150; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guo K, 2009, ANAL CHEM, V81, P3919, DOI 10.1021/ac900166a; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hawkins RA, 2009, AM J CLIN NUTR, V90, p867S, DOI 10.3945/ajcn.2009.27462BB; Hertz L, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010017; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Kozlov AV, 2017, BBA-MOL BASIS DIS, V1863, P2627, DOI 10.1016/j.bbadis.2016.12.020; Lazzarino G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225774; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; McGuire JL, 2019, MOL NEUROBIOL, V56, P2908, DOI 10.1007/s12035-018-1276-5; McKenna MC, 2016, J NEUROSCI RES, V94, P1561, DOI 10.1002/jnr.23908; McKenna MC, 2012, NEUROCHEM RES, V37, P2613, DOI 10.1007/s11064-012-0901-3; McKenna MC, 1996, J NEUROCHEM, V66, P386; Moffett John R, 2013, Front Neuroenergetics, V5, P11, DOI 10.3389/fnene.2013.00011; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Oz G., 2012, NEURAL METABOLISM IN, V4, P921; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skytt DM, 2012, NEUROCHEM INT, V61, P490, DOI 10.1016/j.neuint.2012.04.014; Tang WW, 2019, THERANOSTICS, V9, P932, DOI 10.7150/thno.30408; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]; Wang EY, 2012, J NEUROTRAUM, V29, P295, DOI 10.1089/neu.2011.2043; Wildburger N.C., 2017, LIPIDOMICS NEUROMETH; Wu P, 2013, J NEUROTRAUM, V30, P775, DOI 10.1089/neu.2012.2391; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; YUDKOFF M, 1994, J BIOL CHEM, V269, P27414; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	51	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA		2589-0042		ISCIENCE	iScience	OCT 22	2021	24	10							103108	10.1016/j.isci.2021.103108			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WQ4WA	WOS:000713817400002	34622161	Green Published, gold			2022-02-06	
J	Mah, K; Gladstone, B; Cameron, D; Reed, N				Mah, Katie; Gladstone, Brenda; Cameron, Deb; Reed, Nick			Re/producing the Pediatric Concussion Discourse in clinical rehabilitation practice	DISABILITY AND REHABILITATION			English	Article; Early Access						Young people; pediatric; concussion; critical social theory; discourse; Foucault	TRAUMATIC BRAIN-INJURY; CLIENT-CENTERED PRACTICE; HEALTH-PROMOTION; OCCUPATIONAL-THERAPY; HEAD-INJURY; ADOLESCENTS; RECOVERY; EPIDEMIOLOGY; PERSPECTIVES; EXPERIENCES	Purpose In the field of pediatric concussion, little to no scholarship has examined how clinical practice is shaped by patterned ways of thinking, talking about, and coming to understand concussion and young people (or "discourses of concussion in young people"). In this paper, we examine the ways in which one such discourse, the Pediatric Concussion Discourse (PCD), shapes how young people with concussion, their parents, and clinicians can think about, act in relation to, and experience concussion. Materials and methods This critical rehabilitation research is informed by the post-structuralist theory of Michel Foucault (1926-1984), and the key concepts of power/knowledge, discourse, and the subject. Results Circulating through clinical guidelines for the management of pediatric concussion, the PCD re/produces the expectation that young people with concussion and their parents will behave as "responsible" subjects who follow the recommendations of so-called experts without question. If recommendations are not implemented, the PCD has the potential to constitute these same groups as "nonadherent", re/producing problematic discourses of medical compliance. Conclusions By examining the effects of the PCD, it becomes possible to imagine how clinical practice and research might evolve in new ways that respect the knowledges and experiences of young people with concussion and their parents.	[Mah, Katie; Reed, Nick] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Mah, Katie; Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Gladstone, Brenda] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Gladstone, Brenda] Univ Toronto, Ctr Crit Qualitat Hlth Res, Toronto, ON, Canada; [Cameron, Deb; Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Mah, K (corresponding author), Western Univ, Fac Hlth Sci, Sch Occupat Therapy, 1201 Western Rd, London, ON N6G 1H1, Canada.	kemah@uwo.ca		Cameron, Debra/0000-0003-2567-0564	Kimel Family Graduate Student Scholarship in Paediatric Rehabilitation	This work was supported by a Kimel Family Graduate Student Scholarship in Paediatric Rehabilitation.	ABBINNETT R, 2003, CULTURE IDENTITY CRI, P15104; [Anonymous], 2017, CANADIAN GUIDELINE C; Ayo N, 2012, CRIT PUBLIC HEALTH, V22, P99, DOI 10.1080/09581596.2010.520692; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bedell SE, 2004, ARCH INTERN MED, V164, P1365, DOI 10.1001/archinte.164.13.1365; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Boylan AM, 2009, J EARLY CHILD RES, V7, P264, DOI 10.1177/1476718X09336970; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown K, 2015, VULNERABILITY AND YOUNG PEOPLE: CARE AND SOCIAL CONTROL IN POLICY AND PRACTICE, P1, DOI 10.1332/policypress/9781447318170.001.0001; Brown K, 2011, ETHICS SOC WELF, V5, P313, DOI 10.1080/17496535.2011.597165; Burchell Graham, 1991, FOUCAULT EFFECT STUD, P1, DOI DOI 10.7208/CHICAGO/9780226028811.001.0001; Cassell EJ, 2001, ANN INTERN MED, V134, P1120, DOI 10.7326/0003-4819-134-12-200106190-00012; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cradock G, 2007, CHILDHOOD, V14, P153, DOI 10.1177/0907568207078325; Damji Faraz, 2018, Concussion, V3, pCNC58, DOI 10.2217/cnc-2018-0007; DeMatteo CA, 2021, CLIN J SPORT MED, V31, pE406, DOI 10.1097/JSM.0000000000000800; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Eakin J, 1996, HEALTH PROMOT INT, V11, P157, DOI 10.1093/heapro/11.2.157; Eakin JM, 2016, QUAL INQ, V22, P107, DOI 10.1177/1077800415617207; Effect [Internet], CAMBRIDGE DICT; Effect [Internet], MERRIAM WEBSTER; Fadyl JK, 2020, DISABIL REHABIL, V42, P2959, DOI 10.1080/09638288.2019.1573935; Fadyl JK, 2013, HEALTH-LONDON, V17, P478, DOI 10.1177/1363459312464073; Farias L, 2019, BRIT J OCCUP THER, V82, P693, DOI 10.1177/0308022619862111; FOUCAULT M, 1982, CRIT INQUIRY, V8, P777, DOI 10.1086/448181; FOUCAULT M, 1971, SOC SC INFORM, V10, P7, DOI 10.1177/053901847101000201; FOUCAULT M, 1980, POWER KNOWLEDGE SELE, P68; Foucault Michel., 1982, ARCHAEOLOGY KNOWLEDG; Foucault Michel, 1982, M FOUCAULT STRUCTURA; Foucault Michel, 1977, LANGUAGE COUNTER MEM; Fox N., 1993, POSTMODERNISM SOCIOL; Frank A., 2003, J MED HUMANIT, V24, P179; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gerlach AJ, 2018, SCAND J OCCUP THER, V25, P35, DOI 10.1080/11038128.2017.1327616; Gibson BE, 2020, DISABIL REHABIL, V42, P1529, DOI 10.1080/09638288.2019.1587793; Gibson Barbara E., 2012, Physiotherapy Theory and Practice, V28, P474, DOI 10.3109/09593985.2012.676936; Gibson BE, 2018, MANIPULATING PRACTIC, P35, DOI DOI 10.23865/N0ASP.29; Gordon KE, 2010, PEDIATR NEUROL, V43, P253, DOI 10.1016/j.pediatrneurol.2010.05.012; Haarbauer-Krupa JK, 2018, BRAIN INJURY, V32, P1337, DOI 10.1080/02699052.2018.1482426; Hall S., 2001, DISCOURSE THEORY PRA, P72; Hamdani, 2015, RETHINKING REHABILIT, P69; Hamdani Y, 2015, DISABIL REHABIL, V37, P1144, DOI 10.3109/09638288.2014.956187; Hammell KRW, 2015, SCAND J OCCUP THER, V22, P237, DOI 10.3109/11038128.2015.1004103; Hammell KRW, 2013, SCAND J OCCUP THER, V20, P174, DOI 10.3109/11038128.2012.752032; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Hwang V, 2014, J TRAUMA ACUTE CARE, V77, P117, DOI 10.1097/TA.0000000000000275; Iverson G, 2007, CLIN J SPORT MED, V17, P31; James A., 1997, CONSTRUCTING RECONST; James A., 2012, KEY CONCEPTS CHILDHO; James Allison, 1998, THEORIZING CHILDHOOD; Johnston KN, 2018, J PHYSIOTHER, V64, P137, DOI 10.1016/j.jphys.2018.04.002; Kelly P., 2001, DISCOURSE-ABINGDON, V22, P23, DOI DOI 10.1080/01596300120039731; Kincheloe J.L., 2011, KEY WORKS CRITICAL P, P285; KINCHELOE JL, 2011, SAGE HDB QUALITATIVE, P163; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lupton D, 1995, IMPERATIVE HLTH PUBL; Lupton Deborah., 2013, RISK; Lupton Deborah., 1999, RISK; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Mah K., BRAIN IMPAIR; Mah K., 2021, THESIS U TORONTO TOR; Mah K, 2020, DISABIL REHABIL, V42, P2967, DOI 10.1080/09638288.2019.1574916; Gladstone BM, 2006, SOC SCI MED, V62, P2540, DOI 10.1016/j.socscimed.2005.10.038; McCrea M, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2846; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mills S., 2004, DISCOURSE NEW CRITIC, V2nd; Mills S, 2003, POWER I M FOUCAULT, P48; Minney MJ, 2019, BRAIN INJURY, V33, P168, DOI 10.1080/02699052.2018.1540794; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Morrow V., 1996, CHILD SOC, V10, P90, DOI DOI 10.1111/J.1099-0860.1996.TB00461.X; National Centre for Injury Prevention and Control Division of Unintentional Injury Prevention (US), 2013, GET HEADS CONC SPORT; Nicholls DA., 2009, APORIA, V1, P30; Nickel B, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014129; Nixon SA, 2017, PHYS THER, V97, P249, DOI 10.2522/ptj.20160149; Njelesani J, 2015, SCAND J OCCUP THER, V22, P252, DOI 10.3109/11038128.2015.1049550; OMALLEY P, 1992, ECON SOC, V21, P252, DOI 10.1080/03085149200000013; Packer M., 2010, SCI QUALITATIVE RES; Petersen A., 2000, NEW PUBLIC HLTH HLTH; Petersen A, 2010, CRIT PUBLIC HEALTH, V20, P391, DOI 10.1080/09581596.2010.518379; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Power EM., 2016, NEOLIBERAL GOVERNANC; Qvortrup J, 1985, PLACING CHILDREN DIV; Reed N., 2019, LIVING GUIDELINE DIA; Robertson A, 1998, HEALTH PROMOT INT, V13, P155, DOI 10.1093/heapro/13.2.155; ROSE N, 1992, BRIT J SOCIOL, V43, P173, DOI 10.2307/591464; Russell K, 2017, CAN J NEUROL SCI, V44, P225, DOI 10.1017/cjn.2016.423; SPENDER D, 1980, MAN MADE LANGUAGE; Swaine BR, 2008, BRAIN INJURY, V22, P581, DOI 10.1080/02699050802189701; Teachman G, 2020, SOCIOL HEALTH ILL, V42, P1108, DOI 10.1111/1467-9566.13087; TROSTLE JA, 1988, SOC SCI MED, V27, P1299, DOI 10.1016/0277-9536(88)90194-3; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Yates S, 2010, THEOR PSYCHOL, V20, P52, DOI 10.1177/0959354309345647; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	98	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2021.1996645		OCT 2021	11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	WV6KX	WOS:000717344700001	34762017				2022-02-06	
J	Mofakham, S; Fry, A; Adachi, J; Stefancin, PL; Duong, TQ; Saadon, JR; Winans, NJ; Sharma, H; Feng, GC; Djuric, PM; Mikell, CB				Mofakham, Sima; Fry, Adam; Adachi, Joseph; Stefancin, Patricia L.; Duong, Tim Q.; Saadon, Jordan R.; Winans, Nathan J.; Sharma, Himanshu; Feng, Guanchao; Djuric, Petar M.; Mikell, Charles B.			Electrocorticography reveals thalamic control of cortical dynamics following traumatic brain injury	COMMUNICATIONS BIOLOGY			English	Article							VEGETATIVE STATE; CONSCIOUSNESS; CONNECTIVITY; ATROPHY; STIMULATION; MECHANISMS; COMPLEXITY; PATTERNS; SEIZURES; MODERATE	To begin to uncover the mechanisms underlying the return of consciousness following traumatic brain injury, Mofakham et al. recorded local field potentials from depth cortical regions in these patients. They found that thalamic input to the cortex plays a role in mediating the cortical dynamics associated with recovery of consciousness. The return of consciousness after traumatic brain injury (TBI) is associated with restoring complex cortical dynamics; however, it is unclear what interactions govern these complex dynamics. Here, we set out to uncover the mechanism underlying the return of consciousness by measuring local field potentials (LFP) using invasive electrophysiological recordings in patients recovering from TBI. We found that injury to the thalamus, and its efferent projections, on MRI were associated with repetitive and low complexity LFP signals from a highly structured phase space, resembling a low-dimensional ring attractor. But why do thalamic injuries in TBI patients result in a cortical attractor? We built a simplified thalamocortical model, which connotes that thalamic input facilitates the formation of cortical ensembles required for the return of cognitive function and the content of consciousness. These observations collectively support the view that thalamic input to the cortex enables rich cortical dynamics associated with consciousness.	[Mofakham, Sima; Fry, Adam; Adachi, Joseph; Saadon, Jordan R.; Winans, Nathan J.; Mikell, Charles B.] SUNY Stony Brook, Renaissance Sch Med, Dept Neurosurg, Stony Brook, NY 11794 USA; [Fry, Adam] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA; [Stefancin, Patricia L.; Duong, Tim Q.] SUNY Stony Brook, Renaissance Sch Med, Dept Radiol, Stony Brook, NY USA; [Feng, Guanchao; Djuric, Petar M.] SUNY Stony Brook, Dept Elect & Comp Engn, Stony Brook, NY USA		Mofakham, S; Mikell, CB (corresponding author), SUNY Stony Brook, Renaissance Sch Med, Dept Neurosurg, Stony Brook, NY 11794 USA.	Sima.Mofakham@stonybrookmedicine.edu; Charles.Mikell@stonybrookmedicine.edu			Neurosurgery Department, Stony Brook EEG center; National Science Foundation through the Growing Convergence Research (NSF) [2021002]; Renaissance School of Medicine at Stony Brook University [63845]; Office of the Vice President for Research at Stony Brook University; Stony Brook University Hospital	We thank Susan Fiore, Dr. Il Memming Park, Josue Nasser, Dr. Ramin Parsey, Dr. Christine DeLorenzo, Dr. Raphael Davis, Dr. Elliot H. Smith, Dr. Justine Liang, Dr. Helen Hsieh, Bradley Ashcroft, and Dr. John Anthony Servider for their helpful comments and discussions. We also thank the Neurosurgery Department, Stony Brook EEG center, and Stony Brook University Hospital for providing support. This work was supported by the National Science Foundation through the Growing Convergence Research (NSF Award 2021002), a Targeted Research Opportunity Program FUSION award (63845) from the Renaissance School of Medicine at Stony Brook University, as well as seed grant funding from the Office of the Vice President for Research at Stony Brook University.	Abbott LF, 1999, BRAIN RES BULL, V50, P303, DOI 10.1016/S0361-9230(99)00161-6; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Casarotto S, 2016, ANN NEUROL, V80, P718, DOI 10.1002/ana.24779; Chudy Darko, 2018, J Neurosurg, V128, P1189, DOI 10.3171/2016.10.JNS161071; DOMICH L, 1986, J PHYSIOL-LONDON, V379, P429, DOI 10.1113/jphysiol.1986.sp016262; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Elder Christopher, 2019, Epilepsia Open, V4, P187, DOI 10.1002/epi4.12300; Fell J, 2003, MED HYPOTHESES, V61, P158, DOI 10.1016/S0306-9877(03)00148-8; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Freyer F, 2011, J NEUROSCI, V31, P6353, DOI 10.1523/JNEUROSCI.6693-10.2011; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GLENN LL, 1982, J NEUROSCI, V2, P1387; GOLOMB D, 1994, PHYSICA D, V72, P259, DOI 10.1016/0167-2789(94)90214-3; Haddad AR, 2019, NEUROMODULATION, V22, P373, DOI 10.1111/ner.12944; Halassa MM, 2019, NEURON, V103, P762, DOI 10.1016/j.neuron.2019.06.005; Hebb D.O., 1950, SCI ED, V34, P336; Hindman J, 2018, ANN NEUROL, V84, P926, DOI 10.1002/ana.25377; James W., 1910, PRINCIPLES PSYCHOL; Jobst BC, 2017, EPILEPSIA, V58, P1005, DOI 10.1111/epi.13739; Keller CJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0528; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; King JR, 2013, CURR BIOL, V23, P1914, DOI 10.1016/j.cub.2013.07.075; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; Kulkarni N., 2018, EEG BASED DIAGNOSIS; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Lutkenhoff ES, 2013, NEUROIMAGE-CLIN, V3, P396, DOI 10.1016/j.nicl.2013.09.010; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Matsumoto R, 2004, BRAIN, V127, P2316, DOI 10.1093/brain/awh246; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Mofakham S, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.042427; Mofakham S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122225; Monti MM, 2015, NEUROLOGY, V84, P167, DOI 10.1212/WNL.0000000000001123; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Posner J. B., 2008, PLUM POSNERS DIAGNOS; PRITCHARD WS, 1995, PSYCHOPHYSIOLOGY, V32, P486, DOI 10.1111/j.1469-8986.1995.tb02100.x; Ramasubbu R, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00302; Ramcharan EJ, 2000, VISUAL NEUROSCI, V17, P55, DOI 10.1017/S0952523800171056; Rand D. A., 2006, DYNAMICAL SYSTEMS TU; Redinbaugh MJ, 2020, NEURON, V106, P66, DOI 10.1016/j.neuron.2020.01.005; Rikhye RV, 2018, NAT NEUROSCI, V21, P1753, DOI 10.1038/s41593-018-0269-z; Rohaut B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41042-2; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sarasso S, 2015, CURR BIOL, V25, P3099, DOI 10.1016/j.cub.2015.10.014; Sarasso S, 2014, CLIN EEG NEUROSCI, V45, P40, DOI 10.1177/1550059413513723; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schmitt LI, 2017, NATURE, V545, P219, DOI 10.1038/nature22073; Shine JM, 2021, PROG NEUROBIOL, V199, DOI 10.1016/j.pneurobio.2020.101951; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; SYNEK VM, 1988, J CLIN NEUROPHYSIOL, V5, P161, DOI 10.1097/00004691-198804000-00003; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vogt BA, 2009, CINGULATE NEUROBIOLO; Wang Z, 2021, FRONT SURG, V8, DOI 10.3389/fsurg.2021.627008; Waziri A, 2009, ANN NEUROL, V66, P366, DOI 10.1002/ana.21721; Winans NJ, 2020, J NEUROSURG, V133, P477, DOI 10.3171/2019.2.JNS183568	62	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY		2399-3642		COMMUN BIOL	Commun. Biol.	OCT 21	2021	4	1							1210	10.1038/s42003-021-02738-2			10	Biology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Science & Technology - Other Topics	WK6VZ	WOS:000709864500002	34675341	Green Published, gold			2022-02-06	
J	Mountney, A; Blaze, J; Wang, ZY; Umali, M; Flerlage, WJ; Dougherty, J; Ge, YC; Shear, D; Haghighi, F				Mountney, Andrea; Blaze, Jennifer; Wang, Zhaoyu; Umali, Michelle; Flerlage, William Jesse; Dougherty, Jacqueline; Ge, Yongchao; Shear, Deborah; Haghighi, Fatemeh			Penetrating Ballistic Brain Injury Produces Acute Alterations in Sleep and Circadian-Related Genes in the Rodent Cortex: A Preliminary Study	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; circadian; sleep; prefrontal cortex; gene expression	ACUTE NONCONVULSIVE SEIZURES; MOUSE MODEL; RAT MODEL; MICE; RISK; DISTURBANCES; DISRUPTION; ACTIVATION; EXPRESSION; DISORDERS	Traumatic brain injury (TBI) affects millions of Americans each year, with extremely high prevalence in the Veteran community, and sleep disturbance is one of the most commonly reported symptoms. Reduction in the quality and amount of sleep can negatively impact recovery and result in a wide range of behavioral and physiological symptoms, such as impaired cognition, mood and anxiety disorders, and cardiovascular effects. Thus, to improve long-term patient outcomes and develop novel treatments, it is essential to understand the molecular mechanisms involved in sleep disturbance following TBI. In this effort, we performed transcriptional profiling in an established rodent model of penetrating ballistic brain injury (PBBI) in conjunction with continuous sleep/wake EEG/EMG recording of the first 24 h after injury. Rats subjected to PBBI showed profound differences in sleep architecture. Injured animals spent significantly more time in slow wave sleep and less time in REM sleep compared to sham control animals. To identify PBBI-related transcriptional differences, we then performed transcriptome-wide gene expression profiling at 24 h post-injury, which identified a vast array of immune- related genes differentially expressed in the injured cortex as well as sleep-related genes. Further, transcriptional changes associated with total time spent in various sleep stages were identified. Such molecular changes may underlie the pathology and symptoms that emerge following TBI, including neurodegeneration, sleep disturbance, and mood disorders.	[Mountney, Andrea; Flerlage, William Jesse; Dougherty, Jacqueline; Shear, Deborah] Walter Reed Army Inst Res WRAIR, Silver Spring, MD USA; [Blaze, Jennifer; Wang, Zhaoyu; Umali, Michelle; Ge, Yongchao; Haghighi, Fatemeh] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Haghighi, Fatemeh] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Haghighi, Fatemeh] James J Peters Vet Affairs Med Ctr, Res & Dev Serv, Bronx, NY 10468 USA		Haghighi, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Haghighi, F (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.; Haghighi, F (corresponding author), James J Peters Vet Affairs Med Ctr, Res & Dev Serv, Bronx, NY 10468 USA.	fatemeh.haghighi@mssm.edu					Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Atkinson SE, 2011, J BIOL RHYTHM, V26, P210, DOI 10.1177/0748730411402810; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Blaze J, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.00160; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Buchele F, 2016, J NEUROTRAUM, V33, P1171, DOI 10.1089/neu.2015.4001; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; DeBeer BB, 2017, J NERV MENT DIS, V205, P512, DOI 10.1097/NMD.0000000000000695; Department of Defense Numbers for Traumatic Brain Injury-Totals, TRAUMATIC BRAIN INJU; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dzirasa K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005238; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI [10.15620/cdc.5571, DOI 10.15620/CDC.5571]; Fee DB, 2004, BRAIN RES, V1012, P52, DOI 10.1016/j.brainres.2004.03.028; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Gardani M, 2015, ARCH PHYS MED REHAB, V96, P1691, DOI 10.1016/j.apmr.2015.05.006; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Goldrich DY, 2019, NEUROSENSORY DISORDERS IN MILD TRAUMATIC BRAIN INJURY, P199, DOI 10.1016/B978-0-12-812344-7.00014-5; Grima NA, 2017, CURR OPIN PULM MED, V23, P493, DOI 10.1097/MCP.0000000000000429; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; HEFFNER TG, 1980, PHARMACOL BIOCHEM BE, V13, P453, DOI 10.1016/0091-3057(80)90254-3; Holst SC, 2017, SCI REP-UK, V7, DOI 10.1038/srep45982; Holst SC, 2014, J NEUROSCI, V34, P566, DOI 10.1523/JNEUROSCI.4128-13.2014; Jamnia N, 2017, J NEUROTRAUM, V34, P1351, DOI 10.1089/neu.2016.4517; King PR, 2017, J PSYCHOSOM RES, V96, P60, DOI 10.1016/j.jpsychores.2017.03.012; Konduru SS, 2021, EPILEPSIA OPEN, V6, P181, DOI 10.1002/epi4.12462; Kudo T, 2013, J NEUROPHYSIOL, V110, P1097, DOI 10.1152/jn.00114.2013; Lacaille H, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0300-18.2019; Lan YL, 2019, AM J TRANSL RES, V11, P2616; Lee SW, 2018, J NEUROTRAUM, V35, P1681, DOI 10.1089/neu.2017.5530; Lee SW, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1423-6; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lipton JO, 2017, CELL REP, V20, P868, DOI 10.1016/j.celrep.2017.07.008; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu XCM, 2017, J TRAUMA ACUTE CARE, V83, pS25, DOI 10.1097/TA.0000000000001470; Lu XCM, 2015, J NEUROTRAUM, V32, P1621, DOI 10.1089/neu.2014.3766; Lu XCM, 2013, J NEUROTRAUM, V30, P580, DOI 10.1089/neu.2012.2641; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mountney A, 2016, J NEUROTRAUM, V33, P1492, DOI 10.1089/neu.2015.4139; Mountney A, 2013, J NEUROTRAUM, V30, P1973, DOI 10.1089/neu.2013.3001; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Niwa Y, 2018, CELL REP, V24, P2231, DOI 10.1016/j.celrep.2018.07.082; Noain D, 2018, J NEUROTRAUM, V35, P85, DOI 10.1089/neu.2017.5067; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Phipps HW, 2016, METHODS MOL BIOL, V1462, P61, DOI 10.1007/978-1-4939-3816-2_5; Prevention CfDCa, 2015, REP C TRAUM BRAIN IN; Qu WR, 2016, NEURAL REGEN RES, V11, P248, DOI 10.4103/1673-5374.177732; Ray S, 2020, SCIENCE, V367, P800, DOI 10.1126/science.aaw7365; Rhodes JA, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy193; Rostami E, 2016, METHODS MOL BIOL, V1462, P47, DOI 10.1007/978-1-4939-3816-2_4; Rozas NS, 2015, J NEUROTRAUM, V32, P149, DOI 10.1089/neu.2014.3469; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Satoh A, 2015, AGING CELL, V14, P209, DOI 10.1111/acel.12299; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shi SQ, 2010, CURR BIOL, V20, P316, DOI 10.1016/j.cub.2009.12.034; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Takenouchi T, 2013, AM J MED GENET A, V161A, P1733, DOI 10.1002/ajmg.a.35953; Thomasy Hannah E., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P71, DOI 10.1016/j.nbscr.2016.03.001; Valomon A, 2014, CHRONOBIOL INT, V31, P705, DOI 10.3109/07420528.2014.896376; Van KC, 2016, METHODS MOL BIOL, V1462, P231, DOI 10.1007/978-1-4939-3816-2_14; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	77	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 21	2021	12								745330	10.3389/fneur.2021.745330			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB1GO	WOS:000721083300001	34777213	Green Published, gold			2022-02-06	
J	Gallo, V; McElvenny, DM; Seghezzo, G; Kemp, S; Williamson, E; Lu, K; Mian, S; James, L; Hobbs, C; Davoren, D; Arden, N; Davies, M; Malaspina, A; Loosemore, M; Stokes, K; Cross, M; Crutch, S; Zetterberg, H; Pearce, N				Gallo, Valentina; McElvenny, Damien M.; Seghezzo, Giulia; Kemp, Simon; Williamson, Elizabeth; Lu, Kirsty; Mian, Saba; James, Laura; Hobbs, Catherine; Davoren, Donna; Arden, Nigel; Davies, Madeline; Malaspina, Andrea; Loosemore, Michael; Stokes, Keith; Cross, Matthew; Crutch, Sebastian; Zetterberg, Henrik; Pearce, Neil			Concussion and long-term cognitive function among rugby players-The BRAIN Study	ALZHEIMERS & DEMENTIA			English	Article; Early Access						cognitive function; occupational epidemiology; rugby; sports-related concussion	CHRONIC TRAUMATIC ENCEPHALOPATHY; IMPAIRMENT; COMPOSITE; DEMENTIA; MIDLIFE; RESERVE; DISEASE; UNION; LIFE	Objective The BRAIN Study was established to assess the associations between self-reported concussions and cognitive function among retired rugby players. Methods Former elite-level male rugby union players (50+ years) in England were recruited. Exposure to rugby-related concussion was collected using the BRAIN-Q tool. The primary outcome measure was the Preclinical Alzheimer Cognitive Composite (PACC). Linear regressions were conducted for the association between concussion and PACC score, adjusting for confounders. Results A total of 146 participants were recruited. The mean (standard deviation) length of playing career was 15.8 (5.4) years. A total of 79.5% reported rugby-related concussion(s). No association was found between concussion and PACC (beta -0.03 [95% confidence interval (CI): -1.31, 0.26]). However, participants aged 80+ years reporting 3+ concussions had worse cognitive function than those without concussion (beta -1.04 [95% CI: -1.62, -0.47]). Conclusions Overall there was no association between concussion and cognitive function; however, a significant interaction with age revealed an association in older participants.	[Gallo, Valentina; Seghezzo, Giulia; James, Laura] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London, England; [Gallo, Valentina; McElvenny, Damien M.; Kemp, Simon; Williamson, Elizabeth; Mian, Saba; Hobbs, Catherine; Davoren, Donna; Pearce, Neil] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Gallo, Valentina] Imperial Coll London, Sch Publ Hlth, London, England; [Gallo, Valentina] Univ Groningen, Campus Fryslan,Wirdumerdijk 34, NL-8911 CE Leeuwarden, Netherlands; [McElvenny, Damien M.] Inst Occupat Med, Res Grp, Edinburgh, Midlothian, Scotland; [McElvenny, Damien M.] Univ Manchester, Ctr Occupat & Environm Hlth, Manchester, Lancs, England; [Kemp, Simon; Stokes, Keith] Rugby Football Union, London, England; [Lu, Kirsty; Crutch, Sebastian] UCL Queen Sq Inst Neurol, Dementia Res Ctr, London, England; [Hobbs, Catherine; Davies, Madeline; Stokes, Keith; Cross, Matthew] Univ Bath, Dept Hlth Keith Stokes & Madeleine Davies, Dept Psychol Catherine Hobbs, Bath, Avon, England; [Arden, Nigel; Davies, Madeline] Univ Oxford, Ctr Sport Exercise & Osteoarthrit Res Versus Arth, Oxford, England; [Malaspina, Andrea] Queen Mary Univ London, Blizard Inst, London, England; [Loosemore, Michael] UCL, Inst Sport Exercise & Hlth, London, England; [Cross, Matthew] Premiership Rugby, London, England; [Zetterberg, Henrik] UCL Queen Sq Inst Neurol, UK Dementia Res Inst, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Zetterberg, Henrik] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden; [Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden		Gallo, V (corresponding author), Univ Groningen, Campus Fryslan,Wirdumerdijk 34, NL-8911 CE Leeuwarden, Netherlands.	v.gallo@rug.nl	Gallo, Valentina/X-1139-2018	Gallo, Valentina/0000-0002-1268-8629; Davies, Madeleine/0000-0002-6047-7340; Seghezzo, Giulia/0000-0002-0540-5897	Drake FoundationSmithsonian InstitutionSmithsonian National Museum of Natural History	Drake Foundation	Abazov VM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.081801; Alosco ML, 2019, JAMA NEUROL, V76, P1298, DOI 10.1001/jamaneurol.2019.2244; [Anonymous], 1990, INT STANDARD CLASSIF; Bernick C, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt177; Chan D, 2018, NEUROBIOL AGING, V70, P180, DOI 10.1016/j.neurobiolaging.2018.06.012; Davies MAM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12130-y; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; Donohue MC, 2014, JAMA NEUROL, V71, P961, DOI 10.1001/jamaneurol.2014.803; Gallo V, 2020, J NEUROL NEUROSUR PS, V91, P455, DOI 10.1136/jnnp-2019-321170; Gallo V, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017990; Grober E, 2008, J INT NEUROPSYCH SOC, V14, P266, DOI 10.1017/S1355617708080302; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; James L., BRAIN Q TOOL A UNPUB; Kormas C, 2018, CLIN NEUROPSYCHOL, V32, P152, DOI 10.1080/13854046.2018.1495270; Lee EB, 2019, ACTA NEUROPATHOL, V138, P389, DOI 10.1007/s00401-019-02030-y; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lu K, 2019, NEUROLOGY, V93, pE2144, DOI 10.1212/WNL.0000000000008534; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Major BP, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.549624; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2020, SEMIN NEUROL, V40, P359, DOI 10.1055/s-0040-1713632; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMillan TM., 2017, OCCUP ENVIRON MED, V74; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mormino EC, 2017, ALZHEIMERS DEMENT, V13, P1004, DOI 10.1016/j.jalz.2017.01.018; Morris TP, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-75; Nelson HE., NATL ADULT READING T; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Papp KV, 2014, CLIN NEUROPSYCHOL, V28, P771, DOI 10.1080/13854046.2014.911351; Quarrie KL, 2007, J SPORT SCI, V25, P895, DOI 10.1080/02640410600944659; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Shirk SD, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt94; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stewart W, 2016, QJM-INT J MED, V109, P11, DOI 10.1093/qjmed/hcv070; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Williams JJ., 2005, THESIS U CARDIFF	41	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.												10.1002/alz.12455		OCT 2021	13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WJ3BS	WOS:000708923000001	34668650	Green Published, hybrid			2022-02-06	
J	Pate, J; Mooney, J; Katz, E; Cignetti, C; McLeod, C; Gould, S				Pate, James; Mooney, James; Katz, Erin; Cignetti, Carly; McLeod, Chandler; Gould, Sara			Efficacy of outpatient infusion therapy in pediatric patients with postconcussive headaches	CHILDS NERVOUS SYSTEM			English	Article						Concussion; Mild traumatic brain injury; Posttraumatic headaches; Infusion therapy	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC HEADACHES; UNITED-STATES; MIGRAINE; MANAGEMENT; CHILDREN; PROCHLORPERAZINE; METOCLOPRAMIDE; RECOVERY; TRIAL	Purpose To determine the relative efficacy of intravenous therapy for postconcussive headaches in a pediatric population, as compared to oral therapy. Methods Pediatric patients treated for postconcussive headaches at an outpatient infusion clinic from 2016 to 2018 were selected for inclusion in the study. Of the 95 patients who were treated in clinic, 53 patients were selected for a retrospective chart review. Clinic visits before and after infusions were reviewed to determine changes in headache score (HA), symptom severity score (SSS), and self-reported symptom relief. An age-matched and SSS-matched group served as a control. The control group received only oral therapy for their headaches. The infusion consisted of parenteral ketorolac, compazine, diphenhydramine, and a normal saline bolus (20 mg/kg). Results Following infusion therapy, overall mean HA and SSS scores were both reduced (p < 0.0001). Oral therapy demonstrated a similar mean overall reduction in HA and SS scores (p < 0.0001). While both groups achieved a reduction in HA and SS scores, there was not a statistically significant difference in reduction of symptoms scores between the oral and infusion groups. Conclusion Infusion therapy is as effective at reducing HA and SSS as established oral therapies. Infusion therapy may have a shorter time to headache abortion than oral therapy based on pharmacokinetics. Further, some physicians are unwilling to allow an athlete to return to play while taking suppressive medication. Future studies may show that an infusion could allow a more rapid return to play and resolution of symptoms.	[Pate, James; Katz, Erin; Cignetti, Carly] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Mooney, James] Univ Alabama Birmingham, Dept Neurosurg, 1802 6th Ave South,FOT 1001, Birmingham, AL 35233 USA; [McLeod, Chandler] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Gould, Sara] Univ Alabama Birmingham, Dept Orthoped Surg, Birmingham, AL USA		Mooney, J (corresponding author), Univ Alabama Birmingham, Dept Neurosurg, 1802 6th Ave South,FOT 1001, Birmingham, AL 35233 USA.	jamesmooney@uabmc.edu	Mooney, James/AAU-2905-2021	Mooney, James/0000-0003-1897-1879; Gould, Sara/0000-0002-0713-1156			Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Chan S, 2015, AM J EMERG MED, V33, P635, DOI 10.1016/j.ajem.2015.01.053; Desai N, 2019, CLIN J SPORT MED, V29, P361, DOI 10.1097/JSM.0000000000000646; Friedman BW, 2008, ANN EMERG MED, V52, P399, DOI 10.1016/j.annemergmed.2007.09.027; Friedman BW, 2018, AM J EMERG MED, V36, P285, DOI 10.1016/j.ajem.2017.10.034; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; JONES J, 1989, JAMA-J AM MED ASSOC, V261, P1174, DOI 10.1001/jama.261.8.1174; Kabbouche MA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.4.e62; Kabbouche M, 2015, HEADACHE, V55, P1365, DOI 10.1111/head.12694; Kacperski J, 2016, HEADACHE, V56, P36, DOI 10.1111/head.12737; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Leung S, 2013, HEADACHE, V53, P491, DOI 10.1111/head.12042; Lucas S., 2015, BRAIN NEUROTRAUMA; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Montgomery SA, 1997, ANN NY ACAD SCI, V836, P329, DOI 10.1111/j.1749-6632.1997.tb52368.x; Moreno MA, 2012, ARCH PEDIAT ADOL MED, V166, P296, DOI [10.1001/archpediatrics.2012.8, 10.1001/archpediatrics.2012.79]; Orr SL, 2016, HEADACHE, V56, P911, DOI 10.1111/head.12835; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P270, DOI 10.1016/j.pediatrneurol.2014.10.015; Thanacoody H K Ruben, 2005, Toxicol Rev, V24, P205, DOI 10.2165/00139709-200524030-00013; THOMAS SH, 1994, ANN EMERG MED, V24, P923, DOI 10.1016/S0196-0644(54)00222-3; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Trottier ED, 2012, AM J EMERG MED, V30, P456, DOI 10.1016/j.ajem.2010.12.020	28	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JAN	2022	38	1					103	108		10.1007/s00381-021-05383-6		OCT 2021	6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	XZ9YV	WOS:000709258800001	34671849				2022-02-06	
J	James, L; Davies, M; Mian, SB; Seghezzo, G; Williamson, E; Kemp, S; Arden, N; McElvenny, D; Pearce, N; Gallo, V				James, Laura; Davies, Madeline; Mian, Saba; Seghezzo, Giulia; Williamson, Elizabeth; Kemp, Simon; Arden, Nigel; McElvenny, Damien; Pearce, Neil; Gallo, Valentina			The BRAIN-Q, a tool for assessing self-reported sport-related concussions for epidemiological studies	EPIDEMIOLOGY AND HEALTH			English	Article						Questionnaire; Evaluation; Brain concussion; Sports medicine; Epidemiologic studies	DEFINITION; HISTORY; DISEASE; IMPACT	OBJECTIVES: The BRAIN-Q is a tool aimed at maximising the accuracy and minimising measurement error for retrospectively assessing concussions. This paper reports the agreement of the BRAIN-Q tool when compared to extant questionnaire questions, and its reproducibility when compared with its telephonic version (tBRAIN-Q). METHODS: The BRAIN-Q entails a 3-stage process: defining a concussion, creating a visual timeline with life events, and establishing detailed characteristics for each reported concussion. It was designed to be administered in-person by trained personnel, and was used in the BRAIN study. Its performance was compared with the MSK study, which previously collected a few questions in a broader self-administered questionnaire, and with the tBRAIN-Q Recall, its telephonic version. RESULTS: In total, 101 participants were included, of whom 9 were re-assessed with the tBRAIN-Q. The agreement of the BRAIN-Q with the muscle skeletal-questionnaire for rugby-related concussion was 86.7% (Kappa= 0.6). Rugby-related concussion with loss of consciousness showed lower agreement (82.0%; Kappa= 0.6). The comparison between the BRAIN-Q and the tBRAIN-Q showed good reproducibility. CONCLUSIONS: The BRAIN-Q is a relatively easy tool to administer in face-to-face assessments, and it showed optimal reproducibility. It includes a well-established definition of concussion, and is used to collect detailed information on each concussion, allowing for a number of subgroup analyses (e.g., by severity, age, or context). The BRAIN-Q is easily adaptable to other sporting settings.	[James, Laura; Seghezzo, Giulia; Gallo, Valentina] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London, England; [Davies, Madeline] Univ Bath, Bath, Avon, England; [Mian, Saba; Williamson, Elizabeth; Kemp, Simon; McElvenny, Damien; Pearce, Neil; Gallo, Valentina] London Sch Hyg & Trop Med, London, England; [Kemp, Simon] Rugby Football Union, London, England; [Arden, Nigel] Univ Oxford, Oxford, England; [McElvenny, Damien] Inst Occupat Med, Edinburgh, Midlothian, Scotland; [McElvenny, Damien] Inst Occupat Med, Manchester, Lancs, England; [McElvenny, Damien] Univ Manchester, Manchester, Lancs, England; [Gallo, Valentina] Imperial Coll London, Sch Publ Hlth, London, England; [Gallo, Valentina] Univ Groningen, Dept Sustainable Hlth, Campus Frysland,34 Wirdumerdijk, NL-8911 CE Leeuwarden, Netherlands		Gallo, V (corresponding author), Univ Groningen, Dept Sustainable Hlth, Campus Frysland,34 Wirdumerdijk, NL-8911 CE Leeuwarden, Netherlands.	v.gallo@rug.nl		Davies, Madeleine/0000-0002-6047-7340; Seghezzo, Giulia/0000-0002-0540-5897	Drake Foundation, BRAIN [EPMSZJ20-10]; Queen Mary University of London; Institute of Occupational Medicine	This study was partially funded by the Drake Foundation as part of the BRAIN study funded to the London School of Hygiene and Tropical Medicine (EPMSZJ20-10) in collaboration with Queen Mary University of London and the Institute of Occupational Medicine.	Alosco ML, 2017, BRAIN INJURY, V31, P1116, DOI 10.1080/02699052.2017.1294709; Davies MAM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12130-y; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; England Rugby, 2020, HEADCASE; Gallo V, 2020, J NEUROL NEUROSUR PS, V91, P455, DOI 10.1136/jnnp-2019-321170; Gallo V, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017990; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Mullally WJ, 2017, AM J MED, V130, P885, DOI 10.1016/j.amjmed.2017.04.016; National Institute of Neurological Disorders and Stroke, 2019, FOC TRAUM BRAIN INJU; O'Connell E, 2016, IRISH J MED SCI, V185, P521, DOI 10.1007/s11845-015-1313-6; Pearce N, 2015, NEUROBIOL AGING, V36, P1383, DOI 10.1016/j.neurobiolaging.2014.12.024; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005	18	0	0	0	0	KOREAN SOC EPIDEMIOLOGY	SUWON	DEPT SOCIAL & PREVENTIVE MEDICINE, SUNGKYUNKWAN UNIV SCH MEDICINE, SUWON, 16419, SOUTH KOREA	2092-7193			EPIDEMIOL HEALTH	Epidemiol. Health	OCT 19	2021	43								e2021086	10.4178/epih.e2021086			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	XY4WB	WOS:000736973600001	34696571	Green Submitted, gold			2022-02-06	
J	Sokol-Randell, D; Rotundo, MP; Tierney, G; Cusimano, MD; Deasy, C				Sokol-Randell, Darek; Rotundo, Mario Pasquale; Tierney, Gregory; Cusimano, Michael D.; Deasy, Conor			Video analysis of potential concussions in elite male Hurling: are players being assessed according to league guidelines?	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article; Early Access						Concussion assessment; Video incident analysis; Sport-related concussion	INJURY; RISK	Background Hurling is a fast-paced contact sport that places players at risk of concussion. Given the consequences of repeated concussive impacts, it is imperative that concussion management guidelines are followed. Hypothesis/Purpose. The aim of this study is to determine if potential concussive events (PCEs) in elite Hurling are assessed in accordance with league management guidelines. The secondary objective is to investigate the effectiveness of current concussion training programs. Methods Investigators used a video analysis approach to identify PCEs throughout the 2018 and 2019 inter-county Hurling seasons and championships. Subsequent assessment, return to play (RTP) decision, and signs of concussion were evaluated based on previously validated methods. The results were then compared year-over-year with previous research in Gaelic Football (GF). Results A total of 183 PCEs were identified over 82 matches. PCEs were frequently assessed (86.3%, n = 158) by medical personnel. The majority of assessments were less than 1 min in duration (81.0%, n = 128). Thirteen (7.1%) players were removed following a PCE. There were 43 (23.5%) PCEs that resulted in one or more signs of concussion, of which 10 (23.3%) were removed from play. There was no difference in rate of assessment, duration of assessment, or rate of RTP between 2018 and 2019 in both Hurling and GF, suggesting that current concussion training programs have had limited success. Conclusion In Hurling, players suspected of having sustained a concussion are frequently subject to a brief assessment, and are rarely removed from play. Affirmative action is needed to ensure the consistent application of standardized concussion assessment across the Gaelic Games.	[Sokol-Randell, Darek; Rotundo, Mario Pasquale; Deasy, Conor] Univ Coll Cork, Sch Med, Cork, Ireland; [Sokol-Randell, Darek; Rotundo, Mario Pasquale; Deasy, Conor] Emergency Innovat Res Network, Cork, Ireland; [Tierney, Gregory] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England; [Cusimano, Michael D.] Univ Toronto, Div Neurosurg, St Michaels Hosp, Toronto, ON, Canada; [Deasy, Conor] Cork Univ Hosp, Emergency Dept, Cork, Ireland		Sokol-Randell, D (corresponding author), Univ Coll Cork, Sch Med, Cork, Ireland.; Sokol-Randell, D (corresponding author), Emergency Innovat Res Network, Cork, Ireland.	117105165@umail.ucc.ie		Sokol-Randell, Darek/0000-0002-6751-5645	IReL Consortium	Open Access funding provided by the IReL Consortium.	[Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Armstrong N, 2020, INJURY PREV, V26, P334, DOI 10.1136/injuryprev-2019-043242; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Blake C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005059; Cantu RC, 2016, WORLD NEUROSURG, V95, P601, DOI 10.1016/j.wneu.2016.04.056; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Dale J., 1990, J APPL SPORT PSYCHOL, V2, P67, DOI [DOI 10.1080/10413209008406421, 10.1080/10413209008406421]; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Davis G, 2016, J SCI MED SPORT, V19, P898, DOI 10.1016/j.jsams.2016.02.005; Davis GA, 2019, BRIT J SPORT MED, V53, P1299, DOI 10.1136/bjsports-2018-099727; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Finch CF, 2001, BRIT J SPORT MED, V35, P89, DOI 10.1136/bjsm.35.2.89; Gaelic Athletic Association, 2018, CONC MAN GUID GAEL G; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gieck J., 1982, ATHL TRAIN J NATL AT, V1, P36; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Kavanagh B, 2015, GAA BIGGEST HITS; Khan M, 2008, EYE, V22, P475, DOI 10.1038/sj.eye.6702659; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Lemak L, 2007, CLIN SPORT MED, V26, P227, DOI 10.1016/j.csm.2007.01.003; Ly N, 2015, RULES HURLING EXPLAI; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McLaine AJ, 2005, ATHLET THER TODAY, V10, P11, DOI 10.1123/att.10.6.11; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Meeuwisse WH, 2017, BRIT J SPORT MED, V51, P873, DOI 10.1136/bjsports-2017-097569; Murphy C, 2010, Ir Med J, V103, P174; O'Connor S, 2019, SPORTS HEALTH, V11, P498, DOI 10.1177/1941738119875978; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Sokol-Randell D, 2021, IRISH J MED SCI, V190, P787, DOI 10.1007/s11845-020-02390-5; Sone JY, 2017, J NEUROSURG, V126, P768, DOI 10.3171/2016.2.JNS151972; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Sullivan L, 2018, DEV IMPLEMENTATION E; Sullivan L., 2017, INT J ADOLESC MED HL, V29, P1, DOI [10.1515/ijamh-2015-0084, DOI 10.1515/IJAMH-2015-0084, 10.1515/ijamh-2017-3001]; Tarzi C, 2020, INJURY PREV, V26, P536, DOI 10.1136/injuryprev-2019-043397; Tator C, 2019, CAN J NEUROL SCI, V46, P351, DOI 10.1017/cjn.2019.14	42	0	0	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.												10.1007/s11845-021-02798-7		OCT 2021	8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI4YJ	WOS:000708367300001	34664223	hybrid, Green Published			2022-02-06	
J	Solomon, H				Solomon, Harris			Epidemiology in Motion: Traumatic Brain Injuries in Mumbai	SOUTH ASIA-JOURNAL OF SOUTH ASIAN STUDIES			English	Article						Epidemiology; medicine; mobility; movement; Mumbai; 'rowdy'; 'stunt'; trauma	URBAN; INDIA	This paper is an ethnographic account of traumatic brain injuries (TBIs) based on a study of a public hospital trauma ward in urban India. It explores the contexts, causes and consequences of TBIs in order to make several broader claims. Across two case studies, I argue that epidemiological transitions towards non-infectious disease regimens must be understood as problems of somatic movement. The implication is that bodies make transitions through actual and imagined changes in bodily movements that define how persons become patients, how traumatic injury pulls on clinical resources, and how differences in gender, sexuality, class and caste affect the social dynamics of brain injury in urban settings at every turn.	[Solomon, Harris] Duke Univ, Dept Cultural Anthropol, Durham, NC 27708 USA; [Solomon, Harris] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA		Solomon, H (corresponding author), Duke Univ, Dept Cultural Anthropol, Durham, NC 27708 USA.; Solomon, H (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.	harris.solomon@duke.edu		Solomon, Harris/0000-0002-8792-469X	National Science FoundationNational Science Foundation (NSF); CAREER Faculty Early Career Development Grant [145433]	National Science Foundation, CAREER Faculty Early Career Development Grant [no. 145433].	Amrute S, 2015, PUBLIC CULTURE, V27, P331, DOI 10.1215/08992363-2841892; Banerjee Dwaipayan, 2020, ENDURING CANC LIFE D; Bedi T, 2018, MOD ASIAN STUD, V52, P1604, DOI 10.1017/S0026749X17000191; Bedi T, 2016, CITY SOC, V28, P387, DOI 10.1111/ciso.12098; Benjamin Solomon, IDD WORKING PAPERS, V26; Bhandarkar P, 2021, WORLD J SURG, V45, P380, DOI 10.1007/s00268-020-05805-7; Brunson J, 2014, ETHNOS, V79, P610, DOI 10.1080/00141844.2013.813056; Caduff C, 2019, BIOSOCIETIES, V14, P489, DOI 10.1057/s41292-019-00175-3; Copeman J, 2009, VEINS DEVOTION BLOOD; Dandona L, 2017, LANCET, V390, P2437, DOI 10.1016/S0140-6736(17)32804-0; Dandona R, 2020, LANCET PUBLIC HEALTH, V5, pE86, DOI 10.1016/S2468-2667(19)30246-4; Dhareshwar V., 1997, SUBALTERN STUDIES 9, P201; Dossal Mariam, 1997, IMPERIAL DESIGNS IND; Dumit J, 2004, PICTURING PERSONHOOD; Elden S., 2003, SURVEILLANCE SOC, V1, P240, DOI DOI 10.24908/ss.v1i3.3339; Fisch M., 2018, ANTHR MACHINE TOKYOS; Fitzgerald Des, 2016, Sociol Rev Monogr, V64, P221; Friedner Michele, 2022, BECOMING NORMAL COCH; Gerdin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105606; Gupta S, 2020, J NEUROSURG, V132, P289, DOI 10.3171/2018.8.JNS182182; Kidambi P., 2004, URBAN HIST, V31, P249, DOI DOI 10.1017/S0963926804002135; Kumar V, 2012, PREHOSP DISASTER MED, V27, P216, DOI 10.1017/S1049023X12000544; Langwick SA, 2007, SCI TECHNOL HUM VAL, V32, P88, DOI 10.1177/0162243906293887; Livingston Julie, 2012, IMPROVISING MED AFRI, P32; Mazumdar R, 2010, NOIR URBANISMS: DYSTOPIC IMAGES OF THE MODERN CITY, P150; Mazumdar Ranjani, 2008, SPACES MODERN CITY I, P401; McFarlane C, 2008, INT J URBAN REGIONAL, V32, P415, DOI 10.1111/j.1468-2427.2008.00793.x; Moran-Thomas A., 2019, TRAVELING SUGAR CHRO; Mulla, 2014, VIOLENCE CARE RAPE V; Pinto S, 2014, CONTEMP ETHNOGR, P1; Prakash G, 2010, MUMBAI FABLES, P1; Ralph L., 2014, RENEGADE DREAMS LIVI; Roy N, 2016, WORLD J SURG, V40, P1299, DOI 10.1007/s00268-016-3452-y; Roy Nobhojit, 2017, THESIS; Sadana R, 2010, ECON POLIT WEEKLY, V45, P77; Sadana Rashmi, 2018, ANTHR HUMANISM, V43, P39; Saunders Barry, 2010, CT SUITE WORK DIAGNO; Singha R, 2015, MOD ASIAN STUD, V49, P241, DOI 10.1017/S0026749X13000462; Sivaramakrishnan K, 2019, BIOSOCIETIES, V14, P529, DOI 10.1057/s41292-019-00162-8; Solomon H., 2016, METABOLIC LIVING FOO; Solomon H, 2021, MED ANTHROPOL Q, V35, P102, DOI 10.1111/maq.12603; Solomon H, 2017, MED ANTHROPOL Q, V31, P349, DOI 10.1111/maq.12367; Solomon Harris, 2022, ENVIRON PLANN D, V39, P423; Solomon Harris, 2022, LIFELINES TRAFFIC TR; Sreenath S, 2017, S ASIA, V40, P392, DOI 10.1080/00856401.2017.1296623; Stepputat, 2001, STATES IMAGINATION E, P221; Sundaram R, 2009, ASIAS TRANSFORM, P172; Terry J., 2009, WOMENS STUDIES Q, V37, P200, DOI DOI 10.1353/WSQ.0.0143; Van Hollen CC, 2018, MED ANTHROPOL Q, V32, P59, DOI 10.1111/maq.12406; Vicziany Marika, 2021, S ASIA, V44; WHO, 2014, INJ VIOL FACTS 2014; Yadav S, 2014, GLOBAL HEALTH ACTION, V7, P84, DOI 10.3402/gha.v7.23248	52	0	0	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0085-6401	1479-0270		S ASIA	S. Asia	NOV 2	2021	44	6					1131	1145		10.1080/00856401.2021.1984430		OCT 2021	15	Area Studies; History; Asian Studies	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Area Studies; History; Asian Studies	XR8BM	WOS:000709254400001					2022-02-06	
J	Withington, C; Dowlati, E; Hay, K; Chesney, K; Sarpong, K; Baten, A; Felbaum, DR				Withington, Charles; Dowlati, Ehsan; Hay, Kathryn; Chesney, Kelsi; Sarpong, Kwadwo; Baten, Ahmareen; Felbaum, Daniel R.			Outcomes of patients with nonepileptic transient neurologic symptoms after subdural hematoma evacuation	ACTA NEUROCHIRURGICA			English	Article						Subdural hematoma; Seizure; Antiepileptic drugs; Electroencephalography; Transient neurologic symptoms	TRAUMATIC BRAIN-INJURY; CORTICAL SPREADING DEPRESSION; RISK-FACTORS; EPILEPTIFORM DISCHARGES; POSTTRAUMATIC EPILEPSY; SEIZURES; DEPOLARIZATIONS	Background Patients undergoing a subdural hematoma (SDH) evacuation can experience transient neurological symptoms (TNS) postoperatively. Electroencephalography (EEG) is used to rule out seizures. We aim to characterize patients with TNS and negative epileptiform activity on EEG and compare them to those with positive epileptiform EEG findings. Methods We performed a retrospective study of adult patients who underwent EEG for evaluation of TNS after undergoing SDH evacuation. Patients were stratified based on SDH type (acute and non-acute) and whether or not their EEG demonstrated positive epileptiform activity. A multivariate analysis was performed to identify predictors of negative EEG findings. Results One hundred twenty-nine SDH patients were included (45 (34.9%) acute; 84 (65.1%) non-acute). Overall, 45 (24 acute and 21 non-acute SDH patients) had positive epileptiform EEG findings, and 84 (21 acute and 63 non-acute SDH patients) had a negative EEG. Acute and non-acute SDH patients with positive EEG findings were more likely to suffer from greater than five episodes of TNS, impaired awareness, and motor symptoms, while the negative EEG group was more likely to suffer from negative symptoms. Non-acute SDH patients with positive EEG had longer mean ICU stays (14.6 vs. 7.2; p = 0.005). Both acute and non-acute SDH-positive EEG patients had worse disposition upon discharge (p < 0.05), worse modified Rankin score at discharge (p < 0.05), and 3-month follow-up (p < 0.05) and were more likely to be discharged on more than one antiepileptic drug (p < 0.001). Conclusion Postoperative acute and non-acute SDH patients with TNS and negative EEG results are likely to have a favorable clinical picture. This distinction is therapeutically and prognostically important as these patients may not respond to typical antiepileptic drugs and they have better functional outcomes.	[Withington, Charles; Hay, Kathryn; Sarpong, Kwadwo] Georgetown Univ, Sch Med, 3900 Reservoir Rd NW, Washington, DC USA; [Dowlati, Ehsan; Chesney, Kelsi; Felbaum, Daniel R.] MedStar Georgetown Univ Hosp, Dept Neurosurg, 3800 Reservoir Rd NW,PHC7, Washington, DC 20007 USA; [Baten, Ahmareen] MedStar Washington Hosp Ctr, Dept Neurol, Washington, DC USA; [Felbaum, Daniel R.] MedStar Washington Hosp Ctr, Dept Neurosurg, Washington, DC USA		Dowlati, E (corresponding author), MedStar Georgetown Univ Hosp, Dept Neurosurg, 3800 Reservoir Rd NW,PHC7, Washington, DC 20007 USA.	edowlati@gmail.com		Dowlati, Ehsan/0000-0001-6739-0793			Branco PM, 2017, CURR PHARM DESIGN, V23, P6442, DOI 10.2174/1381612823666171024144318; Carpenter A, 2021, NEUROSURG REV, DOI 10.1007/s10143-021-01553-x; Dowlati E, 2020, WORLD NEUROSURG, V144, P270, DOI 10.1016/j.wneu.2020.08.118; Drenckhahn C, 2012, BRAIN, V135, P853, DOI 10.1093/brain/aws010; Driver J, 2019, NEUROCRIT CARE, V30, P16, DOI 10.1007/s12028-018-0503-2; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Flores G, 2017, ACTA NEUROCHIR, V159, P2033, DOI 10.1007/s00701-017-3298-6; Freeman WD, 2021, CAN J NEUROL SCI, V48, P7, DOI 10.1017/cjn.2020.182; Iorio-Morin C, 2018, J NEUROTRAUM, V35, P1882, DOI 10.1089/neu.2018.5872; KAMINSKI HJ, 1992, AM J MED, V92, P698, DOI 10.1016/0002-9343(92)90790-I; Khan, 2014, J DHAKA MED COLL, V23, P215, DOI [10.3329/jdmc.v23i2.25394, DOI 10.3329/jdmc.v23i2.25394]; Kim JA, 2018, ANN NEUROL, V83, P858, DOI 10.1002/ana.25211; Kizawa Ryusuke, 2021, Rinsho Shinkeigaku, V61, P166, DOI 10.5692/clinicalneurol.cn-001496; Levesque M, 2021, CAN J NEUROL SCI, V48, P31, DOI 10.1017/cjn.2020.128; Levesque M, 2020, NEUROSURGERY, V87, P96, DOI 10.1093/neuros/nyz355; Liou JH, 2020, J CHIN MED ASSOC, V83, P950, DOI 10.1097/JCMA.0000000000000414; Mohammad LM, 2021, J NEUROSURG, V134, P1294, DOI 10.3171/2020.1.JNS192914; Pastor IS, 2021, EXP THER MED, V22, DOI 10.3892/etm.2021.10189; Pollandt S, 2017, J CLIN NEUROPHYSIOL, V34, P55, DOI 10.1097/WNP.0000000000000311; Rabinstein AA, 2010, J NEUROSURG, V112, P455, DOI 10.3171/2009.7.JNS09392; RUBIN G, 1993, ACTA NEUROCHIR, V123, P39, DOI 10.1007/BF01476283; Rudzinski LA, 2011, J CLIN NEUROPHYSIOL, V28, P633, DOI 10.1097/WNP.0b013e31823cc494; SABO RA, 1995, SURG NEUROL, V43, P579, DOI 10.1016/0090-3019(95)00155-7; Schomer AC, 2015, J CLIN NEUROPHYSIOL, V32, pE4, DOI 10.1097/WNP.0000000000000107; Seifi A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-332; Shah NH, 2016, NEUROHOSPITALIST, V6, pNP1, DOI 10.1177/1941874415583118; Westmoreland BF, 2001, J CLIN NEUROPHYSIOL, V18, P20, DOI 10.1097/00004691-200101000-00005; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; Won SY, 2020, EUR J TRAUMA EMERG S, DOI 10.1007/s00068-020-01508-9; Won SY, 2017, WORLD NEUROSURG, V101, P416, DOI 10.1016/j.wneu.2017.02.024; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026; Yuan WH, 2020, J CHIN MED ASSOC, V83, P885, DOI 10.1097/JCMA.0000000000000395	32	0	0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	DEC	2021	163	12					3267	3277		10.1007/s00701-021-05030-8		OCT 2021	11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WZ7WX	WOS:000708815800002	34668079				2022-02-06	
J	Wu, H; Gong, L; Gu, JC; Xing, HW; Qian, ZX; Mao, Q				Wu, Hong; Gong, Liang; Gu, Jia-Cheng; Xing, Hong-Wei; Qian, Zhong-Xin; Mao, Qing			Proper Partial Pressure of Arterial Oxygen for Patients with Traumatic Brain Injury	MEDICAL SCIENCE MONITOR			English	Article						Brain Concussion; Hyperbaric Oxygenation; Hypoxia; Partial Pressure	ACUTE LUNG INJURY; PULMONARY CONTUSION; SECONDARY INSULTS; HYPEROXIA; OUTCOMES; IMPACT; EPIDEMIOLOGY; PATHOGENESIS; ASSOCIATION; MULTICENTER	Background: The partial pressure of arterial oxygen (PaO2) is critical to the outcome of patients with traumatic brain injury (TBI). However, it is not clear what range of PaO2 should be maintained to improve patient outcome. The aim of this study was to explore the PaO2 value needed in the acute phase of TBI and provide new evidence for clinical practice. Material/Methods: A total of 153 patients with TBI were enrolled retrospectively. Univariate and multivariate logistic regression analyses were conducted on sex, Glasgow Coma Scale (GCS) score on admission, PaO2 within 6 h of admission, oxygenation index, and other factors. The Glasgow Outcome Score (GOS) of the patient at discharge was used as an indicator of outcome. The good outcome group had GOS >= 4, and the poor outcome group had GOS <4. Results: The 153 patients were divided into a good outcome group (n=62) and poor outcome group (n=91). There was a significant difference in sex, admission GCS, surgery, airway status, PaO2, and oxygen index within 6 h of admission between the 2 groups. Logistic regression analysis showed that PaO2 <60 mmHg, male sex, and admission GCS score of 3 to 12 were independent risk factors for a poor outcome. Conclusions: Patients with TBI having PaO2 <60 mmHg within 6 h after admission were more likely to have poor outcomes. The upper limit value of PaO2 that affects the outcome of TBI in patients has not been found.	[Wu, Hong; Gu, Jia-Cheng; Mao, Qing] Shanghai Jiao Tong Univ, Renji Hosp, Dept Neurosurg, Sch Med, Shanghai, Peoples R China; [Gong, Liang; Qian, Zhong-Xin] Punan Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Xing, Hong-Wei] Linquan Cty Peoples Hosp, Dept Neurosurg, Fuyang, Anhui, Peoples R China		Mao, Q (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Dept Neurosurg, Sch Med, Shanghai, Peoples R China.	neurojack@163.com			Outstanding Clinical Discipline Project of Shanghai Pudong [PWYgy2018-04]; National Natural Science FundNational Natural Science Foundation of China (NSFC) [81571883]	The present study was supported by the Outstanding Clinical Discipline Project of Shanghai Pudong (PWYgy2018-04) and the National Natural Science Fund (no. 81571883)	Alali AS, 2020, J NEUROSURG, V132, P537, DOI 10.3171/2018.10.JNS18964; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Asher SR, 2013, J NEUROSURG ANESTH, V25, P168, DOI 10.1097/ANA.0b013e318283d350; Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Briain DO, 2018, NEUROCRIT CARE, V29, P443, DOI 10.1007/s12028-018-0553-5; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Davies M, 2018, J NEUROTRAUM, V35, P790, DOI 10.1089/neu.2017.5354; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Fujita M, 2017, J NEUROTRAUM, V34, P1565, DOI 10.1089/neu.2016.4753; Gao GY, 2020, LANCET NEUROL, V19, P670, DOI 10.1016/S1474-4422(20)30182-4; Gravesteijn BY, 2020, BRIT J ANAESTH, V125, P505, DOI 10.1016/j.bja.2020.05.067; Harpso M, 2019, OPEN ACCESS EMERG M, V11, P57, DOI 10.2147/OAEM.S181629; Hawryluk GWJ, 2020, NEUROSURGERY, V87, P427, DOI 10.1093/neuros/nyaa278; Helmerhorst HJF, 2015, CRIT CARE MED, V43, P1508, DOI 10.1097/CCM.0000000000000998; Hu PJ, 2017, AM J PHYSIOL-LUNG C, V313, pL1, DOI 10.1152/ajplung.00485.2016; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kavanagh BP, 2008, MINERVA ANESTESIOL, V74, P285; Leone M, 2003, CHEST, V124, P2261, DOI 10.1378/chest.124.6.2261; Lu GY, 2020, WORLD NEUROSURG, V133, pE135, DOI 10.1016/j.wneu.2019.08.184; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Nathanson MH, 2020, ANAESTHESIA, V75, P234, DOI 10.1111/anae.14866; Orliaguet C, 2000, ANN FR ANESTH, V19, P164; Perl M, 2011, EXPERT REV RESP MED, V5, P115, DOI 10.1586/ERS.10.92; Qaseem A, 2006, ANN INTERN MED, V144, P575, DOI 10.7326/0003-4819-144-8-200604180-00008; Raghava Narayan, 2017, Neurosci Neuroecon, V6, P15, DOI 10.2147/NAN.S105134; Raj R, 2013, CRIT CARE, V17, DOI 10.1186/cc12856; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; TEASDALE G, 1974, LANCET, V2, P81	37	0	0	3	3	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA		1643-3750		MED SCI MONITOR	Med. Sci. Monitor	OCT 19	2021	27								e932318	10.12659/MSM.932318			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	WK8AQ	WOS:000709944500001	34663780	Green Published			2022-02-06	
J	Chrisman, SPD; Kroshus, E; Garrett, K; Gau, J; Harmon, KG; Ramshaw, D; Glang, A				Chrisman, Sara P. D.; Kroshus, Emily; Garrett, Kimberly; Gau, Jeffrey; Harmon, Kimberly G.; Ramshaw, Dane; Glang, Ann			Effectiveness of an Education Platform (GoHuddle) for Increasing Likelihood of Coach Concussion Communication with Athletes	JOURNAL OF NEUROTRAUMA			English	Article						coach; college; communication; concussion; education; online; return to play; sport; symptom reporting	HIGH-SCHOOL; KNOWLEDGE	Research suggests coaches play a central role in establishing a context conducive to concussion reporting, particularly via direct verbal communication about concussion. Informed by qualitative interviews and stakeholder feedback, we developed a web-based concussion education platform for collegiate coaches (GoHuddle). The goal of GoHuddle is to encourage concussion safety-supportive coach communication using behavioral modeling and experiential learning. We then conducted a pre-post survey study to examine the impact of engaging with the platform on coach concussion communication, with outcomes of: (a) expected likelihood of communicating with athletes about concussive symptom reporting; (b) expected likelihood of pressuring medical staff to return athletes to play; and (c) belief in the usefulness of engaging in the communication described in a and b (i.e., response efficacy). We also assessed feasibility and acceptability of the platform in the collegiate sport context. The platform was sent to 435 coaches at five institutions, and 334 (77%) completed surveys (70% male, 37.8 years mean age). After completing GoHuddle, coaches had 2.5 greater odds of expecting to discuss concussion with their team (odds ratio [OR] 2.53, p < 0.001). Response efficacy for talking about concussion also increased significantly post-intervention (OR 3.78, p < 0.001). No significant change was seen in expectancies regarding pressure on medical staff to return athletes to play "as soon as possible." A high proportion (82%) of coaches would recommend this platform for coach concussion education. In conclusion, this study suggests GoHuddle is a feasible and acceptable approach to coach concussion education, and use of this platform holds promise for shifting coach communication about concussion.</p>	[Chrisman, Sara P. D.; Kroshus, Emily; Garrett, Kimberly] Seattle Childrens Res Inst, Seattle, WA 98145 USA; [Chrisman, Sara P. D.; Kroshus, Emily; Harmon, Kimberly G.] Univ Washington, Seattle, WA 98195 USA; [Gau, Jeffrey] Oregon Res Inst, Eugene, OR 97403 USA; [Ramshaw, Dane; Glang, Ann] Univ Oregon, Ctr Brain Injury Res & Training, Eugene, OR 97403 USA		Chrisman, SPD (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371,CW 8-6, Seattle, WA 98145 USA.	sara.chrisman@seattlechildrens.org			Pac-12 Student Athlete Health and Well-Being Initiative	This work was made possible by a grant from the Pac-12 Student Athlete Health and Well-Being Initiative.	Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Beckner BN, 2016, HEALTH COMMUN, V31, P364, DOI 10.1080/10410236.2014.957998; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Chrisman SPD, 2021, J AM COLL HEALTH, DOI 10.1080/07448481.2021.1944166; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroshus E, 2019, HEALTH EDUC BEHAV, V46, P960, DOI 10.1177/1090198119864621; Kroshus E, 2016, CLIN J SPORT MED, V26, P391, DOI 10.1097/JSM.0000000000000272; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P442, DOI 10.1177/1090198115602676; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Mastroleo NR, 2012, ADDICT RES THEORY, V20, P64, DOI 10.3109/16066359.2011.562621; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; MEZIROW J, 1981, ADULT ED, V32, P3, DOI 10.1177/074171368103200101; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; *Seitz C.M., 2014, J ALCOHOL DRUG EDUC, V58, P7, DOI 10.1123/jcsp.2018-0083; The National Collegiate Athletic Association, 2014, 2014 15 NCAA SPORTS, V25th; Weiner BJ, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0635-3; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276	27	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2021	38	22					3119	3125		10.1089/neu.2021.0249		OCT 2021	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	WY7FJ	WOS:000709996500001	34549592				2022-02-06	
J	Hollin, G				Hollin, Gregory			Consider the woodpecker: The contested more-than-human ethics of biomimetic technology and traumatic brain injury	SOCIAL STUDIES OF SCIENCE			English	Article; Early Access						animal models; biomimicry; chronic traumatic encephalopathy; concussion; entanglement; epistemological scaffolding; sport	JUGULAR COMPRESSION COLLAR; SPORTS CONCUSSION; WORKING-MEMORY; ENCEPHALOPATHY; MODEL; MASCULINITY; ACTIVATION; BIOMIMICRY; MEDICINE; BEHAVIOR	Chronic Traumatic Encephalopathy, or CTE, is a neurodegenerative disease caused by traumatic brain injury and most frequently associated with contact sports such as American Football. Perhaps surprisingly, the woodpecker - an animal apparently immune to the effects of head impacts - has increasingly figured into debates surrounding CTE. On the one hand, the woodpecker is described as being contra-human and used to underscore the radical inappropriateness of humans playing football. On the other, there have been attempts to mitigate against the risk of CTE through the creation of biomimetic technologies inspired by woodpeckers. In this article I examine the highly politicized encounters between humans and woodpeckers and discuss how the politics of re-/dis-/en-tanglement during these interspecies relations is rendered meaningful. I show here, first, that those who seek to keep the human and the woodpecker apart envisage social overhaul while biomimetic technologies are put to work for the status quo. Second, I stress that different forms of entanglement have diverse sociopolitical consequences. I conclude by suggesting that the case of the woodpecker troubles a strand of contemporary scholarship in Science and Technology Studies that argues that biotechnologies are inherently transformatory and that foregrounding entanglement and interspecies relations is ethically generative. Instead, a discursive separation of nature and culture may be innovative.	[Hollin, Gregory] Univ Leeds, Leeds, W Yorkshire, England		Hollin, G (corresponding author), Univ Leeds, Sch Sociol & Social Policy, Leeds LS16 6QB, W Yorkshire, England.	g.hollin@leeds.ac.uk					Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Asdal K, 2008, SOC STUD SCI, V38, P899, DOI 10.1177/0306312706098607; Bachynski K., 2019, NO GAME BOYS PLAY HI; Barad K, 2003, SIGNS, V28, P801, DOI 10.1086/345321; Barad K., 2007, M UNIVERSE HALFWAY Q; Barr WB, 2020, CAN PSYCHOL, V61, P151, DOI 10.1037/cap0000210; Birch K, 2013, SCI TECHNOL HUM VAL, V38, P299, DOI 10.1177/0162243912442398; Bonnette S, 2018, EXP BRAIN RES, V236, P2691, DOI 10.1007/s00221-018-5328-x; Carroll Linda, 2012, CONCUSSION CRISIS AN; Casper ST, 2020, SOC SCI MED, V245, DOI 10.1016/j.socscimed.2019.112688; Casper ST, 2019, LANCET NEUROL, V18, P522, DOI 10.1016/S1474-4422(19)30158-9; Casper ST, 2018, HEADACHE, V58, P795, DOI 10.1111/head.13288; Casper ST, 2018, CAN MED ASSOC J, V190, pE140, DOI 10.1503/cmaj.171204; Chivers T., 2009, TELEGRAPH; Daston L., 2019, NATURE UNTIMELY MEDI; Daston L., 2004, MORAL AUTHORITY NATU; Emery N., 2016, BIRD BRAIN EXPLORATI; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Farah G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191526; Fisch M, 2017, SCI TECHNOL HUM VAL, V42, P795, DOI 10.1177/0162243916689599; Float JJ., 2014, Patent No. [2014/0343599, 20140343599]; Float JJ., 2019, Patent No. [10,499,928, 10499928]; Friese C, 2012, SOC STUD SCI, V42, P31, DOI 10.1177/0306312711429995; Furness Z, 2016, POP COMMUN, V14, P49, DOI 10.1080/15405702.2015.1084628; Gabbatiss J., 2018, WOODPECKERS GIVE THE; Garcia-Sancho M, 2019, STUD HIST PHI PART C, V75, P24, DOI 10.1016/j.shpsc.2019.01.002; Giraud E.H., 2019, WHAT COMES ENTANGLEM; Goldstein J, 2015, THEOR CULT SOC, V32, P61, DOI 10.1177/0263276414551032; Haraway D., 2008, SPECIES MEET; Haraway D.J., 1997, MODEST WITNESS 2 MIL; Helmreich S., 2008, SCI CULT-UK, V17, P463, DOI 10.1080/09505430802519256; Hoge M., 2018, BRAINWASHED BAD SCI; Ig Nobel Prizes, IMPR RES; Industrial Designers Society of America, 2017, Q COLL; Johnson E., 2020, TECHNIQUES CULTURE, V23, P13832; Johnson ER, 2015, ENVIRON PLANN D, V33, P296, DOI 10.1068/d23512; Landesman P., 2015, CONCUSSION; Lock M, 2013, ALZHEIMER CONUNDRUM; LYNCH ME, 1988, SOC STUD SCI, V18, P265, DOI 10.1177/030631288018002004; Malcolm D., 2020, CONCUSSION CRISIS SP; Mannix R, 2020, NEUROSCIENCE, V437, P132, DOI 10.1016/j.neuroscience.2020.04.009; Martin A, 2020, BIOSOCIETIES, DOI 10.1057/s41292-020-00209-1; Masco Joseph, 2006, NUCL BORDERLANDS MAN; MAY PRA, 1976, LANCET, V1, P1347; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; McGoey L, 2012, ECON SOC, V41, P1, DOI 10.1080/03085147.2011.637330; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Michael M, 2003, TIME SOC, V12, P127, DOI 10.1177/0961463X03012001372; Myer GD., 2014, NEW YORK TIMES, P19; Myer GD, 2019, BRIT J SPORT MED, V53, P1539, DOI 10.1136/bjsports-2018-099571; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Myer GD, 2014, J ORTHOP SPORT PHYS, V44, P164, DOI 10.2519/jospt.2014.5298; Myers Natasha, 2015, RENDERING LIFE MOL M; Nadis S, 2006, NATURE, V443, P616, DOI 10.1038/443616b; Nelson N., 2018, MODEL BEHAV ANIMAL E; Nelson NC, 2013, SOC STUD SCI, V43, P3, DOI 10.1177/0306312712463815; Nowinski C., 2007, HEAD GAMES FOOTBALLS; O'Connor M., 2007, WHY DONT WOODPECKERS; Omalu B., 2017, TRUTH DOESNT HAVE SI; Omalu B., 2020, WE ARE BECOMING NATI; Omalu B., 2008, PLAY HARD YOUNG FOOT; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Patricios JS, 2014, BRIT J SPORT MED, V48, P76, DOI 10.1136/bjsports-2013-093031; Paxson H, 2014, SOC STUD SCI, V44, P165, DOI 10.1177/0306312713505003; Person J., 2018, 2 YEARS LATER L KUEN; Q Collar Canada, NATURE TELLS US THER; Roosth Sophia, 2017, SYNTHETIC LIFE GOT M; Rotolo T, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113491; Roy D., 2018, MOL FEMINISMS BIOL B; Sandel E., 2020, SHAKEN BRAIN SCI CAR; Schrader A., 2017, CATALYST FEMINISM TH, V3, P1; Schwab IR, 2002, BRIT J OPHTHALMOL, V86, P843, DOI 10.1136/bjo.86.8.843; Schwab IR, 2012, EVOLUTIONS WITNESS E; Sindelar B, 2017, J NEUROTRAUM, V34, P1703, DOI 10.1089/neu.2016.4648; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Smith DH, 2016, LANCET NEUROL, V15, P662, DOI 10.1016/S1474-4422(16)30037-0; Smith DW., 2018, Method to reduce slosh energy absorption and its damaging effects through the reduction of inelastic collisions in an organism, Patent No. [9,987,020, 9987020]; Smith DW., 2014, Methods and devices to reduce the likelihood of injury from concussive or blast forces, Patent No. [8,900,169, 8900169]; Smoliga JM, 2019, BRIT J SPORT MED, V53, DOI 10.1136/bjsports-2018-099594; Smoliga JM, 2018, LANCET NEUROL, V17, P500, DOI 10.1016/S1474-4422(18)30157-1; Smoliga JM, 2017, EPIDEMIOLOGY, V28, P753, DOI 10.1097/EDE.0000000000000694; Smoliga JM, 2017, J APPL PHYSIOL, V122, P215, DOI 10.1152/japplphysiol.00661.2016; STAR SL, 1983, SOC STUD SCI, V13, P205, DOI 10.1177/030631283013002002; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; The Columbus Dispatch, 2017, NEW DEV AIMS PREV CO; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; van Dooren T, 2016, THEOR CULT SOC, V33, P29, DOI 10.1177/0263276415571941; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; Wang LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026490; Wheeler S., 2017, TEASPOON BLOOD MAY H; Whitlock J., 2015, FOOTBALL IS ATTACK; Yuan WH, 2018, J NEUROTRAUM, V35, P1248, DOI 10.1089/neu.2017.5262; Yuan WH, 2019, J NEUROTRAUM, V36, P721, DOI 10.1089/neu.2018.5737; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859; Yuan WH, 2017, J NEUROTRAUM, V34, P2432, DOI 10.1089/neu.2016.4834	96	0	0	3	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0306-3127	1460-3659		SOC STUD SCI	Soc. Stud. Sci.											03063127211052513	10.1177/03063127211052513		OCT 2021	25	History & Philosophy Of Science	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	History & Philosophy of Science	WP6OM	WOS:000713248500001	34657493	Green Accepted			2022-02-06	
J	Kreitzer, N; Jain, S; Young, JS; Sun, XY; Stein, MB; McCrea, MA; Levin, HS; Giacino, JT; Markowitz, AJ; Manley, GT; Nelson, LD				Kreitzer, Natalie; Jain, Sonia; Young, Jacob S.; Sun, Xiaoying; Stein, Murray B.; McCrea, Michael A.; Levin, Harvey S.; Giacino, Joseph T.; Markowitz, Amy J.; Manley, Geoffrey T.; Nelson, Lindsay D.		Transforming Res Clinical Knowledg	Comparing the Quality of Life after Brain Injury-Overall Scale and Satisfaction with Life Scale as Outcome Measures for Traumatic Brain Injury Research	JOURNAL OF NEUROTRAUMA			English	Article						common data elements; friend controls; Glasgow Coma Scale; health related quality of life; orthopedic trauma controls; Quality of Life after Brain Injury Overall Score; Satisfaction with Life Survey; traumatic brain injury	SUBJECTIVE COGNITIVE COMPLAINTS; 1ST 5 YEARS; UNITED-STATES; HEALTH; QOLIBRI; MILD; VALIDATION; RECOMMENDATIONS; TRAJECTORIES; DISABILITY	It is important to measure quality of life (QoL) after traumatic brain injury (TBI), yet limited studies have compared QoL inventories. In 2579 TBI patients, orthopedic trauma controls, and healthy friend control participants, we compared the Quality of Life After Brain Injury-Overall Scale (QOLIBRI-OS), developed for TBI patients, to the Satisfaction with Life Scale (SWLS), an index of generic life satisfaction. We tested the hypothesis that group differences (TBI and orthopedic trauma vs. healthy friend controls) would be larger for the QOLIBRI-OS than the SWLS and that the QOLIBRI-OS would manifest more substantial changes over time in the injured groups, demonstrating more relevance of the QOLIBRI-OS to traumatic injury recovery. (1) We compared the group differences (TBI vs. orthopedic trauma control vs. friend control) in QoL as indexed by the SWLS versus the QOLIBRI-OS and (2) characterized changes across time in these two inventories across 1 year in these three groups. Our secondary objective was to characterize the relationship between TBI severity and QoL. As compared with healthy friend controls, the QOLIBRI reflected greater reductions in QoL than the SWLS for both the TBI group (all time points) and the orthopedic trauma control group (2 weeks and 3 months). The QOLIBRI-OS better captured expected improvements in QoL during the injury recovery course in injured groups than the SWLS, which demonstrated smaller changes over time. TBI severity was not consistently or robustly associated with self-reported QoL. The findings imply that, as compared with the SWLS, the QOLIBRI-OS appears to identify QoL issues more specifically relevant to traumatically injured patients and may be a more appropriate primary QoL outcome measure for research focused on the sequelae of traumatic injuries.</p>	[Kreitzer, Natalie] Univ Cincinnati, Dept Emergency Med, Med Sci Bldg,Room 1654,231 Albert Sabin Way, Cincinnati, OH 45267 USA; [Jain, Sonia; Sun, Xiaoying] Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth & Human Longev Sci, Biostat Res Ctr, La Jolla, CA 92093 USA; [Young, Jacob S.; Markowitz, Amy J.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Psychiat & Family Med, San Diego, CA 92103 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Publ Hlth, San Diego, CA 92103 USA; [McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Giacino, Joseph T.] Harvard Med Sch, Dept Phys Med & Rehabil, Charlestown, MA USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Charlestown, MA USA		Kreitzer, N (corresponding author), Univ Cincinnati, Dept Emergency Med, Med Sci Bldg,Room 1654,231 Albert Sabin Way, Cincinnati, OH 45267 USA.; Markowitz, AJ (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, Zuckerberg San Francisco Gen Hosp & Trauma Ctr, 1001 Potreo Ave,Bldg 1 Rm 101,Box 0899, San Francisco, CA 94143 USA.	kreitzne@ucmail.uc.edu; amymarkowitz@gmail.com	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698	United States National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01NS1365885, R01NS110856]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [W81XWH-14-2-0176]; United States Department of Defense TBI Endpoints Development (TED) Initiative	This study was funded by the United States National Institutes of Health (NIH), NINDS (Grants # U01NS1365885 and# R01NS110856),OneMind,COMPARING QOLIBRI-OS AND SWLS IN TBI RESEARCH9 nbsp; nbsp;and NeuroTrauma Sciences LLC. This work was also supported by the United States Department of Defense TBI Endpoints Development (TED) Initiative (Grant #W81XWH-14-2-0176). The manuscripts contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH and are not necessarily endorsed by the Department of Defense.	Agtarap SD, 2021, J NEUROTRAUM, V38, P546, DOI 10.1089/neu.2020.7055; Albrecht GL, 1999, SOC SCI MED, V48, P977, DOI 10.1016/S0277-9536(98)00411-0; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Castano-Leon AM, 2018, EVAL HEALTH PROF, V41, P456, DOI 10.1177/0163278717702696; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 1998, PSYCHOL INQ, V9, P33, DOI 10.1207/s15327965pli0901_3; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Elliott TR, 2017, J CLIN PSYCHOL, V73, P1160, DOI 10.1002/jclp.22414; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Giustini M, 2014, FUNCT NEUROL, V29, P167, DOI 10.11138/FNeur/2014.29.3.167; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Groswasser Z, 2018, BRAIN INJURY, V32, P879, DOI 10.1080/02699052.2018.1466196; Harfmann EJ, 2020, J NEUROTRAUM, V37, P1408, DOI 10.1089/neu.2019.6746; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Jacobsson L, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0405-y; Jacobsson L, 2013, J REHABIL MED, V45, P1010, DOI 10.2340/16501977-1204; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; JENNETT B, 1975, LANCET, V1, P480; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Kreitzer NP, 2019, J HEAD TRAUMA REHAB, V34, pE10, DOI 10.1097/HTR.0000000000000457; Lin YN, 2016, J NEUROTRAUM, V33, P1363, DOI 10.1089/neu.2015.4094; Lin YN, 2014, J HEAD TRAUMA REHAB, V29, pE37, DOI 10.1097/HTR.0b013e3182816363; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Munivenkatappa A, 2017, INDIAN J MED RES, V146, P77, DOI 10.4103/ijmr.IJMR_1245_14; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Ngwenya LB, 2018, BRAIN INJURY, V32, P1071, DOI 10.1080/02699052.2018.1481527; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Proctor CJ, 2019, DISABIL HEALTH J, V12, P387, DOI 10.1016/j.dhjo.2019.01.001; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Sloan JA, 2011, CANCER J, V17, P63, DOI 10.1097/PPO.0b013e31820e15dc; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stenberg J, 2020, NEUROPSYCHOLOGY, V34, P560, DOI 10.1037/neu0000632; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuechel N, 2005, CURR OPIN NEUROL, V18, P681, DOI 10.1097/01.wco.0000194140.56429.75; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; WAGNER AK, 1995, QUAL LIFE RES, V4, P169, DOI 10.1007/BF01833610; Wanner JP, 2015, J TRAUMA ACUTE CARE, V79, P275, DOI 10.1097/TA.0000000000000749; Wiebe S, 2003, J CLIN EPIDEMIOL, V56, P52, DOI 10.1016/S0895-4356(02)00537-1; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287	56	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2021	38	23					3352	3363		10.1089/neu.2020.7546		OCT 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XJ2CB	WOS:000709978000001	34435894				2022-02-06	
J	Li, XG				Li, Xiaogai			Subject-Specific Head Model Generation by Mesh Morphing: A Personalization Framework and Its Applications	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article						finite element modeling; personalized simulation; traumatic brain injury; brain stimulation; neuroimage registration; biomechanics	ACUTE SUBDURAL-HEMATOMA; FINITE-ELEMENT MODELS; IMAGE REGISTRATION; ELECTRIC-FIELD; BRAIN; NEURODEGENERATION; ALGORITHMS; PREDICTION; STRAIN; IMPACT	Finite element (FE) head models have become powerful tools in many fields within neuroscience, especially for studying the biomechanics of traumatic brain injury (TBI). Subject-specific head models accounting for geometric variations among subjects are needed for more reliable predictions. However, the generation of such models suitable for studying TBIs remains a significant challenge and has been a bottleneck hindering personalized simulations. This study presents a personalization framework for generating subject-specific models across the lifespan and for pathological brains with significant anatomical changes by morphing a baseline model. The framework consists of hierarchical multiple feature and multimodality imaging registrations, mesh morphing, and mesh grouping, which is shown to be efficient with a heterogeneous dataset including a newborn, 1-year-old (1Y), 2Y, adult, 92Y, and a hydrocephalus brain. The generated models of the six subjects show competitive personalization accuracy, demonstrating the capacity of the framework for generating subject-specific models with significant anatomical differences. The family of the generated head models allows studying age-dependent and groupwise brain injury mechanisms. The framework for efficient generation of subject-specific FE head models helps to facilitate personalized simulations in many fields of neuroscience.	[Li, Xiaogai] KTH Royal Inst Technol, Dept Biomed Engn & Hlth Syst, Div Neuron Engn, Stockholm, Sweden		Li, XG (corresponding author), KTH Royal Inst Technol, Dept Biomed Engn & Hlth Syst, Div Neuron Engn, Stockholm, Sweden.	xiaogai@kth.se			KTH Royal Institute of Technology; 16 NIH Institutes and CentersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Clinical Center (CC) [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University; Swedish National Infrastructure for Computing(SNIC) [SNIC 2021/5-406, SNIC 2021/5-459]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2018-05973]	Open access funding provided by KTH Royal Institute of Technology. The author thanks the reviewers whose valuable comments and suggestions significantly improved the quality of the manuscript. This work benefits greatly from the open-source imaging dataset and registration algorithms within the neuro imaging field. The WUM HCP data of the adult subject used in this study were provided [in part] by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and KamilUgurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. The data handling was enabled by resources in projects [SNIC 2021/5-406] and [SNIC 2021/5-459]provided by the Swedish National Infrastructure for Computing(SNIC) at PDC, partially funded by the Swedish Research Council through grant agreement no. 2018-05973	Aimedieu P, 2004, J NEUROSURG, V100, P111, DOI 10.3171/jns.2004.100.1.0111; Alekseichuk I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10581-7; Atsumi N., 2016, INT J VEH SAF, V9, P1, DOI [10.1504/ijvs.2016.077145, DOI 10.1504/IJVS.2016.077145]; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Baker TJ, 2005, PROG AEROSP SCI, V41, P29, DOI 10.1016/j.paerosci.2005.02.002; Beillas P, 2017, TRAFFIC INJ PREV, V18, pS142, DOI 10.1080/15389588.2017.1307971; Bijar A, 2016, ANN BIOMED ENG, V44, P16, DOI 10.1007/s10439-015-1497-y; Bucki M, 2010, MED IMAGE ANAL, V14, P303, DOI 10.1016/j.media.2010.02.003; Castellano-Smith A.D., 2001, MED IMAGE COMPUTING; Couteau B, 2000, J BIOMECH, V33, P1005, DOI 10.1016/S0021-9290(00)00055-5; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; Davis Matthew L, 2016, Stapp Car Crash J, V60, P509; Dickie D.A., 2016, **DATA OBJECT**, DOI [10.7488/ds/1369, DOI 10.7488/DS/1369]; Fernandez JW, 2004, BIOMECH MODEL MECHAN, V2, P139, DOI [10.1007/s10237-003-0036-1, 10.1007/S10237-003-0036-1]; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Fornari S, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0356; Giordano C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187916; Giudice JS, 2021, FRONT BIOENG BIOTECH, V9, DOI 10.3389/fbioe.2021.664268; Giudice JS, 2020, ANN BIOMED ENG, V48, P2412, DOI 10.1007/s10439-020-02584-z; Giudice JS, 2019, ANN BIOMED ENG, V47, P1855, DOI 10.1007/s10439-018-02161-5; Hajiaghamemar M, 2019, INT J LEGAL MED, V133, P847, DOI 10.1007/s00414-018-1918-1; Ho J, 2017, J BIOMECH, V60, P243, DOI 10.1016/j.jbiomech.2017.06.023; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Horstemeyer MF, 2019, ANN BIOMED ENG, V47, P1829, DOI 10.1007/s10439-019-02351-9; Hu JW, 2007, J NEUROSURG, V106, P164, DOI 10.3171/jns.2007.106.1.164; Huang Y, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066004; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2011, FINITE ELEM ANAL DES, V47, P1178, DOI 10.1016/j.finel.2011.05.007; Ji SB, 2009, MED IMAGE ANAL, V13, P659, DOI 10.1016/j.media.2009.05.007; Kim M, 2015, NEUROIMAGE, V105, P257, DOI 10.1016/j.neuroimage.2014.10.019; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Legon W, 2014, NAT NEUROSCI, V17, P322, DOI 10.1038/nn.3620; Li NF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16734-3; Li X., 2015, ADV BIOMED SCI ENG, V2015, P1, DOI 10.15764/abse.2015.01001; Li XG, 2021, BIOMECH MODEL MECHAN, V20, P403, DOI 10.1007/s10237-020-01391-8; Li XG, 2019, FORENSIC SCI INT, V294, P173, DOI 10.1016/j.forsciint.2018.11.008; Li XG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33393-z; Li XG, 2017, BIOMECH MODEL MECHAN, V16, P823, DOI 10.1007/s10237-016-0855-5; Li ZG, 2011, ANN BIOMED ENG, V39, P2984, DOI 10.1007/s10439-011-0409-z; Liu SY, 2020, SHOCK VIB, V2020, DOI 10.1155/2020/8582732; Madhukar A, 2019, ANN BIOMED ENG, V47, P1832, DOI 10.1007/s10439-019-02205-4; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2013, COMPUT METHOD BIOMEC, V16, P271, DOI 10.1080/10255842.2011.617005; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Miller K, 2010, INT J NUMER METH BIO, V26, P117, DOI 10.1002/cnm.1260; Montanino A., 2021, BRAIN MULTIPHYSICS, V2, DOI [10.1016/j.brain.2021.100027, DOI 10.1016/J.BRAIN.2021.100027]; Noel L, 2019, COMPUT MECH, V64, P1375, DOI 10.1007/s00466-019-01717-z; Opitz A, 2015, NEUROIMAGE, V109, P140, DOI 10.1016/j.neuroimage.2015.01.033; Opitz A, 2013, NEUROIMAGE, V81, P253, DOI 10.1016/j.neuroimage.2013.04.067; Ou YM, 2014, IEEE T MED IMAGING, V33, P2039, DOI 10.1109/TMI.2014.2330355; Ou YM, 2011, MED IMAGE ANAL, V15, P622, DOI 10.1016/j.media.2010.07.002; Park G, 2017, COMPUT METHOD BIOMEC, V20, P1151, DOI 10.1080/10255842.2017.1340459; Pedersen K, 2015, NEUROEPIDEMIOLOGY, V45, P20, DOI 10.1159/000381780; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Shepherd JF, 2008, ENG COMPUT-GERMANY, V24, P195, DOI 10.1007/s00366-008-0091-4; Shi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018746; Sigal IA, 2008, J BIOMECH, V41, P1381, DOI 10.1016/j.jbiomech.2008.02.019; Takhounts EG, 2008, STAPP CAR C, V52, P1; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; VANNOORT R, 1981, BIOMATERIALS, V2, P41, DOI 10.1016/0142-9612(81)90086-7; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; von Holst H, 2014, ACTA NEUROCHIR, V156, P1961, DOI 10.1007/s00701-014-2195-5; von Holst H, 2013, J APPL MATH, DOI 10.1155/2013/350359; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; Wang T., 2020, ELECTROOSMOSIS BASED; Weickenmeier J, 2017, J ELASTICITY, V129, P197, DOI 10.1007/s10659-016-9606-1; Weickenmeier J, 2019, J MECH PHYS SOLIDS, V124, P264, DOI 10.1016/j.jmps.2018.10.013; Windhoff M, 2013, HUM BRAIN MAPP, V34, P923, DOI 10.1002/hbm.21479; Wu J, 2019, MED ENG PHYS, V70, P62, DOI 10.1016/j.medengphy.2019.04.007; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhou Z, 2019, J NEUROTRAUM, V36, P2099, DOI 10.1089/neu.2018.6143; Zhou Z, 2020, J BIOMECH, V105, DOI 10.1016/j.jbiomech.2020.109787; Zollei L, 2020, NEUROIMAGE, V218, DOI 10.1016/j.neuroimage.2020.116946	76	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.	OCT 18	2021	9								706566	10.3389/fbioe.2021.706566			17	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	WS6WW	WOS:000715320300001	34733827	Green Published, gold			2022-02-06	
J	Rajagopalan, S; Baker, W; Mahanna-Gabrielli, E; Kofke, AW; Balu, R				Rajagopalan, Swarna; Baker, Wesley; Mahanna-Gabrielli, Elizabeth; Kofke, Andrew William; Balu, Ramani			Hierarchical Cluster Analysis Identifies Distinct Physiological States After Acute Brain Injury	NEUROCRITICAL CARE			English	Article; Early Access						Multimodality neuromonitoring; Cluster analysis; Bioinformatics; Neurocritical care; Big data	LACTATE; MICRODIALYSIS; METABOLISM	Background Analysis of intracranial multimodality monitoring data is challenging, and quantitative methods may help identify unique physiological signatures that inform therapeutic strategies and outcome prediction. The aim of this study was to test the hypothesis that data-driven approaches can identify distinct physiological states from intracranial multimodality monitoring data. Methods This was a single-center retrospective observational study of patients with either severe traumatic brain injury or high-grade subarachnoid hemorrhage who underwent invasive multimodality neuromonitoring. We used hierarchical cluster analysis to group hourly values for heart rate, mean arterial pressure, intracranial pressure, brain tissue oxygen, and cerebral microdialysis across all included patients into distinct groups. Average values for measured physiological variables were compared across the identified clusters, and physiological profiles from identified clusters were mapped onto physiological states known to occur after acute brain injury. The distribution of clusters was compared between patients with favorable outcome (discharged to home or acute rehab) and unfavorable outcome (in-hospital death or discharged to chronic nursing facility). Results A total of 1704 observations from 20 patients were included. Even though the difference in mean values for measured variables between patients with favorable and unfavorable outcome were small, we identified four distinct clusters within our data: (1) events with low brain tissue oxygen and high lactate-to-pyruvate ratio-values (consistent with cerebral ischemia), (2) events with higher intracranial pressure values without evidence for ischemia (3) events which appeared to be physiologically "normal," and (4) events with high cerebral lactate without brain hypoxia (consistent with cerebral hyperglycolysis). Patients with a favorable outcome had a greater proportion of cluster 3 (normal) events, whereas patients with an unfavorable outcome had a greater proportion of cluster 1 (ischemia) and cluster 4 (hyperglycolysis) events (p < 0.0001, Fisher-Freeman-Halton test). Conclusions A data-driven approach can identify distinct groupings from invasive multimodality neuromonitoring data that may have implications for therapeutic strategies and outcome predictions. These groupings could be used as classifiers to train machine learning models that can aid in the treatment of patients with acute brain injury. Further work is needed to replicate the findings of this exploratory study in larger data sets.	[Rajagopalan, Swarna] Rowan Univ, Dept Neurol, Cooper Med Sch, Camden, NJ 08102 USA; [Baker, Wesley] Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA USA; [Mahanna-Gabrielli, Elizabeth] Univ Miami, Miller Sch Med, Dept Anesthesiol Perioperat Med & Pain Management, Miami, FL 33136 USA; [Kofke, Andrew William] Univ Penn, Dept Anesthesiol & Crit Care Med, Perelman Sch Med, Philadelphia, PA USA; [Balu, Ramani] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA		Rajagopalan, S (corresponding author), Rowan Univ, Dept Neurol, Cooper Med Sch, Camden, NJ 08102 USA.; Balu, R (corresponding author), Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA.	Rajagopalan-swarna@cooperhealth.edu; ramani.balu@uphs.upenn.edu	Rajagopalan, Swarna/U-4733-2019	Rajagopalan, Swarna/0000-0002-0490-503X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS08230901A1, NS082309, NS060653]	This work received National Institutes of Health (Grant Nos. 1R01NS08230901A1, NS082309, NS060653).	Amorim E, 2019, CLIN NEUROPHYSIOL, V130, P1908, DOI 10.1016/j.clinph.2019.07.014; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Boluki S, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2832-3; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P133, DOI 10.1097/MCC.0000000000000072; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Calinski TT., 1974, COMMUN STAT, V3, P1, DOI 10.1080/03610927408827101; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Carteron L, 2018, CRIT CARE MED, V46, P1649, DOI 10.1097/CCM.0000000000003274; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Claassen J, 2019, NEW ENGL J MED, V380, P2497, DOI 10.1056/NEJMoa1812757; Cohen MJ, 2010, CRIT CARE, V14, DOI 10.1186/cc8864; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Diedler J, 2010, NEUROCRIT CARE, V12, P313, DOI 10.1007/s12028-010-9350-5; Giannini HM, 2019, CRIT CARE MED, V47, P1485, DOI 10.1097/CCM.0000000000003891; Hand DJ, 2007, DRUG SAFETY, V30, P621, DOI 10.2165/00002018-200730070-00010; Knopf L, 2012, NEUROCRIT CARE, V16, P63, DOI 10.1007/s12028-011-9620-x; Kofke WA, 2020, J NEUROSURG ANESTH, V32, P120, DOI 10.1097/ANA.0000000000000609; Kofke WA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00497; Larach DB, 2011, NEUROCRIT CARE, V15, P609, DOI 10.1007/s12028-011-9517-8; Lazaridis C, 2019, NEUROPHARMACOLOGY, V145, P145, DOI 10.1016/j.neuropharm.2018.06.005; Le Roux P, 2014, CURR OPIN CRIT CARE, V20, P141, DOI 10.1097/MCC.0000000000000078; Magistretti PJ, 2018, NAT REV NEUROSCI, V19, P235, DOI 10.1038/nrn.2018.19; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Oddo M, 2009, STROKE, V40, P1913, DOI 10.1161/STROKEAHA.108.534115; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; Roh D, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0659-0; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Schinkel M, 2019, COMPUT BIOL MED, V115, DOI 10.1016/j.compbiomed.2019.103488; Sorani MD, 2007, NEUROCRIT CARE, V7, P45, DOI 10.1007/s12028-007-0043-7; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Tjepkema-Cloostermans MC, 2019, CRIT CARE MED, V47, P1424, DOI 10.1097/CCM.0000000000003854; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Young B, 2019, NEUROCRIT CARE, V31, P88, DOI 10.1007/s12028-019-00670-2; Zeiler FA, 2020, J NEUROTRAUM, V37, P1854, DOI 10.1089/neu.2020.7024; Zhang Y, 2008, J BIOMED INFORM, V41, P452, DOI 10.1016/j.jbi.2008.03.011	39	0	0	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01362-6		OCT 2021	10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WI5ER	WOS:000708383700001	34661861				2022-02-06	
J	Verga, L; Schwartze, M; Stapert, S; Winkens, I; Kotz, SA				Verga, Laura; Schwartze, Michael; Stapert, Sven; Winkens, Ieke; Kotz, Sonja A.			Dysfunctional Timing in Traumatic Brain Injury Patients: Co-occurrence of Cognitive, Motor, and Perceptual Deficits	FRONTIERS IN PSYCHOLOGY			English	Article						traumatic brain injury; timing; attention; sensorimotor synchronization; processing speed; SDMT = Symbol Digit Modalities Test; Digit Span	TIME PERCEPTION; SENSORIMOTOR SYNCHRONIZATION; ATTENTION; MEMORY; MECHANISMS; EPIDEMIOLOGY; IMPAIRMENT; MODERATE; LESIONS; IMPACT	Timing is an essential part of human cognition and of everyday life activities, such as walking or holding a conversation. Previous studies showed that traumatic brain injury (TBI) often affects cognitive functions such as processing speed and time-sensitive abilities, causing long-term sequelae as well as daily impairments. However, the existing evidence on timing capacities in TBI is mostly limited to perception and the processing of isolated intervals. It is therefore open whether the observed deficits extend to motor timing and to continuous dynamic tasks that more closely match daily life activities. The current study set out to answer these questions by assessing audio motor timing abilities and their relationship with cognitive functioning in a group of TBI patients (n = 15) and healthy matched controls. We employed a comprehensive set of tasks aiming at testing timing abilities across perception and production and from single intervals to continuous auditory sequences. In line with previous research, we report functional impairments in TBI patients concerning cognitive processing speed and perceptual timing. Critically, these deficits extended to motor timing: The ability to adjust to tempo changes in an auditory pacing sequence was impaired in TBI patients, and this motor timing deficit covaried with measures of processing speed. These findings confirm previous evidence on perceptual and cognitive timing deficits resulting from TBI and provide first evidence for comparable deficits in motor behavior. This suggests basic co-occurring perceptual and motor timing impairments that may factor into a wide range of daily activities. Our results thus place TBI into the wider range of pathologies with well-documented timing deficits (such as Parkinson's disease) and encourage the search for novel timing-based therapeutic interventions (e.g., employing dynamic and/or musical stimuli) with high transfer potential to everyday life activities.	[Verga, Laura] Max Planck Inst Psycholinguist, Res Grp Comparat Bioacoust, Nijmegen, Netherlands; [Verga, Laura; Schwartze, Michael; Stapert, Sven; Winkens, Ieke; Kotz, Sonja A.] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [Stapert, Sven] Zuyderland Med Ctr, Dept Med Psychol, Sittard, Netherlands; [Winkens, Ieke] Maastricht Univ, Limburg Brain Injury Ctr, Maastricht, Netherlands		Verga, L (corresponding author), Max Planck Inst Psycholinguist, Res Grp Comparat Bioacoust, Nijmegen, Netherlands.; Verga, L; Kotz, SA (corresponding author), Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands.	laura.verga@mpi.nl; sonja.kotz@maastrichtuniversity.nl		Verga, Laura/0000-0001-8957-5027			Allman M. J., 2015, TIME DISTORTIONS MIN, P37, DOI [10.1163/9789004230699_003, DOI 10.1163/9789004230699_003, DOI 10.1163/J.CTT1W8H2WK.7]; Anderson JW, 2011, NEUROPSYCHOLOGY, V25, P36, DOI 10.1037/a0020333; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Bader F, 2019, CORTEX, V119, P215, DOI 10.1016/j.cortex.2019.04.019; Bakker M, 2014, PSYCHOL METHODS, V19, P409, DOI 10.1037/met0000014; Barwood CHS, 2013, BRAIN INJURY, V27, P671, DOI 10.3109/02699052.2013.775500; Begel V, 2018, ANN PHYS REHABIL MED, V61, P395, DOI 10.1016/j.rehab.2018.04.001; Bella SD, 2017, BEHAV RES METHODS, V49, P1128, DOI 10.3758/s13428-016-0773-6; Benoit CE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00494; Bruijel J, 2018, JMIR RES PROTOC, V7, P137, DOI 10.2196/11295; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Church R.M., 2003, METH NE FRO NEUROSCI, P3, DOI 10.1201/9780203009574.SEC1; CHURCH RM, 1984, ANN NY ACAD SCI, V423, P566, DOI 10.1111/j.1749-6632.1984.tb23459.x; Dalla Bella S, 2018, NEUROPHYSIOL CLIN, V48, P377, DOI 10.1016/j.neucli.2018.10.067; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Falter CM, 2012, Q J EXP PSYCHOL, V65, P2093, DOI 10.1080/17470218.2012.690770; Falter CM, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00026; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Gibbon J., 1984, TIMING TIME PERCEPTI; Grondin S, 2018, SPRINGER HBK, P423, DOI 10.1007/978-3-662-55004-5_21; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Honing H, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00475; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kotz SA, 2015, ANN NY ACAD SCI, V1337, P62, DOI 10.1111/nyas.12657; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Large EW, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00159; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MATES J, 1994, BIOL CYBERN, V70, P475, DOI 10.1007/s004220050050; McAuley JD, 2006, J EXP PSYCHOL GEN, V135, P348, DOI 10.1037/0096-3445.135.3.348; McAuley JD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0401; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Mioni G, 2013, BRAIN COGNITION, V81, P305, DOI 10.1016/j.bandc.2012.12.005; Mioni G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00269; Mioni G, 2013, J CLIN EXP NEUROPSYC, V35, P90, DOI 10.1080/13803395.2012.755151; Mioni G, 2012, J INT NEUROPSYCH SOC, V18, P697, DOI 10.1017/S1355617712000306; Nombela C, 2013, NEUROSCI BIOBEHAV R, V37, P2564, DOI 10.1016/j.neubiorev.2013.08.003; OBoyle DJ, 1996, BRAIN, V119, P51, DOI 10.1093/brain/119.1.51; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perbal S, 2003, NEUROPSYCHOLOGIA, V41, P1599, DOI 10.1016/S0028-3932(03)00110-6; Piras F, 2014, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00217; Pouthas V, 2004, ACTA NEUROBIOL EXP, V64, P367; R Core Team, 2020, R LANG ENV STAT COMP; Rathcke T, 2021, LAB PHONOL, V12, DOI 10.5334/labphon.248; Repp BH, 2004, Q J EXP PSYCHOL-A, V57, P499, DOI 10.1080/02724980343000369; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; RStudio Team, 2020, RSTUDIO INT DEV ENV; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schwartz MF, 1998, NEUROPSYCHOLOGY, V12, P13, DOI 10.1037/0894-4105.12.1.13; Schwartze M, 2013, NEUROSCI BIOBEHAV R, V37, P2587, DOI 10.1016/j.neubiorev.2013.08.005; Schwartze M, 2011, BEHAV BRAIN RES, V216, P685, DOI 10.1016/j.bbr.2010.09.015; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith A., 1982, SYMBOL DIGIT MODALIT; Toplak M, 2005, J ABNORM CHILD PSYCH, V33, P639, DOI 10.1007/s10802-005-6743-6; TUKEY JW, 1958, ANN MATH STAT, V29, P614; Vorberg D., 1996, HDB PERCEPTION ACTIO, V2, P181, DOI DOI 10.1016/S1874-5822(06)80007-1; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; WING AM, 1973, PERCEPT PSYCHOPHYS, V13, P455, DOI 10.3758/BF03205802; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2	68	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	OCT 18	2021	12								731898	10.3389/fpsyg.2021.731898			10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	WS6IU	WOS:000715283400001	34733208	gold, Green Published			2022-02-06	
J	Kim, MS; Cho, MJ; Kim, JW; Jang, SH				Kim, Min Son; Cho, Min Jye; Kim, Jae Woon; Jang, Sung Ho			White Matter Abnormalities in Traumatic Subarachnoid Hemorrhage: A Tract-Based Spatial Statistics Study	MEDICAL SCIENCE MONITOR			English	Article						Anisotropy; Diffusion Tensor Imaging; Spatial Analysis; Subarachnoid Hemorrhage; Traumatic	DIFFUSE AXONAL INJURY; BRAIN-INJURY; HEAD-INJURY; CORTICOSPINAL TRACT; CEREBRAL VASOSPASM; COGNITIVE IMPAIRMENT; CONSORTIUM SURVEY; TENSOR; PATIENT; INTEGRITY	Background: The pathophysiology of traumatic subarachnoid hemorrhage and brain injury has not been fully elucidated. In this study, we examined abnormalities of white matter in isolated traumatic subarachnoid hemorrhage patients by applying tract-based spatial statistics. Material/Methods: For this study, 10 isolated traumatic subarachnoid hemorrhage patients and 10 age-and sex-matched healthy control subjects were recruited. Fractional anisotropy data voxel-wise statistical analyses were conducted through the tract-based spatial statistics as implemented in the FMRIB Software Library. Depending on the intersection between the fractional anisotropy skeleton and the probabilistic white matter atlases of Johns Hopkins University, we calculated mean fractional anisotropy values within the entire tract skeleton and 48 regions of interest. Results: The fractional anisotropy values for 19 of 48 regions of interest showed significant divergences (P<0.05) between the patient group and control group. The regions showing significant differences included the corpus callosum and its adjacent neural structures, the brainstem and its adjacent neural structures, and the subcortical white matter that passes the long neural tract. Conclusions: The results demonstrated abnormalities of white matter in traumatic subarachnoid hemorrhage patients, and the abnormality locations are compatible with areas that are vulnerable to diffuse axonal injury. Based on these results, traumatic subarachnoid hemorrhage patients also exhibit diffuse axonal injuries; thus, traumatic subarachnoid hemorrhage could be an indicator of the presence of severe brain injuries associated with acute or excessive mechanical forces.	[Kim, Min Son; Cho, Min Jye; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu, South Korea; [Kim, Jae Woon] Yeungnam Univ, Coll Med, Dept Radiol, Taegu, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu, South Korea.				National Research Foundation of Korea (NRF) - Korean government (MSIP) [2021R1A2B5B01001386]	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2021R1A2B5B01001386)	Abraham MK, 2016, EMERG MED CLIN N AM, V34, P901, DOI 10.1016/j.emc.2016.06.011; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Aminmansour B, 2009, J RES MED SCI, V14, P343; Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Benson C., 2014, ENCY NEUROLOGICAL SC, V2nd, P998, DOI [10.1016/B978-0-12-385157-4.00326-2, DOI 10.1016/B978-0-12-385157-4.00326-2]; Chestnut RM, 1993, P 8 INT S INTR PRESS, P503; Cho MJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86439-0; Choi JY, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101785; Chung S, 2018, J NEUROTRAUM, V35, P1015, DOI 10.1089/neu.2017.5320; Darwazeh R, 2018, WORLD NEUROSURG, V114, pE624, DOI 10.1016/j.wneu.2018.03.042; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fukuda T, 1998, NEUROSURGERY, V43, P1040, DOI 10.1097/00006123-199811000-00022; GOMEZ CR, 1991, SURG NEUROL, V35, P30, DOI 10.1016/0090-3019(91)90198-I; Grcevic N, 1983, Acta Neurochir Suppl (Wien), V32, P79; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Hong JH, 2012, NEUROSURGERY, V70, P819, DOI 10.1227/NEU.0b013e3182367124; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Hong JH, 2009, BRAIN RES BULL, V80, P30, DOI 10.1016/j.brainresbull.2009.05.021; Jang SH, 2015, AM J NEURORADIOL, V36, P667, DOI 10.3174/ajnr.A4203; Jang SH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017467; Jang SH, 2019, NEURAL REGEN RES, V14, P1556, DOI 10.4103/1673-5374.255977; Jang SH, 2018, J STROKE CEREBROVASC, V27, pE98, DOI 10.1016/j.jstrokecerebrovasdis.2017.12.045; Jang SH, 2018, NEURAL REGEN RES, V13, P563, DOI 10.4103/1673-5374.228763; Jang SH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007356; Jang SH, 2016, ACTA NEUROL BELG, V116, P655, DOI 10.1007/s13760-016-0602-9; Jang SH, 2015, J REHABIL MED, V47, P133, DOI 10.2340/16501977-1896; Jang SH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005613; Jang SH, 2011, NEUROREHABILITATION, V29, P339, DOI 10.3233/NRE-2011-0710; Javed Zeeshan, 2015, Indian J Endocrinol Metab, V19, P753, DOI 10.4103/2230-8210.167561; Lee SJ, 2020, STROKE, V51, pE246, DOI 10.1161/STROKEAHA.120.029996; Kakarieka A, 1997, TRAUMATIC SUBARACHNO, P1; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kwon HG, 2012, NEURAL REGEN RES, V7, P475, DOI 10.3969/j.issn.1673-5374.2012.06.012; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Reijmer YD, 2018, STROKE, V49, P2040, DOI 10.1161/STROKEAHA.118.021622; SANDER D, 1993, J NEUROL SCI, V119, P1, DOI 10.1016/0022-510X(93)90185-2; Sarkari A, 2010, INDIAN J NEUROTRAUM, V7, P135, DOI 10.1016/S0973-0508(10)80028-0; Schwarz CG, 2014, NEUROIMAGE, V94, P65, DOI 10.1016/j.neuroimage.2014.03.026; Schweizer TA, 2012, CLIN NEUROL NEUROSUR, V114, P798, DOI 10.1016/j.clineuro.2011.12.045; Sener S, 2016, NEUROSURGERY, V79, P786, DOI 10.1227/NEU.0000000000001325; Seo JP, 2015, BRAIN INJURY, V29, P110, DOI 10.3109/02699052.2014.973447; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Ullman JS, 1997, AANS, P225; Wright DK, 2021, J NEUROTRAUM, V38, P983, DOI 10.1089/neu.2019.6886; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Yamagata B, 2020, J NEUROTRAUM, V37, P975, DOI 10.1089/neu.2019.6751; Yeo SS, 2012, STROKE, V43, P2239, DOI 10.1161/STROKEAHA.112.661116; Zacko JC, 2011, YOUMANS NEUROLOGICAL, V6th, P3428; Zalesky A, 2011, MAGN RESON IMAGING, V29, P111, DOI 10.1016/j.mri.2010.06.027	61	0	0	1	1	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA		1643-3750		MED SCI MONITOR	Med. Sci. Monitor	OCT 17	2021	27								e933959	10.12659/MSM.933959			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	WI0XR	WOS:000708091200001	34657118				2022-02-06	
J	Basagni, B; Bosetti, S; Cantelli, S; Ermon, S; Rovere, F; Navarrete, E; De Tanti, A; Saviola, D				Basagni, Benedetta; Bosetti, Sara; Cantelli, Sabrina; Ermon, Silvia; Rovere, Federica; Navarrete, Eduardo; De Tanti, Antonio; Saviola, Donatella			Development of a generic version of the multiple errands test for severe acquired brain injuries	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Brain injury; traumatic brain injury; executive functions; ecological evaluation; cognitive rehabilitation	ECOLOGICAL ASSESSMENT; EXECUTIVE FUNCTION; VALIDITY; RELIABILITY; BADS	Background Impairment of executive functions is a frequent and disabling consequence of brain injury. In 1991, Shallice and Burgess elaborated the Multiple Errand Test (MET) to assess everyday troubles associated with this impairment. Objective Our first aim was to create a generic version of MET (MET-G) readily adaptable to different settings and for retesting. The second aim was to validate the revised version to detect executive impairment in individuals with severe ABI. Methods An inter-professional team of experts in neurorehabilitation created a revised version of MET. Twenty-one patients with sABI (severe Acquired Brain Injury) and a control group of 20 neurologically healthy subjects, took part in the testing of MET-G. Results MET-G clearly distinguished people with sABI from healthy controls based on Total error score, task completion, and rule breaking. The test showed good inter-rater reliability and internal consistency. Conclusions The new, generic version of MET was able to differentiate adults with sABI from controls and proved to be a good tool for evaluating executive functions in these patients in daily-life contexts. Indications on how to adapt the test to different contexts and different scoring modalities are provided.	[Basagni, Benedetta; Bosetti, Sara; Cantelli, Sabrina; Ermon, Silvia; Rovere, Federica; De Tanti, Antonio; Saviola, Donatella] Ctr Cardinal Ferrari, Fontanellato, Italy; [Navarrete, Eduardo] Univ Padua, DPSS, Padua, Italy		Basagni, B (corresponding author), Ctr Cardinal Ferrari, Fontanellato, Italy.; Basagni, B (corresponding author), IRCCS Fdn Don Carlo Gnocchi, Florence, Italy.	bbasagni@gmail.com		De Tanti, Antonio/0000-0003-4803-419X			Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Antonucci G., 2014, BADS BEHAV ASSESSMEN; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Chen ChangXiang, 2010, Modern Preventive Medicine, V37, P576; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; Cipresso P, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00405; Clark AJ, 2017, NEUROPSYCHOL REHABIL, V27, P667, DOI 10.1080/09602011.2015.1117981; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; De Tanti A, 2015, EUR J PHYS REHAB MED, V51, P89; DeRight J, 2019, HIST NEUROPSYCHOLOGY, V44, P100; Dieci, 2002, NUOVA RIV NEUROLOGIA, V12, P111; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Fisher A.G, 1995, ASSESSMENT MOTOR PRO; Gajewski PD, 2015, NEUROPSYCHOLOGIA, V73, P195, DOI 10.1016/j.neuropsychologia.2015.04.031; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Godefroy O, 2018, CORTEX, V109, P322, DOI 10.1016/j.cortex.2018.09.026; Hagen C, 1979, REHABILITATION HEAD; Hanna-Pladdy B, 2007, J Neurol Phys Ther, V31, P119; Hyndman R. J., 2019, FORECASTING FUNCTION; Laiacona M, 2000, NEUROL SCI, V21, P279, DOI 10.1007/s100720070065; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Likert R.A, 1983, ARCH PSYCHOL, V140, P239; Loewenthal K.M., 1996, FINAL SCALE ITS VALI; Morrison MT, 2013, AM J OCCUP THER, V67, P460, DOI 10.5014/ajot.2013.007880; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; R Development Core Team, 2012, R LANG ENV STAT COMP; Raspelli S, 2011, STUD HEALTH TECHNOL, V167, P92, DOI 10.3233/978-1-60750-766-6-92; Reber J, 2019, HAND CLINIC, V163, P147, DOI 10.1016/B978-0-12-804281-6.00008-2; Rotenberg S, 2020, ARCH PHYS MED REHAB, V101, P1628, DOI 10.1016/j.apmr.2020.01.019; Selker R., 2021, [No title captured]; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Spielberger C., 1983, ADV PERSONALITY ASSE, V2, P159; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; TEASDALE G, 1974, LANCET, V2, P81; Tupper D., 1990, NEUROPSYCHOLOGY EVER, P3, DOI DOI 10.1007/978-1-4613-1503-2_1; Venables W.N., 2002, MODERN APPL STAT S, V4th ed., DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Wiederhold B.K., 2014, ANN REV CYBERTHERAPY, V99, P40; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570	43	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2021.1990928		OCT 2021	8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	WI9ZH	WOS:000708710500001	34663139				2022-02-06	
J	Brett, BL; Kerr, ZY; Walton, SR; Chandran, A; Defreese, JD; Mannix, R; Echemendia, RJ; Meehan, WP; Guskiewicz, KM; McCrea, M				Brett, Benjamin L.; Kerr, Zachary Y.; Walton, Samuel R.; Chandran, Avinash; Defreese, J. D.; Mannix, Rebekah; Echemendia, Ruben J.; Meehan, William P.; Guskiewicz, Kevin M.; McCrea, Michael			Longitudinal trajectory of depression symptom severity and the influence of concussion history and physical function over a 19-year period among former National Football League (NFL) players: an NFL-LONG Study	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article; Early Access						concussion; traumatic brain injury; depression	HIGH-SCHOOL FOOTBALL; OLDER-ADULTS; MENTAL-HEALTH; RISK; ASSOCIATION; OUTCOMES; LINKING	Objective This study investigated the longitudinal course of depressive symptom severity over 19 years in former American football players and the influence of concussion history, contact sport participation and physical function on observed trajectories. Methods Former American football players completed a general health questionnaire involving demographic information, medical/psychiatric history, concussion/football history and validated measures of depression and physical function at three time points (2001, 2010 and 2019). Parallel process latent growth curve modelling tested associations between concussion history, years of football participation, and overall and change in physical function on the overall level and trajectory of depressive symptoms. Results Among the 333 participants (mean(SD) age, 48.95 (9.37) at enrolment), there was a statistically significant, but small increase in depressive symptom severity from 2001 (48.34 (7.75)) to 2019 (49.77 (9.52)), slope=0.079 (SE=0.11), p=0.007. Those with greater concussion history endorsed greater overall depressive symptom severity, B=1.38 (SE=0.33), p<0.001. Concussion history, B<0.001 (SE=0.02), p=0.997 and years of participation, B<0.001 (SE=0.01), p=0.980, were not associated with rate of change (slope factor) over 19 years. Greater decline in physical function, B=-0.71 (SE=0.16), p<0.001, was predictive of a faster growth rate (ie, steeper increase) of depression symptom endorsement over time. Conclusions Concussion history, not years of participation, was associated with greater depressive symptom severity. Neither factor was predictive of changes over a 19-year period. Decline in physical function was a significant predictor of a steeper trajectory of increased depressive symptoms, independent of concussion effects. This represents one viable target for preventative intervention to mitigate long-term neuropsychiatric difficulties associated with concussion across subsequent decades of life.	[Brett, Benjamin L.; McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Wauwatosa, WI 53226 USA; [Brett, Benjamin L.; McCrea, Michael] Med Coll Wisconsin, Dept Neurol, Wauwatosa, WI 53226 USA; [Kerr, Zachary Y.; Walton, Samuel R.; Defreese, J. D.; Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Mannix, Rebekah] Harvard Med Sch, Dept Pediat & Emergency Med, Boston, MA 02115 USA; [Echemendia, Ruben J.] Psychol & Neurobehav Associates Inc, State Coll, PA USA; [Echemendia, Ruben J.] Univ Missouri, Dept Psychol, Kansas City, MO 64110 USA; [Meehan, William P.] Boston Childrens Hosp, Sports Med Div, Boston, MA USA; [Meehan, William P.] Harvard Med Sch, Dept Pediat & Orthoped, Boston, MA 02115 USA		Brett, BL (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Wauwatosa, WI 53226 USA.	bbrett@mcw.edu		Brett, Benjamin/0000-0003-2849-4658	National Football League (NFL); National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23 AG073528]	This study (NFL-LONG) was funded by the National Football League (NFL) with support from the National Institute on Aging (BLB-Award Number K23 AG073528).	Alosco ML, 2020, NEUROLOGY, V95, pE793, DOI 10.1212/WNL.0000000000010040; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Brett BL, 2021, J NEUROL NEUROSUR PS, V92, P282, DOI 10.1136/jnnp-2020-324244; Brett BL, 2022, J INT NEUROPSYCH SOC, V28, P22, DOI 10.1017/S1355617721000047; Brett BL, 2019, J NEUROPSYCH CLIN N, V31, P17, DOI 10.1176/appi.neuropsych.18040080; Choi SW, 2014, PSYCHOL ASSESSMENT, V26, P513, DOI 10.1037/a0035768; Chondros P, 2018, J AFFECT DISORDERS, V227, P854, DOI 10.1016/j.jad.2017.11.042; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Esopenko C, 2017, J NEUROL NEUROSUR PS, V88, P512, DOI 10.1136/jnnp-2016-315260; Ferrari AJ, 2013, PSYCHOL MED, V43, P471, DOI 10.1017/S0033291712001511; Filbay S, 2019, SPORTS MED, V49, P1723, DOI 10.1007/s40279-019-01163-0; Gallagher D, 2016, J AFFECT DISORDERS, V190, P235, DOI 10.1016/j.jad.2015.09.046; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hutchison MG, 2018, INT J PSYCHOPHYSIOL, V132, P55, DOI 10.1016/j.ijpsycho.2017.11.006; Katz DI, 2021, NEUROLOGY, V96, P848, DOI 10.1212/WNL.0000000000011850; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Kwong E, 2020, J EPIDEMIOL COMMUN H, V74, P882, DOI 10.1136/jech-2019-212451; Levin JB, 2015, AM J GERIAT PSYCHIAT, V23, P1134, DOI 10.1016/j.jagp.2015.04.004; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; Mast BT, 2008, BIOL PSYCHIAT, V64, P320, DOI 10.1016/j.biopsych.2008.01.025; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Mez J, 2021, ALZHEIMERS DEMENT, V17, P1709, DOI 10.1002/alz.12338; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Motl RW, 2005, J BEHAV MED, V28, P385, DOI 10.1007/s10865-005-9005-5; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Richardson RA, 2020, LANCET PSYCHIAT, V7, P673, DOI 10.1016/S2215-0366(20)30151-6; Russell ER, 2020, J NEUROL NEUROSUR PS, V91, P1256, DOI 10.1136/jnnp-2020-323315; Santini ZI, 2020, LANCET PUBLIC HEALTH, V5, pE62, DOI 10.1016/S2468-2667(19)30230-0; Schalet BD, 2015, J GEN INTERN MED, V30, P1517, DOI 10.1007/s11606-015-3360-0; Schuring N, 2017, KNEE SURG SPORT TR A, V25, P3179, DOI 10.1007/s00167-016-4255-2; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Turvey CL, 2009, AM J GERIAT PSYCHIAT, V17, P632, DOI 10.1097/JGP.0b013e31819c498c; Veronese N, 2017, PHYS THER, V97, P659, DOI 10.1093/ptj/pzx017	37	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry												10.1136/jnnp-2021-326602		OCT 2021	8	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	XG9CN	WOS:000725044100001	34663623				2022-02-06	
J	Guo, PP; Jin, Z; Wang, J; Sang, AM; Wu, HS				Guo, Peipei; Jin, Zhao; Wang, Jin; Sang, Aming; Wu, Huisheng			Irisin Rescues Blood-Brain Barrier Permeability following Traumatic Brain Injury and Contributes to the Neuroprotection of Exercise in Traumatic Brain Injury	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							SUBARACHNOID HEMORRHAGE; OXIDATIVE STRESS; OUTCOMES; INFLAMMATION; PATHWAYS; PROTECTS; MODEL; FLUID; TBI	Traumatic brain injury (TBI) has a high incidence, mortality, and morbidity all over the world. One important reason for its poor clinical prognosis is brain edema caused by blood-brain barrier (BBB) dysfunction after TBI. The mechanism may be related to the disorder of mitochondrial morphology and function of neurons in damaged brain tissue, the decrease of uncoupling protein 2 (UCP2) activity, and the increase of inflammatory reaction and oxidative stress. In this study, we aimed to investigate the effects of exogenous irisin on BBB dysfunction after TBI and its role in the neuroprotective effects of endurance exercise (EE) in mice. The concentrations of irisin in cerebrospinal fluid (CSF) and plasma of patients with mild to severe TBI were measured by ELISA. Then, male C57BL/6J mice and UCP2 knockout mice with C57BL/6J background were used to establish the TBI model. The BBB structure and permeability were examined by transmission electron microscopy and Evans blue extravasation, respectively. The protein expressions of irisin, occludin, claudin-5, zonula occludens-1 (ZO-1), nuclear factor E2-related factor 2(Nrf2), quinine oxidoreductase (NQO-1), hemeoxygenase-1 (HO-1), cytochrome C (Cyt-C), cytochrome C oxidase (COX IV), BCL2-associated X protein (Bax), cleaved caspase-3, and UCP2 were detected by western blot. The production of reactive oxygen species (ROS) was evaluated by the dihydroethidium (DHE) staining. The levels of inflammatory factors were detected by ELISA. In this study, we found that the CSF irisin levels were positively correlated with the severity of disease in patients with TBI and both EE and exogenous irisin could reduce BBB damage in a mouse model of TBI. In addition, we used UCP2(-/-) mice and further found that irisin could improve the dysfunction of BBB after TBI by promoting the expression of UCP2 on the mitochondrial membrane of neurons, reducing the damage of mitochondrial structure and function, thus alleviating the inflammatory response and oxidative stress. In conclusion, the results of this study suggested that irisin might alleviate brain edema after TBI by promoting the expression of UCP2 on the mitochondrial membrane of neurons and contribute to the neuroprotection of EE against TBI.</p>	[Guo, Peipei; Wu, Huisheng] Anhui Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Hefei 230022, Anhui, Peoples R China; [Guo, Peipei; Jin, Zhao; Wang, Jin; Sang, Aming; Wu, Huisheng] Wuhan Univ, Zhongnan Hosp, Dept Anesthesiol, Wuhan 430071, Hubei, Peoples R China		Wu, HS (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Hefei 230022, Anhui, Peoples R China.; Wu, HS (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Anesthesiol, Wuhan 430071, Hubei, Peoples R China.	78691228@qq.com; zn000486@whu.edu.cn; jinzhao317@163.com; jinzhaowin@126.com; zn000482@whu.edu.cn			Hubei Provincial Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [2020CFB614]; Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund [znpy2019009, znpy2019020]	AcknowledgmentsThis work was supported by the Hubei Provincial Natural Science Foundation of China (grant No. 2020CFB614) and the Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund (grant Nos. znpy2019009 and znpy2019020).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Alves OL, 2003, ANN NY ACAD SCI, V993, P25, DOI 10.1111/j.1749-6632.2003.tb07508.x; Assis-Nascimento P, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0016-5; Aubrecht TG, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1156-y; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Campos-Pires R, 2019, BRIT J ANAESTH, V123, P60, DOI 10.1016/j.bja.2019.02.032; Chen K, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao6298; Chen YH, 2021, ANTIOXID REDOX SIGN, V34, P154, DOI 10.1089/ars.2019.7982; Chio CC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0867-9; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Dai SH, 2017, FREE RADICAL BIO MED, V108, P345, DOI 10.1016/j.freeradbiomed.2017.04.005; Fan LF, 2017, FREE RADICAL BIO MED, V112, P336, DOI 10.1016/j.freeradbiomed.2017.08.003; Fang J, 2018, DRUG DES DEV THER, V12, P2497, DOI 10.2147/DDDT.S163951; Gao GY, 2020, LANCET NEUROL, V19, P670, DOI 10.1016/S1474-4422(20)30182-4; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Guo PP, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1425; He RY, 2020, MAT SCI ENG C-MATER, V117, DOI 10.1016/j.msec.2020.111314; Jangholi E, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/5872645; Jezek P, 2018, ANTIOXID REDOX SIGN, V29, P667, DOI 10.1089/ars.2017.7225; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Jin Z, 2019, BIOMED PHARMACOTHER, V120, DOI 10.1016/j.biopha.2019.109452; Kramer TJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1550-0; Li DJ, 2017, METABOLISM, V68, P31, DOI 10.1016/j.metabol.2016.12.003; Li YC, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01836-y; Lores-Arnaiz S, 2016, NEUROCHEM RES, V41, P353, DOI 10.1007/s11064-015-1817-5; Lourenco MV, 2019, NAT MED, V25, P165, DOI 10.1038/s41591-018-0275-4; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Mo J, 2019, REDOX BIOL, V20, P75, DOI 10.1016/j.redox.2018.09.022; Normoyle KP, 2015, TRANSL NEUROSCI, V6, P179, DOI 10.1515/tnsci-2015-0019; Nyunt T, 2019, FREE RADICAL BIO MED, V143, P25, DOI 10.1016/j.freeradbiomed.2019.07.024; Ren YF, 2019, ANTIOXID REDOX SIGN, V31, P771, DOI 10.1089/ars.2019.7731; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Sivandzade F, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01818-0; Sun ZZ, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/7879629; Tang JS, 2020, ACTA PHARMACOL SIN B, V10, P987, DOI 10.1016/j.apsb.2020.02.015; van Vliet EA, 2020, NEUROBIOL DIS, V145, DOI 10.1016/j.nbd.2020.105080; Vazquez-Rosa E, 2020, P NATL ACAD SCI USA, V117, P27667, DOI 10.1073/pnas.2010430117; Wang Z, 2018, TRANSL STROKE RES, V9, P74, DOI 10.1007/s12975-017-0559-x; Winkler L, 2021, J CEREBR BLOOD F MET, V41, P132, DOI 10.1177/0271678X20904687; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Zhang L, 2018, NEUROCHEM INT, V118, P304, DOI 10.1016/j.neuint.2018.05.011; Zhu YH, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4783602	43	0	0	6	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.	OCT 16	2021	2021								1118981	10.1155/2021/1118981			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	WP5ST	WOS:000713191900002	34697562	Green Published, gold			2022-02-06	
J	Deng, CL; Yi, RX; Fei, MX; Li, T; Han, YL; Wang, HD				Deng, Chulei; Yi, Renxin; Fei, Maoxing; Li, Tao; Han, Yanling; Wang, Handong			Naringenin attenuates endoplasmic reticulum stress, reduces apoptosis, and improves functional recovery in experimental traumatic brain injury	BRAIN RESEARCH			English	Article						Endoplasmic reticulum stress; Naringenin; Oxidative stress; Traumatic brain injury	CLOSED-HEAD INJURY; SIGNALING PATHWAY; OXIDATIVE STRESS; MECHANISMS; CONTRIBUTES; IMPAIRMENT; ACTIVATION; NECROSIS; NEURONS; DEATH	Traumatic brain injury (TBI) is a significant cause of disability and death worldwide. Accumulating evidence suggests that endoplasmic reticulum (ER) stress would be an important component in the pathogenesis of TBI. Although the neuroprotective effects of naringenin, a natural flavonoid isolated from citrus plants, have been confirmed in several neurological diseases, its mechanism of action in TBI needs further investigation. In ICR mice, we found that TBI induced elevated expression of ER stress marker proteins, including 78-kDa glucose-regulated protein (GRP78) and C/EBP homologous protein (CHOP) in the perilesional cortex, which peaked at 7 days and 3 days after TBI, respectively. The induction of ER stress-related proteins partly coincided with ER architectural changes at 3 days post-TBI, indicating ER stress activation in our TBI model. Our results also revealed that continuous naringenin administration ameliorated neurological dysfunction, cerebral edema, plasmalemma permeability, and neuron cell loss at day 3 after TBI. Further, Naringenin suppressed TBIinduced activation of the ER stress pathway (p-eIF2 alpha, ATF4, and CHOP), oxidative stress and apoptosis on day 3 after TBI. In summary, our data suggest that naringenin could ameliorate TBI-induced secondary brain injury by pleiotropic effects, including ER stress attenuation.	[Deng, Chulei] Southern Med Univ, Jinling Hosp, Sch Clin Med 1, Dept Neurosurg, Nanjing 210002, Peoples R China; [Yi, Renxin] Southeast Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Peoples R China; [Fei, Maoxing; Li, Tao] Nanjing Med Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Peoples R China; [Han, Yanling; Wang, Handong] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China		Wang, HD (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	njhdwang@hotmail.com		Chulei, Deng/0000-0002-8445-7408	China National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81672503, 81702484]	This work was supported by China National Natural Science Foundation (grants No. 81672503 and No. 81702484) .	Al-Dosari DI, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101161; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Cansler SM, 2020, J NEUROSCI RES, V98, P571, DOI 10.1002/jnr.24543; Chavez-Valdez R, 2016, INT J DEV NEUROSCI, V48, P58, DOI 10.1016/j.ijdevneu.2015.11.007; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chtourou Y, 2015, NEUROCHEM RES, V40, P1563, DOI 10.1007/s11064-015-1627-9; Cui QJ, 2014, NEUROCHEM RES, V39, P1254, DOI 10.1007/s11064-014-1306-2; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Fei MX, 2020, BIOCHEM BIOPH RES CO, V523, P361, DOI 10.1016/j.bbrc.2019.12.003; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Hood KN, 2018, J NEUROSCI, V38, P2372, DOI 10.1523/JNEUROSCI.1756-17.2018; Joshi R, 2018, LIFE SCI, V215, P43, DOI 10.1016/j.lfs.2018.10.066; Larner SF, 2006, J NEUROTRAUM, V23, P807, DOI 10.1089/neu.2006.23.807; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Mani S, 2018, NEUROTOX RES, V33, P656, DOI 10.1007/s12640-018-9869-3; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Martin LJ, 2000, NEUROBIOL DIS, V7, P169, DOI 10.1006/nbdi.2000.0282; Mulvihill EE, 2010, ARTERIOSCL THROM VAS, V30, P742, DOI 10.1161/ATVBAHA.109.201095; Nakka VP, 2016, MOL NEUROBIOL, V53, P532, DOI 10.1007/s12035-014-9029-6; Noda S, 2013, MOL NUTR FOOD RES, V57, P2019, DOI 10.1002/mnfr.201300045; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Park S, 2017, MOL HUM REPROD, V23, P842, DOI 10.1093/molehr/gax057; Qi ZH, 2015, MOL MED REP, V12, P7093, DOI 10.3892/mmr.2015.4232; Raza SS, 2013, NEUROSCIENCE, V230, P157, DOI 10.1016/j.neuroscience.2012.10.041; Rebello CJ, 2020, DIABETES OBES METAB, V22, P91, DOI 10.1111/dom.13868; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rungta RL, 2015, CELL, V161, P610, DOI 10.1016/j.cell.2015.03.029; Sen T, 2017, J NEUROSCI, V37, P5900, DOI 10.1523/JNEUROSCI.2343-16.2017; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Tang JY, 2017, MOL CELL BIOCHEM, V424, P111, DOI 10.1007/s11010-016-2848-1; Testai L, 2013, BIOCHEM PHARMACOL, V85, P1634, DOI 10.1016/j.bcp.2013.03.018; Wang DY, 2021, MOL MED REP, V23, DOI 10.3892/mmr.2021.11886; Wang H, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01863-9; Wang T, 2013, NEUROSCIENCE, V231, P70, DOI 10.1016/j.neuroscience.2012.11.019; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Yang ZY, 2019, PHYTOTHER RES, V33, P1114, DOI 10.1002/ptr.6305; Yu LM, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7670854	44	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 15	2021	1769								147591	10.1016/j.brainres.2021.147591			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UI8YJ	WOS:000690884800007	34324877				2022-02-06	
J	Feng, X; Frias, ES; Paladini, MS; Chen, D; Boosalis, Z; Becker, M; Gupta, S; Liu, S; Gupta, N; Rosi, S				Feng, Xi; Frias, Elma S.; Paladini, Maria S.; Chen, David; Boosalis, Zoe; Becker, McKenna; Gupta, Sonali; Liu, Sharon; Gupta, Nalin; Rosi, Susanna			Functional role of brain-engrafted macrophages against brain injuries	JOURNAL OF NEUROINFLAMMATION			English	Article						Microglia; Brain-engrafted macrophages; Cognition; Brain irradiation; CSF-1R inhibitor	MICROGLIA DERIVE; AMYLOID-BETA; COMPLEMENT; MONOCYTES; NEUROGENESIS; REVEALS; SYSTEM; HEALTH; SCULPT; CELLS	Background Brain-resident microglia have a distinct origin compared to macrophages in other organs. Under physiological conditions, microglia are maintained by self-renewal from the local pool, independent of hematopoietic progenitors. Pharmacological depletion of microglia during whole-brain radiotherapy prevents synaptic loss and long-term recognition memory deficits. However, the origin or repopulated cells and the mechanisms behind these protective effects are unknown. Methods CD45(low/int)/CD11b(+) cells from naive brains, irradiated brains, PLX5622-treated brains and PLX5622 + whole-brain radiotherapy-treated brains were FACS sorted and sequenced for transcriptomic comparisons. Bone marrow chimeras were used to trace the origin and long-term morphology of repopulated cells after PLX5622 and whole-brain radiotherapy. FACS analyses of intrinsic and exotic synaptic compartments were used to measure phagocytic activities of microglia and repopulated cells. In addition, concussive brain injuries were given to PLX5622 and brain-irradiated mice to study the potential protective functions of repopulated cells after PLX5622 + whole-brain radiotherapy. Results After a combination of whole-brain radiotherapy and microglia depletion, repopulated cells are brain-engrafted macrophages that originate from circulating monocytes. Comparisons of transcriptomes reveal that brain-engrafted macrophages have an intermediate phenotype that resembles both monocytes and embryonic microglia. In addition, brain-engrafted macrophages display reduced phagocytic activity for synaptic compartments compared to microglia from normal brains in response to a secondary concussive brain injury. Importantly, replacement of microglia by brain-engrafted macrophages spare mice from whole-brain radiotherapy-induced long-term cognitive deficits, and prevent concussive injury-induced memory loss. Conclusions Brain-engrafted macrophages prevent radiation- and concussion-induced brain injuries and cognitive deficits.	[Feng, Xi; Frias, Elma S.; Paladini, Maria S.; Chen, David; Boosalis, Zoe; Becker, McKenna; Gupta, Sonali; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Feng, Xi; Frias, Elma S.; Paladini, Maria S.; Chen, David; Boosalis, Zoe; Becker, McKenna; Gupta, Sonali; Rosi, Susanna] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, Zuckerberg San Francisco Gen Hosp, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA; [Liu, Sharon; Gupta, Nalin; Rosi, Susanna] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94110 USA; [Rosi, Susanna] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94110 USA; [Rosi, Susanna] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94110 USA; [Gupta, Nalin] Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA USA; [Gupta, Nalin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA		Rosi, S (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, Zuckerberg San Francisco Gen Hosp, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94110 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94110 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94110 USA.	Susanna.Rosi@ucsf.edu		Rosi, Susanna/0000-0002-9269-3638	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01CA133216, R01CA213441, R01AG056770]	This work was funded by grants from the National Institutes of Health no. R01CA133216, R01CA213441 and R01AG056770 (S.R.).	Acharya MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31545; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; [Anonymous], 2020, CSF 1R INHIBITOR DCC; Chen HR, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb2119; CHIANG CS, 1993, RADIOTHER ONCOL, V29, P60, DOI 10.1016/0167-8140(93)90174-7; Chou A, 2017, P NATL ACAD SCI USA, V114, pE6420, DOI 10.1073/pnas.1707661114; Cronk JC, 2018, J EXP MED, V215, P1627, DOI 10.1084/jem.20180247; Dagher NN, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0366-9; Denny WA, 2021, EXPERT OPIN THER PAT, V31, P107, DOI 10.1080/13543776.2021.1839414; Elmore MRP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122912; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Fein JA, 2008, AM J PATHOL, V172, P1683, DOI 10.2353/ajpath.2008.070829; Feng X, 2018, ELIFE, V7, DOI 10.7554/eLife.38865; Feng X, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0671-y; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Greene-Schloesser D, 2012, NEURO-ONCOLOGY, V14, P37, DOI 10.1093/neuonc/nos196; Hong S, 2016, DEV CELL, V38, P126, DOI 10.1016/j.devcel.2016.07.006; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Hua K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052728; Huang YB, 2018, NAT NEUROSCI, V21, P530, DOI 10.1038/s41593-018-0090-8; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Krukowski K, 2020, J NEUROTRAUM, V37, P1370, DOI 10.1089/neu.2019.6827; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Krukowski K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26039-7; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2007, ANN NEUROL, V62, P515, DOI 10.1002/ana.21214; Morganti JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093650; Norris GT, 2018, J EXP MED, V215, P1789, DOI 10.1084/jem.20172244; Prieto GA, 2015, P NATL ACAD SCI USA, V112, pE5078, DOI 10.1073/pnas.1514486112; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Rapp SR, 2015, J CLIN ONCOL, V33, P1653, DOI 10.1200/JCO.2014.58.4508; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shi QQ, 2015, J NEUROSCI, V35, P13029, DOI 10.1523/JNEUROSCI.1698-15.2015; Shinohara C, 1997, CANCER RES, V57, P2694; Spangenberg EE, 2016, BRAIN, V139, P1265, DOI 10.1093/brain/aww016; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Wang C, 2020, SCIENCE, V367, P688, DOI 10.1126/science.aaz2288; Warrington JP, 2013, J VASC RES, V50, P445, DOI 10.1159/000354227; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477	55	0	0	4	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	OCT 15	2021	18	1							232	10.1186/s12974-021-02290-0			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	WH4DM	WOS:000707630600001	34654458	gold, Green Published, Green Submitted			2022-02-06	
J	Follmer, B; Varga, AA; Herrmann, KB; Sun, Y; Zehr, EP				Follmer, Bruno; Varga, Aaron Alexander; Herrmann, Konrad Byron; Sun, Yao; Zehr, E. Paul			Effects of chronic exposure to head impacts on the balance function of combat sports athletes	TRANSLATIONAL SPORTS MEDICINE			English	Article						exercise-induced damage; health; injury	POSTURAL CONTROL; CONCUSSION; MANAGEMENT; STABILITY; FOOTBALL; HISTORY; BOARD	We investigated static and dynamic balance in combat sport athletes chronically exposed to head impacts. MMA, boxing, kickboxing, and Muay Thai athletes exposed (AE: n = 19; 14 men, 5 women; 30.2 +/- 4.5 years; 1.76 +/- 0.1 m; 75 +/- 9.2 kg) to head impacts were compared to athletes non-exposed (AnE: n = 25; 18 men, 7 women; 25.1 +/- 3.2 years; 1.78 +/- 0.1 m; 77.4 +/- 10.3 kg), and control individuals (CON: n = 23, 13 men, 10 women; 25.5 +/- 5.8 years; 1.75 +/- 0.1m; 70.4 +/- 12 kg). Static balance was assessed using the Balance Error Scoring System, and dynamic function by center of pressure shift and reactive object tracking. A low-cost balance board was used for both protocols. AE performed worse than CON (0.01 +/- 0.006 vs 0.006 +/- 0.003; P = .02, d = 0.75) in the ellipse area of sway for double-leg stance in firm condition (F-2,F-62 = 3.94, P = .02, eta(2) = 0.11). Static center of pressure and dynamic balance did not differ among groups. The integration of a balance board and a widely used clinical protocol unveiled differences in the ellipse area of static postural sway in the double-leg stance over a firm surface in athletes chronically exposed to head impacts. The combined use of practical, objective, and clinically relevant test protocols is encouraged to detect lasting deficits in static and dynamic balance as a result of chronic exposure to repetitive head impacts.	[Follmer, Bruno; Varga, Aaron Alexander; Herrmann, Konrad Byron; Sun, Yao; Zehr, E. Paul] Univ Victoria, Rehabil Neurosci Lab, Victoria, BC, Canada; [Follmer, Bruno; Sun, Yao; Zehr, E. Paul] Univ Victoria, Sch Exercise Sci Phys & Hlth Educ, Victoria, BC, Canada; [Follmer, Bruno; Sun, Yao; Zehr, E. Paul] Human Discovery Sci Int Collaborat Repair Discove, Vancouver, BC, Canada; [Zehr, E. Paul] Univ Victoria, Ctr Biomed Res, Victoria, BC, Canada; [Zehr, E. Paul] Univ Victoria, Div Med Sci, Victoria, BC, Canada		Zehr, EP (corresponding author), Univ Victoria, Sch Exercise Sci Phys & Hlth Educ, Rehabil Neurosci Lab, Room 172,McKinnon Bldg,3800 Finnerty Rd, Victoria, BC V8P 5C2, Canada.	pzehr@uvic.ca		Follmer, Bruno/0000-0001-5052-9648	Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR	Natural Sciences and Engineering Research Council of Canada	Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Andrade A, 2019, STRENGTH COND J, V41, P51, DOI 10.1519/SSC.0000000000000410; [Anonymous], 1995, GAIT POSTURE; Banman CJ, 2021, J NEUROTRAUM, V38, P2291, DOI 10.1089/neu.2020.7432; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Black SE, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2020-000740; Callahan JL., 2013, SELF REPORTED CONCUS; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Casson IR, 2019, J ALZHEIMERS DIS, V69, P935, DOI 10.3233/JAD-190115; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Cunningham J, 2020, J ATHL TRAINING, V55, P132, DOI 10.4085/1062-6050-297-18; Di Virgilio TG, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00294; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Follmer B, 2021, BRIT J SPORT MED, V55, P1434, DOI 10.1136/bjsports-2021-104519; Follmer B, 2020, PHYSICIAN SPORTSMED, V48, P417, DOI 10.1080/00913847.2020.1729668; Follmer B, 2019, SPORTS HEALTH, V11, P280, DOI 10.1177/1941738119827966; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Ghoul N, 2019, J STRENGTH COND RES, V33, P1570, DOI 10.1519/JSC.0000000000002078; Greenamyre JT, 2015, ENVIRONMENTAL FACTORS IN NEURODEVELOPMENTAL AND NEURODEGENERATIVE DISORDERS, P21, DOI 10.1016/B978-0-12-800228-5.00002-9; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Holmes JD, 2013, CLIN REHABIL, V27, P361, DOI 10.1177/0269215512458684; Johnston W, 2020, SCAND J MED SCI SPOR, V30, P1497, DOI 10.1111/sms.13691; Johnston W, 2019, AM J SPORT MED, V47, P197, DOI 10.1177/0363546518812820; Johnston W, 2017, QJM-INT J MED, V110, P779, DOI 10.1093/qjmed/hcw228; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MCCRORY P, 2017, BRIT J SPORT MED, V51, P838, DOI DOI 10.1136/BJSPORTS-2017-097699; McNerney KM, 2014, J AM ACAD AUDIOL, V25, P521, DOI 10.3766/jaaa.25.6.2; Merritt ED, 2017, J SPORT REHABIL, V26, P518, DOI 10.1123/jsr.2016-0119; Miyashita TL, 2020, J SPORT REHABIL, V29, P310, DOI 10.1123/jsr.2017-0282; Mowbray FI, 2019, CAN J NURS RES, V51, P31, DOI 10.1177/0844562118786647; Murray NG, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/aafcd8; Murray NG, 2018, INT J PSYCHOPHYSIOL, V132, P81, DOI 10.1016/j.ijpsycho.2017.09.018; Raval AD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231452; Rawlings S, 2020, BRAIN RES BULL, V165, P56, DOI 10.1016/j.brainresbull.2020.09.021; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Reilly N, 2020, EXP BRAIN RES, V238, P2783, DOI 10.1007/s00221-020-05934-4; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Sun Y, 2020, J MOTOR BEHAV, V52, P643, DOI 10.1080/00222895.2019.1670129; Velez J.I, 2015, FRONT APPL MATH STAT, V1, P12, DOI [10.3389/fams.2015.00012, DOI 10.3389/FAMS.2015.00012]; Walley Megan, 2014, Clin Diabetes, V32, P76, DOI 10.2337/diaclin.32.2.76	45	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2573-8488		TRANSL SPORTS MED	Transl. Sports Med.	NOV	2021	4	6					798	806		10.1002/tsm2.283		OCT 2021	9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	XU2YU	WOS:000707381000001					2022-02-06	
J	Hashiesh, HM; Jha, NK; Sharma, C; Gupta, PK; Jha, SK; Patil, CR; Goyal, SN; Ojha, SK				Hashiesh, Hebaallah Mamdouh; Jha, Niraj Kumar; Sharma, Charu; Gupta, Piyush Kumar; Jha, Saurabh Kumar; Patil, Chandragouda R.; Goyal, Sameer N.; Ojha, Shreesh K.			Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						CB2 receptor agonists; JWH133; Synthetic cannabinoids; Neuroprotective; Neuroprotection; Neurodegeneration; Neuroinflammation	GERMINAL-MATRIX-HEMORRHAGE; ATTENUATES BRAIN EDEMA; DORSAL-HORN NEURONS; CB2 RECEPTOR; NEUROPATHIC PAIN; IN-VIVO; INDUCED NEUROINFLAMMATION; SUBARACHNOID HEMORRHAGE; ENDOCANNABINOID SYSTEM; SELECTIVE ACTIVATION	The pharmacological activation of cannabinoid type 2 receptors (CB2R) gained attention due to its ability to mitigate neuroinflammatory events without eliciting psychotropic actions, a limiting factor for the drugs tar-geting cannabinoid type 1 receptors (CB1R). Therefore, ligands activating CB2R are receiving enormous importance for therapeutic targeting in numerous neurological diseases including neurodegenerative, neuro-psychiatric and neurodevelopmental disorders as well as traumatic injuries and neuropathic pain where neu-roinflammation is a common accompaniment. Since the characterization of CB2R, many CB2R selective synthetic ligands have been developed with high selectivity and functional activity. Among numerous ligands, JWH133 has been found one of the compounds with high selectivity for CB2R. JWH133 has been reported to exhibit numerous pharmacological activities including antioxidant, anti-inflammatory, anticancer, cardioprotective, hepatoprotective, gastroprotective, nephroprotective, and immunomodulatory. Recent studies have shown that JWH133 possesses potent neuroprotective properties in several neurological disorders, including neuropathic pain, anxiety, epilepsy, depression, alcoholism, psychosis, stroke, and neurodegeneration. Additionally, JWH133 showed to protect neurons from oxidative damage and inflammation, promote neuronal survival and neuro-genesis, and serve as an immunomodulatory agent. The present review comprehensively examined neurophar-macological activities of JWH133 in neurological disorders including neurodegenerative, neurodevelopmental and neuropsychiatric using synoptic tables and elucidated pharmacological mechanisms based on reported ob-servations. Considering the cumulative data, JWH133 appears to be a promising CB2R agonist molecule for further evaluation and it can be a prototype agent in drug discovery and development for a unique class of agents in neurotherapeutics. Further, regulatory toxicology and pharmacokinetic studies are required to determine safety and proceed for clinical evaluation.	[Hashiesh, Hebaallah Mamdouh; Ojha, Shreesh K.] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pharmacol & Therapeut, POB 17666, Al Ain, U Arab Emirates; [Jha, Niraj Kumar; Jha, Saurabh Kumar] Sharda Univ, Sch Engn & Technol, Dept Biotechnol, Greater Noida 201310, Uttar Pradesh, India; [Sharma, Charu] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Internal Med, POB 17666, Al Ain, U Arab Emirates; [Gupta, Piyush Kumar] Sharda Univ, Sch Basic Sci & Res, Dept Life Sci, Greater Noida 201310, Uttar Pradesh, India; [Patil, Chandragouda R.] Delhi Pharmaceut Sci & Res Univ, Dept Pharmacol, Pushp Vihar, New Delhi 110017, India; [Goyal, Sameer N.] Shri Vile Parle Kelavani Mandals Inst Pharm, Shri Vile Parle Kelavani Mandals Inst Pharm, Dhule 424001, Maharashtra, India		Ojha, SK (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pharmacol & Therapeut, POB 17666, Al Ain, U Arab Emirates.	shreeshojha@uaeu.ac.ae	GUPTA, Dr PIYUSH KUMAR/H-1588-2015	GUPTA, Dr PIYUSH KUMAR/0000-0002-3346-910X; Goyal, sameer/0000-0002-5241-7049; OJHA, SHREESH/0000-0001-7801-2966; Hashiesh, Hebaallah/0000-0002-7777-8262; Jha, Dr. Niraj Kumar/0000-0001-9486-4069	United Arab Emirates University, United Arab Emirates; ADEK award for Research Excellence (AARE) [AARE18-194]	The authors sincerely acknowledge the research grant support from United Arab Emirates University, United Arab Emirates. The authors also sincerely acknowledge the research fund support from the ADEK award for Research Excellence (AARE) (AARE18-194).	Alipour M, 2016, DRUG RES, V66, P597, DOI 10.1055/s-0042-112365; Amenta PS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0191-6; Anand U, 2008, PAIN, V138, P667, DOI 10.1016/j.pain.2008.06.007; Aracil-Fernandez A, 2012, NEUROPSYCHOPHARMACOL, V37, P1749, DOI 10.1038/npp.2012.22; Aso E, 2013, J ALZHEIMERS DIS, V35, P847, DOI 10.3233/JAD-130137; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Aymerich MS, 2016, MOL NEUROBIOL, V53, P2312, DOI 10.1007/s12035-015-9213-3; Baker D, 2000, NATURE, V404, P84, DOI 10.1038/35003583; Bassan H, 2007, PEDIATRICS, V120, P785, DOI 10.1542/peds.2007-0211; Beltramo M, 2006, EUR J NEUROSCI, V23, P1530, DOI 10.1111/j.1460-9568.2006.04684.x; Benito C, 2003, J NEUROSCI, V23, P11136; Bie BH, 2018, CURR OPIN ANESTHESIO, V31, P407, DOI 10.1097/ACO.0000000000000616; Bjartmar C, 2003, NEUROTOX RES, V5, P157, DOI 10.1007/BF03033380; Bonnet AE, 2015, AGING DIS, V6, P400, DOI 10.14336/AD.2015.0617; Brodie MJ, 2018, EPILEPSIA, V59, P291, DOI 10.1111/epi.13973; Brown AJ, 2007, BRIT J PHARMACOL, V152, P567, DOI 10.1038/sj.bjp.0707481; Brownjohn PW, 2012, NEUROSCIENCE, V203, P180, DOI 10.1016/j.neuroscience.2011.12.028; Cabanero D, 2020, ELIFE, V9, DOI 10.7554/eLife.55582; Cakir M, 2020, INT IMMUNOPHARMACOL, V78, DOI 10.1016/j.intimp.2019.105978; Cakir M, 2019, LIFE SCI, V217, P25, DOI 10.1016/j.lfs.2018.11.058; Cao QJ, 2021, INT J NEUROSCI, V131, P735, DOI 10.1080/00207454.2020.1796661; Cao QJ, 2018, EXP THER MED, V16, P4784, DOI 10.3892/etm.2018.6788; Carrier EJ, 2004, MOL PHARMACOL, V65, P999, DOI 10.1124/mol.65.4.999; Castane A, 2002, NEUROPHARMACOLOGY, V43, P857, DOI 10.1016/S0028-3908(02)00118-1; Chen DJ, 2017, ACTA PHARMACOL SIN, V38, P312, DOI 10.1038/aps.2016.149; Chen MH, 2016, PROG NEURO-PSYCHOPH, V70, P219, DOI 10.1016/j.pnpbp.2016.02.001; Chin CL, 2008, BRIT J PHARMACOL, V153, P367, DOI 10.1038/sj.bjp.0707506; Chiurchiu V, 2015, IMMUNOLOGY, V144, P352, DOI 10.1111/imm.12441; Choi IY, 2013, AM J PATHOL, V182, P928, DOI 10.1016/j.ajpath.2012.11.024; Chung YC, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.100; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Craske MG, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.24, 10.1038/nrdp.2017.100]; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Croxford JL, 2008, J NEUROIMMUNOL, V193, P120, DOI 10.1016/j.jneuroim.2007.10.024; Curto-Reyes V, 2011, EUR J PHARMACOL, V668, P184, DOI 10.1016/j.ejphar.2011.06.057; Del Fabbro L, 2012, BRAIN RES, V1475, P31, DOI 10.1016/j.brainres.2012.08.008; Delis F, 2017, INT J NEUROPSYCHOPH, V20, P269, DOI 10.1093/ijnp/pyw102; den Boon FS, 2012, P NATL ACAD SCI USA, V109, P3534, DOI 10.1073/pnas.1118167109; Dhopeshwarkar A, 2016, J PHARMACOL EXP THER, V358, P342, DOI 10.1124/jpet.116.232561; Elmes SJR, 2005, PAIN, V118, P327, DOI 10.1016/j.pain.2005.09.005; Elmes SJR, 2004, EUR J NEUROSCI, V20, P2311, DOI 10.1111/j.1460-9568.2004.03690.x; Erickson MA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-150; Farooq RK, 2012, BEHAV BRAIN RES, V231, P130, DOI 10.1016/j.bbr.2012.03.020; Feizi A, 2008, EXP TOXICOL PATHOL, V60, P405, DOI 10.1016/j.etp.2008.04.006; Fernandez-Lopez D, 2012, NEUROSCIENCE, V207, P307, DOI 10.1016/j.neuroscience.2012.01.008; Fernandez-Ruiz J, 2008, MOL CELL ENDOCRINOL, V286, pS91, DOI 10.1016/j.mce.2008.01.001; Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001; Fernandez-Ruiz J, 2015, NEUROTHERAPEUTICS, V12, P793, DOI 10.1007/s13311-015-0381-7; Fraga D, 2011, J NEUROIMMUNE PHARM, V6, P566, DOI 10.1007/s11481-011-9291-6; Franklin A, 2003, J NEUROSCI, V23, P7767; Franklin JM, 2013, EUR NEUROPSYCHOPHARM, V23, P760, DOI 10.1016/j.euroneuro.2012.06.012; Fu WS, 2015, NEUROSCI LETT, V595, P1, DOI 10.1016/j.neulet.2015.04.002; Fujii M, 2016, ACTA NEUROCHIR SUPPL, V121, P135, DOI 10.1007/978-3-319-18497-5_24; Fujii M, 2014, J NEUROL SCI, V342, P101, DOI 10.1016/j.jns.2014.04.034; Gamal M, 2015, J NEUROIMMUNOL, V281, P9, DOI 10.1016/j.jneuroim.2015.02.008; Garcia C, 2011, BRIT J PHARMACOL, V163, P1495, DOI 10.1111/j.1476-5381.2011.01278.x; Garcia-Gutierrez MS, 2010, BRIT J PHARMACOL, V160, P1773, DOI 10.1111/j.1476-5381.2010.00819.x; Garcia-Gutierrez MS, 2013, NEUROPHARMACOLOGY, V73, P388, DOI 10.1016/j.neuropharm.2013.05.034; Garcia-Gutierrez MS, 2012, BRIT J PHARMACOL, V165, P951, DOI 10.1111/j.1476-5381.2011.01625.x; Garcia-Gutierrez MS, 2011, J PSYCHOPHARMACOL, V25, P111, DOI 10.1177/0269881110379507; Gareau Y, 1996, BIOORG MED CHEM LETT, V6, P189, DOI 10.1016/0960-894X(95)00573-C; Gobira PH, 2019, BRIT J PHARMACOL, V176, P1541, DOI 10.1111/bph.14473; Gomez-Canas M, 2016, PHARMACOL RES, V110, P205, DOI 10.1016/j.phrs.2016.03.021; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Grotenhermen F, 2004, NEUROENDOCRINOL LETT, V25, P14; Gupta B, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00065; Hansson PT, 2005, PAIN, V113, P251, DOI 10.1016/j.pain.2004.10.007; Horvath B, 2012, BRIT J PHARMACOL, V165, P2462, DOI 10.1111/j.1476-5381.2011.01381.x; House A, 2001, STROKE, V32, P696, DOI 10.1161/01.STR.32.3.696; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Hu SX, 2011, J NEUROIMMUNE PHARM, V6, P528, DOI 10.1007/s11481-011-9306-3; Huffman JW, 1999, BIOORGAN MED CHEM, V7, P2905, DOI 10.1016/S0968-0896(99)00219-9; Iannotti FA, 2016, PROG LIPID RES, V62, P107, DOI 10.1016/j.plipres.2016.02.002; Ibrahim MM, 2003, P NATL ACAD SCI USA, V100, P10529, DOI 10.1073/pnas.1834309100; Ivy D, 2020, NEUROPSYCHOPHARMACOL, V45, P1330, DOI 10.1038/s41386-020-0696-x; Jafari MR, 2007, BEHAV PHARMACOL, V18, P691, DOI 10.1097/FBP.0b013e3282f00c10; Jhaveri MD, 2008, EUR J NEUROSCI, V27, P1722, DOI 10.1111/j.1460-9568.2008.06162.x; Jia Y, 2020, NEUROSCI LETT, V720, DOI 10.1016/j.neulet.2020.134779; Jing N, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01784-7; Jones CA, 2011, BRIT J PHARMACOL, V164, P1162, DOI 10.1111/j.1476-5381.2011.01386.x; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kim J, 2015, J PHYSIOL-LONDON, V593, P871, DOI 10.1113/jphysiol.2014.286633; Klauke AL, 2014, EUR NEUROPSYCHOPHARM, V24, P608, DOI 10.1016/j.euroneuro.2013.10.008; Kofalvi A, 2016, NEUROPHARMACOLOGY, V110, P519, DOI 10.1016/j.neuropharm.2016.03.015; Koob GF, 2008, ANNU REV PSYCHOL, V59, P29, DOI 10.1146/annurev.psych.59.103006.093548; Krenk L, 2010, ACTA ANAESTH SCAND, V54, P951, DOI 10.1111/j.1399-6576.2010.02268.x; Kruk-Slomka M, 2017, NEUROTOX RES, V31, P410, DOI 10.1007/s12640-017-9702-4; Kruk-Slomka M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9815092; Kruk-Slomka M, 2015, BEHAV BRAIN RES, V284, P24, DOI 10.1016/j.bbr.2015.01.051; Lagalwar S, 1999, J MOL NEUROSCI, V13, P55, DOI 10.1385/JMN:13:1-2:55; Lanciego JL, 2011, J PSYCHOPHARMACOL, V25, P97, DOI 10.1177/0269881110367732; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Li L, 2018, BRAIN RES, V1697, P113, DOI 10.1016/j.brainres.2018.06.006; Li L, 2015, TRANSL STROKE RES, V6, P467, DOI 10.1007/s12975-015-0425-7; Li Y, 2015, NEUROSCIENCE, V311, P253, DOI 10.1016/j.neuroscience.2015.10.041; Lin Li, 2017, Front Immunol, V8, P112, DOI 10.3389/fimmu.2017.00112; Liu QR, 2009, GENES BRAIN BEHAV, V8, P519, DOI 10.1111/j.1601-183X.2009.00498.x; Liu XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075804; Llorente-Berzal A, 2015, PSYCHOPHARMACOLOGY, V232, P2811, DOI 10.1007/s00213-015-3917-y; Lopes JB, 2020, PSYCHOPHARMACOLOGY, V237, P385, DOI 10.1007/s00213-019-05370-5; Lu HC, 2016, BIOL PSYCHIAT, V79, P516, DOI 10.1016/j.biopsych.2015.07.028; Ma ZG, 2019, EBIOMEDICINE, V42, P225, DOI 10.1016/j.ebiom.2019.03.040; Malan TP, 2003, CURR OPIN PHARMACOL, V3, P62, DOI 10.1016/S1471-4892(02)00004-8; Martin-Moreno AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-8; Martin-Moreno AM, 2011, MOL PHARMACOL, V79, P964, DOI 10.1124/mol.111.071290; Marinelli S, 2009, NAT NEUROSCI, V12, P1488, DOI 10.1038/nn.2430; Martin-Sanchez A, 2019, PHARMACOL BIOCHEM BE, V183, P22, DOI 10.1016/j.pbb.2019.06.007; Matalon ST, 2020, UNITED EUR GASTROENT, V8, P271, DOI 10.1177/2050640619889773; Mcguinness D, 2009, J BIOMOL SCREEN, V14, P49, DOI 10.1177/1087057108327329; McLaughlin RJ, 2009, EUR J PHARMACOL, V624, P71, DOI 10.1016/j.ejphar.2009.09.055; MECHOULAM R, 1990, TETRAHEDRON-ASYMMETR, V1, P315, DOI 10.1016/S0957-4166(00)86322-3; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Mendiguren A, 2018, LIFE SCI, V192, P115, DOI 10.1016/j.lfs.2017.11.029; Molina PE, 2011, J NEUROIMMUNE PHARM, V6, P516, DOI 10.1007/s11481-011-9301-8; Molina-Holgado F, 2003, J NEUROSCI, V23, P6470; Morales P, 2018, BIOCHEM PHARMACOL, V157, P8, DOI 10.1016/j.bcp.2018.07.031; Moreira FA, 2009, BEST PRACT RES CL EN, V23, P133, DOI 10.1016/j.beem.2008.09.003; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Murikinati S, 2010, FASEB J, V24, P788, DOI 10.1096/fj.09-141275; Murin Y, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005953; Naguib M, 2008, BRIT J PHARMACOL, V155, P1104, DOI 10.1038/bjp.2008.340; Navarrete F, 2018, BIOCHEM PHARMACOL, V157, P227, DOI 10.1016/j.bcp.2018.07.041; Navarrete F, 2013, NEUROPSYCHOPHARMACOL, V38, P2515, DOI 10.1038/npp.2013.157; Navarrete F, 2012, BRIT J PHARMACOL, V165, P260, DOI 10.1111/j.1476-5381.2011.01542.x; Navarro-Dorado J, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00422; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; O'Connell BK, 2017, EPILEPSY BEHAV, V70, P341, DOI 10.1016/j.yebeh.2016.11.012; Onaivi ES, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001640; Onaivi ES, 2006, ANN NY ACAD SCI, V1074, P514, DOI 10.1196/annals.1369.052; Ortega-Alvaro A, 2011, NEUROPSYCHOPHARMACOL, V36, P1489, DOI 10.1038/npp.2011.34; Patel S, 2004, ENDOCRINOLOGY, V145, P5431, DOI 10.1210/en.2004-0638; Patel S, 2008, EUR J NEUROSCI, V27, P2821, DOI 10.1111/j.1460-9568.2008.06266.x; Patel S, 2017, NEUROSCI BIOBEHAV R, V76, P56, DOI 10.1016/j.neubiorev.2016.12.033; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2005, HANDB EXP PHARMACOL, V168, P1; Poleszak E, 2020, PHARMACOL REP, V72, P1562, DOI 10.1007/s43440-020-00088-0; Poleszak E, 2020, PHARMACOL BIOCHEM BE, V188, DOI 10.1016/j.pbb.2019.172833; Poleszak E, 2020, BEHAV BRAIN RES, V378, DOI 10.1016/j.bbr.2019.112297; Potenzieri C, 2008, BRAIN RES, V1215, P69, DOI 10.1016/j.brainres.2008.03.063; Pottier G, 2017, J CEREBR BLOOD F MET, V37, P1163, DOI 10.1177/0271678X16685105; Powers MS, 2015, ALCOHOL CLIN EXP RES, V39, P2438, DOI 10.1111/acer.12894; Qamri Z, 2009, MOL CANCER THER, V8, P3117, DOI 10.1158/1535-7163.MCT-09-0448; Quartilho A, 2003, ANESTHESIOLOGY, V99, P955, DOI 10.1097/00000542-200310000-00031; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Ramirez SH, 2013, J LEUKOCYTE BIOL, V93, P801, DOI 10.1189/jlb.1012523; Ramirez SH, 2012, J NEUROSCI, V32, P4004, DOI 10.1523/JNEUROSCI.4628-11.2012; Rivera P, 2018, BIOCHEM PHARMACOL, V157, P244, DOI 10.1016/j.bcp.2018.08.005; Rivera P, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00379; Rodriguez-Arias M, 2015, PSYCHOPHARMACOLOGY, V232, P3019, DOI 10.1007/s00213-015-3939-5; Sagar DR, 2005, EUR J NEUROSCI, V22, P371, DOI 10.1111/j.1460-9568.2005.04206.x; Salort G, 2017, PSYCHOPHARMACOLOGY, V234, P925, DOI 10.1007/s00213-017-4537-5; Sanchez C, 2001, CANCER RES, V61, P5784; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Schmidt W, 2012, NEUROSCIENCE, V227, P313, DOI 10.1016/j.neuroscience.2012.09.080; Shapiro L, 2019, EPILEPSIA, V60, P2359, DOI 10.1111/epi.16388; Sheng WS, 2019, PAIN RES MANAG, V2019, DOI 10.1155/2019/1260353; Shi HK, 2020, J HYPERTENS, V38, P886, DOI 10.1097/HJH.0000000000002342; Shi P, 2010, HYPERTENSION, V56, P297, DOI 10.1161/HYPERTENSIONAHA.110.150409; Skaper SD, 1996, P NATL ACAD SCI USA, V93, P3984, DOI 10.1073/pnas.93.9.3984; Soethoudt M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13958; Soini Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-70; Stempel AV, 2016, NEURON, V90, P795, DOI 10.1016/j.neuron.2016.03.034; Sun LL, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0913-7; Tabrizi MA, 2016, CHEM REV, V116, P519, DOI 10.1021/acs.chemrev.5b00411; Tai Sherrica, 2014, Curr Addict Rep, V1, P129; Tambaro Simone, 2012, Recent Pat CNS Drug Discov, V7, P25; Tan Q, 2017, BRAIN RES, V1654, P24, DOI 10.1016/j.brainres.2016.10.016; Tang J, 2017, NEUROPHARMACOLOGY, V119, P157, DOI 10.1016/j.neuropharm.2017.01.027; Tang J, 2016, MOL NEUROBIOL, V53, P1935, DOI 10.1007/s12035-015-9154-x; Tang J, 2015, NEUROPHARMACOLOGY, V95, P424, DOI 10.1016/j.neuropharm.2015.04.028; Tao YH, 2016, BRAIN BEHAV IMMUN, V58, P118, DOI 10.1016/j.bbi.2016.05.020; Tao YH, 2015, BRAIN RES, V1602, P127, DOI 10.1016/j.brainres.2015.01.025; Teune LK, 2010, MOVEMENT DISORD, V25, P2395, DOI 10.1002/mds.23291; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Valenzano KJ, 2005, NEUROPHARMACOLOGY, V48, P658, DOI 10.1016/j.neuropharm.2004.12.008; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Vecchio EA, 2018, BRIT J PHARMACOL, V175, P4036, DOI 10.1111/bph.14337; Vera G, 2013, PHARMACOL BIOCHEM BE, V105, P205, DOI 10.1016/j.pbb.2013.02.008; Viana TG, 2019, NEUROPHARMACOLOGY, V148, P284, DOI 10.1016/j.neuropharm.2019.01.022; Vinters HV, 2015, ANNU REV PATHOL-MECH, V10, P291, DOI 10.1146/annurev-pathol-020712-163927; Viscomi MT, 2009, J NEUROSCI, V29, P4564, DOI 10.1523/JNEUROSCI.0786-09.2009; Wang L, 2018, J ALZHEIMERS DIS, V64, P957, DOI 10.3233/JAD-180142; Wang L, 2018, MOL NEUROBIOL, V55, P4731, DOI 10.1007/s12035-017-0676-2; Wang SS, 2016, BRAIN RES BULL, V121, P91, DOI 10.1016/j.brainresbull.2016.01.006; Wang Z, 2018, INT J MOL MED, V42, P2914, DOI 10.3892/ijmm.2018.3834; Wiley JL, 2002, J PHARMACOL EXP THER, V301, P679, DOI 10.1124/jpet.301.2.679; Wojcieszak J, 2016, J MOL NEUROSCI, V58, P441, DOI 10.1007/s12031-016-0726-7; Wu HM, 2019, HEPATOL COMMUN, V3, P1373, DOI 10.1002/hep4.1415; Wu Q, 2020, INT J MOL MED, V45, P475, DOI 10.3892/ijmm.2019.4439; Wu Q, 2018, EPILEPSY RES, V148, P8, DOI 10.1016/j.eplepsyres.2018.10.002; Xi ZX, 2011, NAT NEUROSCI, V14, P1160, DOI 10.1038/nn.2874; Yamamoto W, 2008, EUR J PHARMACOL, V583, P56, DOI 10.1016/j.ejphar.2008.01.010; Yiangou Y, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-12; Yu W, 2019, INFLAMMATION, V42, P904, DOI 10.1007/s10753-018-0945-x; Yuill MB, 2017, MOL PAIN, V13, DOI 10.1177/1744806917728227; Zarruk JG, 2012, STROKE, V43, P211, DOI 10.1161/STROKEAHA.111.631044; Zenaide Paula Veriato, 2013, Rev. bras. ter. intensiva, V25, P56, DOI 10.1590/S0103-507X2013000100011; Zhang HY, 2017, ADDICT BIOL, V22, P752, DOI 10.1111/adb.12367; Zhang HY, 2015, NEUROPSYCHOPHARMACOL, V40, P1037, DOI 10.1038/npp.2014.297; Zhang HY, 2014, P NATL ACAD SCI USA, V111, pE5007, DOI 10.1073/pnas.1413210111; Zhao JF, 2020, NEUROSCI LETT, V735, DOI 10.1016/j.neulet.2020.135207; Zheng L, 2015, ALCOHOL CLIN EXP RES, V39, P1908, DOI 10.1111/acer.12845; Zhu CZ, 2009, BRIT J PHARMACOL, V157, P645, DOI 10.1111/j.1476-5381.2009.00184.x; Zhu M, 2019, J BONE MINER RES, V34, P739, DOI 10.1002/jbmr.3637; Zoppi S, 2014, BRIT J PHARMACOL, V171, P2814, DOI 10.1111/bph.12607	210	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	OCT 15	2021	909								174398	10.1016/j.ejphar.2021.174398			22	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	UR1JC	WOS:000696511000002	34332924				2022-02-06	
J	Kaminski, TW; Chrisman, SPD; Glutting, J; Wahlquist, V; Eagle, S; Putukian, M; Tierney, R; Broglio, SP; McAllister, TW; McCrea, MA; Pasquina, PF; Kontos, AP				Kaminski, Thomas W.; Chrisman, Sara P. D.; Glutting, Joseph; Wahlquist, Victoria; Eagle, Shawn; Putukian, Margot; Tierney, Ryan; Broglio, Steven P.; McAllister, Thomas W.; McCrea, Michael A.; Pasquina, Paul F.; Kontos, Anthony P.		CARE Site Investigators	Mechanisms of injury for concussions in collegiate soccer: an NCAA/DoD CARE consortium study	SCIENCE AND MEDICINE IN FOOTBALL			English	Article; Early Access						Repetitive head impacts; football; aerial challenges; heading; concussion; mechanism	SURVEILLANCE DESCRIPTIVE EPIDEMIOLOGY; 1ST DECADE; SYSTEM; SEX	Over 9,000 concussions occur annually in intercollegiate soccer in the United States with little known about the incidence of mechanisms (e.g., collisions) and possible factors (e.g., sex) associated with each mechanism. Objective: The purpose of this study was to describe the mechanism of injury (MOI) and examine factors associated with greater risk for specific MOIs involving concussions in collegiate soccer players. Methods: Participants included 3,288 collegiate soccer players from 28 institutions across four competitive seasons, 2014-17. MOIs were documented for 262 soccer-related concussions during the study and placed into one of four categories: collisions, unintentional contact, aerial challenges, and others. Results: 70% of the concussions occurred in DI soccer players. Collisions and unintentional contact were the MOIs that resulted in 66.5% of all concussions. DI and DIII soccer players sustained more concussions by unintentional contact versus collisions and aerial challenges when compared to their DII counterparts. Defenders were more likely than midfielders to sustain concussions by aerial challenges than collisions. As expected, the field players experienced more concussions as a result of collisions, unintentional contact, and aerial challenges when compared to goalkeepers. Conclusions: Future research should explore preventive strategies for decreasing collisions, especially during aerial challenges while heading the soccer ball, and unintentional contacts from errant balls in soccer in order to decrease concussion risk.	[Kaminski, Thomas W.; Wahlquist, Victoria] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA; [Chrisman, Sara P. D.] Seattle Childrens Hosp, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Glutting, Joseph] Univ Delaware, Sch Educ, Newark, DE 19716 USA; [Eagle, Shawn; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Putukian, Margot] Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Tierney, Ryan] Temple Univ, Dept Hlth & Rehabil Sci, Philadelphia, PA 19122 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Pasquina, Paul F.] Uniformed Serv Univ Hlth Sci, Phys Med & Rehabil, Bethesda, MD USA		Kaminski, TW (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, Human Performance Lab, Room 159 Fred Rust Ice Arena 541 South Coll Ave, Newark, DE 19716 USA.	Kaminski@udel.edu		Chrisman, Sara/0000-0001-5373-7223	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium; National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs, through the Combat Casualty Care Research Program; Department of Defense, through the Joint Program Committee 6/Combat Casualty Care Research Program -Psychological Health and Traumatic Brain Injury ProgramUnited States Department of Defense [W81XWH1420151]; U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD	This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Combat Casualty Care Research Program, endorsed by the Department of Defense, through the Joint Program Committee 6/Combat Casualty Care Research Program -Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH1420151. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Agel J, 2007, J ATHL TRAINING, V42, P270; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Chandran Avinash, 2017, Inj Epidemiol, V4, P28, DOI 10.1186/s40621-017-0127-6; Cheng J, 2019, SPORTS HEALTH, V11, P486, DOI 10.1177/1941738119877186; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dick R, 2007, J ATHL TRAINING, V42, P278; DiStefano LJ, 2018, J ATHL TRAINING, V53, P880, DOI 10.4085/1062-6050-156-17; Kerr ZY, 2018, J ATHL TRAINING, V53, P893, DOI 10.4085/1062-6050-166-17; Kerr ZY, 2019, J NEUROTRAUM, V36, P2073, DOI 10.1089/neu.2017.5319; Kunz M., 2007, FIFA MAGAZINE, V7, P11, DOI DOI 10.1080/13673882.2007.9680857; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Master CL, 2021, BRIT J SPORT MED, V55, P1387, DOI 10.1136/bjsports-2020-103316; Mihalik JP, 2020, MED SCI SPORT EXER, V52, P2349, DOI 10.1249/MSS.0000000000002382; Mooney James, 2020, Concussion, V5, pCNC76, DOI 10.2217/cnc-2020-0004; Reneker JC, 2019, MUSCULOSKEL SCI PRAC, V42, P173, DOI 10.1016/j.msksp.2019.04.004; Scholarship Stats.com, 2020, SOCC 2020; Smith NA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0346; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Weber AE, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120921746	21	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2473-3938	2473-4446		SCI MED FOOTBALL	Sci. Med. Football												10.1080/24733938.2021.1991586		OCT 2021	6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WG6LG	WOS:000707105000001					2022-02-06	
J	Lochner, A; Bazzi, A; Guyer, C; Brackney, A				Lochner, Arion; Bazzi, Ahmad; Guyer, Christopher; Brackney, Abigail			Acute Concussion Assessment and Management in the Emergency Department	CURRENT EMERGENCY AND HOSPITAL MEDICINE REPORTS			English	Article						Concussion; Emergency department; Minor head injury; Head trauma; TBI	TRAUMATIC BRAIN-INJURY; TEMPORAL WINDOW; QUICKBRAIN MRI; DIAGNOSIS; CT; IDENTIFICATION; VULNERABILITY; IMPAIRMENT; BIOMARKERS; STATEMENT	Purpose of review This review summarizes how a concussion is defined and diagnosed. We seek to give physicians and other providers a better understanding of the tools available to help diagnose and manage concussion in the Emergency Department. Recent findings There is a paucity of research on how to diagnose and manage concussion in the Emergency Department. What has been done has demonstrated that there are patients with concussion who are not being diagnosed correctly or given proper discharge instructions on their condition. Most of the existing research focuses on sports-specific concussion. Summary Emergency Department physicians have an opportunity to correctly diagnose concussions and ensure patients have a plan for follow-up care and for gradual return to activity.	[Lochner, Arion; Bazzi, Ahmad; Guyer, Christopher; Brackney, Abigail] Henry Ford Hosp, Dept Emergency Med, 2799 W Grand Blvd CFP 2, Detroit, MI 48202 USA		Guyer, C (corresponding author), Henry Ford Hosp, Dept Emergency Med, 2799 W Grand Blvd CFP 2, Detroit, MI 48202 USA.	alochne1@hfhs.org; abazzi1@hfhs.org; cguyer1@hfhs.org; abrackn3@hfhs.org		Guyer, Chistopher/0000-0001-7378-7017			[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; [Anonymous], 2010, CONTR CFD; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bazarian JJ, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.37349; Brooks MA, 2018, J HEAD TRAUMA REHAB, V33, P1, DOI 10.1097/HTR.0000000000000328; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Choe MC, 2015, SEMIN NEUROL, V35, P29, DOI 10.1055/s-0035-1544243; DeAngelis J, 2017, WEST J EMERG MED, V18, P821, DOI 10.5811/westjem.2017.6.33685; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Fallesen P, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-038161; Friedman BW, 2021, NEUROLOGY, V96, pE2323, DOI 10.1212/WNL.0000000000011822; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Green James Ij, 2017, Prim Dent J, V6, P27, DOI 10.1308/205016817821281738; Hanley D, 2018, J NEUROTRAUM, V35, P41, DOI 10.1089/neu.2017.5004; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jacquin A, 2018, COMPUT BIOL MED, V102, P95, DOI 10.1016/j.compbiomed.2018.09.011; Kelly JP, 1997, NEUROLOGY, V48, P581; Kocher KE, 2020, ANN EMERG MED, V75, P192, DOI 10.1016/j.annemergmed.2019.04.033; Koval RR, 2020, ANN EMERG MED, V75, P483, DOI 10.1016/j.annemergmed.2019.08.419; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Mutch CA, 2016, NEUROSURG CLIN N AM, V27, P409, DOI 10.1016/j.nec.2016.05.011; Okonkwo David O, 2014, Neurosurgery, V75 Suppl 4, pS82, DOI 10.1227/NEU.0000000000000493; Papa L, 2016, SPORTS MED ARTHROSC, V24, P108, DOI 10.1097/JSA.0000000000000117; Rowe BH, 2018, AM J EMERG MED, V36, P2144, DOI 10.1016/j.ajem.2018.03.040; Scorza KA, 2019, AM FAM PHYSICIAN, V99, P426; Sheridan DC, 2020, JACEP OPEN, V1, P965, DOI 10.1002/emp2.12113; Sheridan DC, 2017, J NEUROSURG-PEDIATR, V19, P259, DOI 10.3171/2016.7.PEDS16204; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stillman A, 2017, CLEV CLIN J MED, V84, P623, DOI 10.3949/ccjm.84a.16013; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Yengo-Kahn AM, 2019, MED SCI BASEL, V7; Zuckerman SL, 2019, J NEUROSURG, V130, P1634, DOI 10.3171/2018.1.JNS172733	46	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2167-4884			CURR EMERG HOSP ME R	Curr. Emerg. Hosp. Med. Rep.	DEC	2021	9	4					97	104		10.1007/s40138-021-00236-7		OCT 2021	8	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	XG4YJ	WOS:000707545800001					2022-02-06	
J	Oezel, L; Jaekel, C; Bieler, D; Stuewe, D; Neubert, A; Lefering, R; Grassmann, JP; Windolf, J; Thelen, S; Notfall, S				Oezel, L.; Jaekel, C.; Bieler, D.; Stuewe, D.; Neubert, A.; Lefering, R.; Grassmann, J. P.; Windolf, J.; Thelen, S.; Notfall, Sektion			Differences in injury patterns in motorcycle accidents involving children and adolescents	UNFALLCHIRURG			German	Article; Early Access						Motorcycle; Mortality; Traffic accident; Injury; TraumaRegistry	TRAUMA; SEVERITY; OUTCOMES	Background Traffic accidents and the traumatic injury consequences are frequent causes of mortality and irreversible damage in children and young adults. In motorcycle accidents the injury patterns differ depending on the age of the patient. Objective The aim of this study was to describe the typical injury patterns after motorcycle accidents involving children and adolescents as these can have a decisive influence on the prevention and the adequate treatment in the respective patient groups. Material and methods The study included 22,923 patients from the years 2002-2018 which were extracted from the TraumaRegister DGU (R). Injury patterns of 4 age categories were analyzed: group 1 (4-15 years), group 2 (16-17 years), group 3 (18-20 years) and group 4 (21-50 years). Results In both younger age groups, limb injuries mostly of the lower extremities, showed the highest incidence. Moreover, younger patients with traumatic brain injury showed better outcomes despite of initially poor conditions. Ribcage, abdominal, pelvic and spinal injuries are the least frequent in younger patients. In terms of diagnostics, children are less likely to undergo whole-body computed tomography (CT) diagnostics than adults. Conclusion The study revealed age-specific differences with respect to injury patterns in patients involved in motorcycle accidents, either as drivers or co-drivers. Furthermore, the analysis of preclinical and in-hospital treatment elucidated the relevance of preventive and protective measures.	[Oezel, L.; Jaekel, C.; Bieler, D.; Stuewe, D.; Neubert, A.; Grassmann, J. P.; Windolf, J.; Thelen, S.] Heinrich Heine Univ Dusseldorf, Klin Orthopadie & Unfallchirurg, Med Fak, Moorenstr 5, D-40225 Dusseldorf, Germany; [Oezel, L.; Jaekel, C.; Bieler, D.; Stuewe, D.; Neubert, A.; Grassmann, J. P.; Windolf, J.; Thelen, S.] Heinrich Heine Univ Dusseldorf, Univ Klinikum Dusseldorf, Moorenstr 5, D-40225 Dusseldorf, Germany; [Bieler, D.] Bundeswehrzent Krankenhaus Koblenz, Klin Unfallchirurg & Orthopadie Wiederherstellung, Verbrennungsmed, Koblenz, Germany; [Lefering, R.] Univ Witten Herdecke, Inst Forsch Operativen Med, Cologne, Germany		Jaekel, C (corresponding author), Heinrich Heine Univ Dusseldorf, Klin Orthopadie & Unfallchirurg, Med Fak, Moorenstr 5, D-40225 Dusseldorf, Germany.; Jaekel, C (corresponding author), Heinrich Heine Univ Dusseldorf, Univ Klinikum Dusseldorf, Moorenstr 5, D-40225 Dusseldorf, Germany.	Carina.Jaekel@med.uni-duesseldorf.de			Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL.	Acker SN, 2019, SEMIN PEDIATR SURG, V28, P183, DOI 10.1053/j.sempedsurg.2019.04.022; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Arbuthnot M, 2019, J TRAUMA ACUTE CARE, V86, P97, DOI 10.1097/TA.0000000000002082; BACHULIS BL, 1988, AM J SURG, V155, P708, DOI 10.1016/S0002-9610(88)80151-X; Bevan CA, 2008, MED J AUSTRALIA, V189, P17, DOI 10.5694/j.1326-5377.2008.tb01888.x; Bixby SD, 2019, MAGN RESON IMAGING C, V27, P721, DOI 10.1016/j.mric.2019.07.009; Brown TG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150227; Carmai J, 2019, TRAFFIC INJ PREV, V20, pS13, DOI 10.1080/15389588.2019.1616180; Chaari A, 2018, PEDIATR EMERG CARE, V34, P198, DOI 10.1097/PEC.0000000000000756; Daniels DJ, 2015, J NEUROSURG-PEDIATR, V15, P261, DOI 10.3171/2014.9.PEDS14149; de Rome L, 2012, INJURY, V43, P2035, DOI 10.1016/j.injury.2011.10.025; de Rome L, 2014, ACCIDENT ANAL PREV, V73, P392, DOI 10.1016/j.aap.2014.09.022; de Rome L, 2011, ACCIDENT ANAL PREV, V43, P1893, DOI 10.1016/j.aap.2011.04.027; Debus F., 2013, OUP ORTHOP UNFALLCHI, V12, P565, DOI [10.3238/oup.2013.0565-0571, DOI 10.3238/OUP.2013.0565-0571]; DGU, 2020, JAHR 2020 TRAUMAREGI; Eden L, 2019, DTSCH ARZTEBL INT, V116, P479, DOI 10.3238/arztebl.2019.0479; Fan HP, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7434-5; Fitschen-Oestern S, 2020, INJURY, V51, P1608, DOI 10.1016/j.injury.2020.04.022; George MP, 2019, RADIOL CLIN N AM, V57, P843, DOI 10.1016/j.rcl.2019.02.009; Haxhija EQ, 2004, PEDIATR SURG INT, V20, P412, DOI 10.1007/s00383-004-1165-z; Hogue GD, 2015, J PEDIATR ORTHOP B, V24, P139, DOI 10.1097/BPB.0000000000000108; Jandhyala S, 2011, ANZ J SURG, V81, P312, DOI 10.1111/j.1445-2197.2011.05701.x; Kortor J N, 2010, Niger J Med, V19, P475; Leijdesdorff HA, 2012, J TRAUMA ACUTE CARE, V72, P1363, DOI 10.1097/TA.0b013e318250cced; Li QF, 2016, ARCH DIS CHILD, V101, P1063, DOI 10.1136/archdischild-2015-309586; Lin MR, 2008, ACCIDENT ANAL PREV, V40, P1653, DOI 10.1016/j.aap.2008.05.005; Lin MR, 2001, J TRAUMA, V50, P24, DOI 10.1097/00005373-200101000-00004; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Miller B, 2006, J NEUROSURG, V105, P182, DOI 10.3171/ped.2006.105.3.182; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Oxley Jennifer, 2013, Ann Adv Automot Med, V57, P329; Sauber-Schatz EK, 2016, MMWR-MORBID MORTAL W, V65, P672, DOI 10.15585/mmwr.mm6526e1; Theofilatos A, 2014, TRAFFIC INJ PREV, V15, P156, DOI 10.1080/15389588.2013.801554; World Health Organization, 2007, 10 STAT HIGHL GLOB P; Wu D, 2019, TRAFFIC INJ PREV, V20, P196, DOI 10.1080/15389588.2018.1545090	36	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg												10.1007/s00113-021-01090-8		OCT 2021	11	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	WH2WP	WOS:000707545100003	34652472	hybrid			2022-02-06	
J	Pugh, MJ; Kennedy, E; Gugger, JJ; Mayo, J; Tate, D; Swan, A; Kean, J; Altalib, H; Gowda, S; Towne, A; Hinds, S; Van Cott, A; Lopez, MR; Jaramillo, CA; Eapen, BC; McCafferty, RR; Salinsky, M; Cramer, J; McMillan, KK; Kalvesmaki, A; Diaz-Arrastia, R				Pugh, Mary Jo; Kennedy, Eamonn; Gugger, James J.; Mayo, Jamie; Tate, David; Swan, Alicia; Kean, Jacob; Altalib, Hamada; Gowda, Shaila; Towne, Alan; Hinds, Sidney; Van Cott, Anne; Lopez, Maria R.; Jaramillo, Carlos A.; Eapen, Blessen C.; McCafferty, Randall R.; Salinsky, Martin; Cramer, Joyce; McMillan, Katherine K.; Kalvesmaki, Andrea; Diaz-Arrastia, Ramon		MINUTE Study Grp	The Military Injuries: Understanding Post-Traumatic Epilepsy Study: Understanding Relationships among Lifetime Traumatic Brain Injury History, Epilepsy, and Quality of Life	JOURNAL OF NEUROTRAUMA			English	Article						epilepsy; health outcomes; post-traumatic epilepsy; quality of life; traumatic brain injury	NEW-ONSET EPILEPSY; HEALTH-STATUS; VETERANS; IMPACT; AFGHANISTAN; OUTCOMES; IRAQ; TBI; ASSOCIATIONS; INDIVIDUALS	Understanding risk for epilepsy among persons who sustain a mild (mTBI) traumatic brain injury (TBI) is crucial for effective intervention and prevention. However, mTBI is frequently undocumented or poorly documented in health records. Further, health records are non-continuous, such as when persons move through health systems (e.g., from Department of Defense to Veterans Affairs [VA] or between jobs in the civilian sector), making population-based assessments of this relationship challenging. Here, we introduce the MINUTE (Military INjuries-Understanding post-Traumatic Epilepsy) study, which integrates data from the Veterans Health Administration with self-report survey data for post-9/11 veterans (n = 2603) with histories of TBI, epilepsy and controls without a history of TBI or epilepsy. This article describes the MINUTE study design, implementation, hypotheses, and initial results across four groups of interest for neurotrauma: 1) control; 2) epilepsy; 3) TBI; and 4) post-traumatic epilepsy (PTE). Using combined survey and health record data, we test hypotheses examining lifetime history of TBI and the differential impacts of TBI, epilepsy, and PTE on quality of life. The MINUTE study revealed high rates of undocumented lifetime TBIs among veterans with epilepsy who had no evidence of TBI in VA medical records. Further, worse physical functioning and health-related quality of life were found for persons with epilepsy + TBI compared to those with either epilepsy or TBI alone. This effect was not fully explained by TBI severity. These insights provide valuable opportunities to optimize the resilience, delivery of health services, and community reintegration of veterans with TBI and complex comorbidity.</p>	[Pugh, Mary Jo; Tate, David; Kean, Jacob; Kalvesmaki, Andrea] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Pugh, Mary Jo; Kennedy, Eamonn; Mayo, Jamie; Kalvesmaki, Andrea] Univ Utah, Sch Med, Div Epidemiol, Salt Lake City, UT USA; [Tate, David] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Kean, Jacob] Univ Utah, Sch Med, Dept Populat Hlth Sci, Salt Lake City, UT USA; [Gugger, James J.; Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Swan, Alicia] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Altalib, Hamada] VA Connecticut Hlth Care Syst, Epilepsy Ctr Excellence, West Haven, CT USA; [Altalib, Hamada] Yale Univ, Sch Med, Dept Neurol, West Haven, CT 06516 USA; [Altalib, Hamada] Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA; [Gowda, Shaila; Cramer, Joyce] Baylor Sch Med, Dept Neurol, Houston, TX USA; [Towne, Alan] Hunter Holmes McGuire VA Med Ctr, Richmond, VA USA; [Towne, Alan] Virginia Commonwealth Univ, Sch Med, Dept Neurol, Richmond, VA USA; [Hinds, Sidney] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Van Cott, Anne] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Van Cott, Anne] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Lopez, Maria R.] Miami VA Hlth Care Syst, Miami, FL USA; [Lopez, Maria R.] Univ Miami, Sch Med, Dept Neurol, Miami, FL USA; [Jaramillo, Carlos A.] South Texas Vet Healthcare Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Eapen, Blessen C.] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Eapen, Blessen C.] Univ Calif Los Angeles, Los Angeles, CA USA; [McCafferty, Randall R.] Desert Reg Med Ctr, Palm Springs, CA USA; [Salinsky, Martin] VA Portland Healthcare Syst, Portland, OR USA; [Salinsky, Martin] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Cramer, Joyce] Cramer Consulting, Houston, TX USA; [McMillan, Katherine K.] Behav Sci Consulting, San Antonio, TX USA		Pugh, MJ (corresponding author), VA Salt Lake City, Res 181, 500 Foothill Dr, Salt Lake City, UT 84148 USA.	Maryjo.pugh@hsc.utah.edu			Congressionally Directed Medical Research Program, Epilepsy Research Program [W81XWH-16-2-0046]; VA Health Services Research and Development ServiceUS Department of Veterans Affairs [RCS 17-297]	This study was funded by the Congressionally Directed Medical Research Program, Epilepsy Research Program,Project W81XWH-16-2-0046. Dr. Pugh also received funding from a VA Health Services Research and Development Service grant (RCS 17-297). Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the U.S. government, the Department of Defense, or the U.S. Department of Veterans Affairs;no official endorsement should be inferred.	Annegers JF, 1996, MAYO CLIN PROC, V71, P570, DOI 10.4065/71.6.570; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P19; Belanger HG, 2017, J HEAD TRAUMA REHAB, V32, P46, DOI 10.1097/HTR.0000000000000208; Bomyea J, 2019, PSYCHIAT RES, V272, P531, DOI 10.1016/j.psychres.2018.12.021; Bouldin ED, 2021, J HEAD TRAUMA REHAB, V36, P10, DOI 10.1097/HTR.0000000000000574; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Cifu D.X., 2015, TRAUMATIC BRAIN INJU, P6; Cramer JA, 2000, EPILEPSY RES, V41, P29, DOI 10.1016/S0920-1211(00)00127-3; Defense Health Agency, 2020, SURV CAS DEF; Delgado RE, 2018, MIL MED, V183, P379, DOI 10.1093/milmed/usx156; Department of Defense, 2004, CRIT PROCE REQ PHYS; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS23, DOI 10.1016/j.apmr.2017.05.012; Fear NT, 2008, AM J PREV MED, V35, P230, DOI 10.1016/j.amepre.2008.05.027; Grafman J., 1992, EFFECTS COGNITION AD, V57, P369; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Heiberg G, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1101-9; Johnson EK, 2004, EPILEPSIA, V45, P544, DOI 10.1111/j.0013-9580.2004.47003.x; Juengst SB, 2017, EPILEPSY BEHAV, V73, P240, DOI 10.1016/j.yebeh.2017.06.001; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Lequerica AH, 2018, ARCH PHYS MED REHAB, V99, P1811, DOI 10.1016/j.apmr.2018.03.023; Lequerica AH, 2017, NEUROPSYCHOL REHABIL, V27, P1019, DOI 10.1080/09602011.2016.1231120; Manacheril R, 2015, HEALTHCARE-BASEL, V3, P1271, DOI 10.3390/healthcare3041271; McCrea MA, 2017, PHYS MED REH CLIN N, V28, P271, DOI 10.1016/j.pmr.2016.12.005; Mula M, 2019, EPILEPSY BEHAV, V101, DOI 10.1016/j.yebeh.2019.106598; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Pugh MJV, 2008, NEUROLOGY, V70, P2171, DOI 10.1212/01.wnl.0000313157.15089.e6; Pugh MJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222674; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Pugh MJ, 2016, MMWR-MORBID MORTAL W, V65, P1224, DOI 10.15585/mmwr.mm6544a5; Pugh MJ, 2015, EPILEPSIA, V56, P321, DOI 10.1111/epi.12873; Pugh MJV, 2007, INT REV NEUROBIOL, V81, P221, DOI 10.1016/S0074-7742(06)81014-7; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; Pugh MJV, 2009, J AM GERIATR SOC, V57, P237, DOI 10.1111/j.1532-5415.2008.02124.x; Pugh MJV, 2005, EPILEPSIA, V46, P1820, DOI 10.1111/j.1528-1167.2005.00291.x; Pulsipher DT, 2006, EPILEPSY BEHAV, V9, P510, DOI 10.1016/j.yebeh.2006.07.014; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Reyes-Miranda A, 2020, EPILEPSY BEHAV, V106, DOI 10.1016/j.yebeh.2020.107047; Sajatovic M, 2017, EPILEPSY BEHAV, V69, P177, DOI 10.1016/j.yebeh.2016.12.005; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Selim AJ, 2011, QUAL LIFE RES, V20, P1337, DOI 10.1007/s11136-011-9866-y; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Semple BD, 2019, NEUROBIOL DIS, V123, P27, DOI 10.1016/j.nbd.2018.07.018; Silva MA, 2021, ARCH PHYS MED REHAB, V102, P58, DOI 10.1016/j.apmr.2020.08.012; Swan AA, 2018, BRAIN INJURY, V32, P1637, DOI 10.1080/02699052.2018.1518539; Swan AA, 2018, BRAIN INJURY, V32, P1197, DOI 10.1080/02699052.2018.1495340; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; WEISS GH, 1986, ARCH NEUROL-CHICAGO, V43, P771, DOI 10.1001/archneur.1986.00520080019013; Welton JM, 2020, EPILEPSY BEHAV, V104, DOI 10.1016/j.yebeh.2019.106856; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287	50	0	0	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2021	38	20					2841	2850		10.1089/neu.2021.0015			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WL5LP	WOS:000710446800008	34353118				2022-02-06	
J	Rincon, SP; Mukherjee, P; Levin, HS; Temkin, NR; Donald, CLM; Krainak, DM; Sun, XY; Jain, S; Taylor, SR; Markowitz, AJ; Kumar, A; Manley, GT; Yuh, EL				Rincon, Sandra P.; Mukherjee, Pratik; Levin, Harvey S.; Temkin, Nancy R.; Mac Donald, Christine L.; Krainak, Daniel M.; Sun, Xiaoying; Jain, Sonia; Taylor, Sabrina R.; Markowitz, Amy J.; Kumar, Allison; Manley, Geoffrey T.; Yuh, Esther L.		TRACK-TBI Investigators	Interrater Reliability of National Institutes of Health Traumatic Brain Injury Imaging Common Data Elements for Brain Magnetic Resonance Imaging in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						Common Data Elements; FDA Medical Device Development Tool; imaging; interrater reliability; MRI; radiology	VARIABILITY	The National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH-NINDS) Traumatic Brain Injury (TBI) Imaging Common Data Elements (CDEs) are standardized definitions for pathological intracranial lesions based on their appearance on neuroimaging studies. The NIH-NINDS TBI Imaging CDEs were designed to be as consistent as possible with the U.S. Food and Drug Administration (FDA) definition of biomarkers as "an indicator of normal biological processes, pathogenic processes, or biological responses to an exposure or intervention." However, the FDA qualification process for biomarkers requires proof of reliable biomarker test measurements. We determined the interrater reliability of TBI Imaging CDEs on subacute brain magnetic resonance imaging (MRI) performed on 517 mild TBI patients presenting to 11 U.S. level 1 trauma centers. Three U.S. board-certified neuroradiologists independently evaluated brain MRI performed 2 weeks post-injury for the following CDEs: traumatic axonal injury (TAI), diffuse axonal injury (DAI), and brain contusion. We found very high interrater agreement for brain contusion, with prevalence- and bias-adjusted kappa (PABAK) values for pairs of readers from 0.92 [95% confidence interval, 0.88-0.95] to 0.94 [0.90-0.96]. We found intermediate agreement for TAI and DAI, with PABAK values of 0.74-0.78 [0.70-0.82]. The near-perfect agreement for subacute brain contusion is likely attributable to the high conspicuity and distinctive appearance of these lesions on T1-weighted images. Interrater agreement for TAI and DAI was lower, because signal void in small vascular structures, and artifactual foci of signal void, can be difficult to distinguish from the punctate round or linear areas of slight hemorrhage that are a common hallmark of TAI/DAI on MRI.</p>	[Rincon, Sandra P.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Mukherjee, Pratik; Yuh, Esther L.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Taylor, Sabrina R.; Markowitz, Amy J.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Mukherjee, Pratik; Taylor, Sabrina R.; Markowitz, Amy J.; Manley, Geoffrey T.; Yuh, Esther L.] Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA USA; [Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Temkin, Nancy R.; Mac Donald, Christine L.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Krainak, Daniel M.] US FDA, Silver Spring, MD USA; [Sun, Xiaoying; Jain, Sonia] Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth & Longev Sci, Biostat Res Ctr, La Jolla, CA 92093 USA; [Kumar, Allison] Arina Consulting, San Francisco, CA USA		Yuh, EL (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, Brain & Spinal Injury Ctr, 185 Berry St,Lobby 6,Suite 350, San Francisco, CA 94107 USA.	esther.yuh@ucsf.edu			U.S. Department of Defense TBI Endpoints Development Initiative grantUnited States Department of Defense [W81XWH-14-2-0176]; U.S. NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS1365885]; One Mind; NeuroTrauma Sciences; Jackson Family Foundation	This study was supported by U.S. Department of Defense TBI Endpoints Development Initiative grant W81XWH-14-2-0176, U.S. NIH-NINDS grant U01 NS1365885, One Mind, NeuroTrauma Sciences, and the Jackson Family Foundation. The article contents are solely the responsibility of the authors and do not necessarily represent the official views of the sponsors.	Adeniyi O., BIOMARKERS ENDPOINTS; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; de Vet HCW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2125; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; ELMORE JG, 1994, NEW ENGL J MED, V331, P1493, DOI 10.1056/NEJM199412013312206; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Huff JS, 2014, AM J EMERG MED, V32, P606, DOI 10.1016/j.ajem.2014.03.010; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; TEASDALE G, 1974, LANCET, V2, P81; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; U.S. Food and Drug Administration, 2021, MED DEV DEV TOOLS MD; van den Heuvel TLA, 2016, NEUROIMAGE-CLIN, V12, P241, DOI 10.1016/j.nicl.2016.07.002; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	19	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2021	38	20					2831	2840		10.1089/neu.2021.0138			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WL5LP	WOS:000710446800007	34275326	hybrid			2022-02-06	
J	Salemi-Mokri-Boukani, P; Karimian-Sani-Varjovi, H; Safari, MS				Salemi-Mokri-Boukani, Paria; Karimian-Sani-Varjovi, Habib; Safari, Mir-Shahram			The promoting effect of vagus nerve stimulation on Lempel-Ziv complexity index of consciousness	PHYSIOLOGY & BEHAVIOR			English	Article						Visceral afferent; Brain-body interaction; Vagus nerve stimulation; Consciousness	PROPOFOL ANESTHESIA; CORTICAL ACTIVITY; NEURAL RESPONSES; BRAIN; RECOVERY; ACCESS; CORTEX; SLEEP; UNCONSCIOUSNESS; MECHANISMS	Recent studies suggest that vagus nerve stimulation (VNS) promotes cognitive and behavioral restoration after traumatic brain injuries. As vagus nerve has wide effects over the brain and visceral organs, stimulation of the sensory/visceral afferents might have a therapeutic potential to modulate the level of consciousness. One of the most important challenges in studying consciousness is objective evaluation of the consciousness level. Brain complexity that can be measured through Lempel-Ziv complexity (LZC) index was used as a novel mathematical approach for objective measurement of consciousness. The main goal of our study was to examine the effects of VNS on LZC index of consciousness. In this study, we did VNS on the anesthetized rats, and simultaneously LFPs recording was performed in two different cortical areas of primary somatosensory (S-1) or visual (V-1) cortex. LZC and the amplitude of slow waves were computed during different periods of VNS. We found that the LZC index during VNS period was significantly higher in both of the cortical areas of S-1 and V-1. Slow-wave activity decreased during VNS in S-1, while there was no significant change in V-1. Our findings showed that VNS can augment the consciousness level, and LZC index is a more sensitive parameter for detecting the level of consciousness.	[Salemi-Mokri-Boukani, Paria; Karimian-Sani-Varjovi, Habib; Safari, Mir-Shahram] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Sch Med, Tehran, Iran; [Karimian-Sani-Varjovi, Habib; Safari, Mir-Shahram] Brain Future Inst, Tehran, Iran		Safari, MS (corresponding author), Shahid Beheshti Univ Med Sci, Neurosci Reserach Ctr, Daneshjoo Blvd,Evin Ave, Tehran 1983963113, Iran.	Safari@sbmu.ac.ir			Neuroscience Research Center, Shahid Beheshti University of Medical Sciences [26306]	This article has been funded by Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, grant number 26306. The authors would like to thank the Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran for invaluable support.	Abasolo D, 2015, J NEUROPHYSIOL, V113, P2742, DOI 10.1152/jn.00575.2014; Akeju O, 2014, ELIFE, V3, DOI 10.7554/eLife.04499; Barttfeld P, 2015, P NATL ACAD SCI USA, V112, P887, DOI 10.1073/pnas.1418031112; Blefari ML, 2017, EUR J NEUROSCI, V45, P1300, DOI 10.1111/ejn.13567; Boly M, 2017, J NEUROSCI, V37, P9603, DOI 10.1523/JNEUROSCI.3218-16.2017; Bonhomme V, 2016, ANESTHESIOLOGY, V125, P873, DOI 10.1097/ALN.0000000000001275; Bor D, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00063; Borland MS, 2016, BRAIN STIMUL, V9, P117, DOI 10.1016/j.brs.2015.08.018; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Casarotto S, 2016, ANN NEUROL, V80, P718, DOI 10.1002/ana.24779; Cavanna F., 2017, NEUROIMAGE; Childs JE, 2015, JOVE-J VIS EXP, DOI 10.3791/53032; Corazzol M, 2017, CURR BIOL, V27, pR994, DOI 10.1016/j.cub.2017.07.060; Crick FC, 2005, PHILOS T R SOC B, V360, P1271, DOI 10.1098/rstb.2005.1661; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; Del Cul A, 2009, BRAIN, V132, P2531, DOI 10.1093/brain/awp111; Flores FJ, 2017, P NATL ACAD SCI USA, V114, pE6660, DOI 10.1073/pnas.1700148114; Hachem LD, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.6.FOCUS18216; Herrera CG, 2016, NAT NEUROSCI, V19, P290, DOI 10.1038/nn.4209; Hirvonen J, 2016, HUM BRAIN MAPP, V37, P311, DOI 10.1002/hbm.23033; Honjoh S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04497-x; Hudetz AG, 2016, NEUROSCIENCE, V339, P402, DOI 10.1016/j.neuroscience.2016.10.023; Hudetz AG, 2016, NEUROSCI LETT, V628, P132, DOI 10.1016/j.neulet.2016.06.017; Hudetz AG, 2015, BRAIN CONNECT, V5, P10, DOI 10.1089/brain.2014.0230; Jain SK, 2013, BRAIN INJURY, V27, P500, DOI 10.3109/02699052.2013.765597; Jordan D, 2013, ANESTHESIOLOGY, V119, P1031, DOI 10.1097/ALN.0b013e3182a7ca92; Knotts JD, 2018, CURR BIOL, V28, pR749, DOI 10.1016/j.cub.2018.05.033; Koch C, 2016, NAT REV NEUROSCI, V17, DOI 10.1038/nrn.2016.105; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Lewis LD, 2012, P NATL ACAD SCI USA, V109, pE3377, DOI 10.1073/pnas.1210907109; Loerwald KW, 2018, BRAIN STIMUL, V11, P271, DOI 10.1016/j.brs.2017.11.007; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Mashour GA, 2018, TRENDS NEUROSCI, V41, P150, DOI 10.1016/j.tins.2018.01.003; Min BK, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-10; Minert A, 2017, J NEUROSCI, V37, P9320, DOI 10.1523/JNEUROSCI.0544-17.2017; Moe HK, 2018, J NEUROTRAUM, V35, P975, DOI 10.1089/neu.2017.5252; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Odegaard B, 2017, J NEUROSCI, V37, P9593, DOI 10.1523/JNEUROSCI.3217-16.2017; Ovadia-Caro S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037238; Pal D, 2018, CURR BIOL, V28, P2145, DOI 10.1016/j.cub.2018.05.025; Park HD, 2018, CEREB CORTEX, V28, P2351, DOI 10.1093/cercor/bhx136; Park HD, 2016, J NEUROSCI, V36, P8453, DOI 10.1523/JNEUROSCI.0311-16.2016; Park HD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0208; Park HD, 2014, NAT NEUROSCI, V17, P612, DOI 10.1038/nn.3671; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Parvizi J, 2001, COGNITION, V79, P135, DOI 10.1016/S0010-0277(00)00127-X; Pockett S, 2009, CONSCIOUS COGN, V18, P1049, DOI 10.1016/j.concog.2009.08.010; Ranft A, 2016, ANESTHESIOLOGY, V125, P861, DOI 10.1097/ALN.0000000000001322; Redinbaugh MJ, 2020, NEURON, V106, P66, DOI 10.1016/j.neuron.2020.01.005; Rizzo P, 2003, SLEEP, V26, P607, DOI 10.1093/sleep/26.5.607; Salomon R, 2016, J NEUROSCI, V36, P5115, DOI 10.1523/JNEUROSCI.4262-15.2016; Sanders RD, 2012, ANESTHESIOLOGY, V116, P946, DOI 10.1097/ALN.0b013e318249d0a7; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; Sarasso S, 2015, CURR BIOL, V25, P3099, DOI 10.1016/j.cub.2015.10.014; Sarasso S, 2014, CLIN EEG NEUROSCI, V45, P40, DOI 10.1177/1550059413513723; Schiff N, 1999, J COGNITIVE NEUROSCI, V11, P650, DOI 10.1162/089892999563715; Schiff ND, 2020, NEURON, V106, P1, DOI 10.1016/j.neuron.2020.02.016; Shi C, 2013, NEUROL RES, V35, P263, DOI 10.1179/1743132813Y.0000000167; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Smith DC, 2006, J NEUROTRAUM, V23, P1549, DOI 10.1089/neu.2006.23.1549; Stern P, 2017, SCIENCE, V358, P464, DOI 10.1126/science.358.6362.464; Storm JF, 2017, J NEUROSCI, V37, P10882, DOI 10.1523/JNEUROSCI.1838-17.2017; Tallon-Baudry C, 2018, CORTEX, V102, P139, DOI 10.1016/j.cortex.2017.05.019; Tononi G, 2016, NAT REV NEUROSCI, V17, P450, DOI 10.1038/nrn.2016.44; Ward LM, 2011, CONSCIOUS COGN, V20, P464, DOI 10.1016/j.concog.2011.01.007; Wenzel M, 2019, CELL SYST, V8, P467, DOI 10.1016/j.cels.2019.03.007; Winston JS, 2014, NAT NEUROSCI, V17, P482, DOI 10.1038/nn.3677; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P1424, DOI 10.1109/10.966601	72	0	0	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384	1873-507X		PHYSIOL BEHAV	Physiol. Behav.	OCT 15	2021	240								113553	10.1016/j.physbeh.2021.113553			6	Psychology, Biological; Behavioral Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	UY7MT	WOS:000701704100002	34375622				2022-02-06	
J	Salmon, DM; Chua, J; Sullivan, SJ; Whatman, C; Brown, J; Register-Mihalik, J; Murphy, I; Walters, S; Clacy, A; Sole, G; Kerr, ZY; Rasmussen, K; England, M				Salmon, Danielle M.; Chua, Jason; Sullivan, S. John; Whatman, Chris; Brown, James; Register-Mihalik, Johna; Murphy, Ian; Walters, Simon; Clacy, Amanda; Sole, Gisela; Kerr, Zachary Y.; Rasmussen, Karen; England, Mike			Baseline concussion assessment performance of community-based senior rugby players: a cross-sectional study	BRAIN INJURY			English	Article						Concussion; baseline; management; rugby; normative	ASSESSMENT TOOL-3RD EDITION; NORMATIVE REFERENCE VALUES; SPORT CONCUSSION; HIGH-SCHOOL; PRIMARY-CARE; SCAT3; METAANALYSIS; PHYSICIANS; KNOWLEDGE; RETURN	Objective To report pre-season baseline concussion assessment performance among senior rugby players and explore associations between assessment performance and player demographics. Design A cross-sectional study using the New Zealand Rugby Concussion Assessments (NZRCA), comprising symptom, cognitive and dynamic coordination assessments was conducted in the 2018-2019 season. Methods Players' baseline assessments were characterised using descriptive statistics; effect sizes (ES) and t-tests were used to explore associations between player demographic characteristics and NZRCA performance. Results A total of 733 players (11.4% female) aged between 16 and 52 years completed the NZRCA. The median (range) value for symptom severity, endorsed symptoms and "percentage normal" was respectively, 5 (0-40), 5 (0-21) and 90% (30-100%). A perfect standardised assessment of concussion score was achieved by one participant; seven achieved >= 27/30 for immediate recall, and 22 achieved a perfect delayed recall score. Most participants (n = 674, 92%) passed the tandem gait test. Associations between NZRCA performance and gender, concussion history, and Pasifika ethnicity were observed with effect sizes ranging from small (0.18) to large (0.70). Six hundred and twenty-three (85%) participants reported at least one symptom. Conclusions The results from this study could help support decision-making by clinicians, improving the management of concussions in the community setting.	[Salmon, Danielle M.; Chua, Jason; Sullivan, S. John; Murphy, Ian; Rasmussen, Karen; England, Mike] New Zealand Rugby, Injury Prevent & Welf, Wellington, New Zealand; [Whatman, Chris; Walters, Simon] Auckland Univ Technol, Sch Sport & Recreat, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [Brown, James] Stellenbosch Univ, Inst Sport & Exercise Med, Cape Town, South Africa; [Register-Mihalik, Johna; Kerr, Zachary Y.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Register-Mihalik, Johna; Kerr, Zachary Y.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA; [Register-Mihalik, Johna; Kerr, Zachary Y.] Univ N Carolina, Rehab, Chapel Hill, NC 27515 USA; [Register-Mihalik, Johna; Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Clacy, Amanda] Wearebe, Vital Village, Kensington, Qld, Australia; [Sole, Gisela] Univ Otago, Ctr Hlth Act Rehabil Res, Sch Physiotherapy, Dunedin, New Zealand		Salmon, DM (corresponding author), New Zealand Rugby, POB 2172, Wellington 6140, New Zealand.	danielle.salmon@nzrugby.co.nz		Sole, Gisela/0000-0002-1632-0338; Walters, Simon/0000-0002-6467-4982; Chua, Jason/0000-0002-0224-2818; Brown, James/0000-0002-7778-7783; Whatman, Chris/0000-0002-1468-3901	Accident Compensation Corporation through the RugbySmart program; Accident Compensation Corporation; World Rugby	Funding for this study as part of New Zealand Rugby's National Concussion Initiative was provided by Accident Compensation Corporation through the RugbySmart program; The Accident Compensation Corporation; World Rugby.	[Anonymous], 2013, COL MED PRACT NZ; [Anonymous], 2010, BEST HLTH OUTCOMES P; Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Black AM, 2020, J ATHL TRAINING, V55, P116, DOI 10.4085/1062-6050-123-19; Byron K, 2011, PERS SOC PSYCHOL B, V37, P269, DOI 10.1177/0146167210392788; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Chen J, 2020, HEALTH SERV INSIGHTS, V13, DOI 10.1177/1178632920938674; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Eagle SR, 2020, J NEUROSURG-PEDIATR, V26, P165, DOI 10.3171/2020.2.PEDS2025; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Ellis MJ, 2019, PAED CHILD HEALT-CAN, V24, P137, DOI 10.1093/pch/pxy171; Fuller GW, 2018, J SCI MED SPORT, V21, P347, DOI 10.1016/j.jsams.2017.07.025; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Hanninen T, 2017, J SCI MED SPORT, V20, P424, DOI 10.1016/j.jsams.2016.09.009; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Haseler CM, 2010, BRIT J SPORT MED, V44, P1093, DOI 10.1136/bjsm.2010.074021; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Murphy, 2019, SPORTS MED, V50, P1; Norheim N, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000412; Okonkwo David O, 2014, Neurosurgery, V75 Suppl 4, pS82, DOI 10.1227/NEU.0000000000000493; Patricios J, 2012, BRIT J SPORT MED, V46, P198, DOI 10.1136/bjsports-2011-090386; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Raftery, 2020, J SCI MED SPORT, V24; Salmon D, 2020, BRIT J SPORT MED, V54, P300, DOI 10.1136/bjsports-2019-100949; Salmon D, 2020, BRIT J SPORT MED, V54, P298, DOI 10.1136/bjsports-2019-100950; Salmon DM, 2020, BRAIN INJURY, V34, P1794, DOI 10.1080/02699052.2020.1831607; Salmon DM, 2020, J SPORT SCI, V38, P1585, DOI 10.1080/02640414.2020.1749409; Sarmiento K, 2018, BRAIN INJURY, V32, P889, DOI 10.1080/02699052.2018.1466197; SCAT3, 2013, BRIT J SPORT MED, V47, P259; SCAT5, 2017, BRIT J SPORT MED, V51; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; Schneiders AG, 2010, J SCI MED SPORT, V13, P382, DOI 10.1016/j.jsams.2010.01.003; Snedden TR, 2017, CLIN J SPORT MED, V27, P462, DOI 10.1097/JSM.0000000000000389; Tucker R, 2021, CLIN J SPORT MED, V31, pE398, DOI 10.1097/JSM.0000000000000847; Tucker R, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-036894; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611; Zealand, 2006, QUICKST PAC PEOPL; Zealand HRCoN, 2014, PAC HLTH RES GUID NZ, P1; Zemek R, 2015, CAN J EMERG MED, V17, P115, DOI 10.1017/cem.2014.38; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	56	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2021	35	11					1433	1442		10.1080/02699052.2021.1972452		OCT 2021	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XO2HY	WOS:000708241300001	34658272				2022-02-06	
J	Sosa, MAG; De Gasperi, R; Pryor, D; Garcia, GSP; Perez, GM; Abutarboush, R; Kawoos, U; Hogg, S; Ache, B; Janssen, WG; Sowa, A; Tetreault, T; Cook, DG; Tappan, SJ; Gandy, S; Hof, PR; Ahlers, ST; Elder, GA				Sosa, Miguel A. Gama; De Gasperi, Rita; Pryor, Dylan; Garcia, Georgina S. Perez; Perez, Gissel M.; Abutarboush, Rania; Kawoos, Usmah; Hogg, Seth; Ache, Benjamin; Janssen, William G.; Sowa, Allison; Tetreault, Timothy; Cook, David G.; Tappan, Susan J.; Gandy, Sam; Hof, Patrick R.; Ahlers, Stephen T.; Elder, Gregory A.			Low-level blast exposure induces chronic vascular remodeling, perivascular astrocytic degeneration and vascular-associated neuroinflammation	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Animal model; Blast; Brain; Chronic; Vascular; Neurovascular unit; Rat; Vascular pathology; Astrocyte; Tight junctions	TRAUMATIC BRAIN-INJURY; DISORDER-RELATED TRAITS; CEREBRAL-BLOOD-FLOW; ALZHEIMERS-DISEASE; MATRIX METALLOPROTEINASES; MICROGLIAL ACTIVATION; CAPILLARY PERICYTES; INTERSTITIAL FLUID; RAT MODEL; BARRIER	Cerebral vascular injury as a consequence of blast-induced traumatic brain injury is primarily the result of blast wave-induced mechanical disruptions within the neurovascular unit. In rodent models of blast-induced traumatic brain injury, chronic vascular degenerative processes are associated with the development of an age-dependent post-traumatic stress disorder-like phenotype. To investigate the evolution of blast-induced chronic vascular degenerative changes, Long-Evans rats were blast-exposed (3 x 74.5 kPa) and their brains analyzed at different times post-exposure by X-ray microcomputed tomography, immunohistochemistry and electron microscopy. On microcomputed tomography scans, regional cerebral vascular attenuation or occlusion was observed as early as 48 h post-blast, and cerebral vascular disorganization was visible at 6 weeks and more accentuated at 13 months post-blast. Progression of the late-onset pathology was characterized by detachment of the endothelial and smooth muscle cellular elements from the neuropil due to degeneration and loss of arteriolar perivascular astrocytes. Development of this pathology was associated with vascular remodeling and neuroinflammation as increased levels of matrix metalloproteinases (MMP-2 and MMP-9), collagen type IV loss, and microglial activation were observed in the affected vasculature. Blast-induced chronic alterations within the neurovascular unit should affect cerebral blood circulation, glymphatic flow and intramural periarterial drainage, all of which may contribute to development of the blast-induced behavioral phenotype. Our results also identify astrocytic degeneration as a potential target for the development of therapies to treat blast-induced brain injury.	[Sosa, Miguel A. Gama] James J Peters Dept Vet Affairs Med Ctr, Gen Med Res Serv, 130 West Kingsbridge Rd, Bronx, NY 10468 USA; [Sosa, Miguel A. Gama; De Gasperi, Rita; Gandy, Sam; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Dept Psychiat, One Gustave Levy Pl, New York, NY 10029 USA; [Sosa, Miguel A. Gama; De Gasperi, Rita; Garcia, Georgina S. Perez; Janssen, William G.; Sowa, Allison; Gandy, Sam; Hof, Patrick R.; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [De Gasperi, Rita; Pryor, Dylan; Garcia, Georgina S. Perez; Perez, Gissel M.; Gandy, Sam] James J Peters Dept Vet Affairs Med Ctr, Res & Dev Serv, 130 West Kingsbridge Rd, Bronx, NY 10468 USA; [Garcia, Georgina S. Perez; Gandy, Sam; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Dept Neurol, One Gustave Levy Pl, New York, NY 10029 USA; [Janssen, William G.; Sowa, Allison; Hof, Patrick R.] Icahn Sch Med Mt Sinai, Nash Family Dept Neurosci, New York, NY 10029 USA; [Abutarboush, Rania; Kawoos, Usmah; Ahlers, Stephen T.] Naval Med Res Ctr, Operat & Undersea Med Directorate, Dept Neurotrauma, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Abutarboush, Rania; Kawoos, Usmah] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA; [Hogg, Seth; Ache, Benjamin] Micro Photon Inc, 1550 Pond Rd,Suite 110, Allentown, PA 18104 USA; [Tetreault, Timothy; Tappan, Susan J.] MBF Biosci LLC, 185 Allen Brook Lane, Williston, VT 05495 USA; [Cook, David G.] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, 1660 S Columbian Way, Seattle, WA 98108 USA; [Cook, David G.] Univ Washington, Dept Med, 1959 NE Pacific St, Seattle, WA 98195 USA; [Gandy, Sam; Hof, Patrick R.; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Mt Sinai Alzheimers Dis Res Ctr, New York, NY 10029 USA; [Gandy, Sam; Hof, Patrick R.; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA; [Gandy, Sam] Icahn Sch Med Mt Sinai, NFL Neurol Care Ctr, New York, NY 10029 USA; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Care, New York, NY 10029 USA; [Elder, Gregory A.] James J Peters Dept Vet Affairs Med Ctr, Neurol Serv, 130 West Kingsbridge Rd, Bronx, NY 10468 USA		Sosa, MAG (corresponding author), James J Peters Dept Vet Affairs Med Ctr, Gen Med Res Serv, 130 West Kingsbridge Rd, Bronx, NY 10468 USA.; Sosa, MAG (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, One Gustave Levy Pl, New York, NY 10029 USA.; Sosa, MAG (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.	miguel.gama-sosa@mssm.edu			Department of Veterans Affairs, Veterans Health AdministrationUS Department of Veterans Affairs; Rehabilitation Research and Development Service Awards [1I01BX0004067-01, I01RX002660-01, 1 I21 RX003459-01, 1 I21 RX002069-01, 1 I21 RX002876-01]; Department of Defense work unit [0000B999.0000.000]; Alzheimer's Drug Discovery Foundation; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG011508, P30 AG066514]	We sincerely thank the anonymous reviewers whose constructive suggestions improved this manuscript considerably. We also thank Dr. Virginia Lee for generously providing the rat anti-GFAP antibody. The work described in this paper was supported by the Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service Awards 1I01BX0004067-01 (GE), I01RX002660-01 (GE), 1 I21 RX003459-01 (MAGS), 1 I21 RX002069-01 (MAGS) and 1 I21 RX002876-01 (MAGS); by the Department of Defense work unit number 0000B999.0000.000.A1503, the Alzheimer's Drug Discovery Foundation (SG) and by NIA P50 AG011508 and P30 AG066514 to Mary Sano (SG, PRH). MAGS, RDG, DP, GMP, GE, SG, RA, UK, DGC and STA are employees of the U.S. Government. This work was prepared as part of their official duties. Title 17 U.S.C. 105 provides that `Copyright protection under this title is not available for any work of the United States Government.'Title 17 U.S.C. 101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person's official duties. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, Department of Veterans Affairs, nor the U.S. Government.	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Abutarboush R, 2019, J NEUROTRAUM, V36, P3138, DOI 10.1089/neu.2019.6423; Ackermans NL, 2021, J NEUROSCI RES, V99, P2463, DOI 10.1002/jnr.24920; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Aldea R, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00001; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bailey ZS, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00064; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bavle Radhika Manoj, 2016, J Oral Maxillofac Pathol, V20, P339; Ben Menachem-Zidon O, 2011, BRAIN BEHAV IMMUN, V25, P1008, DOI 10.1016/j.bbi.2010.11.007; Benveniste H, 2019, GERONTOLOGY, V65, P106, DOI 10.1159/000490349; Biesecker KR, 2016, J NEUROSCI, V36, P9435, DOI 10.1523/JNEUROSCI.1782-16.2016; Bisht K, 2016, GLIA, V64, P826, DOI 10.1002/glia.22966; Blaze J, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.00160; Brauer PR, 2006, FRONT BIOSCI-LANDMRK, V11, P447, DOI 10.2741/1810; Carare RO, 2008, NEUROPATH APPL NEURO, V34, P131, DOI 10.1111/j.1365-2990.2007.00926.x; da Fonseca ACC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00362; Chavko M, 2011, NAT S SURV BLAST INJ; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2006, J TRAUMA, V61, P933, DOI 10.1097/01.ta.0000233742.75450.47; Cipolla M.J., 2009, CEREBRAL CIRCULATION; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Dickerson MR, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00618; Dorr A, 2007, NEUROIMAGE, V35, P1409, DOI 10.1016/j.neuroimage.2006.12.040; Drake CT, 2007, BRAIN LANG, V102, P141, DOI 10.1016/j.bandl.2006.08.002; Elder GA, 2019, NEUROSCI LETT, V707, DOI 10.1016/j.neulet.2019.134294; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Filosa JA, 2004, CIRC RES, V95, pE73, DOI 10.1161/01.RES.0000148636.60732.2e; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Filosa JA, 2013, AM J PHYSIOL-HEART C, V305, pH609, DOI 10.1152/ajpheart.00359.2013; Franciosi S, 2007, J NEUROSCI METH, V163, P76, DOI 10.1016/j.jneumeth.2007.02.020; Goodrich JA, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0395-3; Grebe A, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0313-z; Hald ES, 2014, TRANSL STROKE RES, V5, P385, DOI 10.1007/s12975-013-0300-3; Halder SK, 2019, P NATL ACAD SCI USA, V116, P26029, DOI 10.1073/pnas.1912178116; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Hamilton Nicola B, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00005; Han XJ, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00210; Hao L, 2004, CIRC RES, V94, P68, DOI 10.1161/01.RES.0000109413.57726.91; Haruwaka K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13812-z; Haurani MJ, 2007, CARDIOVASC RES, V75, P679, DOI 10.1016/j.cardiores.2007.06.016; Hernandez A, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0408-1; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; Hladky SB, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0113-6; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Hotta H, 2016, PROG BRAIN RES, V225, P3, DOI 10.1016/bs.pbr.2016.03.001; Howarth C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00103; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Johnson C, 2004, ARTERIOSCL THROM VAS, V24, P54, DOI 10.1161/01.ATV.0000100402.69997.C3; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kacza J, 1997, INFLAMM RES, V46, P430, DOI 10.1007/s000110050219; Kallakuri S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169239; Kawoos U, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84730-8; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kedarasetti RT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66887-w; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; Kisler K, 2017, NAT NEUROSCI, V20, P406, DOI 10.1038/nn.4489; Kofuji P, 2021, ANNU REV NEUROSCI, V44, P49, DOI 10.1146/annurev-neuro-101920-112225; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kulik T, 2008, NEUROPHARMACOLOGY, V55, P281, DOI 10.1016/j.neuropharm.2008.04.017; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Lannes N, 2017, ONCOTARGET, V8, P114393, DOI 10.18632/oncotarget.23106; Lee HS, 2014, P NATL ACAD SCI USA, V111, pE3343, DOI 10.1073/pnas.1410893111; Li GH, 2000, CIRCULATION, V101, P1362, DOI 10.1161/01.CIR.101.12.1362; Li HL, 2012, MOL MED REP, V6, P774, DOI 10.3892/mmr.2012.1010; Lieberman AP, 2018, CELL METAB, V27, P487, DOI 10.1016/j.cmet.2018.02.015; Logsdon AF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66113-7; Logsdon AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29341-6; Mac Donald CL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6676; Mackie AR, 2011, TEX HEART I J, V38, P474; MacVicar BA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020388; Marina N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13956-y; Martinez-Lemus LA, 2012, BASIC CLIN PHARMACOL, V110, P5, DOI 10.1111/j.1742-7843.2011.00813.x; Martinez-Lemus LA, 2011, AM J PHYSIOL-HEART C, V300, pH2005, DOI 10.1152/ajpheart.01066.2010; Mishra A, 2016, NAT NEUROSCI, V19, P1619, DOI 10.1038/nn.4428; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Naganawa Shinji, 2020, Magn Reson Med Sci, DOI 10.2463/mrms.rev.2020-0122; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Odenbach J, 2011, HYPERTENSION, V57, P123, DOI 10.1161/HYPERTENSIONAHA.110.159525; Omri S, 2011, AM J PATHOL, V179, P942, DOI 10.1016/j.ajpath.2011.04.018; Ota Y, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/185463; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Georgina G, 2021, J NEUROTRAUM, V38, P2030, DOI 10.1089/neu.2020.7398; Perez-Garcia G, 2018, BEHAV BRAIN RES, V340, P117, DOI 10.1016/j.bbr.2016.09.061; Perez-Garcia G, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00176; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Piantino J, 2021, J NEUROTRAUM, V38, P2391, DOI 10.1089/neu.2020.7447; PLAUT A, 1957, J Mt Sinai Hosp N Y, V24, P1112; Price L., 2016, TRANSLATIONAL RES TR; Prinz M, 2021, ANNU REV IMMUNOL, V39, P251, DOI 10.1146/annurev-immunol-093019-110159; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Puro DG, 2007, MICROCIRCULATION, V14, P1, DOI 10.1080/10739680601072099; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Rashid Khalid, 2019, Front Immunol, V10, P1975, DOI 10.3389/fimmu.2019.01975; Robinson ME, 2017, J NEUROTRAUM, V34, pS53, DOI 10.1089/neu.2016.4709; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Rodriguez UA, 2019, JOVE-J VIS EXP, DOI 10.3791/58792; Rosenblatt AS, 2019, PSYCHOL TRAUMA-US, V11, P442, DOI 10.1037/tra0000399; Rubio JE, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95003-9; Rubio JE, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.573647; Schetters STT, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01905; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Sheng JG, 1997, ACTA NEUROPATHOL, V94, P1, DOI 10.1007/s004010050664; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Skotak M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01015; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Sosa MAG, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0483-z; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Sosa MAG, 2010, AM J PATHOL, V176, P353, DOI 10.2353/ajpath.2010.090482; Squire L, 2013, FUNDAMENTAL NEUROSCI; St-Pierre MK, 2020, ASN NEURO, V12, DOI 10.1177/1759091420925335; Steffensen LB, 2018, AM J PHYSIOL-HEART C, V315, pH610, DOI 10.1152/ajpheart.00070.2018; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Stenmark KR, 2013, ANNU REV PHYSIOL, V75, P23, DOI 10.1146/annurev-physiol-030212-183802; Stone JR, 2020, J NEUROTRAUM, V37, P2468, DOI 10.1089/neu.2020.7141; Sullivan DR, 2021, J CEREBR BLOOD F MET, V41, P886, DOI 10.1177/0271678X20935190; Sullivan DR, 2019, J HEAD TRAUMA REHAB, V34, pE18, DOI 10.1097/HTR.0000000000000449; Sullivan EV, 2012, NEUROPSYCHOL REV, V22, P1, DOI 10.1007/s11065-012-9188-z; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; SZENTISTVANYI I, 1984, AM J PHYSIOL, V246, pF835, DOI 10.1152/ajprenal.1984.246.6.F835; THANOS S, 1992, EXP EYE RES, V55, P101, DOI 10.1016/0014-4835(92)90098-D; Toklu HZ, 2015, J CEREBR BLOOD F MET, V35, P1950, DOI 10.1038/jcbfm.2015.151; Torres-Platas SG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-12; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Ueno M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102600; Varnum MM, 2012, ARCH IMMUNOL THER EX, V60, P251, DOI 10.1007/s00005-012-0181-2; Vieillard-Baron A, 2003, HUM GENE THER, V14, P861, DOI 10.1089/104303403765701150; Zagorchev Lyubomir, 2010, J Angiogenes Res, V2, P7, DOI 10.1186/2040-2384-2-7; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	145	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	OCT 15	2021	9	1							167	10.1186/s40478-021-01269-5			27	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WH9JO	WOS:000707985200002	34654480	gold, Green Published			2022-02-06	
J	Xia, W; Xie, J; Cai, ZQ; Liu, XH; Wen, J; Cui, ZK; Zhao, R; Zhou, XM; Chen, JH; Mao, XR; Gu, ZT; Zou, ZM; Zou, ZP; Zhang, Y; Zhao, M; Mac, M; Song, QC; Bai, XC				Xia, Wei; Xie, Jing; Cai, Zhiqing; Liu, Xuhua; Wen, Jing; Cui, Zhong-Kai; Zhao, Run; Zhou, Xiaomei; Chen, Jiahui; Mao, Xinru; Gu, Zhengtao; Zou, Zhimin; Zou, Zhipeng; Zhang, Yue; Zhao, Ming; Mac, Maegele; Song, Qiancheng; Bai, Xiaochun			Damaged brain accelerates bone healing by releasing small extracellular vesicles that target osteoprogenitors	NATURE COMMUNICATIONS			English	Article							OSTEOBLAST DIFFERENTIATION; INJURY; FRACTURE; MODEL; POLARIZATION; EXPRESSION; EXOSOMES; RECEPTOR; BIOLOGY; CELLS	Clinical evidence has established that concomitant traumatic brain injury (TBI) accelerates bone healing, but the underlying mechanism is unclear. This study shows that after TBI, injured neurons, mainly those in the hippocampus, release osteogenic microRNA (miRNA)-enriched small extracellular vesicles (sEVs), which targeted osteoprogenitors in bone to stimulate bone formation. We show that miR-328a-3p and miR-150-5p, enriched in the sEVs after TBI, promote osteogenesis by directly targeting the 3 ' UTR of FOXO4 or CBL, respectively, and hydrogel carrying miR-328a-3p-containing sEVs efficiently repaires bone defects in rats. Importantly, increased fibronectin expression on sEVs surface contributes to targeting of osteoprogenitors in bone by TBI sEVs, thereby implying that modification of the sEVs surface fibronectin could be used in bone-targeted drug delivery. Together, our work unveils a role of central regulation in bone formation and a clear link between injured neurons and osteogenitors, both in animals and clinical settings. Concomitant traumatic brain injury accelerates bone healing, but the mechanism is unclear. Here, the authors show that injured neurons, mainly those in the hippocampus, release osteogenic miRNA-enriched small extracellular vesicles, which targete osteoprogenitors to stimulate bone formation.	[Xia, Wei; Xie, Jing; Cai, Zhiqing; Cui, Zhong-Kai; Zhao, Run; Zhou, Xiaomei; Zou, Zhipeng; Zhang, Yue; Song, Qiancheng; Bai, Xiaochun] Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangdong Prov Key Lab Bone & Joint Degenerat Dis, Guangzhou 510515, Peoples R China; [Liu, Xuhua; Chen, Jiahui] Southern Med Univ, Acad Orthoped, State Key Lab Organ Failure Res, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China; [Wen, Jing] Southern Med Univ, Nanfang Hosp, Dept Radiol, Guangzhou 510515, Guangdong, Peoples R China; [Mao, Xinru] Southern Med Univ, Nanfang Hosp, Dept Clin Lab, Guangzhou 510515, Guangdong, Peoples R China; [Gu, Zhengtao; Zou, Zhimin; Zhao, Ming] Southern Med Univ, Dept Pathophysiol, Guangdong Prov Key Lab Shock & Microcirculat Res, Guangzhou 510515, Guangdong, Peoples R China; [Mac, Maegele] Private Univ Witten Herdecke, Cologne Merheim Med Ctr, Inst Res Operat Med, Ostmerheimerstr 200, D-51109 Cologne, Germany		Song, QC; Bai, XC (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangdong Prov Key Lab Bone & Joint Degenerat Dis, Guangzhou 510515, Peoples R China.	songqc@smu.edu.cn; baixc15@smu.edu.cn		Xia, Wei/0000-0003-2127-1486; Cui, Zhong-Kai/0000-0003-3112-9379; Xie, Jing/0000-0001-5624-458X; Mao, Xinru/0000-0001-7961-4686; Cai, zhiqing/0000-0002-7935-2345	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81991510, 81991511, 81625015]; Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110104002]; Natural Science Foundation of Guangdong Province, ChinaNational Natural Science Foundation of Guangdong Province [2018A030310434, 2017A030313696]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2016M602487]; Medical Research Foundation of Guangdong Province, China [A2017117]	We thank Central Laboratory, Southern Medical University for providing facilities and technical support. This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81991510, 81991511, 81625015), Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2018GZR110104002), Natural Science Foundation of Guangdong Province, China (2018A030310434, 2017A030313696), China Postdoctoral Science Foundation funded project (2016M602487), Medical Research Foundation of Guangdong Province, China (A2017117).	Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Beeton CA, 2004, J BONE JOINT SURG BR, V86B, P912, DOI 10.1302/0301-620x.86b6.14176; Berger JM, 2019, CELL METAB, V30, P890, DOI 10.1016/j.cmet.2019.08.012; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Bohm M, 2012, ENDOCR REV, V33, P623, DOI 10.1210/er.2011-1016; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; Coumans FAW, 2017, CIRC RES, V120, P1632, DOI 10.1161/CIRCRESAHA.117.309417; Dieudonne FX, 2013, STEM CELLS, V31, P1340, DOI 10.1002/stem.1380; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Elefteriou F, 2004, P NATL ACAD SCI USA, V101, P3258, DOI 10.1073/pnas.0308744101; Gao MH, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0039-2; Hadjiargyrou M, 2019, J BONE MINER RES, V34, P797, DOI 10.1002/jbmr.3708; Hill AF, 2019, J NEUROSCI, V39, P9269, DOI 10.1523/JNEUROSCI.0147-18.2019; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Hu JL, 2012, ACTA BIOMATER, V8, P1730, DOI 10.1016/j.actbio.2012.01.029; Hu K, 2016, J CLIN INVEST, V126, P509, DOI 10.1172/JCI82585; Idelevich A, 2018, BONE, V115, P31, DOI 10.1016/j.bone.2018.05.018; Iyer S, 2013, J CLIN INVEST, V123, P3409, DOI 10.1172/JCI68049; Karsenty G, 2012, ANNU REV PHYSIOL, V74, P87, DOI 10.1146/annurev-physiol-020911-153233; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Kostenuik P, 2017, J ORTHOP RES, V35, P213, DOI 10.1002/jor.23460; Li DF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10872; Li Q, 2018, J BONE MINER METAB, V36, P1, DOI 10.1007/s00774-017-0860-5; Luo ZW, 2019, NANOSCALE, V11, P20884, DOI 10.1039/c9nr02791b; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Martin PJ, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0057-5; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Miszczuk D, 2016, MOL NEUROBIOL, V53, P7010, DOI 10.1007/s12035-015-9578-3; Obri A, 2018, NAT REV ENDOCRINOL, V14, P174, DOI 10.1038/nrendo.2017.181; Ono T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10928; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Purushothaman A, 2016, J BIOL CHEM, V291, P1652, DOI 10.1074/jbc.M115.686295; Qin YW, 2017, J BIOL CHEM, V292, P11021, DOI 10.1074/jbc.M116.770941; Rubin C, 2005, CELL RES, V15, P66, DOI 10.1038/sj.cr.7290268; Salvador E, 2018, METHODS MOL BIOL, V1717, P219, DOI 10.1007/978-1-4939-7526-6_17; Schall N, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.135355; Sluijter JPG, 2018, CARDIOVASC RES, V114, P19, DOI 10.1093/cvr/cvx211; Sun WJ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.15; van den Broek M, 2017, ORTHOP TRAUMATOL-SUR, V103, P1127, DOI 10.1016/j.otsr.2017.07.004; Varma VR, 2017, MOL PSYCHIATR, V22, P13, DOI 10.1038/mp.2016.206; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang RS, 2015, J BIOL CHEM, V290, P30684, DOI 10.1074/jbc.M115.671735; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Weilner S, 2015, BONE, V79, P43, DOI 10.1016/j.bone.2015.05.027; Wildburger R, 2001, WIEN KLIN WOCHENSCHR, V113, P119; Xie Y, 2017, J CELL MOL MED, V21, P1033, DOI 10.1111/jcmm.13039; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Zhao SJ, 2020, J BONE MINER RES, V35, P2015, DOI 10.1002/jbmr.4099; Zhao SJ, 2020, THERANOSTICS, V10, P17, DOI 10.7150/thno.36930	51	0	0	33	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY		2041-1723		NAT COMMUN	Nat. Commun.	OCT 15	2021	12	1							6043	10.1038/s41467-021-26302-y			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WH4PG	WOS:000707661200021	34654817	Green Published, gold			2022-02-06	
J	Quang, H; McDonald, S; Huynh-Le, P; Nguyen, TV; Le, NA; Lam-Nguyen, NT; Kumfor, F				Quang, Halle; McDonald, Skye; Huynh-Le, Phuong; Nguyen, Tuong-Vu; Le, Ngoc-Anh; Lam-Nguyen, Nha-Truc; Kumfor, Fiona			Apathy in a High Prevalence Population of Moderate to Severe Traumatic Brain Injury: An Investigation in Vietnam	NEUROPSYCHOLOGY			English	Article; Early Access						motivation; TBI; DAS; family functioning; overprotectiveness	IMPAIRED SELF-AWARENESS; FAMILY; CAREGIVERS; MODEL; SCALE; REHABILITATION; PARTICIPATION; DEFICITS; OUTCOMES; PATIENT	Objective: The reduction of goal-directed behavior, termed apathy, is a pervasive and debilitating syndrome after traumatic brain injury (TBI). However, understanding of apathy as a multifaceted construct is limited, especially in Southeast Asian nations. This study aimed to investigate the severity, insight, and psychosocial influences of apathy in executive, emotional, and initiation dimensions in Vietnam-a country with high prevalence of TBI. Method: One hundred and eleven Vietnamese participants (61 individuals with moderate to severe TBI and 50 healthy controls) and their informants completed the self-rated and informant-rated Dimensional Apathy Scale (DAS) for the assessment of executive, emotional, and initiation apathy severity. Insight of apathy was calculated by subtracting DAS self-ratings from informant ratings. Additionally, carers completed measures assessing psychosocial factors of overall family health and overprotective behavior, while participants rated their own self-efficacy. Results: Our results showed greater informant-rated apathy for all three dimensions in individuals with TBI relative to controls. However, while people with TBI had greater self-rated initiation apathy, they regarded their executive apathy as lower and their emotional apathy as similar compared with controls. Reduced insight in patients was seen for executive and initiation apathy. Across participants, executive apathy was predicted by family functioning and overprotectiveness, emotional apathy was predicted by family functioning, and initiation apathy was predicted by self-efficacy. Conclusions: These findings support the multidimensional characterizations and socio-cultural considerations of apathy after TBI, which will potentially develop both individual-specific and symptom-specific approaches in clinical practice.	[Quang, Halle; McDonald, Skye] Univ New South Wales, Sch Psychol, Kensington, NSW 2033, Australia; [Huynh-Le, Phuong; Nguyen, Tuong-Vu] Cho Ray Hosp, Dept Neurosurg, Ho Chi Minh City, Vietnam; [Le, Ngoc-Anh] Cho Ray Hosp, Dept Clin Res, Ho Chi Minh City, Vietnam; [Lam-Nguyen, Nha-Truc] Cho Ray Hosp, Outpatient Dept, Ho Chi Minh City, Vietnam; [Kumfor, Fiona] Univ Sydney, Sch Psychol, Brain & Mind Ctr, Sydney, NSW, Australia		Quang, H (corresponding author), Univ New South Wales, Sch Psychol, Kensington, NSW 2033, Australia.	halle.quang@unsw.edu.au	Kumfor, Fiona/D-8839-2016	Kumfor, Fiona/0000-0002-3208-075X; Quang, Halle/0000-0002-5236-1823	Australian Government Research Training Program ScholarshipAustralian GovernmentDepartment of Industry, Innovation and Science; UNSW Scientia PhD Scholarship; National Health and Medical Research Council Career Development FellowshipNational Health and Medical Research Council of Australia [GNT1158762]	Halle Quang is supported by an Australian Government Research Training Program Scholarship (no award/grant number) and a UNSW Scientia PhD Scholarship (no award/grant number). Fiona Kumfor is supported by a National Health and Medical Research Council Career Development Fellowship (GNT1158762).	Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Andersson S, 1999, BRAIN INJURY, V13, P393, DOI 10.1080/026990599121458; Arnould A, 2018, J CLIN EXP NEUROPSYC, V40, P650, DOI 10.1080/13803395.2017.1411468; Arnould A, 2018, ARCH CLIN NEUROPSYCH, V33, P808, DOI 10.1093/arclin/acx122; Arnould A, 2015, BRAIN INJURY, V29, P1597, DOI 10.3109/02699052.2015.1075156; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Bivona U, 2019, BRAIN INJURY, V33, P1245, DOI 10.1080/02699052.2019.1641225; Bivona U, 2015, RESTOR NEUROL NEUROS, V33, P335, DOI 10.3233/RNN-140484; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Clark JMR, 2020, REHABIL PSYCHOL, V65, P72, DOI 10.1037/rep0000294; Curtiss G, 2000, J HEAD TRAUMA REHAB, V15, P1113, DOI 10.1097/00001199-200010000-00005; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Dethier M, 2012, J CLIN EXP NEUROPSYC, V34, P936, DOI 10.1080/13803395.2012.702734; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; General Statistics Office of Vietnam, 2019, NUMB TRAFF ACC VIETN; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Gray J.M, 1994, CLIN REHABIL, V8, P188, DOI [10.1177/026921559400800302, DOI 10.1177/026921559400800302, DOI 10.1080/09602010902949207]; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hart T, 2019, NEUROPSYCHOL REHABIL, V29, P1085, DOI 10.1080/09602011.2017.1364271; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Hogeveen J, 2021, J NEUROTRAUM, V38, P2264, DOI 10.1089/neu.2020.7363; Hogeveen J, 2017, CEREB CORTEX, V27, P1401, DOI 10.1093/cercor/bhv317; Holroyd J., 1987, QUESTIONNAIRE RESOUR; Hoofien D, 2004, J CLIN EXP NEUROPSYC, V26, P278, DOI 10.1076/jcen.26.2.278.28084; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lane-Brown A, 2010, J HEAD TRAUMA REHAB, V25, P459, DOI 10.1097/HTR.0b013e3181d98e1d; Le Heron C, 2019, J NEUROL NEUROSUR PS, V90, P302, DOI 10.1136/jnnp-2018-318265; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Manera V, 2020, AM J GERIAT PSYCHIAT, V28, P410, DOI 10.1016/j.jagp.2019.07.014; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Massimo L, 2018, J AM GERIATR SOC, V66, pS4, DOI 10.1111/jgs.15343; Meyer OL, 2015, ASIAN AM J PSYCHOL, V6, P263, DOI 10.1037/aap0000024; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ngoc A.M., 2020, CIGOS 2019 INNOVATIO, P1043, DOI [10.1007/978-981-15-0802-8_167, DOI 10.1007/978-981-15-0802-8_167]; Nguyen T, 2020, QUAL HEALTH RES, V30, P1529, DOI 10.1177/1049732320919390; Pekerti A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101118; Pericall MTL, 2014, DEV MED CHILD NEUROL, V56, P19, DOI 10.1111/dmcn.12237; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Quang H, 2021, CORTEX, V139, P73, DOI 10.1016/j.cortex.2021.02.028; Quang Halle, 2021, J Int Neuropsychol Soc, P1, DOI 10.1017/S135561772100031X; Radakovic R, 2021, J GERIATR PSYCH NEUR, V34, P349, DOI 10.1177/0891988720924716; Radakovic R, 2018, CURR OPIN BEHAV SCI, V22, P42, DOI 10.1016/j.cobeha.2017.12.022; Radakovic R, 2018, INT J GERIATR PSYCH, V33, P151, DOI 10.1002/gps.4697; Radakovic R, 2014, PSYCHIAT RES, V219, P658, DOI 10.1016/j.psychres.2014.06.010; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Robertson K, 2015, BRAIN INJURY, V29, P848, DOI 10.3109/02699052.2015.1005135; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Sodders MD, 2020, HEALTH EQUITY, V4, P304, DOI 10.1089/heq.2020.0007; Sousa VD, 2011, J EVAL CLIN PRACT, V17, P268, DOI 10.1111/j.1365-2753.2010.01434.x; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Starkstein SE, 2014, PSYCHIAT CLIN N AM, V37, P103, DOI 10.1016/j.psc.2013.10.002; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Wearne TA, 2020, NEUROPSYCHOLOGY, V34, P288, DOI 10.1037/neu0000609; Wei G, 2020, J NEUROL, V267, P1086, DOI 10.1007/s00415-019-09679-1; Worthington A, 2018, NEUROPSYCHOLOGIA, V118, P40, DOI 10.1016/j.neuropsychologia.2018.04.012; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Zakzanis KK, 2016, BRAIN INJURY, V30, P986, DOI 10.3109/02699052.2016.1147077	64	0	0	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology												10.1037/neu0000781		OCT 2021	10	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	XS6MM	WOS:000733020500001	34647756				2022-02-06	
J	Bohyn, C; Vande Vyvere, T; De Keyzer, F; Sima, DM; Demaerel, P				Bohyn, Cedric; Vande Vyvere, Thijs; De Keyzer, Frederik; Sima, Diana M.; Demaerel, Philippe			Morphometric evaluation of traumatic axonal injury and the correlation with post-traumatic cerebral atrophy and functional outcome	NEURORADIOLOGY JOURNAL			English	Article; Early Access						Traumatic brain injury (TBI); magnetic resonance imaging (MRI); FLAIR; SWI; brain atrophy; functional outcome	BRAIN-INJURY; MODERATE; MILD; NEUROPATHOLOGY	Introduction Imaging plays a crucial role in the diagnosis, prognosis and follow-up of traumatic brain injury. Whereas computed tomography plays a pivotal role in the acute setting, magnetic resonance imaging is best suited to detect the true extent of traumatic brain injury, and more specifically diffuse axonal injury. Post-traumatic brain atrophy is a well-known complication of traumatic brain injury. Purpose This study investigated the correlation between diffuse axonal injury detected with fluid-attenuated inversion recovery and susceptibility-weighted imaging magnetic resonance imaging, post-traumatic brain atrophy and functional outcome (Glasgow outcome scale - extended). Materials and methods Twenty patients with a closed head injury and diffuse axonal injury detected with fluid-attenuated inversion recovery and susceptibility-weighted imaging were included. The total volumes of the diffuse axonal injury fluid-attenuated inversion recovery lesions were determined for each subject's initial (<14 days) and follow-up magnetic resonance scan (average: day 303 +/- 83 standard deviation). The different brain volumes were automatically quantified using a validated and both US Food and Drug Administration-cleared and CE-marked machine learning algorithm (icobrain). The number of susceptibility-weighted imaging lesions and functional outcome scores (Glasgow outcome scale - extended) were retrieved from the Collaborative European NeuroTrauma Effectiveness Research Traumatic Brain Injury dataset. Results The volumetric fluid-attenuated inversion recovery diffuse axonal injury lesion load showed a significant inverse correlation with functional outcome (Glasgow outcome scale - extended) (r = -0.57; P = 0.0094) and white matter volume change (r = -0.50; P = 0.027). In addition, white matter volume change correlated significantly with the Glasgow outcome scale - extended score (P = 0.0072; r = 0.58). Moreover, there was a strong inverse correlation between longitudinal fluid-attenuated inversion recovery lesion volume change and whole brain volume change (r = -0.63; P = 0.0028). No significant correlation existed between the number of diffuse axonal injury susceptibility-weighted imaging lesions, brain atrophy and functional outcome. Conclusions Volumetric analysis of diffuse axonal injury on fluid-attenuated inversion recovery imaging and automated brain atrophy calculation are potentially useful tools in the clinical management and follow-up of traumatic brain injury patients with diffuse axonal injury.	[Bohyn, Cedric; Demaerel, Philippe] Univ Hosp Leuven, Dept Radiol, Herestr 49, B-3000 Leuven, Belgium; [Vande Vyvere, Thijs; Sima, Diana M.] Icometrix, Res & Dev, Leuven, Belgium; [De Keyzer, Frederik] Univ Hosp Leuven, Dept Med Phys & Qual Control, Leuven, Belgium		Bohyn, C (corresponding author), Univ Hosp Leuven, Dept Radiol, Herestr 49, B-3000 Leuven, Belgium.	cedric_bohyn@hotmail.com	Vande Vyvere, Thijs/AAB-5180-2022	Vande Vyvere, Thijs/0000-0003-4032-5443	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [602150]	The data used in this study were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Commission 7th framework programme (602150). The author(s) would like to thank Sophie Vercruyssen (research engineer, icometrix) for the provided technical support.	Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; de Rooij R, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00144; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Feltrin FS, 2018, BRAIN INJURY, V32, P1413, DOI 10.1080/02699052.2018.1494852; Flusund A-MH, 2019, NORD NEUR C LUND NOR; Fragoso YD, 2017, J CLIN NEUROSCI, V44, P155, DOI 10.1016/j.jocn.2017.06.006; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Harris TC, 2019, ANN BIOMED ENG, V47, P1941, DOI 10.1007/s10439-018-02148-2; Hellstrom T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00125; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Ledig C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188152; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Lu J, 2010, J NEUROTRAUM, V27, P843, DOI 10.1089/neu.2010.1293; Lysandropoulos AP, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.422; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Moe Hans Kristian, 2020, J Neurosurg, P1, DOI 10.3171/2020.6.JNS20112; Niemantsverdriet E, 2018, J ALZHEIMERS DIS, V63, P1509, DOI 10.3233/JAD-171140; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ribbens A., 2015, ALZHEIMERS DEMENT J, V11, pP876; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Ross DE, 2020, BRAIN INJURY, V34, P11, DOI 10.1080/02699052.2019.1669074; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Sima DM, 2017, MULT SCLER J, V23, P559; Storelli L, 2018, RADIOLOGY, V288, P554, DOI 10.1148/radiol.2018172468; Tao JJ, 2015, NEURAL REGEN RES, V10, P1879, DOI 10.4103/1673-5374.170322; voor de Gezondheidszorg FK., 2007, KCE REPORTS, V51, P26	44	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1971-4009	2385-1996		NEURORADIOL J	Neuradiology J.											19714009211049714	10.1177/19714009211049714		OCT 2021	9	Neuroimaging	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WI5AS	WOS:000708373400001	34643120				2022-02-06	
J	Frank, D; Gruenbaum, BF; Shelef, I; Zvenigorodsky, V; Benjamin, Y; Shapoval, O; Gal, R; Zlotnik, A; Melamed, I; Boyko, M				Frank, Dmitry; Gruenbaum, Benjamin F.; Shelef, Ilan; Zvenigorodsky, Vladislav; Benjamin, Yair; Shapoval, Olha; Gal, Ron; Zlotnik, Alexander; Melamed, Israel; Boyko, Matthew			A Novel Histological Technique to Assess Severity of Traumatic Brain Injury in Rodents: Comparisons to Neuroimaging and Neurological Outcomes	FRONTIERS IN NEUROSCIENCE			English	Article						histology; magnetic imaging resonance; methods; rodent; traumatic brain injury	BLOOD GLUTAMATE LEVELS; APPARENT DIFFUSION-COEFFICIENT; RAT MODEL; CEREBRAL-ISCHEMIA; MRI; EDEMA; EPIDEMIOLOGY; BARRIER; STROKE; PROGESTERONE	Here we evaluate an alternative protocol to histologically examine blood-brain barrier (BBB) breakdown, brain edema, and lesion volume following traumatic brain injury (TBI) in the same set of rodent brain samples. We further compare this novel histological technique to measurements determined by magnetic resonance imaging (MRI) and a neurological severity score (NSS). Sixty-six rats were randomly assigned to a sham-operated, mild TBI, moderate TBI, or severe TBI group. 48 h after TBI, NSS, MRI and histological techniques were performed to measure TBI severity outcome. Both the histological and MRI techniques were able to detect measurements of severity outcome, but histologically determined outcomes were more sensitive. The two most sensitive techniques for determining the degree of injury following TBI were NSS and histologically determined BBB breakdown. Our results demonstrate that BBB breakdown, brain edema, and lesion volume following TBI can be accurately measured by histological evaluation of the same set of brain samples	[Frank, Dmitry; Benjamin, Yair; Gal, Ron; Zlotnik, Alexander; Boyko, Matthew] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Anesthesiol & Crit Care, Beer Sheva, Israel; [Gruenbaum, Benjamin F.] Mayo Clin, Dept Anesthesiol & Perioperat Med, Jacksonville, FL 32224 USA; [Shelef, Ilan; Zvenigorodsky, Vladislav] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Radiol, Beer Sheva, Israel; [Shapoval, Olha] Dnepropetrovsk Natl Univ, Dept Physiol, Fac Biol Ecol & Med, Dnepropetrovsk, Ukraine; [Melamed, Israel] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Neurosurg, Beer Sheva, Israel		Boyko, M (corresponding author), Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Anesthesiol & Crit Care, Beer Sheva, Israel.	matthewboykoresearch@gmail.com					Ahishali B, 2021, METHODS MOL BIOL, V2367, P87, DOI 10.1007/7651_2020_316; Albrecht J, 2019, EJNMMI RES, V9, DOI 10.1186/s13550-019-0489-6; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Bardutzky J, 2005, STROKE, V36, P2000, DOI 10.1161/01.STR.0000177486.85508.4d; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; BENVENISTE H, 1992, STROKE, V23, P746, DOI 10.1161/01.STR.23.5.746; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Bontempi P, 2021, EXP GERONTOL, V152, DOI 10.1016/j.exger.2021.111432; Boyko M, 2019, BIOL PROCED ONLINE, V21, DOI 10.1186/s12575-019-0097-x; Boyko M, 2019, BRAIN RES, V1718, P12, DOI 10.1016/j.brainres.2019.04.022; Boyko M, 2013, COGN AFFECT BEHAV NE, V13, P847, DOI 10.3758/s13415-013-0177-3; Boyko M, 2013, BRAIN RES, V1491, P109, DOI 10.1016/j.brainres.2012.10.061; Boyko M, 2011, EUR J NEUROSCI, V34, P1432, DOI 10.1111/j.1460-9568.2011.07864.x; Boyko M, 2011, BEHAV BRAIN RES, V223, P17, DOI 10.1016/j.bbr.2011.03.019; Bratane BT, 2009, BRAIN RES, V1279, P182, DOI 10.1016/j.brainres.2009.05.002; Bridge H, 2006, PHILOS T R SOC B, V361, P137, DOI 10.1098/rstb.2005.1777; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Choi HS, 2015, KOREAN J RADIOL, V16, P791, DOI 10.3348/kjr.2015.16.4.791; Chung P., 2014, J NEUROL NEUROPHYSIO, V5, P1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Denic A, 2011, NEUROTHERAPEUTICS, V8, P3, DOI 10.1007/s13311-010-0002-4; Frank D, 2021, JOVE-J VIS EXP, DOI 10.3791/62291; Frank D, 2020, JOVE-J VIS EXP, DOI 10.3791/61309; Frank D, 2019, NEUROPHARMACOLOGY, V155, P173, DOI 10.1016/j.neuropharm.2019.05.035; Fricke ST, 2004, J NEUROSCI METH, V136, P99, DOI 10.1016/j.jneumeth.2004.01.003; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kobeissy F., 1940, INJURY MODELS CENTRA; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Kuts R, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01105; Kuts R, 2019, JOVE-J VIS EXP, DOI 10.3791/58875; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Lee Bruce, 2005, NeuroRx, V2, P372; Li L, 2018, PATHOL RES PRACT, V214, P174, DOI 10.1016/j.prp.2017.11.016; Lim SW, 2017, WORLD NEUROSURG, V100, P128, DOI 10.1016/j.wneu.2016.12.118; Liu HS, 2013, STROKE, V44, P1872, DOI 10.1161/STROKEAHA.113.001558; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; Meng XJ, 2004, ANN NEUROL, V55, P207, DOI 10.1002/ana.10803; Meymandi MS, 2018, BRAIN RES BULL, V140, P169, DOI 10.1016/j.brainresbull.2018.05.001; Milidonis X, 2015, STROKE, V46, P843, DOI 10.1161/STROKEAHA.114.007560; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Ohayon S, 2012, J NEUROTRAUM, V29, P261, DOI 10.1089/neu.2011.1938; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Perri BR, 1997, J NEUROTRAUM, V14, P15, DOI 10.1089/neu.1997.14.15; Popp I, 2019, RADIOTHER ONCOL, V130, P121, DOI 10.1016/j.radonc.2018.08.019; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Purushotham A, 2015, INT J STROKE, V10, P348, DOI 10.1111/ijs.12068; Ren HH, 2019, NEUROREPORT, V30, P605, DOI 10.1097/WNR.0000000000001213; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saini M, 2009, NEUROL INDIA, V57, P550, DOI 10.4103/0028-3886.57792; Sanchez-Bezanilla S, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00181; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shen Q, 2016, METHODS MOL BIOL, V1462, P645, DOI 10.1007/978-1-4939-3816-2_35; Stoffel M, 2004, J NEUROTRAUM, V21, P733, DOI 10.1089/0897715041269678; Tsesis S, 2013, GYNECOL ENDOCRINOL, V29, P912, DOI 10.3109/09513590.2013.813467; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; van Vliet EA, 2020, NEUROBIOL DIS, V145, DOI 10.1016/j.nbd.2020.105080; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yuan Y, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00562; Yushmanov VE, 2002, MAGNET RESON MED, V47, P562, DOI 10.1002/mrm.10103; Zlotnik A, 2012, J NEUROSURG ANESTH, V24, P30, DOI 10.1097/ANA.0b013e318232deaa; Zlotnik A, 2011, BIOL REPROD, V84, P581, DOI 10.1095/biolreprod.110.088120	68	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	OCT 13	2021	15								733115	10.3389/fnins.2021.733115			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WQ1ZY	WOS:000713621400001	34720861	Green Published, gold			2022-02-06	
J	Jiang, YZ; Chen, YW; Huang, CL; Xia, AQ; Wang, GH; Liu, S				Jiang, Yingzi; Chen, Yuwen; Huang, Chunling; Xia, Anqi; Wang, Guohua; Liu, Su			Hyperbaric oxygen therapy improves neurological function via the p38-MAPK/CCL2 signaling pathway following traumatic brain injury	NEUROREPORT			English	Article						hyperbaric oxygen; traumatic brain injury; p38; CCL2; CCR2	ANIMAL-MODELS; NEUROINFLAMMATION; NEUROPROTECTION; ACTIVATION; APOPTOSIS; RATS	Objective The anti-inflammatory mechanisms of hyperbaric oxygenation (HBO) treatment on traumatic brain injury (TBI)-induced neuroinflammation remain unclear. The aim of this study was expected the effect of HBO on CCL2-related signaling pathway following severe TBI in rats. Methods The severe TBI model in rats was induced by controlled cortical impact. TBI rats were treated with CCR2 antagonist, p38 inhibitor, or HBO. Modified neurological severity scores and Morris water maze were used to evaluate neurological and cognitive function. The expression levels of CCL2 and CCR2 were measured by ELISA and real-time fluorescence quantitative PCR. Phospho-p38 expression was analyzed by western blotting. Results TBI-induced upregulation of CCL2, CCR2, and p38 in the injured cortex. Application of CCR2 antagonist improved neurological and cognitive function of TBI rats. Application of p38 inhibitor decreased expression of CCL2 and CCR2 in the injured of TBI rats, meanwhile improved neurological and cognitive function. HBO improved neurological and cognitive function by decreasing the expressions of CCL2, CCR2, and phospho-p38. Conclusions This study indicates that the p38-MAPK-CCL2 signaling pathway could mediate neuroinflammation and HBO therapy can modulate neuroinflammation by modulating the p38-MAPK-CCL2 signaling pathways following TBI. This study may provide theoretical evidence for HBO treatment in the treatment of TBI.	[Jiang, Yingzi; Chen, Yuwen; Huang, Chunling; Xia, Anqi; Liu, Su] Nantong Univ, Dept Rehabil Med, Affiliated Hosp, Nantong 226000, Jiangsu, Peoples R China; [Jiang, Yingzi; Chen, Yuwen; Huang, Chunling; Xia, Anqi] Nantong Univ, Sch Med, Dept Clin Med, Nantong, Jiangsu, Peoples R China; [Wang, Guohua] Nantong Univ, Inst Special Environm Med, Nantong, Jiangsu, Peoples R China; [Wang, Guohua] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Jiangsu, Peoples R China		Liu, S (corresponding author), Nantong Univ, Dept Rehabil Med, Affiliated Hosp, Nantong 226000, Jiangsu, Peoples R China.	327202278@qq.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81702223]; Science and Technology Planning Project of Nantong [MS22019006]	This project was funded by the National Natural Science Foundation of China (no. 81702223) and the Science and Technology Planning Project of Nantong (MS22019006).	Bobba Ushasree, 2019, Asian J Neurosurg, V14, P87, DOI 10.4103/ajns.AJNS_240_17; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Chesnel C, 2018, CLIN REHABIL, V32, P692, DOI 10.1177/0269215517734294; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Crawford C, 2017, J HEAD TRAUMA REHAB, V32, pE27, DOI 10.1097/HTR.0000000000000256; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Daly S, 2018, J NEUROTRAUM, V35, P623, DOI 10.1089/neu.2017.5225; Deng Z, 2018, NIGER J CLIN PRACT, V21, P401, DOI 10.4103/njcp.njcp_315_16; Gao GY, 2020, LANCET NEUROL, V19, P670, DOI 10.1016/S1474-4422(20)30182-4; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Liang F, 2020, CELL STRESS CHAPERON, V25, P1013, DOI 10.1007/s12192-020-01137-6; Lim SW, 2017, WORLD NEUROSURG, V100, P128, DOI 10.1016/j.wneu.2016.12.118; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Liu R, 2019, MOL IMMUNOL, V112, P30, DOI 10.1016/j.molimm.2019.04.010; Liu S, 2018, INFLAMMATION, V41, P2003, DOI 10.1007/s10753-018-0843-2; Liu S, 2015, EXP BRAIN RES, V233, P3359, DOI 10.1007/s00221-015-4405-7; Liu S, 2013, NEURAL REGEN RES, V8, P3334, DOI 10.3969/j.issn.1673-5374.2013.35.008; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Maggio MG, 2019, J CLIN NEUROSCI, V61, P1, DOI 10.1016/j.jocn.2018.12.020; Meng XE, 2016, MED SCI MONITOR, V22, P284, DOI 10.12659/MSM.894148; Qian HH, 2017, MOL MED REP, V16, P3922, DOI 10.3892/mmr.2017.7079; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Tan ZJ, 2020, ANN CLIN TRANSL NEUR, V7, P742, DOI 10.1002/acn3.51044; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; Wang Y, 2016, MOL MED REP, V14, P5619, DOI 10.3892/mmr.2016.5935; Wee HY, 2015, J SURG RES, V197, P382, DOI 10.1016/j.jss.2015.04.052; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Yuan JW, 2020, CELL MOL NEUROBIOL, V40, P511, DOI 10.1007/s10571-019-00749-6	34	0	0	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	OCT 13	2021	32	15					1255	1262		10.1097/WNR.0000000000001719			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UP9FR	WOS:000695678600005	34494990	hybrid, Green Published			2022-02-06	
J	Martin, BJ; Sober, JD; Millis, SR; Hanks, RA; Reslan, S; Waldron-Perrine, B				Martin, Bess J.; Sober, Jonathan D.; Millis, Scott R.; Hanks, Robin A.; Reslan, Summar; Waldron-Perrine, Brigid			CVLT-3 response bias as an indicator of performance validity in a litigating population	CLINICAL NEUROPSYCHOLOGIST			English	Article; Early Access						Embedded performance validity; CVLT-3; TBI; response bias	TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; BASE RATES; REPEATABLE BATTERY; INCOMPLETE EFFORT; TEST-II	Objective: This study examined the efficacy of CVLT-3 response bias (i.e., parametric and nonparametric response bias) indices in differentiating between a clinical sample with traumatic brain injury and a litigating sample with poor performance validity. Method: Participants included 106 individuals, divided into two groups: clinical group with TBI (n = 56) and a litigating group who demonstrated inadequate performance validity (n = 50), as measured by failure on at least two performance validity tests. Archival CVLT-II data was rescored utilizing the CVLT-3 scoring and normative data. Receiver operator characteristic (ROC) curve analysis was used to evaluate the diagnostic discriminability of the two response bias indices. Results: Both parametric and nonparametric bias indices showed acceptable levels of diagnostic discrimination: AUC = .791 for parametric response bias and AUC = .753 for nonparametric response bias. Conclusions: Parametric response bias' discrimination was statistically superior to the nonparametric responses bias' discrimination. The CVLT-3 response bias score demonstrated good sensitivity and specificity when differentiating between individuals in a clinical sample with TBI and individuals in litigation who demonstrated inadequate performance validity.	[Martin, Bess J.; Sober, Jonathan D.] Rehabil Inst Michigan, Neuropsychol, 261 Mack Ave, Detroit, MI 48201 USA; [Millis, Scott R.; Hanks, Robin A.; Reslan, Summar; Waldron-Perrine, Brigid] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Rehabil Inst Michigan, Detroit, MI USA		Martin, BJ (corresponding author), Rehabil Inst Michigan, Neuropsychol, 261 Mack Ave, Detroit, MI 48201 USA.	bessmartin@fuller.edu					Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Boone K.B., 2018, TXB CLIN NEUROPSYCHO, V2nd ed., P39, DOI DOI 10.4324/9781315271743-4; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis D.C., 2017, CALIFORNIA VERBAL LE, V3rd; Delis DC, 1987, CALIFORNIA VERBAL LE; DEWEER B, 1995, J NEUROL NEUROSUR PS, V58, P590, DOI 10.1136/jnnp.58.5.590; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Green P., 2004, MED SYMPTOM VALIDITY; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Huh TJ, 2006, J INT NEUROPSYCH SOC, V12, P1, DOI 10.1017/S1355617706060024; Kanser RJ, 2021, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2021.1921277; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Martin PK, 2020, ARCH CLIN NEUROPSYCH, V35, P717, DOI 10.1093/arclin/acaa017; McCaul C, 2018, CLIN NEUROPSYCHOL, V32, P1054, DOI 10.1080/13854046.2018.1425481; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Novitski J, 2012, ARCH CLIN NEUROPSYCH, V27, P190, DOI 10.1093/arclin/acr119; Ruff RM, 2016, PSYCHOL INJ LAW, V9, P143, DOI 10.1007/s12207-016-9259-1; Sherman EMS, 2020, ARCH CLIN NEUROPSYCH, V35, P735, DOI 10.1093/arclin/acaa019; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; StataCorp, 2019, STATA STAT SOFTWARE; Stenberg J, 2020, NEUROPSYCHOLOGY, V34, P560, DOI 10.1037/neu0000632; Sweet JJ, 2021, CLIN NEUROPSYCHOL, V35, P1053, DOI 10.1080/13854046.2021.1896036; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Warrington E, 1984, RECOGNITION MEMORY T, V1; Whiteside DM, 2015, CLIN NEUROPSYCHOL, V29, P788, DOI 10.1080/13854046.2015.1093660; Wodushek TR, 2020, APPL NEUROPSYCH-ADUL, V27, P9, DOI 10.1080/23279095.2018.1473251; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	36	0	0	2	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.												10.1080/13854046.2021.1993347		OCT 2021	10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	WM0NT	WOS:000710792700001	34689724				2022-02-06	
J	Nikolova, S; Schwedt, TJ; Li, J; Wu, T; Dumkrieger, GM; Ross, KB; Berisha, V; Chong, CD				Nikolova, Simona; Schwedt, Todd J.; Li, Jing; Wu, Teresa; Dumkrieger, Gina M.; Ross, Katherine B.; Berisha, Visar; Chong, Catherine D.			T2*reduction in patients with acute post-traumatic headache	CEPHALALGIA			English	Article; Early Access						T2*; imaging; mild traumatic brain injury; concussion; iron; migraine; magnetic resonance imaging; structural; anatomical	TRAUMATIC BRAIN-INJURY; MIGRAINE; IRON; MRI; PAIN; STEM; NUCLEI; ABNORMALITIES; RELAXATION	Objectives Although iron accumulation in pain-processing brain regions has been associated with repeated migraine attacks, brain structural changes associated with post-traumatic headache have yet to be elucidated. To determine whether iron accumulation is associated with acute post-traumatic headache, magnetic resonance transverse relaxation rates (T2*) associated with iron accumulation were investigated between individuals with acute post-traumatic headache attributed to mild traumatic brain injury and healthy controls. Methods Twenty individuals with acute post-traumatic headache and 20 age-matched healthy controls underwent 3T brain magnetic resonance imaging including quantitative T2* maps. T2* differences between individuals with post-traumatic headache versus healthy controls were compared using age-matched paired t-tests. Associations of T2* values with headache frequency and number of mild traumatic brain injuries were investigated using multiple linear regression in individuals with post-traumatic headache. Significance was determined using uncorrected p-value and cluster size threshold. Results Individuals with post-traumatic headache had lower T2* values compared to healthy controls in cortical (bilateral frontal, bilateral anterior and posterior cingulate, right postcentral, bilateral temporal, right supramarginal, right rolandic, left insula, left occipital, right parahippocampal), subcortical (left putamen, bilateral hippocampal) and brainstem regions (pons). Within post-traumatic headache subjects, multiple linear regression showed a negative association between T2* in the right inferior parietal/supramarginal regions and number of mild traumatic brain injuries and a negative association between T2* in bilateral cingulate, bilateral precuneus, bilateral supplementary motor areas, bilateral insula, right middle temporal and right lingual areas and headache frequency. Conclusions Acute post-traumatic headache is associated with iron accumulation in multiple brain regions. Correlations with headache frequency and number of lifetime mild traumatic brain injuries suggest that iron accumulation is part of the pathophysiology or a marker of mild traumatic brain injury and post-traumatic headache.	[Nikolova, Simona; Schwedt, Todd J.; Dumkrieger, Gina M.; Chong, Catherine D.] Mayo Clin, Dept Neurol, Phoenix, AZ USA; [Schwedt, Todd J.; Wu, Teresa; Berisha, Visar; Chong, Catherine D.] ASU Mayo Ctr Innovat Imaging, Tempe, AZ USA; [Li, Jing] Georgia Tech, Sch Ind & Syst Engn, Athens, GA USA; [Wu, Teresa] Arizona State Univ, Sch Comp Informat Decis Syst Engn, Tempe, AZ USA; [Ross, Katherine B.] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Berisha, Visar] Arizona State Univ, Sch Elect Comp & Energy Engn, Tempe, AZ USA; [Berisha, Visar] Arizona State Univ, Coll Hlth Solut, Tempe, AZ USA; [Berisha, Visar] Coll Hlth Solut, Phoenix, AZ USA; [Chong, Catherine D.] Mayo Clin, Dept Physiol & Biomed Engn, Phoenix, AZ USA		Chong, CD (corresponding author), 5777 East Mayo Blvd, Phoenix, AZ 85054 USA.	Chong.Catherine@mayo.edu		Dumkrieger, Gina/0000-0001-9519-5370	National Institutes of Health, National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R61NS113315-01]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the National Institutes of Health, National Institute of Neurological Disorders and Stroke, Award Number 1R61NS113315-01.	[Anonymous], 2018, Cephalalgia, V38, P1, DOI 10.1177/0333102417738202; Ashina H, 2020, CEPHALALGIA, V40, P554, DOI 10.1177/0333102420909865; Bahra A, 2001, LANCET, V357, P1016, DOI 10.1016/S0140-6736(00)04250-1; Borsook D, 2012, CEPHALALGIA, V32, P803, DOI 10.1177/0333102412453952; Burrowes SAB, 2020, BRAIN IMAGING BEHAV, V14, P1651, DOI 10.1007/s11682-019-00095-7; Cao Y, 2002, NEUROLOGY, V59, P72, DOI 10.1212/WNL.59.1.72; Chong CD, 2017, NEUROIMAGE-CLIN, V13, P223, DOI 10.1016/j.nicl.2016.10.023; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Daugherty AM, 2015, NEUROPSYCHOL REV, V25, P272, DOI 10.1007/s11065-015-9292-y; Daugherty AM, 2015, J NEUROSCI, V35, P6731, DOI 10.1523/JNEUROSCI.4717-14.2015; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Ferraro S, 2012, PAIN MED, V13, P255, DOI 10.1111/j.1526-4637.2011.01183.x; Gossuin Y, 2004, NMR BIOMED, V17, P427, DOI 10.1002/nbm.903; Granziera C, 2014, HUM BRAIN MAPP, V35, P1461, DOI 10.1002/hbm.22266; Howard L, 2018, HEADACHE, V58, P1397, DOI 10.1111/head.13396; Karsan Nazia, 2018, Continuum (Minneap Minn), V24, P996, DOI 10.1212/CON.0000000000000624; Kruit MC, 2009, CEPHALALGIA, V29, P351, DOI 10.1111/j.1468-2982.2008.01723.x; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; May A, 2013, CEPHALALGIA, V33, P554, DOI 10.1177/0333102412467513; Mayer AR, 2014, J NEUROTRAUM, V31, P189, DOI 10.1089/neu.2013.3069; Palm-Meinders IH, 2017, CEPHALALGIA, V37, P795, DOI 10.1177/0333102416668654; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Schenck JF, 1995, J NEUROL SCI, V134, P10, DOI 10.1016/0022-510X(95)00203-E; Schulte LH, 2020, CEPHALALGIA, V40, P1614, DOI 10.1177/0333102420951465; Schulte LH, 2016, BRAIN, V139, P1987, DOI 10.1093/brain/aww097; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Sydnor VJ, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2020.102190; Tepper SJ, 2012, HEADACHE, V52, P236, DOI 10.1111/j.1526-4610.2011.02056.x; Tortorella P, 2006, J NEUROL SCI, V244, P137, DOI 10.1016/j.jns.2006.01.015; Ulla M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057904; Vila-Pueyo M, 2019, CEPHALALGIA, V39, P1635, DOI 10.1177/0333102418784698; Voormolen DC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111921; Widerstrom-Noga E, 2016, J NEUROTRAUM, V33, P1380, DOI 10.1089/neu.2015.4098; Yao B, 2009, NEUROIMAGE, V44, P1259, DOI 10.1016/j.neuroimage.2008.10.029; Younis S, 2021, J CEREBR BLOOD F MET, V41, P604, DOI 10.1177/0271678X20906902; Younis S, 2017, CURR OPIN NEUROL, V30, P246, DOI 10.1097/WCO.0000000000000436	36	0	0	2	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia											03331024211048509	10.1177/03331024211048509		OCT 2021	9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WI6RP	WOS:000708485500001	34644192				2022-02-06	
J	Yu, Y; Shen, TJ; Zhong, XL; Wang, LL; Tai, WJ; Zou, YH; Qin, J; Zhang, ZH; Zhang, CL				Yu, Ying; Shen, Tianjin; Zhong, Xiaoling; Wang, Lei-Lei; Tai, Wenjiao; Zou, Yuhua; Qin, Jun; Zhang, Zhaohui; Zhang, Chun-Li			NEK6 is an injury-responsive kinase cooperating with STAT3 in regulation of reactive astrogliosis	GLIA			English	Article						glial scar; NEK6; neuroinflammation; reactive astrogliosis; STAT3; traumatic brain injury	TRAUMATIC BRAIN-INJURY; NIMA FAMILY KINASES; SCAR FORMATION; ASTROCYTES; ACTIVATION; TRANSFORMATION; CANCER; SOX2	In response to brain injury, resident astrocytes become reactive and play dynamic roles in neural repair and regeneration. The signaling pathways underlying such reactive astrogliosis remain largely unclear. We here show that NEK6, a NIMA-related serine/threonine protein kinase, is rapidly induced following pathological stimulations and plays critical roles in reactive astrogliosis. Enhanced NEK6 expression promotes reactive astrogliosis and exacerbates brain lesions; and conversely, NEK6 downregulation dampens injury-induced astrocyte reactivity and reduces lesion size. Mechanistically, NEK6 associates with and phosphorylates STAT3. Kinase activity of NEK6 is required for induction of GFAP and PCNA, markers of reactive astrogliosis. Interestingly, NEK6 is also localized in the nucleus and binds to STAT3-responsive genomic elements in astrocytes. These results indicate that NEK6 constitutes a molecular target for the regulation of reactive astrogliosis.	[Yu, Ying; Zhang, Zhaohui] Wuhan Univ, Renmin Hosp, Dept Neurol, Wuhan, Peoples R China; [Yu, Ying; Shen, Tianjin; Zhong, Xiaoling; Wang, Lei-Lei; Tai, Wenjiao; Zou, Yuhua; Zhang, Chun-Li] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA; [Qin, Jun] Wuhan Univ, Zhongnan Hosp, Dept Orthoped Surg, Wuhan, Peoples R China		Zhang, CL (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	chun-li.zhang@utsouthwestern.edu		Zhang, Chun-Li/0000-0002-2639-4605	Texas Alzheimer's Research and Care Consortium [TARCC2020]; Welch FoundationThe Welch Foundation [I-1724]	the Texas Alzheimer's Research and Care Consortium, Grant/Award Number: TARCC2020; Welch Foundation, Grant/Award Number: I-1724	Adib R, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw2939; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Belham C, 2001, CURR BIOL, V11, P1155, DOI 10.1016/S0960-9822(01)00369-4; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chen CH, 2019, CEREB CORTEX, V29, P54, DOI 10.1093/cercor/bhx303; Choi JS, 2003, GLIA, V41, P237, DOI 10.1002/glia.10186; Choudhury AD, 2017, CANCER RES, V77, P753, DOI 10.1158/0008-5472.CAN-16-0455; Escartin C, 2021, NAT NEUROSCI, V24, P312, DOI 10.1038/s41593-020-00783-4; Feige E, 2002, MECH DEVELOP, V110, P219, DOI 10.1016/S0925-4773(01)00573-1; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Islam MM, 2015, STEM CELL REP, V5, P805, DOI 10.1016/j.stemcr.2015.09.015; Jee HJ, 2010, CELL CYCLE, V9, P4703, DOI 10.4161/cc.9.23.14059; Jeon YJ, 2010, J BIOL CHEM, V285, P28126, DOI 10.1074/jbc.M110.137190; Kang WF, 2014, P NATL ACAD SCI USA, V111, pE2987, DOI 10.1073/pnas.1320401111; Koyama Y, 2014, NEUROCHEM INT, V78, P35, DOI 10.1016/j.neuint.2014.08.005; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Liu C, 2011, CELL MOL NEUROBIOL, V31, P259, DOI 10.1007/s10571-010-9616-7; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; Ma SP, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00411-6; Medvedeva YA, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav067; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Shinozaki Y, 2017, CELL REP, V19, P1151, DOI 10.1016/j.celrep.2017.04.047; Smith DK, 2016, STEM CELL REP, V7, P955, DOI 10.1016/j.stemcr.2016.09.013; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Su ZD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4338; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Weintraub AS, 2017, CELL, V171, P1573, DOI 10.1016/j.cell.2017.11.008; Yin MJ, 2003, J BIOL CHEM, V278, P52454, DOI 10.1074/jbc.M308080200; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001	40	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	FEB	2022	70	2					273	286		10.1002/glia.24104		OCT 2021	14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XL6PM	WOS:000706757400001	34643969				2022-02-06	
J	Zhang, YG; Sun, S; Liu, HL; Ren, QJ; Hao, WT; Xin, Q; Xu, JG; Wang, H; Zhang, XD				Zhang, Yunguang; Sun, Si; Liu, Haile; Ren, Qinjuan; Hao, Wenting; Xin, Qi; Xu, Jiangang; Wang, Hao; Zhang, Xiao-Dong			Catalytically active gold clusters with atomic precision for noninvasive early intervention of neurotrauma	JOURNAL OF NANOBIOTECHNOLOGY			English	Article						Gold clusters; Catalytic activity; Traumatic brain injury; Noninvasive administration	TRAUMATIC BRAIN-INJURY; MORRIS WATER MAZE; HIGHLY EFFICIENT; RENAL CLEARANCE; AU-25 CLUSTERS; NANOCLUSTERS; CATALYSIS; AU	Background Neurotrauma is a worldwide public health problem which can be divided into primary and secondary damge. The primary damge is caused by external forces and triggers the overproduction of peroxides and superoxides, leading to long-lasting secondary damage including oxidative stress, wound infection and immunological reactions. The emerging catalysts have shown great potential in the treatment of brain injury and neurogenic inflammation, but are limited to biosafety issues and delivery efficiency. Results Herein, we proposed the noninvasive delivery route to brain trauma by employing highly active gold clusters with enzyme-like activity to achieve the early intervention. The decomposition rate to H2O2 of the ultrasmall gold clusters is 10 times that of glassy carbon (GC) electrodes, indicating excellent catalytic activity. The gold clusters can relieve the oxidative stress and decrease the excessive O-2(center dot-) and H2O2 both in vitro and in vivo. Besides, gold clusters can accelerate the wound healing of brain trauma and alleviate inflammation via inhibiting the activation of astrocytes and microglia through noninvasive adminstration. decrease the peroxide and superoxide of brain tissue. Conclusions Present work shows noninvasive treatment is a promising route for early intervention of brain trauma.	[Zhang, Yunguang; Xu, Jiangang] Xian Univ Posts & Telecommun, Sch Sci, Xian 710121, Peoples R China; [Sun, Si; Liu, Haile; Ren, Qinjuan; Zhang, Xiao-Dong] Tianjin Univ, Sch Sci, Tianjin Key Lab Low Dimens Mat Phys & Preparing T, Tianjin 300350, Peoples R China; [Hao, Wenting; Xin, Qi; Wang, Hao; Zhang, Xiao-Dong] Tianjin Univ, Acad Med Engn & Translat Med, Tianjin Key Lab Brain Sci & Neuroengn, Tianjin 300072, Peoples R China		Xu, JG (corresponding author), Xian Univ Posts & Telecommun, Sch Sci, Xian 710121, Peoples R China.; Zhang, XD (corresponding author), Tianjin Univ, Sch Sci, Tianjin Key Lab Low Dimens Mat Phys & Preparing T, Tianjin 300350, Peoples R China.; Wang, H; Zhang, XD (corresponding author), Tianjin Univ, Acad Med Engn & Translat Med, Tianjin Key Lab Brain Sci & Neuroengn, Tianjin 300072, Peoples R China.	xjgo@xupt.edu.cn; hao_wang@tju.edu.cn; xiaodongzhang@tju.edu.cn	Zhang, Xiaodong/F-4665-2015	Zhang, Xiaodong/0000-0002-7212-0138	NSFCNational Natural Science Foundation of China (NSFC) [91859101, 81971744, U1932107, 81471786]; National Natural Science Foundation of Tianjin [19JCZDJC34000]; Foundation of 'Peiyang Young Researcher' Program of Tianjin University; CAS Interdisciplinary Innovation Team [JCTD-2020-08]	This work was financially supported by the NSFC (Grant Nos. 91859101, 81971744, U1932107, and 81471786), the National Natural Science Foundation of Tianjin (19JCZDJC34000), the Foundation of `Peiyang Young Researcher' Program of Tianjin University, and CAS Interdisciplinary Innovation Team (JCTD-2020-08).	Badhiwala JH, 2019, LANCET NEUROL, V18, P24, DOI 10.1016/S1474-4422(18)30444-7; Cai X, 2019, ANGEW CHEM INT EDIT, V58, P9964, DOI 10.1002/anie.201903853; Chen D, 2020, NANOSCALE HORIZ, V5, P1355, DOI 10.1039/d0nh00207k; Chen K, 2021, COORDIN CHEM REV, V432, DOI 10.1016/j.ccr.2020.213751; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Fan KL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03903-8; Fan Y, 2021, ACS NANO, V15, P2005, DOI 10.1021/acsnano.0c06962; Gao GB, 2019, BIOMATERIALS, V194, P36, DOI 10.1016/j.biomaterials.2018.12.013; Geerts L, 2019, CATAL TODAY, V334, P59, DOI 10.1016/j.cattod.2019.01.062; Gu H, 2013, ACS APPL MATER INTER, V5, P6762, DOI 10.1021/am401738k; Guo F, 2021, J MATER CHEM A, V9, P5468, DOI 10.1039/d0ta10500g; Hao WT, 2020, ACS OMEGA, V5, P24537, DOI 10.1021/acsomega.0c03005; Higaki T, 2019, ANGEW CHEM INT EDIT, V58, P8291, DOI 10.1002/anie.201814156; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jiang YY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15730-x; Joseph B, 2018, J NEUROSCI RES, V96, P589, DOI 10.1002/jnr.24132; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; Kudryashev JA, 2020, ACS SENSORS, V5, P686, DOI 10.1021/acssensors.9b01812; Kwak K, 2019, ACCOUNTS CHEM RES, V52, P12, DOI 10.1021/acs.accounts.8b00379; Li CY, 2020, NAT BIOMED ENG, V4, P579, DOI 10.1038/s41551-020-0574-1; Li CY, 2020, ANGEW CHEM INT EDIT, V59, P247, DOI 10.1002/anie.201911803; Li Z, 2020, CHEM REV, V120, P623, DOI 10.1021/acs.chemrev.9b00311; Liu HL, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20275-0; Liu HL, 2019, ADV MATER, V31, DOI 10.1002/adma.201901015; Liu YF, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb2695; Lu YZ, 2018, NANO ENERGY, V50, P316, DOI 10.1016/j.nanoen.2018.05.052; Ma MM, 2020, ACS NANO, V14, P9894, DOI 10.1021/acsnano.0c02733; Mendoza K, 2019, J NEUROTRAUM, V36, P2139, DOI 10.1089/neu.2018.6027; Mu XY, 2019, NANO LETT, V19, P4527, DOI 10.1021/acs.nanolett.9b01333; Mu XY, 2019, ACS NANO, V13, P1870, DOI 10.1021/acsnano.8b08045; Pink AE, 2021, NEUROPSYCHOL REHABIL, V31, P479, DOI 10.1080/09602011.2019.1706585; Seong H, 2021, ANGEW CHEM INT EDIT, V60, P14563, DOI 10.1002/anie.202102887; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smith ES, 2019, ADV DRUG DELIVER REV, V148, P181, DOI 10.1016/j.addr.2019.02.009; Strubakos CD, 2020, J CEREBR BLOOD F MET, V40, P833, DOI 10.1177/0271678X19845149; Sun S, 2021, NANO LETT, V21, P2562, DOI 10.1021/acs.nanolett.0c05148; Tang Q, 2018, ACCOUNTS CHEM RES, V51, P2793, DOI 10.1021/acs.accounts.8b00380; Tang ZH, 2018, CATALYSTS, V8, DOI 10.3390/catal8020065; Tian SB, 2020, CHEM COMMUN, V56, P1163, DOI 10.1039/c9cc08215h; Tyo EC, 2015, NAT NANOTECHNOL, V10, P577, DOI [10.1038/NNANO.2015.140, 10.1038/nnano.2015.140]; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang JY, 2018, SMALL, V14, DOI 10.1002/smll.201703736; Wang Q, 2021, BIOMED MATER, V16, DOI 10.1088/1748-605X/abe7b4; Wang XJ, 2016, CHEM COMMUN, V52, P9232, DOI 10.1039/c6cc03814j; Wu HB, 2018, BIOMATERIALS, V151, P66, DOI 10.1016/j.biomaterials.2017.10.018; Xu BL, 2019, ANGEW CHEM INT EDIT, V58, P4911, DOI 10.1002/anie.201813994; Xu J, 2018, ANGEW CHEM INT EDIT, V57, P266, DOI 10.1002/anie.201710584; Yan RJ, 2019, ACS NANO, V13, P11552, DOI 10.1021/acsnano.9b05075; Yang BW, 2019, ADV MATER, V31, DOI 10.1002/adma.201901778; Yao QF, 2018, ACCOUNTS CHEM RES, V51, P1338, DOI 10.1021/acs.accounts.8b00065; Yong Y, 2017, ACS NANO, V11, P7164, DOI 10.1021/acsnano.7b03037; Yuan SF, 2021, ANGEW CHEM INT EDIT, V60, P5225, DOI 10.1002/anie.202012499; Yuan X, 2015, NANO RES, V8, P3488, DOI 10.1007/s12274-015-0847-2; Zhang SF, 2021, THERANOSTICS, V11, P2806, DOI 10.7150/thno.51912; Zhang XD, 2016, ADV MATER, V28, P6872, DOI 10.1002/adma.201600706; Zhang XD, 2016, ACS NANO, V10, P4511, DOI 10.1021/acsnano.6b00321; Zhang XD, 2012, BIOMATERIALS, V33, P4628, DOI 10.1016/j.biomaterials.2012.03.020; Zhao S, 2017, J AM CHEM SOC, V139, P1077, DOI 10.1021/jacs.6b12529; Zhou RY, 2021, NANO TODAY, V36, DOI 10.1016/j.nantod.2020.101003; Zhu JT, 2020, ACS NANO, V14, P5600, DOI 10.1021/acsnano.9b10048	62	0	0	10	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1477-3155		J NANOBIOTECHNOL	J. Nanobiotechnol.	OCT 13	2021	19	1							319	10.1186/s12951-021-01071-4			13	Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	WG4YG	WOS:000707001400001	34645450	gold, Green Published, Green Submitted			2022-02-06	
J	Anderson, LM; Samineni, S; Wilder, DM; Lara, M; Eken, O; Urioste, R; Long, JB; Arun, P				Anderson, Laura M.; Samineni, Sridhar; Wilder, Donna M.; Lara, Marisela; Eken, Ondine; Urioste, Rodrigo; Long, Joseph B.; Arun, Peethambaran			The Neurobehavioral Effects of Buprenorphine and Meloxicam on a Blast-Induced Traumatic Brain Injury Model in the Rat	FRONTIERS IN NEUROLOGY			English	Article						blast exposure; traumatic brain injury; neurobehavioral effects; analgesic; meloxicam; buprenorphine	CLOSED-HEAD INJURY; POSTOPERATIVE PAIN; OXIDATIVE STRESS; CYCLOOXYGENASE-2; IRAQ; AFGHANISTAN; INHIBITION; CONCUSSION; RESPONSES; SYMPTOMS	Previous findings have indicated that pain relieving medications such as opioids and non-steroidal anti-inflammatory drugs (NSAIDs) may be neuroprotective after traumatic brain injury in rodents, but only limited studies have been performed in a blast-induced traumatic brain injury (bTBI) model. In addition, many pre-clinical TBI studies performed in rodents did not use analgesics due to the possibility of neuroprotection or other changes in cognitive, behavioral, and pathology outcomes. To examine this in a pre-clinical setting, we examined the neurobehavioral changes in rats given a single pre-blast dose of meloxicam, buprenorphine, or no pain relieving medication and exposed to tightly-coupled repeated blasts in an advanced blast simulator and evaluated neurobehavioral functions up to 28 days post-blast. A 16.7% mortality rate was recorded in the rats treated with buprenorphine, which might be attributed to the physiologically depressive side effects of buprenorphine in combination with isoflurane anesthesia and acute brain injury. Rats given buprenorphine, but not meloxicam, took more time to recover from the isoflurane anesthesia given just before blast. We found that treatment with meloxicam protected repeated blast-exposed rats from vestibulomotor dysfunctions up to day 14, but by day 28 the protective effects had receded. Both pain relieving medications seemed to promote short-term memory deficits in blast-exposed animals, whereas vehicle-treated blast-exposed animals showed only a non-significant trend toward worsening short-term memory by day 27. Open field exploratory behavior results showed that blast exposed rats treated with meloxicam engaged in significantly more locomotor activities and possibly a lesser degree of responses thought to reflect anxiety and depressive-like behaviors than any of the other groups. Rats treated with analgesics to alleviate possible pain from the blast ate more than their counterparts that were not treated with analgesics, which supports that both analgesics were effective in alleviating some of the discomfort that these rats potentially experienced post-blast injury. These results suggest that meloxicam and, to a lesser extent buprenorphine alter a variety of neurobehavioral functions in a rat bTBI model and, because of their impact on these neurobehavioral changes, may be less than ideal analgesic agents for pre-clinical studies evaluating these neurobehavioral responses after TBI.	[Anderson, Laura M.; Samineni, Sridhar] Walter Reed Army Inst Res, Vet Serv Program, Ctr Enabling Capabil, Silver Spring, MD USA; [Wilder, Donna M.; Lara, Marisela; Eken, Ondine; Urioste, Rodrigo; Long, Joseph B.; Arun, Peethambaran] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		Arun, P (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.	peethambaran.arun.ctr@mail.mil			Military Operational Medicine Research	Funding This study was funded by the Military Operational Medicine Research Program at United States Army Medical Research and Materiel Command and the Center for Enabling Capabilities at Walter Reed Army Institute of Research.	[Anonymous], 2018, EXOTIC ANIMAL FORMUL; Arun P, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00438; Arun P, 2020, J NEUROTRAUM, V37, P647, DOI 10.1089/neu.2019.6591; Buprenorphine, 2021, DRUGBANK ONL; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; DUM JE, 1981, BRIT J PHARMACOL, V74, P627, DOI 10.1111/j.1476-5381.1981.tb10473.x; Faden A I, 1996, NIDA Res Monogr, V163, P318; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Fish RE, 2008, AM COLL LAB, P1; Flecknell P., 2015, LAB ANIMAL ANAESTHES; Gavalas A, 1994, Int J Neurosci, V74, P259; Girgis H, 2013, BRAIN RES, V1491, P78, DOI 10.1016/j.brainres.2012.10.049; Hakan T, 2011, INT J NEUROSCI, V121, P142, DOI 10.3109/00207454.2010.537415; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; I.F. Research LA, 2003, GUIDELINES CARE USE; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Kontos Anthony P, 2015, J Trauma Acute Care Surg, V79, pS146, DOI 10.1097/TA.0000000000000667; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kunz T, 2006, RESTOR NEUROL NEUROS, V24, P55; Lamprea MR, 2008, BRAZ J MED BIOL RES, V41, P135, DOI 10.1590/S0100-879X2008000200010; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mattiasson GJ, 2000, J NEUROSCI METH, V95, P75, DOI 10.1016/S0165-0270(99)00162-4; Muelbl MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28062-0; PACIFICI R, 1994, J PHARMACOL EXP THER, V269, P1112; Perez-Garcia G, 2019, NEUROPHARMACOLOGY, V145, P220, DOI 10.1016/j.neuropharm.2018.09.023; Perez-Garcia G, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0357-17.2018; Perez-Garcia G, 2018, BEHAV BRAIN RES, V340, P117, DOI 10.1016/j.bbr.2016.09.061; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Pugh KA, 2017, J AM ASSOC LAB ANIM, V56, P762; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Roughan JV, 2002, LAB ANIM-UK, V36, P322, DOI 10.1258/002367702320162423; Ryu J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88030-z; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sajja VSSS, 2015, SHOCK, V44, P71, DOI 10.1097/SHK.0000000000000311; Santiago JM, 2009, J NEUROTRAUM, V26, P1783, DOI 10.1089/neu.2007.0502; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Sharp BM, 1998, J NEUROIMMUNOL, V83, P45, DOI 10.1016/S0165-5728(97)00220-8; Shultz SR, 2020, J NEUROTRAUM, V37, P2381, DOI 10.1089/neu.2018.6149; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Studlack PE, 2018, BRAIN INJURY, V32, P1866, DOI 10.1080/02699052.2018.1536282; T.B.I.W.G, 2009, J REHABIL RES DEV, V46, pCP1, DOI [10.1682/jrrd.2009.06.0076, DOI 10.1682/JRRD.2009.06.0076]; Thau-Zuchman O, 2012, J NEUROTRAUM, V29, P375, DOI 10.1089/neu.2010.1673; Vuori A, 2004, ACTA ANAESTH SCAND, V48, P738, DOI 10.1111/j.1399-6576.2004.00404.x; Walker JS, 2003, ADV EXP MED BIOL, V521, P148; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Xie K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064907; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zoetis, 2017, SIMB BUPR INJ	61	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 12	2021	12								746370	10.3389/fneur.2021.746370			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WP5YL	WOS:000713206700001	34712199	Green Published, gold			2022-02-06	
J	Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Graham, Simon J.; Schweizer, Tom A.			Sex differences in acute and long-term brain recovery after concussion	HUMAN BRAIN MAPPING			English	Article						ASL; brain injury; concussion; DTI; sex differences	WHITE-MATTER; PROFESSIONAL FOOTBALL; BIDIRECTIONAL CHANGES; RECURRENT CONCUSSION; GENDER-DIFFERENCE; HEAD IMPACTS; BLOOD-FLOW; ACUTE MILD; INJURY; PATHOPHYSIOLOGY	Concussion is associated with acute disturbances in brain function and behavior, with potential long-term effects on brain health. However, it is presently unclear whether there are sex differences in acute and long-term brain recovery. In this study, magnetic resonance imaging (MRI) was used to scan 61 participants with sport-related concussion (30 male, 31 female) longitudinally at acute injury, medical clearance to return to play (RTP), and 1-year post-RTP. A large cohort of 167 controls (80 male, 87 female) was also imaged. Each MRI session assessed cerebral blood flow (CBF), along with white matter fractional anisotropy (FA) and mean diffusivity (MD). For concussed athletes, the parameters were converted to difference scores relative to matched control subgroups, and partial least squares modeled the main and sex-specific effects of concussion. Although male and female athletes did not differ in acute symptoms or time to RTP , all MRI measures showed significant sex differences during recovery. Males had greater reductions in occipital-parietal CBF (mean difference and 95%CI: 9.97 ml/100 g/min, [4.84, 15.12] ml/100 g/min, z = 3.73) and increases in callosal MD (9.07 x 10(-5), [-14.14, -3.60] x 10(-5), z = -3.46), with greatest effects at 1-year post-RTP. In contrast, females had greater reductions in FA of the corona radiata (16.50 x 10(-3), [-22.38, -11.08] x 10(-3), z = -5.60), with greatest effects at RTP. These findings provide new insights into how the brain recovers after a concussion, showing sex differences in both the acute and chronic phases of injury.	[Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Churchill, Nathan W.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada		Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada.	nchurchill.research@gmail.com			Canadian Institute for Military and Veteran Health Research [W7714-145967]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [RN294001-367456, RN356342-401065]; Siemens Healthineers	Canadian Institute for Military and Veteran Health Research, Grant/Award Number: W7714-145967; Canadian Institutes of Health Research, Grant/Award Numbers: RN294001-367456, RN356342-401065; Siemens Healthineers	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Cheng J, 2019, SPORTS HEALTH, V11, P486, DOI 10.1177/1941738119877186; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill NW, 2019, NEUROLOGY, V93, pE1980, DOI 10.1212/WNL.0000000000008523; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gurney KJ, 2006, NEUROBIOL DIS, V23, P87, DOI 10.1016/j.nbd.2006.02.006; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hamer J, 2020, J NEUROTRAUM, V37, P1197, DOI 10.1089/neu.2019.6800; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kastrup A, 1997, STROKE, V28, P2353, DOI 10.1161/01.STR.28.12.2353; Kodiweera C, 2016, NEUROIMAGE, V128, P180, DOI 10.1016/j.neuroimage.2015.12.033; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laule C, 2004, J NEUROL, V251, P284, DOI 10.1007/s00415-004-0306-6; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Liu YN, 2012, MAGN RESON MED, V68, P912, DOI 10.1002/mrm.23286; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Mazumder R, 2010, J MACH LEARN RES, V11, P2287; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGlade E, 2015, BRAIN IMAGING BEHAV, V9, P535, DOI 10.1007/s11682-015-9379-3; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Mendelowitsch A, 2001, BRAIN RES, V901, P230, DOI 10.1016/S0006-8993(01)02359-9; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238; RODRIGUEZ G, 1988, J CEREBR BLOOD F MET, V8, P783, DOI 10.1038/jcbfm.1988.133; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Rubin TG, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519844020; Saunders TD, 2020, CLIN BIOMECH, V74, P14, DOI 10.1016/j.clinbiomech.2020.02.003; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Strauss SB, 2016, AM J NEURORADIOL, V37, P1983, DOI 10.3174/ajnr.A4851; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Tallon CM, 2020, EXP PHYSIOL, V105, P1090, DOI 10.1113/EP088293; Tan H, 2009, J MAGN RESON IMAGING, V29, P1134, DOI 10.1002/jmri.21721; Tarlochan F., 2013, INT, V2, P17; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Yin B, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00028; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	68	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	DEC 15	2021	42	18					5814	5826		10.1002/hbm.25591		OCT 2021	13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	WY6VE	WOS:000706595300001	34643005	Green Published, gold			2022-02-06	
J	Dimitri, GM; Beqiri, E; Placek, MM; Czosnyka, M; Stocchetti, N; Ercole, A; Smielewski, P; Lio, P				Dimitri, Giovanna Maria; Beqiri, Erta; Placek, Michal M.; Czosnyka, Marek; Stocchetti, Nino; Ercole, Ari; Smielewski, Peter; Lio, Pietro		CENTER TBI Collaborators	Modeling Brain-Heart Crosstalk Information in Patients with Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article; Early Access						Intracranial pressure; Traumatic brain injury; CENTER-TBI; Raised intracranial pressure; Raised heart rate	CENTER-TBI; CARE; REGRESSION; MANAGEMENT	Background: Traumatic brain injury (TBI) is an extremely heterogeneous and complex pathology that requires the integration of different physiological measurements for the optimal understanding and clinical management of patients. Information derived from intracranial pressure (ICP) monitoring can be coupled with information obtained from heart rate (HR) monitoring to assess the interplay between brain and heart. The goal of our study is to investigate events of simultaneous increases in HR and ICP and their relationship with patient mortality.. Methods: In our previous work, we introduced a novel measure of brain-heart interaction termed brain-heart crosstalks (ct(np)), as well as two additional brain-heart crosstalks indicators [mutual information (mi(ct)) and average edge overlap (omega(ct))] obtained through a complex network modeling of the brain-heart system. These measures are based on identification of simultaneous increase of HR and ICP. In this article, we investigated the relationship of these novel indicators with respect to mortality in a multicenter TBI cohort, as part of the Collaborative European Neurotrauma Effectiveness Research in TBI high-resolution work package. Results: A total of 226 patients with TBI were included in this cohort. The data set included monitored parameters (ICP and HR), as well as laboratory, demographics, and clinical information. The number of detected brain-heart crosstalks varied (mean 58, standard deviation 57). The Kruskal-Wallis test comparing brain-heart crosstalks measures of survivors and nonsurvivors showed statistically significant differences between the two distributions (p values: 0.02 for mi(ct), 0.005 for ct(np) and 0.006 for omega(ct)). An inverse correlation was found, computed using the point biserial correlation technique, between the three new measures and mortality: - 0.13 for ct(np) (p value 0.04), - 0.19 for omega(ct) (p value 0.002969) and - 0.09 for mi(ct) (p value 0.1396). The measures were then introduced into the logistic regression framework, along with a set of input predictors made of clinical, demographic, computed tomography (CT), and lab variables. The prediction models were obtained by dividing the original cohort into four age groups (16-29, 30-49, 50-65, and 65-85 years of age) to properly treat with the age confounding factor. The best performing models were for age groups 16-29, 50-65, and 65-85, with the deviance of ratio explaining more than 80% in all the three cases. The presence of an inverse relationship between brain-heart crosstalks and mortality was also confirmed. Conclusions: The presence of a negative relationship between mortality and brain-heart crosstalks indicators suggests that a healthy brain-cardiovascular interaction plays a role in TBI.	[Dimitri, Giovanna Maria; Lio, Pietro] Univ Cambridge, Comp Lab, Cambridge, England; [Dimitri, Giovanna Maria] Univ Siena, DIISM, Siena, Italy; [Beqiri, Erta; Placek, Michal M.; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Brain Phys Lab, Cambridge, England; [Beqiri, Erta; Stocchetti, Nino] Univ Milan, Dept Physiol & Transplantat, Milan, Italy; [Placek, Michal M.] Wroclaw Univ Sci & Technol, Fac Fundamental Problems Technol, Dept Biomed Engn, Wroclaw, Poland; [Ercole, Ari] Univ Cam bridge, Div Anesthesia, Cambridge, England		Dimitri, GM (corresponding author), Univ Cambridge, Comp Lab, Cambridge, England.	giovanna.dimitri@unisi.it	; Ercole, Ari/B-6288-2009; Raj, Rahul/K-7693-2012	Radoi, Andreea/0000-0002-0677-3544; Ercole, Ari/0000-0001-8350-8093; Zeiler, Frederick/0000-0003-1737-0510; Raj, Rahul/0000-0003-4243-9591	Universita degli Studi di Siena within the CRUI-CARE Agreement; European UnionEuropean Commission [602150]	Open access funding provided by Universita degli Studi di Siena within the CRUI-CARE Agreement. The study was supported by the European Union Seventh Framework Programme (Grant 602150) for CENTER-TBI.	Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Dimitri Giovanna Maria, 2017, Appl Netw Sci, V2, P29, DOI 10.1007/s41109-017-0050-3; Dimitri GM, 2018, ACTA NEUROCHIR SUPPL, V126, P147, DOI 10.1007/978-3-319-65798-1_31; Dimitri GM, 2020, ACTA NEUROCHIR; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Gao L, 2017, J NEUROTRAUM, V34, P2743, DOI 10.1089/neu.2016.4787; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Luque B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046103; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Placek MM., 2020, ACTA NEUROCHIR, V21, P1; Quaglio G, 2017, LANCET NEUROL, V16, P951, DOI 10.1016/S1474-4422(17)30370-8; Silvani A, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0181; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Valenza G, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2016.0020	23	0	0	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01353-7		OCT 2021	13	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WF8OT	WOS:000706561400002	34642842	hybrid			2022-02-06	
J	Ge, HF; Xue, XS; Xian, JS; Yuan, LB; Wang, L; Zou, YJ; Zhong, J; Jiang, ZY; Shi, JT; Chen, TN; Su, H; Feng, H; Hu, SL				Ge, Hongfei; Xue, Xingsen; Xian, Jishu; Yuan, Linbo; Wang, Long; Zou, Yongjie; Zhong, Jun; Jiang, Zhouyang; Shi, Jiantao; Chen, Tunan; Su, Hong; Feng, Hua; Hu, Shengli			Ferrostatin-1 Alleviates White Matter Injury Via Decreasing Ferroptosis Following Spinal Cord Injury	MOLECULAR NEUROBIOLOGY			English	Article						Spinal cord injury; Ferroptosis; White matter injury; Reactive oxygen species; Ferrostatin-1	FUNCTIONAL RECOVERY; GLIAL SCAR; OLIGODENDROCYTE; NEURONS; PROTEIN; NEUROPROTECTION; DIFFERENTIATION; SUSCEPTIBILITY; GLUTATHIONE; ESTROGEN	Spinal cord injury (SCI), a devastating neurological impairment, usually imposes a long-term psychological stress and high socioeconomic burden for the sufferers and their family. Recent researchers have paid arousing attention to white matter injury and the underlying mechanism following SCI. Ferroptosis has been revealed to be associated with diverse diseases including stroke, cancer, and kidney degeneration. Ferrostatin-1, a potent inhibitor of ferroptosis, has been illustrated to curb ferroptosis in neurons, subsequently improving functional recovery after traumatic brain injury (TBI) and SCI. However, the role of ferroptosis in white matter injury and the therapeutic effect of ferrostatin-1 on SCI are still unknown. Here, our results indicated that ferroptosis played a pivotal role in the secondary white matter injury, and ferrostatin-1 could reduce iron and reactive oxygen species (ROS) accumulation and downregulate the ferroptosis-related genes and its products of IREB2 and PTGS2 to further inhibit ferroptosis in oligodendrocyte, finally reducing white matter injury and promoting functional recovery following SCI in rats. Meanwhile, the results demonstrated that ferrostatin-1 held the potential of inhibiting the activation of reactive astrocyte and microglia. Mechanically, the present study deciphers the potential mechanism of white matter damage, which enlarges the therapeutic effects of ferrostatin-1 on SCI and even in other central nervous system (CNS) diseases existing ferroptosis.	[Ge, Hongfei; Xue, Xingsen; Xian, Jishu; Yuan, Linbo; Wang, Long; Zou, Yongjie; Zhong, Jun; Jiang, Zhouyang; Shi, Jiantao; Chen, Tunan; Su, Hong; Feng, Hua; Hu, Shengli] Army Med Univ, Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China; [Ge, Hongfei; Xue, Xingsen; Xian, Jishu; Yuan, Linbo; Wang, Long; Zou, Yongjie; Zhong, Jun; Jiang, Zhouyang; Shi, Jiantao; Chen, Tunan; Su, Hong; Feng, Hua; Hu, Shengli] Army Med Univ, Third Mil Med Univ, Southwest Hosp, Key Lab Neurotrauma, Chongqing 400038, Peoples R China; [Zou, Yongjie] 908 Hosp Peoples Liberat Army, Dept Neurosurg, Nanchang 330000, Jiangxi, Peoples R China		Feng, H; Hu, SL (corresponding author), Army Med Univ, Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China.; Feng, H; Hu, SL (corresponding author), Army Med Univ, Third Mil Med Univ, Southwest Hosp, Key Lab Neurotrauma, Chongqing 400038, Peoples R China.	fenghua8888@vip.163.com; husl1937@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471261]; Natural Science Foundation of ChongqingNatural Science Foundation of Chongqing [cstc2018jcyjAX0080]	This work was supported by grants from the National Natural Science Foundation of China (approval no. 81471261) and Natural Science Foundation of Chongqing (approval no. cstc2018jcyjAX0080).	Abdalkader M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00466; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bin JM, 2016, J NEUROCHEM, V139, P181, DOI 10.1111/jnc.13745; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Chen B, 2019, BRAIN RES BULL, V153, P122, DOI 10.1016/j.brainresbull.2019.08.013; Chen F, 2014, J SURG RES, V192, P298, DOI 10.1016/j.jss.2014.06.026; Chen JY, 2015, MOL MED REP, V12, P1733, DOI 10.3892/mmr.2015.3601; Chen XS, 2021, EXP NEUROL, V342, DOI 10.1016/j.expneurol.2021.113762; Chu J, 2020, NEURAL REGEN RES, V15, P528, DOI 10.4103/1673-5374.266060; Chu WH, 2015, NEUROCHEM RES, V40, P1472, DOI 10.1007/s11064-015-1618-x; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; Fan BY, 2021, NEURAL REGEN RES, V16, P561, DOI 10.4103/1673-5374.293157; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Feng Z, 2021, REDOX BIOL, V43, DOI 10.1016/j.redox.2021.101984; Ge MH, 2021, CNS NEUROSCI THER, V27, P1023, DOI 10.1111/cns.13657; Guerrero-Hue M, 2019, FASEB J, V33, P8961, DOI 10.1096/fj.201900077R; Guo Y, 2021, EUR J PAIN, V25, P1227, DOI 10.1002/ejp.1737; Han S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2630-3; Hu R, 2012, CRIT CARE MED, V40, P3230, DOI 10.1097/CCM.0b013e3182657560; Hu R, 2011, ANN SURG, V254, P353, DOI 10.1097/SLA.0b013e31822645b4; Hu SL, 2012, J CELL BIOCHEM, V113, P1005, DOI 10.1002/jcb.23432; Hu SL, 2010, CRIT CARE MED, V38, P2181, DOI 10.1097/CCM.0b013e3181f17c0e; Hutson TH, 2019, NAT REV NEUROL, V15, P732, DOI 10.1038/s41582-019-0280-3; Jiang XH, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/8131286; Juurlink BHJ, 1998, GLIA, V22, P371, DOI 10.1002/(SICI)1098-1136(199804)22:4<371::AID-GLIA6>3.0.CO;2-6; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Li L, 2014, NEUROBIOL DIS, V66, P74, DOI 10.1016/j.nbd.2014.02.008; Li SJ, 2021, INT IMMUNOPHARMACOL, V90, DOI 10.1016/j.intimp.2020.107179; Li YC, 2021, CELL MOL NEUROBIOL, V41, P263, DOI 10.1007/s10571-020-00850-1; Ling X, 2007, J NEUROSCI RES, V85, P2175, DOI 10.1002/jnr.21362; Lu JJ, 2020, LIFE SCI, V260, DOI 10.1016/j.lfs.2020.118305; Mekhail M, 2012, PROG NEUROBIOL, V96, P322, DOI 10.1016/j.pneurobio.2012.01.008; Miotto G, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101328; Muhoberac BB, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01195; Qiu YM, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.104919; Serdar M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111381; Shen LS, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00594; Shi JT, 2020, WORLD NEUROSURG, V137, pE9, DOI 10.1016/j.wneu.2019.08.246; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; Wang JJ, 2020, TRANSL NEUROSCI, V11, P173, DOI 10.1515/tnsci-2020-0119; Xia YZ, 2015, NEUROSCI LETT, V590, P74, DOI 10.1016/j.neulet.2015.01.073; Xia YZ, 2008, BIOCHEM BIOPH RES CO, V377, P562, DOI 10.1016/j.bbrc.2008.10.024; Xie BS, 2019, CNS NEUROSCI THER, V25, P465, DOI 10.1111/cns.13069; Yuan JC, 2017, BRAIN RES, V1655, P90, DOI 10.1016/j.brainres.2016.11.002; Yumnamcha T, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01065; Zhang Y, 2020, NEURAL REGEN RES, V15, P1539, DOI 10.4103/1673-5374.274344	49	0	0	6	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2022	59	1					161	176		10.1007/s12035-021-02571-y		OCT 2021	16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YM6HC	WOS:000706040100001	34635980	Green Submitted			2022-02-06	
J	Jeffares, I; Merriman, NA; Doyle, F; Horgan, F; Hickey, A				Jeffares, Isabelle; Merriman, Niamh A.; Doyle, Frank; Horgan, Frances; Hickey, Anne			Designing stroke services for the delivery of cognitive rehabilitation: A qualitative study with stroke rehabilitation professionals	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Stroke; cognitive impairment; cognitive rehabilitation; neuropsychology; qualitative research	TRANSIENT ISCHEMIC ATTACK; TRAUMATIC BRAIN-INJURY; CLINICAL-NEUROPSYCHOLOGY; NEUROLOGICAL DISORDERS; NATIONAL INSTITUTE; CANADIAN STROKE; RECOMMENDATIONS; GUIDELINES; RECOVERY; NEEDS	This qualitative study explored the potential to deliver cognitive rehabilitation for post-stroke cognitive impairment (PSCI), with a specific focus on barriers and facilitators to its delivery from the perspective of Irish stroke rehabilitation professionals. Sixteen semi-structured interviews were completed with healthcare professionals in both hospital and community settings. The sample comprised physiotherapists, occupational therapists, nurses, a stroke physician, a psychologist, a neuropsychologist, a speech and language therapist, a dietician, and a public health nurse. Interviews were audio-recorded and analysed in NVivo using inductive Thematic Analysis. Barriers and facilitators to the delivery of cognitive rehabilitation were identified and described under four key themes: (i) Cognitive screening; (ii) Cognitive rehabilitation: no one size fits all; (iii) Psychology: the lost dimension of stroke rehabilitation; and (iv) Joining the dots in the community. Staffing required to deliver cognitive rehabilitation for PSCI was highlighted as under-resourced in the Republic of Ireland. Inadequate resourcing of neuropsychology and stroke-related psychological services, in particular, has had negative implications for the delivery of cognitive rehabilitation. Stroke-specific cognitive rehabilitation expertise is virtually inaccessible in the community, highlighting an urgent need for investment in specialist rehabilitation teams to deliver cognitive rehabilitation in this setting.	[Jeffares, Isabelle; Merriman, Niamh A.; Doyle, Frank; Hickey, Anne] Univ Med & Hlth Sci, Royal Coll Surg Ireland, Div Populat Hlth Sci, Dept Hlth Psychol, Dublin, Ireland; [Horgan, Frances] Univ Med & Hlth Sci, Royal Coll Surg Ireland, Sch Physiotherapy, Dublin, Ireland		Jeffares, I (corresponding author), Univ Med & Hlth Sci, Royal Coll Surg Ireland, Div Populat Hlth Sci, Struct Populat & Hlth Serv Res Educ Programme SPH, Beaux Lane House, Dublin 2, Ireland.	IsabelleJeffares@rcsi.ie	; Doyle, Frank/C-2750-2012	Merriman, Niamh A./0000-0002-5327-7762; Doyle, Frank/0000-0002-3785-7433; Horgan, N Frances/0000-0002-8773-9953	Health Research Board [SPHeRE/2013/1]	This work was supported by Health Research Board: [Grant Number SPHeRE/2013/1].	Ahmed N, 2017, EUR STROKE J, V2, P95, DOI 10.1177/2396987317699144; [Anonymous], 2008, AM PSYCHOL ASS APA C; Bahar-Fuchs A, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt189; Bennett TL, 2001, ARCH CLIN NEUROPSYCH, V16, P237, DOI 10.1016/S0887-6177(00)00082-2; Brainin M, 2015, EUR J NEUROL, V22, P229, DOI 10.1111/ene.12626; Brannigan C, 2017, DISABIL REHABIL, V39, P211, DOI 10.3109/09638288.2016.1141242; Braun V., 2013, SUCCESSFUL QUALITATI; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Chiti G, 2014, STROKE, V45, P3135, DOI 10.1161/STROKEAHA.114.004590; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Clarke DJ, 2015, J MULTIDISCIP HEALTH, V8, P433, DOI 10.2147/JMDH.S68764; Creswell J. W., 2016, QUAL INQ; Creswell JW, 2017, DESIGNING CONDUCTING, V3rd; Demeyere N, 2016, J NEUROL, V263, P306, DOI 10.1007/s00415-015-7964-4; Demeyere N, 2015, PSYCHOL ASSESSMENT, V27, P883, DOI 10.1037/pas0000082; Department of Health, 2019, NATL STR POL POL PRO; Department of Health, 2011, NATL POL STR PROV NE; Ekstam L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006784; Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413; Gillham S, 2012, PSYCHOL CARE STROKE; Green J., 2014, QUALITATIVE METHODS, V3rd ed; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Han Dong Y, 2014, Int Sch Res Notices, V2014, P216024, DOI 10.1155/2014/216024; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Henssge U., 2011, NATL SENTINEL STROKE; Hessen E, 2018, CLIN NEUROPSYCHOL, V32, P642, DOI 10.1080/13854046.2017.1413210; Hickey A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-111; Hoffmann T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006430.pub2; Hokkanen L, 2019, CLIN NEUROPSYCHOL, V33, P32, DOI 10.1080/13854046.2018.1484169; Hommel M, 2009, J NEUROL NEUROSUR PS, V80, P371, DOI 10.1136/jnnp.2008.157875; Horgan F., 2008, IRISH HEART FDN NATL; Hotter B, 2018, EUR STROKE J, V3, P237, DOI 10.1177/2396987318771174; Intercollegiate Stroke Working Party, 2012, NATL CLIN GUID STR; Intercollegiate Stroke Working Party, 2016, NATL CLIN GUID STR; Irish Heart Foundation: Council for Stroke, 2010, NATL CLIN GUIDELINES; Jeffares I, 2021, DISABIL REHABIL, DOI 10.1080/09638288.2021.1874548; Jeffares I, 2021, DISABIL REHABIL, V43, P773, DOI 10.1080/09638288.2019.1641850; Johnson-Greene D, 2018, ARCH CLIN NEUROPSYCH, V33, P310, DOI 10.1093/arclin/acx126; Kampling H, 2020, DISABIL REHABIL, V42, P1616, DOI 10.1080/09638288.2018.1530308; KOLB B, 2003, FUNDAMENTALS HUMAN N; Lees RA, 2014, DISABIL REHABIL, V36, P339, DOI 10.3109/09638288.2013.791728; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; McElwaine P., 2016, IRISH HEART FDN HSE; McElwaine P, 2015, IRISH HEART FDN HSE; McKevitt C, 2004, STROKE, V35, P1499, DOI 10.1161/01.STR.0000127532.64840.36; McKevitt C, 2011, STROKE, V42, P1398, DOI 10.1161/STROKEAHA.110.598839; Mellon L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0288-2; Merriman NA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024429; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; NICE, 2013, STROKE REHABILITATIO; Norrving B, 2018, EUR STROKE J, V3, P309, DOI 10.1177/2396987318808719; O'Connor C, 2020, INT J QUAL METH, V19, DOI 10.1177/1609406919899220; Pendlebury ST, 2012, CEREBROVASC DIS, V34, P48, DOI 10.1159/000338905; Pendlebury ST, 2013, CEREBROVASC DIS, V36, P355, DOI 10.1159/000355496; Pendlebury ST, 2012, STROKE, V43, P464, DOI 10.1161/STROKEAHA.111.633586; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Quinn TJ, 2018, STROKE, V49, P483, DOI 10.1161/STROKEAHA.117.016994; Quinn TJ, 2009, J REHABIL MED, V41, P99, DOI 10.2340/16501977-0301; Ringelstein EB, 2013, STROKE, V44, P828, DOI 10.1161/STROKEAHA.112.670430; Ritchie J, 2003, QUALITATIVE RES PRAC, P219; Roding J, 2009, DISABIL REHABIL, V31, P1092, DOI 10.1080/09638280802510965; Rogers JM, 2018, NEUROPSYCHOL REV, V28, P285, DOI 10.1007/s11065-018-9378-4; Sachdev PS, 2009, J INT NEUROPSYCH SOC, V15, P915, DOI 10.1017/S1355617709990579; Scottish Intercollegiate Guidelines Network (SIGN), 2010, MAN PAT STROK REH PR; Sexton E, 2019, EUR STROKE J, V4, P160, DOI 10.1177/2396987318825484; Smith S., 2014, EARLIER DISCHARGE BE; Stephens JA, 2015, OTJR-OCCUP PART HEAL, V35, P5, DOI 10.1177/1539449214561765; Stevens E, 2018, BURDEN STROKE EUROPE; Stolwyk RJ, 2016, AUST PSYCHOL, V51, P360, DOI 10.1111/ap.12191; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Ullberg T, 2016, STROKE, V47, P539, DOI 10.1161/STROKEAHA.115.011670; Wilson BA, 2010, WIRES COGN SCI, V1, P108, DOI 10.1002/wcs.15; Winstein CJ, 2016, STROKE, V47, pE98, DOI 10.1161/STR.0000000000000098	76	0	0	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2021.1977155		OCT 2021	24	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	WF9YK	WOS:000706656100001	34648412				2022-02-06	
J	Kamrava, SK; Tavakol, Z; Talebi, A; Farhadi, M; Jalessi, M; Hosseini, SF; Amini, E; Chen, B; Hummel, T; Alizadeh, R				Kamrava, Seyed Kamran; Tavakol, Zeinab; Talebi, Atefeh; Farhadi, Mohammad; Jalessi, Maryam; Hosseini, Seyedeh Fahimeh; Amini, Elahe; Chen, Ben; Hummel, Thomas; Alizadeh, Rafieh			A study of depression, partnership and sexual satisfaction in patients with post-traumatic olfactory disorders	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-INJURY; SMELL; LIFE; ASSOCIATION; DYSFUNCTION; IMPAIRMENT; QUALITY; MARKER; IMPACT	Post-traumatic olfactory dysfunction (PTOD) is associated with a significant decrease in quality of life. The present study aimed to explore whether PTOD is associated with depression and changes in sexuality. There were two groups in this case-control study. The patient group consisted of patients with PTOD (n = 55), and the control group comprised healthy individuals without the olfactory disorder (n = 115). Olfactory function, depression, partnership, and sexual satisfaction were assessed using the Iranian version of the Sniffin' Sticks test (Ir-SST), Beck Depression Inventory (BDI), Enrich Couple Scale (ECS) and Sexual Satisfaction Scale for Women (SSSW). The BDI scores were higher in the patient group than in the control group (p < 0.001). The SSSW score was lower in the patient group than in controls (p < 0.01), although the ECS score was not significantly different between patients and controls. Also, there was no significant difference in the severity of trauma between marital satisfaction and sexual satisfaction. However, the analysis showed a statistically significant difference in depression scores in connection with the head trauma severity. In the PTOD group, depression was increased and sexual satisfaction declined. Understanding the association of olfactory dysfunction with depression and sexuality allows patients and doctors to deal with less notable consequences of this disorder.	[Kamrava, Seyed Kamran; Farhadi, Mohammad; Alizadeh, Rafieh] Iran Univ Med Sci, Hazrat Rasoul Akram Hosp, ENT & Head & Neck Res Ctr & Dept, Five Senses Hlth Inst, Tehran, Iran; [Tavakol, Zeinab] Shahrekord Univ Med Sci, Community Oriented Nursing Midwifery Res Ctr, Nursing & Midwifery Sch, Shahrekord, Iran; [Talebi, Atefeh] Iran Univ Med Sci, Colorectal Res Ctr, Tehran, Iran; [Jalessi, Maryam; Amini, Elahe] Iran Univ Med Sci, Hazrat Rasoul Akram Hosp, Skull Base Res Ctr, Five Senses Hlth Inst, Tehran, Iran; [Hosseini, Seyedeh Fahimeh] Iran Univ Med Sci, Sch Med, Med Phys Dept, Tehran, Iran; [Chen, Ben] Guangzhou Med Univ, Dept Geriatr Psychiat, Affiliated Brain Hosp, Guangzhou Huiai Hosp, Guangzhou, Peoples R China; [Chen, Ben; Hummel, Thomas] Tech Univ, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany		Alizadeh, R (corresponding author), Iran Univ Med Sci, Hazrat Rasoul Akram Hosp, ENT & Head & Neck Res Ctr & Dept, Five Senses Hlth Inst, Tehran, Iran.	Alizadeh.r@iums.ac.ir			Rasoule Akram Hospital ENT research center affiliated with Iran University of Medical Sciences	This study was funded by Rasoule Akram Hospital ENT research center affiliated with Iran University of Medical Sciences.	Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Asoodeh MH, 2011, PROCD SOC BEHV, V30, DOI 10.1016/j.sbspro.2011.10.072; Bahrami N, 2016, IRANIAN J EPIDEMIOLO, V12, P18; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Burke SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040993; Cerda-Molina Ana Lilia, 2013, Front Endocrinol (Lausanne), V4, P159, DOI 10.3389/fendo.2013.00159; Croy I, 2017, J NEUROL, V264, P631, DOI 10.1007/s00415-016-8227-8; Croy I, 2014, J AFFECT DISORDERS, V160, P80, DOI 10.1016/j.jad.2013.12.026; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; Damm M, 2004, HNO, V52, P112, DOI 10.1007/s00106-003-0877-z; Doty RL, 2009, SEMIN NEUROL, V29, P74, DOI 10.1055/s-0028-1124025; Faizal A, 2017, INT MED J MALAYS, V16, P19; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Gudziol V, 2009, J SEX MED, V6, P1924, DOI 10.1111/j.1743-6109.2009.01266.x; Howell Jessica, 2018, World J Otorhinolaryngol Head Neck Surg, V4, P39, DOI 10.1016/j.wjorl.2018.02.001; Hummel T, 2017, RHINOLOGY, V54, P7, DOI 10.4193/Rhino16.248; Johnson CL, 2010, REHABIL PSYCHOL, V55, P180, DOI 10.1037/a0019480; Kamrava S. K., 2021, MED J ISLAMIC REPUBL, V35, P1141; Kohli P, 2016, CHEM SENSES, V41, P479, DOI 10.1093/chemse/bjw061; Langdon C, 2018, J NEUROTRAUM, V35, P2641, DOI 10.1089/neu.2017.5230; Merkonidis C, 2015, EUR ARCH OTO-RHINO-L, V272, P1403, DOI 10.1007/s00405-014-3210-4; Miao XT, 2015, EUR ARCH OTO-RHINO-L, V272, P1945, DOI 10.1007/s00405-014-3278-x; Mullol J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001256; Pause BM, 2001, J PSYCHIAT RES, V35, P271, DOI 10.1016/S0022-3956(01)00029-2; Philpott CM, 2014, CHEM SENSES, V39, P711, DOI 10.1093/chemse/bju043; Proskynitopoulos Phileas J, 2016, Surg Neurol Int, V7, pS263, DOI 10.4103/2152-7806.181981; Rebello K., 2014, PSYCHOLOGY, V5, P8, DOI [10.4236/psych.2014.57088, DOI 10.4236/PSYCH.2014.57088]; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Rochet M, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8050080; Schafer L, 2019, PHYSIOL BEHAV, V201, P64, DOI 10.1016/j.physbeh.2018.12.020; Schriever VA, 2014, CHEM SENSES, V39, P343, DOI 10.1093/chemse/bju005; Sivertsen H, 2015, DEMENT GERIATR COGN, V40, P311, DOI 10.1159/000437299; Taalman H, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00190; Trudel G, 2010, SEXOLOGIES, V19, P137, DOI 10.1016/j.sexol.2009.12.009; Vennemann MM, 2008, J NEUROL, V255, P1121, DOI 10.1007/s00415-008-0807-9; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Zang YP, 2021, ORL J OTO-RHINO-LARY, V83, P2, DOI 10.1159/000511442	40	0	0	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	OCT 12	2021	11	1							20218	10.1038/s41598-021-99627-9			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG2MF	WOS:000706830500090	34642400	gold, Green Published			2022-02-06	
J	Kneavel, M; Ernst, W				Kneavel, Meredith; Ernst, William			Cognitions That Support Concussion Reporting in Collegiate Athletes: An Analysis of a Worksheet Activity	HEALTH EDUCATION & BEHAVIOR			English	Article; Early Access						cognition; concussion; injury prevention; reporting	SPORT-RELATED CONCUSSION; SCHOOL FOOTBALL PLAYERS; PEER; INTERVENTIONS; KNOWLEDGE; EDUCATION; PROGRAM; ATTITUDES; RECOVERY; IMPACT	Background Sports related concussions continue to be a public health concern and improving reporting behavior a focus of educational programs. While educational programs have addressed changes in knowledge of concussion symptoms, it has been challenging to design educational programs which have lasting effects on reporting behavior. Aims The current analysis describes an intervention in which thoughts about reporting behavior are actively written down in a worksheet exercise to "pre-arm" athletes with cognitions designed to enhance reporting behavior prior to the injury event. Method A total of 503 male and female college athletes participating in collision (football, field hockey, ice hockey, lacrosse, and soccer) and contact sports (baseball, basketball, and softball) from 7 colleges/universities competing across all three NCAA divisions provided data collected during a randomized trial of a peer concussion education program. Results Qualitative analysis revealed 10 themes that would improve reporting including short-term benefits, faster recover, safe and healthy return to play, reporting helps the team, reporting protects the brain, risk aversion, long-term benefits, coach will be supportive, teammates will be supportive and understanding, and academic performance will be affected. Discussion Athletes had awareness of key risks involved in concussions and understood both short- and long-term consequences. Conclusion These findings have important implications for understanding how to change athletes' thoughts about reporting concussions.	[Kneavel, Meredith] La Salle Univ, Dept Urban Publ Hlth & Nutrt, Philadelphia, PA 19141 USA; [Ernst, William] Chestnut Hill Coll, Ctr Concuss Educ & Res, Philadelphia, PA USA; [Kneavel, Meredith; Ernst, William] Chestnut Hill Coll, Dept Profess Psychol, Philadelphia, PA USA		Kneavel, M (corresponding author), La Salle Univ, Sch Nursing & Hlth Sci, 1900 West Olney Ave, Philadelphia, PA 19141 USA.	kneavel@lasalle.edu	Kneavel, Meredith/ABG-5233-2021	Kneavel, Meredith/0000-0002-9820-6909; Ernst, William/0000-0002-6774-4528	National Collegiate Athletic Association - U.S. Department of Defense Mind Matters Challenge	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This publication was made possible, in part, with support from the National Collegiate Athletic Association - U.S. Department of Defense Mind Matters Challenge	Adefolalu AO, 2018, S AFR J HIV MED, V19, DOI 10.4102/sajhivmed.v19i1.762; Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Azjen I., 2007, PREDICTION CHANGE HL; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Baugh CM, 2017, J NEUROTRAUM, V34, P790, DOI 10.1089/neu.2016.4585; Beattie J, 2013, PSYCHIATR REHABIL J, V36, P306, DOI 10.1037/prj0000031; BECK AT, 1970, BEHAV THER, V1, P184, DOI 10.1016/S0005-7894(70)80030-2; Bowman-Perrott L, 2013, SCHOOL PSYCHOL REV, V42, P39; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Chia SC, 2006, J COMMUN, V56, P585, DOI 10.1111/j.1460-2466.2006.00302.x; Chinn N.R., 2016, BMJ OPEN SPORT EXERC, V2, P000118, DOI [10.1136/bmjsem-2016-000118, DOI 10.1136/BMJSEM-2016-000118]; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cleveland MJ, 2012, PSYCHOL ADDICT BEHAV, V26, P440, DOI 10.1037/a0026130; Conaghan C, 2021, J SPORT SCI, V39, P552, DOI 10.1080/02640414.2020.1835223; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Craig DI, 2019, ATHL TRAIN SPORTS HL, DOI [10.3928/19425864-20190322-01, DOI 10.3928/19425864-20190322-01]; Creswell J.W., 2018, QUALITATIVE INQUIRY; Dart EH, 2014, SCHOOL PSYCHOL REV, V43, P367, DOI 10.17105/SPR-14-0009.1; Dawson P, 2014, REV EDUC RES, V84, P609, DOI 10.3102/0034654314540007; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis A., 1962, REASON EMOTION PSYCH; Ernst W.J., 2016, PEER CONCUSSION ED P; Ernst W, 2020, J ATHL TRAINING, V55, P448, DOI 10.4085/1062-6050-212-19; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kneavel M, 2021, J AM COLL HEALTH, V69, P435, DOI 10.1080/07448481.2019.1679816; Kneavel ME, 2020, J ATHL TRAINING, V55, P456, DOI 10.4085/1062-6050-0182.19; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P442, DOI 10.1177/1090198115602676; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levitt HM, 2018, AM PSYCHOL, V73, P26, DOI 10.1037/amp0000151; Lincoln Y.S., 2000, HDB QUALITATIVE RES, P163; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rohrbeck CA, 2003, J EDUC PSYCHOL, V95, P240, DOI 10.1037/0022-0663.95.2.240; Sarmiento Kelly, 2019, J Concussion, V3, DOI 10.1177/2059700219861863; Schmidt JD, 2020, J NEUROTRAUM, V37, P593, DOI 10.1089/neu.2019.6637; Scott-Sheldon LAJ, 2012, PSYCHOL ADDICT BEHAV, V26, P393, DOI 10.1037/a0027565; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Turner JS, 2021, COMMUN SPORT, V9, P527, DOI 10.1177/2167479519875709; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Yew RY, 2021, COGNITIVE THER RES, V45, P209, DOI 10.1007/s10608-019-10059-2	51	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1090-1981	1552-6127		HEALTH EDUC BEHAV	Health Educ. Behav.											10901981211046535	10.1177/10901981211046535		OCT 2021	12	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	WI0GB	WOS:000708045000001	34636271				2022-02-06	
J	Abusamak, M; Alrawashdeh, HM				Abusamak, Mohammad; Alrawashdeh, Hamzeh Mohammad			Post-concussion Syndrome Light Sensitivity: A Case Report and Review of the Literature	NEURO-OPHTHALMOLOGY			English	Article; Early Access						Concussion; postconcussion syndrome; photophobia; melanopsin; topical anaesthetic; tinted glasses	TRAUMATIC BRAIN-INJURY; PHOTOPHOBIA; US	Photophobia is considered the second most common symptom of both concussion and post-concussion syndrome. Soldiers on duty experience photophobia after blast-related concussions or mild traumatic brain injury in 60-75% of instances. In addition, soldiers report other symptoms, such as asthenopia, squinting, dry eyes and headaches, for which they are considered to be at high risk. According to the International Brain Injury Association, some concussed patients report indirect symptoms such as multi-tasking difficulties, dizziness, vertigo, and fatigue. Moreover, some concussed individuals experience photophobia for approximately 6 months or indefinitely. We present the case of a 23-year-old soldier who presented with severe photophobia after a mild traumatic head injury. His photophobia was alleviated after the administration of topical anaesthetic drops in the eyes in the absence of any ocular surface pathology. He was diagnosed with post-concussion syndrome light sensitivity and was managed successfully with rose-coloured special photophobia glasses tinted with FL-41. Photophobia is a common neurological symptom in military personnel that needs more attention as it affects body and mind. We have reported an uncommon pathway of photophobia, which may unveil an unrecognised mechanism that may play a role in post-concussion photophobia.	[Abusamak, Mohammad] Al Balqa Appl Univ, Fac Med, Ophthalmol Dept, Alsalt, Jordan; [Abusamak, Mohammad; Alrawashdeh, Hamzeh Mohammad] Amman Eye Clin, Dept Ophthalmol, Amman, Jordan; [Alrawashdeh, Hamzeh Mohammad] Sharif Eye Ctr, Dept Ophthalmol, Irbid, Jordan		Abusamak, M (corresponding author), Al Balqa Appl Univ, Fac Med, Ophthalmol Dept, Alsalt, Jordan.	mabusamak@bau.edu.jo		Abusamak, Mohammad/0000-0002-7832-1184			Alves W., 1993, J HEAD TRAUMA REHAB, V8; Callahan ML, 2018, APPL NEUROPSYCH-ADUL, V25, P126, DOI 10.1080/23279095.2016.1261867; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Clark J, 2017, J ATHL TRAINING, V52, P725, DOI 10.4085/1062-6050-52.4.04; Delic J, 2016, RADIOLOGY, V279, P859, DOI 10.1148/radiol.2015151388; Delwig A, 2018, VISUAL NEUROSCI, V35, DOI 10.1017/S0952523817000359; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Elenberger J, 2020, NEUROLOGY, V95, P826, DOI 10.1212/WNL.0000000000010830; FINE PG, 1995, J NEURO-OPHTHALMOL, V15, P90; Galor A, 2016, EXPERT REV OPHTHALMO, V11, P321, DOI 10.1080/17469899.2016.1222905; Galor A, 2016, BRIT J OPHTHALMOL, V100, P745, DOI 10.1136/bjophthalmol-2015-307094; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Irimia P, 2008, CEPHALALGIA, V28, P626, DOI 10.1111/j.1468-2982.2008.01565.x; Jones RCW, 2016, MED CLIN N AM, V100, P155, DOI 10.1016/j.mcna.2015.08.009; Katz BJ, 2016, SURV OPHTHALMOL, V61, P466, DOI 10.1016/j.survophthal.2016.02.001; Lee CJ, 2018, BRIT J OPHTHALMOL, V102, P667, DOI 10.1136/bjophthalmol-2017-310509; Lei SB, 2018, INVEST OPHTH VIS SCI, V59, P4714, DOI 10.1167/iovs.18-24797; Mansur A, 2018, J NEUROTRAUM, V35, P1886, DOI 10.1089/neu.2017.5539; Marek V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00497; Mares C, 2019, CAN J NEUROL SCI, V46, P14, DOI 10.1017/cjn.2018.361; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x	21	0	0	1	1	TAYLOR & FRANCIS AS	OSLO	KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY	0165-8107	1744-506X		NEURO-OPHTHALMOLOGY	Neuro-Ophthalmol.												10.1080/01658107.2021.1983612		OCT 2021	6	Clinical Neurology; Ophthalmology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology; Ophthalmology	WG6MX	WOS:000707109400001					2022-02-06	
J	Lange, RT; Merritt, VC; Brickell, TA; Dalgard, CL; Soltis, AR; Hershaw, J; Lippa, SM; Gill, J; French, LM				Lange, Rael T.; Merritt, Victoria C.; Brickell, Tracey A.; Dalgard, Clifton L.; Soltis, Anthony R.; Hershaw, Jamie; Lippa, Sara M.; Gill, Jessica; French, Louis M.			Apolipoprotein E e4 is associated with worse self-reported neurobehavioral symptoms following uncomplicated mild traumatic brain injury in US military service members	BEHAVIOURAL BRAIN RESEARCH			English	Article						Apolipoprotein E; Mild traumatic brain injury; Military; Mental health; Neurobehavioral outcome	POSTTRAUMATIC-STRESS-DISORDER; APOE GENOTYPE; CLINICAL UTILITY; HEAD-INJURY; ALZHEIMERS-DISEASE; RISK; VALIDITY-10; TBI; EPSILON-4; DEMENTIA	Past research has found a relationship between the apolipoprotein E (APOE) e4 allele and worse neurobehavioral functioning following mild traumatic brain injury (MTBI) in civilian populations. The purpose of this study was to examine this relationship in service members and veterans (SMVs) following MTBI. Participants were 151 SMVs (103 uncomplicated MTBI; 48 Injured Controls [IC]) prospectively enrolled in the DVBIC-TBICoE 15-Year Longitudinal TBI Study. Participants completed a battery of self-reported neurobehavioral symptom measures on average 76.2 months post-injury (SD = 31.8). APOE genotyping was undertaken using non-fasting blood samples. Participants were classified into four subgroups based on injury (MTBI vs. IC) and APOE e4 allele status (e4 present/absent). In the IC group, there were no significant differences across APOE e4 status subgroups for all measures. In the MTBI group, participants with the APOE e4 allele had significantly worse scores on measures of depression, pain, anxiety, grief, positive well-being, social participation, and resilience compared to those without the e4 allele (d = .44 to d = .69). When comparing the number of 'clinically elevated' neurobehavioral measures simultaneously, the MTBI/e4 present subgroup consistently had a higher number of elevated measures compared to the MTBI/e4 absent, IC/e4 present, and IC/e4 absent subgroups. The APOE e4 allele was associated with poorer neurobehavioral outcome in SMVs in the chronic phase of recovery following MTBI. APOE e4 could be incorporated into screening tools to predict SMVs at risk for poor long-term neurobehavioral outcome in an effort to provide early intervention to improve long-term clinical outcome.	[Lange, Rael T.; Brickell, Tracey A.; Hershaw, Jamie; French, Louis M.] Traumat Brain Injury Ctr Excellence, 1335 E W Hwy, Silver Spring, MD 20910 USA; [Lange, Rael T.; Brickell, Tracey A.; Hershaw, Jamie; Lippa, Sara M.; French, Louis M.] Walter Reed Natl Mil Med Ctr, 4494 Palmer Rd N, Bethesda, MD 20814 USA; [Lange, Rael T.; Brickell, Tracey A.; Hershaw, Jamie; Lippa, Sara M.; French, Louis M.] Natl Intrepid Ctr Excellence, Palmer Rd S, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada; [Merritt, Victoria C.] VA San Diego Healthcare Syst, 3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Merritt, Victoria C.] Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Brickell, Tracey A.; Dalgard, Clifton L.; French, Louis M.] Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Gill, Jessica] NINR, NIH, 10 Ctr Dr, Bethesda, MD 20814 USA; [Lange, Rael T.; Brickell, Tracey A.; Hershaw, Jamie] Gen Dynam Informat Technol, 3150 Fairview Pk Dr, Falls Church, VA 22042 USA; [Dalgard, Clifton L.] Amer Genome Ctr, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Soltis, Anthony R.] Henry M Jackson Fdn, 6720A Rockledge Dr, Bethesda, MD 20817 USA; [Lange, Rael T.; Brickell, Tracey A.] Ctr Excellence Posttraumat Stress Disorder, 1145 Carling Ave, Ottawa, ON K1Z 7K4, Canada; [Soltis, Anthony R.] PRIMER, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Lange, RT (corresponding author), Walter Reed Natl Mil Med Ctr, Traumat Brain Injury Ctr Exc Hence TBICoE, Room 5003,Bldg 19,8901 Wisconsin Ave, Bethesda, MD 20814 USA.	rael.lange@gmail.com; vcabarnes@gmail.com; tbrickell.dvbic@gmail.com; clifton.dalgard@usuhs.edu; anthony.soltis.ctr@usuhs.edu; jamie.n.hershaw.ctr@mail.mil; saralippa@gmail.com; gillj@mail.nih.gov; louis.m.french.civ@mail.mil		Merritt, Victoria/0000-0001-5683-4168; Soltis, Anthony/0000-0002-3394-1275; Dalgard, Clifton/0000-0003-2025-8239	VA Clinical Science Research & Development Service [IK2 CX001952]	Dr. Merritt received salary support during the writing of this manuscript from a Career Development Award from the VA Clinical Science Research & Development Service (IK2 CX001952).	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Catania C, 2009, MOL PSYCHIATR, V14, P95, DOI 10.1038/sj.mp.4002101; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Dong H, 2004, NEUROSCIENCE, V127, P601, DOI 10.1016/j.neuroscience.2004.05.040; Dretsch MN, 2017, APPL NEUROPSYCH-ADUL, V24, P376, DOI 10.1080/23279095.2016.1220947; Efron B., 1993, INTRO BOOTSTRAP; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Ham BJ, 2007, EUR J NEUROSCI, V25, P324, DOI 10.1111/j.1460-9568.2006.05253.x; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; James LM, 2017, EXP BRAIN RES, V235, P1853, DOI 10.1007/s00221-017-4941-4; Kimbrel NA, 2015, PSYCHIAT RES, V229, P326, DOI 10.1016/j.psychres.2015.07.002; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Lange R.T, 2015, J CLIN EXP NEUROPSYC, V37; Lange RT, 2020, NEUROPSYCHOL REHABIL, V30, P1762, DOI 10.1080/09602011.2019.1604385; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Laskowitz DT, 2012, NEUROCRIT CARE, V16, P316, DOI 10.1007/s12028-011-9641-5; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Lippa SM, 2016, J REHABIL RES DEV, V53, P379, DOI 10.1682/JRRD.2015.01.0009; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lyons MJ, 2013, AM J MED GENET B, V162, P762, DOI 10.1002/ajmg.b.32154; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; McCrae M., 2008, MILD TRAUMATIC BRAIN; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Merritt VC, 2018, J NEUROTRAUM, V35, P2272, DOI 10.1089/neu.2017.5372; Merritt VC, 2019, ARCH CLIN NEUROPSYCH, V34, P706, DOI 10.1093/arclin/acy082; Merritt VC, 2018, J CLIN EXP NEUROPSYC, V40, P1050, DOI 10.1080/13803395.2018.1508555; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Panza Francesco, 2011, Int J Alzheimers Dis, V2011, P721457, DOI 10.4061/2011/721457; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rasmussen KL, 2018, CAN MED ASSOC J, V190, pE1033, DOI 10.1503/cmaj.180066; Roby Y, 2017, PSYCHIAT GENET, V27, P121, DOI 10.1097/YPG.0000000000000174; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P353, DOI 10.1080/23279095.2015.1079714; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; Sundstrom A, 2007, INT PSYCHOGERIATR, V19, P159, DOI 10.1017/S1041610206003498; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Wilson M, 2007, BRIT J ANAESTH, V99, P43, DOI 10.1093/bja/aem142	50	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	OCT 11	2021	415								113491	10.1016/j.bbr.2021.113491			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	UH0WB	WOS:000689660000003	34333069				2022-02-06	
J	Lartigue, JW; Dada, OE; Haq, M; Rapaport, S; Sebopelo, LA; Ooi, SZY; Senyuy, WP; Sarpong, K; Vital, A; Khan, T; Karekezi, C; Park, KB				Lartigue, Jean Wilguens; Dada, Olaoluwa Ezekiel; Haq, Makinah; Rapaport, Sarah; Sebopelo, Lorraine Arabang; Ooi, Setthasorn Zhi Yang; Senyuy, Wah Praise; Sarpong, Kwadwo; Vital, Anchelo; Khan, Tariq; Karekezi, Claire; Park, Kee B.			Emphasizing the Role of Neurosurgery Within Global Health and National Health Systems: A Call to Action	FRONTIERS IN SURGERY			English	Article						global neurosurgery; health system; global surgery; NSOAP; surgical system; UHC	SURGERY; AFRICA	Background: Worldwide, neurological disorders are the leading cause of disability-adjusted life years lost and the second leading cause of death. Despite global health capacity-building efforts, each year, 22.6 million individuals worldwide require neurosurgeon's care due to diseases such as traumatic brain injury and hydrocephalus, and 13.8 million of these individuals require surgery. It is clear that neurosurgical care is indispensable in both national and international public health discussions. This study highlights the role neurosurgeons can play in supporting the global health agenda, national surgical plans, and health strengthening systems (HSS) interventions. Methods: Guided by a literature review, the authors discuss key topics such as the global burden of neurosurgical diseases, the current state of neurosurgical care around the world and the inherent benefits of strong neurosurgical capability for health systems. Results: Neurosurgical diseases make up an important part of the global burden of diseases. Many neurosurgeons possess the sustained passion, resilience, and leadership needed to advocate for improved neurosurgical care worldwide. Neurosurgical care has been linked to 14 of the 17 Sustainable Development Goals (SDGs), thus highlighting the tremendous impact neurosurgeons can have upon HSS initiatives. Conclusion: We recommend policymakers and global health actors to: (i) increase the involvement of neurosurgeons within the global health dialogue; (ii) involve neurosurgeons in the national surgical system strengthening process; (iii) integrate neurosurgical care within the global surgery movement; and (iv) promote the training and education of neurosurgeons, especially those residing in Low-and middle-income countries, in the field of global public health.	[Lartigue, Jean Wilguens; Vital, Anchelo] State Univ Haiti, Sch Med & Pharm, Port Au Prince, Haiti; [Dada, Olaoluwa Ezekiel] Univ Ibadan, Coll Med, Ibadan, Nigeria; [Haq, Makinah] Kings Coll London, GKT Sch Med Educ, London, England; [Rapaport, Sarah] Johns Hopkins Sch Med, Baltimore, MD USA; [Sebopelo, Lorraine Arabang] Univ Botswana, Fac Med, Gaborone, Botswana; [Ooi, Setthasorn Zhi Yang] Cardiff Univ, Sch Med, Univ Hosp Wales Main Bldg, Cardiff, Wales; [Senyuy, Wah Praise] Univ Buea, Fac Hlth Sci, Buea, Cameroon; [Sarpong, Kwadwo] Georgetown Univ, Sch Med, Washington, DC USA; [Khan, Tariq] North West Gen Hosp & Res Ctr, Dept Neurosurg, Peshawar, Pakistan; [Karekezi, Claire] Rwanda Mil Hosp, Dept Surg, Neurosurg Unit, Kigali, Rwanda; [Park, Kee B.] Harvard Med Sch, Program Global Surg & Social Change, Global Neurosurg Initiat, Boston, MA 02115 USA		Lartigue, JW (corresponding author), State Univ Haiti, Sch Med & Pharm, Port Au Prince, Haiti.	drlartigue@gmail.com	Sebopelo, Lorraine Arabang/AAZ-6934-2021	Sebopelo, Lorraine Arabang/0000-0003-3905-4834; Ooi, Setthasorn Zhi Yang/0000-0002-7097-0948			Agrawal A., 2021, J GLOB NEUROSURG, V1, P43; Andrews RJ, 2015, EPMA J, V6, DOI 10.1186/s13167-014-0024-9; Barthelemy EJ, 2018, WORLD NEUROSURG, V120, P143, DOI 10.1016/j.wneu.2018.08.070; Dempsey RJ, 2020, NEUROSURGERY, V87, pE88, DOI 10.1093/neuros/nyaa102; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Fares Youssef, 2018, Surg Neurol Int, V9, P199, DOI 10.4103/sni.sni_94_18; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Fezeu Francis, 2018, Cureus, V10, pe3314, DOI 10.7759/cureus.3314; Fuller Anthony, 2016, eNeurologicalSci, V3, P1, DOI 10.1016/j.ensci.2015.10.003; Haglund MM, 2019, J NEUROSURG, V131, P993, DOI 10.3171/2019.4.JNS181747; Haglund MM, 2011, WORLD J SURG, V35, P1175, DOI 10.1007/s00268-011-1080-0; Ham EI, 2020, WORLD NEUROSURG, V143, pE88, DOI 10.1016/j.wneu.2020.06.237; Kanmounye US, 2020, WORLD NEUROSURG, V142, pE420, DOI 10.1016/j.wneu.2020.07.067; Karekezi C, 2020, NEUROSURG FOCUS, V48, DOI 10.3171/2019.12.FOCUS19853; Karekezi C, 2019, WORLD NEUROSURG, V126, P576, DOI 10.1016/j.wneu.2019.03.141; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Mukhopadhyay S, 2019, J NEUROSURG, V130, P1142, DOI 10.3171/2018.10.JNS171723; O'Donohoe TJ, 2020, EUR J NEUROL, V27, P360, DOI 10.1111/ene.14085; Park KB, 2016, WORLD NEUROSURG, V88, P32, DOI 10.1016/j.wneu.2015.12.048; Ferraris KP, 2020, NEUROSURG FOCUS, V48, DOI 10.3171/2019.12.FOCUS19814; Punchak M, 2018, WORLD NEUROSURG, V112, pE240, DOI 10.1016/j.wneu.2018.01.029; Raja IA, 2005, NEUROL MED-CHIR, V45, P433, DOI 10.2176/nmc.45.433; Rock J, 2018, WORLD NEUROSURG, V113, pE239, DOI 10.1016/j.wneu.2018.02.001; Rosseau G, 2020, J NEUROSURG, V132, P1256, DOI 10.3171/2019.11.JNS191823; Rudolfson N, 2019, J NEUROSURG, V130, P1149, DOI 10.3171/2017.12.JNS17281; Sader E, 2017, WORLD NEUROSURG, V98, P397, DOI 10.1016/j.wneu.2016.07.098; Santos MM, 2018, WORLD NEUROSURG, V113, P425, DOI 10.1016/j.wneu.2018.01.084; Servadei F, 2018, WORLD NEUROSURG, V112, P315, DOI 10.1016/j.wneu.2018.01.047; Sixty-Eighth World Health Assembly, 2015, WHA RES 68 15 STRENG; Truche P, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-019-0531-5; United Nations General Assembly, 2015, TRANSF OUR WORLD 203; Velin L, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-003455; Vervoort D, 2019, HEART ASIA, V11, DOI 10.1136/heartasia-2018-011125; Weiss Hannah K, 2020, World Neurosurg X, V5, P100068, DOI 10.1016/j.wnsx.2019.100068	35	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-875X			FRONT SURG	Front. Surg.	OCT 11	2021	8								690735	10.3389/fsurg.2021.690735			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	WU7LQ	WOS:000716723300001	34708069	Green Published, gold			2022-02-06	
J	Tsushima, WT; Choi, SY; Kameoka, A; Ahn, HJ; Murata, NM				Tsushima, William T.; Choi, So Yung; Kameoka, Alyssa; Ahn, Hyeong Jun; Murata, Nathan M.			Sex comparisons in neuropsychological functioning and reported symptoms following a sports-related concussion among high school athletes	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article; Early Access						Concussion; neuropsychological tests; sex characteristics; sports	BASE-LINE; NEUROCOGNITIVE PERFORMANCE; GENDER-DIFFERENCES; INJURY; RECOVERY; AGE; EPIDEMIOLOGY; PLAYERS; FEMALE; TIME	The aim of this study was to compare the neuropsychological functioning and symptoms of female and male high school athletes following a single concussion during the school year. The baseline test scores of the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) of 309 concussed athletes (169 females, 221 males) in varied sports were obtained. After a sport-related concussion, the athletes were re-administered the ImPACT, on the average, 7.25 days after the injury. MANCOVA compared the ImPACT baseline scores, post-concussion scores, and baseline-to-post-concussion changes of the female and male athletes, with p set at 0.01. The only significant sex comparison found females performing better on baseline visual motor speed (p < 0.001). Otherwise, no sex differences were found in baseline test scores, post-concussion scores, and baseline-to-post-concussion changes. The findings tentatively suggest that there are insignificant sex differences in the consequences of sport-related concussion after a week post-injury. Future studies on sex comparisons after a concussion are needed focusing on the acute and sub-acute phases of the recovery period.	[Tsushima, William T.] Straub Med Ctr, Psychiat & Psychol Dept, 888 South King St, Honolulu, HI 96813 USA; [Choi, So Yung] Univ Hawaii, John A Burns Sch Med, Dept Complementary & Integrat Med, Honolulu, HI 96822 USA; [Kameoka, Alyssa] Boston Univ, Dept Neurosci, Aiea, HI USA; [Ahn, Hyeong Jun] Univ Hawaii, John A Burns Sch Med, Off Biostat & Quantitat Hlth Sci, Honolulu, HI 96822 USA; [Murata, Nathan M.] Univ Hawaii, Coll Educ, Honolulu, HI 96822 USA		Tsushima, WT (corresponding author), Straub Med Ctr, Psychiat & Psychol Dept, 888 South King St, Honolulu, HI 96813 USA.	wtsushima@hphmg.org			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54MD00760131, U54GM104944]	This work was partially supported by the National Institutes of Health. So Yung Choi and Hyeong Jun Ahn were partially supported by [grant numbers U54MD00760131 and U54GM104944].	Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Burkhart S.O., 2020, ORTHOP J SPORTS MED, V8, DOI [https://doi.org/10.1177/2325967120s00139, DOI 10.1177/2325967120S00139]; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Granito V.J., 2002, J SPORT BEHAV, V25, P243; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hyde JS, 2019, AM PSYCHOL, V74, P171, DOI 10.1037/amp0000307; ImPACT Applications Inc., 2016, ADM INTERPRETATION M; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kontos AP, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0571-y; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Moser RS, 2019, ARCH CLIN NEUROPSYCH, V34, P50, DOI 10.1093/arclin/acy007; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; R Core Team, 2013, LANGUAGE ENV STAT CO, DOI DOI 11/44679/INDEX.HTM; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tsushima WT, 2020, CLIN J SPORT MED, V30, P52, DOI 10.1097/JSM.0000000000000567; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	35	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child												10.1080/21622965.2021.1969572		OCT 2021	7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	WG0GB	WOS:000706676000001	34641756				2022-02-06	
J	Van Patten, R; Iverson, GL; Terry, DP; Levi, CR; Gardner, AJ				Van Patten, Ryan; Iverson, Grant L.; Terry, Douglas P.; Levi, Christopher R.; Gardner, Andrew J.			Predictors and Correlates of Perceived Cognitive Decline in Retired Professional Rugby League Players	FRONTIERS IN NEUROLOGY			English	Article						retired athletes; sports; brain injury; cognition; subjective cognitive decline; mental health	HIGH-SCHOOL FOOTBALL; SUBJECTIVE MEMORY COMPLAINTS; TRAUMATIC BRAIN-INJURY; INFORMANT QUESTIONNAIRE; ELDERLY IQCODE; MENTAL-HEALTH; RESILIENCE SCALE; OLDER-ADULTS; CONCUSSION; PERFORMANCE	Objective: Rugby league is an international full-contact sport, with frequent concussive injuries. Participation in other full-contact sports such as American football has been considered to be a risk factor for neuropsychiatric sequelae later-in-life, but little research has addressed the mental and cognitive health of retired professional rugby league players. We examined predictors and correlates of perceived (self-reported) cognitive decline in retired National Rugby League (NRL) players. Methods: Participants were 133 retired male elite level rugby league players in Australia. Participants completed clinical interviews, neuropsychological testing, and self-report measures. The Informant Questionnaire on Cognitive Decline in the Elderly, self-report (IQCODE-Self), measured perceived cognitive decline. Results: The median age of the sample was 55.0 (M = 53.1, SD = 13.9, range = 30-89) and the median years of education completed was 12.0 (M = 11.9, SD = 2.6, range = 7-18). The retired players reported a median of 15.0 total lifetime concussions (M = 28.0, SD = 36.6, range = 0-200). The mean IQCODE-Self score was 3.2 (SD = 0.5; Range = 1.3-5.0); 10/133 (7.5%) and 38/133 (28.6%) scored above conservative and liberal cutoffs for cognitive decline on the IQCODE-Self, respectively. Perceived cognitive decline was positively correlated with current depressive symptoms, negatively correlated with years of professional sport exposure and resilience, and unrelated to objective cognition and number of self-reported concussions. A multiple regression model with perceived cognitive decline regressed on age, concussion history, professional rugby league exposure, depression, resilience, objective cognitive functioning, daytime sleepiness, and pain severity showed depression as the only significant predictor. Conclusion: This is the first large study examining subjectively experienced cognitive decline in retired professional rugby league players. Similar to studies from the general population and specialty clinics, no relationship was found between objective cognitive test performance and perceived cognitive decline. Depressive symptoms emerged as the strongest predictor of perceived cognitive decline, suggesting that subjective reports of worsening cognition in retired elite rugby league players might reflect psychological distress rather than current cognitive impairment.	[Van Patten, Ryan; Iverson, Grant L.; Terry, Douglas P.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Van Patten, Ryan; Iverson, Grant L.; Terry, Douglas P.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.; Terry, Douglas P.] MassGen Hosp Children Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.; Terry, Douglas P.] Home Base, Charlestown, MA USA; [Levi, Christopher R.] Sydney Partnership Hlth Educ Res & Enterprise SPH, Liverpool, NSW, Australia; [Levi, Christopher R.] Univ New South Wales, Sch Med, Randwick, NSW, Australia; [Levi, Christopher R.; Gardner, Andrew J.] Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Levi, Christopher R.; Gardner, Andrew J.] Hunter New England Local Hlth Dist Sports Concuss, Waratah, NSW, Australia		Gardner, AJ (corresponding author), Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Sch Med & Publ Hlth, Callaghan, NSW, Australia.; Gardner, AJ (corresponding author), Hunter New England Local Hlth Dist Sports Concuss, Waratah, NSW, Australia.	andrew.gardner@newcastle.edu.au		Gardner, Andrew/0000-0001-5031-5586	Brain Foundation, Australia; Priority Research Centre for Stroke and Brain Injury; National Football League; National Rugby League, ImPACT Applications, Inc; Mooney-Reed Charitable Foundation; Spaulding Research Institute	This study was funded in part by the NSW Sporting Injuries Committee, the Brain Foundation, Australia, and the Priority Research Centre for Stroke and Brain Injury. The authors have received funding from the National Football League for a program of research entitled The Spectrum of Concussion: Predictors of Clinical Recovery, Treatment and Rehabilitation, and Possible Long-Term Effects (PI: GI), although this study was not directly sponsored by that grant. Unrestricted philanthropic support was provided by the National Rugby League, ImPACT Applications, Inc., the Mooney-Reed Charitable Foundation, and the Spaulding Research Institute. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.	Adams JW, 2020, ACTA NEUROPATHOL, V140, P851, DOI 10.1007/s00401-020-02206-x; Alosco ML, 2019, JAMA NEUROL, V76, P1298, DOI 10.1001/jamaneurol.2019.2244; Alosco ML, 2017, J NEUROPSYCH CLIN N, V29, P6, DOI 10.1176/appi.neuropsych.16030043; [Anonymous], 2009, ADV CLIN SOL WAIS 4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benton AL, 1994, MULTILINGUAL APHASIA; Burmester B, 2016, NEUROPSYCHOL REV, V26, P376, DOI 10.1007/s11065-016-9332-2; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Crumley JJ, 2014, PSYCHOL AGING, V29, P250, DOI 10.1037/a0035908; Cunningham J, 2020, J ATHL TRAINING, V55, P132, DOI 10.4085/1062-6050-297-18; de Jonghe J F, 1997, Tijdschr Gerontol Geriatr, V28, P224; Demetriou A, 2020, INT J SPORT EXERC PS, V18, P321, DOI 10.1080/1612197X.2018.1519839; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Drew B, 2019, J CLIN SPORT PSYCHOL, V13, P421, DOI 10.1123/jcsp.2017-0043; Fields L, 2020, ARCH CLIN NEUROPSYCH, V35, P233, DOI 10.1093/arclin/acz008; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Gabbett TJ, 2005, J SPORT SCI, V23, P961, DOI 10.1080/02640410400023381; Galli N, 2015, INT J SPORT EXERC PS, V13, P243, DOI 10.1080/1612197X.2014.946947; Gallo V, 2020, J NEUROL NEUROSUR PS, V91, P455, DOI 10.1136/jnnp-2019-321170; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gardner RC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002246; Golden C.J., 1978, STROOP COLOR WORD TE; Gonzalez SP, 2016, PSYCHOL SPORT EXERC, V23, P31, DOI 10.1016/j.psychsport.2015.10.005; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hosseini SA, 2010, PROCD SOC BEHV, V5, P633, DOI 10.1016/j.sbspro.2010.07.156; Iverson GL., 2021, 150 J SPORTS MED, P4, DOI [10.1097/JSM.0000000000000898, DOI 10.1097/JSM.0000000000000898]; Jansen APD, 2008, J GERIATR PSYCH NEUR, V21, P83, DOI 10.1177/0891988707311558; Janssen PHH, 2017, MAYO CLIN PROC, V92, P66, DOI 10.1016/j.mayocp.2016.09.004; Jessen F, 2020, LANCET NEUROL, V19, P271, DOI 10.1016/S1474-4422(19)30368-0; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jones TV, 2016, J MENT HEALTH, V25, P422, DOI 10.3109/09638237.2015.1124384; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Jorm AF, 2000, PSYCHOL MED, V30, P981, DOI 10.1017/S0033291799002299; JORM AF, 1991, PSYCHOL MED, V21, P785, DOI 10.1017/S0033291700022418; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Jorm AF, 1996, INT J GERIATR PSYCH, V11, P131; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Kelly JP, 1997, NEUROLOGY, V48, P581; King D, 2010, INT J PERF ANAL SPOR, V10, P241, DOI 10.1080/24748668.2010.11868519; Laird ET, 2019, AM J GERIAT PSYCHIAT, V27, P12, DOI 10.1016/j.jagp.2018.08.009; Lebrun F, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02062; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mannes ZL, 2020, HEALTH PSYCHOL, V39, P452, DOI 10.1037/hea0000847; Mannes ZL, 2019, INT REV SPORT EXER P, V12, P265, DOI 10.1080/1750984X.2018.1469162; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Meyers JE., 1995, REY COMPLEX FIGURE T; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mitchell AJ, 2014, ACTA PSYCHIAT SCAND, V130, P439, DOI 10.1111/acps.12336; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; National Institute of Neurological Disorders and Stroke, 2010, US MAN QUAL LIF NEUR; Ngwenya LB, 2018, BRAIN INJURY, V32, P1071, DOI 10.1080/02699052.2018.1481527; Plessow F, 2020, J NEUROTRAUM, V37, P1021, DOI 10.1089/neu.2019.6661; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A., 1964, EXAMEN CLIN PSYCHOL; Roberts AL, 2021, J NEUROTRAUM, V38, P189, DOI 10.1089/neu.2020.7070; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schaffert J, 2020, INT REV PSYCHIATR, V32, P71, DOI 10.1080/09540261.2019.1658572; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Simon MB., THESIS U N CAROLINA; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Steinfeldt JA, 2012, SPORT EXERC PERFORM, V1, P58, DOI 10.1037/a0024919; Taylor CA, 2018, MMWR-MORBID MORTAL W, V67, P753, DOI 10.15585/mmwr.mm6727a1; Thornton AE, 2008, J CLIN EXP NEUROPSYC, V30, P398, DOI 10.1080/13803390701443662; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th, DOI [10.1037/t15169-000, DOI 10.1037/T15169-000]; Wood S, 2017, PHYSICIAN SPORTSMED, V45, P120, DOI 10.1080/00913847.2017.1283209	79	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 11	2021	12								676762	10.3389/fneur.2021.676762			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WU7IR	WOS:000716715500001	34707552	Green Published, gold			2022-02-06	
J	Lininger, MR; Yeargin, SW; Hirschhorn, RM; Mensch, J				Lininger, M. R.; Yeargin, S. W.; Hirschhorn, R. M.; Mensch, J.			Assessing the validity of a helmet fit checklist in a sample of youth football players	RESEARCH IN SPORTS MEDICINE			English	Article; Early Access						Principal components analysis; psychometrics; instrument	HEAD IMPACT EXPOSURE; HIGH-SCHOOL; CONCUSSION; COLLEGIATE; ABILITY; REDUCE	The dynamics of American youth football make it critical to ensure that helmets are appropriately fit to decrease the risk of injuries. Currently, there is only one researcher-developed checklist to determine helmet fit, and psychometric testing is lacking; therefore, the aim of this work was to determine the validity of the checklist. The 13-item checklist was used to measure helmet fit in 267 youth football players prior to the start of the season. Using a Principal Components Analysis to assess validity, a 5-component model was found explaining 58% of the available variance. These results suggest that a single, summative score should not be used for this checklist; rather five scores should be calculated for each component (stability, snugness, size, integrity, and accessory). A more practical and valid tool to assess fit, such as a sub-sectioned chronological American football-specific checklist, can better assist coaches/administrators responsible for helmet fit and player safety.	[Lininger, M. R.] No Arizona Univ, Dept Phys Therapy & Athlet Training, Flagstaff, AZ 86011 USA; [Yeargin, S. W.; Mensch, J.] Univ South Carolina, Dept Exercise Sci, Columbia, SC 29208 USA; [Hirschhorn, R. M.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA		Lininger, MR (corresponding author), No Arizona Univ, POB 15094, Flagstaff, AZ 86011 USA.	monica.lininger@nau.edu					Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; [Anonymous], 2015, CERT; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Breedlove KM, 2017, J ATHL TRAINING, V52, P802, DOI 10.4085/1062-6050-52.6.01; Breedlove KM, 2016, J BIOMECH, V49, P2838, DOI 10.1016/j.jbiomech.2016.06.030; Campolettano ET, 2020, ANN BIOMED ENG, V48, P1640, DOI 10.1007/s10439-020-02505-0; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Cournoyer J, 2016, J ATHL TRAINING, V51, P258, DOI 10.4085/1062-6050-51.4.08; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Greenhill DA, 2016, SPORTS HEALTH, V8, P238, DOI 10.1177/1941738116639027; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Krippendorff K, 2004, HUM COMMUN RES, V30, P411, DOI 10.1093/hcr/30.3.411; Krippendorff K., 2018, CONTENT ANAL INTRO I; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; Lininger MR, 2019, J ATHL TRAINING, V54, P21, DOI 10.4085/1062-6050-47-18; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rivara F P, 1999, Inj Prev, V5, P194; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864; Stevens J., 2001, APPL MULTIVARIATE ST, V4th ed, P325; US Lacrosse, 2014, HELM FITT TIPS; USA Hockey, 2010, HEADS HOCK PROGR GUI; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Williams R.M., 2014, ATHLETIC TRAINING SP, V6, P206, DOI [10.3928/19425864-20140916-05, DOI 10.3928/19425864-20140916-05]; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055; Yu HY, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4040944	32	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.												10.1080/15438627.2021.1988949		OCT 2021	11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WF3XA	WOS:000706240300001	34633258				2022-02-06	
J	Saulino, PA; Greenwald, BD; Gordon, DJ				Saulino, Patrick A.; Greenwald, Brian D.; Gordon, Dustin J.			The changing landscape of the use of medical marijuana after traumatic brain injury: a narrative review	BRAIN INJURY			English	Article						medical marijuana; traumatic brain injury; cannabinoid; brain injury rehabilitation; pharmacology	IMPROVES FUNCTIONAL RECOVERY; CLOSED-HEAD INJURY; ENDOCANNABINOID SYSTEM; AMYLOID-BETA; CANNABIS USE; MOUSE MODEL; BARRIER; INHIBITION; MODULATION; MANAGEMENT	Objective To summarize the potential therapeutic benefits of medical marijuana for patients with traumatic brain injury (TBI). Methods A systematic search was conducted using PubMed and Cochran's library for information regard the safety and efficacy of medical marijuana as a therapeutic agent. We investigated, in depth, articles specifically evaluating medical marijuana's use in TBI, as well as articles that summarized the effects of marijuana in general. Articles from the year 2000-2020 were included. Results A total of 37 articles met our inclusion criteria. An additional 3 articles were obtained from reference lists. Conclusion Studies have shown that medical marijuana can potentially aid the recovery from TBI by modulating the endocannabinoid system, reducing inflammation and secondary injury. Adverse cognitive and physiological effects have been observed in the acute setting as well as chronically, though more research is necessitated. There is also the concern of significant drug-drug interactions that have not been thoroughly studied. Thus, while there is evidence that medical marijuana can be beneficial in the treatment of TBI, more research is necessitated to fully explore the long-term efficacy and adverse effects.	[Saulino, Patrick A.] Rutgers Robert Wood Johnson Med Sch, Ringgold Stand Inst, Piscataway, NJ USA; [Greenwald, Brian D.] JFK Johnson Rehabil Inst, Ringgold Stand Inst, Phys Med & Rehabil, Ctr Brain Injuries, 65 James St, Edison, NJ 08820 USA; [Greenwald, Brian D.] Rutgers Robert Wood Johnson Med Sch New Brunswick, Phys Med & Rehabil, Edison, NJ USA; [Gordon, Dustin J.] Fairleigh Dickinson Univ, Ringgold Stand Inst, Fair Lawn, NJ USA; [Gordon, Dustin J.] Fairleigh Dickinson Univ Teaneck, Teaneck, NJ USA		Greenwald, BD (corresponding author), JFK Johnson Rehabil Inst, Ringgold Stand Inst, Phys Med & Rehabil, Ctr Brain Injuries, 65 James St, Edison, NJ 08820 USA.	brian.greenwald@hmhn.org					Abrams DI, 2015, CLIN PHARMACOL THER, V97, P575, DOI 10.1002/cpt.108; Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Ashtari M, 2011, J PSYCHIATR RES, V45, P1055, DOI 10.1016/j.jpsychires.2011.01.004; Benyo Z, 2016, AM J PHYSIOL-HEART C, V310, pH785, DOI 10.1152/ajpheart.00571.2015; Bondallaz P, 2016, FORENSIC SCI INT, V268, P92, DOI 10.1016/j.forsciint.2016.09.007; Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Burggren AC, 2019, AM J DRUG ALCOHOL AB, V45, P563, DOI 10.1080/00952990.2019.1634086; Calvigioni D, 2014, EUR CHILD ADOLES PSY, V23, P931, DOI 10.1007/s00787-014-0550-y; Centers for Disease Control and Prevention, 2020, DRUG OVERDOSE DEATHS; Corcoran L, 2015, INT REV NEUROBIOL, V125, P203, DOI 10.1016/bs.irn.2015.10.003; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Coussens NP, 2019, J PHARMACOL EXP THER, V371, P396, DOI 10.1124/jpet.119.259408; Crane NA, 2013, J INT NEUROPSYCH SOC, V19, P1009, DOI 10.1017/S135561771300088X; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; DiGiorgio AM, 2020, WORLD NEUROSURG, V135, DOI 10.1016/j.wneu.2019.12.095; DISA Global Solutions, 2020, MAP MAR LEG STAT; Dong C, 2019, CELL MOL LIFE SCI, V76, P729, DOI 10.1007/s00018-018-2955-0; Farrell Deacon, 2018, Curr Anesthesiol Rep, V8, P279, DOI 10.1007/s40140-018-0286-1; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Goldsmith RS, 2015, J OCCUP ENVIRON MED, V57, P518, DOI 10.1097/JOM.0000000000000454; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grenier K, 2020, CAN J NEUROL SCI, V47, P11, DOI 10.1017/cjn.2019.298; Guha A, 2004, POSTGRAD MED J, V80, P650, DOI 10.1136/pgmj.2004.019570; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; Hawley LA, 2018, ARCH PHYS MED REHAB, V99, P1584, DOI 10.1016/j.apmr.2018.02.003; HEISHMAN SJ, 1990, PHARMACOL BIOCHEM BE, V37, P561, DOI 10.1016/0091-3057(90)90028-G; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Hill KP, 2015, JAMA-J AM MED ASSOC, V313, P2474, DOI 10.1001/jama.2015.6199; Hillard CJ, 2000, J PHARMACOL EXP THER, V294, P27; Hryhorowicz S, 2018, EUR J DRUG METAB PH, V43, P1, DOI 10.1007/s13318-017-0416-z; Huestis MA, 2007, CHEM BIODIVERS, V4, P1770, DOI 10.1002/cbdv.200790152; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Kramer JL, 2015, CA-CANCER J CLIN, V65, P109, DOI 10.3322/caac.21260; Lafaye G, 2017, DIALOGUES CLIN NEURO, V19, P309; Layden JE, 2020, NEW ENGL J MED, V382, P903, DOI 10.1056/NEJMoa1911614; Leskovan JJ, 2020, ANN MED SURG, V57, P201, DOI 10.1016/j.amsu.2020.07.031; Lucas CJ, 2018, BRIT J CLIN PHARMACO, V84, P2477, DOI 10.1111/bcp.13710; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Martinez-Vargas M, 2013, INT J MOL SCI, V14, P23341, DOI 10.3390/ijms141223341; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Mestre L, 2005, J NEUROCHEM, V92, P1327, DOI 10.1111/j.1471-4159.2004.02979.x; Neavyn MJ, 2014, J MED TOXICOL, V10, P269, DOI 10.1007/s13181-014-0393-4; Nguyen BM, 2014, AM SURGEON, V80, P979; Nomura DK, 2008, BIOORG MED CHEM LETT, V18, P5875, DOI 10.1016/j.bmcl.2008.08.007; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Parmar JR, 2016, RES SOC ADMIN PHARM, V12, P638, DOI 10.1016/j.sapharm.2015.09.002; Pearson-Dennett V, 2017, DRUG ALCOHOL DEPEN, V178, P215, DOI 10.1016/j.drugalcdep.2017.05.017; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; Russo EB, 2018, FRONT INTEGR NEUROSC, V12, DOI 10.3389/fnint.2018.00051; Salomonsen-Sautel S, 2012, J AM ACAD CHILD PSY, V51, P694, DOI 10.1016/j.jaac.2012.04.004; Schier JG, 2019, MMWR-MORBID MORTAL W, V68, P787, DOI 10.15585/mmwr.mm6836e2; Schurman LD, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00069; Seamon MJ, 2007, AM J HEALTH-SYST PH, V64, P1037, DOI 10.2146/ajhp060471; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Slawek D, 2019, J PRIM CARE COMMUNIT, V10, DOI 10.1177/2150132719884838; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Swartz R, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-3; Taghavi S, 2021, J SURG RES, V257, P42, DOI 10.1016/j.jss.2020.07.011; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Ware MA, 2015, J PAIN, V16, P1233, DOI 10.1016/j.jpain.2015.07.014; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216	70	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV 10	2021	35	12-13					1510	1520		10.1080/02699052.2021.1978548		OCT 2021	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XP4FK	WOS:000705158800001	34632896				2022-02-06	
J	Kerry, G; Holtmannspoetter, M; Kubitz, JC; Steiner, HH				Kerry, Ghassan; Holtmannspoetter, Markus; Kubitz, Jens Christian; Steiner, Hans-Herbert			Factors which influence the complications of external ventricular cerebrospinal fluid drainage	ACTA NEUROCHIRURGICA			English	Article; Early Access						Cerebrospinal fluid; Complication; External ventricular drainage; Hydrocephalus; Metal needle; Polyurethane catheter	TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; PERCUTANEOUS NEEDLE TREPHINATION; PLACEMENT; INFECTIONS; HEMORRHAGE; EXPERIENCE; MANAGEMENT; ACCURACY; GUIDELINES	Background External ventricular drainage (EVD) is one of the most common neurosurgical procedures in emergencies. This study aims to find out which factors influence the occurrence of EVD-related complications in a comparative investigation of metal needles and polyurethane catheters. This is the first clinical study comparing these two systems. Methods Adult patients undergoing pre-coronal EVD placement via freehand burr hole trepanation were included in this prospective study. The exclusion criteria were the open EVD insertion and/or a pre-existing infectious disease of the central nervous system. Results Two hundred consecutive patients were enrolled. Of these, 100 patients were treated by using metal EVD (group 1) and 100 patients with polyurethane catheters (group 2). The overall complication rate was 26% (misplacement 13.5%, hemorrhage 12.5%, infection 2.5%, and dislocation 1%) without statistically significant differences between both groups. Generalized brain edema and midline shift had a significant influence on misplacements (generalized brain edema: p = 0.0002, Cramer-V: 0.307, OR = 7.364, 95% CI: 2.691-20.148; all patients: p = 0.001, Cramer-V: 0.48, OR = 43.5, 95% CI: 4.327-437.295; group 1: p = 0.047, Cramer-V: 0.216, OR = 3.75, 95% CI: 1.064-13.221; group 2: midline shift: p = 0.038, Cramer-V: 0.195, OR = 3.626, 95% CI: 1.389-9.464) all patients: p = 0.053, Cramer-V: 0.231, OR = 5.533, 95% CI 1.131-27.081; group 1: p = 0.138, Cramer-V: 0.168, OR = 2.769, 95% CI: 0.813-9.429 group 2. Hemorrhages were associated with the use of oral anticoagulants or antiplatelet therapy (p = 0.002; Cramer-V: 0.220, OR = 3.798, 95% CI: 1.572-9.175) with a statistically similar influence in both groups. Conclusion Generalized brain edema has a significant influence on misplacements in both groups. Midline shift lost its significance when considering only the patients in group 2. Patients under oral anticoagulation and antiplatelet therapy have increased odds of EVD-associated hemorrhage. Metal needles and polyurethane catheters are equivalent in terms of patient safety when there are no midline shift and generalized brain edema.	[Kerry, Ghassan; Steiner, Hans-Herbert] Paracelsus Med Univ, Dept Neurosurg, Klinikum Nuremberg, Nurnberg, Germany; [Kerry, Ghassan; Steiner, Hans-Herbert] Heidelberg Univ, Med Fac, Heidelberg, Germany; [Holtmannspoetter, Markus] Paracelsus Med Univ, Dept Neuroradiol, Klinikum Nuremberg, Nurnberg, Germany; [Kubitz, Jens Christian] Paracelsus Med Univ, Dept Anesthesiol, Klinikum Nuremberg, Nurnberg, Germany		Kerry, G (corresponding author), Paracelsus Med Univ, Dept Neurosurg, Klinikum Nuremberg, Nurnberg, Germany.	Ghassan.Kerry@klinikum-nuernberg.de					Asaad SK, 2019, ACTA NEUROCHIR, V161, P33, DOI 10.1007/s00701-018-3737-z; Bergdal O, 2013, CLIN NEUROL NEUROSUR, V115, P1972, DOI 10.1016/j.clineuro.2013.05.026; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cinibulak Z, 2016, ACTA NEUROCHIR, V158, P847, DOI 10.1007/s00701-016-2747-y; Cushing H., 1908, SURGERY ITS PRINCIPL, P17; Dawod G, 2020, WORLD NEUROSURG, V140, P131, DOI 10.1016/j.wneu.2020.04.215; Fargen KM, 2016, J NEUROSURG, V124, P1805, DOI 10.3171/2015.5.JNS15299; Foreman PM, 2015, CLIN NEUROL NEUROSUR, V128, P94, DOI 10.1016/j.clineuro.2014.09.026; Gardner PA, 2009, J NEUROSURG, V110, P1021, DOI 10.3171/2008.9.JNS17661; Hersh EH, 2019, WORLD NEUROSURG, V128, pE31, DOI 10.1016/j.wneu.2019.03.197; Hoch V, 2011, FRAUENHEILKUNDE UP2D, V5, P129, DOI [10.1055/s-0031-1271423, DOI 10.1055/S-0031-1271423]; Hockel K, 2018, ACTA NEUROCHIR SUPPL, V126, P281, DOI 10.1007/978-3-319-65798-1_55; Hong BJ, 2021, ACTA NEUROCHIR, V163, P1135, DOI 10.1007/s00701-020-04698-8; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huyette DR, 2008, J NEUROSURG, V108, P88, DOI 10.3171/JNS/2008/108/01/0088; Jackson DA, 2013, NEUROCRIT CARE, V19, P103, DOI 10.1007/s12028-012-9713-1; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Kim JH, 2012, WORLD NEUROSURG, V77, P135, DOI 10.1016/j.wneu.2011.04.017; Kohli G, 2018, WORLD NEUROSURG, V110, pE135, DOI 10.1016/j.wneu.2017.10.129; Kramer A., 2016, KRANKENHAUS PRAXISHY, Vuberarbeitete; Krause F., 1908, CHIRURG GEHIRNS RUCK, P163; Kubilay Z, 2013, J NEUROSURG, V118, P514, DOI 10.3171/2012.11.JNS121336; Le Cat CN, 1752, PHIL T R SOC, V47, P267, DOI [10.1098/rstl.1751.0041, DOI 10.1098/RSTL.1751.0041]; Lewis A, 2017, NEUROHOSPITALIST, V7, P15, DOI 10.1177/1941874416663281; Liu XY, 2019, NEUROCRIT CARE, V30, P617, DOI 10.1007/s12028-018-0648-z; Lo CH, 2007, J NEUROSURG, V106, P378, DOI 10.3171/jns.2007.106.3.378; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Maniker AH, 2006, NEUROSURGERY, V59, P419, DOI 10.1227/01.NEU.0000222817.99752.E6; Mansoor N, 2020, ACTA NEUROCHIR, V162, P755, DOI 10.1007/s00701-020-04247-3; MEYER B, 1994, ACTA NEUROCHIR, V127, P232, DOI 10.1007/BF01808772; Miller C, 2017, J NEUROSURG, V126, P289, DOI 10.3171/2015.12.JNS152341; Nwachuku EL, 2014, NEUROCRIT CARE, V20, P49, DOI 10.1007/s12028-013-9885-3; Ortolano F, 2017, ACTA NEUROCHIR, V159, P1981, DOI 10.1007/s00701-017-3291-0; Schodel P, 2012, J CLIN NEUROSCI, V19, P267, DOI 10.1016/j.jocn.2011.04.026; Talibi SS, 2020, BRIT J NEUROSURG, V34, P181, DOI 10.1080/02688697.2020.1725436; Tillmanns H, 1908, BRIT MED J, V1908, P983; Tsitsopoulos PP, 2019, ACTA NEUROCHIR, V161, P41, DOI 10.1007/s00701-018-3738-y; Tunkel AR, 2017, CLIN INFECT DIS, V64, pE34, DOI 10.1093/cid/ciw861; Wernicke C., 1881, LEHRBUCH GEHIRNKRANK, P186; Wiesmann M, 2001, J CLIN NEUROSCI, V8, P126, DOI 10.1054/jocn.2000.0749; Zeng T, 2010, CHIN J TRAUMATOL, V13, P146, DOI 10.3760/cma.j.issn.1008-1275.2010.03.003; ZENTNER J, 1995, NEUROSURG REV, V18, P31, DOI 10.1007/BF00416475	42	0	0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.												10.1007/s00701-021-05007-7		OCT 2021	11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WE6EK	WOS:000705716200002	34626273				2022-02-06	
J	Van Patten, R; Iverson, GL				Van Patten, Ryan; Iverson, Grant L.			Examining associations between concussion history, subjectively experienced memory problems, and general health factors in older men	CLINICAL NEUROPSYCHOLOGIST			English	Article; Early Access						Traumatic brain injury; aging; cognition; subjective cognitive decline; subjective memory complaints; survey; Amazon's Mechanical Turk	TRAUMATIC BRAIN-INJURY; AMAZONS MECHANICAL TURK; POSTTRAUMATIC-STRESS-DISORDER; MULTIPLE PAST CONCUSSIONS; SPORT-RELATED CONCUSSION; CHRONIC-FATIGUE-SYNDROME; COGNITIVE IMPAIRMENT; UNITED-STATES; CHRONIC PAIN; COMPLAINTS	Objective Examine associations between subjective memory complaints (SMCs), concussion history, and cognitive, psychological, and physical health in older men from the general population. Method Participants were 504 men aged 50-79 who were recruited using an online labor market. Participants completed a survey assessing demographics, medication history, concussion history, recent memory problems, and additional aspects of recent cognitive, mental, and physical health. Results Men with a lifetime history of >= 3 concussions also reported a lifetime history of being prescribed medication for anxiety (46.8%), depression (43.5%), chronic pain (79.0%), and high blood pressure (66.1%). When asked about symptoms experienced over the past year and the past week, they endorsed higher rates of cognitive and mental health problems, migraines, and difficulties with sleep and fatigue. The multivariable logistic regression model for predicting mild or greater memory problems was significant, chi 2(8) = 168.97, p < .001. In unadjusted analyses, significant predictors, in order of magnitude (strongest to weakest), were fatigue (odds ratio [OR] = 3.21), back or neck pain (OR = 2.28), migraines (OR = 2.11), anxiety (OR = 2.07), depression (OR = 2.04), difficulty sleeping (OR = 1.98), and concussion history (OR = 1.49). In the multivariable model, only back or neck pain (OR = 1.51, p = .004) and fatigue (OR = 1.99, p = .004) were significant predictors. Conclusions A personal history of multiple concussions was associated with perceived memory problems, but to a lesser degree than fatigue, back or neck pain, and migraines.	[Van Patten, Ryan; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Van Patten, Ryan; Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.] MassGen Hosp Children Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Home Base, Charlestown, MA USA		Van Patten, R (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, 79-96 Thirteenth St, Charlestown, MA 02129 USA.	Ryan.VanPatten@va.gov		Iverson, Grant/0000-0001-7348-9570	philanthropic funds to the Spaulding Research Institute	This work was supported by philanthropic funds to the Spaulding Research Institute.	Aasvik JK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01338; Attree EA, 2014, PSYCHOL RES BEHAV MA, V7, P67, DOI 10.2147/PRBM.S50645; Attree EA, 2009, CYBERPSYCHOL BEHAV, V12, P379, DOI 10.1089/cpb.2009.0002; Ayache SS, 2017, NEUROPHYSIOL CLIN, V47, P139, DOI 10.1016/j.neucli.2017.02.004; Baker KS, 2018, EUR J PAIN, V22, P601, DOI 10.1002/ejp.1151; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Bowerman B.L., 1990, LINEAR STAT MODELS A, V2nd ed.; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Buhrmester MD, 2018, PERSPECT PSYCHOL SCI, V13, P149, DOI 10.1177/1745691617706516; Burmester B, 2016, NEUROPSYCHOL REV, V26, P376, DOI 10.1007/s11065-016-9332-2; Burnham MJ, 2018, MENT HEALTH RELIG CU, V21, P934, DOI 10.1080/13674676.2018.1486394; Casey LS, 2017, SAGE OPEN, V7, DOI 10.1177/2158244017712774; Casler K, 2013, COMPUT HUM BEHAV, V29, P2156, DOI 10.1016/j.chb.2013.05.009; Chandler J, 2016, ANNU REV CLIN PSYCHO, V12, P53, DOI 10.1146/annurev-clinpsy-021815-093623; Chu HT, 2020, ACTA NEUROL SCAND, V141, P319, DOI 10.1111/ane.13204; Cockshell SJ, 2010, PSYCHOL MED, V40, P1253, DOI 10.1017/S0033291709992054; Cooper C, 2011, AGE AGEING, V40, P711, DOI 10.1093/ageing/afr121; Crumley JJ, 2014, PSYCHOL AGING, V29, P250, DOI 10.1037/a0035908; Cunningham J, 2020, J ATHL TRAINING, V55, P132, DOI 10.4085/1062-6050-297-18; Araújo Caroline Martins de, 2012, Dement. neuropsychol., V6, P74, DOI 10.1590/S1980-57642012DN06020002; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Difallah D, 2018, WSDM'18: PROCEEDINGS OF THE ELEVENTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING, P135, DOI 10.1145/3159652.3159661; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Foti M, 2017, NEUROL SCI, V38, P553, DOI 10.1007/s10072-017-2814-z; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; Gallo V, 2020, J NEUROL NEUROSUR PS, V91, P455, DOI 10.1136/jnnp-2019-321170; Gardner RC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002246; Gil-Gouveia R, 2019, CURR PAIN HEADACHE R, V23, DOI 10.1007/s11916-019-0824-7; Gil-Gouveia R, 2016, PAIN PHYSICIAN, V19, pE137; Gil-Gouveia R, 2015, J NEUROL, V262, P654, DOI 10.1007/s00415-014-7603-5; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Greer N, 2020, J HEAD TRAUMA REHAB, V35, P1, DOI 10.1097/HTR.0000000000000478; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hara K, 2018, PROCEEDINGS OF THE 2018 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2018), DOI 10.1145/3173574.3174023; Hauser DJ, 2016, BEHAV RES METHODS, V48, P400, DOI 10.3758/s13428-015-0578-z; Holmen J., 2013, BMC PSYCHOL, V1, P1, DOI [10.1186/2050-7283-1-19, DOI 10.1186/2050-7283-1-19]; Horton J.J., 2010, ARXIV10042931CS; Ipeirotis P., 2010, DEMOGRAPHICS MECH TU; Iverson G.L., 2020, CLIN J SPORT MED, DOI [10.1097/JSM.0000000000000806, DOI 10.1097/JSM.0000000000000806]; Iverson GL, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.632618; Iverson GL, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.655746; Iverson GL, 2021, J NEUROTRAUM, V38, P538, DOI 10.1089/neu.2020.7041; Izzy S, 2021, J NEUROTRAUM, V38, P1834, DOI 10.1089/neu.2020.7484; Johnson DR, 2012, TEACH PSYCHOL, V39, P245, DOI 10.1177/0098628312456615; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; Keith MG, 2016, IND ORGAN PSYCHOL-US, V9, P162, DOI 10.1017/iop.2015.130; Kristjansdottir H, 2020, CLIN NEUROPSYCHOL, V34, P70, DOI 10.1080/13854046.2020.1814873; Lagogianni C, 2018, NEUROPSYCHOL REHABIL, V28, P57, DOI 10.1080/09602011.2015.1127820; Latysheva N, 2020, ARQ NEURO-PSIQUIAT, V78, P133, DOI [10.1590/0004-282X20190159, 10.1590/0004-282x20190159]; Leavitt VM, 2010, PM&R, V2, P332, DOI 10.1016/j.pmrj.2010.03.027; Lee SH, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0779-1; Litman L, 2015, BEHAV RES METHODS, V47, P519, DOI 10.3758/s13428-014-0483-x; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; Martins IP, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01100-x; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Mazza S, 2018, PROG NEURO-PSYCHOPH, V87, P183, DOI 10.1016/j.pnpbp.2017.08.006; McCredie MN, 2019, ASSESSMENT, V26, P759, DOI 10.1177/1073191118760709; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McKinlay A, 2016, J INT NEUROPSYCH SOC, V22, P717, DOI 10.1017/S1355617716000497; Merz ZC, 2020, CURR PSYCHOL, DOI 10.1007/s12144-020-00741-0; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; Mitchell AJ, 2014, ACTA PSYCHIAT SCAND, V130, P439, DOI 10.1111/acps.12336; Mol M, 2007, INT J GERIATR PSYCH, V22, P393, DOI 10.1002/gps.1686; Moriarty O, 2014, CURR OPIN SUPPORT PA, V8, P130, DOI 10.1097/SPC.0000000000000054; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Mortensen K, 2018, J GEN INTERN MED, V33, P533, DOI 10.1007/s11606-017-4246-0; Moss AJ, 2020, TRENDS COGN SCI, V24, P678, DOI 10.1016/j.tics.2020.05.014; Myers R. H., 1990, CLASSICAL MODERN REG; Ngwenya LB, 2018, BRAIN INJURY, V32, P1071, DOI 10.1080/02699052.2018.1481527; Ogletree AM, 2021, INT J AGING HUM DEV, V93, P700, DOI 10.1177/0091415020940197; Patel KV, 2013, PAIN, V154, P2649, DOI 10.1016/j.pain.2013.07.029; Peer E, 2014, BEHAV RES METHODS, V46, P1023, DOI 10.3758/s13428-013-0434-y; Phelps CE, 2021, TRENDS COGN SCI, V25, P365, DOI 10.1016/j.tics.2021.01.001; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Roberts AL, 2021, J NEUROTRAUM, V38, P189, DOI 10.1089/neu.2020.7070; Roth RS, 2005, ARCH PHYS MED REHAB, V86, P1147, DOI 10.1016/j.apmr.2004.10.041; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Sprouse J, 2011, BEHAV RES METHODS, V43, P155, DOI 10.3758/s13428-010-0039-7; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stillman AM, 2020, J NEUROTRAUM, V37, P305, DOI 10.1089/neu.2018.5925; Taylor CA, 2018, MMWR-MORBID MORTAL W, V67, P753, DOI 10.15585/mmwr.mm6727a1; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Wessling KS, 2017, J CONSUM RES, V44, P211, DOI 10.1093/jcr/ucx053; Westoby CJ, 2009, EUR J PAIN, V13, P970, DOI 10.1016/j.ejpain.2008.11.011; Zhang B, 2020, SURV PRACT, V13, P1, DOI [10.29115/sp-2020-0015, DOI 10.29115/SP-2020-0015]; Zhang YJ, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9080199	95	0	0	5	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.												10.1080/13854046.2021.1991481		OCT 2021	22	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	WJ7GT	WOS:000709209700001	34668844				2022-02-06	
J	Cai, S; Lu, Z				Cai, Shu; Lu, Zheng			Effect of Mild Hypothermia after Craniotomy on the Function of Related Organs in Patients with Traumatic Brain Injury	EMERGENCY MEDICINE INTERNATIONAL			English	Article								Objective. To investigate the effect of mild hypothermia after craniotomy on the function of related organs in patients with traumatic brain injury. Method. A total of 240 patients with craniocerebral injury from January 2017 to December 2020 were retrospectively analyzed. Patients were randomly divided into a control group and an experimental group, with 120 cases in each group. The control group was treated with craniotomy decompression, and the experimental group was treated with early mild hypothermia based on craniotomy decompression. Patients' venous blood was collected before operation (T-0), at the end of operation (T-1), 24 h after operation (T-2), and 2 weeks after operation (T-3) to detect the serum levels of the beta-subunit of S100 protein (S100-beta); soluble growth stimulation expressed gene 2 (sST2), neutrophil gelatinase-associated lipocalin (NGAL), and interleukin 6 (IL-6). The prognostic effect was evaluated after 2 weeks of treatment. Results. After mild hypothermia treatment after craniotomy and decompression, the patients' serum S100-beta, sST2, NGAL, and IL-6 levels at different time points were significantly lower than the control group, and the total effective rate was higher than that of the control group. Conclusion. The treatment of mild hypothermia after craniotomy can reduce the related organs function damage indicators and inflammatory stress response, thus improving clinical efficacy and prognosis.	[Cai, Shu; Lu, Zheng] Nantong Univ, Dept Neurosurg, Affiliated Haian Hosp, Nantong 226600, Jiangsu, Peoples R China		Cai, S (corresponding author), Nantong Univ, Dept Neurosurg, Affiliated Haian Hosp, Nantong 226600, Jiangsu, Peoples R China.	topgunelf@qq.com			Nantong Science and Technology Bureau Project [MSZ18202]	This work was supported by the Nantong Science and Technology Bureau Project (no. MSZ18202).	Alosco ML, 2021, NEUROTHERAPEUTICS, V18, P772, DOI 10.1007/s13311-021-01028-3; Anania P, 2021, NEUROSURG REV, V44, P2415, DOI 10.1007/s10143-020-01438-5; Battaglini D, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.564751; Biegon A, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.576366; Du Q, 2018, CLIN CHIM ACTA, V487, P145, DOI 10.1016/j.cca.2018.09.035; Escamilla-Ocanas C.E., 2020, NEUROLOGIA, V35; Georges A., 2021, TRAUMATIC BRAIN INJU; Ghiam MK, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.635483; Henry J, 2021, ACTA NEUROCHIR, V163, P1423, DOI 10.1007/s00701-021-04809-z; Hugon J, 2021, NEUROCHIRURGIE, V67, P290, DOI 10.1016/j.neuchi.2021.02.003; Jamjoom AAB, 2021, BRAIN, V144, P18, DOI 10.1093/brain/awaa321; Jarrahi A, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100389; Krishnamoorthy V, 2021, CHEST, V160, P956, DOI 10.1016/j.chest.2021.01.016; Le Sage N, 2019, CAN J NEUROL SCI, V46, P599, DOI 10.1017/cjn.2019.61; Li JT, 2021, HISTOL HISTOPATHOL, V36, P921, DOI 10.14670/HH-18-338; Li ZQ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abb6260; Maleki N, 2021, CURR PAIN HEADACHE R, V25, DOI 10.1007/s11916-020-00935-y; Subbarao BS, 2021, PHYS MED REH CLIN N, V32, P223, DOI 10.1016/j.pmr.2021.01.001; Verboon LN, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.620698; Wu XH, 2021, AUST CRIT CARE, V34, P83, DOI 10.1016/j.aucc.2020.05.005; Zhao JB, 2016, J NEUROL SCI, V368, P392, DOI 10.1016/j.jns.2016.07.060; Zou JR, 2021, SYNAPSE, V75, DOI 10.1002/syn.22201	22	0	0	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-2840	2090-2859		EMERG MED INT	Emerg. Med. Int.	OCT 8	2021	2021								4105406	10.1155/2021/4105406			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	WI3AP	WOS:000708237900001	34659832	gold, Green Published			2022-02-06	
J	Chaudhary, M; Adams, MS; Mukhopadhyay, S; Litoiu, M; Sergio, LE				Chaudhary, Mahima; Adams, Meaghan S.; Mukhopadhyay, Sumona; Litoiu, Marin; Sergio, Lauren E.			Sabotage Detection Using DL Models on EEG Data From a Cognitive-Motor Integration Task	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						deep learning; CNN; LSTM; wearable devices; baseline testing; cognitive-motor integration	LIE DETECTION; CONCUSSION	Objective clinical tools, including cognitive-motor integration (CMI) tasks, have the potential to improve concussion rehabilitation by helping to determine whether or not a concussion has occurred. In order to be useful, however, an individual must put forth their best effort. In this study, we have proposed a novel method to detect the difference in cortical activity between best effort (no-sabotage) and willful under-performance (sabotage) using a deep learning (DL) approach on the electroencephalogram (EEG) signals. The EEG signals from a wearable four-channel headband were acquired during a CMI task. Each participant completed sabotage and no-sabotage conditions in random order. A multi-channel convolutional neural network with long short term memory (CNN-LSTM) model with self-attention has been used to perform the time-series classification into sabotage and no-sabotage, by transforming the time-series into two-dimensional (2D) image-based scalogram representations. This approach allows the inspection of frequency-based, and temporal features of EEG, and the use of a multi-channel model facilitates in capturing correlation and causality between different EEG channels. By treating the 2D scalogram as an image, we show that the trained CNN-LSTM classifier based on automated visual analysis can achieve high levels of discrimination and an overall accuracy of 98.71% in case of intra-subject classification, as well as low false-positive rates. The average intra-subject accuracy obtained was 92.8%, and the average inter-subject accuracy was 86.15%. These results indicate that our proposed model performed well on the data of all subjects. We also compare the scalogram-based results with the results that we obtained by using raw time-series, showing that scalogram-based gave better performance. Our method can be applied in clinical applications such as baseline testing, assessing the current state of injury and recovery tracking and industrial applications like monitoring performance deterioration in workplaces.	[Chaudhary, Mahima; Mukhopadhyay, Sumona; Litoiu, Marin] York Univ, Lassonde Sch Engn, Toronto, ON, Canada; [Adams, Meaghan S.; Sergio, Lauren E.] York Univ, Fac Hlth, Toronto, ON, Canada; [Adams, Meaghan S.] Univ Hlth Network, KITE Toronto Rehabil Inst, Toronto, ON, Canada		Sergio, LE (corresponding author), York Univ, Fac Hlth, Toronto, ON, Canada.	lsergio@yorku.ca					Abootalebi V, 2009, COMPUT METH PROG BIO, V94, P48, DOI 10.1016/j.cmpb.2008.10.001; Adams MS, 2020, FRONT INTEGR NEUROSC, V14, DOI 10.3389/fnint.2020.00033; Albawi S, 2017, I C ENG TECHNOL; [Anonymous], 2014, PRINCIPLES ARTIFICIA; Bablani A, 2018, INT CONF COMPUT; Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Cakmak Rumeysa, 2015, 2015 IEEE International Symposium on Robotics and Intelligent Sensors (IRIS), P170, DOI 10.1109/IRIS.2015.7451606; Chaudhary M., 2020, P 30 ANN INT C COMP; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Farah MJ, 2014, NAT REV NEUROSCI, V15, P123, DOI 10.1038/nrn3665; Freed A., 2009, P INT C NEW INT MUS, P116; Gao JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064704; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Goodfellow Ian, 2016, DEEP LEARNING; Greely HT, 2007, AM J LAW MED, V33, P377, DOI 10.1177/009885880703300211; Greff K, 2017, IEEE T NEUR NET LEAR, V28, P2222, DOI 10.1109/TNNLS.2016.2582924; Higgins KL, 2018, ARCH CLIN NEUROPSYCH, V33, P437, DOI 10.1093/arclin/acx071; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hochreiter S, 1997, NEURAL COMPUT, V9, P1735, DOI 10.1162/neco.1997.9.8.1735; Hurtubise Johanna, 2016, Concussion, V1, pCNC17, DOI 10.2217/cnc-2016-0006; Krizhevsky A., 2012, P ADV NEUR INF PRO S; Lee HK, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21121199; Manning KY, 2020, NEUROLOGY, V95, pE402, DOI 10.1212/WNL.0000000000009821; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MICHIE D, 1968, NATURE, V218, P19, DOI 10.1038/218019a0; 김길호, 2019, [Journal of Intelligence and Information Systems, 지능정보연구], V25, P163; Mukhopadhyay S., 2020, IOT 20; Mukhopadhyay S, 2020, CHAOS, V30, DOI 10.1063/5.0009326; Nussbaumer H., 1982, FAST FOURIER TRANSFO; Ordonez FJ, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010115; Rebchuk AD, 2020, J NEUROTRAUM, V37, P1521, DOI 10.1089/neu.2019.6829; Ruffini G, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00806; Sergio LE, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.541630; Simbolon AI, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON AUTOMATION, COGNITIVE SCIENCE, OPTICS, MICRO ELECTRO-MECHANICAL SYSTEM, AND INFORMATION TECHNOLOGY (ICACOMIT), P68, DOI 10.1109/ICACOMIT.2015.7440177; Singh SP, 2021, IEEE SENS J, V21, P8575, DOI 10.1109/JSEN.2020.3045135; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Tapper A, 2017, J SPORT SCI, V35, P231, DOI 10.1080/02640414.2016.1161214; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Vaswani A, 2017, ADV NEUR IN, V30; Wang Hao, 2010, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V27, P746	41	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	OCT 8	2021	15								662875	10.3389/fnhum.2021.662875			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	WM2TV	WOS:000710944000001	34690715	gold, Green Published			2022-02-06	
J	Menichetti, A; Bartsoen, L; Depreitere, B; Vander Sloten, J; Famaey, N				Menichetti, Andrea; Bartsoen, Laura; Depreitere, Bart; Vander Sloten, Jos; Famaey, Nele			A Machine Learning Approach to Investigate the Uncertainty of Tissue-Level Injury Metrics for Cerebral Contusion	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article						brain biomechanics; cerebral contusion; finite element modeling; tissue-level injury criteria; machine learning; controlled cortical impact; traumatic brain injury	CONTROLLED CORTICAL IMPACT; FINITE-ELEMENT-ANALYSIS; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; IN-VIVO; MODELS; STRAIN; PREDICTION; INDENTATION; PATHOPHYSIOLOGY	Controlled cortical impact (CCI) on porcine brain is often utilized to investigate the pathophysiology and functional outcome of focal traumatic brain injury (TBI), such as cerebral contusion (CC). Using a finite element (FE) model of the porcine brain, the localized brain strain and strain rate resulting from CCI can be computed and compared to the experimentally assessed cortical lesion. This way, tissue-level injury metrics and corresponding thresholds specific for CC can be established. However, the variability and uncertainty associated with the CCI experimental parameters contribute to the uncertainty of the provoked cortical lesion and, in turn, of the predicted injury metrics. Uncertainty quantification via probabilistic methods (Monte Carlo simulation, MCS) requires a large number of FE simulations, which results in a time-consuming process. Following the recent success of machine learning (ML) in TBI biomechanical modeling, we developed an artificial neural network as surrogate of the FE porcine brain model to predict the brain strain and the strain rate in a computationally efficient way. We assessed the effect of several experimental and modeling parameters on four FE-derived CC injury metrics (maximum principal strain, maximum principal strain rate, product of maximum principal strain and strain rate, and maximum shear strain). Next, we compared the in silico brain mechanical response with cortical damage data from in vivo CCI experiments on pig brains to evaluate the predictive performance of the CC injury metrics. Our ML surrogate was capable of rapidly predicting the outcome of the FE porcine brain undergoing CCI. The now computationally efficient MCS showed that depth and velocity of indentation were the most influential parameters for the strain and the strain rate-based injury metrics, respectively. The sensitivity analysis and comparison with the cortical damage experimental data indicate a better performance of maximum principal strain and maximum shear strain as tissue-level injury metrics for CC. These results provide guidelines to optimize the design of CCI tests and bring new insights to the understanding of the mechanical response of brain tissue to focal traumatic brain injury. Our findings also highlight the potential of using ML for computationally efficient TBI biomechanics investigations.	[Menichetti, Andrea; Bartsoen, Laura; Vander Sloten, Jos; Famaey, Nele] Katholieke Univ Leuven, Biomech Sect, Dept Mech Engn, Leuven, Belgium; [Depreitere, Bart] Univ Hosp Leuven, Neurosurg, Leuven, Belgium		Menichetti, A (corresponding author), Katholieke Univ Leuven, Biomech Sect, Dept Mech Engn, Leuven, Belgium.	andrea.menichetti@kuleuven.be		Famaey, Nele/0000-0002-7374-8912	Research Foundation Flanders (FWO)FWO [1S25920N]	This research was made possible through a predoctoral fellowship of the Research Foundation Flanders (FWO) (Project no. 1S25920N).	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Alessandri B, 2003, J NEUROTRAUM, V20, P1293, DOI 10.1089/089771503322686094; Anderson ED, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00309; Baker EW, 2019, J NEUROTRAUM, V36, P61, DOI 10.1089/neu.2017.5551; Bartsoen L, 2021, IEEE T BIO-MED ENG, V68, P3273, DOI 10.1109/TBME.2021.3069330; Beleites C, 2005, CHEMOMETR INTELL LAB, V79, P91, DOI 10.1016/j.chemolab.2005.04.008; Borgonovo E, 2007, RELIAB ENG SYST SAFE, V92, P771, DOI 10.1016/j.ress.2006.04.015; Budday S, 2020, ARCH COMPUT METHOD E, V27, P1187, DOI 10.1007/s11831-019-09352-w; Cai L, 2021, ROY SOC OPEN SCI, V8, DOI 10.1098/rsos.201121; Cai YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197992; Cai ZH, 2019, COMPUT METHOD BIOMEC, V22, P169, DOI 10.1080/10255842.2018.1541983; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Davies V, 2019, J R STAT SOC C-APPL, V68, P1555, DOI 10.1111/rssc.12374; De Kegel D., 2018, THESIS KU LEUVEN LEU; De Kegel D, 2021, TRAFFIC INJ PREV, V22, P616, DOI 10.1080/15389588.2021.1957856; De Kegel D, 2018, J MECH BEHAV BIOMED, V79, P122, DOI 10.1016/j.jmbbm.2017.12.023; de Rooij R, 2016, APPL MECH REV, V68, DOI 10.1115/1.4032436; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Elliott MB, 2008, J NEUROSCI METH, V168, P320, DOI 10.1016/j.jneumeth.2007.10.019; Feng Y, 2017, J MECH BEHAV BIOMED, V65, P490, DOI 10.1016/j.jmbbm.2016.09.020; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Gehre C., 2009, 21 ESV C STUTTG, V1, P09; Ghazi K, 2021, J NEUROTRAUM, V38, P1023, DOI 10.1089/neu.2020.7281; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; Hajiaghamemar M, 2021, J NEUROTRAUM, V38, P144, DOI 10.1089/neu.2019.6791; Hajiaghamemar M, 2020, BIOMECH MODEL MECHAN, V19, P1109, DOI 10.1007/s10237-019-01273-8; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Holbourn AHS, 1943, LANCET, V2, P438; Horstemeyer MF, 2019, ANN BIOMED ENG, V47, P1829, DOI 10.1007/s10439-019-02351-9; Huang HM, 2000, MED BIOL ENG COMPUT, V38, P253, DOI 10.1007/BF02347044; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; Kinder HA, 2019, NEURAL REGEN RES, V14, P413, DOI 10.4103/1673-5374.245334; King A. I., 2003, IRCOBI C LISB PORT; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Laz PJ, 2010, P I MECH ENG H, V224, P927, DOI 10.1243/09544119JEIM739; Li Y, 2020, CLIN BIOMECH, V80, DOI 10.1016/j.clinbiomech.2020.105108; Li ZG, 2020, J BIOMECH, V98, DOI 10.1016/j.jbiomech.2019.109380; MacManus DB, 2017, ACTA BIOMATER, V57, P384, DOI 10.1016/j.actbio.2017.05.022; Macmanus DB., 2020, BRAIN MULTIPHYS, V1, P100018, DOI [10.1016/j.brain.2020.100018, DOI 10.1016/J.BRAIN.2020.100018]; MADSEN FF, 1987, ACTA NEUROCHIR, V88, P65, DOI 10.1007/BF01400517; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2011, INT J NUMER METH BIO, V27, P357, DOI 10.1002/cnm.1403; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Meissner A, 2011, EUR SURG RES, V47, P141, DOI 10.1159/000330756; Melvin J.W., 2015, BIOMECHANICS BRAIN I, P221, DOI [10.1007/978-1-4939-1732-7_9, DOI 10.1007/978-1-4939-1732-7_9]; Miller R.T., 1998, STAPP CAR CRASH C SA, DOI [10.4271/983154, DOI 10.4271/983154]; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Pal S, 2008, WEAR, V264, P701, DOI 10.1016/j.wear.2007.06.010; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Pierrat B, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00801; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Qian L, 2018, J MECH BEHAV BIOMED, V82, P210, DOI 10.1016/j.jmbbm.2018.03.031; Rashid B, 2012, J MECH BEHAV BIOMED, V14, P163, DOI 10.1016/j.jmbbm.2012.05.001; Ratnaike TE, 2011, BRIT J NEUROSURG, V25, P410, DOI 10.3109/02688697.2010.548879; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Schroder A, 2021, FRONT BIOENG BIOTECH, V9, DOI 10.3389/fbioe.2021.587082; Scott GG, 2016, BIOMECH MODEL MECHAN, V15, P1101, DOI 10.1007/s10237-015-0747-0; Shreiber D.I., 1997, STAPP CAR CRASH J, V41, P277; Sindelar B, 2017, J NEUROTRAUM, V34, P1703, DOI 10.1089/neu.2016.4648; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Strickland MA, 2010, COMPUT METHOD BIOMEC, V13, P701, DOI 10.1080/10255840903476463; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Trotta A, 2020, INT J MECH SCI, V173, DOI 10.1016/j.ijmecsci.2020.105448; Unnikrishnan G, 2019, ANN BIOMED ENG, V47, P2033, DOI 10.1007/s10439-019-02277-2; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Vanmol L, 2017, THESIS KU LEUVEN LEU; Viano D.C., 1999, J CRASH PREV INJ CON, V1, P35, DOI [10.1080/10286589908915739, DOI 10.1080/10286589908915739]; Walsh DR, 2021, J NEUROTRAUM, V38, P1748, DOI 10.1089/neu.2020.7288; Walsh DR, 2018, ACTA BIOMATER, V80, P237, DOI 10.1016/j.actbio.2018.09.004; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3; Wu SJ, 2020, BIOMECH MODEL MECHAN, V19, P927, DOI 10.1007/s10237-019-01261-y; Wu SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53551-1; Wu TT, 2021, J NEUROTRAUM, V38, P1879, DOI 10.1089/neu.2020.7445; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yates K, 2016, P 14 INT LS DYNA US, P1; Zhan XH, 2021, IEEE T BIO-MED ENG, V68, P3424, DOI 10.1109/TBME.2021.3073380; Zhao W, 2020, J BIOMECH, V104, DOI 10.1016/j.jbiomech.2020.109732; Zhao W, 2020, ANN BIOMED ENG, V48, P1661, DOI 10.1007/s10439-020-02496-y; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z; Zhu F, 2013, INT J NUMER METH BIO, V29, P392, DOI 10.1002/cnm.2518	100	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.	OCT 8	2021	9								714128	10.3389/fbioe.2021.714128			17	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	WM2RF	WOS:000710937200001	34692652	Green Published, gold			2022-02-06	
J	Neumann, R; Volker, J; Hajba, Z; Seiler, S				Neumann, Roland; Voelker, Juliane; Hajba, Zsuzsanna; Seiler, Sigrid			Lesions and reduced working memory impair emotion recognition in self and others	COGNITION & EMOTION			English	Article						Emotion recognition; working memory capacity; brain lesion	FACIAL AFFECT RECOGNITION; TRAUMATIC BRAIN-INJURY; DIFFERENTIATION; PERCEPTION; METAANALYSIS; RESILIENCE; EXPRESSION; DEPRESSION; ABILITIES; FATIGUE	Emotion recognition (ER) can be conceived of as an integration of affective cues in working memory. We examined whether reduced working memory capacity and brain lesions in neural networks involved in emotion processing interactively impair ER of both one's own and another person's emotions. To assess the recognition of one's own and other's emotions, pictures from the International Affective Picture System (IAPS) and facial expressions from the Karolinska Directed Emotional Faces (KDEF) database representing fear, anger, disgust, and sadness were presented to 40 lesioned patients and 40 healthy students. To manipulate working memory, a math task was imposed between exposure to the stimuli and collection of responses. Participants indicated the intensity of each of the four emotions for each picture. ER was computed as the difference between trials where the elicited emotion matched the requested emotion and trials where the elicited and requested emotions did not match. Whereas lesions impaired ER in both self and others, working memory load exclusively decreased recognition of other persons' emotions.	[Neumann, Roland; Voelker, Juliane; Hajba, Zsuzsanna] Univ Trier, Dept Psychol, Trier, Germany; [Seiler, Sigrid] Neuro Reha Team Pasing, Munich, Germany		Neumann, R (corresponding author), Univ Trier, Fachbereich Psychol 1, D-54286 Trier, Germany.	neumannr@uni-trier.de		Volker, Juliane/0000-0002-1630-7440			Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Baldo JV, 2007, NEUROPSYCHOLOGIA, V45, P229, DOI 10.1016/j.neuropsychologia.2006.07.014; Barke A, 2012, J BEHAV THER EXP PSY, V43, P565, DOI 10.1016/j.jbtep.2011.07.006; Barrett L., 2007, SOCIAL PSYCHOL UNCON, P173; Barrett LF, 2001, COGNITION EMOTION, V15, P713, DOI 10.1080/02699930143000239; Bless H, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P423; Braun M, 2005, BRAIN COGNITION, V58, P193, DOI 10.1016/j.bandc.2004.11.003; Chai WJ, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00401; Christophel TB, 2017, TRENDS COGN SCI, V21, P111, DOI 10.1016/j.tics.2016.12.007; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Dal Monte O, 2013, SOC COGN AFFECT NEUR, V8, P632, DOI 10.1093/scan/nss041; Demiralp E, 2012, PSYCHOL SCI, V23, P1410, DOI 10.1177/0956797612444903; Dixon ML, 2017, PSYCHOL BULL, V143, P1033, DOI 10.1037/bul0000096; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Erbas Y, 2016, SOC PSYCHOL PERS SCI, V7, P240, DOI 10.1177/1948550616633504; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Frank MG, 2001, J PERS SOC PSYCHOL, V80, P75, DOI 10.1037/0022-3514.80.1.75; Fydrich T., 2007, FRAGEBOGEN SOZIALEN; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Gordon R. A, 2010, REGRESSION ANAL SOCI; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Joormann J, 2008, J ABNORM PSYCHOL, V117, P182, DOI 10.1037/0021-843X.117.1.182; Kashdan TB, 2015, CURR DIR PSYCHOL SCI, V24, P10, DOI 10.1177/0963721414550708; Kashdan TB, 2010, PSYCHOL SCI, V21, P1341, DOI 10.1177/0956797610379863; Klein-Koerkamp Y, 2012, J ALZHEIMERS DIS, V32, P109, DOI 10.3233/JAD-2012-120553; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Kron A, 2010, J EXP PSYCHOL GEN, V139, P520, DOI 10.1037/a0020008; Lang PJ., 1997, INT AFFECTIVE PICTUR; Lundqvist D., 1998, KAROLINSKA DIRECTED, V91, P630, DOI DOI 10.1037/T27732-000; MAYER JD, 1994, J RES PERS, V28, P351, DOI 10.1006/jrpe.1994.1025; Mayer JD, 2008, ANNU REV PSYCHOL, V59, P507, DOI 10.1146/annurev.psych.59.103006.093646; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Mikels JA, 2005, BEHAV RES METHODS, V37, P626, DOI 10.3758/BF03192732; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Nock MK, 2008, BEHAV THER, V39, P107, DOI 10.1016/j.beth.2007.05.005; Phillips LH, 2008, EMOTION, V8, P184, DOI 10.1037/1528-3542.8.2.184; Pond RS, 2012, EMOTION, V12, P326, DOI 10.1037/a0025762; Quoidbach J, 2014, J EXP PSYCHOL GEN, V143, P2057, DOI 10.1037/a0038025; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Rosenberg H, 2015, NEUROPSYCHOLOGY, V29, P509, DOI 10.1037/neu0000171; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; Salovey P., 1990, IMAG COGN PERS, V9, P185, DOI DOI 10.2190/DUGG-P24E-52WK-6CDG; Salovey P., 1997, EMOTIONAL DEV EMOTIO; Salthouse T, 2012, ANNU REV PSYCHOL, V63, P201, DOI 10.1146/annurev-psych-120710-100328; Scheibe S, 2010, J GERONTOL B-PSYCHOL, V65, P135, DOI 10.1093/geronb/gbp132; Schirmer A, 2017, TRENDS COGN SCI, V21, P216, DOI 10.1016/j.tics.2017.01.001; Snaith, 2011, HADS D DTSCH ADAPTAT; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Tugade MM, 2004, J PERS, V72, P1161, DOI 10.1111/j.1467-6494.2004.00294.x; Wei CJ, 2016, J NEUROL, V263, P269, DOI 10.1007/s00415-015-7958-2; Winkielman, 2005, EMOTION CONSCIOUSNES, P287; Young A., 2002, FACIAL EXPRESSIONS E; Yuvaraj R, 2013, DEMENT GERIATR COGN, V36, P179, DOI 10.1159/000353440; Zeng EQ, 2016, BALK MED J, V33, P152, DOI 10.5152/balkanmedj.2016.15701	61	0	0	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9931	1464-0600		COGNITION EMOTION	Cogn. Emot.	NOV 17	2021	35	8					1527	1542		10.1080/02699931.2021.1983521		OCT 2021	16	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	XE5NU	WOS:000704997100001	34623214				2022-02-06	
J	Olson, L; Vaughn, MG				Olson, Lindamarie; Vaughn, Michael G.			Traumatic Brain Injury and Psychopathic Features Among Juvenile Offenders: Does it Matter Which Traits?	INTERNATIONAL JOURNAL OF OFFENDER THERAPY AND COMPARATIVE CRIMINOLOGY			English	Article; Early Access						psychopathic traits; juvenile offenders; traumatic brain injury (TBI); delinquency; adolescence	MORAL DISENGAGEMENT; ETHNIC-DIFFERENCES; PREVALENCE; BEHAVIOR; PERSONALITY; POPULATION; CHILDREN; YOUTH; RISK; HETEROGENEITY	Psychopathic traits and a history of traumatic brain injury (TBI) are common among imprisoned individuals. Although previous research has examined correlates of TBI among juvenile offenders, little research has explored the relationship between psychopathic traits and TBI among this population. Study objectives included: (1) examine the association between the history of a TBI and psychopathic traits among juvenile offenders and (2) determine if the history of a TBI predicts the manifestation of different psychopathic factors among juvenile offenders. Cross-sectional data from the Multidimensional Youth Residential Inventory consisted of 226 juvenile offenders. Bivariate and multivariate analyses were conducted. Results of linear regression analyses showed that history of a TBI significantly predicted callous unemotional and impulsive irresponsible traits. Clinical implications suggest early intervention is needed to treat the potential long-term effects of TBIs and the development of psychopathic traits. Recommendations for further research are discussed.	[Olson, Lindamarie] Univ Houston, 3511 Cullen Blvd, Houston, TX 77004 USA; [Vaughn, Michael G.] St Louis Univ, St Louis, MO 63103 USA		Olson, L (corresponding author), Univ Houston, 3511 Cullen Blvd, Houston, TX 77004 USA.	leolson@uh.edu		Olson, Lindamarie/0000-0002-6312-6829			Anderson NE, 2014, RESTOR NEUROL NEUROS, V32, P103, DOI 10.3233/RNN-139001; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Bandura A, 1996, J PERS SOC PSYCHOL, V71, P364, DOI 10.1037/0022-3514.71.2.364; Beaver KM, 2011, J CRIM JUST, V39, P426, DOI 10.1016/j.jcrimjus.2011.07.002; Bellesi G, 2019, BRAIN INJURY, V33, P1272, DOI 10.1080/02699052.2019.1641621; Bezdjian S, 2011, PSYCHOL MED, V41, P589, DOI 10.1017/S0033291710000966; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; Brinkley CA, 2004, CLIN PSYCHOL-SCI PR, V11, P69, DOI 10.1093/clipsy/bph054; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Cato MA, 2004, J INT NEUROPSYCH SOC, V10, P453, DOI 10.1017/S1355617704103123; Center for Disease Control and Prevention, 2020, TRAUMATIC BRAIN INJU; Cima M, 2017, INT J LAW PSYCHIAT, V54, P155, DOI 10.1016/j.ijlp.2017.06.011; Coid J, 2009, INT J LAW PSYCHIAT, V32, P134, DOI 10.1016/j.ijlp.2009.02.008; Damasio A., 1994, DESCARTES ERROR EMOT; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; DeLisi M, 2014, YOUTH VIOLENCE JUV J, V12, P295, DOI 10.1177/1541204013506919; Dhingra K, 2015, J CRIM PSYCHOL, V5, P13, DOI 10.1108/JCP-11-2014-0016; Dilley M., 2011, PSYCHIATRIC DISORDER, P301; Dolan MC, 2010, PERS INDIV DIFFER, V49, P995, DOI 10.1016/j.paid.2010.08.011; Durand E, 2016, BRAIN INJURY, V30, P363, DOI 10.3109/02699052.2015.1131848; Farina ASJ, 2018, INT J OFFENDER THER, V62, P4359, DOI 10.1177/0306624X18766491; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Fleminger S., 2010, PSYCHIAT TIMES, V27; Forth AE, 2000, LEA SER PER CLIN PSY, P25; Frazier Annabelle, 2019, Personal Neurosci, V2, pe8, DOI 10.1017/pen.2019.7; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Giedd JN, 2015, SCI AM, V312, P33, DOI 10.1038/scientificamerican0615-32; Gini G, 2015, MERRILL PALMER QUART, V61, P51; Hare RD, 1996, CRIM JUSTICE BEHAV, V23, P25, DOI 10.1177/0093854896023001004; Hare RD, 2008, ANNU REV CLIN PSYCHO, V4, P217, DOI 10.1146/annurev.clinpsy.3.022806.091452; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hughes N, 2015, J HEAD TRAUMA REHAB, V30, P94, DOI 10.1097/HTR.0000000000000124; Hux D, 1998, BRAIN INJURY, V12, P667; IBM Crop, 2019, IBM SPSS STAT MAC VE; Kanwal JS, 2016, ANATOMY PHYSL, V6, DOI DOI 10.4172/2161-0940.1000E135; Kiehl K.A., 2010, JURIMETRICS, V51, P355; Koenig S, 2020, J PSYCHOPATHOL BEHAV, V42, P627, DOI 10.1007/s10862-020-09808-5; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Larsson H, 2006, J ABNORM PSYCHOL, V115, P221, DOI 10.1037/0021-843X.115.2.221; Leenarts LEW, 2017, CHILD ADOL PSYCH MEN, V11, DOI 10.1186/s13034-017-0202-3; Manzanero S., 2017, J CONCUSSION, DOI [10.1177/2059700217726874, DOI 10.1177/2059700217726874]; Marshall J, 2017, PERS INDIV DIFFER, V113, P240, DOI 10.1016/j.paid.2017.03.034; Martins AT, 2012, JUDGM DECIS MAK, V7, P478; Maung HH, 2021, PHILOS PSYCHOL, V34, P502, DOI 10.1080/09515089.2021.1916453; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Meier MH, 2008, J ABNORM PSYCHOL, V117, P377, DOI 10.1037/0021-843X.117.2.377; Moffitt TE, 2005, PSYCHOL BULL, V131, P533, DOI 10.1037/0033-2909.131.4.533; Munivenkatappa A, 2014, NEUROREHABILITATION, V35, P481, DOI 10.3233/NRE-141140; Munoz CG, 2019, PSYCHIAT RES, V275, P189, DOI 10.1016/j.psychres.2019.03.031; National Scientific Council on the Developing Child, 2007, TIM QUAL EARL EXP CO; Ortega-Escobar J, 2017, ANU PSICOL JURID, V27, P57, DOI 10.1016/j.apj.2017.01.003; Orue I, 2019, J INTERPERS VIOLENCE, V34, P2313, DOI 10.1177/0886260516660302; Payne BR, 2001, NAT REV NEUROSCI, V2, P911, DOI 10.1038/35104085; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Petruccelli I, 2017, PSYCHIAT PSYCHOL LAW, V24, P670, DOI 10.1080/13218719.2017.1291291; Pihet S, 2014, CRIM JUSTICE BEHAV, V41, P1214, DOI 10.1177/0093854814540287; Raschle NM, 2018, NEUROIMAGE-CLIN, V17, P856, DOI 10.1016/j.nicl.2017.12.015; Ray B, 2017, CRIM JUSTICE BEHAV, V44, P472, DOI 10.1177/0093854816686631; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Ryan NP, 2015, J HEAD TRAUMA REHAB, V30, P75, DOI 10.1097/HTR.0000000000000123; Schoenberger NE, 2001, J HEAD TRAUMA REHAB, V16, P260, DOI 10.1097/00001199-200106000-00005; Schwartz JA, 2020, J EXP CRIMINOL, V16, P407, DOI 10.1007/s11292-020-09439-6; Schwartz JA, 2021, JUSTICE Q, V38, P196, DOI 10.1080/07418825.2019.1599044; Schwartz JA, 2018, J CRIM JUST, V56, P70, DOI 10.1016/j.jcrimjus.2017.08.004; Sharan T., 2016, THESIS; Sheridan, 2002, PSYCHOPATHS CURRENT, P131; Skeem JL, 2004, LAW HUMAN BEHAV, V28, P505, DOI 10.1023/B:LAHU.0000046431.93095.d8; Skeem JL, 2003, AGGRESS VIOLENT BEH, V8, P513, DOI 10.1016/S1359-1789(02)00098-8; Stickle TR, 2012, J ABNORM CHILD PSYCH, V40, P513, DOI 10.1007/s10802-011-9588-1; Sudarsanan B., 2005, MED J ARMED FORCES I, V62, P259; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Umbach R, 2015, J CRIM JUST, V43, P295, DOI 10.1016/j.jcrimjus.2015.04.003; Vaughn MG, 2019, PSYCHIAT QUART, V90, P151, DOI 10.1007/s11126-018-9617-0; Vaughn MG, 2014, CRIM BEHAV MENT HEAL, V24, P188, DOI 10.1002/cbm.1900; Veeh CA, 2018, PSYCHOL CRIME LAW, V24, P1016, DOI 10.1080/1068316X.2018.1497632; Waldman I.D., 2006, HDB PSYCHOPATHY, P205; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wood RL, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00195; Yildirim BO, 2015, AGGRESS VIOLENT BEH, V24, P9, DOI 10.1016/j.avb.2015.05.001; Zuckerman M, 2003, PERS INDIV DIFFER, V35, P1463, DOI 10.1016/S0191-8869(02)00362-8	86	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0306-624X	1552-6933		INT J OFFENDER THER	Int. J. Offender Ther. Comp. Criminol.											0306624X211049200	10.1177/0306624X211049200		OCT 2021	23	Criminology & Penology; Psychology, Applied	Social Science Citation Index (SSCI)	Criminology & Penology; Psychology	WF1LI	WOS:000706074400001	34622698				2022-02-06	
J	Ransom, DM; Caldwell, CT; DiVirgilio, EK; McNally, KA; Peterson, RL; Ploetz, DM; Sady, MD; Slomine, BS				Ransom, Danielle M.; Caldwell, Carolyn T.; DiVirgilio, Emily K.; McNally, Kelly A.; Peterson, Robin L.; Ploetz, Danielle M.; Sady, Maegan D.; Slomine, Beth S.			Pediatric mTBI during the COVID-19 pandemic: considerations for evaluation and management	CHILD NEUROPSYCHOLOGY			English	Article; Early Access						Concussion; traumatic brain injury; COVID-19; telemedicine; healthcare utilization; pediatrics	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; CONCUSSION; CHILDREN; SYMPTOMS; EPIDEMIOLOGY; TELEMEDICINE; SPORTS; INTERVENTION; TRAJECTORIES	The COVID-19 pandemic has changed healthcare utilization patterns and clinical practice, including pediatric mTBI evaluation and management. Providers treating pediatric mTBI, including neuropsychologists, have a unique role in evaluating and managing an already complex injury in the context of the COVID-19 pandemic with limited empirically based guidelines. In the present paper, we review usual, evidence-based pediatric mTBI care, highlight changes experienced by healthcare providers since the onset of the pandemic, and provide possible considerations and solutions. Three primary challenges to usual care are discussed, including changes to post-injury evaluation, management, and treatment of persistent symptoms. Changing patterns of healthcare utilization have created unique differences in mTBI identification and evaluation, including shifting injury frequency and mechanism, reluctance to seek healthcare, and increasing access to telemedicine. Typical injury management has been compromised by limited access to usual systems/activities (i.e., school, sports, social/leisure activities). Patients may be at higher risk for prolonged recovery due to pre-injury baseline elevations in acute and chronic stressors and reduced access to rehabilitative services targeting persistent symptoms. Considerations and solutions for addressing each of the three challenges are discussed. Neuropsychologists and other pediatric healthcare providers will need to continue to flexibly adapt to the changing needs of youth recovering from mTBI through the duration of the pandemic and beyond. Consistent with pre-pandemic consensus statements, neuropsychologists remain uniquely qualified to evaluate and manage mTBI and provide an increasingly integral role as members of multidisciplinary teams in the context of the global pandemic.	[Ransom, Danielle M.] Johns Hopkins All Childrens Hosp, Ctr Behav Hlth, St Petersburg, FL USA; [Ransom, Danielle M.; Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Ctr Behav Hlth, Baltimore, MD USA; [Caldwell, Carolyn T.; Ploetz, Danielle M.; Slomine, Beth S.] Kennedy Krieger Inst, Ctr Behav Hlth, Baltimore, MD USA; [DiVirgilio, Emily K.; McNally, Kelly A.] Nationwide Childrens Hosp, Ctr Behav Hlth, Columbus, OH USA; [McNally, Kelly A.] Ohio State Univ, Ctr Behav Hlth, Columbus, OH 43210 USA; [Peterson, Robin L.] Childrens Hosp Colorado, Ctr Behav Hlth, Aurora, CO USA; [Peterson, Robin L.] Univ Colorado, Sch Med, Ctr Behav Hlth, Aurora, CO USA; [Sady, Maegan D.] Psychol Assessment Resources Inc, Ctr Behav Hlth, Lutz, FL USA		Ransom, DM (corresponding author), Johns Hopkins All Childrens Hosp, Child Dev & Rehabil Ctr, 880 6th St South,Suite 460, St Petersburg, FL 33704 USA.	DRansom7@jhmi.edu		Ransom, Danielle/0000-0002-5744-9760			[Anonymous], 2019, HEADS UP YOUTH SPORT; Antoon JW, 2021, J HOSP MED, V16, P294, DOI 10.12788/jhm.3608; Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bates LC, 2020, CHILDREN-BASEL, V7, DOI 10.3390/children7090138; Bram JT, 2020, J PEDIATR ORTHOPED, V40, P373, DOI 10.1097/BPO.0000000000001600; Buonsenso D, 2021, ACTA PAEDIATR, V110, P2208, DOI 10.1111/apa.15870; Butryn T, 2017, INT J ACAD MED, V3, P5, DOI 10.4103/IJAM.IJAM_49_17; Cantor JH, 2021, AM J PREV MED, V61, P434, DOI 10.1016/j.amepre.2021.01.030; Chen YX, 2021, AM J PHYS MED REHAB, V100, P321, DOI 10.1097/PHM.0000000000001698; Chrisman SPD, 2021, FRONT PEDIATR, V9, DOI 10.3389/fped.2021.645814; Committee IOP, NEUR TOOLK TEL NEUR; Connery AK, 2016, PHYS MED REH CLIN N, V27, P475, DOI 10.1016/j.pmr.2015.12.001; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; de Miranda DM, 2020, INT J DISAST RISK RE, V51, DOI 10.1016/j.ijdrr.2020.101845; DeLaroche AM, 2021, PEDIATRICS, V147, DOI 10.1542/peds.2020-039628; Dopfer C, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02303-6; Elbin R J, 2021, J Head Trauma Rehabil, DOI 10.1097/HTR.0000000000000707; Engzell P, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022376118; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Harder L, 2020, ARCH CLIN NEUROPSYCH, V35, P1266, DOI 10.1093/arclin/acaa070; Harvey D, 2014, AM J DISTANCE EDUC, V28, P14, DOI 10.1080/08923647.2014.868739; Hatcher-Martin JM, 2020, NEUROLOGY, V94, P30, DOI 10.1212/WNL.0000000000008708; Hewitt KC, 2020, CLIN NEUROPSYCHOL, V34, P1335, DOI 10.1080/13854046.2020.1811891; Hill RM, 2021, PEDIATRICS, V147, DOI 10.1542/peds.2020-029280; Hjelm NM, 2005, J TELEMED TELECARE, V11, P60, DOI 10.1258/1357633053499886; Jones EAK, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052470; Kadambari S, 2020, PEDIATR INFECT DIS J, V39, pE385, DOI 10.1097/INF.0000000000002870; Karvounides D, 2021, HEADACHE, V61, P190, DOI 10.1111/head.14038; Kita H, 2020, BRAIN INJURY, V34, P784, DOI 10.1080/02699052.2020.1753243; Korioth T., 2020, SURVEY PEDIAT REELIN; Koterba CH, 2020, CLIN NEUROPSYCHOL, V34, P1380, DOI 10.1080/13854046.2020.1811892; Kutcher JS, 2013, BRIT J SPORT MED, V47, P299, DOI 10.1136/bjsports-2013-092257; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lazzerini M, 2020, LANCET CHILD ADOLESC, V4, pE10, DOI 10.1016/S2352-4642(20)30108-5; Liguoro I, 2021, EUR J PEDIATR, V180, P1497, DOI 10.1007/s00431-020-03909-9; Loman M, 2021, CHILD NEUROPSYCHOL, V27, P251, DOI 10.1080/09297049.2020.1830962; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lynn RM, 2021, ARCH DIS CHILD, V106, DOI 10.1136/archdischild-2020-319848; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; May KH, 2014, INT J SPORTS PHYS TH, V9, P242; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2021, J ATHL TRAINING, V56, P11, DOI 10.4085/1062-6050-0478.20; McNally KA, 2018, CHILD NEUROPSYCHOL, V24, P396, DOI 10.1080/09297049.2017.1280143; Moore SA, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-00987-8; Parachute, 2017, CAN GUID CONC SPORT; Pelletier JH, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.37227; Peterson RK, 2021, CLIN NEUROPSYCHOL, V35, P99, DOI 10.1080/13854046.2020.1799075; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Pritchard AE, 2020, CLIN NEUROPSYCHOL, V34, P1367, DOI 10.1080/13854046.2020.1806359; Ransom DM, 2020, ARCH CLIN NEUROPSYCH, V35, P1204, DOI 10.1093/arclin/acaa103; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Risen SR, 2017, PM&R, V9, P874, DOI 10.1016/j.pmrj.2016.12.005; Sacks V., 2020, NONPROFIT ORG PARTNE; Sady MD, 2019, J HEAD TRAUMA REHAB, V34, pE35, DOI 10.1097/HTR.0000000000000424; Santing JAL, 2020, NEUROTRAUMA REP, V1, P5, DOI 10.1089/neur.2020.0001; Sarmiento K, 2020, CLIN NEUROPSYCHOL, V34, P259, DOI 10.1080/13854046.2019.1660806; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Sarmiento K, 2018, BRAIN INJURY, V32, P889, DOI 10.1080/02699052.2018.1466197; Shah Aashaka C, 2021, JMIR Pediatr Parent, V4, pe22696, DOI 10.2196/22696; Shepherd HA, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18073515; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Simpson TS, 2021, J HEAD TRAUMA REHAB, V36, pE79, DOI 10.1097/HTR.0000000000000592; Snyder AR, 2019, SEMIN PEDIATR NEUROL, V30, P128, DOI 10.1016/j.spen.2019.03.018; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Svingos A., 2021, 49 ANN M INT NEUR SO; Taddei M, 2020, RES DEV DISABIL, V107, DOI 10.1016/j.ridd.2020.103786; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Tomfohr-Madsen L, 2020, J HEAD TRAUMA REHAB, V35, pE103, DOI 10.1097/HTR.0000000000000504; Toresdahl BG, 2021, HSS J, V17, P18, DOI 10.1177/1556331620975856; Truss K, 2017, J NEUROTRAUM, V34, P2272, DOI 10.1089/neu.2016.4842; Vargas BB, 2017, NEUROLOGY, V88, P1580, DOI 10.1212/WNL.0000000000003841; Wosik J, 2020, J AM MED INFORM ASSN, V27, P957, DOI 10.1093/jamia/ocaa067; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	83	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.												10.1080/09297049.2021.1985101		OCT 2021	19	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WC4TV	WOS:000704252100001	34615434				2022-02-06	
J	Yang, M; Wu, ZY; Yu, H; Cheng, J				Yang, Min; Wu, Zhangyi; Yu, Hai; Cheng, Jun			Reconstruction for diverse fronto-orbital defects with computer-assisted designed and computer-assisted manufactured PEEK implants in one-stage operation Case reports	MEDICINE			English	Article						computer-assisted designed and computer-assisted manufactured; fronto-orbital defect; one-stage operation; polyetheretherketone implant; reconstruction	PATIENT-SPECIFIC IMPLANTS; POLYETHERETHERKETONE; CRANIOPLASTY	Rational: Reconstruction of complex craniofacial defects in fronto-orbital region has been reported to be extremely few. In this study, we report 2 cases with fronto-orbital defects of different etiologies in one-stage surgical reconstruction with polyetheretherketone (PEEK) prosthesis using computer-assisted design and computer-assisted manufactured (CAD-CAM) techniques. Patient concerns: One patient was a 49-year-old man, who admitted with a depressed and comminuted fracture in the left fronto-orbital region as a result of a motor vehicle collision. The other patient was a 45-year-old woman who was hospitalized with an unexpected diagnosis of a fronto-orbital bone tumor during a head CT examination in a minor traumatic brain injury. None of them had a significant past medical history. Diagnoses: The first patient's head computed tomography (CT) showed multiple depressed comminuted fractures in the right fronto-orbital region with localized frontal lobe contusion, and the diagnosis was clear when combined with the mechanism of traumatic head injuries. The second patient's head CT and magnetic resonance image suggested a right lateral orbital neoplastic lesion that distorted peripheral bone, the postoperative pathological examination demonstrated an osteoma with fibromatous hyperplasia, and thus the women's diagnosis was confirmed. Interventions: A three-dimensional image of both patients' skull bone were collected from a high-resolution CT. A virtual surgical planning for lesion excision and defect remodeling based on CAD-CAM techniques was undertaken, and than the reconstruction surgery was performed in a single procedure using PEEK prosthesis. Antibacterial treatment was prescribed routinely. Outcomes: Postoperatively, both patients achieved excellent aesthetic restoration as well as functional recovery of the orbital cavity without neurological or infectious complications during an average 22 months follow-up. Lessons: The CAD-CAM PEEK implants could be a preferred option for reconstruction of patients with various complex fronto-orbital defects.	[Yang, Min] Tongde Hosp Zhejiang Prov, Dept Ophthalmol, Hangzhou, Peoples R China; [Yu, Hai; Cheng, Jun] Hangzhou Normal Univ, Affiliated Hosp, Dept Neurosurg, 126 Wenzhou Rd, Hangzhou, Zhejiang, Peoples R China; [Wu, Zhangyi] Tongde Hosp Zhejiang Prov, Dept Neurosurg, Hangzhou, Peoples R China		Yu, H (corresponding author), Hangzhou Normal Univ, Affiliated Hosp, Dept Neurosurg, 126 Wenzhou Rd, Hangzhou, Zhejiang, Peoples R China.	yuhaineurosg@126.com					Baumann A, 2015, J ORAL MAXIL SURG, V73, pS101, DOI 10.1016/j.joms.2015.06.149; Brandicourt P, 2017, WORLD NEUROSURG, V105, P783, DOI 10.1016/j.wneu.2017.04.049; Chen SH, 2018, ANN PLAS SURG, V81, pS10, DOI 10.1097/SAP.0000000000001606; Chepurnyi Yurii, 2020, J Oral Biol Craniofac Res, V10, P49, DOI 10.1016/j.jobcr.2020.01.006; Dubois L, 2015, J CRANIO MAXILL SURG, V43, P2034, DOI 10.1016/j.jcms.2015.07.019; Feroze AH, 2015, J NEUROSURG, V123, P1098, DOI 10.3171/2014.11.JNS14622; Frodel JL, 2008, FACIAL PLAST SURG, V24, P22, DOI [10.1055/s-2007-1021459, 10.1016/j.fsc.2007.11.013]; Gerbino G, 2013, J ORAL MAXIL SURG, V71, P1969, DOI 10.1016/j.joms.2013.03.021; Kunz C, 2014, CRANIOMAX TRAUM REC, V7, pS92, DOI 10.1055/s-0034-1389562; Masters M, 2015, J ANAT, V227, P460, DOI 10.1111/joa.12364; Patel N, 2017, J CRANIOFAC SURG, V28, P387, DOI 10.1097/SCS.0000000000003313; Scolozzi P, 2007, J CRANIOFAC SURG, V18, P224, DOI 10.1097/01.scs.0000249359.56417.7e; Spetzger U, 2010, MINIM INVASIV THER, V19, P110, DOI 10.3109/13645701003644087; Thien A, 2015, WORLD NEUROSURG, V83, P176, DOI 10.1016/j.wneu.2014.06.003; Wolff A, 2018, J CRANIOFAC SURG, V29, P887, DOI 10.1097/SCS.0000000000004385	15	0	0	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	OCT 8	2021	100	40							e27452	10.1097/MD.0000000000027452			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WC2CZ	WOS:000704071200001	34622866	Green Published, gold			2022-02-06	
J	Yoon, JE; Cho, OH				Yoon, Jeong Eun; Cho, Ok-Hee			Risk Factors Associated With Pressure Ulcers in Patients With Traumatic Brain Injury Admitted to the Intensive Care Unit	CLINICAL NURSING RESEARCH			English	Article; Early Access						pressure injury; traumatic brain injury; intensive care units; risk factors		Pressure injuries (PIs) are one of the most important and frequent complications in patients admitted to the intensive care unit (ICU) or those with traumatic brain injury (TBI). The purpose of this study was to determine the incidence and risk factors of PIs in patients with TBI admitted to the ICU. In this retrospective study, the medical records of 237 patients with TBI admitted to the trauma ICU of a university hospital were examined. Demographic, trauma-related, and treatment-related characteristics of all the patients were evaluated from their records. The incidence of PIs was 13.9%, while the main risk factors were a higher injury severity score, use of mechanical ventilation, vasopressor infusion, lower Braden Scale score, fever, and period of enteral feeding. This study advances the nursing practice in the ICU by predicting the development of PIs and their characteristics in patients with TBI.	[Yoon, Jeong Eun] Chungbuk Natl Univ Hosp, Cheongju, South Korea; [Cho, Ok-Hee] Kongju Natl Univ, Gongju, South Korea		Cho, OH (corresponding author), Kongju Natl Univ, Dept Nursing, Coll Nursing & Hlth, 56 Gongjuhaehak Ro, Gongju Si 314701, Chungcheongnam, South Korea.	ohcho@kongju.ac.kr		CHO, OK-HEE/0000-0002-8882-675X			Abdelmalik PA, 2019, TRANSFUSION, V59, P1529, DOI 10.1111/trf.15171; Alderden J, 2017, INT J NURS STUD, V71, P97, DOI 10.1016/j.ijnurstu.2017.03.012; Alshahrani B, 2021, J CLIN NURS, V30, P2151, DOI 10.1111/jocn.15709; Apostolopoulou E, 2014, HLTH SCI J, V8, P333, DOI DOI 10.7475/KJAN.2015.27.3.347; Becker D, 2017, INTENS CRIT CARE NUR, V42, P55, DOI 10.1016/j.iccn.2017.03.009; Bolorunduro OB, 2011, J SURG RES, V166, P40, DOI 10.1016/j.jss.2010.04.012; Brenner EK, 2020, BRAIN INJURY, V34, P801, DOI 10.1080/02699052.2020.1741033; Cox J, 2017, OSTOMY WOUND MANAG, V63, P30; Cox J, 2015, AM J CRIT CARE, V24, P501, DOI 10.4037/ajcc2015123; de Aguiar Junior Wagner, 2016, J Trauma Nurs, V23, P275, DOI 10.1097/JTN.0000000000000233; Medeiros ABD, 2018, INTENS CRIT CARE NUR, V45, P6, DOI 10.1016/j.iccn.2017.09.007; Dhandapani M, 2014, J CLIN NURS, V23, P1114, DOI 10.1111/jocn.12396; Gorecki C, 2012, J TISSUE VIABILITY, V21, P3, DOI 10.1016/j.jtv.2011.11.001; Haesler E, 2019, PREVENTION TREATMENT; Gonzalez-Mendez MI, 2018, J CLIN NURS, V27, P1028, DOI 10.1111/jocn.14091; Jackson D, 2017, J ADV NURS, V73, P3061, DOI 10.1111/jan.13370; Jonsdottir GM, 2017, ACTA ANAESTH SCAND, V61, P408, DOI 10.1111/aas.12869; Jung Y.J., 2015, J ACUTE CARE SURG, V5, P19, DOI [10.17479/jacs.2015.5.1.19, DOI 10.17479/JACS.2015.5.1.19]; 곽혜란, 2015, [Korean Journal of Adult Nursing, 성인간호학회지], V27, P347, DOI 10.7475/kjan.2014.27.3.347; Nguyen KH, 2015, AUST HEALTH REV, V39, P329, DOI 10.1071/AH14088; Kumar RG, 2020, J HEAD TRAUMA REHAB, V35, pE372, DOI 10.1097/HTR.0000000000000572; Lee S.H., 2020, PUBL HLTH WEEKL REP, V13, P674; Ngubane T, 2011, SOUTH AFR J ANAESTH, V17, P76, DOI 10.1080/22201173.2011.10872737; Nogueira LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112125; Nonnemacher M, 2009, J CLIN NURS, V18, P99, DOI 10.1111/j.1365-2702.2008.02425.x; Odgaard L, 2018, J NEUROSCI NURS, V50, P149, DOI 10.1097/JNN.0000000000000365; Osis SL, 2020, INT J NURS PRACT, V26, DOI 10.1111/ijn.12821; Saghaleini SH, 2018, INDIAN J CRIT CARE M, V22, P283, DOI 10.4103/ijccm.IJCCM_277_17; Zampolini M, 2012, BRAIN INJURY, V26, P27, DOI 10.3109/02699052.2011.635358; Zarei E, 2019, J TISSUE VIABILITY, V28, P70, DOI 10.1016/j.jtv.2019.02.001	30	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1054-7738	1552-3799		CLIN NURS RES	Clin. Nurs. Res.											10547738211050489	10.1177/10547738211050489		OCT 2021	8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	WF3DF	WOS:000706188600001	34622689				2022-02-06	
J	Feichtinger, M; Koch, J				Feichtinger, Michael; Koch, Johannes			Acute symptomatic seizures and posttraumatic epilepsy after traumatic brain injury in adults and children	ZEITSCHRIFT FUR EPILEPTOLOGIE			German	Article						Posttraumatic seizures; Posttraumatic epilepsy; Symptomatic seizures; Epileptogenesis; Traetment of posttraumatic seizures	EPIDEMIOLOGY; PREVENTION; PHENYTOIN; RISK; LEVETIRACETAM; GUIDELINES; MANAGEMENT	Epileptic seizures after traumatic brain injury can be divided into early seizures (within 1 week after trauma) and late posttraumatic seizures (after 1 week). Immediate seizures are a subgroup of early posttraumatic seizures that occur within 24 h after the injury. The term "posttraumatic epilepsy" is used when 2 or more epileptic events are clearly associated with a cerebral trauma. Most posttraumatic seizures start within 2 years after the trauma. The severity of the head injury is related with a higher risk of early and late seizures. In general, the prophylactic use of anticonvulsant drugs is not recommended. It may be effective in reducing the frequency of early posttraumatic seizures but is not proven to influence the development of late seizures or posttraumatic epilepsy.	[Feichtinger, Michael] LKH Hochsteiermark, Abt Neurol, Bruck An Der Mur, Austria; [Koch, Johannes] Paracelsus Med Privatuniv, Univ Klin Kinder & Jugendheilkunde, Mullner Hauptstr 48, A-5020 Salzburg, Austria		Koch, J (corresponding author), Paracelsus Med Privatuniv, Univ Klin Kinder & Jugendheilkunde, Mullner Hauptstr 48, A-5020 Salzburg, Austria.	j.koch@salk.at			Paracelsus Medical University	Open access funding provided by Paracelsus Medical University.	ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Appleton RE, 2002, J NEUROL NEUROSUR PS, V72, P669, DOI 10.1136/jnnp.72.5.669; Arndt DH, 2016, J CHILD NEUROL, V31, P46, DOI 10.1177/0883073814562249; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CAVENESS WF, 1962, J NEUROSURG, V19, P122, DOI 10.3171/jns.1962.19.2.0122; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Debenham S, 2011, CAN J NEUROL SCI, V38, P896, DOI 10.1017/S031716710001249X; DeGrauw X, 2018, EPILEPSY RES, V146, P41, DOI 10.1016/j.eplepsyres.2018.07.012; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; Diamond ML, 2015, EPILEPSIA, V56, P991, DOI 10.1111/epi.13100; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Glotzner FL., 1983, NEUROCHIRURGICA, V26, P666; Granner Mark A., 1996, P227; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hudome S, 1997, PEDIATR RES, V41, P607, DOI 10.1203/00006450-199705000-00002; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Jennet, 1975, EPILEPSY BLUNT HEAD; JENNETT B, 1975, J NEUROL NEUROSUR PS, V38, P378, DOI 10.1136/jnnp.38.4.378; JENNETT B, 1974, ARCH NEUROL-CHICAGO, V30, P394, DOI 10.1001/archneur.1974.00490350052008; Khoshyomn Sami, 2004, Semin Pediatr Surg, V13, P80, DOI 10.1053/j.sempedsurg.2004.01.003; Klein P, 2012, ARCH NEUROL-CHICAGO, V69, P1290, DOI 10.1001/archneurol.2012.445; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; Li HF, 2011, NEUROSCI LETT, V497, P172, DOI 10.1016/j.neulet.2011.02.042; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Salazar Andres M, 2015, Handb Clin Neurol, V128, P525, DOI 10.1016/B978-0-444-63521-1.00033-9; Samland H, 2003, J NEUROSCI RES, V73, P176, DOI 10.1002/jnr.10635; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Temkin N R, 1995, New Horiz, V3, P518; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; WILLMORE LJ, 1978, ANN NEUROL, V4, P329, DOI 10.1002/ana.410040408; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244	43	0	0	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-6782	1610-0646		Z EPILEPTOL	Z. Epileptol.	NOV	2021	34	4			SI		360	364		10.1007/s10309-021-00448-7		OCT 2021	5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WO1LP	WOS:000705809700002		hybrid			2022-02-06	
J	Jochems, D; van Rein, E; Niemeijer, M; van Heijl, M; van Es, MA; Nijboer, T; Leenen, LPH; Houwert, RM; van Wessem, KJP				Jochems, Denise; van Rein, Eveline; Niemeijer, Menco; van Heijl, Mark; van Es, Michael A.; Nijboer, Tanja; Leenen, Luke P. H.; Houwert, R. Marijn; van Wessem, Karlijn J. P.			Incidence, causes and consequences of moderate and severe traumatic brain injury as determined by Abbreviated Injury Score in the Netherlands	SCIENTIFIC REPORTS			English	Article							EMERGENCY-DEPARTMENT VISITS; GLASGOW COMA SCALE; EPIDEMIOLOGY; PATTERNS; OUTCOMES; TRENDS; CARE	Traumatic brain injury (TBI) is a leading cause of death and disability. Epidemiology seems to be changing. TBIs are increasingly caused by falls amongst elderly, whilst we see less polytrauma due to road traffic accidents (RTA). Data on epidemiology is essential to target prevention strategies. A nationwide retrospective cohort study was conducted. The Dutch National Trauma Database was used to identify all patients over 17 years old who were admitted to a hospital with moderate and severe TBI (AIS >= 3) in the Netherlands from January 2015 until December 2017. Subgroup analyses were done for the elderly and polytrauma patients. 12,295 patients were included in this study. The incidence of moderate and severe TBI was 30/100.000 person-years, 13% of whom died. Median age was 65 years and falls were the most common trauma mechanism, followed by RTAs. Amongst elderly, RTAs consisted mostly of bicycle accidents. Mortality rates were higher for elderly (18%) and polytrauma patients (24%). In this national database more elderly patients who most often sustained the injury due to a fall or an RTA were seen. Bicycle accidents were very frequent, suggesting prevention could be an important aspect in order to decrease morbidity and mortality.	[Jochems, Denise; van Rein, Eveline; Niemeijer, Menco; van Heijl, Mark; Leenen, Luke P. H.; Houwert, R. Marijn; van Wessem, Karlijn J. P.] Univ Med Ctr Utrecht, Dept Surg, POB 85500, NL-3508 GA Utrecht, Netherlands; [van Es, Michael A.] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands; [van Es, Michael A.; Nijboer, Tanja] Hoogstr Rehabil, Utrecht, Netherlands; [Nijboer, Tanja] Univ Utrecht, Helmholtz Inst, Dept Expt Psychol, Utrecht, Netherlands; [Nijboer, Tanja] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, UMC Utrecht Brain Ctr, Utrecht, Netherlands		Jochems, D (corresponding author), Univ Med Ctr Utrecht, Dept Surg, POB 85500, NL-3508 GA Utrecht, Netherlands.	d.jochems-3@umcutrecht.nl			 [WAG/mb/18/011787]	We are grateful for the collaboration of The Dutch National Trauma Database, especially A. Mariette Lenselink and Leontien Sturms. The Medical Ethical Review Board of the University Medical Center Utrecht approved this study and granted a waiver of consent (WAG/mb/18/011787).	Centraal bureau voor statistiek (CBS), 2020, BEV GESL LEEFT BURG; Centraal bureau voor statistiek (CBS), 2016, OV DOD DOOR VERK NED, P1; Di Saverio S, 2014, LANGENBECK ARCH SURG, V399, P109, DOI 10.1007/s00423-013-1143-9; Dodds N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027845; Gennarelli TA., 2008, ABBREVIATED INJURY S; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gunning AC, 2015, WORLD J SURG, V39, P2677, DOI 10.1007/s00268-015-3162-x; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Jochems D, 2018, INJURY, V49, P1661, DOI 10.1016/j.injury.2018.05.012; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Jonsdottir GM, 2017, ACTA ANAESTH SCAND, V61, P408, DOI 10.1111/aas.12869; Kuipers E.J., 2018, LANDELIJKE TRAUMAREG; Lystad RP, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000445; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maegele M, 2019, DTSCH ARZTEBL INT, V116, P167, DOI 10.3238/arztebl.2019.0167; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Nederlandse Kanker Registratie, INC LONGK; Olthof D C, 2013, BMJ Qual Saf, V22, P752, DOI 10.1136/bmjqs-2013-001888; Peek J, 2020, EUR J TRAUMA EMERG S, DOI 10.1007/s00068-020-01412-2; Peeters W, 2017, NEUROEPIDEMIOLOGY, V48, P63, DOI 10.1159/000471877; Poos HPAM., 2017, NED TIJDSCHR GENEES, V161; Raj R, 2015, INJURY, V46, P86, DOI 10.1016/j.injury.2014.08.026; Rogers S, 2017, J NURSING ED PRACTIC, V7, P23, DOI [10.5430/jnep. v7n11p23, DOI 10.5430/JNEP.V7N11P23]; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rozenfeld M, 2020, BRAIN INJURY, V34, P515, DOI 10.1080/02699052.2020.1725838; Salottolo K, 2017, J CRIT CARE, V38, P197, DOI 10.1016/j.jcrc.2016.11.034; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Schumacher R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0801-7; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Van Camp L A, 1998, Eur J Emerg Med, V5, P341; Van den Brand CL, 2018, EUR J EMERG MED, V25, P355, DOI 10.1097/MEJ.0000000000000457; van Erp WS, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2014.10.014; van Rein EAJ, 2019, EUR J NEUROL, V26, P274, DOI 10.1111/ene.13804	36	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	OCT 7	2021	11	1							19985	10.1038/s41598-021-99484-6			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WF5XG	WOS:000706376200005	34620973	gold, Green Published			2022-02-06	
J	Palepu, AK; Murali, A; Ballard, JL; Li, R; Ramesh, S; Nguyen, H; Kim, H; Sarma, S; Suarez, JI; Stevens, RD				Palepu, Anil K.; Murali, Aditya; Ballard, Jenna L.; Li, Robert; Ramesh, Samiksha; Nguyen, Hieu; Kim, Hanbiehn; Sarma, Sridevi; Suarez, Jose I.; Stevens, Robert D.			Digital signatures for early traumatic brain injury outcome prediction in the intensive care unit	SCIENTIFIC REPORTS			English	Article							MODELS	Traumatic brain injury (TBI) is a leading neurological cause of death and disability across the world. Early characterization of TBI severity could provide a window for therapeutic intervention and contribute to improved outcome. We hypothesized that granular electronic health record data available in the first 24 h following admission to the intensive care unit (ICU) can be used to differentiate outcomes at discharge. Working from two ICU datasets we focused on patients with a primary admission diagnosis of TBI whose length of stay in ICU was >= 24 h (N = 1689 and 127). Features derived from clinical, laboratory, medication, and physiological time series data in the first 24 h after ICU admission were used to train elastic-net regularized Generalized Linear Models for the prediction of mortality and neurological function at ICU discharge. Model discrimination, determined by area under the receiver operating characteristic curve (AUC) analysis, was 0.903 and 0.874 for mortality and neurological function, respectively. Model performance was successfully validated in an external dataset (AUC 0.958 and 0.878 for mortality and neurological function, respectively). These results demonstrate that computational analysis of data routinely collected in the first 24 h after admission accurately and reliably predict discharge outcomes in ICU stratum TBI patients.	[Palepu, Anil K.; Murali, Aditya; Ballard, Jenna L.; Li, Robert; Ramesh, Samiksha; Nguyen, Hieu; Kim, Hanbiehn; Sarma, Sridevi] Johns Hopkins Univ, Dept Biomed Engn, Whiting Sch Engn, Baltimore, MD USA; [Nguyen, Hieu; Kim, Hanbiehn; Suarez, Jose I.; Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Suarez, Jose I.; Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Suarez, Jose I.; Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Suarez, Jose I.; Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Div Neurosci Crit Care, 600 N Wolfe St,Phipps Suite 455, Baltimore, MD 21287 USA		Stevens, RD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.; Stevens, RD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Stevens, RD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.; Stevens, RD (corresponding author), Johns Hopkins Univ, Sch Med, Div Neurosci Crit Care, 600 N Wolfe St,Phipps Suite 455, Baltimore, MD 21287 USA.	rstevens@jhmi.edu		Nguyen, Hieu/0000-0002-8143-872X			Dijkland SA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6401; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pollard TJ, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.178; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Rubin ML, 2019, J NEUROTRAUM, V36, P2417, DOI 10.1089/neu.2018.6217; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; TEASDALE G, 1974, LANCET, V2, P81; Zadrozny B., 2002, KDD, P694	16	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	OCT 7	2021	11	1							19989	10.1038/s41598-021-99397-4			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WF5XG	WOS:000706376200056	34620915	Green Published, gold			2022-02-06	
J	Dormann, R; Groppel, G; Von Oertzen, TJ				Dormann, Rainer; Groeppel, Gudrun; Von Oertzen, Tim J.			Acute symptomatic epileptic seizures due to internal diseases and noxious agents	ZEITSCHRIFT FUR EPILEPTOLOGIE			German	Article						Intoxication; Electrolyte imbalance; Liver disease; Diabetes mellitus; Medication	DRUG-INDUCED SEIZURES; NEUROLOGICAL COMPLICATIONS; DIABETES-MELLITUS; RISK; HYPOGLYCEMIA; ALCOHOL; HYPONATREMIA; CHILDREN; EVENTS; PEOPLE	Acute symptomatic seizures are defined by a close temporal relationship between an acute event that has a negative impact on the brain and the subsequent occurrence of epileptic seizures. Acute symptomatic seizures may occur as a result of structural brain damage (e.g. traumatic brain injury, stroke) but also in the context of internal diseases or due to the influence of external noxious substances (e.g.. medications, alcohol, illicit drugs). This article describes the most frequent internal causes that can lead to acute symptomatic seizures. The risk of electrolyte imbalances, liver and kidney diseases, intestinal diseases, diabetes mellitus and the influence of various medications are discussed.	[Dormann, Rainer; Groeppel, Gudrun; Von Oertzen, Tim J.] Kepler Univ Klinikum, Klin Neurol 1&2, Wagner Jauregg Weg 15, A-4020 Linz, Austria; [Dormann, Rainer; Von Oertzen, Tim J.] Johannes Kepler Univ Linz, Med Fak, Linz, Austria; [Groeppel, Gudrun] Univ Klin Kinder & Jugendheilkunde, Kepler Univ Klinikum, Linz, Austria		Von Oertzen, TJ (corresponding author), Kepler Univ Klinikum, Klin Neurol 1&2, Wagner Jauregg Weg 15, A-4020 Linz, Austria.	Tim.Vonoertzen@kepleruniklinikum.at	von Oertzen, Tim J/B-6295-2013	von Oertzen, Tim J/0000-0003-2164-7842	Johannes Kepler University Linz	Open access funding provided by Johannes Kepler University Linz.	Alakkas A, 2020, JRSM Open, V11, p2054270420920999, DOI 10.1177/2054270420920999; Alkhachroum AM, 2018, EPILEPSIA, V59, P1392, DOI 10.1111/epi.14442; Alper K, 2007, BIOL PSYCHIAT, V62, P345, DOI 10.1016/j.biopsych.2006.09.023; Alvarado Verduzco H., 2016, CASE REP NEPHROL, V2016, P1, DOI [10.1155/2016/7104098, DOI 10.1155/2016/7104098]; ANNEGERS JF, 1995, EPILEPSIA, V36, P327, DOI 10.1111/j.1528-1157.1995.tb01005.x; Baviera M, 2017, ACTA DIABETOL, V54, P863, DOI 10.1007/s00592-017-1011-0; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Beleza P, 2012, NEUROLOGIST, V18, P109, DOI 10.1097/NRL.0b013e318251e6c3; Berghuis B, 2017, EPILEPSIA, V58, P1227, DOI 10.1111/epi.13777; Boggs JG, 1997, EPILEPSIA, V38, pS55, DOI 10.1111/j.1528-1157.1997.tb04540.x; Bove-Fenderson E, 2018, BEST PRACT RES CL EN, V32, P639, DOI 10.1016/j.beem.2018.05.006; Brathen G, 2005, EUR J NEUROL, V12, P575, DOI 10.1111/j.1468-1331.2005.01247.x; Caraballo RH, 2004, PEDIATR NEUROL, V31, P24, DOI 10.1016/j.pediatrneurol.2003.12.008; Castilla-Guerra L, 2006, EPILEPSIA, V47, P1990, DOI 10.1111/j.1528-1167.2006.00861.x; Chen Y, 2013, CURR DIABETES REV, V9, P350, DOI 10.2174/15733998113099990060; Citak A, 2006, PEDIATR INT, V48, P582, DOI 10.1111/j.1442-200X.2006.02276.x; Cruz-Flores S, 2021, CURR NEUROL NEUROSCI, V21, DOI 10.1007/s11910-021-01105-2; Delanty N, 1998, LANCET, V352, P383, DOI 10.1016/S0140-6736(98)02158-8; Derle E, 2015, EXP CLIN TRANSPLANT, V13, P323, DOI 10.6002/ect.mesot2014.P176; Fain O., 2016, AUTOIMMUN REV, V15, P1129, DOI [10.1016/j.autrev.2016.09.008, DOI 10.1016/J.AUTREV.2016.09.008]; Ferro JM, 2021, J NEUROL SCI, V424, DOI 10.1016/j.jns.2021.117426; Finkelstein Y, 2013, CLIN TOXICOL, V51, P761, DOI 10.3109/15563650.2013.829233; Fischer M, 2017, J NEUROL, V264, P1608, DOI 10.1007/s00415-016-8377-8; Gataullina S, 2015, DEV MED CHILD NEUROL, V57, P194, DOI 10.1111/dmcn.12574; Geibprasert S, 2010, AM J NEURORADIOL, V31, P803, DOI 10.3174/ajnr.A1811; Gkampeta A, 2014, J PEDIAT SCI, V6, DOI [10.17334/jps.80498, DOI 10.17334/JPS.80498]; Gorska N, 2019, NEUROL NEUROCHIR POL, V53, P408, DOI 10.5603/PJNNS.a2019.0052; Halawa I, 2011, EPILEPSIA, V52, P410, DOI 10.1111/j.1528-1167.2010.02939.x; Hamerle M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00401; Hanly JG, 2012, ANN RHEUM DIS, V71, P1502, DOI 10.1136/annrheumdis-2011-201089; Kim YS, 2014, SEIZURE-EUR J EPILEP, V23, P208, DOI 10.1016/j.seizure.2013.11.015; Kirschner RI., 2008, CLIN TOXICOL, V46, P591, DOI [10.1080/15563650802255033, DOI 10.1080/15563650802255033]; Kute VB, 2013, INDIAN J CRIT CARE M, V17, P318, DOI 10.4103/0972-5229.120329; Lapenta L, 2010, EPILEPTIC DISORD, V12, P84, DOI 10.1684/epd.2010.0293; Leach JP, 2012, EPILEPSIA, V53, P48, DOI 10.1111/j.1528-1167.2012.03613.x; Magro-Checa C, 2017, RHEUMATOLOGY, V56, P1676, DOI 10.1093/rheumatology/kex019; Mastaglia FL, 2014, AMINOFFS NEUROLOGY G; McMicken D, 2011, EMERG MED CLIN N AM, V29, P117, DOI 10.1016/j.emc.2010.08.010; MESSING RO, 1984, NEUROLOGY, V34, P1582, DOI 10.1212/WNL.34.12.1582; Nardone R, 2016, J CLIN NEUROL, V12, P21, DOI 10.3988/jcn.2016.12.1.21; Nielsen J, 2013, J CLIN PSYCHIAT, V74, P603, DOI 10.4088/JCP.12r08064; Nitescu VG, 2010, CLIN TOXICOL, V48, P248; Reichert C, 2014, CLIN TOXICOL, V52, P629, DOI 10.3109/15563650.2014.918627; Rezaei NJ, 2018, NEUROL INDIA, V66, P1732, DOI 10.4103/0028-3886.246258; Rogawski Michael A, 2005, Epilepsy Curr, V5, P225, DOI 10.1111/j.1535-7511.2005.00071.x; Shapiro M, 2017, SEMIN PEDIATR NEUROL, V24, P43, DOI 10.1016/j.spen.2017.02.001; Song TJ, 2010, THYROID, V20, P955, DOI 10.1089/thy.2009.0276; Steriade C, 2021, BRAIN, V144, P372, DOI 10.1093/brain/awaa362; Suh Y, 2019, INT J NEUROSCI, V129, P1226, DOI 10.1080/00207454.2019.1655014; SUNDARAM M, 1990, ELECTROEN CLIN NEURO, V75, P358, DOI 10.1016/0013-4694(90)90114-Y; Sutter R, 2015, NEUROLOGY, V85, P1332, DOI 10.1212/WNL.0000000000002023; Sutton F, 2020, EPILEPTIC DISORD, V22, P381, DOI 10.1684/epd.2020.1191; TOLA MR, 1992, J NEUROL, V239, P61, DOI 10.1007/BF00862972; Vriesendorp TM, 2006, CRIT CARE MED, V34, P2714, DOI 10.1097/01.CCM.0000241155.36689.91; Wang XJ, 2013, EPILEPSY BEHAV CASE, V1, P77, DOI 10.1016/j.ebcr.2013.03.001; Wijdicks S, 2014, HDB CLIN NEUROLOGY; Williams AM, 2015, CNS DRUGS, V29, P101, DOI 10.1007/s40263-014-0222-y; Wu CS, 2016, J CLIN PSYCHIAT, V77, pE573, DOI 10.4088/JCP.15m09898	58	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-6782	1610-0646		Z EPILEPTOL	Z. Epileptol.	NOV	2021	34	4			SI		365	372		10.1007/s10309-021-00447-8		OCT 2021	8	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WO1LP	WOS:000704212500001		hybrid, Green Published			2022-02-06	
J	Elliott, TR; Perrin, PB; Bell, AS; Powers, MB; Warren, AM				Elliott, Timothy R.; Perrin, Paul B.; Bell, Anne-Stuart; Powers, Mark B.; Warren, Ann Marie			Resilience, coping, and distress among healthcare service personnel during the COVID-19 pandemic	BMC PSYCHIATRY			English	Article						COVID-19; Healthcare workers; Resilience; Coping; Depression; Anxiety	TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; PERSONALITY; TRAJECTORIES; DEPRESSION; CHILDHOOD; PATTERNS; ANXIETY; STRESS; LONG	Background The COVID-19 pandemic has a detrimental effect on the health and well-being of health care workers (HCWs). The extent to which HCWs may differ in their experience of depression and anxiety is unclear, and longitudinal studies are lacking. The present study examined theorized differences in distress between resilient and non-resilient HCWs over time, as reported in a national online survey. We also examined possible differences in distress as a function of sex and doctoral-level status. Methods A national sample responded to an online survey data that included the study measures. Of the HCWs who responded, 666 had useable data at the two time points. A longitudinal structural equation model tested an a priori model that specified the relationship of a resilient personality prototype to self-reported resilience, coping, depression and anxiety at both measurement occasions. Additional invariance models examined possible differences by sex and doctoral-level status. Results The final model explained 46.4% of the variance in psychological distress at Time 1 and 69.1% at Time 2. A non-resilient personality prototype predicted greater depression and anxiety. A resilient personality prototype was predictive of and operated through self-reported resilience and less disengaged coping to effect lower distress. No effects were found for active coping, however. The final model was generally invariant by sex and HCWs status. Additional analyses revealed that non-doctoral level HCWs had significantly higher depression and anxiety than doctoral-level HCWs on both occasions. Conclusions HCWs differ in their susceptibility to distress imposed by COVID-19. Those who are particularly vulnerable may have characteristics that contribute to a lower sense of confidence and efficacy in stressful situations, and more likely to rely on ineffective, disengaged coping behaviors that can exacerbate stress levels. Individual interventions and institutional policies may be implemented to support HCWs at risk.	[Elliott, Timothy R.; Bell, Anne-Stuart] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Powers, Mark B.] Baylor Univ, Med Ctr, Dallas, TX USA; [Warren, Ann Marie] Baylor Univ, Baylor Scott & White Res Inst, Med Ctr, Dallas, TX USA		Elliott, TR (corresponding author), Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA.	telliott@tamu.edu	Powers, Mark/ABB-3291-2021; Elliott, Timothy R./I-5301-2012; Perrin, Paul/L-5373-2015; Powers, Mark/G-6269-2017	Elliott, Timothy R./0000-0002-6608-7714; Perrin, Paul/0000-0003-2070-215X; Powers, Mark/0000-0001-7898-073X; Warren, Ann Marie/0000-0002-3753-5573	Baylor Scott & White Dallas Foundation; Fund at the Communities Foundation of Texas	Support for this study was provided by the Baylor Scott & White Dallas Foundation and the W. W. Caruth, Jr. Fund at the Communities Foundation of Texas.	Alzueta E, 2021, J CLIN PSYCHOL, V77, P556, DOI 10.1002/jclp.23082; Babore A, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113366; Berry JW, 2007, J PERS ASSESS, V89, P292, DOI 10.1080/00223890701629813; Block J., 1993, STUDYING LIVES TIME, P9, DOI DOI 10.1037/10127-018; Block JH, 1980, DEV COGNITION AFFECT, P39; Bonanno GA, 2011, ANNU REV CLIN PSYCHO, V7, P511, DOI 10.1146/annurev-clinpsy-032210-104526; Byrne B. M, 2006, STRUCTURAL EQUATION, V2nd, P440; Cai WP, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102111; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Carlsten C, 2021, AM J IND MED, V64, P227, DOI 10.1002/ajim.23222; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Caspi A, 2000, J PERS SOC PSYCHOL, V78, P158, DOI 10.1037/0022-3514.78.1.158; David S, 2008, PSYCHOL AGING, V23, P62, DOI 10.1037/0882-7974.23.1.62; De Kock JH, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10070-3; Denissen JJA, 2008, J PERS, V76, P67, DOI 10.1111/j.1467-6494.2007.00480.x; Elliott TR, 2019, REHABIL PSYCHOL, V64, P383, DOI 10.1037/rep0000282; Elliott TR, 2017, J CLIN PSYCHOL, V73, P1160, DOI 10.1002/jclp.22414; Elliott TR, 2015, REHABIL PSYCHOL, V60, P263, DOI 10.1037/rep0000050; Farkas D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120883; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Gramzow RH, 2004, EUR J PERSONALITY, V18, P367, DOI 10.1002/per.513; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Hoyt WT, 2008, REHABIL PSYCHOL, V53, P321, DOI 10.1037/a0013021; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kantamneni N, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103439; Kenny DA., 2012, MEASURING MODEL FIT; Koh D, 2020, OCCUP MED-OXFORD, V70, P3, DOI 10.1093/occmed/kqaa036; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Laird V, 2019, J HAPPINESS STUD, V20, P1419, DOI 10.1007/s10902-018-0004-1; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Meyers LS., 2017, APPL MULTIVARIATE RE, V3, P978; Muller AE, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113441; Ong AD, 2009, J PERS, V77, P1777, DOI 10.1111/j.1467-6494.2009.00600.x; Preti E, 2020, CURR PSYCHIAT REP, V22, DOI 10.1007/s11920-020-01166-z; Sagar R, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113251; Sandal A, 2021, SAF HEALTH WORK-KR, V12, P136, DOI 10.1016/j.shaw.2021.01.001; Song SS, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.618509; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; Twenge JM, 2020, J CLIN PSYCHOL, V76, P2170, DOI 10.1002/jclp.23064; U.S. Bureau of Labor Statistics, 2020, LAB FORC STAT CURR P; Verdolini N, 2021, J AFFECT DISORDERS, V283, P156, DOI 10.1016/j.jad.2021.01.055; Vizheh M, 2020, J DIABETES METAB DIS, V19, P1967, DOI 10.1007/s40200-020-00643-9; Waugh CE, 2011, EMOTION, V11, P1059, DOI 10.1037/a0021786; Wright HM, 2021, J PSYCHIATR RES, V137, P673, DOI 10.1016/j.jpsychires.2020.10.045; Yan LL, 2021, J ANXIETY DISORD, V77, DOI 10.1016/j.janxdis.2020.102328; Yi F, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01993; Zvolensky MJ, 2020, BEHAV RES THER, V134, DOI 10.1016/j.brat.2020.103715	48	0	0	8	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-244X		BMC PSYCHIATRY	BMC Psychiatry	OCT 6	2021	21	1							489	10.1186/s12888-021-03506-6			12	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	WD2PN	WOS:000704789500001	34615501	Green Published, gold			2022-02-06	
J	Guedes, VA; Lai, C; Devoto, C; Edwards, KA; Mithani, S; Sass, D; Vorn, R; Qu, BX; Rusch, HL; Martin, CA; Walker, WC; Wilde, EA; Diaz-Arrastia, R; Gill, JM; Kenney, K				Guedes, Vivian A.; Lai, Chen; Devoto, Christina; Edwards, Katie A.; Mithani, Sara; Sass, Dilorom; Vorn, Rany; Qu, Bao-Xi; Rusch, Heather L.; Martin, Carina A.; Walker, William C.; Wilde, Elisabeth A.; Diaz-Arrastia, Ramon; Gill, Jessica M.; Kenney, Kimbra			Extracellular Vesicle Proteins and MicroRNAs Are Linked to Chronic Post-Traumatic Stress Disorder Symptoms in Service Members and Veterans With Mild Traumatic Brain Injury	FRONTIERS IN PHARMACOLOGY			English	Article						concussion; biomarkers; exosomes; military; PTSD; neurofilament light (NfL)	NEUROFILAMENT LIGHT-CHAIN; AMYLOID PRECURSOR PROTEIN; SERUM INTERLEUKIN-6; TERMINAL FRAGMENTS; SECRETORY PATHWAY; EXOSOMES; DISEASE; BIOMARKER; INFLAMMATION; SOLDIERS	Symptoms of post-traumatic stress disorder (PTSD) are common in military populations, and frequently associated with a history of combat-related mild traumatic brain injury (mTBI). In this study, we examined relationships between severity of PTSD symptoms and levels of extracellular vesicle (EV) proteins and miRNAs measured in the peripheral blood in a cohort of military service members and Veterans (SMs/Vs) with chronic mTBI(s). Participants (n = 144) were divided into groups according to mTBI history and severity of PTSD symptoms on the PTSD Checklist for DSM-5 (PCL-5). We analyzed EV levels of 798 miRNAs (miRNAs) as well as EV and plasma levels of neurofilament light chain (NfL), Tau, Amyloid beta (A beta) 42, A beta 40, interleukin (IL)-10, IL-6, tumor necrosis factor-alpha (TNF alpha), and vascular endothelial growth factor (VEGF). We observed that EV levels of neurofilament light chain (NfL) were elevated in participants with more severe PTSD symptoms (PCL-5 >= 38) and positive mTBI history, when compared to TBI negative controls (p = 0.024) and mTBI participants with less severe PTSD symptoms (p = 0.006). Levels of EV NfL, plasma NfL, and hsa-miR-139-5p were linked to PCL-5 scores in regression models. Our results suggest that levels of NfL, a marker of axonal damage, are associated with PTSD symptom severity in participants with remote mTBI. Specific miRNAs previously linked to neurodegenerative and inflammatory processes, and glucocorticoid receptor signaling pathways, among others, were also associated with the severity of PTSD symptoms. Our findings provide insights into possible signaling pathways linked to the development of persistent PTSD symptoms after TBI and biological mechanisms underlying susceptibility to PTSD.</p>	[Guedes, Vivian A.; Lai, Chen; Devoto, Christina; Edwards, Katie A.; Mithani, Sara; Sass, Dilorom; Vorn, Rany; Qu, Bao-Xi; Rusch, Heather L.; Martin, Carina A.] NINR, Tissue Injury Branch, NIH, Bethesda, MD 20892 USA; [Devoto, Christina; Rusch, Heather L.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Qu, Bao-Xi] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Rehabil Med, Bethesda, MD 20814 USA; [Rusch, Heather L.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Wilde, Elisabeth A.] Univ Utah, George E Wahlen VA Salt Lake City Healthcare Syst, Dept Neurol, CENC Neuroimaging Core, Salt Lake City, UT USA; [Wilde, Elisabeth A.] Univ Utah, Traumat Brain Injury & Concuss Ctr, Dept Neurol, Salt Lake City, UT USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gill, Jessica M.; Kenney, Kimbra] Uniformed Serv Univ Hlth Sci, CENC Biorepository, Bethesda, MD 20814 USA; [Gill, Jessica M.] Johns Hopkins Univ, Sch Nursing & Med, Baltimore, MD USA; [Kenney, Kimbra] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA		Kenney, K (corresponding author), Uniformed Serv Univ Hlth Sci, CENC Biorepository, Bethesda, MD 20814 USA.; Kenney, K (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA.	kimbra.kenney@usuhs.edu		Rusch, Heather/0000-0002-4061-8628; de Alvarenga Guedes, Vivian/0000-0001-8478-2465; Vorn, Rany/0000-0002-9158-9302	Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) AwardUnited States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]; NIH, National Institute of Nursing Research Intramural Research Program; U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma ConsortiumUS Department of Veterans Affairs [W81XWH-13-2-0095]; U.S. Department of Veterans Affairs Long-term Impact of Military-related Brain Injury Consortium/Chronic Effects of Neurotrauma ConsortiumUS Department of Veterans Affairs [1I01CX002097-01]; U.S Department of DefenseUnited States Department of Defense [W81XWH-18-PH/TBIRP-LIMBIC]	This work was supported by grant funding from: Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095 and Department of Veterans Affairs CENC Award I01 CX001135. NIH, National Institute of Nursing Research Intramural Research Program. The U.S. Army Medical Research and Material Command and from the U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma Consortium under Award No. W81XWH-13-2-0095. The U.S. Army Medical Research and Material Command, from the U.S. Department of Veterans Affairs Long-term Impact of Military-related Brain Injury Consortium/Chronic Effects of Neurotrauma Consortium under Award No. 1I01CX002097-01 and the U.S Department of Defense under Award No. W81XWH-18-PH/TBIRP-LIMBIC.	Ahmed Samrein B M, 2017, J Mol Signal, V12, P2, DOI 10.5334/1750-2187-12-2; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bacioglu M, 2016, NEURON, V91, P56, DOI 10.1016/j.neuron.2016.05.018; Beurel E, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00018; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Blessing EM, 2017, PSYCHONEUROENDOCRINO, V82, P91, DOI 10.1016/j.psyneuen.2017.04.016; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Brentnall M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-32; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Chen RJ, 2015, NEUROSCIENCE, V305, P36, DOI 10.1016/j.neuroscience.2015.07.045; Cocucci E, 2015, TRENDS CELL BIOL, V25, P364, DOI 10.1016/j.tcb.2015.01.004; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; Deleo AM, 2018, J NEUROIMMUNE PHARM, V13, P292, DOI 10.1007/s11481-017-9768-z; Devoto C, 2020, J NEUROTRAUM, V37, P2482, DOI 10.1089/neu.2019.6933; Dinkins MB, 2017, J ALZHEIMERS DIS, V60, P757, DOI 10.3233/JAD-160567; Doumatey AP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26065-5; Ebrahimi R, 2021, JAMA CARDIOL, V6, P642, DOI 10.1001/jamacardio.2021.0227; Edmondson D, 2013, AM HEART J, V166, P806, DOI 10.1016/j.ahj.2013.07.031; Fan SY, 2019, J AFFECT DISORDERS, V245, P1089, DOI 10.1016/j.jad.2018.11.095; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fitzgerald W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27190-x; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Garcia-Lacarte M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121548; Gheysarzadeh A, 2018, J RES MED SCI, V23, DOI 10.4103/jrms.JRMS_879_17; Gill J, 2010, BIOL PSYCHIAT, V68, P999, DOI 10.1016/j.biopsych.2010.07.033; Guedes VA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00663; Guedes VA, 2020, NEUROLOGY, V94, pE2412, DOI 10.1212/WNL.0000000000009577; Gupta A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-68; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, LANCET PSYCHIAT, V1, P269, DOI 10.1016/S2215-0366(14)70235-4; Holmes A, 2013, TRENDS NEUROSCI, V36, P23, DOI 10.1016/j.tins.2012.11.003; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Kramer-Albers EM, 2007, PROTEOM CLIN APPL, V1, P1446, DOI 10.1002/prca.200700522; Lee MY, 2019, J CLIN MED, V8, DOI 10.3390/jcm8070963; Leistner Carolin, 2020, Handb Clin Neurol, V175, P55, DOI 10.1016/B978-0-444-64123-6.00004-7; Li HY, 2020, J CLIN INVEST, V130, P877, DOI 10.1172/JCI130363; Lindqvist D, 2014, BRAIN BEHAV IMMUN, V42, P81, DOI 10.1016/j.bbi.2014.06.003; Lugli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139233; Maes M, 1999, BIOL PSYCHIAT, V45, P833, DOI 10.1016/S0006-3223(98)00131-0; Margolis L, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000363; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Meeter LH, 2016, ANN CLIN TRANSL NEUR, V3, P623, DOI 10.1002/acn3.325; Menke RAL, 2015, ANN CLIN TRANSL NEUR, V2, P748, DOI 10.1002/acn3.212; Michopoulos V, 2016, EXP NEUROL, V284, P220, DOI 10.1016/j.expneurol.2016.05.038; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mustapic M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00278; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Nishimura I, 2002, CELL DEATH DIFFER, V9, P199, DOI 10.1038/sj/cdd/4400931; Noh H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-644; O'Donovan A, 2017, BRAIN BEHAV IMMUN, V60, P198, DOI 10.1016/j.bbi.2016.10.014; Oggero S, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01479; Passos IC, 2015, LANCET PSYCHIAT, V2, P1002, DOI 10.1016/S2215-0366(15)00309-0; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Peterson MF, 2015, METHODS, V87, P31, DOI 10.1016/j.ymeth.2015.04.015; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Preische O, 2019, NAT MED, V25, P277, DOI 10.1038/s41591-018-0304-3; Puhakka N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172521; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Rodney T, 2020, BEHAV BRAIN RES, V392, DOI 10.1016/j.bbr.2020.112715; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Scherrer JF, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011133; Scheschowitsch K, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00016; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shahim P, 2020, NEUROLOGY, V95, pE610, DOI 10.1212/WNL.0000000000009983; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Snijders C, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01042; Snijders C, 2018, CURR TOP BEHAV NEURO, V38, P23, DOI 10.1007/7854_2017_32; Speer K, 2018, J INFLAMM RES, V11, P111, DOI 10.2147/JIR.S155903; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Sundahl N, 2015, PHARMACOL THERAPEUT, V152, P28, DOI 10.1016/j.pharmthera.2015.05.001; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Taylor Douglas D., 2013, Frontiers in Genetics, V4, P142, DOI 10.3389/fgene.2013.00142; Thompson AG, 2016, NAT REV NEUROL, V12, P346, DOI 10.1038/nrneurol.2016.68; Todorova D, 2017, CIRC RES, V120, P1658, DOI 10.1161/CIRCRESAHA.117.309681; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vempati P, 2014, CYTOKINE GROWTH F R, V25, P1, DOI 10.1016/j.cytogfr.2013.11.002; Walker WC, 2018, BRAIN INJURY, V32, P1079, DOI 10.1080/02699052.2018.1479041; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Wang HT, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00255; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yehuda R, 2009, ANN NY ACAD SCI, V1179, P56, DOI 10.1111/j.1749-6632.2009.04979.x; Yossifoff M, 2008, EUR J NEUROSCI, V28, P2267, DOI 10.1111/j.1460-9568.2008.06532.x; Yuan AD, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a018309; Zandvakili A, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00879-2; Zetterberg H, 2016, NEURON, V91, P1, DOI 10.1016/j.neuron.2016.06.030	94	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1663-9812		FRONT PHARMACOL	Front. Pharmacol.	OCT 6	2021	12								745348	10.3389/fphar.2021.745348			14	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	WK9ID	WOS:000710031600001	34690777	Green Published, gold			2022-02-06	
J	Lippa, SM; French, LM; Brickell, TA; Driscoll, AE; Glazer, ME; Tippett, CE; Sullivan, JK; Lange, RT				Lippa, Sara M.; French, Louis M.; Brickell, Tracey A.; Driscoll, Angela E.; Glazer, Megan E.; Tippett, Corie E.; Sullivan, Jamie K.; Lange, Rael T.			Post-Traumatic Stress Disorder Symptoms Are Related to Cognition after Complicated Mild and Moderate Traumatic Brain Injury but Not Severe and Penetrating Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognition; military; penetrating brain injury; post-traumatic stress disorder; traumatic brain injury	MENTAL-HEALTH PROBLEMS; MILITARY SERVICE; IRAQ; PERFORMANCE; DEMENTIA; RISK; IMPACT; COMBAT; PTSD; AFGHANISTAN	Although post-traumatic stress disorder (PTSD) has been associated with worse cognitive outcomes after mild traumatic brain injury (TBI), its impact has not been evaluated after more severe TBI. This study aimed to determine whether PTSD symptoms are related to cognition after complicated mild, moderate, severe, and penetrating TBI. Service members (n = 137) with a history of complicated mild/moderate TBI (n = 64) or severe/penetrating TBI (n = 73) were prospectively enrolled from United States Military Treatment Facilities. Participants completed a neuropsychological assessment one year or more post-injury. Six neuropsychological composite scores and an overall test battery mean (OTBM) were considered. Participants were excluded if there was evidence of invalid responding. Hierarchical linear regressions were conducted evaluating neuropsychological performance. The interaction between TBI severity and PTSD Checklist-Civilian version total score was significant for processing speed (beta = 0.208, p = 0.034) and delayed memory (beta = 0.239, p = 0.021) and trended toward significance for immediate memory (beta = 0.190, p = 0.057) and the OTBM (beta = 0.181, p = 0.063). For each of these composite scores, the relationship between PTSD symptoms and cognition was stronger in the complicated mild/moderate TBI group than the severe/penetrating TBI group. Within the severe/penetrating TBI group, PTSD symptoms were unrelated to cognitive performance. In contrast, within the complicated mild/moderate TBI group, PTSD symptoms were significantly related to processing speed (R-2 Delta = 0.077, beta = -0.280, p = 0.019), immediate memory (R-2 Delta = 0.197, beta = -0.448, p < 0.001), delayed memory (R-2 Delta = 0.176, beta = -0.423, p < 0.001), executive functioning (R-2 Delta = 0.100, beta = -0.317, p = 0.008), and the OTBM (R-2 Delta = 0.162, beta = -0.405, p < 0.001). The potential impact of PTSD symptoms on cognition, over and above the impact of brain injury alone, should be considered with service members and veterans with a history of complicated mild/moderate TBI. In addition, in research comparing cognitive outcomes between patients with histories of complicated-mild, moderate, severe, and/or penetrating TBI, it will be important to account for PTSD symptoms.</p>	[Lippa, Sara M.; French, Louis M.; Brickell, Tracey A.; Driscoll, Angela E.; Glazer, Megan E.; Tippett, Corie E.; Sullivan, Jamie K.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Room 1121,Bldg 51,4954N Palmer Rd, Bethesda, MD 20814 USA; [French, Louis M.; Brickell, Tracey A.; Glazer, Megan E.; Tippett, Corie E.; Sullivan, Jamie K.; Lange, Rael T.] Traumat Brain Injury Ctr Excellence, Silver Spring, MD USA; [French, Louis M.; Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Brickell, Tracey A.; Glazer, Megan E.; Tippett, Corie E.; Sullivan, Jamie K.; Lange, Rael T.] Gen Dynam Informat Technol, Falls Church, VA USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [Brickell, Tracey A.; Lange, Rael T.] Ctr Excellence Posttraumat Stress Disorder, Ottawa, ON, Canada		Lippa, SM (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Room 1121,Bldg 51,4954N Palmer Rd, Bethesda, MD 20814 USA.	sara.m.lippa.civ@mail.mil			DHA Contracting Office (CO-NCR) [HT0014-19-C-0004, HT0014]	This work was prepared under Contract HT0014-19-C-0004 with DHA Contracting Office (CO-NCR) HT0014 and, therefore, is defined as U.S. Government work under Title 17 U.S.C.x101. Per Title 17 U.S.C. 105, copyright protection is not available for any work of the U.S. Government. For more information, please contact dha.TBICOEinfo@mail.mil.	Ahmadi N, 2011, AM J CARDIOL, V108, P29, DOI 10.1016/j.amjcard.2011.02.340; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Ben-Porath Y. S., 2011, MMPI 2 RF MINNESOTA; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Delis D.C., 2000, CALIFORNIA VERBAL LE; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Dunbar KE, 2019, CYBERPSYCH BEH SOC N, V22, P761, DOI 10.1089/cyber.2019.0296; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; French LM, 2009, J HEAD TRAUMA REHAB, V24, P1, DOI 10.1097/HTR.0b013e318197a14c; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Green P, 2004, GREENS MED SYMPT VAL; Haarbauer-Krupa J, 2017, J NEUROTRAUM, V34, P50, DOI 10.1089/neu.2015.4158; Hantke Nathan, 2021, Fed Pract, V38, P28, DOI 10.12788/fp.0083; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Heaton R. K., 2004, REVISED COMPREHENSIV; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Iljazi A, 2020, NEUROL SCI, V41, P2737, DOI 10.1007/s10072-020-04458-7; Jurick SM, 2021, J NEUROPSYCH CLIN N, V33, P98, DOI 10.1176/appi.neuropsych.20050128; Knutson KM, 2013, NEUROPSYCHOLOGIA, V51, P686, DOI 10.1016/j.neuropsychologia.2013.01.003; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Lange RT, 2021, J NEUROTRAUM, V38, P63, DOI 10.1089/neu.2019.6852; Lange RT, 2020, J TRAUMA STRESS, V33, P318, DOI 10.1002/jts.22480; Lange RT, 2020, CLIN NEUROPSYCHOL, V34, P1134, DOI 10.1080/13854046.2020.1746832; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lippa SM, 2019, J NEUROTRAUM, V36, P2190, DOI 10.1089/neu.2018.6269; Loignon A, 2020, J HEAD TRAUMA REHAB, V35, pE21, DOI 10.1097/HTR.0000000000000514; Lopez KC, 2017, J NEUROTRAUM, V34, P16, DOI 10.1089/neu.2015.4323; Mac Donald CL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6676; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Mendez MF, 2015, J ALZHEIMERS DIS, V47, P985, DOI 10.3233/JAD-143207; Mora C., 1989, COMBAT EXPOSURE SCAL; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Pearson, 2009, ADV CLIN SOLUTIONS U; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Sumner JA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003197; Sundin J, 2011, INT REV PSYCHIATR, V23, P153, DOI 10.3109/09540261.2011.561303; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Vaccarino V, 2017, NEUROSCI BIOBEHAV R, V74, P297, DOI 10.1016/j.neubiorev.2016.04.023; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Vasterling JJ, 2016, AM J EPIDEMIOL, V184, P796, DOI 10.1093/aje/kww151; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Wang TY, 2016, J AFFECT DISORDERS, V205, P306, DOI 10.1016/j.jad.2016.08.013; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wisdom NM, 2014, CLIN NEUROPSYCHOL, V28, P128, DOI 10.1080/13854046.2013.863977; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61	61	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2021	38	22					3137	3145		10.1089/neu.2021.0120		OCT 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	WY7FJ	WOS:000704530300001	34409857				2022-02-06	
J	Poltavski, D; Biberdorf, D; Poltavski, CP				Poltavski, Dmitri; Biberdorf, David; Poltavski, Carolina Praus			Which Comes First in Sports Vision Training: The Software or the Hardware Update? Utility of Electrophysiological Measures in Monitoring Specialized Visual Training in Youth Athletes	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						sports vision training; visual software; visual hardware; ice hockey; VEP; EEG; STMLI; Senaptec Sensory Station	BRAIN-INJURY MTBI; EVOKED-POTENTIALS; PERFORMANCE; CONCUSSION; GAMMA; REHABILITATION; ADVANTAGE; ATTENTION; ELITE; SPEED	In the present study we combined popular methods of sports vision training (SVT) with traditional oculomotor protocols of Optometric Vision Therapy (OVT) and electrophysiological indexes of EEG and VEP activity to monitor training progress and changes in performance of youth ice hockey players without the history of concussion. We hypothesized that administration of OVT protocols before SVT training may result in larger performance improvements compared to the reverse order due to the initial strengthening of visual hardware capable of handling greater demands during training of visuomotor integration and information processing skills (visual software). In a cross-over design 53 youth ice hockey players (ages 13-18) were randomly assigned to one of the two training groups. Group one (hardware-software group) completed 5 weeks of oculomotor training first followed by 5 weeks of software training. For group 2 (software-hardware) the order of procedures were reversed. After 10 weeks of training both groups significantly improved their performance on all but one measure of the Nike/Senaptec Sensory station measures. Additionally, the software-hardware training order resulted in significantly lower frontal theta-to-gamma amplitude ratios on the Nike/Senaptec test of Near-Far Quickness as well as in faster P100 latencies. Both training orders also resulted in significant decreases in post-treatment P100 amplitude to transient VEP stimuli as well as decreased theta-gamma ratios for perception span, Go/No-Go and Hand Reaction time. The observed changes in the electrophysiological indexes in the present study are thought to reflect greater efficiency in visual information processing and cognitive resource allocation following 10 weeks of visual training. There is also some evidence of the greater effectiveness of the software-hardware training order possibly due to the improved preparedness of the oculomotor system in the youth athletes for administration of targeted protocols of the Optometric Vision Therapy.	[Poltavski, Dmitri; Poltavski, Carolina Praus] Univ North Dakota, Dept Psychol, Grand Forks, ND 58202 USA; [Biberdorf, David] Valley Vis Clin, Grand Forks, ND USA		Poltavski, D (corresponding author), Univ North Dakota, Dept Psychol, Grand Forks, ND 58202 USA.	dmitri.poltavski@und.edu			North Dakota Department of Commerce: Research ND Program [15-02-G-88]	This study was funded by the North Dakota Department of Commerce: Research ND Program. Project title: Evaluation of the Effectiveness of Sports Vision Programs in Improving Performance and Health in ND Youth Athletes. Award Dates: 2015-2017. Award # 15-02-G-88.	Abernethy B., 1987, PHYS ED REV, V10, P5; Abernethy B., 1986, CLIN EXP OPTOM, V69, P189, DOI 10.1111/j.1444-0938.1986.tb04589.x; Appelbaum L.G., 2016, ATHLETIC TRAIN SPORT, V8, P154, DOI [10.3928/19425864-20160314-01, DOI 10.3928/19425864-20160314-01]; Appelbaum LG, 2018, INT REV SPORT EXER P, V11, P160, DOI 10.1080/1750984X.2016.1266376; Appelbaum LG, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00276; Bao M, 2010, J NEUROSCI, V30, P15080, DOI 10.1523/JNEUROSCI.5703-09.2010; Barton JJS, 2020, ANN NEUROL, V88, P453, DOI 10.1002/ana.25820; Borghini G, 2013, IEEE ENG MED BIO, P6619, DOI 10.1109/EMBC.2013.6611073; Borghini G, 2014, NEUROSCI BIOBEHAV R, V44, P58, DOI 10.1016/j.neubiorev.2012.10.003; Buzsaki G, 2001, NEUROCHEM RES, V26, P899, DOI 10.1023/A:1012324231897; Caldani S, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110816; Casco C, 2004, NEUROSCI LETT, V371, P18, DOI 10.1016/j.neulet.2004.08.005; Ciuffreda K.J., 2004, BIOMEDICAL ENG PRINC, P407; Del Percio C, 2007, BRAIN RES BULL, V74, P104, DOI 10.1016/j.brainresbull.2007.05.011; DELPONT E, 1991, INT J SPORTS MED, V12, P293, DOI 10.1055/s-2007-1024684; Derr Peter H., 2002, Documenta Ophthalmologica, V104, P37, DOI 10.1023/A:1014474026114; Di Russo F, 2003, VISION RES, V43, P1837, DOI 10.1016/S0042-6989(03)00299-2; Doppelmayr A, 2008, NEUROPSYCHOLOGIA, V46, P1463, DOI 10.1016/j.neuropsychologia.2007.12.026; EMMERSONHANOVER R, 1994, ELECTROEN CLIN NEURO, V92, P93, DOI 10.1016/0168-5597(94)90049-3; Erickson GB, 2011, OPTOMETRY, V82, P528, DOI 10.1016/j.optm.2011.01.012; Faubert J, 2012, J CLIN SPORT PSYCHOL, V6, P85, DOI 10.1123/jcsp.6.1.85; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferreira J.T., 2002, EYESIGHT, V40; Galpin AJ, 2008, J STRENGTH COND RES, V22, P1901, DOI 10.1519/JSC.0b013e3181887e3f; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hulsdunker T, 2018, EUR J SPORT SCI, V18, P190, DOI 10.1080/17461391.2017.1395912; Jeunet C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58533-2; Kaminski J, 2011, NEUROBIOL LEARN MEM, V95, P19, DOI 10.1016/j.nlm.2010.10.001; Keizer AW, 2010, NEUROIMAGE, V49, P3404, DOI 10.1016/j.neuroimage.2009.11.023; Kofsky M., 1989, AUST J OPTOMETRY, V6, P15; Laycock R, 2008, NEUROSCI BIOBEHAV R, V32, P1409, DOI 10.1016/j.neubiorev.2008.04.008; Laycock R, 2007, NEUROSCI BIOBEHAV R, V31, P363, DOI 10.1016/j.neubiorev.2006.10.003; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Liu SC, 2020, PSYCHOL SPORT EXERC, V51, DOI 10.1016/j.psychsport.2020.101759; Liu YS, 2018, LECT NOTES COMPUT SC, V10830, P106, DOI 10.1007/978-3-662-56672-5_8; Lundqvist M, 2016, NEURON, V90, P152, DOI 10.1016/j.neuron.2016.02.028; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; MCLEOD B, 1991, PERCEPT MOTOR SKILL, V72, P863, DOI 10.2466/PMS.72.3.863-866; Mihalik J.P., 2017, BR J SPORTS MED, V51, pA3; Miller EK, 2018, NEURON, V100, P463, DOI 10.1016/j.neuron.2018.09.023; Oner A, 2004, DOC OPHTHALMOL, V109, P223, DOI 10.1007/s10633-004-7098-y; Poltavski D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54054-9; Poltavski D, 2017, OPTOMETRY VISION SCI, V94, P742, DOI 10.1097/OPX.0000000000001094; Poltavski D, 2015, J SPORT SCI, V33, P597, DOI 10.1080/02640414.2014.951952; Poltavski DV, 2014, BRAIN INJURY, V28, P475, DOI 10.3109/02699052.2014.888771; Quevedo Lluisa, 1999, Clin Exp Optom, V82, P23; Rogozhnikov M.A., 2020, THEORY PRACT PHYS CU, V9, P10; Scheiman M, 2008, OPHTHAL EPIDEMIOL, V15, P24, DOI 10.1080/09286580701772037; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; Shete AN, 2019, INT J APPL EXERC PHY, V8, P18, DOI 10.30472/ijaep.v8i1.353; Sowden P, 1996, PERCEPTION, V25, P1043, DOI 10.1068/p251043; Sowden PT, 2002, VISION RES, V42, P1249, DOI 10.1016/S0042-6989(02)00019-6; Tabachnick BG, 2019, USING MULTIVARIATE S, V7th; TADDEI F, 1991, INT J PSYCHOPHYSIOL, V11, P257, DOI 10.1016/0167-8760(91)90019-T; Tello C, 2010, DOC OPHTHALMOL, V120, P219, DOI 10.1007/s10633-010-9216-3; Thiagarajan P, 2015, BRAIN INJURY, V29, P1475, DOI 10.3109/02699052.2015.1070905; Thiagarajan P, 2014, BRAIN INJURY, V28, P930, DOI 10.3109/02699052.2014.888761; Thiagarajan P, 2014, NEUROREHABILITATION, V34, P129, DOI 10.3233/NRE-131025; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Tirre WC, 1998, PERS INDIV DIFFER, V24, P603, DOI 10.1016/S0191-8869(98)80011-1; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Wang LL, 2015, ACTA PSYCHOL, V157, P74, DOI 10.1016/j.actpsy.2015.02.005; Yadav NK, 2014, BRAIN INJURY, V28, P922, DOI 10.3109/02699052.2014.887227; Zwierko T, 2014, J SPORT SCI, V32, P1519, DOI 10.1080/02640414.2014.903334; Zwierko T, 2010, J HUM KINET, V23, P21, DOI 10.2478/v10078-010-0003-8	66	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	OCT 6	2021	15								732303	10.3389/fnhum.2021.732303			22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	WL0KW	WOS:000710106300001	34690722	gold, Green Published			2022-02-06	
J	Tripathi, R; Gupta, R; Sahu, M; Srivastava, D; Das, A; Ambasta, RK; Kumar, P				Tripathi, Rahul; Gupta, Rohan; Sahu, Mehar; Srivastava, Devesh; Das, Ankita; Ambasta, Rashmi K.; Kumar, Pravir			Free radical biology in neurological manifestations: mechanisms to therapeutics interventions	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article; Early Access						Free radicals; Neurological disorders; DNA damage response; Cell-cycle arrest; Axonal regeneration; Environmental factors	NITRIC-OXIDE SYNTHASE; MITOCHONDRIAL RESPIRATORY-CHAIN; OXIDATIVE STRESS HYPOTHESIS; SOLID LIPID NANOPARTICLES; PROTECTS SCHWANN-CELLS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; TERMINAL HYDROLASE L1; LINKED SOD1 MUTANTS; DNA-DAMAGE RESPONSE	Recent advancements and growing attention about free radicals (ROS) and redox signaling enable the scientific fraternity to consider their involvement in the pathophysiology of inflammatory diseases, metabolic disorders, and neurological defects. Free radicals increase the concentration of reactive oxygen and nitrogen species in the biological system through different endogenous sources and thus increased the overall oxidative stress. An increase in oxidative stress causes cell death through different signaling mechanisms such as mitochondrial impairment, cell-cycle arrest, DNA damage response, inflammation, negative regulation of protein, and lipid peroxidation. Thus, an appropriate balance between free radicals and antioxidants becomes crucial to maintain physiological function. Since the 1brain requires high oxygen for its functioning, it is highly vulnerable to free radical generation and enhanced ROS in the brain adversely affects axonal regeneration and synaptic plasticity, which results in neuronal cell death. In addition, increased ROS in the brain alters various signaling pathways such as apoptosis, autophagy, inflammation and microglial activation, DNA damage response, and cell-cycle arrest, leading to memory and learning defects. Mounting evidence suggests the potential involvement of micro-RNAs, circular-RNAs, natural and dietary compounds, synthetic inhibitors, and heat-shock proteins as therapeutic agents to combat neurological diseases. Herein, we explain the mechanism of free radical generation and its role in mitochondrial, protein, and lipid peroxidation biology. Further, we discuss the negative role of free radicals in synaptic plasticity and axonal regeneration through the modulation of various signaling molecules and also in the involvement of free radicals in various neurological diseases and their potential therapeutic approaches.	[Tripathi, Rahul; Gupta, Rohan; Sahu, Mehar; Srivastava, Devesh; Das, Ankita; Ambasta, Rashmi K.; Kumar, Pravir] Delhi Technol Univ, Mol Neurosci & Funct Genom Lab, Delhi, India; [Kumar, Pravir] Mol Neurosci & Funct Genom Lab, Bawana Rd, Delhi 110042, India		Kumar, P (corresponding author), Delhi Technol Univ, Mol Neurosci & Funct Genom Lab, Delhi, India.; Kumar, P (corresponding author), Mol Neurosci & Funct Genom Lab, Bawana Rd, Delhi 110042, India.	pravirkumar@dtu.ac.in		Kumar, Pravir/0000-0001-7444-2344	Department of Biotechnology, Government of IndiaDepartment of Biotechnology (DBT) India [DBT/2018/DTU/1137]	We would like to thank the senior management of Delhi Technological University for their constant support and infrastructure. The authors would like to thank Department of Biotechnology, Government of India, for providing junior research fellowship to R.T. DBT/2018/DTU/1137.	Acuna AI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3917; Agrawal S, 2018, FREE RADICAL BIO MED, V120, P317, DOI 10.1016/j.freeradbiomed.2018.04.002; Ahmad F, 2018, NEUROPSYCH DIS TREAT, V14, P813, DOI 10.2147/NDT.S148248; Ahmad MF, 2008, J MOL BIOL, V382, P812, DOI 10.1016/j.jmb.2008.07.068; Ahmad S, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.612078; Ahn Eun Hee, 2011, Exp Neurobiol, V20, P169, DOI 10.5607/en.2011.20.4.169; Ul Ahsan A, 2020, MOL NEUROBIOL, V57, P3589, DOI 10.1007/s12035-020-01969-4; Ahtoniemi T, 2008, NEUROBIOL DIS, V32, P479, DOI 10.1016/j.nbd.2008.08.010; Akter R, 2021, CNS NEUROL DISORD-DR, V20, P430, DOI 10.2174/1871527320666210218084444; Al-Chalabi A, 2013, AMYOTROPH LAT SCL FR, V14, P44, DOI 10.3109/21678421.2013.778571; Alam MM, 2016, RSC ADV, V6, P55092, DOI 10.1039/c6ra04821h; Alam ZI, 1997, J NEUROCHEM, V69, P1326; Ali T, 2018, MOL NEUROBIOL, V55, P6076, DOI 10.1007/s12035-017-0798-6; Almeida OP, 2008, AM J GERIAT PSYCHIAT, V16, P92, DOI 10.1097/JGP.0b013e318157cad2; Amakiri N, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00430; Amalraj Augustine, 2017, J Tradit Complement Med, V7, P205, DOI 10.1016/j.jtcme.2016.05.005; Amato A, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8120608; Ambrogini P, 2019, BBA-MOL BASIS DIS, V1865, P1098, DOI 10.1016/j.bbadis.2019.01.026; Ameruoso A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01411; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andres S, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700447; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Andrich J, 2004, J NEURAL TRANSM-SUPP, P111; Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Angelova PR, 2018, FEBS LETT, V592, P692, DOI 10.1002/1873-3468.12964; Anton SD, 2014, EXP GERONTOL, V57, P181, DOI 10.1016/j.exger.2014.05.015; Antonioni A, 2019, RES SPORTS MED, V27, P147, DOI 10.1080/15438627.2018.1563899; Aridon P, 2011, NEURODEGENER DIS, V8, P155, DOI 10.1159/000321548; Armstrong RA, 2019, FOLIA NEUROPATHOL, V57, P87, DOI 10.5114/fn.2019.85929; Arora A, 2021, ENVIRON SCI POLLUT R, V28, P41517, DOI 10.1007/s11356-021-14665-0; Arrigo AP, 2005, ANTIOXID REDOX SIGN, V7, P414, DOI 10.1089/ars.2005.7.414; Arya A, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11030350; Asanuma M, 2004, ACTA MED OKAYAMA, V58, P221; Aseervatham GSB, 2013, ENVIRON SCI POLLUT R, V20, P4356, DOI 10.1007/s11356-013-1748-0; Assis RP, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040332; Nino SA, 2019, ACS CHEM NEUROSCI, V10, P323, DOI 10.1021/acschemneuro.8b00278; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Bachewal P, 2018, BIOFACTORS, V44, P109, DOI 10.1002/biof.1397; BACHMAN DL, 1993, NEUROLOGY, V43, P515, DOI 10.1212/WNL.43.3_Part_1.515; Bagasra O, 1995, P NATL ACAD SCI USA, V92, P12041, DOI 10.1073/pnas.92.26.12041; Bagdas D, 2014, N-S ARCH PHARMACOL, V387, P1101, DOI 10.1007/s00210-014-1034-9; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bandegi AR, 2014, ADV PHARM BULL, V4, P493, DOI 10.5681/apb.2014.073; Barbariga M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72447-z; Barnes RP, 2019, MECH AGEING DEV, V177, P37, DOI 10.1016/j.mad.2018.03.013; Bartesaghi S, 2018, REDOX BIOL, V14, P618, DOI 10.1016/j.redox.2017.09.009; Bartzokis G, 1999, ARCH NEUROL-CHICAGO, V56, P569, DOI 10.1001/archneur.56.5.569; Bartzokis G, 2007, NEUROCHEM RES, V32, P1655, DOI 10.1007/s11064-007-9352-7; Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; Basile A, 2012, INT J PHYTOREMEDIAT, V14, P374, DOI 10.1080/15226514.2011.620653; Baum L, 2008, J CLIN PSYCHOPHARM, V28, P110, DOI 10.1097/jcp.0b013e318160862c; Baum L, 2007, PHARMACOL RES, V56, P509, DOI 10.1016/j.phrs.2007.09.013; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Behl C, 2002, FREE RADICAL BIO MED, V33, P182, DOI 10.1016/S0891-5849(02)00883-3; Behl T, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031413; Behl Tapan, 2020, Asian Pac J Cancer Prev, V21, P593, DOI 10.31557/APJCP.2020.21.3.593; Belikov AV, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0194-3; Belluzzi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038026; Beltz BS, 2007, NEUROSCI LETT, V415, P154, DOI 10.1016/j.neulet.2007.01.010; BENEDETTI A, 1980, BIOCHIM BIOPHYS ACTA, V620, P281, DOI 10.1016/0005-2760(80)90209-X; Benham AM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0403; BENZI G, 1990, J NEUROSCI RES, V26, P120, DOI 10.1002/jnr.490260116; Berggren KL, 2015, REDOX BIOL, V4, P363, DOI 10.1016/j.redox.2015.02.002; Bhat A, 2019, BIOFACTORS, V45, P666, DOI 10.1002/biof.1533; Bhattacharya T, 2021, EXP GERONTOL, V150, DOI 10.1016/j.exger.2021.111352; Bhattacharya T, 2021, CURR TOP MED CHEM, V21, P1014, DOI 10.2174/1568026621666210412151700; BIELSKI BHJ, 1983, J BIOL CHEM, V258, P4759; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Blesa J, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00091; Blesa J, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00155; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Bohr VA, 1999, J BIOENERG BIOMEMBR, V31, P391, DOI 10.1023/A:1005484004167; Bond L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00010; Bonfiglio JJ, 2017, MOL CELL, V65, P932, DOI 10.1016/j.molcel.2017.01.003; Bono-Yague J, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9070577; Borah A, 2013, CNS NEUROSCI THER, V19, P847, DOI 10.1111/cns.12175; Bosco DA, 2006, NAT CHEM BIOL, V2, P249, DOI 10.1038/nchembio782; Boselli M, 2017, J BIOL CHEM, V292, P19209, DOI 10.1074/jbc.M117.815126; Braidy N, 2017, CNS NEUROL DISORD-DR, V16, P387, DOI 10.2174/1871527316666170328113309; BRAND M, 2010, EXP GERONTOL, V45, P683, DOI DOI 10.1007/978-94-007-2512-6_112; Breda C, 2016, P NATL ACAD SCI USA, V113, P5435, DOI 10.1073/pnas.1604453113; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Browne SE, 1999, BRAIN PATHOL, V9, P147; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Buga AM, 2019, ONCOL LETT, V17, P4170, DOI 10.3892/ol.2019.9933; Bui AD, 2018, ANDROLOGIA, V50, DOI 10.1111/and.13012; Butterfield DA, 2001, MECH AGEING DEV, V122, P945, DOI 10.1016/S0047-6374(01)00249-4; Butterfield DA, 1997, J NEUROCHEM, V68, P2451; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Calabrese V, 2002, J NEUROSCI RES, V70, P580, DOI 10.1002/jnr.10408; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Cao JW, 2020, J ETHNOPHARMACOL, V257, DOI 10.1016/j.jep.2020.112884; Carrera-Julia S, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00063; Carri MT, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00041; Caruana M, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00031; CASTEGNA A, 2003, METHOD PHARMACOL TOX, P161; Castro MA, 2009, J NEUROCHEM, V110, P423, DOI 10.1111/j.1471-4159.2009.06151.x; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chahal R, 2021, MOLECULES, V26, DOI 10.3390/molecules26102933; Chakraborty J, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00535; Chang YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002849; Chanvitayapongs S, 1997, NEUROREPORT, V8, P1499, DOI 10.1097/00001756-199704140-00035; Chatgilialoglu C, 2001, EXP GERONTOL, V36, P1459, DOI 10.1016/S0531-5565(01)00132-2; Chen C, 2020, 3 BIOTECH, V10, DOI 10.1007/s13205-019-2032-x; Chen CM, 2007, BIOCHEM BIOPH RES CO, V359, P335, DOI 10.1016/j.bbrc.2007.05.093; Chen JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077023; Chen L, 2020, FREE RADICAL BIO MED, V160, P319, DOI 10.1016/j.freeradbiomed.2020.08.010; Chen XF, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1580967; Chen XF, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-017-0009-6; Chen XP, 2012, NEURAL REGEN RES, V7, P376, DOI 10.3969/j.issn.1673-5374.2012.05.009; Chen Y, 2015, MOLECULES, V20, P21167, DOI 10.3390/molecules201219750; Chen YQ, 2008, AUTOPHAGY, V4, P246, DOI 10.4161/auto.5432; Jin CY, 2007, ACTA PHARMACOL SIN, V28, P1645, DOI 10.1111/j.1745-7254.2007.00651.x; Chia T, 2008, IND HEALTH, V46, P174, DOI 10.2486/indhealth.46.174; Chitkara D, 2012, DRUG DELIV TRANSL RE, V2, P112, DOI 10.1007/s13346-012-0063-5; Cho ES, 2009, MUTAT RES-FUND MOL M, V661, P18, DOI 10.1016/j.mrfmmm.2008.10.021; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Choi YH, 2018, BIOMED PHARMACOTHER, V106, P902, DOI 10.1016/j.biopha.2018.07.035; Chung HJ, 2019, NEUROCHEM RES, V44, P1964, DOI 10.1007/s11064-019-02830-4; Ciancarelli I, 2014, BIOMARKERS, V19, P452, DOI 10.3109/1354750X.2014.935955; Cobley JN, 2018, REDOX BIOL, V15, P490, DOI 10.1016/j.redox.2018.01.008; Cookson MR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009415; Craft N E, 2004, J Nutr Health Aging, V8, P156; Craig L, 2008, J TOXICOL ENV HEAL A, V71, P588, DOI 10.1080/15287390801997732; Crichton R, 2016, IRON METABOLISM, V4th, P22, DOI [10.1002/9781118925645.ch2, DOI 10.1002/9781118925645.CH2]; Crown A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227655; Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354; Czarnek K, 2015, CENT EUR J IMMUNOL, V40, P236, DOI 10.5114/ceji.2015.52837; D'Ambrosio AL, 2001, MOL MED, V7, P367, DOI 10.1007/BF03402183; da Silva FL, 2013, NEUROCHEM INT, V62, P103, DOI 10.1016/j.neuint.2012.10.001; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; Daniel S, 2004, J INORG BIOCHEM, V98, P266, DOI 10.1016/j.jinorgbio.2003.10.014; Danielson SR, 2008, FREE RADICAL BIO MED, V44, P1787, DOI 10.1016/j.freeradbiomed.2008.03.005; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; Dauncey MJ, 2013, NUTRIENTS, V5, P887, DOI 10.3390/nu5030887; Davies NWS, 2010, INT J TRYPTOPHAN RES, V3, P121; Teles RBD, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7043213; de la Torre R, 2016, LANCET NEUROL, V15, P801, DOI 10.1016/S1474-4422(16)30034-5; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Devi KP, 2017, CURR DRUG TARGETS, V18, P1529, DOI 10.2174/1389450117666161227125121; Dewangan AK, 2017, J DRUG DELIV SCI TEC, V41, P269, DOI 10.1016/j.jddst.2017.07.022; DEXTER DT, 1992, ANN NEUROL, V32, pS94, DOI 10.1002/ana.410320716; Di Meo S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1245049; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Ding XR, 2019, TOXICOL LETT, V310, P51, DOI 10.1016/j.toxlet.2019.04.016; Ding YH, 2019, REJUV RES, V22, P289, DOI 10.1089/rej.2018.2107; Dk D., 2017, HEAT SHOCK PROTEINS, V4, P2, DOI [10.4172/2376-0419.1000175, DOI 10.4172/2376-0419.1000175]; Dong LP, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01224; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002; Du XB, 2021, ACS CHEM NEUROSCI, V12, P1112, DOI 10.1021/acschemneuro.0c00549; Duran R, 2010, J NEURAL TRANSM, V117, P325, DOI 10.1007/s00702-009-0364-0; Durcan TM, 2014, EMBO J, V33, P2473, DOI 10.15252/embj.201489729; Durcan TM, 2011, AUTOPHAGY, V7, P233, DOI 10.4161/auto.7.2.14224; Dutta D, 2005, AFR J BIOTECHNOL, V4, P1510; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; El-Naggar ME, 2019, COLLOID SURFACE B, V177, P389, DOI 10.1016/j.colsurfb.2019.02.024; Essawy AE, 2019, ENVIRON SCI POLLUT R, V26, P26060, DOI 10.1007/s11356-019-05862-z; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Fan YT, 2018, FOOD CHEM, V239, P1210, DOI 10.1016/j.foodchem.2017.07.075; Fang YC, 2020, PEERJ, V8, DOI 10.7717/peerj.9308; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Fernandes C, 2014, CURR MED CHEM, V21, P4311, DOI 10.2174/0929867321666140915141836; Fernandez-Garcia E, 2012, FOOD RES INT, V46, P438, DOI 10.1016/j.foodres.2011.06.007; Festa RA, 2011, CURR BIOL, V21, pR877, DOI 10.1016/j.cub.2011.09.040; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Firuzi O, 2011, CURR MED CHEM, V18, P3871, DOI 10.2174/092986711803414368; Flora SJS, 2008, INDIAN J MED RES, V128, P501; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fox JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000334; Fox JH, 2011, J BIOL CHEM, V286, P18320, DOI 10.1074/jbc.M110.199448; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; Frautschy SA, 2013, CURCUMIN YOGA THERAP; Freischmidt A, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-42; Freund-Levi Y, 2014, J ALZHEIMERS DIS, V42, P823, DOI 10.3233/JAD-132042; Fu AL, 2006, BRAIN RES, V1109, P201, DOI 10.1016/j.brainres.2006.06.042; Fu XJ, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/282854; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Gamez J, 2006, J NEUROL SCI, V247, P21, DOI 10.1016/j.jns.2006.03.006; Gamez-Valero A, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9111095; GARDNER HW, 1989, FREE RADICAL BIO MED, V7, P65, DOI 10.1016/0891-5849(89)90102-0; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; German CL, 2015, PHARMACOL REV, V67, P1005, DOI 10.1124/pr.114.010397; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; Giovannoni G, 1998, MULT SCLER J, V4, P212, DOI 10.1177/135245859800400323; Girotto S, 2012, J BIOL CHEM, V287, P18738, DOI 10.1074/jbc.M111.311589; Gleason CE, 2015, J ALZHEIMERS DIS, V47, P1009, DOI 10.3233/JAD-142958; Gluck MR, 2004, J NEUROCHEM, V91, P788, DOI 10.1111/j.1471-4159.2004.02747.x; Golenia A, 2014, PHARMACOL REP, V66, P704, DOI 10.1016/j.pharep.2014.02.021; Gomes AA, 2005, REDOX REP, V10, P91, DOI 10.1179/135100005X38833; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Gonzalez-Hunt Claudia P., 2018, Current Opinion in Toxicology, V7, P87, DOI 10.1016/j.cotox.2017.11.001; Gonzalez-Reyes S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/801418; Gorni Davide, 2020, Aging Med (Milton), V3, P205, DOI 10.1002/agm2.12121; Gorsuch WB, 2012, IMMUNOBIOLOGY, V217, P1026, DOI 10.1016/j.imbio.2012.07.024; GOTZ ME, 1994, PHARMACOL THERAPEUT, V63, P37, DOI 10.1016/0163-7258(94)90055-8; Gray NE, 2014, J ALZHEIMERS DIS, V40, P359, DOI 10.3233/JAD-131913; Grewal AK, 2021, BIOMED PHARMACOTHER, V140, DOI 10.1016/j.biopha.2021.111729; Guegn C, 2001, J NEUROSCI, V21, P6569, DOI 10.1523/JNEUROSCI.21-17-06569.2001; Guo SH, 2007, BIOL PSYCHIAT, V62, P1353, DOI 10.1016/j.biopsych.2007.04.020; Hadad N, 2017, NEUROMOL MED, V19, P436, DOI 10.1007/s12017-017-8459-5; Hajieva P, 2017, MOLECULES, V22, DOI 10.3390/molecules22010159; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Han J, 2010, NEUROSCIENCE, V169, P1039, DOI 10.1016/j.neuroscience.2010.05.049; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARTUNG HP, 1992, J NEUROIMMUNOL, V40, P197, DOI 10.1016/0165-5728(92)90134-7; Hassan SSU, 2021, CURR PHARM DESIGN, V27, P2605, DOI 10.2174/1381612826666200728142244; Hauser DN, 2013, FREE RADICAL BIO MED, V65, P419, DOI 10.1016/j.freeradbiomed.2013.06.030; He B, 2018, EUR J PHARMACOL, V825, P48, DOI 10.1016/j.ejphar.2018.02.024; Heckert EG, 2008, BIOMATERIALS, V29, P2705, DOI 10.1016/j.biomaterials.2008.03.014; Hendriks JJA, 2005, BRAIN RES REV, V48, P185, DOI 10.1016/j.brainresrev.2004.12.008; Hersch SM, 2006, NEUROLOGY, V66, P250, DOI 10.1212/01.wnl.0000194318.74946.b6; Hervera A, 2018, NAT CELL BIOL, V20, P307, DOI 10.1038/s41556-018-0039-x; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hewlings SJ, 2017, FOODS, V6, DOI 10.3390/foods6100092; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Holmstrom KM, 2013, BIOL OPEN, V2, P761, DOI 10.1242/bio.20134853; Hongo N, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00307; Hooten KG, 2015, NEUROTHERAPEUTICS, V12, P364, DOI 10.1007/s13311-014-0329-3; Hou C, 2018, ACS CHEM NEUROSCI, V9, P578, DOI 10.1021/acschemneuro.7b00385; Huang CY, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061707; Huang CW, 2018, CELL PHYSIOL BIOCHEM, V47, P330, DOI 10.1159/000489810; Huang F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060885; Huang YJ, 2013, NEUROSCI LETT, V535, P146, DOI 10.1016/j.neulet.2012.12.051; Huhn S, 2018, NEUROIMAGE, V174, P177, DOI 10.1016/j.neuroimage.2018.03.023; Hussain S, 2013, MOL CELL BIOL, V33, P1188, DOI 10.1128/MCB.01389-12; Hwang CJ, 2016, ONCOTARGET, V7, P46943, DOI 10.18632/oncotarget.10504; Iida T, 2001, NEURO-ONCOLOGY, V3, P73, DOI 10.1093/neuonc/3.2.73; Ino D, 2017, CELL MOL LIFE SCI, V74, P827, DOI 10.1007/s00018-016-2364-1; Iriti M, 2008, WATER AIR SOIL POLL, V187, P285, DOI 10.1007/s11270-007-9517-7; Islam MT, 2017, NEUROL RES, V39, P73, DOI 10.1080/01616412.2016.1251711; Israelson A, 2010, NEURON, V67, P575, DOI 10.1016/j.neuron.2010.07.019; Iverson SL, 2004, ARCH BIOCHEM BIOPHYS, V423, P37, DOI 10.1016/j.abb.2003.12.002; Jackson TS, 1998, CIRC RES, V83, P916; Jaguezeski AM, 2019, J FOOD BIOCHEM, V43, DOI 10.1111/jfbc.12942; Jain S, 2013, FREE RADICAL BIO MED, V65, P117, DOI 10.1016/j.freeradbiomed.2013.05.041; Jana Malabendu, 2013, J Clin Cell Immunol, V4, DOI 10.4172/2155-9899.1000157; Jana S, 2007, BRAIN RES, V1139, P195, DOI 10.1016/j.brainres.2006.09.100; Jedrak P, 2018, METAB BRAIN DIS, V33, P2005, DOI 10.1007/s11011-018-0308-1; Ji WZ, 2021, HIGH ALT MED BIOL, V22, P45, DOI 10.1089/ham.2020.0127; Jia WJ, 2019, HISTOL HISTOPATHOL, V34, P965, DOI 10.14670/HH-18-103; Jia Z, 2007, FREE RADICAL BIO MED, V42, P288, DOI 10.1016/j.freeradbiomed.2006.10.047; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Jung ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep08805; Kabir MT, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11030392; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kafi M, 2019, PHARMACOLOGYONLINE, V1, P104; Kahrizi F, 2016, IRAN J PHARM RES, V15, P835; Kakkar V, 2013, EUR J PHARM BIOPHARM, V85, P339, DOI 10.1016/j.ejpb.2013.02.005; Kalogeris T, 2014, REDOX BIOL, V2, P702, DOI 10.1016/j.redox.2014.05.006; Kang T, 2013, J BIOL CHEM, V288, P34394, DOI 10.1074/jbc.M113.514372; Karimi G, 2011, IRAN J BASIC MED SCI, V14, P308; KAUR H, 1994, FEBS LETT, V350, P9, DOI 10.1016/0014-5793(94)00722-5; Kaur I, 2021, ENVIRON SCI POLLUT R, V28, P8989, DOI 10.1007/s11356-020-12255-0; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Keynes RG, 2004, CURR MOL MED, V4, P179, DOI 10.2174/1566524043479176; Khan J, 2019, TOXICOLOGY, V428, DOI 10.1016/j.tox.2019.152299; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kim J, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0121-4; Kim J, 2016, J NEUROCHEM, V137, P436, DOI 10.1111/jnc.13507; Kim J, 2015, J NEUROSCI, V35, P14717, DOI 10.1523/JNEUROSCI.2053-15.2015; Kim J, 2012, EXP NEUROL, V235, P476, DOI 10.1016/j.expneurol.2011.11.010; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kim M, 2019, ANAT SCI INT, V94, P285, DOI 10.1007/s12565-019-00486-2; Kim S, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-4; Kocha, 2009, EFFICACY SAFETY CURC; Kobe T, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00105; Kong QM, 2010, CELL MOL LIFE SCI, V67, P1817, DOI 10.1007/s00018-010-0277-y; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Korovila I, 2017, REDOX BIOL, V13, P550, DOI 10.1016/j.redox.2017.07.008; Korsvik C, 2007, CHEM COMMUN, P1056, DOI 10.1039/b615134e; Kovac S, 2015, BBA-GEN SUBJECTS, V1850, P794, DOI 10.1016/j.bbagen.2014.11.021; Kovacic P, 2010, J NANOSCI NANOTECHNO, V10, P7919, DOI 10.1166/jnn.2010.3028; Kuhn DM, 1999, J NEUROCHEM, V73, P1309, DOI 10.1046/j.1471-4159.1999.0731309.x; Kumar A, 2018, CNS NEUROL DISORD-DR, V17, P642, DOI 10.2174/187152731709180926121555; Kumar H, 2012, INT J MOL SCI, V13, P10478, DOI 10.3390/ijms130810478; Kumar J, 2015, CNS NEUROL DISORD-DR, V14, P295, DOI 10.2174/1871527314666150116110212; Kumar M, 2018, CNS NEUROL DISORD-DR, V17, P654, DOI 10.2174/1871527317666180605072018; Kurutas EB, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0186-5; Lakey-Beitia J, 2015, MOL NEUROBIOL, V51, P466, DOI 10.1007/s12035-014-8722-9; Laskowitz DT., 2016, TRANSLATIONAL RES TR, P97; Colin-Gonzalez AL, 2015, NEUROCHEM INT, V89, P83, DOI 10.1016/j.neuint.2015.06.011; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee CS, 2003, NEUROCHEM INT, V43, P147, DOI 10.1016/S0197-0186(02)00214-0; Lee DH, 2010, J CLIN BIOCHEM NUTR, V47, P121, DOI 10.3164/jcbn.10-29; Lee GH, 2016, COLLOID SURFACE B, V143, P511, DOI 10.1016/j.colsurfb.2016.03.060; Lee K, 2012, EUR J PHARMACOL, V689, P89, DOI 10.1016/j.ejphar.2012.05.028; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee SJ, 2009, GLIA, V57, P1351, DOI 10.1002/glia.20854; Lee ST, 2012, ANN NEUROL, V72, P269, DOI 10.1002/ana.23588; Lee YK, 2003, BIOCHIMIE, V85, P947, DOI 10.1016/j.biochi.2003.09.012; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Leonard S, 1998, J INORG BIOCHEM, V70, P239, DOI 10.1016/S0162-0134(98)10022-3; Li C, 2018, NEUROPHARMACOLOGY, V135, P151, DOI 10.1016/j.neuropharm.2018.02.034; Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Li L, 2014, J NEUROCHEM, V131, P86, DOI 10.1111/jnc.12769; Li N, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3035125; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Li PY, 2018, NEUROPHARMACOLOGY, V134, P208, DOI 10.1016/j.neuropharm.2017.11.011; Li Q, 2011, J BIOL CHEM, V286, P40151, DOI 10.1074/jbc.M111.279711; Li W, 2013, AGEING RES REV, V12, P1005, DOI 10.1016/j.arr.2013.05.006; Li YX, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13321; Li Z, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00184; Liang N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010016; Lin YF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149750; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Liu J.T., 2015, NEUROIMMUNOL NEUROIN, V2, P131, DOI [DOI 10.4103/2347-8659.156980, 10.4103/2347-8659.156980]; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Liu KJ, 2001, MOL CELL BIOCHEM, V222, P41, DOI 10.1023/A:1017994720562; Liu W, 2011, FREE RADICAL BIO MED, V50, P166, DOI 10.1016/j.freeradbiomed.2010.10.709; Liu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08204-6; Liu Y, 2021, NEUROCHEM INT, V144, DOI 10.1016/j.neuint.2020.104931; Liu ZQ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21145022; Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902; Locatelli FM, 2018, J PHARMACOL SCI, V137, P395, DOI 10.1016/j.jphs.2018.08.006; Loeffler JP, 2016, BRAIN PATHOL, V26, P227, DOI 10.1111/bpa.12350; Long DM., 1989, INTRACRANIAL PRESSUR, V74, P799, DOI [10.1007/s00018-016-2364-1, DOI 10.1007/S00018-016-2364-1]; Long TC, 2006, ENVIRON SCI TECHNOL, V40, P4346, DOI 10.1021/es060589n; Lopez-Gonzalez R, 2016, NEURON, V92, P383, DOI 10.1016/j.neuron.2016.09.015; Lovell MA, 1999, J NEUROCHEM, V72, P771, DOI 10.1046/j.1471-4159.1999.0720771.x; Lucius R, 1998, FREE RADICAL BIO MED, V24, P798, DOI 10.1016/S0891-5849(97)00358-4; Ludtmann MHR, 2014, BIOCHEM J, V457, P415, DOI 10.1042/BJ20130863; Lukiw Walter J, 2012, Int J Biochem Mol Biol, V3, P105; LUND BO, 1993, BIOCHEM PHARMACOL, V45, P2017, DOI 10.1016/0006-2952(93)90012-L; Luo XG, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-12; Lushchak VI, 2007, BIOCHEMISTRY-MOSCOW+, V72, P809, DOI 10.1134/S0006297907080020; Lv XG, 2021, J BIOCHEM MOL TOXIC, V35, DOI 10.1002/jbt.22727; Ma Z, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101653; Maddocks ODK, 2014, MOL CELL, V55, P158, DOI 10.1016/j.molcel.2014.07.001; Maiuri T, 2017, HUM MOL GENET, V26, P395, DOI 10.1093/hmg/ddw395; Makkar R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124424; Mancuso C, 2007, FRONT BIOSCI-LANDMRK, V12, P1107, DOI 10.2741/2130; Margaill I, 2005, FREE RADICAL BIO MED, V39, P429, DOI 10.1016/j.freeradbiomed.2005.05.003; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Marques L, 2020, EXP CELL RES, V395, DOI 10.1016/j.yexcr.2020.112203; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; Martinez MC, 2009, ANTIOXID REDOX SIGN, V11, P669, DOI 10.1089/ars.2007.1993; Martinez-Cue C, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00016; Masaki H, 1997, J DERMATOL SCI, V14, P207, DOI 10.1016/S0923-1811(96)00576-2; Masoud ST, 2015, NEUROBIOL DIS, V74, P66, DOI 10.1016/j.nbd.2014.10.016; Masuda M, 2009, FEBS LETT, V583, P787, DOI 10.1016/j.febslet.2009.01.037; Mazzanti G, 2016, MOLECULES, V21, DOI 10.3390/molecules21091243; McKeon JE, 2015, CELL MOL LIFE SCI, V72, P1811, DOI 10.1007/s00018-014-1781-2; Mesenge C, 1998, EUR J PHARMACOL, V353, P53, DOI 10.1016/S0014-2999(98)00432-4; Mesole SB, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8425643; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Milligan JR, 2003, NUCLEIC ACIDS RES, V31, P6258, DOI 10.1093/nar/gkg816; MIRA L, 1994, BIOCHEM PHARMACOL, V48, P753, DOI 10.1016/0006-2952(94)90053-1; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; MIZUNO Y, 1987, J NEUROCHEM, V48, P1787, DOI 10.1111/j.1471-4159.1987.tb05737.x; Mochel F, 2015, RESVERATROL HUNTINGT; Lazaldin MAM, 2020, EUR J NEUROSCI, V51, P2394, DOI 10.1111/ejn.14662; Mollnes Tom E., 2002, Trends in Immunology, V23, P61, DOI 10.1016/S1471-4906(01)02129-9; MONTI D, 1992, ANN NY ACAD SCI, V673, P70, DOI 10.1111/j.1749-6632.1992.tb27438.x; Moreira Paula I., 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P51; Moretti M, 2017, CNS NEUROSCI THER, V23, P921, DOI 10.1111/cns.12767; Morris EJ, 2001, J NEUROSCI, V21, P5017, DOI 10.1523/JNEUROSCI.21-14-05017.2001; Morris MC, 1998, ALZ DIS ASSOC DIS, V12, P121, DOI 10.1097/00002093-199809000-00001; Morris MC, 2005, AM J CLIN NUTR, V81, P508; MUKAI K, 1993, LIPIDS, V28, P753, DOI 10.1007/BF02535999; Muronetz V, 2014, CURR TOP MED CHEM, V14, P2520, DOI 10.2174/1568026614666141203124057; Mustafa SA, 2015, MUTAGENESIS, V30, P107, DOI 10.1093/mutage/geu048; Naghizadeh B, 2013, PHYTOMEDICINE, V20, P537, DOI 10.1016/j.phymed.2012.12.019; Nakabeppu Y, 2007, J NEUROSCI RES, V85, P919, DOI 10.1002/jnr.21191; Naoi M, 2017, J NEURAL TRANSM, V124, P1515, DOI 10.1007/s00702-017-1797-5; Nato G, 2015, DEVELOPMENT, V142, P840, DOI 10.1242/dev.116657; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356, DOI 10.1152/ajpheart.1992.263.5.H1356; Ngwa HA, 2009, TOXICOL APPL PHARM, V240, P273, DOI 10.1016/j.taap.2009.07.025; Nie Q, 2011, ACTA PHARMACOL SIN, V32, P545, DOI 10.1038/aps.2011.14; Niedzielska E, 2016, MOL NEUROBIOL, V53, P4094, DOI 10.1007/s12035-015-9337-5; Nip J, 2001, ONCOGENE, V20, P910, DOI 10.1038/sj.onc.1204171; Nolfi-Donegan D, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101674; Oe S, 2019, FRONT BIOSCI-LANDMRK, V24, P1203, DOI 10.2741/4776; Ojha S, 2015, DRUG DES DEV THER, V9, P5499, DOI 10.2147/DDDT.S90616; OMAR R, 1993, EUR ARCH PSY CLIN N, V242, P262, DOI 10.1007/BF02190384; Omelchenko A, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1908-3; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Ortiz GG, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/708659; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Padayatty SJ, 2003, J AM COLL NUTR, V22, P18, DOI 10.1080/07315724.2003.10719272; Padmavathi P, 2018, MOL CELL TOXICOL, V14, P27, DOI 10.1007/s13273-018-0004-6; Padurariu M, 2013, PSYCHIAT DANUB, V25, P401; Palazzo L, 2021, CURR OPIN GENET DEV, V71, P106, DOI 10.1016/j.gde.2021.07.005; Palozza P, 2010, J NUTR BIOCHEM, V21, P34, DOI 10.1016/j.jnutbio.2008.10.002; Panday A, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.89; Pangeni R, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/48/485102; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Park C, 2019, MAR DRUGS, V17, DOI 10.3390/md17040225; Patterson J, 2008, EARLY INTERVENTION M; Paul BD, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00068; Paul BD, 2014, NATURE, V509, P96, DOI 10.1038/nature13136; Paul F, 2009, SUNPHENON EGCG EPIGA; Paulo EP De, 2000, INCREASED EXHALATION, V118, P93, DOI [10.1590/s1516-31802000000400004, DOI 10.1590/S1516-31802000000400004]; Pehar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103438; Perier C, 2003, TRENDS NEUROSCI, V26, P345, DOI 10.1016/S0166-2236(03)00144-9; Petrov D, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00068; Pfoh R, 2015, ENDOCR-RELAT CANCER, V22, pT35, DOI 10.1530/ERC-14-0516; Pfohl Stephen R, 2015, J Neuromuscul Dis, V2, P137; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Phaniendra A, 2015, INDIAN J CLIN BIOCHE, V30, P11, DOI 10.1007/s12291-014-0446-0; Pickles S, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0313-8; Pickles S, 2013, HUM MOL GENET, V22, P3947, DOI 10.1093/hmg/ddt249; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Pillai S., 2005, International Journal of Cosmetic Science, V27, P17, DOI 10.1111/j.1467-2494.2004.00241.x; Pizzimenti S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00242; PIZZINO G, 2017, OXID MED CELL LONGEV, V2017, DOI DOI 10.1155/2017/8416763; Polidori MC, 1999, NEUROSCI LETT, V272, P53, DOI 10.1016/S0304-3940(99)00578-9; Polito CA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050655; Poon HF, 2004, J GERONTOL A-BIOL, V59, P478; Poulose SM, 2012, EXPERT REV NEUROTHER, V12, P887, DOI 10.1586/ERN.12.86; Prajapati P, 2015, BBA-MOL BASIS DIS, V1852, P451, DOI 10.1016/j.bbadis.2014.11.019; Pratchayasakul W, 2020, NUTR NEUROSCI, DOI 10.1080/1028415X.2020.1840050; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Puspita L, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0340-9; Qiu ZH, 2006, J BIOL CHEM, V281, P16672, DOI 10.1074/jbc.M511648200; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; Rahman MA, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.639628; Rahman MH, 2021, PROCESSES, V9, DOI 10.3390/pr9020308; Rahman MH, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.619024; Rahman MH, 2021, CNS NEUROL DISORD-DR, V20, P694, DOI 10.2174/1871527319666200722153611; Raimondi M, 2019, AUTOPHAGY, V15, P613, DOI 10.1080/15548627.2018.1535291; Rajman M, 2017, DEVELOPMENT, V144, P2310, DOI 10.1242/dev.144337; Ramirez CM, 2011, ARTERIOSCL THROM VAS, V31, P2707, DOI 10.1161/ATVBAHA.111.232066; Rao Geeta, 2015, J Drug Metab Toxicol, V6, DOI 10.4172/2157-7609.1000187; Rao M. V., 2004, Indian Journal of Experimental Biology, V42, P495; Rastogi R, 2017, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00301; Raza SS, 2011, J NEUROL SCI, V309, P45, DOI 10.1016/j.jns.2011.07.035; Reddy MB., 2015, JBBS, V05, P194, DOI [10.4236/jbbs.2015.56020, DOI 10.4236/JBBS.2015.56020]; Rehder D, 2015, METALLOMICS, V7, P730, DOI 10.1039/c4mt00304g; Reichert CO, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228765; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Richardson JR, 2005, TOXICOL SCI, V88, P193, DOI 10.1093/toxsci/kfi304; Richardson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068256; Ringman John M., 2005, Current Alzheimer Research, V2, P131, DOI 10.2174/1567205053585882; Ringman JM, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt146; Rivas-Arancibia S, 2010, TOXICOL SCI, V113, P187, DOI 10.1093/toxsci/kfp252; Robinson JM, 2008, HISTOCHEM CELL BIOL, V130, P281, DOI 10.1007/s00418-008-0461-4; Rong X, 2021, CURR PHARM DESIGN, V27, P332, DOI 10.2174/1381612826666201023144836; Fernandez-Fernandez MR, 2011, NEUROBIOL DIS, V41, P23, DOI 10.1016/j.nbd.2010.08.014; Rosell A, 2008, ACTA NEUROCHIR SUPPL, V105, P173; Rosomoff HL, 1996, CRIT CARE MED, V24, pS48; Rossi L, 2008, NEUROCHEM RES, V33, P2390, DOI 10.1007/s11064-008-9696-7; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Rubbo H, 1995, ARCH BIOCHEM BIOPHYS, V324, P15, DOI 10.1006/abbi.1995.9935; Saccon RA, 2013, BRAIN, V136, P2342, DOI 10.1093/brain/awt097; Sairazi NSM, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/6565396; Sakai C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187934; Salama A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168688; Saleh RA, 2002, J ANDROL, V23, P737; Salehi B, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9010006; Salem HF, 2019, J DRUG TARGET, V27, P1127, DOI 10.1080/1061186X.2019.1608553; Sandhir R, 2015, NEUROCHEM INT, V89, P209, DOI 10.1016/j.neuint.2015.08.011; Sandhir R, 2010, NEUROCHEM INT, V57, P579, DOI 10.1016/j.neuint.2010.07.005; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Santa-Maria I, 2015, J CLIN INVEST, V125, P681, DOI 10.1172/JCI78421; Santos MJ, 2005, J BIOL CHEM, V280, P41057, DOI 10.1074/jbc.M505160200; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Schreibelt G, 2006, J IMMUNOL, V177, P2630, DOI 10.4049/jimmunol.177.4.2630; Sedlackova L, 2020, J MOL BIOL, V432, P2546, DOI 10.1016/j.jmb.2020.01.020; Segura-Aguilar J, 2014, J NEUROCHEM, V129, P898, DOI 10.1111/jnc.12686; SEREGI A, 1978, EXPERIENTIA, V34, P1056, DOI 10.1007/BF01915344; Serra V, 2003, J BIOL CHEM, V278, P6824, DOI 10.1074/jbc.M207939200; Sghaier R, 2019, FREE RADICAL RES, V53, P535, DOI 10.1080/10715762.2019.1612891; Shah SA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.538; Sharifi-Rad M, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00694; Sharifi-Rad M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041061; Sharma N, 2018, INFLAMMOPHARMACOLOGY, V26, P349, DOI 10.1007/s10787-017-0402-8; Sharma VK, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11050678; Sheikholeslami MA, 2021, EUR J PHARMACOL, V893, DOI 10.1016/j.ejphar.2020.173821; Shenoda B, 2015, TRANSL STROKE RES, V6, P181, DOI 10.1007/s12975-015-0395-9; Shi CX, 2020, MOL MED REP, V21, P123, DOI 10.3892/mmr.2019.10832; Shults CW, 1997, ANN NEUROL, V42, P261, DOI 10.1002/ana.410420221; Siddique Yasir Hasan, 2014, Journal of Dietary Supplements, V11, P121, DOI 10.3109/19390211.2013.859207; Siegel SJ, 2007, BIOCHEMISTRY-US, V46, P1503, DOI 10.1021/bi061853s; Sierksma A, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0285-1; Silverman A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00728; Singh S, 2019, BEHAV PHARMACOL, V30, P688, DOI 10.1097/FBP.0000000000000516; Singhal NK, 2011, J PINEAL RES, V50, P97, DOI 10.1111/j.1600-079X.2010.00819.x; Stockwell BR, 2016, BIOCHEM BIOPH RES CO, V176, P100, DOI [10.1016/j.bbrc.2016.10.086.Lipid, DOI 10.1016/J.BBRC.2016.10.086.LIPID]; van der Goes A, 2001, FASEB J, V15, P1852, DOI 10.1096/fj.00-0881fje; White T, 2015, BDPP TREATMENT MILD; Funmilayo E, 2016, J BIOL CHEM, V291, P15753, DOI 10.1074/jbc.M116.718023; Grassl GA., 2014, SYSTEMS BIOL FREE RA, P393, DOI [10.1007/978-3-642-30018-9_103, DOI 10.1007/978-3-642-30018-9_103]; He W., 2018, LIVER, P247, DOI [10.1016/B978-0-12-803951-9.00021-5, DOI 10.1016/B978-0-12-803951-9.00021-5]; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Mounsey RB, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/617472; Sivak JG., 2010, OPEN TOXICOL J, V4, P13, DOI [10.2174/1874340401004010013, DOI 10.2174/1874340401004010013]; Small GW, 2018, AM J GERIAT PSYCHIAT, V26, P266, DOI 10.1016/j.jagp.2017.10.010; Smith A P, 1999, Nutr Neurosci, V2, P249, DOI 10.1080/1028415X.1999.11747281; Smith EF, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.052; Smith KJ, 1999, BRAIN PATHOL, V9, P69; Smith PY, 2015, HUM MOL GENET, V24, P6721, DOI 10.1093/hmg/ddv377; Sorolla MA, 2008, FREE RADICAL BIO MED, V45, P667, DOI 10.1016/j.freeradbiomed.2008.05.014; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Stahl W, 2003, MOL ASPECTS MED, V24, P345, DOI 10.1016/S0098-2997(03)00030-X; Stefanis L, 1997, CURR OPIN NEUROL, V10, P299, DOI 10.1097/00019052-199708000-00004; Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004; Sun MS, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3804979; Sung S, 2003, FASEB J, V17, P323, DOI 10.1096/fj.03-0961fje; Takalo Mari, 2013, Am J Neurodegener Dis, V2, P1; Tan BL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01162; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tao W, 2020, EUR J NEUROL, V27, P1024, DOI 10.1016/j.ymthe.2020.09.006; Tegenge MA, 2014, EXP NEUROL, V253, P102, DOI 10.1016/j.expneurol.2013.12.016; Teraoka M, 2012, J CLIN BIOCHEM NUTR, V51, P122, DOI 10.3164/jcbn.D-11-00030; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Thapa A, 2015, ADV EXP MED BIOL, V863, P55, DOI 10.1007/978-3-319-18365-7_3; Thapa A, 2011, BIOCHEMISTRY-US, V50, P2445, DOI 10.1021/bi101731d; Thapak P, 2020, CELL MOL NEUROBIOL, DOI 10.1007/s10571-020-01012-z; Toda T, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/784698; Tokarz P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060898; Tokarz P, 2016, REJUV RES, V19, P131, DOI 10.1089/rej.2015.1717; Toledo JP, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.617821; Tonnies E, 2017, J ALZHEIMERS DIS, V57, P1105, DOI 10.3233/JAD-161088; Tosukhowong P, 2016, J NEUROL SCI, V367, P162, DOI 10.1016/j.jns.2016.05.056; Tsai YM, 2011, FOOD CHEM, V127, P918, DOI 10.1016/j.foodchem.2011.01.059; Turner RS, 2015, NEUROLOGY, V85, P1383, DOI 10.1212/WNL.0000000000002035; Ubhi K, 2014, EUR J NEUROSCI, V39, P1026, DOI 10.1111/ejn.12444; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Uddin MS, 2020, CURR PHARM DESIGN, V26, P4690, DOI 10.2174/1381612826666200406075044; Ustun R, 2019, NEUROL RES, V41, P265, DOI 10.1080/01616412.2018.1556494; Uzor NE, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00044; Vaiserman A, 2020, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00447; Valastyan JS, 2014, DIS MODEL MECH, V7, P9, DOI 10.1242/dmm.013474; Valko M, 2016, ARCH TOXICOL, V90, P1, DOI 10.1007/s00204-015-1579-5; van der Goes A, 1998, J NEUROIMMUNOL, V92, P67, DOI 10.1016/S0165-5728(98)00175-1; Van Heerebeek L, 2002, J CLIN PATHOL, V55, P561, DOI 10.1136/jcp.55.8.561; van Horssen J, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.050; van Meeteren ME, 2004, BIOCHEM PHARMACOL, V67, P967, DOI 10.1016/j.bcp.2003.10.018; Van Meter M, 2016, CELL REP, V16, P2641, DOI 10.1016/j.celrep.2016.08.006; Vanaja K, 2013, LIFE SCI, V93, P917, DOI 10.1016/j.lfs.2013.10.019; Varendi K, 2014, CELL MOL LIFE SCI, V71, P4443, DOI 10.1007/s00018-014-1628-x; Vauzour D, 2008, ARCH BIOCHEM BIOPHYS, V476, P145, DOI 10.1016/j.abb.2008.03.011; Veit F, 2015, ANTIOXID REDOX SIGN, V22, P537, DOI 10.1089/ars.2014.6234; Vigo-Pelfrey C, 1992, CELL BIOCHEM FUNCT, V6, P239, DOI [10.1016/0950-4214(92)80032-e, DOI 10.1016/0950-4214(92)80032-E]; Vijayvergiya C, 2005, J NEUROSCI, V25, P2463, DOI 10.1523/JNEUROSCI.4385-04.2005; Vilardo E, 2010, J BIOL CHEM, V285, P18344, DOI 10.1074/jbc.M110.112664; Vina J, 2013, GENISTEIN POSSIBLE T; Vis JC, 1999, NEUROPATH APPL NEURO, V25, P513; von Bernhardi R, 2010, J NEUROCHEM, V112, P1099, DOI 10.1111/j.1471-4159.2009.06537.x; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wagner H, 2018, ARAB J UROL, V16, P35, DOI 10.1016/j.aju.2017.11.001; Walder CE, 1997, STROKE, V28, P2252, DOI 10.1161/01.STR.28.11.2252; Wali G, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00401; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; Wan WB, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00001; Wang CY, 2021, NEUROCHEM RES, V46, P149, DOI 10.1007/s11064-020-03164-2; Wang CY, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101672; Wang F, 2015, AM J OBSTET GYNECOL, V213, P125, DOI 10.1016/j.ajog.2015.01.016; Wang FJ, 2018, TRAFFIC, V19, P918, DOI 10.1111/tra.12613; Wang J, 2015, BIOMATERIALS, V53, P475, DOI 10.1016/j.biomaterials.2015.02.116; Wang JT, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1972714; Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064020; Wang J, 2010, J ALZHEIMERS DIS, V22, P653, DOI 10.3233/JAD-2010-101074; Wang JQ, 2006, ANN OCCUP HYG, V50, P405, DOI 10.1093/annhyg/mei079; Wang YQ, 2015, AUTOPHAGY, V11, P595, DOI 10.1080/15548627.2015.1034408; Wang Z, 2018, TRANSL STROKE RES, V9, P74, DOI 10.1007/s12975-017-0559-x; Wei HY, 2017, TOXICOLOGY, V380, P94, DOI 10.1016/j.tox.2017.01.017; Wei W, 2021, METAB BRAIN DIS, V36, P545, DOI 10.1007/s11011-020-00657-5; Whitehead RE, 2001, J NEUROCHEM, V76, P1242, DOI 10.1046/j.1471-4159.2001.00125.x; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Winterbourn CC, 2015, FREE RADICAL BIO MED, V80, P164, DOI 10.1016/j.freeradbiomed.2014.08.017; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164; WOOD KA, 1995, J NEUROSCI, V15, P5851; Wu J, 2021, EUR J NEUROSCI, V53, P2532, DOI 10.1111/ejn.15150; Wu KC, 2011, TOXICOL SCI, V123, P590, DOI 10.1093/toxsci/kfr183; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Xiao YJ, 2018, PHARMACOL RES, V138, P25, DOI 10.1016/j.phrs.2018.09.008; Xiong R, 2014, NEUROBIOL AGING, V35, P705, DOI 10.1016/j.neurobiolaging.2013.09.027; Xu D, 2019, MOLECULES, V24, DOI 10.3390/molecules24061123; Xu K, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1054797; Xu NJ, 2017, MOLECULES, V22, DOI 10.3390/molecules22122066; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yakunin E, 2010, J NEUROSCI RES, V88, P866, DOI 10.1002/jnr.22246; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yang JX, 2016, ADV EXP MED BIOL, V886, P13, DOI 10.1007/978-94-017-7417-8_2; Yang SH, 2020, MOL NEUROBIOL, V57, P4090, DOI 10.1007/s12035-020-02014-0; Yang XF, 2008, J MOL NEUROSCI, V34, P165, DOI 10.1007/s12031-007-9033-7; Yang XW, 2016, J ETHNOPHARMACOL, V185, P361, DOI 10.1016/j.jep.2016.03.031; Yerbury JJ, 2013, CELL STRESS CHAPERON, V18, P251, DOI 10.1007/s12192-012-0371-1; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z; Yin ZY, 2020, NEUROREPORT, V31, P825, DOI 10.1097/WNR.0000000000001491; Ying YB, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00367-y; Yu Wen-Ran, 2008, Neurosci Bull, V24, P73, DOI 10.1007/s12264-008-0073-y; Yun SJ, 2020, BIOL TRACE ELEM RES, V194, P210, DOI 10.1007/s12011-019-01766-8; Zaidi SMKR, 2004, CLIN CHIM ACTA, V340, P229, DOI 10.1016/j.cccn.2003.11.003; ZAMAN Z, 1992, AGE AGEING, V21, P91, DOI 10.1093/ageing/21.2.91; Zarkovic N, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030767; Zeeshan HMA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030327; Zhang C, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00615; Zhang NS, 2018, THERANOSTICS, V8, P2264, DOI 10.7150/thno.23734; Zhang YW, 2017, MOL CELL, V65, P323, DOI 10.1016/j.molcel.2016.12.013; Zhang Z, 2001, ARCH BIOCHEM BIOPHYS, V392, P311, DOI 10.1006/abbi.2001.2464; Zhao JJ, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00342; Zhao RZ, 2019, INT J MOL MED, V44, P3, DOI 10.3892/ijmm.2019.4188; Zhao YH, 2013, NEUROREPORT, V24, P318, DOI 10.1097/WNR.0b013e32835fb6b0; Zhong HQ, 2015, REDOX BIOL, V4, P193, DOI 10.1016/j.redox.2014.12.011; Zhong HQ, 2014, REDOX BIOL, V2, P878, DOI 10.1016/j.redox.2014.04.003; Zhou Y, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0094-3; Zhu Carolyn W, 2018, Alzheimers Dement (N Y), V4, P609, DOI 10.1016/j.trci.2018.09.009; Zhu HY, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.920101; Zou WG, 2001, J NEUROSCI RES, V64, P646, DOI 10.1002/jnr.1118; Zovoilis A, 2011, EMBO J, V30, P4299, DOI 10.1038/emboj.2011.327; Zucca FA, 2014, NEUROTOX RES, V25, P13, DOI 10.1007/s12640-013-9435-y	624	0	0	7	7	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.												10.1007/s11356-021-16693-2		OCT 2021	48	Environmental Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	WE7UH	WOS:000705825600007	34617231	Bronze			2022-02-06	
J	Wang, YB; Brazdzionis, J; Dong, FL; Patchana, T; Ghanchi, H; Podkovik, S; Wiginton, JG; Marino, M; Duong, J; Wacker, M; Miulli, DE; Neeki, M; Bi, XN; Baudry, M				Wang, Yubin; Brazdzionis, James; Dong, Fanglong; Patchana, Tye; Ghanchi, Hammad; Podkovik, Stacey; Wiginton, James G.; Marino, Maxwell; Duong, Jason; Wacker, Margaret; Miulli, Dan E.; Neeki, Michael; Bi, Xiaoning; Baudry, Michel			P13BP, a Calpain-2-Mediated Breakdown Product of PTPN13, Is a Novel Blood Biomarker for Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						calpain; blood biomarker; PTPN13; traumatic brain injury	CALPAIN; INHIBITOR	Biomarkers play an increasing role in medicinal biology. They are used for diagnosis, management, drug target identification, drug responses, and disease prognosis. We have discovered that calpain-1 and calpain-2 play opposite functions in neurodegeneration, with calpain-1 activation being neuroprotective, while prolonged calpain-2 activation is neurodegenerative. This notion has been validated in several mouse models of acute neuronal injury, in particular in mouse models of traumatic brain injury (TBI) and repeated concussions. We have identified a selective substrate of calpain-2, the tyrosine phosphatase, PTPN13, which is cleaved in brain after TBI. One of the fragments generated by calpain-2, referred to as P13BP, is also found in the blood after TBI both in mice and humans. In humans, P13BP blood levels are significantly correlated with the severity of TBI, as measured by Glasgow Coma Scale scores and loss of consciousness. The results indicate that P13BP represents a novel blood biomarker for TBI.	[Wang, Yubin; Dong, Fanglong; Bi, Xiaoning; Baudry, Michel] Western Univ Hlth Sci, Pomona Valley, CA 91766 USA; [Brazdzionis, James; Patchana, Tye; Ghanchi, Hammad; Podkovik, Stacey; Wiginton, James G.; Marino, Maxwell] Riverside Univ Hlth Syst, Med Ctr, Moreno Valley, CA USA; [Duong, Jason; Wacker, Margaret; Miulli, Dan E.; Neeki, Michael] Arrowhead Reg Med Ctr, Colton, CA USA		Baudry, M (corresponding author), Western Univ Hlth Sci, Grad Coll Biomed Sci, 309 E 2nd St, Pomona, CA 91766 USA.	mbaudry@westernu.edu		Wiginton IV, James/0000-0001-9765-7145	Office of the Assistant Secretary of Defense for Health Affairs through The Defense Medical Research and Development Program [W81XWH-19-1-0329, BA170606]; Daljit and Elaine Sarkaria Chair	work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through The Defense Medical Research and Development Program under Award No. W81XWH-19-1-0329. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. Grant #BA170606. "Optimization of a selective calpain-2 inhibitor for prolonged field care in Traumatic Brain Injury.''.XB is supported in part by funds from the Daljit and Elaine Sarkaria Chair.	Anagli J, 2009, BIOCHEM BIOPH RES CO, V385, P94, DOI 10.1016/j.bbrc.2009.04.141; Baudry M, 2016, TRENDS NEUROSCI, V39, P235, DOI 10.1016/j.tins.2016.01.007; Di Pietro V, 2021, BRIT J SPORT MED, V55, P1395, DOI 10.1136/bjsports-2020-103274; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Kobeissy FH, 2015, BRAIN NEUROTRAUMA MO; Kobeissy FH, 2015, MOL NEUROBIOL, V52, P696, DOI 10.1007/s12035-014-8898-z; Koumura A, 2008, NEUROSCIENCE, V157, P309, DOI 10.1016/j.neuroscience.2008.09.007; Liu S, 2014, BRAIN INJURY, V28, P133, DOI 10.3109/02699052.2013.860479; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; Okonkwo DO, 2020, J NEUROTRAUM, V37, P2460, DOI 10.1089/neu.2020.7140; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Poirier MP, 2000, PEDIATR EMERG CARE, V16, P278, DOI 10.1097/00006565-200008000-00018; Shahim P, 2020, NEUROLOGY, V95, pE623, DOI 10.1212/WNL.0000000000009985; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Siklos M, 2015, ACTA PHARM SIN B, V5, P506, DOI 10.1016/j.apsb.2015.08.001; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Vosler PS, 2009, EXP NEUROL, V218, P213, DOI 10.1016/j.expneurol.2009.04.032; Wang YB, 2018, J NEUROTRAUM, V35, P105, DOI 10.1089/neu.2017.5024; Wang YB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12236-3; Wang YB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4051; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Yildiz-Unal A, 2015, NEUROPSYCH DIS TREAT, V11, P297, DOI 10.2147/NDT.S78226	24	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2021	38	22					3077	3085		10.1089/neu.2021.0229		OCT 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WY7FJ	WOS:000704463800001	34498916				2022-02-06	
J	Cook, CE; Sheean, AJ; Zhou, L; Min, KS; Rhon, DI				Cook, Chad E.; Sheean, Andrew J.; Zhou, Liang; Min, Kyong S.; Rhon, Daniel I.			Does Surgery for Cruciate Ligament and Meniscus Injury Increase the Risk of Comorbidities at 2 Years in the Military System?	JOURNAL OF KNEE SURGERY			English	Article; Early Access						knee surgery; cruciate ligament; meniscus surgery; knee	CONSERVATIVE TREATMENT; PHYSICAL-ACTIVITY; SLEEP-APNEA; OPIOID USE; HEALTH; RECONSTRUCTION; COMPLICATIONS; TEARS; PAIN	This study aims to determine whether surgery for cruciate ligament (anterior or posterior) or meniscus injury increased risks of subsequent comorbidities in beneficiaries of the Military Health System. The study was a retrospective case-control design in which individuals with cruciate or meniscus injuries were divided into two groups (surgery or none). Data were pulled 12 months prior and 24 months following each respective event and presence of comorbidities were compared between the two groups. Bivariate analyses and logistic regression were used to determine if surgery increased the odds of comorbidities. Participants included 1,686 with a cruciate ligament injury (30.1% treated surgically) and 13,146 with a meniscus injury (44.4% treated surgically). Bivariate comparisons of surgery versus nonsurgical treatment found multiple significant differences. After adjusting for covariates, a significant ( p <0.05) protective effect was seen only for meniscus surgery for concussion, insomnia, other mental health disorders, depression, and substance abuse. Surgery had no increased/decreased risk of comorbidities for cruciate ligament injuries. For meniscus injuries, surgery demonstrated a protective effect for six of the comorbidities we assessed. The treatment approach (surgery vs. nonsurgical) did not change the risk of comorbidities in those with a cruciate ligament injury. It is noteworthy that three of the six comorbidities involved mental health disorders. Although the study design does not allow for determination of causation, these findings should compel future prospective study designs that could confirm these findings.	[Cook, Chad E.] Duke Univ, Dept Orthopaed, Durham, NC USA; [Cook, Chad E.] Dept Populat Hlth Sci, Durham, NC USA; [Cook, Chad E.; Rhon, Daniel I.] Duke Clin Res Inst, Durham, NC USA; [Sheean, Andrew J.] Brooke Army Med Ctr, Dept Orthopaed Surg, San Antonio, TX USA; [Zhou, Liang; Min, Kyong S.] Tripler Army Med Ctr, Dept Orthopaed Surg, Honolulu, HI USA; [Rhon, Daniel I.] Brooke Army Med Ctr, Dept Rehabil Med, San Antonio, TX USA		Cook, CE (corresponding author), Duke Univ, 317 Trent Dr, Durham, NC 27710 USA.	chad.cook@duke.edu	Rhon, Daniel/C-9542-2011	Rhon, Daniel/0000-0002-4320-990X; Cook, Chad/0000-0001-8622-8361			Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1017/S0021963098003448; Barber-Westin S, 2020, SPORTS HEALTH, V12, P587, DOI 10.1177/1941738120912846; Benchimol EI, 2016, Z EVIDENZ FORTBILD Q, V115, P33, DOI [10.1016/j.zefq.2016.07.010, 10.1371/journal.pmed.1001885]; Boden BP, 2000, ORTHOPEDICS, V23, P573, DOI 10.3928/0147-7447-20000601-15; Cameron KL, 2016, J ATHL TRAINING, V51, P952, DOI 10.4085/1062-6050-51.5.03; Chow S-C., 2007, SAMPLE SIZE CALCULAT, V2nd, P106; Cremeans-Smith JK, 2006, J BEHAV MED, V29, P215, DOI 10.1007/s10865-005-9045-0; Dijksma CI, 2020, MIL MED, V185, pE480, DOI 10.1093/milmed/usz328; Doral MN, 2018, EFORT OPEN REV, V3, P260, DOI 10.1302/2058-5241.3.170067; Faucett SC, 2019, AM J SPORT MED, V47, P762, DOI 10.1177/0363546518755754; Glogovac G, 2019, ARTHROSCOPY, V35, P2222, DOI 10.1016/j.arthro.2019.01.045; Gwathmey FW, 2012, CLIN ORTHOP RELAT R, V470, P2059, DOI 10.1007/s11999-012-2303-x; Harrington D, 2019, NEW ENGL J MED, V381, P285, DOI 10.1056/NEJMe1906559; Hauschild Veronique D, 2018, US Army Med Dep J, P22; Jones BH, 2018, J SCI MED SPORT, V21, P1139, DOI 10.1016/j.jsams.2018.02.011; Jones DL, 2012, J ARTHROPLASTY, V27, P1289, DOI 10.1016/j.arth.2011.10.030; Jones JC, 2012, J ATHL TRAINING, V47, P67; Kaplan RM, 2007, ANNU REV PUBL HEALTH, V28, P321, DOI 10.1146/annurev.publhealth.28.021406.144141; Kersten RFMR, 2012, PHYS THER, V92, P1109, DOI 10.2522/ptj.20110273; Krause M, 2018, DTSCH ARZTEBL INT, V115, P855, DOI 10.3238/arztebl.2018.0855; Kunze KN, 2019, ARTHROSCOPY, V35, P461, DOI 10.1016/j.arthro.2018.09.021; Lee SH, 2020, CLIN J SPORT MED, V30, P195, DOI 10.1097/JSM.0000000000000585; Li JJ, 2017, ARTHRIT CARE RES, V69, P742, DOI 10.1002/acr.22994; Matthewson G, 2021, CLIN J SPORT MED, V31, P313, DOI 10.1097/JSM.0000000000000762; Molloy JM, 2020, MIL MED, V185, pE1461, DOI 10.1093/milmed/usaa027; Monk AP, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011166.pub2; Moreira-Silva I, 2016, WORKPLACE HEALTH SAF, V64, P210, DOI 10.1177/2165079916629688; Owens BD, 2007, MIL MED, V172, P90, DOI 10.7205/MILMED.172.1.90; Pihl K, 2018, OSTEOARTHR CARTILAGE, V26, P1008, DOI 10.1016/j.joca.2018.05.004; Pujol N, 2012, ORTHOP TRAUMATOL-SUR, V98, pS171, DOI 10.1016/j.otsr.2012.09.007; Pujol N, 2012, ORTHOP TRAUMATOL-SUR, V98, pS160, DOI 10.1016/j.otsr.2012.09.013; Raj MA., 2021, STATPEARLS; Ratzlaff C, 2016, RHEUMATOL INT, V36, P371, DOI 10.1007/s00296-015-3361-7; Rhon DI, 2020, J PRIM CARE COMMUNIT, V11, DOI 10.1177/2150132720957438; Rhon DI, 2019, PAIN PHYSICIAN, V22, pE351; Rhon DI, 2019, BRIT J SPORT MED, V53, P547, DOI 10.1136/bjsports-2018-099294; Rhon DI, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0588-8; Rodriguez MJ, 2019, J KNEE SURG, V32, P134, DOI 10.1055/s-0038-1676956; Schulz MS, 2003, ARCH ORTHOP TRAUM SU, V123, P186, DOI 10.1007/s00402-002-0471-y; Skou ST, 2018, ACTA ORTHOP, V89, P336, DOI 10.1080/17453674.2018.1447281; Stahlman Shauna, 2018, MSMR, V25, P2; Tjoumakaris FP, 2012, CLIN ORTHOP RELAT R, V470, P630, DOI 10.1007/s11999-011-2153-y; Tucker CJ, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119875139; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; van de Graaf VA, 2016, ARTHROSCOPY, V32, P1855, DOI 10.1016/j.arthro.2016.05.036; Walsh TP, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2137-0	46	0	0	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	1538-8506	1938-2480		J KNEE SURG	J. Knee Surg.												10.1055/s-0041-1736197		OCT 2021	10	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	WB6UZ	WOS:000703707000001	34610640				2022-02-06	
J	Govindula, A; Pai, A; Baghel, S; Mudgal, J				Govindula, Anusha; Pai, Anuja; Baghel, Saahil; Mudgal, Jayesh			Molecular mechanisms of cordycepin emphasizing its potential against neuroinflammation: An update	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Neuroinflammation; Cordycepin; CNS disorders; Neuroinflammatory targets; Cordyceps militaris	MEDIATED IMMUNE ACTIVATION; NF-KAPPA-B; NLRP3 INFLAMMASOME; PARKINSONS-DISEASE; CHRONIC STRESS; DEPRESSION; ADENOSINE; RECEPTOR; MICROGLIA; PATHWAYS	Recent research emphasizes the central role of neuroinflammation in complex neurological disorders such as Alzheimer's disease, Parkinson's disease, depression, multiple sclerosis, and traumatic brain injury. Multiple pathological variables with identical molecular mechanisms have been implicated in the development of CNS inflammatory diseases. Therefore, one of the most crucial tasks in the management of CNS disorders is the alleviation of neuroinflammation. However, there are many drawbacks of new pharmacological drugs used in the management of CNS disorders, including medication side effects, and treatment complications. There is a growing inclination towards bioactive constituents of natural origin to unearth the potential remedies. Cordycepin, an adenosine analogue, is one such bioactive constituent with multiple actions, viz., anticancer, antiinflammatory, hepato-protective, antidepressant, anti-Alzheimer's, anti-Parkinsonian and immunomodulatory effects, along with the promotion of remyelination. This review highlights the converging neuroinflammatory targets of cordycepin in Alzheimer's disease, Parkinson's disease, and depression, to substantiate its antineuroinflammatory property. Cordycepin acts by downregulation of adenosine A2 receptor, inhibition of microglial activation, and subsequent inhibition of several neuroinflammatory markers (NF-Kappa B, NLRP3 inflammasome, IL-1 beta, iNOS, COX-2, TNF-alpha, and HMGB1). Cordycepin mitigates LPS-mediated toll-like receptor activation by activating adenosine receptor A1, thereby improving antioxidant enzymes (superoxide dismutase, glutathione peroxidase) levels. These pieces of evidence point to the probable anti-neuroinflammatory mechanisms of cordycepin, which could facilitate the development of new remedies against neuroinflammationassociated CNS disorders.	[Govindula, Anusha; Pai, Anuja; Baghel, Saahil; Mudgal, Jayesh] Manipal Acad Higher Educ, Dept Pharmacol, Manipal Coll Pharmaceut Sci, Manipal 576104, India		Mudgal, J (corresponding author), Manipal Acad Higher Educ, Dept Pharmacol, Manipal Coll Pharmaceut Sci, Manipal 576104, India.	jayeshmudgal@gmail.com	Govindula, Anusha/AAU-7680-2021; Mudgal, Jayesh/H-4733-2019	Govindula, Anusha/0000-0003-2732-0883; Mudgal, Jayesh/0000-0001-8190-7031			Alcocer-Gomez E, 2014, BRAIN BEHAV IMMUN, V36, P111, DOI 10.1016/j.bbi.2013.10.017; Armentero MT, 2011, PHARMACOL THERAPEUT, V132, P280, DOI 10.1016/j.pharmthera.2011.07.004; Beneyto M, 2007, NEUROPSYCHOPHARMACOL, V32, P1888, DOI 10.1038/sj.npp.1301312; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Bohush A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102973; Bortolotto V, 2017, CNS NEUROL DISORD-DR, V16, P1066, DOI 10.2174/1871527315666160803153459; BRATTIN WJ, 1978, MOL CELL ENDOCRINOL, V9, P279, DOI 10.1016/0303-7207(78)90070-9; Cao ZP, 2018, PHYSIOL BEHAV, V184, P135, DOI 10.1016/j.physbeh.2017.11.026; Carvalho K, 2019, BRAIN, V142, P3636, DOI 10.1093/brain/awz288; Cerami C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050993; Chauhan AK, 2018, MOL NEUROBIOL, V55, P2162, DOI 10.1007/s12035-017-0455-0; Chen X., 2018, ASIA PACIFIC J CLIN, V3, P136, DOI [10.4103/2542-3932.245217, DOI 10.4103/2542-3932.245217]; Cheng CY, 2019, LIFE SCI, V223, P120, DOI 10.1016/j.lfs.2019.02.037; Cheng YJ, 2017, METAB BRAIN DIS, V32, P1133, DOI 10.1007/s11011-017-0003-7; Choi DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005482; Choi YH, 2014, DRUG DES DEV THER, V8, P1941, DOI 10.2147/DDDT.S71957; Coelho JE, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00067; Dong ZSW, 2019, EUR J PHARMACOL, V853, P325, DOI 10.1016/j.ejphar.2019.04.015; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Elkhateeb WA, 2019, EGYPT PHARM J, V18, P88, DOI 10.4103/epj.epj_17_19; Franklin TC, 2018, BRAIN BEHAV IMMUN, V72, P2, DOI 10.1016/j.bbi.2017.10.025; Franklin TC, 2018, BIOL PSYCHIAT, V83, P50, DOI 10.1016/j.biopsych.2017.06.034; Gil-martinez A.L., 2020, STUDY LINK NEURONAL, V12, P1, DOI [10.3389/fnagi.2020.00214, DOI 10.3389/FNAGI.2020.00214]; Goncalves FQ, 2019, NEUROBIOL DIS, V132, DOI 10.1016/j.nbd.2019.104570; Guo XY, 2020, NEUROPHARMACOLOGY, V181, DOI 10.1016/j.neuropharm.2020.108336; Guo YX, 2020, LIFE SCI, V263, DOI 10.1016/j.lfs.2020.118582; Han YY, 2019, J NEUROCHEM, V151, P79, DOI 10.1111/jnc.14826; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Hirsch Etienne C, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS210, DOI 10.1016/S1353-8020(11)70065-7; Hughes C, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0792-9; Imamura K, 2015, BIOSCI BIOTECH BIOCH, V79, P1021, DOI 10.1080/09168451.2015.1008977; Jeong JW, 2010, INT IMMUNOPHARMACOL, V10, P1580, DOI 10.1016/j.intimp.2010.09.011; Jia Y, 2019, INT IMMUNOPHARMACOL, V75, DOI 10.1016/j.intimp.2019.105777; Ju HT, 2013, J NEUROSURG, V118, P1239, DOI 10.3171/2013.3.JNS122051; Jung YJ, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00313; Kaufmann FN, 2017, BRAIN BEHAV IMMUN, V64, P367, DOI 10.1016/j.bbi.2017.03.002; Khan MM, 2013, NEUROCHEM INT, V62, P379, DOI 10.1016/j.neuint.2013.01.029; Kim SJ, 2019, LAB INVEST, V99, P1389, DOI 10.1038/s41374-019-0254-5; Kim YO, 2019, SAUDI J BIOL SCI, V26, P1352, DOI 10.1016/j.sjbs.2018.08.011; Kirik, 2016, NEUROSCI BEHAV PHYSL, V46, P284, DOI [DOI 10.1007/S11055-016-0231-Z, 10.1007/s11055-016-0231-z]; Leonard B, 2012, NEUROSCI BIOBEHAV R, V36, P764, DOI 10.1016/j.neubiorev.2011.12.005; Li B, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv112; Liang ZX, 2016, PROG NEUROBIOL, V137, P1, DOI 10.1016/j.pneurobio.2015.11.001; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P664, DOI 10.1016/j.pnpbp.2010.06.014; Mao ZJ, 2017, NEUROCHEM RES, V42, P1104, DOI 10.1007/s11064-017-2185-0; Navia AM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071739; Merighi S., 2018, RECEPTOR, V34, P33, DOI [10.1007/978-3-319-90808-3_3, DOI 10.1007/978-3-319-90808-3_3]; Milner MT, 2021, CURR OPIN IMMUNOL, V68, P116, DOI 10.1016/j.coi.2020.10.011; Ming JCK, 2011, J ETHNOPHARMACOL, V138, P201, DOI 10.1016/j.jep.2011.08.081; Olatunji OJ, 2016, BIOMED PHARMACOTHER, V81, P7, DOI 10.1016/j.biopha.2016.03.009; Origlia N, 2008, J NEUROSCI, V28, P3521, DOI 10.1523/JNEUROSCI.0204-08.2008; Pan Y, 2014, BRAIN BEHAV IMMUN, V41, P90, DOI 10.1016/j.bbi.2014.04.007; Peng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125902; Picca A, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080647; Qin P, 2019, MOLECULES, V24, DOI 10.3390/molecules24122231; Ramesh G., 2014, INFLAMM CELL SIGNAL, V1, pE111, DOI [10.14800/ics.111, DOI 10.14800/ICS.111]; Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586; Rodman LE, 1997, TOXICOL APPL PHARM, V147, P39, DOI 10.1006/taap.1997.8264; Sachdeva S, 2013, SAUDI PHARM J, V21, P245, DOI 10.1016/j.jsps.2012.05.011; Shippy DC, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.563446; Song H, 2018, NEUROTOXICOLOGY, V68, P73, DOI 10.1016/j.neuro.2018.07.008; Sun Y., 2020, J FUNCT FOODS; Swanton T, 2018, SLAS DISCOV, V23, P991, DOI 10.1177/2472555218786210; Szopa A, 2019, PHARMACOL REP, V71, P676, DOI 10.1016/j.pharep.2019.03.007; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Thawkar BS, 2019, J NEUROIMMUNOL, V326, P62, DOI 10.1016/j.jneuroim.2018.11.010; Tuli HS, 2014, 3 BIOTECH, V4, P1, DOI 10.1007/s13205-013-0121-9; van Calker D, 2019, J NEUROCHEM, V151, P11, DOI 10.1111/jnc.14841; Wager CML, 2015, INFECT IMMUN, V83, P4513, DOI 10.1128/IAI.00935-15; Wang JQ, 2005, MOL NEUROBIOL, V32, P237, DOI 10.1385/MN:32:3:237; Weber MD, 2015, J NEUROSCI, V35, P316, DOI 10.1523/JNEUROSCI.3561-14.2015; Welcome MO, 2020, PHARMANUTRITION, V11, DOI 10.1016/j.phanu.2020.100176; Wu AG, 2021, AGEING RES REV, V65, DOI 10.1016/j.arr.2020.101202; Xiao LL, 2020, MOL NEUROBIOL, V57, P5130, DOI 10.1007/s12035-020-02082-2; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yang J, 2017, BIOMED PHARMACOTHER, V95, P1777, DOI 10.1016/j.biopha.2017.09.103; Yang JL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00724; Yang LY, 2020, FUNGAL GENET BIOL, V143, DOI 10.1016/j.fgb.2020.103431; Yang Q, 2020, PSYCHOPHARMACOLOGY, V237, P3201, DOI 10.1007/s00213-020-05604-x; Yang QQ, 2019, GLIA, V67, P1017, DOI 10.1002/glia.23571; Yang RR, 2020, INFLAMMATION, V43, P752, DOI 10.1007/s10753-019-01162-3; Yao LH, 2019, KOREAN J PHYSIOL PHA, V23, P483, DOI 10.4196/kjpp.2019.23.6.483; Zhang HF, 2019, GEN PSYCHIAT, V32, DOI 10.1136/gpsych-2019-100084; Zhang TZ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/438506; Zhang ZT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0539-1; Zhao JJ, 2019, J AFFECT DISORDERS, V256, P117, DOI 10.1016/j.jad.2019.05.065; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P429, DOI 10.1089/acm.1998.4.429	87	0	0	11	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	OCT 5	2021	908								174364	10.1016/j.ejphar.2021.174364			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	UF4XO	WOS:000688578900006	34297967				2022-02-06	
J	Karakurt, G; Whiting, K; Jones, SE; Lowe, MJ; Rao, SM				Karakurt, Gunnur; Whiting, Kathleen; Jones, Stephen E.; Lowe, Mark J.; Rao, Stephen M.			Brain Injury and Mental Health Among the Victims of Intimate Partner Violence: A Case-Series Exploratory Study	FRONTIERS IN PSYCHOLOGY			English	Article						intimate partner violence; traumatic brain injury; brain imaging; mental health; abusive relationship	POSTTRAUMATIC-STRESS-DISORDER; WHITE-MATTER INTEGRITY; FUNCTIONAL CONNECTIVITY; AXONAL INJURY; INTERPERSONAL VIOLENCE; NETWORK CONNECTIVITY; DOMESTIC VIOLENCE; NEURAL MECHANISMS; ANXIETY DISORDER; STRIA TERMINALIS	Intimate partner violence (IPV) survivors frequently report face, head, and neck as their injury site. Many mild traumatic brain injuries (TBIs) are undiagnosed or underreported among IPV survivors while these injuries may be linked to changes in brain function or pathology. TBI sustained due to IPV often occurs over time and ranges in severity. The aim of this case-series study was to explore risk factors, symptoms, and brain changes unique to survivors of intimate partner violence with suspicion of TBI. This case-series exploratory study examines the potential relationships among IPV, mental health issues, and TBI. Participants of this study included six women: 3 women with a history of IPV without any experience of concussive blunt force to the head, and 3 women with a history of IPV with concussive head trauma. Participants completed 7T MRI of the brain, self-report psychological questionnaires regarding their mental health, relationships, and IPV, and the Structured Clinical Interview. MRI scans were analyzed for cerebral hemorrhage, white matter disturbance, and cortical thinning. Results indicated significant differences in resting-state connectivity among survivors of partner violence as well as differences in relationship dynamics and mental health symptoms. White matter hyperintensities are also observed among the survivors. Developing guidelines and recommendations for TBI-risk screening, referrals, and appropriate service provision is crucial for the effective treatment of TBI-associated IPV. Early and accurate characterization of TBI in survivors of IPV may relieve certain neuropsychological consequences.	[Karakurt, Gunnur] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA; [Karakurt, Gunnur] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA; [Whiting, Kathleen] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Jones, Stephen E.; Lowe, Mark J.] Cleveland Clin, Diagnost Radiol, Cleveland, OH 44106 USA; [Rao, Stephen M.] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Cleveland, OH 44106 USA		Karakurt, G (corresponding author), Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA.; Karakurt, G (corresponding author), Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA.	gkk6@case.edu			US National Health Institutes (NIH) grant from the National Library of Medicine [R01-LM012518]; Clinical and Translational Science Collaborative of Cleveland from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health [KL2TR000440]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	This publication was made possible by the US National Health Institutes (NIH) grant R01-LM012518 from the National Library of Medicine. This publication was also made possible in part by the Clinical and Translational Science Collaborative of Cleveland, KL2TR000440 from the National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Akbik OS, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0672-3; Alhalal E, 2020, PSYCHONEUROENDOCRINO, V122, DOI 10.1016/j.psyneuen.2020.104897; Amoroso T, 2017, J NERV MENT DIS, V205, P318, DOI 10.1097/NMD.0000000000000621; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Aupperle RL, 2016, J TRAUMA STRESS, V29, P33, DOI 10.1002/jts.22068; Awasthi S, 2020, NEUROIMAGE-CLIN, V28, DOI 10.1016/j.nicl.2020.102442; Babcock JC, 2000, J FAM VIOLENCE, V15, P391, DOI 10.1023/A:1007558330501; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Beall EB, 2014, NEUROIMAGE, V101, P21, DOI 10.1016/j.neuroimage.2014.06.038; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Berginstrom N, 2020, BRAIN INJURY, V34, P415, DOI 10.1080/02699052.2020.1725124; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Black MC, 2011, AM J LIFESTYLE MED, V5, P428, DOI 10.1177/1559827611410265; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bonomi AE, 2006, AM J PREV MED, V30, P458, DOI 10.1016/j.amepre.2006.01.015; Brain Injury Association of America, 2020, BRAIN INJ BRAIN INJ; Breiding MJ., 2015, INTIMATE PARTNER VIO; Brinkmann L, 2018, NEUROIMAGE, V166, P110, DOI 10.1016/j.neuroimage.2017.10.054; Brinkmann L, 2017, HUM BRAIN MAPP, V38, P2190, DOI 10.1002/hbm.23513; Bueso-Izquierdo N, 2016, SOC COGN AFFECT NEUR, V11, P852, DOI 10.1093/scan/nsw020; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chester DS, 2019, SOC NEUROSCI-UK, V14, P173, DOI 10.1080/17470919.2018.1430613; Cimino AN, 2019, J AGGRESS MALTREAT T, V28, P714, DOI 10.1080/10926771.2019.1587657; Clark AL, 2016, BRAIN INJURY, V30, P864, DOI 10.3109/02699052.2016.1144894; COHEN S, 1986, AM PSYCHOL, V41, P716, DOI 10.1037/0003-066X.41.6.716; Cole SR, 1999, J EPIDEMIOL COMMUN H, V53, P319, DOI 10.1136/jech.53.5.319; Cordero MI, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.32; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Daugherty JC, 2020, J INTERPERS VIOLENCE, DOI 10.1177/0886260520959621; Davenport ND, 2016, BRAIN INJURY, V30, P1491, DOI 10.1080/02699052.2016.1219057; Davis A, 2014, J TRAUMA NURS, V21, P300, DOI 10.1097/JTN.0000000000000086; Derogatis L. R., 1994, SCL 90 R ADM SCORING, VThird; ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321; Esopenko C, 2021, BRAIN IMAGING BEHAV, V15, P475, DOI 10.1007/s11682-020-00417-0; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Falsetti D., 1993, BEHAV THER, V16, P161, DOI DOI 10.1037/T05175-000; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Flegar SJ, 2011, AFR J PSYCHIATRY, V14, P310, DOI [10.4314/ajpsy.v14i4.9, http://dx.doi.org/10.4314/ajpsy.v14i4.9]; Fonzo GA, 2010, BIOL PSYCHIAT, V68, P433, DOI 10.1016/j.biopsych.2010.04.028; Fortier Catherine B, 2021, J Head Trauma Rehabil, DOI 10.1097/HTR.0000000000000700; Fox AS, 2019, NEUROSCI LETT, V693, P58, DOI 10.1016/j.neulet.2017.11.056; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Gerber MR, 2014, J WOMENS HEALTH, V23, P302, DOI 10.1089/jwh.2013.4513; Gibbon M, 1998, STRUCTURED CLIN INTE; Giza CC, 2017, NEURON, V94, P1051, DOI 10.1016/j.neuron.2017.05.003; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.3.CO;2-5; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Graff-Radford J, 2019, BRAIN, V142, P2483, DOI 10.1093/brain/awz162; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Haag H, 2019, J WOMENS HEALTH, V28, P990, DOI 10.1089/jwh.2018.7299; Haag Halina Lin, 2019, Trauma Violence Abuse, p1524838019850623, DOI 10.1177/1524838019850623; Halpern LR, 2017, J NATL MED ASSOC, V109, P252, DOI 10.1016/j.jnma.2017.08.001; Hasen M, 2019, J NEUROTRAUM, V36, P1491, DOI 10.1089/neu.2018.6073; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Henckens MJAG, 2009, J NEUROSCI, V29, P10111, DOI 10.1523/JNEUROSCI.1184-09.2009; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hill RL, 2018, NEUROSCIENCE, V386, P265, DOI 10.1016/j.neuroscience.2018.06.028; Iverson KM, 2020, J INTERPERS VIOLENCE, V35, P2422, DOI 10.1177/0886260517702491; Iverson KM, 2019, COMPR PSYCHIAT, V92, P13, DOI 10.1016/j.comppsych.2019.05.001; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Jacobson NS., 1998, MEN BATTER WOMEN NEW; Karakurt G, 2017, J FAM VIOLENCE, V32, P79, DOI 10.1007/s10896-016-9872-5; Kerig PK, 1996, J FAM PSYCHOL, V10, P454, DOI 10.1037/0893-3200.10.4.454; Kerr N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210128; Khalid F, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19517; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Klimova A, 2019, BIOL PSYCHIAT-COGN N, V4, P81, DOI 10.1016/j.bpsc.2018.10.004; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lee I, 2013, REV NEUROSCIENCE, V24, P27, DOI 10.1515/revneuro-2012-0073; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Lippa Sara M, 2021, Neurotrauma Rep, V2, P245, DOI 10.1089/neur.2021.0002; Liu LY, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-01104-4; Lowe MJ, 2014, BRAIN CONNECT, V4, P558, DOI 10.1089/brain.2014.0265; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lowe MJ, 1997, MAGNET RESON MED, V37, P723, DOI 10.1002/mrm.1910370514; Lynch CE, 2016, BRAIN INJURY, V30, P1414, DOI 10.1080/02699052.2016.1219060; Marin-Morales A, 2022, J INTERPERS VIOLENCE, V37, pNP1463, DOI 10.1177/0886260520926494; Meyer JE, 2021, J INTERPERS VIOLENCE, DOI 10.1177/08862605211016362; Moser DA, 2015, SOC COGN AFFECT NEUR, V10, P645, DOI 10.1093/scan/nsu099; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; Najem D, 2018, BIOCHEM CELL BIOL, V96, P391, DOI 10.1139/bcb-2016-0160; Neumeister P, 2018, BIOL PSYCHOL, V138, P172, DOI 10.1016/j.biopsycho.2018.09.010; Neumeister P, 2017, SOC COGN AFFECT NEUR, V12, P555, DOI 10.1093/scan/nsw165; Nugent S, 2014, AM J PHYSIOL-ENDOC M, V306, pE1315, DOI 10.1152/ajpendo.00067.2014; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Press W., 1986, NUMERICAL RECIPES AR; Purkayastha S, 2019, BRAIN INJURY, V33, P1129, DOI 10.1080/02699052.2019.1631488; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Rodrigo AH, 2016, SOC COGN AFFECT NEUR, V11, P55, DOI 10.1093/scan/nsv091; Roos A, 2017, BRAIN IMAGING BEHAV, V11, P1629, DOI 10.1007/s11682-016-9644-0; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Sakaie KE, 2010, MAGN RESON IMAGING, V28, P290, DOI 10.1016/j.mri.2009.07.004; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Santhanam P, 2019, J NEUROTRAUM, V36, P1093, DOI 10.1089/neu.2017.5541; Schechter DS, 2017, BEHAV BRAIN RES, V325, P268, DOI 10.1016/j.bbr.2016.10.009; Sellnow K, 2020, J PSYCHIATR RES, V121, P197, DOI 10.1016/j.jpsychires.2019.12.002; Shealer M.L., 2017, J ORAL MAXIL SURG, V75, pE387, DOI [10.1016/j.joms.2017.07.110, DOI 10.1016/J.JOMS.2017.07.110]; Sheridan DJ, 2007, TRAUMA VIOLENCE ABUS, V8, P281, DOI 10.1177/1524838007303504; Shirazi SN, 2015, ADV EXP MED BIOL, V872, P235, DOI 10.1007/978-1-4939-2895-8_10; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Siminski N, 2021, BEHAV BRAIN RES, V396, DOI 10.1016/j.bbr.2020.112883; Simmons AN, 2008, BIOL PSYCHIAT, V64, P681, DOI 10.1016/j.biopsych.2008.05.027; Smirl JD, 2019, BRAIN INJURY, V33, P1529, DOI 10.1080/02699052.2019.1658129; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Strigo IA, 2010, BIOL PSYCHIAT, V68, P442, DOI 10.1016/j.biopsych.2010.03.034; Takahashi Courtney, 2015, Handb Clin Neurol, V128, P539, DOI 10.1016/B978-0-444-63521-1.00034-0; Tate DF, 2017, MIL MED, V182, pE1651, DOI 10.7205/MILMED-D-16-00132; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; van den Berg E, 2018, J ALZHEIMERS DIS, V63, P515, DOI 10.3233/JAD-170573; Verdejo-Roman J, 2019, SOC NEUROSCI-UK, V14, P390, DOI 10.1080/17470919.2018.1481882; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Watson William D, 2013, Front Neuroenergetics, V5, P12, DOI 10.3389/fnene.2013.00012; Woods S J, 2000, Issues Ment Health Nurs, V21, P309, DOI 10.1080/016128400248112; Woods SJ, 2008, J MIDWIFERY WOM HEAL, V53, P538, DOI 10.1016/j.jmwh.2008.07.004; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5; Yin B, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00028; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zhang LS, 2013, ADDICT BIOL, V18, P537, DOI 10.1111/j.1369-1600.2011.00381.x; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	133	0	0	7	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	OCT 5	2021	12								710602	10.3389/fpsyg.2021.710602			14	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	WK3OR	WOS:000709638800001	34675836	gold, Green Published			2022-02-06	
J	Weiler, R; Blauwet, C; Clarke, D; Dalton, K; Derman, W; Fagher, K; Gouttebarge, V; Kissick, J; Lee, K; Lexell, J; Van de Vliet, P; Verhagen, E; Webborn, N; Virgile, A; Ahmed, OH				Weiler, Richard; Blauwet, Cheri; Clarke, David; Dalton, Kristine; Derman, Wayne; Fagher, Kristina; Gouttebarge, Vincent; Kissick, James; Lee, Kenneth; Lexell, Jan; Van de Vliet, Peter; Verhagen, Evert; Webborn, Nick; Virgile, Adam; Ahmed, Osman Hassan			Infographic. The first position statement of the Concussion in Para Sport Group	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article; Early Access						disabled persons; sport; brain concussion; head; position statement			[Weiler, Richard] Vrije Univ Amsterdam, Amsterdam Collaborat Hlth & Safety Sports, Univ Med Ctr,Dept Public & Occupat Hlth, Amsterdam Movement Sci,Amsterdam UMC, Amsterdam, Netherlands; [Weiler, Richard] Fortius Clin, Sport & Exercise Med, London, England; [Weiler, Richard; Ahmed, Osman Hassan] Para Football Fdn, Arnhem, Netherlands; [Blauwet, Cheri] Harvard Med Sch, Brigham & Womens Hosp, Spaulding Hosp, Dept Phys Med & Rehabil Spaulding Rehabil, Boston, MA 02115 USA; [Blauwet, Cheri] Kelley Adapt Sports Res Inst, Boston, MA USA; [Clarke, David] Univ Hertfordshire, Hatfield, Herts, England; [Dalton, Kristine] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON, Canada; [Derman, Wayne] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Surg Sci, Inst Sport & Exercise Med,Div Orthopaed Surg, Cape Town, South Africa; [Derman, Wayne] IOC Res Ctr, Cape Town, South Africa; [Fagher, Kristina; Lexell, Jan] Lund Univ, Dept Hlth Sci, Rehabil Med Res Grp, Lund, Sweden; [Gouttebarge, Vincent] Univ Amsterdam, Dept Orthopaed Surg, Amsterdam UMC, Meibergdreef 9, Amsterdam, Netherlands; [Gouttebarge, Vincent] Univ Pretoria, Sect Sports Med, Pretoria, South Africa; [Kissick, James] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Kissick, James; Lexell, Jan] Med Comm, Int Paralymp Comm, Bonn, Germany; [Lee, Kenneth] Med Coll Wisconsin, Spinal Cord Injury Disorder Phys Med & Rehabil, Milwaukee, WI 53226 USA; [Van de Vliet, Peter] Immuneoncol Ctr Cologne, Cologne, Germany; [Van de Vliet, Peter] Former Med & Sci Director Int Paralymp Comm, Bonn, Germany; [Verhagen, Evert] Amsterdam UMC Locatie VUmc, Dept Publ & Occupat Hlth, EMGO, NL-1081 HV Amsterdam, Netherlands; [Webborn, Nick] Univ Brighton, Ctr Sport & Exercise Sci & Med, Eastbourne, England; [Webborn, Nick] Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Virgile, Adam] Univ Vermont, Coll Nursing & Hlth Sci, Burlington, VT USA; [Ahmed, Osman Hassan] Univ Hosp Dorset NHS Fdn Trust, Physiotherapy Dept, Poole, Dorset, England; [Ahmed, Osman Hassan] Univ Portsmouth, Sch Sport Hlth & Exercise Sci, Portsmouth, Hants, England		Verhagen, E (corresponding author), Amsterdam UMC Locatie VUmc, Dept Publ & Occupat Hlth, EMGO, NL-1081 HV Amsterdam, Netherlands.	e.verhagen@amsterdamumc.nl		Derman, Wayne/0000-0002-8879-177X; Kissick, James/0000-0002-7748-9225; Webborn, Nick/0000-0003-3636-5557; Lexell, Jan/0000-0001-5294-3332; Weiler, Richard/0000-0002-6216-839X			Ahmed OH., 2020, FOOTBALL MED PERFORM, V32, P13; Blauwet C, 2019, BRIT J SPORT MED, V53, P1391, DOI 10.1136/bjsports-2018-099997; Derman W, 2018, BRIT J SPORT MED, V52, P24, DOI 10.1136/bjsports-2017-098039; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Weiler R, 2021, BRIT J SPORT MED, V55, P1187, DOI 10.1136/bjsports-2020-103696; Weiler R, 2018, CLIN J SPORT MED, V28, P43, DOI 10.1097/JSM.0000000000000407	6	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.												10.1136/bjsports-2021-104530		OCT 2021	2	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	XD4NW	WOS:000722688900001	34610914	Green Published, hybrid			2022-02-06	
J	Bozdemir, E; Vigil, FA; Chun, SH; Espinoza, L; Bugay, V; Khoury, SM; Holstein, DM; Stoja, A; Lozano, D; Tunca, C; Sprague, SM; Cavazos, JE; Brenner, R; Liston, TE; Shapiro, MS; Lechleiter, JD				Bozdemir, Eda; Vigil, Fabio A.; Chun, Sang H.; Espinoza, Liliana; Bugay, Vladislav; Khoury, Sarah M.; Holstein, Deborah M.; Stoja, Aiola; Lozano, Damian; Tunca, Ceyda; Sprague, Shane M.; Cavazos, Jose E.; Brenner, Robert; Liston, Theodore E.; Shapiro, Mark S.; Lechleiter, James D.			Neuroprotective Roles of the Adenosine A(3) Receptor Agonist AST-004 in Mouse Model of Traumatic Brain Injury	NEUROTHERAPEUTICS			English	Article						ADORA3; Concussion treatment; Mitochondrial metabolism; ATP; Astrocytes	RISK-TAKING; ACTIVATION; STIMULATION; EXTINCTION; RETIGABINE; ANTICONVULSANT; PROGESTERONE; ESTROGEN; RATS; FEAR	Traumatic brain injury (TBI) remains one of the greatest public health concerns with increasing morbidity and mortality rates worldwide. Our group reported that stimulation of astrocyte mitochondrial metabolism by P2Y(1) receptor agonists significantly reduced cerebral edema and reactive gliosis in a TBI model. Subsequent data on the pharmacokinetics (PK) and rapid metabolism of these compounds suggested that neuroprotection was likely mediated by a metabolite, AST-004, which binding data indicated was an adenosine A(3) receptor (A(3)R) agonist. The neuroprotective efficacy of AST-004 was tested in a control closed cortical injury (CCCI) model of TBI in mice. Twenty-four (24) hours post-injury, mice subjected to CCCI and treated with AST-004 (0.22 mg/kg, injected 30 min post-trauma) exhibited significantly less secondary brain injury. These effects were quantified with less cell death (PSVue794 fluorescence) and loss of blood brain barrier breakdown (Evans blue extravasation assay), compared to vehicle-treated TBI mice. TBI-treated mice also exhibited significantly reduced neuroinflammatory markers, glial-fibrillary acidic protein (GFAP, astrogliosis) and ionized Ca2+-binding adaptor molecule 1 (Iba1, microgliosis), both at the mRNA (qRT-PCR) and protein (Western blot and immunofluorescence) levels, respectively. Four (4) weeks post-injury, both male and female TBI mice presented a significant reduction in freezing behavior during contextual fear conditioning (after foot shock). AST-004 treatment prevented this TBI-induced impairment in male mice, but did not significantly affect impairment in female mice. Impairment of spatial memory, assessed 24 and 48 h after the initial fear conditioning, was also reduced in AST-004-treated TBI-male mice. Female TBI mice did not exhibit memory impairment 24 and 48 h after contextual fear conditioning and similarly, AST-004-treated female TBI mice were comparable to sham mice. Finally, AST-004 treatments were found to increase in vivo ATP production in astrocytes (GFAP-targeted luciferase activity), consistent with the proposed mechanism of action. These data reveal AST-004 as a novel A(3)R agonist that increases astrocyte energy production and enhances their neuroprotective efficacy after brain injury.	[Bozdemir, Eda; Chun, Sang H.; Khoury, Sarah M.; Holstein, Deborah M.; Lozano, Damian; Tunca, Ceyda; Lechleiter, James D.] UT Hlth San Antonio, Dept Cell Syst & Anat, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA; [Vigil, Fabio A.; Espinoza, Liliana; Bugay, Vladislav; Stoja, Aiola; Brenner, Robert; Shapiro, Mark S.] UT Hlth San Antonio, Dept Cellular & Integrat Physiol, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA; [Sprague, Shane M.] UT Hlth San Antonio, Dept Neurosurg, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Cavazos, Jose E.] UT Hlth San Antonio, Dept Neurol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Liston, Theodore E.] Astrocyte Pharmaceut Inc, 245 First St,Suite 1800, Cambridge, MA 02142 USA		Lechleiter, JD (corresponding author), UT Hlth San Antonio, Dept Cell Syst & Anat, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	edabozdemir@gmail.com; BorgesVigil@uthscsa.edu; Chun@livemail.uthscsa.edu; EspinozaL3@livemail.uthscsa.edu; bugay@uthscsa.edu; KhouryS@livemail.uthscsa.edu; HolsteinD@uthscsa.edu; stoja@livemail.uthscsa.edu; lozanod5@uthscsa.edu; tunca.ceyda2000@gmail.com; SPRAGUES@uthscsa.edu; CAVAZOSJ@uthscsa.edu; brennerr@uthscsa.edu; liston@astrocytepharma.com; SHAPIROM@uthscsa.edu; lechleiter@uthscsa.edu	Cavazos, Jose/J-4122-2016	Cavazos, Jose/0000-0001-5777-2608	Department of DefenseUnited States Department of Defense [W81XWH-15-1-0283, W81XWH-15-1-0284]; Welch FoundationThe Welch Foundation [AQ-1980-20190330]	These studies were supported by grants from the Department of Defense: W81XWH-15-1-0283 (J. Lechleiter) and W81XWH-15-1-0284 (M. Shapiro) and from the Welch Foundation Grant: AQ-1980-20190330 (R. Brenner).	Abbracchio MP, 1995, MOL PHARMACOL, V48, P1038; Almeida-Correa S, 2014, J PHYSIOL-PARIS, V108, P292, DOI 10.1016/j.jphysparis.2014.08.006; Amabile CM, 2013, PHARMACOTHERAPY, V33, P187, DOI 10.1002/phar.1185; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; BALLARIN M, 1991, ACTA PHYSIOL SCAND, V142, P97, DOI 10.1111/j.1748-1716.1991.tb09133.x; Bayly PV, 2006, BRAIN RES, V1107, P70, DOI 10.1016/j.brainres.2006.05.102; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Bell MJ, 2001, CRIT CARE MED, V29, P399, DOI 10.1097/00003246-200102000-00033; Bennett RE, 2014, J NEUROTRAUM, V31, P1647, DOI 10.1089/neu.2013.3320; Boscia F, 2006, NEUROPHARMACOLOGY, V51, P283, DOI 10.1016/j.neuropharm.2006.03.024; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Bugay V, 2020, J NEUROTRAUM, V37, P248, DOI 10.1089/neu.2018.6333; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; CDC, 2019, TBI GET FACTS CONC T; Chen GJ, 2006, J NEUROSCI RES, V84, P1848, DOI 10.1002/jnr.21071; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Choi IY, 2011, AM J PATHOL, V179, P2042, DOI 10.1016/j.ajpath.2011.07.006; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Ekmark-Lewen S, 2010, J NEUROTRAUM, V27, P1643, DOI 10.1089/neu.2009.0953; Evans MS, 2014, NAT METHODS, V11, P393, DOI [10.1038/NMETH.2839, 10.1038/nmeth.2839]; Farr SA, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02009-7; Fedorova IM, 2003, CELL MOL NEUROBIOL, V23, P431, DOI 10.1023/A:1023601007518; Gessi S, 2001, BRIT J PHARMACOL, V134, P116, DOI 10.1038/sj.bjp.0704254; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Graham BM, 2016, NEUROPSYCHOPHARMACOL, V41, P774, DOI 10.1038/npp.2015.202; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Jacobson KA, 2020, PAIN, V161, P1425, DOI 10.1097/j.pain.0000000000001857; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Jaycox, 2008, INVISIBLE WOUNDS WAR; Kennedy E, 2017, J HEAD TRAUMA REHAB, V32, P425, DOI 10.1097/HTR.0000000000000289; Kim WB, 2017, J NEUROSCI, V37, P4868, DOI 10.1523/JNEUROSCI.3579-16.2017; Klaasse EC, 2008, PURINERG SIGNAL, V4, P21, DOI 10.1007/s11302-007-9086-7; Kohno Y, 1996, BLOOD, V88, P3569, DOI 10.1182/blood.V88.9.3569.bloodjournal8893569; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Liston TE, 2020, PURINERG SIGNAL, V16, P543, DOI 10.1007/s11302-020-09732-z; Matsueda Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209282; Milad MR, 2009, NEUROSCIENCE, V164, P887, DOI 10.1016/j.neuroscience.2009.09.011; Ochaion A, 2009, CELL IMMUNOL, V258, P115, DOI 10.1016/j.cellimm.2009.03.020; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Ozga-Hess JE, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113217; Panel, 2013, REP C TRAUM BRAIN IN; Parpura V, 2017, NEUROCHEM RES, V42, P19, DOI 10.1007/s11064-016-1848-6; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; PHILLIS J W, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P26; Rasband MN, 2016, MOL CELL PROTEOMICS, V15, P355, DOI 10.1074/mcp.R115.053744; Ravi RG, 2002, J MED CHEM, V45, P2090, DOI 10.1021/jm010538v; Rey CD, 2014, NEUROPSYCHOPHARMACOL, V39, P1282, DOI 10.1038/npp.2013.338; RUDOLPHI KA, 1995, ADENOSINE AND ADENINE NUCLEOTIDES: FROM MOLECULAR BIOLOGY TO INTEGRATIVE PHYSIOLOGY, P391; Rundfeldt C, 1997, EUR J PHARMACOL, V336, P243, DOI 10.1016/S0014-2999(97)01249-1; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Sizemore G, 2018, OBM NEUROBIOL, V2; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sontheimer H, GLIAL BIOL MED; Tosh DK, 2014, J MED CHEM, V57, P9901, DOI 10.1021/jm501021n; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Trincavelli ML, 2010, A3 ADENOSINE RECEPTORS FROM CELL BIOLOGY TO PHARMACOLOGY AND THERAPEUTICS, P75, DOI 10.1007/978-90-481-3144-0_5; Trudeau, 2015, HDB ION CHANNELS; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Vigil FA, 2020, J CEREBR BLOOD F MET, V40, P1256, DOI 10.1177/0271678X19857818; Von Lubitz DKJE, 1999, EUR J PHARMACOL, V367, P157, DOI 10.1016/S0014-2999(98)00977-7; von Lubitz DKJE, 2001, EXPERT OPIN INV DRUG, V10, P619, DOI 10.1517/13543784.10.4.619; VONLUBITZ DKJE, 1994, EUR J PHARMACOL, V263, P59, DOI 10.1016/0014-2999(94)90523-1; Wahlman C, 2018, PAIN, V159, P1025, DOI 10.1097/j.pain.0000000000001177; Watts LT, 2013, J NEUROTRAUM, V30, P55, DOI 10.1089/neu.2012.2488; Wickenden AD, 2000, MOL PHARMACOL, V58, P591, DOI 10.1124/mol.58.3.591; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Xu C, 2016, CELL, V167, P961, DOI 10.1016/j.cell.2016.09.051; Yan Luo, 2003, Expert Opin Emerg Drugs, V8, P537, DOI 10.1517/eoed.8.2.537.21128; Yuan SG, 2016, ANGEW CHEM INT EDIT, V55, P10331, DOI 10.1002/anie.201605147; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zheng W, 2013, J CEREBR BLOOD F MET, V33, P600, DOI 10.1038/jcbfm.2012.214; Zheng W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014401; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	77	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1933-7213	1878-7479		NEUROTHERAPEUTICS	Neurotherapeutics	OCT	2021	18	4			SI		2707	2721		10.1007/s13311-021-01113-7		OCT 2021	15	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	YS1MP	WOS:000703358700001	34608616	Green Submitted			2022-02-06	
J	Hakulinen, U; Brander, A; Ilvesmaki, T; Helminen, M; Ohman, J; Luoto, TM; Eskola, H				Hakulinen, Ullamari; Brander, Antti; Ilvesmaki, Tero; Helminen, Mika; Ohman, Juha; Luoto, Teemu M.; Eskola, Hannu			Reliability of the freehand region-of-interest method in quantitative cerebral diffusion tensor imaging	BMC MEDICAL IMAGING			English	Article						Diffusion tensor imaging; Reliability; Repeatability; Intra-class correlation coefficient; Fractional anisotropy; Apparent diffusion coefficient; Axial diffusivity; Radial diffusivity; ROI-based method; Freehand method	TRAUMATIC BRAIN-INJURY; TO-NOISE RATIO; WHITE-MATTER; FRACTIONAL ANISOTROPY; SPATIAL STATISTICS; RADIAL DIFFUSIVITY; FIBER TRACTOGRAPHY; AXONAL INJURY; SPINAL-CORD; REPRODUCIBILITY	Background Diffusion tensor imaging (DTI) is a magnetic resonance imaging (MRI) technique used for evaluating changes in the white matter in brain parenchyma. The reliability of quantitative DTI analysis is influenced by several factors, such as the imaging protocol, pre-processing and post-processing methods, and selected diffusion parameters. The region-of-interest (ROI) method is most widely used of the post-processing methods because it is found in commercial software. The focus of our research was to study the reliability of the freehand ROI method using various intra- and inter-observer analyses. Methods This study included 40 neurologically healthy participants who underwent diffusion MRI of the brain with a 3 T scanner. The measurements were performed at nine different anatomical locations using a freehand ROI method. The data extracted from the ROIs included the regional mean values, intra- and inter-observer variability and reliability. The used DTI parameters were fractional anisotropy (FA), the apparent diffusion coefficient (ADC), and axial (AD) and radial (RD) diffusivity. Results The average intra-class correlation coefficient (ICC) of the intra-observer was found to be 0.9 (excellent). The single ICC results were excellent (> 0.8) or adequate (> 0.69) in eight out of the nine regions in terms of FA and ADC. The most reliable results were found in the frontobasal regions. Significant differences between age groups were also found in the frontobasal regions. Specifically, the FA and AD values were significantly higher and the RD values lower in the youngest age group (18-30 years) compared to the other age groups. Conclusions The quantitative freehand ROI method can be considered highly reliable for the average ICC and mostly adequate for the single ICC. The freehand method is suitable for research work with a well-experienced observer. Measurements should be performed at least twice in the same region to ensure that the results are sufficiently reliable. In our study, reliability was slightly undermined by artifacts in some regions such as the cerebral peduncle and centrum semiovale. From a clinical point of view, the results are most reliable in adults under the age of 30, when age-related changes in brain white matter have not yet occurred.	[Hakulinen, Ullamari] Med Imaging Ctr Pirkanmaa Hosp Dist, Dept Med Phys, Tampere, Finland; [Hakulinen, Ullamari; Brander, Antti; Eskola, Hannu] Med Imaging Ctr Pirkanmaa Hosp Dist, Dept Radiol, Tampere, Finland; [Hakulinen, Ullamari; Ilvesmaki, Tero; Luoto, Teemu M.; Eskola, Hannu] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland; [Helminen, Mika] Tampere Univ, Fac Social Sci, Hlth Sci, Tampere, Finland; [Helminen, Mika] Tampere Univ Hosp, Tays Res Serv, Tampere, Finland; [Ohman, Juha; Luoto, Teemu M.] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Ohman, Juha; Luoto, Teemu M.] Tampere Univ, Tampere, Finland		Hakulinen, U (corresponding author), Med Imaging Ctr Pirkanmaa Hosp Dist, Dept Med Phys, Tampere, Finland.; Hakulinen, U (corresponding author), Med Imaging Ctr Pirkanmaa Hosp Dist, Dept Radiol, Tampere, Finland.; Hakulinen, U (corresponding author), Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland.	ullamari.hakulinen@pshp.fi	Helminen, Mika/I-3900-2016; Eskola, Hannu/G-4279-2014	Helminen, Mika/0000-0001-5695-2084; Eskola, Hannu/0000-0003-1673-2305	Tampere University Hospital Support Foundation, Tampere University Hospital	This study was financially partly supported by Tampere University Hospital Support Foundation, Tampere University Hospital. The funding organization had no role in the design, implementation, and manuscript of the study.	Alegiani AC, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00158; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Anderson AW, 2001, MAGNET RESON MED, V46, P1174, DOI 10.1002/mrm.1315; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Banaszek A, 2015, POL J RADIOL, V80, P457, DOI 10.12659/PJR.894661; Bisdas S, 2008, AM J NEURORADIOL, V29, P1128, DOI 10.3174/ajnr.A1044; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boespflug EL, 2014, BRAIN IMAGING BEHAV, V8, P359, DOI 10.1007/s11682-011-9144-1; Bonekamp D, 2007, NEUROIMAGE, V34, P733, DOI 10.1016/j.neuroimage.2006.09.020; Brander A, 2010, ACTA RADIOL, V51, P800, DOI 10.3109/02841851.2010.495351; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Choi JY, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101785; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; Cox SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13629; Dailey NS, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00118; Deng F, 2018, BRAIN STRUCT FUNCT, V223, P1849, DOI 10.1007/s00429-017-1594-9; Dietrich O, 2008, EUR J RADIOL, V65, P29, DOI 10.1016/j.ejrad.2007.11.005; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Hakulinen U, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-30; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Thierry AGM, 2006, EUR RADIOL, V16, P1651, DOI 10.1007/s00330-006-0175-8; Hunsche S, 2001, RADIOLOGY, V221, P550, DOI 10.1148/radiol.2212001823; Ilvesmaki T, 2017, HUM BRAIN MAPP, V38, P3637, DOI 10.1002/hbm.23619; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Inano S, 2011, AM J NEURORADIOL, V32, P2103, DOI 10.3174/ajnr.A2785; Jahanshad N, 2010, NEUROIMAGE, V52, P455, DOI 10.1016/j.neuroimage.2010.04.236; Jones Derek K, 2010, Top Magn Reson Imaging, V21, P87, DOI 10.1097/RMR.0b013e31821e56ac; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; Kodiweera C, 2016, NEUROIMAGE, V128, P180, DOI 10.1016/j.neuroimage.2015.12.033; Koskinen E, 2013, J NEUROTRAUM, V30, P1587, DOI 10.1089/neu.2013.2943; Lagana M, 2010, Comput Intell Neurosci, P254032, DOI 10.1155/2010/254032; Lazar M, 2003, NEUROIMAGE, V20, P1140, DOI 10.1016/S1053-8119(03)00277-5; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lee CEC, 2009, NEURORADIOLOGY, V51, P3, DOI 10.1007/s00234-008-0441-3; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lieberman G, 2014, J PAIN, V15, P1110, DOI 10.1016/j.jpain.2014.08.002; Lilja Y, 2016, BMC MED IMAGING, V16, DOI 10.1186/s12880-016-0145-9; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Marenco S, 2006, PSYCHIAT RES-NEUROIM, V147, P69, DOI 10.1016/j.pscychresns.2006.01.008; Merisaari H, 2019, NEUROIMAGE, V197, P598, DOI 10.1016/j.neuroimage.2019.04.067; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Mukherjee P, 2005, NEUROIMAG CLIN N AM, V15, P655, DOI 10.1016/j.nic.2005.08.010; Muller MJ, 2006, AM J NEURORADIOL, V27, P440; Nenonen M, 2015, ACTA RADIOL OPEN, V4, DOI 10.1177/2047981614546795; Papinutto ND, 2013, MAGN RESON IMAGING, V31, P827, DOI 10.1016/j.mri.2013.03.004; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Pfefferbaum A, 2003, J MAGN RESON IMAGING, V18, P427, DOI 10.1002/jmri.10377; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Polders DL, 2011, J MAGN RESON IMAGING, V33, P1456, DOI 10.1002/jmri.22554; Sala S, 2012, NEUROBIOL AGING, V33, P488, DOI 10.1016/j.neurobiolaging.2010.04.027; Seizeur R, 2014, SURG RADIOL ANAT, V36, P111, DOI 10.1007/s00276-013-1156-7; Shahim P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11747-3; Shen JM, 2011, BMC MED IMAGING, V11, DOI 10.1186/1471-2342-11-2; Shimony JS, 1999, RADIOLOGY, V212, P770, DOI 10.1148/radiology.212.3.r99au51770; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Virta A, 1999, MAGN RESON IMAGING, V17, P1121, DOI 10.1016/S0730-725X(99)00048-X; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Yoon B, 2008, ARCH GERONTOL GERIAT, V47, P129, DOI 10.1016/j.archger.2007.07.004	66	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2342			BMC MED IMAGING	BMC Med. Imag.	OCT 4	2021	21	1							144	10.1186/s12880-021-00663-8			17	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	WB3KO	WOS:000703474700001	34607554	Green Published, gold, Green Submitted			2022-02-06	
J	Li, CY; Shah, KA; Powell, K; Wu, YC; Chaung, W; Sonti, AN; White, TG; Doobay, M; Yang, WL; Wang, P; Becker, LB; Narayan, RK				Li, Chunyan; Shah, Kevin A.; Powell, Keren; Wu, Yi-Chen; Chaung, Wayne; Sonti, Anup N.; White, Timothy G.; Doobay, Mohini; Yang, Weng-Lang; Wang, Ping; Becker, Lance B.; Narayan, Raj K.			CBF oscillations induced by trigeminal nerve stimulation protect the pericontusional penumbra in traumatic brain injury complicated by hemorrhagic shock	SCIENTIFIC REPORTS			English	Article							CEREBRAL-BLOOD-FLOW; NITRIC-OXIDE; INSPIRATORY RESISTANCE; CENTRAL HYPOVOLEMIA; ARTERIAL-PRESSURE; RESUSCITATION; FLUID; MICROCIRCULATION; OXYGENATION; MODEL	Traumatic peri-contusional penumbra represents crucial targets for therapeutic interventions after traumatic brain injury (TBI). Current resuscitative approaches may not adequately alleviate impaired cerebral microcirculation and, hence, compromise oxygen delivery to peri-contusional areas. Low-frequency oscillations in cerebral blood flow (CBF) may improve cerebral oxygenation in the setting of oxygen deprivation. However, no method has been reported to induce controllable oscillations in CBF and it hasn't been applied as a therapeutic strategy. Electrical stimulation of the trigeminal nerve (TNS) plays a pivotal role in modulating cerebrovascular tone and cerebral perfusion. We hypothesized that TNS can modulate CBF at the targeted frequency band via the trigemino-cerebrovascular network, and TNS-induced CBF oscillations would improve cerebral oxygenation in peri-contusional areas. In a rat model of TBI complicated by hemorrhagic shock, TNS-induced CBF oscillations conferred significant preservation of peri-contusional tissues leading to reduced lesion volume, attenuated hypoxic injury and neuroinflammation, increased eNOS expression, improved neurological recovery and better 10-day survival rate, despite not significantly increasing CBF as compared with those in immediate and delayed resuscitation animals. Our findings indicate that low-frequency CBF oscillations enhance cerebral oxygenation in peri-contusional areas, and play a more significant protective role than improvements in non-oscillatory cerebral perfusion or volume expansion alone.	[Li, Chunyan; Shah, Kevin A.; Powell, Keren; Wu, Yi-Chen; Sonti, Anup N.; White, Timothy G.; Doobay, Mohini; Narayan, Raj K.] Feinstein Inst Med Res, Translat Brain Res Lab, 350 Community Dr, Manhasset, NY 11030 USA; [Li, Chunyan; Shah, Kevin A.; Sonti, Anup N.; White, Timothy G.; Narayan, Raj K.] Zucker Sch Med Hofstra Northwell, Dept Neurosurg, Hempstead, NY USA; [Chaung, Wayne; Wang, Ping] Feinstein Inst Med Res, Ctr Immunol & Inflammat, Manhasset, NY USA; [Yang, Weng-Lang] Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA; [Becker, Lance B.] Zucker Sch Med Hofstra Northwell, Dept Emergency Med, Hempstead, NY USA		Li, CY (corresponding author), Feinstein Inst Med Res, Translat Brain Res Lab, 350 Community Dr, Manhasset, NY 11030 USA.; Li, CY (corresponding author), Zucker Sch Med Hofstra Northwell, Dept Neurosurg, Hempstead, NY USA.	cli11@northwell.edu			US Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-18-1-0773]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was funded by the US Army Medical Research and Materiel Command (USAMRMC) under award #W81XWH-18-1-0773.	Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Athiraman U, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.017477; Bougle A, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-1; Bragin DE, 2018, ADV EXP MED BIOL, V1072, P39, DOI 10.1007/978-3-319-91287-5_7; Bragin DE, 2017, J CEREBR BLOOD F MET, V37, P762, DOI 10.1177/0271678X16684153; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Cetkovic M, 2011, ACTA NEUROCHIR, V153, P1051, DOI 10.1007/s00701-010-0913-1; Chang R, 2017, CRIT CARE CLIN, V33, P15, DOI 10.1016/j.ccc.2016.08.007; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chiluwal A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07219-3; Clark WM, 1997, NEUROLOGY, V49, pS32, DOI 10.1212/WNL.49.5_Suppl_4.S32; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; DeGiorgio CM, 2011, NEUROSURG CLIN N AM, V22, P449, DOI 10.1016/j.nec.2011.07.001; DeGraba TJ, 1998, NEUROLOGY, V51, pS62, DOI 10.1212/WNL.51.3_Suppl_3.S62; Del Zoppo GJ., 1995, PHYSL PATHOPHYSIOLOG, P408; Ding YC, 2002, STROKE, V33, P2492, DOI 10.1161/01.STR.0000028237.15541.CC; Doubovikov ED, 2020, J COMPUT NEUROSCI, V48, P21, DOI 10.1007/s10827-019-00736-2; Drake CT, 2007, BRAIN LANG, V102, P141, DOI 10.1016/j.bandl.2006.08.002; du Sert NP, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000411; FALK JL, 1995, CRIT CARE MED, V23, P4, DOI 10.1097/00003246-199501000-00003; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Gao JQ, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.631286; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hsieh HJ, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-3; Iadecola C, 1997, J NEUROSCI, V17, P9157; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jiang M, 2017, MED GAS RES, V7, P48, DOI 10.4103/2045-9912.202910; Joo W, 2014, CLIN ANAT, V27, P61, DOI 10.1002/ca.22330; Kay VL, 2017, AM J PHYSIOL-REG I, V313, pR132, DOI 10.1152/ajpregu.00385.2016; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kempuraj D, 2021, NEUROTOX RES, V39, P359, DOI 10.1007/s12640-020-00288-9; Keynes RG, 2004, CURR MOL MED, V4, P179, DOI 10.2174/1566524043479176; Kolluru GK, 2010, NITRIC OXIDE-BIOL CH, V22, P304, DOI 10.1016/j.niox.2010.02.004; KUMADA M, 1977, BRAIN RES, V119, P305, DOI 10.1016/0006-8993(77)90313-4; Li CY, 2021, NEUROSURGERY, V88, pE529, DOI 10.1093/neuros/nyab053; Li CY, 2019, CRIT CARE MED, V47, pE478, DOI 10.1097/CCM.0000000000003735; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lutton EM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00582; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Muller CR, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81717-3; Navarro JC, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00494; Navarro JC, 2012, J NEUROTRAUM, V29, P322, DOI 10.1089/neu.2011.1979; Nemzek WR, 1996, TOP MAGN RESON IMAG, V8, P132; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; OKADA Y, 1994, STROKE, V25, P202, DOI 10.1161/01.STR.25.1.202; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Rafols JA, 2015, BRAIN CIRC, V1, P146, DOI [10.4103/2394-8108.172892, DOI 10.4103/2394-8108.172892]; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; Rickards CA, 2008, AVIAT SPACE ENVIR MD, V79, P557, DOI 10.3357/ASEM.2149.2008; Rickards CA, 2007, AM J PHYSIOL-REG I, V293, pR243, DOI 10.1152/ajpregu.00087.2007; Rickards CA, 2011, J APPL PHYSIOL, V111, P1048, DOI 10.1152/japplphysiol.00231.2011; Ritter LS, 2000, STROKE, V31, P1153, DOI 10.1161/01.STR.31.5.1153; RUBANYI GM, 1986, AM J PHYSIOL, V250, P1145, DOI 10.1152/ajpheart.1986.250.6.H1145; Rubin TG, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519844020; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schiller AM, 2017, EXP BIOL MED, V242, P874, DOI 10.1177/1535370217694099; Schweighofer H, 2014, INTENS CARE MED EXP, V2, DOI 10.1186/s40635-014-0024-z; Shi KB, 2019, CELL MOL IMMUNOL, V16, P523, DOI 10.1038/s41423-019-0213-5; Smoliar E, 1998, ANAT REC, V250, P245; Sriram K, 2016, BIOPHYS J, V111, P208, DOI 10.1016/j.bpj.2016.05.034; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; SUZUKI N, 1990, ACTA PHYSIOL SCAND, V138, P307, DOI 10.1111/j.1748-1716.1990.tb08851.x; TSAI AG, 1993, INT J MICROCIRC, V12, P75; Villalba N, 2017, J NEUROTRAUM, V34, P192, DOI 10.1089/neu.2015.4340; Wang B, 2018, CEREBELLUM, V17, P477, DOI 10.1007/s12311-018-0934-5; Wang KC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31709-7; WANG XK, 1994, MOL BRAIN RES, V26, P61, DOI 10.1016/0169-328X(94)90074-4; Ware JB, 2020, J NEUROTRAUM, V37, P2180, DOI 10.1089/neu.2020.7031; White T. G., FRONT NEUROSCI-SWITZ; Zhang R, 2007, STROKE, V38, P1238, DOI 10.1161/01.STR.0000260095.94175.d0; Zhang Z, 2011, CURR MED CHEM, V18, P4335, DOI 10.2174/092986711797200426; Zhu JQ, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0211-9	80	0	0	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	OCT 4	2021	11	1							19652	10.1038/s41598-021-99234-8			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WB5OV	WOS:000703622500085	34608241	gold, Green Published, Green Submitted			2022-02-06	
J	Martin, CL; Arundale, AJH; Kluzek, S; Ferguson, T; Collins, GS; Bullock, GS				Martin, Chelsea L.; Arundale, Amelia J. H.; Kluzek, Stefan; Ferguson, Tyler; Collins, Gary S.; Bullock, Garrett S.			Characterization of Rookie Season Injury and Illness and Career Longevity Among National Basketball Association Players	JAMA NETWORK OPEN			English	Article							CONSENSUS STATEMENT; PREVENTION; SPORTS; RISK	Importance There is limited research investigating injury and illness among professional basketball players during their rookie season. By improving the understanding of injury incidence and risk specific to rookie players, sports medicine clinicians may be able to further individualize injury mitigation programs that address the unique needs of rookie players. Objective To compare incidence and rate ratio (RR) of injury and illness among professional National Basketball Association (NBA) players in their rookie season with veteran players and to explore the association of sustaining an injury rookie season with career longevity. Design, Setting, and Participants This retrospective cohort study used an online data repository and extracted publicly available data about NBA players between the 2007 and 2008 season to the 2018 and 2019 season. Available data for initial injury and all subsequent injuries were extracted during this time frame. Exposures Injury and illness based on injury status during the rookie season of professional NBA players. Main Outcomes and Measures Injury and illness incidence and RR. Association of injury during the rookie season with career longevity was assessed via Poisson regressions. Results Of the 12 basketball seasons analyzed, 904 NBA players were included (mean [SD] age, 24.6 [3.9] years; body mass index, 24.8 [1.8]). The injury and illness incidence for rookie players was 14.28 per 1000 athlete game exposures (AGEs). Among all body regions, ankle injuries had the greatest injury incidence among players injured during their rookie season (3.17 [95% CI, 3.15-3.19] per 1000 AGEs). Rookie athletes demonstrated higher RR compared with veterans across multiple regions of the body (ankle: 1.32; 95% CI, 1.12 to 1.52; foot/toe: 1.29; 95% CI, 0.97 to 1.61; shoulder/arm/elbow: 1.43; 95% CI, 1.10 to 1.77; head/neck: 1.21; 95% CI, 0.61 to 1.81; concussions: 2.39; 95% CI, 1.89 to 2.90; illness: 1.14; 95% CI, 0.87 to 1.40), and demonstrated a higher rate of initial injuries compared with veteran players (1.41; 95% CI, 1.29 to 1.53). Players who sustained an injury rookie season demonstrated an unadjusted decrease in total seasons played (-0.4 [95% CI, -0.5 to -0.3] log years; P < .001), but this decrease was not observed within adjusted analysis (0.1 [95% CI, -0.1 to 0.2] log years; P = .36). Conclusions and Relevance In this study, rookie athletes demonstrated the highest injury incidence at the ankle and increased RR across multiple regions. These findings may reflect differences in preseason conditioning or load variables impacting rookie athletes and warrant further investigation. Future research is needed to determine the association of cumulative injury burden vs a singular injury event on career longevity. This cohort study compares the incidence and rate ratio of injury and illness among rookie professional basketball players with veteran players and explores the association of sustaining an injury rookie season with career longevity. Question What is the rate ratio (RR) of injury and illness among rookie and veteran professional basketball players, and is sustaining an injury during the rookie season associated with career longevity? Findings In this cohort study of 904 professional basketball players, rookies demonstrated higher RRs of injury across multiple categories. Those who sustained an injury during their rookie season did not demonstrate a significant difference in total seasons played. Meaning In this study, rookie athletes demonstrated unique RR profiles compared with veterans, but singular injury occurrence during rookie season was not associated with career longevity; these findings suggest a need to investigate cumulative injury burden and the association with career longevity.	[Martin, Chelsea L.] ATI Phys Therapy, 200 Patewood Dr,C250, Greenville, SC 29615 USA; [Arundale, Amelia J. H.] Icahn Sch Med Mt Sinai Hlth Syst, New York, NY USA; [Arundale, Amelia J. H.] Red Bull GmBH, Red Bull Athlete Performance Ctr, Thalgau, Austria; [Kluzek, Stefan; Bullock, Garrett S.] Univ Oxford, Ctr Sport Exercise & Osteoarthrit Res Versus Arth, Oxford, England; [Kluzek, Stefan; Bullock, Garrett S.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Kluzek, Stefan] Univ Nottingham, Nottingham, England; [Ferguson, Tyler] Univ Oxford, Big Data Inst, Oxford, England; [Collins, Gary S.] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Collins, Gary S.] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Bullock, Garrett S.] Wake Forest Sch Med, Dept Orthopaed Surg, Winston Salem, NC 27101 USA		Martin, CL (corresponding author), ATI Phys Therapy, 200 Patewood Dr,C250, Greenville, SC 29615 USA.	cleonard@elon.edu	Collins, Gary S/A-2258-2014	Collins, Gary S/0000-0002-2772-2316; Kluzek, Stefan/0000-0002-0696-7541			Alfonso F., 2017, CARDIOLOGIA CROATICA, V12, P264, DOI [10.15836/ccar2017.264, DOI 10.15836/CCAR2017.264]; Arundale AJH, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967117750825; Bahr R, 2018, BRIT J SPORT MED, V52, P1018, DOI 10.1136/bjsports-2017-098160; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Basketball Reference, BASK STATS HIST; Bell DR, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0657; Bertagnolli MM, 2017, NEW ENGL J MED, V376, P1178, DOI 10.1056/NEJMsb1702054; Brown KA, 2017, TRANSL PEDIATR, V6, P150, DOI 10.21037/tp.2017.04.03; Cai H, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2956-7; Deitch JR, 2006, AM J SPORT MED, V34, P1077, DOI 10.1177/0363546505285383; Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068; Drakos MC, 2010, SPORTS HEALTH, V2, P284, DOI 10.1177/1941738109357303; Fuller CW, 2006, SCAND J MED SCI SPOR, V16, P83, DOI 10.1111/j.1600-0838.2006.00528.x; Gans I, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118777823; Gatorade Sports Science Institute, GAME BASK; Groothuis PA, 2007, J SPORT ECON, V8, P223, DOI 10.1177/1527002505281228; Hagglund M, 2005, BRIT J SPORT MED, V39, P340, DOI 10.1136/bjsm.2005.018267; Hainline B, 2017, BRIT J SPORT MED, V51, P1245, DOI 10.1136/bjsports-2017-097884; Hertel J, 2002, J ATHL TRAINING, V37, P364; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kester BS, 2017, KNEE SURG SPORT TR A, V25, P3031, DOI 10.1007/s00167-016-4060-y; Khan M, 2018, SPORTS HEALTH, V10, P169, DOI 10.1177/1941738117738988; KUJALA UM, 1994, BRIT MED J, V308, P231, DOI 10.1136/bmj.308.6923.231; Landers RN, 2016, PSYCHOL METHODS, V21, P475, DOI 10.1037/met0000081; Lisman P, 2013, MED SCI SPORT EXER, V45, P636, DOI 10.1249/MSS.0b013e31827a1c4c; Meeuwisse WH, 2007, CLIN J SPORT MED, V17, P215; Moxley JH, 2015, PSYCHOL SPORT EXERC, V16, P128, DOI 10.1016/j.psychsport.2014.07.003; National Basketball Association, NBA ADV STATS; Oki Noffisat O, 2016, Curr Environ Health Rep, V3, P53, DOI 10.1007/s40572-016-0079-y; Opar DA, 2012, SPORTS MED, V42, P209, DOI 10.2165/11594800-000000000-00000; Orchard J., 2001, INT SPORT MED J, V2, P1; Patel BH, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119854199; Pro Sports Transactions, BASKETBALL; Reinking MF, 2016, INT J SPORTS PHYS TH, V11, P854; Riva D, 2016, J STRENGTH COND RES, V30, P461, DOI 10.1519/JSC.0000000000001097; Rogalski B, 2013, J SCI MED SPORT, V16, P499, DOI 10.1016/j.jsams.2012.12.004; Smith S., WHAT IS REAL COST IN; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wang D, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118813083	39	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	OCT 4	2021	4	10							e2128199	10.1001/jamanetworkopen.2021.28199			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WD3QV	WOS:000704860500009	34605914	gold, Green Published			2022-02-06	
J	Norman, EM; Starkey, NJ; Polaschek, DLL				Norman, Emily M.; Starkey, Nicola J.; Polaschek, Devon L. L.			The association between self-reported traumatic brain injury, neuropsychological function, and compliance among people serving community sentences	BRAIN IMPAIRMENT			English	Article; Early Access						Offenders; Probation; Community sentence; Recidivism; Compliance; Neuropsychological assessment	PRISON POPULATION PREVALENCE; ANTISOCIAL-BEHAVIOR; REPEATABLE BATTERY; STATUS RBANS; IMPACT; RECIDIVISM; ATTENTION; DEFICITS; PROFILE; MEMORY	Background: Traumatic brain injury is overrepresented in incarcerated samples and has been linked to a number of poor correctional outcomes. Despite this, no research has explored the impact of a recent TBI on compliance outcomes for individuals serving community-based. Method: We screened for a history of TBI in 106 adults on community sentences and collected compliance (arrests, sentence violations) and related variables (e.g., risk scores, substance use) over 6 months. Sixty-four participants also completed the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), the Comprehensive Trail Making Test and Color-Word Inference Test. Results: A TBI in the last year predicted a significantly higher likelihood of arrest, even when controlling for risk of reconviction and current substance use, but was not associated with non-compliance with sentence conditions nor with performance on the neuropsychological tests. In addition, no significant associations were found between performance on neuropsychological tests and measures of non-compliance. Conclusions: TBI in the last year was an independent predictor of arrest. This result suggests that those with a recent TBI on a community sentence may need additional monitoring or support to reduce the risk of reoffending.	[Norman, Emily M.; Starkey, Nicola J.; Polaschek, Devon L. L.] Univ Waikato, Fac Arts & Social Sci, Hamilton, New Zealand		Norman, EM (corresponding author), Univ Waikato, Fac Arts & Social Sci, Hamilton, New Zealand.	emacdona2000@yahoo.com			University of Waikato Doctoral Scholarship	This work was supported by the University of Waikato Doctoral Scholarship.	Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Andrews D.A., 2000, LEVEL SERVICE CASE M; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Baillargeon J, 2010, ADM POLICY MENT HLTH, V37, P367, DOI 10.1007/s10488-009-0252-9; Bakker L.W., 1999, ROC RISK RECONVICTIO; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; Bonta J., 2007, 20070 PUBL SAF, V6, P1; Bonta J., 2016, PSYCHOL CRIMINAL CON; Bottoms A., 2001, COMMUNITY PENALTIES, P87; Cohen J., 2013, STAT POWER ANAL BEHA; Cornet LJM, 2015, J CRIM JUST, V43, P122, DOI 10.1016/j.jcrimjus.2015.02.003; Corporation A. C, 2017, TRAUMATIC BRAIN INJU; Corrections N.Z.D., 2016, COMMUNITY SENTENCES; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Delis DC., 2001, DELIS KAPLAN EXECUTI; DeLisi M, 2021, INT J OFFENDER THER, V65, P1536, DOI 10.1177/0306624X21992681; Demark J, 2002, BRAIN INJURY, V16, P91, DOI 10.1080/02699050110102059; Dolan M, 2004, J FORENSIC PSYCHI PS, V15, P426, DOI 10.1080/14789940410001721048; Durand E, 2017, ANN PHYS REHABIL MED, V60, P95, DOI 10.1016/j.rehab.2017.02.003; Ellwart T, 2003, DEPRESS ANXIETY, V17, P197, DOI 10.1002/da.10102; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Field A, 2013, DISCOVERING STAT USI; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Green P., 1996, MANUAL COMPUTERISED; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; LaDuke C, 2017, ARCH CLIN NEUROPSYCH, V32, P929, DOI 10.1093/arclin/acx042; Lam M, 2013, PSYCHOL ASSESSMENT, V25, P61, DOI 10.1037/a0030548; LaVigne M., 2011, UC DAVIS J INT LAW P, V15, P37; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Malarbi S, 2017, NEUROSCI BIOBEHAV R, V72, P68, DOI 10.1016/j.neubiorev.2016.11.004; Matheson FI, 2020, BRAIN INJURY, V34, P757, DOI 10.1080/02699052.2020.1753114; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mcmurran M, 2007, PSYCHOL CRIME LAW, V13, P333, DOI 10.1080/10683160601060374; Mitchell T, 2017, NEUROEPIDEMIOLOGY, V48, P164, DOI 10.1159/000479520; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Nagele D, 2018, J OFFENDER REHABIL, V57, P562, DOI 10.1080/10509674.2018.1549178; Norman EM, 2021, PROBAT J, DOI 10.1177/02645505211041579; O'Rourke C, 2016, BRAIN INJURY, V30, P839, DOI 10.3109/02699052.2016.1146967; Ogden JA, 1997, NEW ZEAL J PSYCHOL, V26, P2; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Perkes I, 2011, BRAIN INJURY, V25, P131, DOI 10.3109/02699052.2010.536193; Piccolino AL, 2014, J CORRECT HEALTH CAR, V20, P203, DOI 10.1177/1078345814530871; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Raine A., 1997, PSYCHOPATHOLOGY CRIM; Ramey T, 2019, CNS SPECTRUMS, V24, P102, DOI 10.1017/S1092852918001426; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Ray B, 2017, CRIM JUSTICE BEHAV, V44, P472, DOI 10.1177/0093854816686631; Ray B, 2014, J FORENSIC SCI, V59, P1248, DOI 10.1111/1556-4029.12466; Ribbers GM, 2007, J HEAD TRAUMA REHAB, V22, P234, DOI 10.1097/01.HTR.0000281839.07968.32; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Seruca T, 2015, J FORENSIC PSYCHI PS, V26, P699, DOI 10.1080/14789949.2015.1054856; Shiroma Eric J, 2010, J Correct Health Care, V16, P273, DOI 10.1177/1078345810378253; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Silver J.M., 2018, TXB TRAUMATIC BRAIN; Sorsby A, 2017, CRIMINOL CRIM JUSTIC, V17, P40, DOI 10.1177/1748895816653992; Stewart LA, 2016, INT J LAW PSYCHIAT, V44, P7, DOI 10.1016/j.ijlp.2015.08.026; Strickland JC, 2021, PSYCHOL REV, V128, P336, DOI 10.1037/rev0000263; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Theadom A, 2015, J NEUROTRAUM, V32, P674, DOI 10.1089/neu.2014.3579; Tuominen T., 2017, J SCANDINAVIAN STUDI, V18, P52; Ugwudike P., 2010, OFFENDER SUPERVISION, P351; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wilson AB, 2011, INT J LAW PSYCHIAT, V34, P264, DOI 10.1016/j.ijlp.2011.07.004; Wong S.C.P., 2000, VIOLENCE RISK SCALE; Woolhouse R, 2018, INT J OFFENDER THER, V62, P3135, DOI 10.1177/0306624X17726519; Yukhnenko D, 2020, CNS SPECTRUMS, V25, P252, DOI 10.1017/S1092852919001056	79	0	0	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.											PII S1443964621000152	10.1017/BrImp.2021.15		OCT 2021	17	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	YJ8UE	WOS:000744802400001					2022-02-06	
J	Simmons, KE; Healey, KL; Li, Q; Moore, SD; Klein, RC				Simmons, Kathryn E.; Healey, Kati L.; Li, Qiang; Moore, Scott D.; Klein, Rebecca C.			Effects of sex and genotype in human APOE-targeted replacement mice on alcohol self-administration measured with the automated IntelliCage system before and after repeated mild traumatic brain injury	ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						alcohol; APOE; IntelliCage; sex differences; traumatic brain injury	APOLIPOPROTEIN-E EPSILON-4; ALZHEIMER-DISEASE; DRINKING; MEMORY; RISK; CONSUMPTION; DEMENTIA; DEFICITS; AGE; E4	Background Few studies have examined the association between APOE genotype and alcohol use. Although some of these studies have reported outcomes associated with a history of drinking, none have examined alcohol-seeking behavior. In addition, no preclinical studies have examined alcohol use as a function of APOE genotype with or without traumatic brain injury. Methods Male and female human APOE3- and APOE4-targeted replacement (TR) mice were used to assess voluntary alcohol seeking longitudinally using a 2-bottle choice paradigm conducted within the automated IntelliCage system prior to and following repeated mild TBI (rmTBI). Following an acquisition phase in which the concentration of ethanol (EtOH) was increased to 12%, a variety of drinking paradigms that included extended alcohol access (EAA1 and EAA2), alcohol deprivation effect (ADE), limited access drinking in the dark (DID), and progressive ratio (PR) were used to assess alcohol-seeking behavior. Additional behavioral tasks were performed to measure cognitive function and anxiety-like behavior. Results All groups readily consumed increasing concentrations of EtOH (4-12%) during the acquisition phase. During the EAA1 period (12% EtOH), there was a significant genotype effect in both males and females for EtOH preference. Following a 3-week abstinence period, mice received sham or rmTBI resulting in a genotype- and sex-independent main effect of rmTBI on the recovery of righting reflex and a main effect of rmTBI on spontaneous home-cage activity in females only. Reintroduction of 12% EtOH (EAA2) resulted in a significant effect genotype for alcohol preference in males with APOE4 mice displaying increased preference and motivation for alcohol compared with APOE3 mice independent of TBI while in females, there was a significant genotype x TBI interaction under the ADE and DID paradigms. Finally, there was a main effect of rmTBI on increased risk-seeking behavior in both sexes, but no effect on spatial learning or cognitive flexibility. Conclusion These results suggest that sex and APOE genotype play a significant role in alcohol consumption and may subsequently influence long-term recovery following traumatic brain insults.	[Simmons, Kathryn E.] Duke Univ, Trinity Coll Arts & Sci, Durham, NC USA; [Healey, Kati L.; Li, Qiang; Moore, Scott D.; Klein, Rebecca C.] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; [Moore, Scott D.; Klein, Rebecca C.] Durham Vet Affairs Med Ctr, Durham, NC USA		Klein, RC (corresponding author), Durham VA Med Ctr, 508 Fulton St, Durham, NC 27705 USA.	rebecca.klein@duke.edu			Department of Veterans Affairs, Rehabilitation Research and Development Merit Review AwardUS Department of Veterans Affairs [5I01RX002335]; Biomedical Laboratory Research and Development Merit Review Award [5I01BX001271]; VISN6 Mid-Atlantic Mental Illness Research, Education and Clinical Center	The study received funding from Department of Veterans Affairs, Rehabilitation Research and Development Merit Review Award 5I01RX002335 and Biomedical Laboratory Research and Development Merit Review Award 5I01BX001271; VISN6 Mid-Atlantic Mental Illness Research, Education and Clinical Center.	Altmann A, 2014, ANN NEUROL, V75, P563, DOI 10.1002/ana.24135; Amodeo LR, 2017, ALCOHOL, V59, P43, DOI 10.1016/j.alcohol.2016.12.002; Anttila T, 2004, BMJ-BRIT MED J, V329, P539, DOI 10.1136/bmj.38181.418958.BE; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Berkowitz CL, 2018, JPAD-J PREV ALZHEIM, V5, P245, DOI 10.14283/jpad.2018.35; Bertholomey ML, 2016, PSYCHOPHARMACOLOGY, V233, P2277, DOI 10.1007/s00213-016-4278-x; Bertholomey ML, 2019, PHYSIOL BEHAV, V203, P70, DOI 10.1016/j.physbeh.2017.10.025; Blegen MB, 2018, ALCOHOL, V67, P23, DOI 10.1016/j.alcohol.2017.08.008; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bour A, 2008, BEHAV BRAIN RES, V193, P174, DOI 10.1016/j.bbr.2008.05.008; Carmelli D, 1999, NEUROEPIDEMIOLOGY, V18, P125, DOI 10.1159/000026204; Crabbe JC, 2011, ANN NY ACAD SCI, V1216, P24, DOI 10.1111/j.1749-6632.2010.05895.x; Dere E, 2018, NEUROBIOL LEARN MEM, V150, P136, DOI 10.1016/j.nlm.2018.02.023; Downer B, 2014, ALCOHOL ALCOHOLISM, V49, P17, DOI 10.1093/alcalc/agt144; Dumanis SB, 2013, J NEUROCHEM, V124, P4, DOI 10.1111/j.1471-4159.2012.07908.x; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Fleming RL, 2013, ALCOHOL CLIN EXP RES, V37, P1154, DOI 10.1111/acer.12087; Flory JD, 2000, AM J MED GENET, V96, P707, DOI 10.1002/1096-8628(20001204)96:6<707::AID-AJMG1>3.0.CO;2-V; Griffin WC, 2014, ALCOHOL, V48, P287, DOI 10.1016/j.alcohol.2013.11.006; Grossbard J, 2017, PSYCHIAT SERV, V68, P48, DOI 10.1176/appi.ps.201500290; Holgate JY, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.767; Huo KM, 2012, MOL CELL NEUROSCI, V51, P32, DOI 10.1016/j.mcn.2012.07.002; Kiryk A, 2020, BEHAV BRAIN RES, V388, DOI 10.1016/j.bbr.2020.112620; Kiryk A, 2011, CURR ALZHEIMER RES, V8, P883, DOI 10.2174/156720511798192745; Kivipelto M, 2008, J CELL MOL MED, V12, P2762, DOI 10.1111/j.1582-4934.2008.00296.x; Klein RC, 2010, NEUROSCIENCE, V171, P1265, DOI 10.1016/j.neuroscience.2010.10.027; Klein RC, 2014, NEUROBIOL AGING, V35, P2046, DOI 10.1016/j.neurobiolaging.2014.02.019; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Koskela M, 2018, BEHAV BRAIN RES, V352, P116, DOI 10.1016/j.bbr.2018.03.027; Lipina TV, 2013, NEUROPHARMACOLOGY, V64, P283, DOI 10.1016/j.neuropharm.2012.06.054; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Lopez MF, 2015, PHYSIOL BEHAV, V148, P151, DOI 10.1016/j.physbeh.2014.11.012; Lowing JL, 2014, J NEUROTRAUM, V31, P1700, DOI 10.1089/neu.2013.3286; Lyall DM, 2019, NEUROLOGY, V92, pE2691, DOI 10.1212/WNL.0000000000007551; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; McMurray MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100697; McNamara EH, 2020, EXP NEUROL, V333, DOI 10.1016/j.expneurol.2020.113409; Mechan AO, 2009, J NEUROSCI METH, V180, P43, DOI 10.1016/j.jneumeth.2009.02.018; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mukamal KJ, 2003, JAMA-J AM MED ASSOC, V289, P1405, DOI 10.1001/jama.289.11.1405; Nentwig TB, 2019, ALCOHOL, V79, P93, DOI 10.1016/j.alcohol.2019.01.006; Neu SC, 2017, JAMA NEUROL, V74, P1178, DOI 10.1001/jamaneurol.2017.2188; O'Dell LE, 2004, ALCOHOL CLIN EXP RES, V28, P1676, DOI 10.1097/01.ALC.0000145781.11923.4E; Pagulayan KF, 2016, J NEUROTRAUM, V33, P1390, DOI 10.1089/neu.2015.4071; Panza F, 2009, J ALZHEIMERS DIS, V17, P7, DOI 10.3233/JAD-2009-1009; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Priddy BM, 2017, PHARMACOL BIOCHEM BE, V152, P61, DOI 10.1016/j.pbb.2016.08.001; Radwanska K, 2012, ADDICT BIOL, V17, P601, DOI 10.1111/j.1369-1600.2011.00394.x; Risher ML, 2015, ALCOHOL CLIN EXP RES, V39, P989, DOI 10.1111/acer.12725; Schindler AG, 2021, ALCOHOL CLIN EXP RES, V45, P1051, DOI 10.1111/acer.14605; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; Smutek M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096787; Solfrizzi V, 2009, ARCH NEUROL-CHICAGO, V66, P541, DOI 10.1001/archneurol.2009.35; Spanagel R, 2000, ALCOHOL RES HEALTH, V24, P124; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Vengeliene V, 2014, ALCOHOL, V48, P313, DOI 10.1016/j.alcohol.2014.03.002; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Wilhelm J, 2005, ALCOHOL, V37, P151, DOI 10.1016/j.alcohol.2006.01.002; Younis RM, 2019, PHARMACOL BIOCHEM BE, V184, DOI 10.1016/j.pbb.2019.172740; Yue JK, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.791; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zhu YG, 2012, GLIA, V60, P559, DOI 10.1002/glia.22289; Zilkens RR, 2014, CURR ALZHEIMER RES, V11, P681, DOI 10.2174/1567205011666140812115004	64	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-6008	1530-0277		ALCOHOL CLIN EXP RES	Alcoholism (NY)	NOV	2021	45	11					2231	2245		10.1111/acer.14717		OCT 2021	15	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED)	Substance Abuse	XH6VB	WOS:000703096500001	34585391				2022-02-06	
J	Vychopen, M; Schneider, M; Borger, V; Schuss, P; Behning, C; Vatter, H; Guresir, E				Vychopen, Martin; Schneider, Matthias; Borger, Valeri; Schuss, Patrick; Behning, Charlotte; Vatter, Hartmut; Gueresir, Erdem			Complete hemispheric exposure vs. superior sagittal sinus sparing craniectomy: incidence of shear-bleeding and shunt-dependency	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Decompressive hemicraniectomy; Size; Shear-bleeding	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; HEMICRANIECTOMY; COMPLICATIONS; MULTICENTER; CONTUSIONS; INFARCTION; SIZE	Purpose Decompressive hemicraniectomy (DC) has been established as a standard therapeutical procedure for raised intracranial pressure. However, the size of the DC remains unspecified. The aim of this study was to analyze size related complications following DC. Methods Between 2013 and 2019, 306 patients underwent DC for elevated intracranial pressure at author ' s institution. Anteroposterior and craniocaudal DC size was measured according to the postoperative CT scans. Patients were divided into two groups with (1) exposed superior sagittal sinus (SE) and (2) without superior sagittal sinus exposure (SC). DC related complications e.g. shear-bleeding at the margins of craniectomy and secondary hydrocephalus were evaluated and compared. Results Craniectomy size according to anteroposterior diameter and surface was larger in the SE group; 14.1 +/- 1 cm vs. 13.7 +/- 1.2 cm, p = 0.003, resp. 222.5 +/- 40 cm(2) vs. 182.7 +/- 36.9 cm(2), p < 0.0001. The SE group had significantly lower rates of shear-bleeding: 20/176 patients; (11%), compared to patients of the SC group; 36/130 patients (27%), p = 0.0003, OR 2.9, 95% CI 1.6-5.5. There was no significant difference in the incidence of shunt-dependent hydrocephalus; 19/130 patients (14.6%) vs. 24/176 patients (13.6%), p = 0.9. Conclusions Complete hemispheric exposure in terms of DC with SE was associated with significantly lower levels of iatrogenic shear-bleedings compared to a SC-surgical regime. Although we did not find significant outcome difference, our findings suggest aggressive craniectomy regimes including SE to constitute the surgical treatment strategy of choice for malignant intracranial pressure.	[Vychopen, Martin; Schneider, Matthias; Borger, Valeri; Schuss, Patrick; Vatter, Hartmut; Gueresir, Erdem] Univ Hosp Bonn, Dept Neurosurg, Venusberg Campus 1, D-53127 Bonn, Germany; [Behning, Charlotte] Univ Bonn, Inst Fin Med Biometrie Informat & Epidemiol IMBIE, Dept Med Biometry Informat & Epidemiol, Bonn, Germany		Vychopen, M (corresponding author), Univ Hosp Bonn, Dept Neurosurg, Venusberg Campus 1, D-53127 Bonn, Germany.	martin.vychopen@gmail.com; matthias.schneider@ukbonn.de; valeri.borger@ukbonn.de; patrick.schuss@ukbonn.de; behning@imbie.uni-bonn.de; hartmut.vatter@ukbonn.de; erdem.gueresir@ukbonn.de	Guresir, Erdem/AAV-7224-2021; Schuss, Patrick/ABC-6469-2020	Guresir, Erdem/0000-0001-8319-0847; Schuss, Patrick/0000-0002-5806-2576; Vychopen, Martin/0000-0002-1794-0387	Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL. There are no financial conflicts of interest to disclose.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Akins PT, 2019, WORLD NEUROSURG, V130, pE941, DOI 10.1016/j.wneu.2019.07.041; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cepeda S, 2020, J NEUROSURG, V132, P1623, DOI 10.3171/2019.2.JNS182025; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Fattahian Reza, 2018, Med Arch, V72, P214, DOI 10.5455/medarh.2018.72.214-219; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Fung C, 2012, STROKE, V43, P3207, DOI 10.1161/STROKEAHA.112.666537; Gao CP, 2008, ACTA NEUROCHIR SUPPL, V102, P279, DOI 10.1007/978-3-211-85578-2_52; Goedemans T, 2017, WORLD NEUROSURG, V105, P765, DOI 10.1016/j.wneu.2017.06.069; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; Hanko M, 2021, EUR J TRAUMA EMERG S, V47, P1635, DOI 10.1007/s00068-020-01367-4; Ho MY, 2018, INT J BIOMED IMAGING, V2018, DOI 10.1155/2018/5237693; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Lee MH, 2012, CLIN NEUROL NEUROSUR, V114, P555, DOI 10.1016/j.clineuro.2011.11.027; Moussa WMM, 2017, NEUROSURG REV, V40, P115, DOI 10.1007/s10143-016-0743-6; Reid P, 2018, WORLD NEUROSURG, V119, pE922, DOI 10.1016/j.wneu.2018.08.005; Sedney CL, 2014, J NEUROSCI RURAL PRA, V5, P212, DOI 10.4103/0976-3147.133555; Sturiale CL, 2012, J NEUROTRAUM, V29, P2723, DOI 10.1089/neu.2012.2556; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yamada S, 2012, J STROKE CEREBROVASC, V21, P493, DOI 10.1016/j.jstrokecerebrovasdis.2010.11.010; Yang X-J, 2003, CHIN J TRAUMATOL	27	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-021-01789-8		OCT 2021	9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	WB1TF	WOS:000703361100002	34605961	hybrid			2022-02-06	
J	Cohen, D; Bhushan, B; Hanks, R; Yoon, DP; Johnstone, B; Holliday, G; Grover, A				Cohen, Daniel; Bhushan, Braj; Hanks, Robin; Yoon, Dong Pil; Johnstone, Brick; Holliday, Greyson; Grover, Anita			Examining Cultural, Ethnic, and Religious Differences with the Brief Multidimensional Measure of Religiousness and Spirituality in the US and India	JOURNAL OF RELIGION & HEALTH			English	Article; Early Access						BMMRS; Religion; Culture; Ethnicity	HEALTH RESEARCH; INVOLVEMENT; DIMENSIONS; SUPPORT; SAMPLE	The Brief Multidimensional Measure of Religiousness/Spirituality (BMMRS) is regularly used to measure spirituality and religiosity in U.S. Christian populations, although it has not been used for making comparisons with non-Western groups. This study compared BMMRS results for 109 individuals (60 in the U.S. and 49 in India) with traumatic brain injury (TBI) from different cultures (U.S., India), ethnic groups (African American, Caucasian, South Asian), and religions (Christian, Hindu, Muslim). In general, the results indicated that U.S. African Americans and Christians reported being the most spiritual, South Asians and Hindus the least. Groups differed significantly in self-reported spiritual experiences, but less in frequency of religious activities. Results suggest using caution when applying Western-based measures of religion and spirituality in non-Western, non-Christian populations.	[Cohen, Daniel] Univ Missouri, Dept Class Archeol & Relig, 205 Swallow Hall, Columbia, MO 65211 USA; [Bhushan, Braj] Indian Inst Technol Kanpur, Dept Humanities & Social Sci, Kanpur, Uttar Pradesh, India; [Hanks, Robin] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA; [Yoon, Dong Pil] Univ Missouri, Sch Social Work, Columbia, MO 65211 USA; [Johnstone, Brick; Holliday, Greyson] Univ Missouri, Dept Hlth Psychol, Columbia, MO 65211 USA		Cohen, D (corresponding author), Univ Missouri, Dept Class Archeol & Relig, 205 Swallow Hall, Columbia, MO 65211 USA.	cohenda@missouri.edu			Mizzou Advantage from the University of Missouri	This study was funded by Mizzou Advantage from the University of Missouri. The authors wish to acknowledge the help of Jayanta Verma who assisted in translations.	Adelson N., 2000, BEING ALIVE WELL HLT; Ando M, 2009, J PALLIAT MED, V12, P1091, DOI 10.1089/jpm.2009.0143; BERGER PL, 1973, SOCIAL REALITY RELIG; Bodling A, 2013, INT J THER REHABIL, V20, P72, DOI 10.12968/ijtr.2013.20.2.72; CHATTERS LM, 1992, J GERONTOL, V47, pS269, DOI 10.1093/geronj/47.6.S269; Cox D., 2014, PUBLIC RELIG RES I, V2, P57; Deb S, 2016, J RELIG HEALTH, V55, P1623, DOI 10.1007/s10943-016-0207-x; Eyer JC, 2018, J RELIG HEALTH, V57, P883, DOI 10.1007/s10943-017-0444-7; Fetzer Institute National Institute on Aging Working Group, 1999, MULT MEAS REL SPIR U; Fitzgerald Timothy, 2000, IDEOLOGY RELIG STUDI; Gries P, 2012, J SCI STUD RELIG, V51, P623, DOI 10.1111/j.1468-5906.2012.01683.x; Idler EL, 2003, RES AGING, V25, P327, DOI 10.1177/0164027503025004001; Johnstone B, 2016, J RELIG HEALTH, V55, P572, DOI 10.1007/s10943-015-0170-y; Johnstone B, 2012, J RELIG HEALTH, V51, P1017, DOI 10.1007/s10943-012-9615-8; Johnstone B, 2012, J RELIG HEALTH, V51, P529, DOI 10.1007/s10943-011-9538-9; Johnstone B, 2009, J RELIG HEALTH, V48, P146, DOI 10.1007/s10943-008-9179-9; Kakounda-Moullem H, 2020, J RELIG HEALTH, V59, P1766, DOI 10.1007/s10943-019-00871-1; Kim NY, 2015, COMPR PSYCHIAT, V60, P26, DOI 10.1016/j.comppsych.2015.04.009; Koenig HG, 2021, J RELIG HEALTH, V60, P3467, DOI 10.1007/s10943-021-01373-9; Leach MM., 2001, RES SOCIAL SCI STUDY, V12, P207; LEVIN JS, 1995, SOCIOL QUART, V36, P157, DOI 10.1111/j.1533-8525.1995.tb02325.x; MacDonald DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117701; MADAN TN, 1987, J ASIAN STUD, V46, P747, DOI 10.2307/2057100; Mokuau N, 2001, Pac Health Dialog, V8, P407; Musick MA, 2000, J ADULT DEV, V7, P73, DOI 10.1023/A:1009523722920; Neff JA, 2006, J SCI STUD RELIG, V45, P449, DOI 10.1111/j.1468-5906.2006.00318.x; Pargament K., 1997, PSYCHOL RELIG COPING; Piedmont RL, 2002, AM BEHAV SCI, V45, P1888; Piedmont RL., 2007, RES SOCIAL SCI STUDY, V17, P177; Roth DL, 2012, J RELIG HEALTH, V51, P567, DOI 10.1007/s10943-011-9475-7; Singh K, 2020, J RELIG HEALTH, V59, P2753, DOI 10.1007/s10943-019-00877-9; Stewart C., 2006, INT J PSYCHOL RELIG, V16, P181, DOI [DOI 10.1207/S15327582IJPR1603_3, 10.1207/s15327582ijpr1603_3]; Szaflarski M, 2012, J RELIG HEALTH, V51, P1239, DOI 10.1007/s10943-010-9433-9; TAYLOR RJ, 1999, J BLACK PSYCHOL, V0025; Traphagan J, 2005, RES AGING, V27, P387, DOI 10.1177/0164027505275193; Vespa A, 2017, J RELIG HEALTH, V56, P907, DOI 10.1007/s10943-016-0285-9	36	0	0	2	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0022-4197	1573-6571		J RELIG HEALTH	J. Relig. Health												10.1007/s10943-021-01433-0		OCT 2021	15	Public, Environmental & Occupational Health; Religion	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Public, Environmental & Occupational Health; Religion	WA3NH	WOS:000702795300001	34599709				2022-02-06	
J	Krueger, EM; DiGiorgio, AM; Jagid, J; Cordeiro, JG; Farhat, H				Krueger, Evan M.; DiGiorgio, Anthony M.; Jagid, Jonathan; Cordeiro, Joacir G.; Farhat, Hamad			Current Trends in Mild Traumatic Brain Injury	CUREUS JOURNAL OF MEDICAL SCIENCE			English	Article						covid-19; prognosis; concussion; hemorrhage; mild traumatic brain injury	TRANSFORMING RESEARCH; COMPUTED-TOMOGRAPHY; CLINICAL KNOWLEDGE; ELDERLY-PATIENTS; MANAGEMENT; HEMORRHAGE; IMPACT; RISK	In this review, we provide an overview of the current research and treatment of all types of traumatic brain injury (TBI) before illustrating the need for improved care specific to mild TBI patients. Contemporary issues pertaining to acute care of mild TBI including prognostication, neurosurgical intervention, repeat radiographic imaging, reversal of antiplatelet and anticoagulation medications, and cost savings initiatives are reviewed. Lastly, the effect of COVID-19 on TBI is addressed.	[Krueger, Evan M.] Carle Fdn Hosp, Neurol Surg, Urbana, IL 61801 USA; [DiGiorgio, Anthony M.] Univ Calif San Francisco, Neurol Surg, San Francisco, CA 94143 USA; [Jagid, Jonathan; Cordeiro, Joacir G.] Univ Miami, Neurol Surg, Coral Gables, FL 33124 USA; [Farhat, Hamad] Advocate Aurora Hlth Care, Neurol Surg, Downers Grove, IL USA		Krueger, EM (corresponding author), Carle Fdn Hosp, Neurol Surg, Urbana, IL 61801 USA.	dr.evankrueger@gmail.com					Al-Mufti F, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17431; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; [Anonymous], 2018, BRAIN OXYGEN OPTIMIZ; [Anonymous], 2020, ACUTE CARE NEUROSURG; [Anonymous], 2014, PROTOCOL 14PRT 6944; [Anonymous], 2015, C TRAUM BRAIN INJ EP; [Anonymous], 2016, RATES TBI RELATED EM; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Burke JF, 2020, NEUROSURGERY, V87, pE50, DOI 10.1093/neuros/nyaa116; Campbell-Sills L, 2021, J HEAD TRAUMA REHAB, V36, pE30, DOI 10.1097/HTR.0000000000000602; Cap AP, 2019, LANCET, V394, P1687, DOI 10.1016/S0140-6736(19)32312-8; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Ditty BJ, 2015, J NEUROSURG, V123, P649, DOI 10.3171/2014.10.JNS132713; Fakhry SM, 2021, J TRAUMA ACUTE CARE, V90, P215, DOI 10.1097/TA.0000000000002985; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Greuter L, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19546; Hawryluk GWJ, 2020, NEUROSURGERY, V87, P427, DOI 10.1093/neuros/nyaa278; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Huie JR, 2019, J NEUROTRAUM, V36, P100, DOI 10.1089/neu.2017.5449; Jehan F, 2019, J SURG RES, V236, P224, DOI 10.1016/j.jss.2018.11.050; Joseph B, 2015, JAMA SURG, V150, P866, DOI 10.1001/jamasurg.2015.1134; Kan P, 2021, NEUROSURGERY, V88, P268, DOI 10.1093/neuros/nyaa379; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Krueger EM, 2019, CUREUS, V11, DOI 10.7759/cureus.5982; Link TW, 2019, NEUROSURGERY, V85, P801, DOI 10.1093/neuros/nyy521; Manivannan S, 2021, BRAIN INJURY, V35, P957, DOI 10.1080/02699052.2021.1934731; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; McCrea MA, 2021, JAMA NEUROL, V78, P982, DOI 10.1001/jamaneurol.2021.2043; Nassiri F, 2017, J TRAUMA ACUTE CARE, V83, P725, DOI 10.1097/TA.0000000000001617; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Okonkwo DO, 2020, J NEUROTRAUM, V37, P2460, DOI 10.1089/neu.2020.7140; Prexl O, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0487-0; Puffer RC, 2019, WORLD NEUROSURG, V125, pE909, DOI 10.1016/j.wneu.2019.01.207; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stippler M, 2021, NEUROSURGERY, V88, P773, DOI 10.1093/neuros/nyaa504; Takayama W, 2020, J TRAUMA ACUTE CARE, V89, P523, DOI 10.1097/TA.0000000000002796; Ullman JS, 2016, JAMA SURG, V151, P199, DOI 10.1001/jamasurg.2015.3642; Wang KKW, 2021, ACUTE MED SURG, V8, DOI 10.1002/ams2.622; Yue John K, 2021, J Concussion, V5, DOI 10.1177/20597002211007271; Yue JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00343; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2021, JAMA NEUROL, V78, P1137, DOI 10.1001/jamaneurol.2021.2120; Yun BJ, 2018, ACAD EMERG MED, V25, P769, DOI 10.1111/acem.13350	49	0	0	3	3	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS J MED SCIENCE	Cureus J Med Sci	OCT 2	2021	13	10							e18434	10.7759/cureus.18434			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WD5BE	WOS:000704955100017	34737902	Green Published, gold			2022-02-06	
